![J.P. Nolan et al. / Resuscitation 81 (2010) 1219–1276 1223
The International Consensus on Cardiopulmonary with the science in the consensus document, but will also con-
Science sider geographic, economic and system differences in practice,
and the availability of medical devices and drugs. These 2010
The International Liaison Committee on Resuscitation (ILCOR) ERC Resuscitation Guidelines are derived from the 2010 CoSTR
includes representatives from the American Heart Association document but represent consensus among members of the ERC
(AHA), the European Resuscitation Council (ERC), the Heart and Executive Committee. The ERC Executive Committee considers
Stroke Foundation of Canada (HSFC), the Australian and New these new recommendations to be the most effective and easily
Zealand Committee on Resuscitation (ANZCOR), Resuscitation learned interventions that can be supported by current knowl-
Council of Southern Africa (RCSA), the Inter-American Heart Foun- edge, research and experience. Inevitably, even within Europe,
dation (IAHF), and the Resuscitation Council of Asia (RCA). Since differences in the availability of drugs, equipment, and person-
2000, researchers from the ILCOR member councils have evalu- nel will necessitate local, regional and national adaptation of these
ated resuscitation science in 5-yearly cycles. The conclusions and guidelines. Many of the recommendations made in the ERC Guide-
recommendations of the 2005 International Consensus Conference lines 2005 remain unchanged in 2010, either because no new
on Cardiopulmonary Resuscitation and Emergency Cardiovascular studies have been published or because new evidence since 2005
Care With Treatment Recommendations were published at the end has merely strengthened the evidence that was already avail-
of 2005.37,38 The most recent International Consensus Conference able.
was held in Dallas in February 2010 and the published conclusions
and recommendations from this process form the basis of these
2010 ERC Guidelines.2 Conflict of interest policy for the 2010 ERC Guidelines
Each of the six ILCOR task forces [basic life support (BLS);
advanced life support (ALS); acute coronary syndromes (ACS); All authors of these 2010 ERC Resuscitation Guidelines have
paediatric life support (PLS); neonatal life support (NLS); and edu- signed COI declarations (Appendix B).
cation, implementation and teams (EIT)] identified topics requiring
evidence evaluation and invited international experts to review
them. The literature reviews followed a standardised ‘worksheet’ The Chain of Survival
template including a specifically designed grading system to define
the level of evidence of each study.39 When possible, two expert The actions linking the victim of sudden cardiac arrest with sur-
reviewers were invited to undertake independent evaluations for vival are called the Chain of Survival (Fig. 1.1). The first link of this
each topic. The 2010 International Consensus Conference involved chain indicates the importance of recognising those at risk of car-
313 experts from 30 countries. During the 3 years leading up diac arrest and calling for help in the hope that early treatment
to this conference, 356 worksheet authors reviewed thousands can prevent arrest. The central links depict the integration of CPR
of relevant, peer-reviewed publications to address 277 specific and defibrillation as the fundamental components of early resus-
resuscitation questions, each in standard PICO (Population, Inter- citation in an attempt to restore life. Immediate CPR can double or
vention, Comparison Outcome) format.2 Each science statement triple survival from VF OHCA.42–45 Performing chest-compression-
summarised the experts’ interpretation of all relevant data on a spe- only CPR is better than giving no CPR at all.46,47 Following VF OHCA,
cific topic and consensus draft treatment recommendations were cardiopulmonary resuscitation plus defibrillation within 3–5 min
added by the relevant ILCOR task force. Final wording of science of collapse can produce survival rates as high as 49–75%.48–55 Each
statements and treatment recommendations was completed after minute of delay before defibrillation reduces the probability of sur-
further review by ILCOR member organisations and the editorial vival to discharge by 10–12%.42,56 The final link in the Chain of
board.2 Survival, effective post-resuscitation care, is targeted at preserving
The comprehensive conflict of interest (COI) policy that was function, particularly of the brain and heart. In hospital, the impor-
created for the 2005 International Consensus Conference40 was tance of early recognition of the critically ill patient and activation
revised for 2010.41 Representatives of manufacturers and industry of a medical emergency or rapid response team, with treatment
did not participate in either of the 2005 and the 2010 conferences. aimed at preventing cardiac arrest, is now well accepted.6 Over the
last few years, the importance of the post-cardiac arrest phase of
From science to guidelines treatment, depicted in the fourth ring of the Chain of Survival, has
been increasingly recognised.3 Differences in post-cardiac arrest
As in 2005, the resuscitation organisations forming ILCOR will treatment may account for some of the inter-hospital variability in
publish individual resuscitation guidelines that are consistent outcome after cardiac arrest.57–63
Fig. 1.1. Chain of Survival.](https://image.slidesharecdn.com/fullerc2010guidelines1-101018011940-phpapp02/85/RCP-2010-guidelines-5-320.jpg)
![1240 J.P. Nolan et al. / Resuscitation 81 (2010) 1219–1276
the use of induced hypothermia in comatose survivors of out-of- Biochemical markers
hospital cardiac arrest caused by VF. One randomised trial355 and a Evidence does not support the use of serum (e.g., neuronal spe-
pseudo-randomised trial356 demonstrated improved neurological cific enolase, S100 protein) or CSF biomarkers alone as predictors
outcome at hospital discharge or at 6 months in comatose patients of poor outcomes in comatose patients after cardiac arrest with or
after out-of-hospital VF cardiac arrest. Cooling was initiated within without treatment with therapeutic hypothermia (TH). Limitations
minutes to hours after ROSC and a temperature range of 32–34 ◦ C included small numbers of patients studied and/or inconsistency in
was maintained for 12–24 h. Extrapolation of these data to other cut-off values for predicting poor outcome.
cardiac arrests (e.g., other initial rhythms, in-hospital arrests, pae-
diatric patients) seems reasonable but is supported by only lower Electrophysiological studies
level data.317,357–363 No electrophysiological study reliably predicts outcome of a
The practical application of therapeutic hypothermia is divided comatose patient within the first 24 h after cardiac arrest. If
into three phases: induction, maintenance, and rewarming.364 Ani- somatosensory evoked potentials (SSEP) are measured after 24 h
mal data indicate that earlier cooling after ROSC produces better in comatose cardiac arrest survivors not treated with therapeu-
outcomes.365 External and/or internal cooling techniques can be tic hypothermia, bilateral absence of the N20 cortical response to
used to initiate cooling. An infusion of 30 ml kg−1 of 4 ◦ C saline or median nerve stimulation predicts poor outcome (death or CPC 3
Hartmann’s solution decreases core temperature by approximately or 4) with a FPR of 0.7% (95% CI: 0.1–3.7%).376
1.5 ◦ C. Other methods of inducing and/or maintaining hypothermia
include: simple ice packs and/or wet towels; cooling blankets or Imaging studies
pads; water or air circulating blankets; water circulating gel-coated Many imaging modalities (magnetic resonance imaging [MRI],
pads; intravascular heat exchanger; and cardiopulmonary bypass. computed tomography [CT], single photon emission com-
In the maintenance phase, a cooling method with effective puted tomography [SPECT], cerebral angiography, transcranial
temperature monitoring that avoids temperature fluctuations is Doppler, nuclear medicine, near infra-red spectroscopy [NIRS])
preferred. This is best achieved with external or internal cooling have been studied to determine their utility for prediction
devices that include continuous temperature feedback to achieve a of outcome in adult cardiac arrest survivors.15 There are
set target temperature. Plasma electrolyte concentrations, effective no high-level studies that support the use of any imaging
intravascular volume and metabolic rate can change rapidly dur- modality to predict outcome of comatose cardiac arrest sur-
ing rewarming, as they do during cooling. Thus, rewarming must be vivors.
achieved slowly: the optimal rate is not known, but the consensus
is currently about 0.25–0.5 ◦ C of warming per hour.362 Impact of therapeutic hypothermia on prognostication
The well-recognised physiological effects of hypothermia need There is inadequate evidence to recommend a specific approach
to be managed carefully.364 to prognosticating poor outcome in post-cardiac arrest patients
treated with therapeutic hypothermia. There are no clinical neuro-
logical signs, electrophysiological studies, biomarkers, or imaging
Prognostication
modalities that can reliably predict neurological outcome in the
first 24 h after cardiac arrest. Based on limited available evidence,
Two-thirds of those dying after admission to ICU following out-
potentially reliable prognosticators of poor outcome in patients
of-hospital cardiac arrest die from neurological injury; this has been
treated with therapeutic hypothermia after cardiac arrest include
shown both with227 and without305 therapeutic hypothermia. A
bilateral absence of N20 peak on SSEP ≥24 h after cardiac arrest
quarter of those dying after admission to ICU following in-hospital
(FPR 0%, 95% CI 0–69%) and the absence of both corneal and pupil-
cardiac arrest die from neurological injury. A means of predicting
lary reflexes 3 or more days after cardiac arrest (FPR 0%, 95% CI
neurological outcome that can be applied to individual patients
0–48%).368,377 Limited available evidence also suggests that a Glas-
immediately after ROSC is required. Many studies have focused on
gow Motor Score of 2 or less at 3 days post-ROSC (FPR 14% [95% CI
prediction of poor long-term outcome (vegetative state or death),
3–44%])368 and the presence of status epilepticus (FPR of 7% [95%
based on clinical or test findings that indicate irreversible brain
CI 1–25%] to 11.5% [95% CI 3–31%])378,379 are potentially unreliable
injury, to enable clinicians to limit care or withdraw organ sup-
prognosticators of poor outcome in post-cardiac arrest patients
port. The implications of these prognostic tests are such that they
treated with therapeutic hypothermia. Given the limited available
should have 100% specificity or zero false positive rate (FPR), i.e.,
evidence, decisions to limit care should not be made based on the
proportion of individuals who eventually have a ‘good’ long-term
results of a single prognostication tool.
outcome despite the prediction of a poor outcome.
Organ donation
Clinical examination
There are no clinical neurological signs that predict poor out- Solid organs have been successfully transplanted after cardiac
come (Cerebral Performance Category [CPC] 3 or 4, or death) death.380 This group of patients offers an untapped opportunity
reliably less than 24 h after cardiac arrest. In adult patients who to increase the organ donor pool. Organ retrieval from non-heart
are comatose after cardiac arrest, and who have not been treated beating donors is classified as controlled or uncontrolled.381 Con-
with hypothermia and who do not have confounding factors (such trolled donation occurs after planned withdrawal of treatment
as hypotension, sedatives or muscle relaxants), the absence of both following non-survivable injuries/illnesses. Uncontrolled dona-
pupillary light and corneal reflex at ≥72 h reliably predicts poor tion describes donation after a patient is brought in dead or
outcome (FPR 0%; 95% CI 0–9%).330 Absence of vestibulo-ocular with on-going CPR that fails to restore a spontaneous circula-
reflexes at ≥24 h (FPR 0%; 95% CI 0–14%)366,367 and a GCS motor tion.
score of 2 or less at ≥72 h (FPR 5%; 95% CI 2–9%)330 are less reliable.
Other clinical signs, including myoclonus, are not recommended Cardiac arrest centres
for predicting poor outcome. The presence of myoclonus status in
adults is strongly associated with poor outcome,329,330,368–370 but There is wide variability in survival among hospitals caring
rare cases of good neurological recovery have been described and for patients after resuscitation from cardiac arrest.57–63 There
accurate diagnosis is problematic.371–375 is some low-level evidence that ICUs admitting more than 50](https://image.slidesharecdn.com/fullerc2010guidelines1-101018011940-phpapp02/85/RCP-2010-guidelines-22-320.jpg)
![J.P. Nolan et al. / Resuscitation 81 (2010) 1219–1276 1243
Treatment of acute coronary syndromes—symptoms as soon as possible is recommended for patients presenting with
STEMI and planned PCI. Prasugrel or ticagrelor can be used instead
Glyceryl trinitrate is an effective treatment for ischaemic chest of clopidogrel before planned PCI. Patients with STEMI treated with
pain and has beneficial haemodynamic effects, such as dilation of fibrinolysis should be treated with clopidogrel (300 mg loading
the venous capacitance vessels, dilation of the coronary arteries dose up to an age of 75 years and 75 mg without loading dose if
and, to a minor extent, the peripheral arteries. Glyceryl trinitrate >75 years of age) in addition to ASA and an antithrombin.
may be considered if the systolic blood pressure is above 90 mm Hg
and the patient has ongoing ischaemic chest pain. Glyceryl trini- Glycoprotein (Gp) IIB/IIIA inhibitors
trate can also be useful in the treatment of acute pulmonary Gp IIB/IIIA receptor is the common final link of platelet aggre-
congestion. Nitrates should not be used in patients with hypoten- gation. Eptifibatide and tirofiban lead to reversible inhibition,
sion (systolic blood pressure ≤90 mm Hg), particularly if combined while abciximab leads to irreversible inhibition of the Gp IIB/IIIA
with bradycardia, and in patients with inferior infarction and sus- receptor. There are insufficient data to support routine pre-
pected right ventricular involvement. Use of nitrates under these treatment with Gp IIB/IIIA inhibitors in patients with STEMI or
circumstances can decrease the blood pressure and cardiac output. non-STEMI-ACS.
Morphine is the analgesic of choice for nitrate-refractory pain
and also has calming effects on the patient making sedatives
Antithrombins
unnecessary in most cases. Since morphine is a dilator of venous
capacitance vessels, it may have additional benefit in patients with
Unfractionated heparin (UFH) is an indirect inhibitor of throm-
pulmonary congestion. Give morphine in initial doses of 3–5 mg
bin, which in combination with ASA is used as an adjunct with
intravenously and repeat every few minutes until the patient is
fibrinolytic therapy or primary PCI (PPCI) and is an important part
pain-free. Non-steroidal anti-inflammatory drugs (NSAIDs) should
of treatment of unstable angina and STEMI. There are now several
be avoided for analgesia because of their pro-thrombotic effects.423
alternative antithrombins for the treatment of patients with ACS.
Monitoring of the arterial oxygen saturation (SaO2 ) with pulse
In comparison with UFH, these alternatives have a more specific
oximetry will help to determine the need for supplemental oxy-
factor Xa activity (low molecular weight heparins [LMWH], fonda-
gen. These patients do not need supplemental oxygen unless
parinux) or are direct thrombin inhibitors (bivalirudin). With these
they are hypoxaemic. Limited data suggest that high-flow oxy-
newer antithrombins, in general, there is no need to monitor the
gen may be harmful in patients with uncomplicated myocardial
coagulation system and there is a reduced risk of thrombocytope-
infarction.424–426 Aim to achieve an oxygen saturation of 94–98%, or
nia.
88–92% if the patient is at risk of hypercapnic respiratory failure.427
In comparison with UFH, enoxaparin reduces the combined end-
point of mortality, myocardial infarction and the need for urgent
Treatment of acute coronary syndromes—cause
revascularisation, if given within the first 24–36 h of onset of symp-
toms of non-STEMI-ACS.432,433 For patients with a planned initial
Inhibitors of platelet aggregation
conservative approach, fondaparinux and enoxaparin are reason-
able alternatives to UFH. For patients with an increased bleeding
Inhibition of platelet aggregation is of primary importance for
risk consider giving fondaparinux or bivalirudin, which cause less
initial treatment of coronary syndromes as well as for secondary
bleeding than UFH.434–436 For patients with a planned invasive
prevention, since platelet activation and aggregation is the key
approach, enoxaparin or bivalirudin are reasonable alternatives to
process initiating an ACS.
UFH.
Several randomised studies of patients with STEMI under-
Acetylsalicylic acid (ASA)
going fibrinolysis have shown that additional treatment with
Large randomised controlled trials indicate decreased mortal-
enoxaparin instead of UFH produced better clinical outcomes
ity when ASA (75–325 mg) is given to hospitalised patients with
(irrespective of the fibrinolytic used) but a slightly increased
ACS. A few studies have suggested reduced mortality if ASA is given
bleeding rate in elderly (≥75 years) and low weight patients
earlier.428,429 Therefore, give ASA as soon as possible to all patients
(BW < 60 kg).437–439
with suspected ACS unless the patient has a known true allergy to
Enoxaparin is a safe and effective alternative to UFH for con-
ASA. ASA may be given by the first healthcare provider, bystander
temporary PPCI (i.e., broad use of thienopyridines and/or Gp IIB/IIIA
or by dispatcher assistance according to local protocols. The initial
receptor blockers).440,441 There are insufficient data to recommend
dose of chewable ASA is 160–325 mg. Other forms of ASA (soluble,
any LMWH other than enoxaparin for PPCI in STEMI. Bivalirudin is
IV) may be as effective as chewed tablets.
also a safe alternative to UFH for STEMI and planned PCI.
ADP receptor inhibitors
Thienopyridines (clopidogrel, prasugrel) and the cyclo-pentyl- Strategies and systems of care
triazolo-pyrimidine, ticagrelor, inhibit the ADP receptor irre-
versibly, which further reduces platelet aggregation in addition to Several systematic strategies to improve quality of out-of-
that produced by ASA. hospital care for patients with ACS have been investigated. These
If given in addition to heparin and ASA in high-risk non-STEMI- strategies are principally intended to promptly identify patients
ACS patients, clopidogrel improves outcome.430,431 Clopidogrel with STEMI in order to shorten the delay to reperfusion treatment.
should be given as early as possible in addition to ASA and an Also triage criteria have been developed to select high-risk patients
antithrombin to all patients presenting with non-STEMI-ACS. If a with non-STEMI-ACS for transport to tertiary care centres offering
conservative approach is selected, give a loading dose of 300 mg; 24/7 PCI services. In this context, several specific decisions have to
with a planned PCI strategy, an initial dose of 600 mg may be pre- be made during initial care beyond the basic diagnostic steps nec-
ferred. Prasugrel or ticagrelor can be given instead of clopidogrel. essary for clinical evaluation of the patient and interpretation of a
Although there is no large study on the use of clopidogrel for 12-lead ECG. These decisions relate to:
pre-treatment of patients presenting with STEMI and planned PCI,
it is likely that this strategy is beneficial. Since platelet inhibition (1) Reperfusion strategy in patients with STEMI i.e., PPCI vs. pre-
is more profound with a higher dose, a 600 mg loading dose given hospital fibrinolysis.](https://image.slidesharecdn.com/fullerc2010guidelines1-101018011940-phpapp02/85/RCP-2010-guidelines-25-320.jpg)
![1248 J.P. Nolan et al. / Resuscitation 81 (2010) 1219–1276
• detection of end-tidal CO2 if the child has a perfusing rhythm Circulation
(this may also be seen with effective CPR, but it is not completely • Establish cardiac monitoring [first line—pulse oximetry (SpO2 ),
reliable); ECG and non-invasive blood pressure (NIBP)].
• observation of symmetrical chest wall movement during positive • Secure vascular access. This may be by peripheral IV or IO cannu-
pressure ventilation; lation. If already in situ, a central intravenous catheter should be
• observation of mist in the tube during the expiratory phase of used.
ventilation; • Give a fluid bolus (20 ml kg−1 ) and/or drugs (e.g., inotropes, vaso-
• absence of gastric distension; pressors, anti-arrhythmics) as required.
• equal air entry heard on bilateral auscultation in the axillae and • Isotonic crystalloids are recommended as initial resuscitation
apices of the chest; fluid in infants and children with any type of shock, including
• absence of air entry into the stomach on auscultation; septic shock.515–518
• improvement or stabilisation of SpO2 in the expected range • Assess and re-assess the child continuously, commencing each
(delayed sign!); time with the airway before proceeding to breathing and then
• heart rate moving closer to the age-expected value (or remaining the circulation.
within the normal range) (delayed sign!). • During treatment, capnography, invasive monitoring of arterial
blood pressure, blood gas analysis, cardiac output monitoring,
echocardiography and central venous oxygen saturation (ScvO2 )
If the child is in cardiopulmonary arrest and exhaled CO2 is not may be useful to guide the management of respiratory and/or
detected despite adequate chest compressions, or if there is any circulatory failure.
doubt, confirm tracheal tube position by direct laryngoscopy.
Vascular access. Venous access can be difficult to establish dur-
ing resuscitation of an infant or child: if attempts at establishing
IV access are unsuccessful after one minute, insert an IO needle
Breathing. Give oxygen at the highest concentration (i.e., 100%) instead.519,520 Intraosseous or IV access is much preferred to the
during initial resuscitation. Once circulation is restored, give suffi- tracheal route for giving drugs.521
cient oxygen to maintain an arterial oxygen saturation (SaO2 ) in
the range of 94–98%.498,499
Healthcare providers commonly provide excessive ventila- Adrenaline. The recommended IV/IO dose of adrenaline in chil-
tion during CPR and this may be harmful. Hyperventilation dren for the first and for subsequent doses is 10 g kg−1 . The
causes increased intra-thoracic pressure, decreased cerebral and maximum single dose is 1 mg. If needed, give further doses of
coronary perfusion, and poorer survival rates in animals and adrenaline every 3–5 min. Intratracheal adrenaline is no longer
adults.224,225,286,500–503 Although normoventilation is the objec- recommended,522–525 but if this route is ever used, the dose is ten
tive during resuscitation, it is difficult to know the precise minute times this (100 g kg−1 ).
volume that is being delivered. A simple guide to deliver an accept-
able tidal volume is to achieve modest chest wall rise. Once the Advanced management of cardiopulmonary arrest
airway is protected by tracheal intubation, continue positive pres-
sure ventilation at 10–12 breaths min−1 without interrupting chest 1. When a child becomes unresponsive, without signs of life (no
compressions. When circulation is restored, or if the child still has breathing, cough or any detectable movement), start CPR imme-
a perfusing rhythm, ventilate at 12–20 breaths min−1 to achieve a diately.
normal arterial carbon dioxide tension (PaCO2 ). 2. Provide BMV with 100% oxygen.
Monitoring end-tidal CO2 (ETCO2 ) with a colorimetric detec- 3. Commence monitoring. Send for a manual defibrillator or an AED
tor or capnometer confirms tracheal tube placement in the child to identify and treat shockable rhythms as quickly as possible
weighing more than 2 kg, and may be used in pre- and in-hospital (Fig. 1.13).
settings, as well as during any transportation of the child.504–507
A colour change or the presence of a capnographic waveform for ABC
more than four ventilated breaths indicates that the tube is in the
tracheobronchial tree both in the presence of a perfusing rhythm
Commence and continue with basic life support
and during cardiopulmonary arrest. Capnography does not rule
Oxygenate and ventilate with BMV
out intubation of a bronchus. The absence of exhaled CO2 dur-
Provide positive pressure ventilation with a high inspired oxy-
ing cardiopulmonary arrest does not guarantee tube misplacement
gen concentration
since a low or absent end tidal CO2 may reflect low or absent
Give five rescue breaths followed by external chest compression
pulmonary blood flow.235,508–510 Capnography may also provide
and positive pressure ventilation in the ratio of 15:2
information on the efficiency of chest compressions and can give an
Avoid rescuer fatigue by frequently changing the rescuer per-
early indication of ROSC.511,512 Efforts should be made to improve
forming chest compressions
chest compression quality if the ETCO2 remains below 15 mm Hg
Establish cardiac monitoring
(2 kPa). Current evidence does not support the use of a threshold
Assess cardiac rhythm and signs of life
ETCO2 value as an indicator for the discontinuation of resuscitation
(±Check for a central pulse for no more than 10 s)
efforts.
The self-inflating bulb or aspirating syringe (oesophageal detec-
Non-shockable—asystole, PEA
tor device, ODD) may be used for the secondary confirmation of
tracheal tube placement in children with a perfusing rhythm.513,514
There are no studies on the use of the ODD in children who are in • Give adrenaline IV or IO (10 g kg−1 ) and repeat every 3–5 min.
cardiopulmonary arrest. • Identify and treat any reversible causes (4Hs & 4Ts).
Clinical evaluation of the oxygen saturation of arterial blood
(SaO2 ) is unreliable; therefore, monitor the child’s peripheral oxy- Shockable—VF/pulseless VT
gen saturation continuously by pulse oximetry (SpO2 ). Attempt defibrillation immediately (4 J kg−1 ):](https://image.slidesharecdn.com/fullerc2010guidelines1-101018011940-phpapp02/85/RCP-2010-guidelines-30-320.jpg)
![1266 J.P. Nolan et al. / Resuscitation 81 (2010) 1219–1276
97. White RD, Bunch TJ, Hankins DG. Evolution of a community-wide early defib- 126. Strohmenger HU, Lindner KH, Brown CG. Analysis of the ventricular fibrillation
rillation programme experience over 13 years using police/fire personnel and ECG signal amplitude and frequency parameters as predictors of countershock
paramedics as responders. Resuscitation 2005;65:279–83. success in humans. Chest 1997;111:584–9.
98. Mosesso Jr VN, Davis EA, Auble TE, Paris PM, Yealy DM. Use of automated 127. Strohmenger HU, Eftestol T, Sunde K, et al. The predictive value of ventricu-
external defibrillators by police officers for treatment of out-of-hospital cardiac lar fibrillation electrocardiogram signal frequency and amplitude variables in
arrest. Ann Emerg Med 1998;32:200–7. patients with out-of-hospital cardiac arrest. Anesth Analg 2001;93:1428–33.
99. The Public Access Defibrillation Trial Investigators. Public-access defib- 128. Podbregar M, Kovacic M, Podbregar-Mars A, Brezocnik M. Predicting defibrilla-
rillation and survival after out-of-hospital cardiac arrest. N Engl J Med tion success by ‘genetic’ programming in patients with out-of-hospital cardiac
2004;351:637–46. arrest. Resuscitation 2003;57:153–9.
100. Kitamura T, Iwami T, Kawamura T, Nagao K, Tanaka H, Hiraide A. Nationwide 129. Menegazzi JJ, Callaway CW, Sherman LD, et al. Ventricular fibrillation scaling
public-access defibrillation in Japan. N Engl J Med 2010;362:994–1004. exponent can guide timing of defibrillation and other therapies. Circulation
101. Bardy GH, Lee KL, Mark DB, et al. Home use of automated external defibrillators 2004;109:926–31.
for sudden cardiac arrest. N Engl J Med 2008;358:1793–804. 130. Povoas HP, Weil MH, Tang W, Bisera J, Klouche K, Barbatsis A. Predicting
102. Zafari AM, Zarter SK, Heggen V, et al. A program encouraging early defibril- the success of defibrillation by electrocardiographic analysis. Resuscitation
lation results in improved in-hospital resuscitation efficacy. J Am Coll Cardiol 2002;53:77–82.
2004;44:846–52. 131. Noc M, Weil MH, Tang W, Sun S, Pernat A, Bisera J. Electrocardiographic pre-
103. Destro A, Marzaloni M, Sermasi S, Rossi F. Automatic external defibrillators in diction of the success of cardiac resuscitation. Crit Care Med 1999;27:708–14.
the hospital as well? Resuscitation 1996;31:39–43. 132. Strohmenger HU, Lindner KH, Keller A, Lindner IM, Pfenninger EG. Spectral
104. Spearpoint KG, Gruber PC, Brett SJ. Impact of the Immediate Life Support course analysis of ventricular fibrillation and closed-chest cardiopulmonary resusci-
on the incidence and outcome of in-hospital cardiac arrest calls: an observa- tation. Resuscitation 1996;33:155–61.
tional study over 6 years. Resuscitation 2009;80:638–43. 133. Noc M, Weil MH, Gazmuri RJ, Sun S, Biscera J, Tang W. Ventricular fibrillation
105. Cummins RO, Eisenberg MS, Litwin PE, Graves JR, Hearne TR, Hallstrom AP. voltage as a monitor of the effectiveness of cardiopulmonary resuscitation. J
Automatic external defibrillators used by emergency medical technicians: a Lab Clin Med 1994;124:421–6.
controlled clinical trial. JAMA 1987;257:1605–10. 134. Lightfoot CB, Nremt P, Callaway CW, et al. Dynamic nature of electrocar-
106. Stults KR, Brown DD, Kerber RE. Efficacy of an automated external defibrillator diographic waveform predicts rescue shock outcome in porcine ventricular
in the management of out-of-hospital cardiac arrest: validation of the diagnos- fibrillation. Ann Emerg Med 2003;42:230–41.
tic algorithm and initial clinical experience in a rural environment. Circulation 135. Marn-Pernat A, Weil MH, Tang W, Pernat A, Bisera J. Optimizing timing of
1986;73:701–9. ventricular defibrillation. Crit Care Med 2001;29:2360–5.
107. Kramer-Johansen J, Edelson DP, Abella BS, Becker LB, Wik L, Steen PA. Pauses 136. Hamprecht FA, Achleitner U, Krismer AC, et al. Fibrillation power, an alternative
in chest compression and inappropriate shocks: a comparison of manual and method of ECG spectral analysis for prediction of countershock success in a
semi-automatic defibrillation attempts. Resuscitation 2007;73:212–20. porcine model of ventricular fibrillation. Resuscitation 2001;50:287–96.
108. Pytte M, Pedersen TE, Ottem J, Rokvam AS, Sunde K. Comparison of hands-off 137. Amann A, Achleitner U, Antretter H, et al. Analysing ventricular fibrilla-
time during CPR with manual and semi-automatic defibrillation in a manikin tion ECG-signals and predicting defibrillation success during cardiopulmonary
model. Resuscitation 2007;73:131–6. resuscitation employing N(alpha)-histograms. Resuscitation 2001;50:77–85.
109. Forcina MS, Farhat AY, O’Neil WW, Haines DE. Cardiac arrest survival after 138. Brown CG, Griffith RF, Van Ligten P, et al. Median frequency—a new parameter
implementation of automated external defibrillator technology in the in- for predicting defibrillation success rate. Ann Emerg Med 1991;20:787–9.
hospital setting. Crit Care Med 2009;37:1229–36. 139. Amann A, Rheinberger K, Achleitner U, et al. The prediction of defibrillation
110. Edelson DP, Abella BS, Kramer-Johansen J, et al. Effects of compression depth outcome using a new combination of mean frequency and amplitude in porcine
and pre-shock pauses predict defibrillation failure during cardiac arrest. Resus- models of cardiac arrest. Anesth Analg 2002;95:716–22 [table of contents].
citation 2006;71:137–45. 140. Deakin CD, Nolan JP. European Resuscitation Council guidelines for
111. Yu T, Weil MH, Tang W, et al. Adverse outcomes of interrupted precordial resuscitation 2005. Section 3. Electrical therapies: automated external defib-
compression during automated defibrillation. Circulation 2002;106:368–72. rillators, defibrillation, cardioversion and pacing. Resuscitation 2005;67(Suppl.
112. Gundersen K, Kvaloy JT, Kramer-Johansen J, Steen PA, Eftestol T. Development 1):S25–37.
of the probability of return of spontaneous circulation in intervals without 141. Cobb LA, Fahrenbruch CE, Walsh TR, et al. Influence of cardiopulmonary resus-
chest compressions during out-of-hospital cardiac arrest: an observational citation prior to defibrillation in patients with out-of-hospital ventricular
study. BMC Med 2009;7:6. fibrillation. JAMA 1999;281:1182–8.
113. Lloyd MS, Heeke B, Walter PF, Langberg JJ. Hands-on defibrillation: an analy- 142. Wik L, Hansen TB, Fylling F, et al. Delaying defibrillation to give basic cardiopul-
sis of electrical current flow through rescuers in direct contact with patients monary resuscitation to patients with out-of-hospital ventricular fibrillation:
during biphasic external defibrillation. Circulation 2008;117:2510–4. a randomized trial. JAMA 2003;289:1389–95.
114. Bojar RM, Payne DD, Rastegar H, Diehl JT, Cleveland RJ. Use of self-adhesive 143. Baker PW, Conway J, Cotton C, et al. Defibrillation or cardiopulmonary
external defibrillator pads for complex cardiac surgical procedures. Ann Thorac resuscitation first for patients with out-of-hospital cardiac arrests found by
Surg 1988;46:587–8. paramedics to be in ventricular fibrillation? A randomised control trial. Resus-
115. Bradbury N, Hyde D, Nolan J. Reliability of ECG monitoring with a gel citation 2008;79:424–31.
pad/paddle combination after defibrillation. Resuscitation 2000;44:203–6. 144. Jacobs IG, Finn JC, Oxer HF, Jelinek GA. CPR before defibrillation in
116. Brown J, Rogers J, Soar J. Cardiac arrest during surgery and ventilation out-of-hospital cardiac arrest: a randomized trial. Emerg Med Australas
in the prone position: a case report and systematic review. Resuscitation 2005;17:39–45.
2001;50:233–8. 145. Hayakawa M, Gando S, Okamoto H, Asai Y, Uegaki S, Makise H. Shortening
117. Perkins GD, Davies RP, Soar J, Thickett DR. The impact of manual defibrillation of cardiopulmonary resuscitation time before the defibrillation worsens the
technique on no-flow time during simulated cardiopulmonary resuscitation. outcome in out-of-hospital VF patients. Am J Emerg Med 2009;27:470–4.
Resuscitation 2007;73:109–14. 146. Bradley SM, Gabriel EE, Aufderheide TP, et al. Survival Increases with CPR by
118. Wilson RF, Sirna S, White CW, Kerber RE. Defibrillation of high-risk patients Emergency Medical Services before defibrillation of out-of-hospital ventricu-
during coronary angiography using self-adhesive, preapplied electrode pads. lar fibrillation or ventricular tachycardia: observations from the resuscitation
Am J Cardiol 1987;60:380–2. outcomes consortium. Resuscitation 2010;81:155–62.
119. Stults KR, Brown DD, Cooley F, Kerber RE. Self-adhesive monitor/defibrillation 147. Christenson J, Andrusiek D, Everson-Stewart S, et al. Chest compression fraction
pads improve prehospital defibrillation success. Ann Emerg Med determines survival in patients with out-of-hospital ventricular fibrillation.
1987;16:872–7. Circulation 2009;120:1241–7.
120. Callaway CW, Sherman LD, Mosesso Jr VN, Dietrich TJ, Holt E, Clarkson MC. 148. Olasveengen TM, Vik E, Kuzovlev A, Sunde K. Effect of implementation of new
Scaling exponent predicts defibrillation success for out-of-hospital ventricular resuscitation guidelines on quality of cardiopulmonary resuscitation and sur-
fibrillation cardiac arrest. Circulation 2001;103:1656–61. vival. Resuscitation 2009;80:407–11.
121. Eftestol T, Sunde K, Aase SO, Husoy JH, Steen PA. Predicting outcome of 149. Bobrow BJ, Clark LL, Ewy GA, et al. Minimally interrupted cardiac resuscita-
defibrillation by spectral characterization and nonparametric classification of tion by emergency medical services for out-of-hospital cardiac arrest. JAMA
ventricular fibrillation in patients with out-of-hospital cardiac arrest. Circula- 2008;299:1158–65.
tion 2000;102:1523–9. 150. Rea TD, Helbock M, Perry S, et al. Increasing use of cardiopulmonary resuscita-
122. Eftestol T, Wik L, Sunde K, Steen PA. Effects of cardiopulmonary resuscitation tion during out-of-hospital ventricular fibrillation arrest: survival implications
on predictors of ventricular fibrillation defibrillation success during out-of- of guideline changes. Circulation 2006;114:2760–5.
hospital cardiac arrest. Circulation 2004;110:10–5. 151. Steinmetz J, Barnung S, Nielsen SL, Risom M, Rasmussen LS. Improved survival
123. Weaver WD, Cobb LA, Dennis D, Ray R, Hallstrom AP, Copass MK. Amplitude of after an out-of-hospital cardiac arrest using new guidelines. Acta Anaesthesiol
ventricular fibrillation waveform and outcome after cardiac arrest. Ann Intern Scand 2008;52:908–13.
Med 1985;102:53–5. 152. Jost D, Degrange H, Verret C, et al. DEFI 2005: a randomized controlled trial
124. Brown CG, Dzwonczyk R. Signal analysis of the human electrocardiogram dur- of the effect of automated external defibrillator cardiopulmonary resusci-
ing ventricular fibrillation: frequency and amplitude parameters as predictors tation protocol on outcome from out-of-hospital cardiac arrest. Circulation
of successful countershock. Ann Emerg Med 1996;27:184–8. 2010;121:1614–22.
125. Callaham M, Braun O, Valentine W, Clark DM, Zegans C. Prehospital car- 153. van Alem AP, Chapman FW, Lank P, Hart AA, Koster RW. A prospective,
diac arrest treated by urban first-responders: profile of patient response and randomised and blinded comparison of first shock success of monopha-
prediction of outcome by ventricular fibrillation waveform. Ann Emerg Med sic and biphasic waveforms in out-of-hospital cardiac arrest. Resuscitation
1993;22:1664–77. 2003;58:17–24.](https://image.slidesharecdn.com/fullerc2010guidelines1-101018011940-phpapp02/85/RCP-2010-guidelines-48-320.jpg)
![1270 J.P. Nolan et al. / Resuscitation 81 (2010) 1219–1276
neurological recovery in human cardiac arrest survivors. J Cereb Blood Flow 368. Al Thenayan E, Savard M, Sharpe M, Norton L, Young B. Predictors of poor
Metab 1997;17:430–6. neurologic outcome after induced mild hypothermia following cardiac arrest.
336. Calle PA, Buylaert WA, Vanhaute OA. Glycemia in the post-resuscitation Neurology 2008;71:1535–7.
period. The Cerebral Resuscitation Study Group. Resuscitation 369. Wijdicks EF, Parisi JE, Sharbrough FW. Prognostic value of myoclonus status in
1989;17(Suppl.):S181–8 [discussion S99–S206]. comatose survivors of cardiac arrest. Ann Neurol 1994;35:239–43.
337. Longstreth Jr WT, Diehr P, Inui TS. Prediction of awakening after out-of-hospital 370. Thomke F, Marx JJ, Sauer O, et al. Observations on comatose survivors
cardiac arrest. N Engl J Med 1983;308:1378–82. of cardiopulmonary resuscitation with generalized myoclonus. BMC Neurol
338. Longstreth Jr WT, Inui TS. High blood glucose level on hospital admission and 2005;5:14.
poor neurological recovery after cardiac arrest. Ann Neurol 1984;15:59–63. 371. Arnoldus EP, Lammers GJ. Postanoxic coma: good recovery despite myoclonus
339. Finfer S, Chittock DR, Su SY, et al. Intensive versus conventional glucose control status. Ann Neurol 1995;38:697–8.
in critically ill patients. N Engl J Med 2009;360:1283–97. 372. Celesia GG, Grigg MM, Ross E. Generalized status myoclonicus in acute anoxic
340. Preiser JC, Devos P, Ruiz-Santana S, et al. A prospective randomised multi- and toxic-metabolic encephalopathies. Arch Neurol 1988;45:781–4.
centre controlled trial on tight glucose control by intensive insulin therapy 373. Morris HR, Howard RS, Brown P. Early myoclonic status and outcome
in adult intensive care units: the Glucontrol study. Intensive Care Med after cardiorespiratory arrest. J Neurol Neurosurg Psychiatry 1998;64:
2009;35:1738–48. 267–8.
341. Griesdale DE, de Souza RJ, van Dam RM, et al. Intensive insulin therapy and 374. Datta S, Hart GK, Opdam H, Gutteridge G, Archer J. Post-hypoxic myoclonic
mortality among critically ill patients: a meta-analysis including NICE-SUGAR status: the prognosis is not always hopeless. Crit Care Resusc 2009;11:39–41.
study data. CMAJ 2009;180:821–7. 375. English WA, Giffin NJ, Nolan JP. Myoclonus after cardiac arrest: pitfalls in diag-
342. Wiener RS, Wiener DC, Larson RJ. Benefits and risks of tight glucose control in nosis and prognosis. Anaesthesia 2009;64:908–11.
critically ill adults: a meta-analysis. JAMA 2008;300:933–44. 376. Wijdicks EF, Hijdra A, Young GB, Bassetti CL, Wiebe S. Practice parameter: pre-
343. Krinsley JS, Grover A. Severe hypoglycemia in critically ill patients: risk factors diction of outcome in comatose survivors after cardiopulmonary resuscitation
and outcomes. Crit Care Med 2007;35:2262–7. (an evidence-based review): report of the Quality Standards Subcommittee of
344. Meyfroidt G, Keenan DM, Wang X, Wouters PJ, Veldhuis JD, Van den Berghe the American Academy of Neurology. Neurology 2006;67:203–10.
G. Dynamic characteristics of blood glucose time series during the course of 377. Tiainen M, Kovala TT, Takkunen OS, Roine RO. Somatosensory and brainstem
critical illness: effects of intensive insulin therapy and relative association with auditory evoked potentials in cardiac arrest patients treated with hypothermia.
mortality. Crit Care Med 2010;38:1021–9. Crit Care Med 2005;33:1736–40.
345. Padkin A. Glucose control after cardiac arrest. Resuscitation 2009;80:611–2. 378. Rossetti AO, Oddo M, Liaudet L, Kaplan PW. Predictors of awakening
346. Takino M, Okada Y. Hyperthermia following cardiopulmonary resuscitation. from postanoxic status epilepticus after therapeutic hypothermia. Neurology
Intensive Care Med 1991;17:419–20. 2009;72:744–9.
347. Hickey RW, Kochanek PM, Ferimer H, Alexander HL, Garman RH, Graham 379. Rossetti AO, Logroscino G, Liaudet L, et al. Status epilepticus: an independent
SH. Induced hyperthermia exacerbates neurologic neuronal histologic damage outcome predictor after cerebral anoxia. Neurology 2007;69:255–60.
after asphyxial cardiac arrest in rats. Crit Care Med 2003;31:531–5. 380. Fieux F, Losser MR, Bourgeois E, et al. Kidney retrieval after sudden out of
348. Takasu A, Saitoh D, Kaneko N, Sakamoto T, Okada Y. Hyperthermia: is it an hospital refractory cardiac arrest: a cohort of uncontrolled non heart beating
ominous sign after cardiac arrest? Resuscitation 2001;49:273–7. donors. Crit Care 2009;13:R141.
349. Zeiner A, Holzer M, Sterz F, et al. Hyperthermia after cardiac arrest is associated 381. Kootstra G. Statement on non-heart-beating donor programs. Transplant Proc
with an unfavorable neurologic outcome. Arch Intern Med 2001;161:2007–12. 1995;27:2965.
350. Hickey RW, Kochanek PM, Ferimer H, Graham SH, Safar P. Hypothermia and 382. Vermeer F, Oude Ophuis AJ, vd Berg EJ, et al. Prospective randomised compar-
hyperthermia in children after resuscitation from cardiac arrest. Pediatrics ison between thrombolysis, rescue PTCA, and primary PTCA in patients with
2000;106:118–22. extensive myocardial infarction admitted to a hospital without PTCA facilities:
351. Diringer MN, Reaven NL, Funk SE, Uman GC. Elevated body temperature inde- a safety and feasibility study. Heart 1999;82:426–31.
pendently contributes to increased length of stay in neurologic intensive care 383. Widimsky P, Groch L, Zelizko M, Aschermann M, Bednar F, Suryapranata H.
unit patients. Crit Care Med 2004;32:1489–95. Multicentre randomized trial comparing transport to primary angioplasty vs
352. Gunn AJ, Thoresen M. Hypothermic neuroprotection. NeuroRx 2006;3:154–69. immediate thrombolysis vs combined strategy for patients with acute myocar-
353. Froehler MT, Geocadin RG. Hypothermia for neuroprotection after car- dial infarction presenting to a community hospital without a catheterization
diac arrest: mechanisms, clinical trials and patient care. J Neurol Sci laboratory. The PRAGUE study. Eur Heart J 2000;21:823–31.
2007;261:118–26. 384. Widimsky P, Budesinsky T, Vorac D, et al. Long distance transport for primary
354. McCullough JN, Zhang N, Reich DL, et al. Cerebral metabolic suppression during angioplasty vs immediate thrombolysis in acute myocardial infarction. Final
hypothermic circulatory arrest in humans. Ann Thorac Surg 1999;67:1895–9 results of the randomized national multicentre trial—PRAGUE-2. Eur Heart J
[discussion 919–21]. 2003;24:94–104.
355. Mild therapeutic hypothermia to improve the neurologic outcome after cardiac 385. Le May MR, So DY, Dionne R, et al. A citywide protocol for primary PCI in
arrest. N Engl J Med 2002;346:549–56. ST-segment elevation myocardial infarction. N Engl J Med 2008;358:231–40.
356. Bernard SA, Gray TW, Buist MD, et al. Treatment of comatose survivors 386. Abernathy 3rd JH, McGwin Jr G, Acker 3rd JE, Rue 3rd LW. Impact of a voluntary
of out-of-hospital cardiac arrest with induced hypothermia. N Engl J Med trauma system on mortality, length of stay, and cost at a level I trauma center.
2002;346:557–63. Am Surg 2002;68:182–92.
357. Bernard SA, Jones BM, Horne MK. Clinical trial of induced hypothermia 387. Clemmer TP, Orme Jr JF, Thomas FO, Brooks KA. Outcome of critically injured
in comatose survivors of out-of-hospital cardiac arrest. Ann Emerg Med patients treated at Level I trauma centers versus full-service community hos-
1997;30:146–53. pitals. Crit Care Med 1985;13:861–3.
358. Oddo M, Schaller MD, Feihl F, Ribordy V, Liaudet L. From evidence to clini- 388. Culica D, Aday LA, Rohrer JE. Regionalized trauma care system in Texas: impli-
cal practice: effective implementation of therapeutic hypothermia to improve cations for redesigning trauma systems. Med Sci Monit 2007;13:SR9–18.
patient outcome after cardiac arrest. Crit Care Med 2006;34:1865–73. 389. Hannan EL, Farrell LS, Cooper A, Henry M, Simon B, Simon R. Physiologic trauma
359. Busch M, Soreide E, Lossius HM, Lexow K, Dickstein K. Rapid implementation of triage criteria in adult trauma patients: are they effective in saving lives by
therapeutic hypothermia in comatose out-of-hospital cardiac arrest survivors. transporting patients to trauma centers? J Am Coll Surg 2005;200:584–92.
Acta Anaesthesiol Scand 2006;50:1277–83. 390. Harrington DT, Connolly M, Biffl WL, Majercik SD, Cioffi WG. Transfer times to
360. Storm C, Steffen I, Schefold JC, et al. Mild therapeutic hypothermia shortens definitive care facilities are too long: a consequence of an immature trauma
intensive care unit stay of survivors after out-of-hospital cardiac arrest com- system. Ann Surg 2005;241:961–6 [discussion 6–8].
pared to historical controls. Crit Care 2008;12:R78. 391. Liberman M, Mulder DS, Lavoie A, Sampalis JS. Implementation of a trauma
361. Don CW, Longstreth Jr WT, Maynard C, et al. Active surface cooling protocol care system: evolution through evaluation. J Trauma 2004;56:1330–5.
to induce mild therapeutic hypothermia after out-of-hospital cardiac arrest: a 392. MacKenzie EJ, Rivara FP, Jurkovich GJ, et al. A national evaluation of the effect
retrospective before-and-after comparison in a single hospital. Crit Care Med of trauma-center care on mortality. N Engl J Med 2006;354:366–78.
2009;37:3062–9. 393. Mann NC, Cahn RM, Mullins RJ, Brand DM, Jurkovich GJ. Survival among injured
362. Arrich J. Clinical application of mild therapeutic hypothermia after cardiac geriatric patients during construction of a statewide trauma system. J Trauma
arrest. Crit Care Med 2007;35:1041–7. 2001;50:1111–6.
363. Holzer M, Mullner M, Sterz F, et al. Efficacy and safety of endovascular 394. Mullins RJ, Veum-Stone J, Hedges JR, et al. Influence of a statewide trauma
cooling after cardiac arrest: cohort study and Bayesian approach. Stroke system on location of hospitalization and outcome of injured patients. J Trauma
2006;37:1792–7. 1996;40:536–45 [discussion 45–46].
364. Polderman KH, Herold I. Therapeutic hypothermia and controlled normother- 395. Mullins RJ, Mann NC, Hedges JR, Worrall W, Jurkovich GJ. Preferential benefit
mia in the intensive care unit: practical considerations, side effects, and cooling of implementation of a statewide trauma system in one of two adjacent states.
methods. Crit Care Med 2009;37:1101–20. J Trauma 1998;44:609–16 [discussion 17].
365. Kuboyama K, Safar P, Radovsky A, et al. Delay in cooling negates the beneficial 396. Mullins RJ, Veum-Stone J, Helfand M, et al. Outcome of hospitalized injured
effect of mild resuscitative cerebral hypothermia after cardia arrest in dogs: a patients after institution of a trauma system in an urban area. JAMA
prospective, randomized study. Crit Care Med 1993;21:1348–58. 1994;271:1919–24.
366. Edgren E, Hedstrand U, Nordin M, Rydin E, Ronquist G. Prediction of outcome 397. Mullner R, Goldberg J. An evaluation of the Illinois trauma system. Med Care
after cardiac arrest. Crit Care Med 1987;15:820–5. 1978;16:140–51.
367. Young GB, Doig G, Ragazzoni A. Anoxic-ischemic encephalopathy: clin- 398. Mullner R, Goldberg J. Toward an outcome-oriented medical geography: an
ical and electrophysiological associations with outcome. Neurocrit Care evaluation of the Illinois trauma/emergency medical services system. Soc Sci
2005;2:159–64. Med 1978;12:103–10.](https://image.slidesharecdn.com/fullerc2010guidelines1-101018011940-phpapp02/85/RCP-2010-guidelines-52-320.jpg)
![J.P. Nolan et al. / Resuscitation 81 (2010) 1219–1276 1271
399. Nathens AB, Jurkovich GJ, Rivara FP, Maier RV. Effectiveness of state trauma 427. O’Driscoll BR, Howard LS, Davison AG. BTS guideline for emergency oxygen use
systems in reducing injury-related mortality: a national evaluation. J Trauma in adult patients. Thorax 2008;63(Suppl. 6):vi1–68.
2000;48:25–30 [discussion 1]. 428. Freimark D, Matetzky S, Leor J, et al. Timing of aspirin administration as a
400. Nathens AB, Maier RV, Brundage SI, Jurkovich GJ, Grossman DC. The effect determinant of survival of patients with acute myocardial infarction treated
of interfacility transfer on outcome in an urban trauma system. J Trauma with thrombolysis. Am J Cardiol 2002;89:381–5.
2003;55:444–9. 429. Barbash IM, Freimark D, Gottlieb S, et al. Outcome of myocardial infarction
401. Nicholl J, Turner J. Effectiveness of a regional trauma system in reducing mor- in patients treated with aspirin is enhanced by pre-hospital administration.
tality from major trauma: before and after study. BMJ 1997;315:1349–54. Cardiology 2002;98:141–7.
402. Potoka DA, Schall LC, Gardner MJ, Stafford PW, Peitzman AB, Ford HR. Impact 430. Yusuf S, Zhao F, Mehta SR, Chrolavicius S, Tognoni G, Fox KK. Effects of clopido-
of pediatric trauma centers on mortality in a statewide system. J Trauma grel in addition to aspirin in patients with acute coronary syndromes without
2000;49:237–45. ST-segment elevation. N Engl J Med 2001;345:494–502.
403. Sampalis JS, Lavoie A, Boukas S, et al. Trauma center designation: initial impact 431. Mehta SR, Yusuf S, Peters RJ, et al. Effects of pretreatment with clopi-
on trauma-related mortality. J Trauma 1995;39:232–7 [discussion 7–9]. dogrel and aspirin followed by long-term therapy in patients undergoing
404. Sampalis JS, Denis R, Frechette P, Brown R, Fleiszer D, Mulder D. Direct transport percutaneous coronary intervention: the PCI-CURE study. Lancet 2001;358:
to tertiary trauma centers versus transfer from lower level facilities: impact 527–33.
on mortality and morbidity among patients with major trauma. J Trauma 432. TIMI-11B Investigators, Antman EM, McCabe CH, et al. Enoxaparin prevents
1997;43:288–95 [discussion 95–96]. death and cardiac ischemic events in unstable angina/non-Q-wave myocardial
405. Nichol G, Aufderheide TP, Eigel B, et al. Regional systems of care for out- infarction. Results of the thrombolysis in myocardial infarction (TIMI) 11B trial.
of-hospital cardiac arrest: a policy statement from the American Heart Circulation 1999;100:1593–601.
Association. Circulation 2010;121:709–29. 433. Cohen M, Demers C, Gurfinkel EP, et al. A comparison of low-molecular-weight
406. Nichol G, Soar J. Regional cardiac resuscitation systems of care. Curr Opin Crit heparin with unfractionated heparin for unstable coronary artery disease. Effi-
Care 2010;16:223–30. cacy and safety of subcutaneous enoxaparin in non-Q-wave coronary events
407. Soar J, Packham S. Cardiac arrest centres make sense. Resuscitation study group. N Engl J Med 1997;337:447–52.
2010;81:507–8. 434. Yusuf S, Mehta SR, Chrolavicius S, et al. Comparison of fondaparinux and enoxa-
408. Tunstall-Pedoe H, Vanuzzo D, Hobbs M, et al. Estimation of contribution of parin in acute coronary syndromes. N Engl J Med 2006;354:1464–76.
changes in coronary care to improving survival, event rates, and coronary 435. Mehta SR, Boden WE, Eikelboom JW, et al. Antithrombotic therapy with fon-
heart disease mortality across the WHO MONICA Project populations. Lancet daparinux in relation to interventional management strategy in patients with
2000;355:688–700. ST- and non-ST-segment elevation acute coronary syndromes: an individual
409. Fox KA, Cokkinos DV, Deckers J, Keil U, Maggioni A, Steg G. The ENACT study: patient-level combined analysis of the Fifth and Sixth Organization to Assess
a pan-European survey of acute coronary syndromes. European Network for Strategies in Ischemic Syndromes (OASIS 5 and 6) randomized trials. Circula-
Acute Coronary Treatment. Eur Heart J 2000;21:1440–9. tion 2008;118:2038–46.
410. Goodman SG, Huang W, Yan AT, et al. The expanded global registry of 436. Lincoff AM, Bittl JA, Harrington RA, et al. Bivalirudin and provisional glycopro-
acute coronary events: baseline characteristics, management practices, and tein IIb/IIIa blockade compared with heparin and planned glycoprotein IIb/IIIa
hospital outcomes of patients with acute coronary syndromes. Am Heart J blockade during percutaneous coronary intervention: REPLACE-2 randomized
2009;158:193–201, e1–e5. trial. JAMA 2003;289:853–63.
411. Lowel H, Meisinger C, Heier M, et al. Sex specific trends of sudden car- 437. Efficacy and safety of tenecteplase in combination with enoxaparin, abciximab,
diac death and acute myocardial infarction: results of the population-based or unfractionated heparin: the ASSENT-3 randomised trial in acute myocardial
KORA/MONICA-Augsburg register 1985 to 1998. Dtsch Med Wochenschr infarction. Lancet 2001;358:605–13.
2002;127:2311–6. 438. Eikelboom JW, Quinlan DJ, Mehta SR, Turpie AG, Menown IB, Yusuf S. Unfrac-
412. Thygesen K, Alpert JS, White HD. Universal definition of myocardial infarction. tionated and low-molecular-weight heparin as adjuncts to thrombolysis in
Eur Heart J 2007;28:2525–38. aspirin-treated patients with ST-elevation acute myocardial infarction: a meta-
413. Van de Werf F, Bax J, Betriu A, et al. Management of acute myocardial infarction analysis of the randomized trials. Circulation 2005;112:3855–67.
in patients presenting with persistent ST-segment elevation: the Task Force on 439. Wallentin L, Goldstein P, Armstrong PW, et al. Efficacy and safety of
the Management of ST-Segment Elevation Acute Myocardial Infarction of the tenecteplase in combination with the low-molecular-weight heparin enoxa-
European Society of Cardiology. Eur Heart J 2008;29:2909–45. parin or unfractionated heparin in the prehospital setting: the Assessment
414. Antman EM, Anbe DT, Armstrong PW, et al. ACC/AHA guidelines for the of the Safety and Efficacy of a New Thrombolytic Regimen (ASSENT)-3
management of patients with ST-elevation myocardial infarction—executive PLUS randomized trial in acute myocardial infarction. Circulation 2003;108:
summary: a report of the American College of Cardiology/American Heart 135–42.
Association Task Force on Practice Guidelines (Writing Committee to Revise 440. Zeymer U, Gitt A, Junger C, et al. Efficacy and safety of enoxaparin in unselected
the 1999 Guidelines for the Management of Patients With Acute Myocardial patients with ST-segment elevation myocardial infarction. Thromb Haemost
Infarction). Circulation 2004;110:588–636. 2008;99:150–4.
415. Douglas PS, Ginsburg GS. The evaluation of chest pain in women. N Engl J Med 441. Zeymer U, Gitt A, Zahn R, et al. Efficacy and safety of enoxaparin in combination
1996;334:1311–5. with and without GP IIb/IIIa inhibitors in unselected patients with ST segment
416. Solomon CG, Lee TH, Cook EF, et al. Comparison of clinical presentation of elevation myocardial infarction treated with primary percutaneous coronary
acute myocardial infarction in patients older than 65 years of age to younger intervention. EuroIntervention 2009;4:524–8.
patients: the Multicenter Chest Pain Study experience. Am J Cardiol 1989;63: 442. Bassand JP, Hamm CW, Ardissino D, et al. Guidelines for the diagnosis and
772–6. treatment of non-ST-segment elevation acute coronary syndromes. Eur Heart
417. Ioannidis JP, Salem D, Chew PW, Lau J. Accuracy and clinical effect of out- J 2007;28:1598–660.
of-hospital electrocardiography in the diagnosis of acute cardiac ischemia: a 443. Anderson JL, Adams CD, Antman EM, et al. ACC/AHA 2007 guidelines for
meta-analysis. Ann Emerg Med 2001;37:461–70. the management of patients with unstable angina/non ST-elevation myocar-
418. Kudenchuk PJ, Ho MT, Weaver WD, et al. Accuracy of computer-interpreted dial infarction: a report of the American College of Cardiology/American
electrocardiography in selecting patients for thrombolytic therapy. MITI Heart Association Task Force on Practice Guidelines (Writing Committee to
Project Investigators. J Am Coll Cardiol 1991;17:1486–91. Revise the 2002 Guidelines for the Management of Patients With Unstable
419. Dhruva VN, Abdelhadi SI, Anis A, et al. ST-Segment Analysis Using Wireless Angina/Non ST-Elevation Myocardial Infarction): developed in collaboration
Technology in Acute Myocardial Infarction (STAT-MI) trial. J Am Coll Cardiol with the American College of Emergency Physicians, the Society for Cardiovas-
2007;50:509–13. cular Angiography and Interventions, and the Society of Thoracic Surgeons:
420. Antman EM, Tanasijevic MJ, Thompson B, et al. Cardiac-specific troponin I levels endorsed by the American Association of Cardiovascular and Pulmonary Reha-
to predict the risk of mortality in patients with acute coronary syndromes. N bilitation and the Society for Academic Emergency Medicine. Circulation
Engl J Med 1996;335:1342–9. 2007;116:e148–304.
421. Hess EP, Thiruganasambandamoorthy V, Wells GA, et al. Diagnostic accuracy of 444. Kushner FG, Hand M, Smith SCJJr, et al. 2009 Focused Updates: ACC/AHA
clinical prediction rules to exclude acute coronary syndrome in the emergency guidelines for the management of patients with ST-elevation myocardial
department setting: a systematic review. CJEM 2008;10:373–82. infarction (updating the 2004 Guideline and 2007 Focused Update) and
422. Ramakrishna G, Milavetz JJ, Zinsmeister AR, et al. Effect of exercise treadmill ACC/AHA/SCAI Guidelines on Percutaneous Coronary Intervention (updating
testing and stress imaging on the triage of patients with chest pain: CHEER the 2005 Guideline and 2007 Focused Update): a report of the American
substudy. Mayo Clin Proc 2005;80:322–9. College of Cardiology Foundation/American Heart Association Task Force on
423. Kearney PM, Baigent C, Godwin J, Halls H, Emberson JR, Patrono C. Do selective Practice Guidelines. Circulation 2009;120:2271–306. Erratum in: Circulation.
cyclo-oxygenase-2 inhibitors and traditional non-steroidal anti-inflammatory 010 March 30;121(12):e257. Dosage error in article text.
drugs increase the risk of atherothrombosis? Meta-analysis of randomised 445. Boersma E, Maas AC, Deckers JW, Simoons ML. Early thrombolytic treat-
trials. BMJ 2006;332:1302–8. ment in acute myocardial infarction: reappraisal of the golden hour. Lancet
424. Rawles JM, Kenmure AC. Controlled trial of oxygen in uncomplicated myocar- 1996;348:771–5.
dial infarction. BMJ 1976;1:1121–3. 446. Prehospital thrombolytic therapy in patients with suspected acute myocardial
425. Wijesinghe M, Perrin K, Ranchord A, Simmonds M, Weatherall M, Beasley R. infarction. The European Myocardial Infarction Project Group. N Engl J Med
Routine use of oxygen in the treatment of myocardial infarction: systematic 1993;329:383–9.
review. Heart 2009;95:198–202. 447. Weaver WD, Cerqueira M, Hallstrom AP, et al. Prehospital-initiated vs
426. Cabello JB, Burls A, Emparanza JI, Bayliss S, Quinn T. Oxygen therapy for acute hospital-initiated thrombolytic therapy. The Myocardial Infarction Triage and
myocardial infarction. Cochrane Database Syst Rev 2010;6:CD007160. Intervention Trial. JAMA 1993;270:1211–6.](https://image.slidesharecdn.com/fullerc2010guidelines1-101018011940-phpapp02/85/RCP-2010-guidelines-53-320.jpg)
![1272 J.P. Nolan et al. / Resuscitation 81 (2010) 1219–1276
448. Feasibility, safety, and efficacy of domiciliary thrombolysis by general 477. Brilli RJ, Gibson R, Luria JW, et al. Implementation of a medical emergency
practitioners: Grampian region early anistreplase trial. GREAT Group. BMJ team in a large pediatric teaching hospital prevents respiratory and car-
1992;305:548–53. diopulmonary arrests outside the intensive care unit. Pediatr Crit Care Med
449. Welsh RC, Travers A, Senaratne M, Williams R, Armstrong PW. Feasibility 2007;8:236–46 [quiz 47].
and applicability of paramedic-based prehospital fibrinolysis in a large North 478. Tibballs J, Kinney S, Duke T, Oakley E, Hennessy M. Reduction of paediatric in-
American center. Am Heart J 2006;152:1007–14. patient cardiac arrest and death with a medical emergency team: preliminary
450. Pedley DK, Bissett K, Connolly EM, et al. Prospective observational cohort study results. Arch Dis Child 2005;90:1148–52.
of time saved by prehospital thrombolysis for ST elevation myocardial infarc- 479. Sagarin MJ, Chiang V, Sakles JC, et al. Rapid sequence intubation for pediatric
tion delivered by paramedics. BMJ 2003;327:22–6. emergency airway management. Pediatr Emerg Care 2002;18:417–23.
451. Grijseels EW, Bouten MJ, Lenderink T, et al. Pre-hospital thrombolytic ther- 480. Moynihan RJ, Brock-Utne JG, Archer JH, Feld LH, Kreitzman TR. The effect of
apy with either alteplase or streptokinase. Practical applications, complications cricoid pressure on preventing gastric insufflation in infants and children.
and long-term results in 529 patients. Eur Heart J 1995;16:1833–8. Anesthesiology 1993;78:652–6.
452. Morrison LJ, Verbeek PR, McDonald AC, Sawadsky BV, Cook DJ. Mortality and 481. Salem MR, Joseph NJ, Heyman HJ, Belani B, Paulissian R, Ferrara TP. Cricoid
prehospital thrombolysis for acute myocardial infarction: a meta-analysis. compression is effective in obliterating the esophageal lumen in the presence
JAMA 2000;283:2686–92. of a nasogastric tube. Anesthesiology 1985;63:443–6.
453. Keeley EC, Boura JA, Grines CL. Primary angioplasty versus intravenous throm- 482. Walker RW, Ravi R, Haylett K. Effect of cricoid force on airway calibre in chil-
bolytic therapy for acute myocardial infarction: a quantitative review of 23 dren: a bronchoscopic assessment. Br J Anaesth 2010;104:71–4.
randomised trials. Lancet 2003;361:13–20. 483. Khine HH, Corddry DH, Kettrick RG, et al. Comparison of cuffed and uncuffed
454. Dalby M, Bouzamondo A, Lechat P, Montalescot G. Transfer for primary endotracheal tubes in young children during general anesthesia. Anesthesiol-
angioplasty versus immediate thrombolysis in acute myocardial infarction: ogy 1997;86:627–31 [discussion 27A].
a meta-analysis. Circulation 2003;108:1809–14. 484. Weiss M, Dullenkopf A, Fischer JE, Keller C, Gerber AC. Prospective randomized
455. Steg PG, Bonnefoy E, Chabaud S, et al. Impact of time to treatment on mortality controlled multi-centre trial of cuffed or uncuffed endotracheal tubes in small
after prehospital fibrinolysis or primary angioplasty: data from the CAPTIM children. Br J Anaesth 2009;103:867–73.
randomized clinical trial. Circulation 2003;108:2851–6. 485. Duracher C, Schmautz E, Martinon C, Faivre J, Carli P, Orliaguet G. Evaluation of
456. Bonnefoy E, Steg PG, Boutitie F, et al. Comparison of primary angioplasty and cuffed tracheal tube size predicted using the Khine formula in children. Paediatr
pre-hospital fibrinolysis in acute myocardial infarction (CAPTIM) trial: a 5-year Anaesth 2008;18:113–8.
follow-up. Eur Heart J 2009;30:1598–606. 486. Dullenkopf A, Kretschmar O, Knirsch W, et al. Comparison of tracheal tube cuff
457. Kalla K, Christ G, Karnik R, et al. Implementation of guidelines improves diameters with internal transverse diameters of the trachea in children. Acta
the standard of care: the Viennese registry on reperfusion strategies Anaesthesiol Scand 2006;50:201–5.
in ST-elevation myocardial infarction (Vienna STEMI registry). Circulation 487. Dullenkopf A, Gerber AC, Weiss M. Fit and seal characteristics of a new pae-
2006;113:2398–405. diatric tracheal tube with high volume-low pressure polyurethane cuff. Acta
458. Primary versus tenecteplase-facilitated percutaneous coronary intervention Anaesthesiol Scand 2005;49:232–7.
in patients with ST-segment elevation acute myocardial infarction (ASSENT-4 488. Salgo B, Schmitz A, Henze G, et al. Evaluation of a new recommendation for
PCI): randomised trial. Lancet 2006;367:569–78. improved cuffed tracheal tube size selection in infants and small children. Acta
459. Pinto DS, Kirtane AJ, Nallamothu BK, et al. Hospital delays in reperfusion for Anaesthesiol Scand 2006;50:557–61.
ST-elevation myocardial infarction: implications when selecting a reperfusion 489. Luten RC, Wears RL, Broselow J, et al. Length-based endotracheal tube and
strategy. Circulation 2006;114:2019–25. emergency equipment in pediatrics. Ann Emerg Med 1992;21:900–4.
460. Keeley EC, Boura JA, Grines CL. Comparison of primary and facilitated per- 490. Deakers TW, Reynolds G, Stretton M, Newth CJ. Cuffed endotracheal tubes in
cutaneous coronary interventions for ST-elevation myocardial infarction: pediatric intensive care. J Pediatr 1994;125:57–62.
quantitative review of randomised trials. Lancet 2006;367:579–88. 491. Newth CJ, Rachman B, Patel N, Hammer J. The use of cuffed versus
461. Herrmann HC, Lu J, Brodie BR, et al. Benefit of facilitated percutaneous coronary uncuffed endotracheal tubes in pediatric intensive care. J Pediatr 2004;144:
intervention in high-risk ST-segment elevation myocardial infarction patients 333–7.
presenting to nonpercutaneous coronary intervention hospitals. JACC Cardio- 492. Dorsey DP, Bowman SM, Klein MB, Archer D, Sharar SR. Perioperative use of
vasc Interv 2009;2:917–24. cuffed endotracheal tubes is advantageous in young pediatric burn patients.
462. Gershlick AH, Stephens-Lloyd A, Hughes S, et al. Rescue angioplasty after Burns 2010.
failed thrombolytic therapy for acute myocardial infarction. N Engl J Med 493. Mhanna MJ, Zamel YB, Tichy CM, Super DM. The “air leak” test around the
2005;353:2758–68. endotracheal tube, as a predictor of postextubation stridor, is age dependent
463. Danchin N, Coste P, Ferrieres J, et al. Comparison of thrombolysis followed by in children. Crit Care Med 2002;30:2639–43.
broad use of percutaneous coronary intervention with primary percutaneous 494. Gausche M, Lewis RJ, Stratton SJ, et al. Effect of out-of-hospital pediatric endo-
coronary intervention for ST-segment-elevation acute myocardial infarction: tracheal intubation on survival and neurological outcome: a controlled clinical
data from the french registry on acute ST-elevation myocardial infarction trial. JAMA 2000;283:783–90.
(FAST-MI). Circulation 2008;118:268–76. 495. Kelly JJ, Eynon CA, Kaplan JL, de Garavilla L, Dalsey WC. Use of tube con-
464. Cantor WJ, Fitchett D, Borgundvaag B, et al. Routine early angioplasty after densation as an indicator of endotracheal tube placement. Ann Emerg Med
fibrinolysis for acute myocardial infarction. N Engl J Med 2009;360:2705–18. 1998;31:575–8.
465. Redding JS. The choking controversy: critique of evidence on the Heimlich 496. Andersen KH, Hald A. Assessing the position of the tracheal tube: the reliability
maneuver. Crit Care Med 1979;7:475–9. of different methods. Anaesthesia 1989;44:984–5.
466. Kuisma M, Suominen P, Korpela R. Paediatric out-of-hospital cardiac 497. Andersen KH, Schultz-Lebahn T. Oesophageal intubation can be undetected by
arrests—epidemiology and outcome. Resuscitation 1995;30:141–50. auscultation of the chest. Acta Anaesthesiol Scand 1994;38:580–2.
467. Sirbaugh PE, Pepe PE, Shook JE, et al. A prospective, population-based study 498. Van de Louw A, Cracco C, Cerf C, et al. Accuracy of pulse oximetry in the inten-
of the demographics, epidemiology, management, and outcome of out-of- sive care unit. Intensive Care Med 2001;27:1606–13.
hospital pediatric cardiopulmonary arrest. Ann Emerg Med 1999;33:174–84. 499. Seguin P, Le Rouzo A, Tanguy M, Guillou YM, Feuillu A, Malledant Y. Evidence
468. Hickey RW, Cohen DM, Strausbaugh S, Dietrich AM. Pediatric patients requiring for the need of bedside accuracy of pulse oximetry in an intensive care unit.
CPR in the prehospital setting. Ann Emerg Med 1995;25:495–501. Crit Care Med 2000;28:703–6.
469. Young KD, Seidel JS. Pediatric cardiopulmonary resuscitation: a collective 500. Aufderheide TP, Sigurdsson G, Pirrallo RG, et al. Hyperventilation-
review. Ann Emerg Med 1999;33:195–205. induced hypotension during cardiopulmonary resuscitation. Circulation
470. Reis AG, Nadkarni V, Perondi MB, Grisi S, Berg RA. A prospective investigation 2004;109:1960–5.
into the epidemiology of in-hospital pediatric cardiopulmonary resuscitation 501. Aufderheide TP, Lurie KG. Death by hyperventilation: a common and life-
using the international Utstein reporting style. Pediatrics 2002;109:200–9. threatening problem during cardiopulmonary resuscitation. Crit Care Med
471. Young KD, Gausche-Hill M, McClung CD, Lewis RJ. A prospective, population- 2004;32:S345–51.
based study of the epidemiology and outcome of out-of-hospital pediatric 502. Borke WB, Munkeby BH, Morkrid L, Thaulow E, Saugstad OD. Resuscitation
cardiopulmonary arrest. Pediatrics 2004;114:157–64. with 100% O(2) does not protect the myocardium in hypoxic newborn piglets.
472. Richman PB, Nashed AH. The etiology of cardiac arrest in children and Arch Dis Child Fetal Neonatal Ed 2004;89:F156–60.
young adults: special considerations for ED management. Am J Emerg Med 503. O’Neill JF, Deakin CD. Do we hyperventilate cardiac arrest patients? Resuscita-
1999;17:264–70. tion 2007;73:82–5.
473. Engdahl J, Bang A, Karlson BW, Lindqvist J, Herlitz J. Characteristics and 504. Bhende MS, Thompson AE, Orr RA. Utility of an end-tidal carbon dioxide
outcome among patients suffering from out of hospital cardiac arrest of non- detector during stabilization and transport of critically ill children. Pediatrics
cardiac aetiology. Resuscitation 2003;57:33–41. 1992;89:1042–4.
474. Tibballs J, Kinney S. Reduction of hospital mortality and of preventable car- 505. Bhende MS, LaCovey DC. End-tidal carbon dioxide monitoring in the prehos-
diac arrest and death on introduction of a pediatric medical emergency team. pital setting. Prehosp Emerg Care 2001;5:208–13.
Pediatr Crit Care Med 2009;10:306–12. 506. Ornato JP, Shipley JB, Racht EM, et al. Multicenter study of a portable, hand-
475. Hunt EA, Zimmer KP, Rinke ML, et al. Transition from a traditional code team size, colorimetric end-tidal carbon dioxide detection device. Ann Emerg Med
to a medical emergency team and categorization of cardiopulmonary arrests 1992;21:518–23.
in a children’s center. Arch Pediatr Adolesc Med 2008;162:117–22. 507. Gonzalez del Rey JA, Poirier MP, Digiulio GA. Evaluation of an ambu-
476. Sharek PJ, Parast LM, Leong K, et al. Effect of a rapid response team on hospital- bag valve with a self-contained, colorimetric end-tidal CO2 system in the
wide mortality and code rates outside the ICU in a Children’s Hospital. JAMA detection of airway mishaps: an animal trial. Pediatr Emerg Care 2000;16:
2007;298:2267–74. 121–3.](https://image.slidesharecdn.com/fullerc2010guidelines1-101018011940-phpapp02/85/RCP-2010-guidelines-54-320.jpg)
![J.P. Nolan et al. / Resuscitation 81 (2010) 1219–1276 1273
508. Bhende MS, Karasic DG, Karasic RB. End-tidal carbon dioxide changes during unexplained death: a molecular autopsy of 49 medical examiner/coroner’s
cardiopulmonary resuscitation after experimental asphyxial cardiac arrest. Am cases. Mayo Clin Proc 2004;79:1380–4.
J Emerg Med 1996;14:349–50. 541. Graham EM, Forbus GA, Bradley SM, Shirali GS, Atz AM. Incidence and outcome
509. DeBehnke DJ, Hilander SJ, Dobler DW, Wickman LL, Swart GL. The hemody- of cardiopulmonary resuscitation in patients with shunted single ventricle:
namic and arterial blood gas response to asphyxiation: a canine model of advantage of right ventricle to pulmonary artery shunt. J Thorac Cardiovasc
pulseless electrical activity. Resuscitation 1995;30:169–75. Surg 2006;131:e7–8.
510. Ornato JP, Garnett AR, Glauser FL. Relationship between cardiac output and the 542. Charpie JR, Dekeon MK, Goldberg CS, Mosca RS, Bove EL, Kulik TJ. Postoperative
end-tidal carbon dioxide tension. Ann Emerg Med 1990;19:1104–6. hemodynamics after Norwood palliation for hypoplastic left heart syndrome.
511. Mauer D, Schneider T, Elich D, Dick W. Carbon dioxide levels during Am J Cardiol 2001;87:198–202.
pre-hospital active compression–decompression versus standard cardiopul- 543. Hoffman GM, Mussatto KA, Brosig CL, et al. Systemic venous oxygen saturation
monary resuscitation. Resuscitation 1998;39:67–74. after the Norwood procedure and childhood neurodevelopmental outcome. J
512. Kolar M, Krizmaric M, Klemen P, Grmec S. Partial pressure of end-tidal car- Thorac Cardiovasc Surg 2005;130:1094–100.
bon dioxide successful predicts cardiopulmonary resuscitation in the field: a 544. Johnson BA, Hoffman GM, Tweddell JS, et al. Near-infrared spectroscopy in
prospective observational study. Crit Care 2008;12:R115. neonates before palliation of hypoplastic left heart syndrome. Ann Thorac Surg
513. Sharieff GQ, Rodarte A, Wilton N, Bleyle D. The self-inflating bulb as an airway 2009;87:571–7 [discussion 7–9].
adjunct: is it reliable in children weighing less than 20 kilograms? Acad Emerg 545. Hoffman GM, Tweddell JS, Ghanayem NS, et al. Alteration of the critical arteri-
Med 2003;10:303–8. ovenous oxygen saturation relationship by sustained afterload reduction after
514. Sharieff GQ, Rodarte A, Wilton N, Silva PD, Bleyle D. The self-inflating bulb as an the Norwood procedure. J Thorac Cardiovasc Surg 2004;127:738–45.
esophageal detector device in children weighing more than twenty kilograms: 546. De Oliveira NC, Van Arsdell GS. Practical use of alpha blockade strategy in the
a comparison of two techniques. Ann Emerg Med 2003;41:623–9. management of hypoplastic left heart syndrome following stage one palliation
515. Dung NM, Day NPJ, Tam DTH, et al. Fluid replacement in dengue shock syn- with a Blalock-Taussig shunt. Semin Thorac Cardiovasc Surg Pediatr Card Surg
drome: a randomized, double-blind comparison of four intravenous-fluid Annu 2004;7:11–5.
regimens. Clin Infect Dis 1999;29:787–94. 547. Tweddell JS, Hoffman GM, Mussatto KA, et al. Improved survival of patients
516. Ngo NT, Cao XT, Kneen R, et al. Acute management of dengue shock syndrome: undergoing palliation of hypoplastic left heart syndrome: lessons learned from
a randomized double-blind comparison of 4 intravenous fluid regimens in the 115 consecutive patients. Circulation 2002;106:I82–9.
first hour. Clin Infect Dis 2001;32:204–13. 548. Shekerdemian LS, Shore DF, Lincoln C, Bush A, Redington AN. Negative-
517. Wills BA, Nguyen MD, Ha TL, et al. Comparison of three fluid solutions for pressure ventilation improves cardiac output after right heart surgery.
resuscitation in dengue shock syndrome. N Engl J Med 2005;353:877–89. Circulation 1996;94:II49–55.
518. Upadhyay M, Singhi S, Murlidharan J, Kaur N, Majumdar S. Randomized eval- 549. Shekerdemian LS, Bush A, Shore DF, Lincoln C, Redington AN. Cardiopulmonary
uation of fluid resuscitation with crystalloid (saline) and colloid (polymer interactions after Fontan operations: augmentation of cardiac output using
from degraded gelatin in saline) in pediatric septic shock. Indian Pediatr negative pressure ventilation. Circulation 1997;96:3934–42.
2005;42:223–31. 550. Booth KL, Roth SJ, Thiagarajan RR, Almodovar MC, del Nido PJ, Laussen PC.
519. Lillis KA, Jaffe DM. Prehospital intravenous access in children. Ann Emerg Med Extracorporeal membrane oxygenation support of the Fontan and bidirectional
1992;21:1430–4. Glenn circulations. Ann Thorac Surg 2004;77:1341–8.
520. Kanter RK, Zimmerman JJ, Strauss RH, Stoeckel KA. Pediatric emergency intra- 551. Polderman FN, Cohen J, Blom NA, et al. Sudden unexpected death in chil-
venous access. Evaluation of a protocol. Am J Dis Child 1986;140:132–4. dren with a previously diagnosed cardiovascular disorder. Int J Cardiol
521. Kleinman ME, Oh W, Stonestreet BS. Comparison of intravenous and endotra- 2004;95:171–6.
cheal epinephrine during cardiopulmonary resuscitation in newborn piglets. 552. Sanatani S, Wilson G, Smith CR, Hamilton RM, Williams WG, Adatia I. Sud-
Crit Care Med 1999;27:2748–54. den unexpected death in children with heart disease. Congenit Heart Dis
522. Roberts JR, Greenburg MI, Knaub M, Baskin SI. Comparison of the pharmacolog- 2006;1:89–97.
ical effects of epinephrine administered by the intravenous and endotracheal 553. Morris K, Beghetti M, Petros A, Adatia I, Bohn D. Comparison of hyperventilation
routes. JACEP 1978;7:260–4. and inhaled nitric oxide for pulmonary hypertension after repair of congenital
523. Zaritsky A. Pediatric resuscitation pharmacology. Members of the medications heart disease. Crit Care Med 2000;28:2974–8.
in pediatric resuscitation panel. Ann Emerg Med 1993;22:445–55. 554. Hoeper MM, Galie N, Murali S, et al. Outcome after cardiopulmonary resusci-
524. Manisterski Y, Vaknin Z, Ben-Abraham R, et al. Endotracheal epinephrine: a tation in patients with pulmonary arterial hypertension. Am J Respir Crit Care
call for larger doses. Anesth Analg 2002;95:1037–41 [table of contents]. Med 2002;165:341–4.
525. Efrati O, Ben-Abraham R, Barak A, et al. Endobronchial adrenaline: should it be 555. Rimensberger PC, Spahr-Schopfer I, Berner M, et al. Inhaled nitric oxide ver-
reconsidered? Dose response and haemodynamic effect in dogs. Resuscitation sus aerosolized iloprost in secondary pulmonary hypertension in children with
2003;59:117–22. congenital heart disease: vasodilator capacity and cellular mechanisms. Circu-
526. Saul JP, Scott WA, Brown S, et al. Intravenous amiodarone for incessant tach- lation 2001;103:544–8.
yarrhythmias in children: a randomized, double-blind, antiarrhythmic drug 556. Liu KS, Tsai FC, Huang YK, et al. Extracorporeal life support: a simple and
trial. Circulation 2005;112:3470–7. effective weapon for postcardiotomy right ventricular failure. Artif Organs
527. Tsung JW, Blaivas M. Feasibility of correlating the pulse check with focused 2009;33:504–8.
point-of-care echocardiography during pediatric cardiac arrest: a case series. 557. Dhillon R, Pearson GA, Firmin RK, Chan KC, Leanage R. Extracorporeal mem-
Resuscitation 2008;77:264–9. brane oxygenation and the treatment of critical pulmonary hypertension in
528. Cummins RO, Graves JR, Larsen MP, et al. Out-of-hospital transcutaneous pac- congenital heart disease. Eur J Cardiothorac Surg 1995;9:553–6.
ing by emergency medical technicians in patients with asystolic cardiac arrest. 558. Arpesella G, Loforte A, Mikus E, Mikus PM. Extracorporeal membrane oxygena-
N Engl J Med 1993;328:1377–82. tion for primary allograft failure. Transplant Proc 2008;40:3596–7.
529. Sreeram N, Wren C. Supraventricular tachycardia in infants: response to initial 559. Strueber M, Hoeper MM, Fischer S, et al. Bridge to thoracic organ transplanta-
treatment. Arch Dis Child 1990;65:127–9. tion in patients with pulmonary arterial hypertension using a pumpless lung
530. Benson Jr D, Smith W, Dunnigan A, Sterba R, Gallagher J. Mechanisms of regular assist device. Am J Transplant 2009;9:853–7.
wide QRS tachycardia in infants and children. Am J Cardiol 1982;49:1778–88. 560. Gluckman PD, Wyatt JS, Azzopardi D, et al. Selective head cooling with mild sys-
531. Ackerman MJ, Siu BL, Sturner WQ, et al. Postmortem molecular analysis of temic hypothermia after neonatal encephalopathy: multicentre randomised
SCN5A defects in sudden infant death syndrome. JAMA 2001;286:2264–9. trial. Lancet 2005;365:663–70.
532. Arnestad M, Crotti L, Rognum TO, et al. Prevalence of long-QT syndrome gene 561. Battin MR, Penrice J, Gunn TR, Gunn AJ. Treatment of term infants with head
variants in sudden infant death syndrome. Circulation 2007;115:361–7. cooling and mild systemic hypothermia (35.0 degrees C and 34.5 degrees C)
533. Cronk LB, Ye B, Kaku T, et al. Novel mechanism for sudden infant death syn- after perinatal asphyxia. Pediatrics 2003;111:244–51.
drome: persistent late sodium current secondary to mutations in caveolin-3. 562. Compagnoni G, Pogliani L, Lista G, Castoldi F, Fontana P, Mosca F. Hypothermia
Heart Rhythm 2007;4:161–6. reduces neurological damage in asphyxiated newborn infants. Biol Neonate
534. Millat G, Kugener B, Chevalier P, et al. Contribution of long-QT syn- 2002;82:222–7.
drome genetic variants in sudden infant death syndrome. Pediatr Cardiol 563. Gunn AJ, Gunn TR, Gunning MI, Williams CE, Gluckman PD. Neuroprotec-
2009;30:502–9. tion with prolonged head cooling started before postischemic seizures in fetal
535. Otagiri T, Kijima K, Osawa M, et al. Cardiac ion channel gene mutations in sheep. Pediatrics 1998;102:1098–106.
sudden infant death syndrome. Pediatr Res 2008;64:482–7. 564. Debillon T, Daoud P, Durand P, et al. Whole-body cooling after perinatal
536. Plant LD, Bowers PN, Liu Q, et al. A common cardiac sodium channel variant asphyxia: a pilot study in term neonates. Dev Med Child Neurol 2003;45:
associated with sudden infant death in African Americans. SCN5A S1103Y. J 17–23.
Clin Invest 2006;116:430–5. 565. Shankaran S, Laptook AR, Ehrenkranz RA, et al. Whole-body hypother-
537. Tester DJ, Dura M, Carturan E, et al. A mechanism for sudden infant death mia for neonates with hypoxic-ischemic encephalopathy. N Engl J Med
syndrome (SIDS): stress-induced leak via ryanodine receptors. Heart Rhythm 2005;353:1574–84.
2007;4:733–9. 566. Doherty DR, Parshuram CS, Gaboury I, et al. Hypothermia therapy after pedi-
538. Albert CM, Nam EG, Rimm EB, et al. Cardiac sodium channel gene variants and atric cardiac arrest. Circulation 2009;119:1492–500.
sudden cardiac death in women. Circulation 2008;117:16–23. 567. Coimbra C, Boris-Moller F, Drake M, Wieloch T. Diminished neuronal damage
539. Chugh SS, Senashova O, Watts A, et al. Postmortem molecular screening in in the rat brain by late treatment with the antipyretic drug dipyrone or cooling
unexplained sudden death. J Am Coll Cardiol 2004;43:1625–9. following cerebral ischemia. Acta Neuropathol 1996;92:447–53.
540. Tester DJ, Spoon DB, Valdivia HH, Makielski JC, Ackerman MJ. Targeted muta- 568. Coimbra C, Drake M, Boris-Moller F, Wieloch T. Long-lasting neuro-
tional analysis of the RyR2-encoded cardiac ryanodine receptor in sudden protective effect of postischemic hypothermia and treatment with an](https://image.slidesharecdn.com/fullerc2010guidelines1-101018011940-phpapp02/85/RCP-2010-guidelines-55-320.jpg)
![1274 J.P. Nolan et al. / Resuscitation 81 (2010) 1219–1276
anti-inflammatory/antipyretic drug. Evidence for chronic encephalopathic 605. Bouchama A, Dehbi M, Chaves-Carballo E. Cooling and hemodynamic manage-
processes following ischemia. Stroke 1996;27:1578–85. ment in heatstroke: practical recommendations. Crit Care 2007;11:R54.
569. Losert H, Sterz F, Roine RO, et al. Strict normoglycaemic blood glucose levels in 606. Eshel G, Safar P, Sassano J, Stezoski W. Hyperthermia-induced cardiac arrest in
the therapeutic management of patients within 12 h after cardiac arrest might dogs and monkeys. Resuscitation 1990;20:129–43.
not be necessary. Resuscitation 2008;76:214–20. 607. Eshel G, Safar P, Radovsky A, Stezoski SW. Hyperthermia-induced cardiac
570. Oksanen T, Skrifvars MB, Varpula T, et al. Strict versus moderate glucose arrest in monkeys: limited efficacy of standard CPR. Aviat Space Environ Med
control after resuscitation from ventricular fibrillation. Intensive Care Med 1997;68:415–20.
2007;33:2093–100. 608. Masoli M, Fabian D, Holt S, Beasley R. The global burden of asthma:
571. Palme-Kilander C. Methods of resuscitation in low-Apgar-score newborn executive summary of the GINA Dissemination Committee report. Allergy
infants—a national survey. Acta Paediatr 1992;81:739–44. 2004;59:469–78.
572. Dahm LS, James LS. Newborn temperature and calculated heat loss in the deliv- 609. Global Strategy for Asthma Management and Prevention 2009 [accessed
ery room. Pediatrics 1972;49:504–13. 24.06.10].
573. Stephenson J, Du J, Oliver TK. The effect of cooling on blood gas tensions in 610. Williams TJ, Tuxen DV, Scheinkestel CD, Czarny D, Bowes G. Risk factors for
newborn infants. J Pediatr 1970;76:848–52. morbidity in mechanically ventilated patients with acute severe asthma. Am
574. Gandy GM, Adamsons Jr K, Cunningham N, Silverman WA, James LS. Thermal Rev Respir Dis 1992;146:607–15.
environment and acid–base homeostasis in human infants during the first few 611. Bowman FP, Menegazzi JJ, Check BD, Duckett TM. Lower esophageal sphincter
hours of life. J Clin Invest 1964;43:751–8. pressure during prolonged cardiac arrest and resuscitation. Ann Emerg Med
575. Kent AL, Williams J. Increasing ambient operating theatre temperature and 1995;26:216–9.
wrapping in polyethylene improves admission temperature in premature 612. Leatherman JW, McArthur C, Shapiro RS. Effect of prolongation of expira-
infants. J Paediatr Child Health 2008;44:325–31. tory time on dynamic hyperinflation in mechanically ventilated patients with
576. Knobel RB, Wimmer Jr JE, Holbert D. Heat loss prevention for preterm infants severe asthma. Crit Care Med 2004;32:1542–5.
in the delivery room. J Perinatol 2005;25:304–8. 613. Lapinsky SE, Leung RS. Auto-PEEP and electromechanical dissociation. N Engl
577. Apgar V. A proposal for a new method of evaluation of the newborn infant. Curr J Med 1996;335:674.
Res Anesth Analg 1953:32. 614. Rogers PL, Schlichtig R, Miro A, Pinsky M. Auto-PEEP during CPR. An “occult”
578. Chamberlain G, Banks J. Assessment of the Apgar score. Lancet 1974;2:1225–8. cause of electromechanical dissociation? Chest 1991;99:492–3.
579. Owen CJ, Wyllie JP. Determination of heart rate in the baby at birth. Resuscita- 615. Rosengarten PL, Tuxen DV, Dziukas L, Scheinkestel C, Merrett K, Bowes G. Circu-
tion 2004;60:213–7. latory arrest induced by intermittent positive pressure ventilation in a patient
580. Kamlin CO, Dawson JA, O’Donnell CP, et al. Accuracy of pulse oximetry mea- with severe asthma. Anaesth Intensive Care 1991;19:118–21.
surement of heart rate of newborn infants in the delivery room. J Pediatr 616. Sprung J, Hunter K, Barnas GM, Bourke DL. Abdominal distention is not always a
2008;152:756–60. sign of esophageal intubation: cardiac arrest due to “auto-PEEP”. Anesth Analg
581. O’Donnell CP, Kamlin CO, Davis PG, Carlin JB, Morley CJ. Clinical assessment of 1994;78:801–4.
infant colour at delivery. Arch Dis Child Fetal Neonatal Ed 2007;92:F465–7. 617. Harrison R. Chest compression first aid for respiratory arrest due to acute
582. Cordero Jr L, Hon EH. Neonatal bradycardia following nasopharyngeal stimu- asphyxic asthma. Emerg Med J 2010;27:59–61.
lation. J Pediatr 1971;78:441–7. 618. Deakin CD, McLaren RM, Petley GW, Clewlow F, Dalrymple-Hay MJ. Effects
583. Houri PK, Frank LR, Menegazzi JJ, Taylor R. A randomized, controlled trial of of positive end-expiratory pressure on transthoracic impedance—implications
two-thumb vs two-finger chest compression in a swine infant model of cardiac for defibrillation. Resuscitation 1998;37:9–12.
arrest [see comment]. Prehosp Emerg Care 1997;1:65–7. 619. Galbois A, Ait-Oufella H, Baudel JL, et al. Pleural ultrasound compared to chest
584. David R. Closed chest cardiac massage in the newborn infant. Pediatrics radiographic detection of pneumothorax resolution after drainage. Chest 2010.
1988;81:552–4. 620. Mabuchi N, Takasu H, Ito S, et al. Successful extracorporeal lung assist (ECLA)
585. Menegazzi JJ, Auble TE, Nicklas KA, Hosack GM, Rack L, Goode JS. Two-thumb for a patient with severe asthma and cardiac arrest. Clin Intensive Care
versus two-finger chest compression during CRP in a swine infant model of 1991;2:292–4.
cardiac arrest. Ann Emerg Med 1993;22:240–3. 621. Martin GB, Rivers EP, Paradis NA, Goetting MG, Morris DC, Nowak RM. Emer-
586. Thaler MM, Stobie GH. An improved technique of external caridac compression gency department cardiopulmonary bypass in the treatment of human cardiac
in infants and young children. N Engl J Med 1963;269:606–10. arrest. Chest 1998;113:743–51.
587. Meyer A, Nadkarni V, Pollock A, et al. Evaluation of the Neonatal Resuscita- 622. Soar J, Pumphrey R, Cant A, et al. Emergency treatment of anaphylac-
tion Program’s recommended chest compression depth using computerized tic reactions—guidelines for healthcare providers. Resuscitation 2008;77:
tomography imaging. Resuscitation 2010;81:544–8. 157–69.
588. Wyckoff MH, Perlman JM, Laptook AR. Use of volume expansion during delivery 623. Soar J. Emergency treatment of anaphylaxis in adults: concise guidance. Clin
room resuscitation in near-term and term infants. Pediatrics 2005;115:950–5. Med 2009;9:181–5.
589. Soar J, Deakin CD, Nolan JP, et al. European Resuscitation Council guidelines for 624. Charalambous CP, Zipitis CS, Keenan DJ. Chest reexploration in the intensive
resuscitation 2005. Section 7. Cardiac arrest in special circumstances. Resusci- care unit after cardiac surgery: a safe alternative to returning to the operating
tation 2005;67(Suppl. 1):S135–70. theater. Ann Thorac Surg 2006;81:191–4.
590. Bronstein AC, Spyker DA, Cantilena Jr LR, Green JL, Rumack BH, Giffin SL. 625. McKowen RL, Magovern GJ, Liebler GA, Park SB, Burkholder JA, Maher TD. Infec-
2008 Annual Report of the American Association of Poison Control Centers’ tious complications and cost-effectiveness of open resuscitation in the surgical
National Poison Data System (NPDS): 26th Annual Report. Clin Toxicol (Phila) intensive care unit after cardiac surgery. Ann Thorac Surg 1985;40:388–92.
2009;47:911–1084. 626. Pottle A, Bullock I, Thomas J, Scott L. Survival to discharge following Open Chest
591. Yanagawa Y, Sakamoto T, Okada Y. Recovery from a psychotropic drug over- Cardiac Compression (OCCC). A 4-year retrospective audit in a cardiothoracic
dose tends to depend on the time from ingestion to arrival, the Glasgow specialist centre – Royal Brompton and Harefield NHS Trust, United Kingdom.
Coma Scale, and a sign of circulatory insufficiency on arrival. Am J Emerg Med Resuscitation 2002;52:269–72.
2007;25:757–61. 627. Mackay JH, Powell SJ, Osgathorp J, Rozario CJ. Six-year prospective audit of
592. Zimmerman JL. Poisonings and overdoses in the intensive care unit: general chest reopening after cardiac arrest. Eur J Cardiothorac Surg 2002;22:421–5.
and specific management issues. Crit Care Med 2003;31:2794–801. 628. Birdi I, Chaudhuri N, Lenthall K, Reddy S, Nashef SA. Emergency reinstitution of
593. Warner DS, Bierens JJ, Beerman SB, Katz LM. Drowning: a cry for help. Anes- cardiopulmonary bypass following cardiac surgery: outcome justifies the cost.
thesiology 2009;110:1211–3. Eur J Cardiothorac Surg 2000;17:743–6.
594. Danzl D. Accidental hypothermia. In: Auerbach P, editor. Wilderness medicine. 629. el-Banayosy A, Brehm C, Kizner L, et al. Cardiopulmonary resuscitation after
St. Louis: Mosby; 2007. p. 125–60. cardiac surgery: a two-year study. J Cardiothorac Vasc Anesth 1998;12:390–2.
595. Paal P, Beikircher W, Brugger H. Avalanche emergencies. Review of the current 630. Anthi A, Tzelepis GE, Alivizatos P, Michalis A, Palatianos GM, Geroulanos
situation. Anaesthesist 2006;55:314–24. S. Unexpected cardiac arrest after cardiac surgery: incidence, predisposing
596. Mattu A, Brady WJ, Perron AD. Electrocardiographic manifestations of causes, and outcome of open chest cardiopulmonary resuscitation. Chest
hypothermia. Am J Emerg Med 2002;20:314–26. 1998;113:15–9.
597. Ujhelyi MR, Sims JJ, Dubin SA, Vender J, Miller AW. Defibrillation energy 631. Wahba A, Gotz W, Birnbaum DE. Outcome of cardiopulmonary resuscitation
requirements and electrical heterogeneity during total body hypothermia. Crit following open heart surgery. Scand Cardiovasc J 1997;31:147–9.
Care Med 2001;29:1006–11. 632. Kaiser GC, Naunheim KS, Fiore AC, et al. Reoperation in the intensive care unit.
598. Walpoth BH, Walpoth-Aslan BN, Mattle HP, et al. Outcome of survivors of acci- Ann Thorac Surg 1990;49:903–7 [discussion 8].
dental deep hypothermia and circulatory arrest treated with extracorporeal 633. Rhodes JF, Blaufox AD, Seiden HS, et al. Cardiac arrest in infants after congenital
blood warming. N Engl J Med 1997;337:1500–5. heart surgery. Circulation 1999;100:II194–9.
599. Bouchama A, Knochel JP. Heat stroke. N Engl J Med 2002;346:1978–88. 634. Kempen PM, Allgood R. Right ventricular rupture during closed-chest car-
600. Bouchama A. The 2003 European heat wave. Intensive Care Med 2004;30:1–3. diopulmonary resuscitation after pneumonectomy with pericardiotomy: a
601. Coris EE, Ramirez AM, Van Durme DJ. Heat illness in athletes: the dangerous case report. Crit Care Med 1999;27:1378–9.
combination of heat, humidity and exercise. Sports Med 2004;34:9–16. 635. Bohrer H, Gust R, Bottiger BW. Cardiopulmonary resuscitation after cardiac
602. Grogan H, Hopkins PM. Heat stroke: implications for critical care and anaes- surgery. J Cardiothorac Vasc Anesth 1995;9:352.
thesia. Br J Anaesth 2002;88:700–7. 636. Klintschar M, Darok M, Radner H. Massive injury to the heart after attempted
603. Hadad E, Weinbroum AA, Ben-Abraham R. Drug-induced hyperthermia and active compression–decompression cardiopulmonary resuscitation. Int J Legal
muscle rigidity: a practical approach. Eur J Emerg Med 2003;10:149–54. Med 1998;111:93–6.
604. Halloran LL, Bernard DW. Management of drug-induced hyperthermia. Curr 637. Fosse E, Lindberg H. Left ventricular rupture following external chest compres-
Opin Pediatr 2004;16:211–5. sion. Acta Anaesthesiol Scand 1996;40:502–4.](https://image.slidesharecdn.com/fullerc2010guidelines1-101018011940-phpapp02/85/RCP-2010-guidelines-56-320.jpg)
![J.P. Nolan et al. / Resuscitation 81 (2010) 1219–1276 1275
638. Li Y, Wang H, Cho JH, et al. Defibrillation delivered during the upstroke 671. Cardosi RJ, Porter KB. Cesarean delivery of twins during maternal cardiopul-
phase of manual chest compression improves shock success. Crit Care Med monary arrest. Obstet Gynecol 1998;92:695–7.
2010;38:910–5. 672. Johnson MD, Luppi CJ, Over DC. Cardiopulmonary resuscitation. In: Gam-
639. Li Y, Yu T, Ristagno G, et al. The optimal phasic relationship between bling DR, Douglas MJ, editors. Obstetric anesthesia and uncommon disorders.
synchronized shock and mechanical chest compressions. Resuscitation Philadelphia: W.B. Saunders; 1998. p. 51–74.
2010;81:724–9. 673. Nanson J, Elcock D, Williams M, Deakin CD. Do physiological changes in preg-
640. Rosemurgy AS, Norris PA, Olson SM, Hurst JM, Albrink MH. Prehospital trau- nancy change defibrillation energy requirements? Br J Anaesth 2001;87:237–9.
matic cardiac arrest: the cost of futility. J Trauma 1993;35:468–73. 674. Katz VL, Dotters DJ, Droegemueller W. Perimortem cesarean delivery. Obstet
641. Shimazu S, Shatney CH. Outcomes of trauma patients with no vital signs on Gynecol 1986;68:571–6.
hospital admission. J Trauma 1983;23:213–6. 675. American Heart Association in collaboration with International Liaison Com-
642. Battistella FD, Nugent W, Owings JT, Anderson JT. Field triage of the pulseless mittee on Resuscitation. Guidelines 2000 for Cardiopulmonary Resuscitation
trauma patient. Arch Surg 1999;134:742–5. and Emergency Cardiovascular Care. Circulation 2000;102(Suppl.):I1–384.
643. Stockinger ZT, McSwain Jr NE. Additional evidence in support of withholding 676. Chapter 4; Part 6: cardiac arrest associated with pregnancy.Cummins R, Hazin-
or terminating cardiopulmonary resuscitation for trauma patients in the field. ski M, Field J, editors. ACLS—the reference textbook. Dallas: American Heart
J Am Coll Surg 2004;198:227–31. Association; 2003. p. 143–58.
644. Fulton RL, Voigt WJ, Hilakos AS. Confusion surrounding the treatment of trau- 677. Budnick LD. Bathtub-related electrocutions in the United States, 1979 to 1982.
matic cardiac arrest. J Am Coll Surg 1995;181:209–14. JAMA 1984;252:918–20.
645. Pasquale MD, Rhodes M, Cipolle MD, Hanley T, Wasser T. Defining “dead on 678. Lightning-associated deaths—United States, 1980–1995. MMWR Morb Mortal
arrival”: impact on a level I trauma center. J Trauma 1996;41:726–30. Wkly Rep 1998;47:391–4.
646. Stratton SJ, Brickett K, Crammer T. Prehospital pulseless, unconscious pene- 679. Geddes LA, Bourland JD, Ford G. The mechanism underlying sudden death from
trating trauma victims: field assessments associated with survival. J Trauma electric shock. Med Instrum 1986;20:303–15.
1998;45:96–100. 680. Cooper MA. Lightning injuries: prognostic signs for death. Ann Emerg Med
647. Maron BJ, Estes 3rd NA. Commotio cordis. N Engl J Med 2010;362:917–27. 1980;9:134–8.
648. Maron BJ, Gohman TE, Kyle SB, Estes 3rd NA, Link MS. Clinical profile and 681. Kleinschmidt-DeMasters BK. Neuropathology of lightning-strike injuries.
spectrum of commotio cordis. JAMA 2002;287:1142–6. Semin Neurol 1995;15:323–8.
649. Maron BJ, Estes 3rd NA, Link MS. Task Force 11: commotio cordis. J Am Coll 682. Stewart CE. When lightning strikes. Emerg Med Serv 2000;29:57–67 [quiz 103].
Cardiol 2005;45:1371–3. 683. Cooper MA. Emergent care of lightning and electrical injuries. Semin Neurol
650. Nesbitt AD, Cooper PJ, Kohl P. Rediscovering commotio cordis. Lancet 1995;15:268–78.
2001;357:1195–7. 684. Duclos PJ, Sanderson LM. An epidemiological description of lightning-related
651. Link MS, Estes M, Maron BJ. Sudden death caused by chest wall trauma (com- deaths in the United States. Int J Epidemiol 1990;19:673–9.
motio cordis). In: Kohl P, Sachs F, Franz MR, editors. Cardiac mechano-electric 685. Epperly TD, Stewart JR. The physical effects of lightning injury. J Fam Pract
feedback and arrhythmias: from pipette to patient. Philadelphia: Elsevier Saun- 1989;29:267–72.
ders; 2005. p. 270–6. 686. Whitcomb D, Martinez JA, Daberkow D. Lightning injuries. South Med J
652. Cera SM, Mostafa G, Sing RF, Sarafin JL, Matthews BD, Heniford BT. Physiologic 2002;95:1331–4.
predictors of survival in post-traumatic arrest. Am Surg 2003;69:140–4. 687. Chamberlain DA, Hazinski MF. Education in resuscitation. Resuscitation
653. Esposito TJ, Jurkovich GJ, Rice CL, Maier RV, Copass MK, Ashbaugh DG. Reap- 2003;59:11–43.
praisal of emergency room thoracotomy in a changing environment. J Trauma 688. Yeung J, Perkins GD. Timing of drug administration during CPR and the role of
1991;31:881–5 [discussion 5–7]. simulation. Resuscitation 2010;81:265–6.
654. Martin SK, Shatney CH, Sherck JP, et al. Blunt trauma patients with pre- 689. Berdowski J, Schmohl A, Tijssen JG, Koster RW. Time needed for a regional
hospital pulseless electrical activity (PEA): poor ending assured. J Trauma emergency medical system to implement resuscitation Guidelines 2005—The
2002;53:876–80 [discussion 80–81]. Netherlands experience. Resuscitation 2009;80:1336–41.
655. Domeier RM, McSwain Jr NE, Hopson LR, et al. Guidelines for withholding or 690. Bigham BL, Koprowicz K, Aufderheide TP, et al. Delayed Prehospital Implemen-
termination of resuscitation in prehospital traumatic cardiopulmonary arrest. tation of the 2005 American Heart Association Guidelines for Cardiopulmonary
J Am Coll Surg 2003;196:475–81. Resuscitation and Emergency Cardiac Care. Prehosp Emerg Care 2010.
656. Gervin AS, Fischer RP. The importance of prompt transport of salvage of patients 691. Andersen PO, Jensen MK, Lippert A, Ostergaard D. Identifying non-technical
with penetrating heart wounds. J Trauma 1982;22:443–8. skills and barriers for improvement of teamwork in cardiac arrest teams. Resus-
657. Branney SW, Moore EE, Feldhaus KM, Wolfe RE. Critical analysis of two citation 2010;81:695–702.
decades of experience with postinjury emergency department thoracotomy 692. Flin R, Patey R, Glavin R, Maran N. Anaesthetists’ non-technical skills. Br J
in a regional trauma center. J Trauma 1998;45:87–94 [discussion 5]. Anaesth 2010.
658. Durham III LA, Richardson RJ, Wall Jr MJ, Pepe PE, Mattox KL. Emergency center 693. Axelsson A, Thoren A, Holmberg S, Herlitz J. Attitudes of trained Swedish lay
thoracotomy: impact of prehospital resuscitation. J Trauma 1992;32:775–9. rescuers toward CPR performance in an emergency: a survey of 1012 recently
659. Frezza EE, Mezghebe H. Is 30 minutes the golden period to perform emergency trained CPR rescuers. Resuscitation 2000;44:27–36.
room thoratomy (ERT) in penetrating chest injuries? J Cardiovasc Surg (Torino) 694. Hubble MW, Bachman M, Price R, Martin N, Huie D. Willingness of high school
1999;40:147–51. students to perform cardiopulmonary resuscitation and automated external
660. Powell DW, Moore EE, Cothren CC, et al. Is emergency department resuscitative defibrillation. Prehosp Emerg Care 2003;7:219–24.
thoracotomy futile care for the critically injured patient requiring prehospital 695. Swor RA, Jackson RE, Compton S, et al. Cardiac arrest in private locations: differ-
cardiopulmonary resuscitation? J Am Coll Surg 2004;199:211–5. ent strategies are needed to improve outcome. Resuscitation 2003;58:171–6.
661. Coats TJ, Keogh S, Clark H, Neal M. Prehospital resuscitative thoracotomy for 696. Swor R, Khan I, Domeier R, Honeycutt L, Chu K, Compton S. CPR training and
cardiac arrest after penetrating trauma: rationale and case series. J Trauma CPR performance: do CPR-trained bystanders perform CPR? Acad Emerg Med
2001;50:670–3. 2006;13:596–601.
662. Wise D, Davies G, Coats T, Lockey D, Hyde J, Good A. Emergency thoracotomy: 697. Vaillancourt C, Stiell IG, Wells GA. Understanding and improving low bystander
“how to do it”. Emerg Med J 2005;22:22–4. CPR rates: a systematic review of the literature. CJEM 2008;10:51–65.
663. Kwan I, Bunn F, Roberts I. Spinal immobilisation for trauma patients. Cochrane 698. Boucek CD, Phrampus P, Lutz J, Dongilli T, Bircher NG. Willingness to perform
Database Syst Rev 2001:CD002803. mouth-to-mouth ventilation by health care providers: a survey. Resuscitation
664. Practice management guidelines for emergency department thoracotomy. 2009;80:849–53.
Working Group, Ad Hoc Subcommittee on Outcomes, American College of 699. Caves ND, Irwin MG. Attitudes to basic life support among medical students fol-
Surgeons-Committee on Trauma. J Am Coll Surg 2001;193:303–9. lowing the 2003 SARS outbreak in Hong Kong. Resuscitation 2006;68:93–100.
665. Walcher F, Kortum S, Kirschning T, Weihgold N, Marzi I. Optimized manage- 700. Coons SJ, Guy MC. Performing bystander CPR for sudden cardiac arrest: behav-
ment of polytraumatized patients by prehospital ultrasound. Unfallchirurg ioral intentions among the general adult population in Arizona. Resuscitation
2002;105:986–94. 2009;80:334–40.
666. Kirschning T, Brenner F, Stier M, Weber CF, Walcher F. Pre-hospital emergency 701. Dwyer T. Psychological factors inhibit family members’ confidence to initiate
sonography of trauma patients. Anaesthesist 2009;58:51–60. CPR. Prehosp Emerg Care 2008;12:157–61.
667. Department of Health, Welsh Office, Scottish Office Department of Health, 702. Jelinek GA, Gennat H, Celenza T, O’Brien D, Jacobs I, Lynch D. Community
Department of Health and Social Services, Northern Ireland. Why mothers die. attitudes towards performing cardiopulmonary resuscitation in Western Aus-
Report on confidential enquiries into maternal deaths in the United Kingdom, tralia. Resuscitation 2001;51:239–46.
2000–2002. London: The Stationery Office; 2004. 703. Johnston TC, Clark MJ, Dingle GA, FitzGerald G. Factors influencing Queens-
668. Hogan MC, Foreman KJ, Naghavi M, et al. Maternal mortality for 181 countries, landers’ willingness to perform bystander cardiopulmonary resuscitation.
1980–2008: a systematic analysis of progress towards Millennium Develop- Resuscitation 2003;56:67–75.
ment Goal 5. Lancet 2010;375:1609–23. 704. Kuramoto N, Morimoto T, Kubota Y, et al. Public perception of and willingness
669. Lewis G. The Confidential Enquiry into Maternal and Child Health (CEMACH). to perform bystander CPR in Japan. Resuscitation 2008;79:475–81.
Saving Mothers’ Lives: reviewing maternal deaths to make motherhood safer 705. Omi W, Taniguchi T, Kaburaki T, et al. The attitudes of Japanese high school stu-
– 2003–2005. The Seventh Report of the Confidential Enquiries into Maternal dents toward cardiopulmonary resuscitation. Resuscitation 2008;78:340–5.
Deaths in the United Kingdom. London: CEMACH; 2007. 706. Riegel B, Mosesso VN, Birnbaum A, et al. Stress reactions and perceived difficul-
670. Page-Rodriguez A, Gonzalez-Sanchez JA. Perimortem cesarean section of ties of lay responders to a medical emergency. Resuscitation 2006;70:98–106.
twin pregnancy: case report and review of the literature. Acad Emerg Med 707. Shibata K, Taniguchi T, Yoshida M, Yamamoto K. Obstacles to bystander car-
1999;6:1072–4. diopulmonary resuscitation in Japan. Resuscitation 2000;44:187–93.](https://image.slidesharecdn.com/fullerc2010guidelines1-101018011940-phpapp02/85/RCP-2010-guidelines-57-320.jpg)
![C.D. Deakin et al. / Resuscitation 81 (2010) 1293–1304 1301
6. Weisfeldt ML, Sitlani CM, Ornato JP, et al. Survival after application of auto- arrhythmia analysis algorithm performance, incorporating new waveforms,
matic external defibrillators before arrival of the emergency medical system: and enhancing safety. A statement for health professionals from the American
evaluation in the resuscitation outcomes consortium population of 21 million. Heart Association Task Force on Automatic External Defibrillation, Subcom-
J Am Coll Cardiol 2010;55:1713–20. mittee on AED Safety and Efficacy. Circulation 1997;95:1677–82.
7. Myerburg RJ, Fenster J, Velez M, et al. Impact of community-wide police 37. Dickey W, Dalzell GW, Anderson JM, Adgey AA. The accuracy of decision-
car deployment of automated external defibrillators on survival from out-of- making of a semi-automatic defibrillator during cardiac arrest. Eur Heart J
hospital cardiac arrest. Circulation 2002;106:1058–64. 1992;13:608–15.
8. Capucci A, Aschieri D, Piepoli MF, Bardy GH, Iconomu E, Arvedi M. Tripling 38. Atkinson E, Mikysa B, Conway JA, et al. Specificity and sensitivity of automated
survival from sudden cardiac arrest via early defibrillation without traditional external defibrillator rhythm analysis in infants and children. Ann Emerg Med
education in cardiopulmonary resuscitation. Circulation 2002;106:1065–70. 2003;42:185–96.
9. van Alem AP, Vrenken RH, de Vos R, Tijssen JG, Koster RW. Use of auto- 39. Cecchin F, Jorgenson DB, Berul CI, et al. Is arrhythmia detection by automatic
mated external defibrillator by first responders in out of hospital cardiac arrest: external defibrillator accurate for children? Sensitivity and specificity of an
prospective controlled trial. BMJ 2003;327:1312. automatic external defibrillator algorithm in 696 pediatric arrhythmias. Circu-
10. Valenzuela TD, Bjerke HS, Clark LL, et al. Rapid defibrillation by nontraditional lation 2001;103:2483–8.
responders: the Casino Project. Acad Emerg Med 1998;5:414–5. 40. van Alem AP, Sanou BT, Koster RW. Interruption of cardiopulmonary resusci-
11. Spearpoint KG, Gruber PC, Brett SJ. Impact of the Immediate Life Support course tation with the use of the automated external defibrillator in out-of-hospital
on the incidence and outcome of in-hospital cardiac arrest calls: an observa- cardiac arrest. Ann Emerg Med 2003;42:449–57.
tional study over 6 years. Resuscitation 2009;80:638–43. 41. Rea TD, Helbock M, Perry S, et al. Increasing use of cardiopulmonary resuscita-
12. Waalewijn RA, Tijssen JG, Koster RW. Bystander initiated actions in out- tion during out-of-hospital ventricular fibrillation arrest: survival implications
of-hospital cardiopulmonary resuscitation: results from the Amsterdam of guideline changes. Circulation 2006;114:2760–5.
Resuscitation Study (ARREST). Resuscitation 2001;50:273–9. 42. Gundersen K, Kvaloy JT, Kramer-Johansen J, Steen PA, Eftestol T. Development
13. Swor RA, Jackson RE, Cynar M, et al. Bystander CPR, ventricular fibrillation, and of the probability of return of spontaneous circulation in intervals without
survival in witnessed, unmonitored out-of-hospital cardiac arrest. Ann Emerg chest compressions during out-of-hospital cardiac arrest: an observational
Med 1995;25:780–4. study. BMC Med 2009;7:6.
14. Holmberg M, Holmberg S, Herlitz J. Effect of bystander cardiopulmonary resus- 43. Lloyd MS, Heeke B, Walter PF, Langberg JJ. Hands-on defibrillation: an analy-
citation in out-of-hospital cardiac arrest patients in Sweden. Resuscitation sis of electrical current flow through rescuers in direct contact with patients
2000;47:59–70. during biphasic external defibrillation. Circulation 2008;117:2510–4.
15. Vaillancourt C, Verma A, Trickett J, et al. Evaluating the effectiveness of 44. Miller PH. Potential fire hazard in defibrillation. JAMA 1972;221:192.
dispatch-assisted cardiopulmonary resuscitation instructions. Acad Emerg 45. Hummel III RS, Ornato JP, Weinberg SM, Clarke AM. Spark-generating proper-
Med 2007;14:877–83. ties of electrode gels used during defibrillation. A potential fire hazard. JAMA
16. O’Neill JF, Deakin CD. Evaluation of telephone CPR advice for adult cardiac arrest 1988;260:3021–4.
patients. Resuscitation 2007;74:63–7. 46. ECRI. Defibrillation in oxygen-enriched environments [hazard]. Health Devices
17. Yang CW, Wang HC, Chiang WC, et al. Interactive video instruction improves 1987;16:113–4.
the quality of dispatcher-assisted chest compression-only cardiopulmonary 47. Lefever J, Smith A. Risk of fire when using defibrillation in an oxygen enriched
resuscitation in simulated cardiac arrests. Crit Care Med 2009;37:490–5. atmosphere. Med Devices Agency Safety Notices 1995;3:1–3.
18. Yang CW, Wang HC, Chiang WC, et al. Impact of adding video communication 48. Ward ME. Risk of fires when using defibrillators in an oxygen enriched atmo-
to dispatch instructions on the quality of rescue breathing in simulated cardiac sphere. Resuscitation 1996;31:173.
arrests—a randomized controlled study. Resuscitation 2008;78:327–32. 49. Theodorou AA, Gutierrez JA, Berg RA. Fire attributable to a defibrillation
19. Koster RW, Baubin MA, Caballero A, et al. European Resuscitation Council attempt in a neonate. Pediatrics 2003;112:677–9.
Guidelines for Resuscitation 2010. Section 2. Adult basic life support and use 50. Robertshaw H, McAnulty G. Ambient oxygen concentrations during simulated
of automated external defibrillators. Resuscitation 2010;81:1277–92. cardiopulmonary resuscitation. Anaesthesia 1998;53:634–7.
20. Berdowski J, Schulten RJ, Tijssen JG, van Alem AP, Koster RW. Delaying a shock 51. Cantello E, Davy TE, Koenig KL. The question of removing a ventilation bag
after takeover from the automated external defibrillator by paramedics is asso- before defibrillation. J Accid Emerg Med 1998;15:286.
ciated with decreased survival. Resuscitation 2010;81:287–92. 52. Deakin CD, Paul V, Fall E, Petley GW, Thompson F. Ambient oxygen concentra-
21. Zafari AM, Zarter SK, Heggen V, et al. A program encouraging early defibril- tions resulting from use of the Lund University Cardiopulmonary Assist System
lation results in improved in-hospital resuscitation efficacy. J Am Coll Cardiol (LUCAS) device during simulated cardiopulmonary resuscitation. Resuscitation
2004;44:846–52. 2007;74:303–9.
22. Destro A, Marzaloni M, Sermasi S, Rossi F. Automatic external defibrillators in 53. Kerber RE, Kouba C, Martins J, et al. Advance prediction of transtho-
the hospital as well? Resuscitation 1996;31:39–43. racic impedance in human defibrillation and cardioversion: importance of
23. Forcina MS, Farhat AY, O’Neil WW, Haines DE. Cardiac arrest survival after impedance in determining the success of low-energy shocks. Circulation
implementation of automated external defibrillator technology in the in- 1984;70:303–8.
hospital setting. Crit Care Med 2009;37:1229–36. 54. Kerber RE, Grayzel J, Hoyt R, Marcus M, Kennedy J. Transthoracic resistance in
24. Domanovits H, Meron G, Sterz F, et al. Successful automatic external defibrilla- human defibrillation. Influence of body weight, chest size, serial shocks, paddle
tor operation by people trained only in basic life support in a simulated cardiac size and paddle contact pressure. Circulation 1981;63:676–82.
arrest situation. Resuscitation 1998;39:47–50. 55. Sado DM, Deakin CD, Petley GW, Clewlow F. Comparison of the effects of
25. Cusnir H, Tongia R, Sheka KP, et al. In hospital cardiac arrest: a role for automatic removal of chest hair with not doing so before external defibrillation on
defibrillation. Resuscitation 2004;63:183–8. transthoracic impedance. Am J Cardiol 2004;93:98–100.
26. Chan PS, Krumholz HM, Nichol G, Nallamothu BK. Delayed time to defibrillation 56. Walsh SJ, McCarty D, McClelland AJ, et al. Impedance compensated biphasic
after in-hospital cardiac arrest. N Engl J Med 2008;358:9–17. waveforms for transthoracic cardioversion of atrial fibrillation: a multi-centre
27. Cummins RO, Eisenberg MS, Litwin PE, Graves JR, Hearne TR, Hallstrom AP. comparison of antero-apical and antero-posterior pad positions. Eur Heart J
Automatic external defibrillators used by emergency medical technicians: a 2005;26:1298–302.
controlled clinical trial. JAMA 1987;257:1605–10. 57. Deakin CD, Sado DM, Petley GW, Clewlow F. Differential contribution of skin
28. Stults KR, Brown DD, Kerber RE. Efficacy of an automated external defibrillator impedance and thoracic volume to transthoracic impedance during external
in the management of out-of-hospital cardiac arrest: validation of the diagnos- defibrillation. Resuscitation 2004;60:171–4.
tic algorithm and initial clinical experience in a rural environment. Circulation 58. Deakin C, Sado D, Petley G, Clewlow F. Determining the optimal paddle force
1986;73:701–9. for external defibrillation. Am J Cardiol 2002;90:812–3.
29. Kramer-Johansen J, Edelson DP, Abella BS, Becker LB, Wik L, Steen PA. Pauses 59. Manegold JC, Israel CW, Ehrlich JR, et al. External cardioversion of atrial fib-
in chest compression and inappropriate shocks: a comparison of manual and rillation in patients with implanted pacemaker or cardioverter-defibrillator
semi-automatic defibrillation attempts. Resuscitation 2007;73:212–20. systems: a randomized comparison of monophasic and biphasic shock energy
30. Pytte M, Pedersen TE, Ottem J, Rokvam AS, Sunde K. Comparison of hands-off application. Eur Heart J 2007;28:1731–8.
time during CPR with manual and semi-automatic defibrillation in a manikin 60. Alferness CA. Pacemaker damage due to external countershock in patients
model. Resuscitation 2007;73:131–6. with implanted cardiac pacemakers. Pacing Clin Electrophysiol 1982;5:
31. Edelson DP, Abella BS, Kramer-Johansen J, et al. Effects of compression depth 457–8.
and pre-shock pauses predict defibrillation failure during cardiac arrest. Resus- 61. Panacek EA, Munger MA, Rutherford WF, Gardner SF. Report of nitropatch
citation 2006;71:137–45. explosions complicating defibrillation. Am J Emerg Med 1992;10:128–9.
32. Eftestol T, Sunde K, Steen PA. Effects of interrupting precordial compressions 62. Wrenn K. The hazards of defibrillation through nitroglycerin patches. Ann
on the calculated probability of defibrillation success during out-of-hospital Emerg Med 1990;19:1327–8.
cardiac arrest. Circulation 2002;105:2270–3. 63. Pagan-Carlo LA, Spencer KT, Robertson CE, Dengler A, Birkett C, Kerber
33. Yu T, Weil MH, Tang W, et al. Adverse outcomes of interrupted precordial RE. Transthoracic defibrillation: importance of avoiding electrode placement
compression during automated defibrillation. Circulation 2002;106:368–72. directly on the female breast. J Am Coll Cardiol 1996;27:449–52.
34. Wik L, Kramer-Johansen J, Myklebust H, et al. Quality of cardiopulmonary 64. Deakin CD, Sado DM, Petley GW, Clewlow F. Is the orientation of the api-
resuscitation during out-of-hospital cardiac arrest. JAMA 2005;293:299–304. cal defibrillation paddle of importance during manual external defibrillation?
35. Abella BS, Alvarado JP, Myklebust H, et al. Quality of cardiopulmonary resusci- Resuscitation 2003;56:15–8.
tation during in-hospital cardiac arrest. JAMA 2005;293:305–10. 65. Kirchhof P, Eckardt L, Loh P, et al. Anterior-posterior versus anterior-lateral
36. Kerber RE, Becker LB, Bourland JD, et al. Automatic external defibrillators for electrode positions for external cardioversion of atrial fibrillation: a ran-
public access defibrillation: recommendations for specifying and reporting domised trial. Lancet 2002;360:1275–9.](https://image.slidesharecdn.com/fullerc2010guidelines1-101018011940-phpapp02/85/RCP-2010-guidelines-83-320.jpg)
![C.D. Deakin et al. / Resuscitation 81 (2010) 1305–1352 1309
ing no difference in short- or long-term survival.183,189,191,193–199 resuscitation (CPR). For all in-hospital cardiac arrests, ensure that:
in one study, survival of the event was lower when physicians
were part of the resuscitation team.199 Studies indirectly compar- • cardiorespiratory arrest is recognised immediately;
ing resuscitation outcomes between physician-staffed and other • help is summoned using a standard telephone number;
systems are difficult to interpret because of the extremely high • CPR is started immediately using airway adjuncts, e.g., a pocket
variability between systems, independent of physician-staffing.200 mask and, if indicated, defibrillation attempted as rapidly as pos-
Although some studies have documented higher survival rates sible and certainly within 3 min.
after cardiac arrest in EMS systems that include experienced
physicians,186,188,201–203 compared with those that rely on non- The exact sequence of actions after in-hospital cardiac arrest
physician providers,201,202,204,205 other comparisons have found no will depend on many factors, including:
difference in survival between systems using paramedics or physi-
cians as part of the response.206,207 Well-organised non-physician
• location (clinical/non-clinical area; monitored/unmonitored
systems with highly trained paramedics have also reported high
area);
survival rates.200 Given the inconsistent evidence, the inclusion or
• training of the first responders;
exclusion of physicians among prehospital personnel responding
• number of responders;
to cardiac arrests will depend largely on existing local policy.
• equipment available;
• hospital response system to cardiac arrest and medical emergen-
Termination of resuscitation rules cies (e.g., MET, RRT).
One high-quality, prospective study has demonstrated that
Location
application of a ‘basic life support termination of resuscitation rule’
is predictive of death when applied by defibrillation-only emer-
Patients who have monitored arrests are usually diagnosed
gency medical technicians.208 The rule recommends termination
rapidly. Ward patients may have had a period of deterioration and
when there is no return of spontaneous circulation, no shocks are
an unwitnessed arrest.6,8 Ideally, all patients who are at high risk
administered, and the arrest is not witnessed by EMS personnel. Of
of cardiac arrest should be cared for in a monitored area where
776 patients with cardiac arrest for whom the rule recommended
facilities for immediate resuscitation are available.
termination, four survived [0.5% (95% CI 0.2–0.9)]. Implementation
of the rule would reduce the transportation rate by almost two
thirds. Four studies have shown external generalisability of this Training of first responders
rule.209–212
Additional studies have shown associations with futility of cer- All healthcare professionals should be able to recognise cardiac
tain variables such as no ROSC at scene; non-shockable rhythm; arrest, call for help and start CPR. Staff should do what they have
unwitnessed arrest; no bystander CPR, call response time and been trained to do. For example, staff in critical care and emer-
patient demographics.213–218 gency medicine will have more advanced resuscitation skills than
Two in-hospital studies and one emergency department study staff who are not involved regularly in resuscitation in their nor-
showed that the reliability of termination of resuscitation rules is mal clinical role. Hospital staff who attend a cardiac arrest may
limited in these settings.219–221 have different levels of skill to manage the airway, breathing and
Prospectively validated termination of resuscitation rules such circulation. Rescuers must undertake only the skills in which they
as the ‘basic life support termination of resuscitation rule’ can be are trained and competent.
used to guide termination of prehospital CPR in adults; however,
these must be validated in an emergency medical services system Number of responders
similar to the one in which implementation is proposed. Other rules
for various provider levels, including in-hospital providers, may be The single responder must ensure that help is coming. If other
helpful to reduce variability in decision-making; however, rules staff are nearby, several actions can be undertaken simultaneously.
should be prospectively validated prior to implementation.
Equipment available
CPR versus defibrillation first
All clinical areas should have immediate access to resuscitation
There is evidence that performing chest compressions while equipment and drugs to facilitate rapid resuscitation of the patient
retrieving and charging a defibrillator improves the probability of in cardiopulmonary arrest. Ideally, the equipment used for CPR
survival.222 EMS personnel should provide good-quality CPR while (including defibrillators) and the layout of equipment and drugs
a defibrillator is retrieved, applied and charged, but routine delivery should be standardised throughout the hospital.224,225
of a pre-specified period of CPR (e.g., 2 or 3 min) before rhythm anal-
ysis and a shock is delivered is not recommended. Some emergency
Resuscitation team
medical services have already fully implemented a pre-specified
period of chest compressions before defibrillation; given the lack
The resuscitation team may take the form of a traditional cardiac
of convincing data either supporting or refuting this strategy, it is
arrest team, which is called only when cardiac arrest is recognised.
reasonable for them to continue this practice (see Section 3).223
Alternatively, hospitals may have strategies to recognise patients
at risk of cardiac arrest and summon a team (e.g., MET or RRT)
4c In-hospital resuscitation before cardiac arrest occurs. The term ‘resuscitation team’ reflects
the range of response teams. In hospital cardiac arrests are rarely
After in-hospital cardiac arrest, the division between basic life sudden or unexpected. A strategy of recognising patients at risk of
support and advanced life support is arbitrary; in practice, the cardiac arrest may enable some of these arrests to be prevented, or
resuscitation process is a continuum and is based on common sense. may prevent futile resuscitation attempts in those who are unlikely
The public expect that clinical staff can undertake cardiopulmonary to benefit from CPR.](https://image.slidesharecdn.com/fullerc2010guidelines1-101018011940-phpapp02/85/RCP-2010-guidelines-91-320.jpg)
![C.D. Deakin et al. / Resuscitation 81 (2010) 1305–1352 1335
Disability (optimising neurological recovery) with intensive glucose control.688 Another recent study and two
meta-analyses of studies of tight glucose control versus conven-
Cerebral perfusion tional glucose control in critically ill patients showed no significant
difference in mortality but found tight glucose control was associ-
Immediately after ROSC there is a period of cerebral ated with a significantly increased risk of hypoglycaemia.689–691
hyperaemia.670 After asphyxial cardiac arrest, brain oedema may Severe hypoglycaemia is associated with increased mortality in
occur transiently after ROSC but it is rarely associated with clinically critically ill patients,692 and comatose patients are at particular
relevant increases in intracranial pressure.671,672 Autoregulation of risk from unrecognised hypoglycaemia. There is some evidence
cerebral blood flow is impaired for some time after cardiac arrest, that, irrespective of the target range, variability in glucose values is
which means that cerebral perfusion varies with cerebral perfusion associated with mortality.693
pressure instead of being linked to neuronal activity.673,674 As dis- Based on the available data, following ROSC blood glucose
cussed previously, following ROSC, maintain mean arterial pressure should be maintained at ≤10 mmol l−1 (180 mg dl−1 ).694 Hypo-
near the patient’s normal level. glycaemia should be avoided. Strict glucose control should not
be implemented in adult patients with ROSC after cardiac arrest
Sedation because of the increased risk of hypoglycaemia.
Although it has been common practice to sedate and ventilate Temperature control
patients for at least 24 h after ROSC, there are no high-level data to
support a defined period of ventilation, sedation and neuromuscu- Treatment of hyperpyrexia
lar blockade after cardiac arrest. Patients need to be well-sedated A period of hyperthermia (hyperpyrexia) is common in the
during treatment with therapeutic hypothermia, and the duration first 48 h after cardiac arrest.695–697 Several studies document
of sedation and ventilation is therefore influenced by this treat- an association between post-cardiac arrest pyrexia and poor
ment. There are no data to indicate whether or not the choice outcomes.498,695,697–700 There are no randomised controlled trials
of sedation influences outcome, but a combination of opioids evaluating the effect of treatment of pyrexia (defined as ≥37.6 ◦ C)
and hypnotics is usually used. Short-acting drugs (e.g., propofol, compared to no temperature control in patients after cardiac arrest.
alfentanil, remifentanil) will enable earlier neurological assess- Although the effect of elevated temperature on outcome is not
ment. Adequate sedation will reduce oxygen consumption. During proved, it seems prudent to treat any hyperthermia occurring after
hypothermia, optimal sedation can reduce or prevent shivering, cardiac arrest with antipyretics or active cooling.
which enable the target temperature to be achieved more rapidly.
Use of published sedation scales for monitoring these patients (e.g., Therapeutic hypothermia
the Richmond or Ramsay Scales) may be helpful.675,676 Animal and human data indicate that mild hypothermia is
neuroprotective and improves outcome after a period of global
Control of seizures cerebral hypoxia-ischaemia.701,702 Cooling suppresses many of
the pathways leading to delayed cell death, including apopto-
Seizures or myoclonus or both occur in 5–15% of adult sis (programmed cell death). Hypothermia decreases the cerebral
patients who achieve ROSC and 10–40% of those who remain metabolic rate for oxygen (CMRO2 ) by about 6% for each 1 ◦ C reduc-
comatose.498,677–680 Seizures increase cerebral metabolism by up tion in temperature703 and this may reduce the release of excitatory
to 3-fold681 and may cause cerebral injury: treat promptly and amino acids and free radicals.701 Hypothermia blocks the intra-
effectively with benzodiazepines, phenytoin, sodium valproate, cellular consequences of excitotoxin exposure (high calcium and
propofol, or a barbiturate. Myoclonus can be particularly difficult to glutamate concentrations) and reduces the inflammatory response
treat; phenytoin is often ineffective. Clonazepam is the most effec- associated with the post-cardiac arrest syndrome.
tive antimyoclonic drug, but sodium valproate, levetiracetam and
propofol may also be effective.682 Maintenance therapy should be Which post-cardiac arrest patients should be cooled?. All stud-
started after the first event once potential precipitating causes (e.g., ies of post-cardiac arrest therapeutic hypothermia have included
intracranial haemorrhage, electrolyte imbalance) are excluded. No only patients in coma. There is good evidence supporting the use
studies directly address the use of prophylactic anticonvulsant of induced hypothermia in comatose survivors of out-of-hospital
drugs after cardiac arrest in adults. cardiac arrest caused by VF. One randomised trial704 and a pseudo-
randomised trial669 demonstrated improved neurological outcome
Glucose control at hospital discharge or at 6 months in comatose patients after
out-of-hospital VF cardiac arrest. Cooling was initiated within min-
There is a strong association between high blood glucose utes to hours after ROSC and a temperature range of 32–34 ◦ C was
after resuscitation from cardiac arrest and poor neurological maintained for 12–24 h. Two studies with historical control groups
outcome.498–501,504,634,683,684 Although one randomised controlled showed improvement in neurological outcome after therapeutic
trial in a cardiac surgical intensive care unit showed that tight con- hypothermia for comatose survivors of VF cardiac arrest.705–707
trol of blood glucose (4.4–6.1 mmol l−1 or 80–110 mg dl−1 ) using Extrapolation of these data to other cardiac arrests (e.g., other initial
insulin reduced hospital mortality in critically ill adults,685 a sec- rhythms, in-hospital arrests, paediatric patients) seems reasonable
ond study by the same group in medical ICU patients showed but is supported by only lower level data.
no mortality benefit from tight glucose control.686 In one ran- One small, randomised trial showed reduced plasma lactate
domised trial of patients resuscitated from OHCA with ventricular values and oxygen extraction ratios in a group of comatose sur-
fibrillation, strict glucose control (72–108 mg dl−1 , 4–6 mmol l−1 ]) vivors after cardiac arrest with asystole or PEA who were cooled
gave no survival benefit compared with moderate glucose control with a cooling cap.708 Six studies with historical control groups
(108–144 mg dl−1 , 6–8 mmol l−1 ) and there were more episodes of have shown benefit using therapeutic hypothermia in comatose
hypoglycaemia in the strict glucose control group.687 A large ran- survivors of OHCA after all rhythm arrests.629,632,709–712 Two non-
domised trial of intensive glucose control (4.5–6.0 mmol l−1 ) versus randomised studies with concurrent controls indicate possible
conventional glucose control (10 mmol l−1 or less) in general ICU benefit of hypothermia following cardiac arrest from other initial
patients reported increased 90-day mortality in patients treated rhythms in- and out-of-hospital.713,714](https://image.slidesharecdn.com/fullerc2010guidelines1-101018011940-phpapp02/85/RCP-2010-guidelines-117-320.jpg)
![C.D. Deakin et al. / Resuscitation 81 (2010) 1305–1352 1337
and there is evidence that this therapy makes these tests less reli- hypoxemia, it is reasonable to use unprocessed EEG interpretation
able. (specifically identifying generalized suppression to less than 20 V,
burst suppression pattern with generalized epileptic activity, or dif-
Clinical examination fuse periodic complexes on a flat background) observed between
24 and 72 h after ROSC to assist the prediction of a poor outcome
There are no clinical neurological signs that reliably predict poor (FPR 3%, 95% CI 0.9–11%) in comatose survivors of cardiac arrest
outcome (cerebral performance category [CPC] 3 or 4, or death) less not treated with hypothermia.774 There is inadequate evidence to
than 24 h after cardiac arrest. In adult patients who are comatose support the routine use of other electrophysiological studies (e.g.,
after cardiac arrest, and who have not been treated with hypother- abnormal brainstem auditory evoked potentials) for prognostica-
mia and who do not have confounding factors (such as hypotension, tion of poor outcome in comatose cardiac arrest survivors.606
sedatives or muscle relaxants), the absence of both pupillary light
and corneal reflex at ≥72 h reliably predicts poor outcome (FPR Imaging studies
0%; 95% CI 0–9%).680 Absence of vestibulo-ocular reflexes at ≥24 h
(FPR 0%; 95% CI 0–14%)764,765 and a GCS motor score of 2 or less at Many imaging modalities (magnetic resonance imaging [MRI],
≥72 h (FPR 5%; 95% CI 2–9%)680 are less reliable. Other clinical signs, computed tomography [CT], single photon emission computed
including myoclonus, are not recommended for predicting poor tomography [SPECT], cerebral angiography, transcranial Doppler,
outcome. The presence of myoclonus status in adults is strongly nuclear medicine, near infra-red spectroscopy [NIRS]) have been
associated with poor outcome,679,680,766–768 but rare cases of good studied to determine their utility for prediction of outcome in adult
neurological recovery have been described and accurate diagnosis cardiac arrest survivors.606 There are no level one or level two stud-
is problematic.769–773 ies that support the use of any imaging modality to predict outcome
of comatose cardiac arrest survivors. Overall, those imaging stud-
Biochemical markers ies that have been undertaken were limited by small sample sizes,
variable time of imaging (many very late in the course), lack of com-
Serum neuronal specific enolase elevations are associ- parison with a standardised method of prognostication, and early
ated with poor outcome for comatose patients after cardiac withdrawal of care. Despite tremendous potential, neuroimaging
arrest.680,748,774–792 Although specific cut-off values with a false has yet to be proven as an independently accurate modality for
positive rate of 0% have been reported, clinical application is prediction of outcome in individual comatose cardiac arrest sur-
limited due to variability in the 0% FPR cut-off values reported vivors and, at this time, its routine use for this purpose is not
among various studies. recommended.
Serum S100 elevations are associated with
poor outcome for comatose patients after cardiac Impact of therapeutic hypothermia on prognostication
arrest.680,774–776,782,784,785,787,788,791,793–798
Many other serum markers measured after sustained return There is inadequate evidence to recommend a specific approach
of spontaneous circulation have been associated with poor out- to prognosticating poor outcome in post-cardiac arrest patients
come after cardiac arrest, including BNP,799 vWF,800 ICAM-1,800 treated with therapeutic hypothermia. There are no clinical neuro-
procalcitonin,794 IL-1ra, RANTES, sTNFRII, IL-6, IL-8 and IL-10.645 logical signs, electrophysiological studies, biomarkers, or imaging
However, other studies found no relationship between outcome modalities that can reliably predict neurological outcome in the
and serum IL-8,793 and procalcitonin and sTREM-1.801 first 24 h after cardiac arrest. Based on limited available evidence,
Worse outcomes for comatose survivors of cardiac arrest potentially reliable prognosticators of poor outcome in patients
are also associated with increased levels of cerebrospinal fluid treated with therapeutic hypothermia after cardiac arrest include
(CSF)-CK802,803 and cerebrospinal fluid-CKBB.774,775,777,789,803–807 bilateral absence of N20 peak on SSEP ≥ 24 h after cardiac arrest
However, one study found no relationship between cerebrospinal (FPR 0%, 95% CI 0–69%) and the absence of both corneal and pupil-
fluid-CKBB and prognosis.808 lary reflexes 3 or more days after cardiac arrest (FPR 0%, 95%
Outcomes are also associated with increased cerebrospinal fluid CI 0–48%).766,810 Limited available evidence also suggests that a
levels of other markers including NSE,775,784,789 ), S100,784 LDH, Glasgow Motor Score of 2 or less at 3 days post-ROSC (FPR 14%
GOT,777,803 neurofilament,809 acid phosphatase and lactate.803 [95% CI 3–44%])766 and the presence of status epilepticus (FPR of
Cerebrospinal fluid levels of beta-d-N-acetylglucosaminidase, and 7% [95% CI 1–25%] to 11.5% [95% CI 3–31%])811,812 are potentially
pyruvate were not associated with the prognosis of cardiac unreliable prognosticators of poor outcome in post-cardiac arrest
arrest.803 patients treated with therapeutic hypothermia. One study of 111
In summary, evidence does not support the use of serum or post-cardiac arrest patients treated with therapeutic hypothermia
CSF biomarkers alone as predictors of poor outcomes in comatose attempted to validate prognostic criteria proposed by the Amer-
patients after cardiac arrest with or without treatment with ther- ican Academy of Neurology.774,813 This study demonstrated that
apeutic hypothermia (TH). Limitations included small numbers of clinical exam findings at 36–72 h were unreliable predictors of
patients and/or inconsistency in cut-off values for predicting poor poor neurological outcome while bilaterally absent N20 peak on
outcome. somatosensory evoked potentials (false positive rate 0%, 95% CI
0–13%) and unreactive electroencephalogram background (false
Electrophysiological studies positive rate 0%, 95% CI 0–13%) were the most reliable. A decision
rule derived using this dataset demonstrated that the presence of
No electrophysiological study reliably predicts outcome of a two independent predictors of poor neurological outcome (incom-
comatose patient within the first 24 h after cardiac arrest. If plete recovery brainstem reflexes, early myoclonus, unreactive
somatosensory evoked potentials (SSEP) are measured after 24 h electroencephalogram and bilaterally absent cortical SSEPs) pre-
in comatose cardiac arrest survivors not treated with therapeu- dicted poor neurological outcome with a false positive rate of 0%
tic hypothermia, bilateral absence of the N20 cortical response to (95% CI 0–14%). Serum biomarkers such as NSE are potentially valu-
median nerve stimulation predicts poor outcome (death or CPC 3 or able as adjunctive studies in prognostication of poor outcome in
4) with a FPR of 0.7% (95% CI 0.1–3.7).774 In the absence of confound- patients treated with hypothermia, but their reliability is limited
ing circumstances such as sedatives, hypotension, hypothermia or because few patients have been studied and the assay is not well](https://image.slidesharecdn.com/fullerc2010guidelines1-101018011940-phpapp02/85/RCP-2010-guidelines-119-320.jpg)
![1340 C.D. Deakin et al. / Resuscitation 81 (2010) 1305–1352
102. Zenker P, Schlesinger A, Hauck M, et al. Implementation and impact of a 134. Haupt MT, Bekes CE, Brilli RJ, et al. Guidelines on critical care services and per-
rapid response team in a children’s hospital. Jt Comm J Qual Patient Saf sonnel: recommendations based on a system of categorization of three levels
2007;33:418–25. of care. Crit Care Med 2003;31:2677–83.
103. Dean BS, Decker MJ, Hupp D, Urbach AH, Lewis E, Benes-Stickle J. Condition 135. Peberdy MA, Ornato JP, Larkin GL, et al. Survival from in-hospital cardiac arrest
HELP: a pediatric rapid response team triggered by patients and parents. J during nights and weekends. JAMA 2008;299:785–92.
Healthc Qual 2008;30:28–31. 136. Hillson SD, Rich EC, Dowd B, Luxenberg MG. Call nights and patients care:
104. Ray EM, Smith R, Massie S, et al. Family alert: implementing direct family effects on inpatients at one teaching hospital. J Gen Intern Med 1992;7:405–
activation of a pediatric rapid response team. Jt Comm J Qual Patient Saf 10.
2009;35:575–80. 137. Bell CM, Redelmeier DA. Mortality among patients admitted to hospitals on
105. Kenward G, Castle N, Hodgetts T, Shaikh L. Evaluation of a medical emergency weekends as compared with weekdays. N Engl J Med 2001;345:663–8.
team one year after implementation. Resuscitation 2004;61:257–63. 138. Beck DH, McQuillan P, Smith GB. Waiting for the break of dawn? The effects of
106. Chan PS, Khalid A, Longmore LS, Berg RA, Kosiborod M, Spertus JA. Hospital- discharge time, discharge TISS scores and discharge facility on hospital mor-
wide code rates and mortality before and after implementation of a rapid tality after intensive care. Intensive Care Med 2002;28:1287–93.
response team. JAMA 2008;300:2506–13. 139. Goldfrad C, Rowan K. Consequences of discharges from intensive care at night.
107. Dacey MJ, Mirza ER, Wilcox V, et al. The effect of a rapid response team on Lancet 2000;355:1138–42.
major clinical outcome measures in a community hospital. Crit Care Med 140. Tourangeau AE, Cranley LA, Jeffs L. Impact of nursing on hospital patient mor-
2007;35:2076–82. tality: a focused review and related policy implications. Qual Saf Health Care
108. Story DA, Shelton AC, Poustie SJ, Colin-Thome NJ, McNicol PL. The effect of 2006;15:4–8.
critical care outreach on postoperative serious adverse events. Anaesthesia 141. Aiken LH, Clarke SP, Sloane DM, Sochalski J, Silber JH. Hospital nurse
2004;59:762–6. staffing and patient mortality, nurse burnout, and job dissatisfaction. JAMA
109. Story DA, Shelton AC, Poustie SJ, Colin-Thome NJ, McIntyre RE, McNicol PL. 2002;288:1987–93.
Effect of an anaesthesia department led critical care outreach and acute 142. Parr MJ, Hadfield JH, Flabouris A, Bishop G, Hillman K. The Medical Emergency
pain service on postoperative serious adverse events. Anaesthesia 2006;61: Team: 12 month analysis of reasons for activation, immediate outcome and
24–8. not-for-resuscitation orders. Resuscitation 2001;50:39–44.
110. Flabouris A, Chen J, Hillman K, Bellomo R, Finfer S. Timing and interven- 143. Baskett PJ, Lim A. The varying ethical attitudes towards resuscitation in Europe.
tions of emergency teams during the MERIT study. Resuscitation 2010;81: Resuscitation 2004;62:267–73.
25–30. 144. Baskett PJ, Steen PA, Bossaert L. European Resuscitation Council guidelines
111. Jones D, Bellomo R, Bates S, et al. Long term effect of a medical emergency team for resuscitation 2005, Section 8. The ethics of resuscitation and end-of-life
on cardiac arrests in a teaching hospital. Crit Care 2005;9:R808–15. decisions. Resuscitation 2005;67(Suppl. 1):S171–80.
112. Galhotra S, DeVita MA, Simmons RL, Schmid A. Impact of patient monitoring 145. Lippert FK, Raffay V, Georgiou M, Steen PA, Bossaert L. European Resuscitation
on the diurnal pattern of medical emergency team activation. Crit Care Med Council Guidelines for Resuscitation 2010, Section 10. The ethics of resuscita-
2006;34:1700–6. tion and end-of-life decisions. Resuscitation 2010;81:1445–51.
113. Baxter AD, Cardinal P, Hooper J, Patel R. Medical emergency teams at The 146. Smith GB. Increased do not attempt resuscitation decision making in hospi-
Ottawa Hospital: the first two years. Can J Anaesth 2008;55:223–31. tals with a medical emergency teams system-cause and effect? Resuscitation
114. Benson L, Mitchell C, Link M, Carlson G, Fisher J. Using an advanced prac- 2008;79:346–7.
tice nursing model for a rapid response team. Jt Comm J Qual Patient Saf 147. Chen J, Flabouris A, Bellomo R, Hillman K, Finfer S. The Medical Emergency
2008;34:743–7. Team System and not-for-resuscitation orders: results from the MERIT study.
115. Bertaut Y, Campbell A, Goodlett D. Implementing a rapid-response team using Resuscitation 2008;79:391–7.
a nurse-to-nurse consult approach. J Vasc Nurs 2008;26:37–42. 148. Jones DA, McIntyre T, Baldwin I, Mercer I, Kattula A, Bellomo R. The med-
116. Buist MD, Moore GE, Bernard SA, Waxman BP, Anderson JN, Nguyen TV. ical emergency team and end-of-life care: a pilot study. Crit Care Resusc
Effects of a medical emergency team on reduction of incidence of and mor- 2007;9:151–6.
tality from unexpected cardiac arrests in hospital: preliminary study. BMJ 149. Excellence NIfHaC. NICE clinical guideline 50 Acutely ill patients in hospi-
2002;324:387–90. tal: recognition of and response to acute illness in adults in hospital. London:
117. Buist M, Harrison J, Abaloz E, Van Dyke S. Six year audit of cardiac arrests and National Institute for Health and Clinical Excellence; 2007.
medical emergency team calls in an Australian outer metropolitan teaching 150. Muller D, Agrawal R, Arntz HR. How sudden is sudden cardiac death? Circula-
hospital. BMJ 2007;335:1210–2. tion 2006;114:1146–50.
118. Chamberlain B, Donley K, Maddison J. Patient outcomes using a rapid response 151. Nava A, Bauce B, Basso C, et al. Clinical profile and long-term follow-up of
team. Clin Nurse Spec 2009;23:11–2. 37 families with arrhythmogenic right ventricular cardiomyopathy. J Am Coll
119. Hatler C, Mast D, Bedker D, et al. Implementing a rapid response team to Cardiol 2000;36:2226–33.
decrease emergencies outside the ICU: one hospital’s experience. Medsurg 152. Brugada J, Brugada R, Brugada P. Determinants of sudden cardiac death in indi-
Nurs 2009;18, 84-90,126. viduals with the electrocardiographic pattern of Brugada syndrome and no
120. Jones D, Bellomo R, Bates S, et al. Patient monitoring and the timing of cardiac previous cardiac arrest. Circulation 2003;108:3092–6.
arrests and medical emergency team calls in a teaching hospital. Intensive Care 153. Elliott PM, Poloniecki J, Dickie S, et al. Sudden death in hypertrophic cardiomy-
Med 2006;32:1352–6. opathy: identification of high risk patients. J Am Coll Cardiol 2000;36:2212–8.
121. Moldenhauer K, Sabel A, Chu ES, Mehler PS. Clinical triggers: an alternative to 154. Goldenberg I, Moss AJ, Peterson DR, et al. Risk factors for aborted cardiac arrest
a rapid response team. Jt Comm J Qual Patient Saf 2009;35:164–74. and sudden cardiac death in children with the congenital long-QT syndrome.
122. Offner PJ, Heit J, Roberts R. Implementation of a rapid response team decreases Circulation 2008;117:2184–91.
cardiac arrest outside of the intensive care unit. J Trauma 2007;62:1223–7 155. Hobbs JB, Peterson DR, Moss AJ, et al. Risk of aborted cardiac arrest or
[discussion 7–8]. sudden cardiac death during adolescence in the long-QT syndrome. JAMA
123. Gould D. Promoting patient safety: The Rapid Medical Response Team. Perm J 2006;296:1249–54.
2007;11:26–34. 156. Hulot JS, Jouven X, Empana JP, Frank R, Fontaine G. Natural history and risk
124. Jolley J, Bendyk H, Holaday B, Lombardozzi KA, Harmon C. Rapid response stratification of arrhythmogenic right ventricular dysplasia/cardiomyopathy.
teams: do they make a difference? Dimens Crit Care Nurs 2007;26:253–60, Circulation 2004;110:1879–84.
quiz 61-2. 157. Kofflard MJ, Ten Cate FJ, van der Lee C, van Domburg RT. Hypertrophic car-
125. Konrad D, Jaderling G, Bell M, Granath F, Ekbom A, Martling CR. Reducing diomyopathy in a large community-based population: clinical outcome and
in-hospital cardiac arrests and hospital mortality by introducing a medical identification of risk factors for sudden cardiac death and clinical deterioration.
emergency team. Intensive Care Med 2010;36:100–6. J Am Coll Cardiol 2003;41:987–93.
126. Chen J, Bellomo R, Flabouris A, Hillman K, Finfer S. The relationship between 158. Peters S. Long-term follow-up and risk assessment of arrhythmogenic right
early emergency team calls and serious adverse events. Crit Care Med ventricular dysplasia/cardiomyopathy: personal experience from different pri-
2009;37:148–53. mary and tertiary centres. J Cardiovasc Med (Hagerstown) 2007;8:521–6.
127. Bristow PJ, Hillman KM, Chey T, et al. Rates of in-hospital arrests, deaths and 159. Priori SG, Napolitano C, Gasparini M, et al. Natural history of Brugada
intensive care admissions: the effect of a medical emergency team. Med J Aust syndrome: insights for risk stratification and management. Circulation
2000;173:236–40. 2002;105:1342–7.
128. King E, Horvath R, Shulkin DJ. Establishing a rapid response team (RRT) in an 160. Spirito P, Autore C, Rapezzi C, et al. Syncope and risk of sudden death in hyper-
academic hospital: one year’s experience. J Hosp Med 2006;1:296–305. trophic cardiomyopathy. Circulation 2009;119:1703–10.
129. McFarlan SJ, Hensley S. Implementation and outcomes of a rapid response 161. Sumitomo N, Harada K, Nagashima M, et al. Catecholaminergic polymorphic
team. J Nurs Care Qual 2007;22:307–13, quiz 14-5. ventricular tachycardia: electrocardiographic characteristics and optimal ther-
130. Rothschild JM, Woolf S, Finn KM, et al. A controlled trial of a rapid response apeutic strategies to prevent sudden death. Heart 2003;89:66–70.
system in an academic medical center. Jt Comm J Qual Patient Saf 2008;34, 162. Amital H, Glikson M, Burstein M, et al. Clinical characteristics of unexpected
417-25,365. death among young enlisted military personnel: results of a three-decade ret-
131. Chan PS, Jain R, Nallmothu BK, Berg RA, Sasson C. Rapid Response Teams: a rospective surveillance. Chest 2004;126:528–33.
systematic review and meta-analysis. Arch Intern Med 2010;170:18–26. 163. Basso C, Maron BJ, Corrado D, Thiene G. Clinical profile of congenital coronary
132. Leeson-Payne CG, Aitkenhead AR. A prospective study to assess the demand artery anomalies with origin from the wrong aortic sinus leading to sudden
for a high dependency unit. Anaesthesia 1995;50:383–7. death in young competitive athletes. J Am Coll Cardiol 2000;35:1493–501.
133. Guidelines for the utilisation of intensive care units. European Society of Inten- 164. Corrado D, Basso C, Thiene G. Sudden cardiac death in young people with
sive Care Medicine. Intensive Care Med 1994;20:163–4. apparently normal heart. Cardiovasc Res 2001;50:399–408.](https://image.slidesharecdn.com/fullerc2010guidelines1-101018011940-phpapp02/85/RCP-2010-guidelines-122-320.jpg)
![1346 C.D. Deakin et al. / Resuscitation 81 (2010) 1305–1352
473. Bar-Joseph G, Abramson NS, Kelsey SF, Mashiach T, Craig MT, Safar P. Improved 503. Mackenzie CF. A review of 100 cases of cardiac arrest and the relation of
resuscitation outcome in emergency medical systems with increased usage of potassium, glucose, and haemoglobin levels to survival. West Indian Med J
sodium bicarbonate during cardiopulmonary resuscitation. Acta Anaesthesiol 1975;24:39–45.
Scand 2005;49:6–15. 504. Mullner M, Sterz F, Binder M, Schreiber W, Deimel A, Laggner AN. Blood glu-
474. Weaver WD, Eisenberg MS, Martin JS, et al. Myocardial Infarction Triage and cose concentration after cardiopulmonary resuscitation influences functional
Intervention Project, phase I: patient characteristics and feasibility of prehos- neurological recovery in human cardiac arrest survivors. J Cereb Blood Flow
pital initiation of thrombolytic therapy. J Am Coll Cardiol 1990;15:925–31. Metab 1997;17:430–6.
475. Sandeman DJ, Alahakoon TI, Bentley SC. Tricyclic poisoning—successful man- 505. Skrifvars MB, Pettila V, Rosenberg PH, Castren M. A multiple logistic regres-
agement of ventricular fibrillation following massive overdose of imipramine. sion analysis of in-hospital factors related to survival at six months in
Anaesth Intensive Care 1997;25:542–5. patients resuscitated from out-of-hospital ventricular fibrillation. Resuscita-
476. Lin SR. The effect of dextran and streptokinase on cerebral function and blood tion 2003;59:319–28.
flow after cardiac arrest. An experimental study on the dog. Neuroradiology 506. Ditchey RV, Lindenfeld J. Potential adverse effects of volume loading
1978;16:340–2. on perfusion of vital organs during closed-chest resuscitation. Circulation
477. Fischer M, Bottiger BW, Popov-Cenic S, Hossmann KA. Thrombolysis using 1984;69:181–9.
plasminogen activator and heparin reduces cerebral no-reflow after resuscita- 507. Voorhees WD, Ralston SH, Kougias C, Schmitz PM. Fluid loading with
tion from cardiac arrest: an experimental study in the cat. Intensive Care Med whole blood or Ringer’s lactate solution during CPR in dogs. Resuscitation
1996;22:1214–23. 1987;15:113–23.
478. Ruiz-Bailen M, Aguayo de Hoyos E, Serrano-Corcoles MC, Diaz-Castellanos MA, 508. Gentile NT, Martin GB, Appleton TJ, Moeggenberg J, Paradis NA, Nowak RM.
Ramos-Cuadra JA, Reina-Toral A. Efficacy of thrombolysis in patients with acute Effects of arterial and venous volume infusion on coronary perfusion pressures
myocardial infarction requiring cardiopulmonary resuscitation. Intensive Care during canine CPR. Resuscitation 1991;22:55–63.
Med 2001;27:1050–7. 509. Bender R, Breil M, Heister U, et al. Hypertonic saline during CPR: feasibil-
479. Janata K, Holzer M, Kurkciyan I, et al. Major bleeding complications in car- ity and safety of a new protocol of fluid management during resuscitation.
diopulmonary resuscitation: the place of thrombolytic therapy in cardiac arrest Resuscitation 2007;72:74–81.
due to massive pulmonary embolism. Resuscitation 2003;57:49–55. 510. Bruel C, Parienti JJ, Marie W, et al. Mild hypothermia during advanced
480. Kurkciyan I, Meron G, Sterz F, et al. Pulmonary embolism as a cause of cardiac life support: a preliminary study in out-of-hospital cardiac arrest. Crit Care
arrest: presentation and outcome. Arch Intern Med 2000;160:1529–35. 2008;12:R31.
481. Lederer W, Lichtenberger C, Pechlaner C, Kroesen G, Baubin M. Recombinant 511. Kamarainen A, Virkkunen I, Tenhunen J, Yli-Hankala A, Silfvast T. Prehospital
tissue plasminogen activator during cardiopulmonary resuscitation in 108 induction of therapeutic hypothermia during CPR: a pilot study. Resuscitation
patients with out-of-hospital cardiac arrest. Resuscitation 2001;50:71–6. 2008;76:360–3.
482. Bozeman WP, Kleiner DM, Ferguson KL. Empiric tenecteplase is associated 512. Krep H, Breil M, Sinn D, Hagendorff A, Hoeft A, Fischer M. Effects of hypertonic
with increased return of spontaneous circulation and short term survival in versus isotonic infusion therapy on regional cerebral blood flow after exper-
cardiac arrest patients unresponsive to standard interventions. Resuscitation imental cardiac arrest cardiopulmonary resuscitation in pigs. Resuscitation
2006;69:399–406. 2004;63:73–83.
483. Stadlbauer KH, Krismer AC, Arntz HR, et al. Effects of thrombolysis during out- 513. Soar J, Foster J, Breitkreutz R. Fluid infusion during CPR and after ROSC—is it
of-hospital cardiopulmonary resuscitation. Am J Cardiol 2006;97:305–8. safe? Resuscitation 2009;80:1221–2.
484. Fatovich DM, Dobb GJ, Clugston RA. A pilot randomised trial of thrombolysis 514. Ong ME, Chan YH, Oh JJ, Ngo AS. An observational, prospective study compar-
in cardiac arrest (The TICA trial). Resuscitation 2004;61:309–13. ing tibial and humeral intraosseous access using the EZ-IO. Am J Emerg Med
485. Tiffany PA, Schultz M, Stueven H. Bolus thrombolytic infusions during CPR for 2009;27:8–15.
patients with refractory arrest rhythms: outcome of a case series. Ann Emerg 515. Gerritse BM, Scheffer GJ, Draaisma JM. Prehospital intraosseus access with the
Med 1998;31:124–6. bone injection gun by a helicopter-transported emergency medical team. J
486. Abu-Laban RB, Christenson JM, Innes GD, et al. Tissue plasminogen activator in Trauma 2009;66:1739–41.
cardiac arrest with pulseless electrical activity. N Engl J Med 2002;346:1522–8. 516. Brenner T, Bernhard M, Helm M, et al. Comparison of two intraosseous infusion
487. Bottiger BW, Arntz HR, Chamberlain DA, et al. Thrombolysis during resuscita- systems for adult emergency medical use. Resuscitation 2008;78:314–9.
tion for out-of-hospital cardiac arrest. N Engl J Med 2008;359:2651–62. 517. Frascone RJ, Jensen JP, Kaye K, Salzman JG. Consecutive field trials using two
488. Li X, Fu QL, Jing XL, et al. A meta-analysis of cardiopulmonary resuscitation different intraosseous devices. Prehosp Emerg Care 2007;11:164–71.
with and without the administration of thrombolytic agents. Resuscitation 518. Banerjee S, Singhi SC, Singh S, Singh M. The intraosseous route is a suitable
2006;70:31–6. alternative to intravenous route for fluid resuscitation in severely dehydrated
489. Fava M, Loyola S, Bertoni H, Dougnac A. Massive pulmonary embolism: per- children. Indian Pediatr 1994;31:1511–20.
cutaneous mechanical thrombectomy during cardiopulmonary resuscitation. 519. Brickman KR, Krupp K, Rega P, Alexander J, Guinness M. Typing and screening
J Vasc Interv Radiol 2005;16:119–23. of blood from intraosseous access. Ann Emerg Med 1992;21:414–7.
490. Lederer W, Lichtenberger C, Pechlaner C, Kinzl J, Kroesen G, Baubin M. Long- 520. Fiser RT, Walker WM, Seibert JJ, McCarthy R, Fiser DH. Tibial length following
term survival and neurological outcome of patients who received recombinant intraosseous infusion: a prospective, radiographic analysis. Pediatr Emerg Care
tissue plasminogen activator during out-of-hospital cardiac arrest. Resuscita- 1997;13:186–8.
tion 2004;61:123–9. 521. Ummenhofer W, Frei FJ, Urwyler A, Drewe J. Are laboratory values in bone mar-
491. Zahorec R. Rescue systemic thrombolysis during cardiopulmonary resuscita- row aspirate predictable for venous blood in paediatric patients? Resuscitation
tion. Bratisl Lek Listy 2002;103:266–9. 1994;27:123–8.
492. Konstantinov IE, Saxena P, Koniuszko MD, Alvarez J, Newman MA. Acute mas- 522. Guy J, Haley K, Zuspan SJ. Use of intraosseous infusion in the pediatric trauma
sive pulmonary embolism with cardiopulmonary resuscitation: management patient. J Pediatr Surg 1993;28:158–61.
and results. Tex Heart Inst J 2007;34:41–5 [discussion 5–6]. 523. Macnab A, Christenson J, Findlay J, et al. A new system for sternal intraosseous
493. Scholz KH, Hilmer T, Schuster S, Wojcik J, Kreuzer H, Tebbe U. Thrombolysis infusion in adults. Prehosp Emerg Care 2000;4:173–7.
in resuscitated patients with pulmonary embolism. Dtsch Med Wochenschr 524. Ellemunter H, Simma B, Trawoger R, Maurer H. Intraosseous lines in preterm
1990;115:930–5. and full term neonates. Arch Dis Child Fetal Neonatal Ed 1999;80:F74–5.
494. Gramann J, Lange-Braun P, Bodemann T, Hochrein H. Der Einsatz von Throm- 525. Delguercio LR, Feins NR, Cohn JD, Coomaraswamy RP, Wollman SB, State D.
bolytika in der Reanimation als Ultima ratio zur Überwindung des Herztodes. Comparison of blood flow during external and internal cardiac massage in man.
Intensiv- und Notfallbehandlung 1991;16:134–7. Circulation 1965;31(Suppl. 1):171–80.
495. Klefisch F, Gareis R, Störck T, Möckel M, Danne O. Praklinische ultima-ratio 526. Wik L, Kramer-Johansen J, Myklebust H, et al. Quality of cardiopul-
thrombolyse bei therapierefraktarer kardiopulmonaler reanimation. Inten- monary resuscitation during out-of-hospital cardiac arrest. JAMA 2005;293:
sivmedizin 1995;32:155–62. 299–304.
496. Böttiger BW, Martin E. Thrombolytic therapy during cardiopulmonary resusci- 527. Kramer-Johansen J, Myklebust H, Wik L, et al. Quality of out-of-hospital car-
tation and the role of coagulation activation after cardiac arrest. Curr Opin Crit diopulmonary resuscitation with real time automated feedback: a prospective
Care 2001;7:176–83. interventional study. Resuscitation 2006;71:283–92.
497. Spöhr F, Böttiger BW. Safety of thrombolysis during cardiopulmonary resusci- 528. Sutton RM, Maltese MR, Niles D, et al. Quantitative analysis of chest com-
tation. Drug Saf 2003;26:367–79. pression interruptions during in-hospital resuscitation of older children and
498. Langhelle A, Tyvold SS, Lexow K, Hapnes SA, Sunde K, Steen PA. In-hospital adolescents. Resuscitation 2009;80:1259–63.
factors associated with improved outcome after out-of-hospital cardiac arrest. 529. Sutton RM, Niles D, Nysaether J, et al. Quantitative analysis of CPR quality
A comparison between four regions in Norway. Resuscitation 2003;56:247–63. during in-hospital resuscitation of older children and adolescents. Pediatrics
499. Calle PA, Buylaert WA, Vanhaute OA. Glycemia in the post-resuscitation 2009;124:494–9.
period. The Cerebral Resuscitation Study Group. Resuscitation 530. Boczar ME, Howard MA, Rivers EP, et al. A technique revisited: hemodynamic
1989;17(Suppl.):S181–8 [discussion S99–206]. comparison of closed- and open-chest cardiac massage during human car-
500. Longstreth Jr WT, Diehr P, Inui TS. Prediction of awakening after out-of-hospital diopulmonary resuscitation. Crit Care Med 1995;23:498–503.
cardiac arrest. N Engl J Med 1983;308:1378–82. 531. Anthi A, Tzelepis GE, Alivizatos P, Michalis A, Palatianos GM, Geroulanos
501. Longstreth Jr WT, Inui TS. High blood glucose level on hospital admission and S. Unexpected cardiac arrest after cardiac surgery: incidence, predisposing
poor neurological recovery after cardiac arrest. Ann Neurol 1984;15:59–63. causes, and outcome of open chest cardiopulmonary resuscitation. Chest
502. Longstreth Jr WT, Copass MK, Dennis LK, Rauch-Matthews ME, Stark MS, 1998;113:15–9.
Cobb LA. Intravenous glucose after out-of-hospital cardiopulmonary arrest: 532. Pottle A, Bullock I, Thomas J, Scott L. Survival to discharge following Open Chest
a community-based randomized trial. Neurology 1993;43:2534–41. Cardiac Compression (OCCC). A 4-year retrospective audit in a cardiothoracic](https://image.slidesharecdn.com/fullerc2010guidelines1-101018011940-phpapp02/85/RCP-2010-guidelines-128-320.jpg)
![1348 C.D. Deakin et al. / Resuscitation 81 (2010) 1305–1352
intervention. A report on the use of the LUCAS device. Resuscitation [published correction appears in Ann Intern Med. 1990; 113:996]. Ann Intern
2007;75:454–9. Med 1990;113:104–10.
586. Bonnemeier H, Olivecrona G, Simonis G, et al. Automated continuous 611. Fuster V, Ryden LE, Cannom DS, et al. ACC/AHA/ESC 2006 guidelines for
chest compression for in-hospital cardiopulmonary resuscitation of patients the management of patients with atrial fibrillation: a report of the Ameri-
with pulseless electrical activity: a report of five cases. Int J Cardiol can College of Cardiology/American Heart Association Task Force on Practice
2009;136:e39–50. Guidelines and the European Society of Cardiology Committee for Practice
587. Grogaard HK, Wik L, Eriksen M, Brekke M, Sunde K. Continuous mechanical Guidelines (Writing Committee to Revise the 2001 Guidelines for the Manage-
chest compressions during cardiac arrest to facilitate restoration of coro- ment of Patients With Atrial Fibrillation): developed in collaboration with the
nary circulation with percutaneous coronary intervention. J Am Coll Cardiol European Heart Rhythm Association and the Heart Rhythm Society. Circulation
2007;50:1093–4. 2006;114:e257–354.
588. Larsen AI, Hjornevik A, Bonarjee V, Barvik S, Melberg T, Nilsen DW. Coronary 612. Sticherling C, Tada H, Hsu W, et al. Effects of diltiazem and esmolol on cycle
blood flow and perfusion pressure during coronary angiography in patients length and spontaneous conversion of atrial fibrillation. J Cardiovasc Pharmacol
with ongoing mechanical chest compression: a report on 6 cases. Resuscitation Ther 2002;7:81–8.
2010;81:493–7. 613. Shettigar UR, Toole JG, Appunn DO. Combined use of esmolol and digoxin in the
589. Smekal D, Johansson J, Huzevka T, Rubertsson S. No difference in autopsy acute treatment of atrial fibrillation or flutter. Am Heart J 1993;126:368–74.
detected injuries in cardiac arrest patients treated with manual chest com- 614. Demircan C, Cikriklar HI, Engindeniz Z, et al. Comparison of the effectiveness of
pressions compared with mechanical compressions with the LUCAS device—a intravenous diltiazem and metoprolol in the management of rapid ventricular
pilot study. Resuscitation 2009;80:1104–7. rate in atrial fibrillation. Emerg Med J 2005;22:411–4.
590. Deakin CD, Paul V, Fall E, Petley GW, Thompson F. Ambient oxygen concentra- 615. Wattanasuwan N, Khan IA, Mehta NJ, et al. Acute ventricular rate control in
tions resulting from use of the Lund University Cardiopulmonary Assist System atrial fibrillation: IV combination of diltiazem and digoxin vs. IV diltiazem
(LUCAS) device during simulated cardiopulmonary resuscitation. Resuscitation alone. Chest 2001;119:502–6.
2007;74:303–9. 616. Davey MJ, Teubner D. A randomized controlled trial of magnesium sulfate, in
591. Timerman S, Cardoso LF, Ramires JA, Halperin H. Improved hemodynamic addition to usual care, for rate control in atrial fibrillation. Ann Emerg Med
performance with a novel chest compression device during treatment of in- 2005;45:347–53.
hospital cardiac arrest. Resuscitation 2004;61:273–80. 617. Chiladakis JA, Stathopoulos C, Davlouros P, Manolis AS. Intravenous magne-
592. Halperin H, Berger R, Chandra N, et al. Cardiopulmonary resuscitation with a sium sulfate versus diltiazem in paroxysmal atrial fibrillation. Int J Cardiol
hydraulic-pneumatic band. Crit Care Med 2000;28:N203–6. 2001;79:287–91.
593. Halperin HR, Paradis N, Ornato JP, et al. Cardiopulmonary resuscitation with 618. Dauchot P, Gravenstein JS. Effects of atropine on the electrocardiogram in dif-
a novel chest compression device in a porcine model of cardiac arrest: ferent age groups. Clin Pharmacol Ther 1971;12:274–80.
improved hemodynamics and mechanisms. J Am Coll Cardiol 2004;44: 619. Chamberlain DA, Turner P, Sneddon JM. Effects of atropine on heart-rate in
2214–20. healthy man. Lancet 1967;2:12–5.
594. Hallstrom A, Rea TD, Sayre MR, et al. Manual chest compression vs use of an 620. Bernheim A, Fatio R, Kiowski W, Weilenmann D, Rickli H, Rocca HP. Atropine
automated chest compression device during resuscitation following out-of- often results in complete atrioventricular block or sinus arrest after cardiac
hospital cardiac arrest: a randomized trial. JAMA 2006;295:2620–8. transplantation: an unpredictable and dose-independent phenomenon. Trans-
595. Steinmetz J, Barnung S, Nielsen SL, Risom M, Rasmussen LS. Improved survival plantation 2004;77:1181–5.
after an out-of-hospital cardiac arrest using new guidelines. Acta Anaesthesiol 621. Klumbies A, Paliege R, Volkmann H. Mechanical emergency stimulation in
Scand 2008;52:908–13. asystole and extreme bradycardia. Z Gesamte Inn Med 1988;43:348–52.
596. Casner M, Andersen D, Isaacs SM. Preliminary report of the impact of a new CPR 622. Zeh E, Rahner E. The manual extrathoracal stimulation of the heart. Tech-
assist device on the rate of return of spontaneous circulation in out of hospital nique and effect of the precordial thump (author’s transl). Z Kardiol
cardiac arrest. PreHosp Emerg Med 2005;9:61–7. 1978;67:299–304.
597. Ong ME, Ornato JP, Edwards DP, et al. Use of an automated, load-distributing 623. Chan L, Reid C, Taylor B. Effect of three emergency pacing modalities on
band chest compression device for out-of-hospital cardiac arrest resuscitation. cardiac output in cardiac arrest due to ventricular asystole. Resuscitation
JAMA 2006;295:2629–37. 2002;52:117–9.
598. Paradis N, Young G, Lemeshow S, Brewer J, Halperin H. Inhomogene- 624. Camm AJ, Garratt CJ. Adenosine and supraventricular tachycardia. N Engl J Med
ity and temporal effects in AutoPulse Assisted Prehospital International 1991;325:1621–9.
Resuscitation—an exception from consent trial terminated early. Am J Emerg 625. Wang HE, O’Connor RE, Megargel RE, et al. The use of diltiazem for treat-
Med 2010;28:391–8. ing rapid atrial fibrillation in the out-of-hospital setting. Ann Emerg Med
599. Tomte O, Sunde K, Lorem T, et al. Advanced life support performance with man- 2001;37:38–45.
ual and mechanical chest compressions in a randomized, multicentre manikin 626. Martinez-Marcos FJ, Garcia-Garmendia JL, Ortega-Carpio A, Fernandez-Gomez
study. Resuscitation 2009;80:1152–7. JM, Santos JM, Camacho C. Comparison of intravenous flecainide, propafenone,
600. Wirth S, Korner M, Treitl M, et al. Computed tomography during cardiopul- and amiodarone for conversion of acute atrial fibrillation to sinus rhythm. Am
monary resuscitation using automated chest compression devices—an initial J Cardiol 2000;86:950–3.
study. Eur Radiol 2009;19:1857–66. 627. Kalus JS, Spencer AP, Tsikouris JP, et al. Impact of prophylactic i.v. magnesium
601. Holmstrom P, Boyd J, Sorsa M, Kuisma M. A case of hypothermic cardiac arrest on the efficacy of ibutilide for conversion of atrial fibrillation or flutter. Am J
treated with an external chest compression device (LUCAS) during transport Health Syst Pharm 2003;60:2308–12.
to re-warming. Resuscitation 2005;67:139–41. 628. Nolan JP, Neumar RW, Adrie C, et al. Post-cardiac arrest syndrome: epidemiol-
602. Wik L, Kiil S. Use of an automatic mechanical chest compression device (LUCAS) ogy, pathophysiology, treatment, and prognostication. A Scientific Statement
as a bridge to establishing cardiopulmonary bypass for a patient with hypother- from the International Liaison Committee on Resuscitation; the American
mic cardiac arrest. Resuscitation 2005;66:391–4. Heart Association Emergency Cardiovascular Care Committee; the Council on
603. Sunde K, Wik L, Steen PA. Quality of mechanical, manual standard and active Cardiovascular Surgery and Anesthesia; the Council on Cardiopulmonary, Peri-
compression–decompression CPR on the arrest site and during transport in a operative, and Critical Care; the Council on Clinical Cardiology; the Council on
manikin model. Resuscitation 1997;34:235–42. Stroke. Resuscitation 2008;79:350–79.
604. Lown B, Amarasingham R, Neuman J. New method for terminating car- 629. Sunde K, Pytte M, Jacobsen D, et al. Implementation of a standardised treat-
diac arrhythmias. Use of synchronized capacitor discharge. JAMA 1962;182: ment protocol for post resuscitation care after out-of-hospital cardiac arrest.
548–55. Resuscitation 2007;73:29–39.
605. Zipes DP, Camm AJ, Borggrefe M, et al. ACC/AHA/ESC 2006 guidelines for man- 630. Gaieski DF, Band RA, Abella BS, et al. Early goal-directed hemodynamic opti-
agement of patients with ventricular arrhythmias and the prevention of sudden mization combined with therapeutic hypothermia in comatose survivors of
cardiac death: a report of the American College of Cardiology/American Heart out-of-hospital cardiac arrest. Resuscitation 2009;80:418–24.
Association Task Force and the European Society of Cardiology Committee for 631. Carr BG, Goyal M, Band RA, et al. A national analysis of the relationship
Practice Guidelines (Writing Committee to Develop Guidelines for Manage- between hospital factors and post-cardiac arrest mortality. Intensive Care Med
ment of Patients With Ventricular Arrhythmias and the Prevention of Sudden 2009;35:505–11.
Cardiac Death). J Am Coll Cardiol 2006;48:e247–346. 632. Oddo M, Schaller MD, Feihl F, Ribordy V, Liaudet L. From evidence to clini-
606. Deakin CD, Morrison LJ, Morley PT, et al. 2010 International consensus on car- cal practice: effective implementation of therapeutic hypothermia to improve
diopulmonary resuscitation and emergency cardiovascular care science with patient outcome after cardiac arrest. Crit Care Med 2006;34:1865–73.
treatment recommendations. Part 8: advanced life support. Resuscitation; 633. Knafelj R, Radsel P, Ploj T, Noc M. Primary percutaneous coronary intervention
doi:10.1016/j.resuscitation.2010.08.027, in press. and mild induced hypothermia in comatose survivors of ventricular fibrillation
607. Manz M, Pfeiffer D, Jung W, Lueritz B. Intravenous treatment with magne- with ST-elevation acute myocardial infarction. Resuscitation 2007;74:227–34.
sium in recurrent persistent ventricular tachycardia. New Trends Arrhythmias 634. Nolan JP, Laver SR, Welch CA, Harrison DA, Gupta V, Rowan K. Outcome
1991;7:437–42. following admission to UK intensive care units after cardiac arrest: a sec-
608. Tzivoni D, Banai S, Schuger C, et al. Treatment of torsade de pointes with ondary analysis of the ICNARC Case Mix Programme Database. Anaesthesia
magnesium sulfate. Circulation 1988;77:392–7. 2007;62:1207–16.
609. Delacretaz E. Clinical practice. Supraventricular tachycardia. N Engl J Med 635. Keenan SP, Dodek P, Martin C, Priestap F, Norena M, Wong H. Variation in length
2006;354:1039–51. of intensive care unit stay after cardiac arrest: where you are is as important
610. DiMarco JP, Miles W, Akhtar M, et al. Adenosine for paroxysmal supraventric- as who you are. Crit Care Med 2007;35:836–41.
ular tachycardia: dose ranging and comparison with verapamil: assessment 636. Carr BG, Kahn JM, Merchant RM, Kramer AA, Neumar RW. Inter-hospital vari-
in placebo-controlled, multicenter trials. The Adenosine for PSVT Study Group ability in post-cardiac arrest mortality. Resuscitation 2009;80:30–4.](https://image.slidesharecdn.com/fullerc2010guidelines1-101018011940-phpapp02/85/RCP-2010-guidelines-130-320.jpg)
![1350 C.D. Deakin et al. / Resuscitation 81 (2010) 1305–1352
700. Diringer MN, Reaven NL, Funk SE, Uman GC. Elevated body temperature inde- 729. Kamarainen A, Virkkunen I, Tenhunen J, Yli-Hankala A, Silfvast T. Prehospital
pendently contributes to increased length of stay in neurologic intensive care therapeutic hypothermia for comatose survivors of cardiac arrest: a random-
unit patients. Crit Care Med 2004;32:1489–95. ized controlled trial. Acta Anaesthesiol Scand 2009;53:900–7.
701. Gunn AJ, Thoresen M. Hypothermic neuroprotection. NeuroRx 2006;3:154–69. 730. Kamarainen A, Virkkunen I, Tenhunen J, Yli-Hankala A, Silfvast T. Induction of
702. Froehler MT, Geocadin RG. Hypothermia for neuroprotection after car- therapeutic hypothermia during prehospital CPR using ice-cold intravenous
diac arrest: mechanisms, clinical trials and patient care. J Neurol Sci fluid. Resuscitation 2008;79:205–11.
2007;261:118–26. 731. Hammer L, Vitrat F, Savary D, et al. Immediate prehospital hypothermia pro-
703. McCullough JN, Zhang N, Reich DL, et al. Cerebral metabolic suppression during tocol in comatose survivors of out-of-hospital cardiac arrest. Am J Emerg Med
hypothermic circulatory arrest in humans. Ann Thorac Surg 1999;67:1895–9 2009;27:570–3.
[discussion 919–21]. 732. Aberle J, Kluge S, Prohl J, et al. Hypothermia after CPR through conduc-
704. Mild therapeutic hypothermia to improve the neurologic outcome after cardiac tion and convection—initial experience on an ICU. Intensivmed Notfallmed
arrest. N Engl J Med 2002;346:549–56. 2006;43:37–43.
705. Belliard G, Catez E, Charron C, et al. Efficacy of therapeutic hypothermia 733. Feuchtl A, Gockel B, Lawrenz T, Bartelsmeier M, Stellbrink C. Endovascular cool-
after out-of-hospital cardiac arrest due to ventricular fibrillation. Resuscitation ing improves neurological short-term outcome after prehospital cardiac arrest.
2007;75:252–9. Intensivmedizin 2007;44:37–42.
706. Castrejon S, Cortes M, Salto ML, et al. Improved prognosis after using mild 734. Fries M, Stoppe C, Brucken D, Rossaint R, Kuhlen R. Influence of mild therapeutic
hypothermia to treat cardiorespiratory arrest due to a cardiac cause: compar- hypothermia on the inflammatory response after successful resuscitation from
ison with a control group. Rev Esp Cardiol 2009;62:733–41. cardiac arrest. J Crit Care 2009;24:453–7.
707. Bro-Jeppesen J, Kjaergaard J, Horsted TI, et al. The impact of therapeutic 735. Benson DW, Williams Jr GR, Spencer FC, Yates AJ. The use of hypothermia after
hypothermia on neurological function and quality of life after cardiac arrest. cardiac arrest. Anesth Analg 1959;38:423–8.
Resuscitation 2009;80:171–6. 736. Yanagawa Y, Ishihara S, Norio H, et al. Preliminary clinical outcome study of
708. Hachimi-Idrissi S, Corne L, Ebinger G, Michotte Y, Huyghens L. Mild hypother- mild resuscitative hypothermia after out-of-hospital cardiopulmonary arrest.
mia induced by a helmet device: a clinical feasibility study. Resuscitation Resuscitation 1998;39:61–6.
2001;51:275–81. 737. Damian MS, Ellenberg D, Gildemeister R, et al. Coenzyme Q10 combined
709. Bernard SA, Jones BM, Horne MK. Clinical trial of induced hypothermia with mild hypothermia after cardiac arrest: a preliminary study. Circulation
in comatose survivors of out-of-hospital cardiac arrest. Ann Emerg Med 2004;110:3011–6.
1997;30:146–53. 738. Hay AW, Swann DG, Bell K, Walsh TS, Cook B. Therapeutic hypother-
710. Busch M, Soreide E, Lossius HM, Lexow K, Dickstein K. Rapid implementation of mia in comatose patients after out-of-hospital cardiac arrest. Anaesthesia
therapeutic hypothermia in comatose out-of-hospital cardiac arrest survivors. 2008;63:15–9.
Acta Anaesthesiol Scand 2006;50:1277–83. 739. Zeiner A, Holzer M, Sterz F, et al. Mild resuscitative hypothermia to improve
711. Storm C, Steffen I, Schefold JC, et al. Mild therapeutic hypothermia shortens neurological outcome after cardiac arrest. A clinical feasibility trial. Hypother-
intensive care unit stay of survivors after out-of-hospital cardiac arrest com- mia After Cardiac Arrest (HACA) Study Group. Stroke 2000;31:86–94.
pared to historical controls. Crit Care 2008;12:R78. 740. Uray T, Malzer R. Out-of-hospital surface cooling to induce mild hypothermia
712. Don CW, Longstreth Jr WT, Maynard C, et al. Active surface cooling protocol in human cardiac arrest: a feasibility trial. Resuscitation 2008;77:331–8.
to induce mild therapeutic hypothermia after out-of-hospital cardiac arrest: a 740a. Castren M, Nordberg P, Svensson L, et al. Intra-arrest transnasal evapora-
retrospective before-and-after comparison in a single hospital. Crit Care Med tive cooling: a randomized, prehospital, multicenter study (PRINCE: Pre-ROSC
2009;37:3062–9. IntraNasal Cooling Effectiveness). Circulation 2010;122:729–36.
713. Arrich J. Clinical application of mild therapeutic hypothermia after cardiac 741. Felberg RA, Krieger DW, Chuang R, et al. Hypothermia after cardiac
arrest. Crit Care Med 2007;35:1041–7. arrest: feasibility and safety of an external cooling protocol. Circulation
714. Holzer M, Mullner M, Sterz F, et al. Efficacy and safety of endovascular 2001;104:1799–804.
cooling after cardiac arrest: cohort study and Bayesian approach. Stroke 742. Flint AC, Hemphill JC, Bonovich DC. Therapeutic hypothermia after cardiac
2006;37:1792–7. arrest: performance characteristics and safety of surface cooling with or with-
715. Polderman KH, Herold I. Therapeutic hypothermia and controlled normother- out endovascular cooling. Neurocrit Care 2007;7:109–18.
mia in the intensive care unit: practical considerations, side effects, and cooling 743. Heard KJ, Peberdy MA, Sayre MR, et al. A randomized controlled trial comparing
methods. Crit Care Med 2009;37:1101–20. the Arctic Sun to standard cooling for induction of hypothermia after cardiac
716. Bernard S, Buist M, Monteiro O, Smith K. Induced hypothermia using large arrest. Resuscitation 2010;81:9–14.
volume, ice-cold intravenous fluid in comatose survivors of out-of-hospital 744. Merchant RM, Abella BS, Peberdy MA, et al. Therapeutic hypothermia after
cardiac arrest: a preliminary report. Resuscitation 2003;56:9–13. cardiac arrest: unintentional overcooling is common using ice packs and con-
717. Virkkunen I, Yli-Hankala A, Silfvast T. Induction of therapeutic hypothermia ventional cooling blankets. Crit Care Med 2006;34:S490–4.
after cardiac arrest in prehospital patients using ice-cold Ringer’s solution: a 745. Haugk M, Sterz F, Grassberger M, et al. Feasibility and efficacy of a new non-
pilot study. Resuscitation 2004;62:299–302. invasive surface cooling device in post-resuscitation intensive care medicine.
718. Kliegel A, Losert H, Sterz F, et al. Cold simple intravenous infusions preceding Resuscitation 2007;75:76–81.
special endovascular cooling for faster induction of mild hypothermia after 746. Al-Senani FM, Graffagnino C, Grotta JC, et al. A prospective, multicenter pilot
cardiac arrest—a feasibility study. Resuscitation 2005;64:347–51. study to evaluate the feasibility and safety of using the CoolGard System and
719. Kliegel A, Janata A, Wandaller C, et al. Cold infusions alone are effective for Icy catheter following cardiac arrest. Resuscitation 2004;62:143–50.
induction of therapeutic hypothermia but do not keep patients cool after car- 747. Pichon N, Amiel JB, Francois B, Dugard A, Etchecopar C, Vignon P. Efficacy of
diac arrest. Resuscitation 2007;73:46–53. and tolerance to mild induced hypothermia after out-of-hospital cardiac arrest
720. Kilgannon JH, Roberts BW, Stauss M, et al. Use of a standardized order using an endovascular cooling system. Crit Care 2007;11:R71.
set for achieving target temperature in the implementation of therapeutic 748. Wolff B, Machill K, Schumacher D, Schulzki I, Werner D. Early achievement of
hypothermia after cardiac arrest: a feasibility study. Acad Emerg Med 2008;15: mild therapeutic hypothermia and the neurologic outcome after cardiac arrest.
499–505. Int J Cardiol 2009;133:223–8.
721. Scott BD, Hogue T, Fixley MS, Adamson PB. Induced hypothermia following 749. Nagao K, Kikushima K, Watanabe K, et al. Early induction of hypothermia
out-of-hospital cardiac arrest; initial experience in a community hospital. Clin during cardiac arrest improves neurological outcomes in patients with out-
Cardiol 2006;29:525–9. of-hospital cardiac arrest who undergo emergency cardiopulmonary bypass
722. Kim F, Olsufka M, Carlbom D, et al. Pilot study of rapid infusion of 2 L of 4 and percutaneous coronary intervention. Circ J 2010;74:77–85.
degrees C normal saline for induction of mild hypothermia in hospitalized, 750. Mahmood MA, Zweifler RM. Progress in shivering control. J Neurol Sci
comatose survivors of out-of-hospital cardiac arrest. Circulation 2005;112: 2007;261:47–54.
715–9. 751. Wadhwa A, Sengupta P, Durrani J, et al. Magnesium sulphate only slightly
723. Jacobshagen C, Pax A, Unsold BW, et al. Effects of large volume, ice-cold reduces the shivering threshold in humans. Br J Anaesth 2005;94:756–62.
intravenous fluid infusion on respiratory function in cardiac arrest survivors. 752. Kuboyama K, Safar P, Radovsky A, et al. Delay in cooling negates the beneficial
Resuscitation 2009;80:1223–8. effect of mild resuscitative cerebral hypothermia after cardia arrest in dogs: a
724. Spiel AO, Kliegel A, Janata A, et al. Hemostasis in cardiac arrest patients treated prospective, randomized study. Crit Care Med 1993;21:1348–58.
with mild hypothermia initiated by cold fluids. Resuscitation 2009;80:762–5. 753. Riter HG, Brooks LA, Pretorius AM, Ackermann LW, Kerber RE. Intra-
725. Larsson IM, Wallin E, Rubertsson S. Cold saline infusion and ice packs alone are arrest hypothermia: both cold liquid ventilation with perfluorocarbons and
effective in inducing and maintaining therapeutic hypothermia after cardiac cold intravenous saline rapidly achieve hypothermia, but only cold liquid
arrest. Resuscitation 2010;81:15–9. ventilation improves resumption of spontaneous circulation. Resuscitation
726. Skulec R, Kovarnik T, Dostalova G, Kolar J, Linhart A. Induction of mild hypother- 2009;80:561–6.
mia in cardiac arrest survivors presenting with cardiogenic shock syndrome. 754. Staffey KS, Dendi R, Brooks LA, et al. Liquid ventilation with perfluorocarbons
Acta Anaesthesiol Scand 2008;52:188–94. facilitates resumption of spontaneous circulation in a swine cardiac arrest
727. Hoedemaekers CW, Ezzahti M, Gerritsen A, van der Hoeven JG. Comparison of model. Resuscitation 2008;78:77–84.
cooling methods to induce and maintain normo- and hypothermia in intensive 755. Polderman KH, Peerdeman SM, Girbes AR. Hypophosphatemia and hypomag-
care unit patients: a prospective intervention study. Crit Care 2007;11:R91. nesemia induced by cooling in patients with severe head injury. J Neurosurg
728. Kim F, Olsufka M, Longstreth Jr WT, et al. Pilot randomized clinical trial of 2001;94:697–705.
prehospital induction of mild hypothermia in out-of-hospital cardiac arrest 756. Tortorici MA, Kochanek PM, Poloyac SM. Effects of hypothermia on drug dispo-
patients with a rapid infusion of 4 degrees C normal saline. Circulation sition, metabolism, and response: a focus of hypothermia-mediated alterations
2007;115:3064–70. on the cytochrome P450 enzyme system. Crit Care Med 2007;35:2196–204.](https://image.slidesharecdn.com/fullerc2010guidelines1-101018011940-phpapp02/85/RCP-2010-guidelines-132-320.jpg)
![C.D. Deakin et al. / Resuscitation 81 (2010) 1305–1352 1351
757. Randomized clinical study of thiopental loading in comatose survivors of car- 788. Pfeifer R, Borner A, Krack A, Sigusch HH, Surber R, Figulla HR. Outcome after
diac arrest. Brain Resuscitation Clinical Trial I Study Group. N Engl J Med cardiac arrest: predictive values and limitations of the neuroproteins neuron-
1986;314:397–403. specific enolase and protein S-100 and the Glasgow Coma Scale. Resuscitation
758. Grafton ST, Longstreth Jr WT. Steroids after cardiac arrest: a retrospective study 2005;65:49–55.
with concurrent, nonrandomized controls. Neurology 1988;38:1315–6. 789. Roine RO, Somer H, Kaste M, Viinikka L, Karonen SL. Neurological outcome
759. Mentzelopoulos SD, Zakynthinos SG, Tzoufi M, et al. Vasopressin, epinephrine, after out-of-hospital cardiac arrest. Prediction by cerebrospinal fluid enzyme
and corticosteroids for in-hospital cardiac arrest. Arch Intern Med analysis. Arch Neurol 1989;46:753–6.
2009;169:15–24. 790. Zingler VC, Krumm B, Bertsch T, Fassbender K, Pohlmann-Eden B. Early
760. Gueugniaud PY, Gaussorgues P, Garcia-Darennes F, et al. Early effects of prediction of neurological outcome after cardiopulmonary resuscitation: a
nimodipine on intracranial and cerebral perfusion pressures in cerebral anoxia multimodal approach combining neurobiochemical and electrophysiological
after out-of-hospital cardiac arrest. Resuscitation 1990;20:203–12. investigations may provide high prognostic certainty in patients after cardiac
761. Roine RO, Kaste M, Kinnunen A, Nikki P, Sarna S, Kajaste S. Nimodipine arrest. Eur Neurol 2003;49:79–84.
after resuscitation from out-of-hospital ventricular fibrillation: a placebo- 791. Rosen H, Sunnerhagen KS, Herlitz J, Blomstrand C, Rosengren L. Serum levels
controlled, double-blind, randomized trial. JAMA 1990;264:3171–7. of the brain-derived proteins S-100 and NSE predict long-term outcome after
762. A randomized clinical study of a calcium-entry blocker (lidoflazine) in the treat- cardiac arrest. Resuscitation 2001;49:183–91.
ment of comatose survivors of cardiac arrest. Brain Resuscitation Clinical Trial 792. Dauberschmidt R, Zinsmeyer J, Mrochen H, Meyer M. Changes of neuron-
II Study Group. N Engl J Med 1991;324:1225–31. specific enolase concentration in plasma after cardiac arrest and resuscitation.
763. Laurent I, Adrie C, Vinsonneau C, et al. High-volume hemofiltration after out-of- Mol Chem Neuropathol 1991;14:237–45.
hospital cardiac arrest: a randomized study. J Am Coll Cardiol 2005;46:432–7. 793. Mussack T, Biberthaler P, Kanz KG, et al. Serum S-100B and interleukin-
764. Edgren E, Hedstrand U, Nordin M, Rydin E, Ronquist G. Prediction of outcome 8 as predictive markers for comparative neurologic outcome analysis of
after cardiac arrest. Crit Care Med 1987;15:820–5. patients after cardiac arrest and severe traumatic brain injury. Crit Care Med
765. Young GB, Doig G, Ragazzoni A. Anoxic-ischemic encephalopathy: clin- 2002;30:2669–74.
ical and electrophysiological associations with outcome. Neurocrit Care 794. Fries M, Kunz D, Gressner AM, Rossaint R, Kuhlen R. Procalcitonin serum levels
2005;2:159–64. after out-of-hospital cardiac arrest. Resuscitation 2003;59:105–9.
766. Al Thenayan E, Savard M, Sharpe M, Norton L, Young B. Predictors of poor 795. Hachimi-Idrissi S, Van der Auwera M, Schiettecatte J, Ebinger G, Michotte Y,
neurologic outcome after induced mild hypothermia following cardiac arrest. Huyghens L. S-100 protein as early predictor of regaining consciousness after
Neurology 2008;71:1535–7. out of hospital cardiac arrest. Resuscitation 2002;53:251–7.
767. Wijdicks EF, Parisi JE, Sharbrough FW. Prognostic value of myoclonus status in 796. Piazza O, Cotena S, Esposito G, De Robertis E, Tufano R. S100B is a sensitive but
comatose survivors of cardiac arrest. Ann Neurol 1994;35:239–43. not specific prognostic index in comatose patients after cardiac arrest. Minerva
768. Thomke F, Marx JJ, Sauer O, et al. Observations on comatose survivors Chir 2005;60:477–80.
of cardiopulmonary resuscitation with generalized myoclonus. BMC Neurol 797. Rosen H, Rosengren L, Herlitz J, Blomstrand C. Increased serum levels of the
2005;5:14. S-100 protein are associated with hypoxic brain damage after cardiac arrest.
769. Arnoldus EP, Lammers GJ. Postanoxic coma: good recovery despite myoclonus Stroke 1998;29:473–7.
status. Ann Neurol 1995;38:697–8. 798. Mussack T, Biberthaler P, Kanz KG, Wiedemann E, Gippner-Steppert C, Jochum
770. Celesia GG, Grigg MM, Ross E. Generalized status myoclonicus in acute anoxic M. S-100b, sE-selectin, and sP-selectin for evaluation of hypoxic brain dam-
and toxic-metabolic encephalopathies. Arch Neurol 1988;45:781–4. age in patients after cardiopulmonary resuscitation: pilot study. World J Surg
771. Morris HR, Howard RS, Brown P. Early myoclonic status and outcome after 2001;25:539–43 [discussion 44].
cardiorespiratory arrest. J Neurol Neurosurg Psychiatry 1998;64:267–8. 799. Sodeck GH, Domanovits H, Sterz F, et al. Can brain natriuretic peptide pre-
772. Datta S, Hart GK, Opdam H, Gutteridge G, Archer J. Post-hypoxic myoclonic dict outcome after cardiac arrest? An observational study. Resuscitation
status: the prognosis is not always hopeless. Crit Care Resusc 2009;11: 2007;74:439–45.
39–41. 800. Geppert A, Zorn G, Delle-Karth G, et al. Plasma concentrations of von
773. English WA, Giffin NJ, Nolan JP. Myoclonus after cardiac arrest: pitfalls in diag- Willebrand factor and intracellular adhesion molecule-1 for prediction of
nosis and prognosis. Anaesthesia 2009;64:908–11. outcome after successful cardiopulmonary resuscitation. Crit Care Med
774. Wijdicks EF, Hijdra A, Young GB, Bassetti CL, Wiebe S. Practice parameter: pre- 2003;31:805–11.
diction of outcome in comatose survivors after cardiopulmonary resuscitation 801. Adib-Conquy M, Monchi M, Goulenok C, et al. Increased plasma levels of soluble
(an evidence-based review): report of the Quality Standards Subcommittee of triggering receptor expressed on myeloid cells 1 and procalcitonin after cardiac
the American Academy of Neurology. Neurology 2006;67:203–10. surgery and cardiac arrest without infection. Shock 2007;28:406–10.
775. Zandbergen EG, de Haan RJ, Hijdra A. Systematic review of prediction of poor 802. Longstreth Jr WT, Clayson KJ, Chandler WL, Sumi SM. Cerebrospinal fluid cre-
outcome in anoxic–ischaemic coma with biochemical markers of brain dam- atine kinase activity and neurologic recovery after cardiac arrest. Neurology
age. Intensive Care Med 2001;27:1661–7. 1984;34:834–7.
776. Grubb NR, Simpson C, Sherwood R, et al. Prediction of cognitive dysfunction 803. Karkela J, Pasanen M, Kaukinen S, Morsky P, Harmoinen A. Evaluation of
after resuscitation from out-of-hospital cardiac arrest using serum neuron- hypoxic brain injury with spinal fluid enzymes, lactate, and pyruvate. Crit Care
specific enolase and protein S-100. Heart 2007. Med 1992;20:378–86.
777. Martens P. Serum neuron-specific enolase as a prognostic marker for irre- 804. Rothstein T, Thomas E, Sumi S. Predicting outcome in hypoxic-ischemic coma.
versible brain damage in comatose cardiac arrest survivors. Acad Emerg Med A prospective clinical and electrophysiological study. Electroencephalogr Clin
1996;3:126–31. Neurophysiol 1991;79:101–7.
778. Meynaar IA, Straaten HM, van der Wetering J, et al. Serum neuron-specific 805. Sherman AL, Tirschwell DL, Micklesen PJ, Longstreth Jr WT, Robinson LR.
enolase predicts outcome in post-anoxic coma: a prospective cohort study. Somatosensory potentials. CSF creatine kinase BB activity, and awakening after
Intensive Care Med 2003;29:189–95. cardiac arrest. Neurology 2000;54:889–94.
779. Rech TH, Vieira SR, Nagel F, Brauner JS, Scalco R. Serum neuron-specific enolase 806. Longstreth Jr WT, Clayson KJ, Sumi SM. Cerebrospinal fluid and serum
as early predictor of outcome after in-hospital cardiac arrest: a cohort study. creatine kinase BB activity after out-of-hospital cardiac arrest. Neurology
Crit Care 2006;10:R133. 1981;31:455–8.
780. Reisinger J, Hollinger K, Lang W, et al. Prediction of neurological outcome 807. Tirschwell DL, Longstreth Jr WT, Rauch-Matthews ME, et al. Cerebrospinal fluid
after cardiopulmonary resuscitation by serial determination of serum neuron- creatine kinase BB isoenzyme activity and neurologic prognosis after cardiac
specific enolase. Eur Heart J 2007;28:52–8. arrest. Neurology 1997;48:352–7.
781. Schoerkhuber W, Kittler H, Sterz F, et al. Time course of serum neuron-specific 808. Clemmensen P, Strandgaard S, Rasmussen S, Grande P. Cerebrospinal fluid
enolase. A predictor of neurological outcome in patients resuscitated from creatine kinase isoenzyme BB levels do not predict the clinical outcome in
cardiac arrest. Stroke 1999;30:1598–603. patients unconscious following cardiac resuscitation. Clin Cardiol 1987;10:
782. Bottiger BW, Mobes S, Glatzer R, et al. Astroglial protein S-100 is an early and 235–6.
sensitive marker of hypoxic brain damage and outcome after cardiac arrest in 809. Rosen H, Karlsson JE, Rosengren L. CSF levels of neurofilament is a valuable
humans. Circulation 2001;103:2694–8. predictor of long-term outcome after cardiac arrest. J Neurol Sci 2004;221:
783. Fogel W, Krieger D, Veith M, et al. Serum neuron-specific enolase as early 19–24.
predictor of outcome after cardiac arrest. Crit Care Med 1997;25:1133–8. 810. Tiainen M, Kovala TT, Takkunen OS, Roine RO. Somatosensory and brainstem
784. Martens P, Raabe A, Johnsson P. Serum S-100 and neuron-specific enolase for auditory evoked potentials in cardiac arrest patients treated with hypothermia.
prediction of regaining consciousness after global cerebral ischemia. Stroke Crit Care Med 2005;33:1736–40.
1998;29:2363–6. 811. Rossetti AO, Oddo M, Liaudet L, Kaplan PW. Predictors of awakening
785. Prohl J, Rother J, Kluge S, et al. Prediction of short-term and long-term outcomes from postanoxic status epilepticus after therapeutic hypothermia. Neurology
after cardiac arrest: a prospective multivariate approach combining biochem- 2009;72:744–9.
ical, clinical, electrophysiological, and neuropsychological investigations. Crit 812. Rossetti AO, Logroscino G, Liaudet L, et al. Status epilepticus: an independent
Care Med 2007;35:1230–7. outcome predictor after cerebral anoxia. Neurology 2007;69:255–60.
786. Stelzl T, von Bose MJ, Hogl B, Fuchs HH, Flugel KA. A comparison of the prognos- 813. Rossetti AO, Oddo M, Logroscino G, Kaplan PW. Prognostication after cardiac
tic value of neuron-specific enolase serum levels and somatosensory evoked arrest and hypothermia: a prospective study. Ann Neurol 2010;67:301–7.
potentials in 13 reanimated patients. Eur J Emerg Med 1995;2:24–7. 814. Oksanen T, Tiainen M, Skrifvars MB, et al. Predictive power of serum
787. Tiainen M, Roine RO, Pettila V, Takkunen O. Serum neuron-specific enolase NSE and OHCA score regarding 6-month neurologic outcome after out-of-
and S-100B protein in cardiac arrest patients treated with hypothermia. Stroke hospital ventricular fibrillation and therapeutic hypothermia. Resuscitation
2003;34:2881–6. 2009;80:165–70.](https://image.slidesharecdn.com/fullerc2010guidelines1-101018011940-phpapp02/85/RCP-2010-guidelines-133-320.jpg)
![1352 C.D. Deakin et al. / Resuscitation 81 (2010) 1305–1352
815. Rundgren M, Karlsson T, Nielsen N, Cronberg T, Johnsson P, Friberg H. Neuron 833. Clemmer TP, Orme Jr JF, Thomas FO, Brooks KA. Outcome of critically injured
specific enolase and S-100B as predictors of outcome after cardiac arrest and patients treated at Level I trauma centers versus full-service community hos-
induced hypothermia. Resuscitation 2009;80:784–9. pitals. Crit Care Med 1985;13:861–3.
816. Fieux F, Losser MR, Bourgeois E, et al. Kidney retrieval after sudden out of 834. Culica D, Aday LA, Rohrer JE. Regionalized trauma care system in Texas: impli-
hospital refractory cardiac arrest: a cohort of uncontrolled non heart beating cations for redesigning trauma systems. Med Sci Monit 2007;13:SR9–18.
donors. Crit Care 2009;13:R141. 835. Hannan EL, Farrell LS, Cooper A, Henry M, Simon B, Simon R. Physiologic trauma
817. Kootstra G. Statement on non-heart-beating donor programs. Transplant Proc triage criteria in adult trauma patients: are they effective in saving lives by
1995;27:2965. transporting patients to trauma centers? J Am Coll Surg 2005;200:584–92.
818. Fondevila C, Hessheimer AJ, Ruiz A, et al. Liver transplant using donors after 836. Harrington DT, Connolly M, Biffl WL, Majercik SD, Cioffi WG. Transfer times to
unexpected cardiac death: novel preservation protocol and acceptance criteria. definitive care facilities are too long: a consequence of an immature trauma
Am J Transplant 2007;7:1849–55. system. Ann Surg 2005;241:961–6 [discussion 6–8].
819. Morozumi J, Sakurai E, Matsuno N, et al. Successful kidney transplantation from 837. Liberman M, Mulder DS, Lavoie A, Sampalis JS. Implementation of a trauma
donation after cardiac death using a load-distributing-band chest compression care system: evolution through evaluation. J Trauma 2004;56:1330–5.
device during long warm ischemic time. Resuscitation 2009;80:278–80. 838. MacKenzie EJ, Rivara FP, Jurkovich GJ, et al. A national evaluation of the effect
820. Perkins GD, Brace S, Gates S. Mechanical chest-compression devices: current of trauma-center care on mortality. N Engl J Med 2006;354:366–78.
and future roles. Curr Opin Crit Care 2010;16:203–10. 839. Mann NC, Cahn RM, Mullins RJ, Brand DM, Jurkovich GJ. Survival among injured
821. Engdahl J, Abrahamsson P, Bang A, Lindqvist J, Karlsson T, Herlitz J. Is hospi- geriatric patients during construction of a statewide trauma system. J Trauma
tal care of major importance for outcome after out-of-hospital cardiac arrest? 2001;50:1111–6.
Experience acquired from patients with out-of-hospital cardiac arrest resus- 840. Mullins RJ, Veum-Stone J, Hedges JR, et al. Influence of a statewide trauma
citated by the same Emergency Medical Service and admitted to one of two system on location of hospitalization and outcome of injured patients. J Trauma
hospitals over a 16-year period in the municipality of Goteborg. Resuscitation 1996;40:536–45 [discussion 45–6].
2000;43:201–11. 841. Mullins RJ, Mann NC, Hedges JR, Worrall W, Jurkovich GJ. Preferential benefit
822. Liu JM, Yang Q, Pirrallo RG, Klein JP, Aufderheide TP. Hospital variability of of implementation of a statewide trauma system in one of two adjacent states.
out-of-hospital cardiac arrest survival. Prehosp Emerg Care 2008;12:339–46. J Trauma 1998;44:609–16 [discussion 17].
823. Herlitz J, Engdahl J, Svensson L, Angquist KA, Silfverstolpe J, Holmberg S. Major 842. Mullins RJ, Veum-Stone J, Helfand M, et al. Outcome of hospitalized injured
differences in 1-month survival between hospitals in Sweden among initial patients after institution of a trauma system in an urban area. JAMA
survivors of out-of-hospital cardiac arrest. Resuscitation 2006;70:404–9. 1994;271:1919–24.
824. Callaway CW, Schmicker R, Kampmeyer M, et al. Receiving hospital characteris- 843. Mullner R, Goldberg J. An evaluation of the Illinois trauma system. Med Care
tics associated with survival after out-of-hospital cardiac arrest. Resuscitation 1978;16:140–51.
2010. 844. Mullner R, Goldberg J. Toward an outcome-oriented medical geography: an
825. Davis DP, Fisher R, Aguilar S, et al. The feasibility of a regional cardiac arrest evaluation of the Illinois trauma/emergency medical services system. Soc Sci
receiving system. Resuscitation 2007;74:44–51. Med 1978;12:103–10.
826. Spaite DW, Bobrow BJ, Vadeboncoeur TF, et al. The impact of prehospital trans- 845. Nathens AB, Jurkovich GJ, Rivara FP, Maier RV. Effectiveness of state trauma
port interval on survival in out-of-hospital cardiac arrest: implications for systems in reducing injury-related mortality: a national evaluation. J Trauma
regionalization of post-resuscitation care. Resuscitation 2008;79:61–6. 2000;48:25–30 [discussion 1].
827. Spaite DW, Stiell IG, Bobrow BJ, et al. Effect of transport interval on out-of- 846. Nathens AB, Maier RV, Brundage SI, Jurkovich GJ, Grossman DC. The effect
hospital cardiac arrest survival in the OPALS Study: implications for triaging of interfacility transfer on outcome in an urban trauma system. J Trauma
patients to specialized cardiac arrest centers. Ann Emerg Med 2009. 2003;55:444–9.
828. Vermeer F, Oude Ophuis AJ, vd Berg EJ, et al. Prospective randomised compar- 847. Nicholl J, Turner J. Effectiveness of a regional trauma system in reducing mor-
ison between thrombolysis, rescue PTCA, and primary PTCA in patients with tality from major trauma: before and after study. BMJ 1997;315:1349–54.
extensive myocardial infarction admitted to a hospital without PTCA facilities: 848. Potoka DA, Schall LC, Gardner MJ, Stafford PW, Peitzman AB, Ford HR. Impact
a safety and feasibility study. Heart 1999;82:426–31. of pediatric trauma centers on mortality in a statewide system. J Trauma
829. Widimsky P, Groch L, Zelizko M, Aschermann M, Bednar F, Suryapranata H. 2000;49:237–45.
Multicentre randomized trial comparing transport to primary angioplasty vs 849. Sampalis JS, Lavoie A, Boukas S, et al. Trauma center designation: initial impact
immediate thrombolysis vs combined strategy for patients with acute myocar- on trauma-related mortality. J Trauma 1995;39:232–7 [discussion 7–9].
dial infarction presenting to a community hospital without a catheterization 850. Sampalis JS, Denis R, Frechette P, Brown R, Fleiszer D, Mulder D. Direct transport
laboratory The PRAGUE study. Eur Heart J 2000;21:823–31. to tertiary trauma centers versus transfer from lower level facilities: impact
830. Widimsky P, Budesinsky T, Vorac D, et al. Long distance transport for primary on mortality and morbidity among patients with major trauma. J Trauma
angioplasty vs immediate thrombolysis in acute myocardial infarction. Final 1997;43:288-95 [discussion 95–6].
results of the randomized national multicentre trial–PRAGUE-2. Eur Heart J 851. Nichol G, Aufderheide TP, Eigel B, et al. Regional systems of care for out-
2003;24:94–104. of-hospital cardiac arrest: a policy statement from the American Heart
831. Le May MR, So DY, Dionne R, et al. A citywide protocol for primary PCI in Association. Circulation 2010;121:709–29.
ST-segment elevation myocardial infarction. N Engl J Med 2008;358:231–40. 852. Nichol G, Soar J. Regional cardiac resuscitation systems of care. Curr Opin Crit
832. Abernathy 3rd JH, McGwin Jr G, Acker 3rd JE, Rue 3rd LW. Impact of a voluntary Care 2010;16:223–30.
trauma system on mortality, length of stay, and cost at a level I trauma center. 853. Soar J, Packham S. Cardiac arrest centres make sense. Resuscitation
Am Surg 2002;68:182–92. 2010;81:507–8.](https://image.slidesharecdn.com/fullerc2010guidelines1-101018011940-phpapp02/85/RCP-2010-guidelines-134-320.jpg)
![1354 H.-R. Arntz et al. / Resuscitation 81 (2010) 1353–1363
treatment of tachyarrhythmias. Otherwise, beta-blockers should the first hours after onset of symptoms. Out-of-hospital treatment
be started in low doses only after the patient is stabilised. and initial therapy in the emergency department (ED) may vary
• Guidelines on the use of prophylactic anti-arrhythmics according to local capabilities, resources and regulations. The data
angiotensin converting enzyme (ACE) inhibitors/angiotensin supporting out-of-hospital treatment are often extrapolated from
receptor blockers (ARBs) and statins are unchanged. studies of initial treatment after hospital admission; there are few
high-quality out-of-hospital studies. Comprehensive guidelines for
the diagnosis and treatment of ACS with and without ST eleva-
Introduction tion have been published by the European Society of Cardiology
and the American College of Cardiology/American Heart Associa-
The incidence of acute ST-elevation myocardial infarction (AMI) tion. The current recommendations are in line with these guidelines
is decreasing in many European countries [1]; however, the inci- [6,7].
dence of non-STEMI acute coronary syndrome (non-STEMI ACS)
is increasing [2,3]. Although in-hospital mortality from STEMI has
been reduced significantly by modern reperfusion therapy and
improved secondary prophylaxis, the overall 28-day mortality is Diagnosis and risk stratification in acute coronary
virtually unchanged because about two thirds of those who die do syndromes
so before hospital arrival, mostly from lethal arrhythmias triggered
by ischaemia [4]. Thus, the best chance of improving survival from Since early treatment offers the greatest benefits, and myocar-
an ischaemic attack is reducing the delay from symptom onset to dial ischaemia is the leading precipitant of sudden cardiac death, it
first medical contact and targeted treatment started in the early is essential that the public is aware of the typical symptoms associ-
out-of-hospital phase. ated with ACS. Several groups of patients however, are less likely to
The term acute coronary syndrome (ACS) encompasses three seek prompt medical care when symptoms of an ACS appear. Thus
different entities of the acute manifestation of coronary heart dis- significant delays in the initiation of treatment/reperfusion have
ease (Fig. 5.1): STEMI, NSTEMI and unstable angina pectoris (UAP). been reported in women, the elderly, people belonging to ethnic
Non-ST-elevation myocardial infarction and UAP are usually com- and racial minorities or low socioeconomic classes, and those living
bined in the term non-STEMI-ACS. The common pathophysiology alone [8].
of ACS is a ruptured or eroded atherosclerotic plaque [5]. Elec- Patients at risk, and their families, should be able to recognize
trocardiographic (ECG) characteristics (absence or presence of ST characteristic symptoms such as chest pain, which may radiate
elevation) differentiate STEMI from non-STEMI-ACS. The latter may into other areas of the upper body, often accompanied by other
present with ST-segment depression, nonspecific ST-segment wave symptoms including dyspnoea, sweating, nausea or vomiting and
abnormalities, or even a normal ECG. In the absence of ST elevation, syncope. They should understand the importance of early activa-
an increase in the plasma concentration of cardiac biomarkers, par- tion of the emergency medical service (EMS) system and, ideally,
ticularly troponin T or I as the most specific markers of myocardial should be trained in basic life support (BLS). Optimal strategies for
cell necrosis, indicates NSTEMI. increasing layperson awareness of the various ACS presentations
Acute coronary syndromes are the commonest cause of malig- and improvement of ACS recognition in vulnerable populations
nant arrhythmias leading to sudden cardiac death. The therapeutic remain to be determined.
goals are to treat acute life-threatening conditions, such as ven- Moreover, EMS dispatchers must be trained to recognize ACS
tricular fibrillation (VF) or extreme bradycardia, and to preserve symptoms and to ask targeted questions. When an ACS is suspected,
left ventricular function and prevent heart failure by minimising an EMS crew trained in advanced life support (ALS) and capable of
the extent of myocardial damage. The current guidelines address making the diagnosis and starting treatment should be alerted.
Fig. 5.1. Definitions of acute coronary syndromes (ACS) (STEMI, ST-elevation myocardial infarction; NSTEMI, non-ST-elevation myocardial infarction; UAP, unstable angina
pectoris).](https://image.slidesharecdn.com/fullerc2010guidelines1-101018011940-phpapp02/85/RCP-2010-guidelines-136-320.jpg)
![H.-R. Arntz et al. / Resuscitation 81 (2010) 1353–1363 1355
Given the high urgency for emergency revascularisation in Biomarkers
STEMI and other high-risk patients, specific systems of care can
be implemented to improve STEMI recognition and shorten time In the absence of ST elevation on the ECG, the presence of
to treatment. a suggestive history and elevated concentrations of biomarkers
The sensitivity, specificity, and clinical impact of various diag- (troponin T and troponin I, CK, CK-MB, myoglobin) characterise
nostic strategies have been evaluated for ACS. Information from non-STEMI and distinguish it from STEMI and unstable angina
clinical presentation, ECG, biomarker testing and imaging tech- respectively. Measurement of a cardiac-specific troponin is prefer-
niques should all be taken into account in order to establish the able. Elevated concentrations of troponin are particularly helpful in
diagnosis and at the same time estimate the risk so that optimal identifying patients at increased risk of adverse outcome [20].
decisions for patient admission and therapy/reperfusion are made. Cardiac biomarker testing should be part of the initial evaluation
of all patients presenting to the ED with symptoms suggestive of
cardiac ischaemia [21]. However, the delay in release of biomark-
ers from damaged myocardium prevents their use in diagnosing
Signs and symptoms of ACS
myocardial infarction in the first 4–6 h after the onset of symptoms
[22]. For patients who present within 6 h of symptom onset, and
Typically ACS appears with symptoms such as radiating chest
have an initial negative cardiac troponin, biomarkers should be re-
pain, shortness of breath and sweating; however, atypical symp-
measured between 6 and 12 h after symptom onset. In order to use
toms or unusual presentations may occur in the elderly, in females,
the measured biomarker optimally, clinicians should be familiar
and in diabetics [9,10]. None of these signs and symptoms of ACS
with the sensitivity, precision and institutional norms of the assay,
can be used alone for the diagnosis of ACS. A reduction in chest
and also the release kinetics and clearance. Highly sensitive (ultra-
pain after nitroglycerin administration can be misleading and is
sensitive) cardiac troponin assays have been developed. They can
not recommended as a diagnostic manoeuvre [11]. Symptoms may
increase sensitivity for the diagnosis of MI in patients with symp-
be more intense and last longer in patients with STEMI but are not
toms suspicious of cardiac ischaemia [23]. If the highly sensitive
reliable for discriminating between STEMI and non-STEMI-ACS.
cardiac troponin assays are unavailable, multi-marker evaluation
The patient’s history should be evaluated carefully during first
with CK-MB or myoglobin in conjunction with troponin may be
contact with healthcare providers. It may provide the first clues for
considered to improve the sensitivity of diagnosing AMI.
the presence of an ACS, trigger subsequent investigations and, in
There is no evidence to support the use of troponin point-of-
combination with information from other diagnostic tests, can help
care testing (POCT) in isolation as a primary test in the prehospital
in making triage and therapeutic decisions in the out-of-hospital
setting to evaluate patients with symptoms suspicious of cardiac
setting and the emergency department (ED).
ischaemia [23]. In the ED, use of point-of-care troponin assays
may help to shorten time to treatment and length of ED stay [24].
Until further randomised control trials are performed, other serum
12-lead ECG assays should not be considered first-line steps in the diagnosis and
management of patients presenting with ACS symptoms [25].
A 12-lead ECG is the key investigation for assessment of an ACS.
In case of STEMI, it indicates the need for immediate reperfusion Decision rules for early discharge
therapy (i.e. primary percutaneous coronary intervention (PCI) or
prehospital fibrinolysis). When an ACS is suspected, a 12-lead ECG Attempts have been made to combine evidence from history,
should be acquired and interpreted as soon as possible after first physical examination serial ECGs and serial biomarker measure-
patient contact, to facilitate earlier diagnosis and triage. Prehospital ment in order to form clinical decision rules that would help triage
or ED ECG yields useful diagnostic information when interpreted by of ED patients with suspected ACS.
trained health care providers [12]. None of these rules is adequate and appropriate to identify ED
Recording of a 12-lead ECG out-of-hospital enables advanced chest pain patients with suspected ACS who can be safely dis-
notification to the receiving facility and expedites treatment charged from the ED [26].
decisions after hospital arrival: in many studies, the time from Likewise, the scoring systems for risk stratification of patients
hospital admission to initiating reperfusion therapy is reduced by with ACS that have been validated in the inpatient environment
10–60 min [13,14]. Trained EMS personnel (emergency physicians, (e.g. Thrombolysis in Myocardial Infarction (TIMI) score, Global
paramedics and nurses) can identify STEMI, defined by ST elevation Registry of Acute Coronary Events (GRACE) score, Fast Revascular-
of ≥0.1 mV elevation in at least two adjacent limb leads or >0.2 mV isation in Instability in Coronary Disease (FRISC) score or Goldman
in two adjacent precordial leads, with a high specificity and sensi- Criteria) should not be used to identify low-risk patients suitable
tivity comparable to diagnostic accuracy in the hospital [15–17]. It for discharge from the ED.
is thus reasonable that paramedics and nurses be trained to diag- A subgroup of patients younger than 40 years with non-classical
nose STEMI without direct medical consultation, as long as there is presentations and lacking significant past medical history, who
strict concurrent provision of medically directed quality assurance. have normal serial biomarkers and 12-lead ECGs, have a very low
If interpretation of the prehospital ECG is not available on-site, short-term event rate.
computer interpretation [18,19] or field transmission of the ECG is
reasonable. Recording and transmission of diagnostic quality ECGs Chest pain observation protocols
to the hospital usually takes less than 5 min. When used for the eval-
uation of patients with suspected ACS, computer interpretation of In patients suspected of an ACS the combination of an unremark-
the ECG may increase the specificity of diagnosis of STEMI, espe- able past history and physical examination with negative initial
cially for clinicians inexperienced in reading ECGs. The benefit of ECG and biomarkers cannot be used to exclude ACS reliably. There-
computer interpretation; however, is dependent on the accuracy fore a follow up period is mandatory in order to reach a diagnosis
of the ECG report. Incorrect reports may mislead inexperienced and make therapeutic decisions.
ECG readers. Thus computer-assisted ECG interpretation should Chest pain observation protocols are rapid systems for assess-
not replace, but may be used as an adjunct to, interpretation by ment of patients with suspected ACS. They should generally include
an experienced clinician. a history and physical examination, followed by a period of obser-](https://image.slidesharecdn.com/fullerc2010guidelines1-101018011940-phpapp02/85/RCP-2010-guidelines-137-320.jpg)
![1356 H.-R. Arntz et al. / Resuscitation 81 (2010) 1353–1363
vation, during which serial electrocardiography and cardiac marker rate diagnosis with a reduction in length of stay and costs without
measurements are performed. Patient evaluation should be com- increasing cardiac events. Both the exposure to radiation and iod-
plemented by either a non-invasive evaluation for anatomical inated contrast should be considered when using multi-detector
coronary disease or provocative testing for inducible myocardial computer tomography (MDCT) and myocardial perfusion imaging.
ischaemia at some point after AMI is excluded. These protocols
may be used to improve accuracy in identifying patients requiring Treatment of acute coronary syndromes—symptoms
inpatient admission or further diagnostic testing while maintaining
patient safety, reducing length of stay and reducing costs [27]. Nitrates
In patients presenting to the ED with a history suggestive of ACS,
but normal initial workup, chest pain (observation) units may rep- Glyceryl trinitrate is an effective treatment for ischaemic chest
resent a safe and effective strategy for evaluating patients. They pain and has beneficial haemodynamic effects, such as dilation of
may be recommended as a means to reduce length of stay, hospital the venous capacitance vessels, dilation of the coronary arteries
admissions and healthcare costs, improve diagnostic accuracy and and, to a minor extent, the peripheral arteries. Glyceryl trinitrate
improve quality of life [28]. There is no direct evidence demonstrat- may be considered if the systolic blood pressure is above 90 mm Hg
ing that chest pain units or observation protocols reduce adverse and the patient has ongoing ischaemic chest pain (Fig. 5.2). Glyceryl
cardiovascular outcomes, particularly mortality, for patients pre- trinitrate can also be useful in the treatment of acute pulmonary
senting with possible ACS. congestion. Nitrates should not be used in patients with hypoten-
sion (systolic blood pressure ≤90 mm Hg), particularly if combined
Imaging techniques with bradycardia, and in patients with inferior infarction and sus-
pected right ventricular involvement. Use of nitrates under these
Effective screening of patients with suspected ACS, but with circumstances can decrease the blood pressure and cardiac output.
negative ECG and negative cardiac biomarkers, remains chal-
lenging. Non-invasive imaging techniques (CT angiography [29], Analgesia
cardiac magnetic resonance, myocardial perfusion imaging [30],
and echocardiography [31]) have been evaluated as means of Morphine is the analgesic of choice for nitrate-refractory pain
screening these low-risk patients and identifying subgroups that and also has calming effects on the patient making sedatives
can be discharged home safely. unnecessary in most cases. Since morphine is a dilator of venous
Although there are no large multicentre trials, existing evidence capacitance vessels, it may have additional benefit in patients with
indicates that these diagnostic modalities enable early and accu- pulmonary congestion. Give morphine in initial doses of 3–5 mg
Fig. 5.2. Treatment algorithm for acute coronary syndromes (BP, blood pressure; PCI, percutaneous coronary intervention; UFH, unfractionated heparin). *Prasugrel, 60 mg
loading dose, may be chosen as an alternative to clopidogrel in patients with STEMI and planned PPCI provided there is no history of stroke or transient ischaemic attack. At
the time of writing, ticagrelor has not yet been approved as an alternative to clopidogrel.](https://image.slidesharecdn.com/fullerc2010guidelines1-101018011940-phpapp02/85/RCP-2010-guidelines-138-320.jpg)
![H.-R. Arntz et al. / Resuscitation 81 (2010) 1353–1363 1357
intravenously and repeat every few minutes until the patient is – either with a 300 or 600 mg loading dose – do not postpone
pain-free. Non-steroidal anti-inflammatory drugs (NSAIDs) should treatment until angiography/PCI is undertaken because the high-
be avoided for analgesia because of their pro-thrombotic effects est event rates are observed in the early phase of the syndrome. In
[32]. unselected patients undergoing PCI, pre-treatment with a higher
loading dose of clopidogrel resulted in better outcome [43].
Oxygen Therefore, clopidogrel should be given as early as possible in
addition to ASA and an antithrombin to all patients presenting with
Monitoring of the arterial oxygen saturation with pulse oxime- non-STEMI ACS. If a conservative approach is selected, give a load-
try (SpO2 ) will help to determine the need for supplemental oxygen. ing dose of 300 mg; with a planned PCI strategy, an initial dose of
These patients do not need supplemental oxygen unless they are 600 mg may be preferred.
hypoxaemic. Limited data suggest that high-flow oxygen may
be harmful in patients with uncomplicated myocardial infarction Prasugrel. Prasugrel (60 mg loading dose) may be given instead
[33–35]. Aim to achieve an oxygen saturation of 94–98%, or 88–92% of clopidogrel to patients with high-risk non-STEMI ACS and
if the patient is at risk of hypercapnic respiratory failure [36]. planned PCI at angiography, provided coronary stenoses are suit-
able for PCI. Contraindications (history of TIA/stroke) and the
benefit – risk relation in patients with high bleeding risk (weight
Treatment of acute coronary syndromes—cause
<60 kg, age >75 years) should be considered.
Inhibitors of platelet aggregation
ADP-receptor inhibitors in STEMI
Inhibition of platelet aggregation is of primary importance for Clopidogrel. Although there is no large study on the use of clopi-
initial treatment of coronary syndromes as well as for secondary dogrel for pre-treatment of patients presenting with STEMI and
prevention, since platelet activation and aggregation is the key planned PCI, it is likely that this strategy is beneficial. Since platelet
process initiating an ACS. inhibition is more profound with a higher dose, a 600 mg load-
ing dose given as soon as possible is recommended for patients
Acetylsalicylic acid (ASA) presenting with STEMI and planned PCI.
Two large randomised trials studied clopidogrel compared with
Large randomised controlled trials indicate decreased mortality placebo in patients with STEMI treated conservatively or with fib-
when ASA (75–325 mg) is given to hospitalised patients with ACS. A rinolysis [44,45]. One study included patients up to 75 years of age,
few studies have suggested reduced mortality if ASA is given earlier treated with fibrinolysis, ASA, an antithrombin and a loading dose
[37,38]. Therefore, give ASA as soon as possible to all patients with of 300 mg clopidogrel [45]. Treatment with clopidogrel resulted in
suspected ACS unless the patient has a known true allergy to ASA. fewer occluded culprit coronary arteries at angiography and fewer
ASA may be given by the first healthcare provider, bystander or by re-infarctions, without an increased bleeding risk. The other study
dispatcher assistance according to local protocols. The initial dose investigated STEMI patients without age limits to be treated con-
of chewable ASA is 160–325 mg. Other forms of ASA (soluble, IV) servatively or with fibrinolysis. In this trial, clopidogrel (no loading,
may be as effective as chewed tablets. 75 mg daily) compared with placebo resulted in fewer deaths and a
reduction of the combined endpoint of death and stroke [44]. There-
Adenosine diphosphate (ADP)-receptor inhibitors fore patients with STEMI treated with fibrinolysis should be treated
with clopidogrel (300 mg loading dose up to an age of 75 years and
Thienopyridines (clopidogrel, prasugrel) and the cyclo-pentyl- 75 mg without loading dose if >75 years of age) in addition to ASA
triazolo-pyrimidine, ticagrelor, inhibit the ADP-receptor irre- and an antithrombin.
versibly, which further reduces platelet aggregation in addition to
that produced by ASA. In contrast to clopidogrel, metabolism of pra- Prasugrel. Prasugrel with a loading dose of 60 mg may be given
sugrel and of ticagrelor is independent of a genetically determined in addition to ASA and an antithrombin to patients presenting with
variability of drug metabolism and activation. Therefore prasug- STEMI with planned PCI. Contraindications (history of TIA/stroke),
rel and ticagrelor lead to a more reliable and stronger inhibition of and relation of bleeding risk vs benefit in patients with a body
platelet aggregation. weight <60 kg or aged >75 years should be taken into account. There
A large randomised study comparing a loading dose of 300 mg is no data on prehospital treatment with prasugrel and no data on
clopidogrel followed by 75 mg daily with prasugrel (loading dose prasugrel if used in the context of fibrinolysis.
60 mg, followed by 10 mg daily) in patients with ACS resulted in
fewer major adverse cardiac events (MACE) with prasugrel; how- Glycoprotein (Gp) IIB/IIIA inhibitors
ever, the bleeding rate was higher. Bleeding risk was increased
markedly in patients weighing less than 60 kg and those older than Gp IIB/IIIA receptor inhibition is the common final link of platelet
75 years [39]. A significantly increased intracranial bleeding rate aggregation. Eptifibatide and tirofiban lead to reversible inhibition,
was observed in patients with a history of transient ischaemic while abciximab leads to irreversible inhibition of the Gp IIB/IIIA
attack (TIA) and/or stroke. In another study, ticagrelor proved to receptor. Older studies from the pre-stent era mostly support the
be superior to clopidogrel with respect to MACE [40]. At the time use of this class of drugs [46,47]. Newer studies mostly document
of writing, ticagrelor has not yet been approved as an alternative neutral or worsened outcomes [48–51]. Finally in most support-
to clopidogrel. ing, as well as neutral or opposing studies, bleeding occurred in
more patients treated with Gp IIB/IIIA receptor blockers. There are
ADP-receptor inhibitors in NON-STEMI ACS insufficient data to support routine pre-treatment with Gp IIB/IIIA
inhibitors in patients with STEMI or non-STEMI-ACS. For high-
Clopidogrel. If given in addition to heparin and ASA in high-risk risk patients with non-STEMI-ACS, in-hospital upstream treatment
non-STEMI-ACS patients, clopidogrel improves outcome [41,42]. with eptifibatide or tirofiban may be acceptable whereas abciximab
Even if there is no large scale study investigating pre-treatment may be given only in the context of PCI [47,52]. Newer alterna-
with clopidogrel, compared with peri-interventional application tives for antiplatelet treatment should be considered because of](https://image.slidesharecdn.com/fullerc2010guidelines1-101018011940-phpapp02/85/RCP-2010-guidelines-139-320.jpg)
![1358 H.-R. Arntz et al. / Resuscitation 81 (2010) 1353–1363
the increased bleeding risk with Gp IIB/IIIA inhibitors when used with 0.75 mg kg−1 SC every 12 h without an initial IV dose.
with heparins. Patients with known impaired renal function (creatinine clearance
<30 ml−1 min−1 ) may be given 1 mg kg−1 enoxaparin SC once daily
Antithrombins or may be treated with UFH. There are insufficient data to recom-
mend other LMWH.
Unfractionated heparin (UFH) is an indirect inhibitor of throm-
bin, which in combination with ASA is used as an adjunct with Fondaparinux. Several studies show superiority or neutral out-
fibrinolytic therapy or primary PCI (PPCI) and is an important part come when fondaparinux was compared with UFH as an adjunct for
of treatment of unstable angina and STEMI. Limitations of unfrac- fibrinolysis in STEMI patients [56]. Fondaparinux (initially 2.5 mg
tionated heparin include its unpredictable anticoagulant effect in SC followed by 2.5 mg SC. daily) may be considered specifically with
individual patients, the need to give it intravenously and the need non-fibrin-specific fibrinolytics (i.e. streptokinase) in patients with
to monitor aPTT. Moreover, heparin can induce thrombocytope- a plasma creatinine concentration <3 mg dl−1 (250 m l−1 ).
nia. Since publication of the 2005 ERC guidelines on ACS, large
randomised trials have been performed testing several alternative Bivalirudin. There are insufficient data to recommend
antithrombins for the treatment of patients with ACS. In compar- bivalirudin instead of UFH in STEMI patients to be treated
ison with UFH, these alternatives have a more specific factor Xa with fibrinolysis. Since bleeding risk may be increased by switch-
activity (low molecular weight heparins [LMWH], fondaparinux) ing the anticoagulants, the initial agent should be maintained, with
or are direct thrombin inhibitors (bivalirudin). With these newer the exception of fondaparinux, where additional UFH is necessary
antithrombins, in general, there is no need to monitor the coagula- if an invasive procedure is planned [60].
tion system and there is a reduced risk of thrombocytopenia.
Antithrombins for STEMI patients to be treated with primary PCI
Antithrombins in non-STEMI-ACS (PPCI)
There is a paucity of studies on prehospital or ED initiation of
In comparison with UFH, enoxaparin reduces the combined end- antithrombin treatment for patients with STEMI and planned PPCI.
point of mortality, myocardial infarction and the need for urgent Therefore treatment recommendations for these settings have to
revascularisation, if given within the first 24–36 h of onset of symp- be extrapolated from in-hospital investigations, until the more spe-
toms of non-STEMI-ACS [53,54]. Although enoxaparin causes more cific results of ongoing studies are available.
minor bleeding than UFH, the incidence of serious bleeding is not
increased. Enoxaparin. Several registries and smaller studies documented
Bleeding worsens the prognosis of patients with ACS [55]. Fon- favourable or neutral outcome when enoxaparin was compared
daparinux and bivalirudin cause less bleeding than UFH [56–59]. In with UFH for contemporary PPCI (i.e. broad use of thienopyridines
most of the trials on patients presenting with non-STEMI-ACS, the and/or Gp IIB/IIIA receptor blockers) [65,66]. Therefore, enoxaparin
UFH alternatives were given only after hospital admission; it may is a safe and effective alternative to UFH. There are insufficient
be invalid to extrapolate the results of these studies to the prehos- data to recommend any LMWH other than enoxaparin for PPCI in
pital or ED setting. For patients with a planned initial conservative STEMI. Switching from UFH to enoxaparin or vice versa may lead
approach, fondaparinux and enoxaparin are reasonable alterna- to an increased bleeding risk and therefore should be avoided [60].
tives to UFH. There are insufficient data to recommend any LMWH Dose adjustment of enoxaparin is necessary for patients with renal
other than enoxaparin. For patients with an increased bleeding impairment.
risk consider giving fondaparinux or bivalirudin. For patients with
a planned invasive approach, enoxaparin or bivalirudin are rea- Fondaparinux. When compared with UFH, fondaparinux
sonable alternatives to UFH. In one study, catheter thrombi were resulted in similar clinical outcomes but less bleeding when used in
observed in patients undergoing PCI who had received fonda- the context of PPCI [56]; however, thrombus formation on catheters
parinux – additional UFH was required [56]. Since enoxaparin and required treatment with additional UFH. Even if fondaparinux
fondaparinux may accumulate in patients with renal impairment, reduces the bleeding risk compared with UFH in STEMI patients
dose adjustment is necessary; bivalirudin or UFH are alternatives in undergoing PPCI, the use of the two agents is not recommended
this situation. Bleeding risk may be increased by switching the anti- over UFH alone. The dose of fondaparinux requires adjustment in
coagulant; therefore, the initial agent should be maintained with patients with renal impairment.
the exception of fondaparinux where additional UFH is necessary
for patients undergoing PCI [60].
Bivalirudin. Two large randomised studies documented less
bleeding and a reduction in short and long term mortality when
Antithrombins in STEMI
bivalirudin was compared with UFH plus Gp IIB/IIIA receptor block-
ers in patients with STEMI and planned PCI [67–69]. Several other
Antithrombins for patients to be treated with fibrinolysis
studies and case series showed also better or neutral results and
less bleeding when bivalirudin was compared with UFH; there-
Enoxaparin. Several randomised studies of patients with STEMI
fore, bivalirudin is a safe alternative to UFH. However, a slightly
undergoing fibrinolysis have shown that additional treatment with
increased rate of stent thrombosis was observed within the first
enoxaparin instead of UFH produced better clinical outcomes (irre-
24 h after PCI [67].
spective of the fibrinolytic used) but a slightly increased bleeding
rate in elderly (≥75 years) and low weight patients (BW < 60 kg)
[61–63]. Reduced doses of enoxaparin in elderly and low weight Strategies and systems of care
patients maintained the improved outcome while reducing the
bleeding rate [64]. It is also reasonable to give enoxaparin instead Several systematic strategies to improve quality of out-of-
of UFH for prehospital treatment. hospital care for patients with ACS have been investigated. These
Dosing of enoxaparin: In patients <75 years, give an initial strategies are principally intended to promptly identify patients
bolus of 30 mg IV followed by 1 mg kg−1 SC every 12 h (first with STEMI in order to shorten the delay to reperfusion treatment.
SC dose shortly after the IV bolus). Treat patients ≥75 years Also triage criteria have been developed to select high-risk patients](https://image.slidesharecdn.com/fullerc2010guidelines1-101018011940-phpapp02/85/RCP-2010-guidelines-140-320.jpg)
![H.-R. Arntz et al. / Resuscitation 81 (2010) 1353–1363 1359
with non-STEMI-ACS for transport to tertiary care centres offering Table 5.1
Contraindications for fibrinolysis.a
24/7 PCI services. In this context, several specific decisions have to
be made during initial care beyond the basic diagnostic steps nec- Absolute contraindications
essary for clinical evaluation of the patient and interpretation of a Haemorrhagic stroke or stroke of unknown origin at any time
Ischaemic stroke in the preceding 6 months
12-lead ECG. These decisions relate to:
Central nervous system damage or neoplasms
Recent major trauma/surgery/head injury (within the preceding 3 weeks)
(1) Reperfusion strategy in patients with STEMI i.e. PPCI vs (pre-) Gastro-intestinal bleeding within the last month
hospital fibrinolysis. Known bleeding disorder
(2) Bypassing a closer but non-PCI capable hospital and taking mea- Aortic dissection
sures to shorten the delay to intervention if PPCI is the chosen Relative contraindications
strategy. Transient ischaemic attack in preceding 6 months
(3) Procedures in special situations e.g. for patients successfully Oral anticoagulant therapy
Pregnancy within 1-week post-partum
resuscitated from non-traumatic cardiac arrest, patients with Non-compressible punctures
shock or patients with non-STEMI ACS who are unstable or have Traumatic resuscitation
signs of very high risk. Refractory hypertension (systole. blood pressure >180 mm Hg
Advanced liver disease
Infective endocarditis
Reperfusion strategy in patients presenting with STEMI
Active peptic ulcer
a
Reperfusion therapy in patients with STEMI is the most impor- According to the guidelines of the European Society of Cardiology.
tant advance in the treatment of myocardial infarction in the last 25
years. For patients presenting with STEMI within 12 h of symptom Primary percutaneous intervention
onset, reperfusion should be initiated as soon as possible indepen-
dent of the method chosen [7,70–72]. Reperfusion may be achieved Coronary angioplasty with or without stent placement has
with fibrinolysis, with PPCI, or a combination of both. Efficacy of become the first-line treatment for patients with STEMI, because
reperfusion therapy is profoundly dependent on the duration of it has been shown to be superior to fibrinolysis in the combined
symptoms. Fibrinolysis is effective specifically in the first 2–3 h endpoints of death, stroke and reinfarction in several studies and
after symptom onset; PPCI is less time sensitive [73]. meta-analyses [81,82]. This improvement was found when PPCI
was undertaken by a skilled person in a high-volume centre with a
Fibrinolysis limited delay to first balloon inflation after first medical contact
[83]. Therefore PPCI performed at a high-volume centre shortly
A meta-analysis of six trials involving 6434 patients docu- after first medical contact (FMC), by an experienced operator who
mented a 17% decrease in mortality among patients treated with maintains an appropriate expert status, is the preferred treatment
out-of-hospital fibrinolysis compared with in-hospital fibrinolysis as it improves morbidity and mortality as compared with immedi-
[74]. An effective and safe system for out-of-hospital fibrinolytic ate fibrinolysis.
therapy requires adequate facilities for the diagnosis and treatment
of STEMI and its complications. Ideally, there should be a capability
of communicating with experienced hospital doctors (e.g. emer- Fibrinolysis vs primary PCI
gency physicians or cardiologists). The average time gained with
out-of-hospital fibrinolysis was 60 min, and the results were inde- Primary PCI has been limited by access to catheter laboratory
pendent of the experience of the provider. Thus, giving fibrinolytics facilities, appropriately skilled clinicians and delay to first bal-
out-of-hospital to patients with STEMI or signs and symptoms of an loon inflation. Fibrinolysis therapy is a widely available reperfusion
ACS with presumed new LBBB is beneficial. Fibrinolytic therapy can strategy. Both treatment strategies are well established and have
be given safely by trained paramedics, nurses or physicians using been the subject of large randomised multicentre trials over the last
an established protocol [75–80]. The efficacy is greatest within the decades. Over this time both therapies have evolved significantly
first 3 h of the onset of symptoms [74]. Patients with symptoms of and the body of evidence is heterogeneous. In the randomised stud-
ACS and ECG evidence of STEMI (or presumably new LBBB or true ies comparing PPCI with fibrinolytic therapy, the typical delay from
posterior infarction) presenting directly to the ED should be given decision to the beginning of treatment with either PPCI or fibri-
fibrinolytic therapy as soon as possible unless there is timely access nolytic therapy was less than 60 min. Several reports and registries
to PPCI. comparing fibrinolytic (including prehospital administration) ther-
apy with PPCI showed a trend of improved survival if fibrinolytic
Risks of fibrinolytic therapy therapy was initiated within 2 h of onset of symptoms and was com-
Healthcare professionals who give fibrinolytic therapy must be bined with rescue or delayed PCI [84–86]. In registries that reflect
aware of its contraindications (Table 5.1) and risks. Patients with standard practice more realistically the acceptable PPCI related
large AMIs (e.g. indicated by extensive ECG changes) are likely to delay (i.e. the diagnosis to balloon interval minus the diagnosis
gain most from fibrinolytic therapy. Benefits of fibrinolytic ther- to needle interval) to maintain the superiority of PPCI over fibri-
apy are less impressive in inferior wall infarctions than in anterior nolysis varied considerably between 45 and >180 min depending
infarctions. Older patients have an absolute higher risk of death, on the patients’ conditions (i.e. age, localisation of infarction, and
but the absolute benefit of fibrinolytic therapy is similar to that duration of symptoms) [87]. Moreover there are few data for ben-
of younger patients. Patients over 75 years have an increased efit of PPCI over fibrinolysis in specific subgroups such as patients
risk of intracranial bleeding from fibrinolysis; thus, the absolute post-CABG, with renal failure or with diabetes [88,89]. Time delay
benefit of fibrinolysis is reduced by this complication. The risk to PCI may be significantly shortened by improving the systems of
of intracranial bleeding is increased in patients with a systolic care [13,90–93], e.g.
blood pressure of over 180 mm Hg; this degree of hypertension
is a relative contraindication to fibrinolytic therapy. The risk of • Prehospital ECG registration
intracranial bleeding is also depending on the use of antithrombin • ECG transmission to the receiving hospital
and antiplatelet therapy. • Arranging single call activation of the catheterization laboratory](https://image.slidesharecdn.com/fullerc2010guidelines1-101018011940-phpapp02/85/RCP-2010-guidelines-141-320.jpg)
![1360 H.-R. Arntz et al. / Resuscitation 81 (2010) 1353–1363
• Requiring the catheterization laboratory to be ready within revascularisation (i.e. PPCI, PCI early after fibrinolysis) is indicated
20 min for those patients who develop shock within 36 h after symptom
• Having an attending cardiologists always at the hospital onset of AMI and are suitable for revascularisation [100].
• Providing real-time data feedback Suspect right ventricular infarction in patients with inferior
• Fostering senior management commitment infarction, clinical shock and clear lung fields. ST-segment elevation
• Encouraging a team-based approach ≥1 mm in lead V4R is a useful indicator of right ventricular infarc-
tion. These patients have an in-hospital mortality of up to 30% and
If PPCI cannot be accomplished within an adequate timeframe, many benefit greatly from reperfusion therapy. Avoid nitrates and
independent of the need for emergent transfer, then immediate other vasodilators, and treat hypotension with intravenous fluid.
fibrinolysis should be considered unless there is a contraindication.
For those patients with a contraindication to fibrinolysis, PCI should
still be pursued despite the delay, rather than not providing reper- Reperfusion after successful CPR
fusion therapy at all. For those STEMI patients presenting in shock,
primary PCI (or coronary artery bypass surgery) is the preferred Coronary heart disease is the most frequent cause of out-of-
reperfusion treatment. Fibrinolysis should only be considered if hospital cardiac arrest. Many of these patients will have an acute
there is a substantial delay to PCI. coronary occlusion with signs of STEMI on the ECG, but cardiac
arrest due to ischaemic heart disease can also occur in the absence
Triage and inter-facility transfer for primary PCI of these findings. Several case series have shown that angiography
and, if necessary, PCI is feasible in patients with return of spon-
The risk of death, reinfarction or stroke is reduced if patients taneous circulation (ROSC) after cardiac arrest. In many patients
with STEMI are transferred promptly from community hospitals to coronary artery occlusion or high degree stenoses can be identified
tertiary care facilities for PPCI [82,94,95]. It is less clear whether and treated. Fibrinolysis may be an alternative in patients with ECG
immediate fibrinolytic therapy (in- or out-of-hospital) or transfer signs of STEMI [101]. Therefore in patients with STEMI or new LBBB
for PPCI is superior for younger patients presenting with anterior on ECG following ROSC after out-of-hospital cardiac arrest, imme-
infarction and within a short duration of <2–3 h [87]. Transfer of diate angiography and percutaneous intervention or fibrinolysis
STEMI patients for PPCI is reasonable for those presenting more should be considered [102,103]. It is reasonable to perform imme-
than 3 h but less than 12 h after the onset of symptoms, provided diate angiography and PCI in selected patients despite the lack of
that the transfer can be achieved rapidly. ST elevation on the ECG or prior clinical findings such as chest pain.
It is reasonable to include reperfusion treatment in a standard-
Combination of fibrinolysis and percutaneous coronary ized post-cardiac arrest protocol as part of a strategy to improve
intervention outcome [104]. Reperfusion treatment should not preclude other
Fibrinolysis and PCI may be used in a variety of combinations therapeutic strategies including therapeutic hypothermia.
to restore coronary blood flow and myocardial perfusion. There are
several ways in which the two therapies can be combined. There is
some lack of uniformity in the nomenclature used to describe PCI Primary and secondary prevention
in these regimens. Facilitated PCI is used to describe PCI performed
immediately after fibrinolysis, a pharmaco-invasive strategy refers Preventive interventions in patients presenting with an ACS
to PCI performed routinely 3–24 h after fibrinolysis, and rescue PCI should be initiated early after hospital admission and should be
is defined as PCI performed for a failed reperfusion (as evidenced by continued if already in place. Preventive measures improve prog-
<50% resolution of ST-segment elevation at 60–90 min after com- nosis by reducing the number of major adverse cardiac events.
pletion of fibrinolytic treatment). These strategies are distinct from Prevention with drugs encompasses beta-blockers, angiotensin
a routine PCI approach where the angiography and intervention is converting enzyme (ACE) inhibitors/angiotensin receptor block-
performed several days after successful fibrinolysis. ers (ARB) and statins, as well as basic treatment with ASA and, if
Several studies and meta-analyses demonstrate worse outcome indicated, thienopyridines.
with routine PCI performed immediately or as early as possible
after fibrinolysis [48,95]. Therefore routine facilitated PCI is not
recommended even if there may be some specific subgroups of Beta-blockers
patients which may benefit from this procedure [96]. It is reason-
able to perform angiography and PCI when necessary in patients Several studies, undertaken mainly in the pre-reperfusion era,
with failed fibrinolysis according to clinical signs and/or insufficient indicate a decreased mortality, incidence of reinfarction and car-
ST-segment resolution [97]. diac rupture as well as a lower incidence of ventricular fibrillation
In case of clinically successful fibrinolysis (evidenced by clinical and supraventricular arrhythmia in patients treated early with a
signs and ST-segment resolution >50%), angiography delayed by beta-blocker [105]. Intravenous beta-blockade may also reduce
several hours after fibrinolysis (the ‘pharmaco-invasive’ approach) mortality in patients undergoing PPCI who are not on oral beta-
has been shown to improve outcome. This strategy includes early blockers.
transfer for angiography and PCI if necessary after fibrinolytic treat- Beta-blocker studies are very heterogeneous with respect to
ment [98,99]. time of start of treatment. There is paucity of data on administration
in the prehospital or ED settings. Moreover, recent studies indicate
Special situations an increased risk of cardiogenic shock in patients with STEMI, even
if the rate of severe tachyarrhythmia is reduced by beta-blockade
Cardiogenic shock [106].
There is no evidence to support routine intravenous beta-
Cardiogenic shock (and to some extent severe left ventricular blockers in the prehospital or initial ED settings. It may be indicated
failure) is one of the complications of ACS and has a mortality of in special situations such as severe hypertension or tachyarrhyth-
more than 50%. Cardiogenic shock in STEMI is not a contraindica- mias in the absence of contraindications. It is reasonable to start
tion to fibrinolytic therapy, but PCI is the treatment of choice. Early oral beta-blockers at low doses only after the patient is stabilized.](https://image.slidesharecdn.com/fullerc2010guidelines1-101018011940-phpapp02/85/RCP-2010-guidelines-142-320.jpg)
![H.-R. Arntz et al. / Resuscitation 81 (2010) 1353–1363 1361
Anti-arrhythmics 7. Antman EM, Anbe DT, Armstrong PW, et al. ACC/AHA guidelines for the
management of patients with ST-elevation myocardial infarction—executive
summary: a report of the American College of Cardiology/American Heart
There is no evidence to support the use of anti-arrhythmic pro- Association Task Force on Practice Guidelines (Writing Committee to Revise
phylaxis after ACS. Ventricular fibrillation (VF) accounts for most the 1999 Guidelines for the Management of Patients With Acute Myocardial
of the early deaths from ACS; the incidence of VF is highest in the Infarction). Circulation 2004;110:588–636.
8. Khraim FM, Carey MG. Predictors of pre-hospital delay among patients with
first hours after onset of symptoms. This explains why numerous acute myocardial infarction. Patient Educ Couns 2009;75:155–61.
studies have been performed with the aim of demonstrating the 9. Douglas PS, Ginsburg GS. The evaluation of chest pain in women. N Engl J Med
prophylactic effect of antiarrhythmic therapy [107]. The effects of 1996;334:1311–5.
10. Solomon CG, Lee TH, Cook EF, et al. Comparison of clinical presentation of acute
antiarrhythmic drugs (lidocaine, magnesium, disopyramide, mex- myocardial infarction in patients older than 65 years of age to younger patients:
iletine, verapamil, sotalol, and tocainamide) given prophylactically the Multicenter Chest Pain Study experience. Am J Cardiol 1989;63:772–6.
to patients with ACS have been studied. Prophylaxis with lidocaine 11. Henrikson CA, Howell EE, Bush DE, et al. Chest pain relief by nitroglycerin does
not predict active coronary artery disease. Ann Intern Med 2003;139:979–86.
reduces the incidence of VF but may increase mortality [108]. Rou-
12. Ioannidis JP, Salem D, Chew PW, Lau J. Accuracy and clinical effect of out-
tine treatment with magnesium in patients with AMI does not of-hospital electrocardiography in the diagnosis of acute cardiac ischemia: a
improve mortality. Arrhythmia prophylaxis using disopyramide, meta-analysis. Ann Emerg Med 2001;37:461–70.
mexiletine, verapamil, or other anti-arrhythmics given within the 13. Terkelsen CJ, Lassen JF, Norgaard BL, et al. Reduction of treatment delay in
patients with ST-elevation myocardial infarction: impact of pre-hospital diag-
first hours of an ACS does not improve mortality. Therefore pro- nosis and direct referral to primary percutanous coronary intervention. Eur
phylactic anti-arrhythmics are not recommended. Heart J 2005;26:770–7.
14. Brainard AH, Raynovich W, Tandberg D, Bedrick EJ. The prehospital 12-lead
electrocardiogram’s effect on time to initiation of reperfusion therapy: a sys-
Angiotensin-converting enzyme inhibitors and angiotensin tematic review and meta-analysis of existing literature. Am J Emerg Med
receptor blockers 2005;23:351–6.
15. Swor R, Hegerberg S, McHugh-McNally A, Goldstein M, McEachin CC. Prehospi-
tal 12-lead ECG: efficacy or effectiveness? Prehosp Emerg Care 2006;10:374–7.
Oral ACE inhibitors reduce mortality when given to patients 16. Masoudi FA, Magid DJ, Vinson DR, et al. Implications of the failure to identify
with AMI with or without early reperfusion therapy. The beneficial high-risk electrocardiogram findings for the quality of care of patients with
acute myocardial infarction: results of the Emergency Department Quality in
effects are most pronounced in patients presenting with ante-
Myocardial Infarction (EDQMI) study. Circulation 2006;114:1565–71.
rior infarction, pulmonary congestion or left ventricular ejection 17. Feldman JA, Brinsfield K, Bernard S, White D, Maciejko T. Real-time paramedic
fraction <40%. Do not give ACE inhibitors if the systolic blood pres- compared with blinded physician identification of ST-segment elevation
myocardial infarction: results of an observational study. Am J Emerg Med
sure is less than 100 mm Hg on admission or if there is a known
2005;23:443–8.
contraindication to these drugs. A trend towards higher mortal- 18. Kudenchuk PJ, Ho MT, Weaver WD, et al. Accuracy of computer-interpreted
ity has been documented if an intravenous ACE inhibitor is started electrocardiography in selecting patients for thrombolytic therapy. MITI
within the first 24 h after onset of symptoms. Therefore, give an Project Investigators. J Am Coll Cardiol 1991;17:1486–91.
19. Dhruva VN, Abdelhadi SI, Anis A, et al. ST-segment analysis using wireless
oral ACE inhibitor within 24 h after symptom onset in patients with technology in acute myocardial infarction (STAT-MI) trial. J Am Coll Cardiol
AMI regardless of whether early reperfusion therapy is planned, 2007;50:509–13.
particularly in those patients with anterior infarction, pulmonary 20. Antman EM, Tanasijevic MJ, Thompson B, et al. Cardiac-specific troponin I levels
to predict the risk of mortality in patients with acute coronary syndromes. N
congestion or a left ventricular ejection fraction below 40%. Do not Engl J Med 1996;335:1342–9.
give intravenous ACE inhibitors within 24 h of onset of symptoms. 21. Collinson PO, Gaze DC, Morris F, Morris B, Price A, Goodacre S. Compari-
Give an angiotensin receptor blocker (ARB) to patients intolerant son of biomarker strategies for rapid rule out of myocardial infarction in the
emergency department using ACC/ESC diagnostic criteria. Ann Clin Biochem
of ACE inhibitors [109,110]. 2006;43:273–80.
22. Schuchert A, Hamm C, Scholz J, Klimmeck S, Goldmann B, Meinertz T. Pre-
hospital testing for troponin T in patients with suspected acute myocardial
Statins
infarction. Am Heart J 1999;138:45–8.
23. Keller T, Zeller T, Peetz D, et al. Sensitive troponin I assay in early diagnosis of
Statins reduce the incidence of major adverse cardiovascular acute myocardial infarction. N Engl J Med 2009;361:868–77.
events when given early within the first days after onset an ACS 24. Renaud B, Maison P, Ngako A, et al. Impact of point-of-care testing in the emer-
gency department evaluation and treatment of patients with suspected acute
[111,112]. Initiation of statin therapy should be considered within coronary syndromes. Acad Emerg Med 2008;15:216–24.
24 h of onset of symptoms of ACS unless contraindicated (target 25. Mitchell AM, Garvey JL, Kline JA. Multimarker panel to rule out acute coronary
LDL cholesterol values <80 mg dl−1 [2.1 mmol l−1 ]). If patients are syndromes in low-risk patients. Acad Emerg Med 2006;13:803–6.
26. Hess EP, Thiruganasambandamoorthy V, Wells GA, et al. Diagnostic accuracy of
already receiving statin therapy, it should be not interrupted [113]. clinical prediction rules to exclude acute coronary syndrome in the emergency
department setting: a systematic review. CJEM 2008;10:373–82.
27. Farkouh ME, Smars PA, Reeder GS, et al. A clinical trial of a chest-pain
References observation unit for patients with unstable angina. Chest Pain Evaluation
in the Emergency Room (CHEER) Investigators. N Engl J Med 1998;339:
1. Tunstall-Pedoe H, Vanuzzo D, Hobbs M, et al. Estimation of contribution of 1882–8.
changes in coronary care to improving survival, event rates, and coronary 28. Ramakrishna G, Milavetz JJ, Zinsmeister AR, et al. Effect of exercise treadmill
heart disease mortality across the WHO MONICA Project populations. Lancet testing and stress imaging on the triage of patients with chest pain: CHEER
2000;355:688–700. substudy. Mayo Clin Proc 2005;80:322–9.
2. Fox KA, Cokkinos DV, Deckers J, Keil U, Maggioni A, Steg G. The ENACT study: 29. Goldstein JA, Gallagher MJ, O’Neill WW, Ross MA, O’Neil BJ, Raff GL. A ran-
a pan-European survey of acute coronary syndromes. European Network for domized controlled trial of multi-slice coronary computed tomography for
Acute Coronary Treatment. Eur Heart J 2000;21:1440–9. evaluation of acute chest pain. J Am Coll Cardiol 2007;49:863–71.
3. Goodman SG, Huang W, Yan AT, et al. The expanded Global Registry of Acute 30. Forberg JL, Hilmersson CE, Carlsson M, et al. Negative predictive value and
Coronary Events: baseline characteristics, management practices, and hospital potential cost savings of acute nuclear myocardial perfusion imaging in low
outcomes of patients with acute coronary syndromes. Am Heart J 2009;158, risk patients with suspected acute coronary syndrome: a prospective single
193–201 e1–5. blinded study. BMC Emerg Med 2009;9:12.
4. Lowel H, Meisinger C, Heier M, et al. Sex specific trends of sudden car- 31. Nucifora G, Badano LP, Sarraf-Zadegan N, et al. Comparison of early dobutamine
diac death and acute myocardial infarction: results of the population-based stress echocardiography and exercise electrocardiographic testing for manage-
KORA/MONICA-Augsburg register 1985 to 1998. Dtsch Med Wochenschr ment of patients presenting to the emergency department with chest pain. Am
2002;127:2311–6. J Cardiol 2007;100:1068–73.
5. Thygesen K, Alpert JS, White HD. Universal definition of myocardial infarction. 32. Kearney PM, Baigent C, Godwin J, Halls H, Emberson JR, Patrono C. Do selective
Eur Heart J 2007;28:2525–38. cyclo-oxygenase-2 inhibitors and traditional non-steroidal anti-inflammatory
6. Van de Werf F, Bax J, Betriu A, et al. Management of acute myocardial infarction drugs increase the risk of atherothrombosis? Meta-analysis of randomised
in patients presenting with persistent ST-segment elevation: the task force on trials. BMJ 2006;332:1302–8.
the management of ST-segment elevation acute myocardial infarction of the 33. Rawles JM, Kenmure AC. Controlled trial of oxygen in uncomplicated myocar-
European Society of Cardiology. Eur Heart J 2008;29:2909–45. dial infarction. Br Med J 1976;1:1121–3.](https://image.slidesharecdn.com/fullerc2010guidelines1-101018011940-phpapp02/85/RCP-2010-guidelines-143-320.jpg)
![1362 H.-R. Arntz et al. / Resuscitation 81 (2010) 1353–1363
34. Wijesinghe M, Perrin K, Ranchord A, Simmonds M, Weatherall M, Beasley R. 61. Efficacy and safety of tenecteplase in combination with enoxaparin, abciximab,
Routine use of oxygen in the treatment of myocardial infarction: systematic or unfractionated heparin: the ASSENT-3 randomised trial in acute myocardial
review. Heart 2009;95:198–202. infarction. Lancet 2001;358:605–13.
35. Cabello JB, Burls A, Emparanza JI, Bayliss S, Quinn T. Oxygen therapy for acute 62. Eikelboom JW, Quinlan DJ, Mehta SR, Turpie AG, Menown IB, Yusuf S. Unfrac-
myocardial infarction. Cochrane Database Syst Rev 2010;6:CD007160. tionated and low-molecular-weight heparin as adjuncts to thrombolysis in
36. O’Driscoll BR, Howard LS, Davison AG. BTS guideline for emergency oxygen use aspirin-treated patients with ST-elevation acute myocardial infarction: a meta-
in adult patients. Thorax 2008;63:vi1–68. analysis of the randomized trials. Circulation 2005;112:3855–67.
37. Freimark D, Matetzky S, Leor J, et al. Timing of aspirin administration as a 63. Wallentin L, Goldstein P, Armstrong PW, et al. Efficacy and safety of
determinant of survival of patients with acute myocardial infarction treated tenecteplase in combination with the low-molecular-weight heparin enoxa-
with thrombolysis. Am J Cardiol 2002;89:381–5. parin or unfractionated heparin in the prehospital setting: the assessment of
38. Barbash IM, Freimark D, Gottlieb S, et al. Outcome of myocardial infarction the safety and efficacy of a new thrombolytic regimen (ASSENT)-3 PLUS ran-
in patients treated with aspirin is enhanced by pre-hospital administration. domized trial in acute myocardial infarction. Circulation 2003;108:135–42.
Cardiology 2002;98:141–7. 64. Antman EM, Morrow DA, McCabe CH, et al. Enoxaparin versus unfractionated
39. Wiviott SD, Braunwald E, McCabe CH, et al. Prasugrel versus clopidogrel heparin with fibrinolysis for ST-elevation myocardial infarction. N Engl J Med
in patients with acute coronary syndromes. N Engl J Med 2007;357:2001– 2006;354:1477–88.
15. 65. Zeymer U, Gitt A, Junger C, et al. Efficacy and safety of enoxaparin in unselected
40. Wallentin L, Becker RC, Budaj A, et al. Ticagrelor versus clopidogrel in patients patients with ST-segment elevation myocardial infarction. Thromb Haemost
with acute coronary syndromes. N Engl J Med 2009;361:1045–57. 2008;99:150–4.
41. Yusuf S, Zhao F, Mehta SR, Chrolavicius S, Tognoni G, Fox KK. Effects of clopido- 66. Zeymer U, Gitt A, Zahn R, et al. Efficacy and safety of enoxaparin in combination
grel in addition to aspirin in patients with acute coronary syndromes without with and without GP IIb/IIIa inhibitors in unselected patients with ST segment
ST-segment elevation. N Engl J Med 2001;345:494–502. elevation myocardial infarction treated with primary percutaneous coronary
42. Mehta SR, Yusuf S, Peters RJ, et al. Effects of pretreatment with clopidogrel and intervention. EuroIntervention 2009;4:524–8.
aspirin followed by long-term therapy in patients undergoing percutaneous 67. White HD, Aylward PE, Frey MJ, et al. Randomized, double-blind compari-
coronary intervention: the PCI-CURE study. Lancet 2001;358:527–33. son of hirulog versus heparin in patients receiving streptokinase and aspirin
43. Steinhubl SR, Berger PB, Mann JT, 3rd, et al. Early and sustained dual oral for acute myocardial infarction (HERO). Hirulog Early Reperfusion/Occlusion
antiplatelet therapy following percutaneous coronary intervention: a random- (HERO) Trial Investigators. Circulation 1997;96:2155–61.
ized controlled trial. JAMA 2002;288:2411–20. 68. Stone GW, Witzenbichler B, Guagliumi G, et al. Bivalirudin during primary PCI
44. Chen ZM, Jiang LX, Chen YP, et al. Addition of clopidogrel to aspirin in 45,852 in acute myocardial infarction. N Engl J Med 2008;358:2218–30.
patients with acute myocardial infarction: randomised placebo-controlled 69. Madsen JK, Chevalier B, Darius H, et al. Ischaemic events and bleeding in
trial. Lancet 2005;366:1607–21. patients undergoing percutaneous coronary intervention with concomitant
45. Verheugt FW, Montalescot G, Sabatine MS, et al. Prehospital fibrinolysis bivalirudin treatment. EuroIntervention 2008;3:610–6.
with dual antiplatelet therapy in ST-elevation acute myocardial infarction: 70. Bassand JP, Hamm CW, Ardissino D, et al. Guidelines for the diagnosis and
a substudy of the randomized double blind CLARITY-TIMI 28 trial. J Thromb treatment of non-ST-segment elevation acute coronary syndromes. Eur Heart
Thrombolysis 2007;23:173–9. J 2007;28:1598–660.
46. Bosch X, Marrugat J. Platelet glycoprotein IIb/IIIa blockers for percutaneous 71. Anderson JL, Adams CD, Antman EM, et al. ACC/AHA 2007 Guidelines for the
coronary revascularization, and unstable angina and non-ST-segment eleva- Management of Patients With Unstable Angina/Non ST-Elevation Myocar-
tion myocardial infarction. Cochrane Database Syst Rev 2001:CD002130. dial Infarction: a report of the American College of Cardiology/American
47. Boersma E, Harrington RA, Moliterno DJ, et al. Platelet glycoprotein IIb/IIIa Heart Association Task Force on Practice Guidelines (Writing Committee to
inhibitors in acute coronary syndromes: a meta-analysis of all major ran- Revise the 2002 Guidelines for the Management of Patients With Unstable
domised clinical trials. Lancet 2002;359:189–98 [erratum appears in Lancet Angina/Non ST-Elevation Myocardial Infarction): developed in collaboration
2002 June 15;359(9323):2120]. with the American College of Emergency Physicians, the Society for Cardiovas-
48. Keeley EC, Boura JA, Grines CL. Comparison of primary and facilitated per- cular Angiography and Interventions, and the Society of Thoracic Surgeons:
cutaneous coronary interventions for ST-elevation myocardial infarction: endorsed by the American Association of Cardiovascular and Pulmonary Reha-
quantitative review of randomised trials. Lancet 2006;367:579–88. bilitation and the Society for Academic Emergency Medicine. Circulation
49. Stone GW, Grines CL, Cox DA, et al. Comparison of angioplasty with stent- 2007;116:e148–304.
ing, with or without abciximab, in acute myocardial infarction. N Engl J Med 72. Kushner FG, Hand M, Smith SC, Jr., et al., 2009. Focused updates: ACC/AHA
2002;346:957–66. guidelines for the management of patients with ST-elevation myocardial
50. van’t Hof AW, Ernst N, de Boer MJ, et al. Facilitation of primary coronary infarction (updating the 2004 Guideline and 2007 Focused Update) and
angioplasty by early start of a glycoprotein 2b/3a inhibitor: results of the ongo- ACC/AHA/SCAI guidelines on percutaneous coronary intervention (updating
ing tirofiban in myocardial infarction evaluation (on-TIME) trial. Eur Heart J the 2005 Guideline and 2007 Focused Update): a report of the American
2004;25:837–46. College of Cardiology Foundation/American Heart Association Task Force on
51. Pannu R, Andraws R. Effects of glycoprotein IIb/IIIa inhibitors in patients Practice Guidelines. Circulation 2009;120:2271–306. Erratum in: Circulation.
undergoing percutaneous coronary intervention after pretreatment with clopi- 010 March 30;121(12):e257. Dosage error in article text.
dogrel: a meta-analysis of randomized trials. Crit Pathw Cardiol 2008;7:5–10. 73. Boersma E, Maas AC, Deckers JW, Simoons ML. Early thrombolytic treat-
52. De Luca G, Gibson M, Bellandi F, et al. Early glycoprotein IIb–IIIa inhibitors in ment in acute myocardial infarction: reappraisal of the golden hour. Lancet
primary angioplasty (EGYPT) cooperation. An individual patients’ data meta- 1996;348:771–5.
analysis. Heart 2008. 74. Morrison LJ, Verbeek PR, McDonald AC, Sawadsky BV, Cook DJ. Mortality and
53. TIMI-11B Investigators, Antman EM, McCabe CH, et al. Enoxaparin prevents prehospital thrombolysis for acute myocardial infarction: a meta-analysis.
death and cardiac ischemic events in unstable angina/non-Q-wave myocardial JAMA 2000;283:2686–92.
infarction. Results of the thrombolysis in myocardial infarction (TIMI) 11B trial. 75. Prehospital thrombolytic therapy in patients with suspected acute myocardial
Circulation 1999;100:1593–601. infarction. The European Myocardial Infarction Project Group. N Engl J Med
54. Cohen M, Demers C, Gurfinkel EP, et al. A comparison of low-molecular-weight 1993;329:383–9.
heparin with unfractionated heparin for unstable coronary artery disease. Effi- 76. Weaver WD, Cerqueira M, Hallstrom AP, et al. Prehospital-initiated vs
cacy and Safety of Subcutaneous Enoxaparin in Non-Q-Wave Coronary Events hospital-initiated thrombolytic therapy. The myocardial infarction triage and
Study Group. N Engl J Med 1997;337:447–52. intervention trial. JAMA 1993;270:1211–6.
55. Moscucci M, Fox KA, Cannon CP, et al. Predictors of major bleeding in acute 77. Feasibility, safety, and efficacy of domiciliary thrombolysis by general
coronary syndromes: the Global Registry of Acute Coronary Events (GRACE). practitioners: Grampian region early anistreplase trial. GREAT Group. BMJ
Eur Heart J 2003;24:1815–23. 1992;305:548–53.
56. Yusuf S, Mehta SR, Chrolavicius S, et al. Comparison of fondaparinux and enoxa- 78. Welsh RC, Travers A, Senaratne M, Williams R, Armstrong PW. Feasibility
parin in acute coronary syndromes. N Engl J Med 2006;354:1464–76. and applicability of paramedic-based prehospital fibrinolysis in a large North
57. Mehta SR, Boden WE, Eikelboom JW, et al. Antithrombotic therapy with fon- American center. Am Heart J 2006;152:1007–14.
daparinux in relation to interventional management strategy in patients with 79. Pedley DK, Bissett K, Connolly EM, et al. Prospective observational cohort study
ST- and non-ST-segment elevation acute coronary syndromes: an individual of time saved by prehospital thrombolysis for ST elevation myocardial infarc-
patient-level combined analysis of the Fifth and Sixth Organization to Assess tion delivered by paramedics. BMJ 2003;327:22–6.
Strategies in Ischemic Syndromes (OASIS 5 and 6) randomized trials. Circula- 80. Grijseels EW, Bouten MJ, Lenderink T, et al. Pre-hospital thrombolytic ther-
tion 2008;118:2038–46. apy with either alteplase or streptokinase. Practical applications, complications
58. Lincoff AM, Bittl JA, Harrington RA, et al. Bivalirudin and provisional glycopro- and long-term results in 529 patients. Eur Heart J 1995;16:1833–8.
tein IIb/IIIa blockade compared with heparin and planned glycoprotein IIb/IIIa 81. Keeley EC, Boura JA, Grines CL. Primary angioplasty versus intravenous throm-
blockade during percutaneous coronary intervention: REPLACE-2 randomized bolytic therapy for acute myocardial infarction: a quantitative review of 23
trial. JAMA 2003;289:853–63. randomised trials. Lancet 2003;361:13–20.
59. Stone GW, McLaurin BT, Cox DA, et al. Bivalirudin for patients with acute 82. Dalby M, Bouzamondo A, Lechat P, Montalescot G. Transfer for primary
coronary syndromes. N Engl J Med 2006;355:2203–16. angioplasty versus immediate thrombolysis in acute myocardial infarction:
60. Ferguson JJ, Califf RM, Antman EM, et al. Enoxaparin vs unfractionated heparin a meta-analysis. Circulation 2003;108:1809–14.
in high-risk patients with non-ST-segment elevation acute coronary syn- 83. Magid DJ, Calonge BN, Rumsfeld JS, et al. Relation between hospital primary
dromes managed with an intended early invasive strategy: primary results angioplasty volume and mortality for patients with acute MI treated with pri-
of the SYNERGY randomized trial. JAMA 2004;292:45–54. mary angioplasty vs thrombolytic therapy. JAMA 2000;284:3131–8.](https://image.slidesharecdn.com/fullerc2010guidelines1-101018011940-phpapp02/85/RCP-2010-guidelines-144-320.jpg)
![D. Biarent et al. / Resuscitation 81 (2010) 1364–1388 1381
promptness of extracorporeal life support for a reversible disease and emergency cardiovascular care: international consensus on science. Cir-
process,396–398 and associated special circumstances (e.g., icy water culation 2000;102(Suppl. I):I-46–8.
8. 2005 international consensus on cardiopulmonary resuscitation and emer-
drowning,277,399,400 exposure to toxic drugs). gency cardiovascular care science with treatment recommendations. Part
6: Paediatric basic and advanced life support. Resuscitation 2005;67:
271–91.
Parental presence 9. 2010 international consensus on cardiopulmonary resuscitation and emer-
gency cardiovascular care science with treatment recommendations. Circu-
In some Western societies, the majority of parents prefer to lation, 2010; in press.
10. 2010 international consensus on cardiopulmonary resuscitation and emer-
be present during the resuscitation of their child.401–410 Parental gency cardiovascular care science with treatment recommendations. Resus-
presence has neither been perceived as disruptive403,411–415 nor citation, 2010; in press.
stressful for the staff.401,403,412 Parents witnessing their child’s 11. Richmond S, Wyllie J. European Resuscitation Council Guidelines for Resus-
citation 2010. Section 7. Resuscitation of babies at birth. Resuscitation
resuscitation believe their presence to be beneficial to the 2010;81:1389–99.
child.401–403,410,414–417 Allowing parents to be at the side of their 12. Tibballs J, Weeranatna C. The influence of time on the accuracy of healthcare
child helps them to gain a realistic view of the attempted resus- personnel to diagnose paediatric cardiac arrest by pulse palpation. Resuscita-
tion 2010;81:671–5.
citation and the child’s death. Furthermore, they may have the 13. Tibballs J, Carter B, Kiraly NJ, Ragg P, Clifford M. External and internal biphasic
opportunity to say goodbye to their child. Families who are present direct current shock doses for pediatric ventricular fibrillation and pulseless
at their child’s death show better adjustment and undergo a better ventricular tachycardia. Pediatr Crit Care Med 2010.
14. Sarti A, Savron F, Ronfani L, Pelizzo G, Barbi E. Comparison of three sites to
grieving process.402–404,414,415,417,418
check the pulse and count heart rate in hypotensive infants. Paediatr Anaesth
Parental presence in the resuscitation room may help healthcare 2006;16:394–8.
providers maintain their professional behaviour, whilst helping 15. Sarti A, Savron F, Casotto V, Cuttini M. Heartbeat assessment in infants: a
comparison of four clinical methods. Pediatr Crit Care Med 2005;6:212–5.
them to see the child as a human being and a family member.411
16. de Caen AR, Kleinman ME, Chameides L, et al. International consensus on car-
However in out-of-hospital resuscitation, some EMS providers may diopulmonary resuscitation and emergency cardiovascular care science with
feel threatened by the presence of relatives or are concerned that treatment recommendations. Part 10: Pediatric basic and advanced life sup-
relatives may interfere with their resuscitation efforts.419 Evidence port. Resuscitation, 2010; doi:10.1016/j.resuscitation.2010.08.028; in press.
17. Berg RA, Hilwig RW, Kern KB, Babar I, Ewy GA. Simulated mouth-to-mouth ven-
about parental presence during resuscitation comes from selected
tilation and chest compressions (bystander cardiopulmonary resuscitation)
countries and can probably not be generalised to all of Europe, improves outcome in a swine model of prehospital pediatric asphyxial cardiac
where there could be different socio-cultural and ethical consid- arrest. Crit Care Med 1999;27:1893–9.
18. Dorph E, Wik L, Steen PA. Effectiveness of ventilation-compression ratios 1:5
erations.
and 2:15 in simulated single rescuer paediatric resuscitation. Resuscitation
2002;54:259–64.
Family presence guidelines 19. Turner I, Turner S, Armstrong V. Does the compression to ventilation ratio affect
the quality of CPR: a simulation study. Resuscitation 2002;52:55–62.
20. Babbs CF, Kern KB. Optimum compression to ventilation ratios in CPR under
When relatives are allowed in the resuscitation room, a dedi- realistic, practical conditions: a physiological and mathematical analysis.
cated member of the resuscitation team should be present with the Resuscitation 2002;54:147–57.
parents to explain the process in an empathetic manner, ensuring 21. Babbs CF, Nadkarni V. Optimizing chest compression to rescue ventilation
ratios during one-rescuer CPR by professionals and lay persons: children are
that the parents do not interfere with or distract the resuscitation not just little adults. Resuscitation 2004;61:173–81.
process. If the presence of the parents is impeding the progress of 22. Kitamura T, Iwami T, Kawamura T, et al. Conventional and chest-compression-
the resuscitation, they should be sensitively asked to leave. When only cardiopulmonary resuscitation by bystanders for children who have out-
of-hospital cardiac arrests: a prospective, nationwide, population-based cohort
appropriate, physical contact with the child should be allowed and, study. Lancet 2010.
wherever possible, the parents should be allowed to be with their 23. Houri PK, Frank LR, Menegazzi JJ, Taylor R. A randomized, controlled trial of
dying child at the final moment.411,420–423 two-thumb vs two-finger chest compression in a swine infant model of cardiac
arrest [see comment]. Prehosp Emerg Care 1997;1:65–7.
The leader of the resuscitation team, not the parents, will decide
24. David R. Closed chest cardiac massage in the newborn infant. Pediatrics
when to stop the resuscitation; this should be expressed with sen- 1988;81:552–4.
sitivity and understanding. After the event, the team should be 25. Dorfsman ML, Menegazzi JJ, Wadas RJ, Auble TE. Two-thumb vs two-finger
chest compression in an infant model of prolonged cardiopulmonary resusci-
debriefed, to enable any concerns to be expressed and for the team
tation. Acad Emerg Med 2000;7:1077–82.
to reflect on their clinical practice in a supportive environment. 26. Whitelaw CC, Slywka B, Goldsmith LJ. Comparison of a two-finger versus two-
thumb method for chest compressions by healthcare providers in an infant
mechanical model. Resuscitation 2000;43:213–6.
References 27. Menegazzi JJ, Auble TE, Nicklas KA, Hosack GM, Rack L, Goode JS. Two-thumb
versus two-finger chest compression during CRP in a swine infant model of
1. European Resuscitation Council. Paediatric life support: (including the recom- cardiac arrest. Ann Emerg Med 1993;22:240–3.
mendations for resuscitation of babies at birth). Resuscitation 1998;37:95–6. 28. Stevenson AG, McGowan J, Evans AL, Graham CA. CPR for children: one hand
2. Zideman D, Bingham R, Beattie T, et al. Guidelines for paediatric life support: or two? Resuscitation 2005;64:205–8.
a statement by the Paediatric Life Support Working Party of the European 29. Gurnett CA, Atkins DL. Successful use of a biphasic waveform automated exter-
Resuscitation Council, 1993. Resuscitation 1994;27:91–105. nal defibrillator in a high-risk child. Am J Cardiol 2000;86:1051–3.
3. Phillips B, Zideman D, Wyllie J, Richmond S, van Reempts P. European 30. Konig B, Benger J, Goldsworthy L. Automatic external defibrillation in a 6 year
Resuscitation Council Guidelines 2000 for newly born life support. A state- old. Arch Dis Child 2005;90:310–1.
ment from the Paediatric Life Support Working Group and approved by the 31. Atkinson E, Mikysa B, Conway JA, et al. Specificity and sensitivity of automated
Executive Committee of the European Resuscitation Council. Resuscitation external defibrillator rhythm analysis in infants and children. Ann Emerg Med
2001;48:235–9. 2003;42:185–96.
4. Phillips B, Zideman D, Garcia-Castrillo L, Felix M, Shwarz-Schwierin V. Euro- 32. Cecchin F, Jorgenson DB, Berul CI, et al. Is arrhythmia detection by automatic
pean Resuscitation Council Guidelines 2000 for advanced paediatric life external defibrillator accurate for children? Sensitivity and specificity of an
support. A statement from Paediatric Life Support Working Group and automatic external defibrillator algorithm in 696 pediatric arrhythmias. Circu-
approved by the Executive Committee of the European Resuscitation Council. lation 2001;103:2483–8.
Resuscitation 2001;48:231–4. 33. Atkins DL, Scott WA, Blaufox AD, et al. Sensitivity and specificity of an
5. Biarent D, Bingham R, Richmond S, et al. European Resuscitation Council Guide- automated external defibrillator algorithm designed for pediatric patients.
lines for Resuscitation 2005. Section 6. Paediatric life support. Resuscitation Resuscitation 2008;76:168–74.
2005;67:S97–133. 34. Samson R, Berg R, Bingham R. Pediatric Advanced Life Support Task Force ILCoR.
6. American Heart Association in collaboration with International Liaison Com- Use of automated external defibrillators for children: an update. An advisory
mittee on Resuscitation. Guidelines for cardiopulmonary resuscitation and statement from the Pediatric Advanced Life Support Task Force, International
emergency cardiovascular care – an international consensus on science. Resus- Liaison Committee on Resuscitation. Resuscitation 2003;57:237–43.
citation 2000;46:3–430. 35. Jorgenson D, Morgan C, Snyder D, et al. Energy attenuator for pediatric
7. American Heart Association in collaboration with International Liaison Com- application of an automated external defibrillator. Crit Care Med 2002;30:
mittee on Resuscitation. Guidelines 2000 for cardiopulmonary resuscitation S145–7.](https://image.slidesharecdn.com/fullerc2010guidelines1-101018011940-phpapp02/85/RCP-2010-guidelines-163-320.jpg)
![1388 D. Biarent et al. / Resuscitation 81 (2010) 1364–1388
401. Dudley NC, Hansen KW, Furnival RA, Donaldson AE, Van Wagenen KL, Scaife 412. O’Connell KJ, Farah MM, Spandorfer P, et al. Family presence during pediatric
ER. The effect of family presence on the efficiency of pediatric trauma resusci- trauma team activation: an assessment of a structured program. Pediatrics
tations. Ann Emerg Med 2009;53:777–84, e3. 2007;120:e565–74.
402. Tinsley C, Hill JB, Shah J, et al. Experience of families during cardiopul- 413. Engel KG, Barnosky AR, Berry-Bovia M, et al. Provider experience and atti-
monary resuscitation in a pediatric intensive care unit. Pediatrics 2008;122: tudes toward family presence during resuscitation procedures. J Palliative Med
e799–804. 2007;10:1007–9.
403. Mangurten J, Scott SH, Guzzetta CE, et al. Effects of family presence during 414. Holzhauser K, Finucane J, De Vries S. Family presence during resuscitation:
resuscitation and invasive procedures in a pediatric emergency department. J a randomised controlled trial of the impact of family presence. Australasian
Emerg Nurs 2006;32:225–33. Emerg Nurs J 2005;8:139–47.
404. McGahey-Oakland PR, Lieder HS, Young A, et al. Family experiences during 415. Doyle CJ, Post H, Burney RE, Maino J, Keefe M, Rhee KJ. Family participation
resuscitation at a children’s hospital emergency department. J Pediatr Health during resuscitation: an option. Ann Emerg Med 1987;16:673–5.
Care 2007;21:217–25. 416. Meyers TA, Eichhorn DJ, Guzzetta CE. Do families want to be present during
405. Jones M, Qazi M, Young KD. Ethnic differences in parent preference to be CPR? A retrospective survey. J Emerg Nurs 1998;24:400–5.
present for painful medical procedures. Pediatrics 2005;116:e191–7. 417. Hanson C, Strawser D. Family presence during cardiopulmonary resuscitation:
406. Boie ET, Moore GP, Brummett C, Nelson DR. Do parents want to be foote Hospital emergency department’s nine-year perspective. J Emerg Nurs
present during invasive procedures performed on their children in the emer- 1992;18:104–6.
gency department? A survey of 400 parents. Ann Emerg Med 1999;34: 418. Robinson SM, Mackenzie-Ross S, Campbell Hewson GL, Egleston CV, Prevost AT.
70–4. Psychological effect of witnessed resuscitation on bereaved relatives. Lancet
407. Andrews R, Andrews R. Family presence during a failed major trauma resusci- 1998;352:614–7.
tation attempt of a 15-year-old boy: lessons learned [see comment]. J Emerg 419. Compton S, Madgy A, Goldstein M, et al. Emergency medical service providers’
Nurs 2004;30:556–8. experience with family presence during cardiopulmonary resuscitation. Resus-
408. Dill K, Gance-Cleveland B, Dill K, Gance-Cleveland B. With you until the end: citation 2006;70:223–8.
family presence during failed resuscitation. J Specialists Pediatr Nurs: JSPN 420. Beckman AW, Sloan BK, Moore GP, et al. Should parents be present during
2005;10:204–7. emergency department procedures on children, and who should make that
409. Gold KJ, Gorenflo DW, Schwenk TL, et al. Physician experience with family pres- decision? A survey of emergency physician and nurse attitudes. Acad Emerg
ence during cardiopulmonary resuscitation in children [see comment]. Pediatr Med 2002;9:154–8.
Crit Care Med 2006;7:428–33. 421. Eppich WJ, Arnold LD. Family member presence in the pediatric emergency
410. Duran CR, Oman KS, Abel JJ, Koziel VM, Szymanski D. Attitudes toward and department. Curr Opin Pediatr 2003;15:294–8.
beliefs about family presence: a survey of healthcare providers, patients’ fam- 422. Eichhorn DJ, Meyers TA, Mitchell TG, Guzzetta CE. Opening the doors: family
ilies, and patients. Am J Crit Care 2007;16:270–9. presence during resuscitation. J Cardiovasc Nurs 1996;10:59–70.
411. Meyers TA, Eichhorn DJ, Guzzetta CE, et al. Family presence during invasive 423. Jarvis AS. Parental presence during resuscitation: attitudes of staff on a paedi-
procedures and resuscitation. Am J Nurs 2000;100:32–42, quiz 3. atric intensive care unit. Intensive Crit Care Nurs 1998;14:3–7.](https://image.slidesharecdn.com/fullerc2010guidelines1-101018011940-phpapp02/85/RCP-2010-guidelines-170-320.jpg)
![1398 S. Richmond, J. Wyllie / Resuscitation 81 (2010) 1389–1399
14. O’Donnell CP, Kamlin CO, Davis PG, Carlin JB, Morley CJ. Clinical assessment of 46. Rabi Y, Yee W, Chen SY, Singhal N. Oxygen saturation trends immediately after
infant colour at delivery. Arch Dis Child Fetal Neonatal Ed 2007;92:F465–7. birth. J Pediatr 2006;148:590–4.
15. Cordero Jr L, Hon EH. Neonatal bradycardia following nasopharyngeal stimu- 47. Gonzales GF, Salirrosas A. Arterial oxygen saturation in healthy newborns
lation. J Pediatr 1971;78:441–7. delivered at term in Cerro de Pasco (4340 m) and Lima (150 m). Reprod Biol
16. Houri PK, Frank LR, Menegazzi JJ, Taylor R. A randomized, controlled trial of Endocrinol 2005;3:46.
two-thumb vs two-finger chest compression in a swine infant model of cardiac 48. Escrig R, Arruza L, Izquierdo I, et al. Achievement of targeted saturation
arrest [see comment]. Prehosp Emerg Care 1997;1:65–7. values in extremely low gestational age neonates resuscitated with low
17. David R. Closed chest cardiac massage in the newborn infant. Pediatrics or high oxygen concentrations: a prospective, randomized trial. Pediatrics
1988;81:552–4. 2008;121:875–81.
18. Menegazzi JJ, Auble TE, Nicklas KA, Hosack GM, Rack L, Goode JS. Two-thumb 49. Wang CL, Anderson C, Leone TA, Rich W, Govindaswami B, Finer NN. Resus-
versus two-finger chest compression during CRP in a swine infant model of citation of preterm neonates by using room air or 100% oxygen. Pediatrics
cardiac arrest. Ann Emerg Med 1993;22:240–3. 2008;121:1083–9.
19. Thaler MM, Stobie GH. An improved technique of external caridac compression 50. Peltonen T. Placental transfusion—advantage an disadvantage. Eur J Pediatr
in infants and young children. N Engl J Med 1963;269:606–10. 1981;137:141–6.
20. Meyer A, Nadkarni V, Pollock A, et al. Evaluation of the Neonatal Resuscita- 51. Brady JP, James LS. Heart rate changes in the fetus and newborn infant dur-
tion Program’s recommended chest compression depth using computerized ing labor, delivery, and the immediate neonatal period. Am J Obstet Gynecol
tomography imaging. Resuscitation 2010;81:544–8. 1962;84:1–12.
21. Dean JM, Koehler RC, Schleien CL, et al. Improved blood flow during prolonged 52. Mercer JS, Vohr BR, McGrath MM, Padbury JF, Wallach M, Oh W. Delayed cord
cardiopulmonary resuscitation with 30% duty cycle in infant pigs. Circulation clamping in very preterm infants reduces the incidence of intraventricular
1991;84:896–904. hemorrhage and late-onset sepsis: a randomized, controlled trial. Pediatrics
22. Wyckoff MH, Perlman JM, Laptook AR. Use of volume expansion during delivery 2006;117:1235–42.
room resuscitation in near-term and term infants. Pediatrics 2005;115:950–5. 53. Vyas H, Milner AD, Hopkin IE, Boon AW. Physiologic responses to prolonged
23. Nuffield Council on Bioethics. Critical care decisions in fetal and neonatal and slow-rise inflation in the resuscitation of the asphyxiated newborn infant.
medicine: ethical issues. ISBN 1 904384 14 2006. J Pediatr 1981;99:635–9.
24. Costeloe K, Hennessy E, Gibson AT, Marlow N, Wilkinson AR. The EPICure 54. Mortola JP, Fisher JT, Smith JB, Fox GS, Weeks S, Willis D. Onset of respiration
study: outcomes to discharge from hospital for infants born at the threshold in infants delivered by cesarean section. J Appl Physiol 1982;52:716–24.
of viability. Pediatrics 2000;106:659–71. 55. Hull D. Lung expansion and ventilation during resuscitation of asphyxiated
25. Vohra S, Frent G, Campbell V, Abbott M, Whyte R. Effect of polyethylene occlu- newborn infants. J Pediatr 1969;75:47–58.
sive skin wrapping on heat loss in very low birth weight infants at delivery: a 56. Upton CJ, Milner AD. Endotracheal resuscitation of neonates using a rebreath-
randomized trial. J Pediatr 1999;134:547–51. ing bag. Arch Dis Child 1991;66:39–42.
26. Lenclen R, Mazraani M, Jugie M, et al. Use of a polyethylene bag: a way to 57. Vyas H, Milner AD, Hopkins IE. Intrathoracic pressure and volume changes
improve the thermal environment of the premature newborn at the delivery during the spontaneous onset of respiration in babies born by cesarean section
room. Arch Pediatr 2002;9:238–44. and by vaginal delivery. J Pediatr 1981;99:787–91.
27. Bjorklund LJ, Hellstrom-Westas L. Reducing heat loss at birth in very preterm 58. Vyas H, Field D, Milner AD, Hopkin IE. Determinants of the first inspi-
infants. J Pediatr 2000;137:739–40. ratory volume and functional residual capacity at birth. Pediatr Pulmonol
28. Vohra S, Roberts RS, Zhang B, Janes M, Schmidt B. Heat Loss Prevention (HeLP) 1986;2:189–93.
in the delivery room: a randomized controlled trial of polyethylene occlusive 59. Boon AW, Milner AD, Hopkin IE. Lung expansion, tidal exchange, and forma-
skin wrapping in very preterm infants. J Pediatr 2004;145:750–3. tion of the functional residual capacity during resuscitation of asphyxiated
29. Lieberman E, Eichenwald E, Mathur G, Richardson D, Heffner L, Cohen neonates. J Pediatr 1979;95:1031–6.
A. Intrapartum fever and unexplained seizures in term infants. Pediatrics 60. Ingimarsson J, Bjorklund LJ, Curstedt T, et al. Incomplete protection by prophy-
2000;106:983–8. lactic surfactant against the adverse effects of large lung inflations at birth in
30. Grether JK, Nelson KB. Maternal infection and cerebral palsy in infants of nor- immature lambs. Intensive Care Med 2004;30:1446–53.
mal birth weight. JAMA 1997;278:207–11. 61. Nilsson R, Grossmann G, Robertson B. Bronchiolar epithelial lesions induced
31. Coimbra C, Boris-Moller F, Drake M, Wieloch T. Diminished neuronal damage in the premature rabbit neonate by short periods of artificial ventilation. Acta
in the rat brain by late treatment with the antipyretic drug dipyrone or cooling Pathol Microbiol Scand 1980;88:359–67.
following cerebral ischemia. Acta Neuropathol 1996;92:447–53. 62. Probyn ME, Hooper SB, Dargaville PA, et al. Positive end expiratory pressure
32. Dietrich WD, Alonso O, Halley M, Busto R. Delayed posttraumatic brain hyper- during resuscitation of premature lambs rapidly improves blood gases without
thermia worsens outcome after fluid percussion brain injury: a light and adversely affecting arterial pressure. Pediatr Res 2004;56:198–204.
electron microscopic study in rats. Neurosurgery 1996;38:533–41, discussion 63. Schmolzer GM, Kamlin OF, Dawson JA, Davis PG, Morley CJ. Respiratory
41. monitoring of neonatal resuscitation. Arch Dis Child Fetal Neonatal Ed
33. Carson BS, Losey RW, Bowes Jr WA, Simmons MA. Combined obstetric and 2010;95:F295–303.
pediatric approach to prevent meconium aspiration syndrome. Am J Obstet 64. Hird MF, Greenough A, Gamsu HR. Inflating pressures for effective resuscitation
Gynecol 1976;126:712–5. of preterm infants. Early Hum Dev 1991;26:69–72.
34. Ting P, Brady JP. Tracheal suction in meconium aspiration. Am J Obstet Gynecol 65. Lindner W, Vossbeck S, Hummler H, Pohlandt F. Delivery room management
1975;122:767–71. of extremely low birth weight infants: spontaneous breathing or intubation?
35. Falciglia HS, Henderschott C, Potter P, Helmchen R. Does DeLee suction at Pediatrics 1999;103:961–7.
the perineum prevent meconium aspiration syndrome? Am J Obstet Gynecol 66. Allwood AC, Madar RJ, Baumer JH, Readdy L, Wright D. Changes in resuscitation
1992;167:1243–9. practice at birth. Arch Dis Child Fetal Neonatal Ed 2003;88:F375–9.
36. Wiswell TE, Tuggle JM, Turner BS. Meconium aspiration syndrome: have we 67. Cole AF, Rolbin SH, Hew EM, Pynn S. An improved ventilator system for
made a difference? Pediatrics 1990;85:715–21. delivery-room management of the newborn. Anesthesiology 1979;51:356–8.
37. Wiswell TE, Gannon CM, Jacob J, et al. Delivery room management of the 68. Hoskyns EW, Milner AD, Hopkin IE. A simple method of face mask resuscitation
apparently vigorous meconium-stained neonate: results of the multicenter, at birth. Arch Dis Child 1987;62:376–8.
international collaborative trial. Pediatrics 2000;105:1–7. 69. Ganga-Zandzou PS, Diependaele JF, Storme L, et al. Is Ambu ventilation of new-
38. Vain NE, Szyld EG, Prudent LM, Wiswell TE, Aguilar AM, Vivas NI. Oropha- born infants a simple question of finger-touch? Arch Pediatr 1996;3:1270–2.
ryngeal and nasopharyngeal suctioning of meconium-stained neonates before 70. Finer NN, Rich W, Craft A, Henderson C. Comparison of methods of bag and
delivery of their shoulders: multicentre, randomised controlled trial. Lancet mask ventilation for neonatal resuscitation. Resuscitation 2001;49:299–305.
2004;364:597–602. 71. Kanter RK. Evaluation of mask-bag ventilation in resuscitation of infants. Am J
39. Davis PG, Tan A, O’Donnell CP, Schulze A. Resuscitation of newborn infants Dis Child 1987;141:761–3.
with 100% oxygen or air: a systematic review and meta-analysis. Lancet 72. Esmail N, Saleh M, Ali A. Laryngeal mask airway versus endotracheal intubation
2004;364:1329–33. for Apgar score improvement in neonatal resuscitation. Egypt J Anesthesiol
40. Felderhoff-Mueser U, Bittigau P, Sifringer M, et al. Oxygen causes cell death in 2002;18:115–21.
the developing brain. Neurobiol Dis 2004;17:273–82. 73. Trevisanuto D, Micaglio M, Pitton M, Magarotto M, Piva D, Zanardo V. Laryn-
41. Koch JD, Miles DK, Gilley JA, Yang CP, Kernie SG. Brief exposure to hyper- geal mask airway: is the management of neonates requiring positive pressure
oxia depletes the glial progenitor pool and impairs functional recovery ventilation at birth changing? Resuscitation 2004;62:151–7.
after hypoxic–ischemic brain injury. J Cereb Blood Flow Metab 2008;28: 74. Singh R. Controlled trial to evaluate the use of LMA for neonatal resuscitation.
1294–306. J Anaesth Clin Pharmacol 2005;21:303–6.
42. O’Donnell CP, Kamlin CO, Davis PG, Morley CJ. Feasibility of and delay in 75. Leone TA, Lange A, Rich W, Finer NN. Disposable colorimetric carbon diox-
obtaining pulse oximetry during neonatal resuscitation. J Pediatr 2005;147: ide detector use as an indicator of a patent airway during noninvasive mask
698–9. ventilation. Pediatrics 2006;118:e202–4.
43. Dildy GA, van den Berg PP, Katz M, et al. Intrapartum fetal pulse oximetry: fetal 76. Finer NN, Rich W, Wang C, Leone T. Airway obstruction during mask ventila-
oxygen saturation trends during labor and relation to delivery outcome. Am J tion of very low birth weight infants during neonatal resuscitation. Pediatrics
Obstet Gynecol 1994;171:679–84. 2009;123:865–9.
44. Mariani G, Dik PB, Ezquer A, et al. Pre-ductal and post-ductal O2 saturation in 77. Kempley ST, Moreiras JW, Petrone FL. Endotracheal tube length for neonatal
healthy term neonates after birth. J Pediatr 2007;150:418–21. intubation. Resuscitation 2008;77:369–73.
45. Dawson JA, Kamlin CO, Vento M, et al. Defining the reference range for oxygen 78. Palme-Kilander C, Tunell R. Pulmonary gas exchange during facemask ventila-
saturation for infants after birth. Pediatrics 2010;125:e1340–7. tion immediately after birth. Arch Dis Child 1993;68:11–6.](https://image.slidesharecdn.com/fullerc2010guidelines1-101018011940-phpapp02/85/RCP-2010-guidelines-180-320.jpg)
![J. Soar et al. / Resuscitation 81 (2010) 1400–1433 1401
the myocardium. Evaluation of serum potassium must take into • cardiac arrest (pulseless electrical activity [PEA], ventricular fib-
consideration the effects of changes in serum pH. When serum rillation/pulseless ventricular tachycardia [VF/VT], asystole).
pH decreases (acidaemia), serum potassium increases because
potassium shifts from the cellular to the vascular space. When Treatment of hyperkalaemia
serum pH increases (alkalaemia), serum potassium decreases There are three key treatments for hyperkalaemia5 :
because potassium shifts intracellularly. Anticipate the effects of
pH changes on serum potassium during therapy for hyperkalaemia 1. cardiac protection;
or hypokalaemia. 2. shifting potassium into cells;
3. removing potassium from the body.
Hyperkalaemia
Intravenous calcium salts are not generally indicated in the
This is the most common electrolyte disorder associated with absence of ECG changes. Monitor effectiveness of treatment,
cardiopulmonary arrest. It is usually caused by increased potassium be alert to rebound hyperkalaemia and take steps to prevent
release from cells, impaired excretion by the kidneys or accidental recurrence of hyperkalaemia. When hyperkalaemia is strongly
potassium chloride administration. suspected, e.g., in the presence of ECG changes, start life-saving
treatment even before laboratory results are available. The treat-
ment of hyperkalaemia has been the subject of a Cochrane review.6
Definition
There is no universal definition. We have defined hyperkalaemia
as a serum potassium concentration higher than 5.5 mmol l−1 ; in Patient not in cardiac arrest. Assess ABCDE (Airway, Breathing,
practice, hyperkalaemia is a continuum. As the potassium con- Circulation, Disability, Exposure) and correct any abnormalities.
centration increases above this value the risk of adverse events Obtain intravenous access, check serum potassium and record
increases and the need for urgent treatment increases. Severe an ECG. Treatment is determined according to severity of hyper-
hyperkalaemia has been defined as a serum potassium concentra- kalaemia.
tion higher than 6.5 mmol l−1 . Approximate values are provided to guide treatment.
Mild elevation (5.5–5.9 mmol l−1 ):
Causes
There are several potential causes of hyperkalaemia, includ- • Remove potassium from body: potassium exchange resins –
ing renal failure, drugs (angiotensin converting enzyme inhibitors calcium resonium 15–30 g OR sodium polystyrene sulfonate
(ACE-I), angiotensin II receptor antagonists, potassium spar- (Kayexalate) 15–30 g in 50–100 ml of 20% sorbitol, given either
ing diuretics, non-steroidal anti-inflammatory drugs (NSAIDs), orally or by retention enema (onset in 1–3 h; maximal effect at
beta-blockers, trimethoprim), tissue breakdown (rhabdomyolysis, 6 h).
tumour lysis, haemolysis), metabolic acidosis, endocrine disorders • Address cause of hyperkalaemia to correct and avoid further rise
(Addison’s disease), hyperkalaemic periodic paralysis, or diet (may in serum potassium (e.g., drugs, diet).
be sole cause in patients with advanced chronic kidney disease).
Abnormal erythrocytes or thrombocytosis may cause a spuriously Moderate elevation (6–6.4 mmol l−1 ) without ECG changes:
high potassium concentration.2 The risk of hyperkalaemia is even
greater when there is a combination of factors such as the concomi- • Shift potassium intracellularly with glucose/insulin: 10 units
tant use of ACE-I and NSAIDs or potassium sparing diuretics.
short-acting insulin and 25 g glucose IV over 15–30 min (onset in
15–30 min; maximal effect at 30–60 min; monitor blood glucose).
Recognition of hyperkalaemia • Remove potassium from the body as described above.
Exclude hyperkalaemia in patients with an arrhythmia or • Haemodialysis: consider if oliguric; haemodialysis is more effi-
cardiac arrest.3 Patients may present with weakness progress- cient than peritoneal dialysis at removing potassium.
ing to flaccid paralysis, paraesthesia, or depressed deep tendon
reflexes. Alternatively, the clinical picture can be overshadowed Severe elevation (≥6.5 mmol l−1 ) without ECG changes. Seek expert
by the primary illness causing hyperkalaemia. The first indicator help and:
of hyperkalaemia may also be the presence of ECG abnormali-
ties, arrhythmias, cardiopulmonary arrest or sudden death. The • Use multiple shifting agents.
effect of hyperkalaemia on the ECG depends on the absolute serum • Glucose/insulin (see above).
potassium as well as the rate of increase. Most patients will have • Salbutamol 5 mg nebulised. Several doses (10–20 mg) may be
ECG abnormalities at a serum potassium concentration higher than required (onset in 15–30 min).
6.7 mmol l−1 .4 The use of a blood gas analyser that measures potas- • Sodium bicarbonate: 50 mmol IV over 5 min if metabolic acidosis
sium can reduce delay in recognition. present (onset in 15–30 min). Bicarbonate alone is less effective
The ECG changes associated with hyperkalaemia are usually than glucose plus insulin or nebulised salbutamol; it is best used
progressive and include: in conjunction with these medications.7,8
• Use removal strategies above.
• first degree heart block (prolonged PR interval) [>0.2 s];
• flattened or absent P waves; Severe elevation (≥6.5 mmol l−1 ) WITH toxic ECG changes. Seek
• tall, peaked (tented) T waves [T wave larger than R wave in more expert help and:
than 1 lead];
• ST-segment depression; • Protect the heart first with calcium chloride: 10 ml 10% calcium
• S and T wave merging (sine wave pattern); chloride IV over 2–5 min to antagonise the toxic effects of hyper-
• widened QRS [>0.12 s]; kalaemia at the myocardial cell membrane. This protects the
• ventricular tachycardia; heart by reducing the risk of pulseless VT/VF but does not lower
• bradycardia; serum potassium (onset in 1–3 min).](https://image.slidesharecdn.com/fullerc2010guidelines1-101018011940-phpapp02/85/RCP-2010-guidelines-183-320.jpg)
![J. Soar et al. / Resuscitation 81 (2010) 1400–1433 1403
Table 8.1
Calcium and magnesium disorders with associated clinical presentation, ECG manifestations and recommended treatment.
Disorder Causes Presentation ECG Treatment
Hypercalcaemia Primary or tertiary Confusion Short QT interval Fluid replacement IV
[Calcium] > 2.6 mmol l−1 hyperparathyroidism
Malignancy Weakness Prolonged QRS Interval Furosemide 1 mg kg−1 IV
Sarcoidosis Abdominal pain Flat T waves Hydrocortisone 200–300 mg IV
Drugs Hypotension AV-block Pamidronate 30–90 mg IV
Arrhythmias Cardiac arrest Treat underlying cause
Cardiac arrest
Hypocalcaemia Chronic renal failure Paraesthesia Prolonged QT interval Calcium chloride 10% 10–40 ml
[Calcium] < 2.1 mmol l−1 Acute pancreatitis Tetany T wave inversion Magnesium sulphate 50%
4–8 mmol (if necessary)
Calcium channel blocker Seizures Heart block
overdose
Toxic shock syndrome AV-block Cardiac arrest
Rhabdomyolysis Cardiac arrest
Tumour lysis syndrome
Hypermagnesaemia Renal failure Confusion Prolonged PR and QT Consider treatment when
[Magnesium] > 1.1 mmol l−1 intervals [Magnesium] > 1.75 mmol l−1
Iatrogenic Weakness T wave peaking
Respiratory depression AV-block Calcium chloride 10% 5–10 ml
repeated if necessary
AV-block Cardiac arrest Ventilatory support if
necessary
Cardiac arrest Saline diuresis – 0.9% saline
with furosemide 1 mg kg−1 IV
Haemodialysis
Hypomagnesaemia GI loss Tremor Prolonged PR and QT Severe or symptomatic:
[Magnesium] < 0.6 mmol l−1 Intervals
Polyuria Ataxia ST-segment depression 2 g 50% magnesium sulphate
(4 ml; 8 mmol) IV over 15 min.
Starvation Nystagmus T-wave inversion Torsade de pointes:
Alcoholism Seizures Flattened P waves 2 g 50% magnesium sulphate
(4 ml; 8 mmol) IV over 1–2 min.
Malabsorption Arrhythmias – torsade de pointes Increased QRS duration Seizure:
Cardiac arrest Torsade de pointes 2 g 50% magnesium sulphate
(4 ml; 8 mmol) IV over 10 min.
Calcium and magnesium disorders Prevention of cardiac arrest
The recognition and management of calcium and magnesium
disorders is summarised in Table 8.1. Assess using the ABCDE (Airway, Breathing, Circulation, Dis-
ability, Exposure) approach. Airway obstruction and respiratory
arrest secondary to a decreased conscious level is a common cause
of death after self-poisoning.23 Pulmonary aspiration of gastric
Summary
contents can occur after poisoning with central nervous system
depressants. Early tracheal intubation of unconscious patients by
Electrolyte abnormalities are among the most common causes
a trained person decreases the risk of aspiration. Drug-induced
of cardiac arrhythmias. Of all the electrolyte abnormalities, hyper-
hypotension usually responds to fluid infusion, but occasionally
kalaemia is most rapidly fatal. A high degree of clinical suspicion
vasopressor support (e.g., noradrenaline infusion) is required. A
and aggressive treatment of underlying electrolyte abnormalities
long period of coma in a single position can cause pressure sores
can prevent many patients from progressing to cardiac arrest.
and rhabdomyolysis. Measure electrolytes (particularly potas-
sium), blood glucose and arterial blood gases. Monitor temperature
because thermoregulation is impaired. Both hypothermia and
8b. Poisoning hyperthermia (hyperpyrexia) can occur after overdose of some
drugs. Retain samples of blood and urine for analysis. Patients with
General considerations severe poisoning should be cared for in a critical-care setting.
Interventions such as decontamination, enhanced elimina-
Poisoning rarely causes cardiac arrest, but is a leading cause tion and antidotes may be indicated and are usually second
of death in victims younger than 40 years of age.22 Evidence for line interventions.24 Alcohol excess is often associated with self-
treatment consists primarily of small case-series, animal studies poisoning.
and case reports. Poisoning by therapeutic or recreational drugs
and by household products are the main reasons for hospital
admission and poison centre calls. Inappropriate drug dosing, drug Modifications to BLS/ALS
interactions and other medication errors can also cause harm. Acci-
dental poisoning is commonest in children. Homicidal poisoning • Have a high index of personal safety where there is a suspicious
is uncommon. Industrial accidents, warfare or terrorism can also cause or unexpected cardiac arrest. This is especially so when
cause exposure to harmful substances. more than one casualty collapses simultaneously.](https://image.slidesharecdn.com/fullerc2010guidelines1-101018011940-phpapp02/85/RCP-2010-guidelines-185-320.jpg)
![J. Soar et al. / Resuscitation 81 (2010) 1400–1433 1427
103. Weinberg GL, Di Gregorio G, Ripper R, et al. Resuscitation with lipid ver- 136. Harris NS. Case records of the Massachusetts General Hospital. Case 24-2006. A
sus epinephrine in a rat model of bupivacaine overdose. Anesthesiology 40-year-old woman with hypotension after an overdose of amlodipine. N Engl
2008;108:907–13. J Med 2006;355:602–11.
104. Management of severe local anaesthetic toxicity. Association of Anaesthetists 137. Herbert J, O’Malley C, Tracey J, Dwyer R, Power M. Verapamil overdosage unre-
of Great Britain and Ireland; 2010 [accessed 28.06.10]. sponsive to dextrose/insulin therapy. J Toxicol Clin Toxicol 2001;39:293–4.
105. Mayr VD, Mitterschiffthaler L, Neurauter A, et al. A comparison of the combi- 138. Johansen KK, Belhage B. A 48-year-old woman’s survival from a massive vera-
nation of epinephrine and vasopressin with lipid emulsion in a porcine model pamil overdose. Ugeskr Laeger 2007;169:4074–5.
of asphyxial cardiac arrest after intravenous injection of bupivacaine. Anesth 139. Kanagarajan K, Marraffa JM, Bouchard NC, Krishnan P, Hoffman RS, Stork CM.
Analg 2008;106:1566–71, table of contents. The use of vasopressin in the setting of recalcitrant hypotension due to calcium
106. Hicks SD, Salcido DD, Logue ES, et al. Lipid emulsion combined with channel blocker overdose. Clin Toxicol (Phila) 2007;45:56–9.
epinephrine and vasopressin does not improve survival in a swine model of 140. Marques M, Gomes E, de Oliveira J. Treatment of calcium channel blocker intox-
bupivacaine-induced cardiac arrest. Anesthesiology 2009;111:138–46. ication with insulin infusion: case report and literature review. Resuscitation
107. Hiller DB, Gregorio GD, Ripper R, et al. Epinephrine impairs lipid resus- 2003;57:211–3.
citation from bupivacaine overdose: a threshold effect. Anesthesiology 141. Meyer M, Stremski E, Scanlon M. Successful resuscitation of a verapamil
2009;111:498–505. intoxicated child with a dextrose-insulin infusion. Clin Intensive Care
108. Bailey B. Glucagon in beta-blocker and calcium channel blocker overdoses: a 2003;14:109–13.
systematic review. J Toxicol Clin Toxicol 2003;41:595–602. 142. Morris-Kukoski C, Biswas A, Para M. Insulin “euglycemia” therapy for accidental
109. Fahed S, Grum DF, Papadimos TJ. Labetalol infusion for refractory hypertension nifedipine overdose. J Toxicol Clin Toxicol 2000;38:557.
causing severe hypotension and bradycardia: an issue of patient safety. Patient 143. Ortiz-Munoz L, Rodriguez-Ospina LF, Figueroa-Gonzalez M. Hyperinsulinemic-
Saf Surg 2008;2:13. euglycemic therapy for intoxication with calcium channel blockers. Bol Asoc
110. Fernandes CM, Daya MR. Sotalol-induced bradycardia reversed by glucagon. Med P R 2005;97:182–9.
Can Fam Physician 1995;41:659–60f, 63–5. 144. Patel NP, Pugh ME, Goldberg S, Eiger G. Hyperinsulinemic euglycemia therapy
111. Frishman W, Jacob H, Eisenberg E, Ribner H. Clinical pharmacology of the new for verapamil poisoning: case report. Am J Crit Care 2007;16:18–9.
beta-adrenergic blocking drugs. Part 8. Self-poisoning with beta-adrenoceptor 145. Place R, Carlson A, Leikin J, Hanashiro P. Hyperinsulin therapy in the treatment
blocking agents: recognition and management. Am Heart J 1979;98: of verapamil overdose. J Toxicol Clin Toxicol 2000:576–7.
798–811. 146. Rasmussen L, Husted SE, Johnsen SP. Severe intoxication after an intentional
112. Gabry AL, Pourriat JL, Hoang TD, Lapandry C. Cardiogenic shock caused by meto- overdose of amlodipine. Acta Anaesthesiol Scand 2003;47:1038–40.
prolol poisoning. Reversibility with high doses of glucagon and isoproterenol. 147. Smith SW, Ferguson KL, Hoffman RS, Nelson LS, Greller HA. Prolonged severe
Presse Med 1985;14:229. hypotension following combined amlodipine and valsartan ingestion. Clin Tox-
113. Hazouard E, Ferrandiere M, Lesire V, Joye F, Perrotin D, de Toffol B. Peduncu- icol (Phila) 2008;46:470–4.
lar hallucinosis related to propranolol self-poisoning: efficacy of intravenous 148. Yuan TH, Kerns WPI, Tomaszewski CA, Ford MD, Kline JA. Insulin-glucose as
glucagon. Intensive Care Med 1999;25:336–7. adjunctive therapy for severe calcium channel antagonist poisoning. J Toxicol
114. Khan MI, Miller MT. Beta-blocker toxicity – the role of glucagon. Report of 2 Clin Toxicol 1999;37:463–74.
cases. S Afr Med J 1985;67:1062–3. 149. Dewitt CR, Waksman JC, Pharmacology. Pathophysiology and manage-
115. Moller BH. Letter: massive intoxication with metoprolol. Br Med J 1976;1: ment of calcium channel blocker and beta-blocker toxicity. Toxicol Rev
222. 2004;23:223–38.
116. O’Mahony D, O’Leary P, Molloy MG. Severe oxprenolol poisoning: the impor- 150. Eddleston M, Rajapakse S, Rajakanthan, et al. Anti-digoxin Fab fragments in car-
tance of glucagon infusion. Hum Exp Toxicol 1990;9:101–3. diotoxicity induced by ingestion of yellow oleander: a randomised controlled
117. Wallin CJ, Hulting J. Massive metoprolol poisoning treated with prenalterol. trial. Lancet 2000;355:967–72.
Acta Med Scand 1983;214:253–5. 151. Smith TW, Butler Jr VP, Haber E, et al. Treatment of life-threatening digitalis
118. Weinstein RS, Cole S, Knaster HB, Dahlbert T. Beta blocker overdose with pro- intoxication with digoxin-specific Fab antibody fragments: experience in 26
pranolol and with atenolol. Ann Emerg Med 1985;14:161–3. cases. N Engl J Med 1982;307:1357–62.
119. Alderfliegel F, Leeman M, Demaeyer P, Kahn RJ. Sotalol poisoning associated 152. Wenger TL, Butler VPJ, Haber E, Smith TW. Treatment of 63 severely digitalis-
with asystole. Intensive Care Med 1993;19:57–8. toxic patients with digoxin-specific antibody fragments. J Am Coll Cardiol
120. Kenyon CJ, Aldinger GE, Joshipura P, Zaid GJ. Successful resuscitation using 1985;5:118A–23A.
external cardiac pacing in beta adrenergic antagonist-induced bradyasystolic 153. Antman EM, Wenger TL, Butler Jr VP, Haber E, Smith TW. Treatment of 150 cases
arrest. Ann Emerg Med 1988;17:711–3. of life-threatening digitalis intoxication with digoxin-specific Fab antibody
121. Freestone S, Thomas HM, Bhamra RK, Dyson EH. Severe atenolol poisoning: fragments: final report of a multicenter study. Circulation 1990;81:1744–52.
treatment with prenalterol. Hum Toxicol 1986;5:343–5. 154. Woolf AD, Wenger T, Smith TW, Lovejoy FHJ. The use of digoxin-specific
122. Kerns 2nd W, Schroeder D, Williams C, Tomaszewski C, Raymond R. Insulin Fab fragments for severe digitalis intoxication in children. N Engl J Med
improves survival in a canine model of acute beta-blocker toxicity. Ann Emerg 1992;326:1739–44.
Med 1997;29:748–57. 155. Hickey AR, Wenger TL, Carpenter VP, et al. Digoxin Immune Fab therapy in
123. Holger JS, Engebretsen KM, Fritzlar SJ, Patten LC, Harris CR, Flottemesch TJ. the management of digitalis intoxication: safety and efficacy results of an
Insulin versus vasopressin and epinephrine to treat beta-blocker toxicity. Clin observational surveillance study. J Am Coll Cardiol 1991;17:590–8.
Toxicol (Phila) 2007;45:396–401. 156. Wenger TL. Experience with digoxin immune Fab (ovine) in patients with renal
124. Page C, Hacket LP, Isbister GK. The use of high-dose insulin-glucose eug- impairment. Am J Emerg Med 1991;9:21–3, discussion 33–4.
lycemia in beta-blocker overdose: a case report. J Med Toxicol 2009;5: 157. Wolf U, Bauer D, Traub WH. Metalloproteases of Serratia liquefaciens: degra-
139–43. dation of purified human serum proteins. Zentralbl Bakteriol 1991;276:16–26.
125. Kollef MH. Labetalol overdose successfully treated with amrinone and alpha- 158. Taboulet P, Baud FJ, Bismuth C, Vicaut E. Acute digitalis intoxication – is pacing
adrenergic receptor agonists. Chest 1994;105:626–7. still appropriate? J Toxicol Clin Toxicol 1993;31:261–73.
126. O’Grady J, Anderson S, Pringle D. Successful treatment of severe atenolol over- 159. Lapostolle F, Borron SW, Verdier C, et al. Digoxin-specific Fab fragments as
dose with calcium chloride. CJEM 2001;3:224–7. single first-line therapy in digitalis poisoning. Crit Care Med 2008;36:3014–8.
127. Pertoldi F, D’Orlando L, Mercante WP. Electromechanical dissociation 48 hours 160. Hougen TJ, Lloyd BL, Smith TW. Effects of inotropic and arrhythmogenic digoxin
after atenolol overdose: usefulness of calcium chloride. Ann Emerg Med doses and of digoxin-specific antibody on myocardial monovalent cation trans-
1998;31:777–81. port in the dog. Circ Res 1979;44:23–31.
128. McVey FK, Corke CF. Extracorporeal circulation in the management of massive 161. Clark RF, Selden BS, Curry SC. Digoxin-specific Fab fragments in the treatment
propranolol overdose. Anaesthesia 1991;46:744–6. of oleander toxicity in a canine model. Ann Emerg Med 1991;20:1073–7.
129. Lane AS, Woodward AC, Goldman MR. Massive propranolol overdose poorly 162. Brubacher JR, Lachmanen D, Ravikumar PR, Hoffman RS. Efficacy of digoxin
responsive to pharmacologic therapy: use of the intra-aortic balloon pump. specific Fab fragments (Digibind) in the treatment of toad venom poisoning.
Ann Emerg Med 1987;16:1381–3. Toxicon 1999;37:931–42.
130. Rooney M, Massey KL, Jamali F, Rosin M, Thomson D, Johnson DH. Acebutolol 163. Lechat P, Mudgett-Hunter M, Margolies MN, Haber E, Smith TW. Reversal of
overdose treated with hemodialysis and extracorporeal membrane oxygena- lethal digoxin toxicity in guinea pigs using monoclonal antibodies and Fab
tion. J Clin Pharmacol 1996;36:760–3. fragments. J Pharmacol Exp Ther 1984;229:210–3.
131. Brimacombe JR, Scully M, Swainston R. Propranolol overdose – a dramatic 164. Dasgupta A, Szelei-Stevens KA. Neutralization of free digoxin-like immunore-
response to calcium chloride. Med J Aust 1991;155:267–8. active components of oriental medicines Dan Shen and Lu-Shen-Wan by
132. Olson KR, Erdman AR, Woolf AD, et al. Calcium channel blocker ingestion: the Fab fragment of antidigoxin antibody (Digibind). Am J Clin Pathol
an evidence-based consensus guideline for out-of-hospital management. Clin 2004;121:276–81.
Toxicol (Phila) 2005;43:797–822. 165. Bosse GM, Pope TM. Recurrent digoxin overdose and treatment with digoxin-
133. Boyer EW, Duic PA, Evans A. Hyperinsulinemia/euglycemia therapy for calcium specific Fab antibody fragments. J Emerg Med 1994;12:179–85.
channel blocker poisoning. Pediatr Emerg Care 2002;18:36–7. 166. Borron SW, Baud FJ, Barriot P, Imbert M, Bismuth C. Prospective study of
134. Cohen V, Jellinek SP, Fancher L, et al. Tarka(R) (Trandolapril/Verapamil hydroxocobalamin for acute cyanide poisoning in smoke inhalation. Ann
Hydrochloride Extended-Release) overdose. J Emerg Med 2009. Emerg Med 2007;49:794–801, e1–2.
135. Greene SL, Gawarammana I, Wood DM, Jones AL, Dargan PI. Relative safety of 167. Fortin JL, Giocanti JP, Ruttimann M, Kowalski JJ. Prehospital administration
hyperinsulinaemia/euglycaemia therapy in the management of calcium chan- of hydroxocobalamin for smoke inhalation-associated cyanide poisoning: 8
nel blocker overdose: a prospective observational study. Intensive Care Med years of experience in the Paris Fire Brigade. Clin Toxicol (Phila) 2006;44:
2007;33:2019–24. 37–44.](https://image.slidesharecdn.com/fullerc2010guidelines1-101018011940-phpapp02/85/RCP-2010-guidelines-209-320.jpg)
![1428 J. Soar et al. / Resuscitation 81 (2010) 1400–1433
168. Baud FJ, Barriot P, Toffis V, et al. Elevated blood cyanide concentrations in 203. Goh SH, Low BY. Drowning and near-drowning – some lessons learnt. Ann Acad
victims of smoke inhalation. N Engl J Med 1991;325:1761–6. Med Singapore 1999;28:183–8.
169. Borron SW, Baud FJ, Megarbane B, Bismuth C. Hydroxocobalamin for severe 204. Quan L, Wentz KR, Gore EJ, Copass MK. Outcome and predictors of outcome
acute cyanide poisoning by ingestion or inhalation. Am J Emerg Med in pediatric submersion victims receiving prehospital care in King County,
2007;25:551–8. Washington. Pediatrics 1990;86:586–93.
170. Espinoza OB, Perez M, Ramirez MS. Bitter cassava poisoning in eight children: 205. O’Driscoll BR, Howard LS, Davison AG. BTS guideline for emergency oxygen use
a case report. Vet Hum Toxicol 1992;34:65. in adult patients. Thorax 2008;63:vi1–68.
171. Houeto P, Hoffman JR, Imbert M, Levillain P, Baud FJ. Relation of blood cyanide 206. Perkins GD. In-water resuscitation: a pilot evaluation. Resuscitation
to plasma cyanocobalamin concentration after a fixed dose of hydroxocobal- 2005;65:321–4.
amin in cyanide poisoning. Lancet 1995;346:605–8. 207. Szpilman D, Soares M. In-water resuscitation – is it worthwhile? Resuscitation
172. Pontal P, Bismuth C, Garnier R. Therapeutic attitude in cyanide poisoning: 2004;63:25–31.
retrospective study of 24 non-lethal cases. Vet Hum Toxicol 1982;24:286–7. 208. March NF, Matthews RC. New techniques in external cardiac compressions.
173. Kirk MA, Gerace R, Kulig KW. Cyanide and methemoglobin kinetics in smoke Aquatic cardiopulmonary resuscitation. JAMA 1980;244:1229–32.
inhalation victims treated with the cyanide antidote kit. Ann Emerg Med 209. March NF, Matthews RC. Feasibility study of CPR in the water. Undersea Biomed
1993;22:1413–8. Res 1980;7:141–8.
174. Chen KK, Rose CL. Nitrite and thiosulfate therapy in cyanide poisoning. J Am 210. Manolios N, Mackie I. Drowning and near-drowning on Australian
Med Assoc 1952;149:113–9. beaches patrolled by life-savers: a 10-year study, 1973–1983. Med J Aust
175. Yen D, Tsai J, Wang LM, et al. The clinical experience of acute cyanide poisoning. 1988;148:165–7, 70–1.
Am J Emerg Med 1995;13:524–8. 211. Rosen P, Stoto M, Harley J. The use of the Heimlich maneuver in near-drowning:
176. Iqbal S, Clower JH, Boehmer TK, Yip FY, Garbe P. Carbon monoxide-related institute of Medicine report. J Emerg Med 1995;13:397–405.
hospitalizations in the U.S.: evaluation of a web-based query system for public 212. Modell JH, Calderwood HW, Ruiz BC, Downs JB, Chapman Jr R. Effects of ven-
health surveillance. Public Health Rep 2010;125:423–32. tilatory patterns on arterial oxygenation after near-drowning in sea water.
177. Hampson NB, Zmaeff JL. Outcome of patients experiencing cardiac arrest with Anesthesiology 1974;40:376–84.
carbon monoxide poisoning treated with hyperbaric oxygen. Ann Emerg Med 213. Golden FS, Tipton MJ, Scott RC. Immersion, near-drowning and drowning. Br J
2001;38:36–41. Anaesth 1997;79:214–25.
178. Sloan EP, Murphy DG, Hart R, et al. Complications and protocol considera- 214. Moran I, Zavala E, Fernandez R, Blanch L, Mancebo J. Recruitment manoeuvres
tions in carbon monoxide-poisoned patients who require hyperbaric oxygen in acute lung injury/acute respiratory distress syndrome. Eur Respir J Suppl
therapy: report from a ten-year experience. Ann Emerg Med 1989;18:629–34. 2003;42:37s–42s.
179. Chou KJ, Fisher JL, Silver EJ. Characteristics and outcome of children with carbon 215. Koster RW, Sayre MR, Botha M, et al. 2010 International Consensus on Car-
monoxide poisoning with and without smoke exposure referred for hyperbaric diopulmonary Resuscitation and Emergency Cardiovascular Care Science with
oxygen therapy. Pediatr Emerg Care 2000;16:151–5. Treatment Recommendations. Part 5. Adult Basic Life Support. Resuscitation;
180. Weaver LK, Hopkins RO, Chan KJ, et al. Hyperbaric oxygen for acute carbon doi:10.1016/j.resuscitation.2010.08.005, in press.
monoxide poisoning. N Engl J Med 2002;347:1057–67. 216. Wyatt JP, Tomlinson GS, Busuttil A. Resuscitation of drowning victims in south-
181. Thom SR, Taber RL, Mendiguren II, Clark JM, Hardy KR, Fisher AB. Delayed east Scotland. Resuscitation 1999;41:101–4.
neuropsychologic sequelae after carbon monoxide poisoning: prevention by 217. Schmidt U, Fritz KW, Kasperczyk W, Tscherne H. Successful resuscitation of a
treatment with hyperbaric oxygen. Ann Emerg Med 1995;25:474–80. child with severe hypothermia after cardiac arrest of 88 minutes. Prehospital
182. Scheinkestel CD, Bailey M, Myles PS, et al. Hyperbaric or normobaric oxygen Disaster Med 1995;10:60–2.
for acute carbon monoxide poisoning: a randomised controlled clinical trial. 218. Bolte RG, Black PG, Bowers RS, Thorne JK, Corneli HM. The use of extracorporeal
Med J Aust 1999;170:203–10. rewarming in a child submerged for 66 minutes. JAMA 1988;260:377–9.
183. Raphael JC, Elkharrat D, Jars-Guincestre MC, et al. Trial of normobaric 219. Gregorakos L, Markou N, Psalida V, et al. Near-drowning: clinical course of lung
and hyperbaric oxygen for acute carbon monoxide intoxication. Lancet injury in adults. Lung 2009;187:93–7.
1989;2:414–9. 220. The Acute Respiratory Distress Syndrome Network. Ventilation with lower
184. Juurlink DN, Buckley NA, Stanbrook MB, Isbister GK, Bennett M, McGuigan MA. tidal volumes as compared with traditional tidal volumes for acute lung
Hyperbaric oxygen for carbon monoxide poisoning. Cochrane Database Syst injury and the acute respiratory distress syndrome. N Engl J Med 2000;342:
Rev 2005:CD002041. 1301–8.
185. Buckley NA, Isbister GK, Stokes B, Juurlink DN. Hyperbaric oxygen for carbon 221. Eich C, Brauer A, Timmermann A, et al. Outcome of 12 drowned children
monoxide poisoning: a systematic review and critical analysis of the evidence. with attempted resuscitation on cardiopulmonary bypass: an analysis of
Toxicol Rev 2005;24:75–92. variables based on the “Utstein Style for Drowning”. Resuscitation 2007;75:
186. Satran D, Henry CR, Adkinson C, Nicholson CI, Bracha Y, Henry TD. Cardiovas- 42–52.
cular manifestations of moderate to severe carbon monoxide poisoning. J Am 222. Guenther U, Varelmann D, Putensen C, Wrigge H. Extended therapeutic
Coll Cardiol 2005;45:1513–6. hypothermia for several days during extracorporeal membrane-oxygenation
187. Henry CR, Satran D, Lindgren B, Adkinson C, Nicholson CI, Henry TD. Myocardial after drowning and cardiac arrest two cases of survival with no neurological
injury and long-term mortality following moderate to severe carbon monoxide sequelae. Resuscitation 2009;80:379–81.
poisoning. JAMA 2006;295:398–402. 223. Wood C. Towards evidence based emergency medicine: best BETs from the
188. Warner DS, Bierens JJ, Beerman SB, Katz LM. Drowning: a cry for help. Anes- Manchester Royal Infirmary. BET, 1, prophylactic antibiotics in near-drowning.
thesiology 2009;110:1211–3. Emerg Med J 2010;27:393–4.
189. Peden MM, McGee K. The epidemiology of drowning worldwide. Inj Control 224. Van Berkel M, Bierens JJLM, Lie RLK, et al. Pulmonary oedema, pneumonia and
Saf Promot 2003;10:195–9. mortality in submersion victims a retrospective study in 125 patients. Intensive
190. National water safety statistics; 2006 [accessed 28.06.10]. Care Med 1996;22:101–7.
191. Centers for Disease Control and Prevention. Web-based injury statistics query 225. Nolan JP, Morley PT, Vanden Hoek TL, Hickey RW. Therapeutic hypothermia
and reporting system (WISQARS) (Online). National Center for Injury Preven- after cardiac arrest. An advisory statement by the Advancement Life support
tion and Control, Centers for Disease Control and Prevention (producer); 2005. Task Force of the International Liaison committee on Resuscitation. Resuscita-
Available from: URL: wwwcdcgov/ncipc/wisqars [3.02.2005]. tion 2003;57:231–5.
192. Hu G, Baker SP. Trends in unintentional injury deaths, U.S., 1999–2005: age, 226. Nolan JP, Neumar RW, Adrie C, et al. Post-cardiac arrest syndrome: epidemiol-
gender, and racial/ethnic differences. Am J Prev Med 2009;37:188–94. ogy, pathophysiology, treatment, and prognostication. A Scientific Statement
193. Driscoll TR, Harrison JA, Steenkamp M. Review of the role of alcohol in drowning from the International Liaison Committee on Resuscitation; the American
associated with recreational aquatic activity. Inj Prev 2004;10:107–13. Heart Association Emergency Cardiovascular Care Committee; the Council on
194. Papa L, Hoelle R, Idris A. Systematic review of definitions for drowning inci- Cardiovascular Surgery and Anesthesia; the Council on Cardiopulmonary, Peri-
dents. Resuscitation 2005;65:255–64. operative, and Critical Care; the Council on Clinical Cardiology; the Council on
195. Idris AH, Berg RA, Bierens J, et al. Recommended guidelines for uniform report- Stroke. Resuscitation 2008;79:350–79.
ing of data from drowning: the “Utstein style”. Resuscitation 2003;59:45–57. 227. Tester DJ, Kopplin LJ, Creighton W, Burke AP, Ackerman MJ. Pathogenesis of
196. Layon AJ, Modell JH. Drowning: update 2009. Anesthesiology unexplained drowning: new insights from a molecular autopsy. Mayo Clin Proc
2009;110:1390–401. 2005;80:596–600.
197. Eaton D. Lifesaving. 6th ed. London: Royal Life Saving Society UK; 1995. 228. Soar J, Mancini ME, Bhanji F, et al. 2010 International Consensus on Car-
198. Watson RS, Cummings P, Quan L, Bratton S, Weiss NS. Cervical spine injuries diopulmonary Resuscitation and Emergency Cardiovascular Care Science with
among submersion victims. J Trauma 2001;51:658–62. Treatment Recommendations. Part 12. Education, Implementation, and Teams.
199. Dodd FM, Simon E, McKeown D, Patrick MR. The effect of a cervical collar on Resuscitation; doi:10.1016/j.resuscitation.2010.08.030, in press.
the tidal volume of anaesthetised adult patients. Anaesthesia 1995;50:961–3. 229. Choi G, Kopplin LJ, Tester DJ, Will ML, Haglund CM, Ackerman MJ. Spectrum
200. Proceedings of the 2005 International Consensus on Cardiopulmonary and frequency of cardiac channel defects in swimming-triggered arrhythmia
Resuscitation and Emergency Cardiovascular Care Science with Treatment Rec- syndromes. Circulation 2004;110:2119–24.
ommendations, vol. 67. 2005. p. 157–341. 230. Danzl D. Accidental hypothermia. In: Auerbach P, editor. Wilderness medicine.
201. Venema AM, Groothoff JW, Bierens JJ. The role of bystanders during rescue and St. Louis: Mosby; 2007. p. 125–60.
resuscitation of drowning victims. Resuscitation 2010;81:434–9. 231. Durrer B, Brugger H, Syme D. The medical on-site treatment of hypother-
202. Youn CS, Choi SP, Yim HW, Park KN. Out-of-hospital cardiac arrest due to mia ICAR-MEDCOM recommendation. High Alt Med Biol 2003;4:99–
drowning: an utstein style report of 10 years of experience from St Mary’s 103.
Hospital. Resuscitation 2009;80:778–83.](https://image.slidesharecdn.com/fullerc2010guidelines1-101018011940-phpapp02/85/RCP-2010-guidelines-210-320.jpg)
![J. Soar et al. / Resuscitation 81 (2010) 1400–1433 1429
232. Walpoth BH, Galdikas J, Leupi F, Muehlemann W, Schlaepfer P, Althaus U. 267. el-Kassimi FA, Al-Mashhadani S, Abdullah AK, Akhtar J. Adult respiratory dis-
Assessment of hypothermia with a new “tympanic” thermometer. J Clin Monit tress syndrome and disseminated intravascular coagulation complicating heat
1994;10:91–6. stroke. Chest 1986;90:571–4.
233. Brugger H, Oberhammer R, Adler-Kastner L, Beikircher W. The rate of cooling 268. Waruiru C, Appleton R. Febrile seizures: an update. Arch Dis Child
during avalanche burial; a “Core” issue. Resuscitation 2009;80:956–8. 2004;89:751–6.
234. Lefrant JY, Muller L, de La Coussaye JE, et al. Temperature measurement in 269. Berger J, Hart J, Millis M, Baker AL. Fulminant hepatic failure from heat stroke
intensive care patients: comparison of urinary bladder, oesophageal, rectal, requiring liver transplantation. J Clin Gastroenterol 2000;30:429–31.
axillary, and inguinal methods versus pulmonary artery core method. Intensive 270. Huerta-Alardin AL, Varon J, Marik PE. Bench-to-bedside review: rhabdomyol-
Care Med 2003;29:414–8. ysis – an overview for clinicians. Crit Care 2005;9:158–69.
235. Robinson J, Charlton J, Seal R, Spady D, Joffres MR. Oesophageal, rectal, axillary, 271. Wolff ED, Driessen OMJ. Theophylline intoxication in a child. Ned Tijdschr
tympanic and pulmonary artery temperatures during cardiac surgery. Can J Geneeskd 1977;121:896–901.
Anaesth 1998;45:317–23. 272. Sidor K, Mikolajczyk W, Horwath-Stolarczyk A. Acute poisoning in children
236. Wood S. Interactions between hypoxia and hypothermia. Annu Rev Physiol hospitalized at the Medical University Hospital No 3 in Warsaw, between 1996
1991;53:71–85. and 2000. Pediatr Pol 2002;77:509–16.
237. Schneider SM. Hypothermia: from recognition to rewarming. Emerg Med Rep 273. Boyer EW, Shannon M. The serotonin syndrome. N Engl J Med
1992;13:1–20. 2005;352:1112–20.
238. Gilbert M, Busund R, Skagseth A, Nilsen PÅ, Solbø JP. Resuscitation from acci- 274. Bhanushali MJ, Tuite PJ. The evaluation and management of patients with neu-
dental hypothermia of 13.7 ◦ C with circulatory arrest. Lancet 2000;355:375–6. roleptic malignant syndrome. Neurol Clin 2004;22:389–411.
239. Lexow K. Severe accidental hypothermia: survival after 6 hours 30 minutes of 275. Abraham E, Matthay MA, Dinarello CA, et al. Consensus conference defini-
cardiopulmonary resuscitation. Arctic Med Res 1991;50:112–4. tions for sepsis, septic shock, acute lung injury, and acute respiratory distress
240. Danzl DF, Pozos RS, Auerbach PS, et al. Multicenter hypothermia survey. Ann syndrome: time for a reevaluation. Crit Care Med 2000;28:232–5.
Emerg Med 1987;16:1042–55. 276. Savage MW, Mah PM, Weetman AP, Newell-Price J. Endocrine emergencies.
241. Paal P, Beikircher W, Brugger H. Avalanche emergencies. Review of the current Postgrad Med J 2004;80:506–15.
situation. Anaesthesist 2006;55:314–24. 277. Hadad E, Weinbroum AA, Ben-Abraham R. Drug-induced hyperthermia and
242. Krismer AC, Lindner KH, Kornberger R, et al. Cardiopulmonary resuscitation muscle rigidity: a practical approach. Eur J Emerg Med 2003;10:149–54.
during severe hypothermia in pigs: does epinephrine or vasopressin increase 278. Halloran LL, Bernard DW. Management of drug-induced hyperthermia. Curr
coronary perfusion pressure? Anesth Analg 2000;90:69–73. Opin Pediatr 2004;16:211–5.
243. Kornberger E, Lindner KH, Mayr VD, et al. Effects of epinephrine in a pig model 279. Bouchama A, Dehbi M, Chaves-Carballo E. Cooling and hemodynamic manage-
of hypothermic cardiac arrest and closed-chest cardiopulmonary resuscitation ment in heatstroke: practical recommendations. Crit Care 2007;11:R54.
combined with active rewarming. Resuscitation 2001;50:301–8. 280. Armstrong LE, Crago AE, Adams R, Roberts WO, Maresh CM. Whole-body cool-
244. Stoner J, Martin G, O’Mara K, Ehlers J, Tomlanovich M. Amiodarone and ing of hyperthermic runners: comparison of two field therapies. Am J Emerg
bretylium in the treatment of hypothermic ventricular fibrillation in a canine Med 1996;14:355–8.
model. Acad Emerg Med 2003;10:187–91. 281. Horowitz BZ. The golden hour in heat stroke: use of iced peritoneal lavage. Am
245. Mattu A, Brady WJ, Perron AD. Electrocardiographic manifestations of J Emerg Med 1989;7:616–9.
hypothermia. Am J Emerg Med 2002;20:314–26. 282. Bernard S, Buist M, Monteiro O, Smith K. Induced hypothermia using large
246. Ujhelyi MR, Sims JJ, Dubin SA, Vender J, Miller AW. Defibrillation energy volume, ice-cold intravenous fluid in comatose survivors of out-of-hospital
requirements and electrical heterogeneity during total body hypothermia. Crit cardiac arrest: a preliminary report. Resuscitation 2003;56:9–13.
Care Med 2001;29:1006–11. 283. Schmutzhard E, Engelhardt K, Beer R, et al. Safety and efficacy of a novel
247. Kornberger E, Schwarz B, Lindner KH, Mair P. Forced air surface rewarming in intravascular cooling device to control body temperature in neurologic inten-
patients with severe accidental hypothermia. Resuscitation 1999;41:105–11. sive care patients: a prospective pilot study. Crit Care Med 2002;30:2481–8.
248. Roggla M, Frossard M, Wagner A, Holzer M, Bur A, Roggla G. Severe 284. Al-Senani FM, Graffagnino C, Grotta JC, et al. A prospective, multicenter
accidental hypothermia with or without hemodynamic instability: rewarm- pilot study to evaluate the feasibility and safety of using the CoolGard Sys-
ing without the use of extracorporeal circulation. Wien Klin Wochenschr tem and Icy catheter following cardiac arrest. Resuscitation 2004;62:143–
2002;114:315–20. 50.
249. Weinberg AD, Hamlet MP, Paturas JL, White RD, McAninch GW. Cold weather 285. Behringer W, Safar P, Wu X, et al. Veno-venous extracorporeal blood shunt
emergencies: principles of patient management. Branford, CN: American Med- cooling to induce mild hypothermia in dog experiments and review of cooling
ical Publishing Co.; 1990. methods. Resuscitation 2002;54:89–98.
250. Reuler JB. Hypothermia: pathophysiology, clinical settings, and management. 286. Hostler D, Northington WE, Callaway CW. High-dose diazepam facilitates core
Ann Intern Med 1978;89:519–27. cooling during cold saline infusion in healthy volunteers. Appl Physiol Nutr
251. Zell SC, Kurtz KJ. Severe exposure hypothermia: a resuscitation protocol. Ann Metab 2009;34:582–6.
Emerg Med 1985;14:339–45. 287. Hadad E, Cohen-Sivan Y, Heled Y, Epstein Y. Clinical review: treatment of heat
252. Althaus U, Aeberhard P, Schupbach P, Nachbur BH, Muhlemann W. Manage- stroke: should dantrolene be considered? Crit Care 2005;9:86–91.
ment of profound accidental hypothermia with cardiorespiratory arrest. Ann 288. Channa AB, Seraj MA, Saddique AA, Kadiwal GH, Shaikh MH, Samarkandi AH.
Surg 1982;195:492–5. Is dantrolene effective in heat stroke patients? Crit Care Med 1990;18:290–2.
253. Walpoth BH, Walpoth-Aslan BN, Mattle HP, et al. Outcome of survivors of acci- 289. Bouchama A, Cafege A, Devol EB, Labdi O, el-Assil K, Seraj M. Ineffective-
dental deep hypothermia and circulatory arrest treated with extracorporeal ness of dantrolene sodium in the treatment of heatstroke. Crit Care Med
blood warming. N Engl J Med 1997;337:1500–5. 1991;19:176–80.
254. Silfvast T, Pettila V. Outcome from severe accidental hypothermia in Southern 290. Larach MG, Gronert GA, Allen GC, Brandom BW, Lehman EB. Clinical pre-
Finland – a 10-year review. Resuscitation 2003;59:285–90. sentation, treatment, and complications of malignant hyperthermia in North
255. Ruttmann E, Weissenbacher A, Ulmer H, et al. Prolonged extracorporeal America from 1987 to 2006. Anesth Analg 2010;110:498–507.
membrane oxygenation-assisted support provides improved survival in 291. Krause T, Gerbershagen MU, Fiege M, Weisshorn R, Wappler F. Dantrolene –
hypothermic patients with cardiocirculatory arrest. J Thorac Cardiovasc Surg a review of its pharmacology, therapeutic use and new developments. Anaes-
2007;134:594–600. thesia 2004;59:364–73.
256. Boyd J, Brugger H, Shuster M. Prognostic factors in avalanche resuscitation: a 292. Hall AP, Henry JA. Acute toxic effects of ‘Ecstasy’ (MDMA) and related com-
systematic review. Resuscitation 2010;81:645–52. pounds: overview of pathophysiology and clinical management. Br J Anaesth
257. Bouchama A, Knochel JP. Heat stroke. N Engl J Med 2002;346:1978–88. 2006;96:678–85.
258. Wappler F. Malignant hyperthermia. Eur J Anaesthesiol 2001;18:632–52. 293. Eshel G, Safar P, Sassano J, Stezoski W. Hyperthermia-induced cardiac arrest in
259. Ali SZ, Taguchi A, Rosenberg H. Malignant hyperthermia. Best Pract Res Clin dogs and monkeys. Resuscitation 1990;20:129–43.
Anaesthesiol 2003;17:519–33. 294. Eshel G, Safar P, Radovsky A, Stezoski SW. Hyperthermia-induced cardiac
260. Bouchama A. The 2003 European heat wave. Intensive Care Med 2004;30:1–3. arrest in monkeys: limited efficacy of standard CPR. Aviat Space Environ Med
261. Empana JP, Sauval P, Ducimetiere P, Tafflet M, Carli P, Jouven X. Increase in out- 1997;68:415–20.
of-hospital cardiac arrest attended by the medical mobile intensive care units, 295. Zeiner A, Holzer M, Sterz F, et al. Hyperthermia after cardiac arrest is associated
but not myocardial infarction, during the 2003 heat wave in Paris, France. Crit with an unfavorable neurologic outcome. Arch Intern Med 2001;161:2007–12.
Care Med 2009;37:3079–84. 296. Masoli M, Fabian D, Holt S, Beasley R. The global burden of asthma:
262. Coris EE, Ramirez AM, Van Durme DJ. Heat illness in athletes: the dangerous executive summary of the GINA Dissemination Committee report. Allergy
combination of heat, humidity and exercise. Sports Med 2004;34:9–16. 2004;59:469–78.
263. Grogan H, Hopkins PM. Heat stroke: implications for critical care and anaes- 297. Pearce N, Ait-Khaled N, Beasley R, et al. Worldwide trends in the prevalence of
thesia. Br J Anaesth 2002;88:700–7. asthma symptoms: phase III of the International Study of Asthma and Allergies
264. Bouchama A, De Vol EB. Acid–base alterations in heatstroke. Intensive Care in Childhood (ISAAC). Thorax 2007;62:758–66.
Med 2001;27:680–5. 298. Global strategy for asthma management and prevention 2009; 2009 [accessed
265. Pease S, Bouadma L, Kermarrec N, Schortgen F, Regnier B, Wolff M. Early organ 24.06.10].
dysfunction course, cooling time and outcome in classic heatstroke. Intensive 299. Romagnoli M, Caramori G, Braccioni F, et al. Near-fatal asthma phenotype in
Care Med 2009;35:1454–8. the ENFUMOSA Cohort. Clin Exp Allergy 2007;37:552–7.
266. Akhtar M, Jazayeri MR, Sra J, Blanck Z, Deshpande S, Dhala A. Atrioventricular 300. Turner MO, Noertjojo K, Vedal S, Bai T, Crump S, Fitzgerald JM. Risk factors for
nodal reentry: clinical, electrophysiological, and therapeutic considerations. near-fatal asthma: a case-control study in hospitalized patients with asthma.
Circulation 1993;88:282–95. Am J Respir Crit Care Med 1998;157:1804–9.](https://image.slidesharecdn.com/fullerc2010guidelines1-101018011940-phpapp02/85/RCP-2010-guidelines-211-320.jpg)
![J. Soar et al. / Resuscitation 81 (2010) 1400–1433 1431
364. Gompels LL, Bethune C, Johnston SL, Gompels MM. Proposed use of adrenaline 396. Birdi I, Chaudhuri N, Lenthall K, Reddy S, Nashef SA. Emergency reinstitution of
(epinephrine) in anaphylaxis and related conditions: a study of senior house cardiopulmonary bypass following cardiac surgery: outcome justifies the cost.
officers starting accident and emergency posts. Postgrad Med J 2002;78:416–8. Eur J Cardiothorac Surg 2000;17:743–6.
365. Brown SG, Blackman KE, Stenlake V, Heddle RJ. Insect sting anaphylaxis; 397. el-Banayosy A, Brehm C, Kizner L, et al. Cardiopulmonary resuscitation after
prospective evaluation of treatment with intravenous adrenaline and volume cardiac surgery: a two-year study. J Cardiothorac Vasc Anesth 1998;12:390–2.
resuscitation. Emerg Med J 2004;21:149–54. 398. Anthi A, Tzelepis GE, Alivizatos P, Michalis A, Palatianos GM, Geroulanos
366. Sheikh A, Ten Broek V, Brown SG, Simons FE. H1-antihistamines for the treat- S. Unexpected cardiac arrest after cardiac surgery: incidence, predisposing
ment of anaphylaxis: Cochrane systematic review. Allergy 2007;62:830–7. causes, and outcome of open chest cardiopulmonary resuscitation. Chest
367. Choo KJ, Simons FE, Sheikh A. Glucocorticoids for the treatment of anaphylaxis. 1998;113:15–9.
Cochrane Database Syst Rev 2010;3:CD007596. 399. Wahba A, Gotz W, Birnbaum DE. Outcome of cardiopulmonary resuscitation
368. Green R, Ball A. Alpha-agonists for the treatment of anaphylactic shock. Anaes- following open heart surgery. Scand Cardiovasc J 1997;31:147–9.
thesia 2005;60:621–2. 400. Kaiser GC, Naunheim KS, Fiore AC, et al. Reoperation in the intensive care unit.
369. Kluger MT. The Bispectral Index during an anaphylactic circulatory arrest. Ann Thorac Surg 1990;49:903–7, discussion 8.
Anaesth Intensive Care 2001;29:544–7. 401. Rhodes JF, Blaufox AD, Seiden HS, et al. Cardiac arrest in infants after congenital
370. McBrien ME, Breslin DS, Atkinson S, Johnston JR. Use of methoxamine in the heart surgery. Circulation 1999;100:II194–9.
resuscitation of epinephrine-resistant electromechanical dissociation. Anaes- 402. Dimopoulou I, Anthi A, Michalis A, Tzelepis GE. Functional status and quality
thesia 2001;56:1085–9. of life in long-term survivors of cardiac arrest after cardiac surgery. Crit Care
371. Rocq N, Favier JC, Plancade D, Steiner T, Mertes PM. Successful use of ter- Med 2001;29:1408–11.
lipressin in post-cardiac arrest resuscitation after an epinephrine-resistant 403. Kempen PM, Allgood R. Right ventricular rupture during closed-chest car-
anaphylactic shock to suxamethonium. Anesthesiology 2007;107:166–7. diopulmonary resuscitation after pneumonectomy with pericardiotomy: a
372. Kill C, Wranze E, Wulf H. Successful treatment of severe anaphylactic shock case report. Crit Care Med 1999;27:1378–9.
with vasopressin. Two case reports. Int Arch Allergy Immunol 2004;134: 404. Bohrer H, Gust R, Bottiger BW. Cardiopulmonary resuscitation after cardiac
260–1. surgery. J Cardiothorac Vasc Anesth 1995;9:352.
373. Dewachter P, Raeth-Fries I, Jouan-Hureaux V, et al. A comparison of 405. Klintschar M, Darok M, Radner H. Massive injury to the heart after attempted
epinephrine only, arginine vasopressin only, and epinephrine followed by argi- active compression–decompression cardiopulmonary resuscitation. Int J Legal
nine vasopressin on the survival rate in a rat model of anaphylactic shock. Med 1998;111:93–6.
Anesthesiology 2007;106:977–83. 406. Fosse E, Lindberg H. Left ventricular rupture following external chest compres-
374. Higgins DJ, Gayatri P. Methoxamine in the management of severe anaphylaxis. sion. Acta Anaesthesiol Scand 1996;40:502–4.
Anaesthesia 1999;54:1126. 407. Dunning J, Nandi J, Ariffin S, Jerstice J, Danitsch D, Levine A. The Cardiac Surgery
375. Heytman M, Rainbird A. Use of alpha-agonists for management of ana- Advanced Life Support Course (CALS): delivering significant improvements in
phylaxis occurring under anaesthesia: case studies and review. Anaesthesia emergency cardiothoracic care. Ann Thorac Surg 2006;81:1767–72.
2004;59:1210–5. 408. Dunning J, Fabbri A, Kolh PH, et al. Guideline for resuscitation in cardiac arrest
376. Schummer W, Schummer C, Wippermann J, Fuchs J. Anaphylactic shock: is after cardiac surgery. Eur J Cardiothorac Surg 2009;36:3–28.
vasopressin the drug of choice? Anesthesiology 2004;101:1025–7. 409. Raman J, Saldanha RF, Branch JM, et al. Open cardiac compression in the post-
377. Di Chiara L, Stazi GV, Ricci Z, et al. Role of vasopressin in the treatment of operative cardiac intensive care unit. Anaesth Intensive Care 1989;17:129–35.
anaphylactic shock in a child undergoing surgery for congenital heart disease: 410. Rousou JA, Engelman RM, Flack 3rd JE, Deaton DW, Owen SG. Emergency car-
a case report. J Med Case Reports 2008;2:36. diopulmonary bypass in the cardiac surgical unit can be a lifesaving measure
378. Meng L, Williams EL. Case report: treatment of rocuronium-induced anaphy- in postoperative cardiac arrest. Circulation 1994;90:II280–4.
lactic shock with vasopressin. Can J Anaesth 2008;55:437–40. 411. Parra DA, Totapally BR, Zahn E, et al. Outcome of cardiopulmonary resuscitation
379. Schummer C, Wirsing M, Schummer W. The pivotal role of vasopressin in in a pediatric cardiac intensive care unit. Crit Care Med 2000;28:3296–300.
refractory anaphylactic shock. Anesth Analg 2008;107:620–4. 411a. European Resuscitation Council Guidelines for Resuscitation 2010: Section 6:
380. Hiruta A, Mitsuhata H, Hiruta M, et al. Vasopressin may be useful in the treat- Paediatric life support. Resuscitation 2010; 81:1364–88.
ment of systemic anaphylaxis in rabbits. Shock 2005;24:264–9. 412. Schwarz B, Bowdle TA, Jett GK, et al. Biphasic shocks compared with monopha-
381. Thomas M, Crawford I. Best evidence topic report. Glucagon infusion in sic damped sine wave shocks for direct ventricular defibrillation during open
refractory anaphylactic shock in patients on beta-blockers. Emerg Med J heart surgery. Anesthesiology 2003;98:1063–9.
2005;22:272–3. 413. Li Y, Wang H, Cho JH, et al. Defibrillation delivered during the upstroke
382. Allen SJ, Gallagher A, Paxton LD. Anaphylaxis to rocuronium. Anaesthesia phase of manual chest compression improves shock success. Crit Care Med
2000;55:1223–4. 2010;38:910–5.
383. Lafforgue E, Sleth JC, Pluskwa F, Saizy C. Successful extracorporeal resuscita- 414. Li Y, Yu T, Ristagno G, et al. The optimal phasic relationship between
tion of a probable perioperative anaphylactic shock due to atracurium. Ann Fr synchronized shock and mechanical chest compressions. Resuscitation
Anesth Reanim 2005;24:551–5. 2010;81:724–9.
384. Vatsgar TT, Ingebrigtsen O, Fjose LO, Wikstrom B, Nilsen JE, Wik L. Cardiac arrest 415. Knaggs AL, Delis KT, Spearpoint KG, Zideman DA. Automated external defibril-
and resuscitation with an automatic mechanical chest compression device lation in cardiac surgery. Resuscitation 2002;55:341–5.
(LUCAS) due to anaphylaxis of a woman receiving Caesarean section because 416. Rosemurgy AS, Norris PA, Olson SM, Hurst JM, Albrink MH. Prehospital trau-
of pre-eclampsia. Resuscitation 2006;68:155–9. matic cardiac arrest: the cost of futility. J Trauma 1993;35:468–73.
385. Schwartz LB. Diagnostic value of tryptase in anaphylaxis and mastocytosis. 417. Shimazu S, Shatney CH. Outcomes of trauma patients with no vital signs on
Immunol Allergy Clin North Am 2006;26:451–63. hospital admission. J Trauma 1983;23:213–6.
386. Brown SG, Blackman KE, Heddle RJ. Can serum mast cell tryptase help diagnose 418. Battistella FD, Nugent W, Owings JT, Anderson JT. Field triage of the pulseless
anaphylaxis? Emerg Med Australas 2004;16:120–4. trauma patient. Arch Surg 1999;134:742–5.
387. Tole JW, Lieberman P. Biphasic anaphylaxis: review of incidence, clinical pre- 419. Stockinger ZT, McSwain Jr NE. Additional evidence in support of withholding
dictors, and observation recommendations. Immunol Allergy Clin North Am or terminating cardiopulmonary resuscitation for trauma patients in the field.
2007;27:309–26, viii. J Am Coll Surg 2004;198:227–31.
388. Simons FE, Lieberman PL, Read Jr EJ, Edwards ES. Hazards of unintentional 420. Fulton RL, Voigt WJ, Hilakos AS. Confusion surrounding the treatment of trau-
injection of epinephrine from autoinjectors: a systematic review. Ann Allergy matic cardiac arrest. J Am Coll Surg 1995;181:209–14.
Asthma Immunol 2009;102:282–7. 421. Pasquale MD, Rhodes M, Cipolle MD, Hanley T, Wasser T. Defining “dead on
389. Campbell RL, Luke A, Weaver AL, et al. Prescriptions for self-injectable arrival”: impact on a level I trauma center. J Trauma 1996;41:726–30.
epinephrine and follow-up referral in emergency department patients 422. Stratton SJ, Brickett K, Crammer T. Prehospital pulseless, unconscious pene-
presenting with anaphylaxis. Ann Allergy Asthma Immunol 2008;101: trating trauma victims: field assessments associated with survival. J Trauma
631–6. 1998;45:96–100.
390. Kelso JM. A second dose of epinephrine for anaphylaxis: how often needed and 423. Maron BJ, Estes 3rd NA. Commotio cordis. N Engl J Med 2010;362:917–27.
how to carry. J Allergy Clin Immunol 2006;117:464–5. 424. Maron BJ, Gohman TE, Kyle SB, Estes 3rd NA, Link MS. Clinical profile and
391. Choo K, Sheikh A. Action plans for the long-term management of anaphylaxis: spectrum of commotio cordis. JAMA 2002;287:1142–6.
systematic review of effectiveness. Clin Exp Allergy 2007;37:1090–4. 425. Maron BJ, Estes 3rd NA, Link MS. Task force 11: commotio cordis. J Am Coll
392. Charalambous CP, Zipitis CS, Keenan DJ. Chest reexploration in the intensive Cardiol 2005;45:1371–3.
care unit after cardiac surgery: a safe alternative to returning to the operating 426. Nesbitt AD, Cooper PJ, Kohl P. Rediscovering commotio cordis. Lancet
theater. Ann Thorac Surg 2006;81:191–4. 2001;357:1195–7.
393. McKowen RL, Magovern GJ, Liebler GA, Park SB, Burkholder JA, Maher TD. Infec- 427. Link MS, Estes M, Maron BJ. Sudden death caused by chest wall trauma (com-
tious complications and cost-effectiveness of open resuscitation in the surgical motio cordis). In: Kohl P, Sachs F, Franz MR, editors. Cardiac mechano-electric
intensive care unit after cardiac surgery. Ann Thorac Surg 1985;40:388–92. feedback and arrhythmias: from pipette to patient. Philadelphia: Elsevier Saun-
394. Pottle A, Bullock I, Thomas J, Scott L. Survival to discharge following Open Chest ders; 2005. p. 270–6.
Cardiac Compression (OCCC). A 4-year retrospective audit in a cardiothoracic 428. Maron BJ, Doerer JJ, Haas TS, Tierney DM, Mueller FO. Sudden deaths in young
specialist centre – Royal Brompton and Harefield NHS Trust, United Kingdom. competitive athletes: analysis of 1866 deaths in the United States, 1980–2006.
Resuscitation 2002;52:269–72. Circulation 2009;119:1085–92.
395. Mackay JH, Powell SJ, Osgathorp J, Rozario CJ. Six-year prospective audit 429. Bouillon B, Walther T, Kramer M, Neugebauer E. Trauma and circulatory
of chest reopening after cardiac arrest. Eur J Cardiothorac Surg 2002;22: arrest: 224 preclinical resuscitations in Cologne in 1987–1990. Anaesthesist
421–5. 1994;43:786–90 [in German].](https://image.slidesharecdn.com/fullerc2010guidelines1-101018011940-phpapp02/85/RCP-2010-guidelines-213-320.jpg)
![1432 J. Soar et al. / Resuscitation 81 (2010) 1400–1433
430. Fisher B, Worthen M. Cardiac arrest induced by blunt trauma in children. Pedi- 463. Pepe PE, Roppolo LP, Fowler RL. The detrimental effects of ventilation during
atr Emerg Care 1999;15:274–6. low-blood-flow states. Curr Opin Crit Care 2005;11:212–8.
431. Hazinski MF, Chahine AA, Holcomb 3rd GW, Morris Jr JA. Outcome of cardio- 464. Deakin CD, Davies G, Wilson A. Simple thoracostomy avoids chest drain inser-
vascular collapse in pediatric blunt trauma. Ann Emerg Med 1994;23:1229–35. tion in prehospital trauma. J Trauma 1995;39:373–4.
432. Calkins CM, Bensard DD, Partrick DA, Karrer FM. A critical analysis of out- 465. Luna GK, Pavlin EG, Kirkman T, Copass MK, Rice CL. Hemodynamic effects of
come for children sustaining cardiac arrest after blunt trauma. J Pediatr Surg external cardiac massage in trauma shock. J Trauma 1989;29:1430–3.
2002;37:180–4. 466. Kragh Jr JF, Walters TJ, Baer DG, et al. Survival with emergency tourniquet use
433. Yanagawa Y, Saitoh D, Takasu A, Kaneko N, Sakamoto T, Okada Y. [Experi- to stop bleeding in major limb trauma. Ann Surg 2009;249:1–7.
ence of treatment for blunt traumatic out-of-hospital cardiopulmonary arrest 467. Gao JM, Gao YH, Wei GB, et al. Penetrating cardiac wounds: principles for
patients over 24 years: head injury v.s. non-head injury]. No Shinkei Geka surgical management. World J Surg 2004;28:1025–9.
2004;32:231–5. 468. Kwan I, Bunn F, Roberts I. Timing and volume of fluid administration for
434. Pickens JJ, Copass MK, Bulger EM. Trauma patients receiving CPR: predictors of patients with bleeding. Cochrane Database Syst Rev 2003:CD002245.
survival. J Trauma 2005;58:951–8. 469. Spinella PC, Holcomb JB. Resuscitation and transfusion principles for traumatic
435. Di Bartolomeo S, Sanson G, Nardi G, Michelutto V, Scian F. HEMS vs. ground-BLS hemorrhagic shock. Blood Rev 2009;23:231–40.
care in traumatic cardiac arrest. Prehosp Emerg Care 2005;9:79–84. 470. Pepe PE, Mosesso VN, Falk JJL. Prehospital fluid resuscitation of the patient with
436. Willis CD, Cameron PA, Bernard SA, Fitzgerald M. Cardiopulmonary resuscita- major trauma. Prehosp Emerg Care 2002;6:81–91.
tion after traumatic cardiac arrest is not always futile. Injury 2006;37:448–54. 471. Bickell WH, Wall Jr MJ, Pepe PE, et al. Immediate versus delayed fluid resusci-
437. David JS, Gueugniaud PY, Riou B, et al. Does the prognosis of cardiac arrest tation for hypotensive patients with penetrating torso injuries. N Engl J Med
differ in trauma patients? Crit Care Med 2007;35:2251–5. 1994;331:1105–9.
438. Crewdson K, Lockey D, Davies G. Outcome from paediatric cardiac arrest asso- 472. National Institute for Clinical Excellence. Pre-hospital initiation of fluid
ciated with trauma. Resuscitation 2007;75:29–34. replacement therapy for trauma. London: National Institute for Clinical Excel-
439. Huber-Wagner S, Lefering R, Qvick M, et al. Outcome in 757 severely lence; 2004.
injured patients with traumatic cardiorespiratory arrest. Resuscitation 473. Sumida MP, Quinn K, Lewis PL, et al. Prehospital blood transfusion versus
2007;75:276–85. crystalloid alone in the air medical transport of trauma patients. Air Med J
440. Lockey D, Crewdson K, Davies G. Traumatic cardiac arrest: who are the sur- 2000;19:140–3.
vivors? Ann Emerg Med 2006;48:240–4. 474. Barkana Y, Stein M, Maor R, Lynn M, Eldad A. Prehospital blood transfusion in
441. Cera SM, Mostafa G, Sing RF, Sarafin JL, Matthews BD, Heniford BT. Physiologic prolonged evacuation. J Trauma 1999;46:176–80.
predictors of survival in post-traumatic arrest. Am Surg 2003;69:140–4. 475. Walcher F, Kortum S, Kirschning T, Weihgold N, Marzi I. Optimized manage-
442. Esposito TJ, Jurkovich GJ, Rice CL, Maier RV, Copass MK, Ashbaugh DG. Reap- ment of polytraumatized patients by prehospital ultrasound. Unfallchirurg
praisal of emergency room thoracotomy in a changing environment. J Trauma 2002;105:986–94.
1991;31:881–5, discussion 5–7. 476. Kirschning T, Brenner F, Stier M, Weber CF, Walcher F. Pre-hospital emergency
443. Martin SK, Shatney CH, Sherck JP, et al. Blunt trauma patients with pre- sonography of trauma patients. Anaesthesist 2009;58:51–60.
hospital pulseless electrical activity (PEA): poor ending assured. J Trauma 477. Krismer AC, Wenzel V, Voelckel WG, et al. Employing vasopressin as an adjunct
2002;53:876–80, discussion 80–1. vasopressor in uncontrolled traumatic hemorrhagic shock. Three cases and a
444. Domeier RM, McSwain Jr NE, Hopson LR, et al. Guidelines for withholding or brief analysis of the literature. Anaesthesist 2005;54:220–4.
termination of resuscitation in prehospital traumatic cardiopulmonary arrest. 478. Department of Health, Welsh Office, Scottish Office Department of Health,
J Am Coll Surg 2003;196:475–81. Department of Health and Social Services, Northern Ireland. Why mothers die.
445. Gervin AS, Fischer RP. The importance of prompt transport of salvage of patients Report on confidential enquiries into maternal deaths in the United Kingdom,
with penetrating heart wounds. J Trauma 1982;22:443–8. 2000–2002. London: The Stationery Office; 2004.
446. Branney SW, Moore EE, Feldhaus KM, Wolfe RE. Critical analysis of two 479. Hogan MC, Foreman KJ, Naghavi M, et al. Maternal mortality for 181 countries,
decades of experience with postinjury emergency department thoracotomy 1980–2008: a systematic analysis of progress towards Millennium Develop-
in a regional trauma center. J Trauma 1998;45:87–94, discussion-5. ment Goal 5. Lancet 2010;375:1609–23.
447. Durham III LA, Richardson RJ, Wall Jr MJ, Pepe PE, Mattox KL. Emergency center 480. Lewis G. The Confidential Enquiry into Maternal and Child Health (CEMACH).
thoracotomy: impact of prehospital resuscitation. J Trauma 1992;32:775–9. Saving Mothers’ Lives: Reviewing maternal deaths to make motherhood safer
448. Frezza EE. Mezghebe H. Is 30 minutes the golden period to perform emergency – 2003–2005. The Seventh Report of the Confidential Enquiries into Maternal
room thoratomy (ERT) in penetrating chest injuries? J Cardiovasc Surg (Torino) Deaths in the United Kingdom. London: CEMACH; 2007.
1999;40:147–51. 481. Page-Rodriguez A, Gonzalez-Sanchez JA. Perimortem cesarean section of
449. Powell DW, Moore EE, Cothren CC, et al. Is emergency department resuscitative twin pregnancy: case report and review of the literature. Acad Emerg Med
thoracotomy futile care for the critically injured patient requiring prehospital 1999;6:1072–4.
cardiopulmonary resuscitation? J Am Coll Surg 2004;199:211–5. 482. Cardosi RJ, Porter KB. Cesarean delivery of twins during maternal cardiopul-
450. Coats TJ, Keogh S, Clark H, Neal M. Prehospital resuscitative thoracotomy for monary arrest. Obstet Gynecol 1998;92:695–7.
cardiac arrest after penetrating trauma: rationale and case series. J Trauma 483. Mendonca C, Griffiths J, Ateleanu B, Collis RE. Hypotension following combined
2001;50:670–3. spinal-epidural anaesthesia for Caesarean section. Left lateral position vs. tilted
451. Wise D, Davies G, Coats T, Lockey D, Hyde J, Good A. Emergency thoracotomy: supine position. Anaesthesia 2003;58:428–31.
“how to do it”. Emerg Med J 2005;22:22–4. 484. Rees SG, Thurlow JA, Gardner IC, Scrutton MJ, Kinsella SM. Maternal cardio-
452. Kwan I, Bunn F, Roberts I. Spinal immobilisation for trauma patients. Cochrane vascular consequences of positioning after spinal anaesthesia for Caesarean
Database Syst Rev 2001:CD002803. section: left 15 degree table tilt vs. left lateral. Anaesthesia 2002;57:15–20.
453. Davies G, Lockey D. Establishing the radical intervention of pre-hospital tho- 485. Bamber JH, Dresner M. Aortocaval compression in pregnancy: the effect of
racotomy as a part of normal physician pre-hospital practice. Scand J Trauma changing the degree and direction of lateral tilt on maternal cardiac output.
Resusc Emerg Med 2007;15:106. Anesth Analg 2003;97:256–8, table of contents.
454. Matsumoto H, Mashiko K, Hara Y, et al. Role of resuscitative emergency field 486. Carbonne B, Benachi A, Leveque ML, Cabrol D, Papiernik E. Maternal position
thoracotomy in the Japanese helicopter emergency medical service system. during labor: effects on fetal oxygen saturation measured by pulse oximetry.
Resuscitation 2009;80:1270–4. Obstet Gynecol 1996;88:797–800.
455. Voiglio EJ, Coats TJ, Baudoin YP, Davies GD, Wilson AW. Resuscitative transverse 487. Tamas P, Szilagyi A, Jeges S, et al. Effects of maternal central hemodynamics on
thoracotomy. Ann Chir 2003;128:728–33. fetal heart rate patterns. Acta Obstet Gynecol Scand 2007;86:711–4.
456. Practice management guidelines for emergency department thoracotomy. 488. Abitbol MM. Supine position in labor and associated fetal heart rate changes.
Working Group, Ad Hoc Subcommittee on Outcomes, American College of Obstet Gynecol 1985;65:481–6.
Surgeons-Committee on Trauma. J Am Coll Surg 2001;193:303–9. 489. Ellington C, Katz VL, Watson WJ, Spielman FJ. The effect of lateral tilt on mater-
457. Fialka C, Sebok C, Kemetzhofer P, Kwasny O, Sterz F, Vecsei V. Open-chest nal and fetal hemodynamic variables. Obstet Gynecol 1991;77:201–3.
cardiopulmonary resuscitation after cardiac arrest in cases of blunt chest or 490. Matorras R, Tacuri C, Nieto A, Gutierrez de Teran G, Cortes J. Lack of benefits of
abdominal trauma: a consecutive series of 38 cases. J Trauma 2004;57:809– left tilt in emergent cesarean sections: a randomized study of cardiotocogra-
14. phy, cord acid–base status and other parameters of the mother and the fetus.
458. Jones JH, Murphy MP, Dickson RL, Somerville GG, Brizendine EJ. Emergency J Perinat Med 1998;26:284–92.
physician-verified out-of-hospital intubation: miss rates by paramedics. Acad 491. Kinsella SM, Whitwam JG, Spencer JA. Aortic compression by the uterus: iden-
Emerg Med 2004;11:707–9. tification with the Finapres digital arterial pressure instrument. Br J Obstet
459. Jemmett ME, Kendal KM, Fourre MW, Burton JH. Unrecognized misplacement Gynaecol 1990;97:700–5.
of endotracheal tubes in a mixed urban to rural emergency medical services 492. Kundra P, Khanna S, Habeebullah S, Ravishankar M. Manual displacement of
setting. Acad Emerg Med 2003;10:961–5. the uterus during Caesarean section. Anaesthesia 2007;62:460–5.
460. Katz SH, Falk JL. Misplaced endotracheal tubes by paramedics in an urban 493. Amaro A, Capelli E, Cardoso M, Rosa M, Carvalho J. Manual left uterine displace-
emergency medical services system. Ann Emerg Med 2001;37:32–7. ment or modified Crawford’s edge. A comparative study in spinal anesthesia
461. Deakin CD, Peters R, Tomlinson P, Cassidy M. Securing the prehospital airway: for cesarean delivery. Rev Bras Anestesiol 1998;48:99–104.
a comparison of laryngeal mask insertion and endotracheal intubation by UK 494. Kinsella SM. Lateral tilt for pregnant women: why 15 degrees? Anaesthesia
paramedics. Emerg Med J 2005;22:64–7. 2003;58:835–6.
462. Cobas MA, De la Pena MA, Manning R, Candiotti K, Varon AJ. Prehospital 495. Goodwin AP, Pearce AJ. The human wedge. A manoeuvre to relieve aor-
intubations and mortality: a level 1 trauma center perspective. Anesth Analg tocaval compression during resuscitation in late pregnancy. Anaesthesia
2009;109:489–93. 1992;47:433–4.](https://image.slidesharecdn.com/fullerc2010guidelines1-101018011940-phpapp02/85/RCP-2010-guidelines-214-320.jpg)
![Resuscitation 81 (2010) 1434–1444
Contents lists available at ScienceDirect
Resuscitation
journal homepage: www.elsevier.com/locate/resuscitation
European Resuscitation Council Guidelines for Resuscitation 2010
Section 9. Principles of education in resuscitation
Jasmeet Soar a,∗ , Koenraad G. Monsieurs b , John H.W. Ballance c , Alessandro Barelli d ,
Dominique Biarent e , Robert Greif f , Anthony J. Handley g , Andrew S. Lockey h , Sam Richmond i ,
Charlotte Ringsted j , Jonathan P. Wyllie k , Jerry P. Nolan l , Gavin D. Perkins m
a
Southmead Hospital, North Bristol NHS Trust, Bristol, UK
b
Emergency Department, Ghent University Hospital, Ghent, Belgium
c
Woolhope, Herefordshire, UK
d
Department of Clinical Toxicology – Poison Centre and Emergency Department, Catholic University School of Medicine, Rome, Italy
e
Paediatric Intensive Care and Emergency Medicine, Université Libre de Bruxelles, Queen Fabiola Children’s University Hospital, Brussels, Belgium
f
Department Anesthesiology and Pain Therapy, University Hospital Bern, Inselspital, Bern, Switzerland
g
Honorary Consultant Physician, Colchester, UK
h
Calderdale and Huddersfield NHS Trust, Salterhebble, Halifax, UK
i
Sunderland Royal Hospital, Sunderland, UK
j
University of Copenhagen and Capital Region, Rigshospitalet, Copenhagen, Denmark
k
James Cook University Hospital, Middlesbrough, UK
l
Royal United Hospital, Bath, UK
m
University of Warwick, Warwick Medical School, Warwick, UK
Introduction • Educational interventions should be evaluated to ensure that they
reliably achieve the learning objectives. The aim is to ensure that
Survival from cardiac arrest is determined by the quality of the learners acquire and retain the skills and knowledge that will
scientific evidence behind the guidelines, the effectiveness of edu- enable them to act correctly in actual cardiac arrests and improve
cation and the resources for implementation of the guidelines.1 An patient outcomes.
additional factor is how readily guidelines can be applied in clinical • Short video/computer self-instruction courses, with minimal or
practice and the effect of human factors on putting the theory into no instructor coaching, combined with hands-on practice can
practice.2 Implementation of Guidelines 2010 is likely to be more be considered as an effective alternative to instructor-led basic
successful with a carefully planned, comprehensive implementa- life support (cardiopulmonary resuscitation [CPR] and automated
tion strategy that includes education. Delays in providing training external defibrillator [AED]) courses.
materials and freeing staff for training were cited as reasons for • Ideally all citizens should be trained in standard CPR that includes
delays in the implementation of the 2005 guidelines.3,4 compressions and ventilations. There are circumstances how-
This chapter includes the key educational issues identified ever where training in compression-only CPR is appropriate (e.g.,
by the International Liaison Committee on Resuscitation (ILCOR) opportunistic training with very limited time). Those trained in
evidence evaluation,5 discusses the scientific basis of basic and compression-only CPR should be encouraged to learn standard
advanced level resuscitation training and provides an update on CPR.
the European Resuscitation Council (ERC) life support courses.6 • Basic and advanced life support knowledge and skills deteriorate
in as little as three to six months. The use of frequent assessments
will identify those individuals who require refresher training to
help maintain their knowledge and skills.
Key educational recommendations
• CPR prompt or feedback devices improve CPR skill acquisition
and retention and should be considered during CPR training for
The key issues identified by the Education, Implementation and
laypeople and healthcare professionals.
Teams (EIT) task force of ILCOR during the Guidelines 2010 evidence • An increased emphasis on non-technical skills (NTS) such as
evaluation process5 that are relevant to this chapter are:
leadership, teamwork, task management and structured commu-
nication will help improve the performance of CPR and patient
care.
∗ Corresponding author.
• Team briefings to plan for resuscitation attempts, and debriefings
E-mail address: jas.soar@btinternet.com (J. Soar). based on performance during simulated or actual resuscitation
0300-9572/$ – see front matter © 2010 European Resuscitation Council. Published by Elsevier Ireland Ltd. All rights reserved.
doi:10.1016/j.resuscitation.2010.08.014](https://image.slidesharecdn.com/fullerc2010guidelines1-101018011940-phpapp02/85/RCP-2010-guidelines-216-320.jpg)
![1436 J. Soar et al. / Resuscitation 81 (2010) 1434–1444
The use of AEDs by individuals without prior formal training • Good quality chest compressions including adherence to rate,
can be beneficial and may be life saving.45,56–60 Performance in the depth, full recoil and minimizing hands-off time, and ventilation
use of an AED (e.g., speed of use, correct pad placement) can be using basic skills (e.g., pocket mask, bag mask).
further improved with brief training of laypeople and healthcare • Defibrillation including charging during compressions for manual
professionals.45,50,61,62 defibrillation.
• Advanced life support algorithms.
Duration and frequency of instructor-led basic life support • Non-technical skills (e.g., leadership and team training, commu-
and AED training courses nication).
The optimal duration of instructor-led basic life support and Extended training may cover advanced airway manage-
AED training courses has not been determined and is likely to ment, management of peri-arrest arrhythmias; resuscitation in
vary according to the characteristics of the participants (e.g., lay special circumstances, vascular access, cardiac arrest drugs, post-
or healthcare; previous training; age), the curriculum, the ratio of resuscitation care and ethics.
instructors to participants, the amount of hands-on training and
the use of end of course assessments. Advanced level training methods
Most studies show that CPR skills such as calling for help, chest
compressions and ventilations decay within three to six months Pre-course training
after initial training.43,46,63–68 AED skills are retained for longer than
basic life support skills alone.59,64,69 A variety of methods (such as reading manuals, pretests and
CPR performance can be retained or improved with re- e-learning can be used to prepare candidates before attending a
evaluation and, if required, a brief refresher, or retraining after as life support course.99–107 A recent large randomized controlled
little as three to six months.64,70–73 study of use of a commercially available e-learning simulation
programme before attending an advanced life support course com-
Use of CPR prompt/feedback devices pared with standard preparation with a course manual showed
no improvement in cognitive or psychomotor skills during cardiac
The use of CPR prompt/feedback devices may be considered arrest simulation testing.107,108
during CPR training for laypeople and healthcare professionals.35 There are numerous studies of alternative teaching methods
Devices can be prompting (i.e., signal to perform an action e.g., that claim equivalence or benefit for computer or video-
metronome for compression rate or voice feedback), give feed- based training and decrease the time instructors spend with
back (i.e., after event information based on effect of an action learners.100,101,106,109–123 Any method of pre-course prepara-
such as visual display of compression depth), or a combination of tion that is aimed at improving knowledge and skills or
prompts and feedback. Training using a prompt/feedback device reducing instructor to learner face-to-face time should be for-
can improve CPR skill performance, acquisition and retention. In mally assessed to ensure equivalent or improved learning
these studies acquisition and retention was measured by testing outcomes compared with standard instructor-led courses. A
on a manikin without using the device.63,74–78 Instructors and res- large multicentre randomised controlled trial to test if a 1-day
cuers should be made aware that a compressible support surface face-to-face ALS course supplemented by e-learning material
(e.g., mattress) can cause a prompt/feedback device to overestimate is equivalent to the 2-day face-to-face standard ALS course
depth of compression.79,80 with respect to the course learning outcomes is ongoing
[ISRCTN86380392].
Advanced level training
Simulation and realistic training techniques
Advanced level training curriculum Simulation training is an essential part of resuscitation train-
ing. There is large variation in how simulation can be and is used
Advanced level training is usually for healthcare providers. Cur- for resuscitation training.124 The lack of consistent definitions (e.g.,
ricula should be tailored to match individual learning needs, patient high vs. low fidelity simulation) makes comparisons of studies of
case mix and the individual’s role within the healthcare systems different types of simulation training difficult.
response to cardiac arrest. There is limited evidence about specific Simulation training has fairly consistently,33,125–136 although
interventions that enhance learning and retention from advanced not universally137–143 been shown to improve knowledge and skill
level life support courses. The ERC Advanced Life Support (ALS) performance on manikins. Evidence of change in real life perfor-
course following Guidelines 2005 has been shown to reduce “no- mance is more limited. A small number of before and after studies
flow” fraction but not other elements of quality of CPR performance examining the effects of resuscitation training (including simula-
in cardiac arrest simulations.81 Increased clinical experience of tion) on real life performance have documented improvement in
learners seems to improve long-term retention of knowledge and actual patient outcomes.144–148 These studies are limited by their
skills.82,83 inability to separate the effect of simulation training from other
Studies of advanced life support in actual or simulated educational and temporal factors. One randomised controlled trial
in-hospital arrests,84–94 show improved resuscitation team per- and a prospective case control study which allocated participants
formance when specific team and, or leadership training is added to simulator or standard resuscitation training showed improved
to advanced level courses. Team training and rhythm recognition real life performance of those skills.127,149
skills will be essential to minimize hands-off time when using the There are conflicting data on the effect of increas-
2010 manual defibrillation strategy that includes charging during ing realism (e.g., use of actual resuscitation settings, high
chest compressions.95,96 fidelity manikins) on learning, and few data on patient
Core elements for advanced life support curricula should outcomes.125,128,133,135,137,138,140,141,150–154 One study reported a
include: significant increase in knowledge when using manikins or live
patient models for trauma teaching compared with no manikins
• Cardiac arrest prevention.97,98 or live models.153 In this study there was no difference in knowl-](https://image.slidesharecdn.com/fullerc2010guidelines1-101018011940-phpapp02/85/RCP-2010-guidelines-218-320.jpg)
RCP 2010 guidelines
- 1. Resuscitation 81 (2010) 1219–1276 Contents lists available at ScienceDirect Resuscitation journal homepage: www.elsevier.com/locate/resuscitation European Resuscitation Council Guidelines for Resuscitation 2010 Section 1. Executive summary Jerry P. Nolan a,∗ , Jasmeet Soar b , David A. Zideman c , Dominique Biarent d , Leo L. Bossaert e , Charles Deakin f , Rudolph W. Koster g , Jonathan Wyllie h , Bernd Böttiger i , on behalf of the ERC Guidelines Writing Group1 a Anaesthesia and Intensive Care Medicine, Royal United Hospital, Bath, UK b Anaesthesia and Intensive Care Medicine, Southmead Hospital, North Bristol NHS Trust, Bristol, UK c Imperial College Healthcare NHS Trust, London, UK d Paediatric Intensive Care and Emergency Medicine, Université Libre de Bruxelles, Queen Fabiola Children’s University Hospital, Brussels, Belgium e Cardiology and Intensive Care, University of Antwerp, Antwerp, Belgium f Cardiac Anaesthesia and Critical Care, Southampton University Hospital NHS Trust, Southampton, UK g Department of Cardiology, Academic Medical Center, Amsterdam, The Netherlands h Neonatology and Paediatrics, The James Cook University Hospital, Middlesbrough, UK i Anästhesiologie und Operative Intensivmedizin, Universitätsklinikum Köln, Köln, Germany Introduction 5. Initial management of acute coronary syndromes;7 6. Paediatric life support;8 The publication of these European Resuscitation Council (ERC) 7. Resuscitation of babies at birth;9 Guidelines for cardiopulmonary resuscitation (CPR) updates those 8. Cardiac arrest in special circumstances: electrolyte abnormali- that were published in 2005 and maintains the established 5-yearly ties, poisoning, drowning, accidental hypothermia, hyperther- cycle of guideline changes.1 Like the previous guidelines, these mia, asthma, anaphylaxis, cardiac surgery, trauma, pregnancy, 2010 guidelines are based on the most recent International Consen- electrocution;10 sus on CPR Science with Treatment Recommendations (CoSTR),2 9. Principles of education in resuscitation;11 which incorporated the results of systematic reviews of a wide 10. The ethics of resuscitation and end-of-life decisions.12 range of topics relating to CPR. Resuscitation science continues to advance, and clinical guidelines must be updated regularly to reflect The guidelines that follow do not define the only way that resus- these developments and advise healthcare providers on best prac- citation can be delivered; they merely represent a widely accepted tice. In between the 5-yearly guideline updates, interim scientific view of how resuscitation should be undertaken both safely and statements can inform the healthcare provider about new therapies effectively. The publication of new and revised treatment recom- that might influence outcome significantly.3 mendations does not imply that current clinical care is either unsafe This executive summary provides the essential treatment algo- or ineffective. rithms for the resuscitation of children and adults and highlights the main guideline changes since 2005. Detailed guidance is pro- Summary of main changes since 2005 Guidelines vided in each of the remaining nine sections, which are published as individual papers within this issue of Resuscitation. The sections Basic life support of the 2010 guidelines are: Changes in basic life support (BLS) since the 2005 guidelines 1. Executive summary; include:4,13 2. Adult basic life support and use of automated external defibrillators;4 • Dispatchers should be trained to interrogate callers with strict 3. Electrical therapies: automated external defibrillators, defibril- protocols to elicit information. This information should focus on lation, cardioversion and pacing;5 the recognition of unresponsiveness and the quality of breathing. 4. Adult advanced life support;6 In combination with unresponsiveness, absence of breathing or any abnormality of breathing should start a dispatch protocol for suspected cardiac arrest. The importance of gasping as sign of ∗ Corresponding author. cardiac arrest is emphasised. E-mail address: jerry.nolan@btinternet.com (J.P. Nolan). • All rescuers, trained or not, should provide chest compressions 1 Appendix A (the list of the writing group members). to victims of cardiac arrest. A strong emphasis on delivering 0300-9572/$ – see front matter © 2010 European Resuscitation Council. Published by Elsevier Ireland Ltd. All rights reserved. doi:10.1016/j.resuscitation.2010.08.021
- 2. 1220 J.P. Nolan et al. / Resuscitation 81 (2010) 1219–1276 high quality chest compressions remains essential. The aim • Increased awareness of the warning signs associated with the should be to push to a depth of at least 5 cm at a rate of at potential risk of sudden cardiac death out of hospital. least 100 compressions min−1 , to allow full chest recoil, and to • Removal of the recommendation for a specified period of minimise interruptions in chest compressions. Trained rescuers cardiopulmonary resuscitation (CPR) before out-of-hospital should also provide ventilations with a compression–ventilation defibrillation following cardiac arrest unwitnessed by EMS per- (CV) ratio of 30:2. Telephone-guided chest compression-only CPR sonnel. is encouraged for untrained rescuers. • Continuation of chest compressions while a defibrillator is • The use of prompt/feedback devices during CPR will enable charged – this will minimise the pre-shock pause. immediate feedback to rescuers and is encouraged. The data • The role of the precordial thump is de-emphasised. stored in rescue equipment can be used to monitor and improve • The use of up to three quick successive (stacked) shocks the quality of CPR performance and provide feedback to profes- for ventricular fibrillation/pulseless ventricular tachycardia sional rescuers during debriefing sessions. (VF/VT) occurring in the cardiac catheterisation laboratory or in the immediate post-operative period following cardiac Electrical therapies: automated external defibrillators, surgery. defibrillation, cardioversion and pacing5,14 • Delivery of drugs via a tracheal tube is no longer recommended – if intravenous access cannot be achieved, drugs should be given The most important changes in the 2010 ERC Guidelines for by the intraosseous (IO) route. electrical therapies include: • When treating VF/VT cardiac arrest, adrenaline 1 mg is given after the third shock once chest compressions have restarted and • The importance of early, uninterrupted chest compressions is then every 3–5 min (during alternate cycles of CPR). Amiodarone emphasised throughout these guidelines. 300 mg is also given after the third shock. • Much greater emphasis on minimising the duration of the pre- • Atropine is no longer recommended for routine use in asystole or shock and post-shock pauses; the continuation of compressions pulseless electrical activity (PEA). during charging of the defibrillator is recommended. • Reduced emphasis on early tracheal intubation unless achieved • Emphasis on resumption of chest compressions following defib- by highly skilled individuals with minimal interruption to chest rillation; in combination with continuation of compressions compressions. during defibrillator charging, the delivery of defibrillation should • Increased emphasis on the use of capnography to confirm and be achievable with an interruption in chest compressions of no continually monitor tracheal tube placement, quality of CPR and more than 5 s. to provide an early indication of return of spontaneous circulation • The safety of the rescuer remains paramount, but there is recog- (ROSC). nition in these guidelines that the risk of harm to a rescuer from • The potential role of ultrasound imaging during ALS is recognised. a defibrillator is very small, particularly if the rescuer is wearing • Recognition of the potential harm caused by hyperoxaemia after gloves. The focus is now on a rapid safety check to minimise the ROSC is achieved: once ROSC has been established and the oxy- pre-shock pause. gen saturation of arterial blood (SaO2 ) can be monitored reliably • When treating out-of-hospital cardiac arrest, emergency medical (by pulse oximetry and/or arterial blood gas analysis), inspired services (EMS) personnel should provide good-quality CPR while oxygen is titrated to achieve a SaO2 of 94–98%. a defibrillator is retrieved, applied and charged, but routine deliv- • Much greater detail and emphasis on the treatment of the post- ery of a specified period of CPR (e.g., 2 or 3 min) before rhythm cardiac arrest syndrome. analysis and a shock is delivered is no longer recommended. • Recognition that implementation of a comprehensive, structured For some emergency medical services that have already fully post-resuscitation treatment protocol may improve survival in implemented a specified period of chest compressions before cardiac arrest victims after ROSC. defibrillation, given the lack of convincing data either support- • Increased emphasis on the use of primary percutaneous coronary ing or refuting this strategy, it is reasonable for them to continue intervention in appropriate (including comatose) patients with this practice. sustained ROSC after cardiac arrest. • The use of up to three-stacked shocks may be considered if • Revision of the recommendation for glucose control: in adults VF/VT occurs during cardiac catheterisation or in the early post- with sustained ROSC after cardiac arrest, blood glucose values operative period following cardiac surgery. This three-shock >10 mmol l−1 (>180 mg dl−1 ) should be treated but hypogly- strategy may also be considered for an initial, witnessed VF/VT caemia must be avoided. cardiac arrest when the patient is already connected to a manual • Use of therapeutic hypothermia to include comatose survivors of defibrillator. cardiac arrest associated initially with non-shockable rhythms as • Encouragement of the further development of AED programmes well shockable rhythms. The lower level of evidence for use after – there is a need for further deployment of AEDs in both public cardiac arrest from non-shockable rhythms is acknowledged. and residential areas. • Recognition that many of the accepted predictors of poor out- come in comatose survivors of cardiac arrest are unreliable, Adult advanced life support especially if the patient has been treated with therapeutic hypothermia. The most important changes in the 2010 ERC Advanced Life Support (ALS) Guidelines include6,15 : Initial management of acute coronary syndromes • Increased emphasis on the importance of minimally interrupted Changes in the management of acute coronary syndrome since high-quality chest compressions throughout any ALS interven- the 2005 guidelines include7,16 : tion: chest compressions are paused briefly only to enable specific interventions. • The term non-ST elevation myocardial infarction-acute coronary • Increased emphasis on the use of ‘track-and-trigger systems’ to syndrome (NSTEMI-ACS) has been introduced for both NSTEMI detect the deteriorating patient and enable treatment to prevent and unstable angina pectoris because the differential diagnosis in-hospital cardiac arrest. is dependent on biomarkers that may be detectable only after
- 3. J.P. Nolan et al. / Resuscitation 81 (2010) 1219–1276 1221 several hours, whereas decisions on treatment are dependent on they may add pulse palpation for diagnosing cardiac arrest the clinical signs at presentation. and decide whether they should begin chest compressions or • History, clinical examinations, biomarkers, ECG criteria and risk not. The decision to begin CPR must be taken in less than scores are unreliable for the identification of patients who may 10 s. According to the child’s age, carotid (children), brachial be safely discharged early. (infants) or femoral pulse (children and infants) checks may be • The role of chest pain observation units (CPUs) is to identify, by used. using repeated clinical examinations, ECG and biomarker testing, • The CV ratio used for children should be based on whether those patients who require admission for invasive procedures. one, or more than one rescuer is present. Lay rescuers, who This may include provocative testing and, in selected patients, usually learn only single-rescuer techniques, should be taught imaging procedures such as cardiac computed tomography, mag- to use a ratio of 30 compressions to 2 ventilations, which is netic resonance imaging, etc. the same as the adult guidelines and enables anyone trained • Non-steroidal anti-inflammatory drugs (NSAIDs) should be in BLS to resuscitate children with minimal additional infor- avoided. mation. Rescuers with a duty to respond should learn and use • Nitrates should not be used for diagnostic purposes. a 15:2 CV ratio; however, they can use the 30:2 ratio if they • Supplementary oxygen is to be given only to those patients with are alone, particularly if they are not achieving an adequate hypoxaemia, breathlessness or pulmonary congestion. Hyperox- number of compressions. Ventilation remains a very impor- aemia may be harmful in uncomplicated infarction. tant component of CPR in asphyxial arrests. Rescuers who are • Guidelines for treatment with acetyl salicylic acid (ASA) have unable or unwilling to provide mouth-to-mouth ventilation been made more liberal: ASA may now be given by bystanders should be encouraged to perform at least compression-only with or without EMS dispatcher assistance. CPR. • Revised guidance for new anti-platelet and anti-thrombin treat- • The emphasis is on achieving quality compressions of an ade- ment for patients with ST elevation myocardial infarction (STEMI) quate depth with minimal interruptions to minimise no-flow and non-STEMI-ACS based on therapeutic strategy. time. Compress the chest to at least one third of the anterior- • Gp IIb/IIIa inhibitors before angiography/percutaneous coronary posterior chest diameter in all children (i.e., approximately 4 cm intervention (PCI) are discouraged. in infants and approximately 5 cm in children). Subsequent • The reperfusion strategy in STEMI has been updated: complete release is emphasised. For both infants and children, ◦ Primary PCI (PPCI) is the preferred reperfusion strategy pro- the compression rate should be at least 100 but not greater vided it is performed in a timely manner by an experienced than 120 min−1 . The compression technique for infants includes team. two-finger compression for single rescuers and the two-thumb ◦ A nearby hospital may be bypassed by the EMS provided PPCI encircling technique for two or more rescuers. For older children, can be achieved without too much delay. a one- or two-hand technique can be used, according to rescuer ◦ The acceptable delay between start of fibrinolysis and first bal- preference. loon inflation varies widely between about 45 and 180 min • Automated external defibrillators (AEDs) are safe and successful depending on infarct localisation, age of the patient, and dura- when used in children older than 1 year of age. Purpose- tion of symptoms. made paediatric pads or software attenuate the output of the ◦ ‘Rescue PCI’ should be undertaken if fibrinolysis fails. machine to 50–75 J and these are recommended for children ◦ The strategy of routine PCI immediately after fibrinolysis (‘facil- aged 1–8 years. If an attenuated shock or a manually adjustable itated PCI’) is discouraged. machine is not available, an unmodified adult AED may be used ◦ Patients with successful fibrinolysis but not in a PCI-capable in children older than 1 year. There are case reports of suc- hospital should be transferred for angiography and even- cessful use of AEDs in children aged less than 1 year; in the tual PCI, performed optimally 6–24 h after fibrinolysis (the rare case of a shockable rhythm occurring in a child less than ‘pharmaco-invasive’ approach). 1 year, it is reasonable to use an AED (preferably with dose ◦ Angiography and, if necessary, PCI may be reasonable in attenuator). patients with ROSC after cardiac arrest and may be part of a • To reduce the no flow time, when using a manual defibrillator, standardised post-cardiac arrest protocol. chest compressions are continued while applying and charg- ◦ To achieve these goals, the creation of networks including EMS, ing the paddles or self-adhesive pads (if the size of the child’s non PCI capable hospitals and PCI hospitals is useful. chest allows this). Chest compressions are paused briefly once • Recommendations for the use of beta-blockers are more the defibrillator is charged to deliver the shock. For simplicity and restricted: there is no evidence for routine intravenous beta- consistency with adult BLS and ALS guidance, a single-shock strat- blockers except in specific circumstances such as for the egy using a non-escalating dose of 4 J kg−1 (preferably biphasic, treatment of tachyarrhythmias. Otherwise, beta-blockers should but monophasic is acceptable) is recommended for defibrillation be started in low doses only after the patient is stabilised. in children. • Guidelines on the use of prophylactic anti-arrhythmics • Cuffed tracheal tubes can be used safely in infants and young chil- angiotensin, converting enzyme (ACE) inhibitors/angiotensin dren. The size should be selected by applying a validated formula. receptor blockers (ARBs) and statins are unchanged. • The safety and value of using cricoid pressure during tracheal intubation is not clear. Therefore, the application of cricoid pres- sure should be modified or discontinued if it impedes ventilation Paediatric life support or the speed or ease of intubation. • Monitoring exhaled carbon dioxide (CO2 ), ideally by capnog- Major changes in these new guidelines for paediatric life support raphy, is helpful to confirm correct tracheal tube position and include8,17 : recommended during CPR to help assess and optimize its quality. • Once spontaneous circulation is restored, inspired oxygen should • Recognition of cardiac arrest – Healthcare providers cannot reli- be titrated to limit the risk of hyperoxaemia. ably determine the presence or absence of a pulse in less than • Implementation of a rapid response system in a paediatric in- 10 s in infants or children. Healthcare providers should look patient setting may reduce rates of cardiac and respiratory arrest for signs of life and if they are confident in the technique, and in-hospital mortality.
- 4. 1222 J.P. Nolan et al. / Resuscitation 81 (2010) 1219–1276 • New topics in the 2010 guidelines include channelopathies and enable them to act correctly in actual cardiac arrests and improve several new special circumstances: trauma, single ventricle pre- patient outcomes. and post-1st stage repair, post-Fontan circulation, and pulmonary • Short video/computer self-instruction courses, with minimal or hypertension. no instructor coaching, combined with hands-on practice can be considered as an effective alternative to instructor-led basic life Resuscitation of babies at birth support (CPR and AED) courses. • Ideally all citizens should be trained in standard CPR that includes The following are the main changes that have been made to the compressions and ventilations. There are circumstances how- guidelines for resuscitation at birth in 20109,18 : ever where training in compression-only CPR is appropriate (e.g., opportunistic training with very limited time). Those trained in • For uncompromised babies, a delay in cord clamping of at least compression-only CPR should be encouraged to learn standard 1 min from the complete delivery of the infant, is now recom- CPR. mended. As yet there is insufficient evidence to recommend an • Basic and advanced life support knowledge and skills deteriorate appropriate time for clamping the cord in babies who are severely in as little as 3–6 months. The use of frequent assessments will compromised at birth. identify those individuals who require refresher training to help • For term infants, air should be used for resuscitation at birth. maintain their knowledge and skills. If, despite effective ventilation, oxygenation (ideally guided by • CPR prompt or feedback devices improve CPR skill acquisition oximetry) remains unacceptable, use of a higher concentration and retention and should be considered during CPR training for of oxygen should be considered. laypeople and healthcare professionals. • Preterm babies less than 32 weeks gestation may not reach the • An increased emphasis on non-technical skills (NTS) such as same transcutaneous oxygen saturations in air as those achieved leadership, teamwork, task management and structured commu- by term babies. Therefore blended oxygen and air should be given nication will help improve the performance of CPR and patient judiciously and its use guided by pulse oximetry. If a blend of care. oxygen and air is not available use what is available. • Team briefings to plan for resuscitation attempts, and debriefings • Preterm babies of less than 28 weeks gestation should be com- based on performance during simulated or actual resuscitation pletely covered up to their necks in a food-grade plastic wrap or attempts should be used to help improve resuscitation team and bag, without drying, immediately after birth. They should then be individual performance. nursed under a radiant heater and stabilised. They should remain • Research about the impact of resuscitation training on actual wrapped until their temperature has been checked after admis- patient outcomes is limited. Although manikin studies are useful, sion. For these infants delivery room temperatures should be at researchers should be encouraged to study and report the impact least 26 ◦ C. of educational interventions on actual patient outcomes. • The recommended CV ratio for CPR remains at 3:1 for newborn resuscitation. • Attempts to aspirate meconium from the nose and mouth of the unborn baby, while the head is still on the perineum, are Epidemiology and outcome of cardiac arrest not recommended. If presented with a floppy, apnoeic baby born through meconium it is reasonable to rapidly inspect the Ischaemic heart disease is the leading cause of death in the oropharynx to remove potential obstructions. If appropriate world.20 In Europe, cardiovascular disease accounts for around 40% expertise is available, tracheal intubation and suction may be of all deaths under the age of 75 years.21 Sudden cardiac arrest useful. However, if attempted intubation is prolonged or unsuc- is responsible for more than 60% of adult deaths from coronary cessful, start mask ventilation, particularly if there is persistent heart disease.22 Summary data from 37 communities in Europe bradycardia. indicate that the annual incidence of EMS-treated out-of-hospital • If adrenaline is given then the intravenous route is recommended cardiopulmonary arrests (OHCAs) for all rhythms is 38 per 100,000 using a dose of 10–30 g kg−1 . If the tracheal route is used, it is population.22a Based on these data, the annual incidence of EMS- likely that a dose of at least 50–100 g kg−1 will be needed to treated ventricular fibrillation (VF) arrest is 17 per 100,000 and achieve a similar effect to 10 g kg−1 intravenously. survival to hospital discharge is 10.7% for all-rhythm and 21.2% • Detection of exhaled carbon dioxide in addition to clinical assess- for VF cardiac arrest. Recent data from 10 North American sites ment is recommended as the most reliable method to confirm are remarkably consistent with these figures: median rate of sur- placement of a tracheal tube in neonates with spontaneous cir- vival to hospital discharge was 8.4% after EMS-treated cardiac arrest culation. from any rhythm and 22.0% after VF.23 There is some evidence • Newly born infants born at term or near-term with evolving that long-term survival rates after cardiac arrest are increasing.24,25 moderate to severe hypoxic–ischaemic encephalopathy should, On initial heart rhythm analysis, about 25–30% of OHCA victims where possible, be treated with therapeutic hypothermia. This have VF, a percentage that has declined over the last 20 years.26–30 does not affect immediate resuscitation but is important for post- It is likely that many more victims have VF or rapid ventricular resuscitation care. tachycardia (VT) at the time of collapse but, by the time the first electrocardiogram (ECG) is recorded by EMS personnel, the rhythm Principles of education in resuscitation has deteriorated to asystole.31,32 When the rhythm is recorded soon after collapse, in particular by an on-site AED, the proportion of The key issues identified by the Education, Implementation and patients in VF can be as high as 59%33 to 65%.34 Teams (EIT) task force of the International Liaison Committee on The reported incidence of in-hospital cardiac arrest is more vari- Resuscitation (ILCOR) during the Guidelines 2010 evidence evalu- able, but is in the range of 1–5 per 1000 admissions.35 Recent data ation process are11,19 : from the American Heart Association’s National Registry of CPR indicate that survival to hospital discharge after in-hospital cardiac • Educational interventions should be evaluated to ensure that they arrest is 17.6% (all rhythms).36 The initial rhythm is VF or pulseless reliably achieve the learning objectives. The aim is to ensure that VT in 25% of cases and, of these, 37% survive to leave hospital; after learners acquire and retain the skills and knowledge that will PEA or asystole, 11.5% survive to hospital discharge.
- 5. J.P. Nolan et al. / Resuscitation 81 (2010) 1219–1276 1223 The International Consensus on Cardiopulmonary with the science in the consensus document, but will also con- Science sider geographic, economic and system differences in practice, and the availability of medical devices and drugs. These 2010 The International Liaison Committee on Resuscitation (ILCOR) ERC Resuscitation Guidelines are derived from the 2010 CoSTR includes representatives from the American Heart Association document but represent consensus among members of the ERC (AHA), the European Resuscitation Council (ERC), the Heart and Executive Committee. The ERC Executive Committee considers Stroke Foundation of Canada (HSFC), the Australian and New these new recommendations to be the most effective and easily Zealand Committee on Resuscitation (ANZCOR), Resuscitation learned interventions that can be supported by current knowl- Council of Southern Africa (RCSA), the Inter-American Heart Foun- edge, research and experience. Inevitably, even within Europe, dation (IAHF), and the Resuscitation Council of Asia (RCA). Since differences in the availability of drugs, equipment, and person- 2000, researchers from the ILCOR member councils have evalu- nel will necessitate local, regional and national adaptation of these ated resuscitation science in 5-yearly cycles. The conclusions and guidelines. Many of the recommendations made in the ERC Guide- recommendations of the 2005 International Consensus Conference lines 2005 remain unchanged in 2010, either because no new on Cardiopulmonary Resuscitation and Emergency Cardiovascular studies have been published or because new evidence since 2005 Care With Treatment Recommendations were published at the end has merely strengthened the evidence that was already avail- of 2005.37,38 The most recent International Consensus Conference able. was held in Dallas in February 2010 and the published conclusions and recommendations from this process form the basis of these 2010 ERC Guidelines.2 Conflict of interest policy for the 2010 ERC Guidelines Each of the six ILCOR task forces [basic life support (BLS); advanced life support (ALS); acute coronary syndromes (ACS); All authors of these 2010 ERC Resuscitation Guidelines have paediatric life support (PLS); neonatal life support (NLS); and edu- signed COI declarations (Appendix B). cation, implementation and teams (EIT)] identified topics requiring evidence evaluation and invited international experts to review them. The literature reviews followed a standardised ‘worksheet’ The Chain of Survival template including a specifically designed grading system to define the level of evidence of each study.39 When possible, two expert The actions linking the victim of sudden cardiac arrest with sur- reviewers were invited to undertake independent evaluations for vival are called the Chain of Survival (Fig. 1.1). The first link of this each topic. The 2010 International Consensus Conference involved chain indicates the importance of recognising those at risk of car- 313 experts from 30 countries. During the 3 years leading up diac arrest and calling for help in the hope that early treatment to this conference, 356 worksheet authors reviewed thousands can prevent arrest. The central links depict the integration of CPR of relevant, peer-reviewed publications to address 277 specific and defibrillation as the fundamental components of early resus- resuscitation questions, each in standard PICO (Population, Inter- citation in an attempt to restore life. Immediate CPR can double or vention, Comparison Outcome) format.2 Each science statement triple survival from VF OHCA.42–45 Performing chest-compression- summarised the experts’ interpretation of all relevant data on a spe- only CPR is better than giving no CPR at all.46,47 Following VF OHCA, cific topic and consensus draft treatment recommendations were cardiopulmonary resuscitation plus defibrillation within 3–5 min added by the relevant ILCOR task force. Final wording of science of collapse can produce survival rates as high as 49–75%.48–55 Each statements and treatment recommendations was completed after minute of delay before defibrillation reduces the probability of sur- further review by ILCOR member organisations and the editorial vival to discharge by 10–12%.42,56 The final link in the Chain of board.2 Survival, effective post-resuscitation care, is targeted at preserving The comprehensive conflict of interest (COI) policy that was function, particularly of the brain and heart. In hospital, the impor- created for the 2005 International Consensus Conference40 was tance of early recognition of the critically ill patient and activation revised for 2010.41 Representatives of manufacturers and industry of a medical emergency or rapid response team, with treatment did not participate in either of the 2005 and the 2010 conferences. aimed at preventing cardiac arrest, is now well accepted.6 Over the last few years, the importance of the post-cardiac arrest phase of From science to guidelines treatment, depicted in the fourth ring of the Chain of Survival, has been increasingly recognised.3 Differences in post-cardiac arrest As in 2005, the resuscitation organisations forming ILCOR will treatment may account for some of the inter-hospital variability in publish individual resuscitation guidelines that are consistent outcome after cardiac arrest.57–63 Fig. 1.1. Chain of Survival.
- 6. 1224 J.P. Nolan et al. / Resuscitation 81 (2010) 1219–1276 4. Keeping the airway open, look, listen and feel for breathing: • look for chest movement; • listen at the victim’s mouth for breath sounds; • feel for air on your cheek; • decide if breathing is normal, not normal or absent. In the first few minutes after cardiac arrest, a victim may be barely breathing, or taking infrequent, slow and noisy gasps. Do not confuse this with normal breathing. Look, listen and feel for no more than 10 s to determine whether the victim is breathing normally. If you have any doubt whether breathing is normal, act as if it is not normal. 5a. If he is breathing normally: • turn him into the recovery position (see below); • send or go for help – call 112 or local emergency number for an ambulance; • continue to assess that breathing remains normal. 5b. If the breathing is not normal or absent: • send someone for help and to find and bring an AED if available; or if you are on your own, use your mobile phone to alert the ambulance service – leave the victim only when there is no other option; • start chest compression as follows: ◦ kneel by the side of the victim; ◦ place the heel of one hand in the centre of the victim’s chest; (which is the lower half of the victim’s breastbone (sternum)); ◦ place the heel of your other hand on top of the first hand; ◦ interlock the fingers of your hands and ensure that pressure is not applied over the victim’s ribs. Keep your arms straight. Do not apply any pressure over the upper abdomen or the bottom end of the sternum. ◦ position yourself vertically above the victim’s chest and press down on the sternum at least 5 cm (but not exceeding 6 cm); ◦ after each compression, release all the pressure on the chest without losing contact between your hands and the ster- num; repeat at a rate of at least 100 min−1 (but not exceeding 120 min−1 ); ◦ compression and release should take equal amounts of time. 6a. Combine chest compression with rescue breaths. • After 30 compressions open the airway again using head tilt and chin lift. Fig. 1.2. Basic life support algorithm. • Pinch the soft part of the nose closed, using the index finger and thumb of your hand on the forehead. Adult basic life support • Allow the mouth to open, but maintain chin lift. • Take a normal breath and place your lips around his mouth, Adult BLS sequence making sure that you have a good seal. • Blow steadily into the mouth while watching for the chest to Throughout this section, the male gender implies both males rise, taking about 1 s as in normal breathing; this is an effective and females. rescue breath. Basic life support comprises the following sequence of actions • Maintaining head tilt and chin lift, take your mouth away from (Fig. 1.2). the victim and watch for the chest to fall as air comes out. • Take another normal breath and blow into the victim’s mouth 1. Make sure you, the victim and any bystanders are safe. once more to achieve a total of two effective rescue breaths. The 2. Check the victim for a response: two breaths should not take more than 5 s in all. Then return • gently shake his shoulders and ask loudly: “Are you all right?“ your hands without delay to the correct position on the sternum 3a. If he responds: and give a further 30 chest compressions. • leave him in the position in which you find him, provided there • Continue with chest compressions and rescue breaths in a ratio is no further danger; of 30:2. • try to find out what is wrong with him and get help if needed; • Stop to recheck the victim only if he starts to wake up: to move, • reassess him regularly. opens eyes and to breathe normally. Otherwise, do not interrupt 3b. If he does not respond: resuscitation. • shout for help If your initial rescue breath does not make the chest rise as in ◦ turn the victim onto his back and then open the airway using normal breathing, then before your next attempt: head; tilt and chin lift; • look into the victim’s mouth and remove any obstruction; ◦ place your hand on his forehead and gently tilt his head back; • recheck that there is adequate head tilt and chin lift; ◦ with your fingertips under the point of the victim’s chin, lift • do not attempt more than two breaths each time before return- the chin to open the airway. ing to chest compressions.
- 7. J.P. Nolan et al. / Resuscitation 81 (2010) 1219–1276 1225 If there is more than one rescuer present, another rescuer should to achieve the recommended compression rate and depth by take over delivering CPR every 2 min to prevent fatigue. Ensure prompt/feedback devices that are either built into the AED or man- that interruption of chest compressions is minimal during the ual defibrillator, or are stand-alone devices. changeover of rescuers. 6b. Chest-compression-only CPR may be used as follows: Compression-only CPR • if you are not trained, or are unwilling to give rescue breaths, give chest compressions only; Some healthcare professionals as well as lay rescuers indicate • if only chest compressions are given, these should be continuous, that they would be reluctant to perform mouth-to-mouth ventila- at a rate of at least 100 min−1 (but not exceeding 120 min−1 ). tion, especially in unknown victims of cardiac arrest.74,75 Animal 7. Do not interrupt resuscitation until: studies have shown that chest-compression-only CPR may be as • professional help arrives and takes over; or effective as combined ventilation and compression in the first • the victim starts to wake up: to move, opens eyes and to breathe few minutes after non-asphyxial arrest.76,77 If the airway is open, normally; or occasional gasps and passive chest recoil may provide some air • you become exhausted. exchange, but this may result in ventilation of the dead space only.69,78–80 Animal and mathematical model studies of chest- Recognition of cardiorespiratory arrest compression-only CPR have shown that arterial oxygen stores deplete in 2–4 min.81,82 In adults, the outcome of chest compres- Checking the carotid pulse (or any other pulse) is an inaccu- sion without ventilation is significantly better than the outcome of rate method of confirming the presence or absence of circulation, giving no CPR at all in non-asphyxial arrest.46,47 Several studies of both for lay rescuers and for professionals.64–66 Healthcare pro- human cardiac arrest suggest equivalence of chest-compression- fessionals, as well as lay rescuers, have difficulty determining the only CPR and chest compressions combined with rescue breaths, presence or absence of adequate or normal breathing in unre- but none of these studies exclude the possibility that chest- sponsive victims.67,68 This may be because the victim is making compression-only is inferior to chest compressions combined with occasional (agonal) gasps, which occur in the first minutes after ventilations.47,83 Chest compression-only may be sufficient only onset in up to 40% of cardiac arrests.69 Laypeople should be taught in the first few minutes after collapse. Chest-compression-only to begin CPR if the victim is unconscious (unresponsive) and not CPR is not as effective as conventional CPR for cardiac arrests of breathing normally. It should be emphasised during training that non-cardiac origin (e.g., drowning or suffocation) in adults and the presence of agonal gasps is an indication for starting CPR imme- children.84,85 Chest compression combined with rescue breaths is, diately. therefore, the method of choice for CPR delivered by both trained lay rescuers and professionals. Laypeople should be encouraged to Initial rescue breaths perform compression-only CPR if they are unable or unwilling to provide rescue breaths, or when instructed during an emergency In adults needing CPR, the cardiac arrest is likely to have a pri- call to an ambulance dispatcher centre. mary cardiac cause – CPR should start with chest compression rather than initial ventilations. Time should not be spent checking Risks to the rescuer the mouth for foreign bodies unless attempted rescue breathing fails to make the chest rise. Physical effects The incidence of adverse effects (muscle strain, back symp- Ventilation toms, shortness of breath, hyperventilation) on the rescuer from CPR training and actual performance is very low.86 Several manikin During CPR, the optimal tidal volume, respiratory rate and studies have found that, as a result of rescuer fatigue, chest com- inspired oxygen concentration to achieve adequate oxygenation pression depth can decrease as little as 2 min after starting chest and CO2 removal is unknown. During CPR, blood flow to the lungs is compressions.87 Rescuers should change about every 2 min to pre- substantially reduced, so an adequate ventilation–perfusion ratio vent a decrease in compression quality due to rescuer fatigue. can be maintained with lower tidal volumes and respiratory rates Changing rescuers should not interrupt chest compressions. than normal.70 Hyperventilation is harmful because it increases intrathoracic pressure, which decreases venous return to the heart Risks during defibrillation and reduces cardiac output. Interruptions in chest compression A large randomised trial of public access defibrillation showed reduce survival.71 that AEDs can be used safely by laypeople and first responders.88 A Rescuers should give each rescue breath over about 1 s, with systematic review identified only eight papers that reported a total enough volume to make the victim’s chest rise, but to avoid rapid of 29 adverse events associated with defibrillation.89 Only one of or forceful breaths. The time taken to give two breaths should not these adverse events was published after 1997.90 exceed 5 s. These recommendations apply to all forms of ventilation during CPR, including mouth-to-mouth and bag-mask ventilation Disease transmission with and without supplementary oxygen. There are only very few cases reported where performing CPR has been linked to disease transmission. Three studies showed that Chest compression barrier devices decreased transmission of bacteria in controlled laboratory settings.91,92 Because the risk of disease transmission Chest compressions generate a small but critical amount of is very low, initiating rescue breathing without a barrier device blood flow to the brain and myocardium and increase the likelihood is reasonable. If the victim is known to have a serious infection that defibrillation will be successful. Optimal chest compression appropriate precautions are recommended. technique comprises: compressing the chest at a rate of at least 100 min−1 and to a depth of at least 5 cm (for an adult), but Recovery position not exceeding 6 cm; allowing the chest to recoil completely after There are several variations of the recovery position, each with each compression72,73 ; taking approximately the same amount its own advantages. No single position is perfect for all victims.93,94 of time for compression as relaxation. Rescuers can be assisted The position should be stable, near to a true lateral position with
- 8. 1226 J.P. Nolan et al. / Resuscitation 81 (2010) 1219–1276 Fig. 1.3. Adult foreign-body airway obstruction (choking) sequence. © 2010 ERC. Table 1.1 • if the victim is unresponsive and not breathing normally, send Differentiation between mild and severe foreign body airway obstruction (FBAO)a someone for help and to find and bring an AED if available; Sign Mild obstruction Severe obstruction • if you are on your own, use your mobile phone to alert the ambu- “Are you choking?” “Yes” Unable to speak, lance service – leave the victim only when there is no other may nod option. Other signs Can speak, cough, breathe Cannot 3. Start CPR according to the adult BLS sequence. If you are on your breathe/wheezy own and the AED is in your immediate vicinity, start with applying breathing/silent the AED. attempts to cough/unconsciousness 4. As soon as the AED arrives: a • switch on the AED and attach the electrode pads on the victim’s General signs of FBAO: attack occurs while eating; victim may clutch his neck. bare chest; • if more than one rescuer is present, CPR should be continued the head dependent, and with no pressure on the chest to impair while electrode pads are being attached to the chest; breathing.95 • follow the spoken/visual directions immediately; • ensure that nobody is touching the victim while the AED is analysing the rhythm. Foreign-body airway obstruction (choking) 5a. If a shock is indicated: • ensure that nobody is touching the victim; Foreign-body airway obstruction (FBAO) is an uncommon • push shock button as directed; but potentially treatable cause of accidental death.96 The signs • immediately restart CPR 30:2; and symptoms enabling differentiation between mild and severe • continue as directed by the voice/visual prompts. airway obstruction are summarised in Table 1.1. The adult foreign- 5b. If no shock is indicated: body airway obstruction (choking) sequence is shown in Fig. 1.3. • immediately resume CPR, using a ratio of 30 compressions to 2 rescue breaths; Electrical therapies: automated external • continue as directed by the voice/visual prompts. defibrillators, defibrillation, cardioversion and 6. Continue to follow the AED prompts until: pacing • professional help arrives and takes over; • the victim starts to wake up: moves, opens eyes and breathes Automated external defibrillators normally; • you become exhausted. Automated external defibrillators (AEDs) are safe and effective when used by either laypeople or healthcare professionals (in- or out-of-hospital). Use of an AED by a layperson makes it possible to Public access defibrillation programmes defibrillate many minutes before professional help arrives. Automated external defibrillator programmes should be actively considered for implementation in public places such as Sequence for use of an AED airports,52 sport facilities, offices, in casinos55 and on aircraft,53 where cardiac arrests are usually witnessed and trained rescuers The ERC AED algorithm is shown in Fig. 1.4. are quickly on scene. Lay rescuer AED programmes with very rapid response times, and uncontrolled studies using police officers as 1. Make sure you, the victim, and any bystanders are safe. first responders,97,98 have achieved reported survival rates as high 2. Follow the Adult BLS sequence: as 49–74%.
- 9. J.P. Nolan et al. / Resuscitation 81 (2010) 1219–1276 1227 Fig. 1.4. AED algorithm. © 2010 ERC. The full potential of AEDs has not yet been achieved, because showed higher survival-to-hospital discharge rates when defibril- they are used mostly in public settings, yet 60–80% of cardiac lation was provided through an AED programme than with manual arrests occur at home. Public access defibrillation (PAD) and first defibrillation alone.102,103 Despite limited evidence, AEDs should responder AED programmes may increase the number of victims be considered for the hospital setting as a way to facilitate early who receive bystander CPR and early defibrillation, thus improving defibrillation (a goal of <3 min from collapse), especially in areas survival from out-of-hospital SCA.99 Recent data from nationwide where healthcare providers have no rhythm recognition skills or studies in Japan and the USA33,100 showed that when an AED was where they use defibrillators infrequently. An effective system for available, victims were defibrillated much sooner and with a better training and retraining should be in place.104 Enough healthcare chance of survival. Programmes that make AEDs publicly available providers should be trained to enable the first shock to be given in residential areas have not yet been evaluated. The acquisition within 3 min of collapse anywhere in the hospital. Hospitals should of an AED for individual use at home, even for those considered at monitor collapse-to-first shock intervals and monitor resuscitation high risk of sudden cardiac arrest, has proved not to be effective.101 outcomes. In-hospital use of AEDs Shock in manual versus semi-automatic mode At the time of the 2010 Consensus on CPR Science Conference, Many AEDs can be operated in both manual and semi-automatic there were no published randomised trials comparing in-hospital mode but few studies have compared these two options. The semi- use of AEDs with manual defibrillators. Two lower-level studies automatic mode has been shown to reduce time to first shock when of adults with in-hospital cardiac arrest from shockable rhythms used both in-hospital105 and pre-hospital106 settings, and results
- 10. 1228 J.P. Nolan et al. / Resuscitation 81 (2010) 1219–1276 in higher VF conversion rates,106 and delivery of fewer inappro- exceeded 4–5 min, a period of 1.5–3 min of CPR before shock deliv- priate shocks.107 Conversely, semi-automatic modes result in less ery improved ROSC, survival to hospital discharge141,142 and 1 year time spent performing chest compressions,107,108 mainly because survival142 for adults with out-of-hospital VF or VT compared with of a longer pre-shock pause associated with automated rhythm immediate defibrillation. analysis. Despite these differences, no overall difference in ROSC, More recently, two randomised controlled trials documented survival, or discharge rate from hospital has been demonstrated in that a period of 1.5–3 min of CPR by EMS personnel before defib- any study.105,106,109 The defibrillation mode that affords the best rillation did not improve ROSC or survival to hospital discharge outcome will depend on the system, skills, training and ECG recog- in patients with out-of-hospital VF or pulseless VT, regardless of nition skills of rescuers. A shorter pre-shock pause and lower total EMS response interval.143,144 Four other studies have also failed hands-off-ratio increases vital organ perfusion and the probabil- to demonstrate significant improvements in overall ROSC or sur- ity of ROSC.71,110,111 With manual defibrillators and some AEDs vival to hospital discharge with an initial period of CPR,141,142,145,146 it is possible to perform chest compressions during charging and although one did show a higher rate of favourable neurological out- thereby reduce the pre-shock pause to less than 5 s. Trained individ- come at 30 days and 1 year after cardiac arrest.145 Performing chest uals may deliver defibrillation in manual mode but frequent team compressions while retrieving and charging a defibrillator has been training and ECG recognition skills are essential. shown to improve the probability of survival.147 In any cardiac arrest they have not witnessed, EMS personnel Strategies before defibrillation should provide good-quality CPR while a defibrillator is retrieved, applied and charged, but routine delivery of a specified period of Minimising the pre-shock pause CPR (e.g., 2 or 3 min) before rhythm analysis and a shock is deliv- ered is not recommended. Some emergency medical services have The delay between stopping chest compressions and delivery of already fully implemented a specified period of chest compres- the shock (the pre-shock pause) must be kept to an absolute mini- sions before defibrillation; given the lack of convincing data either mum; even 5–10 s delay will reduce the chances of the shock being supporting or refuting this strategy, it is reasonable for them to successful.71,110,112 The pre-shock pause can easily be reduced to continue this practice. less than 5 s by continuing compressions during charging of the defibrillator and by having an efficient team coordinated by a leader Delivery of defibrillation who communicates effectively. The safety check to ensure that nobody is in contact with the patient at the moment of defibril- One shock versus three-stacked shock sequence lation should be undertaken rapidly but efficiently. The negligible risk of a rescuer receiving an accidental shock is minimised even Interruptions in external chest compression reduces the chances further if all rescuers wear gloves.113 The post-shock pause is min- of converting VF to another rhythm.71 Studies have shown a sig- imised by resuming chest compressions immediately after shock nificantly lower hands-off-ratio with a one-shock instead of a delivery (see below). The entire process of defibrillation should be three-stacked shock protocol148 and some,149–151 but not all,148,152 achievable with no more than a 5 s interruption to chest compres- have suggested a significant survival benefit from this single-shock sions. strategy. When defibrillation is warranted, give a single shock and resume chest compressions immediately following the shock. Do not delay Pads versus paddles CPR for rhythm analysis or a pulse check immediately after a shock. Continue CPR (30 compressions:2 ventilations) for 2 min Self-adhesive defibrillation pads have practical benefits over until rhythm analysis is undertaken and another shock given (if paddles for routine monitoring and defibrillation.114–118 They are indicated) (see Advanced life support).6 safe and effective and are preferable to standard defibrillation If VF/VT occurs during cardiac catheterisation or in the early paddles.119 post-operative period following cardiac surgery (when chest com- pressions could disrupt vascular sutures), consider delivering up Fibrillation waveform analysis to three-stacked shocks before starting chest compressions (see Special circumstances).10 This three-shock strategy may also be con- It is possible to predict, with varying reliability, the success sidered for an initial, witnessed VF/VT cardiac arrest if the patient of defibrillation from the fibrillation waveform.120–139 If optimal is already connected to a manual defibrillator. Although there are defibrillation waveforms and the optimal timing of shock deliv- no data supporting a three-shock strategy in any of these circum- ery can be determined in prospective studies, it should be possible stances, it is unlikely that chest compressions will improve the to prevent the delivery of unsuccessful high energy shocks and already very high chance of return of spontaneous circulation when minimise myocardial injury. This technology is under active devel- defibrillation occurs early in the electrical phase, immediately after opment and investigation but current sensitivity and specificity is onset of VF. insufficient to enable introduction of VF waveform analysis into clinical practice. Waveforms CPR before defibrillation Monophasic defibrillators are no longer manufactured, and although many will remain in use for several years, biphasic defib- Several studies have examined whether a period of CPR prior rillators have now superseded them. to defibrillation is beneficial, particularly in patients with an unwitnessed arrest or prolonged collapse without resuscitation. Monophasic versus biphasic defibrillation A review of evidence for the 2005 guidelines resulted in the rec- Although biphasic waveforms are more effective at terminating ommendation that it was reasonable for EMS personnel to give ventricular arrhythmias at lower energy levels, have demonstrated a period of about 2 min of CPR before defibrillation in patients greater first shock efficacy than monophasic waveforms, and have with prolonged collapse (>5 min).140 This recommendation was greater first shock efficacy for long duration VF/VT.153–155 No based on clinical studies, which showed that when response times randomised studies have demonstrated superiority in terms of
- 11. J.P. Nolan et al. / Resuscitation 81 (2010) 1219–1276 1229 neurologically intact survival to hospital discharge. Biphasic wave- (see Advanced life support).6 Immediate pacing is indicated espe- forms have been shown to be superior to monophasic waveforms cially when the block is at or below the His-Purkinje level. If for elective cardioversion of atrial fibrillation, with greater overall transthoracic pacing is ineffective, consider transvenous pacing. success rates, using less cumulative energy and reducing the sever- ity of cutaneous burns,156–159 and are the waveform of choice for Implantable cardioverter defibrillators this procedure. Implantable cardioverter defibrillators (ICDs) are implanted Energy levels because a patient is considered to be at risk from, or has had, a life- threatening shockable arrhythmia. On sensing a shockable rhythm, Optimal energy levels for both monophasic and biphasic wave- an ICD will discharge approximately 40 J through an internal pac- forms are unknown. The recommendations for energy levels are ing wire embedded in the right ventricle. On detecting VF/VT, ICD based on a consensus following careful review of the current liter- devices will discharge no more than eight times, but may reset if ature. they detect a new period of VF/VT. Discharge of an ICD may cause pectoral muscle contraction in the patient, and shocks to the res- First shock cuer have been documented.179 In view of the low energy levels There are no new published studies looking at the optimal discharged by ICDs, it is unlikely that any harm will come to the energy levels for monophasic waveforms since publication of the rescuer, but the wearing of gloves and minimising contact with the 2005 guidelines. Relatively few studies on biphasic waveforms have patient while the device is discharging is prudent. been published in the past 5 years on which to refine the 2005 guidelines. There is no evidence that one biphasic waveform or Adult advanced life support device is more effective than another. First shock efficacy of the biphasic truncated exponential (BTE) waveform using 150–200 J Prevention of in-hospital cardiac arrest has been reported as 86–98%.153,154,160–162 First shock efficacy of the rectilinear biphasic (RLB) waveform using 120 J is up to Early recognition of the deteriorating patient and prevention 85% (data not published in the paper but supplied by person- of cardiac arrest is the first link in the Chain of Survival.180 Once nel communication).155 Two studies have suggested equivalence cardiac arrest occurs, fewer than 20% of patients having an in- with lower and higher starting energy biphasic defibrillation.163,164 hospital cardiac arrest will survive to go home.36,181,182 Prevention Although human studies have not shown harm (raised biomarkers, of in-hospital cardiac arrest requires staff education, monitoring of ECG changes, ejection fraction) from any biphasic waveform up to patients, recognition of patient deterioration, a system to call for 360 J,163,165 several animal studies have suggested the potential for help and an effective response.183 harm with higher energy levels.166–169 The initial biphasic shock should be no lower than 120 J for RLB The problem waveforms and 150 J for BTE waveforms. Ideally, the initial biphasic shock energy should be at least 150 J for all waveforms. Cardiac arrest in patients in unmonitored ward areas is not usually a sudden unpredictable event, nor is it usually caused Second and subsequent shocks by primary cardiac disease.184 These patients often have slow The 2005 guidelines recommended either a fixed or escalating and progressive physiological deterioration, involving hypoxaemia energy strategy for defibrillation and there is no evidence to change and hypotension that is unnoticed by staff, or is recognised but this recommendation. treated poorly.185–187 Many of these patients have unmonitored arrests, and the underlying cardiac arrest rhythm is usually non- Cardioversion shockable182,188 ; survival to hospital discharge is poor.36,181,188 If electrical cardioversion is used to convert atrial or ventric- Education in acute care ular tachyarrhythmias, the shock must be synchronised to occur with the R wave of the electrocardiogram rather than with the T Staff education is an essential part of implementing a system to wave: VF can be induced if a shock is delivered during the rela- prevent cardiac arrest.189 In an Australian study, virtually all the tive refractory portion of the cardiac cycle.170 Biphasic waveforms improvement in the hospital cardiac arrest rate occurred during are more effective than monophasic waveforms for cardioversion the educational phase of implementation of a medical emergency of AF.156–159 Commencing at high energy levels does not improve team (MET) system.190,191 cardioversion rates compared with lower energy levels.156,171–176 An initial synchronised shock of 120–150 J, escalating if necessary Monitoring and recognition of the critically ill patient is a reasonable strategy based on current data. Atrial flutter and paroxysmal SVT generally require less energy than atrial fibrillation To assist in the early detection of critical illness, each patient for cardioversion.175 Give an initial shock of 100 J monophasic or should have a documented plan for vital signs monitoring that 70–120 J biphasic. Give subsequent shocks using stepwise increases identifies which variables need to be measured and the frequency in energy.177 The energy required for cardioversion of VT depends of measurement.192 Many hospitals now use early warning scores on the morphological characteristics and rate of the arrhythmia.178 (EWS) or calling criteria to identify the need to escalate monitoring, Use biphasic energy levels of 120–150 J for the initial shock. Con- treatment, or to call for expert help (‘track and trigger’).193–197 sider stepwise increases if the first shock fails to achieve sinus rhythm.178 The response to critical illness Pacing The response to patients who are critically ill or who are at risk of becoming critically ill is usually provided by medical Consider pacing in patients with symptomatic bradycardia emergency teams (MET), rapid response teams (RRT), or critical refractory to anti-cholinergic drugs or other second line therapy care outreach teams (CCOT).198–200 These teams replace or coexist
- 12. 1230 J.P. Nolan et al. / Resuscitation 81 (2010) 1219–1276 with traditional cardiac arrest teams, which typically respond to 9. Identify patients for whom cardiopulmonary arrest is an antic- patients already in cardiac arrest. MET/RRT usually comprise med- ipated terminal event and in whom CPR is inappropriate, and ical and nursing staff from intensive care and general medicine and patients who do not wish to be treated with CPR. Hospitals respond to specific calling criteria. CCOT are based predominantly should have a DNAR policy, based on national guidance, which on individual or teams of nurses.201 A recent meta-analysis showed is understood by all clinical staff. RRT/MET systems were associated with a reduction in rates of car- 10. Ensure accurate audit of cardiac arrest, ‘false arrest’, unex- diopulmonary arrest outside the intensive care unit but are not pected deaths and unanticipated ICU admissions using associated with lower hospital mortality rates.202 Medical emer- common datasets. Audit also the antecedents and clinical gency teams have an important role in improving end-of-life and response to these events. do-not-attempt resuscitation (DNAR) decision-making, which at least partly accounts for the reduction in cardiac arrest rates.203–206 Prevention of sudden cardiac death (SCD) out-of-hospital Coronary artery disease is the commonest cause of SCD. Non- Guidelines for prevention of in-hospital cardiac arrest ischaemic cardiomyopathy and valvular disease account for most other SCD events. A small percentage of SCDs are caused by Hospitals should provide a system of care that includes: (a) staff inherited abnormalities (e.g., Brugada syndrome, hypertrophic car- education about the signs of patient deterioration, and the ratio- diomyopathy) or congenital heart disease. Most SCD victims have nale for rapid response to illness, (b) appropriate and regular vital a history of cardiac disease and warning signs, most commonly signs monitoring of patients, (c) clear guidance (e.g., via calling cri- chest pain, in the hour before cardiac arrest.209 Apparently healthy teria or early warning scores) to assist staff in the early detection of children and young adults who suffer SCD can also have signs and patient deterioration, (d) a clear, uniform system of calling for assis- symptoms (e.g., syncope/pre-syncope, chest pain and palpitations) tance, and (e) an appropriate and timely clinical response to calls that should alert healthcare professionals to seek expert help to for assistance.183 The following strategies may prevent avoidable prevent cardiac arrest.210–218 in-hospital cardiac arrests: Prehospital resuscitation 1. Provide care for patients who are critically ill or at risk of clin- ical deterioration in appropriate areas, with the level of care EMS personnel provided matched to the level of patient sickness. There is considerable variation across Europe in the structure 2. Critically ill patients need regular observations: each patient and process of EMS systems. Some countries have adopted almost should have a documented plan for vital signs monitoring that exclusively paramedic/emergency medical technician (EMT)-based identifies which variables need to be measured and the fre- systems while other incorporate prehospital physicians to a greater quency of measurement according to the severity of illness or or lesser extent. Studies indirectly comparing resuscitation out- the likelihood of clinical deterioration and cardiopulmonary comes between physician-staffed and other systems are difficult arrest. Recent guidance suggests monitoring of simple physi- to interpret because of the extremely high variability between sys- ological variables including pulse, blood pressure, respiratory tems, independent of physician-staffing.23 Given the inconsistent rate, conscious level, temperature and SpO2 .192,207 evidence, the inclusion or exclusion of physicians among prehospi- 3. Use a track and trigger system (either ‘calling criteria’ or early tal personnel responding to cardiac arrests will depend largely on warning system) to identify patients who are critically ill and, existing local policy. or at risk of clinical deterioration and cardiopulmonary arrest. 4. Use a patient charting system that enables the regular mea- Termination of resuscitation rules surement and recording of vital signs and, where used, early warning scores. One high-quality, prospective study has demonstrated that 5. Have a clear and specific policy that requires a clinical response application of a ‘basic life support termination of resuscitation rule’ to abnormal physiology, based on the track and trigger system is predictive of death when applied by defibrillation-only emer- used. This should include advice on the further clinical manage- gency medical technicians.219 The rule recommends termination ment of the patient and the specific responsibilities of medical when there is no ROSC, no shocks are administered, and the arrest is and nursing staff. not witnessed by EMS personnel. Prospectively validated termina- 6. The hospital should have a clearly identified response to crit- tion of resuscitation rules such as the ‘basic life support termination ical illness. This may include a designated outreach service or of resuscitation rule’ can be used to guide termination of pre- resuscitation team (e.g., MET, RRT system) capable of respond- hospital CPR in adults; however, these must be validated in an ing in a timely fashion to acute clinical crises identified by the emergency medical services system similar to the one in which track and trigger system or other indicators. This service must implementation is proposed. Other rules for various provider levels, be available 24 h per day. The team must include staff with the including in-hospital providers, may be helpful to reduce variability appropriate acute or critical care skills. in decision-making; however, rules should be prospectively vali- 7. Train all clinical staff in the recognition, monitoring and man- dated before implementation. agement of the critically ill patient. Include advice on clinical management while awaiting the arrival of more experienced In-hospital resuscitation staff. Ensure that staff know their role(s) in the rapid response system. After in-hospital cardiac arrest, the division between basic life 8. Hospitals must empower staff of all disciplines to call for help support and advanced life support is arbitrary; in practice, the when they identify a patient at risk of deterioration or car- resuscitation process is a continuum and is based on common sense. diac arrest. Staff should be trained in the use of structured The public expect that clinical staff can undertake CPR. For all in- communication tools (e.g., SBAR – Situation-Background- hospital cardiac arrests, ensure that: Assessment-Recommendation)208 to ensure effective han- dover of information between doctors, nurses and other • cardiorespiratory arrest is recognised immediately; healthcare professions. • help is summoned using a standard telephone number;
- 13. J.P. Nolan et al. / Resuscitation 81 (2010) 1219–1276 1231 Fig. 1.5. Algorithm for the initial management of in-hospital cardiac arrest. © 2010 ERC. • CPR is started immediately using airway adjuncts if indicated, • Once the patient’s trachea has been intubated or a SAD has been defibrillation attempted as rapidly as possible and certainly inserted, continue chest compressions uninterrupted (except within 3 min. for defibrillation or pulse checks when indicated), at a rate of at least 100 min−1 , and ventilate the lungs at approximately All clinical areas should have immediate access to resus- 10 breaths min−1 . Avoid hyperventilation (both excessive rate citation equipment and drugs to facilitate rapid resuscitation and tidal volume), which may worsen outcome. of the patient in cardiopulmonary arrest. Ideally, the equip- • If there is no airway and ventilation equipment available, con- ment used for CPR (including defibrillators) and the layout of sider giving mouth-to-mouth ventilation. If there are clinical equipment and drugs should be standardised throughout the reasons to avoid mouth-to-mouth contact, or you are unwilling hospital.220,221 or unable to do this, do chest compressions until help or airway The resuscitation team may take the form of a traditional cardiac equipment arrives. arrest team, which is called only when cardiac arrest is recognised. • When the defibrillator arrives, apply the paddles to the patient Alternatively, hospitals may have strategies to recognise patients at and analyse the rhythm. If self-adhesive defibrillation pads are risk of cardiac arrest and summon a team (e.g., MET or RRT) before available, apply these without interrupting chest compressions. cardiac arrest occurs. The use of adhesive electrode pads or a ‘quick-look’ paddles tech- An algorithm for the initial management of in-hospital cardiac nique will enable rapid assessment of heart rhythm compared arrest is shown in Fig. 1.5. with attaching ECG electrodes.222 Pause briefly to assess the heart rhythm. With a manual defibrillator, if the rhythm is VF/VT • One person starts CPR as others call the resuscitation team and charge the defibrillator while another rescuer continues chest collect the resuscitation equipment and a defibrillator. If only one compressions. Once the defibrillator is charged, pause the chest member of staff is present, this will mean leaving the patient. compressions, ensure that all rescuers are clear of the patient and • Give 30 chest compressions followed by 2 ventilations. then give one shock. If using an AED follow the AED’s audio-visual • Minimise interruptions and ensure high-quality compressions. prompts. • Undertaking good-quality chest compressions for a prolonged • Restart chest compressions immediately after the defibrilla- time is tiring; with minimal interruption, try to change the person tion attempt. Minimise interruptions to chest compressions. doing chest compressions every 2 min. Using a manual defibrillator it is possible to reduce the pause • Maintain the airway and ventilate the lungs with the most appro- between stopping and restarting of chest compressions to less priate equipment immediately to hand. A pocket mask, which than 5 s. may be supplemented with an oral airway, is usually readily avail- • Continue resuscitation until the resuscitation team arrives or the able. Alternatively, use a supraglottic airway device (SAD) and patient shows signs of life. Follow the voice prompts if using an self-inflating bag, or bag-mask, according to local policy. Tracheal AED. If using a manual defibrillator, follow the universal algo- intubation should be attempted only by those who are trained, rithm for advanced life support. competent and experienced in this skill. Waveform capnogra- • Once resuscitation is underway, and if there are sufficient staff phy should be routinely available for confirming tracheal tube present, prepare intravenous cannulae and drugs likely to be used placement (in the presence of a cardiac output) and subsequent by the resuscitation team (e.g., adrenaline). monitoring of an intubated patient. • Identify one person to be responsible for handover to the resus- • Use an inspiratory time of 1 s and give enough volume to produce citation team leader. Use a structured communication tool for a normal chest rise. Add supplemental oxygen as soon as possible. handover (e.g., SBAR, RSVP).208,223 Locate the patient’s records.
- 14. 1232 J.P. Nolan et al. / Resuscitation 81 (2010) 1219–1276 Fig. 1.6. ALS cardiac arrest algorithm. © 2010 ERC. • The quality of chest compressions during in-hospital CPR is ALS treatment algorithm frequently sub-optimal.224,225 The importance of uninterrupted chest compressions cannot be over emphasised. Even short inter- Although the ALS cardiac arrest algorithm (Fig. 1.6) is applicable ruptions to chest compressions are disastrous for outcome and to all cardiac arrests, additional interventions may be indicated for every effort must be made to ensure that continuous, effective cardiac arrest caused by special circumstances (see Section 8).10 chest compression is maintained throughout the resuscitation The interventions that unquestionably contribute to improved attempt. The team leader should monitor the quality of CPR and survival after cardiac arrest are prompt and effective bystander BLS, alternate CPR providers if the quality of CPR is poor. Continu- uninterrupted, high-quality chest compressions and early defibril- ous ETCO2 monitoring can be used to indicate the quality of CPR: lation for VF/VT. The use of adrenaline has been shown to increase although an optimal target for ETCO2 during CPR has not been ROSC, but no resuscitation drugs or advanced airway interventions established, a value of less than 10 mm Hg (1.4 kPa) is associated have been shown to increase survival to hospital discharge after with failure to achieve ROSC and may indicate that the quality of cardiac arrest.226–229 Thus, although drugs and advanced airways chest compressions should be improved. If possible, the person are still included among ALS interventions, they are of secondary providing chest compressions should be changed every 2 min, but importance to early defibrillation and high-quality, uninterrupted without causing long pauses in chest compressions. chest compressions.
- 15. J.P. Nolan et al. / Resuscitation 81 (2010) 1219–1276 1233 As with previous guidelines, the ALS algorithm distinguishes shown that a significant increase in end-tidal CO2 occurs when between shockable and non-shockable rhythms. Each cycle is return of spontaneous circulation occurs.235,236 broadly similar, with a total of 2 min of CPR being given before • After each 2-min cycle of CPR, if the rhythm changes to asystole assessing the rhythm and where indicated, feeling for a pulse. or PEA, see ‘non-shockable rhythms’ below. If a non-shockable Adrenaline 1 mg is given every 3–5 min until ROSC is achieved rhythm is present and the rhythm is organised (complexes appear – the timing of the initial dose of adrenaline is described regular or narrow), try to palpate a pulse. Rhythm checks should below. be brief, and pulse checks should be undertaken only if an organ- ised rhythm is observed. If there is any doubt about the presence of a pulse in the presence of an organised rhythm, resume CPR. If Shockable rhythms (ventricular fibrillation/pulseless ROSC has been achieved, begin post-resuscitation care. ventricular tachycardia) Regardless of the arrest rhythm, give further doses of adrenaline The first monitored rhythm is VF/VT in approximately 25% of 1 mg every 3–5 min until ROSC is achieved; in practice, this cardiac arrests, both in-36 or out-of-hospital.24,25,146 VF/VT will will be once every two cycles of the algorithm. If signs of also occur at some stage during resuscitation in about 25% of life return during CPR (purposeful movement, normal breath- cardiac arrests with an initial documented rhythm of asystole or ing, or coughing), check the monitor; if an organised rhythm PEA.36 Having confirmed cardiac arrest, summon help (includ- is present, check for a pulse. If a pulse is palpable, continue ing the request for a defibrillator) and start CPR, beginning with post-resuscitation care and/or treatment of peri-arrest arrhyth- chest compressions, with a CV ratio of 30:2. When the defibrillator mia. If no pulse is present, continue CPR. Providing CPR with arrives, continue chest compressions while applying the paddles or a CV ratio of 30:2 is tiring; change the individual undertaking self-adhesive pads. Identify the rhythm and treat according to the compressions every 2 min, while minimising the interruption in ALS algorithm. compressions. • If VF/VT is confirmed, charge the defibrillator while another Precordial thump rescuer continues chest compressions. Once the defibrillator is charged, pause the chest compressions, quickly ensure that all A single precordial thump has a very low success rate for car- rescuers are clear of the patient and then give one shock (360-J dioversion of a shockable rhythm237–239 and is likely to succeed monophasic or 150–200 J biphasic). only if given within the first few seconds of the onset of a shock- • Minimise the delay between stopping chest compressions and able rhythm.240 There is more success with pulseless VT than delivery of the shock (the preshock pause); even 5–10 s delay with VF. Delivery of a precordial thump must not delay calling for will reduce the chances of the shock being successful.71,110 help or accessing a defibrillator. It is therefore appropriate therapy • Without reassessing the rhythm or feeling for a pulse, resume CPR only when several clinicians are present at a witnessed, monitored (CV ratio 30:2) immediately after the shock, starting with chest arrest, and when a defibrillator is not immediately to hand.241 In compressions. Even if the defibrillation attempt is successful in practice, this is only likely to be in a critical care environment such restoring a perfusing rhythm, it takes time until the post-shock as the emergency department or ICU.239 circulation is established230 and it is very rare for a pulse to be palpable immediately after defibrillation.231 Furthermore, the Airway and ventilation delay in trying to palpate a pulse will further compromise the myocardium if a perfusing rhythm has not been restored.232 During the treatment of persistent VF, ensure good-quality chest • Continue CPR for 2 min, then pause briefly to assess the rhythm; if compressions between defibrillation attempts. Consider reversible still VF/VT, give a second shock (360-J monophasic or 150–360-J causes (4 Hs and 4 Ts) and, if identified, correct them. Check the biphasic). Without reassessing the rhythm or feeling for a pulse, electrode/defibrillating paddle positions and contacts, and the ade- resume CPR (CV ratio 30:2) immediately after the shock, starting quacy of the coupling medium, e.g., gel pads. Tracheal intubation with chest compressions. provides the most reliable airway, but should be attempted only if • Continue CPR for 2 min, then pause briefly to assess the rhythm; the healthcare provider is properly trained and has regular, ongo- if still VF/VT, give a third shock (360-J monophasic or 150–360-J ing experience with the technique. Personnel skilled in advanced biphasic). Without reassessing the rhythm or feeling for a pulse, airway management should attempt laryngoscopy and intubation resume CPR (CV ratio 30:2) immediately after the shock, starting without stopping chest compressions; a brief pause in chest com- with chest compressions. If IV/IO access has been obtained, give pressions may be required as the tube is passed through the vocal adrenaline 1 mg and amiodarone 300 mg once compressions have cords, but this pause should not exceed 10 s. Alternatively, to avoid resumed. If ROSC has not been achieved with this 3rd shock the any interruptions in chest compressions, the intubation attempt adrenaline will improve myocardial blood flow and may increase may be deferred until return of spontaneous circulation. No studies the chance of successful defibrillation with the next shock. In have shown that tracheal intubation increases survival after cardiac animal studies, peak plasma concentrations of adrenaline occur arrest. After intubation, confirm correct tube position and secure it at about 90 s after a peripheral injection.233 If ROSC has been adequately. Ventilate the lungs at 10 breaths min−1 ; do not hyper- achieved after the 3rd shock it is possible that the bolus dose of ventilate the patient. Once the patient’s trachea has been intubated, adrenaline will cause tachycardia and hypertension and precip- continue chest compressions, at a rate of 100 min−1 without paus- itate recurrence of VF. However, naturally occurring adrenaline ing during ventilation. plasma concentrations are high immediately after ROSC,234 and In the absence of personnel skilled in tracheal intubation, a any additional harm caused by exogenous adrenaline has not supraglottic airway device (e.g., laryngeal mask airway) is an been studied. Interrupting chest compressions to check for a per- acceptable alternative (Section 4e). Once a supraglottic airway fusing rhythm midway in the cycle of compressions is also likely device has been inserted, attempt to deliver continuous chest to be harmful. The use of waveform capnography may enable compressions, uninterrupted during ventilation. If excessive gas ROSC to be detected without pausing chest compressions and leakage causes inadequate ventilation of the patient’s lungs, chest may be a way of avoiding a bolus injection of adrenaline after compressions will have to be interrupted to enable ventilation ROSC has been achieved. Two prospective human studies have (using a CV ratio of 30:2).
- 16. 1234 J.P. Nolan et al. / Resuscitation 81 (2010) 1219–1276 Intravascular access and can be treated if those conditions are identified and corrected. Establish intravenous access if this has not already been Survival following cardiac arrest with asystole or PEA is unlikely achieved. Peripheral venous cannulation is quicker, easier to per- unless a reversible cause can be found and treated effectively. form and safer than central venous cannulation. Drugs injected If the initial monitored rhythm is PEA or asystole, start CPR 30:2 peripherally must be followed by a flush of at least 20 ml of fluid. If and give adrenaline 1 mg as soon as venous access is achieved. If intravenous access is difficult or impossible, consider the IO route. asystole is displayed, check without stopping CPR, that the leads are Intraosseous injection of drugs achieves adequate plasma concen- attached correctly. Once an advanced airway has been sited, con- trations in a time comparable with injection through a central tinue chest compressions without pausing during ventilation. After venous catheter.242 The recent availability of mechanical IO devices 2 min of CPR, recheck the rhythm. If asystole is present, resume CPR has increased the ease of performing this technique.243 immediately. If an organised rhythm is present, attempt to palpate Unpredictable plasma concentrations are achieved when drugs a pulse. If no pulse is present (or if there is any doubt about the pres- are given via a tracheal tube, and the optimal tracheal dose of most ence of a pulse), continue CPR. Give adrenaline 1 mg (IV/IO) every drugs is unknown, thus, the tracheal route for drug delivery is no alternate CPR cycle (i.e., about every 3–5 min) once vascular access longer recommended. is obtained. If a pulse is present, begin post-resuscitation care. If signs of life return during CPR, check the rhythm and attempt to Drugs palpate a pulse. During the treatment of asystole or PEA, following a 2-min cycle Adrenaline. Despite the widespread use of adrenaline during of CPR, if the rhythm has changed to VF, follow the algorithm for resuscitation, and several studies involving vasopressin, there is no shockable rhythms. Otherwise, continue CPR and give adrenaline placebo-controlled study that shows that the routine use of any every 3–5 min following the failure to detect a palpable pulse with vasopressor at any stage during human cardiac arrest increases the pulse check. If VF is identified on the monitor midway through a neurologically intact survival to hospital discharge. Despite the 2-min cycle of CPR, complete the cycle of CPR before formal rhythm lack of human data, the use of adrenaline is still recommended, and shock delivery if appropriate – this strategy will minimise based largely on animal data and increased short-term survival in interruptions in chest compressions. humans.227,228 The optimal dose of adrenaline is not known, and there are no data supporting the use of repeated doses. There are Atropine few data on the pharmacokinetics of adrenaline during CPR. The Asystole during cardiac arrest is usually caused by primary optimal duration of CPR and number of shocks that should be given myocardial pathology rather than excessive vagal tone and there before giving drugs is unknown. There is currently insufficient evi- is no evidence that routine use of atropine is beneficial in the dence to support or refute the use of any other vasopressor as treatment of asystole or PEA. Several recent studies have failed an alternative to, or in combination with, adrenaline in any car- to demonstrate any benefit from atropine in out-of-hospital or in- diac arrest rhythm to improve survival or neurological outcome. hospital cardiac arrests226,251–256 ; and its routine use for asystole On the basis of expert consensus, for VF/VT give adrenaline after or PEA is no longer recommended. the third shock once chest compressions have resumed, and then repeat every 3–5 min during cardiac arrest (alternate cycles). Do Potentially reversible causes not interrupt CPR to give drugs. Potential causes or aggravating factors for which specific treat- Anti-arrhythmic drugs. There is no evidence that giving any ment exists must be considered during any cardiac arrest. For ease anti-arrhythmic drug routinely during human cardiac arrest of memory, these are divided into two groups of four based upon increases survival to hospital discharge. In comparison with their initial letter: either H or T. More details on many of these placebo244 and lidocaine,245 the use of amiodarone in shock- conditions are covered in Section 8.10 refractory VF improves the short-term outcome of survival to hospital admission. On the basis of expert consensus, if VF/VT per- Fibrinolysis during CPR sists after three shocks, give 300 mg amiodarone by bolus injection. Fibrinolytic therapy should not be used routinely in cardiac A further dose of 150 mg may be given for recurrent or refrac- arrest.257 Consider fibrinolytic therapy when cardiac arrest is tory VF/VT, followed by an infusion of 900 mg over 24 h. Lidocaine, caused by proven or suspected acute pulmonary embolus. Follow- 1 mg kg−1 , may be used as an alternative if amiodarone is not avail- ing fibrinolysis during CPR for acute pulmonary embolism, survival able, but do not give lidocaine if amiodarone has been given already. and good neurological outcome have been reported in cases requir- ing in excess of 60 min of CPR. If a fibrinolytic drug is given in these Magnesium. The routine use of magnesium in cardiac arrest circumstances, consider performing CPR for at least 60–90 min does not increase survival.246–250 and is not recommended in car- before termination of resuscitation attempts.258,259 Ongoing CPR diac arrest unless torsades de pointes is suspected (see peri-arrest is not a contraindication to fibrinolysis. arrhythmias). Intravenous fluids Bicarbonate. Routine administration of sodium bicarbonate Hypovolaemia is a potentially reversible cause of cardiac arrest. during cardiac arrest and CPR or after ROSC is not recommended. Infuse fluids rapidly if hypovolaemia is suspected. In the initial Give sodium bicarbonate (50 mmol) if cardiac arrest is associated stages of resuscitation there are no clear advantages to using col- with hyperkalaemia or tricyclic antidepressant overdose; repeat loid, so use 0.9% sodium chloride or Hartmann’s solution. Whether the dose according to the clinical condition and the result of serial fluids should be infused routinely during primary cardiac arrest is blood gas analysis. controversial. Ensure normovolaemia, but in the absence of hypo- volaemia, infusion of an excessive volume of fluid is likely to be Non-shockable rhythms (PEA and asystole) harmful.260 Pulseless electrical activity (PEA) is defined as cardiac arrest in Use of ultrasound imaging during advanced life support the presence of electrical activity that would normally be associated Several studies have examined the use of ultrasound during with a palpable pulse. PEA is often caused by reversible conditions, cardiac arrest to detect potentially reversible causes. Although no
- 17. J.P. Nolan et al. / Resuscitation 81 (2010) 1219–1276 1235 studies have shown that use of this imaging modality improves out- management should be able to undertake laryngoscopy without come, there is no doubt that echocardiography has the potential stopping chest compressions; a brief pause in chest compressions to detect reversible causes of cardiac arrest (e.g., cardiac tam- will be required only as the tube is passed through the vocal cords. ponade, pulmonary embolism, aortic dissection, hypovolaemia, No intubation attempt should interrupt chest compressions for pneumothorax).261–268 When available for use by trained clini- more than 10 s. After intubation, tube placement must be confirmed cians, ultrasound may be of use in assisting with diagnosis and and the tube secured adequately. treatment of potentially reversible causes of cardiac arrest. The Several alternative airway devices have been considered for air- integration of ultrasound into advanced life support requires way management during CPR. There are published studies on the considerable training if interruptions to chest compressions use during CPR of the Combitube, the classic laryngeal mask airway are to be minimised. A sub-xiphoid probe position has been (cLMA), the Laryngeal Tube (LT) and the I-gel, but none of these recommended.261,267,269 Placement of the probe just before chest studies have been powered adequately to enable survival to be compressions are paused for a planned rhythm assessment enables studied as a primary endpoint; instead, most researchers have stud- a well-trained operator to obtain views within 10 s. Absence of ied insertion and ventilation success rates. The supraglottic airway cardiac motion on sonography during resuscitation of patients in devices (SADs) are easier to insert than a tracheal tube and, unlike cardiac arrest is highly predictive of death270–272 although sensi- tracheal intubation, can generally be inserted without interrupting tivity and specificity has not been reported. chest compressions.283 Airway management and ventilation Confirmation of correct placement of the tracheal tube Unrecognised oesophageal intubation is the most serious com- Patients requiring resuscitation often have an obstructed air- plication of attempted tracheal intubation. Routine use of primary way, usually secondary to loss of consciousness, but occasionally and secondary techniques to confirm correct placement of the tra- it may be the primary cause of cardiorespiratory arrest. Prompt cheal tube should reduce this risk. Primary assessment includes assessment, with control of the airway and ventilation of the lungs, observation of chest expansion bilaterally, auscultation over the is essential. There are three manoeuvres that may improve the lung fields bilaterally in the axillae (breath sounds should be equal patency of an airway obstructed by the tongue or other upper air- and adequate) and over the epigastrium (breath sounds should way structures: head tilt, chin lift, and jaw thrust. not be heard). Clinical signs of correct tube placement are not Despite a total lack of published data on the use of nasopharyn- completely reliable. Secondary confirmation of tracheal tube place- geal and oropharyngeal airways during CPR, they are often helpful, ment by an exhaled carbon dioxide or oesophageal detection device and sometimes essential, to maintain an open airway, particularly should reduce the risk of unrecognised oesophageal intubation but when resuscitation is prolonged. the performance of the available devices varies considerably and During CPR, give oxygen whenever it is available. There are no all of them should be considered as adjuncts to other confirmatory data to indicate the optimal arterial blood oxygen saturation (SaO2 ) techniques.284 None of the secondary confirmation techniques will during CPR. There are animal data273 and some observational clin- differentiate between a tube placed in a main bronchus and one ical data indicating an association between high SaO2 after ROSC placed correctly in the trachea. and worse outcome.274 Initially, give the highest possible oxygen The accuracy of colorimetric CO2 detectors, oesophageal detec- concentration. As soon as the arterial blood oxygen saturation can tor devices and non-waveform capnometers does not exceed the be measured reliably, by pulse oximeter (SpO2 ) or arterial blood accuracy of auscultation and direct visualization for confirm- gas analysis, titrate the inspired oxygen concentration to achieve ing the tracheal position of a tube in victims of cardiac arrest. an arterial blood oxygen saturation in the range of 94–98%. Waveform capnography is the most sensitive and specific way to confirm and continuously monitor the position of a tracheal Alternative airway devices versus tracheal intubation tube in victims of cardiac arrest and should supplement clinical assessment (auscultation and visualization of tube through cords). There is insufficient evidence to support or refute the use of Existing portable monitors make capnographic initial confirmation any specific technique to maintain an airway and provide ventila- and continuous monitoring of tracheal tube position feasible in tion in adults with cardiopulmonary arrest. Despite this, tracheal almost all settings, including out-of-hospital, emergency depart- intubation is perceived as the optimal method of providing and ment, and in-hospital locations where intubation is performed. In maintaining a clear and secure airway. It should be used only the absence of a waveform capnograph it may be preferable to use when trained personnel are available to carry out the procedure a supraglottic airway device when advanced airway management with a high level of skill and confidence. There is evidence that, is indicated. without adequate training and experience, the incidence of com- plications, is unacceptably high.275 In patients with out-of-hospital CPR techniques and devices cardiac arrest the reliably documented incidence of unrecognised oesophageal intubation ranges from 0.5% to 17%: emergency physi- At best, standard manual CPR produces coronary and cerebral cians – 0.5%276 ; paramedics – 2.4%,277 6%,278,279 9%,280 17%.281 perfusion that is just 30% of normal.285 Several CPR techniques Prolonged attempts at tracheal intubation are harmful; stopping and devices may improve haemodynamics or short-term survival chest compressions during this time will compromise coronary when used by well-trained providers in selected cases. However, and cerebral perfusion. In a study of prehospital intubation by the success of any technique or device depends on the education paramedics during 100 cardiac arrests, the total duration of the and training of the rescuers and on resources (including personnel). interruptions in CPR associated with tracheal intubation attempts In the hands of some groups, novel techniques and adjuncts may was 110 s (IQR 54–198 s; range 13–446 s) and in 25% the inter- be better than standard CPR. However, a device or technique which ruptions were more than 3 min.282 Tracheal intubation attempts provides good quality CPR when used by a highly trained team or accounted for almost 25% of all CPR interruptions. Healthcare per- in a test setting may show poor quality and frequent interruptions sonnel who undertake prehospital intubation should do so only when used in an uncontrolled clinical setting.286 While no circula- within a structured, monitored programme, which should include tory adjunct is currently recommended for routine use instead of comprehensive competency-based training and regular oppor- manual CPR, some circulatory adjuncts are being routinely used in tunities to refresh skills. Personnel skilled in advanced airway both out-of-hospital and in-hospital resuscitation. It is prudent that
- 18. 1236 J.P. Nolan et al. / Resuscitation 81 (2010) 1219–1276 rescuers are well-trained and that if a circulatory adjunct is used, a Peri-arrest arrhythmias program of continuous surveillance be in place to ensure that use of the adjunct does not adversely affect survival. Although man- The correct identification and treatment of arrhythmias in the ual chest compressions are often performed very poorly,287–289 no critically ill patient may prevent cardiac arrest from occurring or adjunct has consistently been shown to be superior to conventional from reoccurring after successful initial resuscitation. These treat- manual CPR. ment algorithms should enable the non-specialist ALS provider to treat the patient effectively and safely in an emergency. If patients are not acutely ill there may be several other treatment options, Impedance threshold device (ITD) including the use of drugs (oral or parenteral) that will be less familiar to the non-expert. In this situation there will be time to The impedance threshold device (ITD) is a valve that limits air seek advice from cardiologists or other senior doctors with the entry into the lungs during chest recoil between chest compres- appropriate expertise. sions; this decreases intrathoracic pressure and increases venous The initial assessment and treatment of a patient with an return to the heart. A recent meta-analysis demonstrated improved arrhythmia should follow the ABCDE approach. Key elements in ROSC and short-term survival but no significant improvement in this process include assessing for adverse signs; administration of either survival to discharge or neurologically intact survival to dis- high flow oxygen; obtaining intravenous access, and establishing charge associated with the use of an ITD in the management of monitoring (ECG, blood pressure, SpO2 ). Whenever possible, record adult OHCA patients.290 In the absence of data showing that the ITD a 12-lead ECG; this will help determine the precise rhythm, either increases survival to hospital discharge, its routine use in cardiac before treatment or retrospectively. Correct any electrolyte abnor- arrest is not recommended. malities (e.g., K+ , Mg2+ , Ca2+ ). Consider the cause and context of arrhythmias when planning treatment. The assessment and treatment of all arrhythmias addresses two Lund University cardiac arrest system (LUCAS) CPR factors: the condition of the patient (stable versus unstable), and the nature of the arrhythmia. Anti-arrhythmic drugs are slower in The Lund University cardiac arrest system (LUCAS) is a gas- onset and less reliable than electrical cardioversion in converting a driven sternal compression device that incorporates a suction cup tachycardia to sinus rhythm; thus, drugs tend to be reserved for sta- for active decompression. Although animal studies showed that ble patients without adverse signs, and electrical cardioversion is LUCAS-CPR improves haemodynamic and short-term survival com- usually the preferred treatment for the unstable patient displaying pared with standard CPR.291,292 there are no published randomised adverse signs. human studies comparing LUCAS-CPR with standard CPR. Adverse signs Load-distributing band CPR (AutoPulse) The presence or absence of adverse signs or symptoms will dic- The load-distributing band (LDB) is a circumferential chest com- tate the appropriate treatment for most arrhythmias. The following pression device comprising a pneumatically actuated constricting adverse factors indicate a patient who is unstable because of the band and backboard. Although the use of LDB-CPR improves arrhythmia. haemodynamics,293–295 results of clinical trials have been con- flicting. Evidence from one multicentre randomised control trial 1. Shock – this is seen as pallor, sweating, cold and clammy extrem- in over 1000 adults documented no improvement in 4-h sur- ities (increased sympathetic activity), impaired consciousness vival and worse neurological outcome when LDB-CPR was used (reduced cerebral blood flow), and hypotension (e.g., systolic by EMS providers for patients with primary out-of-hospital car- blood pressure <90 mm Hg). diac arrest.296 A non-randomised human study reported increased 2. Syncope – loss of consciousness, which occurs as a consequence survival to discharge following OHCA.297 of reduced cerebral blood flow. 3. Heart failure – arrhythmias compromise myocardial perfor- mance by reducing coronary artery blood flow. In acute The current status of LUCAS and AutoPulse situations this is manifested by pulmonary oedema (failure of the left ventricle) and/or raised jugular venous pressure, and hepatic Two large prospective randomised multicentre studies are cur- engorgement (failure of the right ventricle). rently underway to evaluate the LDB (AutoPulse) and the Lund 4. Myocardial ischaemia – this occurs when myocardial oxy- University Cardiac Arrest System (LUCAS). The results of these gen consumption exceeds delivery. Myocardial ischaemia may studies are awaited with interest. In hospital, mechanical devices present with chest pain (angina) or may occur without pain as have been used effectively to support patients undergoing pri- an isolated finding on the 12 lead ECG (silent ischaemia). The mary coronary intervention (PCI)298,299 and CT scans300 and also for presence of myocardial ischaemia is especially important if there prolonged resuscitation attempts (e.g., hypothermia,301,302 poison- is underlying coronary artery disease or structural heart dis- ing, thrombolysis for pulmonary embolism, prolonged transport ease because it may cause further life-threatening complications etc) where rescuer fatigue may impair the effectiveness of manual including cardiac arrest. chest compression. In the prehospital environment where extrica- tion of patients, resuscitation in confined spaces and movement of patients on a trolley often preclude effective manual chest com- Treatment options pressions, mechanical devices may also have an important role. During transport to hospital, manual CPR is often performed poorly; Having determined the rhythm and the presence or absence of mechanical CPR can maintain good quality CPR during an ambu- adverse signs, the options for immediate treatment are categorised lance transfer.303,304 Mechanical devices also have the advantage of as: allowing defibrillation without interruption in external chest com- pression. The role of mechanical devices in all situations requires 1. Electrical (cardioversion, pacing). further evaluation. 2. Pharmacological (anti-arrhythmic (and other) drugs).
- 19. J.P. Nolan et al. / Resuscitation 81 (2010) 1219–1276 1237 Fig. 1.7. Tachycardia algorithm. © 2010 ERC.
- 20. 1238 J.P. Nolan et al. / Resuscitation 81 (2010) 1219–1276 Tachycardias If the patient is stable If the patient with tachycardia is stable (no adverse signs or If the patient is unstable symptoms) and is not deteriorating, drug treatment is likely to be If the patient is unstable and deteriorating, with any of the appropriate (Fig. 1.7). Vagal manoeuvres may be appropriate initial adverse signs and symptoms described above being caused by treatment for a supraventricular tachycardia. the tachycardia, attempt synchronised cardioversion immedi- ately (Fig. 1.7). In patients with otherwise normal hearts, serious Bradycardia signs and symptoms are uncommon if the ventricular rate is <150 beats min−1 . Patients with impaired cardiac function or sig- A bradycardia is defined as a heart rate of <60 beats min−1 . nificant comorbidity may be symptomatic and unstable at lower Assess the patient with bradycardia using the ABCDE approach. heart rates. If cardioversion fails to restore sinus rhythm and the Consider the potential cause of the bradycardia and look for patient remains unstable, give amiodarone 300 mg intravenously the adverse signs. Treat any reversible causes of bradycardia over 10–20 min and re-attempt electrical cardioversion. The load- identified in the initial assessment. If adverse signs are present ing dose of amiodarone can be followed by an infusion of 900 mg start to treat the bradycardia. Initial treatments are pharma- over 24 h. cological, with pacing being reserved for patients unresponsive Fig. 1.8. Bradycardia algorithm. © 2010 ERC.
- 21. J.P. Nolan et al. / Resuscitation 81 (2010) 1219–1276 1239 to pharmacological treatments or with risks factors for asystole definitive data, target the mean arterial blood pressure to achieve (Fig. 1.8). an adequate urine output (1 ml kg−1 h−1 ) and normal or decreasing plasma lactate values, taking into consideration the patient’s nor- Post-resuscitation care mal blood pressure, the cause of the arrest and the severity of any myocardial dysfunction.3 Successful ROSC is the just the first step toward the goal of complete recovery from cardiac arrest. The post-cardiac Disability (optimizing neurological recovery) arrest syndrome, which comprises post-cardiac arrest brain injury, post-cardiac arrest myocardial dysfunction, the systemic Control of seizures ischaemia/reperfusion response, and the persistent precipitat- Seizures or myoclonus or both occur in 5–15% of adult ing pathology, often complicates the post-resuscitation phase.3 patients who achieve ROSC and 10–40% of those who remain The severity of this syndrome will vary with the duration and comatose.58,327–330 Seizures increase cerebral metabolism by up cause of cardiac arrest. It may not occur at all if the car- to 3-fold331 and may cause cerebral injury: treat promptly and diac arrest is brief. Post-cardiac arrest brain injury manifests effectively with benzodiazepines, phenytoin, sodium valproate, as coma, seizures, myoclonus, varying degrees of neurocogni- propofol, or a barbiturate. No studies directly address the use of tive dysfunction and brain death. Among patients surviving to prophylactic anticonvulsant drugs after cardiac arrest in adults. ICU admission but subsequently dying in-hospital, brain injury is the cause of death in 68% after out-of-hospital cardiac arrest Glucose control and in 23% after in-hospital cardiac arrest.227,305 Post-cardiac There is a strong association between high blood glucose arrest brain injury may be exacerbated by microcirculatory fail- after resuscitation from cardiac arrest and poor neurological ure, impaired autoregulation, hypercarbia, hyperoxia, pyrexia, outcome.58,332–338 A large randomised trial of intensive glucose hyperglycaemia and seizures. Significant myocardial dysfunction control (4.5–6.0 mmol l−1 ) versus conventional glucose control is common after cardiac arrest but typically recovers by 2–3 (10 mmol l−1 or less) in general ICU patients reported increased 90- days.306,307 The whole body ischaemia/reperfusion of cardiac arrest day mortality in patients treated with intensive glucose control.339 activates immunological and coagulation pathways contributing to Another recent study and two meta-analyses of studies of tight multiple organ failure and increasing the risk of infection.308,309 glucose control versus conventional glucose control in critically ill Thus, the post-cardiac arrest syndrome has many features in com- patients showed no significant difference in mortality but found mon with sepsis, including intravascular volume depletion and tight glucose control was associated with a significantly increased vasodilation.310,311 risk of hypoglycaemia.340–342 Severe hypoglycaemia is associated with increased mortality in critically ill patients,343 and comatose Airway and breathing patients are at particular risk from unrecognised hypoglycaemia. There is some evidence that, irrespective of the target range, vari- Hypoxaemia and hypercarbia both increase the likelihood of a ability in glucose values is associated with mortality.344 Based on further cardiac arrest and may contribute to secondary brain injury. the available data, following ROSC blood glucose should be main- Several animal studies indicate that hyperoxaemia causes oxida- tained at ≤10 mmol l−1 (180 mg dl−1 ).345 Hypoglycaemia should be tive stress and harms post-ischaemic neurones.273,312–315 A clinical avoided. Strict glucose control should not be implemented in adult registry study documented that post-resuscitation hyperoxaemia patients with ROSC after cardiac arrest because of the increased risk was associated with worse outcome, compared with both normox- of hypoglycaemia. aemia and hypoxaemia.274 In clinical practice, as soon as arterial blood oxygen saturation can be monitored reliably (by blood gas Temperature control analysis and/or pulse oximetry), it may be more practicable to titrate the inspired oxygen concentration to maintain the arterial Treatment of hyperpyrexia. A period of hyperthermia (hyper- blood oxygen saturation in the range of 94–98%. Consider tracheal pyrexia) is common in the first 48 h after cardiac arrest.346–348 intubation, sedation and controlled ventilation in any patient with Several studies document an association between post-cardiac obtunded cerebral function. There are no data to support the target- arrest pyrexia and poor outcomes.58,346,348–351 There are no ran- ing of a specific arterial PCO2 after resuscitation from cardiac arrest, domised controlled trials evaluating the effect of treatment of but it is reasonable to adjust ventilation to achieve normocarbia pyrexia (defined as ≥37.6 ◦ C) compared to no temperature con- and to monitor this using the end-tidal PCO2 and arterial blood gas trol in patients after cardiac arrest. Although the effect of elevated values. temperature on outcome is not proved, it seems prudent to treat any hyperthermia occurring after cardiac arrest with antipyretics Circulation or active cooling. It is well recognised that post-cardiac arrest patients with Therapeutic hypothermia. Animal and human data indicate STEMI should undergo early coronary angiography and percuta- that mild hypothermia is neuroprotective and improves outcome neous coronary intervention (PCI) but, because chest pain and/or after a period of global cerebral hypoxia-ischaemia.352,353 Cool- ST elevation are poor predictors of acute coronary occlusion in ing suppresses many of the pathways leading to delayed cell these patients,316 this intervention should be considered in all death, including apoptosis (programmed cell death). Hypother- post-cardiac arrest patients who are suspected of having coronary mia decreases the cerebral metabolic rate for oxygen (CMRO2 ) by artery disease.316–324 Several studies indicate that the combination about 6% for each 1 ◦ C reduction in temperature354 and this may of therapeutic hypothermia and PCI is feasible and safe after cardiac reduce the release of excitatory amino acids and free radicals.352 arrest caused by acute myocardial infarction.317,323–326 Hypothermia blocks the intracellular consequences of excitotoxin Post-cardiac arrest myocardial dysfunction causes haemody- exposure (high calcium and glutamate concentrations) and reduces namic instability, which manifests as hypotension, low cardiac the inflammatory response associated with the post-cardiac arrest index and arrhythmias.306 If treatment with fluid resuscitation and syndrome. vasoactive drugs is insufficient to support the circulation, consider All studies of post-cardiac arrest therapeutic hypothermia have insertion of an intra-aortic balloon pump.317,325 In the absence of included only patients in coma. There is good evidence supporting
- 22. 1240 J.P. Nolan et al. / Resuscitation 81 (2010) 1219–1276 the use of induced hypothermia in comatose survivors of out-of- Biochemical markers hospital cardiac arrest caused by VF. One randomised trial355 and a Evidence does not support the use of serum (e.g., neuronal spe- pseudo-randomised trial356 demonstrated improved neurological cific enolase, S100 protein) or CSF biomarkers alone as predictors outcome at hospital discharge or at 6 months in comatose patients of poor outcomes in comatose patients after cardiac arrest with or after out-of-hospital VF cardiac arrest. Cooling was initiated within without treatment with therapeutic hypothermia (TH). Limitations minutes to hours after ROSC and a temperature range of 32–34 ◦ C included small numbers of patients studied and/or inconsistency in was maintained for 12–24 h. Extrapolation of these data to other cut-off values for predicting poor outcome. cardiac arrests (e.g., other initial rhythms, in-hospital arrests, pae- diatric patients) seems reasonable but is supported by only lower Electrophysiological studies level data.317,357–363 No electrophysiological study reliably predicts outcome of a The practical application of therapeutic hypothermia is divided comatose patient within the first 24 h after cardiac arrest. If into three phases: induction, maintenance, and rewarming.364 Ani- somatosensory evoked potentials (SSEP) are measured after 24 h mal data indicate that earlier cooling after ROSC produces better in comatose cardiac arrest survivors not treated with therapeu- outcomes.365 External and/or internal cooling techniques can be tic hypothermia, bilateral absence of the N20 cortical response to used to initiate cooling. An infusion of 30 ml kg−1 of 4 ◦ C saline or median nerve stimulation predicts poor outcome (death or CPC 3 Hartmann’s solution decreases core temperature by approximately or 4) with a FPR of 0.7% (95% CI: 0.1–3.7%).376 1.5 ◦ C. Other methods of inducing and/or maintaining hypothermia include: simple ice packs and/or wet towels; cooling blankets or Imaging studies pads; water or air circulating blankets; water circulating gel-coated Many imaging modalities (magnetic resonance imaging [MRI], pads; intravascular heat exchanger; and cardiopulmonary bypass. computed tomography [CT], single photon emission com- In the maintenance phase, a cooling method with effective puted tomography [SPECT], cerebral angiography, transcranial temperature monitoring that avoids temperature fluctuations is Doppler, nuclear medicine, near infra-red spectroscopy [NIRS]) preferred. This is best achieved with external or internal cooling have been studied to determine their utility for prediction devices that include continuous temperature feedback to achieve a of outcome in adult cardiac arrest survivors.15 There are set target temperature. Plasma electrolyte concentrations, effective no high-level studies that support the use of any imaging intravascular volume and metabolic rate can change rapidly dur- modality to predict outcome of comatose cardiac arrest sur- ing rewarming, as they do during cooling. Thus, rewarming must be vivors. achieved slowly: the optimal rate is not known, but the consensus is currently about 0.25–0.5 ◦ C of warming per hour.362 Impact of therapeutic hypothermia on prognostication The well-recognised physiological effects of hypothermia need There is inadequate evidence to recommend a specific approach to be managed carefully.364 to prognosticating poor outcome in post-cardiac arrest patients treated with therapeutic hypothermia. There are no clinical neuro- logical signs, electrophysiological studies, biomarkers, or imaging Prognostication modalities that can reliably predict neurological outcome in the first 24 h after cardiac arrest. Based on limited available evidence, Two-thirds of those dying after admission to ICU following out- potentially reliable prognosticators of poor outcome in patients of-hospital cardiac arrest die from neurological injury; this has been treated with therapeutic hypothermia after cardiac arrest include shown both with227 and without305 therapeutic hypothermia. A bilateral absence of N20 peak on SSEP ≥24 h after cardiac arrest quarter of those dying after admission to ICU following in-hospital (FPR 0%, 95% CI 0–69%) and the absence of both corneal and pupil- cardiac arrest die from neurological injury. A means of predicting lary reflexes 3 or more days after cardiac arrest (FPR 0%, 95% CI neurological outcome that can be applied to individual patients 0–48%).368,377 Limited available evidence also suggests that a Glas- immediately after ROSC is required. Many studies have focused on gow Motor Score of 2 or less at 3 days post-ROSC (FPR 14% [95% CI prediction of poor long-term outcome (vegetative state or death), 3–44%])368 and the presence of status epilepticus (FPR of 7% [95% based on clinical or test findings that indicate irreversible brain CI 1–25%] to 11.5% [95% CI 3–31%])378,379 are potentially unreliable injury, to enable clinicians to limit care or withdraw organ sup- prognosticators of poor outcome in post-cardiac arrest patients port. The implications of these prognostic tests are such that they treated with therapeutic hypothermia. Given the limited available should have 100% specificity or zero false positive rate (FPR), i.e., evidence, decisions to limit care should not be made based on the proportion of individuals who eventually have a ‘good’ long-term results of a single prognostication tool. outcome despite the prediction of a poor outcome. Organ donation Clinical examination There are no clinical neurological signs that predict poor out- Solid organs have been successfully transplanted after cardiac come (Cerebral Performance Category [CPC] 3 or 4, or death) death.380 This group of patients offers an untapped opportunity reliably less than 24 h after cardiac arrest. In adult patients who to increase the organ donor pool. Organ retrieval from non-heart are comatose after cardiac arrest, and who have not been treated beating donors is classified as controlled or uncontrolled.381 Con- with hypothermia and who do not have confounding factors (such trolled donation occurs after planned withdrawal of treatment as hypotension, sedatives or muscle relaxants), the absence of both following non-survivable injuries/illnesses. Uncontrolled dona- pupillary light and corneal reflex at ≥72 h reliably predicts poor tion describes donation after a patient is brought in dead or outcome (FPR 0%; 95% CI 0–9%).330 Absence of vestibulo-ocular with on-going CPR that fails to restore a spontaneous circula- reflexes at ≥24 h (FPR 0%; 95% CI 0–14%)366,367 and a GCS motor tion. score of 2 or less at ≥72 h (FPR 5%; 95% CI 2–9%)330 are less reliable. Other clinical signs, including myoclonus, are not recommended Cardiac arrest centres for predicting poor outcome. The presence of myoclonus status in adults is strongly associated with poor outcome,329,330,368–370 but There is wide variability in survival among hospitals caring rare cases of good neurological recovery have been described and for patients after resuscitation from cardiac arrest.57–63 There accurate diagnosis is problematic.371–375 is some low-level evidence that ICUs admitting more than 50
- 23. J.P. Nolan et al. / Resuscitation 81 (2010) 1219–1276 1241 post-cardiac arrest patients per year produce better survival Acute coronary syndromes are the commonest cause of malig- rates than those admitting less than 20 cases per year.61 There nant arrhythmias leading to sudden cardiac death. The therapeutic is indirect evidence that regional cardiac resuscitation systems goals are to treat acute life-threatening conditions, such as VF or of care improve outcome ST elevation myocardial infarction extreme bradycardia, and to preserve left ventricular function and (STEMI).382–404 prevent heart failure by minimising the extent of myocardial dam- The implication from all these data is that specialist cardiac age. The current guidelines address the first hours after onset of arrest centres and systems of care may be effective but, as yet, there symptoms. Out-of-hospital treatment and initial therapy in the is no direct evidence to support this hypothesis.405–407 emergency department (ED) may vary according to local capabili- ties, resources and regulations. The data supporting out-of-hospital treatment are often extrapolated from studies of initial treatment after hospital admission; there are few high-quality out-of-hospital Initial management of acute coronary syndromes studies. Comprehensive guidelines for the diagnosis and treatment of ACS with and without ST elevation have been published by the Introduction European Society of Cardiology and the American College of Cardi- ology/American Heart Association. The current recommendations The incidence of acute STEMI is decreasing in many Euro- are in line with these guidelines (Figs. 1.9 and 1.10).413,414 pean countries408 ; however, the incidence of non-STEMI acute coronary syndrome (non-STEMI-ACS) is increasing.409,410 Although Diagnosis and risk stratification in acute coronary in-hospital mortality from STEMI has been reduced significantly by syndromes modern reperfusion therapy and improved secondary prophylaxis, the overall 28-day mortality is virtually unchanged because about Patients at risk, and their families, should be able to recognize two-thirds of those who die do so before hospital arrival, mostly characteristic symptoms such as chest pain, which may radiate from lethal arrhythmias triggered by ischaemia.411 Thus, the best into other areas of the upper body, often accompanied by other chance of improving survival from an ischaemic attack is reducing symptoms including dyspnoea, sweating, nausea or vomiting and the delay from symptom onset to first medical contact and targeted syncope. They should understand the importance of early activa- treatment started in the early out-of-hospital phase. tion of the EMS system and, ideally, should be trained in basic life The term acute coronary syndrome (ACS) encompasses three support (BLS). Optimal strategies for increasing layperson aware- different entities of the acute manifestation of coronary heart dis- ness of the various ACS presentations and improvement of ACS ease: STEMI, NSTEMI and unstable angina pectoris (UAP). Non-ST recognition in vulnerable populations remain to be determined. elevation myocardial infarction and UAP are usually combined in Moreover, EMS dispatchers must be trained to recognize ACS symp- the term non-STEMI-ACS. The common pathophysiology of ACS is a toms and to ask targeted questions. ruptured or eroded atherosclerotic plaque.412 Electrocardiographic (ECG) characteristics (absence or presence of ST elevation) differ- Signs and symptoms of ACS entiate STEMI from NSTEMI-ACS. The latter may present with ST segment depression, nonspecific ST segment wave abnormalities, Typically ACS appears with symptoms such as radiating chest or even a normal ECG. In the absence of ST elevation, an increase pain, shortness of breath and sweating; however, atypical symp- in the plasma concentration of cardiac biomarkers, particularly tro- toms or unusual presentations may occur in the elderly, in females, ponin T or I as the most specific markers of myocardial cell necrosis, and in diabetics.415,416 None of these signs and symptoms of ACS indicates NSTEMI. can be used alone for the diagnosis of ACS. Fig. 1.9. Definitions of acute coronary syndromes (ACS); STEMI, ST elevation myocardial infarction; NSTEMI, non-ST elevation myocardial infarction; UAP, unstable angina pectoris.
- 24. 1242 J.P. Nolan et al. / Resuscitation 81 (2010) 1219–1276 Fig. 1.10. Treatment algorithm for acute coronary syndromes; BP, blood pressure; PCI, percutaneous coronary intervention; UFH, unfractionated heparin. *Prasugrel, 60 mg loading dose, may be chosen as an alternative to clopidogrel in patients with STEMI and planned PPCI provided there is no history of stroke or transient ischaemic attack. At the time of writing, ticagrelor has not yet been approved as an alternative to clopidogrel. 12-lead ECG respectively. Measurement of a cardiac-specific troponin is prefer- able. Elevated concentrations of troponin are particularly helpful in A 12-lead ECG is the key investigation for assessment of an ACS. identifying patients at increased risk of adverse outcome.420 In case of STEMI, it indicates the need for immediate reperfusion therapy (i.e., primary percutaneous coronary intervention (PCI) or Decision rules for early discharge prehospital fibrinolysis). When an ACS is suspected, a 12-lead ECG should be acquired and interpreted as soon as possible after first Attempts have been made to combine evidence from history, patient contact, to facilitate earlier diagnosis and triage. Prehospital physical examination serial ECGs and serial biomarker measure- or ED ECG yields useful diagnostic information when interpreted by ment in order to form clinical decision rules that would help triage trained health care providers.417 of ED patients with suspected ACS. Recording of a 12-lead ECG out-of-hospital enables advanced None of these rules is adequate and appropriate to identify ED notification to the receiving facility and expedites treatment deci- chest pain patients with suspected ACS who can be safely dis- sions after hospital arrival. Paramedics and nurses can be trained charged from the ED.421 to diagnose STEMI without direct medical consultation, as long as there is strict concurrent provision of medically directed quality Chest pain observation protocols assurance. If interpretation of the prehospital ECG is not available on-site, computer interpretation418,419 or field transmission of the In patients presenting to the ED with a history suggestive of ECG is reasonable. ACS, but normal initial workup, chest pain (observation) units may represent a safe and effective strategy for evaluating patients. Biomarkers They reduce length of stay, hospital admissions and health- care costs, improve diagnostic accuracy and improve quality of In the absence of ST elevation on the ECG, the presence of life.422 There is no direct evidence demonstrating that chest pain a suggestive history and elevated concentrations of biomarkers units or observation protocols reduce adverse cardiovascular out- (troponin T and troponin I, CK, CK-MB, myoglobin) characterise comes, particularly mortality, for patients presenting with possible non-STEMI and distinguish it from STEMI and unstable angina ACS.
- 25. J.P. Nolan et al. / Resuscitation 81 (2010) 1219–1276 1243 Treatment of acute coronary syndromes—symptoms as soon as possible is recommended for patients presenting with STEMI and planned PCI. Prasugrel or ticagrelor can be used instead Glyceryl trinitrate is an effective treatment for ischaemic chest of clopidogrel before planned PCI. Patients with STEMI treated with pain and has beneficial haemodynamic effects, such as dilation of fibrinolysis should be treated with clopidogrel (300 mg loading the venous capacitance vessels, dilation of the coronary arteries dose up to an age of 75 years and 75 mg without loading dose if and, to a minor extent, the peripheral arteries. Glyceryl trinitrate >75 years of age) in addition to ASA and an antithrombin. may be considered if the systolic blood pressure is above 90 mm Hg and the patient has ongoing ischaemic chest pain. Glyceryl trini- Glycoprotein (Gp) IIB/IIIA inhibitors trate can also be useful in the treatment of acute pulmonary Gp IIB/IIIA receptor is the common final link of platelet aggre- congestion. Nitrates should not be used in patients with hypoten- gation. Eptifibatide and tirofiban lead to reversible inhibition, sion (systolic blood pressure ≤90 mm Hg), particularly if combined while abciximab leads to irreversible inhibition of the Gp IIB/IIIA with bradycardia, and in patients with inferior infarction and sus- receptor. There are insufficient data to support routine pre- pected right ventricular involvement. Use of nitrates under these treatment with Gp IIB/IIIA inhibitors in patients with STEMI or circumstances can decrease the blood pressure and cardiac output. non-STEMI-ACS. Morphine is the analgesic of choice for nitrate-refractory pain and also has calming effects on the patient making sedatives Antithrombins unnecessary in most cases. Since morphine is a dilator of venous capacitance vessels, it may have additional benefit in patients with Unfractionated heparin (UFH) is an indirect inhibitor of throm- pulmonary congestion. Give morphine in initial doses of 3–5 mg bin, which in combination with ASA is used as an adjunct with intravenously and repeat every few minutes until the patient is fibrinolytic therapy or primary PCI (PPCI) and is an important part pain-free. Non-steroidal anti-inflammatory drugs (NSAIDs) should of treatment of unstable angina and STEMI. There are now several be avoided for analgesia because of their pro-thrombotic effects.423 alternative antithrombins for the treatment of patients with ACS. Monitoring of the arterial oxygen saturation (SaO2 ) with pulse In comparison with UFH, these alternatives have a more specific oximetry will help to determine the need for supplemental oxy- factor Xa activity (low molecular weight heparins [LMWH], fonda- gen. These patients do not need supplemental oxygen unless parinux) or are direct thrombin inhibitors (bivalirudin). With these they are hypoxaemic. Limited data suggest that high-flow oxy- newer antithrombins, in general, there is no need to monitor the gen may be harmful in patients with uncomplicated myocardial coagulation system and there is a reduced risk of thrombocytope- infarction.424–426 Aim to achieve an oxygen saturation of 94–98%, or nia. 88–92% if the patient is at risk of hypercapnic respiratory failure.427 In comparison with UFH, enoxaparin reduces the combined end- point of mortality, myocardial infarction and the need for urgent Treatment of acute coronary syndromes—cause revascularisation, if given within the first 24–36 h of onset of symp- toms of non-STEMI-ACS.432,433 For patients with a planned initial Inhibitors of platelet aggregation conservative approach, fondaparinux and enoxaparin are reason- able alternatives to UFH. For patients with an increased bleeding Inhibition of platelet aggregation is of primary importance for risk consider giving fondaparinux or bivalirudin, which cause less initial treatment of coronary syndromes as well as for secondary bleeding than UFH.434–436 For patients with a planned invasive prevention, since platelet activation and aggregation is the key approach, enoxaparin or bivalirudin are reasonable alternatives to process initiating an ACS. UFH. Several randomised studies of patients with STEMI under- Acetylsalicylic acid (ASA) going fibrinolysis have shown that additional treatment with Large randomised controlled trials indicate decreased mortal- enoxaparin instead of UFH produced better clinical outcomes ity when ASA (75–325 mg) is given to hospitalised patients with (irrespective of the fibrinolytic used) but a slightly increased ACS. A few studies have suggested reduced mortality if ASA is given bleeding rate in elderly (≥75 years) and low weight patients earlier.428,429 Therefore, give ASA as soon as possible to all patients (BW < 60 kg).437–439 with suspected ACS unless the patient has a known true allergy to Enoxaparin is a safe and effective alternative to UFH for con- ASA. ASA may be given by the first healthcare provider, bystander temporary PPCI (i.e., broad use of thienopyridines and/or Gp IIB/IIIA or by dispatcher assistance according to local protocols. The initial receptor blockers).440,441 There are insufficient data to recommend dose of chewable ASA is 160–325 mg. Other forms of ASA (soluble, any LMWH other than enoxaparin for PPCI in STEMI. Bivalirudin is IV) may be as effective as chewed tablets. also a safe alternative to UFH for STEMI and planned PCI. ADP receptor inhibitors Thienopyridines (clopidogrel, prasugrel) and the cyclo-pentyl- Strategies and systems of care triazolo-pyrimidine, ticagrelor, inhibit the ADP receptor irre- versibly, which further reduces platelet aggregation in addition to Several systematic strategies to improve quality of out-of- that produced by ASA. hospital care for patients with ACS have been investigated. These If given in addition to heparin and ASA in high-risk non-STEMI- strategies are principally intended to promptly identify patients ACS patients, clopidogrel improves outcome.430,431 Clopidogrel with STEMI in order to shorten the delay to reperfusion treatment. should be given as early as possible in addition to ASA and an Also triage criteria have been developed to select high-risk patients antithrombin to all patients presenting with non-STEMI-ACS. If a with non-STEMI-ACS for transport to tertiary care centres offering conservative approach is selected, give a loading dose of 300 mg; 24/7 PCI services. In this context, several specific decisions have to with a planned PCI strategy, an initial dose of 600 mg may be pre- be made during initial care beyond the basic diagnostic steps nec- ferred. Prasugrel or ticagrelor can be given instead of clopidogrel. essary for clinical evaluation of the patient and interpretation of a Although there is no large study on the use of clopidogrel for 12-lead ECG. These decisions relate to: pre-treatment of patients presenting with STEMI and planned PCI, it is likely that this strategy is beneficial. Since platelet inhibition (1) Reperfusion strategy in patients with STEMI i.e., PPCI vs. pre- is more profound with a higher dose, a 600 mg loading dose given hospital fibrinolysis.
- 26. 1244 J.P. Nolan et al. / Resuscitation 81 (2010) 1219–1276 (2) Bypassing a closer but non-PCI capable hospital and taking mea- combined. Facilitated PCI is PCI performed immediately after fib- sures to shorten the delay to intervention if PPCI is the chosen rinolysis, a pharmaco-invasive strategy refers to PCI performed strategy. routinely 3–24 h after fibrinolysis, and rescue PCI is defined as (3) Procedures in special situations e.g., for patients successfully PCI performed for a failed reperfusion (as evidenced by <50% resuscitated from non-traumatic cardiac arrest, patients with resolution of ST segment elevation at 60–90 min after comple- shock or patients with non-STEMI-ACS who are unstable or tion of fibrinolytic treatment). These strategies are distinct from have signs of very high risk. a routine PCI approach where the angiography and intervention is performed several days after successful fibrinolysis. Several Reperfusion strategy in patients presenting with STEMI studies and meta-analyses demonstrate worse outcome with rou- tine PCI performed immediately or as early as possible after For patients presenting with STEMI within 12 h of symptom fibrinolysis.458,460 Therefore routine facilitated PCI is not recom- onset, reperfusion should be initiated as soon as possible indepen- mended even if there may be some specific subgroups of patients dent of the method chosen.414,442–444 Reperfusion may be achieved that may benefit from this procedure.461 It is reasonable to perform with fibrinolysis, with PPCI, or a combination of both. Efficacy of angiography and PCI when necessary in patients with failed fibri- reperfusion therapy is profoundly dependent on the duration of nolysis according to clinical signs and/or insufficient ST-segment symptoms. Fibrinolysis is effective specifically in the first 2–3 h resolution.462 after symptom onset; PPCI is less time sensitive.445 Giving fib- In the case of clinically successful fibrinolysis (evidenced rinolytics out-of-hospital to patients with STEMI or signs and by clinical signs and ST-segment resolution >50%), angiography symptoms of an ACS with presumed new LBBB is beneficial. Fib- delayed by several hours after fibrinolysis (the ‘pharmaco-invasive’ rinolytic therapy can be given safely by trained paramedics, nurses approach) has been shown to improve outcome. This strategy or physicians using an established protocol.446–451 The efficacy is includes early transfer for angiography and PCI if necessary after greatest within the first 3 h of the onset of symptoms.452 Patients fibrinolytic treatment.463,464 with symptoms of ACS and ECG evidence of STEMI (or presum- ably new LBBB or true posterior infarction) presenting directly to Reperfusion after successful CPR the ED should be given fibrinolytic therapy as soon as possible unless there is timely access to PPCI. Healthcare professionals who Coronary heart disease is the most frequent cause of out-of- give fibrinolytic therapy must be aware of its contraindications and hospital cardiac arrest. Many of these patients will have an acute risks. coronary occlusion with signs of STEMI on the ECG, but cardiac arrest due to ischaemic heart disease can also occur in absence Primary percutaneous intervention of these findings. In patients with STEMI or new LBBB on ECG Coronary angioplasty with or without stent placement has following ROSC after out-of-hospital cardiac arrest, immediate become the first-line treatment for patients with STEMI, because angiography and PCI or fibrinolysis should be considered.316,321 It is it has been shown to be superior to fibrinolysis in the combined reasonable to perform immediate angiography and PCI in selected endpoints of death, stroke and reinfarction in several studies and patients despite the lack of ST elevation on the ECG or prior clinical meta-analyses.453,454 findings such as chest pain. It is reasonable to include reperfu- sion treatment in a standardised post-cardiac arrest protocol as Fibrinolysis versus primary PCI part of a strategy to improve outcome.317 Reperfusion treatment Several reports and registries comparing fibrinolytic (including should not preclude other therapeutic strategies including thera- pre-hospital administration) therapy with PPCI showed a trend of peutic hypothermia. improved survival if fibrinolytic therapy was initiated within 2 h of onset of symptoms and was combined with rescue or delayed Primary and secondary prevention PCI.455–457 If PPCI cannot be accomplished within an adequate timeframe, independent of the need for emergent transfer, then Preventive interventions in patients presenting with an ACS immediate fibrinolysis should be considered unless there is a should be initiated early after hospital admission and should be contraindication. For those STEMI patients presenting in shock, continued if already in place. Preventive measures improve prog- primary PCI (or coronary artery bypass surgery) is the preferred nosis by reducing the number of major adverse cardiac events. reperfusion treatment. Fibrinolysis should be considered only if Prevention with drugs encompasses beta-blockers, angiotensin there is a substantial delay to PCI. converting enzyme (ACE) inhibitors/angiotensin receptor block- ers (ARB) and statins, as well as basic treatment with ASA and, if Triage and inter-facility transfer for primary PCI indicated, thienopyridines. The risk of death, reinfarction or stroke is reduced if patients with STEMI are transferred promptly from community hospitals Paediatric life support to tertiary care facilities for PPCI.383,454,458 It is less clear whether immediate fibrinolytic therapy (in- or out-of-hospital) or transfer Paediatric basic life support for PPCI is superior for younger patients presenting with anterior infarction and within a short duration of <2–3 h.459 Transfer of Sequence of actions STEMI patients for PPCI is reasonable for those presenting more than 3 h but less than 12 h after the onset of symptoms, provided Rescuers who have been taught adult BLS and have no specific that the transfer can be achieved rapidly. knowledge of paediatric resuscitation may use the adult sequence, as outcome is worse if they do nothing. Non-specialists who wish to Combination of fibrinolysis and percutaneous coronary learn paediatric resuscitation because they have responsibility for intervention children (e.g., teachers, school nurses, lifeguards), should be taught Fibrinolysis and PCI may be used in a variety of combina- that it is preferable to modify adult BLS and perform five initial tions to restore coronary blood flow and myocardial perfusion. breaths followed by approximately one minute of CPR before they There are several ways in which the two therapies can be go for help (see adult BLS guideline).
- 27. J.P. Nolan et al. / Resuscitation 81 (2010) 1219–1276 1245 ◦ At the same time, with your fingertip(s) under the point of the child’s chin, lift the chin. Do not push on the soft tissues under the chin as this may obstruct the airway. ◦ If you still have difficulty in opening the airway, try a jaw thrust: place the first two fingers of each hand behind each side of the child’s mandible and push the jaw forward. 4. Keeping the airway open, look, listen and feel for normal breath- ing by putting your face close to the child’s face and looking along the chest: • Look for chest movements. • Listen at the child’s nose and mouth for breath sounds. • Feel for air movement on your cheek. In the first few minutes after a cardiac arrest a child may be taking slow infrequent gasps. Look, listen and feel for no more than 10 s before deciding—if you have any doubt whether breathing is normal, act as if it is not normal: 5A. If the child is breathing normally: • Turn the child on his side into the recovery position (see below) • Send or go for help—call the local emergency number for an ambulance. • Check for continued breathing. 5B. If breathing is not normal or absent: • Remove carefully any obvious airway obstruction. • Give five initial rescue breaths. • While performing the rescue breaths note any gag or cough response to your action. These responses or their absence will form part of your assessment of ‘signs of life’, which will be described later. Rescue breaths for a child over 1 year of age: • Ensure head tilt and chin lift. • Pinch the soft part of the nose closed with the index finger and thumb of your hand on his forehead. • Allow the mouth to open, but maintain chin lift. • Take a breath and place your lips around the mouth, making sure that you have a good seal. • Blow steadily into the mouth over about 1–1.5 s watching for chest rise. • Maintain head tilt and chin lift, take your mouth away from the victim and watch for his chest to fall as air comes out. • Take another breath and repeat this sequence five times. Identify effectiveness by seeing that the child’s chest has risen and fallen in a similar fashion to the movement produced by a normal breath. Fig. 1.11. Paediatric basic life support algorithm for those with a duty to respond. Rescue breaths for an infant: The following sequence is to be followed by those with a duty • Ensure a neutral position of the head and a chin lift. to respond to paediatric emergencies (usually health professional • Take a breath and cover the mouth and nose of the infant with teams) (Fig. 1.11). your mouth, making sure you have a good seal. If the nose and mouth cannot be covered in the older infant, the rescuer may attempt to seal only the infant’s nose or mouth with his mouth 1. Ensure the safety of rescuer and child. (if the nose is used, close the lips to prevent air escape). 2. Check the child’s responsiveness. • Blow steadily into the infant’s mouth and nose over 1–1.5 s, suf- • Gently stimulate the child and ask loudly: Are you all right? ficient to make the chest visibly rise. 3A. If the child responds by answering or moving: • Maintain head position and chin lift, take your mouth away from • Leave the child in the position in which you find him (provided the victim and watch for his chest to fall as air comes out. he is not in further danger). • Take another breath and repeat this sequence five times. • Check his condition and get help if needed. • Reassess him regularly. 3B. If the child does not respond: For both infants and children, if you have difficulty achieving an • Shout for help. effective breath, the airway may be obstructed: • Turn carefully the child on his back. • Open the child’s airway by tilting the head and lifting the chin. • Open the child’s mouth and remove any visible obstruction. Do ◦ Place your hand on his forehead and gently tilt his head back. not perform a blind finger sweep.
- 28. 1246 J.P. Nolan et al. / Resuscitation 81 (2010) 1219–1276 • Ensure that there is adequate head tilt and chin lift but also that • Further qualified help arrives and takes over. the neck is not over extended. • You become exhausted. • If head tilt and chin lift has not opened the airway, try the jaw thrust method. • Make up to five attempts to achieve effective breaths, if still When to call for assistance unsuccessful, move on to chest compressions. It is vital for rescuers to get help as quickly as possible when a 6. Assess the child’s circulation child collapses. Take no more than 10 s to: • Look for signs of life—this includes any movement, coughing or • When more than one rescuer is available, one starts resuscitation normal breathing (not abnormal gasps or infrequent, irregular breaths). while another rescuer goes for assistance. If you check the pulse, ensure you take no more than 10 s. • If only one rescuer is present, undertake resuscitation for about In a child over 1 year—feel for the carotid pulse in the neck. 1 min before going for assistance. To minimise interruption in In an infant—feel for the brachial pulse on the inner aspect of the CPR, it may be possible to carry an infant or small child while upper arm. summoning help. The femoral pulse in the groin, which is half way between the • The only exception to performing 1 min of CPR before going for anterior superior iliac spine and the symphysis pubis, can also be help is in the case of a child with a witnessed, sudden collapse used in infant and children. when the rescuer is alone. In this case, cardiac arrest is likely to 7A. If you are confident that you can detect signs of life within 10 s: be caused by an arrhythmia and the child will need defibrillation. • Continue rescue breathing, if necessary, until the child starts Seek help immediately if there is no one to go for you. breathing effectively on his own. • Turn the child on to his side (into the recovery position) if he remains unconscious. Recovery position • Re-assess the child frequently. 7B. If there are no signs of life, unless you are CERTAIN you can feel An unconscious child whose airway is clear, and who is breath- a definite pulse of greater than 60 beats min−1 within 10 s: ing normally, should be turned on his side into the recovery • Start chest compressions. position. The adult recovery position is suitable for use in children. • Combine rescue breathing and chest compressions: Chest compressions Foreign body airway obstruction (FBAO) For all children, compress the lower half of the sternum. To avoid compressing the upper abdomen, locate the xiphister- Back blows, chest thrusts and abdominal thrusts all increase num by finding the angle where the lowest ribs join in the middle. intra-thoracic pressure and can expel foreign bodies from the air- Compress the sternum one finger’s breadth above this; the com- way. In half of the episodes more than one technique is needed to pression should be sufficient to depress the sternum by at least relieve the obstruction.465 There are no data to indicate which mea- one-third of the depth of the chest. Don’t be afraid to push too hard: sure should be used first or in which order they should be applied. “Push Hard and Fast”. Release the pressure completely and repeat If one is unsuccessful, try the others in rotation until the object is at a rate of at least 100 min−1 (but not exceeding 120 min−1 ). After cleared. 15 compressions, tilt the head, lift the chin, and give two effective The FBAO algorithm for children was simplified and aligned breaths. Continue compressions and breaths in a ratio of 15:2. The with the adult version in 2005 guidelines; this continues to be the best method for compression varies slightly between infants and recommended sequence for managing FBAO (Fig. 1.12). children. The most significant difference from the adult algorithm is that Chest compression in infants abdominal thrusts should not be used for infants. Although abdom- The lone rescuer compresses the sternum with the tips of two inal thrusts have caused injuries in all age groups, the risk is fingers. If there are two or more rescuers, use the encircling tech- particularly high in infants and very young children. This is because nique. Place both thumbs flat side by side on the lower half of the of the horizontal position of the ribs, which leaves the upper sternum (as above) with the tips pointing towards the infant’s head. abdominal viscera much more exposed to trauma. For this rea- Spread the rest of both hands with the fingers together to encircle son, the guidelines for the treatment of FBAO are different between the lower part of the infant’s rib cage with the tips of the fingers infants and children. Signs for the recognition of FBAO in a child are supporting the infant’s back. For both methods, depress the lower listed in Table 1.2. sternum by at least one-third of the depth of the infant’s chest (approximately 4 cm). Chest compression in children over 1 year of age Place the heel of one hand over the lower half of the sternum (as Table 1.2 above). Lift the fingers to ensure that pressure is not applied over Signs of foreign body airway obstruction. the child’s ribs. Position yourself vertically above the victim’s chest General signs of FBAO and, with your arm straight, compress the sternum to depress it by Witnessed episode at least one-third of the depth of the chest (approximately 5 cm). Coughing/choking Sudden onset In larger children or for small rescuers, this is achieved most easily Recent history of playing with/eating small objects by using both hands with the fingers interlocked. Ineffective coughing Effective cough Unable to vocalise Crying or verbal response to questions 8. Do not interrupt resuscitation until: Quiet or silent cough Loud cough • The child shows signs of life (starts to wake up, to move, opens Unable to breathe Able to take a breath before coughing eyes and to breathe normally or a definite pulse of greater than Cyanosis Fully responsive 60 min−1 is palpated). Decreasing level of consciousness
- 29. J.P. Nolan et al. / Resuscitation 81 (2010) 1219–1276 1247 Fig. 1.12. Paediatric foreign body airway obstruction algorithm. © 2010 ERC. Paediatric advanced life support Table 1.3 General recommendation for cuffed and uncuffed tracheal tube sizes (internal diam- eter in mm). Prevention of cardiopulmonary arrest Uncuffed Cuffed In children, secondary cardiopulmonary arrests, caused by Neonates either respiratory or circulatory failure, are more frequent than Premature Gestational age in weeks/10 Not used primary arrests caused by arrhythmias.466–471 So-called asphyx- Full term 3.5 Not usually used Infants 3.5–4.0 3.0–3.5 ial arrests or respiratory arrests are also more common in young Child 1–2 years 4.0–4.5 3.5–4.0 adulthood (e.g., trauma, drowning, poisoning).472,473 The outcome Child >2 years Age/4 + 4 Age/4 + 3.5 from cardiopulmonary arrests in children is poor; identification of the antecedent stages of cardiac or respiratory failure is a prior- tion or analgesia to be intubated; otherwise, intubation must be ity, as effective early intervention may be life saving. The order of preceded by oxygenation (gentle BMV is sometimes required to assessment and intervention for any seriously ill or injured child avoid hypoxia), rapid sedation, analgesia and the use of neuro- follows the ABCDE principles outlined previously for adults. Sum- muscular blocking drugs to minimize intubation complications and moning a paediatric RRT or MET may reduce the risk of respiratory failure.479 The intubator must be experienced and familiar with and/or cardiac arrest in hospitalised children outside the intensive drugs used for rapid-sequence induction. The use of cricoid pres- care setting.202,474–478 sure may prevent or limit regurgitation of gastric contents,480,481 but it may distort the airway and make laryngoscopy and intuba- Management of respiratory and circulatory failure tion more difficult.482 Cricoid pressure should not be used if either intubation or oxygenation is compromised. In children, there are many causes of respiratory and circula- A general recommendation for tracheal tube internal diameters tory failure and they may develop gradually or suddenly. Both may (ID) for different ages is shown in Table 1.3.483–488 This is a guide be initially compensated but will normally decompensate without only and tubes one size larger and smaller should always be avail- adequate treatment. Untreated decompensated respiratory or cir- able. Tracheal tube size can also be estimated from the length of culatory failure will lead to cardiopulmonary arrest. Hence, the aim the child’s body as measured by resuscitation tapes.489 of paediatric life support is early and effective intervention in chil- Uncuffed tracheal tubes have been used traditionally in children dren with respiratory and circulatory failure to prevent progression up to 8 years of age but cuffed tubes may offer advantages in certain to full arrest. circumstances e.g., when lung compliance is poor, airway resis- tance is high or if there is a large air leak from the glottis.483,490,491 Airway and breathing The use of cuffed tubes also makes it more likely that the correct • Open the airway and ensure adequate ventilation and oxygena- tube size will be chosen on the first attempt.483,484,492 As excessive tion. Deliver high-flow oxygen. cuff pressure may lead to ischaemic damage to the surrounding • Establish respiratory monitoring (first line—pulse oximetry/ laryngeal tissue and stenosis, cuff inflation pressure should be mon- SpO2 ). itored and maintained at less than 25 cm H2 O.493 • Achieving adequate ventilation and oxygenation may require use Displaced, misplaced or obstructed tubes occur frequently in of airway adjuncts, bag-mask ventilation (BMV), use of a laryn- the intubated child and are associated with increased risk of geal mask airway (LMA), securing a definitive airway by tracheal death.281,494 No single technique is 100% reliable for distinguish- intubation and positive pressure ventilation. ing oesophageal from tracheal intubation.495–497 Assessment of the • Very rarely, a surgical airway may be required. correct tracheal tube position is made by: Rapid-sequence induction and intubation. The child who is in • laryngoscopic observation of the tube passing beyond the vocal cardiopulmonary arrest and deep coma does not require seda- cords;
- 30. 1248 J.P. Nolan et al. / Resuscitation 81 (2010) 1219–1276 • detection of end-tidal CO2 if the child has a perfusing rhythm Circulation (this may also be seen with effective CPR, but it is not completely • Establish cardiac monitoring [first line—pulse oximetry (SpO2 ), reliable); ECG and non-invasive blood pressure (NIBP)]. • observation of symmetrical chest wall movement during positive • Secure vascular access. This may be by peripheral IV or IO cannu- pressure ventilation; lation. If already in situ, a central intravenous catheter should be • observation of mist in the tube during the expiratory phase of used. ventilation; • Give a fluid bolus (20 ml kg−1 ) and/or drugs (e.g., inotropes, vaso- • absence of gastric distension; pressors, anti-arrhythmics) as required. • equal air entry heard on bilateral auscultation in the axillae and • Isotonic crystalloids are recommended as initial resuscitation apices of the chest; fluid in infants and children with any type of shock, including • absence of air entry into the stomach on auscultation; septic shock.515–518 • improvement or stabilisation of SpO2 in the expected range • Assess and re-assess the child continuously, commencing each (delayed sign!); time with the airway before proceeding to breathing and then • heart rate moving closer to the age-expected value (or remaining the circulation. within the normal range) (delayed sign!). • During treatment, capnography, invasive monitoring of arterial blood pressure, blood gas analysis, cardiac output monitoring, echocardiography and central venous oxygen saturation (ScvO2 ) If the child is in cardiopulmonary arrest and exhaled CO2 is not may be useful to guide the management of respiratory and/or detected despite adequate chest compressions, or if there is any circulatory failure. doubt, confirm tracheal tube position by direct laryngoscopy. Vascular access. Venous access can be difficult to establish dur- ing resuscitation of an infant or child: if attempts at establishing IV access are unsuccessful after one minute, insert an IO needle Breathing. Give oxygen at the highest concentration (i.e., 100%) instead.519,520 Intraosseous or IV access is much preferred to the during initial resuscitation. Once circulation is restored, give suffi- tracheal route for giving drugs.521 cient oxygen to maintain an arterial oxygen saturation (SaO2 ) in the range of 94–98%.498,499 Healthcare providers commonly provide excessive ventila- Adrenaline. The recommended IV/IO dose of adrenaline in chil- tion during CPR and this may be harmful. Hyperventilation dren for the first and for subsequent doses is 10 g kg−1 . The causes increased intra-thoracic pressure, decreased cerebral and maximum single dose is 1 mg. If needed, give further doses of coronary perfusion, and poorer survival rates in animals and adrenaline every 3–5 min. Intratracheal adrenaline is no longer adults.224,225,286,500–503 Although normoventilation is the objec- recommended,522–525 but if this route is ever used, the dose is ten tive during resuscitation, it is difficult to know the precise minute times this (100 g kg−1 ). volume that is being delivered. A simple guide to deliver an accept- able tidal volume is to achieve modest chest wall rise. Once the Advanced management of cardiopulmonary arrest airway is protected by tracheal intubation, continue positive pres- sure ventilation at 10–12 breaths min−1 without interrupting chest 1. When a child becomes unresponsive, without signs of life (no compressions. When circulation is restored, or if the child still has breathing, cough or any detectable movement), start CPR imme- a perfusing rhythm, ventilate at 12–20 breaths min−1 to achieve a diately. normal arterial carbon dioxide tension (PaCO2 ). 2. Provide BMV with 100% oxygen. Monitoring end-tidal CO2 (ETCO2 ) with a colorimetric detec- 3. Commence monitoring. Send for a manual defibrillator or an AED tor or capnometer confirms tracheal tube placement in the child to identify and treat shockable rhythms as quickly as possible weighing more than 2 kg, and may be used in pre- and in-hospital (Fig. 1.13). settings, as well as during any transportation of the child.504–507 A colour change or the presence of a capnographic waveform for ABC more than four ventilated breaths indicates that the tube is in the tracheobronchial tree both in the presence of a perfusing rhythm Commence and continue with basic life support and during cardiopulmonary arrest. Capnography does not rule Oxygenate and ventilate with BMV out intubation of a bronchus. The absence of exhaled CO2 dur- Provide positive pressure ventilation with a high inspired oxy- ing cardiopulmonary arrest does not guarantee tube misplacement gen concentration since a low or absent end tidal CO2 may reflect low or absent Give five rescue breaths followed by external chest compression pulmonary blood flow.235,508–510 Capnography may also provide and positive pressure ventilation in the ratio of 15:2 information on the efficiency of chest compressions and can give an Avoid rescuer fatigue by frequently changing the rescuer per- early indication of ROSC.511,512 Efforts should be made to improve forming chest compressions chest compression quality if the ETCO2 remains below 15 mm Hg Establish cardiac monitoring (2 kPa). Current evidence does not support the use of a threshold Assess cardiac rhythm and signs of life ETCO2 value as an indicator for the discontinuation of resuscitation (±Check for a central pulse for no more than 10 s) efforts. The self-inflating bulb or aspirating syringe (oesophageal detec- Non-shockable—asystole, PEA tor device, ODD) may be used for the secondary confirmation of tracheal tube placement in children with a perfusing rhythm.513,514 There are no studies on the use of the ODD in children who are in • Give adrenaline IV or IO (10 g kg−1 ) and repeat every 3–5 min. cardiopulmonary arrest. • Identify and treat any reversible causes (4Hs & 4Ts). Clinical evaluation of the oxygen saturation of arterial blood (SaO2 ) is unreliable; therefore, monitor the child’s peripheral oxy- Shockable—VF/pulseless VT gen saturation continuously by pulse oximetry (SpO2 ). Attempt defibrillation immediately (4 J kg−1 ):
- 31. J.P. Nolan et al. / Resuscitation 81 (2010) 1219–1276 1249 Fig. 1.13. Paediatric advanced life support algorithm. © 2010 ERC. • Charge the defibrillator while another rescuer continues chest • Give adrenaline every alternate cycle (i.e., every 3–5 min during compressions. CPR) • Once the defibrillator is charged, pause the chest compressions, • Give a second dose of amiodarone 5 mg kg−1 if still in VF/pulseless ensure that all rescuers are clear of the patient. Minimise the VT after the fifth shock.526 delay between stopping chest compressions and delivery of the shock—even 5–10 s delay will reduce the chances of the shock being successful.71,110 If the child remains in VF/pulseless VT, continue to alternate • Give one shock. shocks of 4 J kg−1 with 2 min of CPR. If signs of life become evident, • Resume CPR as soon as possible without reassessing the rhythm. check the monitor for an organised rhythm; if this is present, check • After 2 min, check briefly the cardiac rhythm on the monitor for signs of life and a central pulse and evaluate the haemodynamics • Give second shock (4 J kg−1 ) if still in VF/pulseless VT of the child (blood pressure, peripheral pulse, capillary refill time). • Give CPR for 2 min as soon as possible without reassessing the Identify and treat any reversible causes (4Hs & 4Ts) remember- rhythm. ing that the first 2Hs (hypoxia and hypovolaemia) have the highest • Pause briefly to assess the rhythm; if still in VF/pulseless VT give prevalence in critically ill or injured children. a third shock at 4 J kg−1 . If defibrillation was successful but VF/pulseless VT recurs, • Give adrenaline 10 g kg−1 and amiodarone 5 mg kg−1 after the resume CPR, give amiodarone and defibrillate again at the dose that third shock once CPR has been resumed. was effective previously. Start a continuous infusion of amiodarone.
- 32. 1250 J.P. Nolan et al. / Resuscitation 81 (2010) 1219–1276 Echocardiography may be used to identify potentially treatable Special circumstances causes of cardiac arrest in children. Cardiac activity can be rapidly visualised527 and pericardial tamponade diagnosed.268 However, Channelopathy appropriately skilled operators must be available and its use should When sudden unexplained cardiac arrest occurs in children and be balanced against the interruption to chest compressions during young adults, obtain a complete past medical and family history examination. (including a history of syncopal episodes, seizures, unexplained accidents/drownings, or sudden death) and review any available Arrhythmias previous ECGs. All infants, children, and young adults with sud- den, unexpected death should, if possible, have an unrestricted, Unstable arrhythmias. Check for signs of life and the central complete autopsy, performed preferably by pathologists with train- pulse of any child with an arrhythmia; if signs of life are absent, ing and expertise in cardiovascular pathology.531–540 Consideration treat as for cardiopulmonary arrest. If the child has signs of life and should be given to preservation and genetic analysis of tissue a central pulse, evaluate the haemodynamic status. Whenever the to determine the presence of a channelopathy. Refer families of haemodynamic status is compromised, the first steps are: patients whose cause of death is not found on autopsy to a health care provider/centre with expertise in cardiac rhythm disturbances. 1. Open the airway. 2. Give oxygen and assist ventilation as necessary. Single ventricle post-stage 1 repair 3. Attach ECG monitor or defibrillator and assess the cardiac The incidence of cardiac arrest in infants following single ventri- rhythm. cle stage 1 repair is approximately 20%, with a survival to discharge 4. Evaluate if the rhythm is slow or fast for the child’s age. of 33%.541 There is no evidence that anything other than routine 5. Evaluate if the rhythm is regular or irregular. resuscitative protocols should be followed. Diagnosis of the pre- 6. Measure QRS complex (narrow complexes: <0.08 s duration; arrest state is difficult but it may be assisted by monitoring the wide complexes: >0.08 s). oxygen extraction (superior vena caval ScvO2 ) or near infra-red 7. The treatment options are dependent on the child’s haemody- spectroscopy (cerebral and splanchnic circulations).542–544 Treat- namic stability. ment of high systemic vascular resistance with alpha-adrenergic receptor blockade may improve systemic oxygen delivery,545 Bradycardia is caused commonly by hypoxia, acidosis and/or reduce the incidence of cardiovascular collapse,546 and improve severe hypotension; it may progress to cardiopulmonary arrest. survival.547 Give 100% oxygen, and positive pressure ventilation if required, to any child presenting with bradyarrhythmia and circulatory fail- Single ventricle post-Fontan ure. If a poorly perfused child has a heart rate <60 beats min−1 , Children in the pre-arrest state who have Fontan or hemi-Fontan and they do not respond rapidly to ventilation with oxygen, anatomy may benefit from increased oxygenation and an improved start chest compressions and give adrenaline. If the brady- cardiac output by instituting negative pressure ventilation.548,549 cardia is caused by vagal stimulation (such as after passing Extracorporeal membrane oxygenation (ECMO) may be useful a nasogastric tube), atropine may be effective. Cardiac pacing rescue for children with failing Fontan circulations but no recom- (either transvenous or external) is generally not useful dur- mendation can be made in favour or against ECMO in those with ing resuscitation. It may be considered in cases of AV block hemi-Fontan physiology or for rescue during resuscitation.550 or sinus node dysfunction unresponsive to oxygenation, ven- tilation, chest compressions and other medications; pacing is not effective in asystole or arrhythmias caused by hypoxia or Pulmonary hypertension ischaemia.528 There is an increased risk of cardiac arrest in children with pul- If SVT is the likely rhythm, vagal manoeuvres (Valsalva or div- monary hypertension.551,552 Follow routine resuscitation protocols ing reflex) may be used in haemodynamically stable children. in these patients with emphasis on high FiO2 and alkalo- They can also be used in haemodynamically unstable children, but sis/hyperventilation because this may be as effective as inhaled only if they do not delay chemical (e.g., adenosine) or electrical nitric oxide in reducing pulmonary vascular resistance.553 Resus- cardioversion.529 If the child is unstable with a depressed conscious citation is most likely to be successful in patients with a reversible level, attempt synchronised electrical cardioversion immediately. cause who are treated with intravenous epoprostenol or inhaled Electrical cardioversion (synchronised with R wave) is also indi- nitric oxide.554 If routine medications that reduce pulmonary artery cated when vascular access is not available, or when adenosine has pressure have been stopped, they should be restarted and the use failed to convert the rhythm. The first energy dose for electrical of aerosolised epoprostenol or inhaled nitric oxide considered.555 cardioversion of SVT is 0.5–1 J kg−1 and the second dose is 2 J kg−1 . Right ventricular support devices may improve survival.556–559 In children, wide-QRS complex tachycardia is uncommon and more likely to be supraventricular than ventricular in origin.530 Post-arrest management Nevertheless, in haemodynamically unstable children, it must be considered to be VT until proven otherwise. Synchronised car- The principles of post-cardiac arrest management and treat- dioversion is the treatment of choice for unstable VT with a ment of the post-cardiac arrest syndrome in children are similar pulse. Consider anti-arrhythmic therapy if a second cardioversion to those of adults. attempt is unsuccessful or if VT recurs. Temperature control and management Stable arrhythmias. While maintaining the child’s airway, Hypothermia is common in the child following cardiopul- breathing and circulation, contact an expert before initiating ther- monary resuscitation.350 Central hypothermia (32–34 ◦ C) may be apy. Depending on the child’s clinical history, presentation and ECG beneficial, whereas fever may be detrimental to the injured brain. diagnosis, a child with stable, wide-QRS complex tachycardia may Mild hypothermia has an acceptable safety profile in adults355,356 be treated for SVT and be given vagal manoeuvres or adenosine. and neonates.560–565 While it may improve neurological outcome Amiodarone may be considered as a treatment option if this fails in children, an observational study neither supports nor refutes the or if the diagnosis of VT is confirmed on an ECG. use of therapeutic hypothermia in paediatric cardiac arrest.566
- 33. J.P. Nolan et al. / Resuscitation 81 (2010) 1219–1276 1251 A child who regains a spontaneous circulation, but remains Planned home deliveries comatose after cardiopulmonary arrest, may benefit from being cooled to a core temperature of 32–34 ◦ C for at least 24 h. The suc- Recommendations as to who should attend a planned home cessfully resuscitated child with hypothermia and ROSC should not delivery vary from country to country, but the decision to undergo be actively rewarmed unless the core temperature is below 32 ◦ C. a planned home delivery, once agreed with medical and midwifery Following a period of mild hypothermia, rewarm the child slowly staff, should not compromise the standard of initial resuscitation at 0.25–0.5 ◦ C h−1 . at birth. There will inevitably be some limitations to resuscitation These guidelines are based on evidence from the use of thera- of a newborn baby in the home, because of the distance from fur- peutic hypothermia in neonates and adults. At the time of writing, ther assistance, and this must be made clear to the mother at the there are ongoing, prospective, multicentre trials of therapeutic time plans for home delivery are made. Ideally, two trained profes- hypothermia in children following in- and out-of-hospital cardiac sionals should be present at all home deliveries; one of these must arrest. (www.clinicaltrials.gov; NCT00880087 and NCT00878644) be fully trained and experienced in providing mask ventilation and Fever is common following cardiopulmonary resuscitation and chest compressions in the newborn. is associated with a poor neurological outcome,346,348,349 the risk increasing for each degree of body temperature greater than Equipment and environment 37 ◦ C.349 There are limited experimental data suggesting that the treatment of fever with antipyretics and/or physical cooling Unlike adult cardiopulmonary resuscitation (CPR), resuscitation reduces neuronal damage.567,568 Antipyretics and accepted drugs at birth is often a predictable event. It is therefore possible to pre- to treat fever are safe; therefore, use them to treat fever aggres- pare the environment and the equipment before delivery of the sively. baby. Resuscitation should ideally take place in a warm, well-lit, draught free area with a flat resuscitation surface placed below a Glucose control radiant heater, with other resuscitation equipment immediately Both hyper- and hypo-glycaemia may impair outcome of criti- available. All equipment must be checked frequently. cally ill adults and children and should be avoided, but tight glucose When a birth takes place in a non-designated delivery area, the control may also be harmful. Although there is insufficient evi- recommended minimum set of equipment includes a device for dence to support or refute a specific glucose management strategy safe assisted lung aeration of an appropriate size for the newborn, in children with ROSC after cardiac arrest,3,569,570 it is appropri- warm dry towels and blankets, a sterile instrument for cutting the ate to monitor blood glucose and avoid hypoglycaemia as well as umbilical cord and clean gloves for the attendant and assistants. It sustained hyperglycaemia. may also be helpful to have a suction device with a suitably sized suction catheter and a tongue depressor (or laryngoscope) to enable Resuscitation of babies at birth the oropharynx to be examined. Unexpected deliveries outside hos- pital are most likely to involve emergency services who should plan Preparation for such events. Relatively few babies need any resuscitation at birth. Of those Temperature control that do need help, the overwhelming majority will require only assisted lung aeration. A small minority may need a brief period Naked, wet, newborn babies cannot maintain their body tem- of chest compressions in addition to lung aeration. Of 100,000 perature in a room that feels comfortably warm for adults. babies born in Sweden in one year, only 10 per 1000 (1%) babies Compromised babies are particularly vulnerable.572 Exposure of of 2.5 kg or more appeared to need resuscitation at delivery.571 Of the newborn to cold stress will lower arterial oxygen tension573 those babies receiving resuscitation, 8 per 1000 responded to mask and increase metabolic acidosis.574 Prevent heat loss: inflation and only 2 per 1000 appeared to need intubation. The • Protect the baby from draughts. same study tried to assess the unexpected need for resuscitation • Keep the delivery room warm. For babies less than 28 weeks at birth and found that for low risk babies, i.e., those born after 32 weeks gestation and following an apparently normal labour, about gestation the delivery room temperature should be 26 ◦ C.575,576 • Dry the term baby immediately after delivery. Cover the head 2 per 1000 (0.2%) appeared to need resuscitation at delivery. Of these, 90% responded to mask inflation alone while the remaining and body of the baby, apart from the face, with a warm towel 10% appeared not to respond to mask inflation and therefore were to prevent further heat loss. Alternatively, place the baby skin to intubated at birth (Fig. 1.14). skin with mother and cover both with a towel. • If the baby needs resuscitation then place the baby on a warm Resuscitation or specialist help at birth is more likely to be needed by babies with intrapartum evidence of significant fetal surface under a preheated radiant warmer. • In very preterm babies (especially below 28 weeks) drying and compromise, babies delivering before 35 weeks gestation, babies delivering vaginally by the breech, and multiple pregnancies. wrapping may not be sufficient. A more effective method of keep- Although it is often possible to predict the need for resuscitation ing these babies warm is to cover the head and body of the baby or stabilisation before a baby is born, this is not always the case. (apart from the face) with plastic wrapping, without drying the Therefore, personnel trained in newborn life support should be eas- baby beforehand, and then to place the baby so covered under ily available at every delivery and, should there be any need for radiant heat. intervention, the care of the baby should be their sole responsibil- Initial assessment ity. One person experienced in tracheal intubation of the newborn should ideally be in attendance for deliveries associated with a high The Apgar score was proposed as a “simple, common, clear clas- risk of requiring neonatal resuscitation. Local guidelines indicat- sification or grading of newborn infants” to be used “as a basis ing who should attend deliveries should be developed, based on for discussion and comparison of the results of obstetric practices, current practice and clinical audit. types of maternal pain relief and the effects of resuscitation” (our An organised educational programme in the standards and skills emphasis).577 It was not designed to be assembled and ascribed required for resuscitation of the newborn is therefore essential for in order to then identify babies in need of resuscitation.578 How- any institution in which deliveries occur. ever, individual components of the score, namely respiratory rate,
- 34. 1252 J.P. Nolan et al. / Resuscitation 81 (2010) 1219–1276 Fig. 1.14. Newborn life support algorithm. © 2010 ERC. heart rate and tone, if assessed rapidly, can identify babies needing effective but can be misleading, cord pulsation is only reliable if resuscitation.577 Furthermore, repeated assessment particularly of found to be more than 100 beats min−1 .579 For babies requiring heart rate and, to a lesser extent breathing, can indicate whether resuscitation and/or continued respiratory support, a modern pulse the baby is responding or whether further efforts are needed. oximeter can give an accurate heart rate.580 Breathing Colour Check whether the baby is breathing. If so, evaluate the rate, Colour is a poor means of judging oxygenation,581 which is bet- depth and symmetry of breathing together with any evidence of an ter assessed using pulse oximetry if possible. A healthy baby is born abnormal breathing pattern such as gasping or grunting. blue but starts to become pink within 30 s of the onset of effective breathing. Peripheral cyanosis is common and does not, by itself, Heart rate indicate hypoxemia. Persistent pallor despite ventilation may indi- cate significant acidosis or rarely hypovolaemia. Although colour is This is assessed best by listening to the apex beat with a stetho- a poor method of judging oxygenation, it should not be ignored: if scope. Feeling the pulse in the base of the umbilical cord is often a baby appears blue check oxygenation with a pulse oximeter.
- 35. J.P. Nolan et al. / Resuscitation 81 (2010) 1219–1276 1253 Tone Breathing A very floppy baby is likely to be unconscious and will need After initial steps at birth, if breathing efforts are absent or ventilatory support. inadequate, lung aeration is the priority. In term babies, begin resuscitation with air. The primary measure of adequate initial lung Tactile stimulation inflation is a prompt improvement in heart rate; assess chest wall movement if heart rate does not improve. Drying the baby usually produces enough stimulation to induce For the first few breaths maintain the initial inflation pres- effective breathing. Avoid more vigorous methods of stimulation. If sure for 2–3 s. This will help lung expansion. Most babies needing the baby fails to establish spontaneous and effective breaths follow- resuscitation at birth will respond with a rapid increase in heart ing a brief period of stimulation, further support will be required. rate within 30 s of lung inflation. If the heart rate increases but the baby is not breathing adequately, ventilate at a rate of about Classification according to initial assessment 30 breaths min−1 allowing approximately one second for each inflation, until there is adequate spontaneous breathing. On the basis of the initial assessment, the baby can be placed Adequate passive ventilation is usually indicated by either a into one of three groups: rapidly increasing heart rate or a heart rate that is maintained faster 1. Vigorous breathing or crying than 100 beats min−1 . If the baby does not respond in this way the Good tone Heart rate higher than 100 min−1 most likely cause is inadequate airway control or inadequate venti- This baby requires no intervention other than drying, wrapping lation. Without adequate lung aeration, chest compressions will be in a warm towel and, where appropriate, handing to the mother. ineffective; therefore, confirm lung aeration before progressing to The baby will remain warm through skin-to-skin contact with circulatory support. Some practitioners will ensure airway control mother under a cover, and may be put to the breast at this stage. by tracheal intubation, but this requires training and experience. If 2. Breathing inadequately or apnoeic this skill is not available and the heart rate is decreasing, re-evaluate Normal or reduced tone the airway position and deliver inflation breaths while summon- Heart rate less than 100 min−1 ing a colleague with intubation skills. Continue ventilatory support Dry and wrap. This baby may improve with mask inflation but if until the baby has established normal regular breathing. this does not increase the heart rate adequately, may also require chest compressions. Circulatory support 3. Breathing inadequately or apnoeic Floppy Low or undetectable heart rate Circulatory support with chest compressions is effective only if Often pale suggesting poor perfusion the lungs have first been successfully inflated. Give chest compres- Dry and wrap. This baby will then require immediate airway sions if the heart rate is less than 60 beats min−1 despite adequate control, lung inflation and ventilation. Once this has been success- ventilation. The most effective technique for providing chest com- fully accomplished the baby may also need chest compressions, and pressions is to place the two thumbs side by side over the lower perhaps drugs. third of the sternum just below an imaginary line joining the There remains a very rare group of babies who, though breath- nipples, with the fingers encircling the torso and supporting the ing adequately and with a good heart rate, remain hypoxaemic. This back.583–586 An alternative way to find the correct position of group includes a range of possible diagnoses such as diaphragmatic the thumbs is to identify the xiphisternum and then to place the hernia, surfactant deficiency, congenital pneumonia, pneumotho- thumbs on the sternum one finger’s breadth above this point. The rax, or cyanotic congenital heart disease. sternum is compressed to a depth of approximately one-third of the anterior–posterior diameter of the chest allowing the chest wall to Newborn life support return to its relaxed position between compressions.587 Use a CV ratio of 3:1, aiming to achieve approximately Commence newborn life support if assessment shows that the 120 events min−1 , i.e., approximately 90 compressions and 30 baby has failed to establish adequate regular normal breathing, or breaths. Check the heart rate after about 30 s and periodically there- has a heart rate of less than 100 min−1 . Opening the airway and after. Discontinue chest compressions when the spontaneous heart aerating the lungs is usually all that is necessary. Furthermore, more rate is faster than 60 beats min−1 . complex interventions will be futile unless these two first steps have been successfully completed. Drugs Airway Drugs are rarely indicated in resuscitation of the newly born infant. Bradycardia in the newborn infant is usually caused by Place the baby on his back with the head in a neutral position. inadequate lung inflation or profound hypoxia, and establishing A 2 cm thickness of the blanket or towel placed under the baby’s adequate ventilation is the most important step to correct it. How- shoulders may be helpful in maintaining proper head position. In ever, if the heart rate remains less than 60 beats min−1 despite floppy babies application of jaw thrust or the use of an appropri- adequate ventilation and chest compressions, it is reasonable to ately sized oropharyngeal airway may be helpful in opening the consider the use of drugs. These are best given via an umbilical airway. venous catheter. Suction is needed only if the airway is obstructed and is best done under direct vision. Aggressive pharyngeal suction can delay Adrenaline the onset of spontaneous breathing and cause laryngeal spasm and Despite the lack of human data it is reasonable to use adrenaline vagal bradycardia.582 The presence of thick meconium in a non- when adequate ventilation and chest compressions have failed to vigorous baby is the only indication for considering immediate increase the heart rate above 60 beats min−1 . If adrenaline is used, suction of the oropharynx. Connect a 12–14 FG suction catheter, give 10–30 g kg−1 intravenously as soon as possible. The tracheal or a Yankauer sucker, to a suction source not exceeding minus route is not recommended but if it is used, it is highly likely that 100 mm Hg. doses of 50–100 g kg−1 will be required. Neither the safety nor
- 36. 1254 J.P. Nolan et al. / Resuscitation 81 (2010) 1219–1276 the efficacy of these higher tracheal doses has been studied. Do not Poisoning give these high doses intravenously. Poisoning rarely causes cardiac arrest, but is a leading cause of death in victims younger than 40 years of age.590 Poisoning by Bicarbonate therapeutic or recreational drugs and by household products are There are insufficient data to recommend routine use of bicar- the main reasons for hospital admission and poison centre calls. bonate in resuscitation of the newly born. The hyperosmolarity and Inappropriate drug dosing, drug interactions and other medication carbon dioxide-generating properties of sodium bicarbonate may errors can also cause harm. Accidental poisoning is commonest in impair myocardial and cerebral function. Use of sodium bicarbon- children. Homicidal poisoning is uncommon. Industrial accidents, ate is discouraged during brief CPR. If it is used during prolonged warfare or terrorism can also cause exposure to harmful substances. arrests unresponsive to other therapy, it should be given only after adequate ventilation and circulation is established with CPR. A dose Prevention of cardiac arrest of 1–2 mmol kg−1 may be given by slow intravenous injection after adequate ventilation and perfusion have been established. Assess and treat the victim using the ABCDE (Airway, Breath- ing, Circulation, Disability, Exposure) approach. Airway obstruction Fluids and respiratory arrest secondary to a decreased conscious level is a common cause of death after self-poisoning.591 Pulmonary aspi- If there has been suspected blood loss or the infant appears to be ration of gastric contents can occur after poisoning with central in shock (pale, poor perfusion, weak pulse) and has not responded nervous system depressants. Early tracheal intubation of uncon- adequately to other resuscitative measures then consider giving scious patients by a trained person decreases the risk of aspiration. fluid.588 This is a rare event. In the absence of suitable blood (i.e., Drug-induced hypotension usually responds to fluid infusion, but irradiated and leucocyte-depleted group O Rh-negative blood), occasionally vasopressor support (e.g., noradrenaline infusion) is isotonic crystalloid rather than albumin is the solution of choice required. A long period of coma in a single position can cause pres- for restoring intravascular volume. Give a bolus of 10 ml kg−1 sure sores and rhabdomyolysis. Measure electrolytes (particularly initially. If successful it may need to be repeated to maintain an potassium), blood glucose and arterial blood gases. Monitor tem- improvement. perature because thermoregulation is impaired. Both hypothermia and hyperthermia (hyperpyrexia) can occur after overdose of some drugs. Retain samples of blood and urine for analysis. Patients Stopping resuscitation with severe poisoning should be cared for in a critical care setting. Interventions such as decontamination, enhanced elim- Local and national committees will determine the indications ination and antidotes may be indicated and are usually second for stopping resuscitation. If the heart rate of a newly born baby line interventions.592 Alcohol excess is often associated with self- is not detectable and remains undetectable for 10 min, it is then poisoning. appropriate to consider stopping resuscitation. In cases where the heart rate is less than 60 min−1 at birth and does not improve after Modifications to basic and advanced life support 10 or 15 min of continuous and apparently adequate resuscitative efforts, the choice is much less clear. In this situation there is insuf- • Have a high index of personal safety where there is a suspicious ficient evidence about outcome to enable firm guidance on whether cause or unexpected cardiac arrest. This is especially so when to withhold or to continue resuscitation. more than one casualty collapses simultaneously. • Avoid mouth-to-mouth ventilation in the presence of chemicals Communication with the parents such as cyanide, hydrogen sulphide, corrosives and organophos- phates. It is important that the team caring for the newborn baby • Treat life-threatening tachyarrhythmias with cardioversion informs the parents of the baby’s progress. At delivery, adhere according to the peri-arrest arrhythmia guidelines (see Advanced to local plans for routine care and, if possible, hand the baby to life support).6 This includes correction of electrolyte and acid-base the mother at the earliest opportunity. If resuscitation is required abnormalities. inform the parents of the procedures undertaken and why they • Try to identify the poison(s). Relatives, friends and ambu- were required. Record carefully all discussions and decisions in the lance crews can provide useful information. Examination of mother’s notes prior to delivery and in the baby’s records after birth. the patient may reveal diagnostic clues such as odours, nee- dle marks, pupil abnormalities, and signs of corrosion in the mouth. Cardiac arrest in special circumstances • Measure the patient’s temperature because hypo- or hyperther- mia may occur after drug overdose (see Sections 8d and 8e). Electrolyte abnormalities • Be prepared to continue resuscitation for a prolonged period, par- ticularly in young patients, as the poison may be metabolized or Life-threatening arrhythmias are associated most commonly excreted during extended life support measures. with potassium disorders, particularly hyperkalaemia, and less • Alternative approaches that may be effective in severely poisoned commonly with disorders of serum calcium and magnesium. patients include: higher doses of medication than in standard In some cases therapy for life-threatening electrolyte disorders protocols; non-standard drug therapies; prolonged CPR. should start before laboratory results become available. There is • Consult regional or national poisons centres for information on little or no evidence for the treatment of electrolyte abnormalities treatment of the poisoned patient. The International Programme during cardiac arrest. Guidance during cardiac arrest is based on on Chemical Safety (IPCS) lists poison centres on its website: the strategies used in the non-arrest patient. There are no major http://www.who.int/ipcs/poisons/centre/en/ changes in the treatment of these disorders since the International • On-line databases for information on toxicology and hazardous Guidelines 2005.589 chemicals: (http://toxnet.nlm.nih.gov/)
- 37. J.P. Nolan et al. / Resuscitation 81 (2010) 1219–1276 1255 Drowning with apnoea and cardiac arrest, extracorporeal rewarming is the preferred method of active internal rewarming because it provides The World Health Organisation (WHO) estimates that, world- sufficient circulation and oxygenation while the core body temper- wide, drowning accounts for approximately 450,000 deaths each ature is increased by 8–12 ◦ C h−1 .598 year and drowning is a common cause of accidental death in Europe. During rewarming, patients will require large volumes of fluids After drowning the duration of hypoxia is the most critical factor as vasodilation causes expansion of the intravascular space. Contin- in determining the victim’s outcome; therefore, oxygenation, ven- uous haemodynamic monitoring and warm IV fluids are essential. tilation, and perfusion should be restored as rapidly as possible. Avoid hyperthermia during and after re-warming. Although there Immediate resuscitation at the scene is essential for survival and are no formal studies, once ROSC has been achieved use standard neurological recovery after a drowning incident. This will require strategies for post-resuscitation care, including mild hypothermia provision of CPR by a bystander and immediate activation of the if appropriate. EMS system. Victims who have spontaneous circulation and breath- ing when they reach hospital usually recover with good outcomes. Hyperthermia Research into drowning is limited in comparison with primary car- diac arrest and there is a need for further research in this area.593 Hyperthermia occurs when the body’s ability to thermoregu- The guidelines described in detail in Section 8 of the ERC Guidelines late fails and core temperature exceeds that normally maintained are intended for healthcare professionals and certain groups of lay by homeostatic mechanisms. Hyperthermia may be exogenous, responders that have a special interest in the care of the drowning caused by environmental conditions, or secondary to endogenous victim e.g., lifeguards.10 heat production. Environment-related hyperthermia occurs where heat, usually Accidental hypothermia in the form of radiant energy, is absorbed by the body at a rate faster than can be lost by thermoregulatory mechanisms. Hyperther- Accidental hypothermia exists when the body core temperature mia occurs along a continuum of heat-related conditions, starting unintentionally drops below 35 ◦ C. Hypothermia can be classified with heat stress, progressing to heat exhaustion, to heat stroke arbitrarily as mild (35–32 ◦ C), moderate (32–28 ◦ C) or severe (less (HS) and finally multiorgan dysfunction and cardiac arrest in some than 28 ◦ C).594 In a hypothermic patient, no signs of life alone is instances.599 unreliable for declaring death. In the pre-hospital setting, resuscita- Heat stroke is a systemic inflammatory response with a core tion should be withheld only if the cause of a cardiac arrest is clearly temperature above 40.6 ◦ C, accompanied by mental state change attributable to a lethal injury, fatal illness, prolonged asphyxia, or if and varying levels of organ dysfunction. There are two forms of the chest is incompressible. All the principles of prevention, basic HS: classic non-exertional heat stroke (CHS) occurs during high and advanced life support apply to the hypothermic patient. Use the environmental temperatures and often effects the elderly during same ventilation and chest compression rates as for a normoth- heat waves600 ; Exertional heat stroke (EHS) occurs during strenu- ermic patient. Hypothermia can cause stiffness of the chest wall, ous physical exercise in high environmental temperatures and/or making ventilation and chest compressions more difficult. high humidity usually effects healthy young adults.601 Mortality The hypothermic heart may be unresponsive to cardio- from heat stroke ranges between 10% and 50%.602 active drugs, attempted electrical pacing and defibrillation. Drug The mainstay of treatment is supportive therapy based on opti- metabolism is slowed, leading to potentially toxic plasma concen- mizing the ABCDEs and rapidly cooling the patient.603–605 Start trations of any drugs given repeatedly.595 Withold adrenaline and cooling before the patient reaches hospital. Aim to reduce the core other CPR drugs until the patient has been warmed to a temperature temperature rapidly to approximately 39 ◦ C. Patients with severe higher than approximately 30 ◦ C. Once 30 ◦ C has been reached, the heat stroke need to be managed in a critical-care setting. intervals between drug doses should be doubled when compared There are no specific studies on cardiac arrest in hyperthermia. with normothermia intervals. As normothermia is approached If cardiac arrest occurs, follow standard procedures for basic and (over 35 ◦ C), standard drug protocols should be used. advanced life support and cool the patient. Cooling techniques sim- As the body core temperature decreases, sinus bradycardia ilar to those used to induce therapeutic hypothermia should be tends to give way to atrial fibrillation followed by VF and finally used. There are no data on the effects of hyperthermia on defib- asystole.596 Once in hospital, severely hypothermic victims in car- rillation threshold; therefore, attempt defibrillation according to diac arrest should be rewarmed with active internal methods. current guidelines, while continuing to cool the patient. Animal Arrhythmias other than VF tend to revert spontaneously as the core studies suggest the prognosis is poor compared with normothermic temperature increases, and usually do not require immediate treat- cardiac arrest.606,607 The risk of unfavourable neurological outcome ment. Bradycardia may be physiological in severe hypothermia, and increases for each degree of body temperature >37 ◦ C.349 cardiac pacing is not indicated unless bradycardia associated with haemodynamic compromise persists after re-warming. The tem- Asthma perature at which defibrillation should first be attempted and how often it should be tried in the severely hypothermic patient has The worldwide prevalence of asthma symptoms ranges from 1% not been established. AEDs may be used on these patients. If VF is to 18% of the population with a high prevalence in some European detected, give a shock at the maximum energy setting; if VF/VT per- countries (United Kingdom, Ireland and Scandinavia).608 Annual sists after three shocks, delay further defibrillation attempts until worldwide deaths from asthma have been estimated at 250,000. the core temperature is above 30 ◦ C.597 If an AED is used, follow the National and international guidance for the management of asthma AED prompts while rewarming the patient. CPR and rewarming already exists.608,609 This guidance focuses on the treatment of may have to be continued for several hours to facilitate successful patients with near-fatal asthma and cardiac arrest. defibrillation.597 Rewarming may be passive, active external, or active internal. Causes of asthma-related cardiac arrest Passive rewarming is appropriate in conscious victims with mild hypothermia who are still able to shiver. Hypothermic victims with Cardiac arrest in a person with asthma is often a terminal event an altered consciousness should be taken to a hospital capable of after a period of hypoxaemia; occasionally, it may be sudden. Car- active external and internal rewarming. In a hypothermic patient diac arrest in those with asthma has been linked to:
- 38. 1256 J.P. Nolan et al. / Resuscitation 81 (2010) 1219–1276 • severe bronchospasm and mucous plugging leading to asphyxia Extracorporeal life support (ECLS) can ensure both organ (this condition causes the vast majority of asthma-related perfusion and gas exchange in case of otherwise untreatable res- deaths); piratory and circulatory failure. Cases of successful treatment of • cardiac arrhythmias caused by hypoxia, which is the commonest asthma-related cardiac arrest in adults using ECLS have been cause of asthma-related arrhythmia.610 Arrhythmias can also be reported620,621 ; however, the role of ECLS in cardiac arrest caused caused by stimulant drugs (e.g., beta-adrenergic agonists, amino- by asthma has never been investigated in controlled studies. phylline) or electrolyte abnormalities; • dynamic hyperinflation, i.e., auto-positive end-expiratory pres- Anaphylaxis sure (auto-PEEP), can occur in mechanically ventilated asthmat- ics. Auto-PEEP is caused by air trapping and ‘breath stacking’ (air Anaphylaxis is a severe, life-threatening, generalised or sys- entering the lungs and being unable to escape). Gradual build-up temic hypersensitivity reaction. This is characterised by rapidly of pressure occurs and reduces venous return and blood pressure; developing life-threatening airway and/or breathing and/or cir- • tension pneumothorax (often bilateral). culation problems usually associated with skin and mucosal changes.622,623 Anaphylaxis usually involves the release of inflam- Key interventions to prevent arrest matory mediators from mast cells and, or basophils triggered by an allergen interacting with cell-bound immunoglobulin E (IgE). The patient with severe asthma requires aggressive medical Non-IgE-mediated or non-immune release of mediators can also management to prevent deterioration. Base assessment and treat- occur. Histamine and other inflammatory mediator release are ment on an ABCDE approach. Patients with SaO2 < 92% or with responsible for the vasodilatation, oedema and increased capillary features of life-threatening asthma are at risk of hypercapnic permeability. respiratory failure and require arterial blood gas measurement. Anaphylaxis is the likely diagnosis if a patient who is exposed Experienced clinicians should treat these high-risk patients in a to a trigger (allergen) develops a sudden illness (usually within critical-care area. The specific drugs and the treatment sequence minutes) with rapidly developing life-threatening airway and/or will vary according to local practice but are described in detail in breathing and/or circulation problems usually associated with skin Section 8f of the ERC Guidelines.10 and mucosal changes. Use an ABCDE approach to recognise and treat anaphylaxis. Treatment of cardiac arrest caused by asthma Adrenaline should be given to all patients with life-threatening features. The intramuscular (IM) route is the best for most rescuers Give basic life support according to standard guidelines. Venti- who have to give adrenaline to treat anaphylaxis. Use the following lation will be difficult because of increased airway resistance; try doses: to avoid gastric inflation. Modifications to standard ALS guidelines include considering the need for early tracheal intubation. The very >12 years and adults 500 g IM high airways resistance means that there is a significant risk of gas- >6–12 years 300 g IM tric inflation and hypoventilation of the lungs when attempting to >6 months–6 years 150 g IM <6 months 150 g IM ventilate a severe asthmatic without a tracheal tube. During car- diac arrest this risk is even higher, because the lower oesophageal Intravenous adrenaline should be used only by those experi- sphincter pressure is substantially less than normal.611 enced in the use and titration of vasopressors in their normal clin- Respiratory rates of 8–10 breaths min−1 and tidal volume ical practice (e.g., anaesthetists, emergency physicians, intensive required for a normal chest rise during CPR should not cause care doctors). In adults, titrate IV adrenaline using 50 g boluses dynamic hyperinflation of the lungs (gas trapping). Tidal volume according to response. Initially, give the highest concentration of depends on inspiratory time and inspiratory flow. Lung emptying oxygen possible using a mask with an oxygen reservoir.427 Give a depends on expiratory time and expiratory flow. In mechani- rapid IV fluid challenge (20 ml kg−1 ) in a child or 500–1000 ml in an cally ventilated severe asthmatics, increasing the expiratory time adult) and monitor the response; give further doses as necessary. (achieved by reducing the respiratory rate) provides only moderate Other therapy (steroids, antihistamines, etc) for the treatment of gains in terms of reduced gas trapping when a minute volume of life-threatening asthma is detailed in Section 8g. If cardiac arrest less than 10 l min−1 is used.612 occurs, start CPR immediately and follow current guidelines. Pro- There is limited evidence from case reports of unexpected ROSC longed CPR may be necessary. Rescuers should ensure that help is in patients with suspected gas trapping when the tracheal tube is on its way as early advanced life support (ALS) is essential. disconnected.613–617 If dynamic hyperinflation of the lungs is sus- Measurement of mast cell tryptase will to help confirm a diag- pected during CPR, compression of the chest wall and/or a period nosis of anaphylaxis. Ideally, take three samples: initial sample as of apnoea (disconnection from the tracheal tube) may relieve gas soon as feasible after resuscitation has started; second sample at trapping if dynamic hyperinflation occurs. Although this procedure 1–2 h after the start of symptoms, third sample either at 24 h or in is supported by limited evidence, it is unlikely to be harmful in an convalescence. All patients presenting with anaphylaxis should be otherwise desperate situation.15 Dynamic hyperinflation increases referred to an allergy clinic to identify the cause, and thereby reduce transthoracic impedance.618 Consider higher shock energies for the risk of future reactions and prepare the patient to manage future defibrillation if initial defibrillation attempts fail.14 episodes themselves. There is no good evidence for the use of open-chest cardiac compressions in patients with asthma-associated cardiac arrest. Cardiac arrest following cardiac surgery Working through the four Hs and four Ts will identify potentially reversible causes of asthma-related cardiac arrest. Tension pneu- Cardiac arrest following major cardiac surgery is relatively mothorax can be difficult to diagnose in cardiac arrest; it may common in the immediate post-operative phase, with a reported be indicated by unilateral expansion of the chest wall, shifting incidence of 0.7–2.9%.624–632 It is usually preceded by physio- of the trachea and subcutaneous emphysema. Pleural ultrasound logical deterioration,633 although it can occur suddenly in stable in skilled hands is faster and more sensitive than chest X-ray for patients.630 There are usually specific causes of cardiac arrest, such the detection of pneumothorax.619 Always consider bilateral pneu- as tamponade, hypovolaemia, myocardial ischaemia, tension pneu- mothoraces in asthma-related cardiac arrest. mothorax, or pacing failure. These are all potentially reversible and
- 39. J.P. Nolan et al. / Resuscitation 81 (2010) 1219–1276 1257 if treated promptly cardiac arrest after cardiac surgery has a rel- data are available) neurological outcome is good in only 1.6% of atively high survival rate. Key to the successful resuscitation of those sustaining traumatic cardiorespiratory arrest (TCRA). cardiac arrest in these patients is recognition of the need the need to perform emergency resternotomy early, especially in the context Commotio cordis of tamponade or haemorrhage, where external chest compressions may be ineffective. Commotio cordis is actual or near cardiac arrest caused by a blunt impact to the chest wall over the heart.647–651 A blow to the Starting CPR chest during the vulnerable phase of the cardiac cycle may cause malignant arrhythmias (usually ventricular fibrillation). Commotio Start external chest compressions immediately in all patients cordis occurs mostly during sports (most commonly baseball) and who collapse without an output. Consider reversible causes: recreational activities and victims are usually young males (mean hypoxia – check tube position, ventilate with 100% oxygen; ten- age 14 years). The overall survival rate from commotio cordis is sion pneumothorax – clinical examination, thoracic ultrasound; 15%, but 25% if resuscitation is started within 3 min.651 hypovolaemia, pacing failure. In asystole, secondary to a loss of cardiac pacing, chest compressions may be delayed momentarily Signs of life and initial ECG activity as long as the surgically inserted temporary pacing wires can be connected rapidly and pacing re-established (DDD at 100 min−1 at There are no reliable predictors of survival for TCRA. One study maximum amplitude). The effectiveness of compressions may be reported that the presence of reactive pupils and sinus rhythm verified by looking at the arterial trace, aiming to achieve a systolic correlate significantly with survival.652 In a study of penetrat- blood pressure of at least 80 mm Hg at a rate of 100 min−1 . ing trauma, pupil reactivity, respiratory activity and sinus rhythm were correlated with survival but were unreliable.646 Three stud- ies reported no survivors in patients presenting with asystole or Defibrillation agonal rhythms.642,646,653 Another reported no survivors among those with PEA after blunt trauma.654 Based on these studies, There is concern that external chest compressions can cause the American College of Surgeons and the National Association of sternal disruption or cardiac damage.634–637 In the post-cardiac EMS physicians produced pre-hospital guidelines on withholding surgery ICU, a witnessed and monitored VF/VT cardiac arrest should resuscitation.655 be treated immediately with up to three quick successive (stacked) defibrillation attempts. Three failed shocks in the post-cardiac Treatment surgery setting should trigger the need for emergency rester- notomy. Further defibrillation is attempted as indicated in the Survival from TCRA is correlated with duration of CPR and universal algorithm and should be performed with internal paddles pre-hospital time.644,656–660 Undertake only essential lifesaving at 20 J if resternotomy has been performed. interventions on scene and, if the patient has signs of life, transfer rapidly to the nearest appropriate hospital. Consider on Emergency drugs scene thoracotomy for appropriate patients.661,662 Do not delay for unproven interventions such as spinal immobilization.663 Use adrenaline very cautiously and titrate to effect (intravenous Treat reversible causes: hypoxaemia (oxygenation, ventilation); doses of up to 100 g in adults). Give amiodarone 300 mg after the compressible haemorrhage (pressure, pressure dressings, tourni- 3rd failed defibrillation attempt but do not delay resternotomy. quets, novel haemostatic agents); non-compressible haemorrhage (splints, intravenous fluid); tension pneumothorax (chest decom- Emergency resternotomy pression); cardiac tamponade (immediate thoracotomy). Chest compressions may not be effective in hypovolaemic cardiac arrest, This is an integral part of resuscitation after cardiac surgery, once but most survivors do not have hypovolaemia and in this subgroup all other reversible causes have been excluded. Once adequate air- standard advanced life support may be lifesaving. Standard CPR way and ventilation has been established, and if three attempts at should not delay the treatment of reversible causes (e.g., thoraco- defibrillation have failed in VF/VT, undertake resternotomy with- tomy for cardiac tamponade). out delay. Emergency resternotomy is also indicated in asystole or Resuscitative thoracotomy PEA, when other treatments have failed. If physicians with appropriate skills are on scene, prehospital Internal defibrillation resuscitative thoracotomy may be indicated for selected patients with cardiac arrest associated with penetrating chest injury. Internal defibrillation using paddles applied directly across Emergency department thoracotomy (EDT) is best applied to the ventricles requires considerably less energy than that used patients with penetrating cardiac injuries who arrive at a trauma for external defibrillation. Use 20 J in cardiac arrest, but 5 J if the centre after a short on scene and transport time with witnessed patient has been placed on cardiopulmonary bypass. Continuing signs of life or ECG activity (estimated survival rate 31%).664 After cardiac compressions using the internal paddles while charging the blunt trauma, EDT should be limited to those with vital signs on defibrillator and delivering the shock during the decompression arrival and a witnessed cardiac arrest (estimated survival rate 1.6%). phase of compressions may improve shock success.638,639 Ultrasound Traumatic cardiorespiratory arrest Ultrasound is a valuable tool for the evaluation of the Cardiac arrest caused by trauma has a very high mortality, with compromised trauma patient. Haemoperitoneum, haemo-or pneu- an overall survival of just 5.6% (range 0–17%).640–646 For reasons mothorax and cardiac tamponade can be diagnosed reliably in that are unclear, reported survival rates in the last 5 years are minutes even in the pre-hospital phase.665 Pre-hospital ultrasound better than reported previously. In those who survive (and where is now available, although its benefits are yet to be proven.666
- 40. 1258 J.P. Nolan et al. / Resuscitation 81 (2010) 1219–1276 Cardiac arrest associated with pregnancy If immediate resuscitation attempts fail Mortality related to pregnancy in developed countries is rare, Consider the need for an emergency hysterotomy or caesarean occurring in an estimated 1:30,000 deliveries.667 The fetus must section as soon as a pregnant woman goes into cardiac arrest. In always be considered when an adverse cardiovascular event occurs some circumstances immediate resuscitation attempts will restore in a pregnant woman. Resuscitation guidelines for pregnancy are a perfusing rhythm; in early pregnancy this may enable the preg- based largely on case series, extrapolation from non-pregnant nancy to proceed to term. When initial resuscitation attempts fail, arrests, manikin studies and expert opinion based on the phys- delivery of the fetus may improve the chances of successful resus- iology of pregnancy and changes that occur in normal labour. citation of the mother and fetus.674–676 Studies tend to address causes in developed countries, whereas the most pregnancy-related deaths occur in developing countries. • At gestational age <20 weeks, urgent caesarean delivery need not There were an estimated 342,900 maternal deaths (death during be considered, because a gravid uterus of this size is unlikely to pregnancy, childbirth, or in the 42 days after delivery) worldwide significantly compromise maternal cardiac output. in 2008.668 • At gestational age approximately 20–23 weeks, initiate emer- Causes of cardiac arrest in pregnant women include: cardiac gency hysterotomy to enable successful resuscitation of the disease; pulmonary embolism; psychiatric disorders; hyperten- mother, not survival of the delivered infant, which is unlikely at sive disorders of pregnancy; sepsis; haemorrhage; amniotic fluid this gestational age. embolism; and ectopic pregancy.669 Pregnant women can also sus- • At gestational age approximately ≥24–25 weeks, initiate emer- tain cardiac arrest from the same causes as women of the same age gency hysterotomy to save the life of both the mother and the group. infant. Modifications to BLS guidelines for cardiac arrest during The best survival rate for infants over 24–25 weeks’ gestation pregnancy occurs when delivery of the infant is achieved within 5 min after the mother’s cardiac arrest. This requires that rescuers commence After 20 weeks’ gestation, the pregnant woman’s uterus can the hysterotomy at about 4 min after cardiac arrest. press down against the inferior vena cava and the aorta, impeding venous return and cardiac output. Uterine obstruction of venous Electrocution return can cause pre-arrest hypotension or shock and, in the crit- ically ill patient, may precipitate arrest.670,671 After cardiac arrest, Electrical injury is a relatively infrequent but potentially dev- the compromise in venous return and cardiac output by the gravid astating multisystem injury with high morbidity and mortality, uterus limits the effectiveness of chest compressions. causing 0.54 deaths per 100,000 people each year. Most electrical The key steps for BLS in a pregnant patient are: injuries in adults occur in the workplace and are associated gen- • Call for expert help early (including an obstetrician and neona- erally with high voltage, whereas children are at risk primarily at home, where the voltage is lower (220 V in Europe, Australia and tologist). • Start basic life support according to standard guidelines. Ensure Asia; 110 V in the USA and Canada).677 Electrocution from lightning strikes is rare, but worldwide it causes 1000 deaths each year.678 good quality chest compressions with minimal interruptions. • Manually displace the uterus to the left to remove caval compres- Electric shock injuries are caused by the direct effects of current on cell membranes and vascular smooth muscle. sion. • Add left lateral tilt if this is feasible—the optimal angle of tilt is Respiratory arrest may be caused by paralysis of the cen- tral respiratory control system or the respiratory muscles. unknown. Aim for between 15 and 30◦ . The angle of tilt needs Current may precipitate VF if it traverses the myocardium to allow good quality chest compressions and if needed allow during the vulnerable period (analogous to an R-on-T caesarean delivery of the fetus (see below). phenomenon).679 Electrical current may also cause myocar- dial ischaemia because of coronary artery spasm. Asystole may Modifications to advanced life support be primary, or secondary to asphyxia following respiratory arrest. There is a greater potential for gastro-oesophageal sphincter Lightning strikes deliver as much as 300 kV over a few mil- insufficiency and risk of pulmonary aspiration of gastric contents. liseconds. In those who survive the initial shock, extensive Early tracheal intubation with correctly applied cricoid pressure catecholamine release or autonomic stimulation may occur, caus- decreases this risk. Tracheal intubation will make ventilation of ing hypertension, tachycardia, non-specific ECG changes (including the lungs easier in the presence of increased intra-abdominal prolongation of the QT interval and transient T-wave inversion), pressure. A tracheal tube 0.5–1 mm internal diameter (ID) smaller and myocardial necrosis. Mortality from lightning injuries is as than that used for a non-pregnant woman of similar size may be high as 30%, with up to 70% of survivors sustaining significant necessary because of maternal airway narrowing from oedema morbidity.680–682 and swelling.672 There is no change in transthoracic impedance during pregnancy, suggesting that standard shock energies for defibrillation attempts should be used in pregnant patients.673 Resuscitation Rescuers should attempt to identify common and reversible causes of cardiac arrest in pregnancy during resuscitation attempts. Ensure that any power source is switched off and do not The 4Hs and 4Ts approach helps identify all the common causes approach the casualty until it is safe. Start standard basic and of cardiac arrest in pregnancy. Pregnant patients are at risk of all advanced life support without delay. the other causes of cardiac arrest for their age group (e.g., ana- phylaxis, drug overdose, trauma). Consider the use of abdominal • Airway management may be difficult if there are electrical burns ultrasound by a skilled operator to detect pregnancy and possible around the face and neck. Early tracheal intubation is needed in causes during cardiac arrest in pregnancy; however, do not delay these cases, as extensive soft-tissue oedema may develop caus- other treatments. ing airway obstruction. Head and spine trauma can occur after
- 41. J.P. Nolan et al. / Resuscitation 81 (2010) 1219–1276 1259 electrocution. Immobilize the spine until evaluation can be per- • CPR prompt or feedback devices improve CPR skill acquisition formed. and retention and should be considered during CPR training for • Muscular paralysis, especially after high voltage, may persist laypeople and healthcare professionals. for several hours681 ; ventilatory support is required during this • An increased emphasis on non-technical skills (NTS) such as period. leadership, teamwork, task management and structured commu- • VF is the commonest initial arrhythmia after high-voltage AC nication will help improve the performance of CPR and patient shock; treat with prompt attempted defibrillation. Asystole is care. more common after DC shock; use standard protocols for this • Team briefings to plan for resuscitation attempts, and debriefings and other arrhythmias. based on performance during simulated or actual resuscitation • Remove smouldering clothing and shoes to prevent further ther- attempts should be used to help improve resuscitation team and mal injury. individual performance. • Vigorous fluid therapy is required if there is significant tis- • Research about the impact of resuscitation training on actual sue destruction. Maintain a good urine output to enhance the patient outcomes is limited. Although manikin studies are useful, excretion of myoglobin, potassium and other products of tissue researchers should be encouraged to study and report the impact damage.683 of educational interventions on actual patient outcomes. • Consider early surgical intervention in patients with severe ther- mal injuries. Who and how to train • Maintain spinal immobilization if there is a likelihood of head or neck trauma.684,685 Ideally all citizens should have some knowledge of CPR. There is • Conduct a thorough secondary survey to exclude traumatic insufficient evidence for or against the use of training interventions injuries caused by tetanic muscular contraction or by the person that focus on high-risk populations. However, training can reduce being thrown.685,686 family member and, or patient anxiety, improve emotional adjust- • Electrocution can cause severe, deep soft-tissue injury with rel- ment and empowers individuals to feel that they would be able to atively minor skin wounds, because current tends to follow start CPR.19 neurovascular bundles; look carefully for features of compart- People who require resuscitation training range from laypeople, ment syndrome, which will necessitate fasciotomy. those without formal healthcare training but with a role that places a duty of care upon them (e.g., lifeguards, first aiders), and health- Principles of education in resuscitation care professionals working in a variety of settings including the community, emergency medical systems (EMS), general hospital Survival from cardiac arrest is determined by the quality of the wards and critical care areas. scientific evidence behind the guidelines, the effectiveness of edu- Training should be tailored to the needs of different types of cation and the resources for implementation of the guidelines.687 learners and learning styles to ensure acquisition and retention of An additional factor is how readily guidelines can be applied in resuscitation knowledge and skills. Those who are expected to per- clinical practice and the effect of human factors on putting the the- form CPR regularly need to have knowledge of current guidelines ory into practice.688 Implementation of Guidelines 2010 is likely to and be able to use them effectively as part of a multi-professional be more successful with a carefully planned, comprehensive imple- team. These individuals require more complex training including mentation strategy that includes education. Delays in providing both technical and non-technical skills (e.g., teamwork, leadership, training materials and freeing staff for training were cited as rea- structured communication skills).691,692 They are divided arbi- sons for delays in the implementation of the 2005 guidelines.689,690 trarily into basic level and advanced level training interventions whereas in truth this is a continuum. Key educational recommendations Basic level and AED training The key issues identified by the Education, Implementation and Teams (EIT) task force of ILCOR during the Guidelines 2010 evidence Bystander CPR and early defibrillation saves lives. Many fac- evaluation process are19 : tors decrease the willingness of bystanders to start CPR, including panic, fear of disease, harming the victim or performing CPR • Educational interventions should be evaluated to ensure that they incorrectly.693–708 Providing CPR training to laypeople increases reliably achieve the learning objectives. The aim is to ensure that willingness to perform CPR.696,702–704,709–714 learners acquire and retain the skills and knowledge that will CPR training and performing CPR during an actual cardiac arrest enable them to act correctly in actual cardiac arrests and improve is safe in most circumstances. Individuals undertaking CPR training patient outcomes. should be advised of the nature and extent of the physical activity • Short video/computer self-instruction courses, with minimal or required during the training program. Learners who develop signif- no instructor coaching, combined with hands-on practice can be icant symptoms (e.g., chest pain, severe shortness of breath) during considered as an effective alternative to instructor-led basic life CPR training should be advised to stop. Rescuers who develop sig- support (CPR and AED) courses. nificant symptoms during actual CPR should consider stopping CPR • Ideally all citizens should be trained in standard CPR that includes (see Basic life support guidelines for further information about risks compressions and ventilations. There are circumstances how- to the rescuer).4 ever where training in compression-only CPR is appropriate (e.g., opportunistic training with very limited time). Those trained in compression-only CPR should be encouraged to learn standard Basic life support and AED curriculum CPR. • Basic and advanced life support knowledge and skills deteriorate The curriculum for basic life support and AED training should in as little as three to 6 months. The use of frequent assessments be tailored to the target audience and kept as simple as possible. will identify those individuals who require refresher training to The following should be considered as core elements of the basic help maintain their knowledge and skills. life support and AED curriculum13,19 :
- 42. 1260 J.P. Nolan et al. / Resuscitation 81 (2010) 1219–1276 • Personal and environmental risks before starting CPR. computer driven) with minimal or no instructor coaching can • Recognition of cardiac arrest by assessment of responsiveness, be effective alternatives to instructor-led courses for laypeople opening of the airway and assessment of breathing.4,13 and healthcare providers learning basic life support and AED • Recognition of gasping or abnormal breathing as a sign of cardiac skills.720–734 It is essential that courses include hands-on practice arrest in unconscious unresponsive individuals.69,715 as part of the programme. The use of CPR prompt/feedback devices • Good quality chest compressions (including adherence to rate, may be considered during CPR training for laypeople and healthcare depth, full recoil and minimizing hands-off time) and rescue professionals.716 breathing. • Feedback/prompts (including from devices) during CPR training Duration and frequency of instructor-led basic life support and should be considered to improve skill acquisition and retention AED training courses during basic life support training.716 • All basic life support and AED training should aim to The optimal duration of instructor-led basic life support and teach standard CPR including rescue breathing/ventilations. AED training courses has not been determined and is likely to Chest compression-only CPR training has potential advantages vary according to the characteristics of the participants (e.g., lay over chest compression and ventilation in certain specific or healthcare; previous training; age), the curriculum, the ratio of situations.694,699,702,707,708,711,717,718 An approach to teaching CPR instructors to participants, the amount of hands-on training and is suggested below. the use of end of course assessments. Most studies show that CPR skills such as calling for help, chest Standard CPR versus chest compression-only CPR teaching compressions and ventilations decay within 3–6 months after ini- tial training.722,725,735–740 AED skills are retained for longer than There is controversy about which CPR skills different types of basic life support skills alone.736,741,742 rescuers should be taught. Compression-only CPR is easier and quicker to teach especially when trying to teach a large num- Advanced level training ber of individuals who would not otherwise access CPR training. In many situations however, standard CPR (which includes ven- Advanced level training curriculum tilation/rescuer breathing) is better, for example in children,84 asphyxial arrests, and when bystander CPR is required for more Advanced level training is usually for healthcare providers. Cur- than a few minutes.13 A simplified, education-based approach is ricula should be tailored to match individual learning needs, patient therefore suggested: case mix and the individual’s role within the healthcare system’s response to cardiac arrest. Team training and rhythm recognition • Ideally, full CPR skills (compressions and ventilation using a 30:2 skills will be essential to minimize hands-off time when using the ratio) should be taught to all citizens. 2010 manual defibrillation strategy that includes charging during • When training is time-limited or opportunistic (e.g., EMS chest compressions.117,743 telephone instructions to a bystander, mass events, publicity Core elements for advanced life support curricula should campaigns, YouTube ‘viral’ videos, or the individual does not wish include: to train), training should focus on chest compression-only CPR. • For those trained in compression-only CPR, subsequent train- • Cardiac arrest prevention.192,744 ing should include training in ventilation as well as chest • Good quality chest compressions including adherence to rate, compressions. Ideally these individuals should be trained in depth, full recoil and minimising hands-off time, and ventilation compression-only CPR and then offered training in chest com- using basic skills (e.g., pocket mask, bag mask). pressions with ventilation at the same training session. • Defibrillation including charging during compressions for manual • Those laypersons with a duty of care, such as first aid workers, defibrillation. lifeguards, and child minders, should be taught how to do chest • Advanced life support algorithms. compressions and ventilations. • Non-technical skills (e.g., leadership and team training, commu- • For children, rescuers should be encouraged to use whichever nication). adult sequence they have been taught, as outcome is worse if they do nothing. Non-specialists who wish to learn paediatric Advanced level training methods resuscitation because they have responsibility for children (e.g., parents, teachers, school nurses, lifeguards etc), should be taught A variety of methods (such as reading manuals, pretests and e- that it is preferable to modify adult basic life support and give learning can be used to prepare candidates before attending a life five initial breaths followed by approximately one minute of CPR support course 745–753 before they go for help, if there is no-one to go for them. Chest compression depth for children is at least 1/3 of the A-P diameter Simulation and realistic training techniques of the chest.8 Simulation training is an essential part of resuscitation training. Citizen-CPR training should be promoted for all. However being There is large variation in how simulation can be and is used for untrained should not be a barrier to performing chest compression- resuscitation training.754 The lack of consistent definitions (e.g., only CPR, preferably with dispatcher telephone advice. high vs. low fidelity simulation) makes comparisons of studies of different types of simulation training difficult. Basic life support and AED training methods Advanced life support training intervals There are numerous methods to deliver basic life support and AED training. Traditional, instructor-led training courses remain Knowledge and skill retention declines rapidly after initial the most frequently used method for basic life support and AED resuscitation training. Refresher training is invariably required training.719 When compared with traditional instructor-led train- to maintain knowledge and skills; however, the optimal fre- ing, well designed self-instruction programmes (e.g., video, DVD, quency for refresher training is unclear. Most studies show
- 43. J.P. Nolan et al. / Resuscitation 81 (2010) 1219–1276 1261 that advanced life support skills and knowledge decayed when Acknowledgements tested at three to 6 months after training, 737,755–762 two stud- ies suggested seven to 12 months,763,764 and one study 18 Many individuals have supported the authors in the prepa- months.765 ration of these guidelines. We would particularly like to thank Annelies Pické and Christophe Bostyn for their administrative sup- The ethics of resuscitation and end-of-life decisions port and for co-ordinating much of the work on the algorithms, and Bart Vissers for his role as administrative lead and member Several considerations are required to ensure that the decisions of the ERC Guidelines Steering Group. The algorithms were cre- to attempt or withhold resuscitation attempts are appropriate, and ated by Het Geel Punt bvba, Melkouwen 42a, 2590 Berlaar, Belgium that patients are treated with dignity. These decisions are com- (hgp@hetgeelpunt.be). plex and may be influenced by individual, international and local cultural, legal, traditional, religious, social and economic factors.766 Appendix A. ERC Guidelines Writing Group The 2010 ERC Guidelines include the following topics relating to ethics and end-of-life decisions. Gamal Abbas, Annette Alfonzo, Hans-Richard Arntz, John Bal- lance, Alessandro Barelli, Michael A. Baubin, Dominique Biarent, • Key principles of ethics. Joost Bierens, Robert Bingham, Leo L. Bossaert, Hermann Brugger, • Sudden cardiac arrest in a global perspective. Antonio Caballero, Pascal Cassan, Maaret Castrén, Cristina Granja, • Outcome and prognostication. Nicolas Danchin, Charles D. Deakin, Joel Dunning, Christoph Eich, • When to start and when to stop resuscitation attempts. Marios Georgiou, Robert Greif, Anthony J. Handley, Rudolph W. • Advance directives and do-not-attempt-resuscitation orders. Koster, Freddy K. Lippert, Andrew S. Lockey, David Lockey, Jesús • Family presence during resuscitation. López-Herce, Ian Maconochie, Koenraad G. Monsieurs, Nikolaos • Organ procurement I Nikolaou, Jerry P. Nolan, Peter Paal, Gavin D. Perkins, Violetta • Research in resuscitation and informed content. Raffay, Thomas Rajka, Sam Richmond, Charlotte Ringsted, Antonio • Research and training on the recently dead. ˜ Rodríguez-Núnez, Claudio Sandroni, Gary B. Smith, Jasmeet Soar, Petter A. Steen, Kjetil Sunde, Karl Thies, Jonathan Wyllie, David Zideman. Appendix B. Author conflicts of interest Author Conflict of interest Gamal Abbas Khalifa None Anette Alfonzo Full time NHS Consultant Janusz Andres None Hans-Richard Arntz Employer: Charite – Universitätsmedizin –Berlin (paid) Paid lecturer for Boehringer Ingelheim, Sanofi Aventis, Daiichi-Sankyo (all lectures on acute coronary care) Merck Sharp & Dohme on lipid disorders (total <7000Euros) Vice chairman of the German Resuscitation Council Boehringer Ingelheim, Sanofi Aventis: support of blinded randomised multicenter clinical studies, no salary support, external control of data, no restriction on pending publication John Ballance Medical Advisor to AKE Ltd., a risk mitigation company, and also to A4, a private ambulance company. International Course Co-ordinator for Advanced Life Support and Generic Instructor Courses for the European Resuscitation Council. Full Member of the Resuscitation Council (UK). Occasional advice to Intersurgical Ltd., Wokingham, Berkshire. Alessandro Barelli None Michael Baubin Associate Professor, Anaesthesiology and Critical Care, Innsbruck Medical University, Austria. Chairman Austrian Resuscitation Council. Sometimes paid lectures on CPR or on quality management in EM. Research grant: Österreichische Nationalbank: Satisfaction in Emergency medicine, no personal salary. Dominique Biarent Prize Gert Noel 2008 (research grant). No salary received. Joost Bierens Medical advisor to the Royal Dutch Life Boat Institution (KNRM), paid and volunteer. Consultant to the board of governors of the Society of Prevent people from drowning (MRD), volunteer. Member medical commission International Life Saving Federation (ILSF), volunteer. Bob Bingham Paediatric anaesthetist, Great Ormond Street Hospital, London. Chair: Paediatric Sub-committee Resuscitation Council (UK). Leo Bossaert ERC – not paid. Bernd Böttiger Chairman ERC – not paid. Hermann Brugger Head of Eurac Instute of Mountain Emergency Medicine – paid. 2001–2009: president of the international commission for Mountain Emergency Medicine – voluntary. Studies on avalanche resuscitation examining survival and prognostic factors time of burial and patent airway. Antonio Caballero Emergency Physician: Hospital Universiatrio Virgen del Rocío, Sevilla, Spain. Chairman Spanish Resuscitation Council. Pascal Cassan National Medical Advisor – French Red Cross. Coordinator of the European Reference Centre for first aid education – International Federation of Red Cross & Red Crescent. Member of the board of the French Resuscitation Council (Volunteer unpaid). Maaret Castrén Resuscitaiton Council Finland. TEL-CPR Task Force, Resuscitation Council Sweden. Research nurse, Benechill, 1 year, data controlled by investigator Laerdal Foundation, triage in trauma, 95.000 NOK + 75.000 NOK, tel-CPR: 150.000 NOK.
- 44. 1262 J.P. Nolan et al. / Resuscitation 81 (2010) 1219–1276 Appendix B (Continued ) Author Conflict of interest Nicolas Danchin Board: AstraZeneca, BMS, Eli Lilly, Boehringer-Ingelheim, Merck, Novartis, Sanofi-aventis, Servier, Pfizer. Chair of the Scientific Committee of the French National Health Insurance System. Funding of research grants received: AstraZeneca Eli Lilly, Pfizer, Servier, Merck, Novartis. Charles Deakin Executive Committee, Resuscitation Council (UK). Board, European Resuscitation Council. ALS Co-Chair, ILCOR. Various grants from the Resuscitation Council (UK) and the government National Institute for Health Research (UK). Joel Dunning I run a not for profit Training course called the Cardiac Surgery Advanced Life Support course. Christoph Eich Department of Anaesthesiology, Emergency and Intensive Care Medicine, University Medical Centre, Göttingen, Germany. Member of Executive Committee of the German Resuscitation Council (GRC); Member of the PLS Working Groups of ILCOR and ERC; German Board Member of the European Society of Paediatric Anaesthesia. No payments by any of the above or any other related subjects or organisations. Marios Georgiou Chairman Cyprus Resuscitation Council Christina Granja None Robert Greif Paid: Professor, Department of Anesthesiology and Pain Therapy, University Hospital Bern. Not paid: Advisory Board Medical University Vienna, Editorial Board Current Anaesthesia and Critical Care. Paid: Member of the Cantonal Ethic Committee Bern, CH. Unpaid: ERC Education Advisory Group, National Visiting Committee of Anesthesia Resident Programmes Swiss Anesthesia Society, Swiss Council Member European Airway Management Society, Research Committee Swiss Soc. Emergency Medicine, ESA Subcommittee Emergency Medicine and Resuscitation. Departmental grants, no salary. Anthony Handley Medical Consultant, Virgin Atlantic Airways – Paid Medical Consultant, British Airways – Paid Medical Consultant, DC Leisure – Paid Lecturer, Infomed – Paid Company Secretary, Resuscitation Council Trading Co. Ltd. – Voluntary Executive Member, Resuscitation Council (UK) – Voluntary Chairman, BLS/AED Subcommittee, Resuscitation Council (UK) – Voluntary Chief Medical Adviser, Royal Life Saving Society UK – Voluntary Chairman, Medical Committee, International Lifesaving (ILS) – Voluntary Honorary Medical Officer, Irish Water Safety – Voluntary Rudy W. Koster Academic Medical Center Amsterdam Member scientific board Netherlands Resuscitation Council Beard member ERC Co-chair BLS/AED ILCOR Guidelines process 2010 Physio Control: restricted research grants – industry has no data control – no publication restriction Zoll Medical: restricted research grants – industry has no data control – no publication restriction. Equipment on Loan (Autopulse) Jolife: restricted research grants – industry has no data control – no publication restriction. Equipent on loan (Lucas) Philips: equipment on loan (Philips MRX defibrillator) Research grant netherlands heart Foundation Research Grant Zon-MW (dutch public national research foundation) Freddy Lippert CEO, Medical Director of Emergency Medicine and Emergency Medical Services, Head Office, Capital Region of Denmark European Resuscitation Council, Board Member Danish Resuscitation Council, Board Member Research grant and funding of Ph.D. studies by Laerdal Foundation for Acute Medicine and TrygFonden (Danish foundation) (no restriction on publication) Member of Scientific Advisory Board of TrygFonden (Danish foundation) Andy Lockey Consultant in Emergency Medicine – Calderdale Royal Hospital. Medical Advisor – First on scene training LTD. Honorary Secretary – Resuscitation Council (UK) David Lockey None Jesús López-Herce None Ian Maconochie Consultant in Paediatric – St Mary’s Hospital London. Officer for Clinical Standards: Royal College of Paediatrics + Child Health. Advisor to TSG Associates – company dealing with major incident management. Koen Monsieurs My employer has received compensation from Weinmann for an invited lecture. I have received a research Grant from the Laerdal Foundation. I have academic research agreements with Zoll, Bio-Detek, O-Two systems and Laerdal. These agreements do not include salary or financial support. I am holder of a patent related to thoracic pressures during CPR. Nikolas Nikolaou Konstatopouleio General Hospital, Athens Greece. Chairman, Working Group on CPR of the Hellenic Cardiological Society. Member, Working Group on Acute Cardiac Care. Jerry Nolan Royal United Hospital NHS Trust, Bath (Employer) Co-Chair, International Liaison Committee on Resuscitation Editor-in-Chief, Resuscitation Board Member, European Resuscitation Council Member, Executive Committee, Resuscitation Council (UK) Peter Paal ERC ALS + EPLS Instructor. Funding with material, no money, provided from Laerdal, LMA Company, Intersurgical , VBM No salary support.
- 45. J.P. Nolan et al. / Resuscitation 81 (2010) 1219–1276 1263 Appendix B (Continued ) Author Conflict of interest Gavin Perkins University of Warwick, UK (Employer) Heart of England NHS Foundation Trust (Honorary contract) Medical review panel of first aid books produced by Qualsafe (paid) Vice Chairman Resuscitation Council (UK) ALS Subcommittee Chairman e-learning working group, Resuscitation Council (UK) Co-Director of Research Intensive Care Society (UK) Active grants: Department of Health National Institute for Health Research Clinician Scientist Award Department of Health National Institute for Health Research for Patient Benefit (quality of CPR trial) Department of Health National Institute for Health Research Health Technology Assessment (LUCAS trial) Resuscitation Council (UK) PhD Fellowships (×2) I do not receive any direct personal payment in relation to these grants. My employer (University of Warwick) charge the government funding organisations for my time. There are no restrictions on decision to publish the findings from the research identified above. Editor, Resuscitation Journal Violetta Raffay Emergency medicine specialist in Institute for Emergency Medical Care in Novi Sad, Serbia (paid employment) Head coordinator of Mentor‘s of Emergency Medicine postgraduate students (paid employment) Part-time work in Medical University in Kragujevac with high school and college students (paid) Founder of the Serbian and Montenegrian Resuscitation Council, and Serbian Resuscitation Council, Board member – volountary Chairman of the Serbian Resuscitation Council – volountary ERC Executive Committee and Board member (EC representative) –volountary Founder and member of the South Eastern European Trauma Working Group –volountary Sam Richmond None (Full-time NHS consultant in neonatology. No other relevant paid or unpaid employment) Co-chair of the neonatal section of ILCOR – unpaid Chair of the Newborn Life Support sub-committee of the Resuscitation Council (UK) – unpaid Charlotte Ringsted The Utstein Type Meeting on research in simulation-based education, member of organizing committee, Copenhagen June 2010 (Supported by the Laerdal Foundation); Unpaid member of committee. Funding – no salary support, data controlled by investigator, no restrictions on publication: Tryg Fonden Laerdals Fond for Akutmedicin Laerdal Medical A/S Toyota Fonden Bdr. Hartmanns Fond Lippmann Fonden Frimodt-Heineke Fonden Else og Mogens Wedell-Wedellsborgs Fond Oticon Fonden Antonio Rodriguez-Nunez Representative of the Spanish Pediatric Resuscitation Working Group (of the Spanish Resuscitation Council) Collaborator investigator (no personal funding) in studies supported by the Instituto de Salud Carlos III (principal investigators: Angel Carrillo and Jesús López-Herce). Collaborator and co-author of studies on pediatric resuscitation. Claudio Sandroni Assistant Professor, Catholic University School of Medicine. Member (unpaid) Editorial Board, Resuscitation Journal. Member (unpaid) Scientific Committee, Italian Resuscitation Council. Jas Soar Chair, Resuscitation Council (UK) TF Chair, ILCOR Editor, Resuscitation Peter Andreas Steen Board of Governors, Laerdal Medical Board of Governors, Laerdal Foundation for Acute Medicine Laerdal Foundation for Acute Medicine (charitable, no restrictions on publications) Health Region South-East, Norway (Norwegian Government, no restrictions on publications) Anders Jahres Foundation (charitable, no restrictions on publications) Kjetil Sunde None Karl-Christian Thies Interim Chairman of the ETCO, Past Chairman of the Course Management of the ETC, Representative of the European Society of Anaesthesiology in the ETCO. Jonathan Wyllie Paid: Consultant Neonatologist The James Cook University Hospital, Middlesbrough. UK Un-Paid: North East Ambulance Service clinical governance committee HEMS Clinical governance committee Member or ERC ICC Co-chair ERC NLS Invited Board Member of ERC Board Member of the Northern Deanery Neonatal Network Executive Board All unpaid Board Member of RC(UK) Member of Newborn Life Support Working Group RC(UK) Member of International Advanced Paediatric Life Support working group. ALSG Manchester UK Co-Chair of the Neonatal ILCOR group Co-author Neonatal CoSTR document Co-author NLS manual, RC(UK) Neonatal guidelines, APLS neonatal chapter Co-author ERC Newborn Life Support guidelines All unpaid Unfunded research into neonatal resuscitation including heart rate monitoring and face mask ventilation.
- 46. 1264 J.P. Nolan et al. / Resuscitation 81 (2010) 1219–1276 Appendix B (Continued ) Author Conflict of interest David Zideman Lead Clinician – Emergency Medical Services – London Organising Committee for the Olympic Games, London 2012 (paid). Locum – consultant anaesthetist – Imperial College Healthcare NHS Trust (paid). Honorary consultant – HEMS in London, Kent, Surrey/Sussex (voluntary). District Medical Officer – St John Ambulance (London District) (voluntary). BASICS response doctor (voluntary). ERC – Board & Exec – Immediate Past Chair (unpaid). BASICS – Exec – Immediate Past Chair (unpaid). ILCOR – Honorary Treasurer & Member of Exec (ERC representative). External Examiner – Brighton Medical School (unpaid). External Examiner – HEMS Course – Teeside University (unpaid). References 18. Wyllie J, Perlman JM, Kattwinkel J, et al. International Consensus on Car- 1. Nolan J. European Resuscitation Council Guidelines for resuscitation 2005. Sec- diopulmonary Resuscitation and Emergency Cardiovascular Care Science with tion 1. Introduction. Resuscitation 2005;67(Suppl. 1):S3–6. Treatment Recommendations. Part 11. Neonatal resuscitation. Resuscitation; 2. Nolan JP, Hazinski MF, Billi JE, et al. International Consensus on Cardiopul- doi:10.1016/j.resuscitation.2010.08.029, in press. monary Resuscitation and Emergency Cardiovascular Care Science with 19. Soar J, Mancini ME, Bhanji F, et al. International Consensus on Cardiopulmonary Treatment Recommendations. Part 1. Executive Summary. Resuscitation; Resuscitation and Emergency Cardiovascular Care Science with Treatment Rec- doi:10.1016/j.resuscitation.2010.08.002, in press. ommendations. Part 12. Education, implementation, and teams. Resuscitation; 3. Nolan JP, Neumar RW, Adrie C, et al. Post-cardiac arrest syndrome: epidemiol- doi:10.1016/j.resuscitation.2010.08.030, in press. ogy, pathophysiology, treatment, and prognostication. A Scientific Statement 20. Murray CJ, Lopez AD. Mortality by cause for eight regions of the world: global from the International Liaison Committee on Resuscitation; the American burden of disease study. Lancet 1997;349:1269–76. Heart Association Emergency Cardiovascular Care Committee; the Council on 21. Sans S, Kesteloot H, Kromhout D. The burden of cardiovascular diseases Cardiovascular Surgery and Anesthesia; the Council on Cardiopulmonary, Peri- mortality in Europe. Task force of the European Society of Cardiology on operative, and Critical Care; the Council on Clinical Cardiology; the Council on cardiovascular mortality and morbidity statistics in Europe. Eur Heart J Stroke. Resuscitation 2008;79:350–79. 1997;18:1231–48. 4. Koster RW, Baubin MA, Caballero A, et al. European Resuscitation Council 22. Zheng ZJ, Croft JB, Giles WH, Mensah GA. Sudden cardiac death in the United Guidelines for Resuscitation 2010. Section 2. Adult basic life support and use States, 1989 to 1998. Circulation 2001;104:2158–63. of automated external defibrillators. Resuscitation 2010;81:1277–92. 22a. Atwood C, Eisenberg MS, Herlitz J, Rea TD. Incidence of EMS-treated out-of- 5. Deakin CD, Nolan JP, Sunde K, Koster RW. European Resuscitation Council hospital cardiac arrest in Europe. Resuscitation 2005;67:75–80. Guidelines for Resuscitation 2010. Section 3. Electrical therapies: automated 23. Nichol G, Thomas E, Callaway CW, et al. Regional variation in out-of-hospital external defibrillators, defibrillation, cardioversion and pacing. Resuscitation cardiac arrest incidence and outcome. JAMA 2008;300:1423–31. 2010;81:1293–304. 24. Hollenberg J, Herlitz J, Lindqvist J, et al. Improved survival after out-of-hospital 6. Deakin CD, Nolan JP, Soar J, et al. European Resuscitation Council Guidelines cardiac arrest is associated with an increase in proportion of emergency for Resuscitation 2010. Section 4. Adult advanced life support. Resuscitation crew—witnessed cases and bystander cardiopulmonary resuscitation. Circu- 2010;81:1305–52. lation 2008;118:389–96. 7. Arntz HR, Bossaert L, Danchin N, Nikolaou N. European Resuscitation Coun- 25. Iwami T, Nichol G, Hiraide A, et al. Continuous improvements in “chain of cil Guidelines for Resuscitation 2010. Section 5. Initial management of acute survival” increased survival after out-of-hospital cardiac arrests: a large-scale coronary syndromes. Resuscitation 2010;81:1353–63. population-based study. Circulation 2009;119:728–34. 8. Biarent D, Bingham R, Eich C, et al. European Resuscitation Council Guide- 26. Cobb LA, Fahrenbruch CE, Olsufka M, Copass MK. Changing incidence of out- lines for Resuscitation 2010. Section 6. Paediatric life support. Resuscitation of-hospital ventricular fibrillation, 1980–2000. JAMA 2002;288:3008–13. 2010;81:1364–87. 27. Rea TD, Pearce RM, Raghunathan TE, et al. Incidence of out-of-hospital cardiac 9. Wyllie J, Richmond S. European Resuscitation Council Guidelines for Resus- arrest. Am J Cardiol 2004;93:1455–60. citation 2010. Section 7. Resuscitation of babies at birth. Resuscitation 28. Vaillancourt C, Verma A, Trickett J, et al. Evaluating the effectiveness of 2010;81:1388–98. dispatch-assisted cardiopulmonary resuscitation instructions. Acad Emerg 10. Soar J, Perkins GD, Abbas G, et al. European Resuscitation Council Guidelines Med 2007;14:877–83. for Resuscitation 2010. Section 8. Cardiac arrest in special circumstances: 29. Agarwal DA, Hess EP, Atkinson EJ, White RD. Ventricular fibrilla- electrolyte abnormalities, poisoning, drowning, accidental hypothermia, tion in Rochester, Minnesota: experience over 18 years. Resuscitation hyperthermia, asthma, anaphylaxis, cardiac surgery, trauma, pregnancy, elec- 2009;80:1253–8. trocution. Resuscitation 2010;81:1399–431. 30. Ringh M, Herlitz J, Hollenberg J, Rosenqvist M, Svensson L. Out of hospital car- 11. Soar J, Monsieurs KG, Ballance J, et al. European Resuscitation Council Guide- diac arrest outside home in Sweden, change in characteristics, outcome and lines for Resuscitation. Section 9. Principles of education in resuscitation. availability for public access defibrillation. Scand J Trauma Resusc Emerg Med Resuscitation 2010;81:1432–42. 2009;17:18. 12. Lippert FK, Raffay V, Georgiou M, Steen PA, Bossaert L. European Resuscitation 31. Cummins R, Thies W. Automated external defibrillators and the Advanced Council Guidelines for Resuscitation 2010. Section 10. The ethics of resuscita- Cardiac Life Support Program: a new initiative from the American Heart Asso- tion and end-of-life decisions. Resuscitation 2010;81:1443–9. ciation. Am J Emerg Med 1991;9:91–3. 13. Koster RW, Sayre MR, Botha M, et al. International Consensus on Car- 32. Waalewijn RA, Nijpels MA, Tijssen JG, Koster RW. Prevention of deterioration diopulmonary Resuscitation and Emergency Cardiovascular Care Science with of ventricular fibrillation by basic life support during out-of-hospital cardiac Treatment Recommendations. Part 5. Adult basic life support. Resuscitation; arrest. Resuscitation 2002;54:31–6. doi:10.1016/j.resuscitation.2010.08.005, in press. 33. Weisfeldt ML, Sitlani CM, Ornato JP, et al. Survival after application of auto- 14. Sunde K, Jacobs I, Deakin CD, et al. International Consensus on Car- matic external defibrillators before arrival of the emergency medical system: diopulmonary Resuscitation and Emergency Cardiovascular Care Science evaluation in the resuscitation outcomes consortium population of 21 million. with Treatment Recommendations. Part 6. Defibrillation. Resuscitation; J Am Coll Cardiol 2010;55:1713–20. doi:10.1016/j.resuscitation.2010.08.025, in press. 34. van Alem AP, Vrenken RH, de Vos R, Tijssen JG, Koster RW. Use of auto- mated external defibrillator by first responders in out of hospital cardiac arrest: 15. Deakin CD, Morrison LJ, Morley PT, et al. International Consensus on Car- prospective controlled trial. BMJ 2003;327:1312. diopulmonary Resuscitation and Emergency Cardiovascular Care Science with 35. Sandroni C, Nolan J, Cavallaro F, Antonelli M. In-hospital cardiac arrest: inci- Treatment Recommendations. Part 8. Advanced life support. Resuscitation; dence, prognosis and possible measures to improve survival. Intensive Care doi:10.1016/j.resuscitation.2010.08.027, in press. Med 2007;33:237–45. 16. Bossaert L, O’Connor RE, Arntz H-R, et al. International Consensus on Car- 36. Meaney PA, Nadkarni VM, Kern KB, Indik JH, Halperin HR, Berg RA. Rhythms diopulmonary Resuscitation and Emergency Cardiovascular Care Science with and outcomes of adult in-hospital cardiac arrest. Crit Care Med 2010;38:101–8. Treatment Recommendations. Part 9. Acute coronary syndromes. Resuscita- 37. Proceedings of the 2005 International Consensus on Cardiopulmonary tion; doi:10.1016/j.resuscitation.2010.09.001, in press. Resuscitation and Emergency Cardiovascular Care science with Treatment Rec- 17. de Caen AR, Kleinman ME, Chameides L, et al. International Consensus on ommendations. Resuscitation 2005;67:157–341. Cardiopulmonary Resuscitation and Emergency Cardiovascular Care Science 38. International Liaison Committee on Resuscitation. International Consensus on with Treatment Recommendations. Part 10. Pediatric basic and advanced life Cardiopulmonary Resuscitation and Emergency Cardiovascular Care Science support. Resuscitation; doi:10.1016/j.resuscitation.2010.08.028, in press. with Treatment Recommendations. Circulation 2005;112(Suppl. III):III-1–136.
- 47. J.P. Nolan et al. / Resuscitation 81 (2010) 1219–1276 1265 39. Morley PT, Atkins DL, Billi JE, et al. International Consensus on Cardiopul- 66. Tibballs J, Russell P. Reliability of pulse palpation by healthcare personnel to monary Resuscitation and Emergency Cardiovascular Care Science with diagnose paediatric cardiac arrest. Resuscitation 2009;80:61–4. Treatment Recommendations. Part 3. Evidence evaluation process. Resusci- 67. Ruppert M, Reith MW, Widmann JH, et al. Checking for breathing: evaluation tation; doi:10.1016/j.resuscitation.2010.08.023, in press. of the diagnostic capability of emergency medical services personnel, physi- 40. Billi JE, Zideman DA, Eigel B, Nolan JP, Montgomery WH, Nadkarni VM. Con- cians, medical students, and medical laypersons. Ann Emerg Med 1999;34: flict of interest management before, during, and after the 2005 International 720–9. Consensus Conference on Cardiopulmonary Resuscitation and Emergency Car- 68. Perkins GD, Stephenson B, Hulme J, Monsieurs KG. Birmingham assessment of diovascular Care Science with Treatment Recommendations. Resuscitation breathing study (BABS). Resuscitation 2005;64:109–13. 2005;67:171–3. 69. Bobrow BJ, Zuercher M, Ewy GA, et al. Gasping during cardiac arrest in 41. Shuster M, Billi JE, Bossaert L, et al. International Consensus on Car- humans is frequent and associated with improved survival. Circulation diopulmonary Resuscitation and Emergency Cardiovascular Care Science 2008;118:2550–4. with Treatment Recommendations. Part 4. Conflict of interest man- 70. Taylor RB, Brown CG, Bridges T, Werman HA, Ashton J, Hamlin RL. A model for agement before, during, and after the 2010 International Consensus regional blood flow measurements during cardiopulmonary resuscitation in a Conference on Cardiopulmonary Resuscitation and Emergency Cardio- swine model. Resuscitation 1988;16:107–18. vascular Care Science with Treatment Recommendations. Resuscitation; 71. Eftestol T, Sunde K, Steen PA. Effects of interrupting precordial compressions doi:10.1016/j.resuscitation.2010.08.024, in press. on the calculated probability of defibrillation success during out-of-hospital 42. Valenzuela TD, Roe DJ, Cretin S, Spaite DW, Larsen MP. Estimating effectiveness cardiac arrest. Circulation 2002;105:2270–3. of cardiac arrest interventions: a logistic regression survival model. Circulation 72. Aufderheide TP, Pirrallo RG, Yannopoulos D, et al. Incomplete chest wall 1997;96:3308–13. decompression: a clinical evaluation of CPR performance by EMS person- 43. Holmberg M, Holmberg S, Herlitz J. Factors modifying the effect of bystander nel and assessment of alternative manual chest compression–decompression cardiopulmonary resuscitation on survival in out-of-hospital cardiac arrest techniques. Resuscitation 2005;64:353–62. patients in Sweden. Eur Heart J 2001;22:511–9. 73. Yannopoulos D, McKnite S, Aufderheide TP, et al. Effects of incomplete chest 44. Holmberg M, Holmberg S, Herlitz J, Gardelov B. Survival after cardiac arrest wall decompression during cardiopulmonary resuscitation on coronary and outside hospital in Sweden. Swedish Cardiac Arrest Registry. Resuscitation cerebral perfusion pressures in a porcine model of cardiac arrest. Resuscitation 1998;36:29–36. 2005;64:363–72. 45. Waalewijn RA, Tijssen JG, Koster RW. Bystander initiated actions in out- 74. Ornato JP, Hallagan LF, McMahan SB, Peeples EH, Rostafinski AG. Attitudes of of-hospital cardiopulmonary resuscitation: results from the Amsterdam BCLS instructors about mouth-to-mouth resuscitation during the AIDS epi- Resuscitation Study (ARREST). Resuscitation 2001;50:273–9. demic. Ann Emerg Med 1990;19:151–6. 46. SOS-KANTO Study Group. Cardiopulmonary resuscitation by bystanders 75. Hew P, Brenner B, Kaufman J. Reluctance of paramedics and emergency with chest compression only (SOS-KANTO): an observational study. Lancet medical technicians to perform mouth-to-mouth resuscitation. J Emerg Med 2007;369:920–6. 1997;15:279–84. 47. Iwami T, Kawamura T, Hiraide A, et al. Effectiveness of bystander-initiated 76. Chandra NC, Gruben KG, Tsitlik JE, et al. Observations of ventilation during cardiac-only resuscitation for patients with out-of-hospital cardiac arrest. Cir- resuscitation in a canine model. Circulation 1994;90:3070–5. culation 2007;116:2900–7. 77. Kern KB, Hilwig RW, Berg RA, Sanders AB, Ewy GA. Importance of contin- 48. Weaver WD, Hill D, Fahrenbruch CE, et al. Use of the automatic external defib- uous chest compressions during cardiopulmonary resuscitation: improved rillator in the management of out-of-hospital cardiac arrest. N Engl J Med outcome during a simulated single lay-rescuer scenario. Circulation 2002;105: 1988;319:661–6. 645–9. 49. Auble TE, Menegazzi JJ, Paris PM. Effect of out-of-hospital defibrillation by basic 78. Geddes LA, Rundell A, Otlewski M, Pargett M. How much lung ventilation is life support providers on cardiac arrest mortality: a metaanalysis. Ann Emerg obtained with only chest-compression CPR? Cardiovasc Eng 2008;8:145–8. Med 1995;25:642–58. 79. Berg RA, Kern KB, Hilwig RW, et al. Assisted ventilation does not improve 50. Stiell IG, Wells GA, Field BJ, et al. Improved out-of-hospital cardiac arrest outcome in a porcine model of single-rescuer bystander cardiopulmonary survival through the inexpensive optimization of an existing defibrillation pro- resuscitation. Circulation 1997;95:1635–41. gram: OPALS study phase II. Ontario Prehospital Advanced Life Support. JAMA 80. Berg RA, Kern KB, Hilwig RW, Ewy GA. Assisted ventilation during ‘bystander’ 1999;281:1175–81. CPR in a swine acute myocardial infarction model does not improve outcome. 51. Stiell IG, Wells GA, DeMaio VJ, et al. Modifiable factors associated Circulation 1997;96:4364–71. with improved cardiac arrest survival in a multicenter basic life sup- 81. Turner I, Turner S, Armstrong V. Does the compression to ventilation ratio affect port/defibrillation system: OPALS Study Phase I results. Ontario Prehospital the quality of CPR: a simulation study. Resuscitation 2002;52:55–62. Advanced Life Support. Ann Emerg Med 1999;33:44–50. 82. Dorph E, Wik L, Stromme TA, Eriksen M, Steen PA. Oxygen delivery and return of 52. Caffrey S. Feasibility of public access to defibrillation. Curr Opin Crit Care spontaneous circulation with ventilation:compression ratio 2:30 versus chest 2002;8:195–8. compressions only CPR in pigs. Resuscitation 2004;60:309–18. 53. O’Rourke MF, Donaldson E, Geddes JS. An airline cardiac arrest program. Cir- 83. Bohm K, Rosenqvist M, Herlitz J, Hollenberg J, Svensson L. Survival is simi- culation 1997;96:2849–53. lar after standard treatment and chest compression only in out-of-hospital 54. Page RL, Hamdan MH, McKenas DK. Defibrillation aboard a commercial aircraft. bystander cardiopulmonary resuscitation. Circulation 2007;116:2908–12. Circulation 1998;97:1429–30. 84. Kitamura T, Iwami T, Kawamura T, et al. Conventional and chest-compression- 55. Valenzuela TD, Roe DJ, Nichol G, Clark LL, Spaite DW, Hardman RG. Outcomes only cardiopulmonary resuscitation by bystanders for children who have out- of rapid defibrillation by security officers after cardiac arrest in casinos. N Engl of-hospital cardiac arrests: a prospective, nationwide, population-based cohort J Med 2000;343:1206–9. study. Lancet 2010. 56. Waalewijn RA, de Vos R, Tijssen JG, Koster RW. Survival models for out-of- 85. Kitamura T, Iwami T, Kawamura T, Nagao K, Tanaka H, Hiraide A. Bystander- hospital cardiopulmonary resuscitation from the perspectives of the bystander, initiated rescue breathing for out-of-hospital cardiac arrests of noncardiac the first responder, and the paramedic. Resuscitation 2001;51:113–22. origin. Circulation 2010;122:293–9. 57. Engdahl J, Abrahamsson P, Bang A, Lindqvist J, Karlsson T, Herlitz J. Is hospi- 86. Peberdy MA, Ottingham LV, Groh WJ, et al. Adverse events associated with tal care of major importance for outcome after out-of-hospital cardiac arrest? lay emergency response programs: the public access defibrillation trial expe- Experience acquired from patients with out-of-hospital cardiac arrest resus- rience. Resuscitation 2006;70:59–65. citated by the same Emergency Medical Service and admitted to one of two 87. Sugerman NT, Edelson DP, Leary M, et al. Rescuer fatigue during actual hospitals over a 16-year period in the municipality of Goteborg. Resuscitation in-hospital cardiopulmonary resuscitation with audiovisual feedback: a 2000;43:201–11. prospective multicenter study. Resuscitation 2009;80:981–4. 58. Langhelle A, Tyvold SS, Lexow K, Hapnes SA, Sunde K, Steen PA. In-hospital 88. Hallstrom AP, Ornato JP, Weisfeldt M, et al. Public-access defibrillation and factors associated with improved outcome after out-of-hospital cardiac arrest. survival after out-of-hospital cardiac arrest. N Engl J Med 2004;351:637–46. A comparison between four regions in Norway. Resuscitation 2003;56:247–63. 89. Hoke RS, Heinroth K, Trappe HJ, Werdan K. Is external defibrillation an electric 59. Carr BG, Goyal M, Band RA, et al. A national analysis of the relationship threat for bystanders? Resuscitation 2009;80:395–401. between hospital factors and post-cardiac arrest mortality. Intensive Care Med 90. Dickinson CL, Hall CR, Soar J. Accidental shock to rescuer during successful 2009;35:505–11. defibrillation of ventricular fibrillation—a case of human involuntary auto- 60. Liu JM, Yang Q, Pirrallo RG, Klein JP, Aufderheide TP. Hospital variability of maticity. Resuscitation 2008;76:489. out-of-hospital cardiac arrest survival. Prehosp Emerg Care 2008;12:339–46. 91. Cydulka RK, Connor PJ, Myers TF, Pavza G, Parker M. Prevention of oral bacterial 61. Carr BG, Kahn JM, Merchant RM, Kramer AA, Neumar RW. Inter-hospital vari- flora transmission by using mouth-to-mask ventilation during CPR. J Emerg ability in post-cardiac arrest mortality. Resuscitation 2009;80:30–4. Med 1991;9:317–21. 62. Herlitz J, Engdahl J, Svensson L, Angquist KA, Silfverstolpe J, Holmberg S. Major 92. Blenkharn JI, Buckingham SE, Zideman DA. Prevention of transmission of infec- differences in 1-month survival between hospitals in Sweden among initial tion during mouth-to-mouth resuscitation. Resuscitation 1990;19:151–7. survivors of out-of-hospital cardiac arrest. Resuscitation 2006;70:404–9. 93. Turner S, Turner I, Chapman D, et al. A comparative study of the 1992 and 1997 63. Keenan SP, Dodek P, Martin C, Priestap F, Norena M, Wong H. Variation in length recovery positions for use in the UK. Resuscitation 1998;39:153–60. of intensive care unit stay after cardiac arrest: where you are is as important 94. Handley AJ. Recovery position. Resuscitation 1993;26:93–5. as who you are. Crit Care Med 2007;35:836–41. 95. Anon. Guidelines 2000 for cardiopulmonary resuscitation and emergency 64. Bahr J, Klingler H, Panzer W, Rode H, Kettler D. Skills of lay people in checking cardiovascular care—an international consensus on science. Resuscitation the carotid pulse. Resuscitation 1997;35:23–6. 2000;46:1–447. 65. Nyman J, Sihvonen M. Cardiopulmonary resuscitation skills in nurses and nurs- 96. Fingerhut LA, Cox CS, Warner M. International comparative analysis of injury ing students. Resuscitation 2000;47:179–84. mortality. Findings from the ICE on injury statistics. International Collaborative Effort on Injury Statistics. Adv Data 1998:1–20.
- 48. 1266 J.P. Nolan et al. / Resuscitation 81 (2010) 1219–1276 97. White RD, Bunch TJ, Hankins DG. Evolution of a community-wide early defib- 126. Strohmenger HU, Lindner KH, Brown CG. Analysis of the ventricular fibrillation rillation programme experience over 13 years using police/fire personnel and ECG signal amplitude and frequency parameters as predictors of countershock paramedics as responders. Resuscitation 2005;65:279–83. success in humans. Chest 1997;111:584–9. 98. Mosesso Jr VN, Davis EA, Auble TE, Paris PM, Yealy DM. Use of automated 127. Strohmenger HU, Eftestol T, Sunde K, et al. The predictive value of ventricu- external defibrillators by police officers for treatment of out-of-hospital cardiac lar fibrillation electrocardiogram signal frequency and amplitude variables in arrest. Ann Emerg Med 1998;32:200–7. patients with out-of-hospital cardiac arrest. Anesth Analg 2001;93:1428–33. 99. The Public Access Defibrillation Trial Investigators. Public-access defib- 128. Podbregar M, Kovacic M, Podbregar-Mars A, Brezocnik M. Predicting defibrilla- rillation and survival after out-of-hospital cardiac arrest. N Engl J Med tion success by ‘genetic’ programming in patients with out-of-hospital cardiac 2004;351:637–46. arrest. Resuscitation 2003;57:153–9. 100. Kitamura T, Iwami T, Kawamura T, Nagao K, Tanaka H, Hiraide A. Nationwide 129. Menegazzi JJ, Callaway CW, Sherman LD, et al. Ventricular fibrillation scaling public-access defibrillation in Japan. N Engl J Med 2010;362:994–1004. exponent can guide timing of defibrillation and other therapies. Circulation 101. Bardy GH, Lee KL, Mark DB, et al. Home use of automated external defibrillators 2004;109:926–31. for sudden cardiac arrest. N Engl J Med 2008;358:1793–804. 130. Povoas HP, Weil MH, Tang W, Bisera J, Klouche K, Barbatsis A. Predicting 102. Zafari AM, Zarter SK, Heggen V, et al. A program encouraging early defibril- the success of defibrillation by electrocardiographic analysis. Resuscitation lation results in improved in-hospital resuscitation efficacy. J Am Coll Cardiol 2002;53:77–82. 2004;44:846–52. 131. Noc M, Weil MH, Tang W, Sun S, Pernat A, Bisera J. Electrocardiographic pre- 103. Destro A, Marzaloni M, Sermasi S, Rossi F. Automatic external defibrillators in diction of the success of cardiac resuscitation. Crit Care Med 1999;27:708–14. the hospital as well? Resuscitation 1996;31:39–43. 132. Strohmenger HU, Lindner KH, Keller A, Lindner IM, Pfenninger EG. Spectral 104. Spearpoint KG, Gruber PC, Brett SJ. Impact of the Immediate Life Support course analysis of ventricular fibrillation and closed-chest cardiopulmonary resusci- on the incidence and outcome of in-hospital cardiac arrest calls: an observa- tation. Resuscitation 1996;33:155–61. tional study over 6 years. Resuscitation 2009;80:638–43. 133. Noc M, Weil MH, Gazmuri RJ, Sun S, Biscera J, Tang W. Ventricular fibrillation 105. Cummins RO, Eisenberg MS, Litwin PE, Graves JR, Hearne TR, Hallstrom AP. voltage as a monitor of the effectiveness of cardiopulmonary resuscitation. J Automatic external defibrillators used by emergency medical technicians: a Lab Clin Med 1994;124:421–6. controlled clinical trial. JAMA 1987;257:1605–10. 134. Lightfoot CB, Nremt P, Callaway CW, et al. Dynamic nature of electrocar- 106. Stults KR, Brown DD, Kerber RE. Efficacy of an automated external defibrillator diographic waveform predicts rescue shock outcome in porcine ventricular in the management of out-of-hospital cardiac arrest: validation of the diagnos- fibrillation. Ann Emerg Med 2003;42:230–41. tic algorithm and initial clinical experience in a rural environment. Circulation 135. Marn-Pernat A, Weil MH, Tang W, Pernat A, Bisera J. Optimizing timing of 1986;73:701–9. ventricular defibrillation. Crit Care Med 2001;29:2360–5. 107. Kramer-Johansen J, Edelson DP, Abella BS, Becker LB, Wik L, Steen PA. Pauses 136. Hamprecht FA, Achleitner U, Krismer AC, et al. Fibrillation power, an alternative in chest compression and inappropriate shocks: a comparison of manual and method of ECG spectral analysis for prediction of countershock success in a semi-automatic defibrillation attempts. Resuscitation 2007;73:212–20. porcine model of ventricular fibrillation. Resuscitation 2001;50:287–96. 108. Pytte M, Pedersen TE, Ottem J, Rokvam AS, Sunde K. Comparison of hands-off 137. Amann A, Achleitner U, Antretter H, et al. Analysing ventricular fibrilla- time during CPR with manual and semi-automatic defibrillation in a manikin tion ECG-signals and predicting defibrillation success during cardiopulmonary model. Resuscitation 2007;73:131–6. resuscitation employing N(alpha)-histograms. Resuscitation 2001;50:77–85. 109. Forcina MS, Farhat AY, O’Neil WW, Haines DE. Cardiac arrest survival after 138. Brown CG, Griffith RF, Van Ligten P, et al. Median frequency—a new parameter implementation of automated external defibrillator technology in the in- for predicting defibrillation success rate. Ann Emerg Med 1991;20:787–9. hospital setting. Crit Care Med 2009;37:1229–36. 139. Amann A, Rheinberger K, Achleitner U, et al. The prediction of defibrillation 110. Edelson DP, Abella BS, Kramer-Johansen J, et al. Effects of compression depth outcome using a new combination of mean frequency and amplitude in porcine and pre-shock pauses predict defibrillation failure during cardiac arrest. Resus- models of cardiac arrest. Anesth Analg 2002;95:716–22 [table of contents]. citation 2006;71:137–45. 140. Deakin CD, Nolan JP. European Resuscitation Council guidelines for 111. Yu T, Weil MH, Tang W, et al. Adverse outcomes of interrupted precordial resuscitation 2005. Section 3. Electrical therapies: automated external defib- compression during automated defibrillation. Circulation 2002;106:368–72. rillators, defibrillation, cardioversion and pacing. Resuscitation 2005;67(Suppl. 112. Gundersen K, Kvaloy JT, Kramer-Johansen J, Steen PA, Eftestol T. Development 1):S25–37. of the probability of return of spontaneous circulation in intervals without 141. Cobb LA, Fahrenbruch CE, Walsh TR, et al. Influence of cardiopulmonary resus- chest compressions during out-of-hospital cardiac arrest: an observational citation prior to defibrillation in patients with out-of-hospital ventricular study. BMC Med 2009;7:6. fibrillation. JAMA 1999;281:1182–8. 113. Lloyd MS, Heeke B, Walter PF, Langberg JJ. Hands-on defibrillation: an analy- 142. Wik L, Hansen TB, Fylling F, et al. Delaying defibrillation to give basic cardiopul- sis of electrical current flow through rescuers in direct contact with patients monary resuscitation to patients with out-of-hospital ventricular fibrillation: during biphasic external defibrillation. Circulation 2008;117:2510–4. a randomized trial. JAMA 2003;289:1389–95. 114. Bojar RM, Payne DD, Rastegar H, Diehl JT, Cleveland RJ. Use of self-adhesive 143. Baker PW, Conway J, Cotton C, et al. Defibrillation or cardiopulmonary external defibrillator pads for complex cardiac surgical procedures. Ann Thorac resuscitation first for patients with out-of-hospital cardiac arrests found by Surg 1988;46:587–8. paramedics to be in ventricular fibrillation? A randomised control trial. Resus- 115. Bradbury N, Hyde D, Nolan J. Reliability of ECG monitoring with a gel citation 2008;79:424–31. pad/paddle combination after defibrillation. Resuscitation 2000;44:203–6. 144. Jacobs IG, Finn JC, Oxer HF, Jelinek GA. CPR before defibrillation in 116. Brown J, Rogers J, Soar J. Cardiac arrest during surgery and ventilation out-of-hospital cardiac arrest: a randomized trial. Emerg Med Australas in the prone position: a case report and systematic review. Resuscitation 2005;17:39–45. 2001;50:233–8. 145. Hayakawa M, Gando S, Okamoto H, Asai Y, Uegaki S, Makise H. Shortening 117. Perkins GD, Davies RP, Soar J, Thickett DR. The impact of manual defibrillation of cardiopulmonary resuscitation time before the defibrillation worsens the technique on no-flow time during simulated cardiopulmonary resuscitation. outcome in out-of-hospital VF patients. Am J Emerg Med 2009;27:470–4. Resuscitation 2007;73:109–14. 146. Bradley SM, Gabriel EE, Aufderheide TP, et al. Survival Increases with CPR by 118. Wilson RF, Sirna S, White CW, Kerber RE. Defibrillation of high-risk patients Emergency Medical Services before defibrillation of out-of-hospital ventricu- during coronary angiography using self-adhesive, preapplied electrode pads. lar fibrillation or ventricular tachycardia: observations from the resuscitation Am J Cardiol 1987;60:380–2. outcomes consortium. Resuscitation 2010;81:155–62. 119. Stults KR, Brown DD, Cooley F, Kerber RE. Self-adhesive monitor/defibrillation 147. Christenson J, Andrusiek D, Everson-Stewart S, et al. Chest compression fraction pads improve prehospital defibrillation success. Ann Emerg Med determines survival in patients with out-of-hospital ventricular fibrillation. 1987;16:872–7. Circulation 2009;120:1241–7. 120. Callaway CW, Sherman LD, Mosesso Jr VN, Dietrich TJ, Holt E, Clarkson MC. 148. Olasveengen TM, Vik E, Kuzovlev A, Sunde K. Effect of implementation of new Scaling exponent predicts defibrillation success for out-of-hospital ventricular resuscitation guidelines on quality of cardiopulmonary resuscitation and sur- fibrillation cardiac arrest. Circulation 2001;103:1656–61. vival. Resuscitation 2009;80:407–11. 121. Eftestol T, Sunde K, Aase SO, Husoy JH, Steen PA. Predicting outcome of 149. Bobrow BJ, Clark LL, Ewy GA, et al. Minimally interrupted cardiac resuscita- defibrillation by spectral characterization and nonparametric classification of tion by emergency medical services for out-of-hospital cardiac arrest. JAMA ventricular fibrillation in patients with out-of-hospital cardiac arrest. Circula- 2008;299:1158–65. tion 2000;102:1523–9. 150. Rea TD, Helbock M, Perry S, et al. Increasing use of cardiopulmonary resuscita- 122. Eftestol T, Wik L, Sunde K, Steen PA. Effects of cardiopulmonary resuscitation tion during out-of-hospital ventricular fibrillation arrest: survival implications on predictors of ventricular fibrillation defibrillation success during out-of- of guideline changes. Circulation 2006;114:2760–5. hospital cardiac arrest. Circulation 2004;110:10–5. 151. Steinmetz J, Barnung S, Nielsen SL, Risom M, Rasmussen LS. Improved survival 123. Weaver WD, Cobb LA, Dennis D, Ray R, Hallstrom AP, Copass MK. Amplitude of after an out-of-hospital cardiac arrest using new guidelines. Acta Anaesthesiol ventricular fibrillation waveform and outcome after cardiac arrest. Ann Intern Scand 2008;52:908–13. Med 1985;102:53–5. 152. Jost D, Degrange H, Verret C, et al. DEFI 2005: a randomized controlled trial 124. Brown CG, Dzwonczyk R. Signal analysis of the human electrocardiogram dur- of the effect of automated external defibrillator cardiopulmonary resusci- ing ventricular fibrillation: frequency and amplitude parameters as predictors tation protocol on outcome from out-of-hospital cardiac arrest. Circulation of successful countershock. Ann Emerg Med 1996;27:184–8. 2010;121:1614–22. 125. Callaham M, Braun O, Valentine W, Clark DM, Zegans C. Prehospital car- 153. van Alem AP, Chapman FW, Lank P, Hart AA, Koster RW. A prospective, diac arrest treated by urban first-responders: profile of patient response and randomised and blinded comparison of first shock success of monopha- prediction of outcome by ventricular fibrillation waveform. Ann Emerg Med sic and biphasic waveforms in out-of-hospital cardiac arrest. Resuscitation 1993;22:1664–77. 2003;58:17–24.
- 49. J.P. Nolan et al. / Resuscitation 81 (2010) 1219–1276 1267 154. Carpenter J, Rea TD, Murray JA, Kudenchuk PJ, Eisenberg MS. Defibrillation 183. Smith GB. In-hospital cardiac arrest: is it time for an in-hospital ‘chain of pre- waveform and post-shock rhythm in out-of-hospital ventricular fibrillation vention’? Resuscitation 2010. cardiac arrest. Resuscitation 2003;59:189–96. 184. National Confidential Enquiry into Patient Outcome and Death. An acute prob- 155. Morrison LJ, Dorian P, Long J, et al. Out-of-hospital cardiac arrest rectilinear lem? London: NCEPOD; 2005. biphasic to monophasic damped sine defibrillation waveforms with advanced 185. Hodgetts TJ, Kenward G, Vlackonikolis I, et al. Incidence, location and reasons life support intervention trial (ORBIT). Resuscitation 2005;66:149–57. for avoidable in-hospital cardiac arrest in a district general hospital. Resusci- 156. Mittal S, Ayati S, Stein KM, et al. Transthoracic cardioversion of atrial fibrilla- tation 2002;54:115–23. tion: comparison of rectilinear biphasic versus damped sine wave monophasic 186. Kause J, Smith G, Prytherch D, Parr M, Flabouris A, Hillman K. A comparison shocks. Circulation 2000;101:1282–7. of antecedents to cardiac arrests, deaths and emergency intensive care admis- 157. Page RL, Kerber RE, Russell JK, et al. Biphasic versus monophasic shock sions in Australia and New Zealand, and the United Kingdom—the ACADEMIA waveform for conversion of atrial fibrillation: the results of an inter- study. Resuscitation 2004;62:275–82. national randomized, double-blind multicenter trial. J Am Coll Cardiol 187. Castagna J, Weil MH, Shubin H. Factors determining survival in patients with 2002;39:1956–63. cardiac arrest. Chest 1974;65:527–9. 158. Koster RW, Dorian P, Chapman FW, Schmitt PW, O’Grady SG, Walker RG. A 188. Herlitz J, Bang A, Aune S, Ekstrom L, Lundstrom G, Holmberg S. Characteristics randomized trial comparing monophasic and biphasic waveform shocks for and outcome among patients suffering in-hospital cardiac arrest in monitored external cardioversion of atrial fibrillation. Am Heart J 2004;147:e20. and non-monitored areas. Resuscitation 2001;48:125–35. 159. Ambler JJ, Deakin CD. A randomized controlled trial of efficacy and ST 189. Campello G, Granja C, Carvalho F, Dias C, Azevedo LF, Costa-Pereira A. Imme- change following use of the Welch-Allyn MRL PIC biphasic waveform versus diate and long-term impact of medical emergency teams on cardiac arrest damped sine monophasic waveform for external DC cardioversion. Resuscita- prevalence and mortality: a plea for periodic basic life-support training pro- tion 2006;71:146–51. grams. Crit Care Med 2009;37:3054–61. 160. Martens PR, Russell JK, Wolcke B, et al. Optimal response to cardiac arrest study: 190. Bellomo R, Goldsmith D, Uchino S, et al. A prospective before-and-after trial of defibrillation waveform effects. Resuscitation 2001;49:233–43. a medical emergency team. Med J Aust 2003;179:283–7. 161. Gliner BE, Jorgenson DB, Poole JE, et al. Treatment of out-of-hospital cardiac 191. Bellomo R, Goldsmith D, Uchino S, et al. Prospective controlled trial of effect of arrest with a low-energy impedance-compensating biphasic waveform auto- medical emergency team on postoperative morbidity and mortality rates. Crit matic external defibrillator. The LIFE Investigators. Biomed Instrum Technol Care Med 2004;32:916–21. 1998;32:631–44. 192. DeVita MA, Smith GB, Adam SK, et al. “Identifying the hospitalised patient in 162. White RD, Blackwell TH, Russell JK, Snyder DE, Jorgenson DB. Transthoracic crisis”—a consensus conference on the afferent limb of rapid response systems. impedance does not affect defibrillation, resuscitation or survival in patients Resuscitation 2010;81:375–82. with out-of-hospital cardiac arrest treated with a non-escalating biphasic 193. Goldhill DR, Worthington L, Mulcahy A, Tarling M, Sumner A. The patient-at- waveform defibrillator. Resuscitation 2005;64:63–9. risk team: identifying and managing seriously ill ward patients. Anaesthesia 163. Stiell IG, Walker RG, Nesbitt LP, et al. BIPHASIC trial: a randomized comparison 1999;54:853–60. of fixed lower versus escalating higher energy levels for defibrillation in out- 194. Hodgetts TJ, Kenward G, Vlachonikolis IG, Payne S, Castle N. The identification of-hospital cardiac arrest. Circulation 2007;115:1511–7. of risk factors for cardiac arrest and formulation of activation criteria to alert a 164. Walsh SJ, McClelland AJ, Owens CG, et al. Efficacy of distinct energy delivery medical emergency team. Resuscitation 2002;54:125–31. protocols comparing two biphasic defibrillators for cardiac arrest. Am J Cardiol 195. Subbe CP, Davies RG, Williams E, Rutherford P, Gemmell L. Effect of introduc- 2004;94:378–80. ing the modified early warning score on clinical outcomes, cardio-pulmonary 165. Higgins SL, Herre JM, Epstein AE, et al. A comparison of biphasic and monopha- arrests and intensive care utilisation in acute medical admissions. Anaesthesia sic shocks for external defibrillation. Physio-control biphasic investigators. 2003;58:797–802. Prehosp Emerg Care 2000;4:305–13. 196. Armitage M, Eddleston J, Stokes T. Recognising and responding to acute illness 166. Berg RA, Samson RA, Berg MD, et al. Better outcome after pediatric defibrillation in adults in hospital: summary of NICE guidance. BMJ 2007;335:258–9. dosage than adult dosage in a swine model of pediatric ventricular fibrillation. 197. Hillman K, Chen J, Cretikos M, et al. Introduction of the medical emergency team J Am Coll Cardiol 2005;45:786–9. (MET) system: a cluster-randomised controlled trial. Lancet 2005;365:2091–7. 167. Killingsworth CR, Melnick SB, Chapman FW, et al. Defibrillation threshold 198. Lee A, Bishop G, Hillman KM, Daffurn K. The Medical Emergency Team. Anaesth and cardiac responses using an external biphasic defibrillator with pedi- Intensive Care 1995;23:183–6. atric and adult adhesive patches in pediatric-sized piglets. Resuscitation 199. Devita MA, Bellomo R, Hillman K, et al. Findings of the first consensus confer- 2002;55:177–85. ence on medical emergency teams. Crit Care Med 2006;34:2463–78. 168. Tang W, Weil MH, Sun S, et al. The effects of biphasic waveform design on 200. Ball C, Kirkby M, Williams S. Effect of the critical care outreach team on post-resuscitation myocardial function. J Am Coll Cardiol 2004;43:1228–35. patient survival to discharge from hospital and readmission to critical care: 169. Xie J, Weil MH, Sun S, et al. High-energy defibrillation increases the severity of non-randomised population based study. BMJ 2003;327:1014. postresuscitation myocardial dysfunction. Circulation 1997;96:683–8. 201. Critical care outreach 2003: progress in developing services. The National Out- 170. Lown B. Electrical reversion of cardiac arrhythmias. Br Heart J 1967;29:469–89. reach Report. London, UK: Department of Health and National Health Service 171. Boodhoo L, Mitchell AR, Bordoli G, Lloyd G, Patel N, Sulke N. DC cardioversion Modernisation Agency; 2003. of persistent atrial fibrillation: a comparison of two protocols. Int J Cardiol 202. Chan PS, Jain R, Nallmothu BK, Berg RA, Sasson C. Rapid response teams: a 2007;114:16–21. systematic review and meta-analysis. Arch Intern Med 2010;170:18–26. 172. Boos C, Thomas MD, Jones A, Clarke E, Wilbourne G, More RS. Higher energy 203. Parr MJ, Hadfield JH, Flabouris A, Bishop G, Hillman K. The Medical Emergency monophasic DC cardioversion for persistent atrial fibrillation: is it time to start Team: 12 month analysis of reasons for activation, immediate outcome and at 360 joules? Ann Noninvasive Electrocardiol 2003;8:121–6. not-for-resuscitation orders. Resuscitation 2001;50:39–44. 173. Glover BM, Walsh SJ, McCann CJ, et al. Biphasic energy selection for 204. Smith GB. Increased do not attempt resuscitation decision making in hospi- transthoracic cardioversion of atrial fibrillation. The BEST AF Trial. Heart tals with a medical emergency teams system—cause and effect? Resuscitation 2008;94:884–7. 2008;79:346–7. 174. Rashba EJ, Gold MR, Crawford FA, Leman RB, Peters RW, Shorofsky SR. Efficacy 205. Chen J, Flabouris A, Bellomo R, Hillman K, Finfer S. The Medical Emergency of transthoracic cardioversion of atrial fibrillation using a biphasic, truncated Team System and not-for-resuscitation orders: results from the MERIT study. exponential shock waveform at variable initial shock energies. Am J Cardiol Resuscitation 2008;79:391–7. 2004;94:1572–4. 206. Jones DA, McIntyre T, Baldwin I, Mercer I, Kattula A, Bellomo R. The med- 175. Pinski SL, Sgarbossa EB, Ching E, Trohman RG. A comparison of 50-J ver- ical emergency team and end-of-life care: a pilot study. Crit Care Resusc sus 100-J shocks for direct-current cardioversion of atrial flutter. Am Heart 2007;9:151–6. J 1999;137:439–42. 207. Excellence NIfHaC. NICE clinical guideline 50 acutely ill patients in hospital: 176. Alatawi F, Gurevitz O, White R. Prospective, randomized comparison of two recognition of and response to acute illness in adults in hospital. London: biphasic waveforms for the efficacy and safety of transthoracic biphasic car- National Institute for Health and Clinical Excellence; 2007. dioversion of atrial fibrillation. Heart Rhythm 2005;2:382–7. 208. Marshall S, Harrison J, Flanagan B. The teaching of a structured tool improves 177. Kerber RE, Martins JB, Kienzle MG, et al. Energy, current, and success in defibril- the clarity and content of interprofessional clinical communication. Qual Saf lation and cardioversion: clinical studies using an automated impedance-based Health Care 2009;18:137–40. method of energy adjustment. Circulation 1988;77:1038–46. 209. Muller D, Agrawal R, Arntz HR. How sudden is sudden cardiac death? Circula- 178. Kerber RE, Kienzle MG, Olshansky B, et al. Ventricular tachycardia rate and tion 2006;114:1146–50. morphology determine energy and current requirements for transthoracic car- 210. Amital H, Glikson M, Burstein M, et al. Clinical characteristics of unexpected dioversion. Circulation 1992;85:158–63. death among young enlisted military personnel: results of a three-decade ret- 179. Stockwell B, Bellis G, Morton G, et al. Electrical injury during “hands on” rospective surveillance. Chest 2004;126:528–33. defibrillation—a potential risk of internal cardioverter defibrillators? Resus- 211. Basso C, Maron BJ, Corrado D, Thiene G. Clinical profile of congenital coronary citation 2009;80:832–4. artery anomalies with origin from the wrong aortic sinus leading to sudden 180. Nolan J, Soar J, Eikeland H. The chain of survival. Resuscitation 2006;71: death in young competitive athletes. J Am Coll Cardiol 2000;35:1493–501. 270–1. 212. Corrado D, Basso C, Thiene G. Sudden cardiac death in young people with 181. Gwinnutt CL, Columb M, Harris R. Outcome after cardiac arrest in adults in UK apparently normal heart. Cardiovasc Res 2001;50:399–408. hospitals: effect of the 1997 guidelines. Resuscitation 2000;47:125–35. 213. Drory Y, Turetz Y, Hiss Y, et al. Sudden unexpected death in persons less than 182. Peberdy MA, Kaye W, Ornato JP, et al. Cardiopulmonary resuscitation of adults 40 years of age. Am J Cardiol 1991;68:1388–92. in the hospital: a report of 14720 cardiac arrests from the National Registry of 214. Kramer MR, Drori Y, Lev B. Sudden death in young soldiers. High incidence of Cardiopulmonary Resuscitation. Resuscitation 2003;58:297–308. syncope prior to death. Chest 1988;93:345–7.
- 50. 1268 J.P. Nolan et al. / Resuscitation 81 (2010) 1219–1276 215. Quigley F, Greene M, O’Connor D, Kelly F. A survey of the causes of sudden 247. Allegra J, Lavery R, Cody R, et al. Magnesium sulfate in the treatment of cardiac death in the under 35-year-age group. Ir Med J 2005;98:232–5. refractory ventricular fibrillation in the prehospital setting. Resuscitation 216. Wisten A, Forsberg H, Krantz P, Messner T. Sudden cardiac death in 15–35-year 2001;49:245–9. olds in Sweden during 1992–99. J Intern Med 2002;252:529–36. 248. Fatovich D, Prentice D, Dobb G. Magnesium in in-hospital cardiac arrest. Lancet 217. Wisten A, Messner T. Young Swedish patients with sudden cardiac death 1998;351:446. have a lifestyle very similar to a control population. Scand Cardiovasc J 249. Hassan TB, Jagger C, Barnett DB. A randomised trial to investigate the effi- 2005;39:137–42. cacy of magnesium sulphate for refractory ventricular fibrillation. Emerg Med 218. Wisten A, Messner T. Symptoms preceding sudden cardiac death in the J 2002;19:57–62. young are common but often misinterpreted. Scand Cardiovasc J 2005;39: 250. Miller B, Craddock L, Hoffenberg S, et al. Pilot study of intravenous magnesium 143–9. sulfate in refractory cardiac arrest: safety data and recommendations for future 219. Morrison LJ, Visentin LM, Kiss A, et al. Validation of a rule for termination studies. Resuscitation 1995;30:3–14. of resuscitation in out-of-hospital cardiac arrest. N Engl J Med 2006;355: 251. Stiell IG, Wells GA, Hebert PC, Laupacis A, Weitzman BN. Association of drug 478–87. therapy with survival in cardiac arrest: limited role of advanced cardiac life 220. Gabbott D, Smith G, Mitchell S, et al. Cardiopulmonary resuscitation standards support drugs. Acad Emerg Med 1995;2:264–73. for clinical practice and training in the UK. Resuscitation 2005;64:13–9. 252. Engdahl J, Bang A, Lindqvist J, Herlitz J. Can we define patients with no and 221. Dyson E, Smith GB. Common faults in resuscitation equipment—guidelines for those with some chance of survival when found in asystole out of hospital? checking equipment and drugs used in adult cardiopulmonary resuscitation. Am J Cardiol 2000;86:610–4. Resuscitation 2002;55:137–49. 253. Engdahl J, Bang A, Lindqvist J, Herlitz J. Factors affecting short- and long-term 222. Perkins GD, Roberts C, Gao F. Delays in defibrillation: influence of different prognosis among 1069 patients with out-of-hospital cardiac arrest and pulse- monitoring techniques. Br J Anaesth 2002;89:405–8. less electrical activity. Resuscitation 2001;51:17–25. 223. Featherstone P, Chalmers T, Smith GB. RSVP: a system for communication of 254. Dumot JA, Burval DJ, Sprung J, et al. Outcome of adult cardiopulmonary resusci- deterioration in hospital patients. Br J Nurs 2008;17:860–4. tations at a tertiary referral center including results of “limited” resuscitations. 224. Abella BS, Alvarado JP, Myklebust H, et al. Quality of cardiopulmonary resusci- Arch Intern Med 2001;161:1751–8. tation during in-hospital cardiac arrest. JAMA 2005;293:305–10. 255. Tortolani AJ, Risucci DA, Powell SR, Dixon R. In-hospital cardiopulmonary 225. Abella BS, Sandbo N, Vassilatos P, et al. Chest compression rates during resuscitation during asystole. Therapeutic factors associated with 24-hour sur- cardiopulmonary resuscitation are suboptimal: a prospective study during vival. Chest 1989;96:622–6. in-hospital cardiac arrest. Circulation 2005;111:428–34. 256. Coon GA, Clinton JE, Ruiz E. Use of atropine for brady-asystolic prehospital 226. Stiell IG, Wells GA, Field B, et al. Advanced cardiac life support in out-of-hospital cardiac arrest. Ann Emerg Med 1981;10:462–7. cardiac arrest. N Engl J Med 2004;351:647–56. 257. Bottiger BW, Arntz HR, Chamberlain DA, et al. Thrombolysis during resuscita- 227. Olasveengen TM, Sunde K, Brunborg C, Thowsen J, Steen PA, Wik L. Intravenous tion for out-of-hospital cardiac arrest. N Engl J Med 2008;359:2651–62. drug administration during out-of-hospital cardiac arrest: a randomized trial. 258. Böttiger BW, Martin E. Thrombolytic therapy during cardiopulmonary resusci- JAMA 2009;302:2222–9. tation and the role of coagulation activation after cardiac arrest. Curr Opin Crit 228. Herlitz J, Ekstrom L, Wennerblom B, Axelsson A, Bang A, Holmberg S. Adrenaline Care 2001;7:176–83. in out-of-hospital ventricular fibrillation. Does it make any difference? Resus- 259. Spöhr F, Böttiger BW. Safety of thrombolysis during cardiopulmonary resusci- citation 1995;29:195–201. tation. Drug Saf 2003;26:367–79. 229. Holmberg M, Holmberg S, Herlitz J. Low chance of survival among patients 260. Soar J, Foster J, Breitkreutz R. Fluid infusion during CPR and after ROSC—is it requiring adrenaline (epinephrine) or intubation after out-of-hospital cardiac safe? Resuscitation 2009;80:1221–2. arrest in Sweden. Resuscitation 2002;54:37–45. 261. Price S, Uddin S, Quinn T. Echocardiography in cardiac arrest. Curr Opin Crit 230. Sunde K, Eftestol T, Askenberg C, Steen PA. Quality assessment of defibrillation Care 2010;16:211–5. and advanced life support using data from the medical control module of the 262. Memtsoudis SG, Rosenberger P, Loffler M, et al. The usefulness of defibrillator. Resuscitation 1999;41:237–47. transesophageal echocardiography during intraoperative cardiac arrest in non- 231. Rea TD, Shah S, Kudenchuk PJ, Copass MK, Cobb LA. Automated external cardiac surgery. Anesth Analg 2006;102:1653–7. defibrillators: to what extent does the algorithm delay CPR? Ann Emerg Med 263. Comess KA, DeRook FA, Russell ML, Tognazzi-Evans TA, Beach KW. The inci- 2005;46:132–41. dence of pulmonary embolism in unexplained sudden cardiac arrest with 232. van Alem AP, Sanou BT, Koster RW. Interruption of cardiopulmonary resusci- pulseless electrical activity. Am J Med 2000;109:351–6. tation with the use of the automated external defibrillator in out-of-hospital 264. Niendorff DF, Rassias AJ, Palac R, Beach ML, Costa S, Greenberg M. Rapid car- cardiac arrest. Ann Emerg Med 2003;42:449–57. diac ultrasound of inpatients suffering PEA arrest performed by nonexpert 233. Pytte M, Kramer-Johansen J, Eilevstjonn J, et al. Haemodynamic effects of sonographers. Resuscitation 2005;67:81–7. adrenaline (epinephrine) depend on chest compression quality during car- 265. Tayal VS, Kline JA. Emergency echocardiography to detect pericardial effusion diopulmonary resuscitation in pigs. Resuscitation 2006;71:369–78. in patients in PEA and near-PEA states. Resuscitation 2003;59:315–8. 234. Prengel AW, Lindner KH, Ensinger H, Grunert A. Plasma catecholamine 266. van der Wouw PA, Koster RW, Delemarre BJ, de Vos R, Lampe-Schoenmaeckers concentrations after successful resuscitation in patients. Crit Care Med AJ, Lie KI. Diagnostic accuracy of transesophageal echocardiography during 1992;20:609–14. cardiopulmonary resuscitation. J Am Coll Cardiol 1997;30:780–3. 235. Bhende MS, Thompson AE. Evaluation of an end-tidal CO2 detector during 267. Hernandez C, Shuler K, Hannan H, Sonyika C, Likourezos A, Marshall J. pediatric cardiopulmonary resuscitation. Pediatrics 1995;95:395–9. C.A.U.S.E.: cardiac arrest ultra-sound exam—a better approach to managing 236. Sehra R, Underwood K, Checchia P. End tidal CO2 is a quantitative measure of patients in primary non-arrhythmogenic cardiac arrest. Resuscitation 2008;76: cardiac arrest. Pacing Clin Electrophysiol 2003;26:515–7. 198–206. 237. Amir O, Schliamser JE, Nemer S, Arie M. Ineffectiveness of precordial thump 268. Steiger HV, Rimbach K, Muller E, Breitkreutz R. Focused emergency echocardio- for cardioversion of malignant ventricular tachyarrhythmias. Pacing Clin Elec- graphy: lifesaving tool for a 14-year-old girl suffering out-of-hospital pulseless trophysiol 2007;30:153–6. electrical activity arrest because of cardiac tamponade. Eur J Emerg Med 238. Haman L, Parizek P, Vojacek J. Precordial thump efficacy in termination of 2009;16:103–5. induced ventricular arrhythmias. Resuscitation 2009;80:14–6. 269. Breitkreutz R, Walcher F, Seeger FH. Focused echocardiographic evaluation in 239. Pellis T, Kette F, Lovisa D, et al. Utility of pre-cordial thump for treatment of out resuscitation management: concept of an advanced life support-conformed of hospital cardiac arrest: a prospective study. Resuscitation 2009;80:17–23. algorithm. Crit Care Med 2007;35:S150–61. 240. Kohl P, King AM, Boulin C. Antiarrhythmic effects of acute mechanical stimula- 270. Blaivas M, Fox JC. Outcome in cardiac arrest patients found to have cardiac tion. In: Kohl P, Sachs F, Franz MR, editors. Cardiac mechano-electric feedback standstill on the bedside emergency department echocardiogram. Acad Emerg and arrhythmias: form pipette to patient. Philadelphia: Elsevier Saunders; Med 2001;8:616–21. 2005. p. 304–14. 271. Salen P, O’Connor R, Sierzenski P, et al. Can cardiac sonography and capnog- 241. Caldwell G, Millar G, Quinn E, Vincent R, Chamberlain DA. Simple mechanical raphy be used independently and in combination to predict resuscitation methods for cardioversion: defence of the precordial thump and cough version. outcomes? Acad Emerg Med 2001;8:610–5. BMJ (Clin Res Ed) 1985;291:627–30. 272. Salen P, Melniker L, Chooljian C, et al. Does the presence or absence of sono- 242. Wenzel V, Lindner KH, Augenstein S, et al. Intraosseous vasopressin improves graphically identified cardiac activity predict resuscitation outcomes of cardiac coronary perfusion pressure rapidly during cardiopulmonary resuscitation in arrest patients? Am J Emerg Med 2005;23:459–62. pigs. Crit Care Med 1999;27:1565–9. 273. Balan IS, Fiskum G, Hazelton J, Cotto-Cumba C, Rosenthal RE. Oximetry-guided 243. Shavit I, Hoffmann Y, Galbraith R, Waisman Y. Comparison of two mechanical reoxygenation improves neurological outcome after experimental cardiac intraosseous infusion devices: a pilot, randomized crossover trial. Resuscita- arrest. Stroke 2006;37:3008–13. tion 2009;80:1029–33. 274. Kilgannon JH, Jones AE, Shapiro NI, et al. Association between arterial hyperoxia 244. Kudenchuk PJ, Cobb LA, Copass MK, et al. Amiodarone for resuscitation after following resuscitation from cardiac arrest and in-hospital mortality. JAMA out-of-hospital cardiac arrest due to ventricular fibrillation. N Engl J Med 2010;303:2165–71. 1999;341:871–8. 275. Nolan JP, Soar J. Airway techniques and ventilation strategies. Curr Opin Crit 245. Dorian P, Cass D, Schwartz B, Cooper R, Gelaznikas R, Barr A. Amiodarone as Care 2008;14:279–86. compared with lidocaine for shock-resistant ventricular fibrillation. N Engl J 276. Grmec S. Comparison of three different methods to confirm tracheal tube place- Med 2002;346:884–90. ment in emergency intubation. Intensive Care Med 2002;28:701–4. 246. Thel MC, Armstrong AL, McNulty SE, Califf RM, O’Connor CM. Randomised trial 277. Lyon RM, Ferris JD, Young DM, McKeown DW, Oglesby AJ, Robertson C. Field of magnesium in in-hospital cardiac arrest. Duke Internal Medicine Housestaff. intubation of cardiac arrest patients: a dying art? Emerg Med J 2010;27: Lancet 1997;350:1272–6. 321–3.
- 51. J.P. Nolan et al. / Resuscitation 81 (2010) 1219–1276 1269 278. Jones JH, Murphy MP, Dickson RL, Somerville GG, Brizendine EJ. Emergency 308. Cerchiari EL, Safar P, Klein E, Diven W. Visceral, hematologic and bacteriologic physician-verified out-of-hospital intubation: miss rates by paramedics. Acad changes and neurologic outcome after cardiac arrest in dogs. The visceral post- Emerg Med 2004;11:707–9. resuscitation syndrome. Resuscitation 1993;25:119–36. 279. Pelucio M, Halligan L, Dhindsa H. Out-of-hospital experience with the syringe 309. Adrie C, Monchi M, Laurent I, et al. Coagulopathy after successful cardiopul- esophageal detector device. Acad Emerg Med 1997;4:563–8. monary resuscitation following cardiac arrest: implication of the protein C 280. Jemmett ME, Kendal KM, Fourre MW, Burton JH. Unrecognized misplacement anticoagulant pathway. J Am Coll Cardiol 2005;46:21–8. of endotracheal tubes in a mixed urban to rural emergency medical services 310. Adrie C, Adib-Conquy M, Laurent I, et al. Successful cardiopulmonary setting. Acad Emerg Med 2003;10:961–5. resuscitation after cardiac arrest as a “sepsis-like” syndrome. Circulation 281. Katz SH, Falk JL. Misplaced endotracheal tubes by paramedics in an urban 2002;106:562–8. emergency medical services system. Ann Emerg Med 2001;37:32–7. 311. Adrie C, Laurent I, Monchi M, Cariou A, Dhainaou JF, Spaulding C. Postresusci- 282. Wang HE, Simeone SJ, Weaver MD, Callaway CW. Interruptions in cardiopul- tation disease after cardiac arrest: a sepsis-like syndrome? Curr Opin Crit Care monary resuscitation from paramedic endotracheal intubation. Ann Emerg 2004;10:208–12. Med 2009;54:645–52, e1. 312. Zwemer CF, Whitesall SE, D’Alecy LG. Cardiopulmonary-cerebral resuscitation 283. Gatward JJ, Thomas MJ, Nolan JP, Cook TM. Effect of chest compressions on with 100% oxygen exacerbates neurological dysfunction following nine min- the time taken to insert airway devices in a manikin. Br J Anaesth 2008;100: utes of normothermic cardiac arrest in dogs. Resuscitation 1994;27:159–70. 351–6. 313. Richards EM, Fiskum G, Rosenthal RE, Hopkins I, McKenna MC. Hyperoxic 284. Li J. Capnography alone is imperfect for endotracheal tube placement confir- reperfusion after global ischemia decreases hippocampal energy metabolism. mation during emergency intubation. J Emerg Med 2001;20:223–9. Stroke 2007;38:1578–84. 285. Delguercio LR, Feins NR, Cohn JD, Coomaraswamy RP, Wollman SB, State D. 314. Vereczki V, Martin E, Rosenthal RE, Hof PR, Hoffman GE, Fiskum G. Nor- Comparison of blood flow during external and internal cardiac massage in man. moxic resuscitation after cardiac arrest protects against hippocampal oxidative Circulation 1965;31(Suppl. 1):171–80. stress, metabolic dysfunction, and neuronal death. J Cereb Blood Flow Metab 286. Wik L, Kramer-Johansen J, Myklebust H, et al. Quality of cardiopulmonary 2006;26:821–35. resuscitation during out-of-hospital cardiac arrest. JAMA 2005;293:299–304. 315. Liu Y, Rosenthal RE, Haywood Y, Miljkovic-Lolic M, Vanderhoek JY, Fiskum G. 287. Kramer-Johansen J, Myklebust H, Wik L, et al. Quality of out-of-hospital car- Normoxic ventilation after cardiac arrest reduces oxidation of brain lipids and diopulmonary resuscitation with real time automated feedback: a prospective improves neurological outcome. Stroke 1998;29:1679–86. interventional study. Resuscitation 2006;71:283–92. 316. Spaulding CM, Joly LM, Rosenberg A, et al. Immediate coronary angiography in 288. Sutton RM, Maltese MR, Niles D, et al. Quantitative analysis of chest com- survivors of out-of-hospital cardiac arrest. N Engl J Med 1997;336:1629–33. pression interruptions during in-hospital resuscitation of older children and 317. Sunde K, Pytte M, Jacobsen D, et al. Implementation of a standardised treat- adolescents. Resuscitation 2009;80:1259–63. ment protocol for post resuscitation care after out-of-hospital cardiac arrest. 289. Sutton RM, Niles D, Nysaether J, et al. Quantitative analysis of CPR quality Resuscitation 2007;73:29–39. during in-hospital resuscitation of older children and adolescents. Pediatrics 318. Bendz B, Eritsland J, Nakstad AR, et al. Long-term prognosis after out-of- 2009;124:494–9. hospital cardiac arrest and primary percutaneous coronary intervention. 290. Cabrini L, Beccaria P, Landoni G, et al. Impact of impedance threshold devices Resuscitation 2004;63:49–53. on cardiopulmonary resuscitation: a systematic review and meta-analysis of 319. Keelan PC, Bunch TJ, White RD, Packer DL, Holmes Jr DR. Early direct coro- randomized controlled studies. Crit Care Med 2008;36:1625–32. nary angioplasty in survivors of out-of-hospital cardiac arrest. Am J Cardiol 291. Steen S, Liao Q, Pierre L, Paskevicius A, Sjoberg T. Evaluation of LUCAS, a new 2003;91:1461–3. A6. device for automatic mechanical compression and active decompression resus- 320. Quintero-Moran B, Moreno R, Villarreal S, et al. Percutaneous coronary citation. Resuscitation 2002;55:285–99. intervention for cardiac arrest secondary to ST-elevation acute myocardial 292. Rubertsson S, Karlsten R. Increased cortical cerebral blood flow with LUCAS; a infarction. Influence of immediate paramedical/medical assistance on clinical new device for mechanical chest compressions compared to standard external outcome. J Invasive Cardiol 2006;18:269–72. compressions during experimental cardiopulmonary resuscitation. Resuscita- 321. Garot P, Lefevre T, Eltchaninoff H, et al. Six-month outcome of emer- tion 2005;65:357–63. gency percutaneous coronary intervention in resuscitated patients after 293. Timerman S, Cardoso LF, Ramires JA, Halperin H. Improved hemodynamic cardiac arrest complicating ST-elevation myocardial infarction. Circulation performance with a novel chest compression device during treatment of in- 2007;115:1354–62. hospital cardiac arrest. Resuscitation 2004;61:273–80. 322. Nagao K, Hayashi N, Kanmatsuse K, et al. Cardiopulmonary cerebral resuscita- 294. Halperin H, Berger R, Chandra N, et al. Cardiopulmonary resuscitation with a tion using emergency cardiopulmonary bypass, coronary reperfusion therapy hydraulic-pneumatic band. Crit Care Med 2000;28:N203–6. and mild hypothermia in patients with cardiac arrest outside the hospital. J 295. Halperin HR, Paradis N, Ornato JP, et al. Cardiopulmonary resuscitation with a Am Coll Cardiol 2000;36:776–83. novel chest compression device in a porcine model of cardiac arrest: improved 323. Knafelj R, Radsel P, Ploj T, Noc M. Primary percutaneous coronary intervention hemodynamics and mechanisms. J Am Coll Cardiol 2004;44:2214–20. and mild induced hypothermia in comatose survivors of ventricular fibril- 296. Hallstrom A, Rea TD, Sayre MR, et al. Manual chest compression vs use of an lation with ST-elevation acute myocardial infarction. Resuscitation 2007;74: automated chest compression device during resuscitation following out-of- 227–34. hospital cardiac arrest: a randomized trial. JAMA 2006;295:2620–8. 324. Nielsen N, Hovdenes J, Nilsson F, et al. Outcome, timing and adverse events in 297. Ong ME, Ornato JP, Edwards DP, et al. Use of an automated, load-distributing therapeutic hypothermia after out-of-hospital cardiac arrest. Acta Anaesthe- band chest compression device for out-of-hospital cardiac arrest resuscitation. siol Scand 2009;53:926–34. JAMA 2006;295:2629–37. 325. Hovdenes J, Laake JH, Aaberge L, Haugaa H, Bugge JF. Therapeutic hypother- 298. Larsen AI, Hjornevik AS, Ellingsen CL, Nilsen DW. Cardiac arrest with mia after out-of-hospital cardiac arrest: experiences with patients treated with continuous mechanical chest compression during percutaneous coronary percutaneous coronary intervention and cardiogenic shock. Acta Anaesthesiol intervention. A report on the use of the LUCAS device. Resuscitation Scand 2007;51:137–42. 2007;75:454–9. 326. Wolfrum S, Pierau C, Radke PW, Schunkert H, Kurowski V. Mild therapeutic 299. Wagner H, Terkelsen CJ, Friberg H, et al. Cardiac arrest in the catheterisation hypothermia in patients after out-of-hospital cardiac arrest due to acute ST- laboratory: a 5-year experience of using mechanical chest compres- segment elevation myocardial infarction undergoing immediate percutaneous sions to facilitate PCI during prolonged resuscitation efforts. Resuscitation coronary intervention. Crit Care Med 2008;36:1780–6. 2010;81:383–7. 327. Snyder BD, Hauser WA, Loewenson RB, Leppik IE, Ramirez-Lassepas M, Gum- 300. Wirth S, Korner M, Treitl M, et al. Computed tomography during cardiopul- nit RJ. Neurologic prognosis after cardiopulmonary arrest. III. Seizure activity. monary resuscitation using automated chest compression devices—an initial Neurology 1980;30:1292–7. study. Eur Radiol 2009;19:1857–66. 328. Levy DE, Caronna JJ, Singer BH, Lapinski RH, Frydman H, Plum F. Predicting 301. Holmstrom P, Boyd J, Sorsa M, Kuisma M. A case of hypothermic cardiac arrest outcome from hypoxic-ischemic coma. JAMA 1985;253:1420–6. treated with an external chest compression device (LUCAS) during transport 329. Krumholz A, Stern BJ, Weiss HD. Outcome from coma after cardiopulmonary to re-warming. Resuscitation 2005;67:139–41. resuscitation: relation to seizures and myoclonus. Neurology 1988;38:401–5. 302. Wik L, Kiil S. Use of an automatic mechanical chest compression device (LUCAS) 330. Zandbergen EG, Hijdra A, Koelman JH, et al. Prediction of poor outcome within as a bridge to establishing cardiopulmonary bypass for a patient with hypother- the first 3 days of postanoxic coma. Neurology 2006;66:62–8. mic cardiac arrest. Resuscitation 2005;66:391–4. 331. Ingvar M. Cerebral blood flow and metabolic rate during seizures. Relationship 303. Olasveengen TM, Wik L, Steen PA. Quality of cardiopulmonary resuscitation to epileptic brain damage. Ann N Y Acad Sci 1986;462:194–206. before and during transport in out-of-hospital cardiac arrest. Resuscitation 332. Nolan JP, Laver SR, Welch CA, Harrison DA, Gupta V, Rowan K. Outcome 2008;76:185–90. following admission to UK intensive care units after cardiac arrest: a sec- 304. Sunde K, Wik L, Steen PA. Quality of mechanical, manual standard and active ondary analysis of the ICNARC Case Mix Programme Database. Anaesthesia compression–decompression CPR on the arrest site and during transport in a 2007;62:1207–16. manikin model. Resuscitation 1997;34:235–42. 333. Losert H, Sterz F, Roine RO, et al. Strict normoglycaemic blood glucose levels in 305. Laver S, Farrow C, Turner D, Nolan J. Mode of death after admission to an inten- the therapeutic management of patients within 12 h after cardiac arrest might sive care unit following cardiac arrest. Intensive Care Med 2004;30:2126–8. not be necessary. Resuscitation 2007. 306. Laurent I, Monchi M, Chiche JD, et al. Reversible myocardial dysfunction in 334. Skrifvars MB, Saarinen K, Ikola K, Kuisma M. Improved survival after in- survivors of out-of-hospital cardiac arrest. J Am Coll Cardiol 2002;40:2110–6. hospital cardiac arrest outside critical care areas. Acta Anaesthesiol Scand 307. Ruiz-Bailen M, Aguayo de Hoyos E, Ruiz-Navarro S, et al. Reversible 2005;49:1534–9. myocardial dysfunction after cardiopulmonary resuscitation. Resuscitation 335. Mullner M, Sterz F, Binder M, Schreiber W, Deimel A, Laggner AN. Blood glu- 2005;66:175–81. cose concentration after cardiopulmonary resuscitation influences functional
- 52. 1270 J.P. Nolan et al. / Resuscitation 81 (2010) 1219–1276 neurological recovery in human cardiac arrest survivors. J Cereb Blood Flow 368. Al Thenayan E, Savard M, Sharpe M, Norton L, Young B. Predictors of poor Metab 1997;17:430–6. neurologic outcome after induced mild hypothermia following cardiac arrest. 336. Calle PA, Buylaert WA, Vanhaute OA. Glycemia in the post-resuscitation Neurology 2008;71:1535–7. period. The Cerebral Resuscitation Study Group. Resuscitation 369. Wijdicks EF, Parisi JE, Sharbrough FW. Prognostic value of myoclonus status in 1989;17(Suppl.):S181–8 [discussion S99–S206]. comatose survivors of cardiac arrest. Ann Neurol 1994;35:239–43. 337. Longstreth Jr WT, Diehr P, Inui TS. Prediction of awakening after out-of-hospital 370. Thomke F, Marx JJ, Sauer O, et al. Observations on comatose survivors cardiac arrest. N Engl J Med 1983;308:1378–82. of cardiopulmonary resuscitation with generalized myoclonus. BMC Neurol 338. Longstreth Jr WT, Inui TS. High blood glucose level on hospital admission and 2005;5:14. poor neurological recovery after cardiac arrest. Ann Neurol 1984;15:59–63. 371. Arnoldus EP, Lammers GJ. Postanoxic coma: good recovery despite myoclonus 339. Finfer S, Chittock DR, Su SY, et al. Intensive versus conventional glucose control status. Ann Neurol 1995;38:697–8. in critically ill patients. N Engl J Med 2009;360:1283–97. 372. Celesia GG, Grigg MM, Ross E. Generalized status myoclonicus in acute anoxic 340. Preiser JC, Devos P, Ruiz-Santana S, et al. A prospective randomised multi- and toxic-metabolic encephalopathies. Arch Neurol 1988;45:781–4. centre controlled trial on tight glucose control by intensive insulin therapy 373. Morris HR, Howard RS, Brown P. Early myoclonic status and outcome in adult intensive care units: the Glucontrol study. Intensive Care Med after cardiorespiratory arrest. J Neurol Neurosurg Psychiatry 1998;64: 2009;35:1738–48. 267–8. 341. Griesdale DE, de Souza RJ, van Dam RM, et al. Intensive insulin therapy and 374. Datta S, Hart GK, Opdam H, Gutteridge G, Archer J. Post-hypoxic myoclonic mortality among critically ill patients: a meta-analysis including NICE-SUGAR status: the prognosis is not always hopeless. Crit Care Resusc 2009;11:39–41. study data. CMAJ 2009;180:821–7. 375. English WA, Giffin NJ, Nolan JP. Myoclonus after cardiac arrest: pitfalls in diag- 342. Wiener RS, Wiener DC, Larson RJ. Benefits and risks of tight glucose control in nosis and prognosis. Anaesthesia 2009;64:908–11. critically ill adults: a meta-analysis. JAMA 2008;300:933–44. 376. Wijdicks EF, Hijdra A, Young GB, Bassetti CL, Wiebe S. Practice parameter: pre- 343. Krinsley JS, Grover A. Severe hypoglycemia in critically ill patients: risk factors diction of outcome in comatose survivors after cardiopulmonary resuscitation and outcomes. Crit Care Med 2007;35:2262–7. (an evidence-based review): report of the Quality Standards Subcommittee of 344. Meyfroidt G, Keenan DM, Wang X, Wouters PJ, Veldhuis JD, Van den Berghe the American Academy of Neurology. Neurology 2006;67:203–10. G. Dynamic characteristics of blood glucose time series during the course of 377. Tiainen M, Kovala TT, Takkunen OS, Roine RO. Somatosensory and brainstem critical illness: effects of intensive insulin therapy and relative association with auditory evoked potentials in cardiac arrest patients treated with hypothermia. mortality. Crit Care Med 2010;38:1021–9. Crit Care Med 2005;33:1736–40. 345. Padkin A. Glucose control after cardiac arrest. Resuscitation 2009;80:611–2. 378. Rossetti AO, Oddo M, Liaudet L, Kaplan PW. Predictors of awakening 346. Takino M, Okada Y. Hyperthermia following cardiopulmonary resuscitation. from postanoxic status epilepticus after therapeutic hypothermia. Neurology Intensive Care Med 1991;17:419–20. 2009;72:744–9. 347. Hickey RW, Kochanek PM, Ferimer H, Alexander HL, Garman RH, Graham 379. Rossetti AO, Logroscino G, Liaudet L, et al. Status epilepticus: an independent SH. Induced hyperthermia exacerbates neurologic neuronal histologic damage outcome predictor after cerebral anoxia. Neurology 2007;69:255–60. after asphyxial cardiac arrest in rats. Crit Care Med 2003;31:531–5. 380. Fieux F, Losser MR, Bourgeois E, et al. Kidney retrieval after sudden out of 348. Takasu A, Saitoh D, Kaneko N, Sakamoto T, Okada Y. Hyperthermia: is it an hospital refractory cardiac arrest: a cohort of uncontrolled non heart beating ominous sign after cardiac arrest? Resuscitation 2001;49:273–7. donors. Crit Care 2009;13:R141. 349. Zeiner A, Holzer M, Sterz F, et al. Hyperthermia after cardiac arrest is associated 381. Kootstra G. Statement on non-heart-beating donor programs. Transplant Proc with an unfavorable neurologic outcome. Arch Intern Med 2001;161:2007–12. 1995;27:2965. 350. Hickey RW, Kochanek PM, Ferimer H, Graham SH, Safar P. Hypothermia and 382. Vermeer F, Oude Ophuis AJ, vd Berg EJ, et al. Prospective randomised compar- hyperthermia in children after resuscitation from cardiac arrest. Pediatrics ison between thrombolysis, rescue PTCA, and primary PTCA in patients with 2000;106:118–22. extensive myocardial infarction admitted to a hospital without PTCA facilities: 351. Diringer MN, Reaven NL, Funk SE, Uman GC. Elevated body temperature inde- a safety and feasibility study. Heart 1999;82:426–31. pendently contributes to increased length of stay in neurologic intensive care 383. Widimsky P, Groch L, Zelizko M, Aschermann M, Bednar F, Suryapranata H. unit patients. Crit Care Med 2004;32:1489–95. Multicentre randomized trial comparing transport to primary angioplasty vs 352. Gunn AJ, Thoresen M. Hypothermic neuroprotection. NeuroRx 2006;3:154–69. immediate thrombolysis vs combined strategy for patients with acute myocar- 353. Froehler MT, Geocadin RG. Hypothermia for neuroprotection after car- dial infarction presenting to a community hospital without a catheterization diac arrest: mechanisms, clinical trials and patient care. J Neurol Sci laboratory. The PRAGUE study. Eur Heart J 2000;21:823–31. 2007;261:118–26. 384. Widimsky P, Budesinsky T, Vorac D, et al. Long distance transport for primary 354. McCullough JN, Zhang N, Reich DL, et al. Cerebral metabolic suppression during angioplasty vs immediate thrombolysis in acute myocardial infarction. Final hypothermic circulatory arrest in humans. Ann Thorac Surg 1999;67:1895–9 results of the randomized national multicentre trial—PRAGUE-2. Eur Heart J [discussion 919–21]. 2003;24:94–104. 355. Mild therapeutic hypothermia to improve the neurologic outcome after cardiac 385. Le May MR, So DY, Dionne R, et al. A citywide protocol for primary PCI in arrest. N Engl J Med 2002;346:549–56. ST-segment elevation myocardial infarction. N Engl J Med 2008;358:231–40. 356. Bernard SA, Gray TW, Buist MD, et al. Treatment of comatose survivors 386. Abernathy 3rd JH, McGwin Jr G, Acker 3rd JE, Rue 3rd LW. Impact of a voluntary of out-of-hospital cardiac arrest with induced hypothermia. N Engl J Med trauma system on mortality, length of stay, and cost at a level I trauma center. 2002;346:557–63. Am Surg 2002;68:182–92. 357. Bernard SA, Jones BM, Horne MK. Clinical trial of induced hypothermia 387. Clemmer TP, Orme Jr JF, Thomas FO, Brooks KA. Outcome of critically injured in comatose survivors of out-of-hospital cardiac arrest. Ann Emerg Med patients treated at Level I trauma centers versus full-service community hos- 1997;30:146–53. pitals. Crit Care Med 1985;13:861–3. 358. Oddo M, Schaller MD, Feihl F, Ribordy V, Liaudet L. From evidence to clini- 388. Culica D, Aday LA, Rohrer JE. Regionalized trauma care system in Texas: impli- cal practice: effective implementation of therapeutic hypothermia to improve cations for redesigning trauma systems. Med Sci Monit 2007;13:SR9–18. patient outcome after cardiac arrest. Crit Care Med 2006;34:1865–73. 389. Hannan EL, Farrell LS, Cooper A, Henry M, Simon B, Simon R. Physiologic trauma 359. Busch M, Soreide E, Lossius HM, Lexow K, Dickstein K. Rapid implementation of triage criteria in adult trauma patients: are they effective in saving lives by therapeutic hypothermia in comatose out-of-hospital cardiac arrest survivors. transporting patients to trauma centers? J Am Coll Surg 2005;200:584–92. Acta Anaesthesiol Scand 2006;50:1277–83. 390. Harrington DT, Connolly M, Biffl WL, Majercik SD, Cioffi WG. Transfer times to 360. Storm C, Steffen I, Schefold JC, et al. Mild therapeutic hypothermia shortens definitive care facilities are too long: a consequence of an immature trauma intensive care unit stay of survivors after out-of-hospital cardiac arrest com- system. Ann Surg 2005;241:961–6 [discussion 6–8]. pared to historical controls. Crit Care 2008;12:R78. 391. Liberman M, Mulder DS, Lavoie A, Sampalis JS. Implementation of a trauma 361. Don CW, Longstreth Jr WT, Maynard C, et al. Active surface cooling protocol care system: evolution through evaluation. J Trauma 2004;56:1330–5. to induce mild therapeutic hypothermia after out-of-hospital cardiac arrest: a 392. MacKenzie EJ, Rivara FP, Jurkovich GJ, et al. A national evaluation of the effect retrospective before-and-after comparison in a single hospital. Crit Care Med of trauma-center care on mortality. N Engl J Med 2006;354:366–78. 2009;37:3062–9. 393. Mann NC, Cahn RM, Mullins RJ, Brand DM, Jurkovich GJ. Survival among injured 362. Arrich J. Clinical application of mild therapeutic hypothermia after cardiac geriatric patients during construction of a statewide trauma system. J Trauma arrest. Crit Care Med 2007;35:1041–7. 2001;50:1111–6. 363. Holzer M, Mullner M, Sterz F, et al. Efficacy and safety of endovascular 394. Mullins RJ, Veum-Stone J, Hedges JR, et al. Influence of a statewide trauma cooling after cardiac arrest: cohort study and Bayesian approach. Stroke system on location of hospitalization and outcome of injured patients. J Trauma 2006;37:1792–7. 1996;40:536–45 [discussion 45–46]. 364. Polderman KH, Herold I. Therapeutic hypothermia and controlled normother- 395. Mullins RJ, Mann NC, Hedges JR, Worrall W, Jurkovich GJ. Preferential benefit mia in the intensive care unit: practical considerations, side effects, and cooling of implementation of a statewide trauma system in one of two adjacent states. methods. Crit Care Med 2009;37:1101–20. J Trauma 1998;44:609–16 [discussion 17]. 365. Kuboyama K, Safar P, Radovsky A, et al. Delay in cooling negates the beneficial 396. Mullins RJ, Veum-Stone J, Helfand M, et al. Outcome of hospitalized injured effect of mild resuscitative cerebral hypothermia after cardia arrest in dogs: a patients after institution of a trauma system in an urban area. JAMA prospective, randomized study. Crit Care Med 1993;21:1348–58. 1994;271:1919–24. 366. Edgren E, Hedstrand U, Nordin M, Rydin E, Ronquist G. Prediction of outcome 397. Mullner R, Goldberg J. An evaluation of the Illinois trauma system. Med Care after cardiac arrest. Crit Care Med 1987;15:820–5. 1978;16:140–51. 367. Young GB, Doig G, Ragazzoni A. Anoxic-ischemic encephalopathy: clin- 398. Mullner R, Goldberg J. Toward an outcome-oriented medical geography: an ical and electrophysiological associations with outcome. Neurocrit Care evaluation of the Illinois trauma/emergency medical services system. Soc Sci 2005;2:159–64. Med 1978;12:103–10.
- 53. J.P. Nolan et al. / Resuscitation 81 (2010) 1219–1276 1271 399. Nathens AB, Jurkovich GJ, Rivara FP, Maier RV. Effectiveness of state trauma 427. O’Driscoll BR, Howard LS, Davison AG. BTS guideline for emergency oxygen use systems in reducing injury-related mortality: a national evaluation. J Trauma in adult patients. Thorax 2008;63(Suppl. 6):vi1–68. 2000;48:25–30 [discussion 1]. 428. Freimark D, Matetzky S, Leor J, et al. Timing of aspirin administration as a 400. Nathens AB, Maier RV, Brundage SI, Jurkovich GJ, Grossman DC. The effect determinant of survival of patients with acute myocardial infarction treated of interfacility transfer on outcome in an urban trauma system. J Trauma with thrombolysis. Am J Cardiol 2002;89:381–5. 2003;55:444–9. 429. Barbash IM, Freimark D, Gottlieb S, et al. Outcome of myocardial infarction 401. Nicholl J, Turner J. Effectiveness of a regional trauma system in reducing mor- in patients treated with aspirin is enhanced by pre-hospital administration. tality from major trauma: before and after study. BMJ 1997;315:1349–54. Cardiology 2002;98:141–7. 402. Potoka DA, Schall LC, Gardner MJ, Stafford PW, Peitzman AB, Ford HR. Impact 430. Yusuf S, Zhao F, Mehta SR, Chrolavicius S, Tognoni G, Fox KK. Effects of clopido- of pediatric trauma centers on mortality in a statewide system. J Trauma grel in addition to aspirin in patients with acute coronary syndromes without 2000;49:237–45. ST-segment elevation. N Engl J Med 2001;345:494–502. 403. Sampalis JS, Lavoie A, Boukas S, et al. Trauma center designation: initial impact 431. Mehta SR, Yusuf S, Peters RJ, et al. Effects of pretreatment with clopi- on trauma-related mortality. J Trauma 1995;39:232–7 [discussion 7–9]. dogrel and aspirin followed by long-term therapy in patients undergoing 404. Sampalis JS, Denis R, Frechette P, Brown R, Fleiszer D, Mulder D. Direct transport percutaneous coronary intervention: the PCI-CURE study. Lancet 2001;358: to tertiary trauma centers versus transfer from lower level facilities: impact 527–33. on mortality and morbidity among patients with major trauma. J Trauma 432. TIMI-11B Investigators, Antman EM, McCabe CH, et al. Enoxaparin prevents 1997;43:288–95 [discussion 95–96]. death and cardiac ischemic events in unstable angina/non-Q-wave myocardial 405. Nichol G, Aufderheide TP, Eigel B, et al. Regional systems of care for out- infarction. Results of the thrombolysis in myocardial infarction (TIMI) 11B trial. of-hospital cardiac arrest: a policy statement from the American Heart Circulation 1999;100:1593–601. Association. Circulation 2010;121:709–29. 433. Cohen M, Demers C, Gurfinkel EP, et al. A comparison of low-molecular-weight 406. Nichol G, Soar J. Regional cardiac resuscitation systems of care. Curr Opin Crit heparin with unfractionated heparin for unstable coronary artery disease. Effi- Care 2010;16:223–30. cacy and safety of subcutaneous enoxaparin in non-Q-wave coronary events 407. Soar J, Packham S. Cardiac arrest centres make sense. Resuscitation study group. N Engl J Med 1997;337:447–52. 2010;81:507–8. 434. Yusuf S, Mehta SR, Chrolavicius S, et al. Comparison of fondaparinux and enoxa- 408. Tunstall-Pedoe H, Vanuzzo D, Hobbs M, et al. Estimation of contribution of parin in acute coronary syndromes. N Engl J Med 2006;354:1464–76. changes in coronary care to improving survival, event rates, and coronary 435. Mehta SR, Boden WE, Eikelboom JW, et al. Antithrombotic therapy with fon- heart disease mortality across the WHO MONICA Project populations. Lancet daparinux in relation to interventional management strategy in patients with 2000;355:688–700. ST- and non-ST-segment elevation acute coronary syndromes: an individual 409. Fox KA, Cokkinos DV, Deckers J, Keil U, Maggioni A, Steg G. The ENACT study: patient-level combined analysis of the Fifth and Sixth Organization to Assess a pan-European survey of acute coronary syndromes. European Network for Strategies in Ischemic Syndromes (OASIS 5 and 6) randomized trials. Circula- Acute Coronary Treatment. Eur Heart J 2000;21:1440–9. tion 2008;118:2038–46. 410. Goodman SG, Huang W, Yan AT, et al. The expanded global registry of 436. Lincoff AM, Bittl JA, Harrington RA, et al. Bivalirudin and provisional glycopro- acute coronary events: baseline characteristics, management practices, and tein IIb/IIIa blockade compared with heparin and planned glycoprotein IIb/IIIa hospital outcomes of patients with acute coronary syndromes. Am Heart J blockade during percutaneous coronary intervention: REPLACE-2 randomized 2009;158:193–201, e1–e5. trial. JAMA 2003;289:853–63. 411. Lowel H, Meisinger C, Heier M, et al. Sex specific trends of sudden car- 437. Efficacy and safety of tenecteplase in combination with enoxaparin, abciximab, diac death and acute myocardial infarction: results of the population-based or unfractionated heparin: the ASSENT-3 randomised trial in acute myocardial KORA/MONICA-Augsburg register 1985 to 1998. Dtsch Med Wochenschr infarction. Lancet 2001;358:605–13. 2002;127:2311–6. 438. Eikelboom JW, Quinlan DJ, Mehta SR, Turpie AG, Menown IB, Yusuf S. Unfrac- 412. Thygesen K, Alpert JS, White HD. Universal definition of myocardial infarction. tionated and low-molecular-weight heparin as adjuncts to thrombolysis in Eur Heart J 2007;28:2525–38. aspirin-treated patients with ST-elevation acute myocardial infarction: a meta- 413. Van de Werf F, Bax J, Betriu A, et al. Management of acute myocardial infarction analysis of the randomized trials. Circulation 2005;112:3855–67. in patients presenting with persistent ST-segment elevation: the Task Force on 439. Wallentin L, Goldstein P, Armstrong PW, et al. Efficacy and safety of the Management of ST-Segment Elevation Acute Myocardial Infarction of the tenecteplase in combination with the low-molecular-weight heparin enoxa- European Society of Cardiology. Eur Heart J 2008;29:2909–45. parin or unfractionated heparin in the prehospital setting: the Assessment 414. Antman EM, Anbe DT, Armstrong PW, et al. ACC/AHA guidelines for the of the Safety and Efficacy of a New Thrombolytic Regimen (ASSENT)-3 management of patients with ST-elevation myocardial infarction—executive PLUS randomized trial in acute myocardial infarction. Circulation 2003;108: summary: a report of the American College of Cardiology/American Heart 135–42. Association Task Force on Practice Guidelines (Writing Committee to Revise 440. Zeymer U, Gitt A, Junger C, et al. Efficacy and safety of enoxaparin in unselected the 1999 Guidelines for the Management of Patients With Acute Myocardial patients with ST-segment elevation myocardial infarction. Thromb Haemost Infarction). Circulation 2004;110:588–636. 2008;99:150–4. 415. Douglas PS, Ginsburg GS. The evaluation of chest pain in women. N Engl J Med 441. Zeymer U, Gitt A, Zahn R, et al. Efficacy and safety of enoxaparin in combination 1996;334:1311–5. with and without GP IIb/IIIa inhibitors in unselected patients with ST segment 416. Solomon CG, Lee TH, Cook EF, et al. Comparison of clinical presentation of elevation myocardial infarction treated with primary percutaneous coronary acute myocardial infarction in patients older than 65 years of age to younger intervention. EuroIntervention 2009;4:524–8. patients: the Multicenter Chest Pain Study experience. Am J Cardiol 1989;63: 442. Bassand JP, Hamm CW, Ardissino D, et al. Guidelines for the diagnosis and 772–6. treatment of non-ST-segment elevation acute coronary syndromes. Eur Heart 417. Ioannidis JP, Salem D, Chew PW, Lau J. Accuracy and clinical effect of out- J 2007;28:1598–660. of-hospital electrocardiography in the diagnosis of acute cardiac ischemia: a 443. Anderson JL, Adams CD, Antman EM, et al. ACC/AHA 2007 guidelines for meta-analysis. Ann Emerg Med 2001;37:461–70. the management of patients with unstable angina/non ST-elevation myocar- 418. Kudenchuk PJ, Ho MT, Weaver WD, et al. Accuracy of computer-interpreted dial infarction: a report of the American College of Cardiology/American electrocardiography in selecting patients for thrombolytic therapy. MITI Heart Association Task Force on Practice Guidelines (Writing Committee to Project Investigators. J Am Coll Cardiol 1991;17:1486–91. Revise the 2002 Guidelines for the Management of Patients With Unstable 419. Dhruva VN, Abdelhadi SI, Anis A, et al. ST-Segment Analysis Using Wireless Angina/Non ST-Elevation Myocardial Infarction): developed in collaboration Technology in Acute Myocardial Infarction (STAT-MI) trial. J Am Coll Cardiol with the American College of Emergency Physicians, the Society for Cardiovas- 2007;50:509–13. cular Angiography and Interventions, and the Society of Thoracic Surgeons: 420. Antman EM, Tanasijevic MJ, Thompson B, et al. Cardiac-specific troponin I levels endorsed by the American Association of Cardiovascular and Pulmonary Reha- to predict the risk of mortality in patients with acute coronary syndromes. N bilitation and the Society for Academic Emergency Medicine. Circulation Engl J Med 1996;335:1342–9. 2007;116:e148–304. 421. Hess EP, Thiruganasambandamoorthy V, Wells GA, et al. Diagnostic accuracy of 444. Kushner FG, Hand M, Smith SCJJr, et al. 2009 Focused Updates: ACC/AHA clinical prediction rules to exclude acute coronary syndrome in the emergency guidelines for the management of patients with ST-elevation myocardial department setting: a systematic review. CJEM 2008;10:373–82. infarction (updating the 2004 Guideline and 2007 Focused Update) and 422. Ramakrishna G, Milavetz JJ, Zinsmeister AR, et al. Effect of exercise treadmill ACC/AHA/SCAI Guidelines on Percutaneous Coronary Intervention (updating testing and stress imaging on the triage of patients with chest pain: CHEER the 2005 Guideline and 2007 Focused Update): a report of the American substudy. Mayo Clin Proc 2005;80:322–9. College of Cardiology Foundation/American Heart Association Task Force on 423. Kearney PM, Baigent C, Godwin J, Halls H, Emberson JR, Patrono C. Do selective Practice Guidelines. Circulation 2009;120:2271–306. Erratum in: Circulation. cyclo-oxygenase-2 inhibitors and traditional non-steroidal anti-inflammatory 010 March 30;121(12):e257. Dosage error in article text. drugs increase the risk of atherothrombosis? Meta-analysis of randomised 445. Boersma E, Maas AC, Deckers JW, Simoons ML. Early thrombolytic treat- trials. BMJ 2006;332:1302–8. ment in acute myocardial infarction: reappraisal of the golden hour. Lancet 424. Rawles JM, Kenmure AC. Controlled trial of oxygen in uncomplicated myocar- 1996;348:771–5. dial infarction. BMJ 1976;1:1121–3. 446. Prehospital thrombolytic therapy in patients with suspected acute myocardial 425. Wijesinghe M, Perrin K, Ranchord A, Simmonds M, Weatherall M, Beasley R. infarction. The European Myocardial Infarction Project Group. N Engl J Med Routine use of oxygen in the treatment of myocardial infarction: systematic 1993;329:383–9. review. Heart 2009;95:198–202. 447. Weaver WD, Cerqueira M, Hallstrom AP, et al. Prehospital-initiated vs 426. Cabello JB, Burls A, Emparanza JI, Bayliss S, Quinn T. Oxygen therapy for acute hospital-initiated thrombolytic therapy. The Myocardial Infarction Triage and myocardial infarction. Cochrane Database Syst Rev 2010;6:CD007160. Intervention Trial. JAMA 1993;270:1211–6.
- 54. 1272 J.P. Nolan et al. / Resuscitation 81 (2010) 1219–1276 448. Feasibility, safety, and efficacy of domiciliary thrombolysis by general 477. Brilli RJ, Gibson R, Luria JW, et al. Implementation of a medical emergency practitioners: Grampian region early anistreplase trial. GREAT Group. BMJ team in a large pediatric teaching hospital prevents respiratory and car- 1992;305:548–53. diopulmonary arrests outside the intensive care unit. Pediatr Crit Care Med 449. Welsh RC, Travers A, Senaratne M, Williams R, Armstrong PW. Feasibility 2007;8:236–46 [quiz 47]. and applicability of paramedic-based prehospital fibrinolysis in a large North 478. Tibballs J, Kinney S, Duke T, Oakley E, Hennessy M. Reduction of paediatric in- American center. Am Heart J 2006;152:1007–14. patient cardiac arrest and death with a medical emergency team: preliminary 450. Pedley DK, Bissett K, Connolly EM, et al. Prospective observational cohort study results. Arch Dis Child 2005;90:1148–52. of time saved by prehospital thrombolysis for ST elevation myocardial infarc- 479. Sagarin MJ, Chiang V, Sakles JC, et al. Rapid sequence intubation for pediatric tion delivered by paramedics. BMJ 2003;327:22–6. emergency airway management. Pediatr Emerg Care 2002;18:417–23. 451. Grijseels EW, Bouten MJ, Lenderink T, et al. Pre-hospital thrombolytic ther- 480. Moynihan RJ, Brock-Utne JG, Archer JH, Feld LH, Kreitzman TR. The effect of apy with either alteplase or streptokinase. Practical applications, complications cricoid pressure on preventing gastric insufflation in infants and children. and long-term results in 529 patients. Eur Heart J 1995;16:1833–8. Anesthesiology 1993;78:652–6. 452. Morrison LJ, Verbeek PR, McDonald AC, Sawadsky BV, Cook DJ. Mortality and 481. Salem MR, Joseph NJ, Heyman HJ, Belani B, Paulissian R, Ferrara TP. Cricoid prehospital thrombolysis for acute myocardial infarction: a meta-analysis. compression is effective in obliterating the esophageal lumen in the presence JAMA 2000;283:2686–92. of a nasogastric tube. Anesthesiology 1985;63:443–6. 453. Keeley EC, Boura JA, Grines CL. Primary angioplasty versus intravenous throm- 482. Walker RW, Ravi R, Haylett K. Effect of cricoid force on airway calibre in chil- bolytic therapy for acute myocardial infarction: a quantitative review of 23 dren: a bronchoscopic assessment. Br J Anaesth 2010;104:71–4. randomised trials. Lancet 2003;361:13–20. 483. Khine HH, Corddry DH, Kettrick RG, et al. Comparison of cuffed and uncuffed 454. Dalby M, Bouzamondo A, Lechat P, Montalescot G. Transfer for primary endotracheal tubes in young children during general anesthesia. Anesthesiol- angioplasty versus immediate thrombolysis in acute myocardial infarction: ogy 1997;86:627–31 [discussion 27A]. a meta-analysis. Circulation 2003;108:1809–14. 484. Weiss M, Dullenkopf A, Fischer JE, Keller C, Gerber AC. Prospective randomized 455. Steg PG, Bonnefoy E, Chabaud S, et al. Impact of time to treatment on mortality controlled multi-centre trial of cuffed or uncuffed endotracheal tubes in small after prehospital fibrinolysis or primary angioplasty: data from the CAPTIM children. Br J Anaesth 2009;103:867–73. randomized clinical trial. Circulation 2003;108:2851–6. 485. Duracher C, Schmautz E, Martinon C, Faivre J, Carli P, Orliaguet G. Evaluation of 456. Bonnefoy E, Steg PG, Boutitie F, et al. Comparison of primary angioplasty and cuffed tracheal tube size predicted using the Khine formula in children. Paediatr pre-hospital fibrinolysis in acute myocardial infarction (CAPTIM) trial: a 5-year Anaesth 2008;18:113–8. follow-up. Eur Heart J 2009;30:1598–606. 486. Dullenkopf A, Kretschmar O, Knirsch W, et al. Comparison of tracheal tube cuff 457. Kalla K, Christ G, Karnik R, et al. Implementation of guidelines improves diameters with internal transverse diameters of the trachea in children. Acta the standard of care: the Viennese registry on reperfusion strategies Anaesthesiol Scand 2006;50:201–5. in ST-elevation myocardial infarction (Vienna STEMI registry). Circulation 487. Dullenkopf A, Gerber AC, Weiss M. Fit and seal characteristics of a new pae- 2006;113:2398–405. diatric tracheal tube with high volume-low pressure polyurethane cuff. Acta 458. Primary versus tenecteplase-facilitated percutaneous coronary intervention Anaesthesiol Scand 2005;49:232–7. in patients with ST-segment elevation acute myocardial infarction (ASSENT-4 488. Salgo B, Schmitz A, Henze G, et al. Evaluation of a new recommendation for PCI): randomised trial. Lancet 2006;367:569–78. improved cuffed tracheal tube size selection in infants and small children. Acta 459. Pinto DS, Kirtane AJ, Nallamothu BK, et al. Hospital delays in reperfusion for Anaesthesiol Scand 2006;50:557–61. ST-elevation myocardial infarction: implications when selecting a reperfusion 489. Luten RC, Wears RL, Broselow J, et al. Length-based endotracheal tube and strategy. Circulation 2006;114:2019–25. emergency equipment in pediatrics. Ann Emerg Med 1992;21:900–4. 460. Keeley EC, Boura JA, Grines CL. Comparison of primary and facilitated per- 490. Deakers TW, Reynolds G, Stretton M, Newth CJ. Cuffed endotracheal tubes in cutaneous coronary interventions for ST-elevation myocardial infarction: pediatric intensive care. J Pediatr 1994;125:57–62. quantitative review of randomised trials. Lancet 2006;367:579–88. 491. Newth CJ, Rachman B, Patel N, Hammer J. The use of cuffed versus 461. Herrmann HC, Lu J, Brodie BR, et al. Benefit of facilitated percutaneous coronary uncuffed endotracheal tubes in pediatric intensive care. J Pediatr 2004;144: intervention in high-risk ST-segment elevation myocardial infarction patients 333–7. presenting to nonpercutaneous coronary intervention hospitals. JACC Cardio- 492. Dorsey DP, Bowman SM, Klein MB, Archer D, Sharar SR. Perioperative use of vasc Interv 2009;2:917–24. cuffed endotracheal tubes is advantageous in young pediatric burn patients. 462. Gershlick AH, Stephens-Lloyd A, Hughes S, et al. Rescue angioplasty after Burns 2010. failed thrombolytic therapy for acute myocardial infarction. N Engl J Med 493. Mhanna MJ, Zamel YB, Tichy CM, Super DM. The “air leak” test around the 2005;353:2758–68. endotracheal tube, as a predictor of postextubation stridor, is age dependent 463. Danchin N, Coste P, Ferrieres J, et al. Comparison of thrombolysis followed by in children. Crit Care Med 2002;30:2639–43. broad use of percutaneous coronary intervention with primary percutaneous 494. Gausche M, Lewis RJ, Stratton SJ, et al. Effect of out-of-hospital pediatric endo- coronary intervention for ST-segment-elevation acute myocardial infarction: tracheal intubation on survival and neurological outcome: a controlled clinical data from the french registry on acute ST-elevation myocardial infarction trial. JAMA 2000;283:783–90. (FAST-MI). Circulation 2008;118:268–76. 495. Kelly JJ, Eynon CA, Kaplan JL, de Garavilla L, Dalsey WC. Use of tube con- 464. Cantor WJ, Fitchett D, Borgundvaag B, et al. Routine early angioplasty after densation as an indicator of endotracheal tube placement. Ann Emerg Med fibrinolysis for acute myocardial infarction. N Engl J Med 2009;360:2705–18. 1998;31:575–8. 465. Redding JS. The choking controversy: critique of evidence on the Heimlich 496. Andersen KH, Hald A. Assessing the position of the tracheal tube: the reliability maneuver. Crit Care Med 1979;7:475–9. of different methods. Anaesthesia 1989;44:984–5. 466. Kuisma M, Suominen P, Korpela R. Paediatric out-of-hospital cardiac 497. Andersen KH, Schultz-Lebahn T. Oesophageal intubation can be undetected by arrests—epidemiology and outcome. Resuscitation 1995;30:141–50. auscultation of the chest. Acta Anaesthesiol Scand 1994;38:580–2. 467. Sirbaugh PE, Pepe PE, Shook JE, et al. A prospective, population-based study 498. Van de Louw A, Cracco C, Cerf C, et al. Accuracy of pulse oximetry in the inten- of the demographics, epidemiology, management, and outcome of out-of- sive care unit. Intensive Care Med 2001;27:1606–13. hospital pediatric cardiopulmonary arrest. Ann Emerg Med 1999;33:174–84. 499. Seguin P, Le Rouzo A, Tanguy M, Guillou YM, Feuillu A, Malledant Y. Evidence 468. Hickey RW, Cohen DM, Strausbaugh S, Dietrich AM. Pediatric patients requiring for the need of bedside accuracy of pulse oximetry in an intensive care unit. CPR in the prehospital setting. Ann Emerg Med 1995;25:495–501. Crit Care Med 2000;28:703–6. 469. Young KD, Seidel JS. Pediatric cardiopulmonary resuscitation: a collective 500. Aufderheide TP, Sigurdsson G, Pirrallo RG, et al. Hyperventilation- review. Ann Emerg Med 1999;33:195–205. induced hypotension during cardiopulmonary resuscitation. Circulation 470. Reis AG, Nadkarni V, Perondi MB, Grisi S, Berg RA. A prospective investigation 2004;109:1960–5. into the epidemiology of in-hospital pediatric cardiopulmonary resuscitation 501. Aufderheide TP, Lurie KG. Death by hyperventilation: a common and life- using the international Utstein reporting style. Pediatrics 2002;109:200–9. threatening problem during cardiopulmonary resuscitation. Crit Care Med 471. Young KD, Gausche-Hill M, McClung CD, Lewis RJ. A prospective, population- 2004;32:S345–51. based study of the epidemiology and outcome of out-of-hospital pediatric 502. Borke WB, Munkeby BH, Morkrid L, Thaulow E, Saugstad OD. Resuscitation cardiopulmonary arrest. Pediatrics 2004;114:157–64. with 100% O(2) does not protect the myocardium in hypoxic newborn piglets. 472. Richman PB, Nashed AH. The etiology of cardiac arrest in children and Arch Dis Child Fetal Neonatal Ed 2004;89:F156–60. young adults: special considerations for ED management. Am J Emerg Med 503. O’Neill JF, Deakin CD. Do we hyperventilate cardiac arrest patients? Resuscita- 1999;17:264–70. tion 2007;73:82–5. 473. Engdahl J, Bang A, Karlson BW, Lindqvist J, Herlitz J. Characteristics and 504. Bhende MS, Thompson AE, Orr RA. Utility of an end-tidal carbon dioxide outcome among patients suffering from out of hospital cardiac arrest of non- detector during stabilization and transport of critically ill children. Pediatrics cardiac aetiology. Resuscitation 2003;57:33–41. 1992;89:1042–4. 474. Tibballs J, Kinney S. Reduction of hospital mortality and of preventable car- 505. Bhende MS, LaCovey DC. End-tidal carbon dioxide monitoring in the prehos- diac arrest and death on introduction of a pediatric medical emergency team. pital setting. Prehosp Emerg Care 2001;5:208–13. Pediatr Crit Care Med 2009;10:306–12. 506. Ornato JP, Shipley JB, Racht EM, et al. Multicenter study of a portable, hand- 475. Hunt EA, Zimmer KP, Rinke ML, et al. Transition from a traditional code team size, colorimetric end-tidal carbon dioxide detection device. Ann Emerg Med to a medical emergency team and categorization of cardiopulmonary arrests 1992;21:518–23. in a children’s center. Arch Pediatr Adolesc Med 2008;162:117–22. 507. Gonzalez del Rey JA, Poirier MP, Digiulio GA. Evaluation of an ambu- 476. Sharek PJ, Parast LM, Leong K, et al. Effect of a rapid response team on hospital- bag valve with a self-contained, colorimetric end-tidal CO2 system in the wide mortality and code rates outside the ICU in a Children’s Hospital. JAMA detection of airway mishaps: an animal trial. Pediatr Emerg Care 2000;16: 2007;298:2267–74. 121–3.
- 55. J.P. Nolan et al. / Resuscitation 81 (2010) 1219–1276 1273 508. Bhende MS, Karasic DG, Karasic RB. End-tidal carbon dioxide changes during unexplained death: a molecular autopsy of 49 medical examiner/coroner’s cardiopulmonary resuscitation after experimental asphyxial cardiac arrest. Am cases. Mayo Clin Proc 2004;79:1380–4. J Emerg Med 1996;14:349–50. 541. Graham EM, Forbus GA, Bradley SM, Shirali GS, Atz AM. Incidence and outcome 509. DeBehnke DJ, Hilander SJ, Dobler DW, Wickman LL, Swart GL. The hemody- of cardiopulmonary resuscitation in patients with shunted single ventricle: namic and arterial blood gas response to asphyxiation: a canine model of advantage of right ventricle to pulmonary artery shunt. J Thorac Cardiovasc pulseless electrical activity. Resuscitation 1995;30:169–75. Surg 2006;131:e7–8. 510. Ornato JP, Garnett AR, Glauser FL. Relationship between cardiac output and the 542. Charpie JR, Dekeon MK, Goldberg CS, Mosca RS, Bove EL, Kulik TJ. Postoperative end-tidal carbon dioxide tension. Ann Emerg Med 1990;19:1104–6. hemodynamics after Norwood palliation for hypoplastic left heart syndrome. 511. Mauer D, Schneider T, Elich D, Dick W. Carbon dioxide levels during Am J Cardiol 2001;87:198–202. pre-hospital active compression–decompression versus standard cardiopul- 543. Hoffman GM, Mussatto KA, Brosig CL, et al. Systemic venous oxygen saturation monary resuscitation. Resuscitation 1998;39:67–74. after the Norwood procedure and childhood neurodevelopmental outcome. J 512. Kolar M, Krizmaric M, Klemen P, Grmec S. Partial pressure of end-tidal car- Thorac Cardiovasc Surg 2005;130:1094–100. bon dioxide successful predicts cardiopulmonary resuscitation in the field: a 544. Johnson BA, Hoffman GM, Tweddell JS, et al. Near-infrared spectroscopy in prospective observational study. Crit Care 2008;12:R115. neonates before palliation of hypoplastic left heart syndrome. Ann Thorac Surg 513. Sharieff GQ, Rodarte A, Wilton N, Bleyle D. The self-inflating bulb as an airway 2009;87:571–7 [discussion 7–9]. adjunct: is it reliable in children weighing less than 20 kilograms? Acad Emerg 545. Hoffman GM, Tweddell JS, Ghanayem NS, et al. Alteration of the critical arteri- Med 2003;10:303–8. ovenous oxygen saturation relationship by sustained afterload reduction after 514. Sharieff GQ, Rodarte A, Wilton N, Silva PD, Bleyle D. The self-inflating bulb as an the Norwood procedure. J Thorac Cardiovasc Surg 2004;127:738–45. esophageal detector device in children weighing more than twenty kilograms: 546. De Oliveira NC, Van Arsdell GS. Practical use of alpha blockade strategy in the a comparison of two techniques. Ann Emerg Med 2003;41:623–9. management of hypoplastic left heart syndrome following stage one palliation 515. Dung NM, Day NPJ, Tam DTH, et al. Fluid replacement in dengue shock syn- with a Blalock-Taussig shunt. Semin Thorac Cardiovasc Surg Pediatr Card Surg drome: a randomized, double-blind comparison of four intravenous-fluid Annu 2004;7:11–5. regimens. Clin Infect Dis 1999;29:787–94. 547. Tweddell JS, Hoffman GM, Mussatto KA, et al. Improved survival of patients 516. Ngo NT, Cao XT, Kneen R, et al. Acute management of dengue shock syndrome: undergoing palliation of hypoplastic left heart syndrome: lessons learned from a randomized double-blind comparison of 4 intravenous fluid regimens in the 115 consecutive patients. Circulation 2002;106:I82–9. first hour. Clin Infect Dis 2001;32:204–13. 548. Shekerdemian LS, Shore DF, Lincoln C, Bush A, Redington AN. Negative- 517. Wills BA, Nguyen MD, Ha TL, et al. Comparison of three fluid solutions for pressure ventilation improves cardiac output after right heart surgery. resuscitation in dengue shock syndrome. N Engl J Med 2005;353:877–89. Circulation 1996;94:II49–55. 518. Upadhyay M, Singhi S, Murlidharan J, Kaur N, Majumdar S. Randomized eval- 549. Shekerdemian LS, Bush A, Shore DF, Lincoln C, Redington AN. Cardiopulmonary uation of fluid resuscitation with crystalloid (saline) and colloid (polymer interactions after Fontan operations: augmentation of cardiac output using from degraded gelatin in saline) in pediatric septic shock. Indian Pediatr negative pressure ventilation. Circulation 1997;96:3934–42. 2005;42:223–31. 550. Booth KL, Roth SJ, Thiagarajan RR, Almodovar MC, del Nido PJ, Laussen PC. 519. Lillis KA, Jaffe DM. Prehospital intravenous access in children. Ann Emerg Med Extracorporeal membrane oxygenation support of the Fontan and bidirectional 1992;21:1430–4. Glenn circulations. Ann Thorac Surg 2004;77:1341–8. 520. Kanter RK, Zimmerman JJ, Strauss RH, Stoeckel KA. Pediatric emergency intra- 551. Polderman FN, Cohen J, Blom NA, et al. Sudden unexpected death in chil- venous access. Evaluation of a protocol. Am J Dis Child 1986;140:132–4. dren with a previously diagnosed cardiovascular disorder. Int J Cardiol 521. Kleinman ME, Oh W, Stonestreet BS. Comparison of intravenous and endotra- 2004;95:171–6. cheal epinephrine during cardiopulmonary resuscitation in newborn piglets. 552. Sanatani S, Wilson G, Smith CR, Hamilton RM, Williams WG, Adatia I. Sud- Crit Care Med 1999;27:2748–54. den unexpected death in children with heart disease. Congenit Heart Dis 522. Roberts JR, Greenburg MI, Knaub M, Baskin SI. Comparison of the pharmacolog- 2006;1:89–97. ical effects of epinephrine administered by the intravenous and endotracheal 553. Morris K, Beghetti M, Petros A, Adatia I, Bohn D. Comparison of hyperventilation routes. JACEP 1978;7:260–4. and inhaled nitric oxide for pulmonary hypertension after repair of congenital 523. Zaritsky A. Pediatric resuscitation pharmacology. Members of the medications heart disease. Crit Care Med 2000;28:2974–8. in pediatric resuscitation panel. Ann Emerg Med 1993;22:445–55. 554. Hoeper MM, Galie N, Murali S, et al. Outcome after cardiopulmonary resusci- 524. Manisterski Y, Vaknin Z, Ben-Abraham R, et al. Endotracheal epinephrine: a tation in patients with pulmonary arterial hypertension. Am J Respir Crit Care call for larger doses. Anesth Analg 2002;95:1037–41 [table of contents]. Med 2002;165:341–4. 525. Efrati O, Ben-Abraham R, Barak A, et al. Endobronchial adrenaline: should it be 555. Rimensberger PC, Spahr-Schopfer I, Berner M, et al. Inhaled nitric oxide ver- reconsidered? Dose response and haemodynamic effect in dogs. Resuscitation sus aerosolized iloprost in secondary pulmonary hypertension in children with 2003;59:117–22. congenital heart disease: vasodilator capacity and cellular mechanisms. Circu- 526. Saul JP, Scott WA, Brown S, et al. Intravenous amiodarone for incessant tach- lation 2001;103:544–8. yarrhythmias in children: a randomized, double-blind, antiarrhythmic drug 556. Liu KS, Tsai FC, Huang YK, et al. Extracorporeal life support: a simple and trial. Circulation 2005;112:3470–7. effective weapon for postcardiotomy right ventricular failure. Artif Organs 527. Tsung JW, Blaivas M. Feasibility of correlating the pulse check with focused 2009;33:504–8. point-of-care echocardiography during pediatric cardiac arrest: a case series. 557. Dhillon R, Pearson GA, Firmin RK, Chan KC, Leanage R. Extracorporeal mem- Resuscitation 2008;77:264–9. brane oxygenation and the treatment of critical pulmonary hypertension in 528. Cummins RO, Graves JR, Larsen MP, et al. Out-of-hospital transcutaneous pac- congenital heart disease. Eur J Cardiothorac Surg 1995;9:553–6. ing by emergency medical technicians in patients with asystolic cardiac arrest. 558. Arpesella G, Loforte A, Mikus E, Mikus PM. Extracorporeal membrane oxygena- N Engl J Med 1993;328:1377–82. tion for primary allograft failure. Transplant Proc 2008;40:3596–7. 529. Sreeram N, Wren C. Supraventricular tachycardia in infants: response to initial 559. Strueber M, Hoeper MM, Fischer S, et al. Bridge to thoracic organ transplanta- treatment. Arch Dis Child 1990;65:127–9. tion in patients with pulmonary arterial hypertension using a pumpless lung 530. Benson Jr D, Smith W, Dunnigan A, Sterba R, Gallagher J. Mechanisms of regular assist device. Am J Transplant 2009;9:853–7. wide QRS tachycardia in infants and children. Am J Cardiol 1982;49:1778–88. 560. Gluckman PD, Wyatt JS, Azzopardi D, et al. Selective head cooling with mild sys- 531. Ackerman MJ, Siu BL, Sturner WQ, et al. Postmortem molecular analysis of temic hypothermia after neonatal encephalopathy: multicentre randomised SCN5A defects in sudden infant death syndrome. JAMA 2001;286:2264–9. trial. Lancet 2005;365:663–70. 532. Arnestad M, Crotti L, Rognum TO, et al. Prevalence of long-QT syndrome gene 561. Battin MR, Penrice J, Gunn TR, Gunn AJ. Treatment of term infants with head variants in sudden infant death syndrome. Circulation 2007;115:361–7. cooling and mild systemic hypothermia (35.0 degrees C and 34.5 degrees C) 533. Cronk LB, Ye B, Kaku T, et al. Novel mechanism for sudden infant death syn- after perinatal asphyxia. Pediatrics 2003;111:244–51. drome: persistent late sodium current secondary to mutations in caveolin-3. 562. Compagnoni G, Pogliani L, Lista G, Castoldi F, Fontana P, Mosca F. Hypothermia Heart Rhythm 2007;4:161–6. reduces neurological damage in asphyxiated newborn infants. Biol Neonate 534. Millat G, Kugener B, Chevalier P, et al. Contribution of long-QT syn- 2002;82:222–7. drome genetic variants in sudden infant death syndrome. Pediatr Cardiol 563. Gunn AJ, Gunn TR, Gunning MI, Williams CE, Gluckman PD. Neuroprotec- 2009;30:502–9. tion with prolonged head cooling started before postischemic seizures in fetal 535. Otagiri T, Kijima K, Osawa M, et al. Cardiac ion channel gene mutations in sheep. Pediatrics 1998;102:1098–106. sudden infant death syndrome. Pediatr Res 2008;64:482–7. 564. Debillon T, Daoud P, Durand P, et al. Whole-body cooling after perinatal 536. Plant LD, Bowers PN, Liu Q, et al. A common cardiac sodium channel variant asphyxia: a pilot study in term neonates. Dev Med Child Neurol 2003;45: associated with sudden infant death in African Americans. SCN5A S1103Y. J 17–23. Clin Invest 2006;116:430–5. 565. Shankaran S, Laptook AR, Ehrenkranz RA, et al. Whole-body hypother- 537. Tester DJ, Dura M, Carturan E, et al. A mechanism for sudden infant death mia for neonates with hypoxic-ischemic encephalopathy. N Engl J Med syndrome (SIDS): stress-induced leak via ryanodine receptors. Heart Rhythm 2005;353:1574–84. 2007;4:733–9. 566. Doherty DR, Parshuram CS, Gaboury I, et al. Hypothermia therapy after pedi- 538. Albert CM, Nam EG, Rimm EB, et al. Cardiac sodium channel gene variants and atric cardiac arrest. Circulation 2009;119:1492–500. sudden cardiac death in women. Circulation 2008;117:16–23. 567. Coimbra C, Boris-Moller F, Drake M, Wieloch T. Diminished neuronal damage 539. Chugh SS, Senashova O, Watts A, et al. Postmortem molecular screening in in the rat brain by late treatment with the antipyretic drug dipyrone or cooling unexplained sudden death. J Am Coll Cardiol 2004;43:1625–9. following cerebral ischemia. Acta Neuropathol 1996;92:447–53. 540. Tester DJ, Spoon DB, Valdivia HH, Makielski JC, Ackerman MJ. Targeted muta- 568. Coimbra C, Drake M, Boris-Moller F, Wieloch T. Long-lasting neuro- tional analysis of the RyR2-encoded cardiac ryanodine receptor in sudden protective effect of postischemic hypothermia and treatment with an
- 56. 1274 J.P. Nolan et al. / Resuscitation 81 (2010) 1219–1276 anti-inflammatory/antipyretic drug. Evidence for chronic encephalopathic 605. Bouchama A, Dehbi M, Chaves-Carballo E. Cooling and hemodynamic manage- processes following ischemia. Stroke 1996;27:1578–85. ment in heatstroke: practical recommendations. Crit Care 2007;11:R54. 569. Losert H, Sterz F, Roine RO, et al. Strict normoglycaemic blood glucose levels in 606. Eshel G, Safar P, Sassano J, Stezoski W. Hyperthermia-induced cardiac arrest in the therapeutic management of patients within 12 h after cardiac arrest might dogs and monkeys. Resuscitation 1990;20:129–43. not be necessary. Resuscitation 2008;76:214–20. 607. Eshel G, Safar P, Radovsky A, Stezoski SW. Hyperthermia-induced cardiac 570. Oksanen T, Skrifvars MB, Varpula T, et al. Strict versus moderate glucose arrest in monkeys: limited efficacy of standard CPR. Aviat Space Environ Med control after resuscitation from ventricular fibrillation. Intensive Care Med 1997;68:415–20. 2007;33:2093–100. 608. Masoli M, Fabian D, Holt S, Beasley R. The global burden of asthma: 571. Palme-Kilander C. Methods of resuscitation in low-Apgar-score newborn executive summary of the GINA Dissemination Committee report. Allergy infants—a national survey. Acta Paediatr 1992;81:739–44. 2004;59:469–78. 572. Dahm LS, James LS. Newborn temperature and calculated heat loss in the deliv- 609. Global Strategy for Asthma Management and Prevention 2009 [accessed ery room. Pediatrics 1972;49:504–13. 24.06.10]. 573. Stephenson J, Du J, Oliver TK. The effect of cooling on blood gas tensions in 610. Williams TJ, Tuxen DV, Scheinkestel CD, Czarny D, Bowes G. Risk factors for newborn infants. J Pediatr 1970;76:848–52. morbidity in mechanically ventilated patients with acute severe asthma. Am 574. Gandy GM, Adamsons Jr K, Cunningham N, Silverman WA, James LS. Thermal Rev Respir Dis 1992;146:607–15. environment and acid–base homeostasis in human infants during the first few 611. Bowman FP, Menegazzi JJ, Check BD, Duckett TM. Lower esophageal sphincter hours of life. J Clin Invest 1964;43:751–8. pressure during prolonged cardiac arrest and resuscitation. Ann Emerg Med 575. Kent AL, Williams J. Increasing ambient operating theatre temperature and 1995;26:216–9. wrapping in polyethylene improves admission temperature in premature 612. Leatherman JW, McArthur C, Shapiro RS. Effect of prolongation of expira- infants. J Paediatr Child Health 2008;44:325–31. tory time on dynamic hyperinflation in mechanically ventilated patients with 576. Knobel RB, Wimmer Jr JE, Holbert D. Heat loss prevention for preterm infants severe asthma. Crit Care Med 2004;32:1542–5. in the delivery room. J Perinatol 2005;25:304–8. 613. Lapinsky SE, Leung RS. Auto-PEEP and electromechanical dissociation. N Engl 577. Apgar V. A proposal for a new method of evaluation of the newborn infant. Curr J Med 1996;335:674. Res Anesth Analg 1953:32. 614. Rogers PL, Schlichtig R, Miro A, Pinsky M. Auto-PEEP during CPR. An “occult” 578. Chamberlain G, Banks J. Assessment of the Apgar score. Lancet 1974;2:1225–8. cause of electromechanical dissociation? Chest 1991;99:492–3. 579. Owen CJ, Wyllie JP. Determination of heart rate in the baby at birth. Resuscita- 615. Rosengarten PL, Tuxen DV, Dziukas L, Scheinkestel C, Merrett K, Bowes G. Circu- tion 2004;60:213–7. latory arrest induced by intermittent positive pressure ventilation in a patient 580. Kamlin CO, Dawson JA, O’Donnell CP, et al. Accuracy of pulse oximetry mea- with severe asthma. Anaesth Intensive Care 1991;19:118–21. surement of heart rate of newborn infants in the delivery room. J Pediatr 616. Sprung J, Hunter K, Barnas GM, Bourke DL. Abdominal distention is not always a 2008;152:756–60. sign of esophageal intubation: cardiac arrest due to “auto-PEEP”. Anesth Analg 581. O’Donnell CP, Kamlin CO, Davis PG, Carlin JB, Morley CJ. Clinical assessment of 1994;78:801–4. infant colour at delivery. Arch Dis Child Fetal Neonatal Ed 2007;92:F465–7. 617. Harrison R. Chest compression first aid for respiratory arrest due to acute 582. Cordero Jr L, Hon EH. Neonatal bradycardia following nasopharyngeal stimu- asphyxic asthma. Emerg Med J 2010;27:59–61. lation. J Pediatr 1971;78:441–7. 618. Deakin CD, McLaren RM, Petley GW, Clewlow F, Dalrymple-Hay MJ. Effects 583. Houri PK, Frank LR, Menegazzi JJ, Taylor R. A randomized, controlled trial of of positive end-expiratory pressure on transthoracic impedance—implications two-thumb vs two-finger chest compression in a swine infant model of cardiac for defibrillation. Resuscitation 1998;37:9–12. arrest [see comment]. Prehosp Emerg Care 1997;1:65–7. 619. Galbois A, Ait-Oufella H, Baudel JL, et al. Pleural ultrasound compared to chest 584. David R. Closed chest cardiac massage in the newborn infant. Pediatrics radiographic detection of pneumothorax resolution after drainage. Chest 2010. 1988;81:552–4. 620. Mabuchi N, Takasu H, Ito S, et al. Successful extracorporeal lung assist (ECLA) 585. Menegazzi JJ, Auble TE, Nicklas KA, Hosack GM, Rack L, Goode JS. Two-thumb for a patient with severe asthma and cardiac arrest. Clin Intensive Care versus two-finger chest compression during CRP in a swine infant model of 1991;2:292–4. cardiac arrest. Ann Emerg Med 1993;22:240–3. 621. Martin GB, Rivers EP, Paradis NA, Goetting MG, Morris DC, Nowak RM. Emer- 586. Thaler MM, Stobie GH. An improved technique of external caridac compression gency department cardiopulmonary bypass in the treatment of human cardiac in infants and young children. N Engl J Med 1963;269:606–10. arrest. Chest 1998;113:743–51. 587. Meyer A, Nadkarni V, Pollock A, et al. Evaluation of the Neonatal Resuscita- 622. Soar J, Pumphrey R, Cant A, et al. Emergency treatment of anaphylac- tion Program’s recommended chest compression depth using computerized tic reactions—guidelines for healthcare providers. Resuscitation 2008;77: tomography imaging. Resuscitation 2010;81:544–8. 157–69. 588. Wyckoff MH, Perlman JM, Laptook AR. Use of volume expansion during delivery 623. Soar J. Emergency treatment of anaphylaxis in adults: concise guidance. Clin room resuscitation in near-term and term infants. Pediatrics 2005;115:950–5. Med 2009;9:181–5. 589. Soar J, Deakin CD, Nolan JP, et al. European Resuscitation Council guidelines for 624. Charalambous CP, Zipitis CS, Keenan DJ. Chest reexploration in the intensive resuscitation 2005. Section 7. Cardiac arrest in special circumstances. Resusci- care unit after cardiac surgery: a safe alternative to returning to the operating tation 2005;67(Suppl. 1):S135–70. theater. Ann Thorac Surg 2006;81:191–4. 590. Bronstein AC, Spyker DA, Cantilena Jr LR, Green JL, Rumack BH, Giffin SL. 625. McKowen RL, Magovern GJ, Liebler GA, Park SB, Burkholder JA, Maher TD. Infec- 2008 Annual Report of the American Association of Poison Control Centers’ tious complications and cost-effectiveness of open resuscitation in the surgical National Poison Data System (NPDS): 26th Annual Report. Clin Toxicol (Phila) intensive care unit after cardiac surgery. Ann Thorac Surg 1985;40:388–92. 2009;47:911–1084. 626. Pottle A, Bullock I, Thomas J, Scott L. Survival to discharge following Open Chest 591. Yanagawa Y, Sakamoto T, Okada Y. Recovery from a psychotropic drug over- Cardiac Compression (OCCC). A 4-year retrospective audit in a cardiothoracic dose tends to depend on the time from ingestion to arrival, the Glasgow specialist centre – Royal Brompton and Harefield NHS Trust, United Kingdom. Coma Scale, and a sign of circulatory insufficiency on arrival. Am J Emerg Med Resuscitation 2002;52:269–72. 2007;25:757–61. 627. Mackay JH, Powell SJ, Osgathorp J, Rozario CJ. Six-year prospective audit of 592. Zimmerman JL. Poisonings and overdoses in the intensive care unit: general chest reopening after cardiac arrest. Eur J Cardiothorac Surg 2002;22:421–5. and specific management issues. Crit Care Med 2003;31:2794–801. 628. Birdi I, Chaudhuri N, Lenthall K, Reddy S, Nashef SA. Emergency reinstitution of 593. Warner DS, Bierens JJ, Beerman SB, Katz LM. Drowning: a cry for help. Anes- cardiopulmonary bypass following cardiac surgery: outcome justifies the cost. thesiology 2009;110:1211–3. Eur J Cardiothorac Surg 2000;17:743–6. 594. Danzl D. Accidental hypothermia. In: Auerbach P, editor. Wilderness medicine. 629. el-Banayosy A, Brehm C, Kizner L, et al. Cardiopulmonary resuscitation after St. Louis: Mosby; 2007. p. 125–60. cardiac surgery: a two-year study. J Cardiothorac Vasc Anesth 1998;12:390–2. 595. Paal P, Beikircher W, Brugger H. Avalanche emergencies. Review of the current 630. Anthi A, Tzelepis GE, Alivizatos P, Michalis A, Palatianos GM, Geroulanos situation. Anaesthesist 2006;55:314–24. S. Unexpected cardiac arrest after cardiac surgery: incidence, predisposing 596. Mattu A, Brady WJ, Perron AD. Electrocardiographic manifestations of causes, and outcome of open chest cardiopulmonary resuscitation. Chest hypothermia. Am J Emerg Med 2002;20:314–26. 1998;113:15–9. 597. Ujhelyi MR, Sims JJ, Dubin SA, Vender J, Miller AW. Defibrillation energy 631. Wahba A, Gotz W, Birnbaum DE. Outcome of cardiopulmonary resuscitation requirements and electrical heterogeneity during total body hypothermia. Crit following open heart surgery. Scand Cardiovasc J 1997;31:147–9. Care Med 2001;29:1006–11. 632. Kaiser GC, Naunheim KS, Fiore AC, et al. Reoperation in the intensive care unit. 598. Walpoth BH, Walpoth-Aslan BN, Mattle HP, et al. Outcome of survivors of acci- Ann Thorac Surg 1990;49:903–7 [discussion 8]. dental deep hypothermia and circulatory arrest treated with extracorporeal 633. Rhodes JF, Blaufox AD, Seiden HS, et al. Cardiac arrest in infants after congenital blood warming. N Engl J Med 1997;337:1500–5. heart surgery. Circulation 1999;100:II194–9. 599. Bouchama A, Knochel JP. Heat stroke. N Engl J Med 2002;346:1978–88. 634. Kempen PM, Allgood R. Right ventricular rupture during closed-chest car- 600. Bouchama A. The 2003 European heat wave. Intensive Care Med 2004;30:1–3. diopulmonary resuscitation after pneumonectomy with pericardiotomy: a 601. Coris EE, Ramirez AM, Van Durme DJ. Heat illness in athletes: the dangerous case report. Crit Care Med 1999;27:1378–9. combination of heat, humidity and exercise. Sports Med 2004;34:9–16. 635. Bohrer H, Gust R, Bottiger BW. Cardiopulmonary resuscitation after cardiac 602. Grogan H, Hopkins PM. Heat stroke: implications for critical care and anaes- surgery. J Cardiothorac Vasc Anesth 1995;9:352. thesia. Br J Anaesth 2002;88:700–7. 636. Klintschar M, Darok M, Radner H. Massive injury to the heart after attempted 603. Hadad E, Weinbroum AA, Ben-Abraham R. Drug-induced hyperthermia and active compression–decompression cardiopulmonary resuscitation. Int J Legal muscle rigidity: a practical approach. Eur J Emerg Med 2003;10:149–54. Med 1998;111:93–6. 604. Halloran LL, Bernard DW. Management of drug-induced hyperthermia. Curr 637. Fosse E, Lindberg H. Left ventricular rupture following external chest compres- Opin Pediatr 2004;16:211–5. sion. Acta Anaesthesiol Scand 1996;40:502–4.
- 57. J.P. Nolan et al. / Resuscitation 81 (2010) 1219–1276 1275 638. Li Y, Wang H, Cho JH, et al. Defibrillation delivered during the upstroke 671. Cardosi RJ, Porter KB. Cesarean delivery of twins during maternal cardiopul- phase of manual chest compression improves shock success. Crit Care Med monary arrest. Obstet Gynecol 1998;92:695–7. 2010;38:910–5. 672. Johnson MD, Luppi CJ, Over DC. Cardiopulmonary resuscitation. In: Gam- 639. Li Y, Yu T, Ristagno G, et al. The optimal phasic relationship between bling DR, Douglas MJ, editors. Obstetric anesthesia and uncommon disorders. synchronized shock and mechanical chest compressions. Resuscitation Philadelphia: W.B. Saunders; 1998. p. 51–74. 2010;81:724–9. 673. Nanson J, Elcock D, Williams M, Deakin CD. Do physiological changes in preg- 640. Rosemurgy AS, Norris PA, Olson SM, Hurst JM, Albrink MH. Prehospital trau- nancy change defibrillation energy requirements? Br J Anaesth 2001;87:237–9. matic cardiac arrest: the cost of futility. J Trauma 1993;35:468–73. 674. Katz VL, Dotters DJ, Droegemueller W. Perimortem cesarean delivery. Obstet 641. Shimazu S, Shatney CH. Outcomes of trauma patients with no vital signs on Gynecol 1986;68:571–6. hospital admission. J Trauma 1983;23:213–6. 675. American Heart Association in collaboration with International Liaison Com- 642. Battistella FD, Nugent W, Owings JT, Anderson JT. Field triage of the pulseless mittee on Resuscitation. Guidelines 2000 for Cardiopulmonary Resuscitation trauma patient. Arch Surg 1999;134:742–5. and Emergency Cardiovascular Care. Circulation 2000;102(Suppl.):I1–384. 643. Stockinger ZT, McSwain Jr NE. Additional evidence in support of withholding 676. Chapter 4; Part 6: cardiac arrest associated with pregnancy.Cummins R, Hazin- or terminating cardiopulmonary resuscitation for trauma patients in the field. ski M, Field J, editors. ACLS—the reference textbook. Dallas: American Heart J Am Coll Surg 2004;198:227–31. Association; 2003. p. 143–58. 644. Fulton RL, Voigt WJ, Hilakos AS. Confusion surrounding the treatment of trau- 677. Budnick LD. Bathtub-related electrocutions in the United States, 1979 to 1982. matic cardiac arrest. J Am Coll Surg 1995;181:209–14. JAMA 1984;252:918–20. 645. Pasquale MD, Rhodes M, Cipolle MD, Hanley T, Wasser T. Defining “dead on 678. Lightning-associated deaths—United States, 1980–1995. MMWR Morb Mortal arrival”: impact on a level I trauma center. J Trauma 1996;41:726–30. Wkly Rep 1998;47:391–4. 646. Stratton SJ, Brickett K, Crammer T. Prehospital pulseless, unconscious pene- 679. Geddes LA, Bourland JD, Ford G. The mechanism underlying sudden death from trating trauma victims: field assessments associated with survival. J Trauma electric shock. Med Instrum 1986;20:303–15. 1998;45:96–100. 680. Cooper MA. Lightning injuries: prognostic signs for death. Ann Emerg Med 647. Maron BJ, Estes 3rd NA. Commotio cordis. N Engl J Med 2010;362:917–27. 1980;9:134–8. 648. Maron BJ, Gohman TE, Kyle SB, Estes 3rd NA, Link MS. Clinical profile and 681. Kleinschmidt-DeMasters BK. Neuropathology of lightning-strike injuries. spectrum of commotio cordis. JAMA 2002;287:1142–6. Semin Neurol 1995;15:323–8. 649. Maron BJ, Estes 3rd NA, Link MS. Task Force 11: commotio cordis. J Am Coll 682. Stewart CE. When lightning strikes. Emerg Med Serv 2000;29:57–67 [quiz 103]. Cardiol 2005;45:1371–3. 683. Cooper MA. Emergent care of lightning and electrical injuries. Semin Neurol 650. Nesbitt AD, Cooper PJ, Kohl P. Rediscovering commotio cordis. Lancet 1995;15:268–78. 2001;357:1195–7. 684. Duclos PJ, Sanderson LM. An epidemiological description of lightning-related 651. Link MS, Estes M, Maron BJ. Sudden death caused by chest wall trauma (com- deaths in the United States. Int J Epidemiol 1990;19:673–9. motio cordis). In: Kohl P, Sachs F, Franz MR, editors. Cardiac mechano-electric 685. Epperly TD, Stewart JR. The physical effects of lightning injury. J Fam Pract feedback and arrhythmias: from pipette to patient. Philadelphia: Elsevier Saun- 1989;29:267–72. ders; 2005. p. 270–6. 686. Whitcomb D, Martinez JA, Daberkow D. Lightning injuries. South Med J 652. Cera SM, Mostafa G, Sing RF, Sarafin JL, Matthews BD, Heniford BT. Physiologic 2002;95:1331–4. predictors of survival in post-traumatic arrest. Am Surg 2003;69:140–4. 687. Chamberlain DA, Hazinski MF. Education in resuscitation. Resuscitation 653. Esposito TJ, Jurkovich GJ, Rice CL, Maier RV, Copass MK, Ashbaugh DG. Reap- 2003;59:11–43. praisal of emergency room thoracotomy in a changing environment. J Trauma 688. Yeung J, Perkins GD. Timing of drug administration during CPR and the role of 1991;31:881–5 [discussion 5–7]. simulation. Resuscitation 2010;81:265–6. 654. Martin SK, Shatney CH, Sherck JP, et al. Blunt trauma patients with pre- 689. Berdowski J, Schmohl A, Tijssen JG, Koster RW. Time needed for a regional hospital pulseless electrical activity (PEA): poor ending assured. J Trauma emergency medical system to implement resuscitation Guidelines 2005—The 2002;53:876–80 [discussion 80–81]. Netherlands experience. Resuscitation 2009;80:1336–41. 655. Domeier RM, McSwain Jr NE, Hopson LR, et al. Guidelines for withholding or 690. Bigham BL, Koprowicz K, Aufderheide TP, et al. Delayed Prehospital Implemen- termination of resuscitation in prehospital traumatic cardiopulmonary arrest. tation of the 2005 American Heart Association Guidelines for Cardiopulmonary J Am Coll Surg 2003;196:475–81. Resuscitation and Emergency Cardiac Care. Prehosp Emerg Care 2010. 656. Gervin AS, Fischer RP. The importance of prompt transport of salvage of patients 691. Andersen PO, Jensen MK, Lippert A, Ostergaard D. Identifying non-technical with penetrating heart wounds. J Trauma 1982;22:443–8. skills and barriers for improvement of teamwork in cardiac arrest teams. Resus- 657. Branney SW, Moore EE, Feldhaus KM, Wolfe RE. Critical analysis of two citation 2010;81:695–702. decades of experience with postinjury emergency department thoracotomy 692. Flin R, Patey R, Glavin R, Maran N. Anaesthetists’ non-technical skills. Br J in a regional trauma center. J Trauma 1998;45:87–94 [discussion 5]. Anaesth 2010. 658. Durham III LA, Richardson RJ, Wall Jr MJ, Pepe PE, Mattox KL. Emergency center 693. Axelsson A, Thoren A, Holmberg S, Herlitz J. Attitudes of trained Swedish lay thoracotomy: impact of prehospital resuscitation. J Trauma 1992;32:775–9. rescuers toward CPR performance in an emergency: a survey of 1012 recently 659. Frezza EE, Mezghebe H. Is 30 minutes the golden period to perform emergency trained CPR rescuers. Resuscitation 2000;44:27–36. room thoratomy (ERT) in penetrating chest injuries? J Cardiovasc Surg (Torino) 694. Hubble MW, Bachman M, Price R, Martin N, Huie D. Willingness of high school 1999;40:147–51. students to perform cardiopulmonary resuscitation and automated external 660. Powell DW, Moore EE, Cothren CC, et al. Is emergency department resuscitative defibrillation. Prehosp Emerg Care 2003;7:219–24. thoracotomy futile care for the critically injured patient requiring prehospital 695. Swor RA, Jackson RE, Compton S, et al. Cardiac arrest in private locations: differ- cardiopulmonary resuscitation? J Am Coll Surg 2004;199:211–5. ent strategies are needed to improve outcome. Resuscitation 2003;58:171–6. 661. Coats TJ, Keogh S, Clark H, Neal M. Prehospital resuscitative thoracotomy for 696. Swor R, Khan I, Domeier R, Honeycutt L, Chu K, Compton S. CPR training and cardiac arrest after penetrating trauma: rationale and case series. J Trauma CPR performance: do CPR-trained bystanders perform CPR? Acad Emerg Med 2001;50:670–3. 2006;13:596–601. 662. Wise D, Davies G, Coats T, Lockey D, Hyde J, Good A. Emergency thoracotomy: 697. Vaillancourt C, Stiell IG, Wells GA. Understanding and improving low bystander “how to do it”. Emerg Med J 2005;22:22–4. CPR rates: a systematic review of the literature. CJEM 2008;10:51–65. 663. Kwan I, Bunn F, Roberts I. Spinal immobilisation for trauma patients. Cochrane 698. Boucek CD, Phrampus P, Lutz J, Dongilli T, Bircher NG. Willingness to perform Database Syst Rev 2001:CD002803. mouth-to-mouth ventilation by health care providers: a survey. Resuscitation 664. Practice management guidelines for emergency department thoracotomy. 2009;80:849–53. Working Group, Ad Hoc Subcommittee on Outcomes, American College of 699. Caves ND, Irwin MG. Attitudes to basic life support among medical students fol- Surgeons-Committee on Trauma. J Am Coll Surg 2001;193:303–9. lowing the 2003 SARS outbreak in Hong Kong. Resuscitation 2006;68:93–100. 665. Walcher F, Kortum S, Kirschning T, Weihgold N, Marzi I. Optimized manage- 700. Coons SJ, Guy MC. Performing bystander CPR for sudden cardiac arrest: behav- ment of polytraumatized patients by prehospital ultrasound. Unfallchirurg ioral intentions among the general adult population in Arizona. Resuscitation 2002;105:986–94. 2009;80:334–40. 666. Kirschning T, Brenner F, Stier M, Weber CF, Walcher F. Pre-hospital emergency 701. Dwyer T. Psychological factors inhibit family members’ confidence to initiate sonography of trauma patients. Anaesthesist 2009;58:51–60. CPR. Prehosp Emerg Care 2008;12:157–61. 667. Department of Health, Welsh Office, Scottish Office Department of Health, 702. Jelinek GA, Gennat H, Celenza T, O’Brien D, Jacobs I, Lynch D. Community Department of Health and Social Services, Northern Ireland. Why mothers die. attitudes towards performing cardiopulmonary resuscitation in Western Aus- Report on confidential enquiries into maternal deaths in the United Kingdom, tralia. Resuscitation 2001;51:239–46. 2000–2002. London: The Stationery Office; 2004. 703. Johnston TC, Clark MJ, Dingle GA, FitzGerald G. Factors influencing Queens- 668. Hogan MC, Foreman KJ, Naghavi M, et al. Maternal mortality for 181 countries, landers’ willingness to perform bystander cardiopulmonary resuscitation. 1980–2008: a systematic analysis of progress towards Millennium Develop- Resuscitation 2003;56:67–75. ment Goal 5. Lancet 2010;375:1609–23. 704. Kuramoto N, Morimoto T, Kubota Y, et al. Public perception of and willingness 669. Lewis G. The Confidential Enquiry into Maternal and Child Health (CEMACH). to perform bystander CPR in Japan. Resuscitation 2008;79:475–81. Saving Mothers’ Lives: reviewing maternal deaths to make motherhood safer 705. Omi W, Taniguchi T, Kaburaki T, et al. The attitudes of Japanese high school stu- – 2003–2005. The Seventh Report of the Confidential Enquiries into Maternal dents toward cardiopulmonary resuscitation. Resuscitation 2008;78:340–5. Deaths in the United Kingdom. London: CEMACH; 2007. 706. Riegel B, Mosesso VN, Birnbaum A, et al. Stress reactions and perceived difficul- 670. Page-Rodriguez A, Gonzalez-Sanchez JA. Perimortem cesarean section of ties of lay responders to a medical emergency. Resuscitation 2006;70:98–106. twin pregnancy: case report and review of the literature. Acad Emerg Med 707. Shibata K, Taniguchi T, Yoshida M, Yamamoto K. Obstacles to bystander car- 1999;6:1072–4. diopulmonary resuscitation in Japan. Resuscitation 2000;44:187–93.
- 58. 1276 J.P. Nolan et al. / Resuscitation 81 (2010) 1219–1276 708. Taniguchi T, Omi W, Inaba H. Attitudes toward the performance of bystander 736. Andresen D, Arntz HR, Grafling W, et al. Public access resuscitation program cardiopulmonary resuscitation in Japan. Resuscitation 2007;75:82–7. including defibrillator training for laypersons: a randomized trial to evaluate 709. Moser DK, Dracup K, Doering LV. Effect of cardiopulmonary resuscitation train- the impact of training course duration. Resuscitation 2008;76:419–24. ing for parents of high-risk neonates on perceived anxiety, control, and burden. 737. Smith KK, Gilcreast D, Pierce K. Evaluation of staff’s retention of ACLS and BLS Heart Lung 1999;28:326–33. skills. Resuscitation 2008;78:59–65. 710. Axelsson A, Herlitz J, Ekstrom L, Holmberg S. Bystander-initiated cardiopul- 738. Woollard M, Whitfeild R, Smith A, et al. Skill acquisition and retention in auto- monary resuscitation out-of-hospital. A first description of the bystanders and mated external defibrillator (AED) use and CPR by lay responders: a prospective their experiences. Resuscitation 1996;33:3–11. study. Resuscitation 2004;60:17–28. 711. Donohoe RT, Haefeli K, Moore F. Public perceptions and experiences of myocar- 739. Berden HJ, Willems FF, Hendrick JM, Pijls NH, Knape JT. How frequently should dial infarction, cardiac arrest and CPR in London. Resuscitation 2006;71:70–9. basic cardiopulmonary resuscitation training be repeated to maintain adequate 712. Hamasu S, Morimoto T, Kuramoto N, et al. Effects of BLS training on fac- skills? BMJ 1993;306:1576–7. tors associated with attitude toward CPR in college students. Resuscitation 740. Woollard M, Whitfield R, Newcombe RG, Colquhoun M, Vetter N, Chamberlain 2009;80:359–64. D. Optimal refresher training intervals for AED and CPR skills: a randomised 713. Parnell MM, Pearson J, Galletly DC, Larsen PD. Knowledge of and attitudes controlled trial. Resuscitation 2006;71:237–47. towards resuscitation in New Zealand high-school students. Emerg Med J 741. Riegel B, Nafziger SD, McBurnie MA, et al. How well are cardiopulmonary 2006;23:899–902. resuscitation and automated external defibrillator skills retained over time? 714. Swor R, Compton S, Farr L, et al. Perceived self-efficacy in performing and will- Results from the Public Access Defibrillation (PAD) trial. Acad Emerg Med ingness to learn cardiopulmonary resuscitation in an elderly population in a 2006;13:254–63. suburban community. Am J Crit Care 2003;12:65–70. 742. Beckers SK, Fries M, Bickenbach J, et al. Retention of skills in medical stu- 715. Perkins GD, Walker G, Christensen K, Hulme J, Monsieurs KG. Teaching recog- dents following minimal theoretical instructions on semi and fully automated nition of agonal breathing improves accuracy of diagnosing cardiac arrest. external defibrillators. Resuscitation 2007;72:444–50. Resuscitation 2006;70:432–7. 743. Perkins GD, Lockey AS. Defibrillation-safety versus efficacy. Resuscitation 716. Yeung J, Meeks R, Edelson D, Gao F, Soar J, Perkins GD. The use of CPR 2008;79:1–3. feedback/prompt devices during training and CPR performance: a systematic 744. Perkins GD, Barrett H, Bullock I, et al. The Acute Care Undergraduate TEach- review. Resuscitation 2009;80:743–51. ing (ACUTE) Initiative: consensus development of core competencies in 717. Lam KK, Lau FL, Chan WK, Wong WN. Effect of severe acute respiratory syn- acute care for undergraduates in the United Kingdom. Intensive Care Med drome on bystander willingness to perform cardiopulmonary resuscitation 2005;31:1627–33. (CPR)—is compression-only preferred to standard CPR? Prehosp Disaster Med 745. Schwid HA, Rooke GA, Ross BK, Sivarajan M. Use of a computerized advanced 2007;22:325–9. cardiac life support simulator improves retention of advanced cardiac life sup- 718. Locke CJ, Berg RA, Sanders AB, et al. Bystander cardiopulmonary resuscitation. port guidelines better than a textbook review. Crit Care Med 1999;27:821–4. Concerns about mouth-to-mouth contact. Arch Intern Med 1995;155:938–43. 746. Polglase RF, Parish DC, Buckley RL, Smith RW, Joiner TA. Problem-based ACLS 719. Hoke RS, Chamberlain DA, Handley AJ. A reference automated external defib- instruction: a model approach for undergraduate emergency medical educa- rillator provider course for Europe. Resuscitation 2006;69:421–33. tion. Ann Emerg Med 1989;18:997–1000. 720. Lynch B, Einspruch EL, Nichol G, Becker LB, Aufderheide TP, Idris A. Effective- 747. Clark LJ, Watson J, Cobbe SM, Reeve W, Swann IJ, Macfarlane PW. CPR ‘98: a ness of a 30-min CPR self-instruction program for lay responders: a controlled practical multimedia computer-based guide to cardiopulmonary resuscitation randomized study. Resuscitation 2005;67:31–43. for medical students. Resuscitation 2000;44:109–17. 721. Todd KH, Braslow A, Brennan RT, et al. Randomized, controlled trial of 748. Hudson JN. Computer-aided learning in the real world of medical education: video self-instruction versus traditional CPR training. Ann Emerg Med does the quality of interaction with the computer affect student learning? Med 1998;31:364–9. Educ 2004;38:887–95. 722. Einspruch EL, Lynch B, Aufderheide TP, Nichol G, Becker L. Retention of CPR 749. Jang KS, Hwang SY, Park SJ, Kim YM, Kim MJ. Effects of a web-based teaching skills learned in a traditional AHA Heartsaver course versus 30-min video self- method on undergraduate nursing students’ learning of electrocardiography. training: a controlled randomized study. Resuscitation 2007;74:476–86. J Nurs Educ 2005;44:35–9. 723. Todd KH, Heron SL, Thompson M, Dennis R, O’Connor J, Kellermann AL. Simple 750. Kim JH, Kim WO, Min KT, Yang JY, Nam YT. Learning by computer simulation CPR: a randomized, controlled trial of video self-instructional cardiopulmonary does not lead to better test performance than textbook study in the diagnosis resuscitation training in an African American church congregation. Ann Emerg and treatment of dysrhythmias. J Clin Anesth 2002;14:395–400. Med 1999;34:730–7. 751. Leong SL, Baldwin CD, Adelman AM. Integrating web-based computer 724. Reder S, Cummings P, Quan L. Comparison of three instructional methods cases into a required clerkship: development and evaluation. Acad Med for teaching cardiopulmonary resuscitation and use of an automatic external 2003;78:295–301. defibrillator to high school students. Resuscitation 2006;69:443–53. 752. Rosser JC, Herman B, Risucci DA, Murayama M, Rosser LE, Merrell RC. Effec- 725. Roppolo LP, Pepe PE, Campbell L, et al. Prospective, randomized trial of the tiveness of a CD-ROM multimedia tutorial in transferring cognitive knowledge effectiveness and retention of 30-min layperson training for cardiopulmonary essential for laparoscopic skill training. Am J Surg 2000;179:320–4. resuscitation and automated external defibrillators: The American Airlines 753. Papadimitriou L, Xanthos T, Bassiakou E, Stroumpoulis K, Barouxis D, Iacovi- Study. Resuscitation 2007;74:276–85. dou N. Distribution of pre-course BLS/AED manuals does not influence skill 726. Batcheller AM, Brennan RT, Braslow A, Urrutia A, Kaye W. Cardiopulmonary acquisition and retention in lay rescuers: a randomised study. Resuscitation resuscitation performance of subjects over forty is better following half-hour 2010;81:348–52. video self-instruction compared to traditional four-hour classroom training. 754. Perkins GD. Simulation in resuscitation training. Resuscitation Resuscitation 2000;43:101–10. 2007;73:202–11. 727. Braslow A, Brennan RT, Newman MM, Bircher NG, Batcheller AM, Kaye W. 755. Duran R, Aladag N, Vatansever U, Kucukugurluoglu Y, Sut N, Acunas B. Profi- CPR training without an instructor: development and evaluation of a video ciency and knowledge gained and retained by pediatric residents after neonatal self-instructional system for effective performance of cardiopulmonary resus- resuscitation course. Pediatr Int 2008;50:644–7. citation. Resuscitation 1997;34:207–20. 756. Anthonypillai F. Retention of advanced cardiopulmonary resuscitation knowl- 728. Isbye DL, Rasmussen LS, Lippert FK, Rudolph SF, Ringsted CV. Laypersons may edge by intensive care trained nurses. Intensive Crit Care Nurs 1992;8:180–4. learn basic life support in 24 min using a personal resuscitation manikin. Resus- 757. Boonmak P, Boonmak S, Srichaipanha S, Poomsawat S. Knowledge and skill citation 2006;69:435–42. after brief ACLS training. J Med Assoc Thai 2004;87:1311–4. 729. Moule P, Albarran JW, Bessant E, Brownfield C, Pollock J. A non-randomized 758. Kaye W, Wynne G, Marteau T, et al. An advanced resuscitation training course comparison of e-learning and classroom delivery of basic life support for preregistration house officers. J R Coll Physicians Lond 1990;24:51–4. with automated external defibrillator use: a pilot study. Int J Nurs Pract 759. Semeraro F, Signore L, Cerchiari EL. Retention of CPR performance in anaes- 2008;14:427–34. thetists. Resuscitation 2006;68:101–8. 730. Liberman M, Golberg N, Mulder D, Sampalis J. Teaching cardiopulmonary 760. Skidmore MB, Urquhart H. Retention of skills in neonatal resuscitation. Paediatr resuscitation to CEGEP students in Quebec—a pilot project. Resuscitation Child Health 2001;6:31–5. 2000;47:249–57. 761. Trevisanuto D, Ferrarese P, Cavicchioli P, Fasson A, Zanardo V, Zacchello F. 731. Jones I, Handley AJ, Whitfield R, Newcombe R, Chamberlain D. A preliminary Knowledge gained by pediatric residents after neonatal resuscitation program feasibility study of a short DVD-based distance-learning package for basic life courses. Paediatr Anaesth 2005;15:944–7. support. Resuscitation 2007;75:350–6. 762. Young R, King L. An evaluation of knowledge and skill retention following an 732. Brannon TS, White LA, Kilcrease JN, Richard LD, Spillers JG, Phelps CL. Use in-house advanced life support course. Nurs Crit Care 2000;5:7–14. of instructional video to prepare parents for learning infant cardiopulmonary 763. Grant EC, Marczinski CA, Menon K. Using pediatric advanced life support in resuscitation. Proc (Bayl Univ Med Cent) 2009;22:133–7. pediatric residency training: does the curriculum need resuscitation? Pediatr 733. de Vries W, Turner N, Monsieurs K, Bierens J, Koster R. Comparison of Crit Care Med 2007;8:433–9. instructor-led automated external defibrillation training and three alternative 764. O’Steen DS, Kee CC, Minick MP. The retention of advanced cardiac life support DVD-based training methods. Resuscitation 2010;81:1004–9. knowledge among registered nurses. J Nurs Staff Dev 1996;12:66–72. 734. Perkins GD, Mancini ME. Resuscitation training for healthcare workers. Resus- 765. Hammond F, Saba M, Simes T, Cross R. Advanced life support: retention of citation 2009;80:841–2. registered nurses’ knowledge 18 months after initial training. Aust Crit Care 735. Spooner BB, Fallaha JF, Kocierz L, Smith CM, Smith SC, Perkins GD. An evalu- 2000;13:99–104. ation of objective feedback in basic life support (BLS) training. Resuscitation 766. Baskett PJ, Lim A. The varying ethical attitudes towards resuscitation in Europe. 2007;73:417–24. Resuscitation 2004;62:267–73.
- 59. Resuscitation 81 (2010) 1277–1292 Contents lists available at ScienceDirect Resuscitation journal homepage: www.elsevier.com/locate/resuscitation European Resuscitation Council Guidelines for Resuscitation 2010 Section 2. Adult basic life support and use of automated external defibrillators Rudolph W. Koster a,∗ , Michael A. Baubin b , Leo L. Bossaert c , Antonio Caballero d , Pascal Cassan e , Maaret Castrén f , Cristina Granja g , Anthony J. Handley h , Koenraad G. Monsieurs i , Gavin D. Perkins j , Violetta Raffay k , Claudio Sandroni l a Department of Cardiology, Academic Medical Center, Amsterdam, The Netherlands b Department of Anaesthesiology and Critical Care Medicine, University Hospital Innsbruck, Innsbruck, Austria c Department of Critical Care, University of Antwerp, Antwerp, Belgium d Department of Emergency Medicine, Hospital Universitario Virgen del Rocío, Sevilla, Spain e European Reference Centre for First Aid Education, French Red Cross, Paris, France f Department of Clinical Science and Education, Karolinska Institute, Stockholm, Sweden g Department of Emergency and Intensive Medicine, Hospital Pedro Hispano, Matosinhos, Portugal h Colchester Hospital University NHS Foundation Trust, Colchester, UK i Emergency Medicine, Ghent University Hospital, Ghent, Belgium j Department of Critical Care and Resuscitation, University of Warwick, Warwick Medical School, Warwick, UK k Emergency Medicine, Municipal Institute for Emergency Medicine Novi Sad, Novi Sad, AP Vojvodina, Serbia l Department of Anaesthesiology and Intensive Care, Catholic University School of Medicine, Policlinico Universitario Agostino Gemelli, Rome, Italy Basic life support (BLS) refers to maintaining airway patency • Dispatchers should be trained to interrogate callers with strict and supporting breathing and the circulation, without the use protocols to elicit information. This information should focus on of equipment other than a protective device.1 This section con- the recognition of unresponsiveness and the quality of breathing. tains the guidelines for adult BLS and for the use of an automated In combination with unresponsiveness, absence of breathing or external defibrillator (AED). It also includes recognition of sudden any abnormality of breathing should start a dispatch protocol of cardiac arrest, the recovery position and management of choking suspected cardiac arrest. The importance of gasping as sign of car- (foreign-body airway obstruction). Guidelines for the use of man- diac arrest should result in increased emphasis on its recognition ual defibrillators and starting in-hospital resuscitation are found in during training and dispatch interrogation. Sections 3 and 4.2,3 • All rescuers, trained or not, should provide chest compressions to victims of cardiac arrest. A strong emphasis on delivering high quality chest compressions remains essential. The aim should be Summary of changes since 2005 Guidelines to push to a depth of at least 5 cm at a rate of at least 100 com- pressions per minute, to allow full chest recoil, and to minimise interruptions in chest compressions. Trained rescuers should Many of the recommendations made in the ERC Guide- also provide ventilations with a compression–ventilation ratio of lines 2005 remain unchanged, either because no new studies 30:2. Telephone-guided CPR is encouraged for untrained rescuers have been published or because new evidence since 2005 has who should be told to deliver uninterrupted chest compressions merely strengthened the evidence that was already available. only. Examples of this are the general design of the BLS and AED • In order to maintain high-quality CPR, feedback to rescuers is algorithms, the way the need for cardiopulmonary resuscitation important. The use of prompt/feedback devices during CPR will (CPR) is recognised, the use of AEDs (including the shock pro- enable immediate feedback to rescuers, and the data stored in tocols), the 30:2 ratio of compressions and ventilations, and the rescue equipment can be used to monitor the quality of CPR per- recognition and management of a choking victim. In contrast, formance and provide feedback to professional rescuers during new evidence has been published since 2005 that necessitates debriefing sessions. changes to some components of the 2010 Guidelines. The 2010 • When rescuers apply an AED, the analysis of the heart rhythm changes in comparison with the 2005 Guidelines are summarised and delivery of a shock should not be delayed for a period of CPR; here: however, CPR should be given with minimal interruptions before application of the AED and during its use. • Further development of AED programmes is encouraged—there ∗ Corresponding author. is a need for further deployment of AEDs in both public and resi- E-mail address: r.w.koster@amc.nl (R.W. Koster). dential areas. 0300-9572/$ – see front matter © 2010 European Resuscitation Council. Published by Elsevier Ireland Ltd. All rights reserved. doi:10.1016/j.resuscitation.2010.08.009
- 60. 1278 R.W. Koster et al. / Resuscitation 81 (2010) 1277–1292 Introduction encourage him to give chest compression-only CPR while await- ing the arrival of professional help.24–27 Sudden cardiac arrest (SCA) is a leading cause of death in 3. Early defibrillation: CPR plus defibrillation within 3–5 min of col- Europe. Depending on the way SCA is defined, it affects about lapse can produce survival rates as high as 49–75%.28–35 Each 350,000–700,000 individuals a year.4,5 On initial heart-rhythm minute of delay before defibrillation reduces the probability of analysis, about 25–30% of SCA victims have ventricular fibrillation survival to discharge by 10–12%.19,36 (VF), a percentage that has declined over the last 20 years.6–10 4. Early advanced life support and standardised post-resuscitation It is likely that many more victims have VF or rapid ventricu- care: The quality of treatment during the post-resuscitation lar tachycardia (VT) at the time of collapse but, by the time the phase affects outcome.37–39 Therapeutic hypothermia is now an first electrocardiogram (ECG) is recorded by ambulance personnel, established therapy that greatly contributes to improved sur- their rhythm has deteriorated to asystole.11,12 When the rhythm is vival with good neurological outcome.40–42 recorded soon after collapse, in particular by an on-site AED, the proportion of victims in VF can be as high as 59%13 to 65%.14 Many In most communities, the median time from ambulance call to victims of SCA can survive if bystanders act immediately while VF ambulance arrival (response interval) is 5–8 min,13,14 or 11 min to is still present, but successful resuscitation is much less likely once a first shock.43 During this time the victim’s survival is dependent the rhythm has deteriorated to asystole. on bystanders who initiate BLS and use an AED for defibrillation. The recommended treatment for VF cardiac arrest is immediate Victims of cardiac arrest need immediate CPR. This provides a bystander CPR (combined chest compression and rescue breathing) small but critical blood flow to the heart and brain. It also increases and early electrical defibrillation. Most cardiac arrests of non- the likelihood that a defibrillatory shock will terminate VF and cardiac origin are from respiratory causes such as drowning (among enable the heart to resume an effective rhythm and cardiac out- them many children) and asphyxia. In many areas in the world put. Chest compression is especially important if a shock cannot drowning is a major cause of death (see http://www.who.int/ be delivered sooner than the first few minutes after collapse.44 water sanitation health/diseases/drowning/en/), and rescue After defibrillation, if the heart is still viable, its pacemaker activity breaths are even more critical for successful resuscitation of these resumes and produces an organised rhythm followed by mechani- victims. cal contraction. In the first few minutes after successful termination of VF, the heart rhythm may be slow, and the force of contrac- tions weak; chest compressions must be continued until adequate The chain of survival cardiac function returns.45 Lay rescuers can be trained to use automated external defibril- The following concept of the Chain of Survival summarises the lators (AEDs), which are increasingly available in public places. An vital steps needed for successful resuscitation (Fig. 2.1). Most of AED uses voice prompts to guide the rescuer, analyses the cardiac these links apply to victims of both primary cardiac and asphyxial rhythm and instructs the rescuer to deliver a shock if VF or rapid arrest.15 ventricular tachycardia (VT) is detected. AEDs are extremely accu- rate and will deliver a shock only when VF (or rapid VT) is present.46 1. Early recognition of cardiac arrest: This includes recognition of AED function and operation are discussed in Section 3. the cardiac origin of chest pain; recognition that cardiac arrest Several studies have shown the benefit on survival of immedi- has occurred; and rapid activation of the ambulance service by ate CPR, and the detrimental effect of delay before defibrillation. telephoning 112 or the local emergency number. Recognizing For every minute delay in defibrillation, survival from witnessed cardiac chest pain is particularly important, since the probability VF decreases by 10–12%.19,36 When bystander CPR is provided, of cardiac arrest occurring as a consequence of acute myocar- the decline in survival is more gradual and averages 3–4% per dial ischaemia is at least 21–33% in the first hour after onset minute.12,36,47 Overall, bystander CPR doubles or triples survival of symptoms.16,17 When a call to the ambulance service is made from witnessed cardiac arrest.19,47,48 before a victim collapses, arrival of the ambulance is significantly sooner after collapse and survival tends to be higher.18 2. Early bystander CPR: Immediate CPR can double or triple sur- Adult BLS sequence vival from VF SCA.18–21 Performing chest-compression-only CPR is better than giving no CPR at all.22,23 When a caller has not Throughout this section, the male gender implies both males been trained in CPR, the ambulance dispatcher should strongly and females. Fig. 2.1. Chain of survival.
- 61. R.W. Koster et al. / Resuscitation 81 (2010) 1277–1292 1279 Fig. 2.3. Check the victim for a response. 5a. If he is breathing normally • turn him into the recovery position (see below); • send or go for help—call 112 or local emergency number for an ambulance; • continue to assess that breathing remains normal. Fig. 2.2. Adult basic life support algorithm. 5b. If the breathing is not normal or absent • send someone for help and to find and bring an AED if avail- BLS consists of the following sequence of actions (Fig. 2.2). able; or if you are on your own, use your mobile telephone to alert the ambulance service—leave the victim only when 1. Make sure you, the victim and any bystanders are safe. there is no other option. 2. Check the victim for a response (Fig. 2.3). • gently shake his shoulders and ask loudly: “Are you all right?” 3a. If he responds • leave him in the position in which you find him, provided there is no further danger; • try to find out what is wrong with him and get help if needed; • reassess him regularly. 3b. If he does not respond • shout for help (Fig. 2.4) ◦ turn the victim onto his back and then open the airway using head tilt and chin lift (Fig. 2.5); ◦ place your hand on his forehead and gently tilt his head back; ◦ with your fingertips under the point of the victim’s chin, lift the chin to open the airway. 4. Keeping the airway open, look, listen and feel for breathing (Fig. 2.6). • look for chest movement; • listen at the victim’s mouth for breath sounds; • feel for air on your cheek; • decide if breathing is normal, not normal or absent In the first few minutes after cardiac arrest, a victim may be barely breathing, or taking infrequent, slow and noisy gasps. Do not confuse this with normal breathing. Look, listen and feel for no more than 10 s to determine whether the victim is breathing normally. If you have any doubt whether breathing is normal, act as if it is not normal. Fig. 2.4. Shout for help.
- 62. 1280 R.W. Koster et al. / Resuscitation 81 (2010) 1277–1292 Fig. 2.7. Place the heel of one hand in the centre of the victim’s chest. sternum; repeat at a rate of at least 100 min−1 (but not exceeding 120 min−1 ); ◦ compression and release should take equal amounts of time. 6a. Combine chest compression with rescue breaths. • After 30 compressions open the airway again using head tilt and chin lift (Fig. 2.5). • Pinch the soft part of the nose closed, using the index finger Fig. 2.5. Head tilt and chin lift. and thumb of your hand on the forehead. • Allow the mouth to open, but maintain chin lift. • start chest compression as follows: • Take a normal breath and place your lips around his mouth, ◦ kneel by the side of the victim; making sure that you have a good seal. ◦ place the heel of one hand in the centre of the victim’s • Blow steadily into the mouth while watching for the chest to chest; (which is the lower half of the victim’s breastbone rise (Fig. 2.11), taking about 1 s as in normal breathing; this is (sternum)) (Fig. 2.7); an effective rescue breath. ◦ place the heel of your other hand on top of the first hand • Maintaining head tilt and chin lift, take your mouth away from (Fig. 2.8); the victim and watch for the chest to fall as air comes out ◦ interlock the fingers of your hands and ensure that pres- (Fig. 2.12). sure is not applied over the victim’s ribs. Keep your arms • Take another normal breath and blow into the victim’s mouth straight (Fig. 2.9). Do not apply any pressure over the upper once more to achieve a total of two effective rescue breaths. abdomen or the bottom end of the bony sternum (breast- The two breaths should not take more than 5 s in all. Then bone); return your hands without delay to the correct position on ◦ position yourself vertically above the victim’s chest and the sternum and give a further 30 chest compressions. press down on the sternum at least 5 cm (but not exceeding • Continue with chest compressions and rescue breaths in a 6 cm) (Fig. 2.10); ratio of 30:2. ◦ after each compression, release all the pressure on the • Stop to recheck the victim only if he starts to wake up: to chest without losing contact between your hands and the move, open eyes and to breathe normally. Otherwise, do not interrupt resuscitation. Fig. 2.6. Look, listen and feel for normal breathing. Fig. 2.8. Place the heel of your other hand on top of the first hand.
- 63. R.W. Koster et al. / Resuscitation 81 (2010) 1277–1292 1281 Fig. 2.9. Interlock the fingers of your hands. Keep your arms straight. Fig. 2.10. Press down on the sternum at least 5 cm. If your initial rescue breath does not make the chest rise as in normal breathing, then before your next attempt: • look into the victim’s mouth and remove any obstruction; movement.49 Therefore, the lay rescuer should open the airway • recheck that there is adequate head tilt and chin lift; using a head-tilt-chin-lift manoeuvre for both injured and non- • do not attempt more than two breaths each time before injured victims. returning to chest compressions. Recognition of cardiorespiratory arrest If there is more than one rescuer present, another res- cuer should take over delivering CPR every 2 min to prevent Checking the carotid pulse (or any other pulse) is an inaccu- fatigue. Ensure that interruption of chest compressions is rate method of confirming the presence or absence of circulation, minimal during the changeover of rescuers. For this purpose, both for lay rescuers and for professionals.50–52 There is, however, and to count 30 compressions at the required rate, it may no evidence that checking for movement, breathing or cough- be helpful for the rescuer performing chest compressions ing (“signs of a circulation”) is diagnostically superior. Healthcare to count out loud. Experienced rescuers could do combined two-rescuer CPR and in that situation they should exchange roles/places every 2 min. 6b. Chest-compression-only CPR may be used as follows: • If you are not trained, or are unwilling to give rescue breaths, give chest compressions only. • If only chest compressions are given, these should be con- tinuous, at a rate of at least 100 min−1 (but not exceeding 120 min−1 ). 7. Do not interrupt resuscitation until: • professional help arrives and takes over; or • the victim starts to wake up: to move, open eyes and to breathe normally; or • you become exhausted. Opening the airway The jaw thrust is not recommended for lay rescuers because it is difficult to learn and perform and may itself cause spinal Fig. 2.11. Blow steadily into his mouth whilst watching for his chest to rise.
- 64. 1282 R.W. Koster et al. / Resuscitation 81 (2010) 1277–1292 Initial rescue breaths In primary (non-asphyxial) cardiac arrest the arterial blood is not moving and remains saturated with oxygen for several minutes.62 If CPR is initiated within a few minutes, the blood oxy- gen content remains adequate, and myocardial and cerebral oxygen delivery is limited more by the reduced cardiac output than by a lack of oxygen in the lungs and arterial blood. Initially, therefore, ventilation is less important than chest compressions.63,64 In adults needing CPR, there is a high a-priori probability of a primary cardiac cause. To emphasise the priority of chest com- pressions, it is recommended that CPR should start with chest compression rather than initial ventilations. Time should not be spent checking the mouth for foreign bodies unless attempted res- cue breathing fails to make the chest rise. Ventilation Fig. 2.12. Take your mouth away from the victim and watch for his chest to fall as air comes out. During CPR, the purpose of ventilation is to maintain adequate oxygenation and to remove CO2 . The optimal tidal volume, res- piratory rate and inspired oxygen concentration to achieve this, professionals, as well as lay rescuers, have difficulty determin- however, are not fully known. The current recommendations are ing the presence or absence of adequate or normal breathing in based on the following evidence: unresponsive victims.53,54 This may be because the airway is not open or because the victim is making occasional (agonal) gasps. 1. During CPR, blood flow to the lungs is substantially reduced, so When bystanders are asked by ambulance dispatchers over the an adequate ventilation–perfusion ratio can be maintained with telephone if breathing is present, they often misinterpret agonal lower tidal volumes and respiratory rates than normal.65 gasps as normal breathing. This incorrect information can result 2. Hyperventilation is harmful because it increases intrathoracic in the bystander withholding CPR from a cardiac arrest victim.55 pressure, which decreases venous return to the heart and Agonal gasps are present in up to 40% of cardiac arrest victims reduces cardiac output. Survival is consequently reduced.66 in the first minutes after onset, and are associated with higher 3. Interruptions in chest compression (for example, to check the survival if recognised as a sign of cardiac arrest.56 Bystanders heart rhythm or for a pulse check) have a detrimental effect on describe agonal gasps as barely breathing, heavy or laboured survival.67 breathing, or noisy or gasping breathing.57 Laypeople should, 4. When the airway is unprotected, a tidal volume of 1 l pro- therefore, be taught to begin CPR if the victim is unconscious duces significantly more gastric distension than a tidal volume (unresponsive) and not breathing normally. It should be empha- of 500 ml.68 sised during training that agonal gasps occur commonly in the 5. Low minute-ventilation (lower than normal tidal volume and first few minutes after SCA, and that they are an indication to respiratory rate) can maintain effective oxygenation and ven- start CPR immediately; they should not be confused with normal tilation during CPR.69–72 During adult CPR, tidal volumes of breathing. approximately 500–600 ml (6–7 ml kg−1 ) are recommended. Adequate description of the victim is also of critical importance during communication with the ambulance dispatch centre. It is The current recommendations are, therefore, for rescuers to give important for the dispatcher that the caller can see the victim, each rescue breath over about 1 s, with enough volume to make but in a small minority of cases the caller is not at the scene.58 the victim’s chest rise, but to avoid rapid or forceful breaths. The Information about a victim’s breathing is most important, but the time taken to give two breaths should not exceed 5 s. These recom- description of breathing by callers varies considerably. If the nature mendations apply to all forms of ventilation during CPR, including of the victim’s breathing is not described or actively asked for mouth-to-mouth and bag-mask ventilation with and without sup- by the dispatcher, recognition that the victim has had a cardiac plementary oxygen. arrest is much less likely than if the breathing is described as Mouth-to-nose ventilation is an acceptable alternative to abnormal or absent.59 If, when a caller describes an unconscious mouth-to-mouth ventilation.73 It may be considered if the vic- victim with absent or abnormal breathing, the dispatcher always tim’s mouth is seriously injured or cannot be opened, the rescuer is responded as for cardiac arrest, cases of cardiac arrest would not be assisting a victim in the water, or a mouth-to-mouth seal is difficult missed.60 to achieve. Confirming the absence of a past medical history of seizures There is no published evidence on the safety, effectiveness or can increase the likelihood of recognizing cardiac arrest among vic- feasibility of mouth-to-tracheostomy ventilation, but it may be tims presenting with seizure activity.59,61 Asking about regularity used for a victim with a tracheostomy tube or tracheal stoma who of breathing can also help to recognise cardiac arrest among callers requires rescue breathing. reporting seizure activity. To use bag-mask ventilation requires considerable practice and An experienced dispatcher can improve the survival rate sig- skill.74,75 It can be used by properly trained and experienced res- nificantly: if the dispatcher takes very few cardiac arrest calls per cuers who perform two-rescuer CPR. year, the survival rate is much lower than if he takes more than nine calls a year (22% versus 39%).58 The accuracy of identification of car- Chest compression diac arrest by dispatchers varies from approximately 50% to over 80%. If the dispatcher recognises cardiac arrest, survival is more Chest compressions produce blood flow by increasing the likely because appropriate measures can be taken (e.g. telephone- intrathoracic pressure and by directly compressing the heart. instructed CPR or appropriate ambulance response).25,60 Although chest compressions, performed properly, can produce
- 65. R.W. Koster et al. / Resuscitation 81 (2010) 1277–1292 1283 systolic arterial pressure peaks of 60–80 mm Hg, diastolic pressure is used, care should be taken to avoid interruption in CPR and dis- remains low and mean arterial pressure in the carotid artery sel- lodging intravenous lines or other tubes during board placement. dom exceeds 40 mm Hg.76 Chest compressions generate a small but critical amount of blood flow to the brain and myocardium and Chest decompression increase the likelihood that defibrillation will be successful. Since the 2005 Guidelines were published, chest compression Allowing complete recoil of the chest after each compression prompt/feedback devices have generated new data from victims in results in better venous return to the chest and may improve cardiac arrest that supplement animal and manikin studies.77–81 the effectiveness of CPR.88,89 The optimal method of achieving Recommendations based on this evidence are: this goal, without compromising other aspects of chest compres- sion technique such as compression depth, has not, however, been 1. Each time compressions are resumed, place your hands without established. delay ‘in the centre of the chest’. 2. Compress the chest at a rate of at least 100 min−1 . Feedback on compression technique 3. Ensure that the full compression depth of at least 5 cm (for an adult) is achieved. Rescuers can be assisted to achieve the recommended compres- 4. Allow the chest to recoil completely after each compression, i.e. sion rate and depth by prompt/feedback devices that are either built do not lean on the chest during the relaxation phase of the chest into the AED or manual defibrillator, or are stand-alone devices. The compression. use of such prompt/feedback devices, as part of an overall strategy 5. Take approximately the same amount of time for compression to improve the quality of CPR, may be beneficial. Rescuers should be as relaxation. aware that the accuracy of devices that measure compression depth 6. Minimise interruptions in chest compression in order to ensure varies according to the stiffness of the support surface upon which the victim receives at least 60 compressions in each minute. CPR is being performed (e.g. floor/mattress), and may overestimate 7. Do not rely on feeling the carotid or other pulse as a gauge of compression depth.87 Further studies are needed to determine if effective arterial flow during chest compressions.50,82 these devices improve victim outcomes. Hand position Compression–ventilation ratio For adults receiving chest compressions, rescuers should place their hands on the lower half of the sternum. It is recommended Animal data supported an increase in the ratio of compression that this location be taught in a simplified way, such as, “place the to ventilation to >15:2.90–92 A mathematical model suggests that heel of your hand in the centre of the chest with the other hand a ratio of 30:2 provides the best compromise between blood flow on top.” This instruction should be accompanied by demonstrating and oxygen delivery.93,94 A ratio of 30 compressions to 2 venti- placing the hands on the lower half of the sternum on a manikin. lations was recommended in the Guidelines 2005 for the single Use of the internipple line as a landmark for hand placement is not rescuer attempting resuscitation of an adult or child out of hospi- reliable.83,84 tal, an exception being that a trained healthcare professional should use a ratio of 15:2 for a child. This decreased the number of inter- Compression rate ruptions in compression and the no-flow fraction,95,96 and reduced the likelihood of hyperventilation.66,97 Direct evidence that sur- There is a positive relationship between the number of compres- vival rates have increased from this change, however, is lacking. sions actually delivered per minute and the chance of successful Likewise, there is no new evidence that would suggest a change in resuscitation.81 While the compression rate (the speed at which the recommended compression to ventilation ratio of 30:2. the 30 consecutive compressions are given) should be at least 100 min−1 , the actual number of compressions delivered during Compression-only CPR each minute of CPR will be lower due to interruptions to deliver rescue breaths and allow AED analysis, etc. In one out-of-hospital Some healthcare professionals as well as lay rescuers indicate study, rescuers recorded compression rates of 100–120 min−1 but that they would be reluctant to perform mouth-to-mouth ventila- the mean number of compressions was reduced to 64 min−1 by fre- tion, especially in unknown victims of cardiac arrest.98,99 Animal quent interruptions.79 At least 60 compressions should be delivered studies have shown that chest-compression-only CPR may be as each minute. effective as combined ventilation and compression in the first few minutes after non-asphyxial arrest.63,100 If the airway is open, Compression depth occasional gasps and passive chest recoil may provide some air exchange, but this may result in ventilation of the dead space Fear of doing harm, fatigue and limited muscle strength fre- only.56,101–103 Animal and mathematical model studies of chest- quently result in rescuers compressing the chest less deeply than compression-only CPR have shown that arterial oxygen stores recommended. There is evidence that a compression depth of 5 cm deplete in 2–4 min.92,104 and over results in a higher rate of return of spontaneous circula- In adults, the outcome of chest compression without venti- tion (ROSC), and a higher percentage of victims admitted alive to lation is significantly better than the outcome of giving no CPR hospital, than a compression depth of 4 cm or below.77,78 There is at all in non-asphyxial arrest.22,23 Several studies of human car- no direct evidence that damage from chest compression is related diac arrest have suggested equivalence of chest-compression-only to compression depth, nor has an upper limit of compression depth CPR and chest compressions combined with rescue breaths, but been established in studies. Nevertheless, it is recommended that, none excluded the possibility that chest-compression-only is infe- even in large adults, chest compression depth should not exceed rior to chest compressions combined with ventilations.23,105 One 6 cm. study suggested superiority of chest-compression-only CPR.22 All CPR should be performed on a firm surface when possible. Air- these studies have significant limitations because they were based filled mattresses should be routinely deflated during CPR.85 There on retrospective database analyses, where the type of BLS was is no evidence for or against the use of backboards,86,87 but if one not controlled and did not include CPR according to Guidelines
- 66. 1284 R.W. Koster et al. / Resuscitation 81 (2010) 1277–1292 2005 (30:2 compressions to ventilation ratio). Chest compres- of 29 adverse events associated with defibrillation.116 The causes sion alone may be sufficient only in the first few minutes after included accidental or intentional defibrillator misuse, device mal- collapse. Professional help can be expected on average 8 min or function and accidental discharge during training or maintenance later after a call for help, and chest compression only will result procedures. Four single-case reports described shocks to rescuers in insufficient CPR in many cases. Chest-compression-only CPR from discharging implantable cardioverter defibrillators (ICDs), in is not as effective as conventional CPR for cardiac arrests of one case resulting in a peripheral nerve injury. There are no reports non-cardiac origin (e.g., drowning or suffocation) in adults and of harm to rescuers from attempting defibrillation in wet environ- children.106,107 ments. Chest compression combined with rescue breaths is, therefore, Injury to the rescuer from defibrillation is extremely rare. Never- the method of choice for CPR delivered by both trained lay rescuers theless, rescuers should not continue manual chest compressions and professionals. Laypeople should be encouraged to perform during shock delivery. Victims should not be touched during ICD compression-only CPR if they are unable or unwilling to provide discharge. Direct contact between the rescuer and the victim should rescue breaths, or when instructed during an emergency call to an be avoided when defibrillation is carried out in wet environments. ambulance dispatcher centre.26,27 Psychological effects CPR in confined spaces One large, prospective trial of public access defibrillation Over-the-head CPR for single rescuers and straddle-CPR for reported a few adverse psychological effects associated with CPR two rescuers may be considered for resuscitation in confined or AED use that required intervention.113 Two large, retrospec- spaces.108,109 tive, questionnaire-based reports relating to performance of CPR by a bystander reported that nearly all respondents regarded their Risks to the victim during CPR intervention as a positive experience.117,118 The rare occurrences of adverse psychological effects in rescuers after CPR should be Many rescuers, concerned that delivering chest compressions recognised and managed appropriately. to a victim who is not in cardiac arrest will cause serious com- plications, do not initiate CPR. In a study of dispatch-assisted bystander CPR, however, where non-arrest victims received chest Disease transmission compressions, 12% experienced discomfort but only 2% suffered a fracture: no victims suffered visceral organ injury.110 Bystander There are only very few cases reported where performing CPR CPR extremely rarely leads to serious harm in victims who are has been linked to disease transmission, implicating Salmonella eventually found not to be in cardiac arrest. Rescuers should not, infantis, Staphylococcus aureus, severe acute respiratory syn- therefore, be reluctant to initiate CPR because of concern of causing drome (SARS), meningococcal meningitis, Helicobacter pylori, harm. Herpes simplex virus, cutaneous tuberculosis, stomatitis, tracheitis, Shigella and Streptococcus pyogenes. One report described her- Risks to the rescuer during training and during real-life CPR pes simplex virus infection as a result of training in CPR. One systematic review found that in the absence of high-risk activ- Physical effects ities, such as intravenous cannulation, there were no reports of transmission of hepatitis B, hepatitis C, human immunodeficiency Observational studies of training or actual CPR performance virus (HIV) or cytomegalovirus during either training or actual have described rare occurrences of muscle strain, back symptoms, CPR.119 shortness of breath, hyperventilation, and case reports of pneu- The risk of disease transmission during training and actual CPR mothorax, chest pain, myocardial infarction and nerve injury.111,112 performance is extremely low. Wearing gloves during CPR is rea- The incidence of these events is very low, and CPR training and sonable, but CPR should not be delayed or withheld if gloves are not actual performance is safe in most circumstances.113 Individuals available. Rescuers should take appropriate safety precautions if a undertaking CPR training should be advised of the nature and victim is known to have a serious infection (e.g. HIV, tuberculosis, extent of the physical activity required during the training pro- hepatitis B virus or SARS). gramme. Learners and rescuers who develop significant symptoms (e.g. chest pain or severe shortness of breath) during CPR training Barrier devices should be advised to stop. No human studies have addressed the safety, effectiveness or Rescuer fatigue feasibility of using barrier devices (such as a face shield or face mask) to prevent victim contact during rescuer breathing. Two Several manikin studies have found that chest compression studies showed that barrier devices decreased transmission of bac- depth can decrease as little as 2 min after starting chest compres- teria in controlled laboratory settings.120,121 Because the risk of sions. An in-hospital patient study showed that, even while using disease transmission is very low, initiating rescue breathing with- real-time feedback, the mean depth of compression deteriorated out a barrier device is reasonable. If the victim is known to have a between 1.5 and 3 min after starting CPR.114 It is therefore rec- serious infection (e.g. HIV, tuberculosis, hepatitis B virus, or SARS) ommended that rescuers change about every 2 min to prevent a a barrier device is recommended. decrease in compression quality due to rescuer fatigue. Changing rescuers should not interrupt chest compressions. Recovery position Risks during defibrillation There are several variations of the recovery position, each A large randomised trial of public access defibrillation showed with its own advantages. No single position is perfect for all that AEDs can be used safely by laypeople and first responders.115 victims.122,123 The position should be stable, near to a true lateral A systematic review identified eight papers that reported a total position with the head dependent, and with no pressure on the
- 67. R.W. Koster et al. / Resuscitation 81 (2010) 1277–1292 1285 Fig. 2.13. Place the arm nearest to you out at right angles to his body, elbow bent with the hand palm uppermost. Fig. 2.15. With your other hand, grasp the far leg just above the knee and pull it up, keeping the foot on the ground. Fig. 2.16. The recovery position completed. Keep the head tilted to keep the airway open. Keep the face downward to allow fluids to go out. Foreign-body airway obstruction (choking) Foreign-body airway obstruction (FBAO) is an uncommon but potentially treatable cause of accidental death.125 As most choking Fig. 2.14. Bring the far arm across the chest, and hold the back of the hand against the victim’s cheek nearest to you. events are associated with eating, they are commonly witnessed. Thus, there is often the opportunity for early intervention while the victim is still responsive. chest to impair breathing.124 The ERC recommends the following sequence of actions to place a victim in the recovery position: Recognition • Kneel beside the victim and make sure that both legs are straight. • Place the arm nearest to you out at right angles to the body, elbow Because recognition of airway obstruction is the key to success- bent with the hand palm uppermost (Fig. 2.13). ful outcome, it is important not to confuse this emergency with • Bring the far arm across the chest, and hold the back of the hand fainting, myocardial infarction, seizure or other conditions that may against the victim’s cheek nearest to you (Fig. 2.14). cause sudden respiratory distress, cyanosis or loss of consciousness. • With your other hand, grasp the far leg just above the knee and Foreign bodies may cause either mild or severe airway obstruction. pull it up, keeping the foot on the ground (Fig. 2.15). The signs and symptoms enabling differentiation between mild • Keeping the hand pressed against the cheek, pull on the far leg to and severe airway obstruction are summarised in Table 2.1. It is roll the victim towards you onto his side. important to ask the conscious victim “Are you choking?” • Adjust the upper leg so that both hip and knee are bent at right angles. • Tilt the head back to make sure the airway remains open. • Adjust the hand under the cheek, if necessary, to keep the head Table 2.1 tilted and facing downwards to allow liquid material to drain Differentiation between mild and severe foreign body airway obstruction (FBAO).a from the mouth (Fig. 2.16). Sign Mild obstruction Severe obstruction • Check breathing regularly. “Are you choking?” “Yes” Unable to speak, may nod Other signs Can speak, cough, Cannot breathe/wheezy If the victim has to be kept in the recovery position for more breathe breathing/silent attempts to cough/unconsciousness than 30 min, turn him to the opposite side to relieve the pressure on the lower arm. a General signs of FBAO: attack occurs while eating; victim may clutch his neck.
- 68. 1286 R.W. Koster et al. / Resuscitation 81 (2010) 1277–1292 Fig. 2.17. Adult foreign body airway obstruction treatment algorithm. Adult foreign-body airway obstruction (choking) sequence (this under continuous observation until they improve, as severe airway sequence is also suitable for use in children over the age of 1 year) obstruction may subsequently develop. (Fig. 2.17) Foreign-body airway obstruction with severe airway obstruction 1. If the victim shows signs of mild airway obstruction: • Encourage continued coughing but do nothing else. The clinical data on choking are largely retrospective and anec- 2. If the victim shows signs of severe airway obstruction and is dotal. For conscious adults and children over 1 year with a complete conscious: FBAO, case reports demonstrate the effectiveness of back blows • Apply five back blows as follows: or “slaps”, abdominal thrusts and chest thrusts.126 Approximately ◦ stand to the side and slightly behind the victim; 50% of episodes of airway obstruction are not relieved by a single ◦ support the chest with one hand and lean the victim well technique.127 The likelihood of success is increased when combi- forwards so that when the obstructing object is dislodged it nations of back blows or slaps, and abdominal and chest thrusts are comes out of the mouth rather than goes further down the used.126 airway; A randomised trial in cadavers128 and two prospective studies ◦ give five sharp blows between the shoulder blades with the in anaesthetised volunteers129,130 showed that higher airway pres- heel of your other hand. sures can be generated using chest thrusts compared with abdom- • If five back blows fail to relieve the airway obstruction, give inal thrusts. Since chest thrusts are virtually identical to chest five abdominal thrusts as follows: compressions, rescuers should be taught to start CPR if a victim ◦ stand behind the victim and put both arms round the upper of known or suspected FBAO becomes unconscious. The purpose of part of the abdomen; the chest compressions is primarily to attempt to remove the air- ◦ lean the victim forwards; way obstruction in the unconscious and supine victim, and only sec- ◦ clench your fist and place it between the umbilicus (navel) ondarily to promote circulation. Therefore, chest compressions are and the ribcage; required even when a professional rescuer still feels a pulse. If the ◦ grasp this hand with your other hand and pull sharply obstruction is not relieved, progressive bradycardia and asystole inwards and upwards; will occur. During CPR for choking, each time the airway is opened ◦ repeat five times. the victim’s mouth should be quickly checked for any foreign body • If the obstruction is still not relieved, continue alternating five that has been partly expelled. During CPR in other cases, therefore, back blows with five abdominal thrusts. a routine check of the mouth for foreign bodies is not necessary. 3. If the victim at any time becomes unconscious: • support the victim carefully to the ground; The finger sweep • immediately activate the ambulance service; • begin CPR with chest compressions. No studies have evaluated the routine use of a finger sweep to clear the airway in the absence of visible airway obstruction,131–133 and four case reports have documented harm to the victim131,134 Foreign-body airway obstruction causing mild airway obstruction or rescuer126 during this manoeuvre. Blind finger sweeps should, therefore, be avoided, and solid material in the airway removed Coughing generates high and sustained airway pressures and manually only if it can be seen. may expel the foreign body. Aggressive treatment, with back blows, abdominal thrusts and chest compression, may cause potentially Aftercare and referral for medical review serious complications and could worsen the airway obstruction. It should be reserved for victims who have signs of severe airway Following successful treatment for FBAO, foreign material may obstruction. Victims with mild airway obstruction should remain nevertheless remain in the upper or lower respiratory tract and
- 69. R.W. Koster et al. / Resuscitation 81 (2010) 1277–1292 1287 cause complications later. Victims with a persistent cough, diffi- help. The majority of cases of SCA out of hospital, however, occur in culty swallowing or the sensation of an object being still stuck adults, and although the rate of VF as the first recorded rhythm has in the throat should, therefore, be referred for a medical opinion. declined over recent years, the cause of adult cardiac arrest remains Abdominal thrusts and chest compressions can potentially cause VF in most cases (59%) when documented in the earliest phase by an serious internal injuries, and all victims successfully treated with AED.13 In children, VF is much less common as the primary cardiac these measures should be examined afterwards for injury. arrest rhythm (approximately 7%).135 These additional recommen- dations, therefore, added to the complexity of the guidelines while affecting only a minority of victims. Resuscitation of children (see also Section 6)134a and It is important to be aware that many children do not receive victims of drowning (see also Section 8c)134b resuscitation because potential rescuers fear causing harm if they are not specifically trained in resuscitation for children. This fear For victims of primary cardiac arrest who receive chest- is unfounded; it is far better to use the adult BLS sequence for compression-only CPR, oxygen stores become depleted about resuscitation of a child than to do nothing. For ease of teaching and 2–4 min after initiation of CPR.92,104 The combination of chest com- retention laypeople should be taught that the adult sequence may pressions with ventilation then becomes critically important. After also be used for children who are not responsive and not breathing collapse from asphyxial arrest, a combination of chest compres- or not breathing normally. sions with ventilations is important immediately after the start of The following minor modifications to the adult sequence will resuscitation. Previous guidelines have tried to address this differ- make it even more suitable for use in children. ence in pathophysiology, and have recommended that victims of identifiable asphyxia (drowning, intoxication) and children should • Give 5 initial rescue breaths before starting chest compressions receive 1 min of CPR before the lone rescuer leaves the victim to get (adult sequence of actions, 5b). Fig. 2.18. Algorithm for use of an automated external defibrillator. © 2010 ERC.
- 70. 1288 R.W. Koster et al. / Resuscitation 81 (2010) 1277–1292 • A lone rescuer should perform CPR for approximately 1 min before going for help. • Compress the chest by at least one third of its depth; use 2 fingers for an infant under 1 year; use 1 or 2 hands for a child over 1 year as needed to achieve an adequate depth of compression. The same modifications of 5 initial breaths and 1 min of CPR by the lone rescuer before getting help, may improve outcome for victims of drowning. This modification should be taught only to those who have a specific duty of care to potential drowning victims (e.g. lifeguards). Drowning is easily identified. It can be difficult, on the other hand, for a layperson to determine whether cardiores- piratory arrest is a direct result of trauma or intoxication. These victims should, therefore, be managed according to the standard BLS protocols. Use of an automated external defibrillator Section 3 discusses the guidelines for defibrillation using both automated external defibrillators (AEDs) and manual defibrillators. AEDs are safe and effective when used by laypeople, and make it possible to defibrillate many minutes before professional help arrives. Rescuers should continue CPR with minimal interruption of chest compressions while applying an AED and during its use. Rescuers should concentrate on following the voice prompts imme- Fig. 2.19. Attaching the electrode pads. Place the first electrode pad in the mid- diately they are received, in particular, resuming CPR as soon as axillary line just below the armpit. Place the second electrode just below the right collarbone (clavicle). © 2010 ERC. instructed. Standard AEDs are suitable for use in children older than 8 years. For children between 1 and 8 years paediatric pads should be used, together with an attenuator or a paediatric mode if available; if 5b. If no shock is indicated these are not available, the AED should be used as it is. Use of AEDs • immediately resume CPR, using a ratio of 30 compressions to is not recommended for children <1 year. There are, however, a 2 rescue breaths; few case reports describing the use of AEDs in children aged <1 • continue as directed by the voice/visual prompts. year.136,137 The incidence of shockable rhythms in infants is very 6. Continue to follow the AED prompts until low except when there is cardiac disease135,138,139 ; in these rare • professional help arrives and takes over; cases, if an AED is the only defibrillator available its use should be • the victim starts to wake up: moves, open eyes and breathes considered (preferably with dose attenuator). normally; • you become exhausted. Sequence for use of an AED See Fig. 2.18 1. Make sure you, the victim, and any bystanders are safe. 2. Follow the Adult BLS sequence (steps 1–5). • if the victim is unresponsive and not breathing normally, send someone for help and to find and bring an AED if available; • if you are on your own, use your mobile telephone to alert the ambulance service—leave the victim only when there is no other option. 3. Start CPR according to the adult BLS sequence. If you are on your own and the AED is in your immediate vicinity, start by applying the AED. 4. As soon as the AED arrives • switch on the AED and attach the electrode pads on the victim’s bare chest (Fig. 2.19); • if more than one rescuer is present, CPR should be continued while electrode pads are being attached to the chest; • follow the spoken/visual directions immediately; • ensure that nobody is touching the victim while the AED is analysing the rhythm (Fig. 2.20). 5a. If a shock is indicated • ensure that nobody is touching the victim (Fig. 2.21); • push shock button as directed (fully automatic AEDs will deliver the shock automatically); • immediately restart CPR 30:2 (Fig. 2.22); Fig. 2.20. While the AED analyses the heart rhythm, nobody should touch the victim. • continue as directed by the voice/visual prompts. © 2010 ERC.
- 71. R.W. Koster et al. / Resuscitation 81 (2010) 1277–1292 1289 specified period of CPR, as a routine before rhythm analysis and shock delivery, is not recommended. High-quality CPR, however, must continue while the defibrillation pads are being applied and the defibrillator is being prepared. The importance of early deliv- ery of minimally interrupted chest compression is emphasised. Given the lack of convincing data either supporting or refuting this strategy, it is reasonable for emergency medical services that have already implemented a specified period of chest compression before defibrillation to continue this practice. Voice prompts In several places, the sequence of actions states “follow the voice/visual prompts”. Voice prompts are usually programmable, and it is recommended that they be set in accordance with the sequence of shocks and timings for CPR given in Section 2. These should include at least: 1. a single shock only, when a shockable rhythm is detected; 2. no rhythm check, or check for breathing or a pulse, after the shock; 3. a voice prompt for immediate resumption of CPR after the shock (giving chest compressions in the presence of a spontaneous circulation is not harmful); Fig. 2.21. When the shock button is pressed, make sure that nobody touches the 4. a period of 2 min of CPR before a next prompt to re-analyse the victim. © 2010 ERC. rhythm. The shock sequence and energy levels are discussed in Section 3.2 Fully automatic AEDs Having detected a shockable rhythm, a fully automatic AED will deliver a shock without further input from the rescuer. One manikin study has shown that untrained nursing students commit fewer safety errors using a fully automatic AED rather than a (semi-) automated AED.145 There are no human data to determine whether these findings can be applied to clinical use. Public access defibrillation programmes AED programmes should be actively considered for implemen- tation in non-hospital settings. This refers to public places like airports,32 sport facilities, offices, in casinos35 and on aircraft,33 where cardiac arrests are usually witnessed and trained rescuers are quickly on scene. Lay rescuer AED programmes with very rapid response times, and uncontrolled studies using police offi- cers as first responders,146,147 have achieved reported survival rates as high as 49–74%. These programmes will be successful only if enough trained rescuers and AEDs are available. Fig. 2.22. After the shock the AED will prompt you to start CPR. Do not wait—start The full potential of AEDs has not yet been achieved, because CPR immediately and alternate 30 chest compressions with 2 rescue breaths. © 2010 they are mostly used in public settings, yet 60–80% of cardiac arrests ERC. occur at home. Public access defibrillation (PAD) and first respon- der AED programmes may increase the number of victims who CPR before defibrillation receive bystander CPR and early defibrillation, thus improving sur- vival from out-of-hospital SCA.148 Recent data from nationwide The importance of immediate defibrillation, as soon as an AED studies in Japan and the USA13,43 showed that when an AED was becomes available, has always been emphasised in guidelines and available, victims were defibrillated much sooner and with a bet- during teaching, and is considered to have a major impact on ter chance of survival. However, an AED delivered a shock in only survival from ventricular fibrillation. This concept has been chal- 3.7% and 5% of all VF cardiac arrests, respectively. There was a clear lenged, because evidence has suggested that a period of chest inverse relationship in the Japanese study between the number of compression before defibrillation may improve survival when the AEDs available per square km and the interval between collapse time between calling for the ambulance and its arrival exceeds and the first shock, and a positive relationship with survival. In 5 min.140,141 Two recent clinical studies142,143 and a recent animal both studies, AED shocks still occurred predominantly in a public study144 did not confirm this survival benefit. For this reason, a pre- rather than a residential setting. Dispatched first responders like
- 72. 1290 R.W. Koster et al. / Resuscitation 81 (2010) 1277–1292 police and fire fighters will, in general, have longer response times, 3. Deakin CD, Nolan JP, Soar J, et al. European Resuscitation Council Guidelines but have the potential to reach the whole population. for Resuscitation 2010. Section 4. Adult advanced life support. Resuscitation 2010;81:1305–52. When implementing an AED programme, community and pro- 4. Sans S, Kesteloot H, Kromhout D. The burden of cardiovascular diseases gramme leaders should consider factors such as the strategic mortality in Europe. Task Force of the European Society of Cardiology on location of AEDs, development of a team with responsibility for Cardiovascular Mortality and Morbidity Statistics in Europe. Eur Heart J 1997;18:1231–48. monitoring and maintaining the devices, training and retraining 5. Atwood C, Eisenberg MS, Herlitz J, Rea TD. Incidence of EMS-treated out-of- programmes for the individuals who are likely to use the AED, and hospital cardiac arrest in Europe. Resuscitation 2005;67:75–80. identification of a group of volunteer individuals who are commit- 6. Cobb LA, Fahrenbruch CE, Olsufka M, Copass MK. Changing incidence of out- of-hospital ventricular fibrillation, 1980–2000. JAMA 2002;288:3008–13. ted to using the AED for victims of cardiac arrest.149 7. Rea TD, Pearce RM, Raghunathan TE, et al. Incidence of out-of-hospital cardiac The logistic problem for first responder programmes is that the arrest. Am J Cardiol 2004;93:1455–60. rescuer needs to arrive, not just earlier than the traditional ambu- 8. Vaillancourt C, Verma A, Trickett J, et al. Evaluating the effectiveness of dispatch-assisted cardiopulmonary resuscitation instructions. Acad Emerg lance, but within 5–6 min of the initial call, to enable attempted Med 2007;14:877–83. defibrillation in the electrical or circulatory phase of cardiac 9. Agarwal DA, Hess EP, Atkinson EJ, White RD. Ventricular fibrilla- arrest.44 With longer delays, the survival benefits decrease:36,47 tion in Rochester, Minnesota: experience over 18 years. Resuscitation a few minutes’ gain in time will have little impact when a first 2009;80:1253–8. 10. Ringh M, Herlitz J, Hollenberg J, Rosenqvist M, Svensson L. Out of hospital car- responder arrives more than 10 min after the call,14,150 or when diac arrest outside home in Sweden, change in characteristics, outcome and a first responder does not improve on an already short ambu- availability for public access defibrillation. Scand J Trauma Resusc Emerg Med lance response time.151 However, small reductions in response 2009;17:18. 11. Cummins R, Thies W. Automated external defibrillators and the Advanced intervals achieved by first-responder programmes that impact on Cardiac Life Support Program: a new initiative from the American Heart Asso- many residential victims may be more cost-effective than the larger ciation. Am J Emerg Med 1991;9:91–3. reductions in response interval achieved by PAD programmes that 12. Waalewijn RA, Nijpels MA, Tijssen JG, Koster RW. Prevention of deterioration of ventricular fibrillation by basic life support during out-of-hospital cardiac have an impact on fewer cardiac arrest victims.152,153 arrest. Resuscitation 2002;54:31–6. Programmes that make AEDs publicly available in residential 13. Weisfeldt ML, Sitlani CM, Ornato JP, et al. Survival after application of auto- areas have not yet been evaluated. The acquisition of an AED for matic external defibrillators before arrival of the emergency medical system: evaluation in the resuscitation outcomes consortium population of 21 million. individual use at home, even for those considered at high risk of J Am Coll Cardiol 2010;55:1713–20. sudden cardiac arrest, has proved not to be effective.154 14. van Alem AP, Vrenken RH, de Vos R, Tijssen JG, Koster RW. Use of auto- mated external defibrillator by first responders in out of hospital cardiac arrest: prospective controlled trial. BMJ 2003;327:1312. Universal AED signage 15. Nolan J, Soar J, Eikeland H. The chain of survival. Resuscitation 2006;71:270–1. 16. Muller D, Agrawal R, Arntz HR. How sudden is sudden cardiac death? Circula- When a collapse occurs, and an AED must be found rapidly, sim- tion 2006;114:1146–50. 17. Lowel H, Lewis M, Hormann A. Prognostic significance of prehospital phase in ple and clear signage indicating the location of, and the fastest way acute myocardial infarct. Results of the Augsburg Myocardial Infarct Registry, to an AED is important. ILCOR has designed an AED sign that may be 1985–1988. Dtsch Med Wochenschr 1991;116:729–33. recognised worldwide and is recommended for indicating the loca- 18. Waalewijn RA, Tijssen JG, Koster RW. Bystander initiated actions in out- of-hospital cardiopulmonary resuscitation: results from the Amsterdam tion of an AED (Fig. 2.23). More detailed information on design and Resuscitation Study (ARREST). Resuscitation 2001;50:273–9. application of this AED sign can be found at: https://www.erc.edu/ 19. Valenzuela TD, Roe DJ, Cretin S, Spaite DW, Larsen MP. Estimating effectiveness index.php/newsItem/en/nid=204/ of cardiac arrest interventions: a logistic regression survival model. Circulation 1997;96:3308–13. 20. Holmberg M, Holmberg S, Herlitz J. Factors modifying the effect of bystander cardiopulmonary resuscitation on survival in out-of-hospital cardiac arrest patients in Sweden. Eur Heart J 2001;22:511–9. 21. Holmberg M, Holmberg S, Herlitz J, Gardelov B. Survival after cardiac arrest outside hospital in Sweden. Swedish Cardiac Arrest Registry. Resuscitation 1998;36:29–36. 22. SOS-KANTO Study Group. Cardiopulmonary resuscitation by bystanders with chest compression only (SOS-KANTO): an observational study. Lancet 2007;369:920–6. 23. Iwami T, Kawamura T, Hiraide A, et al. Effectiveness of bystander-initiated cardiac-only resuscitation for patients with out-of-hospital cardiac arrest. Cir- culation 2007;116:2900–7. 24. Rea TD, Eisenberg MS, Culley LL, Becker L. Dispatcher-assisted car- diopulmonary resuscitation and survival in cardiac arrest. Circulation 2001;104:2513–6. 25. Kuisma M, Boyd J, Vayrynen T, Repo J, Nousila-Wiik M, Holmstrom P. Emer- gency call processing and survival from out-of-hospital ventricular fibrillation. Resuscitation 2005;67:89–93. 26. Rea TD, Fahrenbruch C, Culley L, et al. CPR with chest compresssions alone or with rescue breathing. N Engl J Med 2010;363:423–33. 27. Svensson L, Bohm K, Castren M, et al. Compression-only CPR or standard CPR in out-of-hospital cardiac arrest. N Engl J Med 2010;363:434–42. Fig. 2.23. Universal ILCOR signage to indicate presence of an AED. This sign can be 28. Weaver WD, Hill D, Fahrenbruch CE, et al. Use of the automatic external defib- combined with arrows to indicate the direction of the nearest AED. rillator in the management of out-of-hospital cardiac arrest. N Engl J Med 1988;319:661–6. 29. Auble TE, Menegazzi JJ, Paris PM. Effect of out-of-hospital defibrillation by basic life support providers on cardiac arrest mortality: a metaanalysis. Ann Emerg References Med 1995;25:642–58. 30. Stiell IG, Wells GA, Field BJ, et al. Improved out-of-hospital cardiac arrest 1. Recommended guidelines for uniform reporting of data from out-of-hospital survival through the inexpensive optimization of an existing defibrillation pro- cardiac arrest: the ‘Utstein style’. Prepared by a Task Force of Representatives gram: OPALS study phase II. Ontario prehospital advanced life support. JAMA from the European Resuscitation Council, American Heart Association, Heart 1999;281:1175–81. and Stroke Foundation of Canada, Australian Resuscitation Council. Resuscita- 31. Stiell IG, Wells GA, DeMaio VJ, et al. Modifiable factors associated tion 1991;22:1–26. with improved cardiac arrest survival in a multicenter basic life sup- 2. Deakin CD, Nolan JP, Sunde K, Koster RW. European Resuscitation Council port/defibrillation system: OPALS Study Phase I results. Ontario prehospital Guidelines for Resuscitation 2010. Section 3. Electrical therapies: automated advanced life support. Ann Emerg Med 1999;33:44–50. external defibrillators, defibrillation, cardioversion and pacing. Resuscitation 32. Caffrey S. Feasibility of public access to defibrillation. Curr Opin Crit Care 2010;81:1293–304. 2002;8:195–8.
- 73. R.W. Koster et al. / Resuscitation 81 (2010) 1277–1292 1291 33. O’Rourke MF, Donaldson E, Geddes JS. An airline cardiac arrest program. Cir- 62. Mithoefer JC, Mead G, Hughes JM, Iliff LD, Campbell EJ. A method of distin- culation 1997;96:2849–53. guishing death due to cardiac arrest from asphyxia. Lancet 1967;2:654–6. 34. Page RL, Hamdan MH, McKenas DK. Defibrillation aboard a commercial aircraft. 63. Kern KB, Hilwig RW, Berg RA, Sanders AB, Ewy GA. Importance of continuous Circulation 1998;97:1429–30. chest compressions during cardiopulmonary resuscitation: improved outcome 35. Valenzuela TD, Roe DJ, Nichol G, Clark LL, Spaite DW, Hardman RG. Outcomes during a simulated single lay-rescuer scenario. Circulation 2002;105:645–9. of rapid defibrillation by security officers after cardiac arrest in casinos. N Engl 64. Bobrow BJ, Clark LL, Ewy GA, et al. Minimally interrupted cardiac resuscita- J Med 2000;343:1206–9. tion by emergency medical services for out-of-hospital cardiac arrest. JAMA 36. Waalewijn RA, de Vos R, Tijssen JG, Koster RW. Survival models for out-of- 2008;299:1158–65. hospital cardiopulmonary resuscitation from the perspectives of the bystander, 65. Taylor RB, Brown CG, Bridges T, Werman HA, Ashton J, Hamlin RL. A model for the first responder, and the paramedic. Resuscitation 2001;51:113–22. regional blood flow measurements during cardiopulmonary resuscitation in a 37. Carr BG, Kahn JM, Merchant RM, Kramer AA, Neumar RW. Inter-hospital vari- swine model. Resuscitation 1988;16:107–18. ability in post-cardiac arrest mortality. Resuscitation 2009;80:30–4. 66. Aufderheide TP, Sigurdsson G, Pirrallo RG, et al. Hyperventilation- 38. Neumar RW, Nolan JP, Adrie C, et al. Post-cardiac arrest syndrome: epidemiol- induced hypotension during cardiopulmonary resuscitation. Circulation ogy, pathophysiology, treatment, and prognostication. A consensus statement 2004;109:1960–5. from the International Liaison Committee on Resuscitation (American Heart 67. Eftestol T, Sunde K, Steen PA. Effects of interrupting precordial compressions Association, Australian and New Zealand Council on Resuscitation, European on the calculated probability of defibrillation success during out-of-hospital Resuscitation Council, Heart and Stroke Foundation of Canada, InterAmerican cardiac arrest. Circulation 2002;105:2270–3. Heart Foundation, Resuscitation Council of Asia, and the Resuscitation Council 68. Wenzel V, Idris AH, Banner MJ, Kubilis PS, Williams JLJ. Influence of tidal volume of Southern Africa); the American Heart Association Emergency Cardiovascular on the distribution of gas between the lungs and stomach in the nonintubated Care Committee; the Council on Cardiovascular Surgery and Anesthesia; the patient receiving positive-pressure ventilation. Crit Care Med 1998;26:364–8. Council on Cardiopulmonary, Perioperative, and Critical Care; the Council on 69. Idris A, Gabrielli A, Caruso L. Smaller tidal volume is safe and effective for bag- Clinical Cardiology; and the Stroke Council. Circulation 2008;118:2452–83. valve-ventilation, but not for mouth-to-mouth ventilation: an animal model 39. Sunde K, Pytte M, Jacobsen D, et al. Implementation of a standardised treat- for basic life support. Circulation 1999;100:I–644. ment protocol for post resuscitation care after out-of-hospital cardiac arrest. 70. Idris A, Wenzel V, Banner MJ, Melker RJ. Smaller tidal volumes mini- Resuscitation 2007;73:29–39. mize gastric inflation during CPR with an unprotected airway. Circulation 40. Bernard SA, Gray TW, Buist MD, et al. Treatment of comatose survivors 1995;92(Suppl.):I–759. of out-of-hospital cardiac arrest with induced hypothermia. N Engl J Med 71. Dorph E, Wik L, Steen PA. Arterial blood gases with 700 ml tidal volumes during 2002;346:557–63. out-of-hospital CPR. Resuscitation 2004;61:23–7. 41. Mild therapeutic hypothermia to improve the neurologic outcome after cardiac 72. Winkler M, Mauritz W, Hackl W, et al. Effects of half the tidal volume during arrest. N Engl J Med 2002;346:549–56. cardiopulmonary resuscitation on acid–base balance and haemodynamics in 42. Arrich J, Holzer M, Herkner H, Mullner M. Hypothermia for neuroprotection in pigs. Eur J Emerg Med 1998;5:201–6. adults after cardiopulmonary resuscitation. Cochrane Database Syst Rev 2009. 73. Ruben H. The immediate treatment of respiratory failure. Br J Anaesth CD004128. 1964;36:542–9. 43. Kitamura T, Iwami T, Kawamura T, Nagao K, Tanaka H, Hiraide A. Nationwide 74. Elam JO. Bag-valve-mask O2 ventilation. In: Safar P, Elam JO, editors. Advances public-access defibrillation in Japan. N Engl J Med 2010;362:994–1004. in cardiopulmonary resuscitation: the Wolf Creek conference on cardiopul- 44. Weisfeldt ML, Becker LB. Resuscitation after cardiac arrest: a 3-phase time- monary resuscitation. New York, NY: Springer-Verlag, Inc.; 1977. p. 73–9. 75. Dailey RH. The airway: emergency management. St. Louis, MO: Mosby Year sensitive model. JAMA 2002;288:3035–8. Book; 1992. 45. White RD, Russell JK. Refibrillation, resuscitation and survival in out-of- 76. Paradis NA, Martin GB, Goetting MG, et al. Simultaneous aortic, jugular bulb, hospital sudden cardiac arrest victims treated with biphasic automated and right atrial pressures during cardiopulmonary resuscitation in humans. external defibrillators. Resuscitation 2002;55:17–23. Insights into mechanisms. Circulation 1989;80:361–8. 46. Kerber RE, Becker LB, Bourland JD, et al. Automatic external defibrillators for 77. Kramer-Johansen J, Myklebust H, Wik L, et al. Quality of out-of-hospital car- public access defibrillation: recommendations for specifying and reporting diopulmonary resuscitation with real time automated feedback: a prospective arrhythmia analysis algorithm performance, incorporating new waveforms, interventional study. Resuscitation 2006;71:283–92. and enhancing safety. A statement for health professionals from the American 78. Edelson DP, Abella BS, Kramer-Johansen J, et al. Effects of compression depth Heart Association Task Force on Automatic External Defibrillation, Subcom- and pre-shock pauses predict defibrillation failure during cardiac arrest. Resus- mittee on AED Safety and Efficacy. Circulation 1997;95:1677–82. citation 2006;71:137–45. 47. Larsen MP, Eisenberg MS, Cummins RO, Hallstrom AP. Predicting survival 79. Wik L, Kramer-Johansen J, Myklebust H, et al. Quality of cardiopulmonary from out-of-hospital cardiac arrest: a graphic model. Ann Emerg Med resuscitation during out-of-hospital cardiac arrest. JAMA 2005;293:299–304. 1993;22:1652–8. 80. Abella BS, Alvarado JP, Myklebust H, et al. Quality of cardiopulmonary resusci- 48. Holmberg M, Holmberg S, Herlitz J. Effect of bystander cardiopulmonary resus- tation during in-hospital cardiac arrest. JAMA 2005;293:305–10. citation in out-of-hospital cardiac arrest patients in Sweden. Resuscitation 81. Christenson J, Andrusiek D, Everson-Stewart S, et al. Chest compression fraction 2000;47:59–70. determines survival in patients with out-of-hospital ventricular fibrillation. 49. Aprahamian C, Thompson BM, Finger WA, Darin JC. Experimental cervical spine Circulation 2009;120:1241–7. injury model: evaluation of airway management and splinting techniques. Ann 82. Ochoa FJ, Ramalle-Gomara E, Carpintero JM, Garcia A, Saralegui I. Com- Emerg Med 1984;13:584–7. petence of health professionals to check the carotid pulse. Resuscitation 50. Bahr J, Klingler H, Panzer W, Rode H, Kettler D. Skills of lay people in checking 1998;37:173–5. the carotid pulse. Resuscitation 1997;35:23–6. 83. Shin J, Rhee JE, Kim K. Is the inter-nipple line the correct hand position for effec- 51. Nyman J, Sihvonen M. Cardiopulmonary resuscitation skills in nurses and nurs- tive chest compression in adult cardiopulmonary resuscitation? Resuscitation ing students. Resuscitation 2000;47:179–84. 2007;75:305–10. 52. Tibballs J, Russell P. Reliability of pulse palpation by healthcare personnel to 84. Kusunoki S, Tanigawa K, Kondo T, Kawamoto M, Yuge O. Safety of the inter- diagnose paediatric cardiac arrest. Resuscitation 2009;80:61–4. nipple line hand position landmark for chest compression. Resuscitation 53. Ruppert M, Reith MW, Widmann JH, et al. Checking for breathing: evaluation of 2009;80:1175–80. the diagnostic capability of emergency medical services personnel, physicians, 85. Delvaux AB, Trombley MT, Rivet CJ, et al. Design and development of a car- medical students, and medical laypersons. Ann Emerg Med 1999;34:720–9. diopulmonary resuscitation mattress. J Intensive Care Med 2009;24:195–9. 54. Perkins GD, Stephenson B, Hulme J, Monsieurs KG. Birmingham assessment of 86. Perkins GD, Smith CM, Augre C, et al. Effects of a backboard, bed height, and breathing study (BABS). Resuscitation 2005;64:109–13. operator position on compression depth during simulated resuscitation. Inten- 55. Hauff SR, Rea TD, Culley LL, Kerry F, Becker L, Eisenberg MS. Factors impeding sive Care Med 2006;32:1632–5. dispatcher-assisted telephone cardiopulmonary resuscitation. Ann Emerg Med 87. Perkins GD, Kocierz L, Smith SC, McCulloch RA, Davies RP. Compression feed- 2003;42:731–7. back devices over estimate chest compression depth when performed on a bed. 56. Bobrow BJ, Zuercher M, Ewy GA, et al. Gasping during cardiac arrest in Resuscitation 2009;80:79–82. humans is frequent and associated with improved survival. Circulation 88. Aufderheide TP, Pirrallo RG, Yannopoulos D, et al. Incomplete chest wall 2008;118:2550–4. decompression: a clinical evaluation of CPR performance by EMS person- 57. Clark JJ, Larsen MP, Culley LL, Graves JR, Eisenberg MS. Incidence of agonal nel and assessment of alternative manual chest compression–decompression respirations in sudden cardiac arrest. Ann Emerg Med 1992;21:1464–7. techniques. Resuscitation 2005;64:353–62. 58. Karlsten R, Elowsson P. Who calls for the ambulance: implications for decision 89. Yannopoulos D, McKnite S, Aufderheide TP, et al. Effects of incomplete chest support. A descriptive study from a Swedish dispatch centre. Eur J Emerg Med wall decompression during cardiopulmonary resuscitation on coronary and 2004;11:125–9. cerebral perfusion pressures in a porcine model of cardiac arrest. Resuscitation 59. Nurmi J, Pettila V, Biber B, Kuisma M, Komulainen R, Castren M. Effect of 2005;64:363–72. protocol compliance to cardiac arrest identification by emergency medical 90. Sanders AB, Kern KB, Berg RA, Hilwig RW, Heidenrich J, Ewy GA. Survival and dispatchers. Resuscitation 2006;70:463–9. neurologic outcome after cardiopulmonary resuscitation with four different 60. Berdowski J, Beekhuis F, Zwinderman AH, Tijssen JG, Koster RW. Importance of chest compression–ventilation ratios. Ann Emerg Med 2002;40:553–62. the first link: description and recognition of an out-of-hospital cardiac arrest 91. Dorph E, Wik L, Stromme TA, Eriksen M, Steen PA. Quality of CPR with three in an emergency call. Circulation 2009;119:2096–102. different ventilation:compression ratios. Resuscitation 2003;58:193–201. 61. Clawson J, Olola C, Heward A, Patterson B. Cardiac arrest predictability in 92. Dorph E, Wik L, Stromme TA, Eriksen M, Steen PA. Oxygen delivery and return of seizure patients based on emergency medical dispatcher identification of pre- spontaneous circulation with ventilation:compression ratio 2:30 versus chest vious seizure or epilepsy history. Resuscitation 2007;75:298–304. compressions only CPR in pigs. Resuscitation 2004;60:309–18.
- 74. 1292 R.W. Koster et al. / Resuscitation 81 (2010) 1277–1292 93. Babbs CF, Kern KB. Optimum compression to ventilation ratios in CPR under 125. Fingerhut LA, Cox CS, Warner M. International comparative analysis of injury realistic, practical conditions: a physiological and mathematical analysis. mortality. Findings from the ICE on injury statistics. International Collaborative Resuscitation 2002;54:147–57. Effort on Injury Statistics. Adv Data 1998:1–20. 94. Fenici P, Idris AH, Lurie KG, Ursella S, Gabrielli A. What is the optimal chest 126. Proceedings of the 2005 International Consensus on Cardiopulmonary compression–ventilation ratio? Curr Opin Crit Care 2005;11:204–11. Resuscitation and Emergency Cardiovascular Care Science with Treatment Rec- 95. Sayre MR, Cantrell SA, White LJ, Hiestand BC, Keseg DP, Koser S. Impact of the ommendations. Resuscitation 2005;67:157–341. 2005 American Heart Association cardiopulmonary resuscitation and emer- 127. Redding JS. The choking controversy: critique of evidence on the Heimlich gency cardiovascular care guidelines on out-of-hospital cardiac arrest survival. maneuver. Crit Care Med 1979;7:475–9. Prehosp Emerg Care 2009;13:469–77. 128. Langhelle A, Sunde K, Wik L, Steen PA. Airway pressure with chest compres- 96. Olasveengen TM, Vik E, Kuzovlev A, Sunde K. Effect of implementation of new sions versus Heimlich manoeuvre in recently dead adults with complete airway resuscitation guidelines on quality of cardiopulmonary resuscitation and sur- obstruction. Resuscitation 2000;44:105–8. vival. Resuscitation 2009;80:407–11. 129. Guildner CW, Williams D, Subitch T. Airway obstructed by foreign material: 97. Aufderheide TP, Lurie KG. Death by hyperventilation: a common and life- the Heimlich maneuver. JACEP 1976;5:675–7. threatening problem during cardiopulmonary resuscitation. Crit Care Med 130. Ruben H, Macnaughton FI. The treatment of food-choking. Practitioner 2004;32:S345–51. 1978;221:725–9. 98. Ornato JP, Hallagan LF, McMahan SB, Peeples EH, Rostafinski AG. Attitudes of 131. Hartrey R, Bingham RM. Pharyngeal trauma as a result of blind finger sweeps BCLS instructors about mouth-to-mouth resuscitation during the AIDS epi- in the choking child. J Accid Emerg Med 1995;12:52–4. demic. Ann Emerg Med 1990;19:151–6. 132. Elam JO, Ruben AM, Greene DG. Resuscitation of drowning victims. JAMA 99. Hew P, Brenner B, Kaufman J. Reluctance of paramedics and emergency 1960;174:13–6. medical technicians to perform mouth-to-mouth resuscitation. J Emerg Med 133. Ruben HM, Elam JO, Ruben AM, Greene DG. Investigation of upper airway 1997;15:279–84. problems in resuscitation, 1: studies of pharyngeal x-rays and performance 100. Chandra NC, Gruben KG, Tsitlik JE, et al. Observations of ventilation during by laymen. Anesthesiology 1961;22:271–9. resuscitation in a canine model. Circulation 1994;90:3070–5. 134. Kabbani M, Goodwin SR. Traumatic epiglottis following blind finger sweep to 101. Geddes LA, Rundell A, Otlewski M, Pargett M. How much lung ventilation is remove a pharyngeal foreign body. Clin Pediatr (Phila) 1995;34:495–7. obtained with only chest-compression CPR? Cardiovasc Eng 2008;8:145–8. 134a. European Resuscitation Council Guidelines for Resuscitation 2010: Section 6: 102. Berg RA, Kern KB, Hilwig RW, et al. Assisted ventilation does not improve Paediatric life support. Resuscitation 2010; 81:1400–33. outcome in a porcine model of single-rescuer bystander cardiopulmonary 134b. European Resuscitation Council Guidelines for Resuscitation 2010: Section 8: resuscitation. Circulation 1997;95:1635–41. Cardiac arrest in special circumstances. Resuscitation 2010; 81:1364–88. 103. Berg RA, Kern KB, Hilwig RW, Ewy GA. Assisted ventilation during ‘bystander’ 135. Atkins DL, Everson-Stewart S, Sears GK, et al. Epidemiology and outcomes CPR in a swine acute myocardial infarction model does not improve outcome. from out-of-hospital cardiac arrest in children: the Resuscitation Outcomes Circulation 1997;96:4364–71. Consortium Epistry-Cardiac Arrest. Circulation 2009;119:1484–91. 104. Turner I, Turner S, Armstrong V. Does the compression to ventilation ratio affect 136. Bar-Cohen Y, Walsh EP, Love BA, Cecchin F. First appropriate use of automated the quality of CPR: a simulation study. Resuscitation 2002;52:55–62. external defibrillator in an infant. Resuscitation 2005;67:135–7. 105. Bohm K, Rosenqvist M, Herlitz J, Hollenberg J, Svensson L. Survival is simi- 137. Divekar A, Soni R. Successful parental use of an automated external defibrillator lar after standard treatment and chest compression only in out-of-hospital for an infant with long-QT syndrome. Pediatrics 2006;118:e526–9. bystander cardiopulmonary resuscitation. Circulation 2007;116:2908–12. 138. Rodriguez-Nunez A, Lopez-Herce J, Garcia C, Dominguez P, Carrillo A, Bellon 106. Kitamura T, Iwami T, Kawamura T, Nagao K, Tanaka H, Hiraide A. Bystander- JM. Pediatric defibrillation after cardiac arrest: initial response and outcome. initiated rescue breathing for out-of-hospital cardiac arrests of noncardiac Crit Care 2006;10:R113. origin. Circulation 2010;122:293–9. 139. Samson RA, Nadkarni VM, Meaney PA, Carey SM, Berg MD, Berg RA. Out- 107. Kitamura T, Iwami T, Kawamura T, et al. Conventional and chest-compression- comes of in-hospital ventricular fibrillation in children. N Engl J Med only cardiopulmonary resuscitation by bystanders for children who have out- 2006;354:2328–39. of-hospital cardiac arrests: a prospective, nationwide, population-based cohort 140. Cobb LA, Fahrenbruch CE, Walsh TR, et al. Influence of cardiopulmonary resus- study. Lancet 2010;375:1347–54. citation prior to defibrillation in patients with out-of-hospital ventricular 108. Handley AJ, Handley JA. Performing chest compressions in a confined space. fibrillation. JAMA 1999;281:1182–8. Resuscitation 2004;61:55–61. 141. Wik L, Hansen TB, Fylling F, et al. Delaying defibrillation to give basic cardiopul- 109. Perkins GD, Stephenson BT, Smith CM, Gao F. A comparison between monary resuscitation to patients with out-of-hospital ventricular fibrillation: over-the-head and standard cardiopulmonary resuscitation. Resuscitation a randomized trial. JAMA 2003;289:1389–95. 2004;61:155–61. 142. Jacobs IG, Finn JC, Oxer HF, Jelinek GA. CPR before defibrillation in 110. White L, Rogers J, Bloomingdale M, et al. Dispatcher-assisted cardiopul- out-of-hospital cardiac arrest: a randomized trial. Emerg Med Australas monary resuscitation: risks for patients not in cardiac arrest. Circulation 2005;17:39–45. 2010;121:91–7. 143. Baker PW, Conway J, Cotton C, et al. Defibrillation or cardiopulmonary 111. Cheung W, Gullick J, Thanakrishnan G, et al. Injuries occurring in hospital staff resuscitation first for patients with out-of-hospital cardiac arrests found by attending medical emergency team (MET) calls—a prospective, observational paramedics to be in ventricular fibrillation? A randomised control trial. Resus- study. Resuscitation 2009;80:1351–6. citation 2008;79:424–31. 112. Sullivan F, Avstreih D. Pneumothorax during CPR training: case report and 144. Indik JH, Hilwig RW, Zuercher M, Kern KB, Berg MD, Berg RA. Preshock review of the CPR literature. Prehosp Disaster Med 2000;15:64–9. cardiopulmonary resuscitation worsens outcome from circulatory phase ven- 113. Peberdy MA, Ottingham LV, Groh WJ, et al. Adverse events associated with tricular fibrillation with acute coronary artery obstruction in swine. Circ lay emergency response programs: the public access defibrillation trial expe- Arrhythm Electrophysiol 2009;2:179–84. rience. Resuscitation 2006;70:59–65. 145. Monsieurs KG, Vogels C, Bossaert LL, Meert P, Calle PA. A study comparing the 114. Sugerman NT, Edelson DP, Leary M, et al. Rescuer fatigue during actual usability of fully automatic versus semi-automatic defibrillation by untrained in-hospital cardiopulmonary resuscitation with audiovisual feedback: a nursing students. Resuscitation 2005;64:41–7. prospective multicenter study. Resuscitation 2009;80:981–4. 146. White RD, Bunch TJ, Hankins DG. Evolution of a community-wide early defib- 115. Hallstrom AP, Ornato JP, Weisfeldt M, et al. Public-access defibrillation and rillation programme experience over 13 years using police/fire personnel and survival after out-of-hospital cardiac arrest. N Engl J Med 2004;351:637–46. paramedics as responders. Resuscitation 2005;65:279–83. 116. Hoke RS, Heinroth K, Trappe HJ, Werdan K. Is external defibrillation an electric 147. Mosesso Jr VN, Davis EA, Auble TE, Paris PM, Yealy DM. Use of automated threat for bystanders? Resuscitation 2009;80:395–401. external defibrillators by police officers for treatment of out-of-hospital cardiac 117. Axelsson A, Herlitz J, Karlsson T, et al. Factors surrounding cardiopulmonary arrest. Ann Emerg Med 1998;32:200–7. resuscitation influencing bystanders’ psychological reactions. Resuscitation 148. The public access defibrillation trial investigators. Public-access defibril- 1998;37:13–20. lation and survival after out-of-hospital cardiac arrest. N Engl J Med 118. Axelsson A, Herlitz J, Ekstrom L, Holmberg S. Bystander-initiated cardiopul- 2004;351:637–46. monary resuscitation out-of-hospital. A first description of the bystanders and 149. Priori SG, Bossaert LL, Chamberlain DA, et al. Policy statement: ESC–ERC recom- their experiences. Resuscitation 1996;33:3–11. mendations for the use of automated external defibrillators (AEDs) in Europe. 119. Mejicano GC, Maki DG. Infections acquired during cardiopulmonary resusci- Resuscitation 2004;60:245–52. tation: estimating the risk and defining strategies for prevention. Ann Intern 150. Groh WJ, Newman MM, Beal PE, Fineberg NS, Zipes DP. Limited response to Med 1998;129:813–28. cardiac arrest by police equipped with automated external defibrillators: lack 120. Cydulka RK, Connor PJ, Myers TF, Pavza G, Parker M. Prevention of oral bacterial of survival benefit in suburban and rural Indiana—the police as responder auto- flora transmission by using mouth-to-mask ventilation during CPR. J Emerg mated defibrillation evaluation (PARADE). Acad Emerg Med 2001;8:324–30. Med 1991;9:317–21. 151. Sayre MR, Swor R, Pepe PE, Overton J. Current issues in cardiopulmonary resus- 121. Blenkharn JI, Buckingham SE, Zideman DA. Prevention of transmission of infec- citation. Prehosp Emerg Care 2003;7:24–30. tion during mouth-to-mouth resuscitation. Resuscitation 1990;19:151–7. 152. Nichol G, Hallstrom AP, Ornato JP, et al. Potential cost-effectiveness of public 122. Turner S, Turner I, Chapman D, et al. A comparative study of the 1992 and 1997 access defibrillation in the United States. Circulation 1998;97:1315–20. recovery positions for use in the UK. Resuscitation 1998;39:153–60. 153. Nichol G, Valenzuela T, Roe D, Clark L, Huszti E, Wells GA. Cost effective- 123. Handley AJ. Recovery Position. Resuscitation 1993;26:93–5. ness of defibrillation by targeted responders in public settings. Circulation 124. Anonymous. Guidelines 2000 for Cardiopulmonary resuscitation and emer- 2003;108:697–703. gency cardiovascular care—an international consensus on science. Resuscita- 154. Bardy GH, Lee KL, Mark DB, et al. Home use of automated external defibrillators tion 2000;46:1–447. for sudden cardiac arrest. N Engl J Med 2008;358:1793–804.
- 75. Resuscitation 81 (2010) 1293–1304 Contents lists available at ScienceDirect Resuscitation journal homepage: www.elsevier.com/locate/resuscitation European Resuscitation Council Guidelines for Resuscitation 2010 Section 3. Electrical therapies: Automated external defibrillators, defibrillation, cardioversion and pacing Charles D. Deakin a,∗ , Jerry P. Nolan b , Kjetil Sunde c , Rudolph W. Koster d a Southampton University Hospital NHS Trust, Southampton, UK b Royal United Hospital, Bath, UK c Oslo University Hospital Ulleval, Oslo, Norway d Department of Cardiology, Academic Medical Center, Amsterdam, The Netherlands Summary of changes since 2005 Guidelines occurs during cardiac catheterisation or in the early post- operative period following cardiac surgery. This three-shock The most important changes in the 2010 European Resuscitation strategy may also be considered for an initial, witnessed VF/VT Council (ERC) guidelines for electrical therapies include: cardiac arrest when the patient is already connected to a manual defibrillator. • Electrode pastes and gels can spread between the two paddles, • The importance of early, uninterrupted chest compressions is creating the potential for a spark and should not be used emphasised throughout these guidelines. • Much greater emphasis on minimising the duration of the pre- shock and post-shock pauses. The continuation of compressions during charging of the defibrillator is recommended. • Immediate resumption of chest compressions following defib- Introduction rillation is also emphasised; in combination with continuation of compressions during defibrillator charging, the delivery of The chapter presents guidelines for defibrillation using both defibrillation should be achievable with an interruption in chest automated external defibrillators (AEDs) and manual defibrillators. compressions of no more than 5 s. There are only a few differences from the 2005 ERC Guidelines. All • Safety of the rescuer remains paramount, but there is recogni- healthcare providers and lay responders can use AEDs as an inte- tion in these guidelines that the risk of harm to a rescuer from gral component of basic life support. Manual defibrillation is used a defibrillator is very small, particularly if the rescuer is wearing as part of advanced life support (ALS) therapy. Synchronised car- gloves. The focus is now on a rapid safety check to minimise the dioversion and pacing options are included on many defibrillators pre-shock pause. and are also discussed in this chapter. • When treating out-of-hospital cardiac arrest, emergency med- Defibrillation is the passage of an electrical current across the ical services (EMS) personnel should provide good-quality CPR myocardium of sufficient magnitude to depolarise a critical mass while a defibrillator is retrieved, applied and charged, but rou- of myocardium and enable restoration of coordinated electrical tine delivery of a pre-specified period of CPR (e.g., 2 or 3 min) activity. Defibrillation is defined as the termination of fibrillation before rhythm analysis and a shock is delivered is no longer or, more precisely, the absence of VF/VT at 5 s after shock deliv- recommended. For some emergency medical services that have ery; however, the goal of attempted defibrillation is to restore an already fully implemented a pre-specified period of chest com- organised rhythm and a spontaneous circulation. pressions before defibrillation, given the lack of convincing data Defibrillator technology is advancing rapidly. AED interaction either supporting or refuting this strategy, it is reasonable for with the rescuer through voice prompts is now established and them to continue this practice. future technology may enable more specific instructions to be given • The use of up to three-stacked shocks may be considered if by voice prompt. The evolving ability of defibrillators to assess ventricular fibrillation/pulseless ventricular tachycardia (VF/VT) the rhythm whilst CPR is in progress is an important advance and enables rescuers to assess the rhythm without interrupting exter- nal chest compressions. In the future, waveform analysis may also ∗ Corresponding author. enable the defibrillator to calculate the optimal time at which to E-mail address: charlesdeakin@doctors.org.uk (C.D. Deakin). give a shock. 0300-9572/$ – see front matter © 2010 European Resuscitation Council. Published by Elsevier Ireland Ltd. All rights reserved. doi:10.1016/j.resuscitation.2010.08.008
- 76. 1294 C.D. Deakin et al. / Resuscitation 81 (2010) 1293–1304 A vital link in the Chain of Survival In-hospital use of AEDs Defibrillation is a key link in the Chain of Survival and is one At the time of the 2010 Consensus on CPR Science Conference of the few interventions that have been shown to improve out- there were no published randomised trials comparing in-hospital come from VF/VT cardiac arrest. The previous guidelines published use of AEDs with manual defibrillators. Two lower level studies in 2005 rightly emphasized the importance of early defibrillation of adults with in-hospital cardiac arrest from shockable rhythms with minimum delay.1,2 showed higher survival to hospital discharge rates when defib- The probability of successful defibrillation and subsequent sur- rillation was provided through an AED programme than with vival to hospital discharge declines rapidly with time3,4 and the manual defibrillation alone.21,22 One retrospective study23 demon- ability to deliver early defibrillation is one of the most impor- strated no improvements in survival to hospital discharge for tant factors in determining survival from cardiac arrest. For every in-hospital adult cardiac arrest when using an AED compared with minute delay in defibrillation, in the absence of bystander CPR, sur- manual defibrillation. In this study, patients in the AED group vival from witnessed VF decreases by 10–12%.4,5 EMS systems do with initial asystole or pulseless electrical activity (PEA) had a not generally have the capability to deliver defibrillation through lower survival to hospital discharge rate compared with those traditional paramedic responders within the first few minutes of in the manual defibrillator group (15% versus 23%; p = 0.04). A a call and the alternative use of trained lay responders to deliver manikin study showed that use of an AED significantly increased prompt defibrillation using AEDs is now widespread. EMS sys- the likelihood of delivering three shocks but increased the time to tems that have reduced time to defibrillation following cardiac deliver the shocks when compared with manual defibrillators.24 arrest using trained lay responders have reported greatly improved In contrast, a study of mock arrests in simulated patients showed survival to hospital discharge rates,6–9 some as high as 75% if defib- that use of monitoring leads and fully automated defibrilla- rillation is performed within 3 min of collapse.10 This concept has tors reduced time to defibrillation when compared with manual also been extended to in-hospital cardiac arrests where staff, other defibrillators.25 than doctors, are also being trained to defibrillate using an AED Delayed defibrillation may occur when patients sustain car- before arrival of the cardiac arrest team.11 diac arrest in unmonitored hospital beds and in outpatient When bystander CPR is provided, the fall in survival is departments.26 In these areas several minutes may elapse before more gradual and averages 3–4% per minute from collapse to resuscitation teams arrive with a defibrillator and deliver shocks. defibrillation3,4,12 ; bystander CPR can double3,4,13 or triple14 sur- Despite limited evidence, AEDs should be considered for the hospi- vival from witnessed out-of-hospital cardiac arrest. Resuscitation tal setting as a way to facilitate early defibrillation (a goal of <3 min instructions given by the ambulance service before the arrival of from collapse), especially in areas where healthcare providers have trained help increase the quantity and quality of bystander CPR15,16 no rhythm recognition skills or where they use defibrillators infre- and use of video instructions by phone may improve performance quently. An effective system for training and retraining should be further.17,18 in place.11 Enough healthcare providers should be trained to enable All healthcare providers with a duty to perform CPR should be achievement of the goal of providing the first shock within 3 min trained, equipped, and encouraged to perform defibrillation and of collapse anywhere in the hospital. Hospitals should monitor CPR. Early defibrillation should be available throughout all hospi- collapse-to-first shock intervals and monitor resuscitation out- tals, outpatient medical facilities and public areas of mass gathering comes. (see Section 2).19 Those trained in the use of an AED should also be trained to deliver high-quality CPR before arrival of ALS providers Shock in manual versus semi-automatic mode so that the effectiveness of early defibrillation can be optimised. Many AEDs can be operated in both manual and semi-automatic mode but few studies have compared these two options. The semi- Automated external defibrillators automatic mode has been shown to reduce time to first shock when used both in-hospital27 and pre-hospital28 settings, and results Automated external defibrillators are sophisticated, reliable in higher VF conversion rates,28 and delivery of fewer inappro- computerised devices that use voice and visual prompts to guide priate shocks.29 Conversely, semi-automatic modes result in less lay rescuers and healthcare professionals to safely attempt defib- time spent performing chest compressions29,30 mainly because of rillation in cardiac arrest victims. Some AEDs combine guidance for a longer pre-shock pause associated with automated rhythm anal- defibrillation with guidance for the delivery of optimal chest com- ysis. Despite these differences, no overall difference in return of pressions. Use of AEDs by lay or non-healthcare rescuers is covered spontaneous circulation (ROSC), survival, or discharge rate from in Section 2.19 hospital has been demonstrated in any study.23,27,28 The defibrilla- In many situations, an AED is used to provide initial defibrillation tion mode that affords the best outcome will depend on the system, but is subsequently swapped for a manual defibrillator on arrival skills, training and ECG recognition skills of rescuers. A shorter pre- of EMS personnel. If such a swap is done without considering the shock pause and lower total hands-off-ratio increases vital organ phase the AED cycle is in, the next shock may be delayed, which perfusion and the probability of ROSC.31–33 With manual defibril- may compromise outcome.20 For this reason, EMS personnel should lators and some AEDs it is possible to perform chest compressions leave the AED connected while securing airway and IV access. The during charging and thereby reduce the pre-shock pause to less AED should be left attached for the next rhythm analysis and, if than 5 s. Trained individuals may deliver defibrillation in manual indicated, a shock delivered before the AED is swapped for a manual mode but frequent team training and ECG recognition skills are defibrillator. essential. Currently many manufacturers use product-specific electrode to defibrillator connectors, which necessitates the defibrillation pads Automated rhythm analysis also being removed and replaced with a pair compatible with the new defibrillator. Manufacturers are encouraged to collaborate and Automated external defibrillators have microprocessors that develop a universal connector that enables all defibrillation pads analyse several features of the ECG, including frequency and ampli- to be compatible with all defibrillators. This will have significant tude. Developing technology should soon enable AEDs to provide patient benefit and minimise unnecessary waste. information about frequency and depth of chest compressions dur-
- 77. C.D. Deakin et al. / Resuscitation 81 (2010) 1293–1304 1295 ing CPR that may improve basic life support (BLS) performance by compressions prevent the ventilator from delivering adequate all rescuers.34,35 tidal volumes. In this case, the ventilator is usually substituted by Automated external defibrillators have been tested extensively a ventilation bag, which can itself be left connected or detached against libraries of recorded cardiac rhythms and in many trials and removed to a distance of at least 1 m. If the ventilator tub- in adults36,37 and children.38,39 They are extremely accurate in ing is disconnected, ensure it is kept at least 1 m from the patient rhythm analysis. Although most AEDs are not designed to deliver or, better still, switch the ventilator off; modern ventilators gen- synchronised shocks, all AEDs will recommend shocks for VT if the erate massive oxygen flows when disconnected. During normal rate and R-wave morphology and duration exceeds preset values. use, when connected to a tracheal tube, oxygen from a ventilator Most AEDs require a ‘hands-off’ period while the device analyses in the critical care unit will be vented from the main ventilator the rhythm. This ‘hands-off’ period results in interruption to chest housing well away from the defibrillation zone. Patients in the compressions for varying but significant periods of time40 ; a factor critical care unit may be dependent on positive end expiratory shown to have significant adverse impact on outcome from car- pressure (PEEP) to maintain adequate oxygenation; during car- diac arrest.41 Manufacturers of these devices should make every dioversion, when the spontaneous circulation potentially enables effort to develop software that minimises this analysis period to blood to remain well oxygenated, it is particularly appropriate to ensure that interruptions to external chest compressions are kept leave the critically ill patient connected to the ventilator during to a minimum. shock delivery. • Minimise the risk of sparks during defibrillation. Self-adhesive defibrillation pads are less likely to cause sparks than manual Strategies before defibrillation paddles. Minimising the pre-shock pause Some early versions of the LUCAS external chest compression device are driven by high flow rates of oxygen which discharges The delay between stopping chest compressions and delivery of waste gas over the patient’s chest. High ambient levels of oxygen the shock (the pre-shock pause) must be kept to an absolute mini- over the chest have been documented using this device, particularly mum; even 5–10 s delay will reduce the chances of the shock being in relatively confined spaces such as the back of the ambulance and successful.31,32,42 The pre-shock pause can easily be reduced to less caution should be used when defibrillating patients while using the than 5 s by continuing compressions during charging of the defib- oxygen-powered model.52 rillator and by having an efficient team coordinated by a leader who communicates effectively. The safety check to ensure that The technique for electrode contact with the chest nobody is in contact with the patient at the moment of defibril- lation should be undertaken rapidly but efficiently. The negligible Optimal defibrillation technique aims to deliver current across risk of a rescuer receiving an accidental shock is minimised even the fibrillating myocardium in the presence of minimal transtho- further if all rescuers wear gloves.43 The post-shock pause is min- racic impedance. Transthoracic impedance varies considerably imised by resuming chest compressions immediately after shock with body mass, but is approximately 70–80 in adults.53,54 The delivery (see below). The entire process of defibrillation should be techniques described below aim to place external electrodes (pad- achievable with no more than a 5 s interruption to chest compres- dles or self-adhesive pads) in an optimal position using techniques sion. that minimise transthoracic impedance. Safe use of oxygen during defibrillation Shaving the chest In an oxygen-enriched atmosphere, sparking from poorly Patients with a hairy chest have poor electrode-to-skin electri- applied defibrillator paddles can cause a fire.44–49 There are several cal contact and air trapping beneath the electrode. This causes high reports of fires being caused in this way and most have resulted impedance, reduced defibrillation efficacy, risk of arcing (sparks) in significant burns to the patient. There are no case reports of from electrode-to-skin and electrode to electrode and is more fires caused by sparking where defibrillation was delivered using likely to cause burns to the patient’s chest. Rapid shaving of the adhesive pads. In two manikin studies the oxygen concentration area of intended electrode placement may be necessary, but do in the zone of defibrillation was not increased when ventilation not delay defibrillation if a shaver is not immediately available. devices (bag-valve device, self-inflating bag, modern intensive care Shaving the chest per se may reduce transthoracic impedance unit ventilator) were left attached to a tracheal tube or the oxygen slightly and has been recommended for elective DC cardioversion source was vented at least 1 m behind the patient’s mouth.50,51 One with monophasic defibrillators,55 although the efficacy of biphasic study described higher oxygen concentrations and longer washout impedance-compensated waveforms may not be so susceptible to periods when oxygen is administered in confined spaces without higher transthoracic impedance.56 adequate ventilation.52 The risk of fire during attempted defibrillation can be minimised Paddle force by taking the following precautions: If using paddles, apply them firmly to the chest wall. This • Take off any oxygen mask or nasal cannulae and place them at reduces transthoracic impedance by improving electrical contact least 1 m away from the patient’s chest. at the electrode–skin interface and reducing thoracic volume.57 • Leave the ventilation bag connected to the tracheal tube or supra- The defibrillator operator should always press firmly on handheld glottic airway device. Alternatively, disconnect any bag-valve electrode paddles, the optimal force being 8 kg in adult and 5 kg in device from the tracheal tube or supraglottic airway device and children 1–8 years using adult paddles.58 Eight kilogram force may remove it at least 1 m from the patient’s chest during defibrilla- be attainable only by the strongest members of the cardiac arrest tion. team and therefore it is recommended that these individuals apply • If the patient is connected to a ventilator, for example in the the paddles during defibrillation. Unlike self-adhesive pads, manual operating room or critical care unit, leave the ventilator tubing paddles have a bare metal plate that requires a conductive material (breathing circuit) connected to the tracheal tube unless chest placed between the metal and patient’s skin to improve electrical
- 78. 1296 C.D. Deakin et al. / Resuscitation 81 (2010) 1293–1304 contact. Use of bare-metal paddles alone creates high transthoracic • Traditional antero-apical position. impedance and is likely to increase the risk of arcing and worsen • Antero-posterior position (one electrode anteriorly, over the left cutaneous burns from defibrillation. precordium, and the other electrode posteriorly to the heart just inferior to the left scapula). Electrode position Respiratory phase No human studies have evaluated the electrode position as a Transthoracic impedance varies during respiration, being min- determinant of ROSC or survival from VF/VT cardiac arrest. Trans- imal at end-expiration. If possible, defibrillation should be myocardial current during defibrillation is likely to be maximal attempted at this phase of the respiratory cycle. Positive end expira- when the electrodes are placed so that the area of the heart that tory pressure (PEEP) increases transthoracic impedance and should is fibrillating lies directly between them (i.e. ventricles in VF/VT, be minimised during defibrillation. Auto-PEEP (gas trapping) may atria in AF). Therefore, the optimal electrode position may not be be particularly high in asthmatics and may necessitate higher than the same for ventricular and atrial arrhythmias. usual energy levels for defibrillation.69 More patients are presenting with implantable medical devices (e.g., permanent pacemaker, implantable cardioverter defibrillator (ICD)). Medic Alert bracelets are recommended for these patients. Electrode size These devices may be damaged during defibrillation if current is discharged through electrodes placed directly over the device.59,60 The Association for the Advancement of Medical Instrumen- Place the electrode away from the device (at least 8 cm)59 or use an tation recommends a minimum electrode size of for individual alternative electrode position (anterior-lateral, anterior-posterior) electrodes and the sum of the electrode areas should be a minimum as described below. of 150 cm2 .70 Larger electrodes have lower impedance, but exces- Transdermal drug patches may prevent good electrode contact, sively large electrodes may result in less transmyocardial current causing arcing and burns if the electrode is placed directly over the flow.71 patch during defibrillation.61,62 Remove medication patches and For adult defibrillation, both handheld paddle electrodes and wipe the area before applying the electrode. self-adhesive pad electrodes 8–12 cm in diameter are used and function well. Defibrillation success may be higher with electrodes of 12 cm diameter compared with those of 8 cm diameter.54,72 Placement for ventricular arrhythmias and cardiac arrest Standard AEDs are suitable for use in children over the age of 8 Place electrodes (either pads or paddles) in the conventional years. In children between 1 and 8 years use paediatric pads with sternal-apical position. The right (sternal) electrode is placed to an attenuator to reduce delivered energy or a paediatric mode if the right of the sternum, below the clavicle. The apical pad- they are available; if not, use the unmodified machine, taking care dle is placed in the left mid-axillary line, approximately level to ensure that the adult pads do not overlap. Use of AEDs is not with the V6 ECG electrode or female breast. This position should recommended in children less than 1 year. be clear of any breast tissue. It is important that this electrode is placed sufficiently laterally. Other acceptable pad positions Coupling agents include If using manual paddles, disposable gel pads should be used to • Placement of each electrode on the lateral chest walls, one on the reduce impedance at the electrode–skin interface. Electrode pastes right and the other on the left side (bi-axillary). and gels can spread between the two paddles, creating the potential • One electrode in the standard apical position and the other on the for a spark and should not be used. Do not use bare electrodes with- right upper back. out gel pads because the resultant high transthoracic impedance • One electrode anteriorly, over the left precordium, and the other may impair the effectiveness of defibrillation, increase the sever- electrode posteriorly to the heart just inferior to the left scapula. ity of any cutaneous burns and risk arcing with subsequent fire or explosion. It does not matter which electrode (apex/sternum) is placed in Pads versus paddles either position. Transthoracic impedance has been shown to be minimised Self-adhesive defibrillation pads have practical benefits over when the apical electrode is not placed over the female breast.63 paddles for routine monitoring and defibrillation.73–77 They are Asymmetrically shaped apical electrodes have a lower impedance safe and effective and are preferable to standard defibrillation when placed longitudinally rather than transversely.64 paddles.72 Consideration should be given to use of self-adhesive pads in peri-arrest situations and in clinical situations where Placement for atrial arrhythmias patient access is difficult. They have a similar transthoracic Atrial fibrillation is maintained by functional re-entry circuits impedance71 (and therefore efficacy)78,79 to manual paddles and anchored in the left atrium. As the left atrium is located pos- enable the operator to defibrillate the patient from a safe distance teriorly in the thorax, electrode positions that result in a more rather than leaning over the patient as occurs with paddles. When posterior current pathway may theoretically be more effective used for initial monitoring of a rhythm, both pads and paddles for atrial arrhythmias. Although some studies have shown that enable quicker delivery of the first shock compared with standard antero-posterior electrode placement is more effective than the ECG electrodes, but pads are quicker than paddles.80 traditional antero-apical position in elective cardioversion of atrial When gel pads are used with paddles, the electrolyte gel fibrillation,65,66 the majority have failed to demonstrate any clear becomes polarised and thus is a poor conductor after defibrillation. advantage of any specific electrode position.67,68 Efficacy of car- This can cause spurious asystole that may persist for 3–4 min when dioversion may be less dependent on electrode position when using used to monitor the rhythm; a phenomenon not reported with biphasic impedance-compensated waveforms.56 The following self-adhesive pads.74,81 When using a gel pad/paddle combination electrode positions all appear safe and effective for cardioversion confirm a diagnosis of asystole with independent ECG electrodes of atrial arrhythmias: rather than the paddles.
- 79. C.D. Deakin et al. / Resuscitation 81 (2010) 1293–1304 1297 Fibrillation waveform analysis necessary to assess the rhythm and deliver a shock. The AED oper- ator should be prepared to deliver a shock as soon as analysis is It is possible to predict, with varying reliability, the success of complete and the shock is advised, ensuring no rescuer is in contact defibrillation from the fibrillation waveform.82–101 If optimal defib- with the victim. rillation waveforms and the optimal timing of shock delivery can be determined in prospective studies, it should be possible to pre- Delivery of defibrillation vent the delivery of unsuccessful high energy shocks and minimise myocardial injury. This technology is under active development and investigation but current sensitivity and specificity is insuf- One-shock versus three-stacked shock sequence ficient to enable introduction of VF waveform analysis into clinical practice. A major change in the 2005 guidelines was the recommendation to give single rather than three-stacked shocks. This was because CPR versus defibrillation as the initial treatment animal studies had shown that relatively short interruptions in external chest compression to deliver rescue breaths114,115 or per- A number of studies have examined whether a period of CPR form rhythm analysis33 were associated with post-resuscitation prior to defibrillation is beneficial, particularly in patients with myocardial dysfunction and reduced survival. Interruptions in an unwitnessed arrest or prolonged collapse without resuscita- external chest compression also reduced the chances of converting tion. A review of evidence for the 2005 guidelines resulted in VF to another rhythm.32 Analysis of CPR performance during out- the recommendation that it was reasonable for EMS personnel of-hospital34,116 and in-hospital35 cardiac arrest also showed that to give a period of about 2 min of CPR (i.e. about five cycles significant interruptions were common, with chest compressions at 30:2) before defibrillation in patients with prolonged collapse comprising no more than 51–76%34,35 of total CPR time. (>5 min).1 This recommendation was based on clinical studies With first shock efficacy of biphasic waveforms generally where response times exceeded 4–5 min, a period of 1.5–3 min exceeding 90%,117–120 failure to cardiovert VF successfully is more of CPR by paramedics or EMS physicians before shock delivery likely to suggest the need for a period of CPR rather than a further improved ROSC, survival to hospital discharge102,103 and one year shock. Even if the defibrillation attempt is successful in restoring a survival103 for adults with out-of-hospital VF/VT compared with perfusing rhythm, it is very rare for a pulse to be palpable immedi- immediate defibrillation. In some animal studies of VF lasting at ately after defibrillation and the delay in trying to palpate a pulse least 5 min, CPR before defibrillation improved haemodynamics will further compromise the myocardium if a perfusing rhythm has and survival.103–106 A recent ischaemic swine model of cardiac not been restored.40 arrest showed a decreased survival after pre-shock CPR.107 Subsequent studies have shown a significantly lower hands- In contrast, two randomized controlled trials, a period of off-ratio with the one-shock protocol121 and some,41,122,123 but 1.5–3 min of CPR by EMS personnel before defibrillation did not not all,121,124 have suggested a significant survival benefit from improve ROSC or survival to hospital discharge in patients with out- this single-shock strategy. However, all studies except one124 were of-hospital VF/VT, regardless of EMS response interval.108,109 Four before-after studies and all introduced multiple changes in the pro- other studies have also failed to demonstrate significant improve- tocol, making it difficult to attribute a possible survival benefit to ments in overall ROSC or survival to hospital discharge with an one of the changes. initial period of CPR,102,103,110,111 although one did show a higher When defibrillation is warranted, give a single shock and resume rate of favourable neurological outcome at 30 days and one year chest compressions immediately following the shock. Do not delay after cardiac arrest.110 CPR for rhythm reanalysis or a pulse check immediately after a The duration of collapse is frequently difficult to estimate accu- shock. Continue CPR (30 compressions:2 ventilations) for 2 min rately and there is evidence that performing chest compressions until rhythm reanalysis is undertaken and another shock given (if while retrieving and charging a defibrillator improves the proba- indicated) (see Section 4 advanced life support).113 This single- bility of survival.112 For these reasons, in any cardiac arrest they shock strategy is applicable to both monophasic and biphasic have not witnessed, EMS personnel should provide good-quality defibrillators. CPR while a defibrillator is retrieved, applied and charged, but rou- If VF/VT occurs during cardiac catheterisation or in the early tine delivery of a pre-specified period of CPR (e.g., 2 or 3 min) before post-operative period following cardiac surgery (when chest com- rhythm analysis and a shock is delivered is not recommended. pressions could disrupt vascular sutures), consider delivering up Some EMS systems have already fully implemented a pre-specified to three-stacked shocks before starting chest compressions (see period of chest compressions before defibrillation; given the lack Section 8 special circumstances).125 This three-shock strategy may of convincing data either supporting or refuting this strategy, it is also be considered for an initial, witnessed VF/VT cardiac arrest if reasonable for them to continue this practice. the patient is already connected to a manual defibrillator. Although In hospital environments, settings with an AED on-site and there are no data supporting a three-shock strategy in any of these available (including lay responders), or EMS-witnessed events, circumstances, it is unlikely that chest compressions will improve defibrillation should be performed as soon as the defibrillator the already very high chance of return of spontaneous circulation is available. Chest compressions should be performed until just when defibrillation occurs early in the electrical phase, immedi- before the defibrillation attempt (see Section 4 advanced life ately after onset of VF. support).113 The importance of early, uninterrupted chest compressions is Waveforms emphasised throughout these guidelines. In practice, it is often dif- ficult to ascertain the exact time of collapse and, in any case, CPR Historically, defibrillators delivering a monophasic pulse had should be started as soon as possible. The rescuer providing chest been the standard of care until the 1990s. Monophasic defibrillators compressions should interrupt chest compressions only for ven- deliver current that is unipolar (i.e. one direction of current flow) tilations, rhythm analysis and shock delivery, and should resume (Fig. 3.1). Monophasic defibrillators were particularly susceptible chest compressions as soon as a shock is delivered. When two res- to waveform modification depending on transthoracic impedance. cuers are present, the rescuer operating the AED should apply the Small patients with minimal transthoracic impedance received electrodes whilst CPR is in progress. Interrupt CPR only when it is considerably greater transmyocardial current than larger patients,
- 80. 1298 C.D. Deakin et al. / Resuscitation 81 (2010) 1293–1304 Fig. 3.1. Monophasic damped sinusoidal waveform (MDS). Fig. 3.3. Rectilinear biphasic waveform (RLB). Monophasic versus biphasic defibrillation where not only was the current less, but the waveform lengthened to the extent that its efficacy was reduced. Although biphasic waveforms are more effective at terminating Monophasic defibrillators are no longer manufactured, and ventricular arrhythmias at lower energy levels, have demonstrated although many will remain in use for several years, biphasic defib- greater first shock efficacy than monophasic waveforms, and have rillators have now superseded them. Biphasic defibrillators deliver greater first shock efficacy for long duration VF/VT,128–130 no current that flows in a positive direction for a specified duration randomised studies have demonstrated superiority in terms of neu- before reversing and flowing in a negative direction for the remain- rologically intact survival to hospital discharge. ing milliseconds of the electrical discharge. There are two main Some,119,128–133 but not all,134 studies suggest the biphasic types of biphasic waveform: the biphasic truncated exponential waveform improves short-term outcomes of VF termination com- (BTE) (Fig. 3.2) and rectilinear biphasic (RLB) (Fig. 3.3). Biphasic pared with monophasic defibrillation. defibrillators compensate for the wide variations in transthoracic Biphasic waveforms have been shown to be superior to impedance by electronically adjusting the waveform magnitude monophasic waveforms for elective cardioversion of atrial fibril- and duration to ensure optimal current delivery to the myocardium, lation, with greater overall success rates, using less cumulative irrespective of the patient’s size. energy and reducing the severity of cutaneous burns,135–138 and A pulsed biphasic waveform has recently been described in are the waveform of choice for this procedure. which the current rapidly oscillates between baseline and a pos- itive value before inverting in a negative pattern. This waveform is also in clinical use. It may have a similar efficacy as other biphasic Multiphasic versus biphasic defibrillation waveforms, but the single clinical study of this waveform was not performed with an impedance compensating device.126,127 There A number of multiphasic waveforms (e.g. triphasic, quadripha- are several other different biphasic waveforms, all with no clini- sic, multiphasic) have also been trialled in animal studies. Animal cal evidence of superiority for any individual waveform compared data suggest that multiphasic waveforms may defibrillate at lower with another. energies and induce less post-shock myocardial dysfunction.139–141 All manual defibrillators and AEDs that allow manual override These results are limited by studies of short duration of VF (approx- of energy levels should be labelled to indicate their waveform imately 30 s) and lack of human studies for validation. At present, (monophasic or biphasic) and recommended energy levels for there are no human studies comparing a multiphasic waveform attempted defibrillation of VF/VT. with biphasic waveforms for defibrillation and no defibrillator cur- rently available uses multiphasic waveforms. Energy levels Defibrillation requires the delivery of sufficient electrical energy to defibrillate a critical mass of myocardium, abolish the wavefronts of VF and enable restoration of spontaneous synchronized electrical activity in the form of an organised rhythm. The optimal energy for defibrillation is that which achieves defibrillation whilst causing the minimum of myocardial damage.142 Selection of an appropriate energy level also reduces the number of repetitive shocks, which in turn limits myocardial damage.143 Optimal energy levels for both monophasic and biphasic wave- forms are unknown. The recommendations for energy levels are based on a consensus following careful review of the current literature. Although energy levels are selected for defibrillation, Fig. 3.2. Biphasic truncated exponential waveform (BTE). it is the transmyocardial current flow that achieves defibrilla-
- 81. C.D. Deakin et al. / Resuscitation 81 (2010) 1293–1304 1299 tion. Current correlates well with successful defibrillation and cantly different between strategies.150,151 Conversely, a fixed-dose cardioversion.144 The optimal current for defibrillation using a biphasic protocol demonstrated high cardioversion rates (>90%) monophasic waveform is in the range of 30–40 A. Indirect evidence with a three-shock fixed dose protocol but the small number of from measurements during cardioversion for atrial fibrillation cases did not exclude a significant lower ROSC rate for recurrent suggests that the current during defibrillation using biphasic wave- VF.159 Several in-hospital studies using an escalating shock energy forms is in the range of 15–20 A.137 Future technology may enable strategy have demonstrated improvement in cardioversion rates defibrillators to discharge according to transthoracic current; a (compared with fixed dose protocols) in non-arrest rhythms with strategy that may lead to greater consistency in shock success. the same level of energy selected for both biphasic and monophasic Peak current amplitude, average current and phase duration all waveforms.135,137,160–163 need to be studied to determine optimal values and manufacturers are encouraged to explore further this move from energy-based to current-based defibrillation. Monophasic defibrillators Because the initial shock has been unsuccessful at 360 J, second and subsequent shocks should all be delivered at 360 J. First shock Monophasic defibrillators Biphasic defibrillators There are no new published studies looking at the optimal There is no evidence to support either a fixed or escalating energy levels for monophasic waveforms since publication of the energy protocol. Both strategies are acceptable; however, if the first 2005 guidelines. First shock efficacy for long duration cardiac arrest shock is not successful and the defibrillator is capable of delivering using monophasic defibrillation has been reported as 54–63% for shocks of higher energy it is reasonable to increase the energy for a 200 J monophasic truncated exponential (MTE) waveform129,145 subsequent shocks. and 77–91% using a 200 J monophasic damped sinusoidal (MDS) waveform.128–130,145 Because of the lower efficacy of this wave- form, the recommended initial energy level for the first shock using Recurrent ventricular fibrillation a monophasic defibrillator is 360 J. Although higher energy levels If a shockable rhythm recurs after successful defibrillation with risk a greater degree of myocardial injury, the benefits of earlier ROSC, give the next shock with the energy level that had previously conversion to a perfusing rhythm are paramount. Atrioventricular been successful. block is more common with higher monophasic energy levels, but is generally transient and has been shown not to affect survival Other related defibrillation topics to hospital discharge.146 Only one of 27 animal studies demon- strated harm caused by attempted defibrillation using high energy shocks.147 Defibrillation of children Biphasic defibrillators Cardiac arrest is less common in children. Common causes of VF Relatively few studies have been published in the past 5 years in children include trauma, congenital heart disease, long QT inter- on which to refine the 2005 guidelines. There is no evidence that val, drug overdose and hypothermia.164–166 Ventricular fibrillation one biphasic waveform or device is more effective than another. is relatively rare compared with adult cardiac arrest, occurring in 7- First shock efficacy of the BTE waveform using 150–200 J has been 15% of paediatric and adolescent arrests.166–171 Rapid defibrillation reported as 86–98%.128,129,145,148,149 First shock efficacy of the RLB of these patients may improve outcome.171,172 waveform using 120 J is up to 85% (data not published in the paper The optimal energy level, waveform and shock sequence is but supplied by personnel communication).130 First shock efficacy unknown but as with adults, biphasic shocks appear to be at least as of a new pulsed biphasic waveform at 130 J showed a first shock effective as, and less harmful than, monophasic shocks.173–175 The success rate of 90%.126 Two studies have suggested equivalence upper limit for safe defibrillation is unknown, but doses in excess with lower and higher starting energy biphasic defibrillation.150,151 of the previously recommended maximum of 4 J kg−1 (as high as Although human studies have not shown harm (raised biomarkers, 9 J kg−1 ) have defibrillated children effectively without significant ECG changes, ejection fraction) from any biphasic waveform up to adverse effects.38,176,177 360 J,150,152 several animal studies have suggested the potential for The recommended energy levels for manual monophasic defib- harm with higher energy levels.153–156 rillation are 4 J kg−1 for the initial shock and subsequent shocks. The initial biphasic shock should be no lower than 120 J for RLB The same energy levels are recommended for manual biphasic waveforms and 150 J for BTE waveforms. Ideally, the initial biphasic defibrillation.178 As with adults, if a shockable rhythm recurs, use shock energy should be at least 150 J for all waveforms. the energy level for defibrillation that had previously been success- Manufacturers should display the effective waveform dose ful. range on the face of the biphasic defibrillator; older monophasic For defibrillation of children above the age of 8 years, an defibrillators should also be marked clearly with the appropriate AED with standard electrodes is used and standard energy set- dose range. If the rescuer is unaware of the recommended energy tings accepted. For defibrillation of children between 1 and 8 settings of the defibrillator, use the highest setting for all shocks. years, special paediatric electrodes and energy attenuators are recommended; these reduce the delivered energy to a level that Second and subsequent shocks approaches that of the energy recommended for manual defibrilla- tors. When these electrodes are not available, an AED with standard The 2005 guidelines recommended either a fixed or escalating electrodes should be used. For defibrillation of children below 1 energy strategy for defibrillation. Subsequent to these recommen- year of age, an AED, is not recommended; however, there are a few dations, several studies have demonstrated that although an esca- case reports describing the use of AEDs in children aged less than lating strategy reduces the number of shocks required to restore 1 year.179,180 The incidence of shockable rhythms in infants is very an organised rhythm compared with fixed-dose biphasic defib- low except when there is cardiac disease167,181,182 ; in these rare rillation, and may be needed for successful defibrillation,157,158 cases, if an AED is the only defibrillator available, its use should be rates of ROSC or survival to hospital discharge are not signifi- considered (preferably with dose attenuator).
- 82. 1300 C.D. Deakin et al. / Resuscitation 81 (2010) 1293–1304 Cardioversion Pacing If electrical cardioversion is used to convert atrial or ventric- Consider pacing in patients with symptomatic bradycardia ular tachyarrhythmias, the shock must be synchronised to occur refractory to anti-cholinergic drugs or other second line ther- with the R wave of the electrocardiogram rather than with the T apy (see Section 4).113 Immediate pacing is indicated especially wave: VF can be induced if a shock is delivered during the relative when the block is at or below the His-Purkinje level. If transtho- refractory portion of the cardiac cycle.183 Synchronisation can be racic pacing is ineffective, consider transvenous pacing. Whenever difficult in VT because of the wide-complex and variable forms of a diagnosis of asystole is made, check the ECG carefully for the ventricular arrhythmia. Inspect the synchronisation marker care- presence of P waves because this will likely respond to cardiac fully for consistent recognition of the R wave. If needed, choose pacing. The use of epicardial wires to pace the myocardium fol- another lead and/or adjust the amplitude. If synchronisation fails, lowing cardiac surgery is effective and discussed elsewhere. Do not give unsynchronised shocks to the unstable patient in VT to avoid attempt pacing for asystole unless P waves are present; it does not prolonged delay in restoring sinus rhythm. Ventricular fibrillation increase short or long-term survival in- or out-of-hospital.193–201 or pulseless VT requires unsynchronised shocks. Conscious patients For haemodynamically unstable, conscious patients with brad- must be anaesthetised or sedated before attempting synchronised yarrhythmias, percussion pacing as a bridge to electrical pacing cardioversion. may be attempted, although its effectiveness has not been estab- lished. Atrial fibrillation Implantable cardioverter defibrillators Optimal electrode position has been discussed previously, but anterolateral and antero-posterior are both acceptable positions. Implantable cardioverter defibrillators (ICDs) are becoming Biphasic waveforms are more effective than monophasic wave- increasingly common as the devices are implanted more frequently forms for cardioversion of AF135–138 ; and cause less severe skin as the population ages. They are implanted because a patient is con- burns.184 When available, a biphasic defibrillator should be used sidered to be at risk from, or has had, a life-threatening shockable in preference to a monophasic defibrillator. Differences in biphasic arrhythmia and are usually embedded under the pectoral mus- waveforms themselves have not been established. cle below the left clavicle (in a similar position to pacemakers, from which they cannot be immediately distinguished). On sens- Monophasic waveforms ing a shockable rhythm, an ICD will discharge approximately 40 J through an internal pacing wire embedded in the right ventricle. A study of electrical cardioversion for atrial fibrillation indicated On detecting VF/VT, ICD devices will discharge no more than eight that 360 J monophasic damped sinusoidal (MDS) shocks were more times, but may reset if they detect a new period of VF/VT. Patients effective than 100 or 200 J MDS shocks.185 Although a first shock with fractured ICD leads may suffer repeated internal defibrillation of 360 J reduces overall energy requirements for cardioversion,185 as the electrical noise is mistaken for a shockable rhythm; in these 360 J may cause greater myocardial damage and skin burns than circumstances, the patient is likely to be conscious, with the ECG occurs with lower monophasic energy levels and this must be taken showing a relatively normal rate. A magnet placed over the ICD will into consideration. Commence synchronised cardioversion of atrial disable the defibrillation function in these circumstances. fibrillation using an initial energy level of 200 J, increasing in a Discharge of an ICD may cause pectoral muscle contraction in stepwise manner as necessary. the patient, and shocks to the rescuer have been documented.202 In view of the low energy levels discharged by ICDs, it is unlikely that any harm will come to the rescuer, but the wearing of gloves and Biphasic waveforms minimising contact with the patient whilst the device is discharging is prudent. Cardioverter and pacing function should always be re- More data are needed before specific recommendations can evaluated following external defibrillation, both to check the device be made for optimal biphasic energy levels. Commencing at high itself and to check pacing/defibrillation thresholds of the device energy levels has not shown to result in more successful cardiover- leads. sion rates compared to lower energy levels.135,186–191 An initial Pacemaker spikes generated by devices programmed to unipo- synchronised shock of 120–150 J, escalating if necessary is a rea- lar pacing may confuse AED software and emergency personnel, sonable strategy based on current data. and may prevent the detection of VF.203 The diagnostic algorithms of modern AEDs are insensitive to such spikes. Atrial flutter and paroxysmal supraventricular tachycardia References Atrial flutter and paroxysmal SVT generally require less energy than atrial fibrillation for cardioversion.190 Give an initial shock 1. Deakin CD, Nolan JP. European Resuscitation Council guidelines for of 100 J monophasic or 70–120 J biphasic. Give subsequent shocks resuscitation 2005. Section 3. Electrical therapies: automated external defib- using stepwise increases in energy.144 rillators, defibrillation, cardioversion and pacing. Resuscitation 2005;67(Suppl. 1):S25–37. 2. Proceedings of the 2005 International Consensus on Cardiopulmonary Resuscitation and Emergency Cardiovascular Care Science with Treatment Rec- Ventricular tachycardia ommendations. Resuscitation 2005;67:157–341. 3. Larsen MP, Eisenberg MS, Cummins RO, Hallstrom AP. Predicting survival The energy required for cardioversion of VT depends on the from out-of-hospital cardiac arrest: a graphic model. Ann Emerg Med 1993;22:1652–8. morphological characteristics and rate of the arrhythmia.192 Ven- 4. Valenzuela TD, Roe DJ, Cretin S, Spaite DW, Larsen MP. Estimating effectiveness tricular tachycardia with a pulse responds well to cardioversion of cardiac arrest interventions: a logistic regression survival model. Circulation using initial monophasic energies of 200 J. Use biphasic energy lev- 1997;96:3308–13. 5. Waalewijn RA, de Vos R, Tijssen JG, Koster RW. Survival models for out-of- els of 120–150 J for the initial shock. Consider stepwise increases if hospital cardiopulmonary resuscitation from the perspectives of the bystander, the first shock fails to achieve sinus rhythm.192 the first responder, and the paramedic. Resuscitation 2001;51:113–22.
- 83. C.D. Deakin et al. / Resuscitation 81 (2010) 1293–1304 1301 6. Weisfeldt ML, Sitlani CM, Ornato JP, et al. Survival after application of auto- arrhythmia analysis algorithm performance, incorporating new waveforms, matic external defibrillators before arrival of the emergency medical system: and enhancing safety. A statement for health professionals from the American evaluation in the resuscitation outcomes consortium population of 21 million. Heart Association Task Force on Automatic External Defibrillation, Subcom- J Am Coll Cardiol 2010;55:1713–20. mittee on AED Safety and Efficacy. Circulation 1997;95:1677–82. 7. Myerburg RJ, Fenster J, Velez M, et al. Impact of community-wide police 37. Dickey W, Dalzell GW, Anderson JM, Adgey AA. The accuracy of decision- car deployment of automated external defibrillators on survival from out-of- making of a semi-automatic defibrillator during cardiac arrest. Eur Heart J hospital cardiac arrest. Circulation 2002;106:1058–64. 1992;13:608–15. 8. Capucci A, Aschieri D, Piepoli MF, Bardy GH, Iconomu E, Arvedi M. Tripling 38. Atkinson E, Mikysa B, Conway JA, et al. Specificity and sensitivity of automated survival from sudden cardiac arrest via early defibrillation without traditional external defibrillator rhythm analysis in infants and children. Ann Emerg Med education in cardiopulmonary resuscitation. Circulation 2002;106:1065–70. 2003;42:185–96. 9. van Alem AP, Vrenken RH, de Vos R, Tijssen JG, Koster RW. Use of auto- 39. Cecchin F, Jorgenson DB, Berul CI, et al. Is arrhythmia detection by automatic mated external defibrillator by first responders in out of hospital cardiac arrest: external defibrillator accurate for children? Sensitivity and specificity of an prospective controlled trial. BMJ 2003;327:1312. automatic external defibrillator algorithm in 696 pediatric arrhythmias. Circu- 10. Valenzuela TD, Bjerke HS, Clark LL, et al. Rapid defibrillation by nontraditional lation 2001;103:2483–8. responders: the Casino Project. Acad Emerg Med 1998;5:414–5. 40. van Alem AP, Sanou BT, Koster RW. Interruption of cardiopulmonary resusci- 11. Spearpoint KG, Gruber PC, Brett SJ. Impact of the Immediate Life Support course tation with the use of the automated external defibrillator in out-of-hospital on the incidence and outcome of in-hospital cardiac arrest calls: an observa- cardiac arrest. Ann Emerg Med 2003;42:449–57. tional study over 6 years. Resuscitation 2009;80:638–43. 41. Rea TD, Helbock M, Perry S, et al. Increasing use of cardiopulmonary resuscita- 12. Waalewijn RA, Tijssen JG, Koster RW. Bystander initiated actions in out- tion during out-of-hospital ventricular fibrillation arrest: survival implications of-hospital cardiopulmonary resuscitation: results from the Amsterdam of guideline changes. Circulation 2006;114:2760–5. Resuscitation Study (ARREST). Resuscitation 2001;50:273–9. 42. Gundersen K, Kvaloy JT, Kramer-Johansen J, Steen PA, Eftestol T. Development 13. Swor RA, Jackson RE, Cynar M, et al. Bystander CPR, ventricular fibrillation, and of the probability of return of spontaneous circulation in intervals without survival in witnessed, unmonitored out-of-hospital cardiac arrest. Ann Emerg chest compressions during out-of-hospital cardiac arrest: an observational Med 1995;25:780–4. study. BMC Med 2009;7:6. 14. Holmberg M, Holmberg S, Herlitz J. Effect of bystander cardiopulmonary resus- 43. Lloyd MS, Heeke B, Walter PF, Langberg JJ. Hands-on defibrillation: an analy- citation in out-of-hospital cardiac arrest patients in Sweden. Resuscitation sis of electrical current flow through rescuers in direct contact with patients 2000;47:59–70. during biphasic external defibrillation. Circulation 2008;117:2510–4. 15. Vaillancourt C, Verma A, Trickett J, et al. Evaluating the effectiveness of 44. Miller PH. Potential fire hazard in defibrillation. JAMA 1972;221:192. dispatch-assisted cardiopulmonary resuscitation instructions. Acad Emerg 45. Hummel III RS, Ornato JP, Weinberg SM, Clarke AM. Spark-generating proper- Med 2007;14:877–83. ties of electrode gels used during defibrillation. A potential fire hazard. JAMA 16. O’Neill JF, Deakin CD. Evaluation of telephone CPR advice for adult cardiac arrest 1988;260:3021–4. patients. Resuscitation 2007;74:63–7. 46. ECRI. Defibrillation in oxygen-enriched environments [hazard]. Health Devices 17. Yang CW, Wang HC, Chiang WC, et al. Interactive video instruction improves 1987;16:113–4. the quality of dispatcher-assisted chest compression-only cardiopulmonary 47. Lefever J, Smith A. Risk of fire when using defibrillation in an oxygen enriched resuscitation in simulated cardiac arrests. Crit Care Med 2009;37:490–5. atmosphere. Med Devices Agency Safety Notices 1995;3:1–3. 18. Yang CW, Wang HC, Chiang WC, et al. Impact of adding video communication 48. Ward ME. Risk of fires when using defibrillators in an oxygen enriched atmo- to dispatch instructions on the quality of rescue breathing in simulated cardiac sphere. Resuscitation 1996;31:173. arrests—a randomized controlled study. Resuscitation 2008;78:327–32. 49. Theodorou AA, Gutierrez JA, Berg RA. Fire attributable to a defibrillation 19. Koster RW, Baubin MA, Caballero A, et al. European Resuscitation Council attempt in a neonate. Pediatrics 2003;112:677–9. Guidelines for Resuscitation 2010. Section 2. Adult basic life support and use 50. Robertshaw H, McAnulty G. Ambient oxygen concentrations during simulated of automated external defibrillators. Resuscitation 2010;81:1277–92. cardiopulmonary resuscitation. Anaesthesia 1998;53:634–7. 20. Berdowski J, Schulten RJ, Tijssen JG, van Alem AP, Koster RW. Delaying a shock 51. Cantello E, Davy TE, Koenig KL. The question of removing a ventilation bag after takeover from the automated external defibrillator by paramedics is asso- before defibrillation. J Accid Emerg Med 1998;15:286. ciated with decreased survival. Resuscitation 2010;81:287–92. 52. Deakin CD, Paul V, Fall E, Petley GW, Thompson F. Ambient oxygen concentra- 21. Zafari AM, Zarter SK, Heggen V, et al. A program encouraging early defibril- tions resulting from use of the Lund University Cardiopulmonary Assist System lation results in improved in-hospital resuscitation efficacy. J Am Coll Cardiol (LUCAS) device during simulated cardiopulmonary resuscitation. Resuscitation 2004;44:846–52. 2007;74:303–9. 22. Destro A, Marzaloni M, Sermasi S, Rossi F. Automatic external defibrillators in 53. Kerber RE, Kouba C, Martins J, et al. Advance prediction of transtho- the hospital as well? Resuscitation 1996;31:39–43. racic impedance in human defibrillation and cardioversion: importance of 23. Forcina MS, Farhat AY, O’Neil WW, Haines DE. Cardiac arrest survival after impedance in determining the success of low-energy shocks. Circulation implementation of automated external defibrillator technology in the in- 1984;70:303–8. hospital setting. Crit Care Med 2009;37:1229–36. 54. Kerber RE, Grayzel J, Hoyt R, Marcus M, Kennedy J. Transthoracic resistance in 24. Domanovits H, Meron G, Sterz F, et al. Successful automatic external defibrilla- human defibrillation. Influence of body weight, chest size, serial shocks, paddle tor operation by people trained only in basic life support in a simulated cardiac size and paddle contact pressure. Circulation 1981;63:676–82. arrest situation. Resuscitation 1998;39:47–50. 55. Sado DM, Deakin CD, Petley GW, Clewlow F. Comparison of the effects of 25. Cusnir H, Tongia R, Sheka KP, et al. In hospital cardiac arrest: a role for automatic removal of chest hair with not doing so before external defibrillation on defibrillation. Resuscitation 2004;63:183–8. transthoracic impedance. Am J Cardiol 2004;93:98–100. 26. Chan PS, Krumholz HM, Nichol G, Nallamothu BK. Delayed time to defibrillation 56. Walsh SJ, McCarty D, McClelland AJ, et al. Impedance compensated biphasic after in-hospital cardiac arrest. N Engl J Med 2008;358:9–17. waveforms for transthoracic cardioversion of atrial fibrillation: a multi-centre 27. Cummins RO, Eisenberg MS, Litwin PE, Graves JR, Hearne TR, Hallstrom AP. comparison of antero-apical and antero-posterior pad positions. Eur Heart J Automatic external defibrillators used by emergency medical technicians: a 2005;26:1298–302. controlled clinical trial. JAMA 1987;257:1605–10. 57. Deakin CD, Sado DM, Petley GW, Clewlow F. Differential contribution of skin 28. Stults KR, Brown DD, Kerber RE. Efficacy of an automated external defibrillator impedance and thoracic volume to transthoracic impedance during external in the management of out-of-hospital cardiac arrest: validation of the diagnos- defibrillation. Resuscitation 2004;60:171–4. tic algorithm and initial clinical experience in a rural environment. Circulation 58. Deakin C, Sado D, Petley G, Clewlow F. Determining the optimal paddle force 1986;73:701–9. for external defibrillation. Am J Cardiol 2002;90:812–3. 29. Kramer-Johansen J, Edelson DP, Abella BS, Becker LB, Wik L, Steen PA. Pauses 59. Manegold JC, Israel CW, Ehrlich JR, et al. External cardioversion of atrial fib- in chest compression and inappropriate shocks: a comparison of manual and rillation in patients with implanted pacemaker or cardioverter-defibrillator semi-automatic defibrillation attempts. Resuscitation 2007;73:212–20. systems: a randomized comparison of monophasic and biphasic shock energy 30. Pytte M, Pedersen TE, Ottem J, Rokvam AS, Sunde K. Comparison of hands-off application. Eur Heart J 2007;28:1731–8. time during CPR with manual and semi-automatic defibrillation in a manikin 60. Alferness CA. Pacemaker damage due to external countershock in patients model. Resuscitation 2007;73:131–6. with implanted cardiac pacemakers. Pacing Clin Electrophysiol 1982;5: 31. Edelson DP, Abella BS, Kramer-Johansen J, et al. Effects of compression depth 457–8. and pre-shock pauses predict defibrillation failure during cardiac arrest. Resus- 61. Panacek EA, Munger MA, Rutherford WF, Gardner SF. Report of nitropatch citation 2006;71:137–45. explosions complicating defibrillation. Am J Emerg Med 1992;10:128–9. 32. Eftestol T, Sunde K, Steen PA. Effects of interrupting precordial compressions 62. Wrenn K. The hazards of defibrillation through nitroglycerin patches. Ann on the calculated probability of defibrillation success during out-of-hospital Emerg Med 1990;19:1327–8. cardiac arrest. Circulation 2002;105:2270–3. 63. Pagan-Carlo LA, Spencer KT, Robertson CE, Dengler A, Birkett C, Kerber 33. Yu T, Weil MH, Tang W, et al. Adverse outcomes of interrupted precordial RE. Transthoracic defibrillation: importance of avoiding electrode placement compression during automated defibrillation. Circulation 2002;106:368–72. directly on the female breast. J Am Coll Cardiol 1996;27:449–52. 34. Wik L, Kramer-Johansen J, Myklebust H, et al. Quality of cardiopulmonary 64. Deakin CD, Sado DM, Petley GW, Clewlow F. Is the orientation of the api- resuscitation during out-of-hospital cardiac arrest. JAMA 2005;293:299–304. cal defibrillation paddle of importance during manual external defibrillation? 35. Abella BS, Alvarado JP, Myklebust H, et al. Quality of cardiopulmonary resusci- Resuscitation 2003;56:15–8. tation during in-hospital cardiac arrest. JAMA 2005;293:305–10. 65. Kirchhof P, Eckardt L, Loh P, et al. Anterior-posterior versus anterior-lateral 36. Kerber RE, Becker LB, Bourland JD, et al. Automatic external defibrillators for electrode positions for external cardioversion of atrial fibrillation: a ran- public access defibrillation: recommendations for specifying and reporting domised trial. Lancet 2002;360:1275–9.
- 84. 1302 C.D. Deakin et al. / Resuscitation 81 (2010) 1293–1304 66. Botto GL, Politi A, Bonini W, Broffoni T, Bonatti R. External cardioversion of atrial 96. Lightfoot CB, Nremt P, Callaway CW, et al. Dynamic nature of electrocar- fibrillation: role of paddle position on technical efficacy and energy require- diographic waveform predicts rescue shock outcome in porcine ventricular ments. Heart 1999;82:726–30. fibrillation. Ann Emerg Med 2003;42:230–41. 67. Alp NJ, Rahman S, Bell JA, Shahi M. Randomised comparison of antero-lateral 97. Marn-Pernat A, Weil MH, Tang W, Pernat A, Bisera J. Optimizing timing of versus antero-posterior paddle positions for DC cardioversion of persistent ventricular defibrillation. Crit Care Med 2001;29:2360–5. atrial fibrillation. Int J Cardiol 2000;75:211–6. 98. Hamprecht FA, Achleitner U, Krismer AC, et al. Fibrillation power, an alternative 68. Mathew TP, Moore A, McIntyre M, et al. Randomised comparison of electrode method of ECG spectral analysis for prediction of countershock success in a positions for cardioversion of atrial fibrillation. Heart 1999;81:576–9. porcine model of ventricular fibrillation. Resuscitation 2001;50:287–96. 69. Deakin CD, McLaren RM, Petley GW, Clewlow F, Dalrymple-Hay MJ. Effects 99. Amann A, Achleitner U, Antretter H, et al. Analysing ventricular fibrilla- of positive end-expiratory pressure on transthoracic impedance—implications tion ECG-signals and predicting defibrillation success during cardiopulmonary for defibrillation. Resuscitation 1998;37:9–12. resuscitation employing N(alpha)-histograms. Resuscitation 2001;50:77–85. 70. American National Standard: automatic external defibrillators and remote 100. Brown CG, Griffith RF, Van Ligten P, et al. Median frequency—a new parameter controlled defibrillators (DF39). Arlington, Virgina: Association for the for predicting defibrillation success rate. Ann Emerg Med 1991;20:787–9. Advancement of Medical Instrumentation; 1993. 101. Amann A, Rheinberger K, Achleitner U, et al. The prediction of defibrillation 71. Deakin CD, McLaren RM, Petley GW, Clewlow F, Dalrymple-Hay MJ. A com- outcome using a new combination of mean frequency and amplitude in porcine parison of transthoracic impedance using standard defibrillation paddles and models of cardiac arrest. Anesth Analg 2002;95:716–22, table of contents. self-adhesive defibrillation pads. Resuscitation 1998;39:43–6. 102. Cobb LA, Fahrenbruch CE, Walsh TR, et al. Influence of cardiopulmonary resus- 72. Stults KR, Brown DD, Cooley F, Kerber RE. Self-adhesive monitor/defibrillation citation prior to defibrillation in patients with out-of-hospital ventricular pads improve prehospital defibrillation success. Ann Emerg Med fibrillation. JAMA 1999;281:1182–8. 1987;16:872–7. 103. Wik L, Hansen TB, Fylling F, et al. Delaying defibrillation to give basic cardiopul- 73. Bojar RM, Payne DD, Rastegar H, Diehl JT, Cleveland RJ. Use of self-adhesive monary resuscitation to patients with out-of-hospital ventricular fibrillation: external defibrillator pads for complex cardiac surgical procedures. Ann Thorac a randomized trial. JAMA 2003;289:1389–95. Surg 1988;46:587–8. 104. Berg RA, Hilwig RW, Kern KB, Ewy GA. Precountershock cardiopul- 74. Bradbury N, Hyde D, Nolan J. Reliability of ECG monitoring with a gel monary resuscitation improves ventricular fibrillation median frequency and pad/paddle combination after defibrillation. Resuscitation 2000;44:203–6. myocardial readiness for successful defibrillation from prolonged ventric- 75. Brown J, Rogers J, Soar J. Cardiac arrest during surgery and ventilation ular fibrillation: a randomized, controlled swine study. Ann Emerg Med in the prone position: a case report and systematic review. Resuscitation 2002;40:563–70. 2001;50:233–8. 105. Berg RA, Hilwig RW, Ewy GA, Kern KB. Precountershock cardiopulmonary 76. Perkins GD, Davies RP, Soar J, Thickett DR. The impact of manual defibrillation resuscitation improves initial response to defibrillation from prolonged ven- technique on no-flow time during simulated cardiopulmonary resuscitation. tricular fibrillation: a randomized, controlled swine study. Crit Care Med Resuscitation 2007;73:109–14. 2004;32:1352–7. 77. Wilson RF, Sirna S, White CW, Kerber RE. Defibrillation of high-risk patients 106. Kolarova J, Ayoub IM, Yi Z, Gazmuri RJ. Optimal timing for electrical defib- during coronary angiography using self-adhesive, preapplied electrode pads. rillation after prolonged untreated ventricular fibrillation. Crit Care Med Am J Cardiol 1987;60:380–2. 2003;31:2022–8. 78. Kerber RE, Martins JB, Kelly KJ, et al. Self-adhesive preapplied electrode pads 107. Indik JH, Hilwig RW, Zuercher M, Kern KB, Berg MD, Berg RA. Preshock for defibrillation and cardioversion. J Am Coll Cardiol 1984;3:815–20. cardiopulmonary resuscitation worsens outcome from circulatory phase ven- 79. Kerber RE, Martins JB, Ferguson DW, et al. Experimental evaluation and initial tricular fibrillation with acute coronary artery obstruction in swine. Circ clinical application of new self-adhesive defibrillation electrodes. Int J Cardiol Arrhythm Electrophysiol 2009;2:179–84. 1985;8:57–66. 108. Baker PW, Conway J, Cotton C, et al. Defibrillation or cardiopulmonary 80. Perkins GD, Roberts C, Gao F. Delays in defibrillation: influence of different resuscitation first for patients with out-of-hospital cardiac arrests found by monitoring techniques. Br J Anaesth 2002;89:405–8. paramedics to be in ventricular fibrillation? A randomised control trial. Resus- 81. Chamberlain D. Gel pads should not be used for monitoring ECG after defibril- citation 2008;79:424–31. lation. Resuscitation 2000;43:159–60. 109. Jacobs IG, Finn JC, Oxer HF, Jelinek GA. CPR before defibrillation in out-of- 82. Callaway CW, Sherman LD, Mosesso Jr VN, Dietrich TJ, Holt E, Clarkson MC. hospital cardiac arrest: a randomized trial. Emerg Med Aust 2005;17:39–45. Scaling exponent predicts defibrillation success for out-of-hospital ventricular 110. Hayakawa M, Gando S, Okamoto H, Asai Y, Uegaki S, Makise H. Shortening fibrillation cardiac arrest. Circulation 2001;103:1656–61. of cardiopulmonary resuscitation time before the defibrillation worsens the 83. Eftestol T, Sunde K, Aase SO, Husoy JH, Steen PA. Predicting outcome of outcome in out-of-hospital VF patients. Am J Emerg Med 2009;27:470–4. defibrillation by spectral characterization and nonparametric classification of 111. Bradley SM, Gabriel EE, Aufderheide TP, et al. Survival Increases with CPR by ventricular fibrillation in patients with out-of-hospital cardiac arrest. Circula- Emergency Medical Services before defibrillation of out-of-hospital ventricu- tion 2000;102:1523–9. lar fibrillation or ventricular tachycardia: observations from the Resuscitation 84. Eftestol T, Wik L, Sunde K, Steen PA. Effects of cardiopulmonary resuscitation Outcomes Consortium. Resuscitation 2010;81:155–62. on predictors of ventricular fibrillation defibrillation success during out-of- 112. Christenson J, Andrusiek D, Everson-Stewart S, et al. Chest compression fraction hospital cardiac arrest. Circulation 2004;110:10–5. determines survival in patients with out-of-hospital ventricular fibrillation. 85. Weaver WD, Cobb LA, Dennis D, Ray R, Hallstrom AP, Copass MK. Amplitude of Circulation 2009;120:1241–7. ventricular fibrillation waveform and outcome after cardiac arrest. Ann Intern 113. Deakin CD, Nolan JP, Soar J, et al. European Resuscitation Council Guidelines Med 1985;102:53–5. for Resuscitation 2010. Section 4. Adult advanced life support. Resuscitation 86. Brown CG, Dzwonczyk R. Signal analysis of the human electrocardiogram dur- 2010;81:1305–52. ing ventricular fibrillation: frequency and amplitude parameters as predictors 114. Berg RA, Sanders AB, Kern KB, et al. Adverse hemodynamic effects of of successful countershock. Ann Emerg Med 1996;27:184–8. interrupting chest compressions for rescue breathing during cardiopul- 87. Callaham M, Braun O, Valentine W, Clark DM, Zegans C. Prehospital car- monary resuscitation for ventricular fibrillation cardiac arrest. Circulation diac arrest treated by urban first-responders: profile of patient response and 2001;104:2465–70. prediction of outcome by ventricular fibrillation waveform. Ann Emerg Med 115. Kern KB, Hilwig RW, Berg RA, Sanders AB, Ewy GA. Importance of continuous 1993;22:1664–77. chest compressions during cardiopulmonary resuscitation: improved outcome 88. Strohmenger HU, Lindner KH, Brown CG. Analysis of the ventricular fibrillation during a simulated single lay-rescuer scenario. Circulation 2002;105:645–9. ECG signal amplitude and frequency parameters as predictors of countershock 116. Valenzuela TD, Kern KB, Clark LL, et al. Interruptions of chest compressions dur- success in humans. Chest 1997;111:584–9. ing emergency medical systems resuscitation. Circulation 2005;112:1259–65. 89. Strohmenger HU, Eftestol T, Sunde K, et al. The predictive value of ventricu- 117. Bain AC, Swerdlow CD, Love CJ, et al. Multicenter study of principles-based lar fibrillation electrocardiogram signal frequency and amplitude variables in waveforms for external defibrillation. Ann Emerg Med 2001;37:5–12. patients with out-of-hospital cardiac arrest. Anesth Analg 2001;93:1428–33. 118. Poole JE, White RD, Kanz KG, et al. Low-energy impedance-compensating 90. Podbregar M, Kovacic M, Podbregar-Mars A, Brezocnik M. Predicting defibrilla- biphasic waveforms terminate ventricular fibrillation at high rates in victims tion success by ‘genetic’ programming in patients with out-of-hospital cardiac of out-of-hospital cardiac arrest. LIFE Investigators. J Cardiovasc Electrophysiol arrest. Resuscitation 2003;57:153–9. 1997;8:1373–85. 91. Menegazzi JJ, Callaway CW, Sherman LD, et al. Ventricular fibrillation scaling 119. Schneider T, Martens PR, Paschen H, et al. Multicenter, randomized, controlled exponent can guide timing of defibrillation and other therapies. Circulation trial of 150-J biphasic shocks compared with 200- to 360-J monopha- 2004;109:926–31. sic shocks in the resuscitation of out-of-hospital cardiac arrest victims. 92. Povoas HP, Weil MH, Tang W, Bisera J, Klouche K, Barbatsis A. Predicting Optimized Response to Cardiac Arrest (ORCA) Investigators. Circulation the success of defibrillation by electrocardiographic analysis. Resuscitation 2000;102:1780–7. 2002;53:77–82. 120. Rea TD, Shah S, Kudenchuk PJ, Copass MK, Cobb LA. Automated external 93. Noc M, Weil MH, Tang W, Sun S, Pernat A, Bisera J. Electrocardiographic pre- defibrillators: to what extent does the algorithm delay CPR? Ann Emerg Med diction of the success of cardiac resuscitation. Crit Care Med 1999;27:708–14. 2005;46:132–41. 94. Strohmenger HU, Lindner KH, Keller A, Lindner IM, Pfenninger EG. Spectral 121. Olasveengen TM, Vik E, Kuzovlev A, Sunde K. Effect of implementation of new analysis of ventricular fibrillation and closed-chest cardiopulmonary resusci- resuscitation guidelines on quality of cardiopulmonary resuscitation and sur- tation. Resuscitation 1996;33:155–61. vival. Resuscitation 2009;80:407–11. 95. Noc M, Weil MH, Gazmuri RJ, Sun S, Biscera J, Tang W. Ventricular fibrillation 122. Bobrow BJ, Clark LL, Ewy GA, et al. Minimally interrupted cardiac resuscita- voltage as a monitor of the effectiveness of cardiopulmonary resuscitation. J tion by emergency medical services for out-of-hospital cardiac arrest. JAMA Lab Clin Med 1994;124:421–6. 2008;299:1158–65.
- 85. C.D. Deakin et al. / Resuscitation 81 (2010) 1293–1304 1303 123. Steinmetz J, Barnung S, Nielsen SL, Risom M, Rasmussen LS. Improved survival with out-of-hospital cardiac arrest treated with a non-escalating biphasic after an out-of-hospital cardiac arrest using new guidelines. Acta Anaesthesiol waveform defibrillator. Resuscitation 2005;64:63–9. Scand 2008;52:908–13. 150. Stiell IG, Walker RG, Nesbitt LP, et al. BIPHASIC Trial: a randomized comparison 124. Jost D, Degrange H, Verret C, et al. DEFI 2005: a randomized controlled trial of fixed lower versus escalating higher energy levels for defibrillation in out- of the effect of automated external defibrillator cardiopulmonary resusci- of-hospital cardiac arrest. Circulation 2007;115:1511–7. tation protocol on outcome from out-of-hospital cardiac arrest. Circulation 151. Walsh SJ, McClelland AJ, Owens CG, et al. Efficacy of distinct energy delivery 2010;121:1614–22. protocols comparing two biphasic defibrillators for cardiac arrest. Am J Cardiol 125. Soar J, Perkins GD, Abbas G, et al. European Resuscitation Council Guidelines 2004;94:378–80. for Resuscitation 2010. Section 8. Cardiac arrest in special circumstances: 152. Higgins SL, Herre JM, Epstein AE, et al. A comparison of biphasic and monopha- electrolyte abnormalities, poisoning, drowning, accidental hypothermia, sic shocks for external defibrillation. Physio-Control Biphasic Investigators. hyperthermia, asthma, anaphylaxis, cardiac surgery, trauma, pregnancy, elec- Prehosp Emerg Care 2000;4:305–13. trocution. Resuscitation 2010;81:1400–33. 153. Berg RA, Samson RA, Berg MD, et al. Better outcome after pediatric defibrillation 126. Didon JP, Fontaine G, White RD, Jekova I, Schmid JJ, Cansell A. Clinical experi- dosage than adult dosage in a swine model of pediatric ventricular fibrillation. ence with a low-energy pulsed biphasic waveform in out-of-hospital cardiac J Am Coll Cardiol 2005;45:786–9. arrest. Resuscitation 2008;76:350–3. 154. Killingsworth CR, Melnick SB, Chapman FW, et al. Defibrillation threshold 127. Li Y, Wang H, Cho JH, et al. Comparison of efficacy of pulsed biphasic waveform and cardiac responses using an external biphasic defibrillator with pedi- and rectilinear biphasic waveform in a short ventricular fibrillation pig model. atric and adult adhesive patches in pediatric-sized piglets. Resuscitation Resuscitation 2009;80:1047–51. 2002;55:177–85. 128. van Alem AP, Chapman FW, Lank P, Hart AA, Koster RW. A prospective, 155. Tang W, Weil MH, Sun S, et al. The effects of biphasic waveform design on randomised and blinded comparison of first shock success of monopha- post-resuscitation myocardial function. J Am Coll Cardiol 2004;43:1228–35. sic and biphasic waveforms in out-of-hospital cardiac arrest. Resuscitation 156. Xie J, Weil MH, Sun S, et al. High-energy defibrillation increases the severity of 2003;58:17–24. postresuscitation myocardial dysfunction. Circulation 1997;96:683–8. 129. Carpenter J, Rea TD, Murray JA, Kudenchuk PJ, Eisenberg MS. Defibrillation 157. Koster RW, Walker RG, Chapman FW. Recurrent ventricular fibrillation during waveform and post-shock rhythm in out-of-hospital ventricular fibrillation advanced life support care of patients with prehospital cardiac arrest. Resus- cardiac arrest. Resuscitation 2003;59:189–96. citation 2008;78:252–7. 130. Morrison LJ, Dorian P, Long J, et al. Out-of-hospital cardiac arrest rectilinear 158. Walker RG, Koster RW, Sun C, et al. Defibrillation probability and impedance biphasic to monophasic damped sine defibrillation waveforms with advanced change between shocks during resuscitation from out-of-hospital cardiac life support intervention trial (ORBIT). Resuscitation 2005;66:149–57. arrest. Resuscitation 2009;80:773–7. 131. Gliner BE, White RD. Electrocardiographic evaluation of defibrillation shocks 159. Hess EP, Russell JK, Liu PY, White RD. A high peak current 150-J fixed-energy delivered to out-of-hospital sudden cardiac arrest patients. Resuscitation defibrillation protocol treats recurrent ventricular fibrillation (VF) as effec- 1999;41:133–44. tively as initial VF. Resuscitation 2008;79:28–33. 132. Freeman K, Hendey GW, Shalit M, Stroh G. Biphasic defibrillation does not 160. Deakin CD, Ambler JJ. Post-shock myocardial stunning: a prospective ran- improve outcomes compared to monophasic defibrillation in out-of-hospital domised double-blind comparison of monophasic and biphasic waveforms. cardiac arrest. Prehosp Emerg Care 2008;12:152–6. Resuscitation 2006;68:329–33. 133. Hess EP, Atkinson EJ, White RD. Increased prevalence of sustained return of 161. Khaykin Y, Newman D, Kowalewski M, Korley V, Dorian P. Biphasic versus spontaneous circulation following transition to biphasic waveform defibrilla- monophasic cardioversion in shock-resistant atrial fibrillation. J Cardiovasc tion. Resuscitation 2008;77:39–45. Electrophysiol 2003;14:868–72. 134. Kudenchuk PJ, Cobb LA, Copass MK, Olsufka M, Maynard C, Nichol G. 162. Kmec J. Comparison the effectiveness of damped sine wave monophasic and Transthoracic incremental monophasic versus biphasic defibrillation by emer- rectilinear biphasic shocks in patients with persistent atrial fibrillation. Kardi- gency responders (TIMBER): a randomized comparison of monophasic with ologia 2006;15:265–78. biphasic waveform ascending energy defibrillation for the resuscitation 163. Kosior DA, Szulec M, Torbicki A, Opolski G, Rabczenko D. A decrease of enlarged of out-of-hospital cardiac arrest due to ventricular fibrillation. Circulation left atrium following cardioversion of atrial fibrillationpredicts the long-term 2006;114:2010–8. maintenance of sinus rhythm. Kardiol Pol 2005;62:428–37. 135. Mittal S, Ayati S, Stein KM, et al. Transthoracic cardioversion of atrial fibrilla- 164. Kuisma M, Suominen P, Korpela R. Paediatric out-of-hospital cardiac arrests: tion: comparison of rectilinear biphasic versus damped sine wave monophasic epidemiology and outcome. Resuscitation 1995;30:141–50. shocks. Circulation 2000;101:1282–7. 165. Sirbaugh PE, Pepe PE, Shook JE, et al. A prospective, population-based study 136. Page RL, Kerber RE, Russell JK, et al. Biphasic versus monophasic shock of the demographics, epidemiology, management, and outcome of out-of- waveform for conversion of atrial fibrillation: the results of an inter- hospital pediatric cardiopulmonary arrest. Ann Emerg Med 1999;33:174– national randomized, double-blind multicenter trial. J Am Coll Cardiol 84. 2002;39:1956–63. 166. Hickey RW, Cohen DM, Strausbaugh S, Dietrich AM. Pediatric patients requiring 137. Koster RW, Dorian P, Chapman FW, Schmitt PW, O’Grady SG, Walker RG. A CPR in the prehospital setting. Ann Emerg Med 1995;25:495–501. randomized trial comparing monophasic and biphasic waveform shocks for 167. Atkins DL, Everson-Stewart S, Sears GK, et al. Epidemiology and outcomes external cardioversion of atrial fibrillation. Am Heart J 2004;147:e20. from out-of-hospital cardiac arrest in children: the Resuscitation Outcomes 138. Ambler JJ, Deakin CD. A randomized controlled trial of efficacy and ST Consortium Epistry-Cardiac Arrest. Circulation 2009;119:1484–91. change following use of the Welch-Allyn MRL PIC biphasic waveform versus 168. Appleton GO, Cummins RO, Larson MP, Graves JR. CPR and the single rescuer: damped sine monophasic waveform for external DC cardioversion. Resuscita- at what age should you “call first” rather than “call fast”? Ann Emerg Med tion 2006;71:146–51. 1995;25:492–4. 139. Pagan-Carlo LA, Allan JJ, Spencer KT, Birkett CL, Myers R, Kerber RE. Encircling 169. Ronco R, King W, Donley DK, Tilden SJ, Outcome. cost at a children’s hospital fol- overlapping multipulse shock waveforms for transthoracic defibrillation. J Am lowing resuscitation for out-of-hospital cardiopulmonary arrest. Arch Pediatr Coll Cardiol 1998;32:2065–71. Adolesc Med 1995;149:210–4. 140. Zhang Y, Ramabadran RS, Boddicker KA, et al. Triphasic waveforms are superior 170. Losek JD, Hennes H, Glaeser P, Hendley G, Nelson DB. Prehospital care of the to biphasic waveforms for transthoracic defibrillation: experimental studies. J pulseless, nonbreathing pediatric patient. Am J Emerg Med 1987;5:370–4. Am Coll Cardiol 2003;42:568–75. 171. Mogayzel C, Quan L, Graves JR, Tiedeman D, Fahrenbruch C, Herndon P. Out- 141. Zhang Y, Rhee B, Davies LR, et al. Quadriphasic waveforms are superior to of-hospital ventricular fibrillation in children and adolescents: causes and triphasic waveforms for transthoracic defibrillation in a cardiac arrest swine outcomes. Ann Emerg Med 1995;25:484–91. model with high impedance. Resuscitation 2006;68:251–8. 172. Safranek DJ, Eisenberg MS, Larsen MP. The epidemiology of cardiac arrest in 142. Kerber RE. External defibrillation: new technologies. Ann Emerg Med young adults. Ann Emerg Med 1992;21:1102–6. 1984;13:794–7. 173. Berg RA, Chapman FW, Berg MD, et al. Attenuated adult biphasic shocks com- 143. Joglar JA, Kessler DJ, Welch PJ, et al. Effects of repeated electrical defibrillations pared with weight-based monophasic shocks in a swine model of prolonged on cardiac troponin I levels. Am J Cardiol 1999;83:270–2. A6. pediatric ventricular fibrillation. Resuscitation 2004;61:189–97. 144. Kerber RE, Martins JB, Kienzle MG, et al. Energy, current, and success in defibril- 174. Tang W, Weil MH, Jorgenson D, et al. Fixed-energy biphasic waveform defib- lation and cardioversion: clinical studies using an automated impedance-based rillation in a pediatric model of cardiac arrest and resuscitation. Crit Care Med method of energy adjustment. Circulation 1988;77:1038–46. 2002;30:2736–41. 145. Martens PR, Russell JK, Wolcke B, et al. Optimal Response to Cardiac Arrest 175. Clark CB, Zhang Y, Davies LR, Karlsson G, Kerber RE. Pediatric transthoracic study: defibrillation waveform effects. Resuscitation 2001;49:233–43. defibrillation: biphasic versus monophasic waveforms in an experimental 146. Weaver WD, Cobb LA, Copass MK, Hallstrom AP. Ventricular defibrillation: a model. Resuscitation 2001;51:159–63. comparative trial using 175-J and 320-J shocks. N Engl J Med 1982;307:1101–6. 176. Gurnett CA, Atkins DL. Successful use of a biphasic waveform automated exter- 147. Tang W, Weil MH, Sun S, et al. The effects of biphasic and conventional nal defibrillator in a high-risk child. Am J Cardiol 2000;86:1051–3. monophasic defibrillation on postresuscitation myocardial function. J Am Coll 177. Atkins DL, Jorgenson DB. Attenuated pediatric electrode pads for automated Cardiol 1999;34:815–22. external defibrillator use in children. Resuscitation 2005;66:31–7. 148. Gliner BE, Jorgenson DB, Poole JE, et al. Treatment of out-of-hospital cardiac 178. Gutgesell HP, Tacker WA, Geddes LA, Davis S, Lie JT, McNamara DG. Energy arrest with a low-energy impedance-compensating biphasic waveform auto- dose for ventricular defibrillation of children. Pediatrics 1976;58:898–901. matic external defibrillator. The LIFE Investigators. Biomed Instrum Technol 179. Bar-Cohen Y, Walsh EP, Love BA, Cecchin F. First appropriate use of automated 1998;32:631–44. external defibrillator in an infant. Resuscitation 2005;67:135–7. 149. White RD, Blackwell TH, Russell JK, Snyder DE, Jorgenson DB. Transthoracic 180. Divekar A, Soni R. Successful parental use of an automated external defibrillator impedance does not affect defibrillation, resuscitation or survival in patients for an infant with long-QT syndrome. Pediatrics 2006;118:e526–9.
- 86. 1304 C.D. Deakin et al. / Resuscitation 81 (2010) 1293–1304 181. Rodriguez-Nunez A, Lopez-Herce J, Garcia C, Dominguez P, Carrillo A, Bellon 192. Kerber RE, Kienzle MG, Olshansky B, et al. Ventricular tachycardia rate and JM. Pediatric defibrillation after cardiac arrest: initial response and outcome. morphology determine energy and current requirements for transthoracic car- Crit Care 2006;10:R113. dioversion. Circulation 1992;85:158–63. 182. Samson RA, Nadkarni VM, Meaney PA, Carey SM, Berg MD, Berg RA. Out- 193. Hedges JR, Syverud SA, Dalsey WC, Feero S, Easter R, Shultz B. Prehospital trial comes of in-hospital ventricular fibrillation in children. N Engl J Med of emergency transcutaneous cardiac pacing. Circulation 1987;76:1337–43. 2006;354:2328–39. 194. Barthell E, Troiano P, Olson D, Stueven HA, Hendley G. Prehospital exter- 183. Lown B. Electrical reversion of cardiac arrhythmias. Br Heart J 1967;29:469–89. nal cardiac pacing: a prospective, controlled clinical trial. Ann Emerg Med 184. Ambler JJ, Deakin CD. A randomised controlled trial of the effect of biphasic or 1988;17:1221–6. monophasic waveform on the incidence and severity of cutaneous burns fol- 195. Cummins RO, Graves JR, Larsen MP, et al. Out-of-hospital transcutaneous pac- lowing external direct current cardioversion. Resuscitation 2006;71:293–300. ing by emergency medical technicians in patients with asystolic cardiac arrest. 185. Joglar JA, Hamdan MH, Ramaswamy K, et al. Initial energy for elective external N Engl J Med 1993;328:1377–82. cardioversion of persistent atrial fibrillation. Am J Cardiol 2000;86:348–50. 196. Ornato JP, Peberdy MA. The mystery of bradyasystole during cardiac arrest. 186. Boodhoo L, Mitchell AR, Bordoli G, Lloyd G, Patel N, Sulke N. DC cardioversion Ann Emerg Med 1996;27:576–87. of persistent atrial fibrillation: a comparison of two protocols. Int J Cardiol 197. Niemann JT, Adomian GE, Garner D, Rosborough JP. Endocardial and transcuta- 2007;114:16–21. neous cardiac pacing, calcium chloride, and epinephrine in postcountershock 187. Boos C, Thomas MD, Jones A, Clarke E, Wilbourne G, More RS. Higher energy asystole and bradycardias. Crit Care Med 1985;13:699–704. monophasic DC cardioversion for persistent atrial fibrillation: is it time to start 198. Quan L, Graves JR, Kinder DR, Horan S, Cummins RO. Transcutaneous cardiac at 360 joules? Ann Noninvasive Electrocardiol 2003;8:121–6. pacing in the treatment of out-of-hospital pediatric cardiac arrests. Ann Emerg 188. Glover BM, Walsh SJ, McCann CJ, et al. Biphasic energy selection for Med 1992;21:905–9. transthoracic cardioversion of atrial fibrillation. The BEST AF Trial. Heart 199. Dalsey WC, Syverud SA, Hedges JR. Emergency department use of transcuta- 2008;94:884–7. neous pacing for cardiac arrests. Crit Care Med 1985;13:399–401. 189. Rashba EJ, Gold MR, Crawford FA, Leman RB, Peters RW, Shorofsky SR. Efficacy 200. Knowlton AA, Falk RH. External cardiac pacing during in-hospital cardiac arrest. of transthoracic cardioversion of atrial fibrillation using a biphasic, truncated Am J Cardiol 1986;57:1295–8. exponential shock waveform at variable initial shock energies. Am J Cardiol 201. Ornato JP, Carveth WL, Windle JR. Pacemaker insertion for prehospital 2004;94:1572–4. bradyasystolic cardiac arrest. Ann Emerg Med 1984;13:101–3. 190. Pinski SL, Sgarbossa EB, Ching E, Trohman RG. A comparison of 50-J ver- 202. Stockwell B, Bellis G, Morton G, et al. Electrical injury during “hands on” sus 100-J shocks for direct-current cardioversion of atrial flutter. Am Heart defibrillation-A potential risk of internal cardioverter defibrillators? Resusci- J 1999;137:439–42. tation 2009;80:832–4. 191. Alatawi F, Gurevitz O, White R. Prospective, randomized comparison of two 203. Monsieurs KG, Conraads VM, Goethals MP, Snoeck JP, Bossaert LL. Semi- biphasic waveforms for the efficacy and safety of transthoracic biphasic car- automatic external defibrillation and implanted cardiac pacemakers: under- dioversion of atrial fibrillation. Heart Rhythm 2005;2:382–7. standing the interactions during resuscitation. Resuscitation 1995;30:127–31.
- 87. Resuscitation 81 (2010) 1305–1352 Contents lists available at ScienceDirect Resuscitation journal homepage: www.elsevier.com/locate/resuscitation European Resuscitation Council Guidelines for Resuscitation 2010 Section 4. Adult advanced life support Charles D. Deakin a,1 , Jerry P. Nolan b,∗,1 , Jasmeet Soar c , Kjetil Sunde d , Rudolph W. Koster e , Gary B. Smith f , Gavin D. Perkins f a Cardiothoracic Anaesthesia, Southampton General Hospital, Southampton, UK b Anaesthesia and Intensive Care Medicine, Royal United Hospital, Bath, UK c Anaesthesia and Intensive Care Medicine, Southmead Hospital, Bristol, UK d Surgical Intensive Care Unit, Oslo University Hospital Ulleval, Oslo, Norway e Department of Cardiology, Academic Medical Center, Amsterdam, The Netherlands f Critical Care and Resuscitation, University of Warwick, Warwick Medical School, Warwick, UK Summary of changes since 2005 Guidelines then every 3–5 min (during alternate cycles of CPR). Amiodarone 300 mg is also given after the third shock. The most important changes in the 2010 European Resuscitation • Atropine is no longer recommended for routine use in asystole or Council Advanced Life Support (ALS) Guidelines include: pulseless electrical activity. • Reduced emphasis on early tracheal intubation unless achieved • Increased emphasis on the importance of minimally interrupted by highly skilled individuals with minimal interruption to chest high-quality chest compressions throughout any ALS interven- compressions. • Increased emphasis on the use of capnography to confirm and tion: chest compressions are paused briefly only to enable specific interventions. continually monitor tracheal tube placement, quality of CPR and • Increased emphasis on the use of ‘track and trigger systems’ to to provide an early indication of return of spontaneous circulation detect the deteriorating patient and enable treatment to prevent (ROSC). • The potential role of ultrasound imaging during ALS is recognised. in-hospital cardiac arrest. • Increased awareness of the warning signs associated with the • Recognition of the potential harm caused by hyperoxaemia after potential risk of sudden cardiac death out of hospital. ROSC is achieved: once ROSC has been established and the oxy- • Removal of the recommendation for a pre-specified period gen saturation of arterial blood (SaO2 ) can be monitored reliably of cardiopulmonary resuscitation (CPR) before out-of-hospital (by pulse oximetry and/or arterial blood gas analysis), inspired defibrillation following cardiac arrest unwitnessed by the emer- oxygen is titrated to achieve a SaO2 of 94–98%. • Much greater detail and emphasis on the treatment of the post- gency medical services (EMS). • Continuation of chest compressions while a defibrillator is cardiac arrest syndrome. • Recognition that implementation of a comprehensive, structured charged—this will minimise the preshock pause. • The role of the precordial thump is de-emphasised. post-resuscitation treatment protocol may improve survival in • The use of up to three quick successive (stacked) shocks for cardiac arrest victims after ROSC. • Increased emphasis on the use of primary percutaneous coro- ventricular fibrillation/pulseless ventricular tachycardia (VF/VT) occurring in the cardiac catheterisation laboratory or in the nary intervention in appropriate, but comatose, patients with immediate post-operative period following cardiac surgery. sustained ROSC after cardiac arrest. • Delivery of drugs via a tracheal tube is no longer • Revision of the recommendation for glucose control: in adults recommended—if intravenous access cannot be achieved, with sustained ROSC after cardiac arrest, blood glucose values drugs should be given by the intraosseous route. >10 mmol l−1 (>180 mg dl−1 ) should be treated but hypogly- • When treating VF/VT cardiac arrest, adrenaline 1 mg is given caemia must be avoided. • Use of therapeutic hypothermia to include comatose sur- after the third shock once chest compressions have restarted and vivors of cardiac arrest associated initially with non-shockable rhythms as well shockable rhythms. The lower level of evi- dence for use after cardiac arrest from non-shockable rhythms is ∗ Corresponding author. acknowledged. E-mail address: jerry.nolan@btinternet.com (J.P. Nolan). • Recognition that many of the accepted predictors of poor out- 1 These individuals contributed equally to this manuscript and are equal first come in comatose survivors of cardiac arrest are unreliable, co-authors. 0300-9572/$ – see front matter © 2010 European Resuscitation Council. Published by Elsevier Ireland Ltd. All rights reserved. doi:10.1016/j.resuscitation.2010.08.017
- 88. 1306 C.D. Deakin et al. / Resuscitation 81 (2010) 1305–1352 especially if the patient has been treated with therapeutic In an Australian study, virtually all the improvement in the hos- hypothermia. pital cardiac arrest rate occurred during the educational phase of implementation of a medical emergency team (MET) system.45,46 4a Prevention of in-hospital cardiac arrest In studies from Australian and American hospitals with estab- lished rapid response teams, education about the specific criteria for activating their teams led to proactive ICU admission of patients Early recognition of the deteriorating patient and prevention and a reduction in the number of ward cardiac arrests.47–49 A UK of cardiac arrest is the first link in the chain of survival.1 Once study found that the number of cardiac arrest calls decreased while cardiac arrest occurs, fewer than 20% of patients suffering an in- pre-arrest calls increased after implementing a standardised edu- hospital cardiac arrest will survive to go home.2–4 Prevention of cational program in two hospitals; the intervention was associated in-hospital cardiac arrest requires staff education, monitoring of with a decrease in true arrests, and increase in initial survival after patients, recognition of patient deterioration, a system to call for cardiac arrest and survival to discharge.50,51 help and an effective response.5 The problem Monitoring and recognition of the critically ill patient Cardiac arrest in patients in unmonitored ward areas is not In general, the clinical signs of acute illness are similar what- usually a sudden unpredictable event, nor is it usually caused ever the underlying process, as they reflect failing respiratory, by primary cardiac disease.6 These patients often have slow and cardiovascular and neurological systems. Abnormal physiology is progressive physiological deterioration, involving hypoxaemia and common on general wards,52 yet the measurement and recording hypotension that is unnoticed by staff, or is recognised but treated of important physiological observations of sick patients occurs less poorly.7–9 Many of these patients have unmonitored arrests, and frequently than is desirable.6,8,13,16,24,53,54 the underlying cardiac arrest rhythm is usually non-shockable.3,10 To assist in the early detection of critical illness, each patient Survival to hospital discharge is poor.2,4,10 should have a documented plan for vital signs monitoring that The records of patients who have a cardiac arrest or unan- identifies which variables need to be measured and the frequency ticipated intensive care unit (ICU) admission often contain of measurement.26 Many hospitals now use early warning scores evidence of unrecognised, or untreated, respiratory and circula- (EWS) or calling criteria to identify the need to escalate monitor- tion problems.6,8,11–16 The ACADEMIA study showed antecedents ing, treatment, or to call for expert help.13,24,55–57 The use of these in 79% of cardiac arrests, 55% of deaths and 54% of unanticipated ICU systems has been shown to increase the frequency of patient vital admissions.8 Early and effective treatment of seriously ill patients signs measurements.54,58,59 might prevent some cardiac arrests, deaths and unanticipated ICU These calling criteria or ‘track-and-trigger’ systems include admissions. Several studies show that up to a third of patients who single-parameter systems, multiple-parameter systems, aggregate have a false cardiac arrest call subsequently die.17–19 weighted scoring systems or combination systems.60 The aggre- gate weighted track-and-trigger systems offer a graded escalation Nature of the deficiencies in the recognition and response of care, whereas single parameter track and trigger systems provide to patient deterioration an all-or-nothing response. Most of these systems lack robust data to suggest they have These often include: infrequent, late or incomplete vital signs acceptable accuracy for use in the roles for which they are pro- assessments; lack of knowledge of normal vital signs values; poor posed. Low sensitivity of systems means that a significant number design of vital signs charts; poor sensitivity and specificity of ‘track of patients at risk of deterioration leading to cardiac arrest are likely and trigger’ systems; failure of staff to increase monitoring or esca- to be missed.61,62 Hospitals should use a system validated for their late care, and staff workload.20–28 There is also often a failure to specific patient population to identify individuals at increased risk treat abnormalities of the patient’s airway, breathing and circula- of serious clinical deterioration, cardiac arrest, or death, both on tion, incorrect use of oxygen therapy, poor communication, lack of admission and during hospital stay. teamwork and insufficient use of treatment limitation plans.7,14,29 Alterations in physiological variables, singly or in combination are associated with, or can be used to predict the occurrence of car- Education in acute care diac arrest,9,13,15,63,64 hospital death22,23,65–82 and unplanned ICU admission,15,80,83 with varying sensitivity and specificity. Differ- Several studies show that medical and nursing staff lack knowl- ing criteria for ICU admission between hospitals make the use of edge and skills in acute care,30 e.g., oxygen therapy,31 fluid unplanned ICU admission a less useful endpoint to study. and electrolyte balance,32 analgesia,33 issues of consent,34 pulse As one would expect, an increased number of derangements oximetry35,36 and drug doses.37 Medical school training provides increases the likelihood of death.11,15,20,63,77,84–91 The best combi- poor preparation for doctors’ early careers, and fails to teach them nation and cut off values to allow early prediction is not known. the essential aspects of applied physiology and acute care.38 There For aggregate-weighted scoring systems, inclusion of heart rate is a need for an increased emphasis on acute care training of under- (HR), respiratory rate (RR), systolic blood pressure (SBP), AVPU graduate and newly qualified doctors.39,40 There is also little to (alert, vocalizing, pain, unresponsive), temperature, age, and oxy- suggest that the acute care training and knowledge of senior medi- gen saturation achieve the best predictive value.22,61 For single cal staff is better.41,42 Staff often lack confidence when dealing with parameter track-and-trigger systems, cut-off points of HR <35 and acute care problems, and rarely use a systematic approach to the >140 min−1 ; RR <6 and >32 min−1 ; and SBP < 80 mm Hg achieved assessment of critically ill patients.43 the best positive predictive value.23 Taking account of the patient’s Staff education is an essential part of implementing a system age improves the predictive value of both aggregate and single to prevent cardiac arrest.44 However, there are no randomised parameter scoring systems.77 Aggregate-weighted scoring systems controlled studies addressing the impact of specific educational appear to have a rank order of performance that is relatively interventions on improvements in patient outcomes such as the constant.92 A newly devised, aggregate-weighted scoring system earlier recognition or rescue of the deteriorating patient at risk of discriminates better than all others tested using mortality within cardiac or respiratory arrest. 24 h of an early warning score as the outcome.92
- 89. C.D. Deakin et al. / Resuscitation 81 (2010) 1305–1352 1307 The design of vital signs charts or the use of technology may have difference between control and intervention hospitals in reduction an important role in the detection of deterioration and requires in a composite outcome of (a) cardiac arrests without a pre-existing further study.21,93,94 not-for-resuscitation (NFR) order, (b) unplanned ICU admissions, and (c) unexpected deaths (deaths without a pre-existing NFR Calling for help order) taking place in general wards during the 6-month study MET period. Both the control and MET groups demonstrated improved The traditional response to cardiac arrest is a reactive one in outcome compared to baseline. Post hoc analysis of the MERIT study which hospital staff (‘the cardiac arrest team’) attend the patient showed there was a decrease in cardiac arrest and unexpected after the cardiac arrest has occurred. Cardiac arrest teams appear mortality rate with increased activation of the MET system.126 to improve survival after cardiac arrest in circumstances where no Several other studies have also been unable to show a reduc- team has previously existed.95 However, the role of the cardiac tion in cardiac arrest rates associated with the introduction of arrest team has been questioned. In one small study, only patients RRT/MET systems.105,106,108,109,127–130 A single-centre study of the who had return of spontaneous circulation before the cardiac arrest implementation of an early warning scoring system showed an team arrived were discharged from hospital alive.96 When com- increase in cardiac arrests among patients who had higher early bined with the poor survival rate after in-hospital cardiac arrest, warning scores, compared with similar scored patients before the this emphasises the importance of early recognition and treatment intervention.56 of critically ill patients to prevent cardiac arrest. A recent meta-analysis showed RRT/MET systems were associ- Nursing staff and junior doctors often find it difficult to ask for ated with a reduction in rates of cardiopulmonary arrest outside help or escalate treatment as they feel their clinical judgement the intensive care unit but are not associated with lower hospital may be criticised. Hospitals should ensure all staff are empowered mortality rates.131 to call for help and also trained to use structured communica- tion tools such as RSVP (Reason-Story-Vital Signs-Plan)97 or SBAR Appropriate placement of patients (Situation-Background-Assessment-Recommendation)98 tools to ensure effective inter-professional communication. Ideally, the sickest patients should be admitted to an area that can provide the greatest supervision and the highest level of organ The response to critical illness support and nursing care. This often occurs, but some patients are placed incorrectly.132 International organisations have offered def- The response to patients who are critically ill or who are at risk initions of levels of care and produced admission and discharge of becoming critically ill is usually provided by medical emergency criteria for high dependency units (HDUs) and ICUs.133,134 teams (MET), rapid response teams (RRT), or critical care outreach teams (CCOT).99–101 These teams replace or coexist with traditional Staffing levels cardiac arrest teams, which typically respond to patients already in cardiac arrest. MET/RRT usually comprise medical and nursing staff Hospital staffing tends to be at its lowest during the night and from intensive care and general medicine and respond to specific at weekends. This may influence patient monitoring, treatment calling criteria. CCOT are common in the UK, based predominantly and outcomes. Data from the US National Registry of CPR Inves- on individual or teams of nurses.60 Outreach services exist in many tigators shows that survival rates from in-hospital cardiac arrest forms, ranging from a single nurse to a 24-h, 7 days per week multi- are lower during nights and weekends.135 Admission to a gen- professional team. Any member of the healthcare team can initiate eral medical ward after 17.00 h136 or to hospital at weekends137 is a MET/RRT/CCOT call. In some hospitals, the patient’s family and associated with increased mortality. Patients who are discharged friends are also encouraged to activate the team, if necessary.102–104 from ICUs to general wards at night have an increased risk of in- Team interventions often involve simple tasks such as starting hospital death compared with those discharged during the day and oxygen therapy and intravenous fluids.105–109 However, post hoc those discharged to HDUs.138,139 Several studies show that higher analysis of the MERIT study data suggests that all nearly all MET nurse staffing is associated with lower rates of failure-to-rescue, calls required ‘critical care-type’ interventions.110 A circadian pat- and reductions in rates of cardiac arrest rates, pneumonia, shock tern of team activation has been reported, which may suggest that and death.25,140,141 systems for identifying and responding to medical emergencies may not be uniform throughout the 24-h period.111,112 Resuscitation decisions Studying the effect of the MET/RRT/CCOT systems on patient outcomes is difficult because of the complex nature of the inter- The decision to start, continue and terminate resuscitation vention. During the period of most studies of rapid response teams, efforts is based on the balance between the risks, benefits and bur- there has been a major international focus on improving other dens these interventions place on patients, family members and aspects of patient safety, e.g., hospital acquired infections, ear- healthcare providers. There are circumstances where resuscitation lier treatment of sepsis and better medication management, all of is inappropriate and should not be provided. Consider a ‘do not which have the potential to influence patient deterioration and may attempt resuscitation’ (DNAR) decision when the patient: have a beneficial impact on reducing cardiac arrests and hospital deaths. Additionally, a greater focus on improving ‘end of life’ care • does not wish to have CPR; and the making of ‘do not attempt resuscitation’ (DNAR) decisions • will not survive cardiac arrest even if CPR is attempted. also impact cardiac arrest call rates. The available studies do not correct for these confounding factors. Hospital staff often fail to consider whether resuscitation Nevertheless, numerous single centre studies have reported attempts are appropriate and resuscitation attempts in futile cases reduced numbers of cardiac arrests after the implementation are common.142 Even when there is clear evidence that cardiac of RRT/MET systems.45,47,107,111,113–125 However, a well-designed, arrest or death is likely, ward staff rarely make decisions about cluster-randomised controlled trial of the MET system (MERIT the patient’s resuscitation status.8 Many European countries have study) involving 23 hospitals24 did not show a reduction in car- no formal policy for recording DNAR decisions and the practice of diac arrest rate after introduction of a MET when analyzed on an consulting patients about the decision is variable.143,144 Improved intention-to-treat basis. This study was unable to demonstrate a knowledge, training and DNAR decision-making should improve
- 90. 1308 C.D. Deakin et al. / Resuscitation 81 (2010) 1305–1352 patient care and prevent futile CPR attempts (see Section 10).145 Prevention of sudden cardiac death (SCD) Medical emergency teams may have an important role in improving out-of-hospital end-of-life and DNAR decision-making.142,146–148 Coronary artery disease is the commonest cause of SCD. Non- Guidelines for prevention of in-hospital cardiac arrest ischaemic cardiomyopathy and valvular disease account for most other SCD events. A small percentage of SCDs are caused by Hospitals should provide a system of care that includes: (a) staff inherited abnormalities (e.g., Brugada syndrome, hypertrophic car- education about the signs of patient deterioration, and the ratio- diomyopathy) or congenital heart disease. nale for rapid response to illness, (b) appropriate and regular vital Most SCD victims have a history of cardiac disease and warn- signs monitoring of patients, (c) clear guidance (e.g., via calling cri- ing signs, most commonly chest pain, in the hour before cardiac teria or early warning scores) to assist staff in the early detection arrest.150 In patients with a known diagnosis of cardiac disease, syn- of patient deterioration, (d) a clear, uniform system of calling for cope (with or without prodrome—particularly recent or recurrent) assistance, and (e) an appropriate and timely clinical response to is as an independent risk factor for increased risk of death.151–161 calls for assistance.5 The following strategies may prevent avoid- Chest pain on exertion only, and palpitations associated with able in-hospital cardiac arrests. syncope only, are associated with hypertrophic cardiomyopathy, coronary abnormalities, Wolff–Parkinson–White, and arrhythmo- genic right ventricular cardiomyopathy. 1. Provide care for patients who are critically ill or at risk of clin- Apparently healthy children and young adults who suffer SCD ical deterioration in appropriate areas, with the level of care can also have signs and symptoms (e.g., syncope/pre-syncope, chest provided matched to the level of patient sickness. pain and palpitations) that should alert healthcare professionals to 2. Critically ill patients need regular observations: each patient seek expert help to prevent cardiac arrest.162–170 should have a documented plan for vital signs monitoring that Children and young adults presenting with characteristic symp- identifies which variables need to be measured and the fre- toms of arrhythmic syncope should have a specialist cardiology quency of measurement according to the severity of illness or assessment, which should include an ECG and in most cases an the likelihood of clinical deterioration and cardiopulmonary echocardiogram and exercise test. Characteristics of arrhythmic arrest. Recent guidance suggests monitoring of simple physi- syncope include: syncope in the supine position, occurring dur- ological variables including pulse, blood pressure, respiratory ing or after exercise, with no or only brief prodromal symptoms, rate, conscious level, temperature and arterial blood oxygen repetitive episodes, or in individuals with a family history of saturation by pulse oximetry (SpO2 ).26,149 sudden death. In addition, non-pleuritic chest pain, palpitations 3. Use a track-and-trigger system (either ‘calling criteria’ or early associated with syncope, seizures (when resistant to treatment, warning system) to identify patients who are critically ill and, occurring at night or precipitated by exercise, syncope, or loud or at risk of clinical deterioration and cardiopulmonary arrest. noise), and drowning in a competent swimmer should raise suspi- 4. Use a patient charting system that enables the regular mea- cion of increased risk. Systematic evaluation in a clinic specializing surement and recording of vital signs and, where used, early in the care of those at risk for SCD is recommended in family mem- warning scores. bers of young victims of SCD or those with a known cardiac disorder 5. Have a clear and specific policy that requires a clinical response resulting in an increased risk of SCD.151,171–175 A family history of to abnormal physiology, based on the track and trigger system syncope or SCD, palpitations as a symptom, supine syncope and used. This should include advice on the further clinical manage- syncope associated with exercise and emotional stress are more ment of the patient and the specific responsibilities of medical common in patients with long QT syndrome (LQTS).176 In older and nursing staff. adults177,178 the absence of nausea and vomiting before syncope 6. The hospital should have a clearly identified response to crit- and ECG abnormalities is an independent predictor of arrhythmic ical illness. This may include a designated outreach service or syncope. resuscitation team (e.g., MET, RRT system) capable of respond- Inexplicable drowning and drowning in a strong swimmer ing in a timely fashion to acute clinical crises identified by the may be due to LQTS or catecholaminergic polymorphic ventricu- track-and-trigger system or other indicators. This service must lar tachycardia (CPVT).179 There is an association between LQTS be available 24 h per day. The team must include staff with the and presentation with seizure phenotype.180,181 Guidance has been appropriate acute or critical care skills. published for the screening of competitive athletes to identify those 7. Train all clinical staff in the recognition, monitoring and man- at risk of sudden death.182 agement of the critically ill patient. Include advice on clinical management while awaiting the arrival of more experienced staff. Ensure that staff know their role(s) in the rapid response 4b Prehospital resuscitation system. 8. Hospitals must empower staff of all disciplines to call for help EMS personnel when they identify a patient at risk of deterioration or cardiac arrest. Staff should be trained in the use of structured com- There is considerable variation across Europe in the structure munication tools to ensure effective handover of information and process of EMS systems. Some countries have adopted almost between doctors, nurses and other healthcare professions. exclusively paramedic/emergency medical technician (EMT)-based 9. Identify patients for whom cardiopulmonary arrest is an antic- systems while other incorporate prehospital physicians to a greater ipated terminal event and in whom CPR is inappropriate, and or lesser extent. In adult cardiac arrest, physician presence during patients who do not wish to be treated with CPR. Hospitals resuscitation, compared with paramedics alone, has been reported should have a DNAR policy, based on national guidance, which to increase compliance with guidelines183,184 and physicians in is understood by all clinical staff. some systems can perform advanced resuscitation procedures 10. Ensure accurate audit of cardiac arrest, “false arrest”, unex- more successfully.183,185–188 When compared within individual pected deaths and unanticipated ICU admissions using systems, there are contradictory findings with some studies sug- common datasets. Audit also the antecedents and clinical gesting improved survival to hospital discharge when physicians response to these events. are part of the resuscitation team189–192 and other studies suggest-
- 91. C.D. Deakin et al. / Resuscitation 81 (2010) 1305–1352 1309 ing no difference in short- or long-term survival.183,189,191,193–199 resuscitation (CPR). For all in-hospital cardiac arrests, ensure that: in one study, survival of the event was lower when physicians were part of the resuscitation team.199 Studies indirectly compar- • cardiorespiratory arrest is recognised immediately; ing resuscitation outcomes between physician-staffed and other • help is summoned using a standard telephone number; systems are difficult to interpret because of the extremely high • CPR is started immediately using airway adjuncts, e.g., a pocket variability between systems, independent of physician-staffing.200 mask and, if indicated, defibrillation attempted as rapidly as pos- Although some studies have documented higher survival rates sible and certainly within 3 min. after cardiac arrest in EMS systems that include experienced physicians,186,188,201–203 compared with those that rely on non- The exact sequence of actions after in-hospital cardiac arrest physician providers,201,202,204,205 other comparisons have found no will depend on many factors, including: difference in survival between systems using paramedics or physi- cians as part of the response.206,207 Well-organised non-physician • location (clinical/non-clinical area; monitored/unmonitored systems with highly trained paramedics have also reported high area); survival rates.200 Given the inconsistent evidence, the inclusion or • training of the first responders; exclusion of physicians among prehospital personnel responding • number of responders; to cardiac arrests will depend largely on existing local policy. • equipment available; • hospital response system to cardiac arrest and medical emergen- Termination of resuscitation rules cies (e.g., MET, RRT). One high-quality, prospective study has demonstrated that Location application of a ‘basic life support termination of resuscitation rule’ is predictive of death when applied by defibrillation-only emer- Patients who have monitored arrests are usually diagnosed gency medical technicians.208 The rule recommends termination rapidly. Ward patients may have had a period of deterioration and when there is no return of spontaneous circulation, no shocks are an unwitnessed arrest.6,8 Ideally, all patients who are at high risk administered, and the arrest is not witnessed by EMS personnel. Of of cardiac arrest should be cared for in a monitored area where 776 patients with cardiac arrest for whom the rule recommended facilities for immediate resuscitation are available. termination, four survived [0.5% (95% CI 0.2–0.9)]. Implementation of the rule would reduce the transportation rate by almost two thirds. Four studies have shown external generalisability of this Training of first responders rule.209–212 Additional studies have shown associations with futility of cer- All healthcare professionals should be able to recognise cardiac tain variables such as no ROSC at scene; non-shockable rhythm; arrest, call for help and start CPR. Staff should do what they have unwitnessed arrest; no bystander CPR, call response time and been trained to do. For example, staff in critical care and emer- patient demographics.213–218 gency medicine will have more advanced resuscitation skills than Two in-hospital studies and one emergency department study staff who are not involved regularly in resuscitation in their nor- showed that the reliability of termination of resuscitation rules is mal clinical role. Hospital staff who attend a cardiac arrest may limited in these settings.219–221 have different levels of skill to manage the airway, breathing and Prospectively validated termination of resuscitation rules such circulation. Rescuers must undertake only the skills in which they as the ‘basic life support termination of resuscitation rule’ can be are trained and competent. used to guide termination of prehospital CPR in adults; however, these must be validated in an emergency medical services system Number of responders similar to the one in which implementation is proposed. Other rules for various provider levels, including in-hospital providers, may be The single responder must ensure that help is coming. If other helpful to reduce variability in decision-making; however, rules staff are nearby, several actions can be undertaken simultaneously. should be prospectively validated prior to implementation. Equipment available CPR versus defibrillation first All clinical areas should have immediate access to resuscitation There is evidence that performing chest compressions while equipment and drugs to facilitate rapid resuscitation of the patient retrieving and charging a defibrillator improves the probability of in cardiopulmonary arrest. Ideally, the equipment used for CPR survival.222 EMS personnel should provide good-quality CPR while (including defibrillators) and the layout of equipment and drugs a defibrillator is retrieved, applied and charged, but routine delivery should be standardised throughout the hospital.224,225 of a pre-specified period of CPR (e.g., 2 or 3 min) before rhythm anal- ysis and a shock is delivered is not recommended. Some emergency Resuscitation team medical services have already fully implemented a pre-specified period of chest compressions before defibrillation; given the lack The resuscitation team may take the form of a traditional cardiac of convincing data either supporting or refuting this strategy, it is arrest team, which is called only when cardiac arrest is recognised. reasonable for them to continue this practice (see Section 3).223 Alternatively, hospitals may have strategies to recognise patients at risk of cardiac arrest and summon a team (e.g., MET or RRT) 4c In-hospital resuscitation before cardiac arrest occurs. The term ‘resuscitation team’ reflects the range of response teams. In hospital cardiac arrests are rarely After in-hospital cardiac arrest, the division between basic life sudden or unexpected. A strategy of recognising patients at risk of support and advanced life support is arbitrary; in practice, the cardiac arrest may enable some of these arrests to be prevented, or resuscitation process is a continuum and is based on common sense. may prevent futile resuscitation attempts in those who are unlikely The public expect that clinical staff can undertake cardiopulmonary to benefit from CPR.
- 92. 1310 C.D. Deakin et al. / Resuscitation 81 (2010) 1305–1352 Immediate actions for a collapsed patient in a hospital • Shout for help (if not already) An algorithm for the initial management of in-hospital cardiac Turn the victim on to his back and then open the airway: arrest is shown in Fig. 4.1. • Open Airway and check breathing: • Ensure personal safety. ◦ Open the airway using a head tilt chin lift. • Check the victim for a response. ◦ Look in the mouth. If a foreign body or debris is visible attempt • When healthcare professionals see a patient collapse or find a to remove with a finger sweep, forceps or suction as appropri- patient apparently unconscious in a clinical area, they should first ate. shout for help, then assess if the patient is responsive. Gently ◦ If you suspect that there may have been an injury to the neck, shake the shoulders and ask loudly: ‘Are you all right?’ try to open the airway using a jaw thrust. Remember that main- • If other members of staff are nearby, it will be possible to under- taining an airway and adequate ventilation is the overriding take actions simultaneously. priority in managing a patient with a suspected spinal injury. If this is unsuccessful, use just enough head tilt to clear the airway. Use manual in-line stabilisation to minimise head movement if The responsive patient sufficient rescuers are available. Efforts to protect the cervical spine must not jeopardise oxygenation and ventilation. Urgent medical assessment is required. Depending on the local protocols, this may take the form of a resuscitation team (e.g., MET, Keeping the airway open, look, listen, and feel for normal breath- RRT). While awaiting this team, give the patient oxygen, attach ing (an occasional gasp, slow, laboured or noisy breathing is not monitoring and insert an intravenous cannula. normal): The unresponsive patient • Look for chest movement; • Listen at the victim’s mouth for breath sounds; The exact sequence will depend on the training of staff and • Feel for air on your cheek. experience in assessment of breathing and circulation. Trained healthcare staff cannot assess the breathing and pulse sufficiently Look, listen, and feel for no more than 10 s to determine if the reliably to confirm cardiac arrest.226–235 Agonal breathing (occa- victim is breathing normally sional gasps, slow, laboured or noisy breathing) is common in the • Check for signs of a circulation: early stages of cardiac arrest and is a sign of cardiac arrest and should not be confused as a sign of life/circulation.236–239 Agonal ◦ It may be difficult to be certain that there is no pulse. If the breathing can also occur during chest compressions as cerebral per- patient has no signs of life (consciousness, purposeful move- fusion improves, but is not indicative of a return of spontaneous ment, normal breathing, or coughing), start CPR until more circulation. experience help arrives or the patient shows signs of life. Fig. 4.1. Algorithm for the treatment of in-hospital cardiac arrest. © 2010 ERC.
- 93. C.D. Deakin et al. / Resuscitation 81 (2010) 1305–1352 1311 ◦ Those experienced in clinical assessment should assess the then give one shock. If using an automated external defibrillation carotid pulse whilst simultaneously looking for signs of life for (AED) follow the AED’s audio-visual prompts. not more than 10 s. • Restart chest compressions immediately after the defibrillation ◦ If the patient appears to have no signs of life, or if there is attempt. Minimise interruptions to chest compressions. Using a doubt, start CPR immediately. Delivering chest compressions manual defibrillator it is possible to reduce the pause between to a patient with a beating heart is unlikely to cause harm.240 stopping and restarting of chest compressions to less than 5 s. However, delays in diagnosis of cardiac arrest and starting CPR • Continue resuscitation until the resuscitation team arrives or the will adversely effect survival and must be avoided. patient shows signs of life. Follow the voice prompts if using an AED. If using a manual defibrillator, follow the universal algo- If there is a pulse or signs of life, urgent medical assess- rithm for advanced life support (Section 4d). ment is required. Depending on the local protocols, this may take • Once resuscitation is underway, and if there are sufficient staff the form of a resuscitation team. While awaiting this team, give present, prepare intravenous cannulae and drugs likely to be used the patient oxygen, attach monitoring, and insert an intravenous by the resuscitation team (e.g., adrenaline). cannula. When a reliable measurement of oxygen saturation • Identify one person to be responsible for handover to the resus- of arterial blood (e.g., pulse oximetry (SpO2 )) can be achieved, citation team leader. Use a structured communication tool for titrate the inspired oxygen concentration to achieve a SpO2 of handover (e.g., SBAR, RSVP).97,98 Locate the patient’s records. 94–98%. • The quality of chest compressions during in-hospital CPR is If there is no breathing, but there is a pulse (respiratory arrest), frequently sub-optimal.242,243 The importance of uninterrupted ventilate the patient’s lungs and check for a circulation every 10 chest compressions cannot be over emphasised. Even short inter- breaths. ruptions to chest compressions are disastrous for outcome and every effort must be made to ensure that continuous, effective Starting in-hospital CPR chest compression is maintained throughout the resuscitation attempt. Chest compressions should commence at the beginning • One person starts CPR as others call the resuscitation team and of a resuscitation attempt and continue uninterrupted unless collect the resuscitation equipment and a defibrillator. If only one they are briefly paused for a specific intervention (e.g., pulse member of staff is present, this will mean leaving the patient. check). The team leader should monitor the quality of CPR and • Give 30 chest compressions followed by 2 ventilations. alternate CPR providers if the quality of CPR is poor. Continu- • Minimise interruptions and ensure high-quality compressions. ous ETCO2 monitoring can be used to indicate the quality of CPR: • Undertaking good-quality chest compressions for a prolonged although an optimal target for ETCO2 during CPR has not been time is tiring; with minimal interruption, try to change the person established, a value of less than 10 mm Hg (1.4 kPa) is associated doing chest compressions every 2 min. with failure to achieve ROSC and may indicate that the quality of • Maintain the airway and ventilate the lungs with the most appro- chest compressions should be improved. If possible, the person priate equipment immediately to hand. A pocket mask, which providing chest compressions should be alternated every 2 min, may be supplemented with an oral airway, is usually readily avail- but without causing long pauses in chest compressions. able. Alternatively, use a supraglottic airway device (SAD) and self-inflating bag, or bag-mask, according to local policy. Tracheal intubation should be attempted only by those who are trained, 4d ALS treatment algorithm competent and experienced in this skill. Waveform capnogra- phy should be routinely available for confirming tracheal tube Introduction placement (in the presence of a cardiac output) and subsequent monitoring of an intubated patient. Heart rhythms associated with cardiac arrest are divided into • Use an inspiratory time of 1 s and give enough volume to produce two groups: shockable rhythms (ventricular fibrillation/pulseless a normal chest rise. Add supplemental oxygen as soon as possible. ventricular tachycardia (VF/VT)) and non-shockable rhythms (asys- • Once the patient’s trachea has been intubated or a SAD has been tole and pulseless electrical activity (PEA)). The principal difference inserted, continue chest compressions uninterrupted (except in the treatment of these two groups of arrhythmias is the need for for defibrillation or pulse checks when indicated), at a rate of attempted defibrillation in those patients with VF/VT. Subsequent at least 100 min−1 , and ventilate the lungs at approximately actions, including high-quality chest compressions with minimal 10 breaths min−1 . Avoid hyperventilation (both excessive rate interruptions, airway management and ventilation, venous access, and tidal volume), which may worsen outcome. Mechanical ven- administration of adrenaline and the identification and correction tilators may free up a rescuer and ensure appropriate ventilation of reversible factors, are common to both groups. rates and volumes. Although the ALS cardiac arrest algorithm (Fig. 4.2) is applicable • If there is no airway and ventilation equipment available, con- to all cardiac arrests, additional interventions may be indicated for sider giving mouth-to-mouth ventilation. If there are clinical cardiac arrest caused by special circumstances (see Section 8). reasons to avoid mouth-to-mouth contact, or you are unwilling The interventions that unquestionably contribute to improved or unable to do this, do chest compressions until help or airway survival after cardiac arrest are prompt and effective bystander equipment arrives. basic life support (BLS), uninterrupted, high-quality chest compres- • When the defibrillator arrives, apply the paddles to the patient sions and early defibrillation for VF/VT. The use of adrenaline has and analyse the rhythm. If self-adhesive defibrillation pads are been shown to increase return of spontaneous circulation (ROSC), available, apply these without interrupting chest compressions. but no resuscitation drugs or advanced airway interventions have The use of adhesive electrode pads or a ‘quick-look’ paddles tech- been shown to increase survival to hospital discharge after cardiac nique will enable rapid assessment of heart rhythm compared arrest.244–247 Thus, although drugs and advanced airways are still with attaching ECG electrodes.241 Pause briefly to assess the included among ALS interventions, they are of secondary impor- heart rhythm. With a manual defibrillator, if the rhythm is VF/VT tance to early defibrillation and high-quality, uninterrupted chest charge the defibrillator while another rescuer continues chest compressions. compressions. Once the defibrillator is charged, pause the chest As with previous guidelines, the ALS algorithm distinguishes compressions, ensure that all rescuers are clear of the patient and between shockable and non-shockable rhythms. Each cycle is
- 94. 1312 C.D. Deakin et al. / Resuscitation 81 (2010) 1305–1352 broadly similar, with a total of 2 min of CPR being given before Shockable rhythms (ventricular fibrillation/pulseless assessing the rhythm and where indicated, feeling for a pulse. ventricular tachycardia) Adrenaline 1 mg is given every 3–5 min until ROSC is achieved—the timing of the initial dose of adrenaline is described below. In VF/VT, The first monitored rhythm is VF/VT in approximately 25% of a single dose of amiodarone is indicated after three unsuccessful cardiac arrests, both in-4 or out-of-hospital.248–250 VF/VT will also shocks. occur at some stage during resuscitation in about 25% of cardiac Fig. 4.2. Advanced life support cardiac arrest algorithm. © 2010 ERC.
- 95. C.D. Deakin et al. / Resuscitation 81 (2010) 1305–1352 1313 arrests with an initial documented rhythm of asystole or PEA.4 Hav- depleted of oxygen and metabolic substrates. A brief period of ing confirmed cardiac arrest, summon help (including the request chest compressions will deliver oxygen and energy substrates and for a defibrillator) and start CPR, beginning with chest compres- increase the probability of restoring a perfusing rhythm after shock sions, with a compression:ventilation (CV) ratio of 30:2. When the delivery.260 Analyses of VF waveform characteristics predictive of defibrillator arrives, continue chest compressions while applying shock success indicate that the shorter the time between chest the paddles or self-adhesive pads. Identify the rhythm and treat compression and shock delivery, the more likely the shock will according to the ALS algorithm. be successful.260,261 Reduction in the interval from compression to shock delivery by even a few seconds can increase the probability of shock success.251,252 • If VF/VT is confirmed, charge the defibrillator while another Regardless of the arrest rhythm, give adrenaline 1 mg every rescuer continues chest compressions. Once the defibrillator is 3–5 min until ROSC is achieved; in practice, this will be once every charged, pause the chest compressions, quickly ensure that all two cycles of the algorithm. If signs of life return during CPR rescuers are clear of the patient and then give one shock (360-J (purposeful movement, normal breathing, or coughing), check the monophasic or 150–200 J biphasic). monitor; if an organised rhythm is present, check for a pulse. If • Minimise the delay between stopping chest compressions and a pulse is palpable, continue post-resuscitation care and/or treat- delivery of the shock (the preshock pause); even 5–10 s delay ment of peri-arrest arrhythmia. If no pulse is present, continue CPR. will reduce the chances of the shock being successful.251,252 Providing CPR with a CV ratio of 30:2 is tiring; change the individ- • Without reassessing the rhythm or feeling for a pulse, resume CPR ual undertaking compressions every 2 min, while minimising the (CV ratio 30:2) immediately after the shock, starting with chest interruption in compressions. compressions. Even if the defibrillation attempt is successful in restoring a perfusing rhythm, it takes time until the post-shock circulation is established253 and it is very rare for a pulse to Witnessed, monitored VF/VT in the cardiac catheter lab or after be palpable immediately after defibrillation.254 Furthermore, the cardiac surgery delay in trying to palpate a pulse will further compromise the myocardium if a perfusing rhythm has not been restored.255 If a patient has a monitored and witnessed cardiac arrest in the • Continue CPR for 2 min, then pause briefly to assess the rhythm; if catheter laboratory or early after cardiac surgery: still VF/VT, give a second shock (360-J monophasic or 150–360-J biphasic). Without reassessing the rhythm or feeling for a pulse, • Confirm cardiac arrest and shout for help. resume CPR (CV ratio 30:2) immediately after the shock, starting • If the initial rhythm is VF/VT, give up to three quick successive with chest compressions. (stacked) shocks. Start chest compressions immediately after the • Continue CPR for 2 min, then pause briefly to assess the rhythm; third shock and continue CPR for 2 min. if still VF/VT, give a third shock (360-J monophasic or 150–360-J biphasic). Without reassessing the rhythm or feeling for a pulse, This three-shock strategy may also be considered for an initial, resume CPR (CV ratio 30:2) immediately after the shock, starting witnessed VF/VT cardiac arrest if the patient is already connected with chest compressions. If IV/IO access has been obtained, give to a manual defibrillator. Although there are no data supporting a adrenaline 1 mg and amiodarone 300 mg once compressions have three-shock strategy in any of these circumstances, it is unlikely resumed. If ROSC has not been achieved with this 3rd shock the that chest compressions will improve the already very high chance adrenaline will improve myocardial blood flow and may increase of return of spontaneous circulation when defibrillation occurs the chance of successful defibrillation with the next shock. In early in the electrical phase, immediately after onset of VF (see animal studies, peak plasma concentrations of adrenaline occur Section 3).223 at about 90 s after a peripheral injection.256 If ROSC has been achieved after the 3rd shock it is possible that the bolus dose of Precordial thump adrenaline will cause tachycardia and hypertension and precip- itate recurrence of VF. However, naturally occurring adrenaline A single precordial thump has a very low success rate for plasma concentrations are high immediately after ROSC,257 and cardioversion of a shockable rhythm262–264 and is only likely to any additional harm caused by exogenous adrenaline has not succeed if given within the first few seconds of the onset of a been studied. Interrupting chest compressions to check for a per- shockable rhythm.265 There is more success with pulseless VT than fusing rhythm midway in the cycle of compressions is also likely with VF. Delivery of a precordial thump must not delay calling for to be harmful. The use of waveform capnography may enable help or accessing a defibrillator. It is therefore appropriate therapy ROSC to be detected without pausing chect compressions and only when several clinicians are present at a witnessed, monitored may be a way of avoiding a bolus injection of adenaline after arrest, and when a defibrillator is not immediately to hand (see Sec- ROSC has been achieved. Two prospective human studies have tion 3).223,266 In practice, this is only likely to be in a critical care shown that a significant increase in end-tidal CO2 occurs when environment such as the emergency department or ICU.264 return of spontaneous circulation occurs.258,259 A precordial thump should be undertaken immediately after • After each 2-min cycle of CPR, if the rhythm changes to asystole confirmation of cardiac arrest and only by healthcare professionals or PEA, see ‘non-shockable rhythms’ below. If a non-shockable trained in the technique. Using the ulnar edge of a tightly clenched rhythm is present and the rhythm is organised (complexes appear fist, deliver a sharp impact to the lower half of the sternum from a regular or narrow), try to palpate a pulse. Rhythm checks should height of about 20 cm, then retract the fist immediately to create an be brief, and pulse checks should be undertaken only if an organ- impulse-like stimulus. There are very rare reports of a precordial ised rhythm is observed. If there is any doubt about the presence thump converting a perfusing to a non-perfusing rhythm.267 of a pulse in the presence of an organised rhythm, resume CPR. If ROSC has been achieved, begin post-resuscitation care Airway and ventilation During treatment of VF/VT, healthcare providers must prac- During the treatment of persistent VF, ensure good-quality chest tice efficient coordination between CPR and shock delivery. When compressions between defibrillation attempts. Consider reversible VF is present for more than a few minutes, the myocardium is causes (4 Hs and 4 Ts) and, if identified, correct them. Check the
- 96. 1314 C.D. Deakin et al. / Resuscitation 81 (2010) 1305–1352 electrode/defibrillating paddle positions and contacts, and the ade- Drug delivery via a supraglottic airway device is even less reliable quacy of the coupling medium, e.g., gel pads. Tracheal intubation and should not be attempted.278 provides the most reliable airway, but should be attempted only if the healthcare provider is properly trained and has regular, ongo- Adrenaline ing experience with the technique. Personnel skilled in advanced Despite the widespread use of adrenaline during resuscitation, airway management should attempt laryngoscopy and intubation and several studies involving vasopressin, there is no placebo- without stopping chest compressions; a brief pause in chest com- controlled study that shows that the routine use of any vasopressor pressions may be required as the tube is passed between the vocal at any stage during human cardiac arrest increases neurologically cords, but this pause should not exceed 10 s. Alternatively, to avoid intact survival to hospital discharge. Current evidence is insuffi- any interruptions in chest compressions, the intubation attempt cient to support or refute the routine use of any particular drug may be deferred until return of spontaneous circulation. No studies or sequence of drugs. Despite the lack of human data, the use have shown that tracheal intubation increases survival after cardiac of adrenaline is still recommended, based largely on animal data arrest. After intubation, confirm correct tube position and secure it and increased short-term survival in humans.245,246 The alpha- adequately. Ventilate the lungs at 10 breaths min−1 ; do not hyper- adrenergic actions of adrenaline cause vasoconstriction, which ventilate the patient. Once the patient’s trachea has been intubated, increases myocardial and cerebral perfusion pressure. The higher continue chest compressions, at a rate of 100 min−1 without paus- coronary blood flow increases the frequency and amplitude of ing during ventilation. A pause in the chest compressions enables the VF waveform and should improve the chance of restoring a the coronary perfusion pressure to fall substantially. On resuming circulation when defibrillation is attempted.260,279,280 Although compressions there is some delay before the original coronary per- adrenaline improves short-term survival, animal data indicate fusion pressure is restored, thus chest compressions that are not that it impairs the microcirculation281,282 and post-cardiac arrest interrupted for ventilation (or any reason) result in a substantially myocardial dysfunction,283,284 which both might impact on long- higher mean coronary perfusion pressure. term outcome. The optimal dose of adrenaline is not known, and In the absence of personnel skilled in tracheal intubation, a there are no data supporting the use of repeated doses. There are supraglottic airway device (e.g., laryngeal mask airway) is an few data on the pharmacokinetics of adrenaline during CPR. The acceptable alternative (Section 4e). Once a supraglottic airway optimal duration of CPR and number of shocks that should be given device has been inserted, attempt to deliver continuous chest before giving drugs is unknown. On the basis of expert consensus, compressions, uninterrupted during ventilation. If excessive gas for VF/VT give adrenaline after the third shock once chest compres- leakage causes inadequate ventilation of the patient’s lungs, chest sions have resumed, and then repeat every 3–5 min during cardiac compressions will have to be interrupted to enable ventilation arrest (alternate cycles). Do not interrupt CPR to give drugs. (using a CV ratio of 30:2). Intravenous access and drugs Anti-arrhythmic drugs There is no evidence that giving any anti-arrhythmic drug rou- Peripheral versus central venous drug delivery tinely during human cardiac arrest increases survival to hospital Establish intravenous access if this has not already been discharge. In comparison with placebo285 and lidocaine,286 the achieved. Although peak drug concentrations are higher and cir- use of amiodarone in shock-refractory VF improves the short-term culation times are shorter when drugs are injected into a central outcome of survival to hospital admission. In these studies, the venous catheter compared with a peripheral cannula,268 insertion anti-arrhythmic therapy was given if VF/VT persisted after at least of a central venous catheter requires interruption of CPR and is asso- three shocks; however, these were delivered using the conven- ciated with several complications. Peripheral venous cannulation tional three-stacked shocks strategy. There are no data on the use is quicker, easier to perform and safer. Drugs injected peripherally of amiodarone for shock-refractory VF/VT when single shocks are must be followed by a flush of at least 20 ml of fluid and elevation used. On the basis of expert consensus, if VF/VT persists after three of the extremity for 10–20 s to facilitate drug delivery to the central shocks, give 300 mg amiodarone by bolus injection. A further dose circulation. of 150 mg may be given for recurrent or refractory VF/VT, followed by an infusion of 900 mg over 24 h. Lidocaine, 1 mg kg−1 , may be Intraosseous route used as an alternative if amiodarone is not available, but do not If intravenous access is difficult or impossible, consider the IO give lidocaine if amiodarone has been given already. route. Although normally considered as an alternative route for vas- cular access in children, it is now established as an effective route in Magnesium adults.269 Intraosseous injection of drugs achieves adequate plasma The routine use of magnesium in cardiac arrest does not increase concentrations in a time comparable with injection through a cen- survival.287–291 and is not recommended in cardiac arrest unless tral venous catheter.270 The recent availability of mechanical IO torsades de pointes is suspected (see peri-arrest arrhythmias). devices has increased the ease of performing this technique.271 Tracheal route Bicarbonate Unpredictable plasma concentrations are achieved when drugs Routine administration of sodium bicarbonate during cardiac are given via a tracheal tube, and the optimal tracheal dose arrest and CPR or after return of spontaneous circulation is not rec- of most drugs is unknown. During CPR, the equipotent dose of ommended. Give sodium bicarbonate (50 mmol) if cardiac arrest adrenaline given via the trachea is three to ten times higher than is associated with hyperkalaemia or tricyclic antidepressant over- the intravenous dose.272,273 Some animal studies suggest that the dose; repeat the dose according to the clinical condition and the lower adrenaline concentrations achieved when the drug is given result of serial blood gas analysis. During cardiac arrest, arterial via the trachea may produce transient beta-adrenergic effects, blood gas values do not reflect the acid–base state of the tissues292 ; which will cause hypotension and lower coronary artery perfusion the tissue pH will be lower than that in arterial blood. If a central pressure.274–277 Given the completely unreliable plasma concen- venous catheter is in situ, central venous blood gas analysis will pro- trations achieved and increased availability of suitable IO devices, vide a closer estimate of tissue acid/base state than that provided the tracheal route for drug delivery is no longer recommended. by arterial blood.
- 97. C.D. Deakin et al. / Resuscitation 81 (2010) 1305–1352 1315 Persistent ventricular fibrillation/pulseless ventricular tachycardia of memory, these are divided into two groups of four based upon their initial letter: either H or T. More details on many of these In VF/VT persists, consider changing the position of the conditions are covered in Section 8.294 pads/paddles (see Section 3).223 Review all potentially reversible causes (see below) and treat any that are identified. Persistent Use of ultrasound imaging during advanced life support VF/VT may be an indication for percutaneous coronary interven- tion or thrombolysis—in these cases, a mechanical device CPR may Several studies have examined the use of ultrasound during help to maintain high-quality CPR for a prolonged period.293 cardiac arrest to detect potentially reversible causes. Although no The duration of any individual resuscitation attempt is a matter studies have shown that use of this imaging modality improves out- of clinical judgement, taking into consideration the circumstances come, there is no doubt that echocardiography has the potential to and the perceived prospect of a successful outcome. If it was con- detect reversible causes of cardiac arrest (e.g., cardiac tamponade, sidered appropriate to start resuscitation, it is usually considered pulmonary embolism, ischaemia (regional wall motion abnor- worthwhile continuing, as long as the patient remains in VF/VT. mality), aortic dissection, hypovolaemia, pneumothorax).295–302 When available for use by trained clinicians, ultrasound may be Non-shockable rhythms (PEA and asystole) of use in assisting with diagnosis and treatment of potentially reversible causes of cardiac arrest. The integration of ultrasound Pulseless electrical activity (PEA) is defined as cardiac arrest in into advanced life support requires considerable training if inter- the presence of electrical activity that would normally be associated ruptions to chest compressions are to be minimised. A sub-xiphoid with a palpable pulse. These patients often have some mechani- probe position has been recommended.295,301,303 Placement of the cal myocardial contractions, but these are too weak to produce a probe just before chest compressions are paused for a planned detectable pulse or blood pressure—this sometimes described as rhythm assessment enables a well-trained operator to obtain views ‘pseudo-PEA’ (see below). PEA is often caused by reversible con- within 10 s. ditions, and can be treated if those conditions are identified and Absence of cardiac motion on sonography during resuscitation corrected. Survival following cardiac arrest with asystole or PEA is of patients in cardiac arrest is highly predictive of death304–306 unlikely unless a reversible cause can be found and treated effec- although sensitivity and specificity has not been reported. tively. If the initial monitored rhythm is PEA or asystole, start CPR 30:2 The four ‘Hs’ and give adrenaline 1 mg as soon as venous access is achieved. If asystole is displayed, check without stopping CPR, that the leads are Minimise the risk of hypoxia by ensuring that the patient’s lungs attached correctly. Once an advanced airway has been sited, con- are ventilated adequately with 100% oxygen during CPR. Make sure tinue chest compressions without pausing during ventilation. After there is adequate chest rise and bilateral breath sounds. Using the 2 min of CPR, recheck the rhythm. If asystole is present, resume CPR techniques described in Section 4e, check carefully that the tracheal immediately. If an organised rhythm is present, attempt to palpate tube is not misplaced in a bronchus or the oesophagus. a pulse. If no pulse is present (or if there is any doubt about the pres- Pulseless electrical activity caused by hypovolaemia is due usu- ence of a pulse), continue CPR. Give adrenaline 1 mg (IV/IO) every ally to severe haemorrhage. This may be precipitated by trauma alternate CPR cycle (i.e., about every 3–5 min) once vascular access (Section 8h),294 gastrointestinal bleeding or rupture of an aortic is obtained. If a pulse is present, begin post-resuscitation care. If aneurysm. Intravascular volume should be restored rapidly with signs of life return during CPR, check the rhythm and attempt to warmed fluid, coupled with urgent surgery to stop the haemor- palpate a pulse. rhage. Hyperkalaemia, hypokalaemia, hypocalcaemia, acidaemia Whenever a diagnosis of asystole is made, check the ECG care- and other metabolic disorders are detected by biochemical tests fully for the presence of P waves, because this may respond to or suggested by the patient’s medical history, e.g., renal failure cardiac pacing. There is no benefit in attempting to pace true (Section 8a).294 A 12-lead ECG may be diagnostic. Intravenous asystole. If there is doubt about whether the rhythm is asys- calcium chloride is indicated in the presence of hyperkalaemia, tole or fine VF, do not attempt defibrillation; instead, continue hypocalcaemia and calcium channel-blocker overdose. Suspect chest compressions and ventilation. Fine VF that is difficult to hypothermia in any drowning incident (Sections 8c and d)294 ; use distinguish from asystole will not be shocked successfully into a a low-reading thermometer. perfusing rhythm. Continuing good-quality CPR may improve the amplitude and frequency of the VF and improve the chance of suc- The four ‘Ts’ cessful defibrillation to a perfusing rhythm. Delivering repeated shocks in an attempt to defibrillate what is thought to be fine A tension pneumothorax may be the primary cause of PEA VF will increase myocardial injury, both directly from the elec- and may follow attempts at central venous catheter insertion. The tricity and indirectly from the interruptions in coronary blood diagnosis is made clinically. Decompress rapidly by needle thora- flow. cocentesis, and then insert a chest drain. In the context of cardiac During the treatment of asystole or PEA, following a 2-min cycle arrest from major trauma, bilateral thoracostomies may provide of CPR, if the rhythm has changed to VF, follow the algorithm for a more reliable way of decompressing a suspected tension pneu- shockable rhythms. Otherwise, continue CPR and give adrenaline mothorax. every 3–5 min following the failure to detect a palpable pulse with Cardiac tamponade is difficult to diagnose because the typical the pulse check. If VF is identified on the monitor midway through a signs of distended neck veins and hypotension are usually obscured 2-min cycle of CPR, complete the cycle of CPR before formal rhythm by the arrest itself. Cardiac arrest after penetrating chest trauma and shock delivery if appropriate—this strategy will minimise inter- is highly suggestive of tamponade and is an indication for nee- ruptions in chest compressions. dle pericardiocentesis or resuscitative thoracotomy (see Section 8h).294 The increasing use of ultrasound is making the diagnosis Potentially reversible causes of cardiac tamponade much more reliable. In the absence of a specific history, the accidental or deliberate Potential causes or aggravating factors for which specific treat- ingestion of therapeutic or toxic substances may be revealed only ment exists must be considered during any cardiac arrest. For ease by laboratory investigations (Section 8b).294 Where available, the
- 98. 1316 C.D. Deakin et al. / Resuscitation 81 (2010) 1305–1352 appropriate antidotes should be used, but most often treatment is normal breathing pattern of synchronous movement upwards and supportive and standard ALS protocols should be followed. outwards of the abdomen (pushed down by the diaphragm) with The commonest cause of thromboembolic or mechanical cir- the lifting of the chest wall. During airway obstruction, other culatory obstruction is massive pulmonary embolus. If pulmonary accessory muscles of respiration are used, with the neck and the embolism is a possible cause of the cardiac arrest, consider giving shoulder muscles contracting to assist movement of the thoracic a fibrinolytic drug immediately (Section 4f).307 cage. Full examination of the neck, chest and abdomen is required to differentiate the paradoxical movements that may mimic nor- 4e Airway management and ventilation mal respiration. The examination must include listening for the absence of breath sounds in order to diagnose complete airway obstruction reliably; any noisy breathing indicates partial airway Introduction obstruction. During apnoea, when spontaneous breathing move- ments are absent, complete airway obstruction is recognised by Patients requiring resuscitation often have an obstructed air- failure to inflate the lungs during attempted positive pressure ven- way, usually secondary to loss of consciousness, but occasionally tilation. Unless airway patency can be re-established to enable it may be the primary cause of cardiorespiratory arrest. Prompt adequate lung ventilation within a period of a very few minutes, assessment, with control of the airway and ventilation of the lungs, neurological and other vital organ injury may occur, leading to is essential. This will help to prevent secondary hypoxic damage to cardiac arrest. the brain and other vital organs. Without adequate oxygenation it may be impossible to restore a spontaneous cardiac output. These principles may not apply to the witnessed primary cardiac arrest in Basic airway management the vicinity of a defibrillator; in this case, the priority is immediate defibrillation. Once any degree of obstruction is recognised, immediate mea- sures must be taken to create and maintain a clear airway. There are three manoeuvres that may improve the patency of an airway Airway obstruction obstructed by the tongue or other upper airway structures: head tilt, chin lift, and jaw thrust. Causes of airway obstruction Obstruction of the airway may be partial or complete. It may Head tilt and chin lift occur at any level, from the nose and mouth down to the trachea. In the unconscious patient, the commonest site of airway obstruc- The rescuer’s hand is placed on the patient’s forehead and the tion is at the soft palate and epiglottis.308,309 Obstruction may also head gently tilted back; the fingertips of the other hand are placed be caused by vomit or blood (regurgitation of gastric contents or under the point of the patient’s chin, which is lifted gently to stretch trauma), or by foreign bodies. Laryngeal obstruction may be caused the anterior neck structures (Fig. 4.3).310–315 by oedema from burns, inflammation or anaphylaxis. Upper airway stimulation may cause laryngeal spasm. Obstruction of the airway below the larynx is less common, but may arise from excessive bronchial secretions, mucosal oedema, bronchospasm, pulmonary oedema or aspiration of gastric contents. Recognition of airway obstruction Airway obstruction can be subtle and is often missed by health- care professionals, let alone by laypeople. The ‘look, listen and feel’ approach is a simple, systematic method of detecting airway obstruction. • Look for chest and abdominal movements. • Listen and feel for airflow at the mouth and nose. In partial airway obstruction, air entry is diminished and usually noisy. Inspiratory stridor is caused by obstruction at the laryngeal level or above. Expiratory wheeze implies obstruction of the lower airways, which tend to collapse and obstruct during expiration. Other characteristic sounds include: • Gurgling is caused by liquid or semisolid foreign material in the large airways. • Snoring arises when the pharynx is partially occluded by the soft palate or epiglottis. • Crowing is the sound of laryngeal spasm. In a patient who is making respiratory efforts, complete airway obstruction causes paradoxical chest and abdominal movement, often described as ‘see-saw’ breathing. As the patient attempts to breathe in, the chest is drawn in and the abdomen expands; the opposite occurs during expiration. This is in contrast to the Fig. 4.3. Head tilt and chin lift.
- 99. C.D. Deakin et al. / Resuscitation 81 (2010) 1305–1352 1317 Adjuncts to basic airway techniques Despite a total lack of published data on the use of nasopharyn- geal and oropharyngeal airways during CPR, they are often helpful, and sometimes essential, to maintain an open airway, particularly when resuscitation is prolonged. The position of the head and neck must be maintained to keep the airway aligned. Oropharyngeal and nasopharyngeal airways overcome backward displacement of the soft palate and tongue in an unconscious patient, but head tilt and jaw thrust may also be required. Oropharyngeal airways Oropharyngeal airways are available in sizes suitable for the newborn to large adults. An estimate of the size required is obtained by selecting an airway with a length corresponding to the vertical distance between the patient’s incisors and the angle of the jaw. The most common sizes are 2, 3 and 4 for small, medium and large adults, respectively. If the glossopharyngeal and laryngeal reflexes are present, insertion of an oropharyngeal may cause airway vomiting or laryngospasm; thus, insertion should be attempted only in comatose patients (Fig. 4.5). The oropharyngeal airway can become obstructed at three possible sites:323 part of the tongue can occlude the end of the airway; the airway can lodge in the vallecula; and the airway can be obstructed by the epiglottis. Nasopharyngeal airways In patients who are not deeply unconscious, a nasopharyn- Fig. 4.4. Jaw thrust. geal airway is tolerated better than an oropharyngeal airway. The nasopharyngeal airway may be life saving in patients with clenched jaws, trismus or maxillofacial injuries, when insertion of an oral airway is impossible. Inadvertent insertion of a nasopharyngeal air- Jaw thrust way through a fracture of the skull base and into the cranial vault is possible, but extremely rare.324,325 In the presence of a known Jaw thrust is an alternative manoeuvre for bringing the or suspected basal skull fracture an oral airway is preferred but, if mandible forward and relieving obstruction by the soft palate and this is not possible and the airway is obstructed, gentle insertion of epiglottis. The rescuer’s index and other fingers are placed behind a nasopharyngeal airway may be life saving (i.e., the benefits may the angle of the mandible, and pressure is applied upwards and far outweigh the risks). forwards. Using the thumbs, the mouth is opened slightly by down- ward displacement of the chin (Fig. 4.4). These simple positional methods are successful in most cases where airway obstruction results from relaxation of the soft tissues. If a clear airway cannot be achieved, look for other causes of airway obstruction. Use a finger sweep, forceps or suction to remove any solid foreign body seen in the mouth. Remove broken or displaced dentures, but leave well-fitting dentures as they help to maintain the contours of the mouth, facilitating a good seal for ventilation. Airway management in patients with suspected cervical spine injury If spinal injury is suspected (e.g., if the victim has fallen, been struck on the head or neck, or has been rescued after diving into shallow water), maintain the head, neck, chest and lumbar region in the neutral position during resuscitation. Excessive head tilt could aggravate the injury and damage the cervical spinal cord;316–320 however, this complication has not been documented and the rel- ative risk is unknown. When there is a risk of cervical spine injury, establish a clear upper airway by using jaw thrust or chin lift in combination with manual in-line stabilisation (MILS) of the head and neck by an assistant.321,322 If life-threatening airway obstruc- tion persists despite effective application of jaw thrust or chin lift, add head tilt in small increments until the airway is open; establish- ing a patent airway takes priority over concerns about a potential cervical spine injury. Fig. 4.5. Insertion of oropharyngeal airway.
- 100. 1318 C.D. Deakin et al. / Resuscitation 81 (2010) 1305–1352 The tubes are sized in millimetres according to their internal diameter, and the length increases with diameter. The traditional methods of sizing a nasopharyngeal airway (measurement against the patient’s little finger or anterior nares) do not correlate with the airway anatomy and are unreliable.326 Sizes of 6–7 mm are suitable for adults. Insertion can cause damage to the mucosal lining of the nasal airway, resulting in bleeding in up to 30% of cases.327 If the tube is too long it may stimulate the laryngeal or glossopharyngeal reflexes to produce laryngospasm or vomiting. Oxygen During CPR, give oxygen whenever it is available. There are no data to indicate the optimal arterial blood oxygen saturation (SaO2 ) during CPR. There are animal data328 and some observational clini- cal data indicating an association between high SaO2 after ROSC and worse outcome.329 A standard oxygen mask will deliver up to 50% oxygen concentration, providing the flow of oxygen is high enough. A mask with a reservoir bag (non-rebreathing mask), can deliver an inspired oxygen concentration of 85% at flows of 10–15 l min−1 . Initially, give the highest possible oxygen concentration. As soon as the arterial blood oxygen saturation can be measured reliably, by pulse oximeter (SpO2 ) or arterial blood gas analysis, titrate the inspired oxygen concentration to achieve an arterial blood oxygen saturation in the range of 94–98%. Fig. 4.6. Mouth-to-mask ventilation. Suction Use a wide-bore rigid sucker (Yankauer) to remove liquid (blood, saliva and gastric contents) from the upper airway. Use the sucker give two ventilations after each sequence of 30 chest compres- cautiously if the patient has an intact gag reflex; pharyngeal stim- sions. ulation can provoke vomiting. Self-inflating bag Ventilation The self-inflating bag can be connected to a facemask, tracheal Provide artificial ventilation as soon as possible for any patient in tube or supraglottic airway device (SAD). Without supplemental whom spontaneous ventilation is inadequate or absent. Expired air oxygen, the self-inflating bag ventilates the patient’s lungs with ventilation (rescue breathing) is effective, but the rescuer’s expired ambient air (21% oxygen). The delivered oxygen concentration can oxygen concentration is only 16–17%, so it must be replaced as soon be increased to about 85% by using a reservoir system and attaching as possible by ventilation with oxygen-enriched air. The pocket oxygen at a flow 10 l min−1 . resuscitation mask is used widely. It is similar to an anaesthetic Although the bag-mask device enables ventilation with high facemask, and enables mouth-to-mask ventilation. It has a unidi- concentrations of oxygen, its use by a single person requires con- rectional valve, which directs the patient’s expired air away from siderable skill. When used with a face mask, it is often difficult to the rescuer. The mask is transparent so that vomit or blood from the achieve a gas-tight seal between the mask and the patient’s face, patient can be seen. Some masks have a connector for the addition and to maintain a patent airway with one hand while squeezing of oxygen. When using masks without a connector, supplemental the bag with the other.330 Any significant leak will cause hypoven- oxygen can be given by placing the tubing underneath one side and tilation and, if the airway is not patent, gas may be forced into ensuring an adequate seal. Use a two-hand technique to maximise the stomach.331,332 This will reduce ventilation further and greatly the seal with the patient’s face (Fig. 4.6). increase the risk of regurgitation and aspiration.333 Cricoid pres- High airway pressures can be generated if the tidal volume or sure can reduce this risk334,335 but requires the presence of a trained inspiratory flow is excessive, predisposing to gastric inflation and assistant. Poorly applied cricoid pressure may make it more difficult subsequent risk of regurgitation and pulmonary aspiration. The to ventilate the patient’s lungs.334,336–339 possibility of gastric inflation is increased by: The two-person technique for bag-mask ventilation is prefer- able (Fig. 4.7). One person holds the facemask in place using a jaw • malalignment of the head and neck, and an obstructed airway; thrust with both hands, and an assistant squeezes the bag. In this • an incompetent oesophageal sphincter (present in all patients way, a better seal can be achieved and the patient’s lungs can be with cardiac arrest); ventilated more effectively and safely. • a high airway inflation pressure. Once a tracheal tube or a supraglottic airway device has been inserted, ventilate the lungs at a rate of 10 breaths min−1 and con- Conversely, if inspiratory flow is too low, inspiratory time will tinue chest compressions without pausing during ventilations. The be prolonged and the time available to give chest compressions laryngeal seal achieved with a supraglottic airway device is unlikely is reduced. Deliver each breath over approximately 1 s and trans- to be good enough to prevent at least some gas leaking when inspi- fer a volume that corresponds to normal chest movement; this ration coincides with chest compressions. Moderate gas leakage is represents a compromise between giving an adequate volume, acceptable, particularly as most of this gas will pass up through the minimising the risk of gastric inflation, and allowing adequate time patient’s mouth. If excessive gas leakage results in inadequate ven- for chest compressions. During CPR with an unprotected airway, tilation of the patient’s lungs, chest compressions will have to be
- 101. C.D. Deakin et al. / Resuscitation 81 (2010) 1305–1352 1319 A manikin study of simulated cardiac arrest and a study involv- ing fire-fighters ventilating the lungs of anaesthetised patients both showed a significant decrease in gastric inflation with manually- triggered flow-limited oxygen-powered resuscitators and mask compared with a bag-mask.345,346 However, the effect of automatic resuscitators on gastric inflation in humans in cardiac arrest has not been studied, and there are no data demonstrating clear benefit over bag-valve-mask devices. Passive oxygen delivery In the presence of a patent airway, chest compressions alone may result in some ventilation of the lungs.347 Oxygen can be deliv- ered passively, either via an adapted tracheal tube (Boussignac tube),348,349 or with the combination of an oropharyngeal air- way and standard oxygen mask with non-rebreather reservoir.350 Although one study has shown higher neurologically intact survival with passive oxygen delivery (oral airway and oxygen mask) com- pared with bag-mask ventilation after out-of-hospital VF cardiac arrest, this was a retrospective analysis and is subject to numer- ous confounders.350 There is insufficient evidence to support or refute the use of passive oxygen delivery during CPR to improve outcome when compared with oxygen delivery by positive pres- sure ventilation. Until further data are available, passive oxygen delivery without ventilation is not recommended for routine use Fig. 4.7. The two-person technique for bag-mask ventilation. during CPR. interrupted to enable ventilation, using a compression-ventilation Alternative airway devices ratio of 30:2. The tracheal tube has generally been considered the opti- Automatic ventilators mal method of managing the airway during cardiac arrest. There is evidence that, without adequate training and experience, the Very few studies address specific aspects of ventilation dur- incidence of complications, such as unrecognised oesophageal intu- ing advanced life support. There is some data indicating that the bation (6–17% in several studies involving paramedics)351–354 and ventilation rates delivered by healthcare personnel during cardiac dislodgement, is unacceptably high.355 Prolonged attempts at tra- arrest are excessive,242,340,341 although other studies have shown cheal intubation are harmful; the cessation of chest compressions more normal ventilation rates.245,342,343 Automatic ventilators or during this time will compromise coronary and cerebral perfusion. resuscitators provide a constant flow of gas to the patient during Several alternative airway devices have been considered for air- inspiration; the volume delivered is dependent on the inspiratory way management during CPR. There are published studies on the time (a longer time provides a greater tidal volume). Because pres- use during CPR of the Combitube, the classic laryngeal mask air- sure in the airway rises during inspiration, these devices are often way (cLMA), the laryngeal tube (LT) and the I-gel, but none of these pressure limited to protect the lungs against barotrauma. An auto- studies have been powered adequately to enable survival to be matic ventilator can be used with either a facemask or other airway studied as a primary endpoint; instead, most researchers have stud- device (e.g., tracheal tube, supraglottic airway device). ied insertion and ventilation success rates. The supraglottic airway An automatic resuscitator should be set initially to deliver a tidal devices (SADs) are easier to insert than a tracheal tube and, unlike volume of 6–7 ml kg−1 at 10 breaths min−1 . Some ventilators have tracheal intubation, can generally be inserted without interrupting coordinated markings on the controls to facilitate easy and rapid chest compressions.356 adjustment for patients of different sizes, and others are capable of There are no data supporting the routine use of any specific sophisticated variation in respiratory parameters. In the presence approach to airway management during cardiac arrest. The best of a spontaneous circulation, the correct setting will be determined technique is dependent on the precise circumstances of the cardiac by analysis of the patient’s arterial blood gases. arrest and the competence of the rescuer. Automatic resuscitators provide many advantages over alterna- tive methods of ventilation. Laryngeal mask airway (LMA) • In unintubated patients, the rescuer has both hands free for mask The laryngeal mask airway (Fig. 4.8) is quicker and easier to and airway alignment. insert than a tracheal tube.357–364 The original LMA (cLMA), which • Cricoid pressure can be applied with one hand while the other is reusable, has been studied during CPR, but none of these stud- seals the mask on the face. ies has compared it directly with the tracheal tube. A wide variety • In intubated patients they free the rescuer for other tasks.344 of single-use LMAs are used for CPR, but they have different char- • Once set, they provide a constant tidal volume, respiratory rate acteristics to the cLMA and there are no published data on their and minute ventilation; thus, they may help to avoid excessive performance in this setting.365 Reported rates of successful venti- ventilation. lation during CPR with the LMA are very high for in-hospital studies • Are associated with lower peak airway pressures than manual (86–100%)366–369 but generally less impressive (71–90%)370–372 for ventilation, which reduces intrathoracic pressure and facilitates out-of-hospital cardiac arrest (OHCA). The reason for the relatively improved venous return and subsequent cardiac output. disappointing results from the LMA in OHCA is not clear.
- 102. 1320 C.D. Deakin et al. / Resuscitation 81 (2010) 1305–1352 Fig. 4.9. Laryngeal tube. © 2010 ERC. Fig. 4.8. Insertion of a laryngeal mask airway. In a manikin CPR study, use of the LT-D reduced the no-flow time significantly in comparison with use of a tracheal tube.386 When used by inexperienced personnel, ventilation of the lungs of anaesthetised patients is more efficient and easier with an LMA I-gel than with a bag-mask.330 When an LMA can be inserted with- out delay it is preferable to avoid bag-mask ventilation altogether. The cuff of the I-gel is made of thermoplastic elastomer gel In comparison with bag-mask ventilation, use of a self-inflating (styrene ethylene butadene styrene) and does not require infla- bag and LMA during cardiac arrest reduces the incidence of tion; the stem of the I-gel incorporates a bite block and a narrow regurgitation.333 One study showed similar arterial blood gas oesophageal drain tube (Fig. 4.10). It is very easy to insert, values in patients successfully resuscitated after out-of-hospital requiring only minimal training and a laryngeal seal pressure cardiac arrest when either an LMA or bag mask was used.373 of 20–24 cm H2 O can be achieved.387,388 In two manikin studies, In comparison with tracheal intubation, the perceived disadvan- insertion of the I-gel was significantly faster than several other tages of the LMA are the increased risk of aspiration and inability airway devices.356,389 The ease of insertion of the I-gel and its to provide adequate ventilation in patients with low lung and/or favourable leak pressure make it theoretically very attractive as chest-wall compliance. There are no data demonstrating whether a resuscitation airway device for those inexperienced in tracheal or not it is possible to provide adequate ventilation via an LMA with- intubation. Use of the I-gel during cardiac arrest has been reported out interruption of chest compressions. The ability to ventilate the but more data on its use in this setting are awaited.390,391 lungs adequately while continuing to compress the chest may be one of the main benefits of a tracheal tube. There are remarkably Other airway devices few cases of pulmonary aspiration reported in the studies of the LMA during CPR. ProSeal LMA The ProSeal LMA (PLMA) has been studied extensively in anaes- Combitube thetised patients, but there are no studies of its function and performance during CPR. It has several attributes that, in the- The Combitube is a double-lumen tube introduced blindly over ory, make it more suitable than the cLMA for use during CPR: the tongue, and provides a route for ventilation whether the tube improved seal with the larynx enabling ventilation at higher airway has passed into the oesophagus. There are many studies of the Com- bitube in CPR and successful ventilation was achieved in 79–98% of patients.371,374–381 Two RCTs of the Combitube versus tracheal intubation for out-of-hospital cardiac arrest showed no difference in survival.380,381 Use of the Combitube is waning and in many parts of the world it is being replaced by other devices such as the LT. Laryngeal tube The LT was introduced in 2001 (Fig. 4.9); it is known as the King LT airway in the United States. In anaesthetised patients, the perfor- mance of the LT is favourable in comparison with the classic LMA and ProSeal LMA.382,383 After just 2 h of training, nurses success- fully inserted a laryngeal tube and achieved ventilation in 24 of 30 (80%) of OHCAs.384 A disposable version of the laryngeal tube (LT- D) is available and was inserted successfully by paramedics in 92 OHCAs (85 on the first attempt and 7 on the second attempt).385 Fig. 4.10. I-gel. © 2010 ERC.
- 103. C.D. Deakin et al. / Resuscitation 81 (2010) 1305–1352 1321 pressures,392 the inclusion of a gastric drain tube enabling venting (IQR 54–198 s; range 13–446 s) and in 25% the interruptions were of liquid regurgitated gastric contents from the upper oesophagus more than 3 min.405 Tracheal intubation attempts accounted for and passage of a gastric tube to drain liquid gastric contents, and almost 25% of all CPR interruptions. the inclusion of a bite block. The PLMA is slightly more difficult to • A comparatively high failure rate. Intubation success rates cor- insert than a cLMA and is relatively expensive. The Supreme LMA relate with the intubation experience attained by individual (SLMA) is a disposable version of the PLMA. Studies in anaesthetised paramedics.406 Rates for failure to intubate are as high as 50% patients indicate that it is relatively easy to insert and laryngeal seal in prehospital systems with a low patient volume and providers pressures of 24–28 cm H2 O can be achieved.393–395 Data on the use who do not perform intubation frequently.407,408 of the SLMA during cardiac arrest are awaited. Healthcare personnel who undertake prehospital intubation should do so only within a structured, monitored programme, Intubating LMA which should include comprehensive competency-based training The intubating LMA (ILMA) is relatively easy to insert396,397 but and regular opportunities to refresh skills. Rescuers must weigh the subsequent blind insertion of a tracheal tube generally requires risks and benefits of intubation against the need to provide effec- more training.398 One study has documented use of the ILMA after tive chest compressions. The intubation attempt may require some failed intubation by direct laryngoscopy in 24 cardiac arrests by interruption of chest compressions but, once an advanced airway is prehospital physicians in France.399 in place, ventilation will not require interruption of chest compres- sions. Personnel skilled in advanced airway management should be Tracheal intubation able to undertake laryngoscopy without stopping chest compres- sions; a brief pause in chest compressions will be required only as There is insufficient evidence to support or refute the use of the tube is passed through the vocal cords. Alternatively, to avoid any specific technique to maintain an airway and provide ventila- any interruptions in chest compressions, the intubation attempt tion in adults with cardiopulmonary arrest. Despite this, tracheal may be deferred until return of spontaneous circulation.350,409 intubation is perceived as the optimal method of providing and No intubation attempt should interrupt chest compressions for maintaining a clear and secure airway. It should be used only when more than 10 s; if intubation is achievable within these constraints, trained personnel are available to carry out the procedure with a recommence bag-mask ventilation. After intubation, tube place- high level of skill and confidence. A recent systematic review of ment must be confirmed and the tube secured adequately. randomised controlled trials (RCTs) of tracheal intubation versus alternative airway management in acutely ill and injured patients Confirmation of correct placement of the tracheal tube identified just three trials400 : two were RCTs of the Combitube versus tracheal intubation for out-of-hospital cardiac arrest,380,381 Unrecognised oesophageal intubation is the most serious com- which showed no difference in survival. The third study was a plication of attempted tracheal intubation. Routine use of primary RCT of prehospital tracheal intubation versus management of the and secondary techniques to confirm correct placement of the tra- airway with a bag-mask in children requiring airway manage- cheal tube should reduce this risk. ment for cardiac arrest, primary respiratory disorders and severe injuries.401 There was no overall benefit for tracheal intubation; on Clinical assessment the contrary, of the children requiring airway management for a Primary assessment includes observation of chest expansion respiratory problem, those randomised to intubation had a lower bilaterally, auscultation over the lung fields bilaterally in the axil- survival rate that those in the bag-mask group. The Ontario Prehos- lae (breath sounds should be equal and adequate) and over the pital Advanced Life Support (OPALS) study documented no increase epigastrium (breath sounds should not be heard). Clinical signs of in survival to hospital discharge when the skills of tracheal intuba- correct tube placement (condensation in the tube, chest rise, breath tion and injection of cardiac drugs were added to an optimised basic sounds on auscultation of lungs, and inability to hear gas entering life support-automated external defibrillator (BLS-AED) system.244 the stomach) are not completely reliable. The reported sensitiv- The perceived advantages of tracheal intubation over bag-mask ity (proportion of tracheal intubations correctly identified) and ventilation include: enabling ventilation without interrupting specificity (proportion of oesophageal intubations correctly identi- chest compressions402 ; enabling effective ventilation, particularly fied) of clinical assessment varies: sensitivity 74–100%; specificity when lung and/or chest compliance is poor; minimising gastric 66–100%.403,410–413 inflation and therefore the risk of regurgitation; protection against Secondary confirmation of tracheal tube placement by an pulmonary aspiration of gastric contents; and the potential to free exhaled carbon dioxide or oesophageal detection device should the rescuer’s hands for other tasks. Use of the bag-mask is more reduce the risk of unrecognised oesophageal intubation but the per- likely to cause gastric distension that, theoretically, is more likely formance of the available devices varies considerably. Furthermore, to cause regurgitation with risk of aspiration. However, there are none of the secondary confirmation techniques will differentiate no reliable data to indicate that the incidence of aspiration is any between a tube placed in a main bronchus and one placed correctly more in cardiac arrest patients ventilated with bag-mask versus in the trachea. those that are ventilated via tracheal tube. There are inadequate data to identify the optimal method of con- The perceived disadvantages of tracheal intubation over bag- firming tube placement during cardiac arrest, and all devices should valve-mask ventilation include: be considered as adjuncts to other confirmatory techniques.414 There are no data quantifying their ability to monitor tube position • The risk of an unrecognised misplaced tracheal tube—in patients after initial placement. with out-of-hospital cardiac arrest the reliably documented inci- dence ranges from 0.5% to 17%: emergency physicians—0.5%403 ; Oesophageal detector device paramedics—2.4%,404 6%,351,352 9%,353 17%.354 The oesophageal detector device creates a suction force at the • A prolonged period without chest compressions while intubation tracheal end of the tracheal tube, either by pulling back the plunger is attempted—in a study of prehospital intubation by paramedics on a large syringe or releasing a compressed flexible bulb. Air is during 100 cardiac arrests the total duration of the interruptions aspirated easily from the lower airways through a tracheal tube in CPR associated with tracheal intubation attempts was 110 s placed in the cartilage-supported rigid trachea. When the tube is in
- 104. 1322 C.D. Deakin et al. / Resuscitation 81 (2010) 1305–1352 the oesophagus, air cannot be aspirated because the oesophagus and specific way to confirm and continuously monitor the position collapses when aspiration is attempted. The oesophageal detec- of a tracheal tube in victims of cardiac arrest and should supplement tor device may be misleading in patients with morbid obesity, late clinical assessment (auscultation and visualization of tube through pregnancy or severe asthma or when there are copious tracheal cords). Waveform capnography will not discriminate between tra- secretions; in these conditions the trachea may collapse when aspi- cheal and bronchial placement of the tube—careful auscultation ration is attempted.352,410,415–417 The performance of the syringe is essential. Existing portable monitors make capnographic initial oesophageal detector device for identifying tracheal tube posi- confirmation and continuous monitoring of tracheal tube position tion has been reported in five cardiac arrest studies352,418–421 : feasible in almost all settings, including out-of-hospital, emer- the sensitivity was 73–100% and the specificity 50–100%. The gency department, and in-hospital locations where intubation is performance of the bulb oesophageal detector device for identi- performed. In the absence of a waveform capnograph it may be fying tracheal tube position has been reported in three cardiac preferable to use a supraglottic airway device when advanced air- arrest studies410,415,421 : the sensitivity was 71–75% and specificity way management is indicated. 89–100%. Thoracic impedance Carbon dioxide detectors There are smaller changes in thoracic impedance with Carbon dioxide (CO2 ) detector devices measure the concentra- oesophageal ventilations than with ventilation of the lungs.429–431 tion of exhaled carbon dioxide from the lungs. The persistence of Changes in thoracic impedance may be used to detect ventilation432 exhaled CO2 after six ventilations indicates placement of the tra- and oesphageal intubation402,433 during cardiac arrest. It is possible cheal tube in the trachea or a main bronchus.403 Confirmation of that this technology can be used to measure tidal volume during correct placement above the carina will require auscultation of the CPR. The role of thoracic impedance as a tool to detect tracheal tube chest bilaterally in the mid-axillary lines. Broadly, there three types position and adequate ventilation during CPR is undergoing further of carbon dioxide detector device: research but is not yet ready for routine clinical use. 1. Disposable colorimetric end-tidal carbon dioxide (ETCO2 ) detec- Cricoid pressure tors use a litmus paper to detect CO2 , and these devices generally give readings of purple (ETCO2 < 0.5%), tan (ETCO2 0.5–2%) and In non-arrest patients cricoid pressure may offer some measure yellow (ETCO2 > 2%). In most studies, tracheal placement of the of protection to the airway from aspiration but it may also impede tube is considered verified if the tan colour persists after a ventilation or interfere with intubation. The role of cricoid during few ventilations. In cardiac arrest patients, eight studies reveal cardiac arrest has not been studied. Application of cricoid pressure 62–100% sensitivity in detecting tracheal placement of the tra- during bag-mask ventilation reduces gastric inflation.334,335,434,435 cheal tube and an 86–100% specificity in identifying non-tracheal Studies in anaesthetised patients show that cricoid pressure position.258,414,420,422–426 Although colorimetric CO2 detectors impairs ventilation in many patients, increases peak inspiratory identify placement in patients with good perfusion quite well, pressures and causes complete obstruction in up to 50% of patients these devices are less accurate than clinical assessment in car- depending on the amount of cricoid pressure (in the range of rec- diac arrest patients because pulmonary blood flow may be so low ommended effective pressure) that is applied.334–339,436,437 that there is insufficient exhaled carbon dioxide. Furthermore, if The routine use of cricoid pressure in cardiac arrest is not rec- the tracheal tube is in the oesophagus, six ventilations may lead ommended. If cricoid pressure is used during cardiac arrest, the to gastric distension, vomiting and aspiration. pressure should be adjusted, relaxed or released if it impedes ven- 2. Non-waveform electronic digital ETCO2 devices generally mea- tilation or intubation. sure ETCO2 using an infrared spectrometer and display the results with a number; they do not provide a waveform graph- ical display of the respiratory cycle on a capnograph. Five Securing the tracheal tube studies of these devices for identification of tracheal tube posi- tion in cardiac arrest document 70–100% sensitivity and 100% Accidental dislodgement of a tracheal tube can occur at any time, specificity.403,412,414,418,422,427 but may be more likely during resuscitation and during transport. 3. End-tidal CO2 detectors that include a waveform graphical dis- The most effective method for securing the tracheal tube has yet to play (capnographs) are the most reliable for verification of be determined; use either conventional tapes or ties, or purpose- tracheal tube position during cardiac arrest. Two studies of made tracheal tube holders. waveform capnography to verify tracheal tube position in vic- tims of cardiac arrest demonstrate 100% sensitivity and 100% Cricothyroidotomy specificity in identifying correct tracheal tube placement.403,428 Three studies with a cumulative total of 194 tracheal and 22 Occasionally it will be impossible to ventilate an apnoeic patient oesophageal tube placements documented an overall 64% sensi- with a bag-mask, or to pass a tracheal tube or alternative airway tivity and 100% specificity in identifying correct tracheal tube device. This may occur in patients with extensive facial trauma placement when using a capnograph in prehospital cardiac or laryngeal obstruction caused by oedema or foreign material. arrest victims.410,415,421 However, in these studies intubation In these circumstances, delivery of oxygen through a needle or was undertaken only after arrival at hospital (time to intuba- surgical cricothyroidotomy may be life-saving. A tracheostomy is tion averaged more than 30 min) and many of the cardiac arrest contraindicated in an emergency, as it is time consuming, haz- victims studied had prolonged resuscitation times and very pro- ardous and requires considerable surgical skill and equipment. longed transport time. Surgical cricothyroidotomy provides a definitive airway that can be used to ventilate the patient’s lungs until semi-elective intu- Based on the available data, the accuracy of colorimetric CO2 bation or tracheostomy is performed. Needle cricothyroidotomy detectors, oesophageal detector devices and non-waveform cap- is a much more temporary procedure providing only short-term nometers does not exceed the accuracy of auscultation and direct oxygenation. It requires a wide-bore, non-kinking cannula, a high- visualization for confirming the tracheal position of a tube in vic- pressure oxygen source, runs the risk of barotrauma and can be tims of cardiac arrest. Waveform capnography is the most sensitive particularly ineffective in patients with chest trauma. It is also
- 105. C.D. Deakin et al. / Resuscitation 81 (2010) 1305–1352 1323 prone to failure because of kinking of the cannula, and is unsuitable to discharge or neurological outcome.443,444 There are no alterna- for patient transfer. tive vasopressors that provide survival benefit during cardiac arrest resuscitation when compared with adrenaline. 4f Assisting the circulation Participants at the 2010 Consensus Conference debated in depth the treatment recommendations that should follow from this evi- dence. Despite the absence of data demonstrating an increase in Drugs and fluids for cardiac arrest long-term survival, adrenaline has been the standard vasopressor in cardiac arrest. It was agreed that there is currently insufficient This topic is divided into: drugs used during the management evidence to support or refute the use of any other vasopressor as of a cardiac arrest; anti-arrhythmic drugs used in the peri-arrest an alternative to, or in combination with, adrenaline in any cardiac period; other drugs used in the peri-arrest period; fluids; and routes arrest rhythm to improve survival or neurological outcome. Current for drug delivery. Every effort has been made to provide accurate practice still supports adrenaline as the primary vasopressor for the information on the drugs in these guidelines, but literature from treatment of cardiac arrest of all rhythms. Although the evidence the relevant pharmaceutical companies will provide the most up- of benefit from the use of adrenaline is limited, it was felt that the to-date data. improved short-term survival documented in some studies245,246 warranted its continued use, although in the absence of clinical Drugs used during the treatment of cardiac arrest evidence, the dose and timing have not been changed in the 2010 guidelines. Only a few drugs are indicated during the immediate manage- ment of a cardiac arrest, and there is limited scientific evidence Adrenaline supporting their use. Drugs should be considered only after initial shocks have been delivered (if indicated) and chest compressions Indications. and ventilation have been started. The evidence for the optimal timing and order of drug delivery, and the optimal dose, is limited. • Adrenaline is the first drug used in cardiac arrest of any cause: There are three groups of drugs relevant to the management of it is included in the ALS algorithm for use every 3–5 min of CPR cardiac arrest that were reviewed during the 2010 Consensus Con- (alternate cycles). ference: vasopressors, anti-arrhythmics and other drugs. Routes of • Adrenaline is preferred in the treatment of anaphylaxis (Section drug delivery other than the optimal intravenous route were also 8g).294 reviewed and are discussed. • Adrenaline is a second-line treatment for cardiogenic shock. Vasopressors Dose. During cardiac arrest, the initial IV/IO dose of adrenaline is 1 mg. There are no studies showing survival benefit for higher Despite the continued widespread use of adrenaline and doses of adrenaline for patients in refractory cardiac arrest. In some increased use of vasopressin during resuscitation in some coun- cases, an adrenaline infusion is required in the post-resuscitation tries, there is no placebo-controlled study that shows that the period. routine use of any vasopressor during human cardiac arrest Following return of spontaneous circulation, even small doses increases survival to hospital discharge, although improved short- of adrenaline (50–100 g) may induce tachycardia, myocardial term survival has been documented.245,246 The primary goal of ischaemia, VT and VF. Once a perfusing rhythm is established, if cardiopulmonary resuscitation is to re-establish blood flow to vital further adrenaline is deemed necessary, titrate the dose carefully to organs until the restoration of spontaneous circulation. Despite the achieve an appropriate blood pressure. Intravenous doses of 50 g lack of data from cardiac arrest in humans, vasopressors continue are usually sufficient for most hypotensive patients. Use adrenaline to be recommended as a means of increasing cerebral and coronary cautiously in patients with cardiac arrest associated with cocaine perfusion during CPR. or other sympathomimetic drugs. Adrenaline (epinephrine) versus vasopressin Use. Adrenaline is available most commonly in two dilutions: Adrenaline has been the primary sympathomimetic agent for the management of cardiac arrest for 40 years.438 Its • 1 in 10,000 (10 ml of this solution contains 1 mg of adrenaline). alpha-adrenergic, vasoconstrictive effects cause systemic vaso- • 1 in 1000 (1 ml of this solution contains 1 mg of adrenaline). constriction, which increases coronary and cerebral perfusion pressures. The beta-adrenergic actions of adrenaline (inotropic, Both these dilutions are used routinely in Europe. chronotropic) may increase coronary and cerebral blood flow, but concomitant increases in myocardial oxygen consumption, ectopic Anti-arrhythmics ventricular arrhythmias (particularly when the myocardium is acidotic), transient hypoxaemia due to pulmonary arteriovenous As with vasopressors, the evidence that anti-arrhythmic drugs shunting, impaired microcirculation,281 and worse post-cardiac are of benefit in cardiac arrest is limited. No anti-arrhythmic drug arrest myocardial dysfunction283,284 may offset these benefits. given during human cardiac arrest has been shown to increase sur- The potentially deleterious beta-effects of adrenaline have led vival to hospital discharge, although amiodarone has been shown to exploration of alternative vasopressors. Vasopressin is a nat- to increase survival to hospital admission.285,286 Despite the lack urally occurring antidiuretic hormone. In very high doses it is a of human long-term outcome data, the balance of evidence is in powerful vasoconstrictor that acts by stimulation of smooth mus- favour of the use anti-arrhythmic drugs for the management of cle V1 receptors. Three randomised controlled trials439–441 and a arrhythmias in cardiac arrest. meta-analysis442 demonstrated no difference in outcomes (ROSC, survival to discharge, or neurological outcome) with vasopressin Amiodarone versus adrenaline as a first line vasopressor in cardiac arrest. Two Amiodarone is a membrane-stabilising anti-arrhythmic drug more recent studies comparing adrenaline alone or in combination that increases the duration of the action potential and refrac- with vasopressin also demonstrated no difference in ROSC, survival tory period in atrial and ventricular myocardium. Atrioventricular
- 106. 1324 C.D. Deakin et al. / Resuscitation 81 (2010) 1305–1352 conduction is slowed, and a similar effect is seen with accessory arrhythmias occurring in normally polarised cells (e.g., atrial fib- pathways. Amiodarone has a mild negative inotropic action and rillation/flutter). Lidocaine raises the threshold for VF. causes peripheral vasodilation through non-competitive alpha- Lidocaine toxicity causes paraesthesia, drowsiness, confusion blocking effects. The hypotension that occurs with intravenous and muscular twitching progressing to convulsions. It is considered amiodarone is related to the rate of delivery and is due more generally that a safe dose of lidocaine must not exceed 3 mg kg−1 to the solvent (Polysorbate 80 and benzyl alcohol), which causes over the first hour. If there are signs of toxicity, stop the infu- histamine release, rather than the drug itself.445 The use of an sion immediately; treat seizures if they occur. Lidocaine depresses aqueous amiodarone preparation that is relatively free from these myocardial function, but to a much lesser extent than amiodarone. side effects has recently been approved for use in the United The myocardial depression is usually transient and can be treated States.446,447 with intravenous fluids or vasopressors. Following three initial shocks, amiodarone in shock-refractory VF improves the short-term outcome of survival to hospital admis- Indications. Lidocaine is indicated in refractory VF/VT (when sion compared with placebo285 or lidocaine.286 Amiodarone also amiodarone is unavailable). appears to improve the response to defibrillation when given to humans or animals with VF or haemodynamically unstable ventric- Dose. When amiodarone is unavailable, consider an initial dose ular tachycardia.446–450 There is no evidence to indicate the optimal of 100 mg (1–1.5 mg kg−1 ) of lidocaine for VF/pulseless VT refrac- time at which amiodarone should be given when using a single- tory to three shocks. Give an additional bolus of 50 mg if necessary. shock strategy. In the clinical studies to date, the amiodarone was The total dose should not exceed 3 mg kg−1 during the first hour. given if VF/VT persisted after at least three shocks. For this rea- son, and in the absence of any other data, amiodarone 300 mg is Clinical aspects of use. Lidocaine is metabolised by the liver, and recommended if VF/VT persists after three shocks. its half-life is prolonged if the hepatic blood flow is reduced, e.g., in the presence of reduced cardiac output, liver disease or in the Indications. Amiodarone is indicated in elderly. During cardiac arrest normal clearance mechanisms do not function, thus high plasma concentrations may be achieved after a • refractory VF/VT; single dose. After 24 h of continuous infusion, the plasma half-life • haemodynamically stable ventricular tachycardia (VT) and other increases significantly. Reduce the dose in these circumstances, and resistant tachyarrhythmias (Section 4g). regularly review the indication for continued therapy. Lidocaine is less effective in the presence of hypokalaemia and hypomagne- Dose. Consider an initial intravenous dose of 300 mg amio- saemia, which should be corrected immediately. darone, diluted in 5% dextrose (or other suitable solvent) to a volume of 20 ml (or from a pre-filled syringe), if VF/VT persists Magnesium after the third shock. Give a further dose of 150 mg if VF/VT per- Magnesium is an important constituent of many enzyme sys- sists. Amiodarone can cause thrombophlebitis when injected into tems, especially those involved with ATP generation in muscle. a peripheral vein; use a central vein if a central venous catheter is in It plays a major role in neurochemical transmission, where it situ but, if not, use a large peripheral vein or the IO route followed decreases acetylcholine release and reduces the sensitivity of the by a generous flush. Details about the use of amiodarone for the motor endplate. Magnesium also improves the contractile response treatment of other arrhythmias are given in Section 4g. of the stunned myocardium, and limits infarct size by a mechanism that has yet to be fully elucidated.451 The normal plasma range of Clinical aspects of use. Amiodarone may paradoxically be magnesium is 0.8–1.0 mmol l−1 . arrhythmogenic, especially if given concurrently with drugs that Hypomagnesaemia is often associated with hypokalaemia, and prolong the QT interval. However, it has a lower incidence of may contribute to arrhythmias and cardiac arrest. Hypomag- pro-arrhythmic effects than other anti-arrhythmic drugs under nesaemia increases myocardial digoxin uptake and decreases similar circumstances. The major acute adverse effects from amio- cellular Na+/K+ -ATP-ase activity. Patients with hypomagnesaemia, darone are hypotension and bradycardia, which can be prevented hypokalaemia, or both may become cardiotoxic even with ther- by slowing the rate of drug infusion, or can be treated with fluids apeutic digitalis levels. Magnesium deficiency is not uncommon and/or inotropic drugs. The side effects associated with prolonged in hospitalised patients and frequently coexists with other oral use (abnormalities of thyroid function, corneal microdeposits, electrolyte disturbances, particularly hypokalaemia, hypophos- peripheral neuropathy, and pulmonary/hepatic infiltrates) are not phataemia, hyponatraemia and hypocalcaemia. relevant in the acute setting. Although the benefits of giving magnesium in known hypomag- nesaemic states are recognised, the benefit of giving magnesium Lidocaine routinely during cardiac arrest is unproven. Studies in adults in and Until the publication of the 2000 ILCOR guidelines, lidocaine out of hospital287–291,452 have failed to demonstrate any increase was the anti-arrhythmic drug of choice. Comparative studies with in the rate of ROSC when magnesium is given routinely during CPR. amiodarone286 have displaced it from this position, and lido- caine is now recommended only when amiodarone is unavailable. Indications. Magnesium sulphate is indicated in Amiodarone should be available at all hospital arrests and at all out-of-hospital arrests attended by emergency medical services. • ventricular or supraventricular tachycardia associated with Lidocaine is a membrane-stabilising anti-arrhythmic drug that hypomagnesaemia; acts by increasing the myocyte refractory period. It decreases ven- • torsades de pointes; tricular automaticity, and its local anaesthetic action suppresses • digoxin toxicity. ventricular ectopic activity. Lidocaine suppresses activity of depo- larised, arrhythmogenic tissues while interfering minimally with Dose. Give an initial intravenous dose of 2 g (4 ml (8 mmol)) the electrical activity of normal tissues. Therefore, it is effective of 50% magnesium sulphate) peripherally over 1–2 min; it may in suppressing arrhythmias associated with depolarisation (e.g., be repeated after 10–15 min. Preparations of magnesium sulphate ischaemia, digitalis toxicity) but is relatively ineffective against solutions differ among European countries.
- 107. C.D. Deakin et al. / Resuscitation 81 (2010) 1305–1352 1325 Clinical aspects of use. Hypokalaemic patients are often hypo- Buffers magnesaemic. If ventricular tachyarrhythmias arise, intravenous Cardiac arrest results in combined respiratory and metabolic magnesium is a safe, effective treatment. The role of magnesium in acidosis because pulmonary gas exchange ceases and cellular acute myocardial infarction is still in doubt. Magnesium is excreted metabolism becomes anaerobic. The best treatment of acidaemia by the kidneys, but side effects associated with hypermagnesaemia in cardiac arrest is chest compression; some additional benefit is are rare, even in renal failure. Magnesium inhibits smooth muscle gained by ventilation. During cardiac arrest, arterial gas values may contraction, causing vasodilation and a dose-related hypotension, be misleading and bear little relationship to the tissue acid–base which is usually transient and responds to intravenous fluids and state292 ; analysis of central venous blood may provide a better vasopressors. estimation of tissue pH (see Section 4d). Bicarbonate causes gener- ation of carbon dioxide, which diffuses rapidly into cells. It has the following effects. Other drugs • It exacerbates intracellular acidosis. There is no evidence that routinely giving other drugs (e.g., • It produces a negative inotropic effect on ischaemic myocardium. atropine, procainamide, bretylium, calcium and hormones) dur- • It presents a large, osmotically active, sodium load to an already ing human cardiac arrest increases survival to hospital discharge. compromised circulation and brain. Recommendations for the use of these drugs are based on limited • It produces a shift to the left in the oxygen dissociation curve, clinical studies, our understanding of the drug’s pharmacodynamic further inhibiting release of oxygen to the tissues. properties and the pathophysiology of cardiac arrest. Mild acidaemia causes vasodilation and can increase cerebral Atropine blood flow. Therefore, full correction of the arterial blood pH may Atropine antagonises the action of the parasympathetic neu- theoretically reduce cerebral blood flow at a particularly critical rotransmitter acetylcholine at muscarinic receptors. Therefore, it time. As the bicarbonate ion is excreted as carbon dioxide via the blocks the effect of the vagus nerve on both the sinoatrial (SA) node lungs, ventilation needs to be increased. and the atrioventricular (AV) node, increasing sinus automaticity Several animal and clinical studies have examined the use of and facilitating AV node conduction. buffers during cardiac arrest. Clinical studies using Tribonate®466 Side effects of atropine are dose-related (blurred vision, dry or sodium bicarbonate as buffers have failed to demonstrate mouth and urinary retention); they are not relevant during a any advantage.466–472 Only two studies have found clinical cardiac arrest. Acute confusional states may occur after intra- benefit, suggesting that EMS systems using sodium bicarbon- venous injection, particularly in elderly patients. After cardiac ate earlier and more frequently had significantly higher ROSC arrest, dilated pupils should not be attributed solely to atropine. and hospital discharge rates and better long-term neurological Asystole during cardiac arrest is usually due to primary myocar- outcome.473,474 Animal studies have generally been inconclusive, dial pathology rather than excessive vagal tone and there is no but some have shown benefit in giving sodium bicarbonate to evidence that routine use of atropine is beneficial in the treatment treat cardiovascular toxicity (hypotension, cardiac arrhythmias) of asystole or PEA. Several recent studies have failed to demonstrate caused by tricyclic antidepressants and other fast sodium channel any benefit from atropine in out-of-hospital or in-hospital cardiac blockers (Section 8b).294,475 Giving sodium bicarbonate routinely arrests244,453–458 ; and its routine use for asystole or PEA is no longer during cardiac arrest and CPR or after return of spontaneous recommended. circulation is not recommended. Consider sodium bicarbonate Atropine is indicated in: for • life-threatening hyperkalaemia; • sinus, atrial, or nodal bradycardia when the haemodynamic con- • cardiac arrest associated with hyperkalaemia; dition of the patient is unstable (see Section 4g). • tricyclic overdose. Calcium Give 50 mmol (50 ml of an 8.4% solution) of sodium bicarbon- Calcium plays a vital role in the cellular mechanisms underlying ate intravenously. Repeat the dose as necessary, but use acid/base myocardial contraction. There is no data supporting any benefi- analysis (either arterial, central venous or marrow aspirate from cial action for calcium after most cases of cardiac arrest453,459–463 ; IO needle) to guide therapy. Severe tissue damage may be caused conversely, other studies have suggested a possible adverse effect by subcutaneous extravasation of concentrated sodium bicarbon- when given routinely during cardiac arrest (all rhythms).464,465 ate. The solution is incompatible with calcium salts as it causes the High plasma concentrations achieved after injection may be harm- precipitation of calcium carbonate. ful to the ischaemic myocardium and may impair cerebral recovery. Give calcium during resuscitation only when indicated specifically, Fibrinolysis during CPR i.e., in pulseless electrical activity caused by Thrombus formation is a common cause of cardiac arrest, most commonly due to acute myocardial ischaemia following • hyperkalaemia; coronary artery occlusion by thrombus, but occasionally due to • hypocalcaemia; a dislodged venous thrombus causing a pulmonary embolism. • overdose of calcium channel-blocking drugs. The use of fibrinolytic drugs to break down coronary artery and pulmonary artery thrombus has been the subject of sev- eral studies. Fibrinolytics have also been demonstrated in animal The initial dose of 10 ml 10% calcium chloride (6.8 mmol Ca2+ ) studies to have beneficial effects on cerebral blood flow dur- may be repeated if necessary. Calcium can slow the heart rate and ing cardiopulmonary resuscitation,476,477 and a clinical study has precipitate arrhythmias. In cardiac arrest, calcium may be given reported less anoxic encephalopathy after fibrinolytic therapy dur- by rapid intravenous injection. In the presence of a spontaneous ing CPR.478 circulation give it slowly. Do not give calcium solutions and sodium Several studies have examined the use of fibrinolytic ther- bicarbonate simultaneously by the same route. apy given during non-traumatic cardiac arrest unresponsive to
- 108. 1326 C.D. Deakin et al. / Resuscitation 81 (2010) 1305–1352 standard therapy.307,479–484 and some have shown non-significant Alternative routes for drug delivery improvements in survival to hospital discharge,307,481 and greater ICU survival.478 A small series of case reports also reported sur- Intraosseous route vival to discharge in three cases refractory to standard therapy with VF or PEA treated with fibrinolytics.485 Conversely, two large If intravenous access cannot be established within the first 2 min clinical trials486,487 failed to show any significant benefit for fib- of resuscitation, consider gaining IO access. Intraosseous access has rinolytics in out-of-hospital cardiac arrest unresponsive to initial traditionally been used for children because of the difficulties in interventions. gaining intravenous access, but this route has now become estab- Results from the use of fibrinolytics in patients suffering car- lished as a safe and effective route for gaining vascular access in diac arrest from suspected pulmonary embolus have been variable. adults too.271,514–517 Tibial and humeral sites are readily accessible A meta-analysis, which included patients with pulmonary embo- and provide equal flow rates for fluids.514 Intraosseous delivery of lus as a cause of the arrest, concluded that fibrinolytics increased resuscitation drugs will achieve adequate plasma concentrations. the rate of ROSC, survival to discharge and long-term neuro- Several studies indicate that IO access is safe and effective for fluid logical function.488 Several other studies have demonstrated an resuscitation and drug delivery.269,518–524 improvement in ROSC and admission to hospital or the inten- sive care unit, but not in survival to neurologically intact hospital Drugs given via the tracheal tube discharge.307,479–481,483,484,489–492 Although several relatively small clinical studies307,479,481,490 Resuscitation drugs can also be given via the tracheal tube, but and case series478,485,493–495 have not demonstrated any increase the plasma concentrations achieved using this route are very vari- in bleeding complications with thrombolysis during CPR in able although generally considerably lower than those achieved by non-traumatic cardiac arrest, a recent large study487 and the IV or IO routes, particularly with adrenaline. Additionally, rel- meta-analysis488 have shown an increased risk of intracranial atively large volumes of intratracheal fluid impair gas exchange. bleeding associated with the routine use of fibrinolytics dur- With the ease of gaining IO access and the lack of efficacy of tra- ing non-traumatic cardiac arrest. Successful fibrinolysis during cheal drug administration, tracheal administration of drugs is no cardiopulmonary resuscitation is usually associated with good neu- longer recommended rological outcome.488,490,491 Fibrinolytic therapy should not be used routinely in cardiac CPR techniques and devices arrest. Consider fibrinolytic therapy when cardiac arrest is caused by proven or suspected acute pulmonary embolus. Following fib- At best, standard manual CPR produces coronary and cerebral rinolysis during CPR for acute pulmonary embolism, survival and perfusion that is just 30% of normal.525 Several CPR techniques good neurological outcome have been reported in cases requiring and devices may improve haemodynamics or short-term survival in excess of 60 min of CPR. If a fibrinolytic drug is given in these when used by well-trained providers in selected cases. However, circumstances, consider performing CPR for at least 60–90 min the success of any technique or device depends on the education before termination of resuscitation attempts.496,497 Mortality from and training of the rescuers and on resources (including personnel). surgical embolectomy is high if it follows cardiac arrest and In the hands of some groups, novel techniques and adjuncts may should be avoided in patients requiring CPR. In patients who are be better than standard CPR. However, a device or technique which not candidates for fibrinolytic therapy, percutaneous mechanical provides good quality CPR when used by a highly trained team or thromboembolectomy should be considered. Ongoing CPR is not a in a test setting may show poor quality and frequent interruptions contraindication to fibrinolysis. when used in an uncontrolled clinical setting.526 While no circula- tory adjunct is currently recommended for routine use instead of manual CPR, some circulatory adjuncts are being routinely used in Intravenous fluids both out-of-hospital and in-hospital resuscitation. It is prudent that rescuers are well-trained and that if a circulatory adjunct is used, a Hypovolaemia is a potentially reversible cause of cardiac arrest. program of continuous surveillance be in place to ensure that use Infuse fluids rapidly if hypovolaemia is suspected. In the initial of the adjunct does not adversely affect survival. Although man- stages of resuscitation there are no clear advantages to using col- ual chest compressions are often performed very poorly,527–529 no loid, so use 0.9% sodium chloride or Hartmann’s solution. Avoid adjunct has consistently been shown to be superior to conventional dextrose, which is redistributed away from the intravascular space manual CPR. rapidly and causes hyperglycaemia, which may worsen neurologi- cal outcome after cardiac arrest.498–505 Whether fluids should be infused routinely during cardiac arrest Open-chest CPR is controversial. There are no published human studies of rou- tine fluid use compared to no fluids during normovolaemic cardiac Open-chest CPR produces better coronary perfusion coronary arrest. Two animal studies506,507 show that the increase in right pressure than standard CPR530 and may be indicated for patients atrial pressure produced by infusion of normothermic fluid dur- with cardiac arrest caused by trauma, in the early postopera- ing CPR decreases coronary perfusion pressure, and another animal tive phase after cardiothoracic surgery531,532 (see Section 8i)294 or study508 shows that the coronary perfusion pressure rise with when the chest or abdomen is already open (transdiaphragmatic adrenaline during CPR is not improved with the addition of a fluid approach), for example, in trauma surgery. infusion. Small clinical studies have not shown any benefit with hyper- Interposed abdominal compression (IAC-CPR) tonic fluid509 or chilled fluid.510,511 One animal study shows that hypertonic saline improves cerebral blood flow during CPR.512 The IAC-CPR technique involves compression of the abdomen Ensure normovolaemia, but in the absence of hypovolaemia, infu- during the relaxation phase of chest compression.533,534 This sion of an excessive volume of fluid is likely to be harmful.513 Use enhances venous return during CPR535,536 and improves ROSC and intravenous fluid to flush peripherally injected drugs into the cen- short-term survival.537,538 Two studies showed improved survival tral circulation. to hospital discharge with IAC-CPR compared with standard CPR
- 109. C.D. Deakin et al. / Resuscitation 81 (2010) 1305–1352 1327 for in-hospital cardiac arrest,537,538 but another showed no survival Lund University cardiac arrest system (LUCAS) CPR advantage.539 The Lund University cardiac arrest system (LUCAS) is a gas- driven sternal compression device that incorporates a suction cup Active compression-decompression CPR (ACD-CPR) for active decompression. Although animal studies showed that LUCAS-CPR improves haemodynamic and short-term survival com- ACD-CPR is achieved with a hand-held device equipped with a pared with standard CPR.581,582 There are no published randomised suction cup to lift the anterior chest actively during decompression. human studies comparing LUCAS-CPR with standard CPR. A study Decreasing intrathoracic pressure during the decompression phase using LUCAS for witnessed OHCA was unable to show any ben- increases venous return to the heart and increases cardiac output efit (ROSC, survival to hospital or survival to hospital discharge) and subsequent coronary and cerebral perfusion pressures dur- over standard CPR.583 Case series totalling 200 patients have ing the compression phase.540–543 Results of ACD-CPR have been reported variable success in use of the LUCAS device, when imple- mixed. In some clinical studies ACD-CPR improved haemodynamics mented after an unsuccessful period of manual CPR.347,581,584–586 compared with standard CPR,541,543–545 but in another study it did One case series used LUCAS to perform CPR while PCI was being not.546 In three randomised studies,545,547,548 ACD-CPR improved performed.293 Eleven of 43 patients survived to hospital discharge long-term survival after out-of-hospital cardiac arrest; however, neurologically intact. There are several other reports documenting in five other randomised studies, ACD-CPR made no difference to use of LUCAS during PCI.585,587,588 One post-mortem study showed outcome.549–553 The efficacy of ACD-CPR may be highly dependent similar injuries with LUCAS compared with standard CPR.589 The on the quality and duration of training.554 early versions of the LUCAS device which were driven by high flow A meta-analysis of 10 trials of out-of-hospital cardiac arrest and oxygen (LUCASTM 1) should not be used in confined spaces where two of in-hospital cardiac arrest showed no early or late survival defibrillation in high ambient oxygen concentrations may risk a benefit to ACD-CPR over conventional CPR.205 Two post-mortem fire.590 studies have shown more rib and sternal fractures after ACD- CPR compared with conventional CPR,555,556 but another found no Load-distributing band CPR (AutoPulse) difference.557 The load-distributing band (LDB) is a circumferential chest com- pression device comprising a pneumatically actuated constricting Impedance threshold device (ITD) band and backboard. Although the use of LDB CPR improves haemodynamics,591–593 results of clinical trials have been con- The impedance threshold device (ITD) is a valve that lim- flicting. Evidence from one multicenter randomised control trial its air entry into the lungs during chest recoil between chest in over 1000 adults documented no improvement in 4-h sur- compressions; this decreases intrathoracic pressure and increases vival and worse neurological outcome when LDB-CPR was used venous return to the heart. When used with a cuffed tracheal tube by EMS providers for patients with primary out-of-hospital car- and active compression–decompression (ACD),558–560 the ITD is diac arrest.594 However, a post hoc analysis of this study revealed thought to act synergistically to enhance venous return during significant heterogeneity between study sites.598 A further study active decompression. The ITD has also been used during conven- demonstrated lower odds of 30-day survival (OR 0.4) but subgroup tional CPR with a tracheal tube or facemask.561 If rescuers can analysis showed an increased rate of ROSC in LDB-CPR treated maintain a tight face-mask seal, the ITD may create the same neg- patients.595 Other non-randomised human studies have reported ative intrathoracic pressure as when used with a tracheal tube.561 increased rates of sustained ROSC,596,597 increased survival to dis- Most,562–569 but not all,570–573 animal studies have shown charge following OHCA597 and improved hemodynamics following improved haemodynamics or outcomes during CPR when using the failed resuscitation from in-hospital cardiac arrest.591 Evidence device. Several randomised trials have shown differing results. Two from both clinical594,598 and simulation599 studies suggest that site- trials suggest that the use of an ITD in combination with ACD-CPR specific factors may influence resuscitation quality and efficacy of improves 24 h survival and survival to ICU admission in adult OHCA this device. patients,560,574 but these contrast with others which failed to show any improvement in ROSC or 24 h survival.558,561 A recent meta- The current status of LUCAS and AutoPulse analysis demonstrated improved ROSC and short-term survival but no significant improvement in either survival to discharge or neu- Two large prospective randomised multicentre studies are cur- rologically intact survival to discharge associated with the use of an rently underway to evaluate the load-distributing band (AutoPulse) ITD in the management of adult OHCA patients.575 In the absence of and the Lund University cardiac arrest system (LUCAS). The data showing that the ITD increases survival to hospital discharge, results of these studies are awaited with interest. In hospi- its routine use in cardiac arrest is not recommended. tal, mechanical devices have been used effectively to support patients undergoing primary coronary intervention (PCI)293,585 Mechanical piston CPR and CT scans600 and also for prolonged resuscitation attempts (e.g., hypothermia,601,602 poisoning, thrombolysis for pulmonary Mechanical piston devices depress the sternum by means of embolism, prolonged transport, etc.) where rescuer fatigue may a compressed gas-powered plunger mounted on a backboard. In impair the effectiveness of manual chest compression. In the pre- several studies in animals,576 mechanical piston CPR improved hospital environment where extrication of patients, resuscitation end-tidal carbon dioxide, cardiac output, cerebral blood flow, MAP in confined spaces and movement of patients on a trolley often and short-term neurological outcome. Studies in humans also doc- preclude effective manual chest compressions, mechanical devices ument improvement in end-tidal carbon dioxide and mean arterial may also have an important role. During transport to hospital, man- pressure when using mechanical piston CPR compared with con- ual CPR is often performed poorly; mechanical CPR can maintain ventional CPR.577–579 One study has documented that the use of a good quality CPR during an ambulance transfer.343,603 Mechanical piston CPR device compared with manual CPR increases interrup- devices also have the advantage of allowing defibrillation without tion in CPR due to setting up and removal of the device from patients interruption in external chest compression. The role of mechanical during transportation in out-of-hospital adult cardiac arrest.580 devices in all situations requires further evaluation.
- 110. 1328 C.D. Deakin et al. / Resuscitation 81 (2010) 1305–1352 4g Peri-arrest arrhythmias Treatment options The correct identification and treatment of arrhythmias in the Having determined the rhythm and the presence or absence of critically ill patient may prevent cardiac arrest from occurring or adverse signs, the options for immediate treatment are categorised from reoccurring after successful initial resuscitation. The treat- as: ment algorithms described in this section have been designed to enable the non-specialist ALS provider to treat the patient effec- 1. Electrical (cardioversion, pacing). tively and safely in an emergency; for this reason, they have been 2. Pharmacological (anti-arrhythmic (and other) drugs). kept as simple as possible. If patients are not acutely ill there may be several other treatment options, including the use of drugs (oral or parenteral) that will be less familiar to the non-expert. In this sit- Tachycardias uation there will be time to seek advice from cardiologists or other senior doctors with the appropriate expertise. If the patient is unstable More comprehensive information on the management of arrhythmias can be found at www.escardio.org. If the patient is unstable and deteriorating, with any of the adverse signs and symptoms described above being caused by the tachycardia, attempt synchronised cardioversion immediately (Fig. 4.11). In patients with otherwise normal hearts, serious Principles of treatment signs and symptoms are uncommon if the ventricular rate is <150 beats min−1 . Patients with impaired cardiac function or sig- The initial assessment and treatment of a patient with an nificant comorbidity may be symptomatic and unstable at lower arrhythmia should follow the ABCDE approach. Key elements in heart rates. If cardioversion fails to restore sinus rhythm and the this process include assessing for adverse signs; administration of patient remains unstable, give amiodarone 300 mg intravenously high flow oxygen; obtaining intravenous access, and establishing over 10–20 min and re-attempt electrical cardioversion. The load- monitoring (ECG, blood pressure, SpO2 ). Whenever possible, record ing dose of amiodarone can be followed by an infusion of 900 mg a 12-lead ECG; this will help determine the precise rhythm, either over 24 h. before treatment or retrospectively. Correct any electrolyte abnor- Repeated attempts at electrical cardioversion are not appro- malities (e.g., K+ , Mg2+ , Ca2+ ). Consider the cause and context of priate for recurrent (within hours or days) paroxysms (self- arrhythmias when planning treatment. terminating episodes) of atrial fibrillation. This is relatively The assessment and treatment of all arrhythmias addresses two common in critically ill patients who may have ongoing precipi- factors: the condition of the patient (stable versus unstable), and tating factors causing the arrhythmia (e.g., metabolic disturbance, the nature of the arrhythmia. Anti-arrhythmic drugs are slower in sepsis). Cardioversion does not prevent subsequent arrhythmias. If onset and less reliable than electrical cardioversion in converting a there are recurrent episodes, treat them with drugs. tachycardia to sinus rhythm; thus, drugs tend to be reserved for sta- ble patients without adverse signs, and electrical cardioversion is usually the preferred treatment for the unstable patient displaying Synchronised electrical cardioversion adverse signs. If electrical cardioversion is used to convert atrial or ventricu- lar tachyarrhythmias, the shock must be synchronised with the R wave of the ECG rather than with the T wave.604 By avoiding the rel- Adverse signs ative refractory period in this way, the risk of inducing ventricular fibrillation is minimised. Conscious patients must be anaesthetised The presence or absence of adverse signs or symptoms will dic- or sedated before synchronised cardioversion is attempted. For a tate the appropriate treatment for most arrhythmias. The following broad-complex tachycardia and AF, start with 200-J monophasic adverse factors indicate a patient who is unstable because of the or 120–150 J biphasic and increase in increments if this fails (see arrhythmia. Section 3).223 Atrial flutter and paroxysmal supraventricular tachy- cardia (SVT) will often convert with lower energies: start with 100-J monophasic or 70–120-J biphasic. 1. Shock—this is seen as pallor, sweating, cold and clammy extrem- ities (increased sympathetic activity), impaired consciousness (reduced cerebral blood flow), and hypotension (e.g., systolic If the patient is stable blood pressure < 90 mm Hg). 2. Syncope—loss of consciousness, which occurs as a consequence If the patient with tachycardia is stable (no adverse signs or of reduced cerebral blood flow. symptoms) and is not deteriorating, pharmacological treatment 3. Heart failure—arrhythmias compromise myocardial perfor- may be possible. Evaluate the rhythm using a 12-lead ECG and mance by reducing coronary artery blood flow. In acute assess the QRS duration. If the QRS duration is greater than 0.12 s situations this is manifested by pulmonary oedema (failure of the (3 small squares on standard ECG paper) it is classified as a broad left ventricle) and/or raised jugular venous pressure, and hepatic complex tachycardia. If the QRS duration is less than 0.12 s it is a engorgement (failure of the right ventricle). narrow complex tachycardia. 4. Myocardial ischaemia—this occurs when myocardial oxygen All anti-arrhythmic treatments – physical manoeuvres, drugs, or consumption exceeds delivery. Myocardial ischaemia may electrical treatment – can also be pro-arrhythmic, so that clinical present with chest pain (angina) or may occur without pain as deterioration may be caused by the treatment rather than lack of an isolated finding on the 12 lead ECG (silent ischaemia). The effect. The use of multiple anti-arrhythmic drugs or high doses of presence of myocardial ischaemia is especially important if there a single drug can cause myocardial depression and hypotension. is underlying coronary artery disease or structural heart dis- This may cause a deterioration of the cardiac rhythm. Expert help ease because it may cause further life-threatening complications should be sought before using repeated doses or combinations of including cardiac arrest. anti-arrhythmic drugs.
- 111. C.D. Deakin et al. / Resuscitation 81 (2010) 1305–1352 1329 Fig. 4.11. Tachycardia algorithm. © 2010 ERC.
- 112. 1330 C.D. Deakin et al. / Resuscitation 81 (2010) 1305–1352 Broad-complex tachycardia Regular narrow-complex tachycardia Broad-complex tachycardias are usually ventricular in origin.605 Sinus tachycardia. Sinus tachycardia is a common physiological Although broad-complex tachycardias may be caused by supraven- response to a stimulus such as exercise or anxiety. In a sick patient tricular rhythms with aberrant conduction, in the unstable patient it may be seen in response to many stimuli, such as pain, fever, in the peri-arrest context assume they are ventricular in origin. In anaemia, blood loss and heart failure. Treatment is almost always the stable patient with broad-complex tachycardia, the next step directed at the underlying cause; trying to slow sinus tachycardia is to determine if the rhythm is regular or irregular. will make the situation worse. Regular broad complex tachycardia AVNRT and AVRT (paroxysmal SVT). AVNRT is the common- A regular broad-complex tachycardia is likely to be ventricular est type of paroxysmal SVT, often seen in people without any tachycardia or SVT with bundle branch block. If there is uncertainty other form of heart disease and is relatively uncommon in a peri- about the source of the arrhythmia, give intravenous adenosine arrest setting.609 It causes a regular narrow-complex tachycardia, (using the strategy described below) as it may convert the rhythm often with no clearly visible atrial activity on the ECG. Heart rates to sinus and help diagnose the underlying rhythm.606 are usually well above the typical range of sinus rates at rest Stable ventricular tachycardia can be treated with amiodarone (60–120 beats min−1 ). It is usually benign, unless there is additional 300 mg intravenously over 20–60 min followed by an infusion of co-incidental structural heart disease or coronary disease. 900 mg over 24 h. Specialist advice should be sought before con- AV re-entry tachycardia (AVRT) is seen in patients with the sidering alternatives treatments such as procainamide, nifekalant WPW syndrome and is also usually benign unless there happens to or sotalol. be additional structural heart disease. The common type of AVRT is a regular narrow-complex tachycardia, also often having no visible atrial activity on the ECG. Irregular broad complex tachycardia Irregular broad complex tachycardia is most likely to be AF with bundle branch block. Another possible cause is AF with ventric- Atrial flutter with regular AV conduction (often 2:1 block). Atrial ular pre-excitation (Wolff–Parkinson–White (WPW) syndrome). flutter with regular AV conduction (often 2:1 block) produces a There is more variation in the appearance and width of the QRS regular narrow-complex tachycardia in which it may be difficult complexes than in AF with bundle branch block. A third possi- to see atrial activity and identify flutter waves with confidence, so ble cause is polymorphic VT (e.g., torsades de pointes), although it may be indistinguishable initially from AVNRT and AVRT. When this rhythm is relatively unlikely to be present without adverse atrial flutter with 2:1 block or even 1:1 conduction is accompa- features. nied by bundle branch block, it produces a regular broad-complex Seek expert help with the assessment and treatment of irreg- tachycardia that will usually be very difficult to distinguish from VT. ular broad-complex tachyarrhythmia. If treating AF with bundle Treatment of this rhythm as if it were VT will usually be effective, branch block, treat as for AF (see below). If pre-excited AF (or or will lead to slowing of the ventricular response and identifica- atrial flutter) is suspected, avoid adenosine, digoxin, verapamil tion of the rhythm. Most typical atrial flutter has an atrial rate of and diltiazem. These drugs block the AV node and cause a about 300 beats min−1 , so atrial flutter with 2:1 block tends to pro- relative increase in pre-excitation—this can provoke severe tachy- duce a tachycardia of about 150 beats min−1 . Much faster rates are cardias. Electrical cardioversion is usually the safest treatment unlikely to be due to atrial flutter with 2:1 block. option. Treat torsades de pointes VT immediately by stopping all drugs Treatment of regular narrow complex tachycardia. If the patient known to prolong the QT interval. Correct electrolyte abnor- is unstable with adverse features caused by the arrhythmia, malities, especially hypokalaemia. Give magnesium sulphate, 2 g, attempt synchronised electrical cardioversion. It is reasonable to intravenously over 10 min.607,608 Obtain expert help, as other treat- give adenosine to an unstable patient with a regular narrow- ment (e.g., overdrive pacing) may be indicated to prevent relapse complex tachycardia while preparations are made for synchronised once the arrhythmia has been corrected. If adverse features develop cardioversion; however, do not delay electrical cardioversion if the (which is usual), arrange immediate synchronised cardioversion. If adenosine fails to restore sinus rhythm. In the absence of adverse the patient becomes pulseless, attempt defibrillation immediately features, proceed as follows. (cardiac arrest algorithm). • Start with vagal manoeuvres609 : carotid sinus massage or the Narrow-complex tachycardia Valsalva manoeuvre will terminate up to a quarter of episodes of paroxysmal SVT. Carotid sinus massage stimulates barorecep- The first step in the assessment of a narrow complex tachycardia tors, which increase vagal tone and reduces sympathetic drive, is to determine if it is regular or irregular. which slows conduction via the AV node. Carotid sinus mas- The commonest regular narrow-complex tachycardias include: sage is given by applying pressure over the carotid artery at the level of the cricoid cartilage. Massage the area with firm cir- cular movements for about 5 s. If this does not terminate the • sinus tachycardia; arrhythmia, repeat on the opposite side. Avoid carotid massage • AV nodal re-entry tachycardia (AVNRT, the commonest type of if a carotid bruit is present: rupture of an atheromatous plaque SVT); could cause cerebral embolism and stroke. A Valsalva manoeuvre • AV re-entry tachycardia (AVRT), which is associated with (forced expiration against a closed glottis) in the supine position Wolff–Parkinson–White (WPW) syndrome; may be the most effective technique. A practical way of achieving • atrial flutter with regular AV conduction (usually 2:1). this without protracted explanation is to ask the patient to blow into a 20 ml syringe with enough force to push back the plunger. Irregular narrow-complex tachycardia is most commonly AF Record an ECG (preferably multi-lead) during each manoeuvre. or sometimes atrial flutter with variable AV conduction (‘variable If the rhythm is atrial flutter, slowing of the ventricular response block’). will often occur and demonstrate flutter waves.
- 113. C.D. Deakin et al. / Resuscitation 81 (2010) 1305–1352 1331 • If the arrhythmia persists and is not atrial flutter, use adeno- Bradycardia sine. Give 6 mg as a rapid intravenous bolus. Record an ECG (preferably multi-lead) during each injection. If the ventricular A bradycardia is defined as a heart rate of <60 beats min−1 . rate slows transiently but the arrhythmia then persists, look for Bradycardia can have cardiac causes (e.g., myocardial infarction; atrial activity such as atrial flutter or other atrial tachycardia and myocardial ischaemia; sick sinus syndrome), non-cardiac causes treat accordingly. If there is no response to adenosine 6 mg, give (e.g., vasovagal response, hypothermia; hypoglycaemia; hypothy- a 12 mg bolus; if there is no response, give one further 12 mg- roidism, raised intracranial pressure) or be caused by drug toxicity bolus. This strategy will terminate 90–95% of supraventricular (e.g., digoxin; beta-blockers; calcium channel blockers). arrhythmias.610 Bradycardias are caused by reduced sinoatrial node firing or • Successful termination of a tachyarrhythmia by vagal manoeu- failure of the atrial-ventricular conduction system. Reduced sinoa- vres or adenosine indicates that it was almost certainly AVNRT trial node firing is seen in sinus bradycardia (caused by excess or AVRT. Monitor the patients for further rhythm abnormali- vagal tone), sinus arrest, and sick sinus syndrome. Atrioventricu- ties. Treat recurrence either with further adenosine or with a lar (AV) blocks are divided into first, second, and third degrees and longer-acting drug with AV nodal-blocking action (e.g., diltiazem may be associated with multiple medications or electrolyte distur- or verapamil). bances, as well as structural problems caused by acute myocardial • If adenosine is contraindicated or fails to terminate a infarction and myocarditis. A first-degree AV block is defined by regular narrow-complex tachycardia without demon- a prolonged P–R interval (>0.20 s), and is usually benign. Second- strating that it is atrial flutter, give a calcium channel blocker degree AV block is divided into Mobitz types I and II. In Mobitz (e.g., verapamil or diltiazem). type I, the block is at the AV node, is often transient and may be asymptomatic. In Mobitz type II, the block is most often below the Irregular narrow-complex tachycardia AV node at the bundle of His or at the bundle branches, and is often symptomatic, with the potential to progress to complete AV block. An irregular narrow-complex tachycardia is most likely to be AF Third-degree heart block is defined by AV dissociation, which may with an uncontrolled ventricular response or, less commonly, atrial be permanent or transient, depending on the underlying cause. flutter with variable AV block. Record a 12-lead ECG to identify the rhythm. If the patient is unstable with adverse features caused Initial assessment by the arrhythmia, attempt synchronised electrical cardioversion as described above. The European Society of Cardiology provides Assess the patient with bradycardia using the ABCDE approach. detailed guidelines on the management of AF.611 Consider the potential cause of the bradycardia and look for the If there are no adverse features, treatment options include: adverse signs. Treat any reversible causes of bradycardia identified in the initial assessment. If adverse signs are present start to treat • rate control by drug therapy; the bradycardia. Initial treatments are pharmacological, with pac- • rhythm control using drugs to encourage chemical cardioversion; ing being reserved for patients unresponsive to pharmacological • rhythm control by electrical cardioversion; treatments or with risks factors for asystole (Fig. 4.12). • treatment to prevent complications (e.g., anticoagulation). Pharmacological treatment Obtain expert help to determine the most appropriate treatment for the individual patient. The longer a patient remains in AF, the If adverse signs are present, give atropine, 500 g, intravenously greater is the likelihood of atrial clot developing. In general, patients and, if necessary, repeat every 3–5 min to a total of 3 mg. Doses who have been in AF for more than 48 h should not be treated by of atropine of less than 500 g, paradoxically, may cause fur- cardioversion (electrical or chemical) until they have received full ther slowing of the heart rate.618 In healthy volunteers a dose of anticoagulation or absence of atrial clot has been shown by transoe- 3 mg produces the maximum achievable increase in resting heart sophageal echocardiography. If the clinical scenario dictates that rate.619 Use atropine cautiously in the presence of acute coro- cardioversion is required and the duration of AF is greater than nary ischaemia or myocardial infarction; increased heart rate may 48 h (or the duration is unknown) give an initial intravenous bolus worsen ischaemia or increase the zone of infarction injection of heparin followed by a continuous infusion to maintain If treatment with atropine is ineffective, consider second the activated partial thromboplastin time at 1.5–2 times the refer- line drugs. These include isoprenaline (5 g min−1 starting dose), ence control value. Anticoagulation should be continued for at least adrenaline (2–10 g min−1 ) and dopamine (2–10 g kg−1 min−1 ). 4 weeks thereafter.611 Theophylline (100–200 mg slow intravenous injection) should be If the aim is to control heart rate, the drugs of choice are beta- considered if the bradycardia is caused by inferior myocardial blockers612,613 and diltiazem.614,615 Digoxin and amiodarone may infarction, cardiac transplant or spinal cord injury. Consider giving be used in patients with heart failure. Magnesium has also been intravenous glucagon if beta-blockers or calcium channel blockers used although the data supporting this is more limited.616,617 are a potential cause of the bradycardia. Do not give atropine to If the duration of AF is less than 48 h and rhythm control is patients with cardiac transplants—it can cause a high-degree AV considered appropriate, chemical cardioversion may be attempted. block or even sinus arrest.620 Seek expert help and consider ibutilide, flecainide or dofetilide. Amiodarone (300 mg intravenously over 20–60 min followed by Pacing 900 mg over 24 h) may also be used but is less effective. Elec- trical cardioversion remains an option in this setting and will Initiate transcutaneous pacing immediately if there is no restore sinus rhythm in more patients than chemical cardiover- response to atropine, or if atropine is unlikely to be effective. sion. Transcutaneous pacing can be painful and may fail to pro- Seek expert help if any patient with AF is known or found to have duce effective mechanical capture. Verify mechanical capture and ventricular pre-excitation (WPW syndrome). Avoid using adeno- reassess the patient’s condition. Use analgesia and sedation to con- sine, diltiazem, verapamil or digoxin in patients with pre-excited trol pain, and attempt to identify the cause of the bradyarrhythmia. AF or atrial flutter, as these drugs block the AV node and cause a If atropine is ineffective and transcutaneous pacing is not imme- relative increase in pre-excitation. diately available, fist pacing can be attempted while waiting for
- 114. 1332 C.D. Deakin et al. / Resuscitation 81 (2010) 1305–1352 Fig. 4.12. Bradycardia algorithm. © 2010 ERC. pacing equipment621–623 : Give serial rhythmic blows with the terminating paroxysmal SVT with re-entrant circuits that include closed fist over the left lower edge of the sternum to pace the heart the AV node (AVNRT). In other narrow-complex tachycardias, at a physiological rate of 50–70 beats min−1 . adenosine will reveal the underlying atrial rhythms by slowing the Seek expert help to assess the need for temporary transve- ventricular response. It has an extremely short half-life of 10–15 s nous pacing. Temporary transvenous pacing should be considered and, therefore, is given as a rapid bolus into a fast running intra- if there are is a history of recent asystole; Möbitz type II AV block; venous infusion or followed by a saline flush. The smallest dose complete (third-degree) heart block (especially with broad QRS or likely to be effective is 6 mg (which is outside some current licences initial heart rate <40 beats min−1 ) or evidence of ventricular stand- for an initial dose) and, if unsuccessful this can be followed with still of more than 3 s. up to two doses each of 12 mg every 1–2 min. Patients should be warned of transient unpleasant side effects, in particular nausea, Anti-arrhythmic drugs flushing, and chest discomfort.624 Adenosine is not available in some European countries, but adenosine triphosphate (ATP) is an Adenosine alternative. In a few European countries neither preparation may be available; verapamil is probably the next best choice. Theo- Adenosine is a naturally occurring purine nucleotide. It slows phylline and related compounds block the effect of adenosine. transmission across the AV node but has little effect on other Patients receiving dipyridamole or carbamazepine, or with dener- myocardial cells or conduction pathways. It is highly effective for vated (transplanted) hearts, display a markedly exaggerated effect
- 115. C.D. Deakin et al. / Resuscitation 81 (2010) 1305–1352 1333 that may be hazardous. In these patients, or if injected into a central Diltiazem at a dose of 250 g kg−1 , followed by a second dose of vein, reduce the initial dose of adenosine to 3 mg. In the presence 350 g kg−1 , is as effective as verapamil. Verapamil and, to a lesser of WPW syndrome, blockage of conduction across the AV node by extent, diltiazem may decrease myocardial contractility and criti- adenosine may promote conduction across an accessory pathway. cally reduce cardiac output in patients with severe LV dysfunction. In the presence of supraventricular arrhythmias this may cause a For the reasons stated under adenosine (above), calcium channel dangerously rapid ventricular response. In the presence of WPW blockers are considered harmful when given to patients with AF or syndrome, rarely, adenosine may precipitate atrial fibrillation asso- atrial flutter associated with pre-excitation (WPW) syndrome. ciated with a dangerously rapid ventricular response. Beta-adrenergic blockers Amiodarone Beta-blocking drugs (atenolol, metoprolol, labetalol (alpha- and Intravenous amiodarone has effects on sodium, potassium and beta-blocking effects), propranolol, esmolol) reduce the effects of calcium channels as well as alpha- and beta-adrenergic blocking circulating catecholamines and decrease heart rate and blood pres- properties. Indications for intravenous amiodarone include: sure. They also have cardioprotective effects for patients with acute coronary syndromes. Beta-blockers are indicated for the following • control of haemodynamically stable monomorphic VT, polymor- tachycardias: phic VT and wide-complex tachycardia of uncertain origin; • paroxysmal SVT uncontrolled by adenosine, vagal manoeuvres or • narrow-complex regular tachycardias uncontrolled by vagal AV nodal blockade; manoeuvres and adenosine in the patient with preserved ven- • to control rapid ventricular rate due to accessory pathway con- tricular function; duction in pre-excited atrial arrhythmias; • to control rate in AF and atrial flutter when ventricular function • unsuccessful electrical cardioversion. is preserved. Give amiodarone, 300 mg intravenously, over 10–60 min The intravenous dose of atenolol (beta1 ) is 5 mg given over depending on the circumstances and haemodynamic stability of 5 min, repeated if necessary after 10 min. Metoprolol (beta1 ) is the patient. This loading dose is followed by an infusion of 900 mg given in doses of 2–5 mg at 5-min intervals to a total of 15 mg. over 24 h. Additional infusions of 150 mg can be repeated as Propranolol (beta1 and beta2 effects), 100 g kg−1 , is given slowly necessary for recurrent or resistant arrhythmias to a maximum in three equal doses at 2–3-min intervals. manufacturer-recommended total daily dose of 2 g (this maxi- Intravenous esmolol is a short-acting (half-life of 2–9 min) mum licensed dose varies between different countries). In patients beta1 -selective beta-blocker. It is given as an intravenous load- with severely impaired heart function, intravenous amiodarone is ing dose of 500 g kg−1 over 1 min, followed by an infusion of preferable to other anti-arrhythmic drugs for atrial and ventricular 50–200 g kg−1 min−1 . arrhythmias. Major adverse effects from amiodarone are hypoten- Side effects of beta-blockade include bradycardia, AV con- sion and bradycardia, which can be prevented by slowing the rate duction delay and hypotension. Contraindications to the use of of drug infusion. The hypotension associated with amiodarone is beta-adrenergic blocking drugs include second- or third-degree caused by vasoactive solvents (Polysorbate 80 and benzyl alcohol). heart block, hypotension, severe congestive heart failure and lung A new aqueous formulation of amiodarone does not contain these disease associated with bronchospasm. solvents and causes no more hypotension than lidocaine.446 When- ever possible, intravenous amiodarone should be given via a central Magnesium venous catheter; it causes thrombophlebitis when infused into a peripheral vein. In an emergency it can be injected into a large Magnesium is the first line treatment for polymorphic ven- peripheral vein. tricular tachycardia. It may also reduce ventricular rate in atrial fibrillation.617,625–627 Give magnesium sulphate 2 g (8 mmol) over Calcium channel blockers: verapamil and diltiazem 10 min. This can be repeated once if necessary. Verapamil and diltiazem are calcium channel blocking drugs 4h Post-resuscitation care that slow conduction and increase refractoriness in the AV node. Intravenous diltiazem is not available in some countries. These actions may terminate re-entrant arrhythmias and control ventric- Introduction ular response rate in patients with a variety of atrial tachycardias. Indications include: Successful ROSC is the just the first step toward the goal of complete recovery from cardiac arrest. The complex pathophys- • stable regular narrow-complex tachycardias uncontrolled or iological processes that occur following whole body ischaemia unconverted by adenosine or vagal manoeuvres; during cardiac arrest and the subsequent reperfusion response • to control ventricular rate in patients with AF or atrial flutter and following successful resuscitation have been termed the post- preserved ventricular function when the duration of the arrhyth- cardiac arrest syndrome.628 Many of these patients will require mia is less than 48 h. multiple organ support and the treatment they receive this post-resuscitation period influences significantly the ultimate neu- The initial dose of verapamil is 2.5–5 mg intravenously given rological outcome.184,629–633 The post-resuscitation phase starts over 2 min. In the absence of a therapeutic response or drug- at the location where ROSC is achieved but, once stabilised, the induced adverse event, give repeated doses of 5–10 mg every patient is transferred to the most appropriate high-care area (e.g., 15–30 min to a maximum of 20 mg. Verapamil should be given only intensive care unit, coronary care unit) for continued monitor- to patients with narrow-complex paroxysmal SVT or arrhythmias ing and treatment. Of those patients admitted to intensive care known with certainty to be of supraventricular origin. The admin- units after cardiac arrest, approximately 25–56% will survive to istration of calcium channel blockers to a patient with ventricular be discharged from hospital depending on the system and qual- tachycardia may cause cardiovascular collapse. ity of care.498,629,632,634–638 Of the patients that survive to hospital
- 116. 1334 C.D. Deakin et al. / Resuscitation 81 (2010) 1305–1352 discharge, the vast majority have a good neurological outcome Obtain a chest radiograph to check the position of the tracheal tube although many with some cognitive impairment.639 and central venous lines, assess for pulmonary oedema, and detect complications from CPR such as a pneumothorax associated with Post-cardiac arrest syndrome rib fractures. The post-cardiac arrest syndrome comprises post-cardiac arrest brain injury, post-cardiac arrest myocardial dysfunction, the Circulation systemic ischaemia/reperfusion response, and the persistent pre- cipitating pathology.628 The severity of this syndrome will vary The majority of out-of-hospital cardiac arrest patients have with the duration and cause of cardiac arrest. It may not occur coronary artery disease.656,657 Acute changes in coronary plaque at all if the cardiac arrest is brief. Post-cardiac arrest brain injury morphology occur in 40–86% of cardiac arrest survivors and in manifests as coma, seizures, myoclonus, varying degrees of neu- 15–64% of autopsy studies.658 It is well recognised that post- rocognitive dysfunction and brain death. Among patients surviving cardiac arrest patients with ST elevation myocardial infarction to ICU admission but subsequently dying in-hospital, brain injury is (STEMI) should undergo early coronary angiography and per- the cause of death in 68% after out-of hospital cardiac arrest and in cutaneous coronary intervention (PCI) but, because chest pain 23% after in-hospital cardiac arrest.245,640 Post-cardiac arrest brain and/or ST elevation are poor predictors of acute coronary occlu- injury may be exacerbated by microcirculatory failure, impaired sion in these patients,659 this intervention should be considered autoregulation, hypercarbia, hyperoxia, pyrexia, hyperglycaemia in all post-cardiac arrest patients who are suspected of hav- and seizures. Significant myocardial dysfunction is common after ing coronary artery disease.629,633,659–665 Several studies indicate cardiac arrest but typically recovers by 2–3 days.641,642 The whole that the combination of therapeutic hypothermia and PCI is fea- body ischaemia/reperfusion of cardiac arrest activates immuno- sible and safe after cardiac arrest caused by acute myocardial logical and coagulation pathways contributing to multiple organ infarction.629,633,638,665,666 failure and increasing the risk of infection.643,644 Thus, the post- Post-cardiac arrest myocardial dysfunction causes haemody- cardiac arrest syndrome has many features in common with sepsis, namic instability, which manifests as hypotension, low cardiac including intravascular volume depletion and vasodilation.645,646 index and arrhythmias.641 Early echocardiography will enable the degree of myocardial dysfunction to be quantified.642 In the ICU Airway and breathing an arterial line for continuous blood pressure monitoring is essen- tial. Treatment with fluid, inotropes and vasopressors may be Patients who have had a brief period of cardiac arrest responding guided by blood pressure, heart rate, urine output, and rate of immediately to appropriate treatment may achieve an immediate plasma lactate clearance and central venous oxygen saturations. return of normal cerebral function. These patients do not require Non-invasive cardiac output monitors may help to guide treat- tracheal intubation and ventilation but should be given oxygen via ment but there is no evidence that their use affects outcome. If a facemask. Hypoxaemia and hypercarbia both increase the likeli- treatment with fluid resuscitation and vasoactive drugs is insuffi- hood of a further cardiac arrest and may contribute to secondary cient to support the circulation, consider insertion of an intra-aortic brain injury. Several animal studies indicate that hyperoxaemia balloon pump.629,638 Infusion of relatively large volumes of flu- causes oxidative stress and harms post-ischaemic neurones.647–650 ids are tolerated remarkably well by patients with post-cardiac One animal study has demonstrated that adjusting the frac- arrest syndrome.513,629,630,641 Although early goal directed ther- tional inspired concentration (FiO2 ) to produce an arterial oxygen apy is well-established in the treatment of sepsis,667 and has saturation of 94–96% in the first hour after ROSC (‘controlled reoxy- been proposed as a treatment strategy after cardiac arrest,630 genation’) achieved better neurological outcomes than achieved there are no randomised, controlled data to support its routine with the delivery of 100% oxygen.328 A recent clinical registry study use. that included more than 6000 patients supports the animal data and There are very few randomised trials evaluating the role of shows post-resuscitation hyperoxaemia is associated with worse blood pressure on the outcome after cardiac arrest. One randomised outcome, compared with both normoxaemia and hypoxaemia.329 study demonstrated no difference in the neurological outcome In clinical practice, as soon as arterial blood oxygen saturation can among patients randomised to a mean arterial blood pressure be monitored reliably (by blood gas analysis and/or pulse oxime- (MAP) of >100 mm Hg versus ≤100 mm Hg 5 min after ROSC; how- try), it may be more practicable to titrate the inspired oxygen ever, good functional recovery was associated with a higher blood concentration to maintain the arterial blood oxygen saturation in pressure during the first 2 h after ROSC.668 In a registry study of the range of 94–98%. more than 6000 post-cardiac arrest patients, hypotension (systolic Consider tracheal intubation, sedation and controlled venti- blood pressure <90 mm Hg) on admission to ICU was associated lation in any patient with obtunded cerebral function. Ensure with worse outcome.668a Good outcomes have been achieved in the tracheal tube is positioned correctly well above the carina. studies of patients admitted after out-of-hospital cardiac arrest Hypocarbia causes cerebral vasoconstriction and a decreased cere- where the MAP target was low as 65–75 mm Hg629 to as high bral blood flow.651 After cardiac arrest, hypocapnoea induced by as 90–100 mm Hg.632,669 In the absence of definitive data, target hyperventilation causes cerebral ischaemia.652–655 There are no the mean arterial blood pressure to achieve an adequate urine data to support the targeting of a specific arterial PCO2 after resus- output (1 ml kg−1 h−1 ) and normal or decreasing plasma lactate citation from cardiac arrest, but it is reasonable to adjust ventilation values, taking into consideration the patient’s normal blood pres- to achieve normocarbia and to monitor this using the end-tidal sure, the cause of the arrest and the severity of any myocardial PCO2 and arterial blood gas values. dysfunction.628 Importantly, hypothermia may increase urine out- Insert a gastric tube to decompress the stomach; gastric disten- put and impair lactate clearance. sion caused by mouth-to-mouth or bag-mask-valve ventilation will Immediately after a cardiac arrest there is typically a splint the diaphragm and impair ventilation. Give adequate doses of period of hyperkalaemia. Subsequent endogenous catecholamine sedative, which will reduce oxygen consumption. Bolus doses of a release promotes intracellular transportation of potassium, caus- neuromuscular blocking drug may be required, particularly if using ing hypokalaemia. Hypokalaemia may predispose to ventricular therapeutic hypothermia (see below), but try to avoid infusions of arrhythmias. Give potassium to maintain the serum potassium con- neuromuscular blocking drugs because these may mask seizures. centration between 4.0 and 4.5 mmol l−1 .
- 117. C.D. Deakin et al. / Resuscitation 81 (2010) 1305–1352 1335 Disability (optimising neurological recovery) with intensive glucose control.688 Another recent study and two meta-analyses of studies of tight glucose control versus conven- Cerebral perfusion tional glucose control in critically ill patients showed no significant difference in mortality but found tight glucose control was associ- Immediately after ROSC there is a period of cerebral ated with a significantly increased risk of hypoglycaemia.689–691 hyperaemia.670 After asphyxial cardiac arrest, brain oedema may Severe hypoglycaemia is associated with increased mortality in occur transiently after ROSC but it is rarely associated with clinically critically ill patients,692 and comatose patients are at particular relevant increases in intracranial pressure.671,672 Autoregulation of risk from unrecognised hypoglycaemia. There is some evidence cerebral blood flow is impaired for some time after cardiac arrest, that, irrespective of the target range, variability in glucose values is which means that cerebral perfusion varies with cerebral perfusion associated with mortality.693 pressure instead of being linked to neuronal activity.673,674 As dis- Based on the available data, following ROSC blood glucose cussed previously, following ROSC, maintain mean arterial pressure should be maintained at ≤10 mmol l−1 (180 mg dl−1 ).694 Hypo- near the patient’s normal level. glycaemia should be avoided. Strict glucose control should not be implemented in adult patients with ROSC after cardiac arrest Sedation because of the increased risk of hypoglycaemia. Although it has been common practice to sedate and ventilate Temperature control patients for at least 24 h after ROSC, there are no high-level data to support a defined period of ventilation, sedation and neuromuscu- Treatment of hyperpyrexia lar blockade after cardiac arrest. Patients need to be well-sedated A period of hyperthermia (hyperpyrexia) is common in the during treatment with therapeutic hypothermia, and the duration first 48 h after cardiac arrest.695–697 Several studies document of sedation and ventilation is therefore influenced by this treat- an association between post-cardiac arrest pyrexia and poor ment. There are no data to indicate whether or not the choice outcomes.498,695,697–700 There are no randomised controlled trials of sedation influences outcome, but a combination of opioids evaluating the effect of treatment of pyrexia (defined as ≥37.6 ◦ C) and hypnotics is usually used. Short-acting drugs (e.g., propofol, compared to no temperature control in patients after cardiac arrest. alfentanil, remifentanil) will enable earlier neurological assess- Although the effect of elevated temperature on outcome is not ment. Adequate sedation will reduce oxygen consumption. During proved, it seems prudent to treat any hyperthermia occurring after hypothermia, optimal sedation can reduce or prevent shivering, cardiac arrest with antipyretics or active cooling. which enable the target temperature to be achieved more rapidly. Use of published sedation scales for monitoring these patients (e.g., Therapeutic hypothermia the Richmond or Ramsay Scales) may be helpful.675,676 Animal and human data indicate that mild hypothermia is neuroprotective and improves outcome after a period of global Control of seizures cerebral hypoxia-ischaemia.701,702 Cooling suppresses many of the pathways leading to delayed cell death, including apopto- Seizures or myoclonus or both occur in 5–15% of adult sis (programmed cell death). Hypothermia decreases the cerebral patients who achieve ROSC and 10–40% of those who remain metabolic rate for oxygen (CMRO2 ) by about 6% for each 1 ◦ C reduc- comatose.498,677–680 Seizures increase cerebral metabolism by up tion in temperature703 and this may reduce the release of excitatory to 3-fold681 and may cause cerebral injury: treat promptly and amino acids and free radicals.701 Hypothermia blocks the intra- effectively with benzodiazepines, phenytoin, sodium valproate, cellular consequences of excitotoxin exposure (high calcium and propofol, or a barbiturate. Myoclonus can be particularly difficult to glutamate concentrations) and reduces the inflammatory response treat; phenytoin is often ineffective. Clonazepam is the most effec- associated with the post-cardiac arrest syndrome. tive antimyoclonic drug, but sodium valproate, levetiracetam and propofol may also be effective.682 Maintenance therapy should be Which post-cardiac arrest patients should be cooled?. All stud- started after the first event once potential precipitating causes (e.g., ies of post-cardiac arrest therapeutic hypothermia have included intracranial haemorrhage, electrolyte imbalance) are excluded. No only patients in coma. There is good evidence supporting the use studies directly address the use of prophylactic anticonvulsant of induced hypothermia in comatose survivors of out-of-hospital drugs after cardiac arrest in adults. cardiac arrest caused by VF. One randomised trial704 and a pseudo- randomised trial669 demonstrated improved neurological outcome Glucose control at hospital discharge or at 6 months in comatose patients after out-of-hospital VF cardiac arrest. Cooling was initiated within min- There is a strong association between high blood glucose utes to hours after ROSC and a temperature range of 32–34 ◦ C was after resuscitation from cardiac arrest and poor neurological maintained for 12–24 h. Two studies with historical control groups outcome.498–501,504,634,683,684 Although one randomised controlled showed improvement in neurological outcome after therapeutic trial in a cardiac surgical intensive care unit showed that tight con- hypothermia for comatose survivors of VF cardiac arrest.705–707 trol of blood glucose (4.4–6.1 mmol l−1 or 80–110 mg dl−1 ) using Extrapolation of these data to other cardiac arrests (e.g., other initial insulin reduced hospital mortality in critically ill adults,685 a sec- rhythms, in-hospital arrests, paediatric patients) seems reasonable ond study by the same group in medical ICU patients showed but is supported by only lower level data. no mortality benefit from tight glucose control.686 In one ran- One small, randomised trial showed reduced plasma lactate domised trial of patients resuscitated from OHCA with ventricular values and oxygen extraction ratios in a group of comatose sur- fibrillation, strict glucose control (72–108 mg dl−1 , 4–6 mmol l−1 ]) vivors after cardiac arrest with asystole or PEA who were cooled gave no survival benefit compared with moderate glucose control with a cooling cap.708 Six studies with historical control groups (108–144 mg dl−1 , 6–8 mmol l−1 ) and there were more episodes of have shown benefit using therapeutic hypothermia in comatose hypoglycaemia in the strict glucose control group.687 A large ran- survivors of OHCA after all rhythm arrests.629,632,709–712 Two non- domised trial of intensive glucose control (4.5–6.0 mmol l−1 ) versus randomised studies with concurrent controls indicate possible conventional glucose control (10 mmol l−1 or less) in general ICU benefit of hypothermia following cardiac arrest from other initial patients reported increased 90-day mortality in patients treated rhythms in- and out-of-hospital.713,714
- 118. 1336 C.D. Deakin et al. / Resuscitation 81 (2010) 1305–1352 How to cool?. The practical application of therapeutic • Shivering will increase metabolic and heat production, thus hypothermia is divided into three phases: induction, maintenance, reducing cooling rates—strategies to reduce shivering are dis- and rewarming.715 External and/or internal cooling techniques can cussed above. be used to initiate cooling. An infusion of 30 ml kg−1 of 4 ◦ C saline • Mild hypothermia increases systemic vascular resistance, causes or Hartmann’s solution decreases core temperature by approxi- arrhythmias (usually bradycardia).714 mately 1.5 ◦ C629,633,638,706,707,711,716–727 and this technique can be • It causes a diuresis and electrolyte abnormalities such used initiate cooling prehospital.511,728–731 as hypophosphatemia, hypokalemia, hypomagesemia and Other methods of inducing and/or maintaining hypothermia hypocalcemia.715,755 include: • Hypothermia decreases insulin sensitivity and insulin secretion, hyperglycemia,669 which will need treatment with insulin (see • Simple ice packs and/or wet towels are inexpensive; however, glucose control). these methods may be more time consuming for nursing staff, • Mild hypothermia impairs coagulation and increases bleeding may result in greater temperature fluctuations, and do not enable although this has not be confirmed in many clinical studies.629,704 controlled rewarming.633,638,669,705,709,710,725,726,732–734 Ice cold In one registry study an increased rate of minor bleeding occurred fluids alone cannot be used to maintain hypothermia,719 but even with the combination of coronary angiography and therapeutic the addition of simple ice packs may control the temperature hypothermia, but this combination of interventions was the also adequately.725 the best predictor of good outcome.665 • Cooling blankets or pads.727,735–740 • Hypothermia can impair the immune system and increase infec- • Transnasal evaporative cooling.740a tion rates.715,734,736 • Water or air circulating blankets.629,630,632,706,707,712,713,727,741–744 • The serum amylase concentration is commonly increased during • Water circulating gel-coated pads.629,711,720,721,727,738,743,745 hypothermia but the significance of this unclear. • Intravascular heat exchanger, placed usually in the femoral or • The clearance of sedative drugs and neuromuscular blockers is subclavian veins.629,630,713,714,718,724,727,732,733,742,746–748 reduced by up to 30% at a core temperature of 34 ◦ C.756 • Cardiopulmonary bypass.749 Contraindications to hypothermia. Generally recognised con- In most cases, it is easy to cool patients initially after ROSC traindications to therapeutic hypothermia, but which are not because the temperature normally decreases within this first applied universally, include: severe systemic infection, established hour.498,698 Initial cooling is facilitated by neuromuscular block- multiple organ failure, and pre-existing medical coagulopathy ade and sedation, which will prevent shivering.750 Magnesium (fibrinolytic therapy is not a contraindication to therapeutic sulphate, a naturally occurring NMDA receptor antagonist, that hypothermia). reduces the shivering threshold slightly, can also be given to reduce the shivering threshold.715,751 Other therapies In the maintenance phase, a cooling method with effective temperature monitoring that avoids temperature fluctuations is Neuroprotective drugs (coenzyme Q10,737 thiopental,757 preferred. This is best achieved with external or internal cooling glucocorticoids,758,759 nimodipine,760,761 lidoflazine,762 or devices that include continuous temperature feedback to achieve diazepam 452 ) used alone, or as an adjunct to therapeutic hypother- a set target temperature. The temperature is typically monitored mia, have not been demonstrated to increase neurologically intact from a thermistor placed in the bladder and/or oesophagus.715 As survival when included in the post-arrest treatment of cardiac yet, there are no data indicating that any specific cooling technique arrest. There is also insufficient evidence to support the routine increases survival when compared with any other cooling tech- use of high-volume haemofiltration763 to improve neurological nique; however, internal devices enable more precise temperature outcome in patients with ROSC after cardiac arrest. control compared with external techniques.727 Plasma electrolyte concentrations, effective intravascular vol- Prognostication ume and metabolic rate can change rapidly during rewarming, as they do during cooling. Thus, rewarming must be achieved slowly: Two thirds of those dying after admission to ICU following out- the optimal rate is not known, but the consensus is currently about of-hospital cardiac arrest die from neurological injury; this has been 0.25–0.5 ◦ C of warming per hour.713 shown both with245 and without640 therapeutic hypothermia. A quarter of those dying after admission to ICU following in-hospital When to cool?. Animal data indicate that earlier cooling cardiac arrest die from neurological injury. A means of predicting after ROSC produces better outcomes.752 Ultimately, starting neurological outcome that can be applied to individual patients cooling during cardiac arrest may be most beneficial—animal immediately after ROSC is required. Many studies have focused on data indicate that this may facilitate ROSC.753,754 Several clin- prediction of poor long term outcome (vegetative state or death), ical studies have shown that hypothermia can be initiated based on clinical or test findings that indicate irreversible brain prehospital,510,728,729,731,740,740a but, as yet, there are no human injury, to enable clinicians to limit care or withdraw organ sup- data proving that time target temperature produces better out- port. The implications of these prognostic tests are such that they comes. One registry-based case series of 986 comatose post-cardiac should have 100% specificity or zero false positive rate (FPR), i.e., arrest patients suggested that time to initiation of cooling was not proportion of individuals who eventually have a ‘good’ long-term associated with improved neurological outcome post-discharge.665 outcome despite the prediction of a poor outcome. This topic of A case series of 49 consecutive comatose post-cardiac arrest prognostication after cardiac arrest is controversial because: (1) patients intravascularly cooled after out-of-hospital cardiac arrest many studies are confounded by self-fulfilling prophecy (treat- also documented that time to target temperature was not an inde- ment is rarely continued for long enough in sufficient patients pendent predictor of neurologic outcome.748 to enable a true estimate of the false positive rate for any given prognosticator); (2) many studies include so few patients that Physiological effects and complications of hypothermia. The even if the FPR is 0%, the upper limit of the 95% confidence inter- well-recognised physiological effects of hypothermia need to be val may be high; and (3) most prognostication studies have been managed carefully715 : undertaken before implementation of therapeutic hypothermia
- 119. C.D. Deakin et al. / Resuscitation 81 (2010) 1305–1352 1337 and there is evidence that this therapy makes these tests less reli- hypoxemia, it is reasonable to use unprocessed EEG interpretation able. (specifically identifying generalized suppression to less than 20 V, burst suppression pattern with generalized epileptic activity, or dif- Clinical examination fuse periodic complexes on a flat background) observed between 24 and 72 h after ROSC to assist the prediction of a poor outcome There are no clinical neurological signs that reliably predict poor (FPR 3%, 95% CI 0.9–11%) in comatose survivors of cardiac arrest outcome (cerebral performance category [CPC] 3 or 4, or death) less not treated with hypothermia.774 There is inadequate evidence to than 24 h after cardiac arrest. In adult patients who are comatose support the routine use of other electrophysiological studies (e.g., after cardiac arrest, and who have not been treated with hypother- abnormal brainstem auditory evoked potentials) for prognostica- mia and who do not have confounding factors (such as hypotension, tion of poor outcome in comatose cardiac arrest survivors.606 sedatives or muscle relaxants), the absence of both pupillary light and corneal reflex at ≥72 h reliably predicts poor outcome (FPR Imaging studies 0%; 95% CI 0–9%).680 Absence of vestibulo-ocular reflexes at ≥24 h (FPR 0%; 95% CI 0–14%)764,765 and a GCS motor score of 2 or less at Many imaging modalities (magnetic resonance imaging [MRI], ≥72 h (FPR 5%; 95% CI 2–9%)680 are less reliable. Other clinical signs, computed tomography [CT], single photon emission computed including myoclonus, are not recommended for predicting poor tomography [SPECT], cerebral angiography, transcranial Doppler, outcome. The presence of myoclonus status in adults is strongly nuclear medicine, near infra-red spectroscopy [NIRS]) have been associated with poor outcome,679,680,766–768 but rare cases of good studied to determine their utility for prediction of outcome in adult neurological recovery have been described and accurate diagnosis cardiac arrest survivors.606 There are no level one or level two stud- is problematic.769–773 ies that support the use of any imaging modality to predict outcome of comatose cardiac arrest survivors. Overall, those imaging stud- Biochemical markers ies that have been undertaken were limited by small sample sizes, variable time of imaging (many very late in the course), lack of com- Serum neuronal specific enolase elevations are associ- parison with a standardised method of prognostication, and early ated with poor outcome for comatose patients after cardiac withdrawal of care. Despite tremendous potential, neuroimaging arrest.680,748,774–792 Although specific cut-off values with a false has yet to be proven as an independently accurate modality for positive rate of 0% have been reported, clinical application is prediction of outcome in individual comatose cardiac arrest sur- limited due to variability in the 0% FPR cut-off values reported vivors and, at this time, its routine use for this purpose is not among various studies. recommended. Serum S100 elevations are associated with poor outcome for comatose patients after cardiac Impact of therapeutic hypothermia on prognostication arrest.680,774–776,782,784,785,787,788,791,793–798 Many other serum markers measured after sustained return There is inadequate evidence to recommend a specific approach of spontaneous circulation have been associated with poor out- to prognosticating poor outcome in post-cardiac arrest patients come after cardiac arrest, including BNP,799 vWF,800 ICAM-1,800 treated with therapeutic hypothermia. There are no clinical neuro- procalcitonin,794 IL-1ra, RANTES, sTNFRII, IL-6, IL-8 and IL-10.645 logical signs, electrophysiological studies, biomarkers, or imaging However, other studies found no relationship between outcome modalities that can reliably predict neurological outcome in the and serum IL-8,793 and procalcitonin and sTREM-1.801 first 24 h after cardiac arrest. Based on limited available evidence, Worse outcomes for comatose survivors of cardiac arrest potentially reliable prognosticators of poor outcome in patients are also associated with increased levels of cerebrospinal fluid treated with therapeutic hypothermia after cardiac arrest include (CSF)-CK802,803 and cerebrospinal fluid-CKBB.774,775,777,789,803–807 bilateral absence of N20 peak on SSEP ≥ 24 h after cardiac arrest However, one study found no relationship between cerebrospinal (FPR 0%, 95% CI 0–69%) and the absence of both corneal and pupil- fluid-CKBB and prognosis.808 lary reflexes 3 or more days after cardiac arrest (FPR 0%, 95% Outcomes are also associated with increased cerebrospinal fluid CI 0–48%).766,810 Limited available evidence also suggests that a levels of other markers including NSE,775,784,789 ), S100,784 LDH, Glasgow Motor Score of 2 or less at 3 days post-ROSC (FPR 14% GOT,777,803 neurofilament,809 acid phosphatase and lactate.803 [95% CI 3–44%])766 and the presence of status epilepticus (FPR of Cerebrospinal fluid levels of beta-d-N-acetylglucosaminidase, and 7% [95% CI 1–25%] to 11.5% [95% CI 3–31%])811,812 are potentially pyruvate were not associated with the prognosis of cardiac unreliable prognosticators of poor outcome in post-cardiac arrest arrest.803 patients treated with therapeutic hypothermia. One study of 111 In summary, evidence does not support the use of serum or post-cardiac arrest patients treated with therapeutic hypothermia CSF biomarkers alone as predictors of poor outcomes in comatose attempted to validate prognostic criteria proposed by the Amer- patients after cardiac arrest with or without treatment with ther- ican Academy of Neurology.774,813 This study demonstrated that apeutic hypothermia (TH). Limitations included small numbers of clinical exam findings at 36–72 h were unreliable predictors of patients and/or inconsistency in cut-off values for predicting poor poor neurological outcome while bilaterally absent N20 peak on outcome. somatosensory evoked potentials (false positive rate 0%, 95% CI 0–13%) and unreactive electroencephalogram background (false Electrophysiological studies positive rate 0%, 95% CI 0–13%) were the most reliable. A decision rule derived using this dataset demonstrated that the presence of No electrophysiological study reliably predicts outcome of a two independent predictors of poor neurological outcome (incom- comatose patient within the first 24 h after cardiac arrest. If plete recovery brainstem reflexes, early myoclonus, unreactive somatosensory evoked potentials (SSEP) are measured after 24 h electroencephalogram and bilaterally absent cortical SSEPs) pre- in comatose cardiac arrest survivors not treated with therapeu- dicted poor neurological outcome with a false positive rate of 0% tic hypothermia, bilateral absence of the N20 cortical response to (95% CI 0–14%). Serum biomarkers such as NSE are potentially valu- median nerve stimulation predicts poor outcome (death or CPC 3 or able as adjunctive studies in prognostication of poor outcome in 4) with a FPR of 0.7% (95% CI 0.1–3.7).774 In the absence of confound- patients treated with hypothermia, but their reliability is limited ing circumstances such as sedatives, hypotension, hypothermia or because few patients have been studied and the assay is not well
- 120. 1338 C.D. Deakin et al. / Resuscitation 81 (2010) 1305–1352 standardisation.814,815 Given the limited available evidence, deci- 7. Hodgetts TJ, Kenward G, Vlackonikolis I, et al. Incidence, location and reasons sions to limit care should not be made based on the results of a for avoidable in-hospital cardiac arrest in a district general hospital. Resusci- tation 2002;54:115–23. single prognostication tool. 8. Kause J, Smith G, Prytherch D, Parr M, Flabouris A, Hillman K. A comparison of antecedents to cardiac arrests, deaths and emergency intensive care admis- sions in Australia and New Zealand, and the United Kingdom—the ACADEMIA Organ donation study. Resuscitation 2004;62:275–82. 9. Castagna J, Weil MH, Shubin H. Factors determining survival in patients with Solid organs have been successfully transplanted after cardiac cardiac arrest. Chest 1974;65:527–9. 10. Herlitz J, Bang A, Aune S, Ekstrom L, Lundstrom G, Holmberg S. Characteristics death.816 This group of patients offers an untapped opportunity to and outcome among patients suffering in-hospital cardiac arrest in monitored increase the organ donor pool. Organ retrieval from non-heart beat- and non-monitored areas. Resuscitation 2001;48:125–35. ing donors is classified as controlled or uncontrolled.817 Controlled 11. Buist M, Bernard S, Nguyen TV, Moore G, Anderson J. Association between donation occurs after planned withdrawal of treatment following clinically abnormal observations and subsequent in-hospital mortality: a prospective study. Resuscitation 2004;62:137–41. non-survivable injuries/illnesses. Uncontrolled donation describes 12. Franklin C, Mathew J. Developing strategies to prevent inhospital cardiac donation after a patient is brought in dead or with on-going CPR arrest: analyzing responses of physicians and nurses in the hours before the that fails to restore a spontaneous circulation. event. Crit Care Med 1994;22:244–7. 13. Hodgetts TJ, Kenward G, Vlachonikolis IG, Payne S, Castle N. The identification Graft function after transplantation is influenced by the dura- of risk factors for cardiac arrest and formulation of activation criteria to alert a tion of warm ischaemia time from cessation of cardiac output until medical emergency team. Resuscitation 2002;54:125–31. organ preservation is undertaken. Where delays in the initiation 14. McQuillan P, Pilkington S, Allan A, et al. Confidential inquiry into quality of care before admission to intensive care. BMJ 1998;316:1853–8. of organ preservation are anticipated mechanical chest compres- 15. Jacques T, Harrison GA, McLaws ML, Kilborn G. Signs of critical conditions and sion devices may be useful for maintaining effective circulation emergency responses (SOCCER): a model for predicting adverse events in the and organ perfusion whilst the necessary regulatory steps to allow inpatient setting. Resuscitation 2006;69:175–83. 16. McGain F, Cretikos MA, Jones D, et al. Documentation of clinical review and organ donation to occur are undertaken.818–820 vital signs after major surgery. Med J Aust 2008;189:380–3. 17. Cashman JN. In-hospital cardiac arrest: what happens to the false arrests? Cardiac arrest centres Resuscitation 2002;53:271–6. 18. Hein A, Thoren AB, Herlitz J. Characteristics and outcome of false cardiac arrests in hospital. Resuscitation 2006;69:191–7. There is wide variability in survival among hospitals caring for 19. Kenward G, Robinson A, Bradburn S, Steeds R. False cardiac arrests: the right patients after resuscitation from cardiac arrest.498,631,635,636,821–823 time to turn away? Postgrad Med J 2007;83:344–7. 20. Fuhrmann L, Lippert A, Perner A, Ostergaard D. Incidence, staff awareness and There is some low-level evidence that ICUs admitting more than 50 mortality of patients at risk on general wards. Resuscitation 2008;77:325–30. post-cardiac arrest patients per year produce better survival rates 21. Chatterjee MT, Moon JC, Murphy R, McCrea D. The “OBS” chart: an evidence than those admitting less than 20 cases per year.636 Another obser- based approach to re-design of the patient observation chart in a district gen- eral hospital setting. Postgrad Med J 2005;81:663–6. vational study showed that unadjusted survival to discharge was 22. Smith GB, Prytherch DR, Schmidt PE, Featherstone PI. Review and performance greater in hospitals that received ≥40 cardiac arrest patients/year evaluation of aggregate weighted ‘track and trigger’ systems. Resuscitation compared with those that received <40 per year, but this difference 2008;77:170–9. 23. Smith GB, Prytherch DR, Schmidt PE, Featherstone PI, Higgins B. A review, disappeared after adjustment for patient factors.824 and performance evaluation, of single-parameter “track and trigger” systems. Several studies with historic control groups have shown Resuscitation 2008;79:11–21. improved survival after implementation of a comprehensive 24. Hillman K, Chen J, Cretikos M, et al. Introduction of the medical emergency team package of post-resuscitation care that includes therapeutic (MET) system: a cluster-randomised controlled trial. Lancet 2005;365:2091–7. 25. Needleman J, Buerhaus P, Mattke S, Stewart M, Zelevinsky K. Nurse-staffing hypothermia and percutaneous coronary intervention.629,632,633 levels and the quality of care in hospitals. N Engl J Med 2002;346:1715–22. There is also evidence of improved survival after out-of-hospital 26. DeVita MA, Smith GB, Adam SK, et al. Identifying the hospitalised patient in cardiac arrest in large hospitals with cardiac catheter facilities com- crisis”—a consensus conference on the afferent limb of rapid response systems. Resuscitation 2010;81:375–82. pared with smaller hospitals with no cardiac catheter facilities.631 27. Hogan J. Why don’t nurses monitor the respiratory rates of patients? Br J Nurs Several studies of out-of-hospital adult cardiac arrest failed to 2006;15:489–92. demonstrate any effect of transport interval from the scene to the 28. Buist M. The rapid response team paradox: why doesn’t anyone call for help? Crit Care Med 2008;36:634–6. receiving hospital on survival to hospital discharge if return of 29. Andrews T, Waterman H. Packaging: a grounded theory of how to report phys- spontaneous circulation was achieved at the scene and transport iological deterioration effectively. J Adv Nurs 2005;52:473–81. intervals were short (3–11 min).825–827 This implies that it may be 30. Derham C. Achieving comprehensive critical care. Nurs Crit Care 2007;12:124–31. safe to bypass local hospitals and transport the post-cardiac arrest 31. Smith GB, Poplett N. Knowledge of aspects of acute care in trainee doctors. patient to a regional cardiac arrest centre. Postgrad Med J 2002;78:335–8. There is indirect evidence that regional cardiac resuscitation 32. Meek T. New house officers’ knowledge of resuscitation, fluid balance and analgesia. Anaesthesia 2000;55:1128–9. systems of care improve outcome after ST elevation myocardial 33. Gould TH, Upton PM, Collins P. A survey of the intended management of acute infarction (STEMI).828–850 postoperative pain by newly qualified doctors in the south west region of The implication from all these data is that specialist cardiac England in August 1992. Anaesthesia 1994;49:807–10. arrest centres and systems of care may be effective but, as yet, there 34. Jackson E, Warner J. How much do doctors know about consent and capacity? J R Soc Med 2002;95:601–3. is no direct evidence to support this hypothesis.851–853 35. Kruger PS, Longden PJ. A study of a hospital staff’s knowledge of pulse oximetry. Anaesth Intensive Care 1997;25:38–41. 36. Howell M. Pulse oximetry: an audit of nursing and medical staff understanding. References Br J Nurs 2002;11:191–7. 37. Wheeler DW, Remoundos DD, Whittlestone KD, et al. Doctors’ confusion over 1. Nolan J, Soar J, Eikeland H. The chain of survival. Resuscitation 2006;71:270–1. ratios and percentages in drug solutions: the case for standard labelling. J R Soc 2. Gwinnutt CL, Columb M, Harris R. Outcome after cardiac arrest in adults in UK Med 2004;97:380–3. hospitals: effect of the 1997 guidelines. Resuscitation 2000;47:125–35. 38. Goldacre MJ, Lambert T, Evans J, Turner G. Preregistration house officers’ views 3. Peberdy MA, Kaye W, Ornato JP, et al. Cardiopulmonary resuscitation of adults on whether their experience at medical school prepared them well for their in the hospital: a report of 14720 cardiac arrests from the National Registry of jobs: national questionnaire survey. BMJ 2003;326:1011–2. Cardiopulmonary Resuscitation. Resuscitation 2003;58:297–308. 39. Perkins GD, Barrett H, Bullock I, et al. The Acute Care Undergraduate TEach- 4. Meaney PA, Nadkarni VM, Kern KB, Indik JH, Halperin HR, Berg RA. Rhythms ing (ACUTE) Initiative: consensus development of core competencies in and outcomes of adult in-hospital cardiac arrest. Crit Care Med 2010;38:101–8. acute care for undergraduates in the United Kingdom. Intensive Care Med 5. Smith GB. In-hospital cardiac arrest: is it time for an in-hospital ‘chain of pre- 2005;31:1627–33. vention’? Resuscitation 2010. 40. Smith CM, Perkins GD, Bullock I, Bion JF. Undergraduate training in the care 6. National Confidential Enquiry into Patient Outcome and Death. An acute prob- of the acutely ill patient: a literature review. Intensive Care Med 2007;33: lem? London: NCEPOD; 2005. 901–7.
- 121. C.D. Deakin et al. / Resuscitation 81 (2010) 1305–1352 1339 41. Thwaites BC, Shankar S, Niblett D, Saunders J. Can consultants resuscitate? J R 71. Neary WD, Prytherch D, Foy C, Heather BP, Earnshaw JJ. Comparison of differ- Coll Physicians Lond 1992;26:265–7. ent methods of risk stratification in urgent and emergency surgery. Br J Surg 42. Saravanan P, Soar J. A survey of resuscitation training needs of senior anaes- 2007;94:1300–5. thetists. Resuscitation 2005;64:93–6. 72. Asadollahi K, Hastings IM, Beeching NJ, Gill GV. Laboratory risk factors for 43. Featherstone P, Smith GB, Linnell M, Easton S, Osgood VM. Impact of a hospital mortality in acutely admitted patients. QJM 2007;100:501–7. one-day inter-professional course (ALERTtrade mark) on attitudes and con- 73. Jones AE, Aborn LS, Kline JA. Severity of emergency department hypotension fidence in managing critically ill adult patients. Resuscitation 2005;65: predicts adverse hospital outcome. Shock 2004;22:410–4. 329–36. 74. Duckitt RW, Buxton-Thomas R, Walker J, et al. Worthing physiological scoring 44. Campello G, Granja C, Carvalho F, Dias C, Azevedo LF, Costa-Pereira A. Imme- system: derivation and validation of a physiological early-warning system for diate and long-term impact of medical emergency teams on cardiac arrest medical admissions. An observational, population-based single-centre study. prevalence and mortality: a plea for periodic basic life-support training pro- Br J Anaesth 2007;98:769–74. grams. Crit Care Med 2009;37:3054–61. 75. Kellett J, Deane B. The Simple Clinical Score predicts mortality for 30 days after 45. Bellomo R, Goldsmith D, Uchino S, et al. A prospective before-and-after trial of admission to an acute medical unit. QJM 2006;99:771–81. a medical emergency team. Med J Aust 2003;179:283–7. 76. Prytherch DR, Sirl JS, Schmidt P, Featherstone PI, Weaver PC, Smith GB. The use 46. Bellomo R, Goldsmith D, Uchino S, et al. Prospective controlled trial of effect of of routine laboratory data to predict in-hospital death in medical admissions. medical emergency team on postoperative morbidity and mortality rates. Crit Resuscitation 2005;66:203–7. Care Med 2004;32:916–21. 77. Smith GB, Prytherch DR, Schmidt PE, et al. Should age be included as a com- 47. DeVita MA, Braithwaite RS, Mahidhara R, Stuart S, Foraida M, Simmons RL. ponent of track and trigger systems used to identify sick adult patients? Use of medical emergency team responses to reduce hospital cardiopulmonary Resuscitation 2008;78:109–15. arrests. Qual Saf Health Care 2004;13:251–4. 78. Olsson T, Terent A, Lind L. Rapid Emergency Medicine score: a new prognostic 48. Foraida MI, DeVita MA, Braithwaite RS, Stuart SA, Brooks MM, Simmons RL. tool for in-hospital mortality in nonsurgical emergency department patients. Improving the utilization of medical crisis teams (Condition C) at an urban J Intern Med 2004;255:579–87. tertiary care hospital. J Crit Care 2003;18:87–94. 79. Prytherch DR, Sirl JS, Weaver PC, Schmidt P, Higgins B, Sutton GL. Towards 49. Green AL, Williams A. An evaluation of an early warning clinical marker referral a national clinical minimum data set for general surgery. Br J Surg tool. Intensive Crit Care Nurs 2006;22:274–82. 2003;90:1300–5. 50. Spearpoint KG, Gruber PC, Brett SJ. Impact of the Immediate Life Support course 80. Subbe CP, Kruger M, Rutherford P, Gemmel L. Validation of a modified Early on the incidence and outcome of in-hospital cardiac arrest calls: an observa- Warning Score in medical admissions. QJM 2001;94:521–6. tional study over 6 years. Resuscitation 2009;80:638–43. 81. Goodacre S, Turner J, Nicholl J. Prediction of mortality among emergency med- 51. Soar J, Perkins GD, Harris S, et al. The immediate life support course. Resusci- ical admissions. Emerg Med J 2006;23:372–5. tation 2003;57:21–6. 82. Paterson R, MacLeod DC, Thetford D, et al. Prediction of in-hospital mortality 52. Harrison GA, Jacques TC, Kilborn G, McLaws ML. The prevalence of recordings of and length of stay using an early warning scoring system: clinical audit. Clin the signs of critical conditions and emergency responses in hospital wards—the Med 2006;6:281–4. SOCCER study. Resuscitation 2005;65:149–57. 83. Cuthbertson BH, Boroujerdi M, McKie L, Aucott L, Prescott G. Can physiological 53. Hall S, Williams E, Richards S, Subbe C, Gemmell L. Waiting to exhale: variables and early warning scoring systems allow early recognition of the critical care outreach and recording of ventilatory frequency. Br J Anaesth deteriorating surgical patient? Crit Care Med 2007;35:402–9. 2003;90:570–1. 84. Goldhill DR, McNarry AF. Physiological abnormalities in early warning 54. McBride J, Knight D, Piper J, Smith G. Long-term effect of introducing an early scores are related to mortality in adult inpatients. Br J Anaesth 2004;92: warning score on respiratory rate charting on general wards. Resuscitation 882–4. 2005;65:41–4. 85. Harrison GA, Jacques T, McLaws ML, Kilborn G. Combinations of early 55. Goldhill DR, Worthington L, Mulcahy A, Tarling M, Sumner A. The patient-at- signs of critical illness predict in-hospital death-the SOCCER study (signs risk team: identifying and managing seriously ill ward patients. Anaesthesia of critical conditions and emergency responses). Resuscitation 2006;71: 1999;54:853–60. 327–34. 56. Subbe CP, Davies RG, Williams E, Rutherford P, Gemmell L. Effect of introduc- 86. Bell MB, Konrad D, Granath F, Ekbom A, Martling CR. Prevalence and sen- ing the Modified Early Warning score on clinical outcomes, cardio-pulmonary sitivity of MET-criteria in a Scandinavian University Hospital. Resuscitation arrests and intensive care utilisation in acute medical admissions. Anaesthesia 2006;70:66–73. 2003;58:797–802. 87. Gardner-Thorpe J, Love N, Wrightson J, Walsh S, Keeling N. The value of 57. Armitage M, Eddleston J, Stokes T. Recognising and responding to acute illness Modified Early Warning Score (MEWS) in surgical in-patients: a prospective in adults in hospital: summary of NICE guidance. BMJ 2007;335:258–9. observational study. Ann R Coll Surg Engl 2006;88:571–5. 58. Chen J, Hillman K, Bellomo R, Flabouris A, Finfer S, Cretikos M. The impact of 88. Quarterman CP, Thomas AN, McKenna M, McNamee R. Use of a patient infor- introducing medical emergency team system on the documentations of vital mation system to audit the introduction of modified early warning scoring. J signs. Resuscitation 2009;80:35–43. Eval Clin Pract 2005;11:133–8. 59. Odell M, Rechner IJ, Kapila A, et al. The effect of a critical care outreach ser- 89. Goldhill DR, McNarry AF, Hadjianastassiou VG, Tekkis PP. The longer patients vice and an early warning scoring system on respiratory rate recording on the are in hospital before Intensive Care admission the higher their mortality. general wards. Resuscitation 2007;74:470–5. Intensive Care Med 2004;30:1908–13. 60. Critical care outreach 2003: progress in developing services. The National Out- 90. Goldhill DR, McNarry AF, Mandersloot G, McGinley A. A physiologically-based reach Report. London, UK: Department of Health and National Health Service early warning score for ward patients: the association between score and out- Modernisation Agency; 2003. come. Anaesthesia 2005;60:547–53. 61. Gao H, McDonnell A, Harrison DA, et al. Systematic review and evaluation of 91. Boniatti MM, Azzolini N, da Fonseca DL, et al. Prognostic value of the calling physiological track and trigger warning systems for identifying at-risk patients criteria in patients receiving a medical emergency team review. Resuscitation on the ward. Intensive Care Med 2007;33:667–79. 2010;81:667–70. 62. Cuthbertson BH. Optimising early warning scoring systems. Resuscitation 92. Prytherch DR, Smith GB, Schmidt PE, Featherstone PI. ViEWS-Towards a 2008;77:153–4. national early warning score for detecting adult inpatient deterioration. Resus- 63. Cretikos M, Chen J, Hillman K, Bellomo R, Finfer S, Flabouris A. The objective citation 2010;81:932–7. medical emergency team activation criteria: a case–control study. Resuscita- 93. Mitchell IA, McKay H, Van Leuvan C, et al. A prospective controlled trial of the tion 2007;73:62–72. effect of a multi-faceted intervention on early recognition and intervention in 64. Fieselmann J, Hendryx M, Helms C, Wakefield D. Respiratory rate predicts deteriorating hospital patients. Resuscitation 2010. cardiopulmonary arrest for internal medicine patients. J Gen Intern Med 94. Smith GB, Prytherch DR, Schmidt P, et al. Hospital-wide physiological 1993;8:354–60. surveillance-a new approach to the early identification and management of 65. Henry OF, Blacher J, Verdavaine J, Duviquet M, Safar ME. Alpha 1-acid glycopro- the sick patient. Resuscitation 2006;71:19–28. tein is an independent predictor of in-hospital death in the elderly. Age Ageing 95. Sandroni C, Ferro G, Santangelo S, et al. In-hospital cardiac arrest: survival 2003;32:37–42. depends mainly on the effectiveness of the emergency response. Resuscitation 66. Barlow G, Nathwani D, Davey P. The CURB65 pneumonia severity score out- 2004;62:291–7. performs generic sepsis and early warning scores in predicting mortality in 96. Soar J, McKay U. A revised role for the hospital cardiac arrest team? Resuscita- community-acquired pneumonia. Thorax 2007;62:253–9. tion 1998;38:145–9. 67. Sleiman I, Morandi A, Sabatini T, et al. Hyperglycemia as a predictor of in- 97. Featherstone P, Chalmers T, Smith GB. RSVP: a system for communication of hospital mortality in elderly patients without diabetes mellitus admitted to a deterioration in hospital patients. Br J Nurs 2008;17:860–4. sub-intensive care unit. J Am Geriatr Soc 2008;56:1106–10. 98. Marshall S, Harrison J, Flanagan B. The teaching of a structured tool improves 68. Alarcon T, Barcena A, Gonzalez-Montalvo JI, Penalosa C, Salgado A. Factors the clarity and content of interprofessional clinical communication. Qual Saf predictive of outcome on admission to an acute geriatric ward. Age Ageing Health Care 2009;18:137–40. 1999;28:429–32. 99. Lee A, Bishop G, Hillman KM, Daffurn K. The Medical Emergency Team. Anaesth 69. Goel A, Pinckney RG, Littenberg B. APACHE II predicts long-term survival Intensive Care 1995;23:183–6. in COPD patients admitted to a general medical ward. J Gen Intern Med 100. Devita MA, Bellomo R, Hillman K, et al. Findings of the first consensus confer- 2003;18:824–30. ence on medical emergency teams. Crit Care Med 2006;34:2463–78. 70. Rowat AM, Dennis MS, Wardlaw JM. Central periodic breathing observed on 101. Ball C, Kirkby M, Williams S. Effect of the critical care outreach team on hospital admission is associated with an adverse prognosis in conscious acute patient survival to discharge from hospital and readmission to critical care: stroke patients. Cerebrovasc Dis 2006;21:340–7. non-randomised population based study. BMJ 2003;327:1014.
- 122. 1340 C.D. Deakin et al. / Resuscitation 81 (2010) 1305–1352 102. Zenker P, Schlesinger A, Hauck M, et al. Implementation and impact of a 134. Haupt MT, Bekes CE, Brilli RJ, et al. Guidelines on critical care services and per- rapid response team in a children’s hospital. Jt Comm J Qual Patient Saf sonnel: recommendations based on a system of categorization of three levels 2007;33:418–25. of care. Crit Care Med 2003;31:2677–83. 103. Dean BS, Decker MJ, Hupp D, Urbach AH, Lewis E, Benes-Stickle J. Condition 135. Peberdy MA, Ornato JP, Larkin GL, et al. Survival from in-hospital cardiac arrest HELP: a pediatric rapid response team triggered by patients and parents. J during nights and weekends. JAMA 2008;299:785–92. Healthc Qual 2008;30:28–31. 136. Hillson SD, Rich EC, Dowd B, Luxenberg MG. Call nights and patients care: 104. Ray EM, Smith R, Massie S, et al. Family alert: implementing direct family effects on inpatients at one teaching hospital. J Gen Intern Med 1992;7:405– activation of a pediatric rapid response team. Jt Comm J Qual Patient Saf 10. 2009;35:575–80. 137. Bell CM, Redelmeier DA. Mortality among patients admitted to hospitals on 105. Kenward G, Castle N, Hodgetts T, Shaikh L. Evaluation of a medical emergency weekends as compared with weekdays. N Engl J Med 2001;345:663–8. team one year after implementation. Resuscitation 2004;61:257–63. 138. Beck DH, McQuillan P, Smith GB. Waiting for the break of dawn? The effects of 106. Chan PS, Khalid A, Longmore LS, Berg RA, Kosiborod M, Spertus JA. Hospital- discharge time, discharge TISS scores and discharge facility on hospital mor- wide code rates and mortality before and after implementation of a rapid tality after intensive care. Intensive Care Med 2002;28:1287–93. response team. JAMA 2008;300:2506–13. 139. Goldfrad C, Rowan K. Consequences of discharges from intensive care at night. 107. Dacey MJ, Mirza ER, Wilcox V, et al. The effect of a rapid response team on Lancet 2000;355:1138–42. major clinical outcome measures in a community hospital. Crit Care Med 140. Tourangeau AE, Cranley LA, Jeffs L. Impact of nursing on hospital patient mor- 2007;35:2076–82. tality: a focused review and related policy implications. Qual Saf Health Care 108. Story DA, Shelton AC, Poustie SJ, Colin-Thome NJ, McNicol PL. The effect of 2006;15:4–8. critical care outreach on postoperative serious adverse events. Anaesthesia 141. Aiken LH, Clarke SP, Sloane DM, Sochalski J, Silber JH. Hospital nurse 2004;59:762–6. staffing and patient mortality, nurse burnout, and job dissatisfaction. JAMA 109. Story DA, Shelton AC, Poustie SJ, Colin-Thome NJ, McIntyre RE, McNicol PL. 2002;288:1987–93. Effect of an anaesthesia department led critical care outreach and acute 142. Parr MJ, Hadfield JH, Flabouris A, Bishop G, Hillman K. The Medical Emergency pain service on postoperative serious adverse events. Anaesthesia 2006;61: Team: 12 month analysis of reasons for activation, immediate outcome and 24–8. not-for-resuscitation orders. Resuscitation 2001;50:39–44. 110. Flabouris A, Chen J, Hillman K, Bellomo R, Finfer S. Timing and interven- 143. Baskett PJ, Lim A. The varying ethical attitudes towards resuscitation in Europe. tions of emergency teams during the MERIT study. Resuscitation 2010;81: Resuscitation 2004;62:267–73. 25–30. 144. Baskett PJ, Steen PA, Bossaert L. European Resuscitation Council guidelines 111. Jones D, Bellomo R, Bates S, et al. Long term effect of a medical emergency team for resuscitation 2005, Section 8. The ethics of resuscitation and end-of-life on cardiac arrests in a teaching hospital. Crit Care 2005;9:R808–15. decisions. Resuscitation 2005;67(Suppl. 1):S171–80. 112. Galhotra S, DeVita MA, Simmons RL, Schmid A. Impact of patient monitoring 145. Lippert FK, Raffay V, Georgiou M, Steen PA, Bossaert L. European Resuscitation on the diurnal pattern of medical emergency team activation. Crit Care Med Council Guidelines for Resuscitation 2010, Section 10. The ethics of resuscita- 2006;34:1700–6. tion and end-of-life decisions. Resuscitation 2010;81:1445–51. 113. Baxter AD, Cardinal P, Hooper J, Patel R. Medical emergency teams at The 146. Smith GB. Increased do not attempt resuscitation decision making in hospi- Ottawa Hospital: the first two years. Can J Anaesth 2008;55:223–31. tals with a medical emergency teams system-cause and effect? Resuscitation 114. Benson L, Mitchell C, Link M, Carlson G, Fisher J. Using an advanced prac- 2008;79:346–7. tice nursing model for a rapid response team. Jt Comm J Qual Patient Saf 147. Chen J, Flabouris A, Bellomo R, Hillman K, Finfer S. The Medical Emergency 2008;34:743–7. Team System and not-for-resuscitation orders: results from the MERIT study. 115. Bertaut Y, Campbell A, Goodlett D. Implementing a rapid-response team using Resuscitation 2008;79:391–7. a nurse-to-nurse consult approach. J Vasc Nurs 2008;26:37–42. 148. Jones DA, McIntyre T, Baldwin I, Mercer I, Kattula A, Bellomo R. The med- 116. Buist MD, Moore GE, Bernard SA, Waxman BP, Anderson JN, Nguyen TV. ical emergency team and end-of-life care: a pilot study. Crit Care Resusc Effects of a medical emergency team on reduction of incidence of and mor- 2007;9:151–6. tality from unexpected cardiac arrests in hospital: preliminary study. BMJ 149. Excellence NIfHaC. NICE clinical guideline 50 Acutely ill patients in hospi- 2002;324:387–90. tal: recognition of and response to acute illness in adults in hospital. London: 117. Buist M, Harrison J, Abaloz E, Van Dyke S. Six year audit of cardiac arrests and National Institute for Health and Clinical Excellence; 2007. medical emergency team calls in an Australian outer metropolitan teaching 150. Muller D, Agrawal R, Arntz HR. How sudden is sudden cardiac death? Circula- hospital. BMJ 2007;335:1210–2. tion 2006;114:1146–50. 118. Chamberlain B, Donley K, Maddison J. Patient outcomes using a rapid response 151. Nava A, Bauce B, Basso C, et al. Clinical profile and long-term follow-up of team. Clin Nurse Spec 2009;23:11–2. 37 families with arrhythmogenic right ventricular cardiomyopathy. J Am Coll 119. Hatler C, Mast D, Bedker D, et al. Implementing a rapid response team to Cardiol 2000;36:2226–33. decrease emergencies outside the ICU: one hospital’s experience. Medsurg 152. Brugada J, Brugada R, Brugada P. Determinants of sudden cardiac death in indi- Nurs 2009;18, 84-90,126. viduals with the electrocardiographic pattern of Brugada syndrome and no 120. Jones D, Bellomo R, Bates S, et al. Patient monitoring and the timing of cardiac previous cardiac arrest. Circulation 2003;108:3092–6. arrests and medical emergency team calls in a teaching hospital. Intensive Care 153. Elliott PM, Poloniecki J, Dickie S, et al. Sudden death in hypertrophic cardiomy- Med 2006;32:1352–6. opathy: identification of high risk patients. J Am Coll Cardiol 2000;36:2212–8. 121. Moldenhauer K, Sabel A, Chu ES, Mehler PS. Clinical triggers: an alternative to 154. Goldenberg I, Moss AJ, Peterson DR, et al. Risk factors for aborted cardiac arrest a rapid response team. Jt Comm J Qual Patient Saf 2009;35:164–74. and sudden cardiac death in children with the congenital long-QT syndrome. 122. Offner PJ, Heit J, Roberts R. Implementation of a rapid response team decreases Circulation 2008;117:2184–91. cardiac arrest outside of the intensive care unit. J Trauma 2007;62:1223–7 155. Hobbs JB, Peterson DR, Moss AJ, et al. Risk of aborted cardiac arrest or [discussion 7–8]. sudden cardiac death during adolescence in the long-QT syndrome. JAMA 123. Gould D. Promoting patient safety: The Rapid Medical Response Team. Perm J 2006;296:1249–54. 2007;11:26–34. 156. Hulot JS, Jouven X, Empana JP, Frank R, Fontaine G. Natural history and risk 124. Jolley J, Bendyk H, Holaday B, Lombardozzi KA, Harmon C. Rapid response stratification of arrhythmogenic right ventricular dysplasia/cardiomyopathy. teams: do they make a difference? Dimens Crit Care Nurs 2007;26:253–60, Circulation 2004;110:1879–84. quiz 61-2. 157. Kofflard MJ, Ten Cate FJ, van der Lee C, van Domburg RT. Hypertrophic car- 125. Konrad D, Jaderling G, Bell M, Granath F, Ekbom A, Martling CR. Reducing diomyopathy in a large community-based population: clinical outcome and in-hospital cardiac arrests and hospital mortality by introducing a medical identification of risk factors for sudden cardiac death and clinical deterioration. emergency team. Intensive Care Med 2010;36:100–6. J Am Coll Cardiol 2003;41:987–93. 126. Chen J, Bellomo R, Flabouris A, Hillman K, Finfer S. The relationship between 158. Peters S. Long-term follow-up and risk assessment of arrhythmogenic right early emergency team calls and serious adverse events. Crit Care Med ventricular dysplasia/cardiomyopathy: personal experience from different pri- 2009;37:148–53. mary and tertiary centres. J Cardiovasc Med (Hagerstown) 2007;8:521–6. 127. Bristow PJ, Hillman KM, Chey T, et al. Rates of in-hospital arrests, deaths and 159. Priori SG, Napolitano C, Gasparini M, et al. Natural history of Brugada intensive care admissions: the effect of a medical emergency team. Med J Aust syndrome: insights for risk stratification and management. Circulation 2000;173:236–40. 2002;105:1342–7. 128. King E, Horvath R, Shulkin DJ. Establishing a rapid response team (RRT) in an 160. Spirito P, Autore C, Rapezzi C, et al. Syncope and risk of sudden death in hyper- academic hospital: one year’s experience. J Hosp Med 2006;1:296–305. trophic cardiomyopathy. Circulation 2009;119:1703–10. 129. McFarlan SJ, Hensley S. Implementation and outcomes of a rapid response 161. Sumitomo N, Harada K, Nagashima M, et al. Catecholaminergic polymorphic team. J Nurs Care Qual 2007;22:307–13, quiz 14-5. ventricular tachycardia: electrocardiographic characteristics and optimal ther- 130. Rothschild JM, Woolf S, Finn KM, et al. A controlled trial of a rapid response apeutic strategies to prevent sudden death. Heart 2003;89:66–70. system in an academic medical center. Jt Comm J Qual Patient Saf 2008;34, 162. Amital H, Glikson M, Burstein M, et al. Clinical characteristics of unexpected 417-25,365. death among young enlisted military personnel: results of a three-decade ret- 131. Chan PS, Jain R, Nallmothu BK, Berg RA, Sasson C. Rapid Response Teams: a rospective surveillance. Chest 2004;126:528–33. systematic review and meta-analysis. Arch Intern Med 2010;170:18–26. 163. Basso C, Maron BJ, Corrado D, Thiene G. Clinical profile of congenital coronary 132. Leeson-Payne CG, Aitkenhead AR. A prospective study to assess the demand artery anomalies with origin from the wrong aortic sinus leading to sudden for a high dependency unit. Anaesthesia 1995;50:383–7. death in young competitive athletes. J Am Coll Cardiol 2000;35:1493–501. 133. Guidelines for the utilisation of intensive care units. European Society of Inten- 164. Corrado D, Basso C, Thiene G. Sudden cardiac death in young people with sive Care Medicine. Intensive Care Med 1994;20:163–4. apparently normal heart. Cardiovasc Res 2001;50:399–408.
- 123. C.D. Deakin et al. / Resuscitation 81 (2010) 1305–1352 1341 165. Drory Y, Turetz Y, Hiss Y, et al. Sudden unexpected death in persons less than tal emergency medical service in a German metropolitan area. Resuscitation 40 years of age. Am J Cardiol 1991;68:1388–92. 2002;53:15–20. 166. Kramer MR, Drori Y, Lev B. Sudden death in young soldiers. High incidence of 196. Hampton JR, Dowling M, Nicholas C. Comparison of results from a car- syncope prior to death. Chest 1988;93:345–7. diac ambulance manned by medical or non-medical personnel. Lancet 167. Quigley F, Greene M, O’Connor D, Kelly F. A survey of the causes of sudden 1977;1:526–9. cardiac death in the under 35-year-age group. Ir Med J 2005;98:232–5. 197. Schneider T, Mauer D, Diehl P, et al. Early defibrillation by emergency 168. Wisten A, Forsberg H, Krantz P, Messner T. Sudden cardiac death in 15-35-year physicians or emergency medical technicians? A controlled, prospective multi- olds in Sweden during 1992-99. J Intern Med 2002;252:529–36. centre study. Resuscitation 1994;27:197–206. 169. Wisten A, Messner T. Young Swedish patients with sudden cardiac death 198. Soo LH, Gray D, Young T, Skene A, Hampton JR. Influence of ambulance crew’s have a lifestyle very similar to a control population. Scand Cardiovasc J length of experience on the outcome of out-of-hospital cardiac arrest. Eur Heart 2005;39:137–42. J 1999;20:535–40. 170. Wisten A, Messner T. Symptoms preceding sudden cardiac death in the young 199. Yen ZS, Chen YT, Ko PC, et al. Cost-effectiveness of different advanced life sup- are common but often misinterpreted. Scand Cardiovasc J 2005;39:143–9. port providers for victims of out-of-hospital cardiac arrests. J Formos Med Assoc 171. Behr ER, Dalageorgou C, Christiansen M, et al. Sudden arrhythmic death syn- 2006;105:1001–7. drome: familial evaluation identifies inheritable heart disease in the majority 200. Nichol G, Thomas E, Callaway CW, et al. Regional variation in out-of-hospital of families. Eur Heart J 2008;29:1670–80. cardiac arrest incidence and outcome. JAMA 2008;300:1423–31. 172. Brothers JA, Stephens P, Gaynor JW, Lorber R, Vricella LA, Paridon SM. Anoma- 201. Fischer M, Krep H, Wierich D, et al. Comparison of the emergency medical ser- lous aortic origin of a coronary artery with an interarterial course: should vices systems of Birmingham and Bonn: process efficacy and cost effectiveness. family screening be routine? J Am Coll Cardiol 2008;51:2062–4. Anasthesiol Intensivmed Notfallmed Schmerzther 2003;38:630–42. 173. Gimeno JR, Lacunza J, Garcia-Alberola A, et al. Penetrance and risk profile in 202. Bottiger BW, Grabner C, Bauer H, et al. Long term outcome after out-of-hospital inherited cardiac diseases studied in a dedicated screening clinic. Am J Cardiol cardiac arrest with physician staffed emergency medical services: the Utstein 2009;104:406–10. style applied to a midsized urban/suburban area. Heart 1999;82:674–9. 174. Tan HL, Hofman N, van Langen IM, van der Wal AC, Wilde AA. Sudden unex- 203. Bjornsson HM, Marelsson S, Magnusson V, Sigurdsson G, Thornorgeirsson G. plained death: heritability and diagnostic yield of cardiological and genetic Prehospital cardiac life support in the Reykjavik area 1999–2002. Laeknabladid examination in surviving relatives. Circulation 2005;112:207–13. 2006;92:591–7. 175. Moya A, Sutton R, Ammirati F, et al. Guidelines for the diagnosis and man- 204. Mitchell RG, Brady W, Guly UM, Pirrallo RG, Robertson CE. Comparison of two agement of syncope (version 2009): the Task Force for the Diagnosis and emergency response systems and their effect on survival from out of hospital Management of Syncope of the European Society of Cardiology (ESC). Eur Heart cardiac arrest. Resuscitation 1997;35:225–9. J 2009;30:2631–71. 205. Lafuente-Lafuente C, Melero-Bascones M. Active chest 176. Colman N, Bakker A, Linzer M, Reitsma JB, Wieling W, Wilde AA. Value of compression–decompression for cardiopulmonary resuscitation. Cochrane history-taking in syncope patients: in whom to suspect long QT syndrome? Database Syst Rev 2004:CD002751. Europace 2009;11:937–43. 206. Lewis RP, Stang JM, Fulkerson PK, Sampson KL, Scoles A, Warren JV. Effec- 177. Oh JH, Hanusa BH, Kapoor WN. Do symptoms predict cardiac arrhythmias and tiveness of advanced paramedics in a mobile coronary care system. JAMA mortality in patients with syncope? Arch Intern Med 1999;159:375–80. 1979;241:1902–4. 178. Calkins H, Shyr Y, Frumin H, Schork A, Morady F. The value of the clinical history 207. Silfvast T, Ekstrand A. The effect of experience of on-site physicians on survival in the differentiation of syncope due to ventricular tachycardia, atrioventricu- from prehospital cardiac arrest. Resuscitation 1996;31:101–5. lar block, and neurocardiogenic syncope. Am J Med 1995;98:365–73. 208. Morrison LJ, Visentin LM, Kiss A, et al. Validation of a rule for termination of 179. Tester DJ, Kopplin LJ, Creighton W, Burke AP, Ackerman MJ. Pathogenesis of resuscitation in out-of-hospital cardiac arrest. N Engl J Med 2006;355:478–87. unexplained drowning: new insights from a molecular autopsy. Mayo Clin Proc 209. Richman PB, Vadeboncoeur TF, Chikani V, Clark L, Bobrow BJ. Independent eval- 2005;80:596–600. uation of an out-of-hospital termination of resuscitation (TOR) clinical decision 180. Johnson JN, Hofman N, Haglund CM, Cascino GD, Wilde AA, Ackerman MJ. Iden- rule. Acad Emerg Med 2008;15:517–21. tification of a possible pathogenic link between congenital long QT syndrome 210. Morrison LJ, Verbeek PR, Zhan C, Kiss A, Allan KS. Validation of a universal and epilepsy. Neurology 2009;72:224–31. prehospital termination of resuscitation clinical prediction rule for advanced 181. MacCormick JM, McAlister H, Crawford J, et al. Misdiagnosis of long QT and basic life support providers. Resuscitation 2009;80:324–8. syndrome as epilepsy at first presentation. Ann Emerg Med 2009;54: 211. Sasson C, Hegg AJ, Macy M, Park A, Kellermann A, McNally B. Prehospital ter- 26–32. mination of resuscitation in cases of refractory out-of-hospital cardiac arrest. 182. Chandra N, Papadakis M, Sharma S. Preparticipation screening of young com- JAMA 2008;300:1432–8. petitive athletes for cardiovascular disorders. Phys Sportsmed 2010;38:54–63. 212. Skrifvars MB, Vayrynen T, Kuisma M, et al. Comparison of Helsinki and Euro- 183. Olasveengen TM, Lund-Kordahl I, Steen PA, Sunde K. Out-of hospital advanced pean Resuscitation Council “do not attempt to resuscitate” guidelines, and a life support with or without a physician: effects on quality of CPR and outcome. termination of resuscitation clinical prediction rule for out-of-hospital cardiac Resuscitation 2009;80:1248–52. arrest patients found in asystole or pulseless electrical activity. Resuscitation 184. Kirves H, Skrifvars MB, Vahakuopus M, Ekstrom K, Martikainen M, Castren M. 2010. Adherence to resuscitation guidelines during prehospital care of cardiac arrest 213. Ong ME, Jaffey J, Stiell I, Nesbitt L. Comparison of termination-of-resuscitation patients. Eur J Emerg Med 2007;14:75–81. guidelines for basic life support: defibrillator providers in out-of-hospital car- 185. Schneider T, Mauer D, Diehl P, Eberle B, Dick W. Quality of on-site per- diac arrest. Ann Emerg Med 2006;47:337–43. formance in prehospital advanced cardiac life support (ACLS). Resuscitation 214. Morrison LJ, Verbeek PR, Vermeulen MJ, et al. Derivation and evaluation of a 1994;27:207–13. termination of resuscitation clinical prediction rule for advanced life support 186. Arntz HR, Wenzel V, Dissmann R, Marschalk A, Breckwoldt J, Muller D. Out- providers. Resuscitation 2007;74:266–75. of-hospital thrombolysis during cardiopulmonary resuscitation in patients 215. Bailey ED, Wydro GC, Cone DC. Termination of resuscitation in the prehospital with high likelihood of ST-elevation myocardial infarction. Resuscitation setting for adult patients suffering nontraumatic cardiac arrest. National Asso- 2008;76:180–4. ciation of EMS Physicians Standards and Clinical Practice Committee. Prehosp 187. Bell A, Lockey D, Coats T, Moore F, Davies G. Physician Response Unit—a feasi- Emerg Care 2000;4:190–5. bility study of an initiative to enhance the delivery of pre-hospital emergency 216. Verbeek PR, Vermeulen MJ, Ali FH, Messenger DW, Summers J, Morrison LJ. medical care. Resuscitation 2006;69:389–93. Derivation of a termination-of-resuscitation guideline for emergency med- 188. Lossius HM, Soreide E, Hotvedt R, et al. Prehospital advanced life support pro- ical technicians using automated external defibrillators. Acad Emerg Med vided by specially trained physicians: is there a benefit in terms of life years 2002;9:671–8. gained? Acta Anaesthesiol Scand 2002;46:771–8. 217. Ong ME, Tan EH, Ng FS, et al. Comparison of termination-of-resuscitation 189. Dickinson ET, Schneider RM, Verdile VP. The impact of prehospital physi- guidelines for out-of-hospital cardiac arrest in Singapore EMS. Resuscitation cians on out-of-hospital nonasystolic cardiac arrest. Prehosp Emerg Care 2007;75:244–51. 1997;1:132–5. 218. Pircher IR, Stadlbauer KH, Severing AC, et al. A prediction model for out-of- 190. Soo LH, Gray D, Young T, Huff N, Skene A, Hampton JR. Resuscitation from hospital cardiopulmonary resuscitation. Anesth Analg 2009;109:1196–201. out-of-hospital cardiac arrest: is survival dependent on who is available at the 219. van Walraven C, Forster AJ, Parish DC, et al. Validation of a clinical decision aid to scene? Heart 1999;81:47–52. discontinue in-hospital cardiac arrest resuscitations. JAMA 2001;285:1602–6. 191. Frandsen F, Nielsen JR, Gram L, et al. Evaluation of intensified prehospital treat- 220. van Walraven C, Forster AJ, Stiell IG. Derivation of a clinical decision rule for the ment in out-of-hospital cardiac arrest: survival and cerebral prognosis. The discontinuation of in-hospital cardiac arrest resuscitations. Arch Intern Med Odense ambulance study. Cardiology 1991;79:256–64. 1999;159:129–34. 192. Sipria A, Talvik R, Korgvee A, Sarapuu S, Oopik A. Out-of-hospital resuscitation 221. McCullough PA, Thompson RJ, Tobin KJ, Kahn JK, O’Neill WW. Validation of a in Tartu: effect of reorganization of Estonian EMS system. Am J Emerg Med decision support tool for the evaluation of cardiac arrest victims. Clin Cardiol 2000;18:469–73. 1998;21:195–200. 193. Estner HL, Gunzel C, Ndrepepa G, et al. Outcome after out-of-hospital car- 222. Christenson J, Andrusiek D, Everson-Stewart S, et al. Chest compression fraction diac arrest in a physician-staffed emergency medical system according to the determines survival in patients with out-of-hospital ventricular fibrillation. Utstein style. Am Heart J 2007;153:792–9. Circulation 2009;120:1241–7. 194. Eisenburger P, Czappek G, Sterz F, et al. Cardiac arrest patients in an alpine area 223. Deakin CD, Nolan JP, Sunde K, Koster RW. European Resuscitation Council during a six year period. Resuscitation 2001;51:39–46. Guidelines for Resuscitation 2010. Section 3. Electrical therapies: automated 195. Gottschalk A, Burmeister MA, Freitag M, Cavus E, Standl T. Influence of early external defibrillators, defibrillation, cardioversion and pacing. Resuscitation defibrillation on the survival rate and quality of life after CPR in prehospi- 2010;81:1293–304.
- 124. 1342 C.D. Deakin et al. / Resuscitation 81 (2010) 1305–1352 224. Gabbott D, Smith G, Mitchell S, et al. Cardiopulmonary resuscitation standards 254. Rea TD, Shah S, Kudenchuk PJ, Copass MK, Cobb LA. Automated external for clinical practice and training in the UK. Resuscitation 2005;64:13–9. defibrillators: to what extent does the algorithm delay CPR? Ann Emerg Med 225. Dyson E, Smith GB. Common faults in resuscitation equipment—guidelines for 2005;46:132–41. checking equipment and drugs used in adult cardiopulmonary resuscitation. 255. van Alem AP, Sanou BT, Koster RW. Interruption of cardiopulmonary resusci- Resuscitation 2002;55:137–49. tation with the use of the automated external defibrillator in out-of-hospital 226. Brennan RT, Braslow A. Skill mastery in public CPR classes. Am J Emerg Med cardiac arrest. Ann Emerg Med 2003;42:449–57. 1998;16:653–7. 256. Pytte M, Kramer-Johansen J, Eilevstjonn J, et al. Haemodynamic effects of 227. Chamberlain D, Smith A, Woollard M, et al. Trials of teaching methods in basic adrenaline (epinephrine) depend on chest compression quality during car- life support (3): comparison of simulated CPR performance after first train- diopulmonary resuscitation in pigs. Resuscitation 2006;71:369–78. ing and at 6 months, with a note on the value of re-training. Resuscitation 257. Prengel AW, Lindner KH, Ensinger H, Grunert A. Plasma catecholamine 2002;53:179–87. concentrations after successful resuscitation in patients. Crit Care Med 228. Eberle B, Dick WF, Schneider T, Wisser G, Doetsch S, Tzanova I. Checking the 1992;20:609–14. carotid pulse check: diagnostic accuracy of first responders in patients with 258. Bhende MS, Thompson AE. Evaluation of an end-tidal CO2 detector during and without a pulse. Resuscitation 1996;33:107–16. pediatric cardiopulmonary resuscitation. Pediatrics 1995;95:395–9. 229. Lapostolle F, Le Toumelin P, Agostinucci JM, Catineau J, Adnet F. Basic car- 259. Sehra R, Underwood K, Checchia P. End tidal CO2 is a quantitative measure of diac life support providers checking the carotid pulse: performance, degree of cardiac arrest. Pacing Clin Electrophysiol 2003;26:515–7. conviction, and influencing factors. Acad Emerg Med 2004;11:878–80. 260. Eftestol T, Wik L, Sunde K, Steen PA. Effects of cardiopulmonary resuscitation 230. Liberman M, Lavoie A, Mulder D, Sampalis J. Cardiopulmonary resuscita- on predictors of ventricular fibrillation defibrillation success during out-of- tion: errors made by pre-hospital emergency medical personnel. Resuscitation hospital cardiac arrest. Circulation 2004;110:10–5. 1999;42:47–55. 261. Eftestol T, Sunde K, Aase SO, Husoy JH, Steen PA. Predicting outcome of 231. Moule P. Checking the carotid pulse: diagnostic accuracy in students of the defibrillation by spectral characterization and nonparametric classification of healthcare professions. Resuscitation 2000;44:195–201. ventricular fibrillation in patients with out-of-hospital cardiac arrest. Circula- 232. Nyman J, Sihvonen M. Cardiopulmonary resuscitation skills in nurses and nurs- tion 2000;102:1523–9. ing students. Resuscitation 2000;47:179–84. 262. Amir O, Schliamser JE, Nemer S, Arie M. Ineffectiveness of precordial thump 233. Perkins GD, Stephenson B, Hulme J, Monsieurs KG. Birmingham assessment of for cardioversion of malignant ventricular tachyarrhythmias. Pacing Clin Elec- breathing study (BABS). Resuscitation 2005;64:109–13. trophysiol 2007;30:153–6. 234. Ruppert M, Reith MW, Widmann JH, et al. Checking for breathing: evaluation 263. Haman L, Parizek P, Vojacek J. Precordial thump efficacy in termination of of the diagnostic capability of emergency medical services personnel, physi- induced ventricular arrhythmias. Resuscitation 2009;80:14–6. cians, medical students, and medical laypersons. Ann Emerg Med 1999;34: 264. Pellis T, Kette F, Lovisa D, et al. Utility of pre-cordial thump for treatment 720–9. of out of hospital cardiac arrest: a prospective study. Resuscitation 2009;80: 235. Tibballs J, Russell P. Reliability of pulse palpation by healthcare personnel to 17–23. diagnose paediatric cardiac arrest. Resuscitation 2009;80:61–4. 265. Kohl P, King AM, Boulin C. Antiarrhythmic effects of acute mechanical stiumu- 236. Bang A, Herlitz J, Martinell S. Interaction between emergency medical dis- lation. In: Kohl P, Sachs F, Franz MR, editors. Cardiac mechano-electric feedback patcher and caller in suspected out-of-hospital cardiac arrest calls with focus and arrhythmias: form pipette to patient. Philadelphia: Elsevier Saunders; on agonal breathing. A review of 100 tape recordings of true cardiac arrest 2005. p. 304–14. cases. Resuscitation 2003;56:25–34. 266. Caldwell G, Millar G, Quinn E, Vincent R, Chamberlain DA. Simple mechanical 237. Bohm K, Rosenqvist M, Hollenberg J, Biber B, Engerstrom L, Svensson methods for cardioversion: defence of the precordial thump and cough version. L. Dispatcher-assisted telephone-guided cardiopulmonary resuscitation: an Br Med J (Clin Res Ed) 1985;291:627–30. underused lifesaving system. Eur J Emerg Med 2007;14:256–9. 267. Krijne R. Rate acceleration of ventricular tachycardia after a precordial chest 238. Bobrow BJ, Zuercher M, Ewy GA, et al. Gasping during cardiac arrest in thump. Am J Cardiol 1984;53:964–5. humans is frequent and associated with improved survival. Circulation 268. Emerman CL, Pinchak AC, Hancock D, Hagen JF. Effect of injection site on cir- 2008;118:2550–4. culation times during cardiac arrest. Crit Care Med 1988;16:1138–41. 239. Vaillancourt C, Verma A, Trickett J, et al. Evaluating the effectiveness of 269. Glaeser PW, Hellmich TR, Szewczuga D, Losek JD, Smith DS. Five-year experi- dispatch-assisted cardiopulmonary resuscitation instructions. Acad Emerg ence in prehospital intraosseous infusions in children and adults. Ann Emerg Med 2007;14:877–83. Med 1993;22:1119–24. 240. White L, Rogers J, Bloomingdale M, et al. Dispatcher-assisted cardiopul- 270. Wenzel V, Lindner KH, Augenstein S, et al. Intraosseous vasopressin improves monary resuscitation: risks for patients not in cardiac arrest. Circulation coronary perfusion pressure rapidly during cardiopulmonary resuscitation in 2010;121:91–7. pigs. Crit Care Med 1999;27:1565–9. 241. Perkins GD, Roberts C, Gao F. Delays in defibrillation: influence of different 271. Shavit I, Hoffmann Y, Galbraith R, Waisman Y. Comparison of two mechanical monitoring techniques. Br J Anaesth 2002;89:405–8. intraosseous infusion devices: a pilot, randomized crossover trial. Resuscita- 242. Abella BS, Alvarado JP, Myklebust H, et al. Quality of cardiopulmonary resusci- tion 2009;80:1029–33. tation during in-hospital cardiac arrest. JAMA 2005;293:305–10. 272. Schuttler J, Bartsch A, Ebeling BJ, et al. Endobronchial administration of 243. Abella BS, Sandbo N, Vassilatos P, et al. Chest compression rates during adrenaline in preclinical cardiopulmonary resuscitation. Anasth Intensivther cardiopulmonary resuscitation are suboptimal: a prospective study during Notfallmed 1987;22:63–8. in-hospital cardiac arrest. Circulation 2005;111:428–34. 273. Hornchen U, Schuttler J, Stoeckel H, Eichelkraut W, Hahn N. Endobronchial 244. Stiell IG, Wells GA, Field B, et al. Advanced cardiac life support in out-of-hospital instillation of epinephrine during cardiopulmonary resuscitation. Crit Care cardiac arrest. N Engl J Med 2004;351:647–56. Med 1987;15:1037–9. 245. Olasveengen TM, Sunde K, Brunborg C, Thowsen J, Steen PA, Wik L. Intravenous 274. Vaknin Z, Manisterski Y, Ben-Abraham R, et al. Is endotracheal adrenaline drug administration during out-of-hospital cardiac arrest: a randomized trial. deleterious because of the beta adrenergic effect? Anesth Analg 2001;92: JAMA 2009;302:2222–9. 1408–12. 246. Herlitz J, Ekstrom L, Wennerblom B, Axelsson A, Bang A, Holmberg S. Adrenaline 275. Manisterski Y, Vaknin Z, Ben-Abraham R, et al. Endotracheal epinephrine: a in out-of-hospital ventricular fibrillation. Does it make any difference? Resus- call for larger doses. Anesth Analg 2002;95:1037–41, table of contents. citation 1995;29:195–201. 276. Efrati O, Ben-Abraham R, Barak A, et al. Endobronchial adrenaline: should it be 247. Holmberg M, Holmberg S, Herlitz J. Low chance of survival among patients reconsidered? Dose response and haemodynamic effect in dogs. Resuscitation requiring adrenaline (epinephrine) or intubation after out-of-hospital cardiac 2003;59:117–22. arrest in Sweden. Resuscitation 2002;54:37–45. 277. Elizur A, Ben-Abraham R, Manisterski Y, et al. Tracheal epinephrine or nore- 248. Bradley SM, Gabriel EE, Aufderheide TP, et al. Survival Increases with CPR by pinephrine preceded by beta blockade in a dog model. Can beta blockade Emergency Medical Services before defibrillation of out-of-hospital ventricu- bestow any benefits? Resuscitation 2003;59:271–6. lar fibrillation or ventricular tachycardia: observations from the Resuscitation 278. Prengel AW, Rembecki M, Wenzel V, Steinbach G. A comparison of the endotra- Outcomes Consortium. Resuscitation 2010;81:155–62. cheal tube and the laryngeal mask airway as a route for endobronchial lidocaine 249. Hollenberg J, Herlitz J, Lindqvist J, et al. Improved survival after out-of-hospital administration. Anesth Analg 2001;92:1505–9. cardiac arrest is associated with an increase in proportion of emergency 279. Berg RA, Hilwig RW, Kern KB, Ewy GA. Precountershock cardiopul- crew—witnessed cases and bystander cardiopulmonary resuscitation. Circu- monary resuscitation improves ventricular fibrillation median frequency and lation 2008;118:389–96. myocardial readiness for successful defibrillation from prolonged ventric- 250. Iwami T, Nichol G, Hiraide A, et al. Continuous improvements in “chain of ular fibrillation: a randomized, controlled swine study. Ann Emerg Med survival” increased survival after out-of-hospital cardiac arrests: a large-scale 2002;40:563–70. population-based study. Circulation 2009;119:728–34. 280. Achleitner U, Wenzel V, Strohmenger HU, et al. The beneficial effect of basic 251. Edelson DP, Abella BS, Kramer-Johansen J, et al. Effects of compression depth life support on ventricular fibrillation mean frequency and coronary perfusion and pre-shock pauses predict defibrillation failure during cardiac arrest. Resus- pressure. Resuscitation 2001;51:151–8. citation 2006;71:137–45. 281. Fries M, Tang W, Chang YT, Wang J, Castillo C, Weil MH. Microvascular blood 252. Eftestol T, Sunde K, Steen PA. Effects of interrupting precordial compressions flow during cardiopulmonary resuscitation is predictive of outcome. Resusci- on the calculated probability of defibrillation success during out-of-hospital tation 2006;71:248–53. cardiac arrest. Circulation 2002;105:2270–3. 282. Ristagno G, Tang W, Huang L, et al. Epinephrine reduces cerebral perfusion 253. Sunde K, Eftestol T, Askenberg C, Steen PA. Quality assessment of defibrillation during cardiopulmonary resuscitation. Crit Care Med 2009;37:1408–15. and advanced life support using data from the medical control module of the 283. Tang W, Weil MH, Sun S, Gazmuri RJ, Bisera J. Progressive myocardial dysfunc- defibrillator. Resuscitation 1999;41:237–47. tion after cardiac resuscitation. Crit Care Med 1993;21:1046–50.
- 125. C.D. Deakin et al. / Resuscitation 81 (2010) 1305–1352 1343 284. Angelos MG, Butke RL, Panchal AR, et al. Cardiovascular response to 314. Ruben HM, Elam JO, Ruben AM, Greene DG. Investigation of upper airway epinephrine varies with increasing duration of cardiac arrest. Resuscitation problems in resuscitation, 1: studies of pharyngeal x-rays and performance 2008;77:101–10. by laymen. Anesthesiology 1961;22:271–9. 285. Kudenchuk PJ, Cobb LA, Copass MK, et al. Amiodarone for resuscitation after 315. Elam JO, Greene DG, Schneider MA, et al. Head-tilt method of oral resuscitation. out-of-hospital cardiac arrest due to ventricular fibrillation. N Engl J Med JAMA 1960;172:812–5. 1999;341:871–8. 316. Aprahamian C, Thompson BM, Finger WA, Darin JC. Experimental cervical spine 286. Dorian P, Cass D, Schwartz B, Cooper R, Gelaznikas R, Barr A. Amiodarone as injury model: evaluation of airway management and splinting techniques. Ann compared with lidocaine for shock-resistant ventricular fibrillation. N Engl J Emerg Med 1984;13:584–7. Med 2002;346:884–90. 317. Donaldson 3rd WF, Heil BV, Donaldson VP, Silvaggio VJ. The effect of air- 287. Thel MC, Armstrong AL, McNulty SE, Califf RM, O’Connor CM. Randomised trial way maneuvers on the unstable C1-C2 segment. A cadaver study. Spine of magnesium in in-hospital cardiac arrest. Duke Internal Medicine Housestaff. 1997;22:1215–8. Lancet 1997;350:1272–6. 318. Donaldson 3rd WF, Towers JD, Doctor A, Brand A, Donaldson VP. A methodology 288. Allegra J, Lavery R, Cody R, et al. Magnesium sulfate in the treatment of to evaluate motion of the unstable spine during intubation techniques. Spine refractory ventricular fibrillation in the prehospital setting. Resuscitation 1993;18:2020–3. 2001;49:245–9. 319. Hauswald M, Sklar DP, Tandberg D, Garcia JF. Cervical spine movement dur- 289. Fatovich D, Prentice D, Dobb G. Magnesium in in-hospital cardiac arrest. Lancet ing airway management: cinefluoroscopic appraisal in human cadavers. Am J 1998;351:446. Emerg Med 1991;9:535–8. 290. Hassan TB, Jagger C, Barnett DB. A randomised trial to investigate the effi- 320. Brimacombe J, Keller C, Kunzel KH, Gaber O, Boehler M, Puhringer F. Cervical cacy of magnesium sulphate for refractory ventricular fibrillation. Emerg Med spine motion during airway management: a cinefluoroscopic study of the pos- J 2002;19:57–62. teriorly destabilized third cervical vertebrae in human cadavers. Anesth Analg 291. Miller B, Craddock L, Hoffenberg S, et al. Pilot study of intravenous magnesium 2000;91:1274–8. sulfate in refractory cardiac arrest: safety data and recommendations for future 321. Majernick TG, Bieniek R, Houston JB, Hughes HG. Cervical spine movement studies. Resuscitation 1995;30:3–14. during orotracheal intubation. Ann Emerg Med 1986;15:417–20. 292. Weil MH, Rackow EC, Trevino R, Grundler W, Falk JL, Griffel MI. Difference in 322. Lennarson PJ, Smith DW, Sawin PD, Todd MM, Sato Y, Traynelis VC. Cervical acid-base state between venous and arterial blood during cardiopulmonary spinal motion during intubation: efficacy of stabilization maneuvers in the resuscitation. N Engl J Med 1986;315:153–6. setting of complete segmental instability. J Neurosurg Spine 2001;94:265–70. 293. Wagner H, Terkelsen CJ, Friberg H, et al. Cardiac arrest in the catheterisation 323. Marsh AM, Nunn JF, Taylor SJ, Charlesworth CH. Airway obstruction associated laboratory: a 5-year experience of using mechanical chest compres- with the use of the Guedel airway. Br J Anaesth 1991;67:517–23. sions to facilitate PCI during prolonged resuscitation efforts. Resuscitation 324. Schade K, Borzotta A, Michaels A. Intracranial malposition of nasopharyngeal 2010;81:383–7. airway. J Trauma 2000;49:967–8. 294. Soar J, Perkins GD, Abbas G, et al. European Resuscitation Council Guidelines 325. Muzzi DA, Losasso TJ, Cucchiara RF. Complication from a nasopharyngeal air- for Resuscitation 2010. Section 8. Cardiac arrest in special circumstances: way in a patient with a basilar skull fracture. Anesthesiology 1991;74:366–8. electrolyte abnormalities, poisoning, drowning, accidental hypothermia, 326. Roberts K, Porter K. How do you size a nasopharyngeal airway. Resuscitation hyperthermia, asthma, anaphylaxis, cardiac surgery, trauma, pregnancy, elec- 2003;56:19–23. trocution. Resuscitation 2010;81:1400–33. 327. Stoneham MD. The nasopharyngeal airway. Assessment of position by fibre- 295. Price S, Uddin S, Quinn T. Echocardiography in cardiac arrest. Curr Opin Crit optic laryngoscopy. Anaesthesia 1993;48:575–80. Care 2010;16:211–5. 328. Balan IS, Fiskum G, Hazelton J, Cotto-Cumba C, Rosenthal RE. Oximetry-guided 296. Memtsoudis SG, Rosenberger P, Loffler M, et al. The usefulness of reoxygenation improves neurological outcome after experimental cardiac transesophageal echocardiography during intraoperative cardiac arrest in non- arrest. Stroke 2006;37:3008–13. cardiac surgery. Anesth Analg 2006;102:1653–7. 329. Kilgannon JH, Jones AE, Shapiro NI, et al. Association between arterial hyperoxia 297. Comess KA, DeRook FA, Russell ML, Tognazzi-Evans TA, Beach KW. The inci- following resuscitation from cardiac arrest and in-hospital mortality. JAMA dence of pulmonary embolism in unexplained sudden cardiac arrest with 2010;303:2165–71. pulseless electrical activity. Am J Med 2000;109:351–6. 330. Alexander R, Hodgson P, Lomax D, Bullen C. A comparison of the laryngeal mask 298. Niendorff DF, Rassias AJ, Palac R, Beach ML, Costa S, Greenberg M. Rapid car- airway and Guedel airway, bag and face mask for manual ventilation following diac ultrasound of inpatients suffering PEA arrest performed by nonexpert formal training. Anaesthesia 1993;48:231–4. sonographers. Resuscitation 2005;67:81–7. 331. Doerges V, Sauer C, Ocker H, Wenzel V, Schmucker P. Smaller tidal volumes 299. Tayal VS, Kline JA. Emergency echocardiography to detect pericardial effusion during cardiopulmonary resuscitation: comparison of adult and paediatric in patients in PEA and near-PEA states. Resuscitation 2003;59:315–8. self-inflatable bags with three different ventilatory devices. Resuscitation 300. van der Wouw PA, Koster RW, Delemarre BJ, de Vos R, Lampe-Schoenmaeckers 1999;43:31–7. AJ, Lie KI. Diagnostic accuracy of transesophageal echocardiography during 332. Ocker H, Wenzel V, Schmucker P, Dorges V. Effectiveness of various airway cardiopulmonary resuscitation. J Am Coll Cardiol 1997;30:780–3. management techniques in a bench model simulating a cardiac arrest patient. 301. Hernandez C, Shuler K, Hannan H, Sonyika C, Likourezos A, Marshall J. C.A.U.S.E.: J Emerg Med 2001;20:7–12. Cardiac arrest ultra-sound exam—a better approach to managing patients 333. Stone BJ, Chantler PJ, Baskett PJ. The incidence of regurgitation during car- in primary non-arrhythmogenic cardiac arrest. Resuscitation 2008;76:198– diopulmonary resuscitation: a comparison between the bag valve mask and 206. laryngeal mask airway. Resuscitation 1998;38:3–6. 302. Steiger HV, Rimbach K, Muller E, Breitkreutz R. Focused emergency echocardio- 334. Petito SP, Russell WJ. The prevention of gastric inflation—a neglected benefit graphy: lifesaving tool for a 14-year-old girl suffering out-of-hospital pulseless of cricoid pressure. Anaesth Intensive Care 1988;16:139–43. electrical activity arrest because of cardiac tamponade. Eur J Emerg Med 335. Lawes EG, Campbell I, Mercer D. Inflation pressure, gastric insufflation and 2009;16:103–5. rapid sequence induction. Br J Anaesth 1987;59:315–8. 303. Breitkreutz R, Walcher F, Seeger FH. Focused echocardiographic evaluation in 336. Hartsilver EL, Vanner RG. Airway obstruction with cricoid pressure. Anaesthe- resuscitation management: concept of an advanced life support-conformed sia 2000;55:208–11. algorithm. Crit Care Med 2007;35:S150–61. 337. Allman KG. The effect of cricoid pressure application on airway patency. J Clin 304. Blaivas M, Fox JC. Outcome in cardiac arrest patients found to have cardiac Anesth 1995;7:197–9. standstill on the bedside emergency department echocardiogram. Acad Emerg 338. Hocking G, Roberts FL, Thew ME. Airway obstruction with cricoid pressure and Med 2001;8:616–21. lateral tilt. Anaesthesia 2001;56:825–8. 305. Salen P, O’Connor R, Sierzenski P, et al. Can cardiac sonography and capnog- 339. Mac GPJH, Ball DR. The effect of cricoid pressure on the cricoid cartilage raphy be used independently and in combination to predict resuscitation and vocal cords: an endoscopic study in anaesthetised patients. Anaesthesia outcomes? Acad Emerg Med 2001;8:610–5. 2000;55:263–8. 306. Salen P, Melniker L, Chooljian C, et al. Does the presence or absence of sono- 340. Aufderheide TP, Sigurdsson G, Pirrallo RG, et al. Hyperventilation- graphically identified cardiac activity predict resuscitation outcomes of cardiac induced hypotension during cardiopulmonary resuscitation. Circulation arrest patients? Am J Emerg Med 2005;23:459–62. 2004;109:1960–5. 307. Bottiger BW, Bode C, Kern S, et al. Efficacy and safety of thrombolytic ther- 341. O’Neill JF, Deakin CD. Do we hyperventilate cardiac arrest patients? Resuscita- apy after initially unsuccessful cardiopulmonary resuscitation: a prospective tion 2007;73:82–5. clinical trial. Lancet 2001;357:1583–5. 342. Olasveengen TM, Vik E, Kuzovlev A, Sunde K. Effect of implementation of new 308. Boidin MP. Airway patency in the unconscious patient. Br J Anaesth resuscitation guidelines on quality of cardiopulmonary resuscitation and sur- 1985;57:306–10. vival. Resuscitation 2009;80:407–11. 309. Nandi PR, Charlesworth CH, Taylor SJ, Nunn JF, Dore CJ. Effect of general anaes- 343. Olasveengen TM, Wik L, Steen PA. Quality of cardiopulmonary resuscitation thesia on the pharynx. Br J Anaesth 1991;66:157–62. before and during transport in out-of-hospital cardiac arrest. Resuscitation 310. Guildner CW. Resuscitation: opening the airway. A comparative study of tech- 2008;76:185–90. niques for opening an airway obstructed by the tongue. JACEP 1976;5:588–90. 344. Weiss SJ, Ernst AA, Jones R, et al. Automatic transport ventilator versus 311. Safar P, Escarraga LA, Chang F. Upper airway obstruction in the unconscious bag valve in the EMS setting: a prospective, randomized trial. South Med J patient. J Appl Physiol 1959;14:760–4. 2005;98:970–6. 312. Greene DG, Elam JO, Dobkin AB, Studley CL. Cinefluorographic study of hyper- 345. Stallinger A, Wenzel V, Wagner-Berger H, et al. Effects of decreasing inspi- extension of the neck and upper airway patency. JAMA 1961;176:570–3. ratory flow rate during simulated basic life support ventilation of a cardiac 313. Morikawa S, Safar P, Decarlo J. Influence of the headjaw position upon upper arrest patient on lung and stomach tidal volumes. Resuscitation 2002;54: airway patency. Anesthesiology 1961;22:265–70. 167–73.
- 126. 1344 C.D. Deakin et al. / Resuscitation 81 (2010) 1305–1352 346. Noordergraaf GJ, van Dun PJ, Kramer BP, et al. Can first responders achieve and 377. Vezina D, Lessard MR, Bussieres J, Topping C, Trepanier CA. Complications maintain normocapnia when sequentially ventilating with a bag-valve device associated with the use of the Esophageal-Tracheal Combitube. Can J Anaesth and two oxygen-driven resuscitators? A controlled clinical trial in 104 patients. 1998;45:76–80. Eur J Anaesthesiol 2004;21:367–72. 378. Richards CF. Piriform sinus perforation during Esophageal-Tracheal Combitube 347. Deakin CD, O’Neill JF, Tabor T. Does compression-only cardiopulmonary placement. J Emerg Med 1998;16:37–9. resuscitation generate adequate passive ventilation during cardiac arrest? 379. Rumball C, Macdonald D, Barber P, Wong H, Smecher C. Endotracheal intu- Resuscitation 2007;75:53–9. bation and esophageal tracheal Combitube insertion by regular ambulance 348. Saissy JM, Boussignac G, Cheptel E, et al. Efficacy of continuous insuffla- attendants: a comparative trial. Prehosp Emerg Care 2004;8:15–22. tion of oxygen combined with active cardiac compression–decompression 380. Rabitsch W, Schellongowski P, Staudinger T, et al. Comparison of a conventional during out-of-hospital cardiorespiratory arrest. Anesthesiology 2000;92: tracheal airway with the Combitube in an urban emergency medical services 1523–30. system run by physicians. Resuscitation 2003;57:27–32. 349. Bertrand C, Hemery F, Carli P, et al. Constant flow insufflation of oxygen as the 381. Goldenberg IF, Campion BC, Siebold CM, McBride JW, Long LA. Esophageal gas- sole mode of ventilation during out-of-hospital cardiac arrest. Intensive Care tric tube airway vs endotracheal tube in prehospital cardiopulmonary arrest. Med 2006;32:843–51. Chest 1986;90:90–6. 350. Bobrow BJ, Ewy GA, Clark L, et al. Passive oxygen insufflation is superior to bag- 382. Cook TM, McCormick B, Asai T. Randomized comparison of laryngeal tube with valve-mask ventilation for witnessed ventricular fibrillation out-of-hospital classic laryngeal mask airway for anaesthesia with controlled ventilation. Br J cardiac arrest. Ann Emerg Med 2009;54, 656-62 e1. Anaesth 2003;91:373–8. 351. Jones JH, Murphy MP, Dickson RL, Somerville GG, Brizendine EJ. Emergency 383. Cook TM, McKinstry C, Hardy R, Twigg S. Randomized crossover comparison of physician-verified out-of-hospital intubation: miss rates by paramedics. Acad the ProSeal laryngeal mask airway with the Laryngeal Tube during anaesthesia Emerg Med 2004;11:707–9. with controlled ventilation. Br J Anaesth 2003;91:678–83. 352. Pelucio M, Halligan L, Dhindsa H. Out-of-hospital experience with the syringe 384. Kette F, Reffo I, Giordani G, et al. The use of laryngeal tube by nurses in out-of- esophageal detector device. Acad Emerg Med 1997;4:563–8. hospital emergencies: preliminary experience. Resuscitation 2005;66:21–5. 353. Jemmett ME, Kendal KM, Fourre MW, Burton JH. Unrecognized misplacement 385. Wiese CH, Semmel T, Muller JU, Bahr J, Ocker H, Graf BM. The use of of endotracheal tubes in a mixed urban to rural emergency medical services the laryngeal tube disposable (LT-D) by paramedics during out-of-hospital setting. Acad Emerg Med 2003;10:961–5. resuscitation-an observational study concerning ERC guidelines 2005. Resus- 354. Katz SH, Falk JL. Misplaced endotracheal tubes by paramedics in an urban citation 2009;80:194–8. emergency medical services system. Ann Emerg Med 2001;37:32–7. 386. Wiese CH, Bartels U, Schultens A, et al. Using a Laryngeal Tube Suction-Device 355. Nolan JP, Soar J. Airway techniques and ventilation strategies. Curr Opin Crit (LTS-D) reduces the “No Flow Time” in a single rescuer Manikin study. J Emerg Care 2008;14:279–86. Med 2009. 356. Gatward JJ, Thomas MJ, Nolan JP, Cook TM. Effect of chest compressions on 387. Wharton NM, Gibbison B, Gabbott DA, Haslam GM, Muchatuta N, Cook TM. I-gel the time taken to insert airway devices in a manikin. Br J Anaesth 2008;100: insertion by novices in manikins and patients. Anaesthesia 2008;63:991–5. 351–6. 388. Gatward JJ, Cook TM, Seller C, et al. Evaluation of the size 4 i-gel airway in one 357. Davies PR, Tighe SQ, Greenslade GL, Evans GH. Laryngeal mask airway and hundred non-paralysed patients. Anaesthesia 2008;63:1124–30. tracheal tube insertion by unskilled personnel. Lancet 1990;336:977–9. 389. Jackson KM, Cook TM. Evaluation of four airway training manikins as patient 358. Flaishon R, Sotman A, Ben-Abraham R, Rudick V, Varssano D, Weinbroum AA. simulators for the insertion of eight types of supraglottic airway devices. Anaes- Antichemical protective gear prolongs time to successful airway management: thesia 2007;62:388–93. a randomized, crossover study in humans. Anesthesiology 2004;100:260–6. 390. Soar J. The I-gel supraglottic airway and resuscitation—some initial thoughts. 359. Ho BY, Skinner HJ, Mahajan RP. Gastro-oesophageal reflux during day case Resuscitation 2007;74:197. gynaecological laparoscopy under positive pressure ventilation: laryngeal 391. Thomas M, Benger J. Pre-hospital resuscitation using the iGEL. Resuscitation mask vs. tracheal intubation. Anaesthesia 1998;53:921–4. 2009;80:1437. 360. Reinhart DJ, Simmons G. Comparison of placement of the laryngeal mask air- 392. Cook TM, Nolan JP, Verghese C, et al. Randomized crossover comparison of the way with endotracheal tube by paramedics and respiratory therapists. Ann proseal with the classic laryngeal mask airway in unparalysed anaesthetized Emerg Med 1994;24:260–3. patients. Br J Anaesth 2002;88:527–33. 361. Rewari W, Kaul HL. Regurgitation and aspiration during gynaecological 393. Timmermann A, Cremer S, Eich C, et al. Prospective clinical and fiberoptic evalu- laparoscopy: comparison between laryngeal mask airway and tracheal intu- ation of the Supreme laryngeal mask airway. Anesthesiology 2009;110:262–5. bation. J Anaesthesiol Clin Pharmacol 1999;15:67–70. 394. Cook TM, Gatward JJ, Handel J, et al. Evaluation of the LMA Supreme in 100 362. Pennant JH, Walker MB. Comparison of the endotracheal tube and laryn- non-paralysed patients. Anaesthesia 2009;64:555–62. geal mask in airway management by paramedical personnel. Anesth Analg 395. Hosten T, Gurkan Y, Ozdamar D, Tekin M, Toker K, Solak M. A new supraglottic 1992;74:531–4. airway device: LMA-supreme, comparison with LMA-Proseal. Acta Anaesthe- 363. Maltby JR, Beriault MT, Watson NC, Liepert DJ, Fick GH. LMA-Classic and LMA- siol Scand 2009;53:852–7. ProSeal are effective alternatives to endotracheal intubation for gynecologic 396. Burgoyne L, Cyna A. Laryngeal mask vs intubating laryngeal mask: inser- laparoscopy. Can J Anaesth 2003;50:71–7. tion and ventilation by inexperienced resuscitators. Anaesth Intensive Care 364. Deakin CD, Peters R, Tomlinson P, Cassidy M. Securing the prehospital airway: 2001;29:604–8. a comparison of laryngeal mask insertion and endotracheal intubation by UK 397. Choyce A, Avidan MS, Shariff A, Del Aguila M, Radcliffe JJ, Chan T. A comparison paramedics. Emerg Med J 2005;22:64–7. of the intubating and standard laryngeal mask airways for airway management 365. Cook TM, Hommers C. New airways for resuscitation? Resuscitation by inexperienced personnel. Anaesthesia 2001;56:357–60. 2006;69:371–87. 398. Baskett PJ, Parr MJ, Nolan JP. The intubating laryngeal mask. Results of a mul- 366. Verghese C, Prior-Willeard PF, Baskett PJ. Immediate management of the air- ticentre trial with experience of 500 cases. Anaesthesia 1998;53:1174–9. way during cardiopulmonary resuscitation in a hospital without a resident 399. Tentillier E, Heydenreich C, Cros AM, Schmitt V, Dindart JM, Thicoipe M. Use anaesthesiologist. Eur J Emerg Med 1994;1:123–5. of the intubating laryngeal mask airway in emergency pre-hospital difficult 367. Kokkinis K. The use of the laryngeal mask airway in CPR. Resuscitation intubation. Resuscitation 2008;77:30–4. 1994;27:9–12. 400. Lecky F, Bryden D, Little R, Tong N, Moulton C. Emergency intubation for acutely 368. Leach A, Alexander CA, Stone B. The laryngeal mask in cardiopulmonary ill and injured patients. Cochrane Database Syst Rev 2008:CD001429. resuscitation in a district general hospital: a preliminary communication. 401. Gausche M, Lewis RJ, Stratton SJ, et al. Effect of out-of-hospital pediatric endo- Resuscitation 1993;25:245–8. tracheal intubation on survival and neurological outcome: a controlled clinical 369. The use of the laryngeal mask airway by nurses during cardiopulmonary resus- trial. JAMA 2000;283:783–90. citation: results of a multicentre trial. Anaesthesia 1994;49:3–7. 402. Kramer-Johansen J, Wik L, Steen PA. Advanced cardiac life support before 370. Rumball CJ, MacDonald D. The PTL, Combitube, laryngeal mask, and oral and after tracheal intubation—direct measurements of quality. Resuscitation airway: a randomized prehospital comparative study of ventilatory device 2006;68:61–9. effectiveness and cost-effectiveness in 470 cases of cardiorespiratory arrest. 403. Grmec S. Comparison of three different methods to confirm tracheal tube place- Prehosp Emerg Care 1997;1:1–10. ment in emergency intubation. Intensive Care Med 2002;28:701–4. 371. Tanigawa K, Shigematsu A. Choice of airway devices for 12,020 cases 404. Lyon RM, Ferris JD, Young DM, McKeown DW, Oglesby AJ, Robertson C. Field of nontraumatic cardiac arrest in Japan. Prehosp Emerg Care 1998;2:96– intubation of cardiac arrest patients: a dying art? Emerg Med J 2010;27:321–3. 100. 405. Wang HE, Simeone SJ, Weaver MD, Callaway CW. Interruptions in cardiopul- 372. Grantham H, Phillips G, Gilligan JE. The laryngeal mask in prehospital emer- monary resuscitation from paramedic endotracheal intubation. Ann Emerg gency care 1994;6:193–7. Med 2009;54:645e1–52e1. 373. Comparison of arterial blood gases of laryngeal mask airway and bag-valve- 406. Garza AG, Gratton MC, Coontz D, Noble E, Ma OJ. Effect of paramedic experience mask ventilation in out-of-hospital cardiac arrests. Circ J 2009;73:490–6. on orotracheal intubation success rates. J Emerg Med 2003;25:251–6. 374. Staudinger T, Brugger S, Watschinger B, et al. Emergency intubation with 407. Sayre MR, Sakles JC, Mistler AF, Evans JL, Kramer AT, Pancioli AM. Field trial of the Combitube: comparison with the endotracheal airway. Ann Emerg Med endotracheal intubation by basic EMTs. Ann Emerg Med 1998;31:228–33. 1993;22:1573–5. 408. Bradley JS, Billows GL, Olinger ML, Boha SP, Cordell WH, Nelson DR. Prehospital 375. Lefrancois DP, Dufour DG. Use of the esophageal tracheal combitube by basic oral endotracheal intubation by rural basic emergency medical technicians. emergency medical technicians. Resuscitation 2002;52:77–83. Ann Emerg Med 1998;32:26–32. 376. Ochs M, Vilke GM, Chan TC, Moats T, Buchanan J. Successful prehospital 409. Bobrow BJ, Clark LL, Ewy GA, et al. Minimally interrupted cardiac resuscita- airway management by EMT-Ds using the combitube. Prehosp Emerg Care tion by emergency medical services for out-of-hospital cardiac arrest. JAMA 2000;4:333–7. 2008;299:1158–65.
- 127. C.D. Deakin et al. / Resuscitation 81 (2010) 1305–1352 1345 410. Takeda T, Tanigawa K, Tanaka H, Hayashi Y, Goto E, Tanaka K. The assessment 440. Wenzel V, Krismer AC, Arntz HR, Sitter H, Stadlbauer KH, Lindner KH. A com- of three methods to identify tracheal tube placement in the emergency setting. parison of vasopressin and epinephrine for out-of-hospital cardiopulmonary Resuscitation 2003:56. resuscitation. N Engl J Med 2004;350:105–13. 411. Knapp S, Kofler J, Stoiser B, et al. The assessment of four different methods 441. Stiell IG, Hebert PC, Wells GA, et al. Vasopressin versus epinephrine for inhos- to verify tracheal tube placement in the critical care setting. Anesth Analg pital cardiac arrest: a randomised controlled trial. Lancet 2001;358:105–9. 1999;88:766–70. 442. Aung K, Htay T. Vasopressin for cardiac arrest: a systematic review and meta- 412. Grmec S, Mally S. Prehospital determination of tracheal tube placement in analysis. Arch Intern Med 2005;165:17–24. severe head injury. Emerg Med J 2004;21:518–20. 443. Callaway CW, Hostler D, Doshi AA, et al. Usefulness of vasopressin admin- 413. Yao YX, Jiang Z, Lu XH, He JH, Ma XX, Zhu JH. A clinical study of impedance istered with epinephrine during out-of-hospital cardiac arrest. Am J Cardiol graph in verifying tracheal intubation. Zhonghua Yi Xue Za Zhi 2007;87: 2006;98:1316–21. 898–901. 444. Gueugniaud PY, David JS, Chanzy E, et al. Vasopressin and epinephrine 414. Li J. Capnography alone is imperfect for endotracheal tube placement confir- vs. epinephrine alone in cardiopulmonary resuscitation. N Engl J Med mation during emergency intubation. J Emerg Med 2001;20:223–9. 2008;359:21–30. 415. Tanigawa K, Takeda T, Goto E, Tanaka K. Accuracy and reliability of the self- 445. Masini E, Planchenault J, Pezziardi F, Gautier P, Gagnol JP. Histamine-releasing inflating bulb to verify tracheal intubation in out-of-hospital cardiac arrest properties of Polysorbate 80 in vitro and in vivo: correlation with its hypoten- patients. Anesthesiology 2000;93:1432–6. sive action in the dog. Agents Actions 1985;16:470–7. 416. Baraka A, Khoury PJ, Siddik SS, Salem MR, Joseph NJ. Efficacy of the self-inflating 446. Somberg JC, Bailin SJ, Haffajee CI, et al. Intravenous lidocaine versus intra- bulb in differentiating esophageal from tracheal intubation in the parturient venous amiodarone (in a new aqueous formulation) for incessant ventricular undergoing cesarean section. Anesth Analg 1997;84:533–7. tachycardia. Am J Cardiol 2002;90:853–9. 417. Davis DP, Stephen KA, Vilke GM. Inaccuracy in endotracheal tube verification 447. Somberg JC, Timar S, Bailin SJ, et al. Lack of a hypotensive effect with rapid using a Toomey syringe. J Emerg Med 1999;17:35–8. administration of a new aqueous formulation of intravenous amiodarone. Am 418. Bozeman WP, Hexter D, Liang HK, Kelen GD. Esophageal detector device ver- J Cardiol 2004;93:576–81. sus detection of end-tidal carbon dioxide level in emergency intubation. Ann 448. Skrifvars MB, Kuisma M, Boyd J, et al. The use of undiluted amiodarone in Emerg Med 1996;27:595–9. the management of out-of-hospital cardiac arrest. Acta Anaesthesiol Scand 419. Jenkins WA, Verdile VP, Paris PM. The syringe aspiration technique to verify 2004;48:582–7. endotracheal tube position. Am J Emerg Med 1994;12:413–6. 449. Petrovic T, Adnet F, Lapandry C. Successful resuscitation of ventricular fibrilla- 420. Schaller RJ, Huff JS, Zahn A. Comparison of a colorimetric end-tidal CO2 detector tion after low-dose amiodarone. Ann Emerg Med 1998;32:518–9. and an esophageal aspiration device for verifying endotracheal tube place- 450. Levine JH, Massumi A, Scheinman MM, et al. Intravenous amiodarone for ment in the prehospital setting: a six-month experience. Prehosp Disaster Med recurrent sustained hypotensive ventricular tachyarrhythmias. Intravenous 1997;12:57–63. Amiodarone Multicenter Trial Group. J Am Coll Cardiol 1996;27:67–75. 421. Tanigawa K, Takeda T, Goto E, Tanaka K. The efficacy of esophageal detector 451. Matsusaka T, Hasebe N, Jin YT, Kawabe J, Kikuchi K. Magnesium reduces devices in verifying tracheal tube placement: a randomized cross-over study myocardial infarct size via enhancement of adenosine mechanism in rabbits. of out-of-hospital cardiac arrest patients. Anesth Analg 2001;92:375–8. Cardiovasc Res 2002;54:568–75. 422. Anton WR, Gordon RW, Jordan TM, Posner KL, Cheney FW. A disposable 452. Longstreth Jr WT, Fahrenbruch CE, Olsufka M, Walsh TR, Copass MK, Cobb end-tidal CO2 detector to verify endotracheal intubation. Ann Emerg Med LA. Randomized clinical trial of magnesium, diazepam, or both after out-of- 1991;20:271–5. hospital cardiac arrest. Neurology 2002;59:506–14. 423. MacLeod BA, Heller MB, Gerard J, Yealy DM, Menegazzi JJ. Verification of endo- 453. Stiell IG, Wells GA, Hebert PC, Laupacis A, Weitzman BN. Association of drug tracheal tube placement with colorimetric end-tidal CO2 detection. Ann Emerg therapy with survival in cardiac arrest: limited role of advanced cardiac life Med 1991;20:267–70. support drugs. Acad Emerg Med 1995;2:264–73. 424. Ornato JP, Shipley JB, Racht EM, et al. Multicenter study of a portable, hand- 454. Engdahl J, Bang A, Lindqvist J, Herlitz J. Can we define patients with no and size, colorimetric end-tidal carbon dioxide detection device. Ann Emerg Med those with some chance of survival when found in asystole out of hospital? 1992;21:518–23. Am J Cardiol 2000;86:610–4. 425. Sanders KC, Clum 3rd WB, Nguyen SS, Balasubramaniam S. End-tidal carbon 455. Engdahl J, Bang A, Lindqvist J, Herlitz J. Factors affecting short- and long-term dioxide detection in emergency intubation in four groups of patients. J Emerg prognosis among 1069 patients with out-of-hospital cardiac arrest and pulse- Med 1994;12:771–7. less electrical activity. Resuscitation 2001;51:17–25. 426. Varon AJ, Morrina J, Civetta JM. Clinical utility of a colorimetric end-tidal CO2 456. Dumot JA, Burval DJ, Sprung J, et al. Outcome of adult cardiopulmonary resusci- detector in cardiopulmonary resuscitation and emergency intubation. J Clin tations at a tertiary referral center including results of “limited” resuscitations. Monit 1991;7:289–93. Arch Intern Med 2001;161:1751–8. 427. Vukmir RB, Heller MB, Stein KL. Confirmation of endotracheal tube place- 457. Tortolani AJ, Risucci DA, Powell SR, Dixon R. In-hospital cardiopulmonary ment: a miniaturized infrared qualitative CO2 detector. Ann Emerg Med resuscitation during asystole. Therapeutic factors associated with 24-hour sur- 1991;20:726–9. vival. Chest 1989;96:622–6. 428. Silvestri S, Ralls GA, Krauss B, et al. The effectiveness of out-of-hospital use of 458. Coon GA, Clinton JE, Ruiz E. Use of atropine for brady-asystolic prehospital continuous end-tidal carbon dioxide monitoring on the rate of unrecognized cardiac arrest. Ann Emerg Med 1981;10:462–7. misplaced intubation within a regional emergency medical services system. 459. Harrison EE, Amey BD. The use of calcium in cardiac resuscitation. Am J Emerg Ann Emerg Med 2005;45:497–503. Med 1983;1:267–73. 429. Mehta KH, Turley A, Peyrasse P, Janes J, Hall JE. An assessment of the ability 460. Stueven HA, Thompson B, Aprahamian C, Tonsfeldt DJ, Kastenson EH. The effec- of impedance respirometry distinguish oesophageal from tracheal intubation. tiveness of calcium chloride in refractory electromechanical dissociation. Ann Anaesthesia 2002;57:1090–3. Emerg Med 1985;14:626–9. 430. Absolom M, Roberts R, Bahlmann UB, Hall JE, Armstrong T, Turley A. The use 461. Stueven HA, Thompson B, Aprahamian C, Tonsfeldt DJ, Kastenson EH. Lack of impedance respirometry to confirm tracheal intubation in children. Anaes- of effectiveness of calcium chloride in refractory asystole. Ann Emerg Med thesia 2006;61:1145–8. 1985;14:630–2. 431. Kramer-Johansen J, Eilevstjonn J, Olasveengen TM, Tomlinson AE, Dorph E, 462. Stueven HA, Thompson BM, Aprahamian C, Tonsfeldt DJ. Calcium chloride: Steen PA. Transthoracic impedance changes as a tool to detect malpositioned reassessment of use in asystole. Ann Emerg Med 1984;13:820–2. tracheal tubes. Resuscitation 2008;76:11–6. 463. Gando S, Tedo I, Tujinaga H, Kubota M. Variation in serum ionized calcium on 432. Risdal M, Aase SO, Stavland M, Eftestol T. Impedance-based ventilation cardiopulmonary resuscitation. J Anesth 1988;2:154–60. detection during cardiopulmonary resuscitation. IEEE Trans Biomed Eng 464. Stueven H, Thompson BM, Aprahamian C, Darin JC. Use of calcium in prehos- 2007;54:2237–45. pital cardiac arrest. Ann Emerg Med 1983;12:136–9. 433. Pytte M, Olasveengen TM, Steen PA, Sunde K. Misplaced and dislodged endo- 465. van Walraven C, Stiell IG, Wells GA, Hebert PC, Vandemheen K. Do advanced tracheal tubes may be detected by the defibrillator during cardiopulmonary cardiac life support drugs increase resuscitation rates from in-hospital cardiac resuscitation. Acta Anaesthesiol Scand 2007;51:770–2. arrest? The OTAC Study Group. Ann Emerg Med 1998;32:544–53. 434. Salem MR, Wong AY, Mani M, Sellick BA. Efficacy of cricoid pressure in pre- 466. Dybvik T, Strand T, Steen PA. Buffer therapy during out-of-hospital cardiopul- venting gastric inflation during bag-mask ventilation in pediatric patients. monary resuscitation. Resuscitation 1995;29:89–95. Anesthesiology 1974;40:96–8. 467. Aufderheide TP, Martin DR, Olson DW, et al. Prehospital bicarbonate use in 435. Moynihan RJ, Brock-Utne JG, Archer JH, Feld LH, Kreitzman TR. The effect of cardiac arrest: a 3-year experience. Am J Emerg Med 1992;10:4–7. cricoid pressure on preventing gastric insufflation in infants and children. 468. Delooz H, Lewi PJ. Are inter-center differences in EMS-management and Anesthesiology 1993;78:652–6. sodium-bicarbonate administration important for the outcome of CPR? The 436. Ho AM, Wong W, Ling E, Chung DC, Tay BA. Airway difficulties caused by Cerebral Resuscitation Study Group. Resuscitation 1989;17(Suppl.):S199–206. improperly applied cricoid pressure. J Emerg Med 2001;20:29–31. 469. Roberts D, Landolfo K, Light R, Dobson K. Early predictors of mortality for 437. Shorten GD, Alfille PH, Gliklich RE. Airway obstruction following application of hospitalized patients suffering cardiopulmonary arrest. Chest 1990;97:413–9. cricoid pressure. J Clin Anesth 1991;3:403–5. 470. Suljaga-Pechtel K, Goldberg E, Strickon P, Berger M, Skovron ML. Cardiopul- 438. Proceedings of the guidelines 2000 conference for cardiopulmonary resuscita- monary resuscitation in a hospitalized population: prospective study of factors tion and emergency cardiovascular care: an international consensus on science. associated with outcome. Resuscitation 1984;12:77–95. Ann Emerg Med 2001;37:S1–200. 471. Weil MH, Trevino RP, Rackow EC. Sodium bicarbonate during CPR. Does it help 439. Lindner KH, Dirks B, Strohmenger HU, Prengel AW, Lindner IM, Lurie KG. or hinder? Chest 1985;88:487. Randomised comparison of epinephrine and vasopressin in patients with out- 472. Vukmir RB, Katz L. Sodium bicarbonate improves outcome in prolonged pre- of-hospital ventricular fibrillation. Lancet 1997;349:535–7. hospital cardiac arrest. Am J Emerg Med 2006;24:156–61.
- 128. 1346 C.D. Deakin et al. / Resuscitation 81 (2010) 1305–1352 473. Bar-Joseph G, Abramson NS, Kelsey SF, Mashiach T, Craig MT, Safar P. Improved 503. Mackenzie CF. A review of 100 cases of cardiac arrest and the relation of resuscitation outcome in emergency medical systems with increased usage of potassium, glucose, and haemoglobin levels to survival. West Indian Med J sodium bicarbonate during cardiopulmonary resuscitation. Acta Anaesthesiol 1975;24:39–45. Scand 2005;49:6–15. 504. Mullner M, Sterz F, Binder M, Schreiber W, Deimel A, Laggner AN. Blood glu- 474. Weaver WD, Eisenberg MS, Martin JS, et al. Myocardial Infarction Triage and cose concentration after cardiopulmonary resuscitation influences functional Intervention Project, phase I: patient characteristics and feasibility of prehos- neurological recovery in human cardiac arrest survivors. J Cereb Blood Flow pital initiation of thrombolytic therapy. J Am Coll Cardiol 1990;15:925–31. Metab 1997;17:430–6. 475. Sandeman DJ, Alahakoon TI, Bentley SC. Tricyclic poisoning—successful man- 505. Skrifvars MB, Pettila V, Rosenberg PH, Castren M. A multiple logistic regres- agement of ventricular fibrillation following massive overdose of imipramine. sion analysis of in-hospital factors related to survival at six months in Anaesth Intensive Care 1997;25:542–5. patients resuscitated from out-of-hospital ventricular fibrillation. Resuscita- 476. Lin SR. The effect of dextran and streptokinase on cerebral function and blood tion 2003;59:319–28. flow after cardiac arrest. An experimental study on the dog. Neuroradiology 506. Ditchey RV, Lindenfeld J. Potential adverse effects of volume loading 1978;16:340–2. on perfusion of vital organs during closed-chest resuscitation. Circulation 477. Fischer M, Bottiger BW, Popov-Cenic S, Hossmann KA. Thrombolysis using 1984;69:181–9. plasminogen activator and heparin reduces cerebral no-reflow after resuscita- 507. Voorhees WD, Ralston SH, Kougias C, Schmitz PM. Fluid loading with tion from cardiac arrest: an experimental study in the cat. Intensive Care Med whole blood or Ringer’s lactate solution during CPR in dogs. Resuscitation 1996;22:1214–23. 1987;15:113–23. 478. Ruiz-Bailen M, Aguayo de Hoyos E, Serrano-Corcoles MC, Diaz-Castellanos MA, 508. Gentile NT, Martin GB, Appleton TJ, Moeggenberg J, Paradis NA, Nowak RM. Ramos-Cuadra JA, Reina-Toral A. Efficacy of thrombolysis in patients with acute Effects of arterial and venous volume infusion on coronary perfusion pressures myocardial infarction requiring cardiopulmonary resuscitation. Intensive Care during canine CPR. Resuscitation 1991;22:55–63. Med 2001;27:1050–7. 509. Bender R, Breil M, Heister U, et al. Hypertonic saline during CPR: feasibil- 479. Janata K, Holzer M, Kurkciyan I, et al. Major bleeding complications in car- ity and safety of a new protocol of fluid management during resuscitation. diopulmonary resuscitation: the place of thrombolytic therapy in cardiac arrest Resuscitation 2007;72:74–81. due to massive pulmonary embolism. Resuscitation 2003;57:49–55. 510. Bruel C, Parienti JJ, Marie W, et al. Mild hypothermia during advanced 480. Kurkciyan I, Meron G, Sterz F, et al. Pulmonary embolism as a cause of cardiac life support: a preliminary study in out-of-hospital cardiac arrest. Crit Care arrest: presentation and outcome. Arch Intern Med 2000;160:1529–35. 2008;12:R31. 481. Lederer W, Lichtenberger C, Pechlaner C, Kroesen G, Baubin M. Recombinant 511. Kamarainen A, Virkkunen I, Tenhunen J, Yli-Hankala A, Silfvast T. Prehospital tissue plasminogen activator during cardiopulmonary resuscitation in 108 induction of therapeutic hypothermia during CPR: a pilot study. Resuscitation patients with out-of-hospital cardiac arrest. Resuscitation 2001;50:71–6. 2008;76:360–3. 482. Bozeman WP, Kleiner DM, Ferguson KL. Empiric tenecteplase is associated 512. Krep H, Breil M, Sinn D, Hagendorff A, Hoeft A, Fischer M. Effects of hypertonic with increased return of spontaneous circulation and short term survival in versus isotonic infusion therapy on regional cerebral blood flow after exper- cardiac arrest patients unresponsive to standard interventions. Resuscitation imental cardiac arrest cardiopulmonary resuscitation in pigs. Resuscitation 2006;69:399–406. 2004;63:73–83. 483. Stadlbauer KH, Krismer AC, Arntz HR, et al. Effects of thrombolysis during out- 513. Soar J, Foster J, Breitkreutz R. Fluid infusion during CPR and after ROSC—is it of-hospital cardiopulmonary resuscitation. Am J Cardiol 2006;97:305–8. safe? Resuscitation 2009;80:1221–2. 484. Fatovich DM, Dobb GJ, Clugston RA. A pilot randomised trial of thrombolysis 514. Ong ME, Chan YH, Oh JJ, Ngo AS. An observational, prospective study compar- in cardiac arrest (The TICA trial). Resuscitation 2004;61:309–13. ing tibial and humeral intraosseous access using the EZ-IO. Am J Emerg Med 485. Tiffany PA, Schultz M, Stueven H. Bolus thrombolytic infusions during CPR for 2009;27:8–15. patients with refractory arrest rhythms: outcome of a case series. Ann Emerg 515. Gerritse BM, Scheffer GJ, Draaisma JM. Prehospital intraosseus access with the Med 1998;31:124–6. bone injection gun by a helicopter-transported emergency medical team. J 486. Abu-Laban RB, Christenson JM, Innes GD, et al. Tissue plasminogen activator in Trauma 2009;66:1739–41. cardiac arrest with pulseless electrical activity. N Engl J Med 2002;346:1522–8. 516. Brenner T, Bernhard M, Helm M, et al. Comparison of two intraosseous infusion 487. Bottiger BW, Arntz HR, Chamberlain DA, et al. Thrombolysis during resuscita- systems for adult emergency medical use. Resuscitation 2008;78:314–9. tion for out-of-hospital cardiac arrest. N Engl J Med 2008;359:2651–62. 517. Frascone RJ, Jensen JP, Kaye K, Salzman JG. Consecutive field trials using two 488. Li X, Fu QL, Jing XL, et al. A meta-analysis of cardiopulmonary resuscitation different intraosseous devices. Prehosp Emerg Care 2007;11:164–71. with and without the administration of thrombolytic agents. Resuscitation 518. Banerjee S, Singhi SC, Singh S, Singh M. The intraosseous route is a suitable 2006;70:31–6. alternative to intravenous route for fluid resuscitation in severely dehydrated 489. Fava M, Loyola S, Bertoni H, Dougnac A. Massive pulmonary embolism: per- children. Indian Pediatr 1994;31:1511–20. cutaneous mechanical thrombectomy during cardiopulmonary resuscitation. 519. Brickman KR, Krupp K, Rega P, Alexander J, Guinness M. Typing and screening J Vasc Interv Radiol 2005;16:119–23. of blood from intraosseous access. Ann Emerg Med 1992;21:414–7. 490. Lederer W, Lichtenberger C, Pechlaner C, Kinzl J, Kroesen G, Baubin M. Long- 520. Fiser RT, Walker WM, Seibert JJ, McCarthy R, Fiser DH. Tibial length following term survival and neurological outcome of patients who received recombinant intraosseous infusion: a prospective, radiographic analysis. Pediatr Emerg Care tissue plasminogen activator during out-of-hospital cardiac arrest. Resuscita- 1997;13:186–8. tion 2004;61:123–9. 521. Ummenhofer W, Frei FJ, Urwyler A, Drewe J. Are laboratory values in bone mar- 491. Zahorec R. Rescue systemic thrombolysis during cardiopulmonary resuscita- row aspirate predictable for venous blood in paediatric patients? Resuscitation tion. Bratisl Lek Listy 2002;103:266–9. 1994;27:123–8. 492. Konstantinov IE, Saxena P, Koniuszko MD, Alvarez J, Newman MA. Acute mas- 522. Guy J, Haley K, Zuspan SJ. Use of intraosseous infusion in the pediatric trauma sive pulmonary embolism with cardiopulmonary resuscitation: management patient. J Pediatr Surg 1993;28:158–61. and results. Tex Heart Inst J 2007;34:41–5 [discussion 5–6]. 523. Macnab A, Christenson J, Findlay J, et al. A new system for sternal intraosseous 493. Scholz KH, Hilmer T, Schuster S, Wojcik J, Kreuzer H, Tebbe U. Thrombolysis infusion in adults. Prehosp Emerg Care 2000;4:173–7. in resuscitated patients with pulmonary embolism. Dtsch Med Wochenschr 524. Ellemunter H, Simma B, Trawoger R, Maurer H. Intraosseous lines in preterm 1990;115:930–5. and full term neonates. Arch Dis Child Fetal Neonatal Ed 1999;80:F74–5. 494. Gramann J, Lange-Braun P, Bodemann T, Hochrein H. Der Einsatz von Throm- 525. Delguercio LR, Feins NR, Cohn JD, Coomaraswamy RP, Wollman SB, State D. bolytika in der Reanimation als Ultima ratio zur Überwindung des Herztodes. Comparison of blood flow during external and internal cardiac massage in man. Intensiv- und Notfallbehandlung 1991;16:134–7. Circulation 1965;31(Suppl. 1):171–80. 495. Klefisch F, Gareis R, Störck T, Möckel M, Danne O. Praklinische ultima-ratio 526. Wik L, Kramer-Johansen J, Myklebust H, et al. Quality of cardiopul- thrombolyse bei therapierefraktarer kardiopulmonaler reanimation. Inten- monary resuscitation during out-of-hospital cardiac arrest. JAMA 2005;293: sivmedizin 1995;32:155–62. 299–304. 496. Böttiger BW, Martin E. Thrombolytic therapy during cardiopulmonary resusci- 527. Kramer-Johansen J, Myklebust H, Wik L, et al. Quality of out-of-hospital car- tation and the role of coagulation activation after cardiac arrest. Curr Opin Crit diopulmonary resuscitation with real time automated feedback: a prospective Care 2001;7:176–83. interventional study. Resuscitation 2006;71:283–92. 497. Spöhr F, Böttiger BW. Safety of thrombolysis during cardiopulmonary resusci- 528. Sutton RM, Maltese MR, Niles D, et al. Quantitative analysis of chest com- tation. Drug Saf 2003;26:367–79. pression interruptions during in-hospital resuscitation of older children and 498. Langhelle A, Tyvold SS, Lexow K, Hapnes SA, Sunde K, Steen PA. In-hospital adolescents. Resuscitation 2009;80:1259–63. factors associated with improved outcome after out-of-hospital cardiac arrest. 529. Sutton RM, Niles D, Nysaether J, et al. Quantitative analysis of CPR quality A comparison between four regions in Norway. Resuscitation 2003;56:247–63. during in-hospital resuscitation of older children and adolescents. Pediatrics 499. Calle PA, Buylaert WA, Vanhaute OA. Glycemia in the post-resuscitation 2009;124:494–9. period. The Cerebral Resuscitation Study Group. Resuscitation 530. Boczar ME, Howard MA, Rivers EP, et al. A technique revisited: hemodynamic 1989;17(Suppl.):S181–8 [discussion S99–206]. comparison of closed- and open-chest cardiac massage during human car- 500. Longstreth Jr WT, Diehr P, Inui TS. Prediction of awakening after out-of-hospital diopulmonary resuscitation. Crit Care Med 1995;23:498–503. cardiac arrest. N Engl J Med 1983;308:1378–82. 531. Anthi A, Tzelepis GE, Alivizatos P, Michalis A, Palatianos GM, Geroulanos 501. Longstreth Jr WT, Inui TS. High blood glucose level on hospital admission and S. Unexpected cardiac arrest after cardiac surgery: incidence, predisposing poor neurological recovery after cardiac arrest. Ann Neurol 1984;15:59–63. causes, and outcome of open chest cardiopulmonary resuscitation. Chest 502. Longstreth Jr WT, Copass MK, Dennis LK, Rauch-Matthews ME, Stark MS, 1998;113:15–9. Cobb LA. Intravenous glucose after out-of-hospital cardiopulmonary arrest: 532. Pottle A, Bullock I, Thomas J, Scott L. Survival to discharge following Open Chest a community-based randomized trial. Neurology 1993;43:2534–41. Cardiac Compression (OCCC). A 4-year retrospective audit in a cardiothoracic
- 129. C.D. Deakin et al. / Resuscitation 81 (2010) 1305–1352 1347 specialist centre - Royal Brompton and Harefield NHS Trust, United Kingdom. compression–decompression cardiopulmonary resuscitation. Crit Care Med Resuscitation 2002;52:269–72. 2005;33:990–4. 533. Babbs CF. Interposed abdominal compression CPR: a comprehensive evidence 560. Wolcke BB, Mauer DK, Schoefmann MF, et al. Comparison of stan- based review. Resuscitation 2003;59:71–82. dard cardiopulmonary resuscitation versus the combination of active 534. Babbs CF, Nadkarni V. Optimizing chest compression to rescue ventilation compression–decompression cardiopulmonary resuscitation and an inspira- ratios during one-rescuer CPR by professionals and lay persons: children are tory impedance threshold device for out-of-hospital cardiac arrest. Circulation not just little adults. Resuscitation 2004;61:173–81. 2003;108:2201–5. 535. Beyar R, Kishon Y, Kimmel E, Neufeld H, Dinnar U. Intrathoracic and abdominal 561. Aufderheide TP, Pirrallo RG, Provo TA, Lurie KG. Clinical evaluation of an pressure variations as an efficient method for cardiopulmonary resuscita- inspiratory impedance threshold device during standard cardiopulmonary tion: studies in dogs compared with computer model results. Cardiovasc Res resuscitation in patients with out-of-hospital cardiac arrest. Crit Care Med 1985;19:335–42. 2005;33:734–40. 536. Voorhees WD, Niebauer MJ, Babbs CF. Improved oxygen delivery during car- 562. Lurie KG, Barnes TA, Zielinski TM, McKnite SH. Evaluation of a prototypic diopulmonary resuscitation with interposed abdominal compressions. Ann inspiratory impedance threshold valve designed to enhance the efficiency of Emerg Med 1983;12:128–35. cardiopulmonary resuscitation. Respir Care 2003;48:52–7. 537. Sack JB, Kesselbrenner MB, Bregman D. Survival from in-hospital cardiac arrest 563. Lurie KG, Coffeen P, Shultz J, McKnite S, Detloff B, Mulligan K. Improving active with interposed abdominal counterpulsation during cardiopulmonary resus- compression–decompression cardiopulmonary resuscitation with an inspira- citation. JAMA 1992;267:379–85. tory impedance valve. Circulation 1995;91:1629–32. 538. Sack JB, Kesselbrenner MB, Jarrad A. Interposed abdominal compression- 564. Lurie KG, Mulligan KA, McKnite S, Detloff B, Lindstrom P, Lindner KH. Optimiz- cardiopulmonary resuscitation and resuscitation outcome during asystole and ing standard cardiopulmonary resuscitation with an inspiratory impedance electromechanical dissociation. Circulation 1992;86:1692–700. threshold valve. Chest 1998;113:1084–90. 539. Mateer JR, Stueven HA, Thompson BM, Aprahamian C, Darin JC. Pre-hospital 565. Lurie KG, Voelckel WG, Zielinski T, et al. Improving standard cardiopulmonary IAC-CPR versus standard CPR: paramedic resuscitation of cardiac arrests. Am J resuscitation with an inspiratory impedance threshold valve in a porcine model Emerg Med 1985;3:143–6. of cardiac arrest. Anesth Analg 2001;93:649–55. 540. Lindner KH, Pfenninger EG, Lurie KG, Schurmann W, Lindner IM, Ahnefeld FW. 566. Lurie KG, Zielinski T, McKnite S, Aufderheide T, Voelckel W. Use of an inspi- Effects of active compression–decompression resuscitation on myocardial and ratory impedance valve improves neurologically intact survival in a porcine cerebral blood flow in pigs. Circulation 1993;88:1254–63. model of ventricular fibrillation. Circulation 2002;105:124–9. 541. Shultz JJ, Coffeen P, Sweeney M, et al. Evaluation of standard and active 567. Raedler C, Voelckel WG, Wenzel V, et al. Vasopressor response in a compression–decompression CPR in an acute human model of ventricular fib- porcine model of hypothermic cardiac arrest is improved with active rillation. Circulation 1994;89:684–93. compression–decompression cardiopulmonary resuscitation using the inspi- 542. Chang MW, Coffeen P, Lurie KG, Shultz J, Bache RJ, White CW. Active ratory impedance threshold valve. Anesth Analg 2002;95:1496–502. compression–decompression CPR improves vital organ perfusion in a dog 568. Voelckel WG, Lurie KG, Zielinski T, et al. The effects of positive end-expiratory model of ventricular fibrillation. Chest 1994;106:1250–9. pressure during active compression decompression cardiopulmonary resus- 543. Orliaguet GA, Carli PA, Rozenberg A, Janniere D, Sauval P, Delpech P. End-tidal citation with the inspiratory threshold valve. Anesth Analg 2001;92: carbon dioxide during out-of-hospital cardiac arrest resuscitation: compari- 967–74. son of active compression–decompression and standard CPR. Ann Emerg Med 569. Yannopoulos D, Aufderheide TP, Gabrielli A, et al. Clinical and hemodynamic 1995;25:48–51. comparison of 15:2 and 30:2 compression-to-ventilation ratios for cardiopul- 544. Guly UM, Mitchell RG, Cook R, Steedman DJ, Robertson CE. Paramedics and monary resuscitation. Crit Care Med 2006;34:1444–9. technicians are equally successful at managing cardiac arrest outside hospital. 570. Mader TJ, Kellogg AR, Smith J, et al. A blinded, randomized controlled evaluation BMJ 1995;310:1091–4. of an impedance threshold device during cardiopulmonary resuscitation in 545. Tucker KJ, Galli F, Savitt MA, Kahsai D, Bresnahan L, Redberg RF. Active swine. Resuscitation 2008;77:387–94. compression–decompression resuscitation: effect on resuscitation success 571. Menegazzi JJ, Salcido DD, Menegazzi MT, et al. Effects of an impedance after in-hospital cardiac arrest. J Am Coll Cardiol 1994;24:201–9. threshold device on hemodynamics and restoration of spontaneous cir- 546. Malzer R, Zeiner A, Binder M, et al. Hemodynamic effects of active culation in prolonged porcine ventricular fibrillation. Prehosp Emerg Care compression–decompression after prolonged CPR. Resuscitation 2007;11:179–85. 1996;31:243–53. 572. Langhelle A, Stromme T, Sunde K, Wik L, Nicolaysen G, Steen PA. Inspiratory 547. Lurie KG, Shultz JJ, Callaham ML, et al. Evaluation of active impedance threshold valve during CPR. Resuscitation 2002;52:39–48. compression–decompression CPR in victims of out-of-hospital cardiac 573. Herff H, Raedler C, Zander R, et al. Use of an inspiratory impedance threshold arrest. JAMA 1994;271:1405–11. valve during chest compressions without assisted ventilation may result in 548. Cohen TJ, Goldner BG, Maccaro PC, et al. A comparison of active hypoxaemia. Resuscitation 2007;72:466–76. compression–decompression cardiopulmonary resuscitation with standard 574. Plaisance P, Lurie KG, Vicaut E, et al. Evaluation of an impedance threshold cardiopulmonary resuscitation for cardiac arrests occurring in the hospital. device in patients receiving active compression–decompression cardiopul- N Engl J Med 1993;329:1918–21. monary resuscitation for out of hospital cardiac arrest. Resuscitation 549. Schwab TM, Callaham ML, Madsen CD, Utecht TA. A randomized clinical trial 2004;61:265–71. of active compression–decompression CPR vs standard CPR in out-of-hospital 575. Cabrini L, Beccaria P, Landoni G, et al. Impact of impedance threshold devices cardiac arrest in two cities. JAMA 1995;273:1261–8. on cardiopulmonary resuscitation: a systematic review and meta-analysis of 550. Stiell I, H’ebert P, Well G, et al. Tne Ontario trial of active randomized controlled studies. Crit Care Med 2008;36:1625–32. compression–decompression cardiopulmonary resuscitation for in-hospital 576. Wik L, Bircher NG, Safar P. A comparison of prolonged manual and mechan- and prehospital cardiac arrest. JAMA 1996;275:1417–23. ical external chest compression after cardiac arrest in dogs. Resuscitation 551. Mauer D, Schneider T, Dick W, Withelm A, Elich D, Mauer M. Active 1996;32:241–50. compression–decompression resuscitation: a prospective, randomized study 577. Dickinson ET, Verdile VP, Schneider RM, Salluzzo RF. Effectiveness of mechan- in a two-tiered EMS system with physicians in the field. Resuscitation ical versus manual chest compressions in out-of-hospital cardiac arrest 1996;33:125–34. resuscitation: a pilot study. Am J Emerg Med 1998;16:289–92. 552. Nolan J, Smith G, Evans R, et al. The United Kingdom pre-hospital study of active 578. McDonald JL. Systolic and mean arterial pressures during manual and mechan- compression–decompression resuscitation. Resuscitation 1998;37:119–25. ical CPR in humans. Ann Emerg Med 1982;11:292–5. 553. Luiz T, Ellinger K, Denz C. Active compression–decompression cardiopul- 579. Ward KR, Menegazzi JJ, Zelenak RR, Sullivan RJ, McSwain Jr NE. A comparison monary resuscitation does not improve survival in patients with prehospital of chest compressions between mechanical and manual CPR by monitoring cardiac arrest in a physician-manned emergency medical system. J Cardiotho- end-tidal PCO2 during human cardiac arrest. Ann Emerg Med 1993;22:669–74. rac Vasc Anesth 1996;10:178–86. 580. Wang HC, Chiang WC, Chen SY, et al. Video-recording and time-motion 554. Plaisance P, Lurie KG, Vicaut E, et al. A comparison of standard cardiopul- analyses of manual versus mechanical cardiopulmonary resuscitation during monary resuscitation and active compression–decompression resuscitation ambulance transport. Resuscitation 2007;74:453–60. for out-of-hospital cardiac arrest. French Active Compression-Decompression 581. Steen S, Liao Q, Pierre L, Paskevicius A, Sjoberg T. Evaluation of LUCAS, a new Cardiopulmonary Resuscitation Study Group. N Engl J Med 1999;341:569–75. device for automatic mechanical compression and active decompression resus- 555. Baubin M, Rabl W, Pfeiffer KP, Benzer A, Gilly H. Chest injuries after active citation. Resuscitation 2002;55:285–99. compression–decompression cardiopulmonary resuscitation (ACD-CPR) in 582. Rubertsson S, Karlsten R. Increased cortical cerebral blood flow with LUCAS; a cadavers. Resuscitation 1999;43:9–15. new device for mechanical chest compressions compared to standard external 556. Rabl W, Baubin M, Broinger G, Scheithauer R. Serious complications from active compressions during experimental cardiopulmonary resuscitation. Resuscita- compression–decompression cardiopulmonary resuscitation. Int J Legal Med tion 2005;65:357–63. 1996;109:84–9. 583. Axelsson C, Nestin J, Svensson L, Axelsson AB, Herlitz J. Clinical consequences 557. Hoke RS, Chamberlain D. Skeletal chest injuries secondary to cardiopulmonary of the introduction of mechanical chest compression in the EMS system resuscitation. Resuscitation 2004;63:327–38. for treatment of out-of-hospital cardiac arrest—a pilot study. Resuscitation 558. Plaisance P, Lurie KG, Payen D. Inspiratory impedance during active 2006;71:47–55. compression–decompression cardiopulmonary resuscitation: a randomized 584. Steen S, Sjoberg T, Olsson P, Young M. Treatment of out-of-hospital cardiac evaluation in patients in cardiac arrest. Circulation 2000;101:989–94. arrest with LUCAS, a new device for automatic mechanical compression and 559. Plaisance P, Soleil C, Lurie KG, Vicaut E, Ducros L, Payen D. Use of an inspi- active decompression resuscitation. Resuscitation 2005;67:25–30. ratory impedance threshold device on a facemask and endotracheal tube 585. Larsen AI, Hjornevik AS, Ellingsen CL, Nilsen DW. Cardiac arrest with to reduce intrathoracic pressures during the decompression phase of active continuous mechanical chest compression during percutaneous coronary
- 130. 1348 C.D. Deakin et al. / Resuscitation 81 (2010) 1305–1352 intervention. A report on the use of the LUCAS device. Resuscitation [published correction appears in Ann Intern Med. 1990; 113:996]. Ann Intern 2007;75:454–9. Med 1990;113:104–10. 586. Bonnemeier H, Olivecrona G, Simonis G, et al. Automated continuous 611. Fuster V, Ryden LE, Cannom DS, et al. ACC/AHA/ESC 2006 guidelines for chest compression for in-hospital cardiopulmonary resuscitation of patients the management of patients with atrial fibrillation: a report of the Ameri- with pulseless electrical activity: a report of five cases. Int J Cardiol can College of Cardiology/American Heart Association Task Force on Practice 2009;136:e39–50. Guidelines and the European Society of Cardiology Committee for Practice 587. Grogaard HK, Wik L, Eriksen M, Brekke M, Sunde K. Continuous mechanical Guidelines (Writing Committee to Revise the 2001 Guidelines for the Manage- chest compressions during cardiac arrest to facilitate restoration of coro- ment of Patients With Atrial Fibrillation): developed in collaboration with the nary circulation with percutaneous coronary intervention. J Am Coll Cardiol European Heart Rhythm Association and the Heart Rhythm Society. Circulation 2007;50:1093–4. 2006;114:e257–354. 588. Larsen AI, Hjornevik A, Bonarjee V, Barvik S, Melberg T, Nilsen DW. Coronary 612. Sticherling C, Tada H, Hsu W, et al. Effects of diltiazem and esmolol on cycle blood flow and perfusion pressure during coronary angiography in patients length and spontaneous conversion of atrial fibrillation. J Cardiovasc Pharmacol with ongoing mechanical chest compression: a report on 6 cases. Resuscitation Ther 2002;7:81–8. 2010;81:493–7. 613. Shettigar UR, Toole JG, Appunn DO. Combined use of esmolol and digoxin in the 589. Smekal D, Johansson J, Huzevka T, Rubertsson S. No difference in autopsy acute treatment of atrial fibrillation or flutter. Am Heart J 1993;126:368–74. detected injuries in cardiac arrest patients treated with manual chest com- 614. Demircan C, Cikriklar HI, Engindeniz Z, et al. Comparison of the effectiveness of pressions compared with mechanical compressions with the LUCAS device—a intravenous diltiazem and metoprolol in the management of rapid ventricular pilot study. Resuscitation 2009;80:1104–7. rate in atrial fibrillation. Emerg Med J 2005;22:411–4. 590. Deakin CD, Paul V, Fall E, Petley GW, Thompson F. Ambient oxygen concentra- 615. Wattanasuwan N, Khan IA, Mehta NJ, et al. Acute ventricular rate control in tions resulting from use of the Lund University Cardiopulmonary Assist System atrial fibrillation: IV combination of diltiazem and digoxin vs. IV diltiazem (LUCAS) device during simulated cardiopulmonary resuscitation. Resuscitation alone. Chest 2001;119:502–6. 2007;74:303–9. 616. Davey MJ, Teubner D. A randomized controlled trial of magnesium sulfate, in 591. Timerman S, Cardoso LF, Ramires JA, Halperin H. Improved hemodynamic addition to usual care, for rate control in atrial fibrillation. Ann Emerg Med performance with a novel chest compression device during treatment of in- 2005;45:347–53. hospital cardiac arrest. Resuscitation 2004;61:273–80. 617. Chiladakis JA, Stathopoulos C, Davlouros P, Manolis AS. Intravenous magne- 592. Halperin H, Berger R, Chandra N, et al. Cardiopulmonary resuscitation with a sium sulfate versus diltiazem in paroxysmal atrial fibrillation. Int J Cardiol hydraulic-pneumatic band. Crit Care Med 2000;28:N203–6. 2001;79:287–91. 593. Halperin HR, Paradis N, Ornato JP, et al. Cardiopulmonary resuscitation with 618. Dauchot P, Gravenstein JS. Effects of atropine on the electrocardiogram in dif- a novel chest compression device in a porcine model of cardiac arrest: ferent age groups. Clin Pharmacol Ther 1971;12:274–80. improved hemodynamics and mechanisms. J Am Coll Cardiol 2004;44: 619. Chamberlain DA, Turner P, Sneddon JM. Effects of atropine on heart-rate in 2214–20. healthy man. Lancet 1967;2:12–5. 594. Hallstrom A, Rea TD, Sayre MR, et al. Manual chest compression vs use of an 620. Bernheim A, Fatio R, Kiowski W, Weilenmann D, Rickli H, Rocca HP. Atropine automated chest compression device during resuscitation following out-of- often results in complete atrioventricular block or sinus arrest after cardiac hospital cardiac arrest: a randomized trial. JAMA 2006;295:2620–8. transplantation: an unpredictable and dose-independent phenomenon. Trans- 595. Steinmetz J, Barnung S, Nielsen SL, Risom M, Rasmussen LS. Improved survival plantation 2004;77:1181–5. after an out-of-hospital cardiac arrest using new guidelines. Acta Anaesthesiol 621. Klumbies A, Paliege R, Volkmann H. Mechanical emergency stimulation in Scand 2008;52:908–13. asystole and extreme bradycardia. Z Gesamte Inn Med 1988;43:348–52. 596. Casner M, Andersen D, Isaacs SM. Preliminary report of the impact of a new CPR 622. Zeh E, Rahner E. The manual extrathoracal stimulation of the heart. Tech- assist device on the rate of return of spontaneous circulation in out of hospital nique and effect of the precordial thump (author’s transl). Z Kardiol cardiac arrest. PreHosp Emerg Med 2005;9:61–7. 1978;67:299–304. 597. Ong ME, Ornato JP, Edwards DP, et al. Use of an automated, load-distributing 623. Chan L, Reid C, Taylor B. Effect of three emergency pacing modalities on band chest compression device for out-of-hospital cardiac arrest resuscitation. cardiac output in cardiac arrest due to ventricular asystole. Resuscitation JAMA 2006;295:2629–37. 2002;52:117–9. 598. Paradis N, Young G, Lemeshow S, Brewer J, Halperin H. Inhomogene- 624. Camm AJ, Garratt CJ. Adenosine and supraventricular tachycardia. N Engl J Med ity and temporal effects in AutoPulse Assisted Prehospital International 1991;325:1621–9. Resuscitation—an exception from consent trial terminated early. Am J Emerg 625. Wang HE, O’Connor RE, Megargel RE, et al. The use of diltiazem for treat- Med 2010;28:391–8. ing rapid atrial fibrillation in the out-of-hospital setting. Ann Emerg Med 599. Tomte O, Sunde K, Lorem T, et al. Advanced life support performance with man- 2001;37:38–45. ual and mechanical chest compressions in a randomized, multicentre manikin 626. Martinez-Marcos FJ, Garcia-Garmendia JL, Ortega-Carpio A, Fernandez-Gomez study. Resuscitation 2009;80:1152–7. JM, Santos JM, Camacho C. Comparison of intravenous flecainide, propafenone, 600. Wirth S, Korner M, Treitl M, et al. Computed tomography during cardiopul- and amiodarone for conversion of acute atrial fibrillation to sinus rhythm. Am monary resuscitation using automated chest compression devices—an initial J Cardiol 2000;86:950–3. study. Eur Radiol 2009;19:1857–66. 627. Kalus JS, Spencer AP, Tsikouris JP, et al. Impact of prophylactic i.v. magnesium 601. Holmstrom P, Boyd J, Sorsa M, Kuisma M. A case of hypothermic cardiac arrest on the efficacy of ibutilide for conversion of atrial fibrillation or flutter. Am J treated with an external chest compression device (LUCAS) during transport Health Syst Pharm 2003;60:2308–12. to re-warming. Resuscitation 2005;67:139–41. 628. Nolan JP, Neumar RW, Adrie C, et al. Post-cardiac arrest syndrome: epidemiol- 602. Wik L, Kiil S. Use of an automatic mechanical chest compression device (LUCAS) ogy, pathophysiology, treatment, and prognostication. A Scientific Statement as a bridge to establishing cardiopulmonary bypass for a patient with hypother- from the International Liaison Committee on Resuscitation; the American mic cardiac arrest. Resuscitation 2005;66:391–4. Heart Association Emergency Cardiovascular Care Committee; the Council on 603. Sunde K, Wik L, Steen PA. Quality of mechanical, manual standard and active Cardiovascular Surgery and Anesthesia; the Council on Cardiopulmonary, Peri- compression–decompression CPR on the arrest site and during transport in a operative, and Critical Care; the Council on Clinical Cardiology; the Council on manikin model. Resuscitation 1997;34:235–42. Stroke. Resuscitation 2008;79:350–79. 604. Lown B, Amarasingham R, Neuman J. New method for terminating car- 629. Sunde K, Pytte M, Jacobsen D, et al. Implementation of a standardised treat- diac arrhythmias. Use of synchronized capacitor discharge. JAMA 1962;182: ment protocol for post resuscitation care after out-of-hospital cardiac arrest. 548–55. Resuscitation 2007;73:29–39. 605. Zipes DP, Camm AJ, Borggrefe M, et al. ACC/AHA/ESC 2006 guidelines for man- 630. Gaieski DF, Band RA, Abella BS, et al. Early goal-directed hemodynamic opti- agement of patients with ventricular arrhythmias and the prevention of sudden mization combined with therapeutic hypothermia in comatose survivors of cardiac death: a report of the American College of Cardiology/American Heart out-of-hospital cardiac arrest. Resuscitation 2009;80:418–24. Association Task Force and the European Society of Cardiology Committee for 631. Carr BG, Goyal M, Band RA, et al. A national analysis of the relationship Practice Guidelines (Writing Committee to Develop Guidelines for Manage- between hospital factors and post-cardiac arrest mortality. Intensive Care Med ment of Patients With Ventricular Arrhythmias and the Prevention of Sudden 2009;35:505–11. Cardiac Death). J Am Coll Cardiol 2006;48:e247–346. 632. Oddo M, Schaller MD, Feihl F, Ribordy V, Liaudet L. From evidence to clini- 606. Deakin CD, Morrison LJ, Morley PT, et al. 2010 International consensus on car- cal practice: effective implementation of therapeutic hypothermia to improve diopulmonary resuscitation and emergency cardiovascular care science with patient outcome after cardiac arrest. Crit Care Med 2006;34:1865–73. treatment recommendations. Part 8: advanced life support. Resuscitation; 633. Knafelj R, Radsel P, Ploj T, Noc M. Primary percutaneous coronary intervention doi:10.1016/j.resuscitation.2010.08.027, in press. and mild induced hypothermia in comatose survivors of ventricular fibrillation 607. Manz M, Pfeiffer D, Jung W, Lueritz B. Intravenous treatment with magne- with ST-elevation acute myocardial infarction. Resuscitation 2007;74:227–34. sium in recurrent persistent ventricular tachycardia. New Trends Arrhythmias 634. Nolan JP, Laver SR, Welch CA, Harrison DA, Gupta V, Rowan K. Outcome 1991;7:437–42. following admission to UK intensive care units after cardiac arrest: a sec- 608. Tzivoni D, Banai S, Schuger C, et al. Treatment of torsade de pointes with ondary analysis of the ICNARC Case Mix Programme Database. Anaesthesia magnesium sulfate. Circulation 1988;77:392–7. 2007;62:1207–16. 609. Delacretaz E. Clinical practice. Supraventricular tachycardia. N Engl J Med 635. Keenan SP, Dodek P, Martin C, Priestap F, Norena M, Wong H. Variation in length 2006;354:1039–51. of intensive care unit stay after cardiac arrest: where you are is as important 610. DiMarco JP, Miles W, Akhtar M, et al. Adenosine for paroxysmal supraventric- as who you are. Crit Care Med 2007;35:836–41. ular tachycardia: dose ranging and comparison with verapamil: assessment 636. Carr BG, Kahn JM, Merchant RM, Kramer AA, Neumar RW. Inter-hospital vari- in placebo-controlled, multicenter trials. The Adenosine for PSVT Study Group ability in post-cardiac arrest mortality. Resuscitation 2009;80:30–4.
- 131. C.D. Deakin et al. / Resuscitation 81 (2010) 1305–1352 1349 637. Niskanen M, Reinikainen M, Kurola J. Outcome from intensive care after cardiac segment elevation myocardial infarction undergoing immediate percutaneous arrest: comparison between two patient samples treated in 1986-87 and 1999- coronary intervention. Crit Care Med 2008;36:1780–6. 2001 in Finnish ICUs. Acta Anaesthesiol Scand 2007;51:151–7. 667. Rivers E, Nguyen B, Havstad S, et al. Early goal-directed therapy in the treatment 638. Hovdenes J, Laake JH, Aaberge L, Haugaa H, Bugge JF. Therapeutic hypother- of severe sepsis and septic shock. N Engl J Med 2001;345:1368–77. mia after out-of-hospital cardiac arrest: experiences with patients treated with 668. Mullner M, Sterz F, Binder M, et al. Arterial blood pressure after human cardiac percutaneous coronary intervention and cardiogenic shock. Acta Anaesthesiol arrest and neurological recovery. Stroke 1996;27:59–62. Scand 2007;51:137–42. 668a. Trzeciak S, Jones AE, Kilgannon JH, et al. Significance of arterial hypotension 639. Soar J, Mancini ME, Bhanji F, et al. 2010 International consensus on car- after resuscitation from cardiac arrest. Crit Care Med 2009;37:2895–903. diopulmonary resuscitation and emergency cardiovascular care science with 669. Bernard SA, Gray TW, Buist MD, et al. Treatment of comatose survivors treatment recommendations. Part 12: education, implementation, and teams. of out-of-hospital cardiac arrest with induced hypothermia. N Engl J Med Resuscitation; doi:10.1016/j.resuscitation.2010.08.030, in press. 2002;346:557–63. 640. Laver S, Farrow C, Turner D, Nolan J. Mode of death after admission to an inten- 670. Angelos MG, Ward KR, Hobson J, Beckley PD. Organ blood flow following car- sive care unit following cardiac arrest. Intensive Care Med 2004;30:2126–8. diac arrest in a swine low-flow cardiopulmonary bypass model. Resuscitation 641. Laurent I, Monchi M, Chiche JD, et al. Reversible myocardial dysfunction in 1994;27:245–54. survivors of out-of-hospital cardiac arrest. J Am Coll Cardiol 2002;40:2110–6. 671. Sakabe T, Tateishi A, Miyauchi Y, et al. Intracranial pressure following car- 642. Ruiz-Bailen M, Aguayo de Hoyos E, Ruiz-Navarro S, et al. Reversible diopulmonary resuscitation. Intensive Care Med 1987;13:256–9. myocardial dysfunction after cardiopulmonary resuscitation. Resuscitation 672. Morimoto Y, Kemmotsu O, Kitami K, Matsubara I, Tedo I. Acute brain swelling 2005;66:175–81. after out-of-hospital cardiac arrest: pathogenesis and outcome. Crit Care Med 643. Cerchiari EL, Safar P, Klein E, Diven W. Visceral, hematologic and bacteriologic 1993;21:104–10. changes and neurologic outcome after cardiac arrest in dogs. The visceral post- 673. Nishizawa H, Kudoh I. Cerebral autoregulation is impaired in patients resusci- resuscitation syndrome. Resuscitation 1993;25:119–36. tated after cardiac arrest. Acta Anaesthesiol Scand 1996;40:1149–53. 644. Adrie C, Monchi M, Laurent I, et al. Coagulopathy after successful cardiopul- 674. Sundgreen C, Larsen FS, Herzog TM, Knudsen GM, Boesgaard S, Aldershvile monary resuscitation following cardiac arrest: implication of the protein C J. Autoregulation of cerebral blood flow in patients resuscitated from cardiac anticoagulant pathway. J Am Coll Cardiol 2005;46:21–8. arrest. Stroke 2001;32:128–32. 645. Adrie C, Adib-Conquy M, Laurent I, et al. Successful cardiopulmonary 675. Ely EW, Truman B, Shintani A, et al. Monitoring sedation status over time in resuscitation after cardiac arrest as a “sepsis-like” syndrome. Circulation ICU patients: reliability and validity of the Richmond Agitation-Sedation Scale 2002;106:562–8. (RASS). JAMA 2003;289:2983–91. 646. Adrie C, Laurent I, Monchi M, Cariou A, Dhainaou JF, Spaulding C. Postresusci- 676. De Jonghe B, Cook D, Appere-De-Vecchi C, Guyatt G, Meade M, Outin H. Using tation disease after cardiac arrest: a sepsis-like syndrome? Curr Opin Crit Care and understanding sedation scoring systems: a systematic review. Intensive 2004;10:208–12. Care Med 2000;26:275–85. 647. Zwemer CF, Whitesall SE, D’Alecy LG. Cardiopulmonary-cerebral resuscitation 677. Snyder BD, Hauser WA, Loewenson RB, Leppik IE, Ramirez-Lassepas M, Gum- with 100% oxygen exacerbates neurological dysfunction following nine min- nit RJ. Neurologic prognosis after cardiopulmonary arrest. III: seizure activity. utes of normothermic cardiac arrest in dogs. Resuscitation 1994;27:159–70. Neurology 1980;30:1292–7. 648. Richards EM, Fiskum G, Rosenthal RE, Hopkins I, McKenna MC. Hyperoxic 678. Levy DE, Caronna JJ, Singer BH, Lapinski RH, Frydman H, Plum F. Predicting reperfusion after global ischemia decreases hippocampal energy metabolism. outcome from hypoxic–ischemic coma. JAMA 1985;253:1420–6. Stroke 2007;38:1578–84. 679. Krumholz A, Stern BJ, Weiss HD. Outcome from coma after cardiopulmonary 649. Vereczki V, Martin E, Rosenthal RE, Hof PR, Hoffman GE, Fiskum G. Nor- resuscitation: relation to seizures and myoclonus. Neurology 1988;38:401–5. moxic resuscitation after cardiac arrest protects against hippocampal oxidative 680. Zandbergen EG, Hijdra A, Koelman JH, et al. Prediction of poor outcome within stress, metabolic dysfunction, and neuronal death. J Cereb Blood Flow Metab the first 3 days of postanoxic coma. Neurology 2006;66:62–8. 2006;26:821–35. 681. Ingvar M. Cerebral blood flow and metabolic rate during seizures. Relationship 650. Liu Y, Rosenthal RE, Haywood Y, Miljkovic-Lolic M, Vanderhoek JY, Fiskum G. to epileptic brain damage. Ann NY Acad Sci 1986;462:194–206. Normoxic ventilation after cardiac arrest reduces oxidation of brain lipids and 682. Caviness JN, Brown P. Myoclonus: current concepts and recent advances. Lancet improves neurological outcome. Stroke 1998;29:1679–86. Neurol 2004;3:598–607. 651. Menon DK, Coles JP, Gupta AK, et al. Diffusion limited oxygen delivery following 683. Losert H, Sterz F, Roine RO, et al. Strict normoglycaemic blood glucose levels in head injury. Crit Care Med 2004;32:1384–90. the therapeutic management of patients within 12 h after cardiac arrest might 652. Buunk G, van der Hoeven JG, Meinders AE. Cerebrovascular reactivity in not be necessary. Resuscitation 2007. comatose patients resuscitated from a cardiac arrest. Stroke 1997;28:1569–73. 684. Skrifvars MB, Saarinen K, Ikola K, Kuisma M. Improved survival after in- 653. Buunk G, van der Hoeven JG, Meinders AE. A comparison of near-infrared spec- hospital cardiac arrest outside critical care areas. Acta Anaesthesiol Scand troscopy and jugular bulb oximetry in comatose patients resuscitated from a 2005;49:1534–9. cardiac arrest. Anaesthesia 1998;53:13–9. 685. van den Berghe G, Wouters P, Weekers F, et al. Intensive insulin therapy in the 654. Roine RO, Launes J, Nikkinen P, Lindroth L, Kaste M. Regional cerebral blood critically ill patients. N Engl J Med 2001;345:1359–67. flow after human cardiac arrest. A hexamethylpropyleneamine oxime single 686. Van den Berghe G, Wilmer A, Hermans G, et al. Intensive insulin therapy in the photon emission computed tomographic study. Arch Neurol 1991;48:625–9. medical ICU. N Engl J Med 2006;354:449–61. 655. Beckstead JE, Tweed WA, Lee J, MacKeen WL. Cerebral blood flow and 687. Oksanen T, Skrifvars MB, Varpula T, et al. Strict versus moderate glucose metabolism in man following cardiac arrest. Stroke 1978;9:569–73. control after resuscitation from ventricular fibrillation. Intensive Care Med 656. Zheng ZJ, Croft JB, Giles WH, Mensah GA. Sudden cardiac death in the United 2007;33:2093–100. States, 1989 to 1998. Circulation 2001;104:2158–63. 688. Finfer S, Chittock DR, Su SY, et al. Intensive versus conventional glucose control 657. Pell JP, Sirel JM, Marsden AK, Ford I, Walker NL, Cobbe SM. Presentation, man- in critically ill patients. N Engl J Med 2009;360:1283–97. agement, and outcome of out of hospital cardiopulmonary arrest: comparison 689. Preiser JC, Devos P, Ruiz-Santana S, et al. A prospective randomised multi- by underlying aetiology. Heart 2003;89:839–42. centre controlled trial on tight glucose control by intensive insulin therapy 658. Zipes DP, Wellens HJ. Sudden cardiac death. Circulation 1998;98:2334–51. in adult intensive care units: the Glucontrol study. Intensive Care Med 659. Spaulding CM, Joly LM, Rosenberg A, et al. Immediate coronary angiography in 2009;35:1738–48. survivors of out-of-hospital cardiac arrest. N Engl J Med 1997;336:1629–33. 690. Griesdale DE, de Souza RJ, van Dam RM, et al. Intensive insulin therapy and 660. Bendz B, Eritsland J, Nakstad AR, et al. Long-term prognosis after out-of- mortality among critically ill patients: a meta-analysis including NICE-SUGAR hospital cardiac arrest and primary percutaneous coronary intervention. study data. CMAJ 2009;180:821–7. Resuscitation 2004;63:49–53. 691. Wiener RS, Wiener DC, Larson RJ. Benefits and risks of tight glucose control in 661. Keelan PC, Bunch TJ, White RD, Packer DL, Holmes Jr DR. Early direct coro- critically ill adults: a meta-analysis. JAMA 2008;300:933–44. nary angioplasty in survivors of out-of-hospital cardiac arrest. Am J Cardiol 692. Krinsley JS, Grover A. Severe hypoglycemia in critically ill patients: risk factors 2003;91:1461–3. A6. and outcomes. Crit Care Med 2007;35:2262–7. 662. Quintero-Moran B, Moreno R, Villarreal S, et al. Percutaneous coronary 693. Meyfroidt G, Keenan DM, Wang X, Wouters PJ, Veldhuis JD, Van den Berghe intervention for cardiac arrest secondary to ST-elevation acute myocardial G. Dynamic characteristics of blood glucose time series during the course of infarction. Influence of immediate paramedical/medical assistance on clinical critical illness: effects of intensive insulin therapy and relative association with outcome. J Invasive Cardiol 2006;18:269–72. mortality. Crit Care Med 2010;38:1021–9. 663. Garot P, Lefevre T, Eltchaninoff H, et al. Six-month outcome of emer- 694. Padkin A. Glucose control after cardiac arrest. Resuscitation 2009;80:611–2. gency percutaneous coronary intervention in resuscitated patients after 695. Takino M, Okada Y. Hyperthermia following cardiopulmonary resuscitation. cardiac arrest complicating ST-elevation myocardial infarction. Circulation Intensive Care Med 1991;17:419–20. 2007;115:1354–62. 696. Hickey RW, Kochanek PM, Ferimer H, Alexander HL, Garman RH, Graham 664. Nagao K, Hayashi N, Kanmatsuse K, et al. Cardiopulmonary cerebral resuscita- SH. Induced hyperthermia exacerbates neurologic neuronal histologic damage tion using emergency cardiopulmonary bypass, coronary reperfusion therapy after asphyxial cardiac arrest in rats. Crit Care Med 2003;31:531–5. and mild hypothermia in patients with cardiac arrest outside the hospital. J 697. Takasu A, Saitoh D, Kaneko N, Sakamoto T, Okada Y. Hyperthermia: is it an Am Coll Cardiol 2000;36:776–83. ominous sign after cardiac arrest? Resuscitation 2001;49:273–7. 665. Nielsen N, Hovdenes J, Nilsson F, et al. Outcome, timing and adverse events in 698. Zeiner A, Holzer M, Sterz F, et al. Hyperthermia after cardiac arrest is associated therapeutic hypothermia after out-of-hospital cardiac arrest. Acta Anaesthe- with an unfavorable neurologic outcome. Arch Intern Med 2001;161:2007–12. siol Scand 2009;53:926–34. 699. Hickey RW, Kochanek PM, Ferimer H, Graham SH, Safar P. Hypothermia and 666. Wolfrum S, Pierau C, Radke PW, Schunkert H, Kurowski V. Mild therapeutic hyperthermia in children after resuscitation from cardiac arrest. Pediatrics hypothermia in patients after out-of-hospital cardiac arrest due to acute ST- 2000;106:118–22.
- 132. 1350 C.D. Deakin et al. / Resuscitation 81 (2010) 1305–1352 700. Diringer MN, Reaven NL, Funk SE, Uman GC. Elevated body temperature inde- 729. Kamarainen A, Virkkunen I, Tenhunen J, Yli-Hankala A, Silfvast T. Prehospital pendently contributes to increased length of stay in neurologic intensive care therapeutic hypothermia for comatose survivors of cardiac arrest: a random- unit patients. Crit Care Med 2004;32:1489–95. ized controlled trial. Acta Anaesthesiol Scand 2009;53:900–7. 701. Gunn AJ, Thoresen M. Hypothermic neuroprotection. NeuroRx 2006;3:154–69. 730. Kamarainen A, Virkkunen I, Tenhunen J, Yli-Hankala A, Silfvast T. Induction of 702. Froehler MT, Geocadin RG. Hypothermia for neuroprotection after car- therapeutic hypothermia during prehospital CPR using ice-cold intravenous diac arrest: mechanisms, clinical trials and patient care. J Neurol Sci fluid. Resuscitation 2008;79:205–11. 2007;261:118–26. 731. Hammer L, Vitrat F, Savary D, et al. Immediate prehospital hypothermia pro- 703. McCullough JN, Zhang N, Reich DL, et al. Cerebral metabolic suppression during tocol in comatose survivors of out-of-hospital cardiac arrest. Am J Emerg Med hypothermic circulatory arrest in humans. Ann Thorac Surg 1999;67:1895–9 2009;27:570–3. [discussion 919–21]. 732. Aberle J, Kluge S, Prohl J, et al. Hypothermia after CPR through conduc- 704. Mild therapeutic hypothermia to improve the neurologic outcome after cardiac tion and convection—initial experience on an ICU. Intensivmed Notfallmed arrest. N Engl J Med 2002;346:549–56. 2006;43:37–43. 705. Belliard G, Catez E, Charron C, et al. Efficacy of therapeutic hypothermia 733. Feuchtl A, Gockel B, Lawrenz T, Bartelsmeier M, Stellbrink C. Endovascular cool- after out-of-hospital cardiac arrest due to ventricular fibrillation. Resuscitation ing improves neurological short-term outcome after prehospital cardiac arrest. 2007;75:252–9. Intensivmedizin 2007;44:37–42. 706. Castrejon S, Cortes M, Salto ML, et al. Improved prognosis after using mild 734. Fries M, Stoppe C, Brucken D, Rossaint R, Kuhlen R. Influence of mild therapeutic hypothermia to treat cardiorespiratory arrest due to a cardiac cause: compar- hypothermia on the inflammatory response after successful resuscitation from ison with a control group. Rev Esp Cardiol 2009;62:733–41. cardiac arrest. J Crit Care 2009;24:453–7. 707. Bro-Jeppesen J, Kjaergaard J, Horsted TI, et al. The impact of therapeutic 735. Benson DW, Williams Jr GR, Spencer FC, Yates AJ. The use of hypothermia after hypothermia on neurological function and quality of life after cardiac arrest. cardiac arrest. Anesth Analg 1959;38:423–8. Resuscitation 2009;80:171–6. 736. Yanagawa Y, Ishihara S, Norio H, et al. Preliminary clinical outcome study of 708. Hachimi-Idrissi S, Corne L, Ebinger G, Michotte Y, Huyghens L. Mild hypother- mild resuscitative hypothermia after out-of-hospital cardiopulmonary arrest. mia induced by a helmet device: a clinical feasibility study. Resuscitation Resuscitation 1998;39:61–6. 2001;51:275–81. 737. Damian MS, Ellenberg D, Gildemeister R, et al. Coenzyme Q10 combined 709. Bernard SA, Jones BM, Horne MK. Clinical trial of induced hypothermia with mild hypothermia after cardiac arrest: a preliminary study. Circulation in comatose survivors of out-of-hospital cardiac arrest. Ann Emerg Med 2004;110:3011–6. 1997;30:146–53. 738. Hay AW, Swann DG, Bell K, Walsh TS, Cook B. Therapeutic hypother- 710. Busch M, Soreide E, Lossius HM, Lexow K, Dickstein K. Rapid implementation of mia in comatose patients after out-of-hospital cardiac arrest. Anaesthesia therapeutic hypothermia in comatose out-of-hospital cardiac arrest survivors. 2008;63:15–9. Acta Anaesthesiol Scand 2006;50:1277–83. 739. Zeiner A, Holzer M, Sterz F, et al. Mild resuscitative hypothermia to improve 711. Storm C, Steffen I, Schefold JC, et al. Mild therapeutic hypothermia shortens neurological outcome after cardiac arrest. A clinical feasibility trial. Hypother- intensive care unit stay of survivors after out-of-hospital cardiac arrest com- mia After Cardiac Arrest (HACA) Study Group. Stroke 2000;31:86–94. pared to historical controls. Crit Care 2008;12:R78. 740. Uray T, Malzer R. Out-of-hospital surface cooling to induce mild hypothermia 712. Don CW, Longstreth Jr WT, Maynard C, et al. Active surface cooling protocol in human cardiac arrest: a feasibility trial. Resuscitation 2008;77:331–8. to induce mild therapeutic hypothermia after out-of-hospital cardiac arrest: a 740a. Castren M, Nordberg P, Svensson L, et al. Intra-arrest transnasal evapora- retrospective before-and-after comparison in a single hospital. Crit Care Med tive cooling: a randomized, prehospital, multicenter study (PRINCE: Pre-ROSC 2009;37:3062–9. IntraNasal Cooling Effectiveness). Circulation 2010;122:729–36. 713. Arrich J. Clinical application of mild therapeutic hypothermia after cardiac 741. Felberg RA, Krieger DW, Chuang R, et al. Hypothermia after cardiac arrest. Crit Care Med 2007;35:1041–7. arrest: feasibility and safety of an external cooling protocol. Circulation 714. Holzer M, Mullner M, Sterz F, et al. Efficacy and safety of endovascular 2001;104:1799–804. cooling after cardiac arrest: cohort study and Bayesian approach. Stroke 742. Flint AC, Hemphill JC, Bonovich DC. Therapeutic hypothermia after cardiac 2006;37:1792–7. arrest: performance characteristics and safety of surface cooling with or with- 715. Polderman KH, Herold I. Therapeutic hypothermia and controlled normother- out endovascular cooling. Neurocrit Care 2007;7:109–18. mia in the intensive care unit: practical considerations, side effects, and cooling 743. Heard KJ, Peberdy MA, Sayre MR, et al. A randomized controlled trial comparing methods. Crit Care Med 2009;37:1101–20. the Arctic Sun to standard cooling for induction of hypothermia after cardiac 716. Bernard S, Buist M, Monteiro O, Smith K. Induced hypothermia using large arrest. Resuscitation 2010;81:9–14. volume, ice-cold intravenous fluid in comatose survivors of out-of-hospital 744. Merchant RM, Abella BS, Peberdy MA, et al. Therapeutic hypothermia after cardiac arrest: a preliminary report. Resuscitation 2003;56:9–13. cardiac arrest: unintentional overcooling is common using ice packs and con- 717. Virkkunen I, Yli-Hankala A, Silfvast T. Induction of therapeutic hypothermia ventional cooling blankets. Crit Care Med 2006;34:S490–4. after cardiac arrest in prehospital patients using ice-cold Ringer’s solution: a 745. Haugk M, Sterz F, Grassberger M, et al. Feasibility and efficacy of a new non- pilot study. Resuscitation 2004;62:299–302. invasive surface cooling device in post-resuscitation intensive care medicine. 718. Kliegel A, Losert H, Sterz F, et al. Cold simple intravenous infusions preceding Resuscitation 2007;75:76–81. special endovascular cooling for faster induction of mild hypothermia after 746. Al-Senani FM, Graffagnino C, Grotta JC, et al. A prospective, multicenter pilot cardiac arrest—a feasibility study. Resuscitation 2005;64:347–51. study to evaluate the feasibility and safety of using the CoolGard System and 719. Kliegel A, Janata A, Wandaller C, et al. Cold infusions alone are effective for Icy catheter following cardiac arrest. Resuscitation 2004;62:143–50. induction of therapeutic hypothermia but do not keep patients cool after car- 747. Pichon N, Amiel JB, Francois B, Dugard A, Etchecopar C, Vignon P. Efficacy of diac arrest. Resuscitation 2007;73:46–53. and tolerance to mild induced hypothermia after out-of-hospital cardiac arrest 720. Kilgannon JH, Roberts BW, Stauss M, et al. Use of a standardized order using an endovascular cooling system. Crit Care 2007;11:R71. set for achieving target temperature in the implementation of therapeutic 748. Wolff B, Machill K, Schumacher D, Schulzki I, Werner D. Early achievement of hypothermia after cardiac arrest: a feasibility study. Acad Emerg Med 2008;15: mild therapeutic hypothermia and the neurologic outcome after cardiac arrest. 499–505. Int J Cardiol 2009;133:223–8. 721. Scott BD, Hogue T, Fixley MS, Adamson PB. Induced hypothermia following 749. Nagao K, Kikushima K, Watanabe K, et al. Early induction of hypothermia out-of-hospital cardiac arrest; initial experience in a community hospital. Clin during cardiac arrest improves neurological outcomes in patients with out- Cardiol 2006;29:525–9. of-hospital cardiac arrest who undergo emergency cardiopulmonary bypass 722. Kim F, Olsufka M, Carlbom D, et al. Pilot study of rapid infusion of 2 L of 4 and percutaneous coronary intervention. Circ J 2010;74:77–85. degrees C normal saline for induction of mild hypothermia in hospitalized, 750. Mahmood MA, Zweifler RM. Progress in shivering control. J Neurol Sci comatose survivors of out-of-hospital cardiac arrest. Circulation 2005;112: 2007;261:47–54. 715–9. 751. Wadhwa A, Sengupta P, Durrani J, et al. Magnesium sulphate only slightly 723. Jacobshagen C, Pax A, Unsold BW, et al. Effects of large volume, ice-cold reduces the shivering threshold in humans. Br J Anaesth 2005;94:756–62. intravenous fluid infusion on respiratory function in cardiac arrest survivors. 752. Kuboyama K, Safar P, Radovsky A, et al. Delay in cooling negates the beneficial Resuscitation 2009;80:1223–8. effect of mild resuscitative cerebral hypothermia after cardia arrest in dogs: a 724. Spiel AO, Kliegel A, Janata A, et al. Hemostasis in cardiac arrest patients treated prospective, randomized study. Crit Care Med 1993;21:1348–58. with mild hypothermia initiated by cold fluids. Resuscitation 2009;80:762–5. 753. Riter HG, Brooks LA, Pretorius AM, Ackermann LW, Kerber RE. Intra- 725. Larsson IM, Wallin E, Rubertsson S. Cold saline infusion and ice packs alone are arrest hypothermia: both cold liquid ventilation with perfluorocarbons and effective in inducing and maintaining therapeutic hypothermia after cardiac cold intravenous saline rapidly achieve hypothermia, but only cold liquid arrest. Resuscitation 2010;81:15–9. ventilation improves resumption of spontaneous circulation. Resuscitation 726. Skulec R, Kovarnik T, Dostalova G, Kolar J, Linhart A. Induction of mild hypother- 2009;80:561–6. mia in cardiac arrest survivors presenting with cardiogenic shock syndrome. 754. Staffey KS, Dendi R, Brooks LA, et al. Liquid ventilation with perfluorocarbons Acta Anaesthesiol Scand 2008;52:188–94. facilitates resumption of spontaneous circulation in a swine cardiac arrest 727. Hoedemaekers CW, Ezzahti M, Gerritsen A, van der Hoeven JG. Comparison of model. Resuscitation 2008;78:77–84. cooling methods to induce and maintain normo- and hypothermia in intensive 755. Polderman KH, Peerdeman SM, Girbes AR. Hypophosphatemia and hypomag- care unit patients: a prospective intervention study. Crit Care 2007;11:R91. nesemia induced by cooling in patients with severe head injury. J Neurosurg 728. Kim F, Olsufka M, Longstreth Jr WT, et al. Pilot randomized clinical trial of 2001;94:697–705. prehospital induction of mild hypothermia in out-of-hospital cardiac arrest 756. Tortorici MA, Kochanek PM, Poloyac SM. Effects of hypothermia on drug dispo- patients with a rapid infusion of 4 degrees C normal saline. Circulation sition, metabolism, and response: a focus of hypothermia-mediated alterations 2007;115:3064–70. on the cytochrome P450 enzyme system. Crit Care Med 2007;35:2196–204.
- 133. C.D. Deakin et al. / Resuscitation 81 (2010) 1305–1352 1351 757. Randomized clinical study of thiopental loading in comatose survivors of car- 788. Pfeifer R, Borner A, Krack A, Sigusch HH, Surber R, Figulla HR. Outcome after diac arrest. Brain Resuscitation Clinical Trial I Study Group. N Engl J Med cardiac arrest: predictive values and limitations of the neuroproteins neuron- 1986;314:397–403. specific enolase and protein S-100 and the Glasgow Coma Scale. Resuscitation 758. Grafton ST, Longstreth Jr WT. Steroids after cardiac arrest: a retrospective study 2005;65:49–55. with concurrent, nonrandomized controls. Neurology 1988;38:1315–6. 789. Roine RO, Somer H, Kaste M, Viinikka L, Karonen SL. Neurological outcome 759. Mentzelopoulos SD, Zakynthinos SG, Tzoufi M, et al. Vasopressin, epinephrine, after out-of-hospital cardiac arrest. Prediction by cerebrospinal fluid enzyme and corticosteroids for in-hospital cardiac arrest. Arch Intern Med analysis. Arch Neurol 1989;46:753–6. 2009;169:15–24. 790. Zingler VC, Krumm B, Bertsch T, Fassbender K, Pohlmann-Eden B. Early 760. Gueugniaud PY, Gaussorgues P, Garcia-Darennes F, et al. Early effects of prediction of neurological outcome after cardiopulmonary resuscitation: a nimodipine on intracranial and cerebral perfusion pressures in cerebral anoxia multimodal approach combining neurobiochemical and electrophysiological after out-of-hospital cardiac arrest. Resuscitation 1990;20:203–12. investigations may provide high prognostic certainty in patients after cardiac 761. Roine RO, Kaste M, Kinnunen A, Nikki P, Sarna S, Kajaste S. Nimodipine arrest. Eur Neurol 2003;49:79–84. after resuscitation from out-of-hospital ventricular fibrillation: a placebo- 791. Rosen H, Sunnerhagen KS, Herlitz J, Blomstrand C, Rosengren L. Serum levels controlled, double-blind, randomized trial. JAMA 1990;264:3171–7. of the brain-derived proteins S-100 and NSE predict long-term outcome after 762. A randomized clinical study of a calcium-entry blocker (lidoflazine) in the treat- cardiac arrest. Resuscitation 2001;49:183–91. ment of comatose survivors of cardiac arrest. Brain Resuscitation Clinical Trial 792. Dauberschmidt R, Zinsmeyer J, Mrochen H, Meyer M. Changes of neuron- II Study Group. N Engl J Med 1991;324:1225–31. specific enolase concentration in plasma after cardiac arrest and resuscitation. 763. Laurent I, Adrie C, Vinsonneau C, et al. High-volume hemofiltration after out-of- Mol Chem Neuropathol 1991;14:237–45. hospital cardiac arrest: a randomized study. J Am Coll Cardiol 2005;46:432–7. 793. Mussack T, Biberthaler P, Kanz KG, et al. Serum S-100B and interleukin- 764. Edgren E, Hedstrand U, Nordin M, Rydin E, Ronquist G. Prediction of outcome 8 as predictive markers for comparative neurologic outcome analysis of after cardiac arrest. Crit Care Med 1987;15:820–5. patients after cardiac arrest and severe traumatic brain injury. Crit Care Med 765. Young GB, Doig G, Ragazzoni A. Anoxic-ischemic encephalopathy: clin- 2002;30:2669–74. ical and electrophysiological associations with outcome. Neurocrit Care 794. Fries M, Kunz D, Gressner AM, Rossaint R, Kuhlen R. Procalcitonin serum levels 2005;2:159–64. after out-of-hospital cardiac arrest. Resuscitation 2003;59:105–9. 766. Al Thenayan E, Savard M, Sharpe M, Norton L, Young B. Predictors of poor 795. Hachimi-Idrissi S, Van der Auwera M, Schiettecatte J, Ebinger G, Michotte Y, neurologic outcome after induced mild hypothermia following cardiac arrest. Huyghens L. S-100 protein as early predictor of regaining consciousness after Neurology 2008;71:1535–7. out of hospital cardiac arrest. Resuscitation 2002;53:251–7. 767. Wijdicks EF, Parisi JE, Sharbrough FW. Prognostic value of myoclonus status in 796. Piazza O, Cotena S, Esposito G, De Robertis E, Tufano R. S100B is a sensitive but comatose survivors of cardiac arrest. Ann Neurol 1994;35:239–43. not specific prognostic index in comatose patients after cardiac arrest. Minerva 768. Thomke F, Marx JJ, Sauer O, et al. Observations on comatose survivors Chir 2005;60:477–80. of cardiopulmonary resuscitation with generalized myoclonus. BMC Neurol 797. Rosen H, Rosengren L, Herlitz J, Blomstrand C. Increased serum levels of the 2005;5:14. S-100 protein are associated with hypoxic brain damage after cardiac arrest. 769. Arnoldus EP, Lammers GJ. Postanoxic coma: good recovery despite myoclonus Stroke 1998;29:473–7. status. Ann Neurol 1995;38:697–8. 798. Mussack T, Biberthaler P, Kanz KG, Wiedemann E, Gippner-Steppert C, Jochum 770. Celesia GG, Grigg MM, Ross E. Generalized status myoclonicus in acute anoxic M. S-100b, sE-selectin, and sP-selectin for evaluation of hypoxic brain dam- and toxic-metabolic encephalopathies. Arch Neurol 1988;45:781–4. age in patients after cardiopulmonary resuscitation: pilot study. World J Surg 771. Morris HR, Howard RS, Brown P. Early myoclonic status and outcome after 2001;25:539–43 [discussion 44]. cardiorespiratory arrest. J Neurol Neurosurg Psychiatry 1998;64:267–8. 799. Sodeck GH, Domanovits H, Sterz F, et al. Can brain natriuretic peptide pre- 772. Datta S, Hart GK, Opdam H, Gutteridge G, Archer J. Post-hypoxic myoclonic dict outcome after cardiac arrest? An observational study. Resuscitation status: the prognosis is not always hopeless. Crit Care Resusc 2009;11: 2007;74:439–45. 39–41. 800. Geppert A, Zorn G, Delle-Karth G, et al. Plasma concentrations of von 773. English WA, Giffin NJ, Nolan JP. Myoclonus after cardiac arrest: pitfalls in diag- Willebrand factor and intracellular adhesion molecule-1 for prediction of nosis and prognosis. Anaesthesia 2009;64:908–11. outcome after successful cardiopulmonary resuscitation. Crit Care Med 774. Wijdicks EF, Hijdra A, Young GB, Bassetti CL, Wiebe S. Practice parameter: pre- 2003;31:805–11. diction of outcome in comatose survivors after cardiopulmonary resuscitation 801. Adib-Conquy M, Monchi M, Goulenok C, et al. Increased plasma levels of soluble (an evidence-based review): report of the Quality Standards Subcommittee of triggering receptor expressed on myeloid cells 1 and procalcitonin after cardiac the American Academy of Neurology. Neurology 2006;67:203–10. surgery and cardiac arrest without infection. Shock 2007;28:406–10. 775. Zandbergen EG, de Haan RJ, Hijdra A. Systematic review of prediction of poor 802. Longstreth Jr WT, Clayson KJ, Chandler WL, Sumi SM. Cerebrospinal fluid cre- outcome in anoxic–ischaemic coma with biochemical markers of brain dam- atine kinase activity and neurologic recovery after cardiac arrest. Neurology age. Intensive Care Med 2001;27:1661–7. 1984;34:834–7. 776. Grubb NR, Simpson C, Sherwood R, et al. Prediction of cognitive dysfunction 803. Karkela J, Pasanen M, Kaukinen S, Morsky P, Harmoinen A. Evaluation of after resuscitation from out-of-hospital cardiac arrest using serum neuron- hypoxic brain injury with spinal fluid enzymes, lactate, and pyruvate. Crit Care specific enolase and protein S-100. Heart 2007. Med 1992;20:378–86. 777. Martens P. Serum neuron-specific enolase as a prognostic marker for irre- 804. Rothstein T, Thomas E, Sumi S. Predicting outcome in hypoxic-ischemic coma. versible brain damage in comatose cardiac arrest survivors. Acad Emerg Med A prospective clinical and electrophysiological study. Electroencephalogr Clin 1996;3:126–31. Neurophysiol 1991;79:101–7. 778. Meynaar IA, Straaten HM, van der Wetering J, et al. Serum neuron-specific 805. Sherman AL, Tirschwell DL, Micklesen PJ, Longstreth Jr WT, Robinson LR. enolase predicts outcome in post-anoxic coma: a prospective cohort study. Somatosensory potentials. CSF creatine kinase BB activity, and awakening after Intensive Care Med 2003;29:189–95. cardiac arrest. Neurology 2000;54:889–94. 779. Rech TH, Vieira SR, Nagel F, Brauner JS, Scalco R. Serum neuron-specific enolase 806. Longstreth Jr WT, Clayson KJ, Sumi SM. Cerebrospinal fluid and serum as early predictor of outcome after in-hospital cardiac arrest: a cohort study. creatine kinase BB activity after out-of-hospital cardiac arrest. Neurology Crit Care 2006;10:R133. 1981;31:455–8. 780. Reisinger J, Hollinger K, Lang W, et al. Prediction of neurological outcome 807. Tirschwell DL, Longstreth Jr WT, Rauch-Matthews ME, et al. Cerebrospinal fluid after cardiopulmonary resuscitation by serial determination of serum neuron- creatine kinase BB isoenzyme activity and neurologic prognosis after cardiac specific enolase. Eur Heart J 2007;28:52–8. arrest. Neurology 1997;48:352–7. 781. Schoerkhuber W, Kittler H, Sterz F, et al. Time course of serum neuron-specific 808. Clemmensen P, Strandgaard S, Rasmussen S, Grande P. Cerebrospinal fluid enolase. A predictor of neurological outcome in patients resuscitated from creatine kinase isoenzyme BB levels do not predict the clinical outcome in cardiac arrest. Stroke 1999;30:1598–603. patients unconscious following cardiac resuscitation. Clin Cardiol 1987;10: 782. Bottiger BW, Mobes S, Glatzer R, et al. Astroglial protein S-100 is an early and 235–6. sensitive marker of hypoxic brain damage and outcome after cardiac arrest in 809. Rosen H, Karlsson JE, Rosengren L. CSF levels of neurofilament is a valuable humans. Circulation 2001;103:2694–8. predictor of long-term outcome after cardiac arrest. J Neurol Sci 2004;221: 783. Fogel W, Krieger D, Veith M, et al. Serum neuron-specific enolase as early 19–24. predictor of outcome after cardiac arrest. Crit Care Med 1997;25:1133–8. 810. Tiainen M, Kovala TT, Takkunen OS, Roine RO. Somatosensory and brainstem 784. Martens P, Raabe A, Johnsson P. Serum S-100 and neuron-specific enolase for auditory evoked potentials in cardiac arrest patients treated with hypothermia. prediction of regaining consciousness after global cerebral ischemia. Stroke Crit Care Med 2005;33:1736–40. 1998;29:2363–6. 811. Rossetti AO, Oddo M, Liaudet L, Kaplan PW. Predictors of awakening 785. Prohl J, Rother J, Kluge S, et al. Prediction of short-term and long-term outcomes from postanoxic status epilepticus after therapeutic hypothermia. Neurology after cardiac arrest: a prospective multivariate approach combining biochem- 2009;72:744–9. ical, clinical, electrophysiological, and neuropsychological investigations. Crit 812. Rossetti AO, Logroscino G, Liaudet L, et al. Status epilepticus: an independent Care Med 2007;35:1230–7. outcome predictor after cerebral anoxia. Neurology 2007;69:255–60. 786. Stelzl T, von Bose MJ, Hogl B, Fuchs HH, Flugel KA. A comparison of the prognos- 813. Rossetti AO, Oddo M, Logroscino G, Kaplan PW. Prognostication after cardiac tic value of neuron-specific enolase serum levels and somatosensory evoked arrest and hypothermia: a prospective study. Ann Neurol 2010;67:301–7. potentials in 13 reanimated patients. Eur J Emerg Med 1995;2:24–7. 814. Oksanen T, Tiainen M, Skrifvars MB, et al. Predictive power of serum 787. Tiainen M, Roine RO, Pettila V, Takkunen O. Serum neuron-specific enolase NSE and OHCA score regarding 6-month neurologic outcome after out-of- and S-100B protein in cardiac arrest patients treated with hypothermia. Stroke hospital ventricular fibrillation and therapeutic hypothermia. Resuscitation 2003;34:2881–6. 2009;80:165–70.
- 134. 1352 C.D. Deakin et al. / Resuscitation 81 (2010) 1305–1352 815. Rundgren M, Karlsson T, Nielsen N, Cronberg T, Johnsson P, Friberg H. Neuron 833. Clemmer TP, Orme Jr JF, Thomas FO, Brooks KA. Outcome of critically injured specific enolase and S-100B as predictors of outcome after cardiac arrest and patients treated at Level I trauma centers versus full-service community hos- induced hypothermia. Resuscitation 2009;80:784–9. pitals. Crit Care Med 1985;13:861–3. 816. Fieux F, Losser MR, Bourgeois E, et al. Kidney retrieval after sudden out of 834. Culica D, Aday LA, Rohrer JE. Regionalized trauma care system in Texas: impli- hospital refractory cardiac arrest: a cohort of uncontrolled non heart beating cations for redesigning trauma systems. Med Sci Monit 2007;13:SR9–18. donors. Crit Care 2009;13:R141. 835. Hannan EL, Farrell LS, Cooper A, Henry M, Simon B, Simon R. Physiologic trauma 817. Kootstra G. Statement on non-heart-beating donor programs. Transplant Proc triage criteria in adult trauma patients: are they effective in saving lives by 1995;27:2965. transporting patients to trauma centers? J Am Coll Surg 2005;200:584–92. 818. Fondevila C, Hessheimer AJ, Ruiz A, et al. Liver transplant using donors after 836. Harrington DT, Connolly M, Biffl WL, Majercik SD, Cioffi WG. Transfer times to unexpected cardiac death: novel preservation protocol and acceptance criteria. definitive care facilities are too long: a consequence of an immature trauma Am J Transplant 2007;7:1849–55. system. Ann Surg 2005;241:961–6 [discussion 6–8]. 819. Morozumi J, Sakurai E, Matsuno N, et al. Successful kidney transplantation from 837. Liberman M, Mulder DS, Lavoie A, Sampalis JS. Implementation of a trauma donation after cardiac death using a load-distributing-band chest compression care system: evolution through evaluation. J Trauma 2004;56:1330–5. device during long warm ischemic time. Resuscitation 2009;80:278–80. 838. MacKenzie EJ, Rivara FP, Jurkovich GJ, et al. A national evaluation of the effect 820. Perkins GD, Brace S, Gates S. Mechanical chest-compression devices: current of trauma-center care on mortality. N Engl J Med 2006;354:366–78. and future roles. Curr Opin Crit Care 2010;16:203–10. 839. Mann NC, Cahn RM, Mullins RJ, Brand DM, Jurkovich GJ. Survival among injured 821. Engdahl J, Abrahamsson P, Bang A, Lindqvist J, Karlsson T, Herlitz J. Is hospi- geriatric patients during construction of a statewide trauma system. J Trauma tal care of major importance for outcome after out-of-hospital cardiac arrest? 2001;50:1111–6. Experience acquired from patients with out-of-hospital cardiac arrest resus- 840. Mullins RJ, Veum-Stone J, Hedges JR, et al. Influence of a statewide trauma citated by the same Emergency Medical Service and admitted to one of two system on location of hospitalization and outcome of injured patients. J Trauma hospitals over a 16-year period in the municipality of Goteborg. Resuscitation 1996;40:536–45 [discussion 45–6]. 2000;43:201–11. 841. Mullins RJ, Mann NC, Hedges JR, Worrall W, Jurkovich GJ. Preferential benefit 822. Liu JM, Yang Q, Pirrallo RG, Klein JP, Aufderheide TP. Hospital variability of of implementation of a statewide trauma system in one of two adjacent states. out-of-hospital cardiac arrest survival. Prehosp Emerg Care 2008;12:339–46. J Trauma 1998;44:609–16 [discussion 17]. 823. Herlitz J, Engdahl J, Svensson L, Angquist KA, Silfverstolpe J, Holmberg S. Major 842. Mullins RJ, Veum-Stone J, Helfand M, et al. Outcome of hospitalized injured differences in 1-month survival between hospitals in Sweden among initial patients after institution of a trauma system in an urban area. JAMA survivors of out-of-hospital cardiac arrest. Resuscitation 2006;70:404–9. 1994;271:1919–24. 824. Callaway CW, Schmicker R, Kampmeyer M, et al. Receiving hospital characteris- 843. Mullner R, Goldberg J. An evaluation of the Illinois trauma system. Med Care tics associated with survival after out-of-hospital cardiac arrest. Resuscitation 1978;16:140–51. 2010. 844. Mullner R, Goldberg J. Toward an outcome-oriented medical geography: an 825. Davis DP, Fisher R, Aguilar S, et al. The feasibility of a regional cardiac arrest evaluation of the Illinois trauma/emergency medical services system. Soc Sci receiving system. Resuscitation 2007;74:44–51. Med 1978;12:103–10. 826. Spaite DW, Bobrow BJ, Vadeboncoeur TF, et al. The impact of prehospital trans- 845. Nathens AB, Jurkovich GJ, Rivara FP, Maier RV. Effectiveness of state trauma port interval on survival in out-of-hospital cardiac arrest: implications for systems in reducing injury-related mortality: a national evaluation. J Trauma regionalization of post-resuscitation care. Resuscitation 2008;79:61–6. 2000;48:25–30 [discussion 1]. 827. Spaite DW, Stiell IG, Bobrow BJ, et al. Effect of transport interval on out-of- 846. Nathens AB, Maier RV, Brundage SI, Jurkovich GJ, Grossman DC. The effect hospital cardiac arrest survival in the OPALS Study: implications for triaging of interfacility transfer on outcome in an urban trauma system. J Trauma patients to specialized cardiac arrest centers. Ann Emerg Med 2009. 2003;55:444–9. 828. Vermeer F, Oude Ophuis AJ, vd Berg EJ, et al. Prospective randomised compar- 847. Nicholl J, Turner J. Effectiveness of a regional trauma system in reducing mor- ison between thrombolysis, rescue PTCA, and primary PTCA in patients with tality from major trauma: before and after study. BMJ 1997;315:1349–54. extensive myocardial infarction admitted to a hospital without PTCA facilities: 848. Potoka DA, Schall LC, Gardner MJ, Stafford PW, Peitzman AB, Ford HR. Impact a safety and feasibility study. Heart 1999;82:426–31. of pediatric trauma centers on mortality in a statewide system. J Trauma 829. Widimsky P, Groch L, Zelizko M, Aschermann M, Bednar F, Suryapranata H. 2000;49:237–45. Multicentre randomized trial comparing transport to primary angioplasty vs 849. Sampalis JS, Lavoie A, Boukas S, et al. Trauma center designation: initial impact immediate thrombolysis vs combined strategy for patients with acute myocar- on trauma-related mortality. J Trauma 1995;39:232–7 [discussion 7–9]. dial infarction presenting to a community hospital without a catheterization 850. Sampalis JS, Denis R, Frechette P, Brown R, Fleiszer D, Mulder D. Direct transport laboratory The PRAGUE study. Eur Heart J 2000;21:823–31. to tertiary trauma centers versus transfer from lower level facilities: impact 830. Widimsky P, Budesinsky T, Vorac D, et al. Long distance transport for primary on mortality and morbidity among patients with major trauma. J Trauma angioplasty vs immediate thrombolysis in acute myocardial infarction. Final 1997;43:288-95 [discussion 95–6]. results of the randomized national multicentre trial–PRAGUE-2. Eur Heart J 851. Nichol G, Aufderheide TP, Eigel B, et al. Regional systems of care for out- 2003;24:94–104. of-hospital cardiac arrest: a policy statement from the American Heart 831. Le May MR, So DY, Dionne R, et al. A citywide protocol for primary PCI in Association. Circulation 2010;121:709–29. ST-segment elevation myocardial infarction. N Engl J Med 2008;358:231–40. 852. Nichol G, Soar J. Regional cardiac resuscitation systems of care. Curr Opin Crit 832. Abernathy 3rd JH, McGwin Jr G, Acker 3rd JE, Rue 3rd LW. Impact of a voluntary Care 2010;16:223–30. trauma system on mortality, length of stay, and cost at a level I trauma center. 853. Soar J, Packham S. Cardiac arrest centres make sense. Resuscitation Am Surg 2002;68:182–92. 2010;81:507–8.
- 135. Resuscitation 81 (2010) 1353–1363 Contents lists available at ScienceDirect Resuscitation journal homepage: www.elsevier.com/locate/resuscitation European Resuscitation Council Guidelines for Resuscitation 2010 Section 5. Initial management of acute coronary syndromes Hans-Richard Arntz a,1 , Leo L. Bossaert b,∗,1 , Nicolas Danchin c , Nikolaos I. Nikolaou d a Department of Cardiology, Campus Benjamin Franklin, Charite, Berlin, Germany b Department of Critical Care, University of Antwerp, Antwerp, Belgium c Department of Coronary Artery Disease and Intensive Cardiac Care, Hôpital Européen Georges Pompidou, Paris, France d Constantopouleio General Hospital, Athens, Greece Summary of main changes since 2005 Guidelines Causal treatment Changes in the management of acute coronary syndrome since • Guidelines for treatment with acetyl salicylic acid (ASA) have the 2005 guidelines include: been made more liberal and it may now be given by bystanders with or without dispatchers assistance. • Revised guidance for new antiplatelet and antithrombin treat- Definitions ment for patients with ST elevation myocardial infarction (STEMI) The term non-ST-elevation myocardial infarction-acute coro- and non-STEMI-ACS based on therapeutic strategy. • Gp IIb/IIIa inhibitors before angiography/percutaneous coronary nary syndrome (non-STEMI-ACS) has been introduced for both NSTEMI and unstable angina pectoris because the differential diag- intervention (PCI) are discouraged. nosis is dependent on biomarkers that may be detectable only after hours, whereas decisions on treatment are dependent on the clin- Reperfusion strategy in STEMI ical signs at presentation. • Primary PCI (PPCI) is the preferred reperfusion strategy provided Chest pain units and decision rules for early discharge it is performed in a timely manner by an experienced team. • A nearby hospital may be bypassed by emergency medical ser- • History, clinical examinations, biomarkers, ECG criteria and risk vices (EMS) provided PPCI can be achieved without too much scores are unreliable for the identification of patients who may delay. • The acceptable delay between start of fibrinolysis and first bal- be safely discharged early. • The role of chest pain observation units (CPUs) is to identify, by loon inflation varies widely between about 45 and 180 min using repeated clinical examinations, ECG and biomarker testing, depending on infarct localisation, age of the patient, and duration those patients who require admission for invasive procedures. of symptoms. • ‘Rescue PCI’ should be undertaken if fibrinolysis fails. This may include provocative testing and, in selected patients, • The strategy of routine PCI immediately after fibrinolysis (‘facili- imaging procedures as cardiac computed tomography, magnetic resonance imaging, etc. tated PCI’) is discouraged. • Patients with successful fibrinolysis but not in a PCI-capable hos- pital should be transferred for angiography and eventual PCI, Symptomatic treatment performed optimally 6–24 h after fibrinolysis (the ‘pharmaco- • Non-steroidal anti-inflammatory drugs (NSAIDs) should be invasive’ approach). • Angiography and, if necessary, PCI may be reasonable in patients avoided. • Nitrates should not be used for diagnostic purposes. with return of spontaneous circulation (ROSC) after cardiac arrest • Supplementary oxygen to be given only to those patients with and may be part of a standardised post-cardiac arrest protocol. • To achieve these goals, the creation of networks including EMS, hypoxaemia, breathlessness or pulmonary congestion. Hyperox- non-PCI capable hospitals and PCI hospitals is useful. aemia may be harmful in uncomplicated infarction. Primary and secondary prevention ∗ Corresponding author. • Recommendations for the use of beta-blockers are more E-mail address: leo.bossaert@ua.ac.be (L.L. Bossaert). 1 These individuals contributed equally to this manuscript and are equal first co- restricted: there is no evidence for routine intravenous beta- authors. blockers except in specific circumstances such as for the 0300-9572/$ – see front matter © 2010 European Resuscitation Council. Published by Elsevier Ireland Ltd. All rights reserved. doi:10.1016/j.resuscitation.2010.08.016
- 136. 1354 H.-R. Arntz et al. / Resuscitation 81 (2010) 1353–1363 treatment of tachyarrhythmias. Otherwise, beta-blockers should the first hours after onset of symptoms. Out-of-hospital treatment be started in low doses only after the patient is stabilised. and initial therapy in the emergency department (ED) may vary • Guidelines on the use of prophylactic anti-arrhythmics according to local capabilities, resources and regulations. The data angiotensin converting enzyme (ACE) inhibitors/angiotensin supporting out-of-hospital treatment are often extrapolated from receptor blockers (ARBs) and statins are unchanged. studies of initial treatment after hospital admission; there are few high-quality out-of-hospital studies. Comprehensive guidelines for the diagnosis and treatment of ACS with and without ST eleva- Introduction tion have been published by the European Society of Cardiology and the American College of Cardiology/American Heart Associa- The incidence of acute ST-elevation myocardial infarction (AMI) tion. The current recommendations are in line with these guidelines is decreasing in many European countries [1]; however, the inci- [6,7]. dence of non-STEMI acute coronary syndrome (non-STEMI ACS) is increasing [2,3]. Although in-hospital mortality from STEMI has been reduced significantly by modern reperfusion therapy and improved secondary prophylaxis, the overall 28-day mortality is Diagnosis and risk stratification in acute coronary virtually unchanged because about two thirds of those who die do syndromes so before hospital arrival, mostly from lethal arrhythmias triggered by ischaemia [4]. Thus, the best chance of improving survival from Since early treatment offers the greatest benefits, and myocar- an ischaemic attack is reducing the delay from symptom onset to dial ischaemia is the leading precipitant of sudden cardiac death, it first medical contact and targeted treatment started in the early is essential that the public is aware of the typical symptoms associ- out-of-hospital phase. ated with ACS. Several groups of patients however, are less likely to The term acute coronary syndrome (ACS) encompasses three seek prompt medical care when symptoms of an ACS appear. Thus different entities of the acute manifestation of coronary heart dis- significant delays in the initiation of treatment/reperfusion have ease (Fig. 5.1): STEMI, NSTEMI and unstable angina pectoris (UAP). been reported in women, the elderly, people belonging to ethnic Non-ST-elevation myocardial infarction and UAP are usually com- and racial minorities or low socioeconomic classes, and those living bined in the term non-STEMI-ACS. The common pathophysiology alone [8]. of ACS is a ruptured or eroded atherosclerotic plaque [5]. Elec- Patients at risk, and their families, should be able to recognize trocardiographic (ECG) characteristics (absence or presence of ST characteristic symptoms such as chest pain, which may radiate elevation) differentiate STEMI from non-STEMI-ACS. The latter may into other areas of the upper body, often accompanied by other present with ST-segment depression, nonspecific ST-segment wave symptoms including dyspnoea, sweating, nausea or vomiting and abnormalities, or even a normal ECG. In the absence of ST elevation, syncope. They should understand the importance of early activa- an increase in the plasma concentration of cardiac biomarkers, par- tion of the emergency medical service (EMS) system and, ideally, ticularly troponin T or I as the most specific markers of myocardial should be trained in basic life support (BLS). Optimal strategies for cell necrosis, indicates NSTEMI. increasing layperson awareness of the various ACS presentations Acute coronary syndromes are the commonest cause of malig- and improvement of ACS recognition in vulnerable populations nant arrhythmias leading to sudden cardiac death. The therapeutic remain to be determined. goals are to treat acute life-threatening conditions, such as ven- Moreover, EMS dispatchers must be trained to recognize ACS tricular fibrillation (VF) or extreme bradycardia, and to preserve symptoms and to ask targeted questions. When an ACS is suspected, left ventricular function and prevent heart failure by minimising an EMS crew trained in advanced life support (ALS) and capable of the extent of myocardial damage. The current guidelines address making the diagnosis and starting treatment should be alerted. Fig. 5.1. Definitions of acute coronary syndromes (ACS) (STEMI, ST-elevation myocardial infarction; NSTEMI, non-ST-elevation myocardial infarction; UAP, unstable angina pectoris).
- 137. H.-R. Arntz et al. / Resuscitation 81 (2010) 1353–1363 1355 Given the high urgency for emergency revascularisation in Biomarkers STEMI and other high-risk patients, specific systems of care can be implemented to improve STEMI recognition and shorten time In the absence of ST elevation on the ECG, the presence of to treatment. a suggestive history and elevated concentrations of biomarkers The sensitivity, specificity, and clinical impact of various diag- (troponin T and troponin I, CK, CK-MB, myoglobin) characterise nostic strategies have been evaluated for ACS. Information from non-STEMI and distinguish it from STEMI and unstable angina clinical presentation, ECG, biomarker testing and imaging tech- respectively. Measurement of a cardiac-specific troponin is prefer- niques should all be taken into account in order to establish the able. Elevated concentrations of troponin are particularly helpful in diagnosis and at the same time estimate the risk so that optimal identifying patients at increased risk of adverse outcome [20]. decisions for patient admission and therapy/reperfusion are made. Cardiac biomarker testing should be part of the initial evaluation of all patients presenting to the ED with symptoms suggestive of cardiac ischaemia [21]. However, the delay in release of biomark- ers from damaged myocardium prevents their use in diagnosing Signs and symptoms of ACS myocardial infarction in the first 4–6 h after the onset of symptoms [22]. For patients who present within 6 h of symptom onset, and Typically ACS appears with symptoms such as radiating chest have an initial negative cardiac troponin, biomarkers should be re- pain, shortness of breath and sweating; however, atypical symp- measured between 6 and 12 h after symptom onset. In order to use toms or unusual presentations may occur in the elderly, in females, the measured biomarker optimally, clinicians should be familiar and in diabetics [9,10]. None of these signs and symptoms of ACS with the sensitivity, precision and institutional norms of the assay, can be used alone for the diagnosis of ACS. A reduction in chest and also the release kinetics and clearance. Highly sensitive (ultra- pain after nitroglycerin administration can be misleading and is sensitive) cardiac troponin assays have been developed. They can not recommended as a diagnostic manoeuvre [11]. Symptoms may increase sensitivity for the diagnosis of MI in patients with symp- be more intense and last longer in patients with STEMI but are not toms suspicious of cardiac ischaemia [23]. If the highly sensitive reliable for discriminating between STEMI and non-STEMI-ACS. cardiac troponin assays are unavailable, multi-marker evaluation The patient’s history should be evaluated carefully during first with CK-MB or myoglobin in conjunction with troponin may be contact with healthcare providers. It may provide the first clues for considered to improve the sensitivity of diagnosing AMI. the presence of an ACS, trigger subsequent investigations and, in There is no evidence to support the use of troponin point-of- combination with information from other diagnostic tests, can help care testing (POCT) in isolation as a primary test in the prehospital in making triage and therapeutic decisions in the out-of-hospital setting to evaluate patients with symptoms suspicious of cardiac setting and the emergency department (ED). ischaemia [23]. In the ED, use of point-of-care troponin assays may help to shorten time to treatment and length of ED stay [24]. Until further randomised control trials are performed, other serum 12-lead ECG assays should not be considered first-line steps in the diagnosis and management of patients presenting with ACS symptoms [25]. A 12-lead ECG is the key investigation for assessment of an ACS. In case of STEMI, it indicates the need for immediate reperfusion Decision rules for early discharge therapy (i.e. primary percutaneous coronary intervention (PCI) or prehospital fibrinolysis). When an ACS is suspected, a 12-lead ECG Attempts have been made to combine evidence from history, should be acquired and interpreted as soon as possible after first physical examination serial ECGs and serial biomarker measure- patient contact, to facilitate earlier diagnosis and triage. Prehospital ment in order to form clinical decision rules that would help triage or ED ECG yields useful diagnostic information when interpreted by of ED patients with suspected ACS. trained health care providers [12]. None of these rules is adequate and appropriate to identify ED Recording of a 12-lead ECG out-of-hospital enables advanced chest pain patients with suspected ACS who can be safely dis- notification to the receiving facility and expedites treatment charged from the ED [26]. decisions after hospital arrival: in many studies, the time from Likewise, the scoring systems for risk stratification of patients hospital admission to initiating reperfusion therapy is reduced by with ACS that have been validated in the inpatient environment 10–60 min [13,14]. Trained EMS personnel (emergency physicians, (e.g. Thrombolysis in Myocardial Infarction (TIMI) score, Global paramedics and nurses) can identify STEMI, defined by ST elevation Registry of Acute Coronary Events (GRACE) score, Fast Revascular- of ≥0.1 mV elevation in at least two adjacent limb leads or >0.2 mV isation in Instability in Coronary Disease (FRISC) score or Goldman in two adjacent precordial leads, with a high specificity and sensi- Criteria) should not be used to identify low-risk patients suitable tivity comparable to diagnostic accuracy in the hospital [15–17]. It for discharge from the ED. is thus reasonable that paramedics and nurses be trained to diag- A subgroup of patients younger than 40 years with non-classical nose STEMI without direct medical consultation, as long as there is presentations and lacking significant past medical history, who strict concurrent provision of medically directed quality assurance. have normal serial biomarkers and 12-lead ECGs, have a very low If interpretation of the prehospital ECG is not available on-site, short-term event rate. computer interpretation [18,19] or field transmission of the ECG is reasonable. Recording and transmission of diagnostic quality ECGs Chest pain observation protocols to the hospital usually takes less than 5 min. When used for the eval- uation of patients with suspected ACS, computer interpretation of In patients suspected of an ACS the combination of an unremark- the ECG may increase the specificity of diagnosis of STEMI, espe- able past history and physical examination with negative initial cially for clinicians inexperienced in reading ECGs. The benefit of ECG and biomarkers cannot be used to exclude ACS reliably. There- computer interpretation; however, is dependent on the accuracy fore a follow up period is mandatory in order to reach a diagnosis of the ECG report. Incorrect reports may mislead inexperienced and make therapeutic decisions. ECG readers. Thus computer-assisted ECG interpretation should Chest pain observation protocols are rapid systems for assess- not replace, but may be used as an adjunct to, interpretation by ment of patients with suspected ACS. They should generally include an experienced clinician. a history and physical examination, followed by a period of obser-
- 138. 1356 H.-R. Arntz et al. / Resuscitation 81 (2010) 1353–1363 vation, during which serial electrocardiography and cardiac marker rate diagnosis with a reduction in length of stay and costs without measurements are performed. Patient evaluation should be com- increasing cardiac events. Both the exposure to radiation and iod- plemented by either a non-invasive evaluation for anatomical inated contrast should be considered when using multi-detector coronary disease or provocative testing for inducible myocardial computer tomography (MDCT) and myocardial perfusion imaging. ischaemia at some point after AMI is excluded. These protocols may be used to improve accuracy in identifying patients requiring Treatment of acute coronary syndromes—symptoms inpatient admission or further diagnostic testing while maintaining patient safety, reducing length of stay and reducing costs [27]. Nitrates In patients presenting to the ED with a history suggestive of ACS, but normal initial workup, chest pain (observation) units may rep- Glyceryl trinitrate is an effective treatment for ischaemic chest resent a safe and effective strategy for evaluating patients. They pain and has beneficial haemodynamic effects, such as dilation of may be recommended as a means to reduce length of stay, hospital the venous capacitance vessels, dilation of the coronary arteries admissions and healthcare costs, improve diagnostic accuracy and and, to a minor extent, the peripheral arteries. Glyceryl trinitrate improve quality of life [28]. There is no direct evidence demonstrat- may be considered if the systolic blood pressure is above 90 mm Hg ing that chest pain units or observation protocols reduce adverse and the patient has ongoing ischaemic chest pain (Fig. 5.2). Glyceryl cardiovascular outcomes, particularly mortality, for patients pre- trinitrate can also be useful in the treatment of acute pulmonary senting with possible ACS. congestion. Nitrates should not be used in patients with hypoten- sion (systolic blood pressure ≤90 mm Hg), particularly if combined Imaging techniques with bradycardia, and in patients with inferior infarction and sus- pected right ventricular involvement. Use of nitrates under these Effective screening of patients with suspected ACS, but with circumstances can decrease the blood pressure and cardiac output. negative ECG and negative cardiac biomarkers, remains chal- lenging. Non-invasive imaging techniques (CT angiography [29], Analgesia cardiac magnetic resonance, myocardial perfusion imaging [30], and echocardiography [31]) have been evaluated as means of Morphine is the analgesic of choice for nitrate-refractory pain screening these low-risk patients and identifying subgroups that and also has calming effects on the patient making sedatives can be discharged home safely. unnecessary in most cases. Since morphine is a dilator of venous Although there are no large multicentre trials, existing evidence capacitance vessels, it may have additional benefit in patients with indicates that these diagnostic modalities enable early and accu- pulmonary congestion. Give morphine in initial doses of 3–5 mg Fig. 5.2. Treatment algorithm for acute coronary syndromes (BP, blood pressure; PCI, percutaneous coronary intervention; UFH, unfractionated heparin). *Prasugrel, 60 mg loading dose, may be chosen as an alternative to clopidogrel in patients with STEMI and planned PPCI provided there is no history of stroke or transient ischaemic attack. At the time of writing, ticagrelor has not yet been approved as an alternative to clopidogrel.
- 139. H.-R. Arntz et al. / Resuscitation 81 (2010) 1353–1363 1357 intravenously and repeat every few minutes until the patient is – either with a 300 or 600 mg loading dose – do not postpone pain-free. Non-steroidal anti-inflammatory drugs (NSAIDs) should treatment until angiography/PCI is undertaken because the high- be avoided for analgesia because of their pro-thrombotic effects est event rates are observed in the early phase of the syndrome. In [32]. unselected patients undergoing PCI, pre-treatment with a higher loading dose of clopidogrel resulted in better outcome [43]. Oxygen Therefore, clopidogrel should be given as early as possible in addition to ASA and an antithrombin to all patients presenting with Monitoring of the arterial oxygen saturation with pulse oxime- non-STEMI ACS. If a conservative approach is selected, give a load- try (SpO2 ) will help to determine the need for supplemental oxygen. ing dose of 300 mg; with a planned PCI strategy, an initial dose of These patients do not need supplemental oxygen unless they are 600 mg may be preferred. hypoxaemic. Limited data suggest that high-flow oxygen may be harmful in patients with uncomplicated myocardial infarction Prasugrel. Prasugrel (60 mg loading dose) may be given instead [33–35]. Aim to achieve an oxygen saturation of 94–98%, or 88–92% of clopidogrel to patients with high-risk non-STEMI ACS and if the patient is at risk of hypercapnic respiratory failure [36]. planned PCI at angiography, provided coronary stenoses are suit- able for PCI. Contraindications (history of TIA/stroke) and the benefit – risk relation in patients with high bleeding risk (weight Treatment of acute coronary syndromes—cause <60 kg, age >75 years) should be considered. Inhibitors of platelet aggregation ADP-receptor inhibitors in STEMI Inhibition of platelet aggregation is of primary importance for Clopidogrel. Although there is no large study on the use of clopi- initial treatment of coronary syndromes as well as for secondary dogrel for pre-treatment of patients presenting with STEMI and prevention, since platelet activation and aggregation is the key planned PCI, it is likely that this strategy is beneficial. Since platelet process initiating an ACS. inhibition is more profound with a higher dose, a 600 mg load- ing dose given as soon as possible is recommended for patients Acetylsalicylic acid (ASA) presenting with STEMI and planned PCI. Two large randomised trials studied clopidogrel compared with Large randomised controlled trials indicate decreased mortality placebo in patients with STEMI treated conservatively or with fib- when ASA (75–325 mg) is given to hospitalised patients with ACS. A rinolysis [44,45]. One study included patients up to 75 years of age, few studies have suggested reduced mortality if ASA is given earlier treated with fibrinolysis, ASA, an antithrombin and a loading dose [37,38]. Therefore, give ASA as soon as possible to all patients with of 300 mg clopidogrel [45]. Treatment with clopidogrel resulted in suspected ACS unless the patient has a known true allergy to ASA. fewer occluded culprit coronary arteries at angiography and fewer ASA may be given by the first healthcare provider, bystander or by re-infarctions, without an increased bleeding risk. The other study dispatcher assistance according to local protocols. The initial dose investigated STEMI patients without age limits to be treated con- of chewable ASA is 160–325 mg. Other forms of ASA (soluble, IV) servatively or with fibrinolysis. In this trial, clopidogrel (no loading, may be as effective as chewed tablets. 75 mg daily) compared with placebo resulted in fewer deaths and a reduction of the combined endpoint of death and stroke [44]. There- Adenosine diphosphate (ADP)-receptor inhibitors fore patients with STEMI treated with fibrinolysis should be treated with clopidogrel (300 mg loading dose up to an age of 75 years and Thienopyridines (clopidogrel, prasugrel) and the cyclo-pentyl- 75 mg without loading dose if >75 years of age) in addition to ASA triazolo-pyrimidine, ticagrelor, inhibit the ADP-receptor irre- and an antithrombin. versibly, which further reduces platelet aggregation in addition to that produced by ASA. In contrast to clopidogrel, metabolism of pra- Prasugrel. Prasugrel with a loading dose of 60 mg may be given sugrel and of ticagrelor is independent of a genetically determined in addition to ASA and an antithrombin to patients presenting with variability of drug metabolism and activation. Therefore prasug- STEMI with planned PCI. Contraindications (history of TIA/stroke), rel and ticagrelor lead to a more reliable and stronger inhibition of and relation of bleeding risk vs benefit in patients with a body platelet aggregation. weight <60 kg or aged >75 years should be taken into account. There A large randomised study comparing a loading dose of 300 mg is no data on prehospital treatment with prasugrel and no data on clopidogrel followed by 75 mg daily with prasugrel (loading dose prasugrel if used in the context of fibrinolysis. 60 mg, followed by 10 mg daily) in patients with ACS resulted in fewer major adverse cardiac events (MACE) with prasugrel; how- Glycoprotein (Gp) IIB/IIIA inhibitors ever, the bleeding rate was higher. Bleeding risk was increased markedly in patients weighing less than 60 kg and those older than Gp IIB/IIIA receptor inhibition is the common final link of platelet 75 years [39]. A significantly increased intracranial bleeding rate aggregation. Eptifibatide and tirofiban lead to reversible inhibition, was observed in patients with a history of transient ischaemic while abciximab leads to irreversible inhibition of the Gp IIB/IIIA attack (TIA) and/or stroke. In another study, ticagrelor proved to receptor. Older studies from the pre-stent era mostly support the be superior to clopidogrel with respect to MACE [40]. At the time use of this class of drugs [46,47]. Newer studies mostly document of writing, ticagrelor has not yet been approved as an alternative neutral or worsened outcomes [48–51]. Finally in most support- to clopidogrel. ing, as well as neutral or opposing studies, bleeding occurred in more patients treated with Gp IIB/IIIA receptor blockers. There are ADP-receptor inhibitors in NON-STEMI ACS insufficient data to support routine pre-treatment with Gp IIB/IIIA inhibitors in patients with STEMI or non-STEMI-ACS. For high- Clopidogrel. If given in addition to heparin and ASA in high-risk risk patients with non-STEMI-ACS, in-hospital upstream treatment non-STEMI-ACS patients, clopidogrel improves outcome [41,42]. with eptifibatide or tirofiban may be acceptable whereas abciximab Even if there is no large scale study investigating pre-treatment may be given only in the context of PCI [47,52]. Newer alterna- with clopidogrel, compared with peri-interventional application tives for antiplatelet treatment should be considered because of
- 140. 1358 H.-R. Arntz et al. / Resuscitation 81 (2010) 1353–1363 the increased bleeding risk with Gp IIB/IIIA inhibitors when used with 0.75 mg kg−1 SC every 12 h without an initial IV dose. with heparins. Patients with known impaired renal function (creatinine clearance <30 ml−1 min−1 ) may be given 1 mg kg−1 enoxaparin SC once daily Antithrombins or may be treated with UFH. There are insufficient data to recom- mend other LMWH. Unfractionated heparin (UFH) is an indirect inhibitor of throm- bin, which in combination with ASA is used as an adjunct with Fondaparinux. Several studies show superiority or neutral out- fibrinolytic therapy or primary PCI (PPCI) and is an important part come when fondaparinux was compared with UFH as an adjunct for of treatment of unstable angina and STEMI. Limitations of unfrac- fibrinolysis in STEMI patients [56]. Fondaparinux (initially 2.5 mg tionated heparin include its unpredictable anticoagulant effect in SC followed by 2.5 mg SC. daily) may be considered specifically with individual patients, the need to give it intravenously and the need non-fibrin-specific fibrinolytics (i.e. streptokinase) in patients with to monitor aPTT. Moreover, heparin can induce thrombocytope- a plasma creatinine concentration <3 mg dl−1 (250 m l−1 ). nia. Since publication of the 2005 ERC guidelines on ACS, large randomised trials have been performed testing several alternative Bivalirudin. There are insufficient data to recommend antithrombins for the treatment of patients with ACS. In compar- bivalirudin instead of UFH in STEMI patients to be treated ison with UFH, these alternatives have a more specific factor Xa with fibrinolysis. Since bleeding risk may be increased by switch- activity (low molecular weight heparins [LMWH], fondaparinux) ing the anticoagulants, the initial agent should be maintained, with or are direct thrombin inhibitors (bivalirudin). With these newer the exception of fondaparinux, where additional UFH is necessary antithrombins, in general, there is no need to monitor the coagula- if an invasive procedure is planned [60]. tion system and there is a reduced risk of thrombocytopenia. Antithrombins for STEMI patients to be treated with primary PCI Antithrombins in non-STEMI-ACS (PPCI) There is a paucity of studies on prehospital or ED initiation of In comparison with UFH, enoxaparin reduces the combined end- antithrombin treatment for patients with STEMI and planned PPCI. point of mortality, myocardial infarction and the need for urgent Therefore treatment recommendations for these settings have to revascularisation, if given within the first 24–36 h of onset of symp- be extrapolated from in-hospital investigations, until the more spe- toms of non-STEMI-ACS [53,54]. Although enoxaparin causes more cific results of ongoing studies are available. minor bleeding than UFH, the incidence of serious bleeding is not increased. Enoxaparin. Several registries and smaller studies documented Bleeding worsens the prognosis of patients with ACS [55]. Fon- favourable or neutral outcome when enoxaparin was compared daparinux and bivalirudin cause less bleeding than UFH [56–59]. In with UFH for contemporary PPCI (i.e. broad use of thienopyridines most of the trials on patients presenting with non-STEMI-ACS, the and/or Gp IIB/IIIA receptor blockers) [65,66]. Therefore, enoxaparin UFH alternatives were given only after hospital admission; it may is a safe and effective alternative to UFH. There are insufficient be invalid to extrapolate the results of these studies to the prehos- data to recommend any LMWH other than enoxaparin for PPCI in pital or ED setting. For patients with a planned initial conservative STEMI. Switching from UFH to enoxaparin or vice versa may lead approach, fondaparinux and enoxaparin are reasonable alterna- to an increased bleeding risk and therefore should be avoided [60]. tives to UFH. There are insufficient data to recommend any LMWH Dose adjustment of enoxaparin is necessary for patients with renal other than enoxaparin. For patients with an increased bleeding impairment. risk consider giving fondaparinux or bivalirudin. For patients with a planned invasive approach, enoxaparin or bivalirudin are rea- Fondaparinux. When compared with UFH, fondaparinux sonable alternatives to UFH. In one study, catheter thrombi were resulted in similar clinical outcomes but less bleeding when used in observed in patients undergoing PCI who had received fonda- the context of PPCI [56]; however, thrombus formation on catheters parinux – additional UFH was required [56]. Since enoxaparin and required treatment with additional UFH. Even if fondaparinux fondaparinux may accumulate in patients with renal impairment, reduces the bleeding risk compared with UFH in STEMI patients dose adjustment is necessary; bivalirudin or UFH are alternatives in undergoing PPCI, the use of the two agents is not recommended this situation. Bleeding risk may be increased by switching the anti- over UFH alone. The dose of fondaparinux requires adjustment in coagulant; therefore, the initial agent should be maintained with patients with renal impairment. the exception of fondaparinux where additional UFH is necessary for patients undergoing PCI [60]. Bivalirudin. Two large randomised studies documented less bleeding and a reduction in short and long term mortality when Antithrombins in STEMI bivalirudin was compared with UFH plus Gp IIB/IIIA receptor block- ers in patients with STEMI and planned PCI [67–69]. Several other Antithrombins for patients to be treated with fibrinolysis studies and case series showed also better or neutral results and less bleeding when bivalirudin was compared with UFH; there- Enoxaparin. Several randomised studies of patients with STEMI fore, bivalirudin is a safe alternative to UFH. However, a slightly undergoing fibrinolysis have shown that additional treatment with increased rate of stent thrombosis was observed within the first enoxaparin instead of UFH produced better clinical outcomes (irre- 24 h after PCI [67]. spective of the fibrinolytic used) but a slightly increased bleeding rate in elderly (≥75 years) and low weight patients (BW < 60 kg) [61–63]. Reduced doses of enoxaparin in elderly and low weight Strategies and systems of care patients maintained the improved outcome while reducing the bleeding rate [64]. It is also reasonable to give enoxaparin instead Several systematic strategies to improve quality of out-of- of UFH for prehospital treatment. hospital care for patients with ACS have been investigated. These Dosing of enoxaparin: In patients <75 years, give an initial strategies are principally intended to promptly identify patients bolus of 30 mg IV followed by 1 mg kg−1 SC every 12 h (first with STEMI in order to shorten the delay to reperfusion treatment. SC dose shortly after the IV bolus). Treat patients ≥75 years Also triage criteria have been developed to select high-risk patients
- 141. H.-R. Arntz et al. / Resuscitation 81 (2010) 1353–1363 1359 with non-STEMI-ACS for transport to tertiary care centres offering Table 5.1 Contraindications for fibrinolysis.a 24/7 PCI services. In this context, several specific decisions have to be made during initial care beyond the basic diagnostic steps nec- Absolute contraindications essary for clinical evaluation of the patient and interpretation of a Haemorrhagic stroke or stroke of unknown origin at any time Ischaemic stroke in the preceding 6 months 12-lead ECG. These decisions relate to: Central nervous system damage or neoplasms Recent major trauma/surgery/head injury (within the preceding 3 weeks) (1) Reperfusion strategy in patients with STEMI i.e. PPCI vs (pre-) Gastro-intestinal bleeding within the last month hospital fibrinolysis. Known bleeding disorder (2) Bypassing a closer but non-PCI capable hospital and taking mea- Aortic dissection sures to shorten the delay to intervention if PPCI is the chosen Relative contraindications strategy. Transient ischaemic attack in preceding 6 months (3) Procedures in special situations e.g. for patients successfully Oral anticoagulant therapy Pregnancy within 1-week post-partum resuscitated from non-traumatic cardiac arrest, patients with Non-compressible punctures shock or patients with non-STEMI ACS who are unstable or have Traumatic resuscitation signs of very high risk. Refractory hypertension (systole. blood pressure >180 mm Hg Advanced liver disease Infective endocarditis Reperfusion strategy in patients presenting with STEMI Active peptic ulcer a Reperfusion therapy in patients with STEMI is the most impor- According to the guidelines of the European Society of Cardiology. tant advance in the treatment of myocardial infarction in the last 25 years. For patients presenting with STEMI within 12 h of symptom Primary percutaneous intervention onset, reperfusion should be initiated as soon as possible indepen- dent of the method chosen [7,70–72]. Reperfusion may be achieved Coronary angioplasty with or without stent placement has with fibrinolysis, with PPCI, or a combination of both. Efficacy of become the first-line treatment for patients with STEMI, because reperfusion therapy is profoundly dependent on the duration of it has been shown to be superior to fibrinolysis in the combined symptoms. Fibrinolysis is effective specifically in the first 2–3 h endpoints of death, stroke and reinfarction in several studies and after symptom onset; PPCI is less time sensitive [73]. meta-analyses [81,82]. This improvement was found when PPCI was undertaken by a skilled person in a high-volume centre with a Fibrinolysis limited delay to first balloon inflation after first medical contact [83]. Therefore PPCI performed at a high-volume centre shortly A meta-analysis of six trials involving 6434 patients docu- after first medical contact (FMC), by an experienced operator who mented a 17% decrease in mortality among patients treated with maintains an appropriate expert status, is the preferred treatment out-of-hospital fibrinolysis compared with in-hospital fibrinolysis as it improves morbidity and mortality as compared with immedi- [74]. An effective and safe system for out-of-hospital fibrinolytic ate fibrinolysis. therapy requires adequate facilities for the diagnosis and treatment of STEMI and its complications. Ideally, there should be a capability of communicating with experienced hospital doctors (e.g. emer- Fibrinolysis vs primary PCI gency physicians or cardiologists). The average time gained with out-of-hospital fibrinolysis was 60 min, and the results were inde- Primary PCI has been limited by access to catheter laboratory pendent of the experience of the provider. Thus, giving fibrinolytics facilities, appropriately skilled clinicians and delay to first bal- out-of-hospital to patients with STEMI or signs and symptoms of an loon inflation. Fibrinolysis therapy is a widely available reperfusion ACS with presumed new LBBB is beneficial. Fibrinolytic therapy can strategy. Both treatment strategies are well established and have be given safely by trained paramedics, nurses or physicians using been the subject of large randomised multicentre trials over the last an established protocol [75–80]. The efficacy is greatest within the decades. Over this time both therapies have evolved significantly first 3 h of the onset of symptoms [74]. Patients with symptoms of and the body of evidence is heterogeneous. In the randomised stud- ACS and ECG evidence of STEMI (or presumably new LBBB or true ies comparing PPCI with fibrinolytic therapy, the typical delay from posterior infarction) presenting directly to the ED should be given decision to the beginning of treatment with either PPCI or fibri- fibrinolytic therapy as soon as possible unless there is timely access nolytic therapy was less than 60 min. Several reports and registries to PPCI. comparing fibrinolytic (including prehospital administration) ther- apy with PPCI showed a trend of improved survival if fibrinolytic Risks of fibrinolytic therapy therapy was initiated within 2 h of onset of symptoms and was com- Healthcare professionals who give fibrinolytic therapy must be bined with rescue or delayed PCI [84–86]. In registries that reflect aware of its contraindications (Table 5.1) and risks. Patients with standard practice more realistically the acceptable PPCI related large AMIs (e.g. indicated by extensive ECG changes) are likely to delay (i.e. the diagnosis to balloon interval minus the diagnosis gain most from fibrinolytic therapy. Benefits of fibrinolytic ther- to needle interval) to maintain the superiority of PPCI over fibri- apy are less impressive in inferior wall infarctions than in anterior nolysis varied considerably between 45 and >180 min depending infarctions. Older patients have an absolute higher risk of death, on the patients’ conditions (i.e. age, localisation of infarction, and but the absolute benefit of fibrinolytic therapy is similar to that duration of symptoms) [87]. Moreover there are few data for ben- of younger patients. Patients over 75 years have an increased efit of PPCI over fibrinolysis in specific subgroups such as patients risk of intracranial bleeding from fibrinolysis; thus, the absolute post-CABG, with renal failure or with diabetes [88,89]. Time delay benefit of fibrinolysis is reduced by this complication. The risk to PCI may be significantly shortened by improving the systems of of intracranial bleeding is increased in patients with a systolic care [13,90–93], e.g. blood pressure of over 180 mm Hg; this degree of hypertension is a relative contraindication to fibrinolytic therapy. The risk of • Prehospital ECG registration intracranial bleeding is also depending on the use of antithrombin • ECG transmission to the receiving hospital and antiplatelet therapy. • Arranging single call activation of the catheterization laboratory
- 142. 1360 H.-R. Arntz et al. / Resuscitation 81 (2010) 1353–1363 • Requiring the catheterization laboratory to be ready within revascularisation (i.e. PPCI, PCI early after fibrinolysis) is indicated 20 min for those patients who develop shock within 36 h after symptom • Having an attending cardiologists always at the hospital onset of AMI and are suitable for revascularisation [100]. • Providing real-time data feedback Suspect right ventricular infarction in patients with inferior • Fostering senior management commitment infarction, clinical shock and clear lung fields. ST-segment elevation • Encouraging a team-based approach ≥1 mm in lead V4R is a useful indicator of right ventricular infarc- tion. These patients have an in-hospital mortality of up to 30% and If PPCI cannot be accomplished within an adequate timeframe, many benefit greatly from reperfusion therapy. Avoid nitrates and independent of the need for emergent transfer, then immediate other vasodilators, and treat hypotension with intravenous fluid. fibrinolysis should be considered unless there is a contraindication. For those patients with a contraindication to fibrinolysis, PCI should still be pursued despite the delay, rather than not providing reper- Reperfusion after successful CPR fusion therapy at all. For those STEMI patients presenting in shock, primary PCI (or coronary artery bypass surgery) is the preferred Coronary heart disease is the most frequent cause of out-of- reperfusion treatment. Fibrinolysis should only be considered if hospital cardiac arrest. Many of these patients will have an acute there is a substantial delay to PCI. coronary occlusion with signs of STEMI on the ECG, but cardiac arrest due to ischaemic heart disease can also occur in the absence Triage and inter-facility transfer for primary PCI of these findings. Several case series have shown that angiography and, if necessary, PCI is feasible in patients with return of spon- The risk of death, reinfarction or stroke is reduced if patients taneous circulation (ROSC) after cardiac arrest. In many patients with STEMI are transferred promptly from community hospitals to coronary artery occlusion or high degree stenoses can be identified tertiary care facilities for PPCI [82,94,95]. It is less clear whether and treated. Fibrinolysis may be an alternative in patients with ECG immediate fibrinolytic therapy (in- or out-of-hospital) or transfer signs of STEMI [101]. Therefore in patients with STEMI or new LBBB for PPCI is superior for younger patients presenting with anterior on ECG following ROSC after out-of-hospital cardiac arrest, imme- infarction and within a short duration of <2–3 h [87]. Transfer of diate angiography and percutaneous intervention or fibrinolysis STEMI patients for PPCI is reasonable for those presenting more should be considered [102,103]. It is reasonable to perform imme- than 3 h but less than 12 h after the onset of symptoms, provided diate angiography and PCI in selected patients despite the lack of that the transfer can be achieved rapidly. ST elevation on the ECG or prior clinical findings such as chest pain. It is reasonable to include reperfusion treatment in a standard- Combination of fibrinolysis and percutaneous coronary ized post-cardiac arrest protocol as part of a strategy to improve intervention outcome [104]. Reperfusion treatment should not preclude other Fibrinolysis and PCI may be used in a variety of combinations therapeutic strategies including therapeutic hypothermia. to restore coronary blood flow and myocardial perfusion. There are several ways in which the two therapies can be combined. There is some lack of uniformity in the nomenclature used to describe PCI Primary and secondary prevention in these regimens. Facilitated PCI is used to describe PCI performed immediately after fibrinolysis, a pharmaco-invasive strategy refers Preventive interventions in patients presenting with an ACS to PCI performed routinely 3–24 h after fibrinolysis, and rescue PCI should be initiated early after hospital admission and should be is defined as PCI performed for a failed reperfusion (as evidenced by continued if already in place. Preventive measures improve prog- <50% resolution of ST-segment elevation at 60–90 min after com- nosis by reducing the number of major adverse cardiac events. pletion of fibrinolytic treatment). These strategies are distinct from Prevention with drugs encompasses beta-blockers, angiotensin a routine PCI approach where the angiography and intervention is converting enzyme (ACE) inhibitors/angiotensin receptor block- performed several days after successful fibrinolysis. ers (ARB) and statins, as well as basic treatment with ASA and, if Several studies and meta-analyses demonstrate worse outcome indicated, thienopyridines. with routine PCI performed immediately or as early as possible after fibrinolysis [48,95]. Therefore routine facilitated PCI is not recommended even if there may be some specific subgroups of Beta-blockers patients which may benefit from this procedure [96]. It is reason- able to perform angiography and PCI when necessary in patients Several studies, undertaken mainly in the pre-reperfusion era, with failed fibrinolysis according to clinical signs and/or insufficient indicate a decreased mortality, incidence of reinfarction and car- ST-segment resolution [97]. diac rupture as well as a lower incidence of ventricular fibrillation In case of clinically successful fibrinolysis (evidenced by clinical and supraventricular arrhythmia in patients treated early with a signs and ST-segment resolution >50%), angiography delayed by beta-blocker [105]. Intravenous beta-blockade may also reduce several hours after fibrinolysis (the ‘pharmaco-invasive’ approach) mortality in patients undergoing PPCI who are not on oral beta- has been shown to improve outcome. This strategy includes early blockers. transfer for angiography and PCI if necessary after fibrinolytic treat- Beta-blocker studies are very heterogeneous with respect to ment [98,99]. time of start of treatment. There is paucity of data on administration in the prehospital or ED settings. Moreover, recent studies indicate Special situations an increased risk of cardiogenic shock in patients with STEMI, even if the rate of severe tachyarrhythmia is reduced by beta-blockade Cardiogenic shock [106]. There is no evidence to support routine intravenous beta- Cardiogenic shock (and to some extent severe left ventricular blockers in the prehospital or initial ED settings. It may be indicated failure) is one of the complications of ACS and has a mortality of in special situations such as severe hypertension or tachyarrhyth- more than 50%. Cardiogenic shock in STEMI is not a contraindica- mias in the absence of contraindications. It is reasonable to start tion to fibrinolytic therapy, but PCI is the treatment of choice. Early oral beta-blockers at low doses only after the patient is stabilized.
- 143. H.-R. Arntz et al. / Resuscitation 81 (2010) 1353–1363 1361 Anti-arrhythmics 7. Antman EM, Anbe DT, Armstrong PW, et al. ACC/AHA guidelines for the management of patients with ST-elevation myocardial infarction—executive summary: a report of the American College of Cardiology/American Heart There is no evidence to support the use of anti-arrhythmic pro- Association Task Force on Practice Guidelines (Writing Committee to Revise phylaxis after ACS. Ventricular fibrillation (VF) accounts for most the 1999 Guidelines for the Management of Patients With Acute Myocardial of the early deaths from ACS; the incidence of VF is highest in the Infarction). Circulation 2004;110:588–636. 8. Khraim FM, Carey MG. Predictors of pre-hospital delay among patients with first hours after onset of symptoms. This explains why numerous acute myocardial infarction. Patient Educ Couns 2009;75:155–61. studies have been performed with the aim of demonstrating the 9. Douglas PS, Ginsburg GS. The evaluation of chest pain in women. N Engl J Med prophylactic effect of antiarrhythmic therapy [107]. The effects of 1996;334:1311–5. 10. Solomon CG, Lee TH, Cook EF, et al. Comparison of clinical presentation of acute antiarrhythmic drugs (lidocaine, magnesium, disopyramide, mex- myocardial infarction in patients older than 65 years of age to younger patients: iletine, verapamil, sotalol, and tocainamide) given prophylactically the Multicenter Chest Pain Study experience. Am J Cardiol 1989;63:772–6. to patients with ACS have been studied. Prophylaxis with lidocaine 11. Henrikson CA, Howell EE, Bush DE, et al. Chest pain relief by nitroglycerin does not predict active coronary artery disease. Ann Intern Med 2003;139:979–86. reduces the incidence of VF but may increase mortality [108]. Rou- 12. Ioannidis JP, Salem D, Chew PW, Lau J. Accuracy and clinical effect of out- tine treatment with magnesium in patients with AMI does not of-hospital electrocardiography in the diagnosis of acute cardiac ischemia: a improve mortality. Arrhythmia prophylaxis using disopyramide, meta-analysis. Ann Emerg Med 2001;37:461–70. mexiletine, verapamil, or other anti-arrhythmics given within the 13. Terkelsen CJ, Lassen JF, Norgaard BL, et al. Reduction of treatment delay in patients with ST-elevation myocardial infarction: impact of pre-hospital diag- first hours of an ACS does not improve mortality. Therefore pro- nosis and direct referral to primary percutanous coronary intervention. Eur phylactic anti-arrhythmics are not recommended. Heart J 2005;26:770–7. 14. Brainard AH, Raynovich W, Tandberg D, Bedrick EJ. The prehospital 12-lead electrocardiogram’s effect on time to initiation of reperfusion therapy: a sys- Angiotensin-converting enzyme inhibitors and angiotensin tematic review and meta-analysis of existing literature. Am J Emerg Med receptor blockers 2005;23:351–6. 15. Swor R, Hegerberg S, McHugh-McNally A, Goldstein M, McEachin CC. Prehospi- tal 12-lead ECG: efficacy or effectiveness? Prehosp Emerg Care 2006;10:374–7. Oral ACE inhibitors reduce mortality when given to patients 16. Masoudi FA, Magid DJ, Vinson DR, et al. Implications of the failure to identify with AMI with or without early reperfusion therapy. The beneficial high-risk electrocardiogram findings for the quality of care of patients with acute myocardial infarction: results of the Emergency Department Quality in effects are most pronounced in patients presenting with ante- Myocardial Infarction (EDQMI) study. Circulation 2006;114:1565–71. rior infarction, pulmonary congestion or left ventricular ejection 17. Feldman JA, Brinsfield K, Bernard S, White D, Maciejko T. Real-time paramedic fraction <40%. Do not give ACE inhibitors if the systolic blood pres- compared with blinded physician identification of ST-segment elevation myocardial infarction: results of an observational study. Am J Emerg Med sure is less than 100 mm Hg on admission or if there is a known 2005;23:443–8. contraindication to these drugs. A trend towards higher mortal- 18. Kudenchuk PJ, Ho MT, Weaver WD, et al. Accuracy of computer-interpreted ity has been documented if an intravenous ACE inhibitor is started electrocardiography in selecting patients for thrombolytic therapy. MITI within the first 24 h after onset of symptoms. Therefore, give an Project Investigators. J Am Coll Cardiol 1991;17:1486–91. 19. Dhruva VN, Abdelhadi SI, Anis A, et al. ST-segment analysis using wireless oral ACE inhibitor within 24 h after symptom onset in patients with technology in acute myocardial infarction (STAT-MI) trial. J Am Coll Cardiol AMI regardless of whether early reperfusion therapy is planned, 2007;50:509–13. particularly in those patients with anterior infarction, pulmonary 20. Antman EM, Tanasijevic MJ, Thompson B, et al. Cardiac-specific troponin I levels to predict the risk of mortality in patients with acute coronary syndromes. N congestion or a left ventricular ejection fraction below 40%. Do not Engl J Med 1996;335:1342–9. give intravenous ACE inhibitors within 24 h of onset of symptoms. 21. Collinson PO, Gaze DC, Morris F, Morris B, Price A, Goodacre S. Compari- Give an angiotensin receptor blocker (ARB) to patients intolerant son of biomarker strategies for rapid rule out of myocardial infarction in the emergency department using ACC/ESC diagnostic criteria. Ann Clin Biochem of ACE inhibitors [109,110]. 2006;43:273–80. 22. Schuchert A, Hamm C, Scholz J, Klimmeck S, Goldmann B, Meinertz T. Pre- hospital testing for troponin T in patients with suspected acute myocardial Statins infarction. Am Heart J 1999;138:45–8. 23. Keller T, Zeller T, Peetz D, et al. Sensitive troponin I assay in early diagnosis of Statins reduce the incidence of major adverse cardiovascular acute myocardial infarction. N Engl J Med 2009;361:868–77. events when given early within the first days after onset an ACS 24. Renaud B, Maison P, Ngako A, et al. Impact of point-of-care testing in the emer- gency department evaluation and treatment of patients with suspected acute [111,112]. Initiation of statin therapy should be considered within coronary syndromes. Acad Emerg Med 2008;15:216–24. 24 h of onset of symptoms of ACS unless contraindicated (target 25. Mitchell AM, Garvey JL, Kline JA. Multimarker panel to rule out acute coronary LDL cholesterol values <80 mg dl−1 [2.1 mmol l−1 ]). If patients are syndromes in low-risk patients. Acad Emerg Med 2006;13:803–6. 26. Hess EP, Thiruganasambandamoorthy V, Wells GA, et al. Diagnostic accuracy of already receiving statin therapy, it should be not interrupted [113]. clinical prediction rules to exclude acute coronary syndrome in the emergency department setting: a systematic review. CJEM 2008;10:373–82. 27. Farkouh ME, Smars PA, Reeder GS, et al. A clinical trial of a chest-pain References observation unit for patients with unstable angina. Chest Pain Evaluation in the Emergency Room (CHEER) Investigators. N Engl J Med 1998;339: 1. Tunstall-Pedoe H, Vanuzzo D, Hobbs M, et al. Estimation of contribution of 1882–8. changes in coronary care to improving survival, event rates, and coronary 28. Ramakrishna G, Milavetz JJ, Zinsmeister AR, et al. Effect of exercise treadmill heart disease mortality across the WHO MONICA Project populations. Lancet testing and stress imaging on the triage of patients with chest pain: CHEER 2000;355:688–700. substudy. Mayo Clin Proc 2005;80:322–9. 2. Fox KA, Cokkinos DV, Deckers J, Keil U, Maggioni A, Steg G. The ENACT study: 29. Goldstein JA, Gallagher MJ, O’Neill WW, Ross MA, O’Neil BJ, Raff GL. A ran- a pan-European survey of acute coronary syndromes. European Network for domized controlled trial of multi-slice coronary computed tomography for Acute Coronary Treatment. Eur Heart J 2000;21:1440–9. evaluation of acute chest pain. J Am Coll Cardiol 2007;49:863–71. 3. Goodman SG, Huang W, Yan AT, et al. The expanded Global Registry of Acute 30. Forberg JL, Hilmersson CE, Carlsson M, et al. Negative predictive value and Coronary Events: baseline characteristics, management practices, and hospital potential cost savings of acute nuclear myocardial perfusion imaging in low outcomes of patients with acute coronary syndromes. Am Heart J 2009;158, risk patients with suspected acute coronary syndrome: a prospective single 193–201 e1–5. blinded study. BMC Emerg Med 2009;9:12. 4. Lowel H, Meisinger C, Heier M, et al. Sex specific trends of sudden car- 31. Nucifora G, Badano LP, Sarraf-Zadegan N, et al. Comparison of early dobutamine diac death and acute myocardial infarction: results of the population-based stress echocardiography and exercise electrocardiographic testing for manage- KORA/MONICA-Augsburg register 1985 to 1998. Dtsch Med Wochenschr ment of patients presenting to the emergency department with chest pain. Am 2002;127:2311–6. J Cardiol 2007;100:1068–73. 5. Thygesen K, Alpert JS, White HD. Universal definition of myocardial infarction. 32. Kearney PM, Baigent C, Godwin J, Halls H, Emberson JR, Patrono C. Do selective Eur Heart J 2007;28:2525–38. cyclo-oxygenase-2 inhibitors and traditional non-steroidal anti-inflammatory 6. Van de Werf F, Bax J, Betriu A, et al. Management of acute myocardial infarction drugs increase the risk of atherothrombosis? Meta-analysis of randomised in patients presenting with persistent ST-segment elevation: the task force on trials. BMJ 2006;332:1302–8. the management of ST-segment elevation acute myocardial infarction of the 33. Rawles JM, Kenmure AC. Controlled trial of oxygen in uncomplicated myocar- European Society of Cardiology. Eur Heart J 2008;29:2909–45. dial infarction. Br Med J 1976;1:1121–3.
- 144. 1362 H.-R. Arntz et al. / Resuscitation 81 (2010) 1353–1363 34. Wijesinghe M, Perrin K, Ranchord A, Simmonds M, Weatherall M, Beasley R. 61. Efficacy and safety of tenecteplase in combination with enoxaparin, abciximab, Routine use of oxygen in the treatment of myocardial infarction: systematic or unfractionated heparin: the ASSENT-3 randomised trial in acute myocardial review. Heart 2009;95:198–202. infarction. Lancet 2001;358:605–13. 35. Cabello JB, Burls A, Emparanza JI, Bayliss S, Quinn T. Oxygen therapy for acute 62. Eikelboom JW, Quinlan DJ, Mehta SR, Turpie AG, Menown IB, Yusuf S. Unfrac- myocardial infarction. Cochrane Database Syst Rev 2010;6:CD007160. tionated and low-molecular-weight heparin as adjuncts to thrombolysis in 36. O’Driscoll BR, Howard LS, Davison AG. BTS guideline for emergency oxygen use aspirin-treated patients with ST-elevation acute myocardial infarction: a meta- in adult patients. Thorax 2008;63:vi1–68. analysis of the randomized trials. Circulation 2005;112:3855–67. 37. Freimark D, Matetzky S, Leor J, et al. Timing of aspirin administration as a 63. Wallentin L, Goldstein P, Armstrong PW, et al. Efficacy and safety of determinant of survival of patients with acute myocardial infarction treated tenecteplase in combination with the low-molecular-weight heparin enoxa- with thrombolysis. Am J Cardiol 2002;89:381–5. parin or unfractionated heparin in the prehospital setting: the assessment of 38. Barbash IM, Freimark D, Gottlieb S, et al. Outcome of myocardial infarction the safety and efficacy of a new thrombolytic regimen (ASSENT)-3 PLUS ran- in patients treated with aspirin is enhanced by pre-hospital administration. domized trial in acute myocardial infarction. Circulation 2003;108:135–42. Cardiology 2002;98:141–7. 64. Antman EM, Morrow DA, McCabe CH, et al. Enoxaparin versus unfractionated 39. Wiviott SD, Braunwald E, McCabe CH, et al. Prasugrel versus clopidogrel heparin with fibrinolysis for ST-elevation myocardial infarction. N Engl J Med in patients with acute coronary syndromes. N Engl J Med 2007;357:2001– 2006;354:1477–88. 15. 65. Zeymer U, Gitt A, Junger C, et al. Efficacy and safety of enoxaparin in unselected 40. Wallentin L, Becker RC, Budaj A, et al. Ticagrelor versus clopidogrel in patients patients with ST-segment elevation myocardial infarction. Thromb Haemost with acute coronary syndromes. N Engl J Med 2009;361:1045–57. 2008;99:150–4. 41. Yusuf S, Zhao F, Mehta SR, Chrolavicius S, Tognoni G, Fox KK. Effects of clopido- 66. Zeymer U, Gitt A, Zahn R, et al. Efficacy and safety of enoxaparin in combination grel in addition to aspirin in patients with acute coronary syndromes without with and without GP IIb/IIIa inhibitors in unselected patients with ST segment ST-segment elevation. N Engl J Med 2001;345:494–502. elevation myocardial infarction treated with primary percutaneous coronary 42. Mehta SR, Yusuf S, Peters RJ, et al. Effects of pretreatment with clopidogrel and intervention. EuroIntervention 2009;4:524–8. aspirin followed by long-term therapy in patients undergoing percutaneous 67. White HD, Aylward PE, Frey MJ, et al. Randomized, double-blind compari- coronary intervention: the PCI-CURE study. Lancet 2001;358:527–33. son of hirulog versus heparin in patients receiving streptokinase and aspirin 43. Steinhubl SR, Berger PB, Mann JT, 3rd, et al. Early and sustained dual oral for acute myocardial infarction (HERO). Hirulog Early Reperfusion/Occlusion antiplatelet therapy following percutaneous coronary intervention: a random- (HERO) Trial Investigators. Circulation 1997;96:2155–61. ized controlled trial. JAMA 2002;288:2411–20. 68. Stone GW, Witzenbichler B, Guagliumi G, et al. Bivalirudin during primary PCI 44. Chen ZM, Jiang LX, Chen YP, et al. Addition of clopidogrel to aspirin in 45,852 in acute myocardial infarction. N Engl J Med 2008;358:2218–30. patients with acute myocardial infarction: randomised placebo-controlled 69. Madsen JK, Chevalier B, Darius H, et al. Ischaemic events and bleeding in trial. Lancet 2005;366:1607–21. patients undergoing percutaneous coronary intervention with concomitant 45. Verheugt FW, Montalescot G, Sabatine MS, et al. Prehospital fibrinolysis bivalirudin treatment. EuroIntervention 2008;3:610–6. with dual antiplatelet therapy in ST-elevation acute myocardial infarction: 70. Bassand JP, Hamm CW, Ardissino D, et al. Guidelines for the diagnosis and a substudy of the randomized double blind CLARITY-TIMI 28 trial. J Thromb treatment of non-ST-segment elevation acute coronary syndromes. Eur Heart Thrombolysis 2007;23:173–9. J 2007;28:1598–660. 46. Bosch X, Marrugat J. Platelet glycoprotein IIb/IIIa blockers for percutaneous 71. Anderson JL, Adams CD, Antman EM, et al. ACC/AHA 2007 Guidelines for the coronary revascularization, and unstable angina and non-ST-segment eleva- Management of Patients With Unstable Angina/Non ST-Elevation Myocar- tion myocardial infarction. Cochrane Database Syst Rev 2001:CD002130. dial Infarction: a report of the American College of Cardiology/American 47. Boersma E, Harrington RA, Moliterno DJ, et al. Platelet glycoprotein IIb/IIIa Heart Association Task Force on Practice Guidelines (Writing Committee to inhibitors in acute coronary syndromes: a meta-analysis of all major ran- Revise the 2002 Guidelines for the Management of Patients With Unstable domised clinical trials. Lancet 2002;359:189–98 [erratum appears in Lancet Angina/Non ST-Elevation Myocardial Infarction): developed in collaboration 2002 June 15;359(9323):2120]. with the American College of Emergency Physicians, the Society for Cardiovas- 48. Keeley EC, Boura JA, Grines CL. Comparison of primary and facilitated per- cular Angiography and Interventions, and the Society of Thoracic Surgeons: cutaneous coronary interventions for ST-elevation myocardial infarction: endorsed by the American Association of Cardiovascular and Pulmonary Reha- quantitative review of randomised trials. Lancet 2006;367:579–88. bilitation and the Society for Academic Emergency Medicine. Circulation 49. Stone GW, Grines CL, Cox DA, et al. Comparison of angioplasty with stent- 2007;116:e148–304. ing, with or without abciximab, in acute myocardial infarction. N Engl J Med 72. Kushner FG, Hand M, Smith SC, Jr., et al., 2009. Focused updates: ACC/AHA 2002;346:957–66. guidelines for the management of patients with ST-elevation myocardial 50. van’t Hof AW, Ernst N, de Boer MJ, et al. Facilitation of primary coronary infarction (updating the 2004 Guideline and 2007 Focused Update) and angioplasty by early start of a glycoprotein 2b/3a inhibitor: results of the ongo- ACC/AHA/SCAI guidelines on percutaneous coronary intervention (updating ing tirofiban in myocardial infarction evaluation (on-TIME) trial. Eur Heart J the 2005 Guideline and 2007 Focused Update): a report of the American 2004;25:837–46. College of Cardiology Foundation/American Heart Association Task Force on 51. Pannu R, Andraws R. Effects of glycoprotein IIb/IIIa inhibitors in patients Practice Guidelines. Circulation 2009;120:2271–306. Erratum in: Circulation. undergoing percutaneous coronary intervention after pretreatment with clopi- 010 March 30;121(12):e257. Dosage error in article text. dogrel: a meta-analysis of randomized trials. Crit Pathw Cardiol 2008;7:5–10. 73. Boersma E, Maas AC, Deckers JW, Simoons ML. Early thrombolytic treat- 52. De Luca G, Gibson M, Bellandi F, et al. Early glycoprotein IIb–IIIa inhibitors in ment in acute myocardial infarction: reappraisal of the golden hour. Lancet primary angioplasty (EGYPT) cooperation. An individual patients’ data meta- 1996;348:771–5. analysis. Heart 2008. 74. Morrison LJ, Verbeek PR, McDonald AC, Sawadsky BV, Cook DJ. Mortality and 53. TIMI-11B Investigators, Antman EM, McCabe CH, et al. Enoxaparin prevents prehospital thrombolysis for acute myocardial infarction: a meta-analysis. death and cardiac ischemic events in unstable angina/non-Q-wave myocardial JAMA 2000;283:2686–92. infarction. Results of the thrombolysis in myocardial infarction (TIMI) 11B trial. 75. Prehospital thrombolytic therapy in patients with suspected acute myocardial Circulation 1999;100:1593–601. infarction. The European Myocardial Infarction Project Group. N Engl J Med 54. Cohen M, Demers C, Gurfinkel EP, et al. A comparison of low-molecular-weight 1993;329:383–9. heparin with unfractionated heparin for unstable coronary artery disease. Effi- 76. Weaver WD, Cerqueira M, Hallstrom AP, et al. Prehospital-initiated vs cacy and Safety of Subcutaneous Enoxaparin in Non-Q-Wave Coronary Events hospital-initiated thrombolytic therapy. The myocardial infarction triage and Study Group. N Engl J Med 1997;337:447–52. intervention trial. JAMA 1993;270:1211–6. 55. Moscucci M, Fox KA, Cannon CP, et al. Predictors of major bleeding in acute 77. Feasibility, safety, and efficacy of domiciliary thrombolysis by general coronary syndromes: the Global Registry of Acute Coronary Events (GRACE). practitioners: Grampian region early anistreplase trial. GREAT Group. BMJ Eur Heart J 2003;24:1815–23. 1992;305:548–53. 56. Yusuf S, Mehta SR, Chrolavicius S, et al. Comparison of fondaparinux and enoxa- 78. Welsh RC, Travers A, Senaratne M, Williams R, Armstrong PW. Feasibility parin in acute coronary syndromes. N Engl J Med 2006;354:1464–76. and applicability of paramedic-based prehospital fibrinolysis in a large North 57. Mehta SR, Boden WE, Eikelboom JW, et al. Antithrombotic therapy with fon- American center. Am Heart J 2006;152:1007–14. daparinux in relation to interventional management strategy in patients with 79. Pedley DK, Bissett K, Connolly EM, et al. Prospective observational cohort study ST- and non-ST-segment elevation acute coronary syndromes: an individual of time saved by prehospital thrombolysis for ST elevation myocardial infarc- patient-level combined analysis of the Fifth and Sixth Organization to Assess tion delivered by paramedics. BMJ 2003;327:22–6. Strategies in Ischemic Syndromes (OASIS 5 and 6) randomized trials. Circula- 80. Grijseels EW, Bouten MJ, Lenderink T, et al. Pre-hospital thrombolytic ther- tion 2008;118:2038–46. apy with either alteplase or streptokinase. Practical applications, complications 58. Lincoff AM, Bittl JA, Harrington RA, et al. Bivalirudin and provisional glycopro- and long-term results in 529 patients. Eur Heart J 1995;16:1833–8. tein IIb/IIIa blockade compared with heparin and planned glycoprotein IIb/IIIa 81. Keeley EC, Boura JA, Grines CL. Primary angioplasty versus intravenous throm- blockade during percutaneous coronary intervention: REPLACE-2 randomized bolytic therapy for acute myocardial infarction: a quantitative review of 23 trial. JAMA 2003;289:853–63. randomised trials. Lancet 2003;361:13–20. 59. Stone GW, McLaurin BT, Cox DA, et al. Bivalirudin for patients with acute 82. Dalby M, Bouzamondo A, Lechat P, Montalescot G. Transfer for primary coronary syndromes. N Engl J Med 2006;355:2203–16. angioplasty versus immediate thrombolysis in acute myocardial infarction: 60. Ferguson JJ, Califf RM, Antman EM, et al. Enoxaparin vs unfractionated heparin a meta-analysis. Circulation 2003;108:1809–14. in high-risk patients with non-ST-segment elevation acute coronary syn- 83. Magid DJ, Calonge BN, Rumsfeld JS, et al. Relation between hospital primary dromes managed with an intended early invasive strategy: primary results angioplasty volume and mortality for patients with acute MI treated with pri- of the SYNERGY randomized trial. JAMA 2004;292:45–54. mary angioplasty vs thrombolytic therapy. JAMA 2000;284:3131–8.
- 145. H.-R. Arntz et al. / Resuscitation 81 (2010) 1353–1363 1363 84. Steg PG, Bonnefoy E, Chabaud S, et al. Impact of time to treatment on mortality data from the french registry on acute ST-elevation myocardial infarction after prehospital fibrinolysis or primary angioplasty: data from the CAPTIM (FAST-MI). Circulation 2008;118:268–76. randomized clinical trial. Circulation 2003;108:2851–6. 99. Cantor WJ, Fitchett D, Borgundvaag B, et al. Routine early angioplasty after 85. Bonnefoy E, Steg PG, Boutitie F, et al. Comparison of primary angioplasty and fibrinolysis for acute myocardial infarction. N Engl J Med 2009;360:2705–18. pre-hospital fibrinolysis in acute myocardial infarction (CAPTIM) trial: a 5-year 100. Hochman JS, Sleeper LA, Webb JG, et al. Early revascularization in acute myocar- follow-up. Eur Heart J 2009;30:1598–606. dial infarction complicated by cardiogenic shock. SHOCK Investigators. Should 86. Kalla K, Christ G, Karnik R, et al. Implementation of guidelines improves we emergently revascularize occluded coronaries for cardiogenic shock. N Engl the standard of care: the Viennese registry on reperfusion strategies J Med 1999;341:625–34. in ST-elevation myocardial infarction (Vienna STEMI registry). Circulation 101. Arntz HR, Wenzel V, Dissmann R, Marschalk A, Breckwoldt J, Muller D. Out- 2006;113:2398–405. of-hospital thrombolysis during cardiopulmonary resuscitation in patients 87. Pinto DS, Kirtane AJ, Nallamothu BK, et al. Hospital delays in reperfusion for with high likelihood of ST-elevation myocardial infarction. Resuscitation ST-elevation myocardial infarction: implications when selecting a reperfusion 2008;76:180–4. strategy. Circulation 2006;114:2019–25. 102. Garot P, Lefevre T, Eltchaninoff H, et al. Six-month outcome of emer- 88. Madsen MM, Busk M, Sondergaard HM, et al. Does diabetes mellitus abolish the gency percutaneous coronary intervention in resuscitated patients after beneficial effect of primary coronary angioplasty on long-term risk of reinfarc- cardiac arrest complicating ST-elevation myocardial infarction. Circulation tion after acute ST-segment elevation myocardial infarction compared with 2007;115:1354–62. fibrinolysis? (A DANAMI-2 substudy). Am J Cardiol 2005;96:1469–75. 103. Spaulding CM, Joly LM, Rosenberg A, et al. Immediate coronary angiography in 89. Peterson LR, Chandra NC, French WJ, Rogers WJ, Weaver WD, Tiefenbrunn survivors of out-of-hospital cardiac arrest. N Engl J Med 1997;336:1629–33. AJ. Reperfusion therapy in patients with acute myocardial infarction and 104. Sunde K, Pytte M, Jacobsen D, et al. Implementation of a standardised treat- prior coronary artery bypass graft surgery (National Registry of Myocardial ment protocol for post resuscitation care after out-of-hospital cardiac arrest. Infarction-2). Am J Cardiol 1999;84:1287–91. Resuscitation 2007;73:29–39. 90. Kereiakes DJ, Gibler WB, Martin LH, Pieper KS, Anderson LC. Relative 105. Yusuf S, Peto R, Lewis J, Collins R, Sleight P. Beta blockade during and after importance of emergency medical system transport and the prehospital elec- myocardial infarction: an overview of the randomized trials. Prog Cardiovasc trocardiogram on reducing hospital time delay to therapy for acute myocardial Dis 1985;27:335–71. infarction: a preliminary report from the Cincinnati Heart Project. Am Heart J 106. Chen ZM, Pan HC, Chen YP, et al. Early intravenous then oral metoprolol 1992;123:835–40. in 45,852 patients with acute myocardial infarction: randomised placebo- 91. Le May MR, So DY, Dionne R, et al. A citywide protocol for primary PCI in controlled trial. Lancet 2005;366:1622–32. ST-segment elevation myocardial infarction. N Engl J Med 2008;358:231–40. 107. Teo KK, Yusuf S, Furberg CD. Effects of prophylactic antiarrhythmic drug ther- 92. Gross BW, Dauterman KW, Moran MG, et al. An approach to shorten time apy in acute myocardial infarction. An overview of results from randomized to infarct artery patency in patients with ST-segment elevation myocardial controlled trials. JAMA 1993;270:1589–95. infarction. Am J Cardiol 2007;99:1360–3. 108. Hine LK, Laird N, Hewitt P, Chalmers TC. Meta-analytic evidence against pro- 93. Bradley EH, Herrin J, Wang Y, et al. Strategies for reducing the door-to-balloon phylactic use of lidocaine in acute myocardial infarction. Arch Intern Med time in acute myocardial infarction. N Engl J Med 2006;355:2308–20. 1989;149:2694–8. 94. Widimsky P, Groch L, Zelizko M, Aschermann M, Bednar F, Suryapranata H. 109. Swedberg K, Held P, Kjekshus J, Rasmussen K, Ryden L, Wedel H. Effects of the Multicentre randomized trial comparing transport to primary angioplasty vs early administration of enalapril on mortality in patients with acute myocar- immediate thrombolysis vs combined strategy for patients with acute myocar- dial infarction. Results of the Cooperative New Scandinavian Enalapril Survival dial infarction presenting to a community hospital without a catheterization Study II (CONSENSUS II). N Engl J Med 1992;327:678–84. laboratory. The PRAGUE study. Eur Heart J 2000;21:823–31. 110. Indications for ACE inhibitors in the early treatment of acute myocardial 95. Primary versus tenecteplase-facilitated percutaneous coronary intervention infarction: systematic overview of individual data from 100,000 patients in in patients with ST-segment elevation acute myocardial infarction (ASSENT-4 randomized trials. ACE Inhibitor Myocardial Infarction Collaborative Group. PCI): randomised trial. Lancet 2006;367:569–78. Circulation 1998;97:2202–12. 96. Herrmann HC, Lu J, Brodie BR, et al. Benefit of facilitated percutaneous coronary 111. Patti G, Pasceri V, Colonna G, et al. Atorvastatin pretreatment improves intervention in high-risk ST-segment elevation myocardial infarction patients outcomes in patients with acute coronary syndromes undergoing early percu- presenting to nonpercutaneous coronary intervention hospitals. JACC Cardio- taneous coronary intervention: results of the ARMYDA-ACS randomized trial. vasc Interv 2009;2:917–24. J Am Coll Cardiol 2007;49:1272–8. 97. Gershlick AH, Stephens-Lloyd A, Hughes S, et al. Rescue angioplasty after 112. Hulten E, Jackson JL, Douglas K, George S, Villines TC. The effect of early, failed thrombolytic therapy for acute myocardial infarction. N Engl J Med intensive statin therapy on acute coronary syndrome: a meta-analysis of ran- 2005;353:2758–68. domized controlled trials. Arch Intern Med 2006;166:1814–21. 98. Danchin N, Coste P, Ferrieres J, et al. Comparison of thrombolysis followed by 113. Heeschen C, Hamm CW, Laufs U, Snapinn S, Bohm M, White HD. Withdrawal broad use of percutaneous coronary intervention with primary percutaneous of statins increases event rates in patients with acute coronary syndromes. coronary intervention for ST-segment-elevation acute myocardial infarction: Circulation 2002;105:1446–52.
- 146. Resuscitation 81 (2010) 1364–1388 Contents lists available at ScienceDirect Resuscitation journal homepage: www.elsevier.com/locate/resuscitation European Resuscitation Council Guidelines for Resuscitation 2010 Section 6. Paediatric life support Dominique Biarent a,∗ , Robert Bingham b , Christoph Eich c , Jesús López-Herce d , Ian Maconochie e , Antonio Rodríguez-Núnez f , Thomas Rajka g , David Zideman h ˜ a Paediatric Intensive Care, Hôpital Universitaire des Enfants, 15 av JJ Crocq, Brussels, Belgium b Great Ormond Street Hospital for Children, London, UK c Zentrum Anaesthesiologie, Rettungs- und Intensivmedizin, Universitätsmedizin Göttingen, Robert-Koch-Str. 40, D-37075 Göttingen, Germany d Pediatric Intensive Care Department, Hospital General Universitario Gregorio Mara˜ón, Complutense University of Madrid, Madrid, Spain n e St Mary’s Hospital, Imperial College Healthcare NHS Trust, London, UK f University of Santiago de Compostela FEAS, Pediatric Emergency and Critical Care Division, Pediatric Area Hospital Clinico Universitario de Santiago de Compostela, 15706 Santiago de Compostela, Spain g Oslo University Hospital, Kirkeveien, Oslo, Norway h Imperial College Healthcare NHS Trust, London, UK Introduction Summary of changes since the 2005 Guidelines These guidelines on paediatric life support are based on two Guideline changes have been made in response to convincing main principles: (1) the incidence of critical illness, particularly new scientific evidence and to simplify teaching and retention. cardiopulmonary arrest, and injury in children is much lower than As before, there remains a paucity of good-quality evidence on in adults; (2) most paediatric emergencies are served primarily by paediatric resuscitation. Therefore to facilitate and support dissem- providers who are not paediatric specialists and who have limited ination and implementation of the PLS Guidelines, changes have paediatric emergency medical experience. Therefore, guidelines on been made only if there is new, high-level scientific evidence or paediatric life support must incorporate the best available scientific to ensure consistency with the adult guidelines. The feasibility of evidence but must also be simple and feasible. Finally, interna- applying the same guidance for all adults and children remains tional guidelines need to acknowledge the variation in national and a major topic of study. Major changes in these new guidelines local emergency medical infrastructures and allow flexibility when include: necessary. Recognition of cardiac arrest The process Healthcare providers cannot reliably determine the presence or absence of a pulse in less than 10 s in infants or children.12,13 Therefore pulse palpation cannot be the sole determinant of car- The European Resuscitation Council (ERC) published guide- diac arrest and the need for chest compressions. If the victim is lines for paediatric life support (PLS) in 1994, 1998, 2000 unresponsive, not breathing normally, and there are no signs of life, and 2005.1–5 The latter two were based on the International lay rescuers should begin CPR. Healthcare providers should look for Consensus on Science published by the International Liaison Com- signs of life and if they are confident in the technique, they may add mittee on Resuscitation (ILCOR).6–8 This process was repeated in pulse palpation for diagnosing cardiac arrest and decide whether 2009/2010, and the resulting Consensus on Science with Treat- they should begin chest compressions or not. The decision to begin ment Recommendations (CoSTR) was published simultaneously in CPR must be taken in less than 10 s. According to the child’s age, Resuscitation, Circulation and Pediatrics.9,10 The PLS Working Party carotid (children), brachial (infants) or femoral pulse (children and of the ERC has developed the ERC PLS Guidelines based on the infants) checks may be used.14,15 2010 CoSTR and supporting scientific literature. The guidelines for resuscitation of babies at birth are now covered in Section 7.11 Compression ventilation ratios The compression ventilation (CV) ratio used for children should ∗ Corresponding author. be based on whether one, or more than one rescuer is present.16 Lay E-mail address: dominique.biarent@huderf.be (D. Biarent). rescuers, who usually learn only single-rescuer techniques, should 0300-9572/$ – see front matter © 2010 European Resuscitation Council. Published by Elsevier Ireland Ltd. All rights reserved. doi:10.1016/j.resuscitation.2010.08.012
- 147. D. Biarent et al. / Resuscitation 81 (2010) 1364–1388 1365 be taught to use a ratio of 30 compressions to 2 ventilations which is assessing the rhythm (see Section 4).44–47 To reduce the no-flow the same as the adult guidelines and enables anyone trained in basic time, chest compressions should be continued while applying and life support (BLS) to resuscitate children with minimal additional charging the paddles or self-adhesive pads (if the size of the child’s information. Rescuers with a duty to respond should learn and use chest allows this). Chest compressions should be briefly paused a 15:2 CV ratio as this has been validated in animal and manikin once the defibrillator is charged to deliver the shock. The ideal studies.17–21 This latter group, who would normally be healthcare energy dose for safe and effective defibrillation in children is professionals, should receive enhanced training targeted specifi- unknown, but animal models and small paediatric case series show cally at the resuscitation of children. For them, simplicity would that doses larger than 4 J kg−1 defibrillate effectively with negligible be lost if a different ratio was taught for the scenario when one or side effects.29,37,48,49 Clinical studies in children indicate that doses two or more rescuers were present. However, those with a duty to of 2 J kg−1 are insufficient in most cases.13,42,50 Biphasic shocks are respond can use the 30:2 ratio if they are alone, particularly if they at least as effective and produce less post-shock myocardial dys- are not achieving an adequate number of compressions because function than monophasic shocks.36,37,49,51–53 of difficulty in the transition between ventilation and compres- Therefore, for simplicity and consistency with adult BLS and sion. Ventilation remains a very important component of CPR in ALS guidance, a single-shock strategy using a non-escalating dose asphyxial arrests.22 Rescuers who are unable or unwilling to pro- of 4 J kg−1 (preferably biphasic but monophasic is acceptable) is vide mouth-to-mouth ventilation should be encouraged to perform recommended for defibrillation in children. Use the largest size at least compression-only CPR. paddles or pads that fit on the infant or child’s chest in the antero- lateral or antero-posterior position without the pads/paddles CPR quality touching each other.13 The compression technique for infants includes two-finger Airway compression for single rescuers and the two-thumb encircling technique for two or more rescuers.23–27 For older children, a Cuffed tracheal tubes one- or two-hand technique can be used, according to rescuer preference.28 The emphasis is on achieving an adequate depth of Cuffed tracheal tubes can be used safely in infants and young compression: at least 1/3 of the anterior-posterior chest diameter children. The size should be selected by applying a validated for- in all children (i.e., approximately 4 cm in infants and approxi- mula. mately 5 cm in children). Subsequent complete release should also be emphasised. Chest compressions must be performed with min- Cricoid pressure imal interruptions to minimise no-flow time. For both infants and children, the compression rate should be at least 100 but not greater The safety and value of using cricoid pressure during tracheal than 120 min−1 . intubation is not clear. Therefore, the application of cricoid pressure should be modified or discontinued if it impedes ventilation or the Defibrillation speed or ease of intubation. Automated external defibrillators Capnometry Case reports indicate that automated external defibrillators Monitoring exhaled carbon dioxide (CO2 ), ideally by capnog- (AEDs) are safe and successful when used in children older than raphy, is helpful to confirm correct tracheal tube position and 1 year of age.29,30 Automated external defibrillators are capable of recommended during CPR to help assess and optimize its quality. identifying arrhythmias in children accurately; in particular, they are extremely unlikely to advise a shock inappropriately.31–33 Con- Titration of oxygen sequently, the use of AEDs is indicated in all children aged greater than 1 year.34 Nevertheless, if there is any possibility that an AED Based on increasing evidence of potential harm from hyperox- may need to be used in children, the purchaser should check that aemia after cardiac arrest, once spontaneous circulation is restored, the performance of the particular model has been tested against inspired oxygen should be titrated to limit the risk of hyperoxaemia. paediatric arrhythmias. Many manufacturers now supply purpose- made paediatric pads or software, which typically attenuate the Rapid response systems output of the machine to 50–75 J35 and these are recommended for children aged 1–8 years.36,37 If an attenuated shock or a manu- Implementation of a rapid response system in a paediatric in- ally adjustable machine is not available, an unmodified adult AED patient setting may reduce rates of cardiac and respiratory arrest may be used in children older than 1 year.38 The evidence to sup- and in-hospital mortality. port a recommendation for the use of AEDs in children aged less than 1 year is limited to case reports.39,40 The incidence of shock- New topics able rhythms in infants is very low except when they suffer from cardiac disease.41–43 In these rare cases, the risk/benefit ratio may New topics in the 2010 guidelines include channelopathies (i.e., be favourable and use of an AED (preferably with dose attenuator) the importance of autopsy and subsequent family testing) and should be considered. several new special circumstances: trauma, single ventricle pre- and post-1st stage repair, post-Fontan circulation, and pulmonary Manual defibrillators hypertension. The treatment recommendation for paediatric ventricular fib- rillation (VF) or paediatric pulseless ventricular tachycardia (VT) Terminology remains immediate defibrillation. In adult advanced life support (ALS), the recommendation is to give a single shock and then In the following text the masculine includes the feminine and resume CPR immediately without checking for a pulse or re- child refers to both infants and children unless noted otherwise.
- 148. 1366 D. Biarent et al. / Resuscitation 81 (2010) 1364–1388 The term newly born refers to a neonate immediately after deliv- ery. A neonate is a child within 4 weeks of age. An infant is a child under 1 year of age, and the term child refers to children between 1 year and onset of puberty. From puberty children are referred to as adolescents for whom the adult guidelines apply. Furthermore, it is necessary to differentiate between infants and older children, as there are some important differences with respect to diagnos- tic and interventional techniques between these two groups. The onset of puberty, which is the physiological end of childhood, is the most logical landmark for the upper age limit for use of paediatric guidance. If rescuers believe the victim to be a child they should use the paediatric guidelines. If a misjudgement is made and the victim turns out to be a young adult, little harm will accrue, as studies of aetiology have shown that the paediatric pattern of cardiac arrest continues into early adulthood.54 A. Paediatric basic life support Sequence of actions Rescuers who have been taught adult BLS and have no specific knowledge of paediatric resuscitation may use the adult sequence, as outcome is worse if they do nothing. Non-specialists who wish to learn paediatric resuscitation because they have responsibility for children (e.g., teachers, school nurses, lifeguards), should be taught that it is preferable to modify adult BLS and perform five initial breaths followed by approximately 1 min of CPR before they go for help (see adult BLS guideline). The following sequence is to be followed by those with a duty to respond to paediatric emergencies (usually health professional teams) (Fig. 6.1). 1. Ensure the safety of rescuer and child. 2. Check the child’s responsiveness: • Gently stimulate the child and ask loudly: are you all right? Fig. 6.1. Paediatric basic life support algorithm for those with a duty to respond to paediatric emergencies. 3A. If the child responds by answering or moving: • Leave the child in the position in which you find him (pro- vided he is not in further danger). In the first few minutes after a cardiac arrest a child may be • Check his condition and get help if needed. taking slow infrequent gasps. Look, listen and feel for no more than • Re-assess him regularly. 10 s before deciding – if you have any doubt whether breathing is 3B. If the child does not respond: normal, act as if it is not normal: • Shout for help. • Turn carefully the child on his back. 5A. If the child is breathing normally: • Open the child’s airway by tilting the head and lifting the chin. • Turn the child on his side into the recovery position (see ◦ Place your hand on his forehead and gently tilt his head below). back. • Send or go for help – call the local emergency number for an ◦ At the same time, with your fingertip(s) under the point of ambulance. the child’s chin, lift the chin. Do not push on the soft tissues • Check for continued breathing. under the chin as this may obstruct the airway. 5B. If breathing is not normal or absent: ◦ If you still have difficulty in opening the airway, try a jaw • Carefully remove any obvious airway obstruction. thrust: place the first two fingers of each hand behind each • Give five initial rescue breaths. side of the child’s mandible and push the jaw forward. • While performing the rescue breaths note any gag or cough response to your action. These responses or their absence will Have a low threshold for suspecting an injury to the neck; if so, form part of your assessment of ‘signs of life’, which will be try to open the airway by jaw thrust alone. If jaw thrust alone does described later. not enable adequate airway patency, add head tilt a small amount at a time until the airway is open. Rescue breaths for a child over 1 year of age (Fig. 6.2): 4. Keeping the airway open, look, listen and feel for normal breath- • Ensure head tilt and chin lift. ing by putting your face close to the child’s face and looking along • Pinch the soft part of the nose closed with the index finger and the chest: thumb of your hand on his forehead. • Look for chest movements. • Allow the month to open, but maintain chin lift. • Listen at the child’s nose and mouth for breath sounds. • Take a breath and place your lips around the mouth, making sure • Feel for air movement on your cheek. that you have a good seal.
- 149. D. Biarent et al. / Resuscitation 81 (2010) 1364–1388 1367 For both infants and children, if you have difficulty achieving an effective breath, the airway may be obstructed: • Open the child’s mouth and remove any visible obstruction. Do not perform a blind finger sweep. • Ensure that there is adequate head tilt and chin lift but also that the neck is not over extended. • If head tilt and chin lift has not opened the airway, try the jaw thrust method. • Make up to five attempts to achieve effective breaths, if still unsuccessful, move on to chest compressions. 6. Assess the child’s circulation. Take no more than 10 s to: • Look for signs of life – this includes any movement, coughing or normal breathing (not abnormal gasps or infrequent, irregular breaths). If you check the pulse, ensure you take no more than 10 s. Fig. 6.2. Mouth-to-mouth ventilation – child. In a child over 1 year – feel for the carotid pulse in the neck. In an infant – feel for the brachial pulse on the inner aspect of the upper arm. • Blow steadily into the mouth over about 1–1.5 s watching for The femoral pulse in the groin, which is half way between the chest rise. anterior superior iliac spine and the symphysis pubis, can also • Maintain head tilt and chin lift, take your mouth away from the be used in infant and children. victim and watch for his chest to fall as air comes out. • Take another breath and repeat this sequence five times. Identify 7A. If you are confident that you can detect signs of life within 10 s: effectiveness by seeing that the child’s chest has risen and fallen in • Continue rescue breathing, if necessary, until the child starts a similar fashion to the movement produced by a normal breath. breathing effectively on his own. • Turn the child on to his side (into the recovery position) if he Rescue breaths for an infant (Fig. 6.3): remains unconscious. • Re-assess the child frequently. • Ensure a neutral position of the head (as an infant’s head is usually 7B. If there are no signs of life, unless you are CERTAIN you can feel flexed when supine, this may require some extension) and a chin a definite pulse of greater than 60 beats min−1 within 10 s: • Start chest compressions. lift. • Take a breath and cover the mouth and nose of the infant with • Combine rescue breathing and chest compressions: your mouth, making sure you have a good seal. If the nose and mouth cannot be covered in the older infant, the rescuer may Chest compressions: attempt to seal only the infant’s nose or mouth with his mouth For all children, compress the lower half of the sternum: To avoid (if the nose is used, close the lips to prevent air escape). compressing the upper abdomen, locate the xiphisternum by find- • Blow steadily into the infant’s mouth and nose over 1–1.5 s, suf- ing the angle where the lowest ribs join in the middle. Compress the ficient to make the chest visibly rise. sternum one finger’s breadth above this; the compression should be • Maintain head position and chin lift, take your mouth away from sufficient to depress the sternum by at least one third of the depth the victim and watch for his chest to fall as air comes out. of the chest. Don’t be afraid to push too hard: “Push Hard and Fast”. • Take another breath and repeat this sequence five times. Release the pressure completely and repeat at a rate of at least 100 min−1 (but not exceeding 120 min−1 ). After 15 compressions, tilt the head, lift the chin, and give two effective breaths. Continue compressions and breaths in a ratio of 15:2. The best method for compression varies slightly between infants and children. Chest compression in infants (Fig. 6.4): The lone rescuer com- presses the sternum with the tips of two fingers. If there are two or more rescuers, use the encircling technique. Place both thumbs flat side by side on the lower half of the sternum (as above) with the tips pointing towards the infant’s head. Spread the rest of both hands with the fingers together to encircle the lower part of the infant’s rib cage with the tips of the fingers supporting the infant’s back. For both methods, depress the lower sternum by at least one third of the depth of the infant’s chest. Chest compression in children over 1 year of age (Figs. 6.5 and 6.6): Place the heel of one hand over the lower half of the sternum (as above). Lift the fingers to ensure that pressure is not applied over the child’s ribs. Position yourself vertically above the victim’s chest and, with your arm straight, compress the sternum to depress it by at least one third of the depth of the chest. In larger children or for small rescuers, this is achieved most easily by using both hands Fig. 6.3. Mouth-to-mouth and nose ventilation – infant. with the fingers interlocked.
- 150. 1368 D. Biarent et al. / Resuscitation 81 (2010) 1364–1388 Fig. 6.4. Chest compression – infant. 8. Do not interrupt resuscitation until: • The child shows signs of life (starts to wake up, to move, opens eyes and to breathe normally or a definite pulse of greater than 60 min−1 is palpated). • Further qualified help arrives and takes over. • You become exhausted. When to call for assistance It is vital for rescuers to get help as quickly as possible when a child collapses. Fig. 6.6. Chest compression with two hands – child. • When more than one rescuer is available, one starts resuscitation while another rescuer goes for assistance. • The only exception to performing 1 min of CPR before going for • If only one rescuer is present, undertake resuscitation for about help is in the case of a child with a witnessed, sudden collapse 1 min before going for assistance. To minimise interruption in when the rescuer is alone. In this case, cardiac arrest is likely to CPR, it may be possible to carry an infant or small child whilst be caused by an arrhythmia and the child will need defibrillation. summoning help. Seek help immediately if there is no one to go for you. Recovery position An unconscious child whose airway is clear, and who is breath- ing normally, should be turned on his side into the recovery position. There are several recovery positions; they all aim to prevent airway obstruction and reduce the likelihood of fluids such as saliva, secretions or vomit from entering into the upper airway. There are important principles to be followed. • Place the child in as near true lateral position as possible, with his mouth dependent, which should enable the free drainage of fluid. • The position should be stable. In an infant, this may require a small pillow or a rolled-up blanket to be placed along his back to maintain the position, so preventing the infant from rolling into either the supine or prone position. • Avoid any pressure on the child’s chest that may impair breathing. • It should be possible to turn the child onto his side and back again to the recovery position easily and safely, taking into consider- ation the possibility of cervical spine injury by in-line cervical Fig. 6.5. Chest compression with one hand – child. stabilisation techniques.
- 151. D. Biarent et al. / Resuscitation 81 (2010) 1364–1388 1369 Fig. 6.7. Paediatric foreign body airway obstruction algorithm. • Regularly change side to avoid pressure points (i.e., every 30 min). or stridor (Table 6.1). Similar signs and symptoms may be asso- • The adult recovery position is suitable for use in children. ciated with other causes of airway obstruction such as laryngitis or epiglottitis; these conditions are managed differently to that of Foreign body airway obstruction FBAO. Suspect FBAO if the onset was very sudden and there are no other signs of illness; there may be clues to alert the rescuer, e.g., No new evidence on this subject was presented during the 2010 a history of eating or playing with small items immediately before Consensus Conference. Back blows, chest thrusts and abdominal the onset of symptoms. thrusts all increase intrathoracic pressure and can expel foreign bodies from the airway. In half of the episodes more than one tech- Relief of FBAO (Fig. 6.7) nique is needed to relieve the obstruction.55 There are no data to indicate which measure should be used first or in which order they 1. Safety and summoning assistance should be applied. If one is unsuccessful, try the others in rotation Safety is paramount: rescuers must not place themselves in dan- until the object is cleared. ger and should consider the safest treatment of the choking child. The foreign body airway obstruction (FBAO) algorithm for chil- If the child is coughing effectively, no external manoeuvre is dren was simplified and aligned with the adult version in 2005 necessary. Encourage the child to cough, and monitor continually. guidelines; this continues to be the recommended sequence for If the child’s coughing is (or is becoming) ineffective, shout for managing FBAO (Fig. 6.7). help immediately and determine the child’s conscious level. The most significant difference from the adult algorithm is that abdominal thrusts should not be used for infants. Although abdom- inal thrusts have caused injuries in all age groups, the risk is 2. Conscious child with FBAO particularly high in infants and very young children. This is because If the child is still conscious but has absent or ineffective cough- of the horizontal position of the ribs, which leaves the upper ing, give back blows. abdominal viscera much more exposed to trauma. For this rea- If back blows do not relieve the FBAO, give chest thrusts to son, the guidelines for the treatment of FBAO are different between infants or abdominal thrusts to children. These manoeuvres create infants and children. an artificial cough, increasing intrathoracic pressure and dislodging the foreign body. Recognition of foreign body airway obstruction When a foreign body enters the airway the child reacts imme- diately by coughing in an attempt to expel it. A spontaneous cough Table 6.1 Sign of foreign body airway obstruction. is likely to be more effective and safer than any manoeuvre a rescuer might perform. However, if coughing is absent or ineffec- General signs of FBAO tive and the object completely obstructs the airway, the child will Witnessed episode Coughing/choking rapidly become asphyxiated. Active interventions to relieve FBAO Sudden onset are therefore required only when coughing becomes ineffective, Recent history of playing with/eating small objects but they then need to be commenced rapidly and confidently. The majority of choking events in infants and children occur during play Ineffective coughing Effective cough or eating episodes, when a carer is usually present; thus, the events Unable to vocalise Crying or verbal response to questions are frequently witnessed and interventions are usually initiated Quiet or silent cough Loud cough when the child is conscious. Unable to breathe Able to take a breath before coughing Foreign body airway obstruction is characterised by the sud- Cyanosis Fully responsive Decreasing level of consciousness den onset of respiratory distress associated with coughing, gagging
- 152. 1370 D. Biarent et al. / Resuscitation 81 (2010) 1364–1388 Back blows in infants. 3. Unconscious child with FBAO If the child with FBAO is, or becomes, unconscious, place him on • Support the infant in a head downward, prone position, to enable a firm, flat surface. Call out, or send, for help if it is still not available. gravity to assist removal of the foreign body. Do not leave the child at this stage; proceed as follows: • A seated or kneeling rescuer should be able to support the infant safely across their lap. Airway opening. Open the mouth and look for any obvious • Support the infant’s head by placing the thumb of one hand, at object. If one is seen, make an attempt to remove it with a sin- the angle of the lower jaw, and one or two fingers from the same gle finger sweep. Do not attempt blind or repeated finger sweeps hand, at the same point on the other side of the jaw. – these can impact the object more deeply into the pharynx and • Do not compress the soft tissues under the infant’s jaw, as this cause injury. will exacerbate the airway obstruction. • Deliver up to five sharp back blows with the heel of one hand in Rescue breaths. Open the airway using a head tilt/chin lift and the middle of the back between the shoulder blades. attempt five rescue breaths. Assess the effectiveness of each breath: • The aim is too relieve the obstruction with each blow rather than if a breath does not make the chest rise, reposition the head before to give all five. making the next attempt. Back blows in children over 1 year. Chest compressions and CPR. • Back blows are more effective if the child is positioned head down. • Attempt five rescue breaths and if there is no response (moving, • A small child may be placed across the rescuer’s lap as with the coughing, spontaneous breaths) proceed to chest compressions infant. • If this is not possible, support the child in a forward leaning posi- without further assessment of the circulation. • Follow the sequence for single rescuer CPR (step 7B above) for tion and deliver the back blows from behind. approximately a minute before summoning the EMS (if this has not already been done by someone else). If back blows fail to dislodge the object, and the child is still • When the airway is opened for attempted delivery of rescue conscious, use chest thrusts for infants or abdominal thrusts for breaths, look to see if the foreign body can be seen in the mouth. children. Do not use abdominal thrusts (Heimlich manoeuvre) in • If an object is seen, attempt to remove it with a single finger infants. sweep. • If it appears the obstruction has been relieved, open and check Chest thrusts for infants. the airway as above; deliver rescue breaths if the child is not breathing. • Turn the infant into a head downward supine position. This is • If the child regains consciousness and exhibits spontaneous achieved safely by placing the free arm along the infant’s back effective breathing, place him in a safe position on his side (recov- and encircling the occiput with the hand. ery position) and monitor breathing and conscious level whilst • Support the infant down your arm, which is placed down (or awaiting the arrival of the EMS. across) your thigh. • Identify the landmark for chest compressions (on the lower half of B. Paediatric advanced life support the sternum, approximately a finger’s breadth above the xiphis- ternum). Prevention of cardiopulmonary arrest • Give five chest thrusts; these are similar to chest compressions but sharper and delivered at a slower rate. In children, secondary cardiopulmonary arrests, caused by either respiratory or circulatory failure, are more frequent than Abdominal thrusts for children over 1 year. primary arrests caused by arrhythmias.56–61 So-called asphyxial arrests or respiratory arrests are also more common in young adult- • Stand or kneel behind the child; place your arms under the child’s hood (e.g., trauma, drowning, poisoning).62,63 The outcome from arms and encircle his torso. cardiopulmonary arrests in children is poor; identification of the • Clench your fist and place it between the umbilicus and xiphis- antecedent stages of cardiac or respiratory failure is a priority, as ternum. effective early intervention may be life saving. • Grasp this hand with the other hand and pull sharply inwards and The order of assessment and intervention for any seriously ill or upwards. injured child follows the ABC principles. • Repeat up to five times. • Ensure that pressure is not applied to the xiphoid process or the • A indicates airway (Ac for airway and cervical spine stabilisation lower rib cage – this may cause abdominal trauma. for the injured child). • B indicates breathing. • C indicates circulation (with haemorrhage control in injured Following the chest or abdominal thrusts, re-assess the child. If the object has not been expelled and the victim is still con- child). scious, continue the sequence of back blows and chest (for infant) Interventions are made at each step of the assessment as abnor- or abdominal (for children) thrusts. Call out, or send, for help if it is malities are identified. The next step of the assessment is not started still not available. Do not leave the child at this stage. until the preceding abnormality has been managed and corrected If the object is expelled successfully, assess the child’s clinical if possible. Summoning a paediatric rapid response team or med- condition. It is possible that part of the object may remain in the ical emergency team may reduce the risk of respiratory and/or respiratory tract and cause complications. If there is any doubt, seek cardiac arrest in hospitalised children outside the intensive care medical assistance. Abdominal thrusts may cause internal injuries setting.64–69 This team should include at least one paediatrician and all victims treated with abdominal thrusts should be examined with specific knowledge in the field and one specialised nurse, and by a doctor.5 should be called to evaluate a potentially critically ill child who is
- 153. D. Biarent et al. / Resuscitation 81 (2010) 1364–1388 1371 not already in a paediatric intensive care unit (PICU) or paediatric • Unresponsiveness to pain (coma). emergency department (ED). • Apnoea or gasping respiratory pattern. • Absent circulation. • Pallor or deep cyanosis. Diagnosing respiratory failure: assessment of A and B Assessment of a potentially critically ill child starts with assess- ment of airway (A) and breathing (B). Abnormalities in airway Palpation of a pulse is not reliable as the sole determinant of the patency or gas exchange in the lungs can lead to respiratory failure. need for chest compressions.71,72 If cardiac arrest is suspected, and Signs of respiratory failure include: in the absence of signs of life, rescuers (lay and professional) should begin CPR unless they are certain they can feel a central pulse within 10 s (infants – brachial or femoral artery; children – carotid • Respiratory rate outside the normal range for the child’s age – or femoral artery). If there is any doubt, start CPR.72–75 If personnel either too fast or too slow. skilled in echocardiography are available, this investigation may • Initially increasing work of breathing, which may progress to help to detect cardiac activity and potentially treatable causes for inadequate/decreased work of breathing as the patient tires or the arrest.76 However, echocardiography must not interfere with compensatory mechanisms fail, additional noises such as stridor, the performance of chest compressions. wheeze, grunting, or the loss of breath sounds. • Decreased tidal volume marked by shallow breathing, decreased chest expansion or decreased air entry at auscultation. • Hypoxaemia (without/with supplemental oxygen) generally Management of respiratory and circulatory failure identified by cyanosis but best evaluated by pulse oximetry. In children, there are many causes of respiratory and circula- There may be associated signs in other organ systems that are tory failure and they may develop gradually or suddenly. Both may either affected by inadequate ventilation and oxygenation or act to be initially compensated but will normally decompensate without compensate the respiratory problem. These are detectable in step adequate treatment. Untreated decompensated respiratory or cir- C of the assessment and include: culatory failure will lead to cardiopulmonary arrest. Hence, the aim of paediatric life support is early and effective intervention in chil- dren with respiratory and circulatory failure to prevent progression • Increasing tachycardia (compensatory mechanism in an attempt to full arrest. to increase oxygen delivery). • Pallor. • Bradycardia (ominous indicator of the loss of compensatory mechanisms). Airway and breathing • Alteration in the level of consciousness (a sign that compensatory mechanisms are overwhelmed). • Open the airway and ensure adequate ventilation and oxygena- tion. Deliver high-flow oxygen. Diagnosing circulatory failure: assessment of C • Establish respiratory monitoring (first line – pulse oximetry/ SpO2 ). Circulatory failure (or shock) is characterised by a mismatch • Achieving adequate ventilation and oxygenation may require use between metabolic demand by the tissues and delivery of oxy- of airway adjuncts, bag-mask ventilation (BMV), use of a laryn- gen and nutrients by the circulation.70 Physiological compensatory geal mask airway (LMA), securing a definitive airway by tracheal mechanisms lead to changes in the heart rate, in the systemic intubation and positive pressure ventilation. vascular resistance (which commonly increases as an adaptive • Very rarely, a surgical airway may be required. response) and in tissue and organ perfusion. Signs of circulatory failure include: Circulation • Increased heart rate (bradycardia is an ominous sign of physio- logical decompensation). • Establish cardiac monitoring (first line – pulse oximetry/SpO2 , • Decreased systemic blood pressure. • Decreased peripheral perfusion (prolonged capillary refill time, electrocardiography/ECG and non-invasive blood pres- sure/NIBP). decreased skin temperature, pale or mottled skin). • Secure intravascular access. This may be by peripheral intra- • Weak or absent peripheral pulses. • Decreased or increased intravascular volume. venous (IV) or by intraosseous (IO) cannulation. If already in situ, • Decreased urine output and metabolic acidosis. a central intravenous catheter should be used. • Give a fluid bolus (20 ml kg−1 ) and/or drugs (e.g., inotropes, vaso- pressors, anti-arrhythmics) as required. Other systems may be affected, for example: • Isotonic crystalloids are recommended as initial resuscitation fluid in infants and children with any type of shock, including • Respiratory frequency may be increased initially, in an attempt to septic shock.77–80 improve oxygen delivery, later becoming slow and accompanied • Assess and re-assess the child continuously, commencing each by decompensated circulatory failure. time with the airway before proceeding to breathing and then • Level of consciousness may decrease because of poor cerebral the circulation. perfusion. • During treatment, capnography, invasive monitoring of arterial blood pressure, blood gas analysis, cardiac output monitoring, Diagnosing cardiopulmonary arrest echocardiography and central venous oxygen saturation (ScvO2 ) may be useful to guide the treatment of respiratory and/or circu- Signs of cardiopulmonary arrest include: latory failure.
- 154. 1372 D. Biarent et al. / Resuscitation 81 (2010) 1364–1388 Airway Table 6.2 General recommendation for cuffed and uncuffed tracheal tube sizes (internal diam- eter in mm). Open the airway using basic life support techniques. Oropha- ryngeal and nasopharyngeal airways adjuncts can help maintain Uncuffed Cuffed the airway. Use the oropharyngeal airway only in the unconscious Neonatespremature Gestational age in weeks/10 Not used child, in whom there is no gag reflex. Use the appropriate size (from Neonates Full term 3.5 Not usually used the incisors to the angle of the mandible), to avoid pushing the Infants 3.5–4.0 3.0–3.5 Child 1–2 years 4.0–4.5 3.5–4.0 tongue backward and obstructing the epiglottis, or directly com- Child >2 years Age/4 + 4 Age/4 + 3.5 pressing the glottis. The soft palate in the child can be damaged by insertion of the oropharyngeal airway – avoid this by insert- ing the oropharyngeal airway with care; do not use any force. The Rapid-sequence induction and intubation nasopharyngeal airway is usually tolerated better in the conscious The child who is in cardiopulmonary arrest and/or deep coma or semi-conscious child (who has an effective gag reflex), but should does not require sedation or analgesia to be intubated; otherwise, not be used if there is a basal skull fracture or a coagulopathy. The intubation must be preceded by oxygenation (gentle BMV is some- correct insertion depth should be sized from the nostrils to the times required to avoid hypoxia), rapid sedation, analgesia and the angle of the mandible but must be re-assessed after insertion. These use of neuromuscular blocking drugs to minimise intubation com- simple airway adjuncts do not protect the airway from aspiration plications and failure.98 The intubator must be experienced and of secretions, blood or stomach contents. familiar with drugs used for rapid-sequence induction. The use of cricoid pressure may prevent or limit regurgitation of gastric Laryngeal mask airway (LMA) contents99,100 but it may distort the airway and make laryngoscopy and intubation more difficult.101 Cricoid pressure should not be Although bag-mask ventilation remains the recommended first used if either intubation or oxygenation is compromised. line method for achieving airway control and ventilation in chil- dren, the LMA is an acceptable airway device for providers trained Tracheal tube sizes in its use.81,82 It is particularly helpful in airway obstruction caused A general recommendation for tracheal tube internal diameters by supraglottic airway abnormalities or if bag-mask ventilation is (ID) for different ages is shown in Table 6.2.102–107 This is a guide not possible. The LMA does not totally protect the airway from only and tubes one size larger and smaller should always be avail- aspiration of secretions, blood or stomach contents, and therefore able. Tracheal tube size can also be estimated from the length of close observation is required. Use of the LMA is associated with a the child’s body as measured by resuscitation tapes.108 higher incidence of complications in small children compared with adults.83,84 Other supraglottic airway devices (e.g., laryngeal tube), which have been used successfully in children’s anaesthesia, may Cuffed versus uncuffed tracheal tubes also be useful in an emergency but there are few data on the use of Uncuffed tracheal tubes have been used traditionally in children these devices in paediatric emergencies.85 up to 8 years of age but cuffed tubes may offer advantages in certain circumstances e.g., when lung compliance is poor, airway resis- tance is high or if there is a large air leak from the glottis.102,109,110 Tracheal intubation The use of cuffed tubes also makes it more likely that the correct tube size will be chosen on the first attempt.102,103,111 The correctly Tracheal intubation is the most secure and effective way to sized cuffed tracheal tube is as safe as an uncuffed tube for infants establish and maintain the airway, prevent gastric distension, pro- and children (not for neonates) provided attention is paid to its tect the lungs against pulmonary aspiration, enable optimal control placement, size and cuff inflation pressure.109,110,112 As excessive of the airway pressure and provide positive end expiratory pres- cuff pressure may lead to ischaemic damage to the surrounding sure (PEEP). The oral route is preferable during resuscitation. Oral laryngeal tissue and stenosis, cuff inflation pressure should be mon- intubation is quicker and simpler, and is associated with fewer itored and maintained at less than 25 cm H2 O.112 complications than nasal placement. In the conscious child, the judicious use of anaesthetics, sedatives and neuromuscular block- ing drugs is essential in order to avoid multiple intubation attempts Confirmation of correct tracheal tube placement or intubation failure.86–95 The anatomy of a child’s airway dif- Displaced, misplaced or obstructed tubes occur frequently in fers significantly from that of an adult; hence, intubation of a the intubated child and are associated with increased risk of child requires special training and experience. Clinical examina- death.113,114 No single technique is 100% reliable for distinguishing tion and capnography must be used to confirm correct tracheal oesophageal from tracheal intubation.115–117 tube placement. The tracheal tube must be secured and vital signs Assessment of the correct tracheal tube position is made by: monitored.96 It is also essential to plan an alternative airway man- agement technique in case the trachea cannot be intubated. • laryngoscopic observation of the tube passing beyond the vocal There is currently no evidence-based recommendation defining cords; the setting-, patient- and operator-related criteria for prehospital • detection of end-tidal CO2 (by colorimetry or capnometry/- tracheal intubation of children. Prehospital tracheal intubation of graphy) if the child has a perfusing rhythm (this may also be seen children may be considered if: with effective CPR, but it is not completely reliable); • observation of symmetrical chest wall movement during positive (1) the airway and/or breathing is seriously compromised or pressure ventilation; threatened; • observation of mist in the tube during the expiratory phase of (2) the mode and duration of transport require the airway to be ventilation; secured early (e.g., air transport); and • absence of gastric distension; (3) if the operator is adequately skilled in advanced paediatric • equal air entry heard on bilateral auscultation in the axillae and airway management including the use of drugs to facilitate apices of the chest; tracheal intubation.97 • absence of air entry into the stomach on auscultation;
- 155. D. Biarent et al. / Resuscitation 81 (2010) 1364–1388 1373 • improvement or stabilisation of SpO2 in the expected range Bag-mask ventilation (BMV) (delayed sign!); Bag-mask ventilation (BMV) is effective and safe for a child • improvement of heart rate towards the age-expected value (or requiring assisted ventilation for a short period, i.e., in the prehos- remaining within the normal range) (delayed sign!). pital setting or in an emergency department.114,132–135 Assess the effectiveness of BMV by observing adequate chest rise, monitor- If the child is in cardiopulmonary arrest and exhaled CO2 is not ing heart rate and auscultating for breath sounds, and measuring detected despite adequate chest compressions, or if there is any peripheral oxygen saturation (SpO2 ). Any healthcare provider with doubt, confirm tracheal tube position by direct laryngoscopy. After a responsibility for treating children must be able to deliver BMV correct placement and confirmation, secure the tracheal tube and effectively. re-assess its position. Maintain the child’s head in the neutral posi- tion. Flexion of the head drives the tube further into the trachea Prolonged ventilation whereas extension may pull it out of the airway.118 Confirm the If prolonged ventilation is required, the benefits of a secured air- position of the tracheal tube at the mid-trachea by chest X-ray; the way probably outweigh the potential risks associated with tracheal tracheal tube tip should be at the level of the 2nd or 3rd thoracic intubation. For emergency intubation, both cuffed and uncuffed vertebra. tracheal tubes are acceptable. DOPES is a useful acronym for the causes of sudden deterioration in an intubated child: Monitoring of breathing and ventilation Displacement of the tracheal tube. End-tidal CO2 Obstruction of the tracheal tube or of the heat and moisture Monitoring end-tidal CO2 (ETCO2 ) with a colorimetric detec- exchanger (HME). tor or capnometer confirms tracheal tube placement in the child Pneumothorax. weighing more than 2 kg, and may be used in pre- and in-hospital Equipment failure (source of gas, bag-mask, ventilator, etc.). settings, as well as during any transportation of the child.136–139 Stomach (gastric distension may alter diaphragm mechanics). A colour change or the presence of a capnographic waveform for more than four ventilated breaths indicates that the tube is in the Breathing tracheobronchial tree both in the presence of a perfusing rhythm and during cardiopulmonary arrest. Capnography does not rule out Oxygenation intubation of a bronchus. The absence of exhaled CO2 during car- diopulmonary arrest does not guarantee tube misplacement since Give oxygen at the highest concentration (i.e., 100%) during a low or absent ETCO2 may reflect low or absent pulmonary blood initial resuscitation. Once circulation is restored, give sufficient flow.140–143 oxygen to maintain an arterial oxygen saturation (SaO2 ) in the Capnography may also provide information on the efficiency of range of 94–98%.119,120 chest compressions and can give an early indication of ROSC.144,145 Studies in neonates suggest some advantages of using room air Efforts should be made to improve chest compression quality if during resuscitation (see Section 7).11,121–124 In the older child, the ETCO2 remains below 15 mmHg (2 kPa). Care must be taken there is no evidence of benefit for air instead of oxygen, so use when interpreting ETCO2 values especially after the administration 100% oxygen for initial resuscitation and after return of a sponta- of adrenaline or other vasoconstrictor drugs when there may be neous circulation (ROSC) titrate the fraction inspired oxygen (FiO2 ) a transient decrease in values,146–150 or after the use of sodium to achieve a SaO2 in the range of 94–98%. In smoke inhalation (car- bicarbonate when there may be a transient increase.151 Current bon monoxide poisoning) and severe anaemia however a high FiO2 evidence does not support the use of a threshold ETCO2 value as an should be maintained until the problem has been solved because indicator for the discontinuation of resuscitation efforts. in these circumstances dissolved oxygen plays an important role in oxygen transport. Oesophageal detector devices The self-inflating bulb or aspirating syringe (oesophageal detec- Ventilation tor device, ODD) may be used for the secondary confirmation of tracheal tube placement in children with a perfusing rhythm.152,153 Healthcare providers commonly provide excessive ventilation There are no studies on the use of the ODD in children who are in during CPR and this may be harmful. Hyperventilation causes cardiopulmonary arrest. increased intrathoracic pressure, decreased cerebral and coronary perfusion, and poorer survival rates in animals and adults.125–131 Pulse oximetry Although normoventilation is the objective during resuscitation, it Clinical evaluation of the oxygen saturation of arterial blood is difficult to know the precise minute volume that is being deliv- (SaO2 ) is unreliable; therefore, monitor the child’s peripheral ered. A simple guide to deliver an acceptable tidal volume is to oxygen saturation continuously by pulse oximetry (SpO2 ). Pulse achieve modest chest wall rise. Use a ratio of 15 chest compressions oximetry can be unreliable under certain conditions, for example, to 2 ventilations and a compression rate of 100–120 min−1 .125 Once if the child is in circulatory failure, in cardiopulmonary arrest or has ROSC has been achieved, provide normal ventilation (rate/volume) poor peripheral perfusion. Although pulse oximetry is relatively based on the victim’s age and, as soon as possible, by monitoring simple, it is a poor guide to tracheal tube displacement. Capnog- end-tidal CO2 and blood gas values. raphy detects tracheal tube dislodgement more rapidly than pulse Once the airway is protected by tracheal intubation, continue oximetry.154 positive pressure ventilation at 10–12 breaths min−1 without interrupting chest compressions. Take care to ensure that lung Circulation inflation is adequate during chest compressions. When circulation is restored, or if the child still has a perfusing rhythm, ventilate at Vascular access 12–20 breaths min−1 to achieve a normal arterial carbon dioxide tension (PaCO2 ). Hyperventilation and hypoventilation are harm- Vascular access is essential to enable drugs and fluids to be ful. given, and blood samples obtained. Venous access can be dif-
- 156. 1374 D. Biarent et al. / Resuscitation 81 (2010) 1364–1388 ficult to establish during resuscitation of an infant or child. In is hypoglycaemia.190–193 Monitor glucose levels and avoid hypo- critically ill children, whenever venous access is not readily attain- glycaemia; infants and small children are particularly prone to able intraosseous access should be considered early, especially hypoglycaemia. if the child is in cardiac arrest or decompensated circulatory failure.155–157 In any case, in critically ill children, if attempts at Adenosine establishing intravenous (IV) access are unsuccessful after 1 min, insert an intraosseous (IO) needle instead.155,158 Adenosine is an endogenous nucleotide that causes a brief atri- oventricular (AV) block and impairs accessory bundle re-entry at Intraosseous access the level of the AV node. Adenosine is recommended for the treat- Intraosseous access is a rapid, safe, and effective route to give ment of supraventricular tachycardia (SVT).194 It is safe because drugs, fluids and blood products.159–168 The onset of action and it has a short half-life (10 s); give it intravenously via upper limb time to achieve adequate plasma drug concentrations are sim- or central veins to minimise the time taken to reach the heart. ilar to that achieved via the central venous route.169,170 Bone Give adenosine rapidly, followed by a flush of 3–5 ml of normal marrow samples can be used to cross match for blood type or saline.195 Adenosine must be used with caution in asthmatics, sec- group171 for chemical analysis172,173 and for blood gas measure- ond or third degree AV block, long QT syndromes and in cardiac ment (the values are comparable to central venous blood gases if transplant recipients. no drug has been injected in the cavity).172,174–176 However sam- ples can damage autoanalysers and should be used preferably in Adrenaline (epinephrine) cartridge analyser. Flush each drug with a bolus of normal saline to ensure dispersal beyond the marrow cavity, and to achieve Adrenaline is an endogenous catecholamine with potent , 1 faster distribution to the central circulation. Inject large boluses and 2 adrenergic actions. It is placed prominently in the car- of fluid using manual pressure. Intraosseous access can be main- diac arrest treatment algorithms for non-shockable and shockable tained until definitive IV access has been established. The benefits rhythms. Adrenaline induces vasoconstriction, increases diastolic of semi-automated IO devices remain to be seen but preliminary pressure and thereby improves coronary artery perfusion pres- experiences show them to be rapid and effective for obtaining cir- sure, enhances myocardial contractility, stimulates spontaneous culatory access.167,168,177,178 contractions, and increases the amplitude and frequency of VF, so increasing the likelihood of successful defibrillation. Intravenous access The recommended IV/IO dose of adrenaline in children for Peripheral IV access provides plasma concentrations of the first and for subsequent doses is 10 g kg−1 . The max- drugs and clinical responses equivalent to central or IO imum single dose is 1 mg. If needed, give further doses of access.156,157,179–181 Central venous lines provide more secure adrenaline every 3–5 min. Intratracheal adrenaline is no longer long-term access but, compared with IO or peripheral IV access, recommended,196–199 but if this route is ever used, the dose is ten offer no advantages during resuscitation.156,179–181 times this (100 g kg−1 ). The use of higher doses of adrenaline via the IV or IO route Tracheal tube access is not recommended routinely as it does not improve survival or neurological outcome after cardiopulmonary arrest.200–203 Intraosseous or IV access should be definitely preferred to the Once spontaneous circulation is restored, a continuous infu- tracheal route for giving drugs.182 Drugs given via the trachea have sion of adrenaline may be required. Its haemodynamic effects are highly variable absorption but, for guidance, the following dosages dose related; there is also considerable variability in response have been recommended: between children; therefore, titrate the infusion dose to the desired effect. High infusion rates may cause excessive vasocon- Adrenaline 100 g kg−1 striction, compromising extremity, mesenteric, and renal blood Lidocaine 2–3 mg kg−1 flow. High-dose adrenaline can cause severe hypertension and Atropine 30 g kg−1 tachyarrhythmias.204 The optimal dose of naloxone is not known. To avoid tissue damage it is essential to give adrenaline through Dilute the drug in 5 ml of normal saline and follow adminis- a secure intravascular line (IV or IO). Adrenaline (and other cate- tration with five ventilations.183–185 Do not give non-lipid soluble cholamines) is inactivated by alkaline solutions and should never medications (e.g., glucose, bicarbonate, calcium) via the tracheal be mixed with sodium bicarbonate.205 tube because they will damage the airway mucosa. Amiodarone Fluids and drugs Amiodarone is a non-competitive inhibitor of adrenergic recep- Volume expansion is indicated when a child shows signs of tors: it depresses conduction in myocardial tissue and therefore circulatory failure in the absence of volume overload.186 Isotonic slows AV conduction, and prolongs the QT interval and the crystalloids are recommended as the initial resuscitation fluid for refractory period. Except when given for the treatment of refrac- infants and children with any type of circulatory failure. tory VF/pulseless VT, amiodarone must be injected slowly (over If systemic perfusion is inadequate, give a bolus of 20 ml kg−1 of 10–20 min) with systemic blood pressure and ECG monitoring to an isotonic crystalloid even if the systemic blood pressure is normal. avoid causing hypotension. This side effect is less common with the Following every bolus, re-assess the child’s clinical state, using ABC, aqueous solution.206 Other rare but significant adverse effects are to decide whether a further bolus or other treatment is required. bradycardia and polymorphic VT.207 There are insufficient data to make recommendations about the use of hypertonic saline for circulatory failure associated with head Atropine injuries or hypovolaemia.187,188 There are also insufficient data to recommend delayed Atropine accelerates sinus and atrial pacemakers by blocking fluid resuscitation in the hypotensive child with blunt the parasympathetic response. It may also increase AV conduction. trauma.189 Avoid dextrose containing solutions unless there Small doses (< 100 g) may cause paradoxical bradycardia.208 In
- 157. D. Biarent et al. / Resuscitation 81 (2010) 1364–1388 1375 bradycardia with poor perfusion that is unresponsive to ventilation Vasopressin – terlipressin and oxygenation, the first line drug is adrenaline, not atropine. Atropine is recommended for bradycardia caused by increased Vasopressin is an endogenous hormone that acts at specific vagal tone or cholinergic drug toxicity.209–212 receptors, mediating systemic vasoconstriction (via V1 receptor) and the reabsorption of water in the renal tubule (by the V2 Calcium receptor).246 There is currently insufficient evidence to support or refute the use of vasopressin or terlipressin as an alternative to, Calcium is essential for myocardial function213,214 but routine or in combination with, adrenaline in any cardiac arrest rhythm in use of calcium does not improve the outcome from cardiopul- adults or children.247–258 monary arrest.215–217 Some studies have reported that terlipressin (a long-acting Calcium is indicated in the presence of hypocalcaemia, analogue of vasopressin with comparable effects) improves haemo- calcium channel blocker overdose, hypermagnesaemia and dynamics in children with refractory, vasodilatory septic shock, hyperkalaemia.218–220 but its impact on survival is less clear.255–257,259,260 Two paediatric series suggested that terlipressin could be effective in refractory cardiac arrest.258,261 Glucose These drugs could be used in cardiac arrest refractory to several adrenaline doses. Data from neonates, children and adults indicate that both hyper- and hypo-glycaemia are associated with poor outcome after Defibrillators cardiopulmonary arrest,221–223 but it is uncertain if this is causative or merely an association.224 Check blood or plasma glucose concen- Defibrillators are either automatically or manually operated, tration and monitor closely in any ill or injured child, including after and may be capable of delivering either monophasic or biphasic cardiac arrest. Do not give glucose-containing fluids during CPR shocks. Manual defibrillators capable of delivering the full energy unless hypoglycaemia is present. Avoid hyper- and hypo-glycaemia requirements from neonates upwards must be available within following ROSC. Strict glucose control has not shown survival bene- hospitals and in other healthcare facilities caring for children at fits in adults when compared with moderate glucose control225,226 risk of cardiopulmonary arrest. Automated external defibrillators and it increases the risk of hypoglycaemia in neonates, children and (AEDs) are preset for all variables including the energy dose. adults.227–231 Pad/paddle size for defibrillation Magnesium Select the largest possible available paddles to provide good con- There is no evidence for giving magnesium routinely during tact with the chest wall. The ideal size is unknown but there should cardiopulmonary arrest.232 Magnesium treatment is indicated in be good separation between the pads.13,262,263 the child with documented hypomagnesaemia or with torsades de Recommended sizes are: pointes VT regardless of the cause.233 • 4.5 cm diameter for infants and children weighing <10 kg. Sodium bicarbonate • 8–12 cm diameter for children >10 kg (older than 1 year). Do not give sodium bicarbonate routinely during cardiopul- To decrease skin and thoracic impedance, an electrically con- monary arrest or after ROSC.220,234,235 After effective ventilation ducting interface is required between the skin and the paddles. and chest compressions have been achieved and adrenaline given, Preformed gel pads or self-adhesive defibrillation electrodes are sodium bicarbonate may be considered for the child with prolonged effective. Do not use ultrasound gel, saline-soaked gauze, alcohol- cardiopulmonary arrest and/or severe metabolic acidosis. Sodium soaked gauze/pads or ultrasound gel. bicarbonate may also be considered in case of haemodynamic instability and co-existing hyperkalaemia, or in the management Position of the paddles of tricyclic antidepressant drug overdose. Excessive quantities of sodium bicarbonate may impair tissue oxygen delivery, produce Apply the paddles firmly to the bare chest in the antero-lateral hypokalaemia, hypernatraemia, hyperosmolality, and inactivate position, one paddle placed below the right clavicle and the other catecholamines. in the left axilla (Fig. 6.8). If the paddles are too large and there is a danger of charge arcing across the paddles, one should be placed on Lidocaine the upper back, below the left scapula and the other on the front, to the left of the sternum. This is known as the antero-posterior Lidocaine is less effective than amiodarone for defibrillation- position and is also acceptable. resistant VF/pulseless VT in adults236 and therefore is not the first line treatment in defibrillation-resistant VF/pulseless VT in chil- Optimal paddle force dren. To decrease transthoracic impedance during defibrillation, Procainamide apply a force of 3 kg for children weighing < 10 kg and 5 kg for larger children.264,265 In practice, this means that the paddles should be Procainamide slows intra-atrial conduction and prolongs the applied firmly. QRS and QT intervals. It can be used in SVT237–239 or VT240 resis- tant to other medications in the haemodynamically stable child. Energy dose in children However, paediatric data are sparse and procainamide should be The ideal energy dose for safe and effective defibrillation used cautiously.241,242 Procainamide is a potent vasodilator and can is unknown. Biphasic shocks are at least as effective and pro- cause hypotension: infuse it slowly with careful monitoring.243–245 duce less post-shock myocardial dysfunction than monophasic
- 158. 1376 D. Biarent et al. / Resuscitation 81 (2010) 1364–1388 Shockable – VF/pulseless VT Attempt defibrillation immediately (4 J kg−1 ): • Charge the defibrillator while another rescuer continues chest compressions. • Once the defibrillator is charged, pause the chest compressions, ensure that all rescuers are clear of the patient. Minimise the delay between stopping chest compressions and delivery of the shock – even 5–10 s delay will reduce the chances of the shock being successful.268,269 • Give one shock. • Resume CPR as soon as possible without re-assessing the rhythm. • After 2 min, check briefly the cardiac rhythm on the monitor. • Give second shock (4 J kg−1 ) if still in VF/pulseless VT. • Give CPR for 2 min as soon as possible without re-assessing the rhythm. • Pause briefly to assess the rhythm; if still in VF/pulseless VT give a third shock at 4 J kg−1 . Fig. 6.8. Paddle positions for defibrillation – child. • Give adrenaline 10 g kg−1 and amiodarone 5 mg kg−1 after the third shock once CPR has been resumed. • Give adrenaline every alternate cycle (i.e., every 3–5 min during shocks.36,49,51–53,266 Animal models show better results with pae- CPR). diatric doses of 3–4 J kg−1 than with lower doses,49 or adult doses.38 • Give a second dose of amiodarone 5 mg/kg270 if still in Clinical studies in children indicate that doses of 2 J kg−1 are insuf- VF/pulseless VT after the fifth shock. ficient in most cases.12,38,42 Doses larger than 4 J kg−1 (as much as 9 J kg−1 ) have defibrillated children effectively with negligible side If the child remains in VF/pulseless VT, continue to alternate effects.29,48 When using a manual defibrillator, use 4 J kg−1 (prefer- shocks of 4 J kg−1 with 2 min of CPR. If signs of life become evident, ably biphasic but monophasic waveform is also acceptable) for the check the monitor for an organised rhythm; if this is present, check first and subsequent shocks. for signs of life and a central pulse and evaluate the haemodynamics If no manual defibrillator is available, use an AED that can of the child (blood pressure, peripheral pulse, capillary refill time). recognise paediatric shockable rhythms.31,32,267 The AED should Identify and treat any reversible causes (4 Hs and 4 Ts) remem- be equipped with a dose attenuator which decreases the deliv- bering that the first 2 Hs (hypoxia and hypovolaemia) have the ered energy to a lower dose more suitable for children aged 1–8 highest prevalence in critically ill or injured children (Fig. 6.11). years (50–75 J).34,37 If such an AED in not available, use a stan- If defibrillation was successful but VF/pulseless VT recurs, dard AED and the preset adult energy levels. For children above resume CPR, give amiodarone and defibrillate again at 4 J Kg−1 . Start 8 years, use a standard AED with standard paddles. Although the a continuous infusion of amiodarone. evidence to support a recommendation for the use of AEDs (prefer- ably with dose attenuator) in children less than 1 year is limited to case reports,39,40 it is acceptable if no other option is available. Reversible causes of cardiac arrest The reversible causes of cardiac arrest can be considered quickly Advanced management of cardiopulmonary arrest by recalling the 4 Hs and 4 Ts: (Fig. 6.9) • Hypoxia. ABC • Hypovolaemia. • Hyper/hypokalaemia. Commence and continue with basic life support • Hypothermia. Oxygenate and ventilate with BMV • Tension pneumothorax. • Toxic/therapeutic disturbances. • Provide positive pressure ventilation with a high inspired oxygen • Tamponade (coronary or pulmonary). concentration • Thrombosis (coronary or pulmonary). • Give five rescue breaths followed by external chest compression and positive pressure ventilation in the ratio of 15:2 Sequence of events in cardiopulmonary arrest • Avoid rescuer fatigue by frequently changing the rescuer per- forming chest compressions 1. When a child becomes unresponsive, without signs of life (no • Establish cardiac monitoring breathing, cough or any detectable movement), start CPR imme- diately. Assess cardiac rhythm and signs of life 2. Provide BMV with 100% oxygen. (±check for a central pulse for no more than 10 s) 3. Commence monitoring. Send for a manual defibrillator or an AED to identify and treat shockable rhythms as quickly as possible. Non-shockable – asystole, pulseless electrical activity (PEA) In the less common circumstance of a witnessed sudden col- • Give adrenaline IV or IO (10 g kg−1 ) and repeat every 3–5 min. lapse, early activation of the emergency services and getting an • Identify and treat any reversible causes (4 Hs and 4 Ts) (Fig. 6.10). AED may be more appropriate; start CPR as soon as possible.
- 159. D. Biarent et al. / Resuscitation 81 (2010) 1364–1388 1377 Fig. 6.9. Paediatric advanced life support algorithm. Cardiac monitoring Echocardiography may be used to identify potentially treatable causes of cardiac arrest in children. Cardiac activity can be rapidly Position the cardiac monitor leads or defibrillation paddles visualised76 and pericardial tamponade diagnosed.272 However, as soon as possible to enable differentiation between a shock- appropriately skilled operators must be available and its use should able and a non-shockable cardiac rhythm. Invasive monitoring be balanced against the interruption to chest compressions during of systemic blood pressure may help to improve effectiveness of examination. chest compression271 but must not delay the provision of basic or advanced resuscitation. Non-shockable rhythms Shockable rhythms are pulseless VT and VF. These rhythms are more likely after sudden collapse in children with heart disease or Most cardiopulmonary arrests in children and adolescents adolescents.41–43 Non-shockable rhythms are pulseless electrical are of respiratory origin.54,58,273–275 A period of immediate CPR activity (PEA), bradycardia (<60 min−1 with no signs of circula- is therefore mandatory in this age group before searching for tion), and asystole. PEA and bradycardia often have wide-QRS an AED or manual defibrillator, as its immediate availabil- complexes. ity will not improve the outcome of a respiratory arrest.17,276
- 160. 1378 D. Biarent et al. / Resuscitation 81 (2010) 1364–1388 Fig. 6.10. Paediatric algorithm for non-shockable rhythm. Fig. 6.11. Paediatric algorithm for shockable rhythm. Bystander CPR is associated with a better neurological out- for every minute delay in defibrillation (without any CPR), survival come in adults and children.277–279 The most common ECG decreases by 7–10%. Survival after more than 12 min of VF in adult patterns in infants, children and adolescents with cardiopul- victims is <5%.281 Cardiopulmonary resuscitation provided before monary arrest are asystole and PEA. PEA is characterised by defibrillation for response intervals longer than 5 min improved organised, wide or narrow complex electrical activity, usually outcome in some studies,282,283 but not in others.284 (but not always) at a slow rate, and absent pulses. It com- Secondary VF is present at some point in up to 27% of in-hospital monly follows a period of hypoxia or myocardial ischaemia, resuscitation events. It has a much poorer prognosis than primary but occasionally can have a reversible cause (i.e., one of the 4 VF.43 Hs and 4 Ts) that led to a sudden impairment of cardiac out- put. Drugs in shockable rhythms Shockable rhythms Adrenaline (epinephrine) Adrenaline is given every 3–5 min by the IV or IO route in pref- Primary VF occurs in 3.8–19% of cardiopulmonary arrests erence to the tracheal tube route. in children.13,41–43,60,274,275,277 The incidence of VF/pulseless VT increases with age.267,280 The primary determinant of survival from Amiodarone in VF/pulseless VT VT/pulseless VT cardiopulmonary arrest is the time to defibrillation. Amiodarone is indicated in defibrillation-resistant VF/pulseless Prehospital defibrillation within the first 3 min of witnessed adult VT. Experimental and clinical experience with amiodarone in chil- VF arrest results in >50% survival. However, the success of defibrilla- dren is scarce; evidence from adult studies236,285,286 demonstrates tion decreases dramatically the longer the time until defibrillation: increased survival to hospital admission, but not to hospital dis-
- 161. D. Biarent et al. / Resuscitation 81 (2010) 1364–1388 1379 charge. One paediatric case series demonstrates the effectiveness of ble, omit vagal manoeuvres and adenosine and attempt electrical amiodarone for life-threatening ventricular arrhythmias.287 There- cardioversion immediately. fore, IV amiodarone has a role in the treatment of defibrillation Electrical cardioversion (synchronised with R wave) is also indi- refractory or recurrent VF/pulseless VT in children. cated when vascular access is not available, or when adenosine has failed to convert the rhythm. The first energy dose for elec- Extracorporeal life support trical cardioversion of SVT is 0.5–1 J kg−1 and the second dose is 2 J kg−1 . If unsuccessful, give amiodarone or procainamide under Extracorporeal life support should be considered for children guidance from a paediatric cardiologist or intensivist before the with cardiac arrest refractory to conventional CPR, if the arrest third attempt. Verapamil may be considered as an alternative occurs in a highly supervised environment and available exper- therapy in older children but should not be routinely used in tise and equipment to rapidly initiate extracorporeal life support infants. (ECLS). Amiodarone has been shown to be effective in the treatment of SVT in several paediatric studies.270,287,290–297 However, since most studies of amiodarone use in narrow complex tachycardias have Arrhythmias been for junctional ectopic tachycardia in postoperative children, the applicability of its use in all cases of SVT may be limited. If the Unstable arrhythmias child is haemodynamically stable, early consultation with an expert is recommended before giving amiodarone. An expert should also Check for signs of life and the central pulse of any child with an be consulted about alternative treatment strategies because the arrhythmia; if signs of life are absent, treat as for cardiopulmonary evidence to support other drugs in the treatment of SVT is limited arrest. If the child has signs of life and a central pulse, evaluate and inconclusive.298,299 If amiodarone is used in this circumstance, the haemodynamic status. Whenever the haemodynamic status is avoid rapid administration because hypotension is common. compromised, the first steps are: Wide complex tachycardia 1. Open the airway. In children, wide-QRS complex tachycardia is uncommon and 2. Give oxygen and assist ventilation as necessary. more likely to be supraventricular than ventricular in origin.300 3. Attach ECG monitor or defibrillator and assess the cardiac Nevertheless, in haemodynamically unstable children, it must be rhythm. considered to be VT until proven otherwise. Ventricular tachycardia 4. Evaluate if the rhythm is slow or fast for the child’s age. occurs most often in the child with underlying heart disease (e.g., 5. Evaluate if the rhythm is regular or irregular. after cardiac surgery, cardiomyopathy, myocarditis, electrolyte 6. Measure QRS complex (narrow complexes: <0.08 s duration; disorders, prolonged QT interval, central intracardiac catheter). wide complexes: >0.08 s). Synchronised cardioversion is the treatment of choice for unsta- 7. The treatment options are dependent on the child’s haemody- ble VT with a pulse. Consider anti-arrhythmic therapy if a second namic stability. cardioversion attempt is unsuccessful or if VT recurs. Amiodarone has been shown to be effective in treating pae- Bradycardia diatric arrhythmias,291 although cardiovascular side effects are common.270,287,292,297,301 Bradycardia is caused commonly by hypoxia, acidosis and/or severe hypotension; it may progress to cardiopulmonary arrest. Stable arrhythmias Give 100% oxygen, and positive pressure ventilation if required, to any child presenting with bradyarrhythmia and circulatory failure. Whilst maintaining the child’s airway, breathing and circula- If a poorly perfused child has a heart rate <60 beats min−1 , tion, contact an expert before initiating therapy. Depending on the and they do not respond rapidly to ventilation with oxygen, start child’s clinical history, presentation and ECG diagnosis, a child with chest compressions and give adrenaline. If the bradycardia is caused stable, wide-QRS complex tachycardia may be treated for SVT and by vagal stimulation (such as after passing a nasogastric tube), be given vagal manoeuvres or adenosine. Amiodarone may be con- atropine may be effective. sidered as a treatment option if this fails or if the diagnosis of VT is Cardiac pacing (either transvenous or external) is generally confirmed on an ECG. Procainamide may also be considered in sta- not useful during resuscitation. It may be considered in cases of ble SVT refractory to vagal manoeuvres and adenosine,239,302–304 AV block or sinus node dysfunction unresponsive to oxygena- and in stable VT.239,240,305,306 Do not give procainamide with amio- tion, ventilation, chest compressions and other medications; pacing darone. is not effective in asystole or arrhythmias caused by hypoxia or ischaemia.288 Special circumstances Tachycardia Channelopathy Narrow complex tachycardia If SVT is the likely rhythm, vagal manoeuvres (Valsalva or diving When sudden unexplained cardiac arrest occurs in children and reflex) may be used in haemodynamically stable children. They can young adults, obtain a complete past medical and family history also be used in haemodynamically unstable children, but only if (including a history of syncopal episodes, seizures, unexplained they do not delay chemical or electrical cardioversion.289 If the child accidents/drownings, or sudden death) and review any available is unstable with a depressed conscious level, attempt synchronised previous ECGs. All infants, children, and young adults with sud- electrical cardioversion immediately. den, unexpected death should, if possible, have an unrestricted, Adenosine is usually effective in converting SVT into sinus complete autopsy, performed preferably by pathologists with train- rhythm. It is given by rapid, intravenous injection as close as prac- ing and expertise in cardiovascular pathology.307–316 Consideration ticable to the heart (see above), and followed immediately by a should be given to preservation and genetic analysis of tissue bolus of normal saline. If the child is too haemodynamically unsta- to determine the presence of a channelopathy. Refer families of
- 162. 1380 D. Biarent et al. / Resuscitation 81 (2010) 1364–1388 patients whose cause of death is not found on autopsy to a health dopamine and noradrenaline) may improve the child’s post-arrest care provider/centre with expertise in cardiac rhythm disturbances. haemodynamic values but the drugs must be titrated according to the clinical condition.349–359 Life support for blunt or penetrating trauma Temperature control and management There is a very high mortality associated with cardiac arrest from major (blunt or penetrating) trauma.317–320 There is little evidence Hypothermia is common in the child following cardiopul- to support any additional specific interventions that are different monary resuscitation.360 Central hypothermia (32–34 ◦ C) may be from the routine management of cardiac arrest; however, the use beneficial, whereas fever may be detrimental to the injured brain. of resuscitative thoracotomy may be considered in children with Mild hypothermia has an acceptable safety profile in adults361,362 penetrating injuries.321–325 and neonates.363–368 Whilst it may improve neurological outcome in children, an observational study neither supports nor refutes the Single ventricle post-stage 1 repair use of therapeutic hypothermia in paediatric cardiac arrest.369 A child who regains a spontaneous circulation, but remains The incidence of cardiac arrest in infants following single ventri- comatose after cardiopulmonary arrest, may benefit from being cle stage 1 repair is approximately 20%, with a survival to discharge cooled to a core temperature of 32–34 ◦ C for at least 24 h. The suc- of 33%.326 There is no evidence that anything other than routine cessfully resuscitated child with hypothermia and ROSC should not resuscitative protocols should be followed. Diagnosis of the pre- be actively rewarmed unless the core temperature is below 32 ◦ C. arrest state is difficult but it may be assisted by monitoring the Following a period of mild hypothermia, rewarm the child slowly oxygen extraction (superior vena caval ScvO2 ) or near infrared at 0.25–0.5 ◦ C h−1 . spectroscopy (cerebral and splanchnic circulations).327–329 Treat- There are several methods to induce, monitor and maintain ment of high systemic vascular resistance with alpha-adrenergic body temperature in children. External and/or internal cooling receptor blockade may improve systemic oxygen delivery,330 techniques can be used to initiate cooling.370–372 Shivering can be reduce the incidence of cardiovascular collapse,331 and improve prevented by deep sedation and neuromuscular blockade. Com- survival.332 plications can occur and include an increased risk of infection, cardiovascular instability, coagulopathy, hyperglycaemia and elec- Single ventricle post-Fontan trolyte abnormalities.373–375 These guidelines are based on evidence from the use of thera- Children in the pre-arrest state who have Fontan or hemi-Fontan peutic hypothermia in neonates and adults. At the time of writing, anatomy may benefit from increased oxygenation and an improved there are ongoing, prospective, multicentre trials of therapeutic cardiac output by instituting negative pressure ventilation.333,334 hypothermia in children following in- and out-of-hospital cardiac Extracorporeal membrane oxygenation (ECMO) may be useful arrest (www.clinicaltrials.gov; NCT00880087 and NCT00878644). rescue for children with failing Fontan circulations but no recom- Fever is common following cardiopulmonary resuscitation and mendation can be made in favour or against ECMO in those with is associated with a poor neurological outcome,376–378 the risk hemi-Fontan physiology or for rescue during resuscitation.335 increasing for each degree of body temperature greater than 37 ◦ C.376 There are limited experimental data suggesting that Pulmonary hypertension the treatment of fever with antipyretics and/or physical cooling reduces neuronal damage.379,380 Antipyretics and accepted drugs There is an increased risk of cardiac arrest in children with pul- to treat fever are safe; therefore, use them to treat fever aggres- monary hypertension.336,337 Follow routine resuscitation protocols sively. in these patients with emphasis on high FiO2 and alkalo- sis/hyperventilation because this may be as effective as inhaled Glucose control nitric oxide in reducing pulmonary vascular resistance.338 Resus- citation is most likely to be successful in patients with a reversible Both hyper- and hypo-glycaemia may impair outcome of criti- cause who are treated with intravenous epoprostenol or inhaled cally ill adults and children and should be avoided,228–230,381–383 nitric oxide.339 If routine medications that reduce pulmonary artery but tight glucose control may also be harmful.231,384 Although pressure have been stopped, they should be restarted and the use there is insufficient evidence to support or refute a specific glu- of aerosolised epoprostenol or inhaled nitric oxide considered.340 cose management strategy in children with ROSC after cardiac Right ventricular support devices may improve survival.341–344 arrest,225,226,345 it is appropriate to monitor blood glucose and avoid hypoglycaemia as well as sustained hyperglycaemia. Post-arrest management Prognosis of cardiopulmonary arrest After prolonged, complete, whole-body hypoxia-ischaemia ROSC has been described as an unnatural pathophysiological state, Although several factors are associated with outcome after created by successful CPR.345 Post-arrest management must be a cardiopulmonary arrest and resuscitation41,60,385–389 there are no multidisciplinary activity and include all the treatments needed simple guidelines to determine when resuscitative efforts become for complete neurological recovery. The main goals are to reverse futile. brain injury and myocardial dysfunction, and to treat the systemic After 20 min of resuscitation, the resuscitation team leader ischaemia/reperfusion response and any persistent precipitating should consider whether or not to stop.273,390–394 The rele- pathology. vant considerations in the decision to continue the resuscitation include the cause of arrest,60,395 pre-existing medical conditions, Myocardial dysfunction age,41,389 site of arrest, whether the arrest was witnessed,60,394 the duration of untreated cardiopulmonary arrest (‘no flow’), num- Myocardial dysfunction is common after cardiopulmonary ber of doses of adrenaline, the ETCO2 value, the presence of a resuscitation.345–348 Vasoactive drugs (adrenaline, dobutamine, shockable rhythm as the first or subsequent rhythm,386,387 the
- 163. D. Biarent et al. / Resuscitation 81 (2010) 1364–1388 1381 promptness of extracorporeal life support for a reversible disease and emergency cardiovascular care: international consensus on science. Cir- process,396–398 and associated special circumstances (e.g., icy water culation 2000;102(Suppl. I):I-46–8. 8. 2005 international consensus on cardiopulmonary resuscitation and emer- drowning,277,399,400 exposure to toxic drugs). gency cardiovascular care science with treatment recommendations. Part 6: Paediatric basic and advanced life support. Resuscitation 2005;67: 271–91. Parental presence 9. 2010 international consensus on cardiopulmonary resuscitation and emer- gency cardiovascular care science with treatment recommendations. Circu- In some Western societies, the majority of parents prefer to lation, 2010; in press. 10. 2010 international consensus on cardiopulmonary resuscitation and emer- be present during the resuscitation of their child.401–410 Parental gency cardiovascular care science with treatment recommendations. Resus- presence has neither been perceived as disruptive403,411–415 nor citation, 2010; in press. stressful for the staff.401,403,412 Parents witnessing their child’s 11. Richmond S, Wyllie J. European Resuscitation Council Guidelines for Resus- citation 2010. Section 7. Resuscitation of babies at birth. Resuscitation resuscitation believe their presence to be beneficial to the 2010;81:1389–99. child.401–403,410,414–417 Allowing parents to be at the side of their 12. Tibballs J, Weeranatna C. The influence of time on the accuracy of healthcare child helps them to gain a realistic view of the attempted resus- personnel to diagnose paediatric cardiac arrest by pulse palpation. Resuscita- tion 2010;81:671–5. citation and the child’s death. Furthermore, they may have the 13. Tibballs J, Carter B, Kiraly NJ, Ragg P, Clifford M. External and internal biphasic opportunity to say goodbye to their child. Families who are present direct current shock doses for pediatric ventricular fibrillation and pulseless at their child’s death show better adjustment and undergo a better ventricular tachycardia. Pediatr Crit Care Med 2010. 14. Sarti A, Savron F, Ronfani L, Pelizzo G, Barbi E. Comparison of three sites to grieving process.402–404,414,415,417,418 check the pulse and count heart rate in hypotensive infants. Paediatr Anaesth Parental presence in the resuscitation room may help healthcare 2006;16:394–8. providers maintain their professional behaviour, whilst helping 15. Sarti A, Savron F, Casotto V, Cuttini M. Heartbeat assessment in infants: a comparison of four clinical methods. Pediatr Crit Care Med 2005;6:212–5. them to see the child as a human being and a family member.411 16. de Caen AR, Kleinman ME, Chameides L, et al. International consensus on car- However in out-of-hospital resuscitation, some EMS providers may diopulmonary resuscitation and emergency cardiovascular care science with feel threatened by the presence of relatives or are concerned that treatment recommendations. Part 10: Pediatric basic and advanced life sup- relatives may interfere with their resuscitation efforts.419 Evidence port. Resuscitation, 2010; doi:10.1016/j.resuscitation.2010.08.028; in press. 17. Berg RA, Hilwig RW, Kern KB, Babar I, Ewy GA. Simulated mouth-to-mouth ven- about parental presence during resuscitation comes from selected tilation and chest compressions (bystander cardiopulmonary resuscitation) countries and can probably not be generalised to all of Europe, improves outcome in a swine model of prehospital pediatric asphyxial cardiac where there could be different socio-cultural and ethical consid- arrest. Crit Care Med 1999;27:1893–9. 18. Dorph E, Wik L, Steen PA. Effectiveness of ventilation-compression ratios 1:5 erations. and 2:15 in simulated single rescuer paediatric resuscitation. Resuscitation 2002;54:259–64. Family presence guidelines 19. Turner I, Turner S, Armstrong V. Does the compression to ventilation ratio affect the quality of CPR: a simulation study. Resuscitation 2002;52:55–62. 20. Babbs CF, Kern KB. Optimum compression to ventilation ratios in CPR under When relatives are allowed in the resuscitation room, a dedi- realistic, practical conditions: a physiological and mathematical analysis. cated member of the resuscitation team should be present with the Resuscitation 2002;54:147–57. parents to explain the process in an empathetic manner, ensuring 21. Babbs CF, Nadkarni V. Optimizing chest compression to rescue ventilation ratios during one-rescuer CPR by professionals and lay persons: children are that the parents do not interfere with or distract the resuscitation not just little adults. Resuscitation 2004;61:173–81. process. If the presence of the parents is impeding the progress of 22. Kitamura T, Iwami T, Kawamura T, et al. Conventional and chest-compression- the resuscitation, they should be sensitively asked to leave. When only cardiopulmonary resuscitation by bystanders for children who have out- of-hospital cardiac arrests: a prospective, nationwide, population-based cohort appropriate, physical contact with the child should be allowed and, study. Lancet 2010. wherever possible, the parents should be allowed to be with their 23. Houri PK, Frank LR, Menegazzi JJ, Taylor R. A randomized, controlled trial of dying child at the final moment.411,420–423 two-thumb vs two-finger chest compression in a swine infant model of cardiac arrest [see comment]. Prehosp Emerg Care 1997;1:65–7. The leader of the resuscitation team, not the parents, will decide 24. David R. Closed chest cardiac massage in the newborn infant. Pediatrics when to stop the resuscitation; this should be expressed with sen- 1988;81:552–4. sitivity and understanding. After the event, the team should be 25. Dorfsman ML, Menegazzi JJ, Wadas RJ, Auble TE. Two-thumb vs two-finger chest compression in an infant model of prolonged cardiopulmonary resusci- debriefed, to enable any concerns to be expressed and for the team tation. Acad Emerg Med 2000;7:1077–82. to reflect on their clinical practice in a supportive environment. 26. Whitelaw CC, Slywka B, Goldsmith LJ. Comparison of a two-finger versus two- thumb method for chest compressions by healthcare providers in an infant mechanical model. Resuscitation 2000;43:213–6. References 27. Menegazzi JJ, Auble TE, Nicklas KA, Hosack GM, Rack L, Goode JS. Two-thumb versus two-finger chest compression during CRP in a swine infant model of 1. European Resuscitation Council. Paediatric life support: (including the recom- cardiac arrest. Ann Emerg Med 1993;22:240–3. mendations for resuscitation of babies at birth). Resuscitation 1998;37:95–6. 28. Stevenson AG, McGowan J, Evans AL, Graham CA. CPR for children: one hand 2. Zideman D, Bingham R, Beattie T, et al. Guidelines for paediatric life support: or two? Resuscitation 2005;64:205–8. a statement by the Paediatric Life Support Working Party of the European 29. Gurnett CA, Atkins DL. Successful use of a biphasic waveform automated exter- Resuscitation Council, 1993. Resuscitation 1994;27:91–105. nal defibrillator in a high-risk child. Am J Cardiol 2000;86:1051–3. 3. Phillips B, Zideman D, Wyllie J, Richmond S, van Reempts P. European 30. Konig B, Benger J, Goldsworthy L. Automatic external defibrillation in a 6 year Resuscitation Council Guidelines 2000 for newly born life support. A state- old. Arch Dis Child 2005;90:310–1. ment from the Paediatric Life Support Working Group and approved by the 31. Atkinson E, Mikysa B, Conway JA, et al. Specificity and sensitivity of automated Executive Committee of the European Resuscitation Council. Resuscitation external defibrillator rhythm analysis in infants and children. Ann Emerg Med 2001;48:235–9. 2003;42:185–96. 4. Phillips B, Zideman D, Garcia-Castrillo L, Felix M, Shwarz-Schwierin V. Euro- 32. Cecchin F, Jorgenson DB, Berul CI, et al. Is arrhythmia detection by automatic pean Resuscitation Council Guidelines 2000 for advanced paediatric life external defibrillator accurate for children? Sensitivity and specificity of an support. A statement from Paediatric Life Support Working Group and automatic external defibrillator algorithm in 696 pediatric arrhythmias. Circu- approved by the Executive Committee of the European Resuscitation Council. lation 2001;103:2483–8. Resuscitation 2001;48:231–4. 33. Atkins DL, Scott WA, Blaufox AD, et al. Sensitivity and specificity of an 5. Biarent D, Bingham R, Richmond S, et al. European Resuscitation Council Guide- automated external defibrillator algorithm designed for pediatric patients. lines for Resuscitation 2005. Section 6. Paediatric life support. Resuscitation Resuscitation 2008;76:168–74. 2005;67:S97–133. 34. Samson R, Berg R, Bingham R. Pediatric Advanced Life Support Task Force ILCoR. 6. American Heart Association in collaboration with International Liaison Com- Use of automated external defibrillators for children: an update. An advisory mittee on Resuscitation. Guidelines for cardiopulmonary resuscitation and statement from the Pediatric Advanced Life Support Task Force, International emergency cardiovascular care – an international consensus on science. Resus- Liaison Committee on Resuscitation. Resuscitation 2003;57:237–43. citation 2000;46:3–430. 35. Jorgenson D, Morgan C, Snyder D, et al. Energy attenuator for pediatric 7. American Heart Association in collaboration with International Liaison Com- application of an automated external defibrillator. Crit Care Med 2002;30: mittee on Resuscitation. Guidelines 2000 for cardiopulmonary resuscitation S145–7.
- 164. 1382 D. Biarent et al. / Resuscitation 81 (2010) 1364–1388 36. Tang W, Weil MH, Jorgenson D, et al. Fixed-energy biphasic waveform defib- 66. Hunt EA, Zimmer KP, Rinke ML, et al. Transition from a traditional code team rillation in a pediatric model of cardiac arrest and resuscitation. Crit Care Med to a medical emergency team and categorization of cardiopulmonary arrests 2002;30:2736–41. in a children’s center. Arch Pediatr Adolesc Med 2008;162:117–22. 37. Berg RA, Chapman FW, Berg MD, et al. Attenuated adult biphasic shocks com- 67. Sharek PJ, Parast LM, Leong K, et al. Effect of a rapid response team on hospital- pared with weight-based monophasic shocks in a swine model of prolonged wide mortality and code rates outside the ICU in a Children’s Hospital. JAMA pediatric ventricular fibrillation. Resuscitation 2004;61:189–97. 2007;298:2267–74. 38. Berg RA, Samson RA, Berg MD, et al. Better outcome after pediatric defibrillation 68. Brilli RJ, Gibson R, Luria JW, et al. Implementation of a medical emergency dosage than adult dosage in a swine model of pediatric ventricular fibrillation. team in a large pediatric teaching hospital prevents respiratory and car- J Am Coll Cardiol 2005;45:786–9. diopulmonary arrests outside the intensive care unit. Pediatr Crit Care Med 39. Bar-Cohen Y, Walsh EP, Love BA, Cecchin F. First appropriate use of automated 2007;8:236–46, quiz 47. external defibrillator in an infant. Resuscitation 2005;67:135–7. 69. Tibballs J, Kinney S, Duke T, Oakley E, Hennessy M. Reduction of paediatric in- 40. Divekar A, Soni R. Successful parental use of an automated external defibrillator patient cardiac arrest and death with a medical emergency team: preliminary for an infant with long-QT syndrome. Pediatrics 2006;118:e526–9. results. Arch Dis Child 2005;90:1148–52. 41. Atkins DL, Everson-Stewart S, Sears GK, et al. Epidemiology and outcomes 70. Carcillo JA. Pediatric septic shock and multiple organ failure. Crit Care Clin from out-of-hospital cardiac arrest in children: the Resuscitation Outcomes 2003;19:413–40, viii. Consortium Epistry-Cardiac Arrest. Circulation 2009;119:1484–91. 71. Tibballs J, Russell P. Reliability of pulse palpation by healthcare personnel to 42. Rodriguez-Nunez A, Lopez-Herce J, Garcia C, Dominguez P, Carrillo A, Bellon diagnose paediatric cardiac arrest. Resuscitation 2009;80:61–4. JM. Pediatric defibrillation after cardiac arrest: initial response and outcome. 72. Eberle B, Dick WF, Schneider T, Wisser G, Doetsch S, Tzanova I. Checking the Crit Care 2006;10:R113. carotid pulse check: diagnostic accuracy of first responders in patients with 43. Samson RA, Nadkarni VM, Meaney PA, Carey SM, Berg MD, Berg RA. Out- and without a pulse. Resuscitation 1996;33:107–16. comes of in-hospital ventricular fibrillation in children. N Engl J Med 73. Moule P. Checking the carotid pulse: diagnostic accuracy in students of the 2006;354:2328–39. healthcare professions. Resuscitation 2000;44:195–201. 44. Rea TD, Helbock M, Perry S, et al. Increasing use of cardiopulmonary resuscita- 74. Lapostolle F, Le Toumelin P, Agostinucci JM, Catineau J, Adnet F. Basic car- tion during out-of-hospital ventricular fibrillation arrest: survival implications diac life support providers checking the carotid pulse: performance, degree of of guideline changes. Circulation 2006;114:2760–5. conviction, and influencing factors. Acad Emerg Med 2004;11:878–80. 45. Menegazzi JJ, Hsieh M, Niemann JT, Swor RA. Derivation of clinical predictors 75. Frederick K, Bixby E, Orzel MN, Stewart-Brown S, Willett K. Will changing the of failed rescue shock during out-of-hospital ventricular fibrillation. Prehosp emphasis from ‘pulseless’ to ‘no signs of circulation’ improve the recall scores Emerg Care 2008;12:347–51. for effective life support skills in children? Resuscitation 2002;55:255–61. 46. Rea TD, Shah S, Kudenchuk PJ, Copass MK, Cobb LA. Automated external 76. Tsung JW, Blaivas M. Feasibility of correlating the pulse check with focused defibrillators: to what extent does the algorithm delay CPR? Ann Emerg Med point-of-care echocardiography during pediatric cardiac arrest: a case series. 2005;46:132–41. Resuscitation 2008;77:264–9. 47. Becker L, Gold LS, Eisenberg M, White L, Hearne T, Rea T. Ventricular fib- 77. Dung NM, Day NPJ, Tam DTH, et al. Fluid replacement in dengue shock syn- rillation in King County, Washington: a 30-year perspective. Resuscitation drome: a randomized, double-blind comparison of four intravenous-fluid 2008;79:22–7. regimens. Clin Infect Dis 1999;29:787–94. 48. Rossano J, Quan L, Schiff M, MA K, DL A. Survival is not correlated with defib- 78. Ngo NT, Cao XT, Kneen R, et al. Acute management of dengue shock syndrome: rillation dosing in pediatric out-of-hospital ventricular fibrillation. Circulation a randomized double-blind comparison of 4 intravenous fluid regimens in the 2003;108. IV-320-1. first hour. Clin Infect Dis 2001;32:204–13. 49. Clark CB, Zhang Y, Davies LR, Karlsson G, Kerber RE. Pediatric transthoracic 79. Wills BA, Nguyen MD, Ha TL, et al. Comparison of three fluid solutions for defibrillation: biphasic versus monophasic waveforms in an experimental resuscitation in dengue shock syndrome. N Engl J Med 2005;353:877–89. model. Resuscitation 2001;51:159–63. 80. Upadhyay M, Singhi S, Murlidharan J, Kaur N, Majumdar S. Randomized eval- 50. Berg MD, Samson RA, Meyer RJ, Clark LL, Valenzuela TD, Berg RA. Pediatric uation of fluid resuscitation with crystalloid (saline) and colloid (polymer defibrillation doses often fail to terminate prolonged out-of-hospital ventric- from degraded gelatin in saline) in pediatric septic shock. Indian Pediatr ular fibrillation in children. Resuscitation 2005;67:63–7. 2005;42:223–31. 51. Schneider T, Martens PR, Paschen H, et al. Multicenter, randomized, controlled 81. Rechner JA, Loach VJ, Ali MT, Barber VS, Young JD, Mason DG. A comparison of trial of 150-J biphasic shocks compared with 200- to 360-J monopha- the laryngeal mask airway with facemask and oropharyngeal airway for man- sic shocks in the resuscitation of out-of-hospital cardiac arrest victims. ual ventilation by critical care nurses in children. Anaesthesia 2007;62:790–5. Optimized Response to Cardiac Arrest (ORCA) Investigators. Circulation 82. Blevin AE, McDouall SF, Rechner JA, et al. A comparison of the laryngeal mask 2000;102:1780–7. airway with the facemask and oropharyngeal airway for manual ventilation by 52. Faddy SC, Powell J, Craig JC. Biphasic and monophasic shocks for transthoracic first responders in children. Anaesthesia 2009;64:1312–6. defibrillation: a meta analysis of randomised controlled trials. Resuscitation 83. Park C, Bahk JH, Ahn WS, Do SH, Lee KH. The laryngeal mask airway in infants 2003;58:9–16. and children. Can J Anaesth 2001;48:413–7. 53. van Alem AP, Chapman FW, Lank P, Hart AA, Koster RW. A prospective, 84. Harnett M, Kinirons B, Heffernan A, Motherway C, Casey W. Airway complica- randomised and blinded comparison of first shock success of monopha- tions in infants: comparison of laryngeal mask airway and the facemask-oral sic and biphasic waveforms in out-of-hospital cardiac arrest. Resuscitation airway. Can J Anaesth 2000;47:315–8. 2003;58:17–24. 85. Scheller B, Schalk R, Byhahn C, et al. Laryngeal tube suction II for difficult airway 54. Safranek DJ, Eisenberg MS, Larsen MP. The epidemiology of cardiac arrest in management in neonates and small infants. Resuscitation 2009;80:805–10. young adults. Ann Emerg Med 1992;21:1102–6. 86. Hedges JR, Mann NC, Meischke H, Robbins M, Goldberg R, Zapka J. Assessment 55. Redding JS. The choking controversy: critique of evidence on the Heimlich of chest pain onset and out-of-hospital delay using standardized interview maneuver. Crit Care Med 1979;7:475–9. questions: the REACT Pilot Study. Rapid Early Action for Coronary Treatment 56. Kuisma M, Suominen P, Korpela R. Paediatric out-of-hospital cardiac arrests – (REACT) Study Group. Acad Emerg Med 1998;5:773–80. epidemiology and outcome. Resuscitation 1995;30:141–50. 87. Murphy-Macabobby M, Marshall WJ, Schneider C, Dries D. Neuromuscular 57. Sirbaugh PE, Pepe PE, Shook JE, et al. A prospective, population-based study blockade in aeromedical airway management. Ann Emerg Med 1992;21:664–8. of the demographics, epidemiology, management, and outcome of out-of- 88. Sayre M, Weisgerber I. The use of neuromuscular blocking agents by air medical hospital pediatric cardiopulmonary arrest. Ann Emerg Med 1999;33:174–84. services. J Air Med Transp 1992;11:7–11. 58. Hickey RW, Cohen DM, Strausbaugh S, Dietrich AM. Pediatric patients requiring 89. Rose W, Anderson L, Edmond S. Analysis of intubations. Before and after estab- CPR in the prehospital setting. Ann Emerg Med 1995;25:495–501. lishment of a rapid sequence intubation protocol for air medical use. Air Med 59. Young KD, Seidel JS. Pediatric cardiopulmonary resuscitation: a collective J 1994;13:475–8. review. Ann Emerg Med 1999;33:195–205. 90. Sing RF, Reilly PM, Rotondo MF, Lynch MJ, McCans JP, Schwab CW. Out-of- 60. Reis AG, Nadkarni V, Perondi MB, Grisi S, Berg RA. A prospective investigation hospital rapid-sequence induction for intubation of the pediatric patient. Acad into the epidemiology of in-hospital pediatric cardiopulmonary resuscita- Emerg Med 1996;3:41–5. tion using the international Utstein reporting style. Pediatrics 2002;109: 91. Ma OJ, Atchley RB, Hatley T, Green M, Young J, Brady W. Intubation success 200–9. rates improve for an air medical program after implementing the use of neu- 61. Young KD, Gausche-Hill M, McClung CD, Lewis RJ. A prospective, population- romuscular blocking agents. Am J Emerg Med 1998;16:125–7. based study of the epidemiology and outcome of out-of-hospital pediatric 92. Tayal V, Riggs R, Marx J, Tomaszewski C, Schneider R. Rapid-sequence intu- cardiopulmonary arrest. Pediatrics 2004;114:157–64. bation at an emergency medicine residency: success rate and adverse events 62. Richman PB, Nashed AH. The etiology of cardiac arrest in children and during a two-year period. Acad Emerg Med 1999;6:31–7. young adults: special considerations for ED management. Am J Emerg Med 93. Wang HE, Sweeney TA, O’Connor RE, Rubinstein H. Failed prehospital intuba- 1999;17:264–70. tions: an analysis of emergency department courses and outcomes. Prehosp 63. Engdahl J, Bang A, Karlson BW, Lindqvist J, Herlitz J. Characteristics and Emerg Care 2001;5:134–41. outcome among patients suffering from out of hospital cardiac arrest of non- 94. Kaye K, Frascone RJ, Held T. Prehospital rapid-sequence intubation: a pilot cardiac aetiology. Resuscitation 2003;57:33–41. training program. Prehosp Emerg Care 2003;7:235–40. 64. Tibballs J, Kinney S. Reduction of hospital mortality and of preventable car- 95. Wang HE, Kupas DF, Paris PM, Bates RR, Costantino JP, Yealy DM. Multivari- diac arrest and death on introduction of a pediatric medical emergency team. ate predictors of failed prehospital endotracheal intubation. Acad Emerg Med Pediatr Crit Care Med 2009;10:306–12. 2003;10:717–24. 65. Chan PS, Jain R, Nallmothu BK, Berg RA, Sasson C. Rapid response teams: a 96. Pepe P, Zachariah B, Chandra N. Invasive airway technique in resuscitation. Ann systematic review and meta-analysis. Arch Intern Med 2010;170:18–26. Emerg Med 1991;22:393–403.
- 165. D. Biarent et al. / Resuscitation 81 (2010) 1364–1388 1383 97. Eich C, Roessler M, Nemeth M, Russo SG, Heuer JF, Timmermann A. Character- 130. Borke WB, Munkeby BH, Morkrid L, Thaulow E, Saugstad OD. Resuscitation istics and outcome of prehospital paediatric tracheal intubation attended by with 100% O(2) does not protect the myocardium in hypoxic newborn piglets. anaesthesia-trained emergency physicians. Resuscitation 2009;80:1371–7. Arch Dis Child Fetal Neonatal Ed 2004;89:F156–60. 98. Sagarin MJ, Chiang V, Sakles JC, et al. Rapid sequence intubation for pediatric 131. O’Neill JF, Deakin CD. Do we hyperventilate cardiac arrest patients? Resuscita- emergency airway management. Pediatr Emerg Care 2002;18:417–23. tion 2007;73:82–5. 99. Moynihan RJ, Brock-Utne JG, Archer JH, Feld LH, Kreitzman TR. The effect of 132. Stockinger ZT, McSwain Jr NE. Prehospital endotracheal intubation for cricoid pressure on preventing gastric insufflation in infants and children. trauma does not improve survival over bag-valve-mask ventilation. J Trauma Anesthesiology 1993;78:652–6. 2004;56:531–6. 100. Salem MR, Joseph NJ, Heyman HJ, Belani B, Paulissian R, Ferrara TP. Cricoid 133. Pitetti R, Glustein JZ, Bhende MS. Prehospital care and outcome of pediatric compression is effective in obliterating the esophageal lumen in the presence out-of-hospital cardiac arrest. Prehosp Emerg Care 2002;6:283–90. of a nasogastric tube. Anesthesiology 1985;63:443–6. 134. Cooper A, DiScala C, Foltin G, Tunik M, Markenson D, Welborn C. Prehospital 101. Walker RW, Ravi R, Haylett K. Effect of cricoid force on airway calibre in chil- endotracheal intubation for severe head injury in children: a reappraisal. Semin dren: a bronchoscopic assessment. Br J Anaesth 2010;104:71–4. Pediatr Surg 2001;10:3–6. 102. Khine HH, Corddry DH, Kettrick RG, et al. Comparison of cuffed and uncuffed 135. DiRusso SM, Sullivan T, Risucci D, Nealon P, Slim M. Intubation of pediatric endotracheal tubes in young children during general anesthesia. Anesthesiol- trauma patients in the field: predictor of negative outcome despite risk strati- ogy 1997;86:627–31, discussion 27A. fication. J Trauma 2005;59:84–90, discussion – 1. 103. Weiss M, Dullenkopf A, Fischer JE, Keller C, Gerber AC. Prospective randomized 136. Bhende MS, Thompson AE, Orr RA. Utility of an end-tidal carbon dioxide controlled multi-centre trial of cuffed or uncuffed endotracheal tubes in small detector during stabilization and transport of critically ill children. Pediatrics children. Br J Anaesth 2009;103:867–73. 1992;89:1042–4. 104. Duracher C, Schmautz E, Martinon C, Faivre J, Carli P, Orliaguet G. Evaluation of 137. Bhende MS, LaCovey DC. End-tidal carbon dioxide monitoring in the prehos- cuffed tracheal tube size predicted using the Khine formula in children. Paediatr pital setting. Prehosp Emerg Care 2001;5:208–13. Anaesth 2008;18:113–8. 138. Ornato JP, Shipley JB, Racht EM, et al. Multicenter study of a portable, hand- 105. Dullenkopf A, Kretschmar O, Knirsch W, et al. Comparison of tracheal tube cuff size, colorimetric end-tidal carbon dioxide detection device. Ann Emerg Med diameters with internal transverse diameters of the trachea in children. Acta 1992;21:518–23. Anaesthesiol Scand 2006;50:201–5. 139. Gonzalez del Rey JA, Poirier MP, Digiulio GA. Evaluation of an ambu-bag valve 106. Dullenkopf A, Gerber AC, Weiss M. Fit and seal characteristics of a new pae- with a self-contained, colorimetric end-tidal CO2 system in the detection of diatric tracheal tube with high volume-low pressure polyurethane cuff. Acta airway mishaps: an animal trial. Pediatr Emerg Care 2000;16:121–3. Anaesthesiol Scand 2005;49:232–7. 140. Bhende MS, Thompson AE. Evaluation of an end-tidal CO2 detector during 107. Salgo B, Schmitz A, Henze G, et al. Evaluation of a new recommendation for pediatric cardiopulmonary resuscitation. Pediatrics 1995;95:395–9. improved cuffed tracheal tube size selection in infants and small children. Acta 141. Bhende MS, Karasic DG, Karasic RB. End-tidal carbon dioxide changes during Anaesthesiol Scand 2006;50:557–61. cardiopulmonary resuscitation after experimental asphyxial cardiac arrest. Am 108. Luten RC, Wears RL, Broselow J, et al. Length-based endotracheal tube and J Emerg Med 1996;14:349–50. emergency equipment in pediatrics. Ann Emerg Med 1992;21:900–4. 142. DeBehnke DJ, Hilander SJ, Dobler DW, Wickman LL, Swart GL. The hemody- 109. Deakers TW, Reynolds G, Stretton M, Newth CJ. Cuffed endotracheal tubes in namic and arterial blood gas response to asphyxiation: a canine model of pediatric intensive care. J Pediatr 1994;125:57–62. pulseless electrical activity. Resuscitation 1995;30:169–75. 110. Newth CJ, Rachman B, Patel N, Hammer J. The use of cuffed versus uncuffed 143. Ornato JP, Garnett AR, Glauser FL. Relationship between cardiac output and the endotracheal tubes in pediatric intensive care. J Pediatr 2004;144:333–7. end-tidal carbon dioxide tension. Ann Emerg Med 1990;19:1104–6. 111. Dorsey DP, Bowman SM, Klein MB, Archer D, Sharar SR. Perioperative use of 144. Mauer D, Schneider T, Elich D, Dick W. Carbon dioxide levels during cuffed endotracheal tubes is advantageous in young pediatric burn patients. pre-hospital active compression – decompression versus standard cardiopul- Burns 2010. monary resuscitation. Resuscitation 1998;39:67–74. 112. Mhanna MJ, Zamel YB, Tichy CM, Super DM. The “air leak” test around the 145. Kolar M, Krizmaric M, Klemen P, Grmec S. Partial pressure of end-tidal car- endotracheal tube, as a predictor of postextubation stridor, is age dependent bon dioxide successful predicts cardiopulmonary resuscitation in the field: a in children. Crit Care Med 2002;30:2639–43. prospective observational study. Crit Care 2008;12:R115. 113. Katz SH, Falk JL. Misplaced endotracheal tubes by paramedics in an urban 146. Callaham M, Barton C, Matthay M. Effect of epinephrine on the ability of end- emergency medical services system. Ann Emerg Med 2001;37:32–7. tidal carbon dioxide readings to predict initial resuscitation from cardiac arrest. 114. Gausche M, Lewis RJ, Stratton SJ, et al. Effect of out-of-hospital pediatric endo- Crit Care Med 1992;20:337–43. tracheal intubation on survival and neurological outcome: a controlled clinical 147. Cantineau JP, Merckx P, Lambert Y, Sorkine M, Bertrand C, Duvaldestin P. Effect trial. JAMA 2000;283:783–90. of epinephrine on end-tidal carbon dioxide pressure during prehospital car- 115. Kelly JJ, Eynon CA, Kaplan JL, de Garavilla L, Dalsey WC. Use of tube con- diopulmonary resuscitation. Am J Emerg Med 1994;12:267–70. densation as an indicator of endotracheal tube placement. Ann Emerg Med 148. Chase PB, Kern KB, Sanders AB, Otto CW, Ewy GA. Effects of graded doses of 1998;31:575–8. epinephrine on both noninvasive and invasive measures of myocardial per- 116. Andersen KH, Hald A. Assessing the position of the tracheal tube: the reliability fusion and blood flow during cardiopulmonary resuscitation. Crit Care Med of different methods. Anaesthesia 1989;44:984–5. 1993;21:413–9. 117. Andersen KH, Schultz-Lebahn T. Oesophageal intubation can be undetected by 149. Gonzalez ER, Ornato JP, Garnett AR, Levine RL, Young DS, Racht EM. Dose- auscultation of the chest. Acta Anaesthesiol Scand 1994;38:580–2. dependent vasopressor response to epinephrine during CPR in human beings. 118. Hartrey R, Kestin IG. Movement of oral and nasal tracheal tubes as a result of Ann Emerg Med 1989;18:920–6. changes in head and neck position. Anaesthesia 1995;50:682–7. 150. Lindberg L, Liao Q, Steen S. The effects of epinephrine/norepinephrine on 119. Van de Louw A, Cracco C, Cerf C, et al. Accuracy of pulse oximetry in the inten- end-tidal carbon dioxide concentration, coronary perfusion pressure and sive care unit. Intensive Care Med 2001;27:1606–13. pulmonary arterial blood flow during cardiopulmonary resuscitation. Resusci- 120. Seguin P, Le Rouzo A, Tanguy M, Guillou YM, Feuillu A, Malledant Y. Evidence tation 2000;43:129–40. for the need of bedside accuracy of pulse oximetry in an intensive care unit. 151. Falk JL, Rackow EC, Weil MH. End-tidal carbon dioxide concentration during Crit Care Med 2000;28:703–6. cardiopulmonary resuscitation. N Engl J Med 1988;318:607–11. 121. Tan A, Schulze A, O’Donnell CP, Davis PG. Air versus oxygen for resuscitation 152. Sharieff GQ, Rodarte A, Wilton N, Bleyle D. The self-inflating bulb as an airway of infants at birth. Cochrane Database Syst Rev 2004:CD002273. adjunct: is it reliable in children weighing less than 20 kilograms? Acad Emerg 122. Ramji S, Rasaily R, Mishra PK, et al. Resuscitation of asphyxiated newborns with Med 2003;10:303–8. room air or 100% oxygen at birth: a multicentric clinical trial. Indian Pediatr 153. Sharieff GQ, Rodarte A, Wilton N, Silva PD, Bleyle D. The self-inflating bulb as an 2003;40:510–7. esophageal detector device in children weighing more than twenty kilograms: 123. Vento M, Asensi M, Sastre J, Garcia-Sala F, Pallardo FV, Vina J. Resuscitation a comparison of two techniques. Ann Emerg Med 2003;41:623–9. with room air instead of 100% oxygen prevents oxidative stress in moderately 154. Poirier MP, Gonzalez Del-Rey JA, McAneney CM, DiGiulio GA. Utility of moni- asphyxiated term neonates. Pediatrics 2001;107:642–7. toring capnography, pulse oximetry, and vital signs in the detection of airway 124. Saugstad OD. Resuscitation of newborn infants with room air or oxygen. Semin mishaps: a hyperoxemic animal model. Am J Emerg Med 1998;16:350–2. Neonatol 2001;6:233–9. 155. Lillis KA, Jaffe DM. Prehospital intravenous access in children. Ann Emerg Med 125. Aufderheide TP, Sigurdsson G, Pirrallo RG, et al. Hyperventilation- 1992;21:1430–4. induced hypotension during cardiopulmonary resuscitation. Circulation 156. Neufeld JD, Marx JA, Moore EE, Light AI. Comparison of intraosseous, central, 2004;109:1960–5. and peripheral routes of crystalloid infusion for resuscitation of hemorrhagic 126. Aufderheide TP, Lurie KG. Death by hyperventilation: a common and life- shock in a swine model. J Trauma 1993;34:422–8. threatening problem during cardiopulmonary resuscitation. Crit Care Med 157. Hedges JR, Barsan WB, Doan LA, et al. Central versus peripheral intravenous 2004;32:S345–51. routes in cardiopulmonary resuscitation. Am J Emerg Med 1984;2:385–90. 127. Wik L, Kramer-Johansen J, Myklebust H, et al. Quality of cardiopul- 158. Kanter RK, Zimmerman JJ, Strauss RH, Stoeckel KA. Pediatric emergency intra- monary resuscitation during out-of-hospital cardiac arrest. JAMA 2005;293: venous access. Evaluation of a protocol. Am J Dis Child 1986;140:132–4. 299–304. 159. Banerjee S, Singhi SC, Singh S, Singh M. The intraosseous route is a suitable 128. Abella BS, Alvarado JP, Myklebust H, et al. Quality of cardiopulmonary resusci- alternative to intravenous route for fluid resuscitation in severely dehydrated tation during in-hospital cardiac arrest. JAMA 2005;293:305–10. children. Indian Pediatr 1994;31:1511–20. 129. Abella BS, Sandbo N, Vassilatos P, et al. Chest compression rates during 160. Glaeser PW, Hellmich TR, Szewczuga D, Losek JD, Smith DS. Five-year experi- cardiopulmonary resuscitation are suboptimal: a prospective study during ence in prehospital intraosseous infusions in children and adults. Ann Emerg in-hospital cardiac arrest. Circulation 2005;111:428–34. Med 1993;22:1119–24.
- 166. 1384 D. Biarent et al. / Resuscitation 81 (2010) 1364–1388 161. Guy J, Haley K, Zuspan SJ. Use of intraosseous infusion in the pediatric trauma 190. Katz LM, Wang Y, Ebmeyer U, Radovsky A, Safar P. Glucose plus insulin infu- patient. J Pediatr Surg 1993;28:158–61. sion improves cerebral outcome after asphyxial cardiac arrest. Neuroreport 162. Orlowski JP, Julius CJ, Petras RE, Porembka DT, Gallagher JM. The safety of 1998;9:3363–7. intraosseous infusions: risks of fat and bone marrow emboli to the lungs. Ann 191. Longstreth Jr WT, Copass MK, Dennis LK, Rauch-Matthews ME, Stark MS, Emerg Med 1989;18:1062–7. Cobb LA. Intravenous glucose after out-of-hospital cardiopulmonary arrest: 163. Orlowski JP, Porembka DT, Gallagher JM, Lockrem JD, VanLente F. Compar- a community-based randomized trial. Neurology 1993;43:2534–41. ison study of intraosseous, central intravenous, and peripheral intravenous 192. Chang YS, Park WS, Ko SY, et al. Effects of fasting and insulin-induced hypo- infusions of emergency drugs. Am J Dis Child 1990;144:112–7. glycemia on brain cell membrane function and energy metabolism during 164. Abe KK, Blum GT, Yamamoto LG. Intraosseous is faster and easier than umbilical hypoxia-ischemia in newborn piglets. Brain Res 1999;844:135–42. venous catheterization in newborn emergency vascular access models. Am J 193. Cherian L, Goodman JC, Robertson CS. Hyperglycemia increases brain injury Emerg Med 2000;18:126–9. caused by secondary ischemia after cortical impact injury in rats. Crit Care 165. Ellemunter H, Simma B, Trawoger R, Maurer H. Intraosseous lines in preterm Med 1997;25:1378–83. and full term neonates. Arch Dis Child Fetal Neonatal Ed 1999;80:F74–5. 194. Paul T, Bertram H, Bokenkamp R, Hausdorf G. Supraventricular tachycardia in 166. Fiorito BA, Mirza F, Doran TM, et al. Intraosseous access in the setting of pedi- infants, children and adolescents: diagnosis, and pharmacological and inter- atric critical care transport. Pediatr Crit Care Med 2005;6:50–3. ventional therapy. Paediatr Drugs 2000;2:171–81. 167. Horton MA, Beamer C. Powered intraosseous insertion provides safe and effec- 195. Losek JD, Endom E, Dietrich A, Stewart G, Zempsky W, Smith K. Adenosine and tive vascular access for pediatric emergency patients. Pediatr Emerg Care pediatric supraventricular tachycardia in the emergency department: multi- 2008;24:347–50. center study and review. Ann Emerg Med 1999;33:185–91. 168. Frascone RJ, Jensen J, Wewerka SS, Salzman JG. Use of the pediatric EZ-IO nee- 196. Roberts JR, Greenburg MI, Knaub M, Baskin SI. Comparison of the pharmacolog- dle by emergency medical services providers. Pediatr Emerg Care 2009;25: ical effects of epinephrine administered by the intravenous and endotracheal 329–32. routes. JACEP 1978;7:260–4. 169. Cameron JL, Fontanarosa PB, Passalaqua AM. A comparative study of peripheral 197. Zaritsky A. Pediatric resuscitation pharmacology. Members of the Medications to central circulation delivery times between intraosseous and intravenous in Pediatric Resuscitation Panel. Ann Emerg Med 1993;22:445–55. injection using a radionuclide technique in normovolemic and hypovolemic 198. Manisterski Y, Vaknin Z, Ben-Abraham R, et al. Endotracheal epinephrine: a canines. J Emerg Med 1989;7:123–7. call for larger doses. Anesth Analg 2002;95:1037–41, table of contents. 170. Warren DW, Kissoon N, Sommerauer JF, Rieder MJ. Comparison of fluid infusion 199. Efrati O, Ben-Abraham R, Barak A, et al. Endobronchial adrenaline: should it be rates among peripheral intravenous and humerus, femur, malleolus, and tibial reconsidered? Dose response and haemodynamic effect in dogs. Resuscitation intraosseous sites in normovolemic and hypovolemic piglets. Ann Emerg Med 2003;59:117–22. 1993;22:183–6. 200. Patterson MD, Boenning DA, Klein BL, et al. The use of high-dose epinephrine for 171. Brickman KR, Krupp K, Rega P, Alexander J, Guinness M. Typing and screening patients with out-of-hospital cardiopulmonary arrest refractory to prehospital of blood from intraosseous access. Ann Emerg Med 1992;21:414–7. interventions. Pediatr Emerg Care 2005;21:227–37. 172. Johnson L, Kissoon N, Fiallos M, Abdelmoneim T, Murphy S. Use of intraosseous 201. Perondi MB, Reis AG, Paiva EF, Nadkarni VM, Berg RA. A comparison of high- blood to assess blood chemistries and hemoglobin during cardiopulmonary dose and standard-dose epinephrine in children with cardiac arrest. N Engl J resuscitation with drug infusions. Crit Care Med 1999;27:1147–52. Med 2004;350:1722–30. 173. Ummenhofer W, Frei FJ, Urwyler A, Drewe J. Are laboratory values in bone mar- 202. Carpenter TC, Stenmark KR. High-dose epinephrine is not superior to standard- row aspirate predictable for venous blood in paediatric patients? Resuscitation dose epinephrine in pediatric in-hospital cardiopulmonary arrest. Pediatrics 1994;27:123–8. 1997;99:403–8. 174. Abdelmoneim T, Kissoon N, Johnson L, Fiallos M, Murphy S. Acid-base status of 203. Dieckmann RA, Vardis R. High-dose epinephrine in pediatric out-of-hospital blood from intraosseous and mixed venous sites during prolonged cardiopul- cardiopulmonary arrest. Pediatrics 1995;95:901–13. monary resuscitation and drug infusions. Crit Care Med 1999;27:1923–8. 204. Berg RA, Otto CW, Kern KB, et al. High-dose epinephrine results in greater 175. Voelckel WG, Lindner KH, Wenzel V, et al. Intraosseous blood gases during early mortality after resuscitation from prolonged cardiac arrest in pigs: a hypothermia: correlation with arterial, mixed venous, and sagittal sinus blood. prospective, randomized study. Crit Care Med 1994;22:282–90. Crit Care Med 2000;28:2915–20. 205. Rubertsson S, Wiklund L. Hemodynamic effects of epinephrine in combination 176. Kissoon N, Peterson R, Murphy S, Gayle M, Ceithaml E, Harwood-Nuss A. with different alkaline buffers during experimental, open-chest, cardiopul- Comparison of pH and carbon dioxide tension values of central venous monary resuscitation. Crit Care Med 1993;21:1051–7. and intraosseous blood during changes in cardiac output. Crit Care Med 206. Somberg JC, Timar S, Bailin SJ, et al. Lack of a hypotensive effect with rapid 1994;22:1010–5. administration of a new aqueous formulation of intravenous amiodarone. Am 177. Eisenkraft A, Gilat E, Chapman S, Baranes S, Egoz I, Levy A. Efficacy of the bone J Cardiol 2004;93:576–81. injection gun in the treatment of organophosphate poisoning. Biopharm Drug 207. Yap S-C, Hoomtje T, Sreeram N. Polymorphic ventricular tachycardia after use Dispos 2007;28:145–50. of intravenous amiodarone for postoperative junctional ectopic tachycardia. 178. Brenner T, Bernhard M, Helm M, et al. Comparison of two intraosseous infusion Int J Cardiol 2000;76:245–7. systems for adult emergency medical use. Resuscitation 2008;78:314–9. 208. Dauchot P, Gravenstein JS. Effects of atropine on the electrocardiogram in dif- 179. Venkataraman ST, Orr RA, Thompson AE. Percutaneous infraclavicular sub- ferent age groups. Clin Pharmacol Ther 1971;12:274–80. clavian vein catheterization in critically ill infants and children. J Pediatr 209. Yilmaz O, Eser M, Sahiner A, Altintop L, Yesildag O. Hypotension, bradycardia 1988;113:480–5. and syncope caused by honey poisoning. Resuscitation 2006;68:405–8. 180. Fleisher G, Caputo G, Baskin M. Comparison of external jugular and periph- 210. Brady WJ, Swart G, DeBehnke DJ, Ma OJ, Aufderheide TP. The efficacy of eral venous administration of sodium bicarbonate in puppies. Crit Care Med atropine in the treatment of hemodynamically unstable bradycardia and atri- 1989;17:251–4. oventricular block: prehospital and emergency department considerations. 181. Stenzel JP, Green TP, Fuhrman BP, Carlson PE, Marchessault RP. Percutaneous Resuscitation 1999;41:47–55. femoral venous catheterizations: a prospective study of complications. J Pedi- 211. Smith I, Monk TG, White PF. Comparison of transesophageal atrial pacing with atr 1989;114:411–5. anticholinergic drugs for the treatment of intraoperative bradycardia. Anesth 182. Kleinman ME, Oh W, Stonestreet BS. Comparison of intravenous and endotra- Analg 1994;78:245–52. cheal epinephrine during cardiopulmonary resuscitation in newborn piglets. 212. Chadda KD, Lichstein E, Gupta PK, Kourtesis P. Effects of atropine in patients Crit Care Med 1999;27:2748–54. with bradyarrhythmia complicating myocardial infarction: usefulness of an 183. Hahnel JH, Lindner KH, Schurmann C, Prengel A, Ahnefeld FW. Plasma lido- optimum dose for overdrive. Am J Med 1977;63:503–10. caine levels and PaO2 with endobronchial administration: dilution with normal 213. Stulz PM, Scheidegger D, Drop LJ, Lowenstein E, Laver MB. Ventricular pump saline or distilled water? Ann Emerg Med 1990;19:1314–7. performance during hypocalcemia: clinical and experimental studies. J Thorac 184. Jasani MS, Nadkarni VM, Finkelstein MS, Mandell GA, Salzman SK, Norman ME. Cardiovasc Surg 1979;78:185–94. Effects of different techniques of endotracheal epinephrine administration in 214. van Walraven C, Stiell IG, Wells GA, Hebert PC, Vandemheen K. Do advanced pediatric porcine hypoxic-hypercarbic cardiopulmonary arrest. Crit Care Med cardiac life support drugs increase resuscitation rates from in-hospital cardiac 1994;22:1174–80. arrest? The OTAC Study Group. Ann Emerg Med 1998;32:544–53. 185. Steinfath M, Scholz J, Schulte am Esch J, Laer S, Reymann A, Scholz H. The tech- 215. Paraskos JA. Cardiovascular pharmacology III: atropine, calcium, calcium block- nique of endobronchial lidocaine administration does not influence plasma ers, and (beta)-blockers. Circulation 1986;74:IV-86–9. concentration profiles and pharmacokinetic parameters in humans. Resusci- 216. Stueven HA, Thompson B, Aprahamian C, Tonsfeldt DJ, Kastenson EH. The effec- tation 1995;29:55–62. tiveness of calcium chloride in refractory electromechanical dissociation. Ann 186. Carcillo JA, Fields AI. Clinical practice parameters for hemodynamic sup- Emerg Med 1985;14:626–9. port of pediatric and neonatal patients in septic shock. Crit Care Med 217. Stueven HA, Thompson B, Aprahamian C, Tonsfeldt DJ, Kastenson EH. Lack 2002;30:1365–78. of effectiveness of calcium chloride in refractory asystole. Ann Emerg Med 187. Simma B, Burger R, Falk M, Sacher P, Fanconi S. A prospective, random- 1985;14:630–2. ized, and controlled study of fluid management in children with severe head 218. Srinivasan V, Morris MC, Helfaer MA, Berg RA, Nadkarni VM. Calcium injury: lactated Ringer’s solution versus hypertonic saline. Crit Care Med use during in-hospital pediatric cardiopulmonary resuscitation: a report 1998;26:1265–70. from the National Registry of Cardiopulmonary Resuscitation. Pediatrics 188. Myburgh J, Cooper DJ, Finfer S, et al. Saline or albumin for fluid resuscitation 2008;121:e1144–51. in patients with traumatic brain injury. N Engl J Med 2007;357:874–84. 219. de Mos N, van Litsenburg RR, McCrindle B, Bohn DJ, Parshuram CS. Pediatric in- 189. Rocha E, Silva M. Hypertonic saline resuscitation. Medicina 1998;58: intensive-care-unit cardiac arrest: incidence, survival, and predictive factors. 393–402. Crit Care Med 2006;34:1209–15.
- 167. D. Biarent et al. / Resuscitation 81 (2010) 1364–1388 1385 220. Meert KL, Donaldson A, Nadkarni V, et al. Multicenter cohort study of in- 251. Callaway CW, Hostler D, Doshi AA, et al. Usefulness of vasopressin admin- hospital pediatric cardiac arrest. Pediatr Crit Care Med 2009;10:544–53. istered with epinephrine during out-of-hospital cardiac arrest. Am J Cardiol 221. Srinivasan V, Spinella PC, Drott HR, Roth CL, Helfaer MA, Nadkarni V. Associ- 2006;98:1316–21. ation of timing, duration, and intensity of hyperglycemia with intensive care 252. Gueugniaud PY, David JS, Chanzy E, et al. Vasopressin and epinephrine unit mortality in critically ill children. Pediatr Crit Care Med 2004;5:329–36. vs. epinephrine alone in cardiopulmonary resuscitation. N Engl J Med 222. Krinsley JS. Effect of an intensive glucose management protocol on the mortal- 2008;359:21–30. ity of critically ill adult patients. Mayo Clin Proc 2004;79:992–1000. 253. Mukoyama T, Kinoshita K, Nagao K, Tanjoh K. Reduced effectiveness of vaso- 223. Losek JD. Hypoglycemia and the ABC’S (sugar) of pediatric resuscitation. Ann pressin in repeated doses for patients undergoing prolonged cardiopulmonary Emerg Med 2000;35:43–6. resuscitation. Resuscitation 2009;80:755–61. 224. Finney SJ, Zekveld C, Elia A, Evans TW. Glucose control and mortality in critically 254. Aung K, Htay T. Vasopressin for cardiac arrest: a systematic review and meta- ill patients. JAMA 2003;290:2041–7. analysis. Arch Intern Med 2005;165:17–24. 225. Losert H, Sterz F, Roine RO, et al. Strict normoglycaemic blood glucose levels in 255. Matok I, Vard A, Efrati O, et al. Terlipressin as rescue therapy for the therapeutic management of patients within 12 h after cardiac arrest might intractable hypotension due to septic shock in children. Shock 2005;23: not be necessary. Resuscitation 2008;76:214–20. 305–10. 226. Oksanen T, Skrifvars MB, Varpula T, et al. Strict versus moderate glucose 256. Peters MJ, Booth RA, Petros AJ. Terlipressin bolus induces systemic vasocon- control after resuscitation from ventricular fibrillation. Intensive Care Med striction in septic shock. Pediatr Crit Care Med 2004;5:112–5. 2007;33:2093–100. 257. Rodriguez-Nunez A, Lopez-Herce J, Gil-Anton J, Hernandez A, Rey C. Rescue 227. Beardsall K, Vanhaesebrouck S, Ogilvy-Stuart AL, et al. Early insulin therapy in treatment with terlipressin in children with refractory septic shock: a clinical very-low-birth-weight infants. N Engl J Med 2008;359:1873–84. study. Crit Care 2006;10:R20. 228. Vlasselaers D, Milants I, Desmet L, et al. Intensive insulin therapy for patients in 258. Gil-Anton J, Lopez-Herce J, Morteruel E, Carrillo A, Rodriguez-Nunez A. Pedi- paediatric intensive care: a prospective, randomised controlled study. Lancet atric cardiac arrest refractory to advanced life support: is there a role for 2009;373:547–56. terlipressin? Pediatr Crit Care Med 2010;11:139–41. 229. Gandhi GY, Murad MH, Flynn DN, et al. Effect of perioperative insulin infusion 259. Rodriguez-Nunez A, Fernandez-Sanmartin M, Martinon-Torres F, Gonzalez- on surgical morbidity and mortality: systematic review and meta-analysis of Alonso N, Martinon-Sanchez JM. Terlipressin for catecholamine-resistant randomized trials.7. Mayo Clin Proc 2008;83:418–30. septic shock in children. Intensive Care Med 2004;30:477–80. 230. Griesdale DE, de Souza RJ, van Dam RM, et al. Intensive insulin therapy and 260. Yildizdas D, Yapicioglu H, Celik U, Sertdemir Y, Alhan E. Terlipressin as a rescue mortality among critically ill patients: a meta-analysis including NICE-SUGAR therapy for catecholamine-resistant septic shock in children. Intensive Care study data. CMAJ 2009;180:821–7. Med 2008;34:511–7. 231. Finfer S, Chittock DR, Su SY, et al. Intensive versus conventional glucose control 261. Matok I, Vardi A, Augarten A, et al. Beneficial effects of terlipressin in pro- in critically ill patients. N Engl J Med 2009;360:1283–97. longed pediatric cardiopulmonary resuscitation: a case series. Crit Care Med 232. Allegra J, Lavery R, Cody R, et al. Magnesium sulfate in the treatment of 2007;35:1161–4. refractory ventricular fibrillation in the prehospital setting. Resuscitation 262. Atkins DL, Kerber RE. Pediatric defibrillation: current flow is improved by using 2001;49:245–9. “adult” electrode paddles. Pediatrics 1994;94:90–3. 233. Tzivoni D, Banai S, Schuger C, et al. Treatment of torsade de pointes with 263. Atkins DL, Sirna S, Kieso R, Charbonnier F, Kerber RE. Pediatric defibrillation: magnesium sulfate. Circulation 1988;77:392–7. importance of paddle size in determining transthoracic impedance. Pediatrics 234. Lokesh L, Kumar P, Murki S, Narang A. A randomized controlled trial of sodium 1988;82:914–8. bicarbonate in neonatal resuscitation-effect on immediate outcome. Resusci- 264. Deakin C, Sado D, Petley G, Clewlow F. Determining the optimal paddle force tation 2004;60:219–23. for external defibrillation. Am J Cardiol 2002;90:812–3. 235. Bar-Joseph G, Abramson NS, Kelsey SF, Mashiach T, Craig MT, Safar P. Improved 265. Bennetts SH, Deakin CD, Petley GW, Clewlow F. Is optimal paddle force applied resuscitation outcome in emergency medical systems with increased usage of during paediatric external defibrillation? Resuscitation 2004;60:29–32. sodium bicarbonate during cardiopulmonary resuscitation. Acta Anaesthesiol 266. Berg MD, Banville IL, Chapman FW, et al. Attenuating the defibrillation dosage Scand 2005;49:6–15. decreases postresuscitation myocardial dysfunction in a swine model of pedi- 236. Dorian P, Cass D, Schwartz B, Cooper R, Gelaznikas R, Barr A. Amiodarone as atric ventricular fibrillation. Pediatr Crit Care Med 2008;9:429–34. compared with lidocaine for shock-resistant ventricular fibrillation. N Engl J 267. Atkins DL, Hartley LL, York DK. Accurate recognition and effective treatment Med 2002;346:884–90. of ventricular fibrillation by automated external defibrillators in adolescents. 237. Walsh EP, Saul JP, Sholler GF, et al. Evaluation of a staged treatment protocol Pediatrics 1998;101:393–7. for rapid automatic junctional tachycardia after operation for congenital heart 268. Edelson DP, Abella BS, Kramer-Johansen J, et al. Effects of compression depth disease. J Am Coll Cardiol 1997;29:1046–53. and pre-shock pauses predict defibrillation failure during cardiac arrest. Resus- 238. Wang JD, Fu YC, Jan SL, Chi CS. Verapamil sensitive idiopathic ventricular tachy- citation 2006;71:137–45. cardia in an infant. Jpn Heart J 2003;44:667–71. 269. Eftestol T, Sunde K, Steen PA. Effects of interrupting precordial compressions 239. Chang PM, Silka MJ, Moromisato DY, Bar-Cohen Y. Amiodarone versus pro- on the calculated probability of defibrillation success during out-of-hospital cainamide for the acute treatment of recurrent supraventricular tachycardia cardiac arrest. Circulation 2002;105:2270–3. in pediatric patients. Circ Arrhythm Electrophysiol 2010;3:134–40. 270. Saul JP, Scott WA, Brown S, et al. Intravenous amiodarone for incessant tach- 240. Singh BN, Kehoe R, Woosley RL, Scheinman M, Quart B. Multicenter trial of yarrhythmias in children: a randomized, double-blind, antiarrhythmic drug sotalol compared with procainamide in the suppression of inducible ven- trial. Circulation 2005;112:3470–7. tricular tachycardia: a double-blind, randomized parallel evaluation. Sotalol 271. Pierpont GL, Kruse JA, Nelson DH. Intra-arterial monitoring during car- Multicenter Study Group. Am Heart J 1995;129:87–97. diopulmonary resuscitation. Catheterization Cardiovasc Diagn 1985;11: 241. Luedtke SA, Kuhn RJ, McCaffrey FM. Pharmacologic management of 513–20. supraventricular tachycardias in children. Part 1: Wolff-Parkinson-White and 272. Steiger HV, Rimbach K, Muller E, Breitkreutz R. Focused emergency echocardio- atrioventricular nodal reentry. Ann Pharmacother 1997;31:1227–43. graphy: lifesaving tool for a 14-year-old girl suffering out-of-hospital pulseless 242. Luedtke SA, Kuhn RJ, McCaffrey FM. Pharmacologic management of supraven- electrical activity arrest because of cardiac tamponade. Eur J Emerg Med tricular tachycardias in children. Part 2: Atrial flutter, atrial fibrillation, 2009;16:103–5. and junctional and atrial ectopic tachycardia. Ann Pharmacother 1997;31: 273. Zaritsky A, Nadkarni V, Getson P, Kuehl K. CPR in children. Ann Emerg Med 1347–59. 1987;16:1107–11. 243. Mandapati R, Byrum CJ, Kavey RE, et al. Procainamide for rate control of post- 274. Mogayzel C, Quan L, Graves JR, Tiedeman D, Fahrenbruch C, Herndon P. Out- surgical junctional tachycardia. Pediatr Cardiol 2000;21:123–8. of-hospital ventricular fibrillation in children and adolescents: causes and 244. Wang JN, Wu JM, Tsai YC, Lin CS. Ectopic atrial tachycardia in children. J Formos outcomes. Ann Emerg Med 1995;25:484–91. Med Assoc 2000;99:766–70. 275. Herlitz J, Engdahl J, Svensson L, Young M, Angquist KA, Holmberg S. Charac- 245. Wang R, Schuyler J, Raymond R. The role of the cell membrane bicarbonate teristics and outcome among children suffering from out of hospital cardiac exchanger in NaHCO3 therapy of imipramine cardiac dysfunction. J Toxicol arrest in Sweden. Resuscitation 2005;64:37–40. Clin Toxicol 1997;35:533. 276. Berg RA. Role of mouth-to-mouth rescue breathing in bystander car- 246. Holmes CL, Landry DW, Granton JT. Science review: vasopressin and the diopulmonary resuscitation for asphyxial cardiac arrest. Crit Care Med cardiovascular system. Part 1 – Receptor physiology. Crit Care 2003;7: 2000;28(Suppl.):N193–5. 427–34. 277. Kuisma M, Suominen P, Korpela R. Paediatric out-of-hospital cardiac arrests: 247. Voelckel WG, Lurie KG, McKnite S, et al. Effects of epinephrine and vasopressin epidemiology and outcome. Resuscitation 1995;30:141–50. in a piglet model of prolonged ventricular fibrillation and cardiopulmonary 278. Kyriacou DN, Arcinue EL, Peek C, Kraus JF. Effect of immediate resuscitation on resuscitation. Crit Care Med 2002;30:957–62. children with submersion injury. Pediatrics 1994;94:137–42. 248. Voelckel WG, Lurie KG, McKnite S, et al. Comparison of epinephrine and vaso- 279. Berg RA, Hilwig RW, Kern KB, Ewy GA. Bystander” chest compressions and pressin in a pediatric porcine model of asphyxial cardiac arrest. Crit Care Med assisted ventilation independently improve outcome from piglet asphyxial 2000;28:3777–83. pulseless “cardiac arrest”. Circulation 2000;101:1743–8. 249. Mann K, Berg RA, Nadkarni V. Beneficial effects of vasopressin in prolonged 280. Appleton GO, Cummins RO, Larson MP, Graves JR. CPR and the single rescuer: pediatric cardiac arrest: a case series. Resuscitation 2002;52:149–56. at what age should you “call first” rather than “call fast”? Ann Emerg Med 250. Duncan JM, Meaney P, Simpson P, Berg RA, Nadkarni V, Schexnayder S. Vaso- 1995;25:492–4. pressin for in-hospital pediatric cardiac arrest: results from the American Heart 281. Larsen MP, Eisenberg MS, Cummins RO, Hallstrom AP. Predicting survival Association National Registry of Cardiopulmonary Resuscitation. Pediatr Crit from out-of-hospital cardiac arrest: a graphic model. Ann Emerg Med Care Med 2009;10:191–5. 1993;22:1652–8.
- 168. 1386 D. Biarent et al. / Resuscitation 81 (2010) 1364–1388 282. Cobb LA, Fahrenbruch CE, Walsh TR, et al. Influence of cardiopulmonary resus- 312. Plant LD, Bowers PN, Liu Q, et al. A common cardiac sodium channel variant citation prior to defibrillation in patients with out-of-hospital ventricular associated with sudden infant death in African Americans, SCN5A S1103Y. J fibrillation. JAMA 1999;281:1182–8. Clin Invest 2006;116:430–5. 283. Wik L, Hansen TB, Fylling F, et al. Delaying defibrillation to give basic cardiopul- 313. Tester DJ, Dura M, Carturan E, et al. A mechanism for sudden infant death monary resuscitation to patients with out-of-hospital ventricular fibrillation: syndrome (SIDS): stress-induced leak via ryanodine receptors. Heart Rhythm a randomized trial. JAMA 2003;289:1389–95. 2007;4:733–9. 284. Jacobs IG, Finn JC, Oxer HF, Jelinek GA. CPR before defibrillation in 314. Albert CM, Nam EG, Rimm EB, et al. Cardiac sodium channel gene variants and out-of-hospital cardiac arrest: a randomized trial. Emerg Med Australas sudden cardiac death in women. Circulation 2008;117:16–23. 2005;17:39–45. 315. Chugh SS, Senashova O, Watts A, et al. Postmortem molecular screening in 285. Somberg JC, Bailin SJ, Haffajee CI, et al. Intravenous lidocaine versus intra- unexplained sudden death. J Am Coll Cardiol 2004;43:1625–9. venous amiodarone (in a new aqueous formulation) for incessant ventricular 316. Tester DJ, Spoon DB, Valdivia HH, Makielski JC, Ackerman MJ. Targeted muta- tachycardia. Am J Cardiol 2002;90:853–9. tional analysis of the RyR2-encoded cardiac ryanodine receptor in sudden 286. Kudenchuk PJ, Cobb LA, Copass MK, et al. Amiodarone for resuscitation after unexplained death: a molecular autopsy of 49 medical examiner/coroner’s out-of-hospital cardiac arrest due to ventricular fibrillation. N Engl J Med cases. Mayo Clin Proc 2004;79:1380–4. 1999;341:871–8. 317. Calkins CM, Bensard DD, Partrick DA, Karrer FM. A critical analysis of out- 287. Perry JC, Fenrich AL, Hulse JE, Triedman JK, Friedman RA, Lamberti JJ. Pediatric come for children sustaining cardiac arrest after blunt trauma. J Pediatr Surg use of intravenous amiodarone: efficacy and safety in critically ill patients from 2002;37:180–4. a multicenter protocol. J Am Coll Cardiol 1996;27:1246–50. 318. Crewdson K, Lockey D, Davies G. Outcome from paediatric cardiac arrest asso- 288. Cummins RO, Graves JR, Larsen MP, et al. Out-of-hospital transcutaneous pac- ciated with trauma. Resuscitation 2007;75:29–34. ing by emergency medical technicians in patients with asystolic cardiac arrest. 319. Lopez-Herce Cid J, Dominguez Sampedro P, Rodriguez Nunez A, et al. Car- N Engl J Med 1993;328:1377–82. diorespiratory arrest in children with trauma. An Pediatr (Barc) 2006;65: 289. Sreeram N, Wren C. Supraventricular tachycardia in infants: response to initial 439–47. treatment. Arch Dis Child 1990;65:127–9. 320. Perron AD, Sing RF, Branas CC, Huynh T. Predicting survival in pediatric trauma 290. Bianconi L, Castro A, Dinelli M, et al. Comparison of intravenously administered patients receiving cardiopulmonary resuscitation in the prehospital setting. dofetilide versus amiodarone in the acute termination of atrial fibrillation and Prehosp Emerg Care 2001;5:6–9. flutter. A multicentre, randomized, double-blind, placebo-controlled study. Eur 321. Sheikh A, Brogan T. Outcome and cost of open- and closed-chest car- Heart J 2000;21:1265–73. diopulmonary resuscitation in pediatric cardiac arrests. Pediatrics 1994;93: 291. Burri S, Hug MI, Bauersfeld U. Efficacy and safety of intravenous amiodarone 392–8. for incessant tachycardias in infants. Eur J Pediatr 2003;162:880–4. 322. Beaver BL, Colombani PM, Buck JR, Dudgeon DL, Bohrer SL, Haller Jr JA. Effi- 292. Celiker A, Ceviz N, Ozme S. Effectiveness and safety of intravenous amio- cacy of emergency room thoracotomy in pediatric trauma. J Pediatr Surg darone in drug-resistant tachyarrhythmias of children. Acta Paediatr Jpn 1987;22:19–23. 1998;40:567–72. 323. Powell RW, Gill EA, Jurkovich GJ, Ramenofsky ML. Resuscitative thoracotomy 293. Dodge-Khatami A, Miller O, Anderson R, Gil-Jaurena J, Goldman A, de Leval M. in children and adolescents. Am Surg 1988;54:188–91. Impact of junctional ectopic tachycardia on postoperative morbidity following 324. Rothenberg SS, Moore EE, Moore FA, Baxter BT, Moore JB, Cleveland HC. Emer- repair of congenital heart defects. Eur J Cardiothorac Surg 2002;21:255–9. gency department thoracotomy in children – a critical analysis. J Trauma 294. Figa FH, Gow RM, Hamilton RM, Freedom RM. Clinical efficacy and safety of 1989;29:1322–5. intravenous Amiodarone in infants and children. Am J Cardiol 1994;74:573–7. 325. Suominen P, Rasanen J, Kivioja A. Efficacy of cardiopulmonary resuscitation in 295. Hoffman TM, Bush DM, Wernovsky G, et al. Postoperative junctional ectopic pulseless paediatric trauma patients. Resuscitation 1998;36:9–13. tachycardia in children: incidence, risk factors, and treatment. Ann Thorac Surg 326. Graham EM, Forbus GA, Bradley SM, Shirali GS, Atz AM. Incidence and outcome 2002;74:1607–11. of cardiopulmonary resuscitation in patients with shunted single ventricle: 296. Soult JA, Munoz M, Lopez JD, Romero A, Santos J, Tovaruela A. Efficacy and safety advantage of right ventricle to pulmonary artery shunt. J Thorac Cardiovasc of intravenous amiodarone for short-term treatment of paroxysmal supraven- Surg 2006;131:e7–8. tricular tachycardia in children. Pediatr Cardiol 1995;16:16–9. 327. Charpie JR, Dekeon MK, Goldberg CS, Mosca RS, Bove EL, Kulik TJ. Postoperative 297. Haas NA, Camphausen CK. Acute hemodynamic effects of intravenous amio- hemodynamics after Norwood palliation for hypoplastic left heart syndrome. darone treatment in pediatric patients with cardiac surgery. Clin Res Cardiol Am J Cardiol 2001;87:198–202. 2008;97:801–10. 328. Hoffman GM, Mussatto KA, Brosig CL, et al. Systemic venous oxygen saturation 298. Adamson PC, Rhodes LA, Saul JP, et al. The pharmacokinetics of esmolol after the Norwood procedure and childhood neurodevelopmental outcome. J in pediatric subjects with supraventricular arrhythmias. Pediatr Cardiol Thorac Cardiovasc Surg 2005;130:1094–100. 2006;27:420–7. 329. Johnson BA, Hoffman GM, Tweddell JS, et al. Near-infrared spectroscopy in 299. Chrysostomou C, Beerman L, Shiderly D, Berry D, Morell VO, Munoz R. neonates before palliation of hypoplastic left heart syndrome. Ann Thorac Surg Dexmedetomidine: a novel drug for the treatment of atrial and junctional tach- 2009;87:571–7, discussion 7–9. yarrhythmias during the perioperative period for congenital cardiac surgery: 330. Hoffman GM, Tweddell JS, Ghanayem NS, et al. Alteration of the critical arteri- a preliminary study. Anesth Analg 2008;107:1514–22. ovenous oxygen saturation relationship by sustained afterload reduction after 300. Benson Jr D, Smith W, Dunnigan A, Sterba R, Gallagher J. Mechanisms of reg- the Norwood procedure. J Thorac Cardiovasc Surg 2004;127:738–45. ular wide QRS tachycardia in infants and children. Am J Cardiol 1982;49: 331. De Oliveira NC, Van Arsdell GS. Practical use of alpha blockade strategy in the 1778–88. management of hypoplastic left heart syndrome following stage one palliation 301. Drago F, Mazza A, Guccione P, Mafrici A, Di Liso G, Ragonese P. Amiodarone with a Blalock-Taussig shunt. Semin Thorac Cardiovasc Surg Pediatr Card Surg used alone or in combination with propranolol: a very effective therapy for Annu 2004;7:11–5. tachyarrhythmias in infants and children. Pediatr Cardiol 1998;19:445–9. 332. Tweddell JS, Hoffman GM, Mussatto KA, et al. Improved survival of patients 302. Benson DJ, Dunnigan A, Green T, Benditt D, Schneider S. Periodic procainamide undergoing palliation of hypoplastic left heart syndrome: lessons learned from for paroxysmal tachycardia. Circulation 1985;72:147–52. 115 consecutive patients. Circulation 2002;106:I82–9. 303. Komatsu C, Ishinaga T, Tateishi O, Tokuhisa Y, Yoshimura S. Effects of 333. Shekerdemian LS, Shore DF, Lincoln C, Bush A, Redington AN. Negative- four antiarrhythmic drugs on the induction and termination of paroxysmal pressure ventilation improves cardiac output after right heart surgery. supraventricular tachycardia. Jpn Circ J 1986;50:961–72. Circulation 1996;94:II49–55. 304. Mandel WJ, Laks MM, Obayashi K, Hayakawa H, Daley W. The Wolff-Parkinson- 334. Shekerdemian LS, Bush A, Shore DF, Lincoln C, Redington AN. Cardiopulmonary White syndrome: pharmacologic effects of procaine amide. Am Heart J interactions after Fontan operations: augmentation of cardiac output using 1975;90:744–54. negative pressure ventilation. Circulation 1997;96:3934–42. 305. Meldon SW, Brady WJ, Berger S, Mannenbach M. Pediatric ventricular 335. Booth KL, Roth SJ, Thiagarajan RR, Almodovar MC, del Nido PJ, Laussen PC. tachycardia: a review with three illustrative cases. Pediatr Emerg Care Extracorporeal membrane oxygenation support of the Fontan and bidirectional 1994;10:294–300. Glenn circulations. Ann Thorac Surg 2004;77:1341–8. 306. Shih JY, Gillette PC, Kugler JD, et al. The electrophysiologic effects of 336. Polderman FN, Cohen J, Blom NA, et al. Sudden unexpected death in chil- procainamide in the immature heart. Pediatr Pharmacol (New York) dren with a previously diagnosed cardiovascular disorder. Int J Cardiol 1982;2:65–73. 2004;95:171–6. 307. Ackerman MJ, Siu BL, Sturner WQ, et al. Postmortem molecular analysis of 337. Sanatani S, Wilson G, Smith CR, Hamilton RM, Williams WG, Adatia I. Sud- SCN5A defects in sudden infant death syndrome. JAMA 2001;286:2264–9. den unexpected death in children with heart disease. Congenit Heart Dis 308. Arnestad M, Crotti L, Rognum TO, et al. Prevalence of long-QT syndrome 2006;1:89–97. gene variants in sudden infant death syndrome. Circulation 2007;115: 338. Morris K, Beghetti M, Petros A, Adatia I, Bohn D. Comparison of hyperventilation 361–7. and inhaled nitric oxide for pulmonary hypertension after repair of congenital 309. Cronk LB, Ye B, Kaku T, et al. Novel mechanism for sudden infant death syn- heart disease. Crit Care Med 2000;28:2974–8. drome: persistent late sodium current secondary to mutations in caveolin-3. 339. Hoeper MM, Galie N, Murali S, et al. Outcome after cardiopulmonary resusci- Heart Rhythm 2007;4:161–6. tation in patients with pulmonary arterial hypertension. Am J Respir Crit Care 310. Millat G, Kugener B, Chevalier P, et al. Contribution of long-QT syn- Med 2002;165:341–4. drome genetic variants in sudden infant death syndrome. Pediatr Cardiol 340. Rimensberger PC, Spahr-Schopfer I, Berner M, et al. Inhaled nitric oxide ver- 2009;30:502–9. sus aerosolized iloprost in secondary pulmonary hypertension in children with 311. Otagiri T, Kijima K, Osawa M, et al. Cardiac ion channel gene mutations in congenital heart disease: vasodilator capacity and cellular mechanisms. Circu- sudden infant death syndrome. Pediatr Res 2008;64:482–7. lation 2001;103:544–8.
- 169. D. Biarent et al. / Resuscitation 81 (2010) 1364–1388 1387 341. Liu KS, Tsai FC, Huang YK, et al. Extracorporeal life support: a simple and 368. Shankaran S, Laptook AR, Ehrenkranz RA, et al. Whole-body hypother- effective weapon for postcardiotomy right ventricular failure. Artif Organs mia for neonates with hypoxic-ischemic encephalopathy. N Engl J Med 2009;33:504–8. 2005;353:1574–84. 342. Dhillon R, Pearson GA, Firmin RK, Chan KC, Leanage R. Extracorporeal mem- 369. Doherty DR, Parshuram CS, Gaboury I, et al. Hypothermia therapy after pedi- brane oxygenation and the treatment of critical pulmonary hypertension in atric cardiac arrest. Circulation 2009;119:1492–500. congenital heart disease. Eur J Cardiothorac Surg 1995;9:553–6. 370. Hachimi-Idrissi S, Corne L, Ebinger G, Michotte Y, Huyghens L. Mild hypother- 343. Arpesella G, Loforte A, Mikus E, Mikus PM. Extracorporeal membrane oxygena- mia induced by a helmet device: a clinical feasibility study. Resuscitation tion for primary allograft failure. Transplant Proc 2008;40:3596–7. 2001;51:275–81. 344. Strueber M, Hoeper MM, Fischer S, et al. Bridge to thoracic organ transplanta- 371. Bernard S, Buist M, Monteiro O, Smith K. Induced hypothermia using large tion in patients with pulmonary arterial hypertension using a pumpless lung volume, ice-cold intravenous fluid in comatose survivors of out-of-hospital assist device. Am J Transplant 2009;9:853–7. cardiac arrest: a preliminary report. Resuscitation 2003;56:9–13. 345. Nolan JP, Neumar RW, Adrie C, et al. Post-cardiac arrest syndrome: epidemiol- 372. Kliegel A, Losert H, Sterz F, et al. Cold simple intravenous infusions preceding ogy, pathophysiology, treatment, and prognostication. A Scientific Statement special endovascular cooling for faster induction of mild hypothermia after from the International Liaison Committee on Resuscitation; the American cardiac arrest – a feasibility study. Resuscitation 2005;64:347–51. Heart Association Emergency Cardiovascular Care Committee; the Council on 373. Polderman KH. Application of therapeutic hypothermia in the ICU: opportu- Cardiovascular Surgery and Anesthesia; the Council on Cardiopulmonary, Peri- nities and pitfalls of a promising treatment modality. Part 1: Indications and operative, and Critical Care; the Council on Clinical Cardiology; the Council on evidence. Intensive Care Med 2004;30:556–75. Stroke. Resuscitation 2008;79:350–79. 374. Polderman KH. Application of therapeutic hypothermia in the intensive care 346. Hildebrand CA, Hartmann AG, Arcinue EL, Gomez RJ, Bing RJ. Cardiac perfor- unit. Opportunities and pitfalls of a promising treatment modality. Part 2: mance in pediatric near-drowning. Crit Care Med 1988;16:331–5. Practical aspects and side effects. Intensive Care Med 2004;30:757–69. 347. Checchia PA, Sehra R, Moynihan J, Daher N, Tang W, Weil MH. Myocardial 375. Polderman KH, Peerdeman SM, Girbes AR. Hypophosphatemia and hypomag- injury in children following resuscitation after cardiac arrest. Resuscitation nesemia induced by cooling in patients with severe head injury. J Neurosurg 2003;57:131–7. 2001;94:697–705. 348. Mayr V, Luckner G, Jochberger S, et al. Arginine vasopressin in advanced car- 376. Zeiner A, Holzer M, Sterz F, et al. Hyperthermia after cardiac arrest is associated diovascular failure during the post-resuscitation phase after cardiac arrest. with an unfavorable neurologic outcome. Arch Intern Med 2001;161:2007–12. Resuscitation 2007;72:35–44. 377. Takino M, Okada Y. Hyperthermia following cardiopulmonary resuscitation. 349. Huang L, Weil MH, Sun S, Cammarata G, Cao L, Tang W. Levosimendan Intensive Care Med 1991;17:419–20. improves postresuscitation outcomes in a rat model of CPR. J Lab Clin Med 378. Takasu A, Saitoh D, Kaneko N, Sakamoto T, Okada Y. Hyperthermia: is it an 2005;146:256–61. ominous sign after cardiac arrest? Resuscitation 2001;49:273–7. 350. Huang L, Weil MH, Tang W, Sun S, Wang J. Comparison between dobutamine 379. Coimbra C, Boris-Moller F, Drake M, Wieloch T. Diminished neuronal damage and levosimendan for management of postresuscitation myocardial dysfunc- in the rat brain by late treatment with the antipyretic drug dipyrone or cooling tion. Crit Care Med 2005;33:487–91. following cerebral ischemia. Acta Neuropathol 1996;92:447–53. 351. Kern KB, Hilwig RW, Rhee KH, Berg RA. Myocardial dysfunction after resuscita- 380. Coimbra C, Drake M, Boris-Moller F, Wieloch T. Long-lasting neuro- tion from cardiac arrest: an example of global myocardial stunning. J Am Coll protective effect of postischemic hypothermia and treatment with an Cardiol 1996;28:232–40. anti-inflammatory/antipyretic drug. Evidence for chronic encephalopathic 352. Meyer RJ, Kern KB, Berg RA, Hilwig RW, Ewy GA. Post-resuscitation right processes following ischemia. Stroke 1996;27:1578–85. ventricular dysfunction: delineation and treatment with dobutamine. Resus- 381. van den Berghe G, Wouters P, Weekers F, et al. Intensive insulin therapy in the citation 2002;55:187–91. critically ill patients. N Engl J Med 2001;345:1359–67. 353. Studer W, Wu X, Siegemund M, Marsch S, Seeberger M, Filipovic M. Influence 382. Van den Berghe G, Wilmer A, Hermans G, et al. Intensive insulin therapy in the of dobutamine on the variables of systemic haemodynamics, metabolism, and medical ICU. N Engl J Med 2006;354:449–61. intestinal perfusion after cardiopulmonary resuscitation in the rat. Resuscita- 383. Wiener RS, Wiener DC, Larson RJ. Benefits and risks of tight glucose control in tion 2005;64:227–32. critically ill adults: a meta-analysis. JAMA 2008;300:933–44. 354. Vasquez A, Kern KB, Hilwig RW, Heidenreich J, Berg RA, Ewy GA. Optimal dos- 384. Treggiari MM, Karir V, Yanez ND, Weiss NS, Daniel S, Deem SA. Intensive insulin ing of dobutamine for treating post-resuscitation left ventricular dysfunction. therapy and mortality in critically ill patients. Crit Care 2008;12:R29. Resuscitation 2004;61:199–207. 385. Slonim AD, Patel KM, Ruttimann UE, Pollack MM. Cardiopulmonary resuscita- 355. Hoffman TM, Wernovsky G, Atz AM, et al. Efficacy and safety of milrinone in tion in pediatric intensive care units. Crit Care Med 1997;25:1951–5. preventing low cardiac output syndrome in infants and children after correc- 386. Rodriguez-Nunez A, Lopez-Herce J, Garcia C, et al. Effectiveness and long-term tive surgery for congenital heart disease. Circulation 2003;107:996–1002. outcome of cardiopulmonary resuscitation in paediatric intensive care units in 356. Alvarez J, Bouzada M, Fernandez AL, et al. Hemodynamic effects of levosi- Spain. Resuscitation 2006;71:301–9. mendan compared with dobutamine in patients with low cardiac output after 387. Nadkarni VM, Larkin GL, Peberdy MA, et al. First documented rhythm and clin- cardiac surgery. Rev Esp Cardiol 2006;59:338–45. ical outcome from in-hospital cardiac arrest among children and adults. JAMA 357. Jorgensen K, Bech-Hanssen O, Houltz E, Ricksten SE. Effects of levosimendan 2006;295:50–7. on left ventricular relaxation and early filling at maintained preload and after- 388. Meaney PA, Nadkarni VM, Cook EF, et al. Higher survival rates among load conditions after aortic valve replacement for aortic stenosis. Circulation younger patients after pediatric intensive care unit cardiac arrests. Pediatrics 2008;117:1075–81. 2006;118:2424–33. 358. Lobato EB, Willert JL, Looke TD, Thomas J, Urdaneta F. Effects of milrinone versus 389. Tibballs J, Kinney S. A prospective study of outcome of in-patient paediatric epinephrine on left ventricular relaxation after cardiopulmonary bypass fol- cardiopulmonary arrest. Resuscitation 2006;71:310–8. lowing myocardial revascularization: assessment by color m-mode and tissue 390. Gillis J, Dickson D, Rieder M, Steward D, Edmonds J. Results of inpatient pedi- Doppler. J Cardiothorac Vasc Anesth 2005;19:334–9. atric resuscitation. Crit Care Med 1986;14:469–71. 359. Nijhawan N, Nicolosi AC, Montgomery MW, Aggarwal A, Pagel PS, Warltier DC. 391. Schindler MB, Bohn D, Cox PN, et al. Outcome of out-of-hospital cardiac or Levosimendan enhances cardiac performance after cardiopulmonary bypass: respiratory arrest in children. N Engl J Med 1996;335:1473–9. a prospective, randomized placebo-controlled trial. J Cardiovasc Pharmacol 392. Suominen P, Korpela R, Kuisma M, Silfvast T, Olkkola KT. Paediatric cardiac 1999;34:219–28. arrest and resuscitation provided by physician-staffed emergency care units. 360. Hickey RW, Kochanek PM, Ferimer H, Graham SH, Safar P. Hypothermia and Acta Anaesthesiol Scand 1997;41:260–5. hyperthermia in children after resuscitation from cardiac arrest. Pediatrics 393. Lopez-Herce J, Garcia C, Dominguez P, et al. Outcome of out-of-hospital car- 2000;106:118–22. diorespiratory arrest in children. Pediatr Emerg Care 2005;21:807–15. 361. Mild therapeutic hypothermia to improve the neurologic outcome after cardiac 394. Lopez-Herce J, Garcia C, Dominguez P, et al. Characteristics and outcome of arrest. N Engl J Med 2002;346:549–56. cardiorespiratory arrest in children. Resuscitation 2004;63:311–20. 362. Bernard SA, Gray TW, Buist MD, et al. Treatment of comatose survivors 395. Hazinski MF, Chahine AA, Holcomb 3rd GW, Morris Jr JA. Outcome of cardio- of out-of-hospital cardiac arrest with induced hypothermia. N Engl J Med vascular collapse in pediatric blunt trauma. Ann Emerg Med 1994;23:1229–35. 2002;346:557–63. 396. Morris MC, Wernovsky G, Nadkarni VM. Survival outcomes after extracorporeal 363. Gluckman PD, Wyatt JS, Azzopardi D, et al. Selective head cooling with mild sys- cardiopulmonary resuscitation instituted during active chest compressions fol- temic hypothermia after neonatal encephalopathy: multicentre randomised lowing refractory in-hospital pediatric cardiac arrest. Pediatr Crit Care Med trial. Lancet 2005;365:663–70. 2004;5:440–6. 364. Battin MR, Penrice J, Gunn TR, Gunn AJ. Treatment of term infants with head 397. Duncan BW, Ibrahim AE, Hraska V, et al. Use of rapid-deployment extra- cooling and mild systemic hypothermia (35.0 degrees C and 34.5 degrees C) corporeal membrane oxygenation for the resuscitation of pediatric patients after perinatal asphyxia. Pediatrics 2003;111:244–51. with heart disease after cardiac arrest. J Thorac Cardiovasc Surg 1998;116: 365. Compagnoni G, Pogliani L, Lista G, Castoldi F, Fontana P, Mosca F. Hypothermia 305–11. reduces neurological damage in asphyxiated newborn infants. Biol Neonate 398. Parra DA, Totapally BR, Zahn E, et al. Outcome of cardiopulmonary resus- 2002;82:222–7. citation in a pediatric cardiac intensive care unit. Crit Care Med 2000;28: 366. Gunn AJ, Gunn TR, Gunning MI, Williams CE, Gluckman PD. Neuroprotec- 3296–300. tion with prolonged head cooling started before postischemic seizures in fetal 399. Idris AH, Berg RA, Bierens J, et al. Recommended guidelines for uniform report- sheep. Pediatrics 1998;102:1098–106. ing of data from drowning: the “Utstein style”. Resuscitation 2003;59:45–57. 367. Debillon T, Daoud P, Durand P, et al. Whole-body cooling after perinatal 400. Eich C, Brauer A, Timmermann A, et al. Outcome of 12 drowned children with asphyxia: a pilot study in term neonates. Dev Med Child Neurol 2003;45: attempted resuscitation on cardiopulmonary bypass: an analysis of variables 17–23. based on the “Utstein Style for Drowning”. Resuscitation 2007;75:42–52.
- 170. 1388 D. Biarent et al. / Resuscitation 81 (2010) 1364–1388 401. Dudley NC, Hansen KW, Furnival RA, Donaldson AE, Van Wagenen KL, Scaife 412. O’Connell KJ, Farah MM, Spandorfer P, et al. Family presence during pediatric ER. The effect of family presence on the efficiency of pediatric trauma resusci- trauma team activation: an assessment of a structured program. Pediatrics tations. Ann Emerg Med 2009;53:777–84, e3. 2007;120:e565–74. 402. Tinsley C, Hill JB, Shah J, et al. Experience of families during cardiopul- 413. Engel KG, Barnosky AR, Berry-Bovia M, et al. Provider experience and atti- monary resuscitation in a pediatric intensive care unit. Pediatrics 2008;122: tudes toward family presence during resuscitation procedures. J Palliative Med e799–804. 2007;10:1007–9. 403. Mangurten J, Scott SH, Guzzetta CE, et al. Effects of family presence during 414. Holzhauser K, Finucane J, De Vries S. Family presence during resuscitation: resuscitation and invasive procedures in a pediatric emergency department. J a randomised controlled trial of the impact of family presence. Australasian Emerg Nurs 2006;32:225–33. Emerg Nurs J 2005;8:139–47. 404. McGahey-Oakland PR, Lieder HS, Young A, et al. Family experiences during 415. Doyle CJ, Post H, Burney RE, Maino J, Keefe M, Rhee KJ. Family participation resuscitation at a children’s hospital emergency department. J Pediatr Health during resuscitation: an option. Ann Emerg Med 1987;16:673–5. Care 2007;21:217–25. 416. Meyers TA, Eichhorn DJ, Guzzetta CE. Do families want to be present during 405. Jones M, Qazi M, Young KD. Ethnic differences in parent preference to be CPR? A retrospective survey. J Emerg Nurs 1998;24:400–5. present for painful medical procedures. Pediatrics 2005;116:e191–7. 417. Hanson C, Strawser D. Family presence during cardiopulmonary resuscitation: 406. Boie ET, Moore GP, Brummett C, Nelson DR. Do parents want to be foote Hospital emergency department’s nine-year perspective. J Emerg Nurs present during invasive procedures performed on their children in the emer- 1992;18:104–6. gency department? A survey of 400 parents. Ann Emerg Med 1999;34: 418. Robinson SM, Mackenzie-Ross S, Campbell Hewson GL, Egleston CV, Prevost AT. 70–4. Psychological effect of witnessed resuscitation on bereaved relatives. Lancet 407. Andrews R, Andrews R. Family presence during a failed major trauma resusci- 1998;352:614–7. tation attempt of a 15-year-old boy: lessons learned [see comment]. J Emerg 419. Compton S, Madgy A, Goldstein M, et al. Emergency medical service providers’ Nurs 2004;30:556–8. experience with family presence during cardiopulmonary resuscitation. Resus- 408. Dill K, Gance-Cleveland B, Dill K, Gance-Cleveland B. With you until the end: citation 2006;70:223–8. family presence during failed resuscitation. J Specialists Pediatr Nurs: JSPN 420. Beckman AW, Sloan BK, Moore GP, et al. Should parents be present during 2005;10:204–7. emergency department procedures on children, and who should make that 409. Gold KJ, Gorenflo DW, Schwenk TL, et al. Physician experience with family pres- decision? A survey of emergency physician and nurse attitudes. Acad Emerg ence during cardiopulmonary resuscitation in children [see comment]. Pediatr Med 2002;9:154–8. Crit Care Med 2006;7:428–33. 421. Eppich WJ, Arnold LD. Family member presence in the pediatric emergency 410. Duran CR, Oman KS, Abel JJ, Koziel VM, Szymanski D. Attitudes toward and department. Curr Opin Pediatr 2003;15:294–8. beliefs about family presence: a survey of healthcare providers, patients’ fam- 422. Eichhorn DJ, Meyers TA, Mitchell TG, Guzzetta CE. Opening the doors: family ilies, and patients. Am J Crit Care 2007;16:270–9. presence during resuscitation. J Cardiovasc Nurs 1996;10:59–70. 411. Meyers TA, Eichhorn DJ, Guzzetta CE, et al. Family presence during invasive 423. Jarvis AS. Parental presence during resuscitation: attitudes of staff on a paedi- procedures and resuscitation. Am J Nurs 2000;100:32–42, quiz 3. atric intensive care unit. Intensive Crit Care Nurs 1998;14:3–7.
- 171. Resuscitation 81 (2010) 1389–1399 Contents lists available at ScienceDirect Resuscitation journal homepage: www.elsevier.com/locate/resuscitation European Resuscitation Council Guidelines for Resuscitation 2010 Section 7. Resuscitation of babies at birth Sam Richmond a,1 , Jonathan Wyllie b,∗,1 a Neonatology, Sunderland Royal Hospital, Sunderland, UK b Neonatology and Paediatrics, The James Cook University Hospital, Middlesbrough, UK Introduction remain wrapped until their temperature has been checked after admission. For these infants delivery room temperatures should The following guidelines for resuscitation at birth have been be at least 26 ◦ C. developed during the process that culminated in the 2010 Inter- • The recommended compression:ventilation ratio for CPR remains national Consensus Conference on Emergency Cardiovascular Care at 3:1 for newborn resuscitation. (ECC) and Cardiopulmonary Resuscitation (CPR) Science with • Attempts to aspirate meconium from the nose and mouth of Treatment Recommendations.1,2 They are an extension of the the unborn baby, while the head is still on the perineum, are guidelines already published by the ERC3 and take into account not recommended. If presented with a floppy, apnoeic baby recommendations made by other national and international organ- born through meconium it is reasonable to rapidly inspect the isations. oropharynx to remove potential obstructions. If appropriate expertise is available, tracheal intubation and suction may be useful. However, if attempted intubation is prolonged or unsuc- Summary of changes since 2005 Guidelines cessful, start mask ventilation, particularly if there is persistent bradycardia. The following are the main changes that have been made to the • If adrenaline (epinephrine) is given then the intravenous route is guidelines for resuscitation at birth in 2010: recommended using a dose of 10–30 g kg−1 . If the tracheal route is used, it is likely that a dose of at least 50–100 g kg−1 will be • For uncompromised babies, a delay in cord clamping of at least needed to achieve a similar effect to 10 g kg−1 intravenously. • Detection of exhaled carbon dioxide in addition to clinical assess- 1 min from the complete delivery of the infant, is now recom- mended. As yet there is insufficient evidence to recommend an ment is recommended as the most reliable method to confirm appropriate time for clamping the cord in babies who are severely placement of a tracheal tube in neonates with spontaneous cir- compromised at birth. culation. • For term infants, air should be used for resuscitation at birth. • Newly born infants born at term or near-term with evolving mod- If, despite effective ventilation, oxygenation (ideally guided by erate to severe hypoxic–ischemic encephalopathy should, where oximetry) remains unacceptable, use of a higher concentration possible, be offered therapeutic hypothermia. This does not affect of oxygen should be considered. immediate resuscitation but is important for post-resuscitation • Preterm babies less than 32 weeks gestation may not reach care. the same arterial blood oxygen saturations in air as those achieved by term babies. Therefore blended oxygen and air The guidelines that follow do not define the only way that resusci- should be given judiciously and its use guided by pulse oxime- tation at birth should be achieved; they merely represent a widely try. If a blend of oxygen and air is not available use what is accepted view of how resuscitation at birth can be carried out both available. safely and effectively (Fig. 7.1). • Preterm babies of less than 28 weeks gestation should be com- pletely covered in a food-grade plastic wrap or bag up to their Preparation necks, without drying, immediately after birth. They should then be nursed under a radiant heater and stabilised. They should Relatively few babies need any resuscitation at birth. Of those that do need help, the overwhelming majority will require only assisted lung aeration. A small minority may need a brief period of ∗ Corresponding author. chest compressions in addition to lung aeration. Of 100,000 babies E-mail address: jonathan.wyllie@stees.nhs.uk (J. Wyllie). born in Sweden in 1 year, only 10 per 1000 (1%) babies of 2.5 kg or 1 Both authors contributed equally to this manuscript and share first authorship. more appeared to need resuscitation at delivery.4 Of those babies 0300-9572/$ – see front matter © 2010 European Resuscitation Council. Published by Elsevier Ireland Ltd. All rights reserved. doi:10.1016/j.resuscitation.2010.08.018
- 172. 1390 S. Richmond, J. Wyllie / Resuscitation 81 (2010) 1389–1399 Fig. 7.1. Newborn life support algorithm. receiving resuscitation, 8 per 1000 responded to mask inflation and delivering vaginally by the breech, and multiple pregnancies. only 2 per 1000 appeared to need intubation. The same study tried Although it is often possible to predict the need for resuscitation to assess the unexpected need for resuscitation at birth and found or stabilisation before a baby is born, this is not always the case. that for low risk babies, i.e. those born after 32 weeks gestation Therefore, personnel trained in newborn life support should be eas- and following an apparently normal labour, about 2 per 1000 (0.2%) ily available at every delivery and, should there be any need for appeared to need resuscitation at delivery. Of these, 90% responded intervention, the care of the baby should be their sole responsibil- to mask inflation alone while the remaining 10% appeared not to ity. One person experienced in tracheal intubation of the newborn respond to mask inflation and therefore were intubated at birth. should ideally be in attendance for deliveries associated with a high Resuscitation or specialist help at birth is more likely to be risk of requiring neonatal resuscitation. Local guidelines indicat- needed by babies with intrapartum evidence of significant fetal ing who should attend deliveries should be developed, based on compromise, babies delivering before 35 weeks gestation, babies current practice and clinical audit.
- 173. S. Richmond, J. Wyllie / Resuscitation 81 (2010) 1389–1399 1391 An organised educational programme in the standards and skills Initial assessment required for resuscitation of the newborn is therefore essential for any institution in which deliveries occur. The Apgar score was proposed as a “simple, common, clear clas- sification or grading of newborn infants” to be used “as a basis for discussion and comparison of the results of obstetric practices, Planned home deliveries types of maternal pain relief and the effects of resuscitation” (our emphasis).10 It was not designed to be assembled and ascribed in Recommendations as to who should attend a planned home order to then identify babies in need of resuscitation.11 However, delivery vary from country to country, but the decision to undergo individual components of the score, namely respiratory rate, heart a planned home delivery, once agreed with medical and midwifery rate and tone, if assessed rapidly, can identify babies needing resus- staff, should not compromise the standard of initial resuscitation citation (and Virginia Apgar herself found that heart rate was the at birth. There will inevitably be some limitations to resuscitation most important predictor of immediate outcome).10 Furthermore, of a newborn baby in the home, because of the distance from fur- repeated assessment particularly of heart rate and, to a lesser extent ther assistance, and this must be made clear to the mother at the breathing, can indicate whether the baby is responding or whether time plans for home delivery are made. Ideally, two trained profes- further efforts are needed. sionals should be present at all home deliveries; one of these must be fully trained and experienced in providing mask ventilation and Breathing chest compressions in the newborn. Check whether the baby is breathing. If so, evaluate the rate, depth and symmetry of breathing together with any evidence of an Equipment and environment abnormal breathing pattern such as gasping or grunting. Unlike adult CPR, resuscitation at birth is often a predictable Heart rate event. It is therefore possible to prepare the environment and the equipment before delivery of the baby. Resuscitation should ideally This is best assessed by listening to the apex beat with a stetho- take place in a warm, well-lit, draught free area with a flat resuscita- scope. Feeling the pulse in the base of the umbilical cord is often tion surface placed below a radiant heater, with other resuscitation effective but can be misleading, cord pulsation is only reliable if equipment immediately available. All equipment must be checked found to be more than 100 beats per minute (bpm).12 For babies frequently. requiring resuscitation and/or continued respiratory support, a When a birth takes place in a non-designated delivery area, the modern pulse oximeter can give an accurate heart rate.13 recommended minimum set of equipment includes a device for safe assisted lung aeration of an appropriate size for the newborn, Colour warm dry towels and blankets, a sterile instrument for cutting the umbilical cord and clean gloves for the attendant and assistants. It Colour is a poor means of judging oxygenation,14 which is bet- may also be helpful to have a suction device with a suitably sized ter assessed using pulse oximetry if possible. A healthy baby is born suction catheter and a tongue depressor (or laryngoscope) to enable blue but starts to become pink within 30 s of the onset of effective the oropharynx to be examined. Unexpected deliveries outside hos- breathing. Peripheral cyanosis is common and does not, by itself, pital are most likely to involve emergency services who should plan indicate hypoxemia. Persistent pallor despite ventilation may indi- for such events. cate significant acidosis or rarely hypovolaemia. Although colour is a poor method of judging oxygenation, it should not be ignored: if a baby appears blue check oxygenation with a pulse oximeter. Temperature control Tone Naked, wet, newborn babies cannot maintain their body tem- perature in a room that feels comfortably warm for adults. A very floppy baby is likely to be unconscious and will need Compromised babies are particularly vulnerable.5 Exposure of the ventilatory support. newborn to cold stress will lower arterial oxygen tension6 and increase metabolic acidosis.7 Prevent heat loss: Tactile stimulation • Protect the baby from draughts. Drying the baby usually produces enough stimulation to induce • Keep the delivery room warm. For babies less than 28 weeks effective breathing. Avoid more vigorous methods of stimulation. If the baby fails to establish spontaneous and effective breaths follow- gestation the delivery room temperature should be 26 ◦ C.8,9 • Dry the term baby immediately after delivery. Cover the head ing a brief period of stimulation, further support will be required. and body of the baby, apart from the face, with a warm towel to prevent further heat loss. Alternatively, place the baby skin to Classification according to initial assessment skin with mother and cover both with a towel. • If the baby needs resuscitation then place the baby on a warm On the basis of the initial assessment, the baby can be placed surface under a preheated radiant warmer. into one of three groups: • In very preterm babies (especially below 28 weeks) drying and wrapping may not be sufficient. A more effective method of keep- 1. Vigorous breathing or crying ing these babies warm is to cover the head and body of the baby Good tone (apart from the face) with plastic wrapping, without drying the Heart rate higher than 100 min−1 baby beforehand, and then to place the baby so covered under This baby requires no intervention other than drying, wrap- radiant heat. ping in a warm towel and, where appropriate, handing to the
- 174. 1392 S. Richmond, J. Wyllie / Resuscitation 81 (2010) 1389–1399 mother. The baby will remain warm through skin-to-skin con- tact with mother under a cover, and may be put to the breast at this stage. 2. Breathing inadequately or apnoeic Normal or reduced tone Heart rate less than 100 min−1 Dry and wrap. This baby may improve with mask inflation but if this does not increase the heart rate adequately, may also require chest compressions. 3. Breathing inadequately or apnoeic Floppy Low or undetectable heart rate Often pale suggesting poor perfusion Dry and wrap. This baby will then require immediate air- way control, lung inflation and ventilation. Once this has been successfully accomplished the baby may also need chest com- pressions, and perhaps drugs. There remains a very rare group of babies who, though breath- ing adequately and with a good heart rate, remain hypoxaemic. This group includes a range of possible diagnoses such as diaphragmatic Fig. 7.3. Mask ventilation of newborn. hernia, surfactant deficiency, congenital pneumonia, pneumotho- rax, or cyanotic congenital heart disease. attempted this is best done under direct vision. Connect a 12–14 Newborn life support FG suction catheter, or a Yankauer sucker, to a suction source not exceeding minus 100 mm Hg. Commence newborn life support if assessment shows that the baby has failed to establish adequate regular normal breathing, or Breathing has a heart rate of less than 100 min−1 . Opening the airway and aerating the lungs is usually all that is necessary. Furthermore, more After initial steps at birth, if breathing efforts are absent or inad- complex interventions will be futile unless these two first steps equate, lung aeration is the priority (Fig. 7.3). In term babies, begin have been successfully completed. resuscitation with air. The primary measure of adequate initial lung inflation is a prompt improvement in heart rate; assess chest wall Airway movement if heart rate does not improve. For the first five inflation breaths maintain the initial inflation Place the baby on his or her back with the head in a neutral pressure for 2–3 s. This will help lung expansion. Most babies need- position (Fig. 7.2). A 2 cm thickness of the blanket or towel placed ing resuscitation at birth will respond with a rapid increase in under the baby’s shoulder may be helpful in maintaining proper heart rate within 30 s of lung inflation. If the heart rate increases head position. In floppy babies application of jaw thrust or the use but the baby is not breathing adequately, ventilate at a rate of of an appropriately sized oropharyngeal airway may be helpful in about 30 breaths min−1 allowing approximately 1 s for each infla- opening the airway. tion, until there is adequate spontaneous breathing. Suction is needed only if the airway is obstructed. Obstruction Adequate passive ventilation is usually indicated by either a may be caused by particulate meconium but can also be caused rapidly increasing heart rate or a heart rate that is maintained faster by blood clots, thick tenacious mucus or vernix even in deliver- than 100 min−1 . If the baby does not respond in this way the most ies where meconium staining is not present. However, aggressive likely cause is inadequate airway control or inadequate ventilation. pharyngeal suction can delay the onset of spontaneous breathing Look for passive chest movement in time with inflation efforts; if and cause laryngeal spasm and vagal bradycardia.15 The presence these are present then lung aeration has been achieved. If these of thick meconium in a non-vigorous baby is the only indication are absent then airway control and lung aeration has not been con- for considering immediate suction of the oropharynx. If suction is firmed. Without adequate lung aeration, chest compressions will be ineffective; therefore, confirm lung aeration before progressing to circulatory support. Some practitioners will ensure airway control by tracheal intu- bation, but this requires training and experience. If this skill is not available and the heart rate is decreasing, re-evaluate the airway position and deliver inflation breaths while summoning a colleague with intubation skills. Continue ventilatory support until the baby has established nor- mal regular breathing. Circulatory support Circulatory support with chest compressions is effective only if the lungs have first been successfully inflated. Give chest com- pressions if the heart rate is less than 60 min−1 despite adequate Fig. 7.2. Newborn with head in neutral position. ventilation.
- 175. S. Richmond, J. Wyllie / Resuscitation 81 (2010) 1389–1399 1393 Bicarbonate If effective spontaneous cardiac output is not restored despite adequate ventilation and adequate chest compressions, reversing intracardiac acidosis may improve myocardial function and achieve a spontaneous circulation. There are insufficient data to recom- mend routine use of bicarbonate in resuscitation of the newly born. The hyperosmolarity and carbon dioxide-generating properties of sodium bicarbonate may impair myocardial and cerebral function. Use of sodium bicarbonate is discouraged during brief CPR. If it is used during prolonged arrests unresponsive to other therapy, it should be given only after adequate ventilation and circulation is established with CPR. A dose of 1–2 mmol kg−1 may be given by slow intravenous injection after adequate ventilation and perfusion have been established. Fluids If there has been suspected blood loss or the infant appears to be in shock (pale, poor perfusion, weak pulse) and has not responded adequately to other resuscitative measures then consider giving Fig. 7.4. Ventilation and chest compression of newborn. fluid.22 This is a rare event. In the absence of suitable blood (i.e. irradiated and leucocyte-depleted group O Rh-negative blood), iso- The most effective technique for providing chest compressions tonic crystalloid rather than albumin is the solution of choice for is to place the two thumbs side by side over the lower third of the restoring intravascular volume. Give a bolus of 10 ml kg−1 initially. sternum just below an imaginary line joining the nipples, with the If successful it may need to be repeated to maintain an improve- fingers encircling the torso and supporting the back (Fig. 7.4).16–19 ment. An alternative way to find the correct position of the thumbs is to identify the xiphisternum and then to place the thumbs Stopping resuscitation on the sternum one finger’s breadth above this point. The ster- num is compressed to a depth of approximately one-third of the Local and national committees will determine the indications anterior–posterior diameter of the chest allowing the chest wall to for stopping resuscitation. If the heart rate of a newly born baby return to its relaxed position between compressions.20 is not detectable and remains undetectable for 10 min, it is then Use a ratio of three compressions to one ventilation, aiming to appropriate to consider stopping resuscitation. The decision to achieve approximately 120 events per minute, i.e. approximately continue resuscitation efforts when the heart rate has been unde- 90 compressions and 30 ventilations. There are theoretical advan- tectable for longer than 10 min is often complex and may be tages to allowing a relaxation phase that is very slightly longer than influenced by issues such as the presumed aetiology, the gesta- the compression phase.21 However, the quality of the compressions tion of the baby, the potential reversibility of the situation, and and breaths are probably more important than the rate. the parents’ previous expressed feelings about acceptable risk of Check the heart rate after about 30 s and every 30 s thereafter. morbidity. Discontinue chest compressions when the spontaneous heart rate In cases where the heart rate is less than 60 min−1 at birth and is faster than 60 min−1 . does not improve after 10 or 15 min of continuous and apparently adequate resuscitative efforts, the choice is much less clear. In this situation there is insufficient evidence about outcome to enable Drugs firm guidance on whether to withhold or to continue resuscitation. Drugs are rarely indicated in resuscitation of the newly born Communication with the parents infant. Bradycardia in the newborn infant is usually caused by inadequate lung inflation or profound hypoxia, and establishing It is important that the team caring for the newborn baby adequate ventilation is the most important step to correct it. How- informs the parents of the baby’s progress. At delivery, adhere to ever, if the heart rate remains less than 60 min−1 despite adequate ventilation and chest compressions, it is reasonable to consider the use of drugs. These are best given via an umbilical venous catheter (Fig. 7.5). Adrenaline Despite the lack of human data it is reasonable to use adrenaline when adequate ventilation and chest compressions have failed to increase the heart rate above 60 min−1 . If adrenaline is used, a dose of 10–30 g kg−1 should be administered intravenously as soon as possible. The tracheal route is not recommended (see below) but if it is used, it is highly likely that doses of 50–100 g kg−1 will be required. Neither the safety nor the efficacy of these higher tracheal doses has been studied. Do not give these high doses intravenously. Fig. 7.5. Newborn umbilical cord showing the arteries and veins.
- 176. 1394 S. Richmond, J. Wyllie / Resuscitation 81 (2010) 1389–1399 the routine local plan and, if possible, hand the baby to the mother suctioning of non-vigorous babies with meconium-stained amni- at the earliest opportunity. If resuscitation is required inform the otic fluid, if feasible. However, if attempted intubation is prolonged parents of the procedures undertaken and why they were required. or unsuccessful, mask ventilation should be implemented, partic- Decisions to discontinue resuscitation should ideally involve ularly if there is persistent bradycardia. senior paediatric staff. Whenever possible, the decision to attempt resuscitation of an extremely preterm baby should be taken in close consultation with the parents and senior paediatric and obstetric Air or 100% oxygen staff. Where a difficulty has been foreseen, for example in the case of severe congenital malformation, discuss the options and progno- For the newly born infant in need of resuscitation at birth, the sis with the parents, midwives, obstetricians and birth attendants rapid establishment of pulmonary gas exchange to replace the fail- before delivery.23 Record carefully all discussions and decisions in ure of placental respiration is the key to success. In the past it has the mother’s notes prior to delivery and in the baby’s records after seemed reasonable that delivery of a high concentration of oxygen birth. to the tissues at risk of hypoxia might help to reduce the number of cells which were damaged by the anaerobic process. However, in the last 30 years the ‘oxygen paradox’ – the fact that cell and tissue Specific questions addressed at the 2010 Consensus injury is increased if hypoxic tissue is then exposed to high concen- Conference on CPR Science trations of oxygen – has been recognized, the role of free radicals, antioxidants and their link with apoptosis and reperfusion injury Maintaining normal temperature in preterm infants has been explored, and the idea of oxidative stress established. In the light of this knowledge it has become increasingly difficult to Significantly preterm babies are likely to become hypothermic sustain the idea that exposure to high concentrations of oxygen, despite careful application of the traditional techniques for keeping however brief, is without risk. Furthermore, randomised studies in them warm (drying, wrapping and placing under radiant heat).24 asphyxiated newborn babies strongly suggest that air is certainly Several randomised controlled trials and observational studies as effective as 100% oxygen, if not more effective, at least in the have shown that placing the preterm baby under radiant heat and short term.39 then covering the baby with food-grade plastic wrapping with- There is also abundant evidence from animal and human stud- out drying them, significantly improves temperature on admission ies that hyperoxaemia alone is damaging to the brain and other to intensive care compared with traditional techniques.25–27 The organs at the cellular level, particularly after asphyxia. Animal baby’s temperature must be monitored closely because of the small studies suggest that the risk is greatest to the immature brain but described risk of inducing hyperthermia with this technique.28 during the brain growth spurt (mid-pregnancy to 3 years).40 All resuscitation procedures including intubation, chest compres- These risks include deleterious effects on glial progenitor cells and sion and insertion of lines, can be achieved with the plastic cover myelination.41 in place. Significantly preterm babies maintain their temperature Other issues include concerns that pulmonary vascular resis- better when the ambient temperature of the delivery room is 26 ◦ C tance may take longer to resolve if air is used rather than oxygen or higher.8,9 for lung inflation at birth. However, though two studies have shown Infants born to febrile mothers have a higher incidence of peri- that it may be reduced a little further and a little faster by use of natal respiratory depression, neonatal seizures, early mortality, oxygen rather than air, there is a price to pay. Exposure to high con- and cerebral palsy.28–30 Animal studies indicate that hyperthermia centrations of oxygen at birth results in the creation of increased during or following ischaemia is associated with a progression of reactive oxygen species which, in turn, reduces the potential for cerebral injury.31,32 Hyperthermia should be avoided. pulmonary artery vaso-relaxation later in the neonatal course. There are now numerous reports of oximetry data following Meconium delivery. When using technology available from the early 2000 s, a reliable reading can be obtained from >90% of normal term births, In the past it was hoped that clearing meconium from the air- approximately 80% of those born preterm, and 80–90% of those way of babies at birth would reduce the incidence and severity apparently requiring resuscitation, within 2 min of birth.42 Uncom- of meconium aspiration syndrome (MAS). However, studies sup- promised babies born at term at sea level have SaO2 ∼60% during porting this view were based on a comparison of suctioning on labour,43 which increases to >90% by 10 min.44 The 25th percentile the outcome of a group of babies with the outcome of historical is approximately 40% at birth and increases to ∼80% at 10 min.45 controls.33,34 Furthermore other studies failed to find any evidence Values are lower in those born by Caesarean section46 and those of benefit from this practice.35,36 More recently, a multi-centre ran- born at altitude.47 Those born preterm may take longer to reach domised controlled trial reported in 200037 showed that routine >90%.45 Those given supplemental oxygen had a higher incidence elective intubation and suctioning of these infants, if vigorous at of SaO2 >95%, even when a protocol to decrease the FiO2 was imple- birth, did not reduce MAS and a further randomised study published mented, although the extent of this was restricted by insufficient in 2004 showed that suctioning the nose and mouth of such babies power and the particular protocols used in the studies.48,49 on the perineum and before delivery of the shoulders (intrapartum Recommendation: In term infants receiving resuscitation at birth suctioning) was also ineffective.38 Intrapartum suctioning and rou- with positive-pressure ventilation, it is best to begin with air as tine intubation and suctioning of vigorous infants born through opposed to 100% oxygen. If, despite effective ventilation, there is meconium-stained liquor are not recommended. There remains no increase in heart rate or oxygenation (guided by oximetry wher- the question of what to do with non-vigorous infants in this sit- ever possible) remains unacceptable, use a higher concentration of uation. Observational studies have confirmed that these babies are oxygen. at increased risk of meconium aspiration syndrome but there have As many preterm babies less than 32 weeks gestation will not been no randomised studies of the effect of intubation followed by achieve target values for transcutaneous oxygen saturation in air, suctioning versus no intubation in this group. blended oxygen and air may be given judiciously and ideally guided Recommendation: In the absence of randomised, controlled tri- by pulse oximetry. Both hyperoxaemia and hypoxemia should be als, there is insufficient evidence to recommend a change in the avoided. If a blend of oxygen and air is not available, resuscitation current practice of performing direct oropharyngeal and tracheal should be initiated with air.
- 177. S. Richmond, J. Wyllie / Resuscitation 81 (2010) 1389–1399 1395 Timing of cord clamping maintaining a positive end expiratory pressure (PEEP) imme- diately after birth protects against lung damage. Positive end Cine-radiographic studies of babies taking their first breath at expiratory pressure also improves lung compliance and gas delivery showed that those whose cords were clamped prior to exchange.61,62 this had an immediate decrease in the size of the heart during the Both over-inflation and repeated collapse of the alveoli have subsequent three or four cardiac cycles. The heart then increased in been shown to cause damage in animal studies. Inflation pressure size to almost the same size as the fetal heart. The initial decrease is measured in an imperfect attempt to limit tidal volume. Ideally in size could be interpreted as being due to filling of the of the tidal volume would be measured, and after lung aeration, limited newly-opened pulmonary vascular system during aeration with the to between 4 and 8 ml kg−1 to avoid over-distension.63 subsequent increase in size occurring as a consequence of blood When ventilating preterm infants, very obvious passive chest returning to the heart from the lung.50 Brady and James drew wall movement may indicate excessive tidal volumes and should attention to the occurrence of a bradycardia apparently induced be avoided. Monitoring of pressure may help to provide consistent by clamping the cord before the first breath and noted that this inflations and avoid high pressures. If positive-pressure ventilation did not occur in babies where clamping occurred after breath- is required, an initial inflation pressure of 20–25 cm H2 O is ade- ing was established.51 Might such early clamping of the cord in quate for most preterm infants.64,65 If a prompt increase in heart a significantly preterm infant, whose ability to inflate his lungs rate or chest movement is not obtained, higher pressures may be by generating negative intrathoracic pressures is already compro- needed. If continued positive-pressure ventilation is required, PEEP mised, either induce or prolong a bradycardia leading to a ‘need’ may be beneficial. Continuous positive airway pressure (CPAP) in for resuscitation? spontaneously breathing preterm infants following resuscitation Studies in term infants clamped late have shown an improve- may also be beneficial.65 ment in iron status and a number of other haematological indices over the next 3–6 months. They have also shown greater use of Devices phototherapy for jaundice in the delayed group but the use of phototherapy was neither controlled nor defined and many would Effective ventilation can be achieved with a flow-inflating, a regard this of little consequence. self-inflating bag or with a T-piece mechanical device designed to Studies in preterm infants have consistently shown improved regulate pressure.66–68 The blow-off valves of self-inflating bags stability in the immediate postnatal period and reduced exposure are flow-dependent and pressures generated may exceed the value to blood transfusion in the ensuing weeks. Some studies have sug- specified by the manufacturer if compressed vigoruously.69 Target gested a reduced incidence of intraventricular haemorrhage and of inflation pressures and long inspiratory times are achieved more late-onset sepsis.52 Again some studies report increased jaundice consistently in mechanical models when using T-piece devices and use of phototherapy but there have been no reports of increased than when using bags,70 although the clinical implications are not use of exchange transfusion. clear. More training is required to provide an appropriate pres- Studies have not addressed any effect of delaying cord clamping sure using flow-inflating bags compared with self-inflating bags.71 on babies apparently needing resuscitation at birth because such A self-inflating bag, a flow-inflating bag, or a T-piece mechanical babies have been excluded. device, all designed to regulate pressure or limit pressure applied Recommendation: Delay in umbilical cord clamping for at least to the airway, can be used to ventilate a newborn. 1 min is recommended for newborn infants not requiring resus- citation. A similar delay should be applied to premature babies Laryngeal mask airways being stabilised. For babies requiring resuscitation, resuscitative intervention remains the priority. A number of studies have shown that laryngeal mask airways (LMAs) can be effectively used at birth to ventilate babies weighing Initial breaths and assisted ventilation over 2000 g, greater than 33 weeks gestation and apparently need- ing resuscitation. Case reports suggest that laryngeal masks have In term infants, spontaneous or assisted initial inflations been successfully used when intubation has been tried and failed – create a functional residual capacity (FRC).53–59 The optimum and occasionally vice-versa. There are few data on smaller or less pressure, inflation time and flow required to establish an mature babies. effective FRC has not been determined. Average initial peak Recommendation: The laryngeal mask airway can be used in inflating pressures of 30–40 cm H2 O (inflation time undefined) resuscitation of the newborn, particularly if facemask ventilation usually ventilate unresponsive term infants successfully.54,56,57,59 is unsuccessful or tracheal intubation is unsuccessful or not feasi- Assisted ventilation rates of 30–60 breaths min−1 are used com- ble. The laryngeal mask airway may be considered as an alternative monly, but the relative efficacy of various rates has not been to a facemask for positive-pressure ventilation among newborns investigated. weighing more than 2000 g or delivered ≥34 weeks gestation. Where pressure is being monitored, an initial inflation pressure There is limited evidence, however, to evaluate its use for new- of 20 cm H2 O may be effective, but 30–40 cm H2 O or higher may borns weighing <2000 g or delivered <34 weeks gestation. The be required in some term babies. If pressure is not being moni- laryngeal mask airway may be considered as an alternative to tra- tored but merely limited by a non-adjustable ‘blow-off’ valve, use cheal intubation as a secondary airway for resuscitation among the minimum inflation required to achieve an increase in heart newborns weighing more than 2000 g or delivered ≥34 weeks rate. There is insufficient evidence to recommend an optimum gestation.72–74 The laryngeal mask airway has not been evaluated in inflation time. In summary, try to provide artificial ventilation at the setting of meconium-stained fluid, during chest compressions, 30–60 breaths min−1 to achieve or maintain a heart rate higher than or for the administration of emergency intra-tracheal medica- 100 min−1 promptly. tions. Assisted ventilation of preterm infants Carbon dioxide detection with face mask or LMA ventilation Animal studies show that preterm lungs are easily damaged Colorimetric exhaled CO2 detectors have been used during mask by large-volume inflations immediately after birth60 and that ventilation of a few preterm infants in the intensive care unit75 and
- 178. 1396 S. Richmond, J. Wyllie / Resuscitation 81 (2010) 1389–1399 Table 7.1 Route and dose of adrenaline (epinephrine) Oral tracheal tube lengths by gestation. Gestation (weeks) Tracheal tube at lips (cm) Despite the widespread use of adrenaline during resuscitation, 23–24 5.5 no placebo controlled clinical trials have evaluated its effectiveness, 25–26 6.0 nor has the ideal dose or route of administration been defined. 27–29 6.5 Neonatal case series or case reports85,86 indicate that adrenaline 30–32 7.0 administered by the tracheal route using a wide range of doses 33–34 7.5 (3–250 g kg−1 ) may be associated with return of spontaneous cir- 35–37 8.0 38–40 8.5 culation (ROSC) or an increase in heart rate. These case series are 41–43 9.0 limited by inconsistent standards for adrenaline administration and are subject to both selection and reporting bias. One good quality case series indicates that tracheal adrenaline (10 g kg−1 ) is likely to be less effective than the same dose in the delivery room,76 and may help to identify airway obstruction. administered intravenously.87 This is consistent with evidence Neither additional benefit above clinical assessment alone, nor risks extrapolated from neonatal animal models indicating that higher attributed to their use have been identified. The use of exhaled CO2 doses (50–100 g kg−1 ) of adrenaline may be required when given detectors with other interfaces (e.g. nasal airways, laryngeal masks) via the tracheal route to achieve the same blood adrenaline concen- during PPV in the delivery room has not been reported. trations and haemodynamic response as achieved after intravenous administration.88,89 Adult animal models demonstrate that blood concentrations of adrenaline are significantly lower following tra- Confirming tracheal tube placement cheal compared with intravenous administration90,91 and that tracheal doses ranging from 50 to 100 g kg−1 may be required to Tracheal intubation may be considered at several points during achieve ROSC.92 neonatal resuscitation: Although it has been widely assumed that adrenaline can be given faster by the tracheal route than by the intravenous route, • When suctioning to remove meconium or other tracheal blockage no clinical trials have evaluated this hypothesis. Two studies have is required. reported cases of inappropriately early use of tracheal adrenaline • If bag-mask ventilation is ineffective or prolonged. before airway and breathing are established.85,86 One case series • When chest compressions are performed. describing in-hospital paediatric cardiac arrests suggested that sur- • Special circumstances (e.g. congenital diaphragmatic hernia or vival was higher among infants who received their first dose of birth weight below 1000 g). adrenaline by the tracheal route; however, the time required for first dose administration using the tracheal and intravenous routes The use and timing of tracheal intubation will depend on the skill were not provided.93 and experience of the available resuscitators. Appropriate tube Paediatric94,95 and newborn animal studies96 showed no ben- lengths based on gestation are shown in Table 7.1.77 efit and a trend toward reduced survival and worse neurological Tracheal tube placement must be assessed visually during intu- status after high-dose intravenous adrenaline (100 mcg kg−1 ) dur- bation, and positioning confirmed. Following tracheal intubation ing resuscitation. This is in contrast to a single paediatric case and intermittent positive-pressure, a prompt increase in heart rate series using historic controls that indicated a marked improvement is a good indication that the tube is in the tracheobronchial tree.78 in ROSC using high-dose intravenous adrenaline (100 mcg kg−1 ). Exhaled CO2 detection is effective for confirmation of tracheal tube However, a meta-analysis of five adult clinical trials indicates that placement in infants, including VLBW infants79–82 and neonatal whilst high-dose intravenous adrenaline may increase ROSC, it studies suggest that it confirms tracheal intubation in neonates offers no benefit in survival to hospital discharge.97 with a cardiac output more rapidly and more accurately than clin- Recommendation: If adrenaline is administered, give an intra- ical assessment alone.81–83 Failure to detect exhaled CO2 strongly venous dose 10–30 g kg−1 as soon as possible. Higher intravenous suggests oesophageal intubation79,81 but false negative readings doses should not be given and may be harmful. If intravenous access have been reported during cardiac arrest79 and in VLBW infants is not available, then it may be reasonable to try tracheal adrenaline. despite models suggesting efficacy.84 However, neonatal studies If adrenaline is administered by the tracheal route, it is likely that a have excluded infants in need of extensive resuscitation. There is larger dose (50–100 g kg−1 ) will be required to achieve a similar no comparative information to recommend any one method for effect to the 10 g kg−1 intravenous dose. detection of exhaled carbon dioxide in the neonatal population. False positives may occur with colorimetric devices contaminated Post-resuscitation care with adrenaline (epinephrine), surfactant and atropine.75 Poor or absent pulmonary blood flow or tracheal obstruction Babies who have required resuscitation may later deteriorate. may prevent detection of exhaled CO2 despite correct tracheal tube Once adequate ventilation and circulation are established, the placement. Tracheal tube placement is identified correctly in nearly infant should be maintained in or transferred to an environment all patients who are not in cardiac arrest;80 however, in critically in which close monitoring and anticipatory care can be provided. ill infants with poor cardiac output, inability to detect exhaled CO2 despite correct placement may lead to unnecessary extuba- Glucose tion. Other clinical indicators of correct tracheal tube placement include evaluation of condensed humidified gas during exhalation Hypoglycaemia was associated with adverse neurological out- and presence or absence of chest movement, but these have not come in a neonatal animal model of asphyxia and resuscitation.98 been evaluated systematically in newborn babies. Newborn animals that were hypoglycaemic at the time of an anoxic Recommendation: Detection of exhaled carbon dioxide in addi- or hypoxic–ischemic insult had larger areas of cerebral infarction tion to clinical assessment is recommended as the most reliable and/or decreased survival compared to controls.99,100 One clinical method to confirm tracheal placement in neonates with sponta- study demonstrated an association between hypoglycaemia and neous circulation. poor neurological outcome following perinatal asphyxia.101 In
- 179. S. Richmond, J. Wyllie / Resuscitation 81 (2010) 1389–1399 1397 adults, children and extremely low-birth-weight infants receiving guidelines must be interpreted according to current regional out- intensive care, hyperglycaemia has been associated with a worse comes. outcome.102–104 However, in paediatric patients, hyperglycaemia after hypoxia–ischaemia does not appear to be harmful,105 which • Where gestation, birth weight, and/or congenital anomalies are confirms data from animal studies106 some of which suggest it associated with almost certain early death, and unacceptably may be protective.107 However, the range of blood glucose con- high morbidity is likely among the rare survivors, resuscitation is centration that is associated with the least brain injury following not indicated.122 Examples from the published literature include: asphyxia and resuscitation cannot be defined based on available extreme prematurity (gestational age less than 23 weeks and/or evidence. Infants who require significant resuscitation should be birthweight less than 400 g), and anomalies such as anencephaly monitored and treated to maintain glucose in the normal range. and confirmed Trisomy 13 or 18. • Resuscitation is nearly always indicated in conditions associated Induced hypothermia with a high survival rate and acceptable morbidity. This will gen- erally include babies with gestational age of 25 weeks or above Several randomised, controlled, multi-centre trials of (unless there is evidence of fetal compromise such as intrauterine induced hypothermia (33.5–34.5 ◦ C) of babies born at more infection or hypoxia–ischaemia) and those with most congenital than 36 weeks gestational age, with moderate to severe malformations. hypoxic–ischemic encephalopathy have shown that cooling • In conditions associated with uncertain prognosis, where there significantly reduced death and neuro-developmental disability at is borderline survival and a relatively high rate of morbidity, and 18 months.108–111 Systemic and selective head cooling produced where the anticipated burden to the child is high, parental desires similar results.109–113 Modest hypothermia may be associated regarding resuscitation should be supported. with bradycardia and elevated blood pressure that do not usually require treatment, but a rapid increase in body temperature may Withdrawing resuscitation efforts cause hypotension.114 Profound hypothermia (core temperature below 33 ◦ C) may cause arrhythmia, bleeding, thrombosis, and Data from infants without signs of life from birth, lasting at sepsis, but studies so far have not reported these complications in least 10 min or longer, show either high mortality or severe neuro- infants treated with modest hypothermia.109,115 developmental disability.123,124 If faced with a newly born baby Newly born infants born at term or near-term with evolv- with no detectable heart rate which remains undetectable for ing moderate to severe hypoxic–ischemic encephalopathy should, 10 min, it is appropriate to then consider stopping resuscitation. where possible, be offered therapeutic hypothermia. Whole body The decision to continue resuscitation efforts when the infant has cooling and selective head cooling are both appropriate strategies. no detectable heart rate for longer than 10 min is often complex Cooling should be initiated and conducted under clearly defined and may be influenced by issues such as the presumed aetiology protocols with treatment in neonatal intensive care facilities and of the arrest, the gestation of the baby, the potential reversibility with the capabilities for multidisciplinary care. Treatment should of the situation, and the parents’ previous expressed feelings about be consistent with the protocols used in the randomised clini- acceptable risk of morbidity. cal trials (i.e. commence within 6 h of birth, continue for 72 h of If the heart rate is less than 60 min−1 at birth and persisting after birth and re-warm over at least 4 h). Animal data would strongly 10 or 15 min the situation is even less clear and a firm recommen- suggest that the effectiveness of cooling is related to early inter- dation cannot be made. vention. There is no evidence in human newborns that cooling is effective if started more than 6 h after birth. Carefully mon- References itor for known adverse effects of cooling – thrombocytopenia and hypotension. All treated infants should be followed longitu- 1. Wyllie J, Perlman JM, Kattwinkel J, et al. 2010 International Consensus on Car- dinally. diopulmonary Resuscitation and Emergency Cardiovascular Care Science with Treatment Recommendations. Part 11. Neonatal resuscitation. Resuscitation; Withholding or discontinuing resuscitation doi:10.1016/j.resuscitation.2010.08.029, in press. 2. Perlman JM, Wyllie J, Kattwinkel J, et al. 2010 International Consensus on Car- diopulmonary Resuscitation and Emergency Cardiovascular Care Science with Mortality and morbidity for newborns varies according to region Treatment Recommendations. Part 11. Neonatal resuscitation. Circulation; in and to availability of resources.116 Social science studies indicate press. that parents desire a larger role in decisions to resuscitate and to 3. Biarent D, Bingham R, Richmond S, et al. European Resuscitation Council Guide- lines for Resuscitation 2005. Section 6. Paediatric life support. Resuscitation continue life support in severely compromised babies.117 Opinions 2005;67(Suppl. 1):S97–133. vary amongst providers, parents and societies about the balance of 4. Palme-Kilander C. Methods of resuscitation in low-Apgar-score newborn benefits and disadvantages of using aggressive therapies in such infants—a national survey. Acta Paediatr 1992;81:739–44. 5. Dahm LS, James LS. Newborn temperature and calculated heat loss in the deliv- babies.118,119 ery room. Pediatrics 1972;49:504–13. 6. Stephenson J, Du JTKO. The effect if cooling on blood gas tensions in newborn Withholding resuscitation infants. J Pediatr 1970;76:848–52. 7. Gandy GM, Adamsons Jr K, Cunningham N, Silverman WA, James LS. Thermal environment and acid-base homeostasis in human infants during the first few It is possible to identify conditions associated with high mor- hours of life. J Clin Invest 1964;43:751–8. tality and poor outcome, where withholding resuscitation may be 8. Kent AL, Williams J. Increasing ambient operating theatre temperature and wrapping in polyethylene improves admission temperature in premature considered reasonable, particularly when there has been the oppor- infants. J Paediatr Child Health 2008;44:325–31. tunity for discussion with parents.24,120,121 9. Knobel RB, Wimmer Jr JE, Holbert D. Heat loss prevention for preterm infants A consistent and coordinated approach to individual cases by in the delivery room. J Perinatol 2005;25:304–8. 10. Apgar V. A proposal for a new method of evaluation of the newborn infant. Curr the obstetric and neonatal teams and the parents is an impor- Res Anesth Analg 1953;32. tant goal.23 Withholding resuscitation and discontinuation of 11. Chamberlain G, Banks J. Assessment of the Apgar score. Lancet 1974;2:1225–8. life-sustaining treatment during or following resuscitation are 12. Owen CJ, Wyllie JP. Determination of heart rate in the baby at birth. Resuscita- considered by many to be ethically equivalent and clinicians tion 2004;60:213–7. 13. Kamlin CO, Dawson JA, O’Donnell CP, et al. Accuracy of pulse oximetry mea- should not be hesitant to withdraw support when the pos- surement of heart rate of newborn infants in the delivery room. J Pediatr sibility of functional survival is highly unlikely. The following 2008;152:756–60.
- 180. 1398 S. Richmond, J. Wyllie / Resuscitation 81 (2010) 1389–1399 14. O’Donnell CP, Kamlin CO, Davis PG, Carlin JB, Morley CJ. Clinical assessment of 46. Rabi Y, Yee W, Chen SY, Singhal N. Oxygen saturation trends immediately after infant colour at delivery. Arch Dis Child Fetal Neonatal Ed 2007;92:F465–7. birth. J Pediatr 2006;148:590–4. 15. Cordero Jr L, Hon EH. Neonatal bradycardia following nasopharyngeal stimu- 47. Gonzales GF, Salirrosas A. Arterial oxygen saturation in healthy newborns lation. J Pediatr 1971;78:441–7. delivered at term in Cerro de Pasco (4340 m) and Lima (150 m). Reprod Biol 16. Houri PK, Frank LR, Menegazzi JJ, Taylor R. A randomized, controlled trial of Endocrinol 2005;3:46. two-thumb vs two-finger chest compression in a swine infant model of cardiac 48. Escrig R, Arruza L, Izquierdo I, et al. Achievement of targeted saturation arrest [see comment]. Prehosp Emerg Care 1997;1:65–7. values in extremely low gestational age neonates resuscitated with low 17. David R. Closed chest cardiac massage in the newborn infant. Pediatrics or high oxygen concentrations: a prospective, randomized trial. Pediatrics 1988;81:552–4. 2008;121:875–81. 18. Menegazzi JJ, Auble TE, Nicklas KA, Hosack GM, Rack L, Goode JS. Two-thumb 49. Wang CL, Anderson C, Leone TA, Rich W, Govindaswami B, Finer NN. Resus- versus two-finger chest compression during CRP in a swine infant model of citation of preterm neonates by using room air or 100% oxygen. Pediatrics cardiac arrest. Ann Emerg Med 1993;22:240–3. 2008;121:1083–9. 19. Thaler MM, Stobie GH. An improved technique of external caridac compression 50. Peltonen T. Placental transfusion—advantage an disadvantage. Eur J Pediatr in infants and young children. N Engl J Med 1963;269:606–10. 1981;137:141–6. 20. Meyer A, Nadkarni V, Pollock A, et al. Evaluation of the Neonatal Resuscita- 51. Brady JP, James LS. Heart rate changes in the fetus and newborn infant dur- tion Program’s recommended chest compression depth using computerized ing labor, delivery, and the immediate neonatal period. Am J Obstet Gynecol tomography imaging. Resuscitation 2010;81:544–8. 1962;84:1–12. 21. Dean JM, Koehler RC, Schleien CL, et al. Improved blood flow during prolonged 52. Mercer JS, Vohr BR, McGrath MM, Padbury JF, Wallach M, Oh W. Delayed cord cardiopulmonary resuscitation with 30% duty cycle in infant pigs. Circulation clamping in very preterm infants reduces the incidence of intraventricular 1991;84:896–904. hemorrhage and late-onset sepsis: a randomized, controlled trial. Pediatrics 22. Wyckoff MH, Perlman JM, Laptook AR. Use of volume expansion during delivery 2006;117:1235–42. room resuscitation in near-term and term infants. Pediatrics 2005;115:950–5. 53. Vyas H, Milner AD, Hopkin IE, Boon AW. Physiologic responses to prolonged 23. Nuffield Council on Bioethics. Critical care decisions in fetal and neonatal and slow-rise inflation in the resuscitation of the asphyxiated newborn infant. medicine: ethical issues. ISBN 1 904384 14 2006. J Pediatr 1981;99:635–9. 24. Costeloe K, Hennessy E, Gibson AT, Marlow N, Wilkinson AR. The EPICure 54. Mortola JP, Fisher JT, Smith JB, Fox GS, Weeks S, Willis D. Onset of respiration study: outcomes to discharge from hospital for infants born at the threshold in infants delivered by cesarean section. J Appl Physiol 1982;52:716–24. of viability. Pediatrics 2000;106:659–71. 55. Hull D. Lung expansion and ventilation during resuscitation of asphyxiated 25. Vohra S, Frent G, Campbell V, Abbott M, Whyte R. Effect of polyethylene occlu- newborn infants. J Pediatr 1969;75:47–58. sive skin wrapping on heat loss in very low birth weight infants at delivery: a 56. Upton CJ, Milner AD. Endotracheal resuscitation of neonates using a rebreath- randomized trial. J Pediatr 1999;134:547–51. ing bag. Arch Dis Child 1991;66:39–42. 26. Lenclen R, Mazraani M, Jugie M, et al. Use of a polyethylene bag: a way to 57. Vyas H, Milner AD, Hopkins IE. Intrathoracic pressure and volume changes improve the thermal environment of the premature newborn at the delivery during the spontaneous onset of respiration in babies born by cesarean section room. Arch Pediatr 2002;9:238–44. and by vaginal delivery. J Pediatr 1981;99:787–91. 27. Bjorklund LJ, Hellstrom-Westas L. Reducing heat loss at birth in very preterm 58. Vyas H, Field D, Milner AD, Hopkin IE. Determinants of the first inspi- infants. J Pediatr 2000;137:739–40. ratory volume and functional residual capacity at birth. Pediatr Pulmonol 28. Vohra S, Roberts RS, Zhang B, Janes M, Schmidt B. Heat Loss Prevention (HeLP) 1986;2:189–93. in the delivery room: a randomized controlled trial of polyethylene occlusive 59. Boon AW, Milner AD, Hopkin IE. Lung expansion, tidal exchange, and forma- skin wrapping in very preterm infants. J Pediatr 2004;145:750–3. tion of the functional residual capacity during resuscitation of asphyxiated 29. Lieberman E, Eichenwald E, Mathur G, Richardson D, Heffner L, Cohen neonates. J Pediatr 1979;95:1031–6. A. Intrapartum fever and unexplained seizures in term infants. Pediatrics 60. Ingimarsson J, Bjorklund LJ, Curstedt T, et al. Incomplete protection by prophy- 2000;106:983–8. lactic surfactant against the adverse effects of large lung inflations at birth in 30. Grether JK, Nelson KB. Maternal infection and cerebral palsy in infants of nor- immature lambs. Intensive Care Med 2004;30:1446–53. mal birth weight. JAMA 1997;278:207–11. 61. Nilsson R, Grossmann G, Robertson B. Bronchiolar epithelial lesions induced 31. Coimbra C, Boris-Moller F, Drake M, Wieloch T. Diminished neuronal damage in the premature rabbit neonate by short periods of artificial ventilation. Acta in the rat brain by late treatment with the antipyretic drug dipyrone or cooling Pathol Microbiol Scand 1980;88:359–67. following cerebral ischemia. Acta Neuropathol 1996;92:447–53. 62. Probyn ME, Hooper SB, Dargaville PA, et al. Positive end expiratory pressure 32. Dietrich WD, Alonso O, Halley M, Busto R. Delayed posttraumatic brain hyper- during resuscitation of premature lambs rapidly improves blood gases without thermia worsens outcome after fluid percussion brain injury: a light and adversely affecting arterial pressure. Pediatr Res 2004;56:198–204. electron microscopic study in rats. Neurosurgery 1996;38:533–41, discussion 63. Schmolzer GM, Kamlin OF, Dawson JA, Davis PG, Morley CJ. Respiratory 41. monitoring of neonatal resuscitation. Arch Dis Child Fetal Neonatal Ed 33. Carson BS, Losey RW, Bowes Jr WA, Simmons MA. Combined obstetric and 2010;95:F295–303. pediatric approach to prevent meconium aspiration syndrome. Am J Obstet 64. Hird MF, Greenough A, Gamsu HR. Inflating pressures for effective resuscitation Gynecol 1976;126:712–5. of preterm infants. Early Hum Dev 1991;26:69–72. 34. Ting P, Brady JP. Tracheal suction in meconium aspiration. Am J Obstet Gynecol 65. Lindner W, Vossbeck S, Hummler H, Pohlandt F. Delivery room management 1975;122:767–71. of extremely low birth weight infants: spontaneous breathing or intubation? 35. Falciglia HS, Henderschott C, Potter P, Helmchen R. Does DeLee suction at Pediatrics 1999;103:961–7. the perineum prevent meconium aspiration syndrome? Am J Obstet Gynecol 66. Allwood AC, Madar RJ, Baumer JH, Readdy L, Wright D. Changes in resuscitation 1992;167:1243–9. practice at birth. Arch Dis Child Fetal Neonatal Ed 2003;88:F375–9. 36. Wiswell TE, Tuggle JM, Turner BS. Meconium aspiration syndrome: have we 67. Cole AF, Rolbin SH, Hew EM, Pynn S. An improved ventilator system for made a difference? Pediatrics 1990;85:715–21. delivery-room management of the newborn. Anesthesiology 1979;51:356–8. 37. Wiswell TE, Gannon CM, Jacob J, et al. Delivery room management of the 68. Hoskyns EW, Milner AD, Hopkin IE. A simple method of face mask resuscitation apparently vigorous meconium-stained neonate: results of the multicenter, at birth. Arch Dis Child 1987;62:376–8. international collaborative trial. Pediatrics 2000;105:1–7. 69. Ganga-Zandzou PS, Diependaele JF, Storme L, et al. Is Ambu ventilation of new- 38. Vain NE, Szyld EG, Prudent LM, Wiswell TE, Aguilar AM, Vivas NI. Oropha- born infants a simple question of finger-touch? Arch Pediatr 1996;3:1270–2. ryngeal and nasopharyngeal suctioning of meconium-stained neonates before 70. Finer NN, Rich W, Craft A, Henderson C. Comparison of methods of bag and delivery of their shoulders: multicentre, randomised controlled trial. Lancet mask ventilation for neonatal resuscitation. Resuscitation 2001;49:299–305. 2004;364:597–602. 71. Kanter RK. Evaluation of mask-bag ventilation in resuscitation of infants. Am J 39. Davis PG, Tan A, O’Donnell CP, Schulze A. Resuscitation of newborn infants Dis Child 1987;141:761–3. with 100% oxygen or air: a systematic review and meta-analysis. Lancet 72. Esmail N, Saleh M, Ali A. Laryngeal mask airway versus endotracheal intubation 2004;364:1329–33. for Apgar score improvement in neonatal resuscitation. Egypt J Anesthesiol 40. Felderhoff-Mueser U, Bittigau P, Sifringer M, et al. Oxygen causes cell death in 2002;18:115–21. the developing brain. Neurobiol Dis 2004;17:273–82. 73. Trevisanuto D, Micaglio M, Pitton M, Magarotto M, Piva D, Zanardo V. Laryn- 41. Koch JD, Miles DK, Gilley JA, Yang CP, Kernie SG. Brief exposure to hyper- geal mask airway: is the management of neonates requiring positive pressure oxia depletes the glial progenitor pool and impairs functional recovery ventilation at birth changing? Resuscitation 2004;62:151–7. after hypoxic–ischemic brain injury. J Cereb Blood Flow Metab 2008;28: 74. Singh R. Controlled trial to evaluate the use of LMA for neonatal resuscitation. 1294–306. J Anaesth Clin Pharmacol 2005;21:303–6. 42. O’Donnell CP, Kamlin CO, Davis PG, Morley CJ. Feasibility of and delay in 75. Leone TA, Lange A, Rich W, Finer NN. Disposable colorimetric carbon diox- obtaining pulse oximetry during neonatal resuscitation. J Pediatr 2005;147: ide detector use as an indicator of a patent airway during noninvasive mask 698–9. ventilation. Pediatrics 2006;118:e202–4. 43. Dildy GA, van den Berg PP, Katz M, et al. Intrapartum fetal pulse oximetry: fetal 76. Finer NN, Rich W, Wang C, Leone T. Airway obstruction during mask ventila- oxygen saturation trends during labor and relation to delivery outcome. Am J tion of very low birth weight infants during neonatal resuscitation. Pediatrics Obstet Gynecol 1994;171:679–84. 2009;123:865–9. 44. Mariani G, Dik PB, Ezquer A, et al. Pre-ductal and post-ductal O2 saturation in 77. Kempley ST, Moreiras JW, Petrone FL. Endotracheal tube length for neonatal healthy term neonates after birth. J Pediatr 2007;150:418–21. intubation. Resuscitation 2008;77:369–73. 45. Dawson JA, Kamlin CO, Vento M, et al. Defining the reference range for oxygen 78. Palme-Kilander C, Tunell R. Pulmonary gas exchange during facemask ventila- saturation for infants after birth. Pediatrics 2010;125:e1340–7. tion immediately after birth. Arch Dis Child 1993;68:11–6.
- 181. S. Richmond, J. Wyllie / Resuscitation 81 (2010) 1389–1399 1399 79. Aziz HF, Martin JB, Moore JJ. The pediatric disposable end-tidal carbon 101. Salhab WA, Wyckoff MH, Laptook AR, Perlman JM. Initial hypoglycemia and dioxide detector role in endotracheal intubation in newborns. J Perinatol neonatal brain injury in term infants with severe fetal acidemia. Pediatrics 1999;19:110–3. 2004;114:361–6. 80. Bhende MS, LaCovey D. A note of caution about the continuous use of colori- 102. Kent TA, Soukup VM, Fabian RH. Heterogeneity affecting outcome from acute metric end-tidal CO2 detectors in children. Pediatrics 1995;95:800–1. stroke therapy: making reperfusion worse. Stroke 2001;32:2318–27. 81. Repetto JE, Donohue P-CP, Baker SF, Kelly L, Nogee LM. Use of capnography in 103. Srinivasan V, Spinella PC, Drott HR, Roth CL, Helfaer MA, Nadkarni V. Associ- the delivery room for assessment of endotracheal tube placement. J Perinatol ation of timing, duration, and intensity of hyperglycemia with intensive care 2001;21:284–7. unit mortality in critically ill children. Pediatr Crit Care Med 2004;5:329–36. 82. Roberts WA, Maniscalco WM, Cohen AR, Litman RS, Chhibber A. The use of 104. Hays SP, Smith EO, Sunehag AL. Hyperglycemia is a risk factor for early capnography for recognition of esophageal intubation in the neonatal intensive death and morbidity in extremely low birth-weight infants. Pediatrics care unit. Pediatr Pulmonol 1995;19:262–8. 2006;118:1811–8. 83. Hosono S, Inami I, Fujita H, Minato M, Takahashi S, Mugishima H. A role of 105. Klein GW, Hojsak JM, Schmeidler J, Rapaport R. Hyperglycemia and outcome end-tidal CO(2) monitoring for assessment of tracheal intubations in very in the pediatric intensive care unit. J Pediatr 2008;153:379–84. low birth weight infants during neonatal resuscitation at birth. J Perinat Med 106. LeBlanc MH, Huang M, Patel D, Smith EE, Devidas M. Glucose given 2009;37:79–84. after hypoxic ischemia does not affect brain injury in piglets. Stroke 84. Garey DM, Ward R, Rich W, Heldt G, Leone T, Finer NN. Tidal volume thresh- 1994;25:1443–7, discussion 8. old for colorimetric carbon dioxide detectors available for use in neonates. 107. Hattori H, Wasterlain CG. Posthypoxic glucose supplement reduces Pediatrics 2008;121:e1524–7. hypoxic–ischemic brain damage in the neonatal rat. Ann Neurol 85. Jankov RP, Asztalos EV, Skidmore MB. Favourable neurological outcomes fol- 1990;28:122–8. lowing delivery room cardiopulmonary resuscitation of infants < or = 750 g at 108. Edwards AD, Brocklehurst P, Gunn AJ, et al. Neurological outcomes at 18 birth. J Paediatr Child Health 2000;36:19–22. months of age after moderate hypothermia for perinatal hypoxic ischaemic 86. O’Donnell AI, Gray PH, Rogers YM. Mortality and neurodevelopmental out- encephalopathy: synthesis and meta-analysis of trial data. BMJ 2010;340:c363. come for infants receiving adrenaline in neonatal resuscitation. J Paediatr Child 109. Gluckman PD, Wyatt JS, Azzopardi D, et al. Selective head cooling with mild sys- Health 1998;34:551–6. temic hypothermia after neonatal encephalopathy: multicentre randomised 87. Barber CA, Wyckoff MH. Use and efficacy of endotracheal versus intravenous trial. Lancet 2005;365:663–70. epinephrine during neonatal cardiopulmonary resuscitation in the delivery 110. Shankaran S, Laptook AR, Ehrenkranz RA, et al. Whole-body hypother- room. Pediatrics 2006;118:1028–34. mia for neonates with hypoxic–ischemic encephalopathy. N Engl J Med 88. Crespo SG, Schoffstall JM, Fuhs LR, Spivey WH. Comparison of two doses 2005;353:1574–84. of endotracheal epinephrine in a cardiac arrest model. Ann Emerg Med 111. Azzopardi DV, Strohm B, Edwards AD, et al. Moderate hypothermia to treat 1991;20:230–4. perinatal asphyxial encephalopathy. N Engl J Med 2009;361:1349–58. 89. Jasani MS, Nadkarni VM, Finkelstein MS, Mandell GA, Salzman SK, Norman ME. 112. Eicher DJ, Wagner CL, Katikaneni LP, et al. Moderate hypothermia in neonatal Effects of different techniques of endotracheal epinephrine administration in encephalopathy: efficacy outcomes. Pediatr Neurol 2005;32:11–7. pediatric porcine hypoxic–hypercarbic cardiopulmonary arrest. Crit Care Med 113. Lin ZL, Yu HM, Lin J, Chen SQ, Liang ZQ, Zhang ZY. Mild hypothermia via selec- 1994;22:1174–80. tive head cooling as neuroprotective therapy in term neonates with perinatal 90. Mielke LL, Frank C, Lanzinger MJ, et al. Plasma catecholamine levels following asphyxia: an experience from a single neonatal intensive care unit. J Perinatol tracheal and intravenous epinephrine administration in swine. Resuscitation 2006;26:180–4. 1998;36:187–92. 114. Thoresen M, Whitelaw A. Cardiovascular changes during mild therapeutic 91. Roberts JR, Greenberg MI, Knaub MA, Kendrick ZV, Baskin SI. Blood levels hypothermia and rewarming in infants with hypoxic–ischemic encephalopa- following intravenous and endotracheal epinephrine administration. JACEP thy. Pediatrics 2000;106:92–9. 1979;8:53–6. 115. Shankaran S, Laptook A, Wright LL, et al. Whole-body hypothermia for neonatal 92. Hornchen U, Schuttler J, Stoeckel H, Eichelkraut W, Hahn N. Endobronchial encephalopathy: animal observations as a basis for a randomized, controlled instillation of epinephrine during cardiopulmonary resuscitation. Crit Care pilot study in term infants. Pediatrics 2002;110:377–85. Med 1987;15:1037–9. 116. De Leeuw R, Cuttini M, Nadai M, et al. Treatment choices for extremely preterm 93. Guay J, Lortie L. An evaluation of pediatric in-hospital advanced life support infants: an international perspective. J Pediatr 2000;137:608–16. interventions using the pediatric Utstein guidelines: a review of 203 cardiores- 117. Lee SK, Penner PL, Cox M. Comparison of the attitudes of health care profes- piratory arrests. Can J Anaesth 2004;51:373–8. sionals and parents toward active treatment of very low birth weight infants. 94. Perondi MB, Reis AG, Paiva EF, Nadkarni VM, Berg RA. A comparison of high- Pediatrics 1991;88:110–4. dose and standard-dose epinephrine in children with cardiac arrest. N Engl J 118. Kopelman LM, Irons TG, Kopelman AE. Neonatologists judge the “Baby Doe” Med 2004;350:1722–30. regulations. N Engl J Med 1988;318:677–83. 95. Patterson MD, Boenning DA, Klein BL, et al. The use of high-dose epinephrine for 119. Sanders MR, Donohue PK, Oberdorf MA, Rosenkrantz TS, Allen MC. Perceptions patients with out-of-hospital cardiopulmonary arrest refractory to prehospital of the limit of viability: neonatologists’ attitudes toward extremely preterm interventions. Pediatr Emerg Care 2005;21:227–37. infants. J Perinatol 1995;15:494–502. 96. Berg RA, Otto CW, Kern KB, et al. A randomized, blinded trial of high-dose 120. Draper ES, Manktelow B, Field DJ, James D. Tables for predicting survival for epinephrine versus standard-dose epinephrine in a swine model of pediatric preterm births are updated. BMJ 2003;327:872. asphyxial cardiac arrest. Crit Care Med 1996;24:1695–700. 121. Cole TJ, Hey E, Richmond S. The PREM score: a graphical tool for predicting 97. Vandycke C, Martens P. High dose versus standard dose epinephrine in cardiac survival in very preterm births. Arch Dis Child Fetal Neonatal Ed 2010;95: arrest—a meta-analysis. Resuscitation 2000;45:161–6. F14–9. 98. Brambrink AM, Ichord RN, Martin LJ, Koehler RC, Traystman RJ. Poor outcome 122. Swamy R, Mohapatra S, Bythell M, Embleton ND. Survival in infants live born after hypoxia-ischemia in newborns is associated with physiological abnor- at less than 24 weeks’ gestation: the hidden morbidity of non-survivors. Arch malities during early recovery. Possible relevance to secondary brain injury Dis Child Fetal Neonatal Ed 2010;95:F293–4. after head trauma in infants. Exp Toxicol Pathol 1999;51:151–62. 123. Jain L, Ferre C, Vidyasagar D, Nath S, Sheftel D. Cardiopulmonary resuscita- 99. Vannucci RC, Vannucci SJ. Cerebral carbohydrate metabolism during hypo- tion of apparently stillborn infants: survival and long-term outcome. J Pediatr glycemia and anoxia in newborn rats. Ann Neurol 1978;4:73–9. 1991;118:778–82. 100. Yager JY, Heitjan DF, Towfighi J, Vannucci RC. Effect of insulin-induced and 124. Haddad B, Mercer BM, Livingston JC, Talati A, Sibai BM. Outcome after success- fasting hypoglycemia on perinatal hypoxic–ischemic brain damage. Pediatr ful resuscitation of babies born with apgar scores of 0 at both 1 and 5 minutes. Res 1992;31:138–42. Am J Obstet Gynecol 2000;182:1210–4.
- 182. Resuscitation 81 (2010) 1400–1433 Contents lists available at ScienceDirect Resuscitation journal homepage: www.elsevier.com/locate/resuscitation European Resuscitation Council Guidelines for Resuscitation 2010 Section 8. Cardiac arrest in special circumstances: Electrolyte abnormalities, poisoning, drowning, accidental hypothermia, hyperthermia, asthma, anaphylaxis, cardiac surgery, trauma, pregnancy, electrocution Jasmeet Soar a,∗ , Gavin D. Perkins b , Gamal Abbas c , Annette Alfonzo d , Alessandro Barelli e , Joost J.L.M. Bierens f , Hermann Brugger g , Charles D. Deakin h , Joel Dunning i , Marios Georgiou j , Anthony J. Handley k , David J. Lockey l , Peter Paal m , Claudio Sandroni n , Karl-Christian Thies o , David A. Zideman p , Jerry P. Nolan q a Anaesthesia and Intensive Care Medicine, Southmead Hospital, North Bristol NHS Trust, Bristol, UK b University of Warwick, Warwick Medical School, Warwick, UK c Emergency Department, Al Rahba Hospital, Abu Dhabi, United Arab Emirates d Queen Margaret Hospital, Dunfermline, Fife, UK e Intensive Care Medicine and Clinical Toxicology, Catholic University School of Medicine, Rome, Italy f Maxima Medical Centre, Eindhoven, The Netherlands g EURAC Institute of Mountain Emergency Medicine, Bozen, Italy h Cardiac Anaesthesia and Critical Care, Southampton University Hospital NHS Trust, Southampton, UK i Department of Cardiothoracic Surgery, James Cook University Hospital, Middlesbrough, UK j Nicosia General Hospital, Nicosia, Cyprus k Honorary Consultant Physician, Colchester, UK l Anaesthesia and Intensive Care Medicine, Frenchay Hospital, Bristol, UK m Department of Anesthesiology and Critical Care Medicine, University Hospital Innsbruck, Innsbruck, Austria n Critical Care Medicine at Policlinico Universitario Agostino Gemelli, Catholic University School of Medicine, Rome, Italy o Birmingham Children’s Hospital, Birmingham, UK p Imperial College Healthcare NHS Trust, London, UK q Anaesthesia and Intensive Care Medicine, Royal United Hospital, Bath, UK 8a. Life-threatening electrolyte disorders no major changes in the treatment of these disorders since Guide- lines 2005.1 Overview Prevention of electrolyte disorders Electrolyte abnormalities can cause cardiac arrhythmias or car- diopulmonary arrest. Life-threatening arrhythmias are associated Identify and treat life-threatening electrolyte abnormalities most commonly with potassium disorders, particularly hyper- before cardiac arrest occurs. Remove any precipitating factors (e.g., kalaemia, and less commonly with disorders of serum calcium and drugs) and monitor electrolyte values to prevent recurrence of the magnesium. In some cases therapy for life-threatening electrolyte abnormality. Monitor renal function in patients at risk of elec- disorders should start before laboratory results become available. trolyte disorders (e.g., chronic kidney disease, cardiac failure). In The electrolyte values for definitions have been chosen as a haemodialysis patients, review the dialysis prescription regularly guide to clinical decision-making. The precise values that trigger to avoid inappropriate electrolyte shifts during treatment. treatment decisions will depend on the patient’s clinical condition and rate of change of electrolyte values. Potassium disorders There is little or no evidence for the treatment of electrolyte abnormalities during cardiac arrest. Guidance during cardiac arrest Potassium homeostasis is based on the strategies used in the non-arrest patient. There are Extracellular potassium concentration is regulated tightly between 3.5 and 5.0 mmol l−1 . A large concentration gradient normally exists between intracellular and extracellular fluid ∗ Corresponding author. compartments. This potassium gradient across cell membranes E-mail address: jas.soar@btinternet.com (J. Soar). contributes to the excitability of nerve and muscle cells, including 0300-9572/$ – see front matter © 2010 European Resuscitation Council. Published by Elsevier Ireland Ltd. All rights reserved. doi:10.1016/j.resuscitation.2010.08.015
- 183. J. Soar et al. / Resuscitation 81 (2010) 1400–1433 1401 the myocardium. Evaluation of serum potassium must take into • cardiac arrest (pulseless electrical activity [PEA], ventricular fib- consideration the effects of changes in serum pH. When serum rillation/pulseless ventricular tachycardia [VF/VT], asystole). pH decreases (acidaemia), serum potassium increases because potassium shifts from the cellular to the vascular space. When Treatment of hyperkalaemia serum pH increases (alkalaemia), serum potassium decreases There are three key treatments for hyperkalaemia5 : because potassium shifts intracellularly. Anticipate the effects of pH changes on serum potassium during therapy for hyperkalaemia 1. cardiac protection; or hypokalaemia. 2. shifting potassium into cells; 3. removing potassium from the body. Hyperkalaemia Intravenous calcium salts are not generally indicated in the This is the most common electrolyte disorder associated with absence of ECG changes. Monitor effectiveness of treatment, cardiopulmonary arrest. It is usually caused by increased potassium be alert to rebound hyperkalaemia and take steps to prevent release from cells, impaired excretion by the kidneys or accidental recurrence of hyperkalaemia. When hyperkalaemia is strongly potassium chloride administration. suspected, e.g., in the presence of ECG changes, start life-saving treatment even before laboratory results are available. The treat- ment of hyperkalaemia has been the subject of a Cochrane review.6 Definition There is no universal definition. We have defined hyperkalaemia as a serum potassium concentration higher than 5.5 mmol l−1 ; in Patient not in cardiac arrest. Assess ABCDE (Airway, Breathing, practice, hyperkalaemia is a continuum. As the potassium con- Circulation, Disability, Exposure) and correct any abnormalities. centration increases above this value the risk of adverse events Obtain intravenous access, check serum potassium and record increases and the need for urgent treatment increases. Severe an ECG. Treatment is determined according to severity of hyper- hyperkalaemia has been defined as a serum potassium concentra- kalaemia. tion higher than 6.5 mmol l−1 . Approximate values are provided to guide treatment. Mild elevation (5.5–5.9 mmol l−1 ): Causes There are several potential causes of hyperkalaemia, includ- • Remove potassium from body: potassium exchange resins – ing renal failure, drugs (angiotensin converting enzyme inhibitors calcium resonium 15–30 g OR sodium polystyrene sulfonate (ACE-I), angiotensin II receptor antagonists, potassium spar- (Kayexalate) 15–30 g in 50–100 ml of 20% sorbitol, given either ing diuretics, non-steroidal anti-inflammatory drugs (NSAIDs), orally or by retention enema (onset in 1–3 h; maximal effect at beta-blockers, trimethoprim), tissue breakdown (rhabdomyolysis, 6 h). tumour lysis, haemolysis), metabolic acidosis, endocrine disorders • Address cause of hyperkalaemia to correct and avoid further rise (Addison’s disease), hyperkalaemic periodic paralysis, or diet (may in serum potassium (e.g., drugs, diet). be sole cause in patients with advanced chronic kidney disease). Abnormal erythrocytes or thrombocytosis may cause a spuriously Moderate elevation (6–6.4 mmol l−1 ) without ECG changes: high potassium concentration.2 The risk of hyperkalaemia is even greater when there is a combination of factors such as the concomi- • Shift potassium intracellularly with glucose/insulin: 10 units tant use of ACE-I and NSAIDs or potassium sparing diuretics. short-acting insulin and 25 g glucose IV over 15–30 min (onset in 15–30 min; maximal effect at 30–60 min; monitor blood glucose). Recognition of hyperkalaemia • Remove potassium from the body as described above. Exclude hyperkalaemia in patients with an arrhythmia or • Haemodialysis: consider if oliguric; haemodialysis is more effi- cardiac arrest.3 Patients may present with weakness progress- cient than peritoneal dialysis at removing potassium. ing to flaccid paralysis, paraesthesia, or depressed deep tendon reflexes. Alternatively, the clinical picture can be overshadowed Severe elevation (≥6.5 mmol l−1 ) without ECG changes. Seek expert by the primary illness causing hyperkalaemia. The first indicator help and: of hyperkalaemia may also be the presence of ECG abnormali- ties, arrhythmias, cardiopulmonary arrest or sudden death. The • Use multiple shifting agents. effect of hyperkalaemia on the ECG depends on the absolute serum • Glucose/insulin (see above). potassium as well as the rate of increase. Most patients will have • Salbutamol 5 mg nebulised. Several doses (10–20 mg) may be ECG abnormalities at a serum potassium concentration higher than required (onset in 15–30 min). 6.7 mmol l−1 .4 The use of a blood gas analyser that measures potas- • Sodium bicarbonate: 50 mmol IV over 5 min if metabolic acidosis sium can reduce delay in recognition. present (onset in 15–30 min). Bicarbonate alone is less effective The ECG changes associated with hyperkalaemia are usually than glucose plus insulin or nebulised salbutamol; it is best used progressive and include: in conjunction with these medications.7,8 • Use removal strategies above. • first degree heart block (prolonged PR interval) [>0.2 s]; • flattened or absent P waves; Severe elevation (≥6.5 mmol l−1 ) WITH toxic ECG changes. Seek • tall, peaked (tented) T waves [T wave larger than R wave in more expert help and: than 1 lead]; • ST-segment depression; • Protect the heart first with calcium chloride: 10 ml 10% calcium • S and T wave merging (sine wave pattern); chloride IV over 2–5 min to antagonise the toxic effects of hyper- • widened QRS [>0.12 s]; kalaemia at the myocardial cell membrane. This protects the • ventricular tachycardia; heart by reducing the risk of pulseless VT/VF but does not lower • bradycardia; serum potassium (onset in 1–3 min).
- 184. 1402 J. Soar et al. / Resuscitation 81 (2010) 1400–1433 • Use multiple shifting agents (see above). automated external defibrillators in dialysis centres can facilitate • Use removal strategies. early defibrillation.19 • Prompt specialist referral is essential. Vascular access. In life-threatening circumstances and cardiac Patient in cardiac arrest. Modifications to BLS There are no arrest, vascular access used for haemodialysis can be used to give modifications to basic life support in the presence of electrolyte drugs.13 abnormalities. Modifications to ALS Potentially reversible causes. All of the standard reversible causes (4 Hs and 4 Ts) apply to dialysis patients. Electrolyte • Follow the universal algorithm. Hyperkalaemia can be confirmed disorders, particularly hyperkalaemia, and fluid overload (e.g., pul- rapidly using a blood gas analyser if available. Protect the heart monary oedema) are most common causes. first: give 10 ml 10% calcium chloride IV by rapid bolus injection. • Shift potassium into cells: Hypokalaemia ◦ Glucose/insulin: 10 units short-acting insulin and 25 g glucose IV by rapid injection. Hypokalaemia is common in hospital patients.20 Hypokalaemia ◦ Sodium bicarbonate: 50 mmol IV by rapid injection (if severe increases the incidence of arrhythmias, particularly in patients with acidosis or renal failure). pre-existing heart disease and in those treated with digoxin. • Remove potassium from body: dialysis: consider this for car- diac arrest induced by hyperkalaemia that is resistant to medical Definition treatment. Several dialysis modes have been used safely and Hypokalaemia is defined as a serum potassium < 3.5 mmol l−1 . effectively in cardiac arrest, but this may only be available in Severe hypokalaemia is defined as a K+ < 2.5 mmol l−1 and may be specialist centres. associated with symptoms. Indications for dialysis Causes Haemodialysis (HD) is the most effective method for removal Causes of hypokalaemia include gastrointestinal loss (diar- of potassium from the body. The principle mechanism of action rhoea), drugs (diuretics, laxatives, steroids), renal losses (renal is the diffusion of potassium ions across the membrane down the tubular disorders, diabetes insipidus, dialysis), endocrine disorders potassium ion gradient. The typical decline in serum potassium is (Cushing’s Syndrome, hyperaldosteronism), metabolic alkalosis, 1 mmol l−1 in the first 60 min, followed by 1 mmol l−1 over the next magnesium depletion, and poor dietary intake. Treatment strate- 2 h. The efficacy of HD in decreasing serum potassium concentra- gies used for hyperkalaemia may also induce hypokalaemia. tion can be improved by performing dialysis with a low potassium concentration in the dialysate,9 a high blood flow rate10 or a high Recognition of hypokalaemia dialysate bicarbonate concentration.11 Exclude hypokalaemia in every patient with an arrhythmia or Consider haemodialysis early for hyperkalaemia associated cardiac arrest. In dialysis patients, hypokalaemia occurs commonly with established renal failure, oliguric acute kidney injury at the end of a haemodialysis session or during treatment with (<400 ml day−1 urine output) or when there is marked tissue break- peritoneal dialysis. down. Dialysis is also indicated when hyperkalaemia is resistant As serum potassium concentration decreases, the nerves and to medical treatment. Serum potassium frequently rebounds after muscles are predominantly affected causing fatigue, weakness, initial treatment. In unstable patients continuous renal replace- leg cramps, constipation. In severe cases (K+ < 2.5 mmol l−1 ), rhab- ment therapy (CRRT) (e.g., continuous veno-veno haemofiltration) domyolysis, ascending paralysis and respiratory difficulties may is less likely to compromise cardiac output than intermittent occur. haemodialysis. CRRT is now widely available in many intensive care ECG features of hypokalaemia are: units. • U waves; Cardiac arrest in haemodialysis patients • T wave flattening; Cardiac arrest is the most common cause of death in haemodial- • ST-segment changes; ysis patients.12 Events occurring particularly during haemodialysis • arrhythmias, especially if patient is taking digoxin; treatment, pose several novel considerations. • cardiopulmonary arrest (PEA, pulseless VT/VF, asystole). Initial steps. Call the resuscitation team and seek expert help Treatment immediately. Whilst BLS is underway, a trained dialysis nurse This depends on the severity of hypokalaemia and the presence should be assigned to the dialysis machine. The conventional of symptoms and ECG abnormalities. Gradual replacement of potas- practice is to return the patient’s blood volume and take off sium is preferable, but in an emergency, intravenous potassium haemodialysis, although this approach is not the most time- is required. The maximum recommended IV dose of potassium efficient.13 is 20 mmol h−1 , but more rapid infusion (e.g., 2 mmol min−1 for 10 min, followed by 10 mmol over 5–10 min) is indicated for unsta- Defibrillation. A shockable cardiac rhythm (VF/VT) is more ble arrhythmias when cardiac arrest is imminent. Continuous ECG common in patients undergoing haemodialysis14,15 than in the gen- monitoring is essential during IV infusion and the dose should be eral population.16,17 titrated after repeated sampling of serum potassium levels. The safest method to deliver a shock during dialysis requires Many patients who are potassium deficient are also deficient further study. Most haemodialysis machine manufacturers rec- in magnesium. Magnesium is important for potassium uptake and ommend disconnection from the dialysis equipment prior to for the maintenance of intracellular potassium levels, particularly defibrillation.18 An alternative and rapid disconnect technique for in the myocardium. Repletion of magnesium stores will facilitate haemodialysis has been described. Disconnection during contin- more rapid correction of hypokalaemia and is recommended in uous venovenous haemofiltration is not required.13 The use of severe cases of hypokalaemia.21
- 185. J. Soar et al. / Resuscitation 81 (2010) 1400–1433 1403 Table 8.1 Calcium and magnesium disorders with associated clinical presentation, ECG manifestations and recommended treatment. Disorder Causes Presentation ECG Treatment Hypercalcaemia Primary or tertiary Confusion Short QT interval Fluid replacement IV [Calcium] > 2.6 mmol l−1 hyperparathyroidism Malignancy Weakness Prolonged QRS Interval Furosemide 1 mg kg−1 IV Sarcoidosis Abdominal pain Flat T waves Hydrocortisone 200–300 mg IV Drugs Hypotension AV-block Pamidronate 30–90 mg IV Arrhythmias Cardiac arrest Treat underlying cause Cardiac arrest Hypocalcaemia Chronic renal failure Paraesthesia Prolonged QT interval Calcium chloride 10% 10–40 ml [Calcium] < 2.1 mmol l−1 Acute pancreatitis Tetany T wave inversion Magnesium sulphate 50% 4–8 mmol (if necessary) Calcium channel blocker Seizures Heart block overdose Toxic shock syndrome AV-block Cardiac arrest Rhabdomyolysis Cardiac arrest Tumour lysis syndrome Hypermagnesaemia Renal failure Confusion Prolonged PR and QT Consider treatment when [Magnesium] > 1.1 mmol l−1 intervals [Magnesium] > 1.75 mmol l−1 Iatrogenic Weakness T wave peaking Respiratory depression AV-block Calcium chloride 10% 5–10 ml repeated if necessary AV-block Cardiac arrest Ventilatory support if necessary Cardiac arrest Saline diuresis – 0.9% saline with furosemide 1 mg kg−1 IV Haemodialysis Hypomagnesaemia GI loss Tremor Prolonged PR and QT Severe or symptomatic: [Magnesium] < 0.6 mmol l−1 Intervals Polyuria Ataxia ST-segment depression 2 g 50% magnesium sulphate (4 ml; 8 mmol) IV over 15 min. Starvation Nystagmus T-wave inversion Torsade de pointes: Alcoholism Seizures Flattened P waves 2 g 50% magnesium sulphate (4 ml; 8 mmol) IV over 1–2 min. Malabsorption Arrhythmias – torsade de pointes Increased QRS duration Seizure: Cardiac arrest Torsade de pointes 2 g 50% magnesium sulphate (4 ml; 8 mmol) IV over 10 min. Calcium and magnesium disorders Prevention of cardiac arrest The recognition and management of calcium and magnesium disorders is summarised in Table 8.1. Assess using the ABCDE (Airway, Breathing, Circulation, Dis- ability, Exposure) approach. Airway obstruction and respiratory arrest secondary to a decreased conscious level is a common cause of death after self-poisoning.23 Pulmonary aspiration of gastric Summary contents can occur after poisoning with central nervous system depressants. Early tracheal intubation of unconscious patients by Electrolyte abnormalities are among the most common causes a trained person decreases the risk of aspiration. Drug-induced of cardiac arrhythmias. Of all the electrolyte abnormalities, hyper- hypotension usually responds to fluid infusion, but occasionally kalaemia is most rapidly fatal. A high degree of clinical suspicion vasopressor support (e.g., noradrenaline infusion) is required. A and aggressive treatment of underlying electrolyte abnormalities long period of coma in a single position can cause pressure sores can prevent many patients from progressing to cardiac arrest. and rhabdomyolysis. Measure electrolytes (particularly potas- sium), blood glucose and arterial blood gases. Monitor temperature because thermoregulation is impaired. Both hypothermia and 8b. Poisoning hyperthermia (hyperpyrexia) can occur after overdose of some drugs. Retain samples of blood and urine for analysis. Patients with General considerations severe poisoning should be cared for in a critical-care setting. Interventions such as decontamination, enhanced elimina- Poisoning rarely causes cardiac arrest, but is a leading cause tion and antidotes may be indicated and are usually second of death in victims younger than 40 years of age.22 Evidence for line interventions.24 Alcohol excess is often associated with self- treatment consists primarily of small case-series, animal studies poisoning. and case reports. Poisoning by therapeutic or recreational drugs and by household products are the main reasons for hospital admission and poison centre calls. Inappropriate drug dosing, drug Modifications to BLS/ALS interactions and other medication errors can also cause harm. Acci- dental poisoning is commonest in children. Homicidal poisoning • Have a high index of personal safety where there is a suspicious is uncommon. Industrial accidents, warfare or terrorism can also cause or unexpected cardiac arrest. This is especially so when cause exposure to harmful substances. more than one casualty collapses simultaneously.
- 186. 1404 J. Soar et al. / Resuscitation 81 (2010) 1400–1433 • Avoid mouth-to-mouth ventilation in the presence of chemicals Laxatives (cathartics) or emetics (e.g., ipecacuanha) have no role such as cyanide, hydrogen sulphide, corrosives and organophos- in the management of the acutely poisoned patient and are not phates. recommended.26,32,33 • Treat life-threatening tachyarrhythmias with cardioversion according to the peri-arrest arrhythmia guidelines (see Section 4, Enhancing elimination Advanced Life Support).24a This includes correction of electrolyte and acid-base abnormalities. Urine alkalinisation (urine pH of 7.5 or higher) by intra- • Try to identify the poison(s). Relatives, friends and ambulance venous sodium bicarbonate infusion is a first line treatment crews can provide useful information. Examination of the patient for moderate-to-severe salicylate poisoning in patients who may reveal diagnostic clues such as odours, needle marks, pupil do not need haemodialysis.25 Urine alkalinisation with high abnormalities, and signs of corrosion in the mouth. urine flow (approximately 600 ml h−1 ) should also be con- • Measure the patient’s temperature because hypo- or hyperther- sidered in patients with severe poisoning by the herbicides mia may occur after drug overdose (see Sections 8d and 8e). 2,4-dichlorophenoxyacetic acid and methylchlorophenoxypro- • Be prepared to continue resuscitation for a prolonged period, par- pionic acid (mecoprop). Hypokalaemia is the most common ticularly in young patients, as the poison may be metabolized or complication of alkalaemia. excreted during extended life support measures. Haemodialysis or haemoperfusion should be considered in • Alternative approaches which may be effective in severely poi- specific life-threatening poisonings only. Haemodialysis removes soned patients include: higher doses of medication than in drugs or metabolites that are water soluble, have a low volume standard protocols; non-standard drug therapies; prolonged CPR. of distribution and low plasma protein binding. Haemoperfusion • Consult regional or national poisons centres for information on can remove substances that have a high degree of plasma protein treatment of the poisoned patient. The International Programme binding on Chemical Safety (IPCS) lists poison centres on its website: http://www.who.int/ipcs/poisons/centre/en/. Specific poisonings • Online databases for information on toxicology and hazardous chemicals: (http://toxnet.nlm.nih.gov/). These guidelines address only some causes of cardiorespiratory arrest due to acute poisoning. Benzodiazepines Specific therapeutic measures Patients at risk of cardiac arrest There are few specific therapeutic measures for poisoning that Overdose of benzodiazepines can cause loss of consciousness, are useful immediately and improve outcomes.25–29 respiratory depression and hypotension. Flumazenil, a competi- Therapeutic measures include decontamination, multiple-dose tive antagonist of benzodiazepines, should only be used only for activated charcoal, enhancing elimination and the use of specific reversal of sedation caused by a single ingestion of any of the antidotes. Many of these interventions should be used only based benzodiazepines and when there is no history or risk of seizures. on expert advice. For up-to-date guidance in severe or uncommon Reversal of benzodiazepine intoxication with flumazenil can be poisonings, seek advice from a poisons centre. associated with significant toxicity (seizure, arrhythmia, hypoten- sion, and withdrawal syndrome) in patients with benzodiazepine Gastrointestinal decontamination dependence or co-ingestion of proconvulsant medications such as tricyclic antidepressants.34–36 The routine use of flumazenil in the Activated charcoal adsorbs most drugs. Its benefit decreases comatose overdose patient is not recommended. over time after ingestion. There is no evidence that treatment with activated charcoal improves clinical outcome. Consider giving a Modifications to BLS/ALS single dose of activated charcoal to patients who have ingested a There are no specific modifications required for cardiac arrest potentially toxic amount of poison (known to be adsorbed by acti- caused by benzodiazepines.36–40 vated charcoal) up to 1 h previously.30 Give it only to patients with an intact or protected airway. Opioids Multiple-dose activated charcoal significantly increases drug elimination, but no controlled study in poisoned patients has Opioid poisoning causes respiratory depression followed by res- shown a reduction in morbidity and mortality and should only be piratory insufficiency or respiratory arrest. The respiratory effects used following expert advice. There is little evidence to support of opioids are reversed rapidly by the opiate antagonist naloxone. the use of gastric lavage. It should only be considered within 1 h of ingestion of a potentially life-threatening amount of a poison. Even Patients at risk of cardiac arrest then, clinical benefit has not been confirmed in controlled stud- In severe respiratory depression caused by opioids, there are ies. Gastric lavage is contraindicated if the airway is not protected fewer adverse events when airway opening, oxygen administra- and if a hydrocarbon with high aspiration potential or a corrosive tion and ventilation are carried out before giving naloxone.41–47 substance has been ingested.27,28 The use of naloxone can prevent the need for intubation. The pre- Volunteer studies show substantial decreases in the bioavail- ferred route for giving naloxone depends on the skills of the rescuer: ability of ingested drugs but no controlled clinical trials show that IV, intramuscular (IM), subcutaneous (SC) and intranasal (IN) routes whole-bowel irrigation improves the outcome of the poisoned can be used. The non-IV routes can be quicker because time is saved patient. Based on volunteer studies, whole-bowel irrigation may in not having to establish IV access, which can be extremely diffi- be considered for potentially toxic ingestions of sustained-release cult in an IV drug abuser. The initial doses of naloxone are 400 g or enteric-coated drugs. Its use for the removal of iron, lead, zinc, IV,43 800 g IM, 800 g SC,43 or 2 mg IN.48,49 Large opioid over- or packets of illicit drugs is a theoretical option. Whole-bowel doses may require titration of naloxone to a total dose of 6–10 mg. irrigation is contraindicated in patients with bowel obstruction, The duration of action of naloxone is approximately 45–70 min, but perforation, ileus, and haemodynamic instability.31 respiratory depression can persist for 4–5 h after opioid overdose.
- 187. J. Soar et al. / Resuscitation 81 (2010) 1400–1433 1405 Thus, the clinical effects of naloxone may not last as long as those and labetolol).85–87 is limited. The best choice of anti-arrhythmic of a significant opioid overdose. Titrate the dose until the victim is drug for the treatment of cocaine-induced tachyarrhythmias is not breathing adequately and has protective airway reflexes. known. Acute withdrawal from opioids produces a state of sympathetic excess and may cause complications such as pulmonary oedema, Modifications to BLS/ALS ventricular arrhythmia and severe agitation. Use naloxone reversal If cardiac arrest occurs, follow standard resuscitation of opioid intoxication with caution in patients suspected of opioid guidelines.88 dependence. Local anaesthetics Modifications for ALS There are no studies supporting the use of naloxone once car- Systemic toxicity of local anaesthetics involves the central diac arrest associated with opioid toxicity has occurred. Cardiac nervous system, the cardiovascular system. Severe agitation, arrest is usually secondary to a respiratory arrest and associated loss of consciousness, with or without tonic–clonic convulsions, with severe brain hypoxia. Prognosis is poor.42 Giving naloxone is sinus bradycardia, conduction blocks, asystole and ventricular unlikely to be harmful. Once cardiac arrest has occurred, follow tachyarrhythmias can all occur. Toxicity can be potentiated in preg- standard resuscitation protocols. nancy, extremes of age, or hypoxaemia. Toxicity typically occurs in the setting of regional anaesthesia, when a bolus of local anaesthetic Tricyclic antidepressants inadvertently enters an artery or vein. This section addresses both tricyclic and related cyclic Patients at risk of cardiac arrest drugs (e.g., amitriptyline, desipramine, imipramine, nortriptyline, Evidence for specific treatment is limited to case reports involv- doxepin, and clomipramine). Self-poisoning with tricyclic antide- ing cardiac arrest and severe cardiovascular toxicity and animal pressants is common and can cause hypotension, seizures, coma studies. Patients with both cardiovascular collapse and cardiac and life-threatening arrhythmias. Cardiac toxicity mediated by arrest attributable to local anaesthetic toxicity may benefit from anticholinergic and Na+ channel-blocking effects can produce a treatment with intravenous 20% lipid emulsion in addition to stan- wide complex tachycardia (VT). Hypotension is exacerbated by dard advanced life support.89–103 Give an initial intravenous bolus alpha-1 receptor blockade. Anticholinergic effects include mydri- of 20% lipid emulsion followed by an infusion at 15 ml kg−1 h−1 . asis, fever, dry skin, delirium, tachycardia, ileus, and urinary Give up to three bolus doses of lipid at 5-min intervals and con- retention. Most life-threatening problems occur within the first 6 h tinue the infusion until the patient is stable or has received up to a after ingestion.50–52 maximum of 12 ml kg−1 of lipid emulsion.104 Patient at risk of cardiac arrest Modifications to BLS/ALS A widening QRS complex (>100 ms) and right axis deviation Standard cardiac arrests drugs (e.g., adrenaline) should be indicates a greater risk of arrhythmias.53–55 Sodium bicarbon- given according to standard guidelines, although animal studies ate should be considered for the treatment of tricyclic-induced provide inconsistent evidence for their role in local anaesthetic ventricular conduction abnormalities.56–63 While no study has toxicity.100,103,105–107 investigated the optimal target arterial pH with bicarbonate ther- apy, a pH of 7.45–7.55 has been commonly accepted and seems Beta-blockers reasonable. Intravenous lipid infusions in experimental models of tricyclic Beta-blocker toxicity causes bradyarrhythmias and negative toxicity have suggested benefit but there are few human data.64,65 inotropic effects that are difficult to treat, and can lead to cardiac Anti-tricyclic antibodies have also been beneficial in experimental arrest. models of tricyclic cardiotoxicity.66–71 One small human study72 provided evidence of safety but clinical benefit has not been shown. Patients at risk of cardiac arrest Evidence for treatment is based on case reports and ani- Modifications to BLS/ALS mal studies. Improvement has been reported with glucagon There are no randomised controlled trials evaluating conven- (50–150 g kg−1 ),108–121 high-dose insulin and glucose,122–124 tional versus alternative treatments for cardiac arrest caused by phosphodiesterase inhibitors,125,126 calcium salts,127 extracorpo- tricyclic toxicity. One small case-series of cardiac arrest patients, real and intra-aortic balloon pump support,128–130 and calcium showed improvement with the use of sodium bicarbonate.73 salts.131 Cocaine Calcium channel blockers Sympathetic overstimulation associated with cocaine toxicity Calcium channel blocker overdose is emerging as a common can cause agitation, tachycardia, hypertensive crisis, hyperthermia cause of prescription drug poisoning deaths.22,132 Overdose of and coronary vasoconstriction causing myocardial ischaemia with short-acting drugs can rapidly progress to cardiac arrest. Overdose angina. by sustained-release formulations can result in delayed onset of arrhythmias, shock, and sudden cardiac collapse. Asymptomatic Patients at risk of cardiac arrest patients are unlikely to develop symptoms if the interval between In patients with severe cardiovascular toxicity, alpha blockers the ingestion and the call is greater than 6 h for immediate-release (phentolamine),74 benzodiazepines (lorazepam, diazepam),75,76 products, 18 h for modified-release products other than verapamil, calcium channel blockers (verapamil),77 morphine,78 and sub- and 24 h for modified-release verapamil. lingual nitroglycerine79,80 may be used as needed to control hypertension, tachycardia, myocardial ischaemia and agitation. The Patients at risk of cardiac arrest evidence for or against the use of beta-blocker drugs,81–84 includ- Intensive cardiovascular support is needed for managing a ing those beta-blockers with alpha blocking properties (carvedilol massive calcium channel blocker overdose. While calcium chlo-
- 188. 1406 J. Soar et al. / Resuscitation 81 (2010) 1400–1433 ride in high doses can overcome some of the adverse effects, it return of spontaneous circulation is achieved; however, hyper- rarely restores normal cardiovascular status. Haemodynamic insta- baric oxygen therapy may be considered in these patients as it bility may respond to high doses of insulin given with glucose may reduce the risk of developing persistent or delayed neuro- supplementation and electrolyte monitoring in addition to stan- logical injury.177–185 The risks inherent in transporting critically dard treatments including fluids and inotropic drugs.133–148 Other ill post-arrest patients to a hyperbaric facility may be significant, potentially useful treatments include glucagon, vasopressin and and must be weighed against the possibility of benefit on a case- phosphodiesterse inhibitors.139,149 by-case basis. Patients who develop myocardial injury caused by carbon monoxide have an increased risk of cardiac and all-cause Digoxin mortality lasting at least 7 years after the event; it is reasonable to recommend cardiology follow-up for these patients.186,187 Although cases of digoxin poisoning are fewer than those involv- ing calcium channel and beta-blockers, the mortality rate from 8c. Drowning digoxin is far greater. Other drugs including calcium channel blockers and amiodarone can also cause plasma concentrations of Overview digoxin to rise. Atrioventricular conduction abnormalities and ven- tricular hyperexcitability due to digoxin toxicity can lead to severe Drowning is a common cause of accidental death in Europe. arrhythmias and cardiac arrest. After drowning the duration of hypoxia is the most critical factor in determining the victim’s outcome; therefore, oxygenation, ven- Patients at risk of cardiac arrest tilation, and perfusion should be restored as rapidly as possible. Standard resuscitation measures and specific antidote therapy Immediate resuscitation at the scene is essential for survival and with digoxin-specific antibody fragments should be used if there neurological recovery after a drowning incident. This will require are arrhythmias associated with haemodynamic instability.150–163 provision of CPR by a bystander and immediate activation of the Antibody-specific therapy may also be effective in poisoning from EMS system. Victims who have spontaneous circulation and breath- plants as well as Chinese herbal medications containing digitalis ing when they reach hospital usually recover with good outcomes. glycosides.150,164,165 Digoxin-specific antibody fragments interfere Research into drowning is limited in comparison with primary car- with digoxin immunoassay measurements and can lead to overes- diac arrest and there is a need for further research in this area.188 timation of plasma digoxin concentrations. These guidelines are intended for healthcare professionals and cer- tain groups of lay responders that have a special interest in the care Cyanide of the drowning victim, e.g., lifeguards. Cyanide is generally considered to be a rare cause of acute poi- Epidemiology soning; however, cyanide exposure occurs relatively frequently in patients with smoke inhalation from residential or industrial fires. The World Health Organization (WHO) estimates that, world- Its main toxicity results from inactivation of cytochrome oxidase wide, drowning accounts for approximately 450,000 deaths each (at cytochrome a3), thus uncoupling mitochondrial oxidative phos- year. A further 1.3 million disability-adjusted life-years are lost phorylation and inhibiting cellular respiration, even in the presence each year as a result of premature death or disability from of adequate oxygen supply. Tissues with the highest oxygen needs drowning189 ; 97% of deaths from drowning occur in low- and (brain and heart) are the most severely affected by acute cyanide middle-income countries.189 In 2006 there were 312 accidental poisoning. deaths from drowning in the United Kingdom190 and 3582 in the United States,191 yielding an annual incidence of drowning of Patients at risk of cardiac arrest 0.56 and 1.2 per 100,000 population, respectively.192 Death from Patients with severe cardiovascular toxicity (cardiac arrest, car- drowning is more common in young males, and is the leading diovascular instability, metabolic acidosis, or altered mental status) cause of accidental death in Europe in this group.189 Factors associ- caused by known or suspected cyanide poisoning should receive ated with drowning (e.g., suicide, traffic accidents, alcohol and drug cyanide antidote therapy in addition to standard resuscitation, abuse) varies between countries.193 including oxygen. Initial therapy should include a cyanide scav- enger (either intravenous hydroxocobalamin or a nitrite – i.e., Definitions, classifications and reporting intravenous sodium nitrite and/or inhaled amyl nitrite), followed as soon as possible by intravenous sodium thiosulphate.166–175 Over 30 different terms have been used to describe the Hydroxocobalamin and nitrites are equally effective but hydroxo- process and outcome from submersion- and immersion-related cobalamin may be safer because it does not cause methaemoglobin incidents.194 The International Liaison Committee on Resuscita- formation or hypotension. tion (ILCOR) defines drowning as “a process resulting in primary respiratory impairment from submersion/immersion in a liquid Modifications to BLS/ALS medium. Implicit in this definition is that a liquid/air interface In case of cardiac arrest caused by cyanide, standard ALS treat- is present at the entrance of the victim’s airway, preventing the ment will fail to restore spontaneous circulation as long as cellular victim from breathing air. The victim may live or die after this pro- respiration is blocked. Antidote treatment is needed for reactiva- cess, but whatever the outcome, he or she has been involved in a tion of cytochrome oxidase. drowning incident”.195 Immersion means to be covered in water or other fluid. For drowning to occur, usually at least the face and air- Carbon monoxide way must be immersed. Submersion implies that the entire body, including the airway, is under the water or other fluid. Carbon monoxide poisoning is common. There were about ILCOR recommends that the following terms, previously used, 25,000 carbon monoxide related hospital admissions reported in should no longer be used: dry and wet drowning, active and passive the US in 2005.176 Patients who develop cardiac arrest caused drowning, silent drowning, secondary drowning and drowned ver- by carbon monoxide rarely survive to hospital discharge, even if sus near-drowned.195 The Utstein drowning style should be used
- 189. J. Soar et al. / Resuscitation 81 (2010) 1400–1433 1407 when reporting outcomes from drowning incidents to improve water-slide use, signs of trauma or signs of alcohol intoxication. If consistency in information between studies.195 the victim is pulseless and apnoeic remove them from the water as quickly as possible (even if a back support device is not available), Pathophysiology while attempting to limit neck flexion and extension. The pathophysiology of drowning has been described in Rescue breathing. The first and most important treatment for detail.195,196 In brief, after submersion, the victim initially breath the drowning victim is alleviation of hypoxaemia. Prompt initia- holds before developing laryngospasm. During this time the victim tion of rescue breathing or positive pressure ventilation increases frequently swallows large quantities of water. As breath hold- survival.201–204 If possible supplement rescue breaths/ventilations ing/laryngospasm continues, hypoxia and hypercapnia develops. with oxygen.205 Give five initial ventilations/rescue breaths as soon Eventually these reflexes abate and the victim aspirates water as possible. into their lungs leading to worsening hypoxaemia. Without rescue Rescue breathing can be initiated whilst the victim is still in shal- and restoration of ventilation the victim will become bradycardic low water provided the safety of the rescuer is not compromised. before sustaining a cardiac arrest. The key feature to note in the It is likely to be difficult to pinch the victim’s nose, so mouth-to- pathophysiology of drowning is that cardiac arrest occurs as a con- nose ventilation may be used as an alternative to mouth-to-mouth sequence of hypoxia and correction of hypoxaemia is critical to ventilation. obtaining a return of spontaneous circulation. If the victim is in deep water, open their airway and if there is no spontaneous breathing start in-water rescue breathing if trained Treatment to do so. In-water resuscitation is possible,206 but should ideally be performed with the support of a buoyant rescue aid.207 Give 10–15 Treatment of a drowning victim involves four distinct but inter- rescue breaths over approximately 1 min.207 If normal breathing related phases. These comprise (i) aquatic rescue, (ii) basic life does not start spontaneously, and the victim is <5 min of from land, support, (iii) advanced life support, and (iv) post-resuscitation care. continue rescue breaths while towing. If more than an estimated Rescue and resuscitation of the drowning victim almost always 5 min from land, give further rescue breaths over 1 min, then bring involves a multi-professional team approach. The initial rescue the victim to land as quickly as possible without further attempts from the water is usually undertaken either by bystanders or those at ventilation.207 with a duty to respond such as trained lifeguards or lifeboat oper- ators. Basic life support is often provided by the initial responders Chest compression. The victim should be placed on a firm before arrival of the emergency medical services. Resuscitation surface before starting chest compressions as compressions are frequently continues into hospital where, if return of sponta- ineffective in the water.208,209 Confirm the victim is unresponsive neous circulation is achieved, transfer to critical care often follows. and not breathing normally and then give 30 chest compressions. Drowning incidents vary in their complexity from an incident Continue CPR in a ratio of 30 compressions to 2 ventilations. Most involving a single victim to one that involves several or multiple drowning victims will have sustained cardiac arrest secondary to victims. The emergency response will vary according to the num- hypoxia. In these patients, compression-only CPR is likely to be less ber of victims involved and available resources. If the number of effective and should be avoided. victims outweighs the available resources then a system of triage to determine who to prioritise for treatment is likely to be neces- Automated external defibrillation. Once CPR is in progress, if an sary. The remainder of this section will focus on the management of AED is available, dry the victim’s chest, attach the AED pads and the individual drowning victim where there are sufficient resources turn the AED on. Deliver shocks according to the AED prompts. available. Regurgitation during resuscitation. Although rescue breathing Basic life support is difficult to perform perfectly on a drowning victim because of the need for very high inflation pressures or the presence of fluid Aquatic rescue and recovery from the water. Always be aware of in the airway, every attempt should be made to continue ventila- personal safety and minimize the danger to yourself and the vic- tion until advanced life support providers arrive. Regurgitation of tim at all times. Whenever possible, attempt to save the drowning stomach contents and swallowed/inhaled water is common during victim without entry into the water. Talking to the victim, reach- resuscitation from drowning.210 If this prevents ventilation com- ing with a rescue aid (e.g., stick or clothing), or throwing a rope pletely, turn the victim on their side and remove the regurgitated or buoyant rescue aid may be effective if the victim is close to dry material using directed suction if possible. Care should be taken land. Alternatively, use a boat or other water vehicle to assist with if spinal injury is suspected but this should not prevent or delay the rescue. Avoid entry into the water whenever possible. If entry life-saving interventions such as airway opening, ventilations and into the water is essential, take a buoyant rescue aid or flotation chest compressions. Abdominal thrusts can cause regurgitation of device.197 It is safer to enter the water with two rescuers than alone. gastric contents and other life-threatening injuries and should not Never dive head first in the water when attempting a rescue. You be used.211 may lose visual contact with the victim and run the risk of a spinal injury. Advanced life support Remove all drowning victims from the water by the fastest and safest means available and resuscitate as quickly as possible. The Airway and breathing. Give high-flow oxygen, ideally through incidence of cervical spine injury in drowning victims is very low an oxygen mask with reservoir bag, during the initial assessment (approximately 0.5%).198 Spinal immobilisation can be difficult to of the spontaneously breathing drowning victim.205 Consider non- perform in the water and can delay removal from the water and invasive ventilation or continuous positive airway pressure if the adequate resuscitation of the victim. Poorly applied cervical collars victim fails to respond to treatment with high-flow oxygen.212 Use can also cause airway obstruction in unconscious patients.199 Cer- pulse oximetry and arterial blood gas analysis to titrate the con- vical spine immobilisation is not indicated unless signs of severe centration of inspired oxygen. Consider early tracheal intubation injury are apparent or the history is consistent with the possibility and controlled ventilation for victims who fail to respond to these of severe injury.200 These circumstances include a history of diving, initial measures or who have a reduced level of consciousness. Take
- 190. 1408 J. Soar et al. / Resuscitation 81 (2010) 1400–1433 care to ensure optimal preoxygenation before intubation. Use a shown to improve survival in patients with ARDS.220 The severity rapid-sequence induction with cricoid pressure to reduce the risk of of lung injury varies from a mild self-limiting illness to refractory aspiration.213 Pulmonary oedema fluid may pour from the airway hypoxaemia. In severe cases extracorporeal membrane oxygena- and may need suctioning to enable a view of the larynx. tion has been used with some success.221,222 The clinical and cost After the tracheal tube is confirmed in position, titrate the effectiveness of these interventions has not been formally tested in inspired oxygen concentration to achieve an SaO2 of 94–98%.205 Set randomised controlled trials. positive end-expiratory pressure (PEEP) to at least 5–10 cm H2 O, Pneumonia is common after drowning. Prophylactic antibiotics however higher PEEP levels (15–20 cm H2 O) may be required if the have not been shown to be of benefit,223 although they may be patients is severely hypoxaemic.214 considered after submersion in grossly contaminated water such In the event of cardiopulmonary arrest protect the airway of as sewage. Give broad-spectrum antibiotics if signs of infection the victim early in the resuscitation attempt, ideally with a cuffed develop subsequently.200,224 tracheal tube – reduced pulmonary compliance requiring high inflation pressures may limit the use of a supraglottic airway device. Hypothermia after drowning. Victims of submersion may develop primary or secondary hypothermia. If the submersion Circulation and defibrillation. Differentiating respiratory from occurs in icy water (<5 ◦ C or 41◦ F), hypothermia may develop cardiac arrest is particularly important in the drowning victim. rapidly and provide some protection against hypoxia. Such effects, Delaying the initiation of chest compressions if the victim is in however, have typically been reported after submersion of children cardiac arrest will reduce survival. in ice-cold water.189 Hypothermia may also develop as a secondary The typical post-arrest gasping is very difficult to distinguish complication of the submersion and subsequent heat loss through from the initial respiratory efforts of a spontaneous recovering evaporation during attempted resuscitation (see Section 8d). drowning victim. Palpation of the pulse as the sole indicator of the Case reports describing patients with severe accidental presence or absence of cardiac arrest is unreliable.215 When avail- hypothermia have shown that survival is possible after either pas- able additional diagnostic information should be obtained from sive or active warming.200 In contrast, there is evidence of benefit other monitoring modalities such as ECG trace, end-tidal CO2 , and from induced hypothermia for comatose victims resuscitated from echocardiography to confirm the diagnosis of cardiac arrest. pre-hospital cardiac arrests.225,226 To date, there is no convinc- If the victim is in cardiac arrest, follow standard advanced life ing evidence to guide therapy in this patient group. A pragmatic support protocols. If the victims core body temperature is less than approach might be to consider rewarming until a core temperature 30 ◦ C, limit defibrillation attempts to three, and withhold IV drugs of 32–34 ◦ C is achieved, taking care to avoid hyperthermia (>37 ◦ C) until the core body temperature increases above 30 ◦ C (see Section during the subsequent period of intensive care (International Life 8d). Saving Federation, 2003). During prolonged immersion, victims may become hypo- volaemic from the hydrostatic pressure of the water on the body. Give IV fluid to correct hypovolaemia. After return of spontaneous Other supportive care. Attempts have been made to improve circulation, use haemodynamic monitoring to guide fluid resusci- neurological outcome following drowning with the use of barbitu- tation. rates, intracranial pressure (ICP) monitoring, and steroids. None of these interventions has been shown to alter outcome. In fact, signs Discontinuing resuscitation efforts of intracranial hypertension serve as a symptom of significant neu- Making a decision to discontinue resuscitation efforts on a rological hypoxic injury, and there is no evidence that attempts to victim of drowning is notoriously difficult. No single factor can alter the ICP will affect outcome.200 accurately predict good or poor survival with 100% certainty. Decisions made in the field frequently prove later to have been incorrect.216 Continue resuscitation unless there is clear evidence Follow-up. Cardiac arrhythmias may cause rapid loss of con- that such attempts are futile (e.g., massive traumatic injuries, rigor sciousness leading to drowning if the victim is in water at the time. mortis, putrefaction etc), or timely evacuation to a medical facility Take a careful history in survivors of a drowning incident to identify is not possible. Neurologically intact survival has been reported in features suggestive of arrhythmic syncope. Symptoms may include several victims submerged for greater than 60 min however these syncope (whilst supine position, during exercise, with brief prodro- rare case reports almost invariably occur in children submerged in mal symptoms, repetitive episodes or associated with palpitations), ice-cold water.217,218 seizures or a family history of sudden death. The absence of struc- tural heart disease at post-mortem examination does not rule the Post-resuscitation care possibility of sudden cardiac death. Post-mortem genetic analysis has proved helpful in these situations and should be considered if Salt versus fresh water. Much attention has focused in the there is uncertainty over the cause of a drowning death.227–229 past on differences between salt-water and fresh-water drowning. Extensive data from animal studies and human case-series have shown that, irrespective of the tonicity of the inhaled fluid, the 8d. Accidental hypothermia predominant pathophysiological process is hypoxaemia, driven by surfactant wash-out and dysfunction, alveolar collapse, atelecta- Definition sis, and intrapulmonary shunting. Small differences in electrolyte disturbance are rarely of any clinical relevance and do not usually Accidental hypothermia exists when the body core temperature require treatment. unintentionally drops below 35 ◦ C. Hypothermia can be classified arbitrarily as mild (35–32 ◦ C), moderate (32–28 ◦ C) or severe (less Lung injury. Victims of drowning are at risk of developing than 28 ◦ C).230 The Swiss staging system231 based on clinical signs acute respiratory distress syndrome (ARDS) after submersion.219 can be used by rescuers at the scene to describe victims: stage I – Although there are no randomised controlled trials undertaken clearly conscious and shivering; stage II – impaired consciousness specifically in this population of patients it seems reasonable to without shivering; stage III – unconscious; stage IV – no breathing; include strategies such as protective ventilation that have been and stage V – death due to irreversible hypothermia.
- 191. J. Soar et al. / Resuscitation 81 (2010) 1400–1433 1409 Diagnosis advantages of adequate oxygenation and protection from aspira- tion outweigh the minimal risk of triggering VF by performing Accidental hypothermia may be under-diagnosed in countries tracheal intubation.240 with a temperate climate. In persons with normal thermoreg- Clear the airway and, if there is no spontaneous respiratory ulation, hypothermia may develop during exposure to cold effort, ventilate the patient’s lungs with high concentrations of oxy- environments, particularly wet or windy conditions, and in people gen. Consider careful tracheal intubation when indicated according who have been immobilised, or following immersion in cold water. to advanced life support guidelines. Palpate a central artery, look When thermoregulation is impaired, for example, in the elderly at the ECG (if available), and look for signs of life for up to 1 min and very young, hypothermia may follow a mild insult. The risk of before concluding that there is no cardiac output. Echocardiogra- hypothermia is also increased by drug or alcohol ingestion, exhaus- phy or ultrasound with Doppler may be used to establish whether tion, illness, injury or neglect especially when there is a decrease there is a cardiac output or peripheral blood flow. If there is any in the level of consciousness. Hypothermia may be suspected from doubt about whether a pulse is present, start CPR immediately. the clinical history or a brief external examination of a collapsed Once CPR is under way, confirm hypothermia with a low-reading patient. A low-reading thermometer is needed to measure the core thermometer. temperature and confirm the diagnosis. The core temperature mea- The hypothermic heart may be unresponsive to cardio- sured in the lower third of the oesophagus correlates well with the active drugs, attempted electrical pacing and defibrillation. Drug temperature of the heart. Epitympanic (‘tympanic’) measurement metabolism is slowed, leading to potentially toxic plasma concen- – using a thermistor technique – is a reliable alternative but may trations of any drugs given repeatedly.241 The evidence for the be lower than the oesophageal temperature if the environmental efficacy of drugs in severe hypothermia is limited and based mainly temperature is very cold, the probe is not well insulated, the exter- on animal studies. For instance, in severe hypothermic cardiac nal auditory canal is blocked or during cardiac arrest when there is arrest, adrenaline may be effective in increasing coronary perfusion no flow in the carotid artery.232 Widely available ‘tympanic’ ther- pressure, but not survival.242,243 The efficacy of amiodarone is also mometers based on infrared technique do not seal the ear canal and reduced.244 For these reasons, withhold adrenaline and other CPR are not designed for low core temperature readings.233 In the hospi- drugs until the patient has been warmed to a temperature higher tal setting, the method of temperature measurement should be the than approximately 30 ◦ C. Once 30 ◦ C has been reached, the inter- same throughout resuscitation and rewarming. Use oesophageal, vals between drug doses should be doubled when compared with bladder, rectal or tympanic temperature measurements.234,235 normothermia intervals. As normothermia is approached (over 35 ◦ C), standard drug protocols should be used. Remember to rule Decision to resuscitate out other primary causes of cardiorespiratory arrest using the 4 Hs and 4 Ts approach (e.g., drug overdose, hypothyroidism, trauma). Cooling of the human body decreases cellular oxygen consump- tion by ∼6% per 1 ◦ C decrease in core temperature.236 At 28 ◦ C Arrhythmias oxygen consumption is reduced by ∼50% and at 22 ◦ C by ∼75%. In some cases, hypothermia can exert a protective effect on the As the body core temperature decreases, sinus bradycardia brain and vital organs237 and intact neurological recovery may tends to give way to atrial fibrillation followed by VF and finally be possible even after prolonged cardiac arrest if deep hypother- asystole.245 Once in hospital, severely hypothermic victims in car- mia develops before asphyxia. Beware of diagnosing death in a diac arrest should be rewarmed with active internal methods. hypothermic patient because cold alone may produce a very slow, Arrhythmias other than VF tend to revert spontaneously as the core small-volume, irregular pulse and unrecordable blood pressure. In temperature increases, and usually do not require immediate treat- a hypothermic patient, no signs of life (Swiss hypothermia stage ment. Bradycardia may be physiological in severe hypothermia, and IV) alone is unreliable for declaring death. At 18 ◦ C the brain can cardiac pacing is not indicated unless bradycardia associated with tolerate periods of circulatory arrest for ten times longer than at haemodynamic compromise persists after rewarming. 37 ◦ C. Dilated pupils can be caused by a variety of insults and must The temperature at which defibrillation should first be not be regarded as a sign of death. Good quality survival has been attempted and how often it should be tried in the severely reported after cardiac arrest and a core temperature of 13.7 ◦ C after hypothermic patient has not been established. AEDs may be used immersion in cold water with prolonged CPR.238 In another case, on these patients. If VF is detected, give a shock at the maximum a severely hypothermic patient was resuscitated successfully after energy setting; if VF/VT persists after three shocks, delay further six and a half hours of CPR.239 defibrillation attempts until the core temperature is above 30 ◦ C.246 In the pre-hospital setting, resuscitation should be withheld If an AED is used, follow the AED prompts while rewarming the only if the cause of a cardiac arrest is clearly attributable to a lethal patient. CPR and rewarming may have to be continued for several injury, fatal illness, prolonged asphyxia, or if the chest is incom- hours to facilitate successful defibrillation.246 pressible. In all other patients the traditional guiding principle that “no one is dead until warm and dead” should be considered. In Rewarming remote wilderness areas, the impracticalities of achieving rewarm- ing have to be considered. In the hospital setting involve senior General measures for all victims include removal from the doctors and use clinical judgment to determine when to stop resus- cold environment, prevention of further heat loss and rapid trans- citating a hypothermic arrest victim. fer to hospital. In the field, a patient with moderate or severe hypothermia (Swiss stages ≥ II) should be immobilised and han- Resuscitation dled carefully, oxygenated adequately, monitored (including ECG and core temperature), and the whole body dried and insulated.241 All the principles of prevention, basic and advanced life support Wet clothes should be cut off rather than stripped off; this will avoid apply to the hypothermic patient. Use the same ventilation and excessive movement of the victim. Conscious victims can mobilise chest compression rates as for a normothermic patient. Hypother- as exercise rewarms a person more rapidly than shivering. Exer- mia can cause stiffness of the chest wall, making ventilation and cise can increase any after-drop, i.e., further cooling after removal chest compressions more difficult. Do not delay urgent procedures, from a cold environment. Somnolent or comatose victims have a such as inserting vascular catheters and tracheal intubation. The low threshold for developing VF or pulseless VT and should be
- 192. 1410 J. Soar et al. / Resuscitation 81 (2010) 1400–1433 immobilised and kept horizontal to avoid an after-drop or cardio- skiers, snowboarders and snowmobilers. Death from avalanches vascular collapse. Adequate oxygenation is essential to stabilise the is due to asphyxia, trauma and hypothermia. Avalanches occur in myocardium and all victims should receive supplemental oxygen. If areas that are difficult to access by rescuers in a timely manner, and the patient is unconscious, the airway should be protected. Pre hos- burials frequently involve multiple victims. The decision to initiate pital, prolonged investigation and treatments should be avoided, as full resuscitative measures should be determined by the number of further heat loss is difficult to prevent. victims and the resources available, and should be informed by the Rewarming may be passive, active external, or active internal. likelihood of survival.256 Avalanche victims are not likely to survive Passive rewarming is appropriate in conscious victims with mild when they are: hypothermia who are still able to shiver. This is best achieved by full body insulation with wool blankets, aluminium foil, cap and • buried >35 min and in cardiac arrest with an obstructed airway warm environment. The application of chemical heat packs to the on extrication; trunk is particularly helpful in moderate and severe hypothermia • buried initially and in cardiac arrest with an obstructed airway to prevent further heat loss in the pre hospital setting. If the patient on extrication, and an initial core temperature of <32◦ ; is unconscious and the airway is not secured, insulation should • buried initially and in cardiac arrest on extrication with an initial be arranged around the patient in the recovery (lateral decubitus) serum potassium of >12 mmol. position. Rewarming in the field with heated intravenous fluids and warm humidified gases is not efficient. Infusing a litre of 40 ◦ C warm Full resuscitative measures, including extracorporeal rewarm- fluid to a 70 kg patient at 28 ◦ C elevates the core temperature by ing, when available, are indicated for all other avalanche victims only about 0.3 ◦ C.241 Intensive active rewarming must not delay without evidence of an unsurvivable injury. transport to a hospital where advanced rewarming techniques, continuous monitoring and observation are available. In general, 8e. Hyperthermia alert hypothermic and shivering victims without an arrhythmia may be transported to the nearest hospital for passive rewarming and observation. Hypothermic victims with an altered conscious- Definition ness should be taken to a hospital capable of active external and internal rewarming. Hyperthermia occurs when the body’s ability to thermoregu- Several active in-hospital rewarming techniques have been late fails and core temperature exceeds that normally maintained described, although in a patient with stable circulation no tech- by homeostatic mechanisms. Hyperthermia may be exogenous, nique has shown better survival over others. Active external caused by environmental conditions, or secondary to endogenous rewarming techniques include forced air rewarming and warmed heat production. (up to 42 ◦ C) intravenous fluids. These techniques are effective Environment-related hyperthermia occurs where heat, usually (rewarming rate 1–1.5 ◦ C h−1 ) in patients with severe hypothermia in the form of radiant energy, is absorbed by the body at a rate faster and a perfusing rhythm.247,248 Even in severe hypothermia no sig- than can be lost by thermoregulatory mechanisms. Hyperther- nificant after-drop or malignant arrhythmias have been reported. mia occurs along a continuum of heat-related conditions, starting Rewarming with forced air and warm fluid has been widely imple- with heat stress, progressing to heat exhaustion, to heat stroke mented by clinicians because it is easy and effective. Active internal (HS) and finally multiorgan dysfunction and cardiac arrest in some rewarming techniques include warm humidified gases; gastric, instances.257 peritoneal, pleural or bladder lavage with warmed fluids (at 40 ◦ C), Malignant hyperthermia (MH) is a rare disorder of skeletal and extracorporeal rewarming.237,249–253 muscle calcium homeostasis characterised by muscle contracture In a hypothermic patient with apnoea and cardiac arrest, and life-threatening hypermetabolic crisis following exposure of extracorporeal rewarming is the preferred method of active inter- genetically predisposed individuals to halogenated anaesthetics nal rewarming because it provides sufficient circulation and and depolarizing muscle relaxants.258,259 oxygenation while the core body temperature is increased by The key features and treatment of heat stress and heat exhaus- 8–12 ◦ C h−1 .253 Survivors in one case-series had an average of tion are included in Table 8.2. 65 min of conventional CPR before cardiopulmonary bypass,254 which underlines that continuous CPR is essential. Unfortunately, Heat stroke facilities for extracorporeal rewarming are not always available and a combination of rewarming techniques may have to be used. It Heat stroke is a systemic inflammatory response with a core is advisable to contact the destination hospital well in advance temperature above 40.6 ◦ C, accompanied by mental state change of arrival to make sure that the unit can accept the patient for and varying levels of organ dysfunction. There are two forms of HS: extracorporeal rewarming. Extracorporeal membrane oxygenation classic non-exertional heat stroke (CHS) occurs during high envi- (ECMO) reduces the risk of intractable cardiorespiratory failure ronmental temperatures and often effects the elderly during heat commonly observed after rewarming and may be a preferable waves260 ; The 2003 heatwave in France was associated with an extracorporeal rewarming procedure.255 increased incidence of cardiac arrests in those over 60-years old.261 During rewarming, patients will require large volumes of fluids Exertional heat stroke (EHS) occurs during strenuous physical exer- as vasodilation causes expansion of the intravascular space. Contin- cise in high environmental temperatures and/or high humidity uous haemodynamic monitoring and warm IV fluids are essential. usually effects healthy young adults.262 Mortality from heat stroke Avoid hyperthermia during and after rewarming. Although there ranges between 10 and 50%.263 are no formal studies, once ROSC has been achieved use standard strategies for post-resuscitation care, including mild hypothermia Predisposing factors if appropriate (Section 4g).24a The elderly are at increased risk for heat-related illness because Avalanche burial of underlying illness, medication use, declining thermoregula- tory mechanisms and limited social support. There are several In Europe and North America, there are about 150 snow risk factors: lack of acclimatization, dehydration, obesity, alco- avalanche deaths each year. Most are sports-related and involve hol, cardiovascular disease, skin conditions (psoriasis, eczema,
- 193. J. Soar et al. / Resuscitation 81 (2010) 1400–1433 1411 Table 8.2 Heat stress and heat exhaustion. Condition Features Treatment Heat stress Normal or mild temperature elevation Rest Heat oedema: swelling of feet and ankles Elevation of oedematous limbs Heat syncope: vasodilation causing hypotension Cooling Heat cramps: sodium depletion causing cramps Oral rehydration Salt replacement Heat exhaustion Systemic reaction to prolonged heat exposure As above (hours to days) Consider IV fluids and ice packs for severe cases Temperature > 37 ◦ C and < 40 ◦ C Headache, dizziness, nausea, vomiting, tachycardia, hypotension, sweating muscle pain, weakness and cramps Haemoconcentration Hyponatraemia or hypernatraemia May progress rapidly to heat stroke scleroderma, burn, cystic fibrosis), hyperthyroidism, phaeochro- Cooling techniques mocytoma and drugs (anticholinergics, diamorphine, cocaine, amphetamine, phenothiazines, sympathomimetics, calcium chan- Several cooling methods have been described, but there are few nel blockers, beta-blockers). formal trials to determine which method is best. Simple cooling techniques include drinking cool fluids, fanning the completely undressed patient and spraying tepid water on the patient. Ice Clinical presentation packs over areas where there are large superficial blood vessels (axillae, groins, neck) may also be useful. Surface cooling methods Heat stroke can resemble septic shock and may be caused by may cause shivering. In cooperative stable patients, immersion in similar mechanisms.264 A single centre case-series reported 14 ICU cold water can be effective280 ; however, this may cause periph- deaths in 22 heat stroke patients admitted to ICU with multiple eral vasoconstriction, shunt blood away from the periphery and organ failure.265 Features include: reduce heat dissipation. Immersion is also not practical in the sick- est patients. • core temperature 40.6 ◦ C or more; Further techniques to cool patients with hyperthermia are sim- • hot, dry skin (sweating is present in about 50% of cases of exer- ilar to those used for therapeutic hypothermia after cardiac arrest (see Section 4g).24a Cold intravenous fluids will decrease body tional heat stroke); • early signs and symptoms, e.g., extreme fatigue, headache, faint- temperature. Gastric, peritoneal,281 pleural or bladder lavage with cold water will lower the core temperature. Intravascular cooling ing, facial flushing, vomiting and diarrhoea; • cardiovascular dysfunction including arrhythmias266 and techniques include the use of cold IV fluids,282 intravascular cool- ing catheters283,284 and extracorporeal circuits,285 e.g., continuous hypotension; • respiratory dysfunction including ARDS267 ; veno-veno haemofiltration or cardiopulmonary bypass. • central nervous system dysfunction including seizures and coma268 ; Drug therapy in heat stroke • liver and renal failure269 ; • coagulopathy267 ; There are no specific drug therapies in heat stroke to lower core • rhabdomyolysis.270 temperature. There is no good evidence that antipyretics (e.g., non- steroidal anti-inflammatory drugs or paracetamol) are effective in heat stroke. Diazepam may be useful to treat seizures and facili- Other clinical conditions need to be considered, including: tate cooling.286 Dantrolene (see below) has not been shown to be beneficial.287–289 • drug toxicity271,272 ; • Malignant hyperthermia drug withdrawal syndrome; • serotonin syndrome273 ; • Malignant hyperthermia is a life-threatening genetic sensitivity neuroleptic malignant syndrome274 ; • of skeletal muscles to volatile anaesthetics and depolarizing neuro- sepsis275 ; • muscular blocking drugs, occurring during or after anaesthesia.290 central nervous system infection; • Stop triggering agents immediately; give oxygen, correct acido- endocrine disorders, e.g., thyroid storm, phaeochromocytoma.276 sis and electrolyte abnormalities. Start active cooling and give dantrolene.291 Management Other drugs such as 3,4-methylenedioxymethamphetamine (MDMA, ‘ecstasy’) and amphetamines also cause a condition sim- The mainstay of treatment is supportive therapy based on opti- ilar to malignant hyperthermia and the use of dantrolene may be mizing the ABCDEs and rapidly cooling the patient.277–279 Start beneficial.292 cooling before the patient reaches hospital. Aim to rapidly reduce the core temperature to approximately 39 ◦ C. Patients with severe Modifications to cardiopulmonary resuscitation and heat stroke need to be managed in a critical-care setting. Use post-resuscitation care haemodynamic monitoring to guide fluid therapy. Large volumes of fluid may be required. Correct electrolyte abnormalities as There are no specific studies on cardiac arrest in hyperther- described in Section 8a. mia. If cardiac arrest occurs, follow standard procedures for basic
- 194. 1412 J. Soar et al. / Resuscitation 81 (2010) 1400–1433 and advanced life support and cool the patient. Cooling techniques Diagnosis similar to those used to induce therapeutic hypothermia should be used (see Section 4g).24a There are no data on the effects of Wheezing is a common physical finding, but severity does hyperthermia on defibrillation threshold; therefore, attempt defib- not correlate with the degree of airway obstruction. The absence rillation according to current guidelines, while continuing to cool of wheezing may indicate critical airway obstruction, whereas the patient. Animal studies suggest the prognosis is poor compared increased wheezing may indicate a positive response to bron- with normothermic cardiac arrest.293,294 The risk of unfavourable chodilator therapy. SaO2 may not reflect progressive alveolar neurological outcome increases for each degree of body tempera- hypoventilation, particularly if oxygen is being given. The SaO2 ture >37 ◦ C.295 Provide post-resuscitation care according to normal may initially decrease during therapy because beta-agonists cause guidelines. both bronchodilation and vasodilation and may initially increase intrapulmonary shunting. Other causes of wheezing include: pulmonary oedema, 8f. Asthma chronic obstructive pulmonary disease (COPD), pneumonia, anaphylaxis,305 pneumonia, foreign bodies, pulmonary embolism, Introduction bronchiectasis and subglottic mass.306 The severity of an asthma attack is defined in Table 8.3. Worldwide, approximately 300 million people of all ages and ethnic backgrounds have asthma.296 The worldwide prevalence of asthma symptoms ranges from 1 to 18% of the population with Key interventions to prevent arrest a high prevalence in some European countries (United Kingdom, Ireland and Scandinavia).296 International differences in asthma The patient with severe asthma requires aggressive medical symptom prevalence appears to be decreasing in recent years, management to prevent deterioration. Base assessment and treat- especially in adolescents.297 The World Health Organisation has ment on an ABCDE approach. Patients with SaO2 < 92% or with estimated that 15 million disability-adjusted life-years (DALYs) are features of life-threatening asthma are at risk of hypercapnia and lost annually from asthma, representing 1% of the global disease require arterial blood gas measurement. Experienced clinicians burden. Annual worldwide deaths from asthma have been esti- should treat these high-risk patients in a critical-care area. The spe- mated at 250,000. The death rate does not appear to be correlated cific drugs and the treatment sequence will vary according to local with asthma prevalence.296 National and international guidance practice. for the management of asthma already exists.296,298 This guidance focuses on the treatment of patients with near-fatal asthma and Oxygen cardiac arrest. Use a concentration of inspired oxygen that will achieve an SaO2 Patients at risk of asthma-related cardiac arrest 94–98%.205 High-flow oxygen by mask is sometimes necessary. The risk of near-fatal asthma attacks is not necessarily related to asthma severity.299 Patients most at risk include those with: Table 8.3 The severity of asthma. • a history of near-fatal asthma requiring intubation and mechan- Asthma Features ical ventilation; Near-fatal Raised PaCO2 and/or requiring • a hospitalisation or emergency care for asthma in the past mechanical ventilation with raised year300 ; inflation pressures • low or no use of inhaled corticosteroids301 ; Life-threatening Any one of: • an increasing use and dependence of beta-2 agonists302 ; PEF < 33% best or predicted • anxiety, depressive disorders and/or poor compliance with bradycardia therapy.303 SpO2 < 92%, dysrhythmia PaO2 < 8 kPa, hypotension Normal PaCO2 (4.6–6.0 kPa Causes of cardiac arrest (35–45 mmHg)), exhaustion Silent chest, confusion Cyanosis, coma Cardiac arrest in a person with asthma is often a terminal event Feeble respiratory effort after a period of hypoxaemia; occasionally, it may be sudden. Car- diac arrest in those with asthma has been linked to: Acute severe Any one of: PEF 33–50% best or predicted Respiratory rate > 25 min−1 • severe bronchospasm and mucous plugging leading to asphyxia Heart rate > 110 min−1 (this condition causes the vast majority of asthma-related Inability to complete sentences in one breath deaths); • cardiac arrhythmias caused by hypoxia, which is the commonest Moderate Increasing symptoms cause of asthma-related arrhythmia.304 Arrhythmias can also be exacerbation PEF > 50–75% best or predicted No features of acute severe asthma caused by stimulant drugs (e.g., beta-adrenergic agonists, amino- phylline) or electrolyte abnormalities; Brittle Type 1: wide PEF variability (>40% • dynamic hyperinflation, i.e., auto-positive end-expiratory pres- diurnal variation for >50% of the time over a period >150 days) sure (auto-PEEP), can occur in mechanically ventilated asthmat- despite intense therapy ics. Auto-PEEP is caused by air trapping and ‘breath stacking’ (air Type 2: sudden severe attacks on a entering the lungs and being unable to escape). Gradual build-up background of apparently well of pressure occurs and reduces venous return and blood pressure; controlled asthma • tension pneumothorax (often bilateral). PEF, peak expiratory flow.
- 195. J. Soar et al. / Resuscitation 81 (2010) 1400–1433 1413 Nebulised beta-2 agonists to report in 2012 and should provide definitive evidence on the role of magnesium in acute severe asthma. Salbutamol, 5 mg nebulised, is the cornerstone of therapy for acute asthma in most of the world. Repeated doses every Aminophylline 15–20 min are often needed. Severe asthma may necessitate con- A Cochrane review of intravenous aminophylline found no tinuous nebulised salbutamol. Nebuliser units that can be driven evidence of benefit and a higher incidence of adverse effects by high-flow oxygen should be available. The hypoventilation (tachycardia, vomiting) compared with standard care alone.316,317 associated with severe or near-fatal asthma may prevent effec- Whether aminophylline has a place as an additional therapy after tive delivery of nebulised drugs. If a nebuliser is not immediately treatment with established medications such as inhaled beta- available beta-2 agonists can be temporarily administered by agonists and systemic corticosteroids remains uncertain. If after repeating activations of a metered dose inhaler via a large volume obtaining senior advice the decision is taken to administer IV spacer device.298,307 Nebulised adrenaline does not provide addi- aminophylline a loading dose of 5 mg kg−1 is given over 20–30 min tional benefit over and above nebulised beta-2 agonists in acute (unless on maintenance therapy), followed by an infusion of asthma.308 500–700 g kg−1 h−1 . Serum theophylline concentrations should be maintained below 20 g ml−1 to avoid toxicity. Intravenous corticosteroids Early use of systemic corticosteroids for acute asthma in the Beta-2 agonists emergency department significantly reduces hospital admission A Cochrane review on intravenous beta-2 agonists compared rates, especially for those patients not receiving concomitant cor- with nebulised beta-2 agonists found no evidence of benefit and ticosteroid therapy.309 Although there is no difference in clinical some evidence of increased side effects compared with inhaled effects between oral and IV formulations of corticosteroids,310 the treatment.318 Salbutamol may be given as either a slow IV injection IV route is preferable because patients with near-fatal asthma may (250 g IV slowly) or continuous infusion of 3–20 g min−1 . vomit or be unable to swallow. Leukotriene receptor antagonists Nebulised anticholinergics There are few data on the use of intravenous leukotriene recep- tor antagonists.319 Further studies are required to confirm the Nebulised anticholinergics (ipratropium, 0.5 mg 4–6 hourly) findings of a recent randomised controlled trial which demon- may produce additional bronchodilation in severe asthma or in strated evidence of additional bronchodilation when intravenous those who do not respond to beta-agonists.311,312 LRTA montelukast was used as a rescue therapy.320 Nebulised magnesium sulphate Subcutaneous or intramuscular adrenaline and terbutaline Results of small randomised controlled trials showed that a neb- Adrenaline and terbutaline are adrenergic agents that may be ulised isotonic solution of magnesium sulphate (250 mmol l−1 ) in a given subcutaneously to patients with acute severe asthma. The volume of 2.5–5 ml in combination with beta-2 agonists is safe and dose of subcutaneous adrenaline is 300 g up to a total of 3 doses it is associated with both an improvement of pulmonary function at 20-min intervals. Adrenaline may cause an increase in heart rate, tests and a non-significant trend towards lower rates of hospital myocardial irritability and increased oxygen demand; however, admission in patients with acute severe asthma.313 Further studies its use (even in patients over 35-years old) is well tolerated.321 are needed to confirm those findings. Terbutaline is given in a dose of 250 g subcutaneously, which can be repeated in 30–60 min. These drugs are more commonly given Intravenous bronchodilators to children with acute asthma and, although most studies have shown them to be equally effective,322 one study concluded that Nebulised bronchodilators are the first line treatment for acute terbutaline was superior.323 These alternative routes may need to severe and life-threatening exacerbations of asthma. There is a be considered when IV access is impossible. Patients with asthma lack of definitive evidence for or against the use of intravenous are at increased risk of anaphylaxis. Sometimes it may be difficult bronchodilators in this setting. Trials have primarily included spon- to distinguish severe life-threatening asthma from anaphylaxis. In taneously breathing patients with moderate to life-threatening these circumstances intramuscular adrenaline given according to exacerbations of asthma, evidence in ventilated patients with the anaphylaxis guidelines may be appropriate (Section 8g). life-threatening asthma or cardiac arrest is sparse. The use of intra- venous bronchodilators should generally be restricted to patients Intravenous fluids and electrolytes unresponsive to nebulised therapy or where nebulised/inhaled therapy is not possible (e.g., a patient receiving bag-mask venti- Severe or near-fatal asthma is associated with dehydration and lation). hypovolaemia, and this will further compromise the circulation in patients with dynamic hyperinflation of the lungs. If there is Intravenous magnesium sulphate evidence of hypovolaemia or dehydration, give IV fluids. Beta-2 Studies of intravenous magnesium sulphate in acute severe and agonists and steroids may induce hypokalaemia, which should be life-threatening asthma have produced conflicting results.314,315 corrected with electrolyte supplements. Magnesium sulphate causes bronchial smooth muscle relaxation independent of the serum magnesium level and has only minor side effects (flushing, light-headedness). Given the low risk of serious Heliox side effects from magnesium sulphate it would seem reasonable to use intravenous magnesium sulphate (1.2–2 g IV slowly) in adults Heliox is a mixture of helium and oxygen (usually 80:20 or with life-threatening unresponsive to nebulised therapy. The mul- 70:30). A meta-analysis of four clinical trials did not support the use ticentre randomised controlled trial 3Mg (ISRCTN04417063) is due of heliox in the initial treatment of patients with acute asthma.324
- 196. 1414 J. Soar et al. / Resuscitation 81 (2010) 1400–1433 Referral to intensive care Dynamic hyperinflation increases transthoracic impedance.337 Consider higher shock energies for defibrillation if initial defibril- Patients that fail to respond to initial treatment, or develop signs lation attempts fail.338 of life-threatening asthma, should be assessed by an intensive care There is no good evidence for the use of open-chest cardiac specialist. Admission to intensive care after asthma-related car- compressions in patients with asthma-associated cardiac arrest. diac arrest is associated with significantly poorer outcomes than Working through the 4 Hs and 4 Ts will identify potentially if cardiac arrest does not occur.325 reversible causes of asthma-related cardiac arrest. Tension pneu- Rapid sequence induction and tracheal intubation should be mothorax can be difficult to diagnose in cardiac arrest; it may considered if, despite efforts to optimize drug therapy, the patient be indicated by unilateral expansion of the chest wall, shifting has: of the trachea and subcutaneous emphysema. Pleural ultrasound in skilled hands is faster and more sensitive than chest X-ray for • a decreasing conscious level, coma; the detection of pneumothorax.339 If pneumothorax is suspected, • persisting or worsening hypoxaemia; release air from the pleural space with needle decompression. • deteriorating respiratory acidosis despite intensive therapy; Insert a large-gauge cannula in the second intercostal space, above • findings of severe agitation, confusion and fighting against the the rib, in the mid-clavicular line, being careful to avoid direct punc- oxygen mask (clinical signs of hypoxaemia); ture of the lung. If air is emitted, insert a chest tube. Always consider • progressive exhaustion; bilateral pneumothoraces in asthma-related cardiac arrest. • respiratory or cardiac arrest. Extracorporeal life support (ECLS) can ensure both organ perfusion and gas exchange in case of otherwise untreatable res- Elevation of the PaCO2 alone does not indicate the need for tra- piratory and circulatory failure. Cases of successful treatment of cheal intubation.326 Treat the patient, not the numbers. asthma-related cardiac arrest in adults using ECLS have been reported340,341 ; however, the role of ECLS in cardiac arrest caused Non-invasive ventilation by asthma has never been investigated in controlled studies. The use of ECLS requires appropriate skills and equipment which may Non-invasive ventilation decreases the intubation rate and mor- not be available everywhere. tality in COPD327 ; however, its role in patients with severe acute asthma is uncertain. There is insufficient evidence to recommend 8g. Anaphylaxis its routine use in asthma.328 Treatment of cardiac arrest Definition of anaphylaxis Basic life support A precise definition of anaphylaxis is not important for its emergency treatment. There is no universally agreed definition. Give basic life support according to standard guidelines. Venti- The European Academy of Allergology and Clinical Immunol- lation will be difficult because of increased airway resistance; try ogy Nomenclature Committee proposed the following broad to avoid gastric inflation. definition342 : Anaphylaxis is a severe, life-threatening, generalised or systemic hypersensitivity reaction. This is characterised by Advanced life support rapidly developing life-threatening airway and/or breathing and/or circulation problems usually associated with skin and mucosal Modifications to standard ALS guidelines include considering changes.305,343 the need for early tracheal intubation. The peak airway pressures Anaphylaxis usually involves the release of inflammatory medi- recorded during ventilation of patients with severe asthma (mean ators from mast cells and, or basophils triggered by an allergen 67.8 ± 11.1 cm H2 O in 12 patients) are significantly higher than interacting with cell-bound immunoglobulin E (IgE). Non-IgE- the normal lower oesophageal sphincter pressure (approximately mediated or non-immune release of mediators can also occur. 20 cm H2 O).329 There is a significant risk of gastric inflation and Histamine and other inflammatory mediator release are respon- hypoventilation of the lungs when attempting to ventilate a severe sible for the vasodilatation, oedema and increased capillary asthmatic without a tracheal tube. During cardiac arrest this risk is permeability. even higher, because the lower oesophageal sphincter pressure is substantially less than normal.330 Epidemiology Respiratory rates of 8–10 breaths min−1 and tidal volume required for a normal chest rise during CPR should not cause The overall frequency of episodes of anaphylaxis using current dynamic hyperinflation of the lungs (gas trapping). Tidal volume data lies between 30 and 950 cases per 100,000 persons per year depends on inspiratory time and inspiratory flow. Lung emptying and a lifetime prevalence of between 50 and 2000 episodes per depends on expiratory time and expiratory flow. In mechani- 100,000 persons or 0.05–2.0%.344 Anaphylaxis can be triggered by cally ventilated severe asthmatics, increasing the expiratory time any of a very broad range of triggers including foods, drugs, stinging (achieved by reducing the respiratory rate) provides only moderate insects, and latex. Food is the commonest trigger in children and gains in terms of reduced gas trapping when a minute volume of drugs the commonest in adults.345 Virtually any food or drug can less than 10 l min−1 is used.329 be implicated, but certain foods (nuts) and drugs (muscle relax- There is limited evidence from case reports of unexpected ROSC ants, antibiotics, NSAIDs and aspirin) cause most reactions.346 A in patients with suspected gas trapping when the tracheal tube is significant number of cases of anaphylaxis are idiopathic. disconnected.331–335 If dynamic hyperinflation of the lungs is sus- The overall prognosis of anaphylaxis is good, with a case fatality pected during CPR, compression of the chest wall and/or a period ratio of less than 1% reported in most population-based studies. of apnoea (disconnection of tracheal tube) may relieve gas trap- Anaphylaxis and risk of death is increased in those with pre- ping if dynamic hyperinflation occurs. Although this procedure is existing asthma, particularly if the asthma is poorly controlled, supported by limited evidence, it is unlikely to be harmful in an severe or in asthmatics who delay treatment with adrenaline.347,348 otherwise desperate situation.336 When anaphylaxis is fatal, death usually occurs very soon after
- 197. J. Soar et al. / Resuscitation 81 (2010) 1400–1433 1415 contact with the trigger. From a case-series, fatal food reactions • There may be erythema, urticaria (also called hives, nettle rash, cause respiratory arrest typically after 30–35 min; insect stings weals or welts), or angioedema (eyelids, lips, and sometimes in cause collapse from shock after 10–15 min; and deaths caused the mouth and throat). by intravenous medication occur most commonly within 5 min. Death never occurred more than 6 h after contact with the trig- Most patients who have skin changes caused by allergy do not ger. go on to develop anaphylaxis. Recognition of an anaphylaxis Treatment of an anaphylaxis Anaphylaxis is the likely diagnosis if a patient who is exposed Use an ABCDE approach to recognise and treat anaphylaxis. to a trigger (allergen) develops a sudden illness (usually within Treat life-threatening problems as you find them. The basic princi- minutes) with rapidly developing life-threatening airway and/or ples of treatment are the same for all age groups. All patients who breathing and/or circulation problems usually associated with skin have suspected anaphylaxis should be monitored (e.g., by ambu- and mucosal changes. The reaction is usually unexpected. lance crew, in the emergency department etc,) as soon as possible. Many patients with anaphylaxis are not given the cor- Minimal monitoring includes pulse oximetry, non-invasive blood rect treatment.349 Confusion arises because some patients have pressure and 3-lead ECG. systemic allergic reactions that are less severe. For example, gener- alised urticaria, angioedema, and rhinitis would not be described as Patient positioning anaphylaxis, because the life-threatening features are not present. Patients with anaphylaxis can deteriorate and are at risk of car- Anaphylaxis guidelines must therefore take into account some diac arrest if made to sit up or stand up.354 All patients should be inevitable diagnostic errors, with an emphasis on the need for placed in a comfortable position. Patients with airway and breath- safety. Patients can have either an airway and/or breathing and/or ing problems may prefer to sit up as this will make breathing easier. circulation problem: Lying flat with or without leg elevation is helpful for patients with a low blood pressure (circulation problem). Airway problems Remove the trigger if possible • Airway swelling, e.g., throat and tongue swelling (pharyn- geal/laryngeal oedema). Stop any drug suspected of causing anaphylaxis. Remove the • Hoarse voice. stinger after a bee sting. Early removal is more important than the • Stridor. method of removal.355 Do not delay definitive treatment if remov- ing the trigger is not feasible. Breathing problems Cardiorespiratory arrest following an anaphylaxis • Shortness of breath. • Wheeze. Start cardiopulmonary resuscitation (CPR) immediately and fol- • Confusion caused by hypoxia. low current guidelines. Prolonged CPR may be necessary. Rescuers • Respiratory arrest. should ensure that help is on its way as early advanced life support • Life-threatening asthma with no features of anaphylaxis can be (ALS) is essential. triggered by food allergy.350 Airway obstruction Circulation problems Anaphylaxis can cause airway swelling and obstruction. This • Pale, clammy. will make airway and ventilation interventions (e.g., bag-mask ven- • Tachycardia. tilation, tracheal intubation, cricothyroidotomy) difficult. Call for • Hypotension. expert help early. • Decreased conscious level. • Myocardial ischaemia and electrocardiograph (ECG) changes Drugs and their delivery even in individuals with normal coronary arteries.351 Adrenaline (epinephrine) • Cardiac arrest. Adrenaline is the most important drug for the treatment of anaphylaxis.356,357 Although there are no randomised controlled Circulation problems (often referred to as anaphylactic shock) trials,358 adrenaline is a logical treatment and there is consistent can be caused by direct myocardial depression, vasodilation and anecdotal evidence supporting its use to ease breathing and circu- capillary leak, and loss of fluid from the circulation. Bradycardia is lation problems associated with anaphylaxis. As an alpha-receptor usually a late feature, often preceding cardiac arrest.352 agonist, it reverses peripheral vasodilation and reduces oedema. Its beta-receptor activity dilates the bronchial airways, increases Skin and, or mucosal changes the force of myocardial contraction, and suppresses histamine and leukotriene release. There are beta-2 adrenergic receptors on mast These should be assessed as part of the exposure when using cells that inhibit activation, and so early adrenaline attenuates the ABCDE approach. the severity of IgE-mediated allergic reactions. Adrenaline seems to work best when given early after the onset of the reaction359 • They are often the first feature and present in over 80% of ana- but it is not without risk, particularly when given intravenously. phylaxis cases.353 Adverse effects are extremely rare with correct doses injected • They can be subtle or dramatic. intramuscularly (IM). • There may be just skin, just mucosal, or both skin and mucosal Adrenaline should be given to all patients with life-threatening changes any where on the body. features. If these features are absent but there are other features of
- 198. 1416 J. Soar et al. / Resuscitation 81 (2010) 1400–1433 a systemic allergic reaction, the patient needs careful observation Oxygen (give as soon as available) and symptomatic treatment using the ABCDE approach. Initially, give the highest concentration of oxygen possible using a mask with an oxygen reservoir.205 Ensure high-flow oxygen (usu- Intramuscular (IM) adrenaline. The intramuscular (IM) route ally greater than 10 litres min−1 ) to prevent collapse of the reservoir is the best for most individuals who have to give adrenaline to during inspiration. If the patient’s trachea is intubated, ventilate the treat anaphylaxis. Monitor the patient as soon as possible (pulse, lungs with high concentration oxygen using a self-inflating bag. blood pressure, ECG, and pulse oximetry). This will help monitor the response to adrenaline. The IM route has several benefits: Fluids (give as soon as available) Large volumes of fluid may leak from the patient’s circulation • There is a greater margin of safety. during anaphylaxis. There will also be vasodilation. If there is intra- • It does not require intravenous access. venous access, infuse intravenous fluids immediately. Give a rapid • The IM route is easier to learn. IV fluid challenge (20 ml kg−1 ) in a child or 500–1000 ml in an adult) and monitor the response; give further doses as necessary. There is The best site for IM injection is the anterolateral aspect of the no evidence to support the use of colloids over crystalloids in this middle third of the thigh. The needle for injection needs to be long setting. Consider colloid infusion as a cause in a patient receiving a enough to ensure that the adrenaline is injected into muscle.360 colloid at the time of onset of an anaphylaxis and stop the infusion. The subcutaneous or inhaled routes for adrenaline are not recom- A large volume of fluid may be needed. mended for the treatment of anaphylaxis because they are less If intravenous access is delayed or impossible, the intra-osseous effective than the IM route.361–363 route can be used for fluids or drugs. Do not delay the administra- tion of IM adrenaline attempting intra-osseous access. Adrenaline IM dose. The evidence for the recommended doses is weak. Doses are based on what is considered to be safe and practical Antihistamines (after initial resuscitation) to draw up and inject in an emergency. Antihistamines are a second line treatment for anaphylaxis. The (The equivalent volume of 1:1000 adrenaline is shown in evidence to support their use is weak, but there are logical rea- brackets) sons for them.366 Antihistamines (H1 -antihistamine) help counter histamine-mediated vasodilation and bronchoconstriction. There >12 years and adults: 500 g IM (0.5 ml) is little evidence to support the routine use of an H2 -antihistamine >6–12 years: 300 g IM (0.3 ml) (e.g., ranitidine, cimetidine) for the initial treatment of an anaphy- >6 months–6 years: 150 g IM (0.15 ml) laxis. <6 months: 150 g IM (0.15 ml) Repeat the IM adrenaline dose if there is no improvement in Steroids (give after initial resuscitation) the patient’s condition. Further doses can be given at about 5-min Corticosteroids may help prevent or shorten protracted reac- intervals according to the patient’s response. tions although the evidence is very limited.367 In asthma, early corticosteroid treatment is beneficial in adults and children. There is little evidence on which to base the optimum dose of hydrocor- Intravenous (IV) adrenaline (for specialist use only). There is a tisone in anaphylaxis. much greater risk of causing harmful side effects by inappropriate dosage or misdiagnosis of anaphylaxis when using IV adrenaline.364 Intravenous adrenaline should be used only by those experienced Other drugs in the use and titration of vasopressors in their normal clinical practice (e.g., anaesthetists, emergency physicians, intensive care Bronchodilators. The presenting symptoms and signs of a doctors). In patients with a spontaneous circulation, intravenous severe anaphylaxis and life-threatening asthma can be the same. adrenaline can cause life-threatening hypertension, tachycardia, Consider further bronchodilator therapy with salbutamol (inhaled arrhythmias, and myocardial ischaemia. If IV access is not available or IV), ipratropium (inhaled), aminophyline (IV) or magnesium (IV) or not achieved rapidly, use the IM route for adrenaline. Patients (see Section 8f above). Intravenous magnesium is a vasodilator and who are given IV adrenaline must be monitored – continuous ECG can make hypotension worse. and pulse oximetry and frequent non-invasive blood pressure mea- surements as a minimum. Patients who require repeated IM doses Cardiac drugs. Adrenaline remains the first line vasopressor of adrenaline may benefit from IV adrenaline. It is essential that for the treatment of anaphylaxis. There are animal studies and these patients receive expert help early. case reports describing the use of other vasopressors and inotropes (noradrenaline, vasopressin, terlipressin metaraminol, methoxam- Adrenaline IV bolus dose – adult. Titrate IV adrenaline using ine, and glucagon) when initial resuscitation with adrenaline and 50 g boluses according to response. If repeated adrenaline doses fluids has not been successful.368–380 Use these drugs only in spe- are needed, start an IV adrenaline infusion.352,365 cialist settings (e.g., intensive care units) where there is experience in their use. Glucagon can be useful to treat anaphylaxis in a patient taking a beta-blocker.381 Some case reports of cardiac arrest Adrenaline IV bolus dose – children. IM adrenaline is the pre- suggest cardiopulmonary bypass 382,383 or mechanical support of ferred route for children having anaphylaxis. The IV route is circulation384 may also be helpful. recommended only in specialist paediatric settings by those famil- iar with its use (e.g., paediatric anaesthetists, paediatric emergency physicians, paediatric intensivists) and if the patient is monitored Investigations and IV access is already available. There is no evidence on which to base a dose recommendation – the dose is titrated according to Undertake the usual investigations appropriate for a medical response. A child may respond to a dose as small as 1 g kg−1 . This emergency, e.g., 12-lead ECG, chest X-ray, urea and electrolytes, requires very careful dilution and checking to prevent dose errors. arterial blood gases etc.
- 199. J. Soar et al. / Resuscitation 81 (2010) 1400–1433 1417 Mast cell tryptase patient’s general practitioner. All patients presenting with anaphy- laxis should be referred to an allergy clinic to identify the cause, The specific test to help confirm a diagnosis of anaphylaxis is and thereby reduce the risk of future reactions and prepare the measurement of mast cell tryptase. Tryptase is the major protein patient to manage future episodes themselves. Patients need to component of mast cell secretory granules. In anaphylaxis, mast know the allergen responsible and how to avoid it. Patients need cell degranulation leads to markedly increased blood tryptase con- to be able to recognise the early symptoms of anaphylaxis, so that centrations. Tryptase concentrations in the blood may not increase they can summon help quickly and prepare to use their emergency significantly until 30 min or more after the onset of symptoms, and medication. Although there are no randomised clinical trials, there peak 1–2 h after onset.385 The half-life of tryptase is short (approx- is evidence that individualised action plans for self-management imately 2 h), and concentrations may be back to normal within should decrease the risk of recurrence.391 6–8 h, so timing of any blood samples is very important. The time of onset of the anaphylaxis is the time when symptoms were first 8h. Cardiac arrest following cardiac surgery noticed. Cardiac arrest following major cardiac surgery is relatively (a) Minimum: one sample at 1–2 h after the start of symptoms. common in the immediate post-operative phase, with a reported (b) Ideally: three timed samples: incidence of 0.7–2.9%.392–400 It is usually preceded by physio- logical deterioration,401 although it can occur suddenly in stable • Initial sample as soon as feasible after resuscitation has started – patients.398 There are usually specific causes of cardiac arrest, such do not delay resuscitation to take sample. as tamponade, hypovolaemia, myocardial ischaemia, tension pneu- • Second sample at 1–2 h after the start of symptoms mothorax, or pacing failure. These are all potentially reversible and • Third sample either at 24 h or in convalescence (for example in a if treated promptly cardiac arrest after cardiac surgery has a rel- follow-up allergy clinic). This provides baseline tryptase levels – atively high survival rate. If cardiac arrest occurs during the first some individuals have an elevated baseline level. 24 h after cardiac surgery, the rate of survival to hospital discharge is 54%399 to 79%398,402 in adults and 41% in children.401 Serial samples have better specificity and sensitivity than a sin- Key to the successful resuscitation of cardiac arrest in these gle measurement in the confirmation of anaphylaxis.386 patients is the need to perform emergency resternotomy early, especially in the context of tamponade or haemorrhage, where Discharge and follow-up external chest compressions may be ineffective. Patients who have had suspected anaphylaxis (i.e., an airway, Identification of cardiac arrest breathing or circulation (ABC) problem) should be treated and then observed in a clinical area with facilities for treating life- Patients in the ICU are highly monitored and an arrest is most threatening ABC problems. Patients with a good response to initial likely to be signalled by monitoring alarms where absence of pulsa- treatment should be warned of the possibility of an early recur- tion or perfusing pressure on the arterial line, loss of pulse oximeter, rence of symptoms and in some circumstances should be kept pulmonary artery (PA) trace, or end-tidal CO2 trace can be suffi- under observation. The exact incidence of biphasic reactions is cient to indicate cardiac arrest without the need to palpate a central unknown. Although studies quote an incidence of 1–20%, it is not pulse. clear whether all the patients in these studies actually had an ana- phylaxis and whether the initial treatment was appropriate.387 Starting CPR There is no reliable way of predicting who will have a biphasic reaction. It is therefore important that decisions about discharge Start external chest compressions immediately in all patients are made for each patient by an experienced clinician. who collapse without an output. Consider reversible causes: Before discharge from hospital all patients must be: hypoxia – check tube position, ventilate with 100% oxygen; ten- sion pneumothorax – clinical examination, thoracic ultrasound; • Reviewed by a senior clinician. hypovolaemia, pacing failure. In asystole, secondary to a loss of • Given clear instructions to return to hospital if symptoms return. cardiac pacing, external massage may be delayed momentarily as • Considered for antihistamines and oral steroids therapy for up to long as the surgically inserted temporary pacing wires can be con- 3 days. This is helpful for treatment of urticaria and may decrease nected rapidly and pacing re-established (DDD at 100 min−1 at the chance of further reaction. maximum amplitude). The effectiveness of compressions may be • Considered for an adrenaline auto-injector, or given a verified by looking at the arterial trace, aiming to achieve a sys- replacement.388–390 tolic blood pressure of at least 80 mmHg at a rate of 100 min−1 . • Have a plan for follow-up, including contact with the patient’s Inability to attain this pressure may indicate tamponade, tension general practitioner. pneumothorax, or exanguinating haemorrhage and should precip- itate emergency resternotomy. Intra-aortic balloon pumps should An adrenaline auto-injector is an appropriate treatment for be changed to pressure triggering during CPR. In PEA, switch off the patients at increased risk of idiopathic anaphylaxis, or for anyone pacemaker – a temporary pacemaker may potentially hide under- at continued high risk of reaction, e.g., to triggers such as venom lying VF. stings and food-induced reactions (unless easy to avoid). An auto- injector is not usually necessary for patients who have suffered Defibrillation drug-induced anaphylaxis, unless it is difficult to avoid the drug. Ideally, all patients should be assessed by an allergy specialist and There is concern that external chest compressions can cause have a treatment plan based on their individual risk. sternal disruption or cardiac damage.403–406 In the post-cardiac Individuals provided with an auto-injector on discharge from surgery ICU, a witnessed and monitored VF/VT cardiac arrest should hospital must be given instructions and training on when and how be treated immediately with up to three quick successive (stacked) to use it. Ensure appropriate follow-up including contact with the defibrillation attempts. Three failed shocks in the post-cardiac
- 200. 1418 J. Soar et al. / Resuscitation 81 (2010) 1400–1433 surgery setting should trigger the need for emergency rester- Patients with non-sternotomy cardiac surgery notomy. Further defibrillation is attempted as indicated in the universal algorithm and should be performed with internal paddles These guidelines are appropriate for patients following non- at 20 J if resternotomy has been performed. sternotomy cardiac surgery, but surgeons performing these operations should have already given clear instructions for chest Emergency drugs reopening. Patients undergoing port-access mitral procedures or minimally invasive coronary bypass graft surgery are likely to Use adrenaline very cautiously and titrate to effect (intravenous require an emergency sternotomy, as very poor access is obtained doses of 100 or less micrograms in adults). In order to exclude by opening or extending a mini-thoracotomy incision. Equipment a medication error as the cause of the arrest, stop all drug infu- and guidelines should be kept close to the patient. sions and check if they are correct. If there is concern about patient awareness, restart the anaesthetic drugs. Atropine is no longer rec- Children ommended for the treatment of cardiac arrest as there is little evidence to show it is effective in patients who have been given The incidence of cardiac arrest after cardiac surgery in chil- adrenaline. Individual clinicians may use atropine at their discre- dren is 4%411 and survival rates are similar to those of adults. The tion in post-cardiac surgery cardiac arrest if they feel it is indicated. causes are also similar, although one case-series documented pri- Treat bradycardia with atropine, according to the bradycardia algo- mary respiratory arrest in 11%. The guidance given in this section rithm (see Section 4 Advanced Life Support).24a is equally applicable to children, with appropriate modification of Give amiodarone 300 mg after the 3rd failed defibrillation defibrillation energy and drug doses (see Section 6 Paediatric Life attempt but do not delay resternotomy. An irritable myocardium Support).411a Use extreme caution and check doses carefully when following cardiac surgery is caused most commonly by myocardial giving intravenous adrenaline doses to children in cardiac arrest ischaemia and correction of this, rather than giving amiodarone, is after cardiac surgery. Use smaller doses of adrenaline in this setting more likely to achieve myocardial stability. (e.g., 1 g kg−1 ) under the guidance of experienced clinicians. Emergency resternotomy Internal defibrillation This is an integral part of resuscitation after cardiac surgery, once all other reversible causes have been excluded. Once ade- Internal defibrillation using paddles applied directly across the quate an airway and ventilation has been established, and if three ventricles requires considerably less energy than that used for attempts at defibrillation have failed in VF/VT, undertake rester- external defibrillation. Biphasic shocks are more effective than notomy without delay. Emergency resternotomy is also indicated monophasic shocks for direct defibrillation.412 For biphasic shocks, in asystole or PEA, when other treatments have failed. Resusci- starting at 5 J creates the optimum conditions for lowest threshold tation teams should be well rehearsed in this technique so that and cumulative energy, whereas 10–20 J offers optimum conditions it can be performed safely within 5 min of the onset of cardiac for more rapid defibrillation and fewer shocks,412 thus 20 J is the arrest. Resternotomy equipment should be prepared as soon as most applicable energy in an arrest situation, whereas 5 J would be an arrest is identified. Simplification of the resternotomy tray and adequate if the patient has been placed on cardiopulmonary bypass. regular manikin rehearsals are key measures to ensure a prompt Continuing cardiac compressions using the internal paddles resternotomy.407,408 All medical members of the patient care team whilst charging the defibrillator and delivering the shock during should be trained to perform resternotomy if a surgeon is not avail- the decompression phase of compressions may improve shock able within 5 min. Improved survival and better quality of life is success.413,414 well documented with rapid resternotomy.394,395,409 It is acceptable to perform external defibrillation after emer- Resternotomy should be a standard part of resuscitation within gency resternotomy. Apply external pads preoperatively to all 10 days after cardiac surgery. The overall survival to discharge patients undergoing resternotomy surgery.415 Use the defibril- following internal cardiac massage is 17%394 to 25%395 although lation energy level indicated in the universal algorithm. If the survival rates are much lower when chest opening is performed sternum is widely open the impedence may be significantly outside the specialised environment of the post-cardiac surgery increased – if external defibrillation is chosen over internal defib- ICU.395 rillation close the sternal retractor before shock delivery. Reinstitution of emergency cardiopulmonary bypass 8i. Traumatic cardiorespiratory arrest The need for emergency cardiopulmonary bypass (CPB) occurs Introduction in approximately 0.8% patients at a mean of 7 h post-operatively396 and is usually indicated to correct surgical bleeding or graft occlu- Cardiac arrest caused by trauma has a very high mortality, with sion and rest the myocardium. Emergency institution of CPB should an overall survival of just 5.6% (range 0–17%) (Table 8.4).416–422 For be available on all units undertaking cardiac surgery. Survival to reasons that are unclear, reported survival rates in the last 5 years discharge rates of 32%,395 42%396 and 56.3%410 have been reported are better than reported previously (Table 8.4) In those who survive when CPB is reinstituted on the ICU. (and where data are available) neurological outcome is good in only Survival rates decline rapidly when this procedure is undertaken 1.6% of those sustaining traumatic cardiorespiratory arrest (TCRA). more than 24 h after surgery and when performed on the ward rather than the ICU. Emergency CPB should probably be restricted to patients who arrest within 72 h of surgery, as surgically reme- Diagnosis of traumatic cardiorespiratory arrest diable problems are unlikely after this time.395 Ensuring adequate anticoagulation before starting CPB, or the use of a heparin-bonded The diagnosis of TCRA is made clinically: the trauma patient is circuit, is important. The need for a further period of cross-clamping unresponsive, apnoeic and pulseless. Both asystole and organised does not preclude a favourable outcome.396 cardiac activity without cardiac output are regarded as TCRA.
- 201. J. Soar et al. / Resuscitation 81 (2010) 1400–1433 1419 Table 8.4 Survival after out of hospital traumatic cardiac arrest. Source Entry criteria: Number of Penetrating/ Blunt/survivors/ children or adults patients/survivors/ survivors/good good neurological requiring CPR good neurological neurological outcome before or on outcome outcome hospital admission Shimazu and Shatney417 TCRA on admission 267 7 4 Rosemurgy et al.416 CPR before admission 138 42 96 0 0 0 0 0 0 Bouillon et al.429 CPR on scene 224 4 3 Battistella et al.418 CPR at scene, en route or in the ED 604 300 304 16 12 4 9 9 0 Fisher and Worthen430 Children requiring CPR before or on 65 65 admission after blunt trauma 1 1 0 0 Hazinski et al.431 Children requiring CPR or being 38 38 severely hypotensive on admission 1 1 after blunt trauma 0 0 Stratton et al.422 Unconscious, pulseless at scene 879 497 382 9 4 5 3 3 0 Calkins et al.432 Children requiring CPR after blunt 25 25 trauma 2 2 2 2 Yanagawa et al.433 OHCA in blunt trauma 332 332 6 6 0 0 Pickens et al.434 CPR on scene 184 94 90 14 9 5 9 5 4 Di Bartolomeo et al.435 CPR on scene 129 2 0 Willis et al.436 CPR on scene 89 18 71 4 2 2 4 2 2 David et al.437 CPR on scene 268 5 1 Crewdson et al.438 80 children who required CPR on 80 7 73 scene after trauma 7 0 7 3 0 3 Huber-Wagner et al.439 CPR on scene or after arrival 757 43 714 130 ? ? 28 ? ? Pasquale et al.421 CPR before or on hospital admission 106 21 85 3 1 2 Lockey et al.440 CPR on scene 871 114 757 68 9 59 Cera et al.441 CPR on 161 admission 15 Totals 5217 1136 3032 293 (5.6%) 37 (3.3%) 94 (3.1%) Commotio cordis malignant arrhythmias (usually ventricular fibrillation). Syncope after chest wall impact may be caused by non-sustained arrhythmic Commotio cordis is actual or near cardiac arrest caused by a events. Commotio cordis occurs mostly during sports (most com- blunt impact to the chest wall over the heart.423–427 A blow to the monly baseball) and recreational activities and victims are usually chest during the vulnerable phase of the cardiac cycle may cause young males (mean age 14 years). In a series of 1866 cardiac arrests
- 202. 1420 J. Soar et al. / Resuscitation 81 (2010) 1400–1433 in athletes in Minneapolis, 65 (3%) were due to commotio cordis.428 life, transfer rapidly to the nearest appropriate hospital. Consider The registry is accruing 5–15 cases of commotio cordis each year. on scene thoracostomy for appropriate patients.450,451 Do not delay The overall survival rate from commotio cordis is 15%, but 25% if for unproven interventions such as spinal immobilisation.452 resuscitation is started within 3 min.427 1. Treatment of reversible causes: • Hypoxaemia (oxygenation, ventilation). Trauma secondary to medical events • Compressible haemorrhage (pressure, pressure dressings, tourni- A cardiorespiratory arrest due to a medical condition (e.g., car- quets, novel haemostatic agents). • Non-compressible haemorrhage (splints, intravenous fluid). diac arrhythmia, hypoglycaemia, seizure) can cause a secondary • Tension pneumothorax (chest decompression). traumatic event (e.g., fall, road traffic accident etc). Despite the • Cardiac tamponade (immediate thoracotomy) initial reported mechanism, traumatic injuries may not be the pri- mary cause of a cardiorespiratory arrest and standard advanced life 2. Chest compressions: although they may not be effective in support, including chest compressions, may be appropriate. hypovolaemic cardiac arrest most survivors do not have hypo- volaemia and in this subgroup standard advanced life support may Mechanism of injury be life-saving. Blunt trauma 3. Standard CPR should not delay the treatment of reversible causes (e.g., thoracotomy for cardiac tamponade). Of 3032 patients with cardiac arrest after blunt trauma, 94 (3.1%) survived. Only 15 out of 1476 patients (1%) were reported to have Resuscitative thoracotomy a good neurological outcome (Table 8.4). Pre-hospital Penetrating trauma Resuscitative thoracotomy has been reported as futile if out of hospital time has exceeded 30 min448 ; others consider thoraco- Of 1136 patients with cardiac arrest after penetrating injury, tomy to be futile in patients with blunt trauma requiring more there were 37 (3.3%) survivors 19 of which (1.9%) had a good neu- than 5 min of pre-hospital CPR and in patients with penetrating rological outcome (Table 8.4). trauma requiring more than 15 min of CPR.449 With these time A confounding factor in both blunt and penetrating trauma sur- limits in mind, one UK service recommends that if surgical inter- vival rates is that some studies report survival including those vention cannot be accomplished within 10 min after loss of pulse pronounced dead on scene and others do not. in patients with penetrating chest injury, on scene thoracotomy should be considered.450 Based on this approach, of 71 patients Signs of life and initial ECG activity who underwent thoracotomy at scene, thirteen patients survived and eleven of these made a good neurological recovery.453 In con- There are no reliable predictors of survival for TCRA. One study trast, pre-hospital thoracotomy for 34 patients with blunt trauma reported that the presence of reactive pupils and sinus rhythm in Japan has not produced any survivors.454 correlate significantly with survival.441 In a study of penetrat- ing trauma, pupil reactivity, respiratory activity and sinus rhythm Hospital were correlated with survival but were unreliable.422 Three stud- A relatively simple technique for resuscitative thoracotomy has ies reported no survivors in patients presenting with asystole or been described recently.451,455 agonal rhythms.418,422,442 Another reported no survivors in PEA The American College of Surgeons has published practice guide- after blunt trauma.443 Based on these studies, the American Col- lines for emergency department thoracotomy (EDT) based on a lege of Surgeons and the National Association of EMS physicians meta-analysis of 42 outcome studies including 7035 EDT’s.456 The produced pre-hospital guidelines on withholding resuscitation.444 overall survival rate was 7.8% and, of 226 survivors (5%), only 34 They recommend withholding resuscitation in: (15%) had a neurological deficit. The investigators concluded that EDT: (i) blunt trauma patients presenting with apnoea, pulselessness and without organised ECG activity; 1. After blunt trauma, should be limited to those with vital signs (ii) penetrating trauma patients found apnoeic and pulseless after on arrival and a witnessed cardiac arrest (estimated survival rate rapid assessment for signs of life such as pupillary reflexes, 1.6%). spontaneous movement, or organised ECG activity. 2. Is best applied to patients with penetrating cardiac injuries who arrive at the trauma centre after a short on scene and trans- Three retrospective studies question these recommendations port time with witnessed signs of life or ECG activity (estimated and report survivors who would have had resuscitation withheld if survival rate 31%). the guidelines had been followed.434,436,440 3. Should be undertaken in penetrating non-cardiac thoracic injuries even though survival rates are low. Treatment 4. Should be undertaken in patients with exsanguinating abdom- inal vascular injury even though survival rates are low. This Survival from TCRA is correlated with duration of CPR and pre- procedure should be used as an adjunct to definitive repair of hospital time.420,445–449 Prolonged CPR is associated with a poor abdominal vascular injury. outcome; the maximum CPR time associated with favourable out- come is 16 min.420,445–447 The level of pre-hospital intervention One European study reports a survival rate of 10% in blunt will depend on the skills of local EMS providers, but treatment on trauma patients undergoing EDT within twenty min after wit- scene should focus on good quality BLS and ALS and exclusion of nessed cardiac arrest. Three of the four survivors had intrabdominal reversible causes. Look for and treat any medical condition that haemorrhage. They conclude that in moribund patients with blunt may have precipitated the trauma event. Undertake only essential chest or abdominal trauma EDT should be performed as early as life-saving interventions on scene and, if the patient has signs of possible.457
- 203. J. Soar et al. / Resuscitation 81 (2010) 1400–1433 1421 Airway management Fluids and blood transfusion on scene Effective airway management is essential to maintain oxygena- Fluid resuscitation of trauma patients before haemorrhage is tion of the severely compromised trauma patient. In one study, controlled is controversial and there is no clear consensus on tracheal intubation on scene of patients with TCRA doubled the tol- when it should be started and what fluids should be given.468,469 erated period of CPR before emergency department thoracotomy – Limited evidence and general consensus support a more conser- the mean duration of CPR for survivors who were intubated in the vative approach to intravenous fluid infusion, with permissive field was 9.1 versus 4.2 min for those were not intubated.447 hypotension until surgical haemostasis is achieved.470,471 In the UK, Tracheal intubation in trauma patients is a difficult procedure the National Institute for Clinical Excellence (NICE) has published with a high failure rate if carried out by less experienced care guidelines on pre-hospital fluid replacement in trauma.472 The rec- providers.458–462 Use basic airway management manoeuvres and ommendations include giving 250 ml boluses of crystalloid solution alternative airways to maintain oxygenation if tracheal intubation until a radial pulse is achieved and not delaying rapid transport cannot be accomplished immediately. If these measures fail a sur- of trauma victims for fluid infusion in the field. Pre-hospital fluid gical airway is indicated. therapy may have a role in prolonged entrapments but there is no reliable evidence for this.473,474 Ventilation Ultrasound In low cardiac output conditions, positive pressure ventilation causes further circulatory depression, or even cardiac arrest, by Ultrasound is a valuable tool in the evaluation of the impeding venous return to the heart.463 Monitor ventilation with compromised trauma patient. Haemoperitoneum, haemo-or pneu- continuous waveform capnography and adjust to achieve nor- mothorax and cardiac tamponade can be diagnosed reliably in mocapnia. This may enable slow respiratory rates and low tidal minutes even in the pre-hospital phase.475 Diagnostic peritoneal volumes and the corresponding decrease in transpulmonary pres- lavage and needle pericardiocentesis have virtually disappeared sure may increase venous return and cardiac output. from clinical practice since the introduction of sonography in trauma care. Pre-hospital ultrasound is now available, although its Chest decompression benefits are yet to be proven.476 Effective decompression of a tension pneumothorax can be Vasopressors achieved quickly by lateral or anterior thoracostomy, which, in the presence of positive pressure ventilation, is likely to be more effec- The possible role of vasopressors (e.g., vasopressin) in trauma tive than needle thoracostomy and quicker than inserting a chest resuscitation is unclear and is based mainly on case reports.477 tube.464 8j. Cardiac arrest associated with pregnancy Effectiveness of chest compressions in TCRA Overview In hypovolaemic cardiac arrest, chest compressions are unlikely to be as effective as in cardiac arrest from other causes.465 However Mortality related to pregnancy in developed countries is rare, most survivors of TCRA have reasons other than pure hypovolaemia occurring in an estimated 1:30,000 deliveries.478 The fetus must for their arrest and these patients may benefit from standard always be considered when an adverse cardiovascular event occurs advanced life support interventions.436,438,440 Patients with cardiac in a pregnant woman. Fetal survival usually depends on mater- tamponade are also less likely to benefit from chest compressions nal survival. Resuscitation guidelines for pregnancy are based and should, where possible, have immediate surgical release of largely on case series, extrapolation from non-pregnant arrests, tamponade. Return of spontaneous circulation with advanced life manikin studies and expert opinion based on the physiology support in patients with TCRA has been described and chest com- of pregnancy and changes that occur in normal labour. Studies pressions are still the standard of care in patients with cardiac arrest tend to address causes in developed countries, whereas the most irrespective of aetiology. pregnancy-related deaths occur in developing countries. There were an estimated 342,900 maternal deaths (death during preg- Haemorrhage control nancy, childbirth, or in the 42 days after delivery) worldwide in 2008.479 Early haemorrhage control is vital. Handle the patient gently Significant physiological changes occur during pregnancy, e.g., at all times to prevent clot disruption. Apply external compres- cardiac output, blood volume, minute ventilation and oxygen con- sion, and pelvic and limb splints when appropriate. Delays in sumption all increase. Furthermore, the gravid uterus can cause surgical haemostasis are disastrous for patients with exsanguinat- significant compression of iliac and abdominal vessels when the ing trauma. Recent conflicts have seen a resurgence in the use mother is in the supine position, resulting in reduced cardiac output of tourniquets to stop life-threatening limb haemorrhage.466 It is and hypotension. unlikely that the same benefits will be seen in civilian trauma prac- tice. Causes Pericardiocentesis There are many causes of cardiac arrest in pregnant women. A review of nearly 2 million pregnancies in the UK480 showed that In patients with suspected trauma-related cardiac tamponade, maternal deaths (death during pregnancy, childbirth, or in the 42 needle pericardiocentesis is probably not a useful procedure.467 days after delivery) between 2003 and 2005 were associated with: There is no evidence of benefit in the literature. It may increase scene time, can cause myocardial injury and delays effective ther- • cardiac disease; apeutic measures such as emergency thoracotomy. • pulmonary embolism;
- 204. 1422 J. Soar et al. / Resuscitation 81 (2010) 1400–1433 • psychiatric disorders; • Start basic life support according to standard guidelines. Ensure • hypertensive disorders of pregnancy; good quality chest compressions with minimal interruptions. • sepsis; • Manually displace the uterus to the left to remove caval compres- • haemorrhage; sion. • amniotic-fluid embolism; • Add left lateral tilt if this is feasible – the optimal angle of tilt is • ectopic pregnancy. unknown. Aim for between 15◦ and 30◦ . Even a small amount of tilt may be better than no tilt. The angle of tilt used needs to allow Pregnant women can also sustain cardiac arrest from the same good quality chest compressions and if needed allow Caesarean causes as women of the same age group. delivery of the fetus. • Start preparing for emergency Caesarean section (see below) – the fetus will need to be delivered if initial resuscitation efforts Key interventions to prevent cardiac arrest fail. In an emergency, use an ABCDE approach. Many cardiovascu- Modifications to advanced life support lar problems associated with pregnancy are caused by aortocaval compression. Treat a distressed or compromised pregnant patient There is a greater potential for gastro-oesophageal sphincter as follows: insufficiency and risk of pulmonary aspiration of gastric contents. Early tracheal intubation with correctly applied cricoid pressure • Place the patient in the left lateral position or manually and gently decreases this risk. Tracheal intubation will make ventilation of the displace the uterus to the left. lungs easier in the presence of increased intra-abdominal pressure. • Give high-flow oxygen guided by pulse oximetry. A tracheal tube 0.5–1 mm internal diameter (ID) smaller than • Give a fluid bolus if there is hypotension or evidence of hyo- that used for a non-pregnant woman of similar size may be nec- volaemia. essary because of maternal airway narrowing from oedema and • Immediately re-evaluate the need for any drugs being given. swelling.498 One study documented that the upper airways in the • Seek expert help early. Obstetric and neonatal specialists should third trimester of pregnancy are narrower compared with their be involved early in the resuscitation. postpartum state and to non-pregnant controls.499 Tracheal intuba- • Identify and treat the underlying cause. tion may be more difficult in the pregnant patient.500 Expert help, a failed intubation drill and the use of alternative airway devices Modifications to BLS guidelines for cardiac arrest may be needed (see Section 4).24a,501 There is no change in transthoracic impedance during preg- After 20 weeks gestation, the pregnant woman’s uterus can nancy, suggesting that standard shock energies for defibrillation press down against the inferior vena cava and the aorta, impeding attempts should be used in pregnant patients.502 There is no evi- venous return and cardiac output. Uterine obstruction of venous dence that shocks from a direct current defibrillator have adverse return can cause pre-arrest hypotension or shock and, in the crit- effects on the fetal heart. Left lateral tilt and large breasts will ically ill patient, may precipitate arrest.481,482 After cardiac arrest, make it difficult to place an apical defibrillator paddle. Adhesive the compromise in venous return and cardiac output by the gravid defibrillator pads are preferable to paddles in pregnancy. uterus limits the effectiveness of chest compressions. Non-arrest studies show that left lateral tilt improves mater- nal blood pressure, cardiac output and stroke volume 483–485 and Reversible causes improves fetal oxygenation and heart rate.486–488 Two studies found no improvement in maternal or fetal variables with 10–20◦ Rescuers should attempt to identify common and reversible left lateral tilt.489,490 One study found more aortic compression at causes of cardiac arrest in pregnancy during resuscitation attempts. 15◦ left lateral tilt when compared with a full left lateral tilt.484 The 4 Hs and 4 Ts approach helps identify all the common causes of Aortic compression has been found to persist at over 30◦ of tilt.491 cardiac arrest in pregnancy. Pregnant patients are at risk of all the Two non-arrest studies show that manual left uterine displacement other causes of cardiac arrest for their age group (e.g., anaphylaxis, with the patient supine is as good as or better than left lateral tilt drug overdose, trauma). Consider the use of abdominal ultrasound in relieving aortocaval compression, as assessed by the incidence by a skilled operator to detect pregnancy and possible causes during of hypotension and ephedrine use.492,493 Non-cardiac arrest data cardiac arrest in pregnancy; however, do not delay other treat- show that the gravid uterus can be shifted away from the cava ments. Specific causes of cardiac arrest in pregnancy include the in most cases by placing the patient in 15◦ of left lateral decubi- following. tus position.494 The value of relieving aortic or caval compression during CPR is, however, unknown. Haemorrhage Unless the pregnant victim is on a tilting operating table, left lateral tilt is not easy to perform whilst maintaining good quality Life-threatening haemorrhage can occur both antenatally and chest compressions. A variety of methods to achieve a left lateral tilt postnatally. Postpartum haemorrhage is the commonest single have been described including placing the victim on the rescuers cause of maternal death worldwide and is estimated to cause one knees495 , pillows or blankets, and the Cardiff wedge496 although maternal death every 7 min.503 Associations include ectopic preg- their efficacy in actual cardiac arrests is unknown. Even when a nancy, placental abruption, placenta praevia, placenta accreta, and tilting table is used, the angle of tilt is often overestimated.497 In a uterine rupture.480 A massive haemorrhage protocol must be avail- manikin study, the ability to provide effective chest compressions able in all units and should be updated and rehearsed regularly in decreased as the angle of left lateral tilt increased and that at an conjunction with the blood bank. Women at high risk of bleeding angle of greater than 30◦ the manikin tended to roll.496 should be delivered in centres with facilities for blood transfu- The key steps for BLS in a pregnant patient are: sion, intensive care and other interventions, and plans should be made in advance for their management. Treatment is based on an • Call for expert help early (including an obstetrician and neona- ABCDE approach. The key step is to stop the bleeding. Consider the tologist). following:
- 205. J. Soar et al. / Resuscitation 81 (2010) 1400–1433 1423 • fluid resuscitation including use of rapid transfusion system and Amniotic-fluid embolism was associated with induction of labour, cell salvage504 ; multiple pregnancy, older, and ethnic-minority women. Caesarean • oxytocin and prostaglandin analogues to correct uterine delivery was associated with postnatal amniotic-fluid embolism. atony505 ; Treatment is supportive, as there is no specific therapy based on • massaging the uterus506 ; an ABCDE approach and correction of coagulopathy. Successful use • correction of coagulopathy including use of tranexamic acid or of extracorporeal life support techniques for women suffering life- recombinant activated factor VII507–509 ; threatening amniotic-fluid embolism during labour and delivery is • uterine balloon tamponade510,511 ; reported.534 • uterine compression sutures512 ; • angiography and endovascular embolization513 ; If immediate resuscitation attempts fail • hysterectomy514,515 ; • aortic cross-clamping in catastrophic haemorrhage.516 Consider the need for an emergency hysterotomy or Caesarean section as soon as a pregnant woman goes into cardiac arrest. In Cardiovascular disease some circumstances immediate resuscitation attempts will restore a perfusing rhythm; in early pregnancy this may enable the preg- Myocardial infarction and aneurysm or dissection of the aorta nancy to proceed to term. When initial resuscitation attempts fail, or its branches, and peripartum cardiomyopathy cause most deaths delivery of the fetus may improve the chances of successful resus- from acquired cardiac disease.517,518 Patients with known cardiac citation of the mother and fetus.535–537 One systematic review disease need to be managed in a specialist unit. Pregnant women documented 38 cases of Caesarean section during CPR, with 34 sur- may develop an acute coronary syndrome, typically in association viving infants and 13 maternal survivors at discharge, suggesting with risk factors such as obesity, older age, higher parity, smok- that Caesarean section may have improved maternal and neonatal ing, diabetes, pre-existing hypertension and a family history of outcomes.538 The best survival rate for infants over 24–25 weeks ischaemic heart disease.480,519 Pregnant patients can have atyp- gestation occurs when delivery of the infant is achieved within ical features such as epigastric pain and vomiting. Percutaneous 5 min after the mother’s cardiac arrest.535,539–541 This requires that coronary intervention (PCI) is the reperfusion strategy of choice the provider commence the hysterotomy at about 4 min after car- for ST-elevation myocardial infarction in pregnancy. Thrombolysis diac arrest. At older gestational ages (30–38 weeks), infant survival should be considered if urgent PCI is unavailable. A review of 200 is possible even when delivery was after 5 min from the onset of cases of thrombolysis for massive pulmonary embolism in preg- maternal cardiac arrest.538 A case-series suggests increased use of nancy reported a maternal death rate of 1% and concluded that Caesarean section during CPR with team training542 ; in this series thrombolytic therapy is reasonably safe in pregnancy.520 no deliveries were achieved within 5 min after starting resuscita- Increasing numbers of women with congenital heart disease are tion. Eight of the twelve women had ROSC after delivery, with two becoming pregnant.521 Heart failure and arrhythmias are the com- maternal and five newborn survivors. Maternal case fatality rate monest problems, especially in those with cyanotic heart disease. was 83%. Neonatal case fatality rate was 58%.542 Pregnant women with known congenital heart disease should be Delivery will relieve caval compression and may improve managed in specialist centres. chances of maternal resuscitation. The Caesarean delivery also enables access to the infant so that newborn resuscitation can Pre-eclampsia and eclampsia begin. Eclampsia is defined as the development of convulsions and/or Decision-making for emergency hysterotomy (Caesarean section) unexplained coma during pregnancy or postpartum in patients with signs and symptoms of pre-eclampsia.522,523 Magnesium sul- The gravid uterus reaches a size that will begin to compro- phate is effective in preventing approximately half of the cases mise aortocaval blood flow at approximately 20 weeks gestation; of eclampsia developing in labour or immediately postpartum in however, fetal viability begins at approximately 24–25 weeks.543 women with pre-eclampsia.524–526 Portable ultrasound is available in some emergency departments and may aid in determination of gestational age (in experienced Pulmonary embolism hands) and positioning, provided its use does not delay the deci- sion to perform emergency hysterotomy.544 Aim for delivery within The estimated incidence of pulmonary embolism is 1–1.5 per 5 min of onset of cardiac arrest. This will mean that Caesarean 10,000 pregnancies, with a case fatality of 3.5% (95% CI 1.1–8.0%).527 section needs to ideally take place where the cardiac arrest has Risk factors include obesity, increased age, and immobility. Suc- occurred to avoid delays. cessful use of fibrinolytics for massive, life-threatening pulmonary embolism in pregnant women has been reported.520,528–531 • At gestational age less than 20 weeks, urgent Caesarean delivery need not be considered, because a gravid uterus of this size is Amniotic-fluid embolism unlikely to significantly compromise maternal cardiac output. • At gestational age approximately 20–23 weeks, initiate emer- Amniotic-fluid embolism usually presents around the time gency hysterotomy to enable successful resuscitation of the of delivery with sudden cardiovascular collapse, breathlessness, mother, not survival of the delivered infant, which is unlikely at cyanosis, arrhythmias, hypotension and haemorrhage associated this gestational age. with disseminated intravascular coagulopathy.532 Patients may • At gestational age approximately ≥24–25 weeks, initiate emer- have warning signs preceding collapse including breathlessness, gency hysterotomy to save the life of both the mother and the chest pain, feeling cold, light-headedness, distress, panic, a feeling infant. of pins and needles in the fingers, nausea, and vomiting. The UK Obstetric Surveillance System identified 60 cases of Post-resuscitation care amniotic-fluid embolism between 2005 and 2009. The reported incidence was 2.0 per 100,000 deliveries (95% CI 1.5–2.5%)533 Post-resuscitation care should follow standard guidelines. Ther- The case fatality is 13–30% and perinatal mortality is 9–44%.532 apeutic hypothermia has been used safely and effectively in early
- 206. 1424 J. Soar et al. / Resuscitation 81 (2010) 1400–1433 pregnancy with fetal heart monitoring and resulted in favourable the upper limbs, hands and wrists, whereas for lightning they are maternal and fetal outcome after a term delivery.544a Implantable mostly on the head, neck and shoulders. Injury may also occur indi- cardioverter defibrillators (ICDs) have been used in patients during rectly through ground current or current “splashing” from a tree or pregnancy.545 other object that is hit by lightning.550 Explosive force may cause blunt trauma.551 The pattern and severity of injury from a light- Preparation for cardiac arrest in pregnancy ning strike varies considerably, even among affected individuals from a single group.552–554 As with industrial and domestic electric Advanced life support in pregnancy requires coordination of shock, death is caused by cardiac553–557 or respiratory arrest.550,558 maternal resuscitation, Caesarean delivery of the fetus and new- In those who survive the initial shock, extensive catecholamine born resuscitation ideally within 5 min. To achieve this, units likely release or autonomic stimulation may occur, causing hypertension, to deal with cardiac arrest in pregnancy should: tachycardia, non-specific ECG changes (including prolongation of the QT interval and transient T-wave inversion), and myocardial • have plans and equipment in place for resuscitation of both the necrosis. Creatine kinase may be released from myocardial and pregnant woman and newborn; skeletal muscle. Lightning can also cause central and peripheral • ensure early involvement of obstetric, anaesthetic and neonatal nerve damage; brain haemorrhage and oedema, and peripheral teams; nerve injury are common. Mortality from lightning injuries is as • ensure regular training in obstetric emergencies.546 high as 30%, with up to 70% of survivors sustaining significant morbidity.559–561 8k. Electrocution Diagnosis Introduction The circumstances surrounding the incident are not always Electrical injury is a relatively infrequent but potentially dev- known. Unconscious patients with linear or punctuate burns or astating multisystem injury with high morbidity and mortality, feathering should be treated as a victims of lightning strike.550 causing 0.54 deaths per 100,000 people each year. Most electrical injuries in adults occur in the workplace and are associated gen- Rescue erally with high voltage, whereas children are at risk primarily at home, where the voltage is lower (220 V in Europe, Australia and Ensure that any power source is switched off and do not Asia; 110 V in the USA and Canada).547 Electrocution from lightning approach the casualty until it is safe. High-voltage (above domes- strikes is rare, but worldwide it causes 1000 deaths each year.548 tic mains) electricity can arc and conduct through the ground for Electric shock injuries are caused by the direct effects of cur- up to a few metres around the casualty. It is safe to approach and rent on cell membranes and vascular smooth muscle. The thermal handle casualties after lightning strike, although it would be wise energy associated with high-voltage electrocution will also cause to move to a safer environment, particularly if lightning has been burns. Factors influencing the severity of electrical injury include seen within 30 min.550 whether the current is alternating (AC) or direct (DC), voltage, mag- nitude of energy delivered, resistance to current flow, pathway of Resuscitation current through the patient, and the area and duration of contact. Skin resistance is decreased by moisture, which increases the likeli- Start standard basic and advanced life support without delay. hood of injury. Electric current follows the path of least resistance; conductive neurovascular bundles within limbs are particularly • Airway management may be difficult if there are electrical burns prone to damage. around the face and neck. Early tracheal intubation is needed in Contact with AC may cause tetanic contraction of skeletal mus- these cases, as extensive soft-tissue oedema may develop caus- cle, which may prevent release from the source of electricity. ing airway obstruction. Head and spine trauma can occur after Myocardial or respiratory failure may cause immediate death. electrocution. Immobilise the spine until evaluation can be per- formed. • Respiratory arrest may be caused by paralysis of the central res- • Muscular paralysis, especially after high voltage, may persist piratory control system or the respiratory muscles. for several hours560 ; ventilatory support is required during this • Current may precipitate VF if it traverses the myocardium during period. the vulnerable period (analogous to an R-on-T phenomenon).549 • VF is the commonest initial arrhythmia after high-voltage AC Electrical current may also cause myocardial ischaemia because shock; treat with prompt attempted defibrillation. Asystole is of coronary artery spasm. Asystole may be primary, or secondary more common after DC shock; use standard protocols for this to asphyxia following respiratory arrest. and other arrhythmias. • Remove smouldering clothing and shoes to prevent further ther- Current that traverses the myocardium is more likely to be fatal. mal injury. A transthoracic (hand-to-hand) pathway is more likely to be fatal • Vigorous fluid therapy is required if there is significant tis- than a vertical (hand-to-foot) or straddle (foot-to-foot) pathway. sue destruction. Maintain a good urine output to enhance the There may be extensive tissue destruction along the current path- excretion of myoglobin, potassium and other products of tissue way. damage.557 • Consider early surgical intervention in patients with severe ther- Lightning strike mal injuries. Lightning strikes deliver as much as 300 kV over a few millisec- • Maintain spinal immobilisation if there is a likelihood of head or onds. Most of the current from a lightning strike passes over the neck trauma.562,563 surface of the body in a process called ‘external flashover’. Both • Conduct a thorough secondary survey to exclude traumatic industrial shocks and lightning strikes cause deep burns at the point injuries caused by tetanic muscular contraction or by the person of contact. For industrial shocks the points of contact are usually on being thrown.563,564
- 207. J. Soar et al. / Resuscitation 81 (2010) 1400–1433 1425 • Electrocution can cause severe, deep soft-tissue injury with rel- 11. Heguilen RM, Sciurano C, Bellusci AD, et al. The faster potassium-lowering atively minor skin wounds, because current tends to follow effect of high dialysate bicarbonate concentrations in chronic haemodialysis patients. Nephrol Dial Transplant 2005;20:591–7. neurovascular bundles; look carefully for features of compart- 12. Pun PH, Lehrich RW, Smith SR, Middleton JP. Predictors of survival after ment syndrome, which will necessitate fasciotomy. cardiac arrest in outpatient hemodialysis clinics. Clin J Am Soc Nephrol 2007;2:491–500. 13. Alfonzo AV, Simpson K, Deighan C, Campbell S, Fox J. Modifications to advanced Patients struck by lightning are most likely to die if they sus- life support in renal failure. Resuscitation 2007;73:12–28. tain immediate cardiac or respiratory arrest and are not treated 14. Davis TR, Young BA, Eisenberg MS, Rea TD, Copass MK, Cobb LA. Outcome of rapidly. When multiple victims are struck simultaneously by light- cardiac arrests attended by emergency medical services staff at community outpatient dialysis centers. Kidney Int 2008;73:933–9. ning, rescuers should give highest priority to patients in respiratory 15. Lafrance JP, Nolin L, Senecal L, Leblanc M. Predictors and outcome of cardiopul- or cardiac arrest. Victims with respiratory arrest may require only monary resuscitation (CPR) calls in a large haemodialysis unit over a seven-year ventilation to avoid secondary hypoxic cardiac arrest. Resuscitative period. Nephrol Dial Transplant 2006;21:1006–12. 16. Sandroni C, Nolan J, Cavallaro F, Antonelli M. In-hospital cardiac arrest: inci- attempts may have higher success rates in lightning victims than in dence, prognosis and possible measures to improve survival. Intensive Care patients with cardiac arrest from other causes, and efforts may be Med 2007;33:237–45. effective even when the interval before the resuscitative attempt is 17. Meaney PA, Nadkarni VM, Kern KB, Indik JH, Halperin HR, Berg RA. Rhythms and outcomes of adult in-hospital cardiac arrest. Crit Care Med 2010;38:101–8. prolonged.558 Dilated or non-reactive pupils should never be used 18. Bird S, Petley GW, Deakin CD, Clewlow F. Defibrillation during renal dialy- as a prognostic sign, particularly in patients suffering a lightning sis: a survey of UK practice and procedural recommendations. Resuscitation strike.550 2007;73:347–53. 19. Lehrich RW, Pun PH, Tanenbaum ND, Smith SR, Middleton JP. Automated There are conflicting reports on the vulnerability of the fetus to external defibrillators and survival from cardiac arrest in the outpatient electric shock. The clinical spectrum of electrical injury ranges from hemodialysis clinic. J Am Soc Nephrol 2007;18:312–20. a transient unpleasant sensation for the mother with no effect on 20. Rastegar A, Soleimani M. Hypokalaemia and hyperkalaemia. Postgrad Med J her fetus, to fetal death either immediately or a few days later. Sev- 2001;77:759–64. 21. Cohn JN, Kowey PR, Whelton PK, Prisant LM. New guidelines for potassium eral factors, such as the magnitude of the current and the duration replacement in clinical practice: a contemporary review by the National of contact, are thought to affect outcome.565 Council on Potassium in Clinical Practice. Arch Intern Med 2000;160: 2429–36. 22. Bronstein AC, Spyker DA, Cantilena Jr LR, Green JL, Rumack BH, Giffin SL. Further treatment and prognosis 2008 annual report of the American Association of Poison Control Centers’ National Poison Data System (NPDS): 26th Annual Report. Clin Toxicol (Phila) 2009;47:911–1084. Immediate resuscitation of young victims in cardiac arrest from 23. Yanagawa Y, Sakamoto T, Okada Y. Recovery from a psychotropic drug over- electrocution can result in long-term survival. Successful resuscita- dose tends to depend on the time from ingestion to arrival, the Glasgow tion has been reported after prolonged life support. All those who Coma Scale, and a sign of circulatory insufficiency on arrival. Am J Emerg Med survive electrical injury should be monitored in hospital if they 2007;25:757–61. 24. Zimmerman JL. Poisonings and overdoses in the intensive care unit: general have a history of cardiorespiratory problems or have had: and specific management issues. Crit Care Med 2003;31:2794–801. 24a. European Resuscitation Council Guidelines for Resuscitation 2010: Section 4: • loss of consciousness; Adult advanced life support. Resuscitation 2010; 81:1305–52. 25. Proudfoot AT, Krenzelok EP, Vale JA. Position paper on urine alkalinization. J • cardiac arrest; Toxicol Clin Toxicol 2004;42:1–26. • electrocardiographic abnormalities; 26. Greene S, Harris C, Singer J. Gastrointestinal decontamination of the poisoned • soft-tissue damage and burns. patient. Pediatr Emerg Care 2008;24:176–86, quiz 87–9. 27. Vale JA. Position statement: gastric lavage. American Academy of Clinical Tox- icology; European Association of Poisons Centres and Clinical Toxicologists. J Severe burns (thermal or electrical), myocardial necrosis, the Toxicol Clin Toxicol 1997;35:711–9. 28. Vale JA, Kulig K. Position paper: gastric lavage. J Toxicol Clin Toxicol extent of central nervous system injury, and secondary mul- 2004;42:933–43. tisystem organ failure determine the morbidity and long-term 29. Krenzelok EP, McGuigan M, Lheur P. Position statement: ipecac syrup, prognosis. There is no specific therapy for electrical injury, and the American Academy of Clinical Toxicology; European Association of Poi- management is symptomatic. Prevention remains the best way to sons Centres and Clinical Toxicologists. J Toxicol Clin Toxicol 1997;35:699– 709. minimize the prevalence and severity of electrical injury. 30. Chyka PA, Seger D, Krenzelok EP, Vale JA. Position paper: single-dose activated charcoal. Clin Toxicol (Phila) 2005;43:61–87. 31. Position paper: whole bowel irrigation. J Toxicol Clin Toxicol 2004;42:843–54. References 32. Krenzelok EP. Ipecac syrup-induced emesis. . .no evidence of benefit. Clin Tox- icol (Phila) 2005;43:11–2. 1. Soar J, Deakin CD, Nolan JP, et al. European Resuscitation Council guidelines for 33. Position paper: ipecac syrup. J Toxicol Clin Toxicol 2004;42:133–43. resuscitation 2005. Section 7. Cardiac arrest in special circumstances. Resusci- 34. Pitetti RD, Singh S, Pierce MC. Safe and efficacious use of procedural sedation tation 2005;67:S135–70. and analgesia by nonanesthesiologists in a pediatric emergency department. 2. Smellie WS. Spurious hyperkalaemia. BMJ 2007;334:693–5. Arch Pediatr Adolesc Med 2003;157:1090–6. 3. Niemann JT, Cairns CB. Hyperkalemia and ionized hypocalcemia during cardiac 35. Treatment of benzodiazepine overdose with flumazenil. The Flumazenil in Ben- arrest and resuscitation: possible culprits for postcountershock arrhythmias? zodiazepine Intoxication Multicenter Study Group. Clin Ther 1992;14:978– Ann Emerg Med 1999;34:1–7. 95. 4. Ahmed J, Weisberg LS. Hyperkalemia in dialysis patients. Semin Dial 36. Lheureux P, Vranckx M, Leduc D, Askenasi R. Flumazenil in mixed benzodi- 2001;14:348–56. azepine/tricyclic antidepressant overdose: a placebo-controlled study in the 5. Alfonzo AV, Isles C, Geddes C, Deighan C. Potassium disorders – clinical spec- dog. Am J Emerg Med 1992;10:184–8. trum and emergency management. Resuscitation 2006;70:10–25. 37. Beauvoir C, Passeron D, du Cailar G, Millet E. Diltiazem poisoning: hemody- 6. Mahoney B, Smith W, Lo D, Tsoi K, Tonelli M, Clase C. Emergency interventions namic aspects. Ann Fr Anesth Reanim 1991;10:154–7. for hyperkalaemia. Cochrane Database Syst Rev 2005:CD003235. 38. Gillart T, Loiseau S, Azarnoush K, Gonzalez D, Guelon D. Resuscitation after 7. Ngugi NN, McLigeyo SO, Kayima JK. Treatment of hyperkalaemia by alter- three hours of cardiac arrest with severe hypothermia following a toxic coma. ing the transcellular gradient in patients with renal failure: effect of various Ann Fr Anesth Reanim 2008;27:510–3. therapeutic approaches. East Afr Med J 1997;74:503–9. 39. Nordt SP, Clark RF. Midazolam: a review of therapeutic uses and toxicity. J 8. Allon M, Shanklin N. Effect of bicarbonate administration on plasma potassium Emerg Med 1997;15:357–65. in dialysis patients: interactions with insulin and albuterol. Am J Kidney Dis 40. Machin KL, Caulkett NA. Cardiopulmonary effects of propofol and a 1996;28:508–14. medetomidine-midazolam-ketamine combination in mallard ducks. Am J Vet 9. Zehnder C, Gutzwiller JP, Huber A, Schindler C, Schneditz D. Low-potassium and Res 1998;59:598–602. glucose-free dialysis maintains urea but enhances potassium removal. Nephrol 41. Osterwalder JJ. Naloxone – for intoxications with intravenous heroin and Dial Transplant 2001;16:78–84. heroin mixtures – harmless or hazardous? A prospective clinical study. J Toxicol 10. Gutzwiller JP, Schneditz D, Huber AR, Schindler C, Garbani E, Zehnder CE. Clin Toxicol 1996;34:409–16. Increasing blood flow increases kt/V(urea) and potassium removal but fails 42. Sporer KA, Firestone J, Isaacs SM. Out-of-hospital treatment of opioid overdoses to improve phosphate removal. Clin Nephrol 2003;59:130–6. in an urban setting. Acad Emerg Med 1996;3:660–7.
- 208. 1426 J. Soar et al. / Resuscitation 81 (2010) 1400–1433 43. Wanger K, Brough L, Macmillan I, Goulding J, MacPhail I, Christenson JM. 75. Baumann BM, Perrone J, Hornig SE, Shofer FS, Hollander JE. Randomized, Intravenous vs subcutaneous naloxone for out-of-hospital management of pre- double-blind, placebo-controlled trial of diazepam, nitroglycerin, or both for sumed opioid overdose. Acad Emerg Med 1998;5:293–9. treatment of patients with potential cocaine-associated acute coronary syn- 44. Hasan RA, Benko AS, Nolan BM, Campe J, Duff J, Zureikat GY. Cardiorespiratory dromes. Acad Emerg Med 2000;7:878–85. effects of naloxone in children. Ann Pharmacother 2003;37:1587–92. 76. Honderick T, Williams D, Seaberg D, Wears R. A prospective, randomized, con- 45. Sporer KA. Acute heroin overdose. Ann Intern Med 1999;130:584–90. trolled trial of benzodiazepines and nitroglycerine or nitroglycerine alone in 46. Kaplan JL, Marx JA, Calabro JJ, et al. Double-blind, randomized study of nalme- the treatment of cocaine-associated acute coronary syndromes. Am J Emerg fene and naloxone in emergency department patients with suspected narcotic Med 2003;21:39–42. overdose. Ann Emerg Med 1999;34:42–50. 77. Negus BH, Willard JE, Hillis LD, et al. Alleviation of cocaine-induced coronary 47. Schneir AB, Vadeboncoeur TF, Offerman SR, et al. Massive OxyContin ingestion vasoconstriction with intravenous verapamil. Am J Cardiol 1994;73:510–3. refractory to naloxone therapy. Ann Emerg Med 2002;40:425–8. 78. Saland KE, Hillis LD, Lange RA, Cigarroa JE. Influence of morphine sulfate on 48. Kelly AM, Kerr D, Dietze P, Patrick I, Walker T, Koutsogiannis Z. Randomised cocaine-induced coronary vasoconstriction. Am J Cardiol 2002;90:810–1. trial of intranasal versus intramuscular naloxone in prehospital treatment for 79. Brogan WCI, Lange RA, Kim AS, Moliterno DJ, Hillis LD. Alleviation of suspected opioid overdose. Med J Aust 2005;182:24–7. cocaine-induced coronary vasoconstriction by nitroglycerin. J Am Coll Cardiol 49. Robertson TM, Hendey GW, Stroh G, Shalit M. Intranasal naloxone is a viable 1991;18:581–6. alternative to intravenous naloxone for prehospital narcotic overdose. Prehosp 80. Hollander JE, Hoffman RS, Gennis P, et al. Nitroglycerin in the treatment of Emerg Care 2009;13:512–5. cocaine associated chest pain – clinical safety and efficacy. J Toxicol Clin Toxicol 50. Tokarski GF, Young MJ. Criteria for admitting patients with tricyclic antide- 1994;32:243–56. pressant overdose. J Emerg Med 1988;6:121–4. 81. Dattilo PB, Hailpern SM, Fearon K, Sohal D, Nordin C. Beta-blockers are associ- 51. Banahan Jr BF, Schelkun PH. Tricyclic antidepressant overdose: conservative ated with reduced risk of myocardial infarction after cocaine use. Ann Emerg management in a community hospital with cost-saving implications. J Emerg Med 2008;51:117–25. Med 1990;8:451–4. 82. Vongpatanasin W, Mansour Y, Chavoshan B, Arbique D, Victor RG. Cocaine stim- 52. Hulten BA, Adams R, Askenasi R, et al. Predicting severity of tricyclic antide- ulates the human cardiovascular system via a central mechanism of action. pressant overdose. J Toxicol Clin Toxicol 1992;30:161–70. Circulation 1999;100:497–502. 53. Bailey B, Buckley NA, Amre DK. A meta-analysis of prognostic indicators to 83. Lange RA, Cigarroa RG, Flores ED, et al. Potentiation of cocaine-induced predict seizures, arrhythmias or death after tricyclic antidepressant overdose. coronary vasoconstriction by beta-adrenergic blockade. Ann Intern Med J Toxicol Clin Toxicol 2004;42:877–88. 1990;112:897–903. 54. Thanacoody HK, Thomas SH. Tricyclic antidepressant poisoning: cardiovascu- 84. Sand IC, Brody SL, Wrenn KD, Slovis CM. Experience with esmolol for the treat- lar toxicity. Toxicol Rev 2005;24:205–14. ment of cocaine-associated cardiovascular complications. Am J Emerg Med 55. Woolf AD, Erdman AR, Nelson LS, et al. Tricyclic antidepressant poisoning: 1991;9:161–3. an evidence-based consensus guideline for out-of-hospital management. Clin 85. Sofuoglu M, Brown S, Babb DA, Pentel PR, Hatsukami DK. Carvedilol affects Toxicol (Phila) 2007;45:203–33. the physiological and behavioral response to smoked cocaine in humans. Drug 56. Hoffman JR, Votey SR, Bayer M, Silver L. Effect of hypertonic sodium bicarbonate Alcohol Depend 2000;60:69–76. in the treatment of moderate-to-severe cyclic antidepressant overdose. Am J 86. Sofuoglu M, Brown S, Babb DA, Pentel PR, Hatsukami DK. Effects of labetalol Emerg Med 1993;11:336–41. treatment on the physiological and subjective response to smoked cocaine. 57. Koppel C, Wiegreffe A, Tenczer J. Clinical course, therapy, outcome and ana- Pharmacol Biochem Behav 2000;65:255–9. lytical data in amitriptyline and combined amitriptyline/chlordiazepoxide 87. Boehrer JD, Moliterno DJ, Willard JE, Hillis LD, Lange RA. Influence of overdose. Hum Exp Toxicol 1992;11:458–65. labetalol on cocaine-induced coronary vasoconstriction in humans. Am J Med 58. Brown TC. Tricyclic antidepressant overdosage: experimental studies on the 1993;94:608–10. management of circulatory complications. Clin Toxicol 1976;9:255–72. 88. Hsue PY, McManus D, Selby V, et al. Cardiac arrest in patients who smoke crack 59. Hedges JR, Baker PB, Tasset JJ, Otten EJ, Dalsey WC, Syverud SA. Bicarbonate cocaine. Am J Cardiol 2007;99:822–4. therapy for the cardiovascular toxicity of amitriptyline in an animal model. J 89. Litz RJ, Popp M, Stehr SN, Koch T. Successful resuscitation of a patient with Emerg Med 1985;3:253–60. ropivacaine-induced asystole after axillary plexus block using lipid infusion. 60. Knudsen K, Abrahamsson J. Epinephrine and sodium bicarbonate inde- Anaesthesia 2006;61:800–1. pendently and additively increase survival in experimental amitriptyline 90. Rosenblatt MA, Abel M, Fischer GW, Itzkovich CJ, Eisenkraft JB. Successful use poisoning. Crit Care Med 1997;25:669–74. of a 20% lipid emulsion to resuscitate a patient after a presumed bupivacaine- 61. Nattel S, Mittleman M. Treatment of ventricular tachyarrhythmias result- related cardiac arrest. Anesthesiology 2006;105:217–8. ing from amitriptyline toxicity in dogs. J Pharmacol Exp Ther 1984;231: 91. Marwick PC, Levin AI, Coetzee AR. Recurrence of cardiotoxicity after lipid 430–5. rescue from bupivacaine-induced cardiac arrest. Anesth Analg 2009;108: 62. Pentel P, Benowitz N. Efficacy and mechanism of action of sodium bicarbon- 1344–6. ate in the treatment of desipramine toxicity in rats. J Pharmacol Exp Ther 92. Smith HM, Jacob AK, Segura LG, Dilger JA, Torsher LC. Simulation education in 1984;230:12–9. anesthesia training: a case report of successful resuscitation of bupivacaine- 63. Sasyniuk BI, Jhamandas V, Valois M. Experimental amitriptyline intoxica- induced cardiac arrest linked to recent simulation training. Anesth Analg tion: treatment of cardiac toxicity with sodium bicarbonate. Ann Emerg Med 2008;106:1581–4, table of contents. 1986;15:1052–9. 93. Warren JA, Thoma RB, Georgescu A, Shah SJ. Intravenous lipid infusion in the 64. Yoav G, Odelia G, Shaltiel C. A lipid emulsion reduces mortality from successful resuscitation of local anesthetic-induced cardiovascular collapse clomipramine overdose in rats. Vet Hum Toxicol 2002;44:30. after supraclavicular brachial plexus block. Anesth Analg 2008;106:1578–80, 65. Harvey M, Cave G. Intralipid outperforms sodium bicarbonate in a rabbit model table of contents. of clomipramine toxicity. Ann Emerg Med 2007;49:178–85, 85e1–4. 94. Foxall GL, Hardman JG, Bedforth NM. Three-dimensional, multiplanar, 66. Brunn GJ, Keyler DE, Pond SM, Pentel PR. Reversal of desipramine toxicity ultrasound-guided, radial nerve block. Reg Anesth Pain Med 2007;32: in rats using drug-specific antibody Fab’ fragment: effects on hypotension 516–21. and interaction with sodium bicarbonate. J Pharmacol Exp Ther 1992;260: 95. Shah S, Gopalakrishnan S, Apuya J, Martin T. Use of Intralipid in an infant with 1392–9. impending cardiovascular collapse due to local anesthetic toxicity. J Anesth 67. Brunn GJ, Keyler DE, Ross CA, Pond SM, Pentel PR. Drug-specific F(ab’)2 frag- 2009;23:439–41. ment reduces desipramine cardiotoxicity in rats. Int J Immunopharmacol 96. Zimmer C, Piepenbrink K, Riest G, Peters J. Cardiotoxic and neurotoxic effects 1991;13:841–51. after accidental intravascular bupivacaine administration. Therapy with lido- 68. Hursting MJ, Opheim KE, Raisys VA, Kenny MA, Metzger G. Tricyclic caine propofol and lipid emulsion. Anaesthesist 2007;56:449–53. antidepressant-specific Fab fragments alter the distribution and elimination 97. Litz RJ, Roessel T, Heller AR, Stehr SN. Reversal of central nervous system and of desipramine in the rabbit: a model for overdose treatment. J Toxicol Clin cardiac toxicity after local anesthetic intoxication by lipid emulsion injection. Toxicol 1989;27:53–66. Anesth Analg 2008;106:1575–7, table of contents. 69. Pentel PR, Scarlett W, Ross CA, Landon J, Sidki A, Keyler DE. Reduction of 98. Ludot H, Tharin JY, Belouadah M, Mazoit JX, Malinovsky JM. Successful desipramine cardiotoxicity and prolongation of survival in rats with the resuscitation after ropivacaine and lidocaine-induced ventricular arrhyth- use of polyclonal drug-specific antibody Fab fragments. Ann Emerg Med mia following posterior lumbar plexus block in a child. Anesth Analg 1995;26:334–41. 2008;106:1572–4, table of contents. 70. Pentel PR, Ross CA, Landon J, Sidki A, Shelver WL, Keyler DE. Reversal of 99. Cave G, Harvey MG, Winterbottom T. Evaluation of the Association of Anaes- desipramine toxicity in rats with polyclonal drug-specific antibody Fab frag- thetists of Great Britain and Ireland lipid infusion protocol in bupivacaine ments. J Lab Clin Med 1994;123:387–93. induced cardiac arrest in rabbits. Anaesthesia 2009;64:732–7. 71. Dart RC, Sidki A, Sullivan Jr JB, Egen NB, Garcia RA. Ovine desipramine antibody 100. Di Gregorio G, Schwartz D, Ripper R, et al. Lipid emulsion is superior to vaso- fragments reverse desipramine cardiovascular toxicity in the rat. Ann Emerg pressin in a rodent model of resuscitation from toxin-induced cardiac arrest. Med 1996;27:309–15. Crit Care Med 2009;37:993–9. 72. Heard K, Dart RC, Bogdan G, et al. A preliminary study of tricyclic antidepressant 101. Weinberg GL, VadeBoncouer T, Ramaraju GA, Garcia-Amaro MF, Cwik MJ. Pre- (TCA) ovine FAB for TCA toxicity. Clin Toxicol (Phila) 2006;44:275–81. treatment or resuscitation with a lipid infusion shifts the dose–response to 73. Pentel P, Peterson CD. Asystole complicating physostigmine treatment of tri- bupivacaine-induced asystole in rats. Anesthesiology 1998;88:1071–5. cyclic antidepressant overdose. Ann Emerg Med 1980;9:588–90. 102. Weinberg G, Ripper R, Feinstein DL, Hoffman W. Lipid emulsion infusion res- 74. Lange RA, Cigarroa RG, Yancy Jr CW, et al. Cocaine-induced coronary-artery cues dogs from bupivacaine-induced cardiac toxicity. Reg Anesth Pain Med vasoconstriction. N Engl J Med 1989;321:1557–62. 2003;28:198–202.
- 209. J. Soar et al. / Resuscitation 81 (2010) 1400–1433 1427 103. Weinberg GL, Di Gregorio G, Ripper R, et al. Resuscitation with lipid ver- 136. Harris NS. Case records of the Massachusetts General Hospital. Case 24-2006. A sus epinephrine in a rat model of bupivacaine overdose. Anesthesiology 40-year-old woman with hypotension after an overdose of amlodipine. N Engl 2008;108:907–13. J Med 2006;355:602–11. 104. Management of severe local anaesthetic toxicity. Association of Anaesthetists 137. Herbert J, O’Malley C, Tracey J, Dwyer R, Power M. Verapamil overdosage unre- of Great Britain and Ireland; 2010 [accessed 28.06.10]. sponsive to dextrose/insulin therapy. J Toxicol Clin Toxicol 2001;39:293–4. 105. Mayr VD, Mitterschiffthaler L, Neurauter A, et al. A comparison of the combi- 138. Johansen KK, Belhage B. A 48-year-old woman’s survival from a massive vera- nation of epinephrine and vasopressin with lipid emulsion in a porcine model pamil overdose. Ugeskr Laeger 2007;169:4074–5. of asphyxial cardiac arrest after intravenous injection of bupivacaine. Anesth 139. Kanagarajan K, Marraffa JM, Bouchard NC, Krishnan P, Hoffman RS, Stork CM. Analg 2008;106:1566–71, table of contents. The use of vasopressin in the setting of recalcitrant hypotension due to calcium 106. Hicks SD, Salcido DD, Logue ES, et al. Lipid emulsion combined with channel blocker overdose. Clin Toxicol (Phila) 2007;45:56–9. epinephrine and vasopressin does not improve survival in a swine model of 140. Marques M, Gomes E, de Oliveira J. Treatment of calcium channel blocker intox- bupivacaine-induced cardiac arrest. Anesthesiology 2009;111:138–46. ication with insulin infusion: case report and literature review. Resuscitation 107. Hiller DB, Gregorio GD, Ripper R, et al. Epinephrine impairs lipid resus- 2003;57:211–3. citation from bupivacaine overdose: a threshold effect. Anesthesiology 141. Meyer M, Stremski E, Scanlon M. Successful resuscitation of a verapamil 2009;111:498–505. intoxicated child with a dextrose-insulin infusion. Clin Intensive Care 108. Bailey B. Glucagon in beta-blocker and calcium channel blocker overdoses: a 2003;14:109–13. systematic review. J Toxicol Clin Toxicol 2003;41:595–602. 142. Morris-Kukoski C, Biswas A, Para M. Insulin “euglycemia” therapy for accidental 109. Fahed S, Grum DF, Papadimos TJ. Labetalol infusion for refractory hypertension nifedipine overdose. J Toxicol Clin Toxicol 2000;38:557. causing severe hypotension and bradycardia: an issue of patient safety. Patient 143. Ortiz-Munoz L, Rodriguez-Ospina LF, Figueroa-Gonzalez M. Hyperinsulinemic- Saf Surg 2008;2:13. euglycemic therapy for intoxication with calcium channel blockers. Bol Asoc 110. Fernandes CM, Daya MR. Sotalol-induced bradycardia reversed by glucagon. Med P R 2005;97:182–9. Can Fam Physician 1995;41:659–60f, 63–5. 144. Patel NP, Pugh ME, Goldberg S, Eiger G. Hyperinsulinemic euglycemia therapy 111. Frishman W, Jacob H, Eisenberg E, Ribner H. Clinical pharmacology of the new for verapamil poisoning: case report. Am J Crit Care 2007;16:18–9. beta-adrenergic blocking drugs. Part 8. Self-poisoning with beta-adrenoceptor 145. Place R, Carlson A, Leikin J, Hanashiro P. Hyperinsulin therapy in the treatment blocking agents: recognition and management. Am Heart J 1979;98: of verapamil overdose. J Toxicol Clin Toxicol 2000:576–7. 798–811. 146. Rasmussen L, Husted SE, Johnsen SP. Severe intoxication after an intentional 112. Gabry AL, Pourriat JL, Hoang TD, Lapandry C. Cardiogenic shock caused by meto- overdose of amlodipine. Acta Anaesthesiol Scand 2003;47:1038–40. prolol poisoning. Reversibility with high doses of glucagon and isoproterenol. 147. Smith SW, Ferguson KL, Hoffman RS, Nelson LS, Greller HA. Prolonged severe Presse Med 1985;14:229. hypotension following combined amlodipine and valsartan ingestion. Clin Tox- 113. Hazouard E, Ferrandiere M, Lesire V, Joye F, Perrotin D, de Toffol B. Peduncu- icol (Phila) 2008;46:470–4. lar hallucinosis related to propranolol self-poisoning: efficacy of intravenous 148. Yuan TH, Kerns WPI, Tomaszewski CA, Ford MD, Kline JA. Insulin-glucose as glucagon. Intensive Care Med 1999;25:336–7. adjunctive therapy for severe calcium channel antagonist poisoning. J Toxicol 114. Khan MI, Miller MT. Beta-blocker toxicity – the role of glucagon. Report of 2 Clin Toxicol 1999;37:463–74. cases. S Afr Med J 1985;67:1062–3. 149. Dewitt CR, Waksman JC, Pharmacology. Pathophysiology and manage- 115. Moller BH. Letter: massive intoxication with metoprolol. Br Med J 1976;1: ment of calcium channel blocker and beta-blocker toxicity. Toxicol Rev 222. 2004;23:223–38. 116. O’Mahony D, O’Leary P, Molloy MG. Severe oxprenolol poisoning: the impor- 150. Eddleston M, Rajapakse S, Rajakanthan, et al. Anti-digoxin Fab fragments in car- tance of glucagon infusion. Hum Exp Toxicol 1990;9:101–3. diotoxicity induced by ingestion of yellow oleander: a randomised controlled 117. Wallin CJ, Hulting J. Massive metoprolol poisoning treated with prenalterol. trial. Lancet 2000;355:967–72. Acta Med Scand 1983;214:253–5. 151. Smith TW, Butler Jr VP, Haber E, et al. Treatment of life-threatening digitalis 118. Weinstein RS, Cole S, Knaster HB, Dahlbert T. Beta blocker overdose with pro- intoxication with digoxin-specific Fab antibody fragments: experience in 26 pranolol and with atenolol. Ann Emerg Med 1985;14:161–3. cases. N Engl J Med 1982;307:1357–62. 119. Alderfliegel F, Leeman M, Demaeyer P, Kahn RJ. Sotalol poisoning associated 152. Wenger TL, Butler VPJ, Haber E, Smith TW. Treatment of 63 severely digitalis- with asystole. Intensive Care Med 1993;19:57–8. toxic patients with digoxin-specific antibody fragments. J Am Coll Cardiol 120. Kenyon CJ, Aldinger GE, Joshipura P, Zaid GJ. Successful resuscitation using 1985;5:118A–23A. external cardiac pacing in beta adrenergic antagonist-induced bradyasystolic 153. Antman EM, Wenger TL, Butler Jr VP, Haber E, Smith TW. Treatment of 150 cases arrest. Ann Emerg Med 1988;17:711–3. of life-threatening digitalis intoxication with digoxin-specific Fab antibody 121. Freestone S, Thomas HM, Bhamra RK, Dyson EH. Severe atenolol poisoning: fragments: final report of a multicenter study. Circulation 1990;81:1744–52. treatment with prenalterol. Hum Toxicol 1986;5:343–5. 154. Woolf AD, Wenger T, Smith TW, Lovejoy FHJ. The use of digoxin-specific 122. Kerns 2nd W, Schroeder D, Williams C, Tomaszewski C, Raymond R. Insulin Fab fragments for severe digitalis intoxication in children. N Engl J Med improves survival in a canine model of acute beta-blocker toxicity. Ann Emerg 1992;326:1739–44. Med 1997;29:748–57. 155. Hickey AR, Wenger TL, Carpenter VP, et al. Digoxin Immune Fab therapy in 123. Holger JS, Engebretsen KM, Fritzlar SJ, Patten LC, Harris CR, Flottemesch TJ. the management of digitalis intoxication: safety and efficacy results of an Insulin versus vasopressin and epinephrine to treat beta-blocker toxicity. Clin observational surveillance study. J Am Coll Cardiol 1991;17:590–8. Toxicol (Phila) 2007;45:396–401. 156. Wenger TL. Experience with digoxin immune Fab (ovine) in patients with renal 124. Page C, Hacket LP, Isbister GK. The use of high-dose insulin-glucose eug- impairment. Am J Emerg Med 1991;9:21–3, discussion 33–4. lycemia in beta-blocker overdose: a case report. J Med Toxicol 2009;5: 157. Wolf U, Bauer D, Traub WH. Metalloproteases of Serratia liquefaciens: degra- 139–43. dation of purified human serum proteins. Zentralbl Bakteriol 1991;276:16–26. 125. Kollef MH. Labetalol overdose successfully treated with amrinone and alpha- 158. Taboulet P, Baud FJ, Bismuth C, Vicaut E. Acute digitalis intoxication – is pacing adrenergic receptor agonists. Chest 1994;105:626–7. still appropriate? J Toxicol Clin Toxicol 1993;31:261–73. 126. O’Grady J, Anderson S, Pringle D. Successful treatment of severe atenolol over- 159. Lapostolle F, Borron SW, Verdier C, et al. Digoxin-specific Fab fragments as dose with calcium chloride. CJEM 2001;3:224–7. single first-line therapy in digitalis poisoning. Crit Care Med 2008;36:3014–8. 127. Pertoldi F, D’Orlando L, Mercante WP. Electromechanical dissociation 48 hours 160. Hougen TJ, Lloyd BL, Smith TW. Effects of inotropic and arrhythmogenic digoxin after atenolol overdose: usefulness of calcium chloride. Ann Emerg Med doses and of digoxin-specific antibody on myocardial monovalent cation trans- 1998;31:777–81. port in the dog. Circ Res 1979;44:23–31. 128. McVey FK, Corke CF. Extracorporeal circulation in the management of massive 161. Clark RF, Selden BS, Curry SC. Digoxin-specific Fab fragments in the treatment propranolol overdose. Anaesthesia 1991;46:744–6. of oleander toxicity in a canine model. Ann Emerg Med 1991;20:1073–7. 129. Lane AS, Woodward AC, Goldman MR. Massive propranolol overdose poorly 162. Brubacher JR, Lachmanen D, Ravikumar PR, Hoffman RS. Efficacy of digoxin responsive to pharmacologic therapy: use of the intra-aortic balloon pump. specific Fab fragments (Digibind) in the treatment of toad venom poisoning. Ann Emerg Med 1987;16:1381–3. Toxicon 1999;37:931–42. 130. Rooney M, Massey KL, Jamali F, Rosin M, Thomson D, Johnson DH. Acebutolol 163. Lechat P, Mudgett-Hunter M, Margolies MN, Haber E, Smith TW. Reversal of overdose treated with hemodialysis and extracorporeal membrane oxygena- lethal digoxin toxicity in guinea pigs using monoclonal antibodies and Fab tion. J Clin Pharmacol 1996;36:760–3. fragments. J Pharmacol Exp Ther 1984;229:210–3. 131. Brimacombe JR, Scully M, Swainston R. Propranolol overdose – a dramatic 164. Dasgupta A, Szelei-Stevens KA. Neutralization of free digoxin-like immunore- response to calcium chloride. Med J Aust 1991;155:267–8. active components of oriental medicines Dan Shen and Lu-Shen-Wan by 132. Olson KR, Erdman AR, Woolf AD, et al. Calcium channel blocker ingestion: the Fab fragment of antidigoxin antibody (Digibind). Am J Clin Pathol an evidence-based consensus guideline for out-of-hospital management. Clin 2004;121:276–81. Toxicol (Phila) 2005;43:797–822. 165. Bosse GM, Pope TM. Recurrent digoxin overdose and treatment with digoxin- 133. Boyer EW, Duic PA, Evans A. Hyperinsulinemia/euglycemia therapy for calcium specific Fab antibody fragments. J Emerg Med 1994;12:179–85. channel blocker poisoning. Pediatr Emerg Care 2002;18:36–7. 166. Borron SW, Baud FJ, Barriot P, Imbert M, Bismuth C. Prospective study of 134. Cohen V, Jellinek SP, Fancher L, et al. Tarka(R) (Trandolapril/Verapamil hydroxocobalamin for acute cyanide poisoning in smoke inhalation. Ann Hydrochloride Extended-Release) overdose. J Emerg Med 2009. Emerg Med 2007;49:794–801, e1–2. 135. Greene SL, Gawarammana I, Wood DM, Jones AL, Dargan PI. Relative safety of 167. Fortin JL, Giocanti JP, Ruttimann M, Kowalski JJ. Prehospital administration hyperinsulinaemia/euglycaemia therapy in the management of calcium chan- of hydroxocobalamin for smoke inhalation-associated cyanide poisoning: 8 nel blocker overdose: a prospective observational study. Intensive Care Med years of experience in the Paris Fire Brigade. Clin Toxicol (Phila) 2006;44: 2007;33:2019–24. 37–44.
- 210. 1428 J. Soar et al. / Resuscitation 81 (2010) 1400–1433 168. Baud FJ, Barriot P, Toffis V, et al. Elevated blood cyanide concentrations in 203. Goh SH, Low BY. Drowning and near-drowning – some lessons learnt. Ann Acad victims of smoke inhalation. N Engl J Med 1991;325:1761–6. Med Singapore 1999;28:183–8. 169. Borron SW, Baud FJ, Megarbane B, Bismuth C. Hydroxocobalamin for severe 204. Quan L, Wentz KR, Gore EJ, Copass MK. Outcome and predictors of outcome acute cyanide poisoning by ingestion or inhalation. Am J Emerg Med in pediatric submersion victims receiving prehospital care in King County, 2007;25:551–8. Washington. Pediatrics 1990;86:586–93. 170. Espinoza OB, Perez M, Ramirez MS. Bitter cassava poisoning in eight children: 205. O’Driscoll BR, Howard LS, Davison AG. BTS guideline for emergency oxygen use a case report. Vet Hum Toxicol 1992;34:65. in adult patients. Thorax 2008;63:vi1–68. 171. Houeto P, Hoffman JR, Imbert M, Levillain P, Baud FJ. Relation of blood cyanide 206. Perkins GD. In-water resuscitation: a pilot evaluation. Resuscitation to plasma cyanocobalamin concentration after a fixed dose of hydroxocobal- 2005;65:321–4. amin in cyanide poisoning. Lancet 1995;346:605–8. 207. Szpilman D, Soares M. In-water resuscitation – is it worthwhile? Resuscitation 172. Pontal P, Bismuth C, Garnier R. Therapeutic attitude in cyanide poisoning: 2004;63:25–31. retrospective study of 24 non-lethal cases. Vet Hum Toxicol 1982;24:286–7. 208. March NF, Matthews RC. New techniques in external cardiac compressions. 173. Kirk MA, Gerace R, Kulig KW. Cyanide and methemoglobin kinetics in smoke Aquatic cardiopulmonary resuscitation. JAMA 1980;244:1229–32. inhalation victims treated with the cyanide antidote kit. Ann Emerg Med 209. March NF, Matthews RC. Feasibility study of CPR in the water. Undersea Biomed 1993;22:1413–8. Res 1980;7:141–8. 174. Chen KK, Rose CL. Nitrite and thiosulfate therapy in cyanide poisoning. J Am 210. Manolios N, Mackie I. Drowning and near-drowning on Australian Med Assoc 1952;149:113–9. beaches patrolled by life-savers: a 10-year study, 1973–1983. Med J Aust 175. Yen D, Tsai J, Wang LM, et al. The clinical experience of acute cyanide poisoning. 1988;148:165–7, 70–1. Am J Emerg Med 1995;13:524–8. 211. Rosen P, Stoto M, Harley J. The use of the Heimlich maneuver in near-drowning: 176. Iqbal S, Clower JH, Boehmer TK, Yip FY, Garbe P. Carbon monoxide-related institute of Medicine report. J Emerg Med 1995;13:397–405. hospitalizations in the U.S.: evaluation of a web-based query system for public 212. Modell JH, Calderwood HW, Ruiz BC, Downs JB, Chapman Jr R. Effects of ven- health surveillance. Public Health Rep 2010;125:423–32. tilatory patterns on arterial oxygenation after near-drowning in sea water. 177. Hampson NB, Zmaeff JL. Outcome of patients experiencing cardiac arrest with Anesthesiology 1974;40:376–84. carbon monoxide poisoning treated with hyperbaric oxygen. Ann Emerg Med 213. Golden FS, Tipton MJ, Scott RC. Immersion, near-drowning and drowning. Br J 2001;38:36–41. Anaesth 1997;79:214–25. 178. Sloan EP, Murphy DG, Hart R, et al. Complications and protocol considera- 214. Moran I, Zavala E, Fernandez R, Blanch L, Mancebo J. Recruitment manoeuvres tions in carbon monoxide-poisoned patients who require hyperbaric oxygen in acute lung injury/acute respiratory distress syndrome. Eur Respir J Suppl therapy: report from a ten-year experience. Ann Emerg Med 1989;18:629–34. 2003;42:37s–42s. 179. Chou KJ, Fisher JL, Silver EJ. Characteristics and outcome of children with carbon 215. Koster RW, Sayre MR, Botha M, et al. 2010 International Consensus on Car- monoxide poisoning with and without smoke exposure referred for hyperbaric diopulmonary Resuscitation and Emergency Cardiovascular Care Science with oxygen therapy. Pediatr Emerg Care 2000;16:151–5. Treatment Recommendations. Part 5. Adult Basic Life Support. Resuscitation; 180. Weaver LK, Hopkins RO, Chan KJ, et al. Hyperbaric oxygen for acute carbon doi:10.1016/j.resuscitation.2010.08.005, in press. monoxide poisoning. N Engl J Med 2002;347:1057–67. 216. Wyatt JP, Tomlinson GS, Busuttil A. Resuscitation of drowning victims in south- 181. Thom SR, Taber RL, Mendiguren II, Clark JM, Hardy KR, Fisher AB. Delayed east Scotland. Resuscitation 1999;41:101–4. neuropsychologic sequelae after carbon monoxide poisoning: prevention by 217. Schmidt U, Fritz KW, Kasperczyk W, Tscherne H. Successful resuscitation of a treatment with hyperbaric oxygen. Ann Emerg Med 1995;25:474–80. child with severe hypothermia after cardiac arrest of 88 minutes. Prehospital 182. Scheinkestel CD, Bailey M, Myles PS, et al. Hyperbaric or normobaric oxygen Disaster Med 1995;10:60–2. for acute carbon monoxide poisoning: a randomised controlled clinical trial. 218. Bolte RG, Black PG, Bowers RS, Thorne JK, Corneli HM. The use of extracorporeal Med J Aust 1999;170:203–10. rewarming in a child submerged for 66 minutes. JAMA 1988;260:377–9. 183. Raphael JC, Elkharrat D, Jars-Guincestre MC, et al. Trial of normobaric 219. Gregorakos L, Markou N, Psalida V, et al. Near-drowning: clinical course of lung and hyperbaric oxygen for acute carbon monoxide intoxication. Lancet injury in adults. Lung 2009;187:93–7. 1989;2:414–9. 220. The Acute Respiratory Distress Syndrome Network. Ventilation with lower 184. Juurlink DN, Buckley NA, Stanbrook MB, Isbister GK, Bennett M, McGuigan MA. tidal volumes as compared with traditional tidal volumes for acute lung Hyperbaric oxygen for carbon monoxide poisoning. Cochrane Database Syst injury and the acute respiratory distress syndrome. N Engl J Med 2000;342: Rev 2005:CD002041. 1301–8. 185. Buckley NA, Isbister GK, Stokes B, Juurlink DN. Hyperbaric oxygen for carbon 221. Eich C, Brauer A, Timmermann A, et al. Outcome of 12 drowned children monoxide poisoning: a systematic review and critical analysis of the evidence. with attempted resuscitation on cardiopulmonary bypass: an analysis of Toxicol Rev 2005;24:75–92. variables based on the “Utstein Style for Drowning”. Resuscitation 2007;75: 186. Satran D, Henry CR, Adkinson C, Nicholson CI, Bracha Y, Henry TD. Cardiovas- 42–52. cular manifestations of moderate to severe carbon monoxide poisoning. J Am 222. Guenther U, Varelmann D, Putensen C, Wrigge H. Extended therapeutic Coll Cardiol 2005;45:1513–6. hypothermia for several days during extracorporeal membrane-oxygenation 187. Henry CR, Satran D, Lindgren B, Adkinson C, Nicholson CI, Henry TD. Myocardial after drowning and cardiac arrest two cases of survival with no neurological injury and long-term mortality following moderate to severe carbon monoxide sequelae. Resuscitation 2009;80:379–81. poisoning. JAMA 2006;295:398–402. 223. Wood C. Towards evidence based emergency medicine: best BETs from the 188. Warner DS, Bierens JJ, Beerman SB, Katz LM. Drowning: a cry for help. Anes- Manchester Royal Infirmary. BET, 1, prophylactic antibiotics in near-drowning. thesiology 2009;110:1211–3. Emerg Med J 2010;27:393–4. 189. Peden MM, McGee K. The epidemiology of drowning worldwide. Inj Control 224. Van Berkel M, Bierens JJLM, Lie RLK, et al. Pulmonary oedema, pneumonia and Saf Promot 2003;10:195–9. mortality in submersion victims a retrospective study in 125 patients. Intensive 190. National water safety statistics; 2006 [accessed 28.06.10]. Care Med 1996;22:101–7. 191. Centers for Disease Control and Prevention. Web-based injury statistics query 225. Nolan JP, Morley PT, Vanden Hoek TL, Hickey RW. Therapeutic hypothermia and reporting system (WISQARS) (Online). National Center for Injury Preven- after cardiac arrest. An advisory statement by the Advancement Life support tion and Control, Centers for Disease Control and Prevention (producer); 2005. Task Force of the International Liaison committee on Resuscitation. Resuscita- Available from: URL: wwwcdcgov/ncipc/wisqars [3.02.2005]. tion 2003;57:231–5. 192. Hu G, Baker SP. Trends in unintentional injury deaths, U.S., 1999–2005: age, 226. Nolan JP, Neumar RW, Adrie C, et al. Post-cardiac arrest syndrome: epidemiol- gender, and racial/ethnic differences. Am J Prev Med 2009;37:188–94. ogy, pathophysiology, treatment, and prognostication. A Scientific Statement 193. Driscoll TR, Harrison JA, Steenkamp M. Review of the role of alcohol in drowning from the International Liaison Committee on Resuscitation; the American associated with recreational aquatic activity. Inj Prev 2004;10:107–13. Heart Association Emergency Cardiovascular Care Committee; the Council on 194. Papa L, Hoelle R, Idris A. Systematic review of definitions for drowning inci- Cardiovascular Surgery and Anesthesia; the Council on Cardiopulmonary, Peri- dents. Resuscitation 2005;65:255–64. operative, and Critical Care; the Council on Clinical Cardiology; the Council on 195. Idris AH, Berg RA, Bierens J, et al. Recommended guidelines for uniform report- Stroke. Resuscitation 2008;79:350–79. ing of data from drowning: the “Utstein style”. Resuscitation 2003;59:45–57. 227. Tester DJ, Kopplin LJ, Creighton W, Burke AP, Ackerman MJ. Pathogenesis of 196. Layon AJ, Modell JH. Drowning: update 2009. Anesthesiology unexplained drowning: new insights from a molecular autopsy. Mayo Clin Proc 2009;110:1390–401. 2005;80:596–600. 197. Eaton D. Lifesaving. 6th ed. London: Royal Life Saving Society UK; 1995. 228. Soar J, Mancini ME, Bhanji F, et al. 2010 International Consensus on Car- 198. Watson RS, Cummings P, Quan L, Bratton S, Weiss NS. Cervical spine injuries diopulmonary Resuscitation and Emergency Cardiovascular Care Science with among submersion victims. J Trauma 2001;51:658–62. Treatment Recommendations. Part 12. Education, Implementation, and Teams. 199. Dodd FM, Simon E, McKeown D, Patrick MR. The effect of a cervical collar on Resuscitation; doi:10.1016/j.resuscitation.2010.08.030, in press. the tidal volume of anaesthetised adult patients. Anaesthesia 1995;50:961–3. 229. Choi G, Kopplin LJ, Tester DJ, Will ML, Haglund CM, Ackerman MJ. Spectrum 200. Proceedings of the 2005 International Consensus on Cardiopulmonary and frequency of cardiac channel defects in swimming-triggered arrhythmia Resuscitation and Emergency Cardiovascular Care Science with Treatment Rec- syndromes. Circulation 2004;110:2119–24. ommendations, vol. 67. 2005. p. 157–341. 230. Danzl D. Accidental hypothermia. In: Auerbach P, editor. Wilderness medicine. 201. Venema AM, Groothoff JW, Bierens JJ. The role of bystanders during rescue and St. Louis: Mosby; 2007. p. 125–60. resuscitation of drowning victims. Resuscitation 2010;81:434–9. 231. Durrer B, Brugger H, Syme D. The medical on-site treatment of hypother- 202. Youn CS, Choi SP, Yim HW, Park KN. Out-of-hospital cardiac arrest due to mia ICAR-MEDCOM recommendation. High Alt Med Biol 2003;4:99– drowning: an utstein style report of 10 years of experience from St Mary’s 103. Hospital. Resuscitation 2009;80:778–83.
- 211. J. Soar et al. / Resuscitation 81 (2010) 1400–1433 1429 232. Walpoth BH, Galdikas J, Leupi F, Muehlemann W, Schlaepfer P, Althaus U. 267. el-Kassimi FA, Al-Mashhadani S, Abdullah AK, Akhtar J. Adult respiratory dis- Assessment of hypothermia with a new “tympanic” thermometer. J Clin Monit tress syndrome and disseminated intravascular coagulation complicating heat 1994;10:91–6. stroke. Chest 1986;90:571–4. 233. Brugger H, Oberhammer R, Adler-Kastner L, Beikircher W. The rate of cooling 268. Waruiru C, Appleton R. Febrile seizures: an update. Arch Dis Child during avalanche burial; a “Core” issue. Resuscitation 2009;80:956–8. 2004;89:751–6. 234. Lefrant JY, Muller L, de La Coussaye JE, et al. Temperature measurement in 269. Berger J, Hart J, Millis M, Baker AL. Fulminant hepatic failure from heat stroke intensive care patients: comparison of urinary bladder, oesophageal, rectal, requiring liver transplantation. J Clin Gastroenterol 2000;30:429–31. axillary, and inguinal methods versus pulmonary artery core method. Intensive 270. Huerta-Alardin AL, Varon J, Marik PE. Bench-to-bedside review: rhabdomyol- Care Med 2003;29:414–8. ysis – an overview for clinicians. Crit Care 2005;9:158–69. 235. Robinson J, Charlton J, Seal R, Spady D, Joffres MR. Oesophageal, rectal, axillary, 271. Wolff ED, Driessen OMJ. Theophylline intoxication in a child. Ned Tijdschr tympanic and pulmonary artery temperatures during cardiac surgery. Can J Geneeskd 1977;121:896–901. Anaesth 1998;45:317–23. 272. Sidor K, Mikolajczyk W, Horwath-Stolarczyk A. Acute poisoning in children 236. Wood S. Interactions between hypoxia and hypothermia. Annu Rev Physiol hospitalized at the Medical University Hospital No 3 in Warsaw, between 1996 1991;53:71–85. and 2000. Pediatr Pol 2002;77:509–16. 237. Schneider SM. Hypothermia: from recognition to rewarming. Emerg Med Rep 273. Boyer EW, Shannon M. The serotonin syndrome. N Engl J Med 1992;13:1–20. 2005;352:1112–20. 238. Gilbert M, Busund R, Skagseth A, Nilsen PÅ, Solbø JP. Resuscitation from acci- 274. Bhanushali MJ, Tuite PJ. The evaluation and management of patients with neu- dental hypothermia of 13.7 ◦ C with circulatory arrest. Lancet 2000;355:375–6. roleptic malignant syndrome. Neurol Clin 2004;22:389–411. 239. Lexow K. Severe accidental hypothermia: survival after 6 hours 30 minutes of 275. Abraham E, Matthay MA, Dinarello CA, et al. Consensus conference defini- cardiopulmonary resuscitation. Arctic Med Res 1991;50:112–4. tions for sepsis, septic shock, acute lung injury, and acute respiratory distress 240. Danzl DF, Pozos RS, Auerbach PS, et al. Multicenter hypothermia survey. Ann syndrome: time for a reevaluation. Crit Care Med 2000;28:232–5. Emerg Med 1987;16:1042–55. 276. Savage MW, Mah PM, Weetman AP, Newell-Price J. Endocrine emergencies. 241. Paal P, Beikircher W, Brugger H. Avalanche emergencies. Review of the current Postgrad Med J 2004;80:506–15. situation. Anaesthesist 2006;55:314–24. 277. Hadad E, Weinbroum AA, Ben-Abraham R. Drug-induced hyperthermia and 242. Krismer AC, Lindner KH, Kornberger R, et al. Cardiopulmonary resuscitation muscle rigidity: a practical approach. Eur J Emerg Med 2003;10:149–54. during severe hypothermia in pigs: does epinephrine or vasopressin increase 278. Halloran LL, Bernard DW. Management of drug-induced hyperthermia. Curr coronary perfusion pressure? Anesth Analg 2000;90:69–73. Opin Pediatr 2004;16:211–5. 243. Kornberger E, Lindner KH, Mayr VD, et al. Effects of epinephrine in a pig model 279. Bouchama A, Dehbi M, Chaves-Carballo E. Cooling and hemodynamic manage- of hypothermic cardiac arrest and closed-chest cardiopulmonary resuscitation ment in heatstroke: practical recommendations. Crit Care 2007;11:R54. combined with active rewarming. Resuscitation 2001;50:301–8. 280. Armstrong LE, Crago AE, Adams R, Roberts WO, Maresh CM. Whole-body cool- 244. Stoner J, Martin G, O’Mara K, Ehlers J, Tomlanovich M. Amiodarone and ing of hyperthermic runners: comparison of two field therapies. Am J Emerg bretylium in the treatment of hypothermic ventricular fibrillation in a canine Med 1996;14:355–8. model. Acad Emerg Med 2003;10:187–91. 281. Horowitz BZ. The golden hour in heat stroke: use of iced peritoneal lavage. Am 245. Mattu A, Brady WJ, Perron AD. Electrocardiographic manifestations of J Emerg Med 1989;7:616–9. hypothermia. Am J Emerg Med 2002;20:314–26. 282. Bernard S, Buist M, Monteiro O, Smith K. Induced hypothermia using large 246. Ujhelyi MR, Sims JJ, Dubin SA, Vender J, Miller AW. Defibrillation energy volume, ice-cold intravenous fluid in comatose survivors of out-of-hospital requirements and electrical heterogeneity during total body hypothermia. Crit cardiac arrest: a preliminary report. Resuscitation 2003;56:9–13. Care Med 2001;29:1006–11. 283. Schmutzhard E, Engelhardt K, Beer R, et al. Safety and efficacy of a novel 247. Kornberger E, Schwarz B, Lindner KH, Mair P. Forced air surface rewarming in intravascular cooling device to control body temperature in neurologic inten- patients with severe accidental hypothermia. Resuscitation 1999;41:105–11. sive care patients: a prospective pilot study. Crit Care Med 2002;30:2481–8. 248. Roggla M, Frossard M, Wagner A, Holzer M, Bur A, Roggla G. Severe 284. Al-Senani FM, Graffagnino C, Grotta JC, et al. A prospective, multicenter accidental hypothermia with or without hemodynamic instability: rewarm- pilot study to evaluate the feasibility and safety of using the CoolGard Sys- ing without the use of extracorporeal circulation. Wien Klin Wochenschr tem and Icy catheter following cardiac arrest. Resuscitation 2004;62:143– 2002;114:315–20. 50. 249. Weinberg AD, Hamlet MP, Paturas JL, White RD, McAninch GW. Cold weather 285. Behringer W, Safar P, Wu X, et al. Veno-venous extracorporeal blood shunt emergencies: principles of patient management. Branford, CN: American Med- cooling to induce mild hypothermia in dog experiments and review of cooling ical Publishing Co.; 1990. methods. Resuscitation 2002;54:89–98. 250. Reuler JB. Hypothermia: pathophysiology, clinical settings, and management. 286. Hostler D, Northington WE, Callaway CW. High-dose diazepam facilitates core Ann Intern Med 1978;89:519–27. cooling during cold saline infusion in healthy volunteers. Appl Physiol Nutr 251. Zell SC, Kurtz KJ. Severe exposure hypothermia: a resuscitation protocol. Ann Metab 2009;34:582–6. Emerg Med 1985;14:339–45. 287. Hadad E, Cohen-Sivan Y, Heled Y, Epstein Y. Clinical review: treatment of heat 252. Althaus U, Aeberhard P, Schupbach P, Nachbur BH, Muhlemann W. Manage- stroke: should dantrolene be considered? Crit Care 2005;9:86–91. ment of profound accidental hypothermia with cardiorespiratory arrest. Ann 288. Channa AB, Seraj MA, Saddique AA, Kadiwal GH, Shaikh MH, Samarkandi AH. Surg 1982;195:492–5. Is dantrolene effective in heat stroke patients? Crit Care Med 1990;18:290–2. 253. Walpoth BH, Walpoth-Aslan BN, Mattle HP, et al. Outcome of survivors of acci- 289. Bouchama A, Cafege A, Devol EB, Labdi O, el-Assil K, Seraj M. Ineffective- dental deep hypothermia and circulatory arrest treated with extracorporeal ness of dantrolene sodium in the treatment of heatstroke. Crit Care Med blood warming. N Engl J Med 1997;337:1500–5. 1991;19:176–80. 254. Silfvast T, Pettila V. Outcome from severe accidental hypothermia in Southern 290. Larach MG, Gronert GA, Allen GC, Brandom BW, Lehman EB. Clinical pre- Finland – a 10-year review. Resuscitation 2003;59:285–90. sentation, treatment, and complications of malignant hyperthermia in North 255. Ruttmann E, Weissenbacher A, Ulmer H, et al. Prolonged extracorporeal America from 1987 to 2006. Anesth Analg 2010;110:498–507. membrane oxygenation-assisted support provides improved survival in 291. Krause T, Gerbershagen MU, Fiege M, Weisshorn R, Wappler F. Dantrolene – hypothermic patients with cardiocirculatory arrest. J Thorac Cardiovasc Surg a review of its pharmacology, therapeutic use and new developments. Anaes- 2007;134:594–600. thesia 2004;59:364–73. 256. Boyd J, Brugger H, Shuster M. Prognostic factors in avalanche resuscitation: a 292. Hall AP, Henry JA. Acute toxic effects of ‘Ecstasy’ (MDMA) and related com- systematic review. Resuscitation 2010;81:645–52. pounds: overview of pathophysiology and clinical management. Br J Anaesth 257. Bouchama A, Knochel JP. Heat stroke. N Engl J Med 2002;346:1978–88. 2006;96:678–85. 258. Wappler F. Malignant hyperthermia. Eur J Anaesthesiol 2001;18:632–52. 293. Eshel G, Safar P, Sassano J, Stezoski W. Hyperthermia-induced cardiac arrest in 259. Ali SZ, Taguchi A, Rosenberg H. Malignant hyperthermia. Best Pract Res Clin dogs and monkeys. Resuscitation 1990;20:129–43. Anaesthesiol 2003;17:519–33. 294. Eshel G, Safar P, Radovsky A, Stezoski SW. Hyperthermia-induced cardiac 260. Bouchama A. The 2003 European heat wave. Intensive Care Med 2004;30:1–3. arrest in monkeys: limited efficacy of standard CPR. Aviat Space Environ Med 261. Empana JP, Sauval P, Ducimetiere P, Tafflet M, Carli P, Jouven X. Increase in out- 1997;68:415–20. of-hospital cardiac arrest attended by the medical mobile intensive care units, 295. Zeiner A, Holzer M, Sterz F, et al. Hyperthermia after cardiac arrest is associated but not myocardial infarction, during the 2003 heat wave in Paris, France. Crit with an unfavorable neurologic outcome. Arch Intern Med 2001;161:2007–12. Care Med 2009;37:3079–84. 296. Masoli M, Fabian D, Holt S, Beasley R. The global burden of asthma: 262. Coris EE, Ramirez AM, Van Durme DJ. Heat illness in athletes: the dangerous executive summary of the GINA Dissemination Committee report. Allergy combination of heat, humidity and exercise. Sports Med 2004;34:9–16. 2004;59:469–78. 263. Grogan H, Hopkins PM. Heat stroke: implications for critical care and anaes- 297. Pearce N, Ait-Khaled N, Beasley R, et al. Worldwide trends in the prevalence of thesia. Br J Anaesth 2002;88:700–7. asthma symptoms: phase III of the International Study of Asthma and Allergies 264. Bouchama A, De Vol EB. Acid–base alterations in heatstroke. Intensive Care in Childhood (ISAAC). Thorax 2007;62:758–66. Med 2001;27:680–5. 298. Global strategy for asthma management and prevention 2009; 2009 [accessed 265. Pease S, Bouadma L, Kermarrec N, Schortgen F, Regnier B, Wolff M. Early organ 24.06.10]. dysfunction course, cooling time and outcome in classic heatstroke. Intensive 299. Romagnoli M, Caramori G, Braccioni F, et al. Near-fatal asthma phenotype in Care Med 2009;35:1454–8. the ENFUMOSA Cohort. Clin Exp Allergy 2007;37:552–7. 266. Akhtar M, Jazayeri MR, Sra J, Blanck Z, Deshpande S, Dhala A. Atrioventricular 300. Turner MO, Noertjojo K, Vedal S, Bai T, Crump S, Fitzgerald JM. Risk factors for nodal reentry: clinical, electrophysiological, and therapeutic considerations. near-fatal asthma: a case-control study in hospitalized patients with asthma. Circulation 1993;88:282–95. Am J Respir Crit Care Med 1998;157:1804–9.
- 212. 1430 J. Soar et al. / Resuscitation 81 (2010) 1400–1433 301. Ernst P, Spitzer WO, Suissa S, et al. Risk of fatal and near-fatal asthma in relation 333. Rosengarten PL, Tuxen DV, Dziukas L, Scheinkestel C, Merrett K, Bowes G. Circu- to inhaled corticosteroid use. JAMA 1992;268:3462–4. latory arrest induced by intermittent positive pressure ventilation in a patient 302. Suissa S, Blais L, Ernst P. Patterns of increasing beta-agonist use and the risk of with severe asthma. Anaesth Intensive Care 1991;19:118–21. fatal or near-fatal asthma. Eur Respir J 1994;7:1602–9. 334. Sprung J, Hunter K, Barnas GM, Bourke DL. Abdominal distention is not always a 303. Alvarez GG, Fitzgerald JM. A systematic review of the psychological risk factors sign of esophageal intubation: cardiac arrest due to “auto-PEEP”. Anesth Analg associated with near fatal asthma or fatal asthma. Respiration 2007;74:228–36. 1994;78:801–4. 304. Williams TJ, Tuxen DV, Scheinkestel CD, Czarny D, Bowes G. Risk factors for 335. Harrison R. Chest compression first aid for respiratory arrest due to acute morbidity in mechanically ventilated patients with acute severe asthma. Am asphyxic asthma. Emerg Med J 2010;27:59–61. Rev Respir Dis 1992;146:607–15. 336. Deakin CD, Morrison LJ, Morley PT, et al. 2010 International Consensus on Car- 305. Soar J, Pumphrey R, Cant A, et al. Emergency treatment of anaphylactic reac- diopulmonary Resuscitation and Emergency Cardiovascular Care Science with tions – guidelines for healthcare providers. Resuscitation 2008;77:157–69. Treatment Recommendations. Part 8. Advanced Life Support. Resuscitation; 306. Kokturk N, Demir N, Kervan F, Dinc E, Koybasioglu A, Turktas H. A subglot- doi:10.1016/j.resuscitation.2010.08.027, in press. tic mass mimicking near-fatal asthma: a challenge of diagnosis. J Emerg Med 337. Deakin CD, McLaren RM, Petley GW, Clewlow F, Dalrymple-Hay MJ. Effects of 2004;26:57–60. positive end-expiratory pressure on transthoracic impedance – implications 307. Levy ML, Thomas M, Small I, Pearce L, Pinnock H, Stephenson P. Summary of for defibrillation. Resuscitation 1998;37:9–12. the 2008 BTS/SIGN British Guideline on the management of asthma. Prim Care 338. Sunde K, Jacobs I, Deakin CD, et al. 2010 International Consensus on Respir J 2009;18:S1–16. Cardiopulmonary Resuscitation and Emergency Cardiovascular Care Sci- 308. Rodrigo GJ, Nannini LJ. Comparison between nebulized adrenaline and beta2 ence with Treatment Recommendations. Part 6. Defibrillation. Resuscitation; agonists for the treatment of acute asthma. A meta-analysis of randomized doi:10.1016/j.resuscitation.2010.08.025, in press. trials. Am J Emerg Med 2006;24:217–22. 339. Galbois A, Ait-Oufella H, Baudel JL, et al. Pleural ultrasound compared to chest 309. Rowe BH, Spooner CH, Ducharme FM, Bretzlaff JA, Bota GW. Corticosteroids radiographic detection of pneumothorax resolution after drainage. Chest 2010. for preventing relapse following acute exacerbations of asthma. Cochrane 340. Mabuchi N, Takasu H, Ito S, et al. Successful extracorporeal lung assist (ECLA) Database Syst Rev 2001:CD000195. for a patient with severe asthma and cardiac arrest. Clin Intensive Care 310. Ratto D, Alfaro C, Sipsey J, Glovsky MM, Sharma OP. Are intravenous corticos- 1991;2:292–4. teroids required in status asthmaticus? JAMA 1988;260:527–9. 341. Martin GB, Rivers EP, Paradis NA, Goetting MG, Morris DC, Nowak RM. Emer- 311. Aaron SD. The use of ipratropium bromide for the management of acute gency department cardiopulmonary bypass in the treatment of human cardiac asthma exacerbation in adults and children: a systematic review. J Asthma arrest. Chest 1998;113:743–51. 2001;38:521–30. 342. Johansson SG, Bieber T, Dahl R, et al. Revised nomenclature for allergy 312. Rodrigo G, Rodrigo C, Burschtin O. A meta-analysis of the effects of ipratropium for global use: report of the Nomenclature Review Committee of the bromide in adults with acute asthma. Am J Med 1999;107:363–70. World Allergy Organization, October 2003. J Allergy Clin Immunol 2004;113: 313. Blitz M, Blitz S, Beasely R, et al. Inhaled magnesium sulfate in the treatment of 832–6. acute asthma. Cochrane Database Syst Rev 2005:CD003898. 343. Soar J. Emergency treatment of anaphylaxis in adults: concise guidance. Clin 314. Mohammed S, Goodacre S. Intravenous and nebulised magnesium sul- Med 2009;9:181–5. phate for acute asthma: systematic review and meta-analysis. Emerg Med J 344. Lieberman P, Camargo Jr CA, Bohlke K, et al. Epidemiology of anaphylaxis: 2007;24:823–30. findings of the American College of Allergy, Asthma and Immunology Epi- 315. Bradshaw TA, Matusiewicz SP, Crompton GK, Innes JA, Greening AP. Intra- demiology of Anaphylaxis Working Group. Ann Allergy Asthma Immunol venous magnesium sulphate provides no additive benefit to standard 2006;97:596–602. management in acute asthma. Respir Med 2008;102:143–9. 345. Muraro A, Roberts G, Clark A, et al. The management of anaphylaxis in child- 316. Cowman S, Butler J. Towards evidence based emergency medicine: best BETs hood: position paper of the European academy of allergology and clinical from the Manchester Royal Infirmary. BET 3. The use of intravenous amino- immunology. Allergy 2007;62:857–71. phylline in addition to beta-agonists and steroids in acute asthma. Emerg Med 346. Harper NJ, Dixon T, Dugue P, et al. Suspected anaphylactic reactions associated J 2008;25:289–90. with anaesthesia. Anaesthesia 2009;64:199–211. 317. Parameswaran K, Belda J, Rowe BH. Addition of intravenous aminophylline 347. Pumphrey RS. Fatal anaphylaxis in the UK, 1992–2001. Novartis Found Symp to 2 -agonists in adults with acute asthma. Cochrane Database Syst Rev 2004;257:116–28, discussion 28–32, 57–60, 185–276. 2000:CD002742. 348. Gonzalez-Perez A, Aponte Z, Vidaurre CF, Rodriguez LA. Anaphylaxis epi- 318. Travers A, Jones AP, Kelly K, Barker SJ, Camargo CA, Rowe BH. Intravenous demiology in patients with and patients without asthma: a United Kingdom beta2-agonists for acute asthma in the emergency department. Cochrane database review. J Allergy Clin Immunol 2010;125, 1098–104 e1. Database Syst Rev 2001:CD002988. 349. Capps JA, Sharma V, Arkwright PD. Prevalence, outcome and pre-hospital man- 319. Kuitert LM, Watson D. Antileukotrienes as adjunctive therapy in acute asthma. agement of anaphylaxis by first aiders and paramedical ambulance staff in Drugs 2007;67:1665–70. Manchester, UK. Resuscitation 2010;81:653–7. 320. Camargo Jr CA, Gurner DM, Smithline HA, et al. A randomized placebo- 350. Roberts G, Patel N, Levi-Schaffer F, Habibi P, Lack G. Food allergy as a risk factor controlled study of intravenous montelukast for the treatment of acute asthma. for life-threatening asthma in childhood: a case-controlled study. J Allergy Clin J Allergy Clin Immunol 2010;125:374–80. Immunol 2003;112:168–74. 321. Cydulka R, Davison R, Grammer L, Parker M, Mathews JIV. The use of 351. Gikas A, Lazaros G, Kontou-Fili K. Acute ST-segment elevation myocardial epinephrine in the treatment of older adult asthmatics. Ann Emerg Med infarction after amoxycillin-induced anaphylactic shock in a young adult with 1988;17:322–6. normal coronary arteries: a case report. BMC Cardiovasc Disord 2005;5:6. 322. Victoria MS, Battista CJ, Nangia BS. Comparison of subcutaneous terbutaline 352. Brown SG. Cardiovascular aspects of anaphylaxis: implications for treatment with epinephrine in the treatment of asthma in children. J Allergy Clin Immunol and diagnosis. Curr Opin Allergy Clin Immunol 2005;5:359–64. 1977;59:128–35. 353. Sampson HA, Munoz-Furlong A, Campbell RL, et al. Second symposium on the 323. Victoria MS, Battista CJ, Nangia BS. Comparison between epinephrine and definition and management of anaphylaxis: summary report – Second National terbutaline injections in the acute management of asthma. J Asthma Institute of Allergy and Infectious Disease/Food Allergy and Anaphylaxis Net- 1989;26:287–90. work symposium. J Allergy Clin Immunol 2006;117:391–7. 324. Rodrigo GJ, Rodrigo C, Pollack CV, Rowe B. Use of helium-oxygen mixtures in 354. Pumphrey RSH. Fatal posture in anaphylactic shock. J Allergy Clin Immunol the treatment of acute asthma: a systematic review. Chest 2003;123:891–6. 2003;112:451–2. 325. Gupta D, Keogh B, Chung KF, et al. Characteristics and outcome for admissions 355. Visscher PK, Vetter RS, Camazine S. Removing bee stings. Lancet to adult, general critical care units with acute severe asthma: a secondary anal- 1996;348:301–2. ysis of the ICNARC Case Mix Programme Database. Crit Care 2004;8:R112–21. 356. Simpson CR, Sheikh A. Adrenaline is first line treatment for the emergency 326. Brenner B, Corbridge T, Kazzi A. Intubation and mechanical ventilation treatment of anaphylaxis. Resuscitation 2010;81:641–2. of the asthmatic patient in respiratory failure. J Allergy Clin Immunol 357. Kemp SF, Lockey RF, Simons FE. Epinephrine: the drug of choice for anaphylaxis. 2009;124:S19–28. A statement of the World Allergy Organization. Allergy 2008;63:1061–70. 327. Antonelli M, Pennisi MA, Montini L. Clinical review: noninvasive ventila- 358. Sheikh A, Shehata YA, Brown SG, Simons FE. Adrenaline (epinephrine) for the tion in the clinical setting – experience from the past 10 years. Crit Care treatment of anaphylaxis with and without shock. Cochrane Database Syst Rev 2005;9:98–103. 2008:CD006312. 328. Ram FS, Wellington S, Rowe BH, Wedzicha JA. Non-invasive positive pressure 359. Bautista E, Simons FE, Simons KJ, et al. Epinephrine fails to hasten hemody- ventilation for treatment of respiratory failure due to severe acute exacerba- namic recovery in fully developed canine anaphylactic shock. Int Arch Allergy tions of asthma. Cochrane Database Syst Rev 2005:CD004360. Immunol 2002;128:151–64. 329. Leatherman JW, McArthur C, Shapiro RS. Effect of prolongation of expira- 360. Song TT, Nelson MR, Chang JH, Engler RJ, Chowdhury BA. Adequacy of the tory time on dynamic hyperinflation in mechanically ventilated patients with epinephrine autoinjector needle length in delivering epinephrine to the intra- severe asthma. Crit Care Med 2004;32:1542–5. muscular tissues. Ann Allergy Asthma Immunol 2005;94:539–42. 330. Bowman FP, Menegazzi JJ, Check BD, Duckett TM. Lower esophageal sphincter 361. Simons FE, Gu X, Simons KJ. Epinephrine absorption in adults: intramuscular pressure during prolonged cardiac arrest and resuscitation. Ann Emerg Med versus subcutaneous injection. J Allergy Clin Immunol 2001;108:871–3. 1995;26:216–9. 362. Simons FE, Roberts JR, Gu X, Simons KJ. Epinephrine absorption in children 331. Lapinsky SE, Leung RS. Auto-PEEP and electromechanical dissociation. N Engl with a history of anaphylaxis. J Allergy Clin Immunol 1998;101:33–7. J Med 1996;335:674. 363. Simons FE, Gu X, Johnston LM, Simons KJ. Can epinephrine inhalations be sub- 332. Rogers PL, Schlichtig R, Miro A, Pinsky M. Auto-PEEP during CPR. An “occult” stituted for epinephrine injection in children at risk for systemic anaphylaxis? cause of electromechanical dissociation? Chest 1991;99:492–3. Pediatrics 2000;106:1040–4.
- 213. J. Soar et al. / Resuscitation 81 (2010) 1400–1433 1431 364. Gompels LL, Bethune C, Johnston SL, Gompels MM. Proposed use of adrenaline 396. Birdi I, Chaudhuri N, Lenthall K, Reddy S, Nashef SA. Emergency reinstitution of (epinephrine) in anaphylaxis and related conditions: a study of senior house cardiopulmonary bypass following cardiac surgery: outcome justifies the cost. officers starting accident and emergency posts. Postgrad Med J 2002;78:416–8. Eur J Cardiothorac Surg 2000;17:743–6. 365. Brown SG, Blackman KE, Stenlake V, Heddle RJ. Insect sting anaphylaxis; 397. el-Banayosy A, Brehm C, Kizner L, et al. Cardiopulmonary resuscitation after prospective evaluation of treatment with intravenous adrenaline and volume cardiac surgery: a two-year study. J Cardiothorac Vasc Anesth 1998;12:390–2. resuscitation. Emerg Med J 2004;21:149–54. 398. Anthi A, Tzelepis GE, Alivizatos P, Michalis A, Palatianos GM, Geroulanos 366. Sheikh A, Ten Broek V, Brown SG, Simons FE. H1-antihistamines for the treat- S. Unexpected cardiac arrest after cardiac surgery: incidence, predisposing ment of anaphylaxis: Cochrane systematic review. Allergy 2007;62:830–7. causes, and outcome of open chest cardiopulmonary resuscitation. Chest 367. Choo KJ, Simons FE, Sheikh A. Glucocorticoids for the treatment of anaphylaxis. 1998;113:15–9. Cochrane Database Syst Rev 2010;3:CD007596. 399. Wahba A, Gotz W, Birnbaum DE. Outcome of cardiopulmonary resuscitation 368. Green R, Ball A. Alpha-agonists for the treatment of anaphylactic shock. Anaes- following open heart surgery. Scand Cardiovasc J 1997;31:147–9. thesia 2005;60:621–2. 400. Kaiser GC, Naunheim KS, Fiore AC, et al. Reoperation in the intensive care unit. 369. Kluger MT. The Bispectral Index during an anaphylactic circulatory arrest. Ann Thorac Surg 1990;49:903–7, discussion 8. Anaesth Intensive Care 2001;29:544–7. 401. Rhodes JF, Blaufox AD, Seiden HS, et al. Cardiac arrest in infants after congenital 370. McBrien ME, Breslin DS, Atkinson S, Johnston JR. Use of methoxamine in the heart surgery. Circulation 1999;100:II194–9. resuscitation of epinephrine-resistant electromechanical dissociation. Anaes- 402. Dimopoulou I, Anthi A, Michalis A, Tzelepis GE. Functional status and quality thesia 2001;56:1085–9. of life in long-term survivors of cardiac arrest after cardiac surgery. Crit Care 371. Rocq N, Favier JC, Plancade D, Steiner T, Mertes PM. Successful use of ter- Med 2001;29:1408–11. lipressin in post-cardiac arrest resuscitation after an epinephrine-resistant 403. Kempen PM, Allgood R. Right ventricular rupture during closed-chest car- anaphylactic shock to suxamethonium. Anesthesiology 2007;107:166–7. diopulmonary resuscitation after pneumonectomy with pericardiotomy: a 372. Kill C, Wranze E, Wulf H. Successful treatment of severe anaphylactic shock case report. Crit Care Med 1999;27:1378–9. with vasopressin. Two case reports. Int Arch Allergy Immunol 2004;134: 404. Bohrer H, Gust R, Bottiger BW. Cardiopulmonary resuscitation after cardiac 260–1. surgery. J Cardiothorac Vasc Anesth 1995;9:352. 373. Dewachter P, Raeth-Fries I, Jouan-Hureaux V, et al. A comparison of 405. Klintschar M, Darok M, Radner H. Massive injury to the heart after attempted epinephrine only, arginine vasopressin only, and epinephrine followed by argi- active compression–decompression cardiopulmonary resuscitation. Int J Legal nine vasopressin on the survival rate in a rat model of anaphylactic shock. Med 1998;111:93–6. Anesthesiology 2007;106:977–83. 406. Fosse E, Lindberg H. Left ventricular rupture following external chest compres- 374. Higgins DJ, Gayatri P. Methoxamine in the management of severe anaphylaxis. sion. Acta Anaesthesiol Scand 1996;40:502–4. Anaesthesia 1999;54:1126. 407. Dunning J, Nandi J, Ariffin S, Jerstice J, Danitsch D, Levine A. The Cardiac Surgery 375. Heytman M, Rainbird A. Use of alpha-agonists for management of ana- Advanced Life Support Course (CALS): delivering significant improvements in phylaxis occurring under anaesthesia: case studies and review. Anaesthesia emergency cardiothoracic care. Ann Thorac Surg 2006;81:1767–72. 2004;59:1210–5. 408. Dunning J, Fabbri A, Kolh PH, et al. Guideline for resuscitation in cardiac arrest 376. Schummer W, Schummer C, Wippermann J, Fuchs J. Anaphylactic shock: is after cardiac surgery. Eur J Cardiothorac Surg 2009;36:3–28. vasopressin the drug of choice? Anesthesiology 2004;101:1025–7. 409. Raman J, Saldanha RF, Branch JM, et al. Open cardiac compression in the post- 377. Di Chiara L, Stazi GV, Ricci Z, et al. Role of vasopressin in the treatment of operative cardiac intensive care unit. Anaesth Intensive Care 1989;17:129–35. anaphylactic shock in a child undergoing surgery for congenital heart disease: 410. Rousou JA, Engelman RM, Flack 3rd JE, Deaton DW, Owen SG. Emergency car- a case report. J Med Case Reports 2008;2:36. diopulmonary bypass in the cardiac surgical unit can be a lifesaving measure 378. Meng L, Williams EL. Case report: treatment of rocuronium-induced anaphy- in postoperative cardiac arrest. Circulation 1994;90:II280–4. lactic shock with vasopressin. Can J Anaesth 2008;55:437–40. 411. Parra DA, Totapally BR, Zahn E, et al. Outcome of cardiopulmonary resuscitation 379. Schummer C, Wirsing M, Schummer W. The pivotal role of vasopressin in in a pediatric cardiac intensive care unit. Crit Care Med 2000;28:3296–300. refractory anaphylactic shock. Anesth Analg 2008;107:620–4. 411a. European Resuscitation Council Guidelines for Resuscitation 2010: Section 6: 380. Hiruta A, Mitsuhata H, Hiruta M, et al. Vasopressin may be useful in the treat- Paediatric life support. Resuscitation 2010; 81:1364–88. ment of systemic anaphylaxis in rabbits. Shock 2005;24:264–9. 412. Schwarz B, Bowdle TA, Jett GK, et al. Biphasic shocks compared with monopha- 381. Thomas M, Crawford I. Best evidence topic report. Glucagon infusion in sic damped sine wave shocks for direct ventricular defibrillation during open refractory anaphylactic shock in patients on beta-blockers. Emerg Med J heart surgery. Anesthesiology 2003;98:1063–9. 2005;22:272–3. 413. Li Y, Wang H, Cho JH, et al. Defibrillation delivered during the upstroke 382. Allen SJ, Gallagher A, Paxton LD. Anaphylaxis to rocuronium. Anaesthesia phase of manual chest compression improves shock success. Crit Care Med 2000;55:1223–4. 2010;38:910–5. 383. Lafforgue E, Sleth JC, Pluskwa F, Saizy C. Successful extracorporeal resuscita- 414. Li Y, Yu T, Ristagno G, et al. The optimal phasic relationship between tion of a probable perioperative anaphylactic shock due to atracurium. Ann Fr synchronized shock and mechanical chest compressions. Resuscitation Anesth Reanim 2005;24:551–5. 2010;81:724–9. 384. Vatsgar TT, Ingebrigtsen O, Fjose LO, Wikstrom B, Nilsen JE, Wik L. Cardiac arrest 415. Knaggs AL, Delis KT, Spearpoint KG, Zideman DA. Automated external defibril- and resuscitation with an automatic mechanical chest compression device lation in cardiac surgery. Resuscitation 2002;55:341–5. (LUCAS) due to anaphylaxis of a woman receiving Caesarean section because 416. Rosemurgy AS, Norris PA, Olson SM, Hurst JM, Albrink MH. Prehospital trau- of pre-eclampsia. Resuscitation 2006;68:155–9. matic cardiac arrest: the cost of futility. J Trauma 1993;35:468–73. 385. Schwartz LB. Diagnostic value of tryptase in anaphylaxis and mastocytosis. 417. Shimazu S, Shatney CH. Outcomes of trauma patients with no vital signs on Immunol Allergy Clin North Am 2006;26:451–63. hospital admission. J Trauma 1983;23:213–6. 386. Brown SG, Blackman KE, Heddle RJ. Can serum mast cell tryptase help diagnose 418. Battistella FD, Nugent W, Owings JT, Anderson JT. Field triage of the pulseless anaphylaxis? Emerg Med Australas 2004;16:120–4. trauma patient. Arch Surg 1999;134:742–5. 387. Tole JW, Lieberman P. Biphasic anaphylaxis: review of incidence, clinical pre- 419. Stockinger ZT, McSwain Jr NE. Additional evidence in support of withholding dictors, and observation recommendations. Immunol Allergy Clin North Am or terminating cardiopulmonary resuscitation for trauma patients in the field. 2007;27:309–26, viii. J Am Coll Surg 2004;198:227–31. 388. Simons FE, Lieberman PL, Read Jr EJ, Edwards ES. Hazards of unintentional 420. Fulton RL, Voigt WJ, Hilakos AS. Confusion surrounding the treatment of trau- injection of epinephrine from autoinjectors: a systematic review. Ann Allergy matic cardiac arrest. J Am Coll Surg 1995;181:209–14. Asthma Immunol 2009;102:282–7. 421. Pasquale MD, Rhodes M, Cipolle MD, Hanley T, Wasser T. Defining “dead on 389. Campbell RL, Luke A, Weaver AL, et al. Prescriptions for self-injectable arrival”: impact on a level I trauma center. J Trauma 1996;41:726–30. epinephrine and follow-up referral in emergency department patients 422. Stratton SJ, Brickett K, Crammer T. Prehospital pulseless, unconscious pene- presenting with anaphylaxis. Ann Allergy Asthma Immunol 2008;101: trating trauma victims: field assessments associated with survival. J Trauma 631–6. 1998;45:96–100. 390. Kelso JM. A second dose of epinephrine for anaphylaxis: how often needed and 423. Maron BJ, Estes 3rd NA. Commotio cordis. N Engl J Med 2010;362:917–27. how to carry. J Allergy Clin Immunol 2006;117:464–5. 424. Maron BJ, Gohman TE, Kyle SB, Estes 3rd NA, Link MS. Clinical profile and 391. Choo K, Sheikh A. Action plans for the long-term management of anaphylaxis: spectrum of commotio cordis. JAMA 2002;287:1142–6. systematic review of effectiveness. Clin Exp Allergy 2007;37:1090–4. 425. Maron BJ, Estes 3rd NA, Link MS. Task force 11: commotio cordis. J Am Coll 392. Charalambous CP, Zipitis CS, Keenan DJ. Chest reexploration in the intensive Cardiol 2005;45:1371–3. care unit after cardiac surgery: a safe alternative to returning to the operating 426. Nesbitt AD, Cooper PJ, Kohl P. Rediscovering commotio cordis. Lancet theater. Ann Thorac Surg 2006;81:191–4. 2001;357:1195–7. 393. McKowen RL, Magovern GJ, Liebler GA, Park SB, Burkholder JA, Maher TD. Infec- 427. Link MS, Estes M, Maron BJ. Sudden death caused by chest wall trauma (com- tious complications and cost-effectiveness of open resuscitation in the surgical motio cordis). In: Kohl P, Sachs F, Franz MR, editors. Cardiac mechano-electric intensive care unit after cardiac surgery. Ann Thorac Surg 1985;40:388–92. feedback and arrhythmias: from pipette to patient. Philadelphia: Elsevier Saun- 394. Pottle A, Bullock I, Thomas J, Scott L. Survival to discharge following Open Chest ders; 2005. p. 270–6. Cardiac Compression (OCCC). A 4-year retrospective audit in a cardiothoracic 428. Maron BJ, Doerer JJ, Haas TS, Tierney DM, Mueller FO. Sudden deaths in young specialist centre – Royal Brompton and Harefield NHS Trust, United Kingdom. competitive athletes: analysis of 1866 deaths in the United States, 1980–2006. Resuscitation 2002;52:269–72. Circulation 2009;119:1085–92. 395. Mackay JH, Powell SJ, Osgathorp J, Rozario CJ. Six-year prospective audit 429. Bouillon B, Walther T, Kramer M, Neugebauer E. Trauma and circulatory of chest reopening after cardiac arrest. Eur J Cardiothorac Surg 2002;22: arrest: 224 preclinical resuscitations in Cologne in 1987–1990. Anaesthesist 421–5. 1994;43:786–90 [in German].
- 214. 1432 J. Soar et al. / Resuscitation 81 (2010) 1400–1433 430. Fisher B, Worthen M. Cardiac arrest induced by blunt trauma in children. Pedi- 463. Pepe PE, Roppolo LP, Fowler RL. The detrimental effects of ventilation during atr Emerg Care 1999;15:274–6. low-blood-flow states. Curr Opin Crit Care 2005;11:212–8. 431. Hazinski MF, Chahine AA, Holcomb 3rd GW, Morris Jr JA. Outcome of cardio- 464. Deakin CD, Davies G, Wilson A. Simple thoracostomy avoids chest drain inser- vascular collapse in pediatric blunt trauma. Ann Emerg Med 1994;23:1229–35. tion in prehospital trauma. J Trauma 1995;39:373–4. 432. Calkins CM, Bensard DD, Partrick DA, Karrer FM. A critical analysis of out- 465. Luna GK, Pavlin EG, Kirkman T, Copass MK, Rice CL. Hemodynamic effects of come for children sustaining cardiac arrest after blunt trauma. J Pediatr Surg external cardiac massage in trauma shock. J Trauma 1989;29:1430–3. 2002;37:180–4. 466. Kragh Jr JF, Walters TJ, Baer DG, et al. Survival with emergency tourniquet use 433. Yanagawa Y, Saitoh D, Takasu A, Kaneko N, Sakamoto T, Okada Y. [Experi- to stop bleeding in major limb trauma. Ann Surg 2009;249:1–7. ence of treatment for blunt traumatic out-of-hospital cardiopulmonary arrest 467. Gao JM, Gao YH, Wei GB, et al. Penetrating cardiac wounds: principles for patients over 24 years: head injury v.s. non-head injury]. No Shinkei Geka surgical management. World J Surg 2004;28:1025–9. 2004;32:231–5. 468. Kwan I, Bunn F, Roberts I. Timing and volume of fluid administration for 434. Pickens JJ, Copass MK, Bulger EM. Trauma patients receiving CPR: predictors of patients with bleeding. Cochrane Database Syst Rev 2003:CD002245. survival. J Trauma 2005;58:951–8. 469. Spinella PC, Holcomb JB. Resuscitation and transfusion principles for traumatic 435. Di Bartolomeo S, Sanson G, Nardi G, Michelutto V, Scian F. HEMS vs. ground-BLS hemorrhagic shock. Blood Rev 2009;23:231–40. care in traumatic cardiac arrest. Prehosp Emerg Care 2005;9:79–84. 470. Pepe PE, Mosesso VN, Falk JJL. Prehospital fluid resuscitation of the patient with 436. Willis CD, Cameron PA, Bernard SA, Fitzgerald M. Cardiopulmonary resuscita- major trauma. Prehosp Emerg Care 2002;6:81–91. tion after traumatic cardiac arrest is not always futile. Injury 2006;37:448–54. 471. Bickell WH, Wall Jr MJ, Pepe PE, et al. Immediate versus delayed fluid resusci- 437. David JS, Gueugniaud PY, Riou B, et al. Does the prognosis of cardiac arrest tation for hypotensive patients with penetrating torso injuries. N Engl J Med differ in trauma patients? Crit Care Med 2007;35:2251–5. 1994;331:1105–9. 438. Crewdson K, Lockey D, Davies G. Outcome from paediatric cardiac arrest asso- 472. National Institute for Clinical Excellence. Pre-hospital initiation of fluid ciated with trauma. Resuscitation 2007;75:29–34. replacement therapy for trauma. London: National Institute for Clinical Excel- 439. Huber-Wagner S, Lefering R, Qvick M, et al. Outcome in 757 severely lence; 2004. injured patients with traumatic cardiorespiratory arrest. Resuscitation 473. Sumida MP, Quinn K, Lewis PL, et al. Prehospital blood transfusion versus 2007;75:276–85. crystalloid alone in the air medical transport of trauma patients. Air Med J 440. Lockey D, Crewdson K, Davies G. Traumatic cardiac arrest: who are the sur- 2000;19:140–3. vivors? Ann Emerg Med 2006;48:240–4. 474. Barkana Y, Stein M, Maor R, Lynn M, Eldad A. Prehospital blood transfusion in 441. Cera SM, Mostafa G, Sing RF, Sarafin JL, Matthews BD, Heniford BT. Physiologic prolonged evacuation. J Trauma 1999;46:176–80. predictors of survival in post-traumatic arrest. Am Surg 2003;69:140–4. 475. Walcher F, Kortum S, Kirschning T, Weihgold N, Marzi I. Optimized manage- 442. Esposito TJ, Jurkovich GJ, Rice CL, Maier RV, Copass MK, Ashbaugh DG. Reap- ment of polytraumatized patients by prehospital ultrasound. Unfallchirurg praisal of emergency room thoracotomy in a changing environment. J Trauma 2002;105:986–94. 1991;31:881–5, discussion 5–7. 476. Kirschning T, Brenner F, Stier M, Weber CF, Walcher F. Pre-hospital emergency 443. Martin SK, Shatney CH, Sherck JP, et al. Blunt trauma patients with pre- sonography of trauma patients. Anaesthesist 2009;58:51–60. hospital pulseless electrical activity (PEA): poor ending assured. J Trauma 477. Krismer AC, Wenzel V, Voelckel WG, et al. Employing vasopressin as an adjunct 2002;53:876–80, discussion 80–1. vasopressor in uncontrolled traumatic hemorrhagic shock. Three cases and a 444. Domeier RM, McSwain Jr NE, Hopson LR, et al. Guidelines for withholding or brief analysis of the literature. Anaesthesist 2005;54:220–4. termination of resuscitation in prehospital traumatic cardiopulmonary arrest. 478. Department of Health, Welsh Office, Scottish Office Department of Health, J Am Coll Surg 2003;196:475–81. Department of Health and Social Services, Northern Ireland. Why mothers die. 445. Gervin AS, Fischer RP. The importance of prompt transport of salvage of patients Report on confidential enquiries into maternal deaths in the United Kingdom, with penetrating heart wounds. J Trauma 1982;22:443–8. 2000–2002. London: The Stationery Office; 2004. 446. Branney SW, Moore EE, Feldhaus KM, Wolfe RE. Critical analysis of two 479. Hogan MC, Foreman KJ, Naghavi M, et al. Maternal mortality for 181 countries, decades of experience with postinjury emergency department thoracotomy 1980–2008: a systematic analysis of progress towards Millennium Develop- in a regional trauma center. J Trauma 1998;45:87–94, discussion-5. ment Goal 5. Lancet 2010;375:1609–23. 447. Durham III LA, Richardson RJ, Wall Jr MJ, Pepe PE, Mattox KL. Emergency center 480. Lewis G. The Confidential Enquiry into Maternal and Child Health (CEMACH). thoracotomy: impact of prehospital resuscitation. J Trauma 1992;32:775–9. Saving Mothers’ Lives: Reviewing maternal deaths to make motherhood safer 448. Frezza EE. Mezghebe H. Is 30 minutes the golden period to perform emergency – 2003–2005. The Seventh Report of the Confidential Enquiries into Maternal room thoratomy (ERT) in penetrating chest injuries? J Cardiovasc Surg (Torino) Deaths in the United Kingdom. London: CEMACH; 2007. 1999;40:147–51. 481. Page-Rodriguez A, Gonzalez-Sanchez JA. Perimortem cesarean section of 449. Powell DW, Moore EE, Cothren CC, et al. Is emergency department resuscitative twin pregnancy: case report and review of the literature. Acad Emerg Med thoracotomy futile care for the critically injured patient requiring prehospital 1999;6:1072–4. cardiopulmonary resuscitation? J Am Coll Surg 2004;199:211–5. 482. Cardosi RJ, Porter KB. Cesarean delivery of twins during maternal cardiopul- 450. Coats TJ, Keogh S, Clark H, Neal M. Prehospital resuscitative thoracotomy for monary arrest. Obstet Gynecol 1998;92:695–7. cardiac arrest after penetrating trauma: rationale and case series. J Trauma 483. Mendonca C, Griffiths J, Ateleanu B, Collis RE. Hypotension following combined 2001;50:670–3. spinal-epidural anaesthesia for Caesarean section. Left lateral position vs. tilted 451. Wise D, Davies G, Coats T, Lockey D, Hyde J, Good A. Emergency thoracotomy: supine position. Anaesthesia 2003;58:428–31. “how to do it”. Emerg Med J 2005;22:22–4. 484. Rees SG, Thurlow JA, Gardner IC, Scrutton MJ, Kinsella SM. Maternal cardio- 452. Kwan I, Bunn F, Roberts I. Spinal immobilisation for trauma patients. Cochrane vascular consequences of positioning after spinal anaesthesia for Caesarean Database Syst Rev 2001:CD002803. section: left 15 degree table tilt vs. left lateral. Anaesthesia 2002;57:15–20. 453. Davies G, Lockey D. Establishing the radical intervention of pre-hospital tho- 485. Bamber JH, Dresner M. Aortocaval compression in pregnancy: the effect of racotomy as a part of normal physician pre-hospital practice. Scand J Trauma changing the degree and direction of lateral tilt on maternal cardiac output. Resusc Emerg Med 2007;15:106. Anesth Analg 2003;97:256–8, table of contents. 454. Matsumoto H, Mashiko K, Hara Y, et al. Role of resuscitative emergency field 486. Carbonne B, Benachi A, Leveque ML, Cabrol D, Papiernik E. Maternal position thoracotomy in the Japanese helicopter emergency medical service system. during labor: effects on fetal oxygen saturation measured by pulse oximetry. Resuscitation 2009;80:1270–4. Obstet Gynecol 1996;88:797–800. 455. Voiglio EJ, Coats TJ, Baudoin YP, Davies GD, Wilson AW. Resuscitative transverse 487. Tamas P, Szilagyi A, Jeges S, et al. Effects of maternal central hemodynamics on thoracotomy. Ann Chir 2003;128:728–33. fetal heart rate patterns. Acta Obstet Gynecol Scand 2007;86:711–4. 456. Practice management guidelines for emergency department thoracotomy. 488. Abitbol MM. Supine position in labor and associated fetal heart rate changes. Working Group, Ad Hoc Subcommittee on Outcomes, American College of Obstet Gynecol 1985;65:481–6. Surgeons-Committee on Trauma. J Am Coll Surg 2001;193:303–9. 489. Ellington C, Katz VL, Watson WJ, Spielman FJ. The effect of lateral tilt on mater- 457. Fialka C, Sebok C, Kemetzhofer P, Kwasny O, Sterz F, Vecsei V. Open-chest nal and fetal hemodynamic variables. Obstet Gynecol 1991;77:201–3. cardiopulmonary resuscitation after cardiac arrest in cases of blunt chest or 490. Matorras R, Tacuri C, Nieto A, Gutierrez de Teran G, Cortes J. Lack of benefits of abdominal trauma: a consecutive series of 38 cases. J Trauma 2004;57:809– left tilt in emergent cesarean sections: a randomized study of cardiotocogra- 14. phy, cord acid–base status and other parameters of the mother and the fetus. 458. Jones JH, Murphy MP, Dickson RL, Somerville GG, Brizendine EJ. Emergency J Perinat Med 1998;26:284–92. physician-verified out-of-hospital intubation: miss rates by paramedics. Acad 491. Kinsella SM, Whitwam JG, Spencer JA. Aortic compression by the uterus: iden- Emerg Med 2004;11:707–9. tification with the Finapres digital arterial pressure instrument. Br J Obstet 459. Jemmett ME, Kendal KM, Fourre MW, Burton JH. Unrecognized misplacement Gynaecol 1990;97:700–5. of endotracheal tubes in a mixed urban to rural emergency medical services 492. Kundra P, Khanna S, Habeebullah S, Ravishankar M. Manual displacement of setting. Acad Emerg Med 2003;10:961–5. the uterus during Caesarean section. Anaesthesia 2007;62:460–5. 460. Katz SH, Falk JL. Misplaced endotracheal tubes by paramedics in an urban 493. Amaro A, Capelli E, Cardoso M, Rosa M, Carvalho J. Manual left uterine displace- emergency medical services system. Ann Emerg Med 2001;37:32–7. ment or modified Crawford’s edge. A comparative study in spinal anesthesia 461. Deakin CD, Peters R, Tomlinson P, Cassidy M. Securing the prehospital airway: for cesarean delivery. Rev Bras Anestesiol 1998;48:99–104. a comparison of laryngeal mask insertion and endotracheal intubation by UK 494. Kinsella SM. Lateral tilt for pregnant women: why 15 degrees? Anaesthesia paramedics. Emerg Med J 2005;22:64–7. 2003;58:835–6. 462. Cobas MA, De la Pena MA, Manning R, Candiotti K, Varon AJ. Prehospital 495. Goodwin AP, Pearce AJ. The human wedge. A manoeuvre to relieve aor- intubations and mortality: a level 1 trauma center perspective. Anesth Analg tocaval compression during resuscitation in late pregnancy. Anaesthesia 2009;109:489–93. 1992;47:433–4.
- 215. J. Soar et al. / Resuscitation 81 (2010) 1400–1433 1433 496. Rees GA, Willis BA. Resuscitation in late pregnancy. Anaesthesia 530. Thabut G, Thabut D, Myers RP, et al. Thrombolytic therapy of pulmonary 1988;43:347–9. embolism: a meta-analysis. J Am Coll Cardiol 2002;40:1660–7. 497. Jones SJ, Kinsella SM, Donald FA. Comparison of measured and estimated angles 531. Patel RK, Fasan O, Arya R. Thrombolysis in pregnancy. Thromb Haemost of table tilt at Caesarean section. Br J Anaesth 2003;90:86–7. 2003;90:1216–7. 498. Johnson MD, Luppi CJ, Over DC. Cardiopulmonary resuscitation. In: Gam- 532. Conde-Agudelo A, Romero R. Amniotic fluid embolism: an evidence-based bling DR, Douglas MJ, editors. Obstetric anesthesia and uncommon disorders. review. Am J Obstet Gynecol 2009;201:e1–13. Philadelphia: W.B. Saunders; 1998. p. 51–74. 533. Knight M, Tuffnell D, Brocklehurst P, Spark P, Kurinczuk JJ. Incidence and risk 499. Izci B, Vennelle M, Liston WA, Dundas KC, Calder AA, Douglas NJ. Sleep- factors for amniotic-fluid embolism. Obstet Gynecol 2010;115:910–7. disordered breathing and upper airway size in pregnancy and post-partum. 534. Stanten RD, Iverson LI, Daugharty TM, Lovett SM, Terry C, Blumenstock E. Eur Respir J 2006;27:321–7. Amniotic fluid embolism causing catastrophic pulmonary vasoconstriction: 500. Rahman K, Jenkins JG. Failed tracheal intubation in obstetrics: no more frequent diagnosis by transesophageal echocardiogram and treatment by cardiopul- but still managed badly. Anaesthesia 2005;60:168–71. monary bypass. Obstet Gynecol 2003;102:496–8. 501. Henderson JJ, Popat MT, Latto IP, Pearce AC. Difficult Airway Society guide- 535. Katz VL, Dotters DJ, Droegemueller W. Perimortem cesarean delivery. Obstet lines for management of the unanticipated difficult intubation. Anaesthesia Gynecol 1986;68:571–6. 2004;59:675–94. 536. American Heart Association in collaboration with International Liaison 502. Nanson J, Elcock D, Williams M, Deakin CD. Do physiological changes in preg- Committee on Resuscitation. Guidelines 2000 for Cardiopulmonary Resus- nancy change defibrillation energy requirements? Br J Anaesth 2001;87:237–9. citation and Emergency Cardiovascular Care. Circulation 2000;102:I1– 503. Potts M, Prata N, Sahin-Hodoglugil NN. Maternal mortality: one death every 384. 7 min. Lancet 2010;375:1762–3. 537. Cardiac arrest associated with pregnancy.Cummins R, Hazinski M, Field J, edi- 504. Geoghegan J, Daniels JP, Moore PA, Thompson PJ, Khan KS, Gulmezoglu AM. tors. ACLS-the reference textbook. Dallas: American Heart Association; 2003. Cell salvage at Caesarean section: the need for an evidence-based approach. p. 143–58. Chapter 4; Part 6. BJOG 2009;116:743–7. 538. Katz V, Balderston K, DeFreest M. Perimortem cesarean delivery: were our 505. Bouwmeester FW, Bolte AC, van Geijn HP. Pharmacological and surgical ther- assumptions correct? Am J Obstet Gynecol 2005;192:1916–20, discussion apy for primary postpartum hemorrhage. Curr Pharm Des 2005;11:759– 20–1. 73. 539. Oates S, Williams GL, Rees GA. Cardiopulmonary resuscitation in late preg- 506. Hofmeyr GJ, Abdel-Aleem H, Abdel-Aleem MA. Uterine massage for preventing nancy. BMJ 1988;297:404–5. postpartum haemorrhage. Cochrane Database Syst Rev 2008:CD006431. 540. Strong THJ, Lowe RA. Perimortem cesarean section. Am J Emerg Med 507. Sekhavat L, Tabatabaii A, Dalili M, Farajkhoda T, Tafti AD. Efficacy of tranexamic 1989;7:489–94. acid in reducing blood loss after cesarean section. J Matern Fetal Neonatal Med 541. Boyd R, Teece S. Towards evidence based emergency medicine: best BETs from 2009;22:72–5. the Manchester Royal Infirmary. Perimortem Caesarean section. Emerg Med J 508. Phillips LE, McLintock C, Pollock W, et al. Recombinant activated factor VII 2002;19:324–5. in obstetric hemorrhage: experiences from the Australian and New Zealand 542. Dijkman A, Huisman CM, Smit M, et al. Cardiac arrest in pregnancy: increasing Haemostasis Registry. Anesth Analg 2009;109:1908–15. use of perimortem cesarean section due to emergency skills training? BJOG 509. Bomken C, Mathai S, Biss T, Loughney A, Hanley J. Recombinant activated factor 2010;117:282–7. VII (rFVIIa) in the management of major obstetric haemorrhage: a case series 543. Allen MC, Donohue PK, Dusman AE. The limit of viability – neonatal outcome and a proposed guideline for use. Obstet Gynecol Int 2009;2009:364843. of infants born at 22 to 25 weeks’ gestation. N Engl J Med 1993;329:1597–601. 510. Doumouchtsis SK, Papageorghiou AT, Vernier C, Arulkumaran S. Management 544. Moore C, Promes SB. Ultrasound in pregnancy. Emerg Med Clin North Am of postpartum hemorrhage by uterine balloon tamponade: prospective evalu- 2004;22:697–722. ation of effectiveness. Acta Obstet Gynecol Scand 2008;87:849–55. 544a. Rittenberger JC, Kelly E, Jang D, Greer K, Heffner A. Successful outcome utilizing 511. Georgiou C. Balloon tamponade in the management of postpartum haemor- hypothermia after cardiac arrest in pregnancy: a case report. Crit Care Med rhage: a review. BJOG 2009;116:748–57. 2008;36:1354–6. 512. El-Hamamy E. CBL. A worldwide review of the uses of the uterine compression 545. Natale A, Davidson T, Geiger MJ, Newby K. Implantable cardioverter- suture techniques as alternative to hysterectomy in the management of severe defibrillators and pregnancy: a safe combination? Circulation post-partum haemorrhage. J Obstet Gynaecol 2005;25:143–9. 1997;96:2808–12. 513. Hong TM, Tseng HS, Lee RC, Wang JH, Chang CY. Uterine artery emboliza- 546. Siassakos D, Crofts JF, Winter C, Weiner CP, Draycott TJ. The active com- tion: an effective treatment for intractable obstetric haemorrhage. Clin Radiol ponents of effective training in obstetric emergencies. BJOG 2009;116: 2004;59:96–101. 1028–32. 514. Knight M. Peripartum hysterectomy in the UK: management and outcomes of 547. Budnick LD. Bathtub-related electrocutions in the United States, 1979 to 1982. the associated haemorrhage. BJOG 2007;114:1380–7. JAMA 1984;252:918–20. 515. Rossi AC, Lee RH, Chmait RH. Emergency postpartum hysterectomy for 548. Lightning-associated deaths – United States, 1980–1995. MMWR Morb Mortal uncontrolled postpartum bleeding: a systematic review. Obstet Gynecol Wkly Rep 1998;47:391–4. 2010;115:637–44. 549. Geddes LA, Bourland JD, Ford G. The mechanism underlying sudden death from 516. Yu S, Pennisi JA, Moukhtar M, Friedman EA. Placental abruption in asso- electric shock. Med Instrum 1986;20:303–15. ciation with advanced abdominal pregnancy. A case report. J Reprod Med 550. Zafren K, Durrer B, Herry JP, Brugger H. Lightning injuries: prevention 1995;40:731–5. and on-site treatment in mountains and remote areas. Official guide- 517. Ray P, Murphy GJ, Shutt LE. Recognition and management of maternal cardiac lines of the International Commission for Mountain Emergency Medicine disease in pregnancy. Br J Anaesth 2004;93:428–39. and the Medical Commission of the International Mountaineering and 518. Abbas AE, Lester SJ, Connolly H. Pregnancy and the cardiovascular system. Int Climbing Federation (ICAR and UIAA MEDCOM). Resuscitation 2005;65: J Cardiol 2005;98:179–89. 369–72. 519. James AH, Jamison MG, Biswas MS, Brancazio LR, Swamy GK, Myers ER. Acute 551. Cherington M. Lightning injuries. Ann Emerg Med 1995;25:517–9. myocardial infarction in pregnancy: a United States population-based study. 552. Fahmy FS, Brinsden MD, Smith J, Frame JD. Lightning: the multisystem group Circulation 2006;113:1564–71. injuries. J Trauma 1999;46:937–40. 520. Ahearn GS, Hadjiliadis D, Govert JA, Tapson VF. Massive pulmonary embolism 553. Patten BM. Lightning and electrical injuries. Neurol Clin 1992;10:1047–58. during pregnancy successfully treated with recombinant tissue plasminogen 554. Browne BJ, Gaasch WR. Electrical injuries and lightning. Emerg Med Clin North activator: a case report and review of treatment options. Arch Intern Med Am 1992;10:211–29. 2002;162:1221–7. 555. Kleiner JP, Wilkin JH. Cardiac effects of lightning stroke. JAMA 521. Drenthen W, Pieper PG, Roos-Hesselink JW, et al. Outcome of pregnancy in 1978;240:2757–9. women with congenital heart disease: a literature review. J Am Coll Cardiol 556. Lichtenberg R, Dries D, Ward K, Marshall W, Scanlon P. Cardiovascular effects 2007;49:2303–11. of lightning strikes. J Am Coll Cardiol 1993;21:531–6. 522. Sibai B, Dekker G, Kupferminc M. Pre-eclampsia. Lancet 2005;365:785–99. 557. Cooper MA. Emergent care of lightning and electrical injuries. Semin Neurol 523. Sibai BM. Diagnosis, prevention, and management of eclampsia. Obstet Gynecol 1995;15:268–78. 2005;105:402–10. 558. Milzman DP, Moskowitz L, Hardel M. Lightning strikes at a mass gathering. 524. Duley L, Gulmezoglu AM, Henderson-Smart DJ. Magnesium sulphate and other South Med J 1999;92:708–10. anticonvulsants for women with pre-eclampsia. Cochrane Database Syst Rev 559. Cooper MA. Lightning injuries: prognostic signs for death. Ann Emerg Med 2003:CD000025. 1980;9:134–8. 525. Duley L, Henderson-Smart D. Magnesium sulphate versus phenytoin for 560. Kleinschmidt-DeMasters BK. Neuropathology of lightning-strike injuries. eclampsia. Cochrane Database Syst Rev 2003:CD000128. Semin Neurol 1995;15:323–8. 526. Duley L, Henderson-Smart D. Magnesium sulphate versus diazepam for 561. Stewart CE. When lightning strikes. Emerg Med Serv 2000;29:57–67, quiz 103. eclampsia. Cochrane Database Syst Rev 2003:CD000127. 562. Duclos PJ, Sanderson LM. An epidemiological description of lightning-related 527. Knight M. Antenatal pulmonary embolism: risk factors, management and out- deaths in the United States. Int J Epidemiol 1990;19:673–9. comes. BJOG 2008;115:453–61. 563. Epperly TD, Stewart JR. The physical effects of lightning injury. J Fam Pract 528. Dapprich M, Boessenecker W. Fibrinolysis with alteplase in a pregnant woman 1989;29:267–72. with stroke. Cerebrovasc Dis 2002;13:290. 564. Whitcomb D, Martinez JA, Daberkow D. Lightning injuries. South Med J 529. Turrentine MA, Braems G, Ramirez MM. Use of thrombolytics for the treat- 2002;95:1331–4. ment of thromboembolic disease during pregnancy. Obstet Gynecol Surv 565. Goldman RD, Einarson A, Koren G. Electric shock during pregnancy. Can Fam 1995;50:534–41. Physician 2003;49:297–8.
- 216. Resuscitation 81 (2010) 1434–1444 Contents lists available at ScienceDirect Resuscitation journal homepage: www.elsevier.com/locate/resuscitation European Resuscitation Council Guidelines for Resuscitation 2010 Section 9. Principles of education in resuscitation Jasmeet Soar a,∗ , Koenraad G. Monsieurs b , John H.W. Ballance c , Alessandro Barelli d , Dominique Biarent e , Robert Greif f , Anthony J. Handley g , Andrew S. Lockey h , Sam Richmond i , Charlotte Ringsted j , Jonathan P. Wyllie k , Jerry P. Nolan l , Gavin D. Perkins m a Southmead Hospital, North Bristol NHS Trust, Bristol, UK b Emergency Department, Ghent University Hospital, Ghent, Belgium c Woolhope, Herefordshire, UK d Department of Clinical Toxicology – Poison Centre and Emergency Department, Catholic University School of Medicine, Rome, Italy e Paediatric Intensive Care and Emergency Medicine, Université Libre de Bruxelles, Queen Fabiola Children’s University Hospital, Brussels, Belgium f Department Anesthesiology and Pain Therapy, University Hospital Bern, Inselspital, Bern, Switzerland g Honorary Consultant Physician, Colchester, UK h Calderdale and Huddersfield NHS Trust, Salterhebble, Halifax, UK i Sunderland Royal Hospital, Sunderland, UK j University of Copenhagen and Capital Region, Rigshospitalet, Copenhagen, Denmark k James Cook University Hospital, Middlesbrough, UK l Royal United Hospital, Bath, UK m University of Warwick, Warwick Medical School, Warwick, UK Introduction • Educational interventions should be evaluated to ensure that they reliably achieve the learning objectives. The aim is to ensure that Survival from cardiac arrest is determined by the quality of the learners acquire and retain the skills and knowledge that will scientific evidence behind the guidelines, the effectiveness of edu- enable them to act correctly in actual cardiac arrests and improve cation and the resources for implementation of the guidelines.1 An patient outcomes. additional factor is how readily guidelines can be applied in clinical • Short video/computer self-instruction courses, with minimal or practice and the effect of human factors on putting the theory into no instructor coaching, combined with hands-on practice can practice.2 Implementation of Guidelines 2010 is likely to be more be considered as an effective alternative to instructor-led basic successful with a carefully planned, comprehensive implementa- life support (cardiopulmonary resuscitation [CPR] and automated tion strategy that includes education. Delays in providing training external defibrillator [AED]) courses. materials and freeing staff for training were cited as reasons for • Ideally all citizens should be trained in standard CPR that includes delays in the implementation of the 2005 guidelines.3,4 compressions and ventilations. There are circumstances how- This chapter includes the key educational issues identified ever where training in compression-only CPR is appropriate (e.g., by the International Liaison Committee on Resuscitation (ILCOR) opportunistic training with very limited time). Those trained in evidence evaluation,5 discusses the scientific basis of basic and compression-only CPR should be encouraged to learn standard advanced level resuscitation training and provides an update on CPR. the European Resuscitation Council (ERC) life support courses.6 • Basic and advanced life support knowledge and skills deteriorate in as little as three to six months. The use of frequent assessments will identify those individuals who require refresher training to help maintain their knowledge and skills. Key educational recommendations • CPR prompt or feedback devices improve CPR skill acquisition and retention and should be considered during CPR training for The key issues identified by the Education, Implementation and laypeople and healthcare professionals. Teams (EIT) task force of ILCOR during the Guidelines 2010 evidence • An increased emphasis on non-technical skills (NTS) such as evaluation process5 that are relevant to this chapter are: leadership, teamwork, task management and structured commu- nication will help improve the performance of CPR and patient care. ∗ Corresponding author. • Team briefings to plan for resuscitation attempts, and debriefings E-mail address: jas.soar@btinternet.com (J. Soar). based on performance during simulated or actual resuscitation 0300-9572/$ – see front matter © 2010 European Resuscitation Council. Published by Elsevier Ireland Ltd. All rights reserved. doi:10.1016/j.resuscitation.2010.08.014
- 217. J. Soar et al. / Resuscitation 81 (2010) 1434–1444 1435 attempts should be used to help improve resuscitation team and • Good quality chest compressions (including adherence to rate, individual performance. depth, full recoil and minimizing hands-off time) and rescue • Research about the impact of resuscitation training on actual breathing. patient outcomes is limited. Although manikin studies are useful, • Feedback/prompts (including from devices) during CPR training researchers should be encouraged to study and report the impact should be considered to improve skill acquisition and retention of educational interventions on actual patient outcomes. during basic life support training.35 • All basic life support and AED training should aim to teach standard CPR including rescue breathing/ventilations. Who and how to train Chest compression-only CPR training has potential advantages over chest compression and ventilation in certain specific Ideally all citizens should have some knowledge of CPR. There is situations.10,15,18,23,24,27,36,37 An approach to teaching CPR is sug- insufficient evidence for or against the use of training interventions gested below. that focus on high risk populations. However, training can reduce family member and, or patient anxiety, improve emotional adjust- Standard CPR versus chest compression-only CPR teaching ment and empowers individuals to feel that they would be able to start CPR.5 There is controversy about which CPR skills different types of People that require resuscitation training range from laypeople, rescuers should be taught. Compression-only CPR is easier and those without formal healthcare training but with a role that places quicker to teach especially when trying to teach a large num- a duty of care upon them (e.g., lifeguards, first aiders), and health- ber of individuals who would not otherwise access CPR training. care professionals working in a variety of settings including the In many situations however, standard CPR (which includes ven- community, emergency medical systems (EMS), general hospital tilation/rescuer breathing) is better, for example in children,38 wards and critical care areas. asphyxial arrests, and when bystander CPR is required for more Training should be tailored to the needs of different types of than a few minutes.32 A simplified, education-based approach is learners and learning styles to ensure acquisition and retention of therefore suggested: resuscitation knowledge and skills. Those who are expected to per- form CPR regularly need to have knowledge of current guidelines • Ideally, full CPR skills (compressions and ventilation using a 30:2 and be able to use them effectively as part of a multi-professional ratio) should be taught to all citizens. team. These individuals require more complex training including • When training is time-limited or opportunistic (e.g., EMS both technical and non-technical skills (e.g., teamwork, leadership, telephone instructions to a bystander, mass events, publicity structured communication skills).7,8 In the next section we have campaigns, YouTube ‘viral’ videos, or the individual does not wish arbitrarily divided these into basic level and advanced level training to train), training should focus on chest compression-only CPR. interventions whereas in truth this is a continuum. Most research in • For those trained in compression-only CPR, subsequent train- this area is based on training rescuers in adult resuscitation skills. ing should include training in ventilation as well as chest Much of this research also applies to training in resuscitation of compressions. Ideally these individuals should be trained in children and of the newborn. compression-only CPR and then offered training in chest com- pressions with ventilation at the same training session. Basic level and AED training • Those laypersons with a duty of care, such as first aid workers, lifeguards, and child minders, should be taught how to do chest Bystander CPR and early defibrillation saves lives. Many fac- compressions and ventilations. • For children, rescuers should be encouraged to use whichever tors decrease the willingness of bystanders to start CPR, including panic, fear of disease, harming the victim or performing CPR adult sequence they have been taught, as outcome is worse if they incorrectly.9–24 Providing CPR training to laypeople increases will- do nothing. Non-specialists who wish to learn paediatric resusci- ingness to perform CPR.12,18–20,25–30 tation because they have responsibility for children (e.g., parents, CPR training and doing CPR during an actual cardiac arrest is teachers, school nurses, lifeguards etc), should be taught that it safe in most circumstances. Individuals undertaking CPR training is preferable to modify adult basic life support and give five ini- should be advised of the nature and extent of the physical activity tial breaths followed by approximately 1 min of CPR before they required during the training program. Learners who develop signif- go for help, if there is no-one to go for them. Chest compression icant symptoms (e.g., chest pain, severe shortness of breath) during depth for children is at least one-third of the A-P diameter of the CPR training should be advised to stop. Rescuers who develop sig- chest.39 • Citizen-CPR training should be promoted for all. However nificant symptoms during actual CPR should consider stopping CPR (see basic life support guidelines for further information about risks being untrained should not be a barrier to performing chest to the rescuer).31 compression-only CPR, preferably with dispatcher telephone advice. Basic life support and AED curriculum Basic life support and AED training methods The curriculum for basic life support and AED training should There are numerous methods to deliver basic life support and be tailored to the target audience and kept as simple as possible. AED training. Traditional, instructor-led training courses remain The following should be considered as core elements of the basic the most frequently used method for basic life support and AED life support and AED curriculum5,32 : training.40 When compared with traditional instructor-led train- ing, well designed self-instruction programmes (e.g., video, DVD, • Personal and environmental risks before starting CPR. computer driven) with minimal or no instructor coaching can be • Recognition of cardiac arrest by assessment of responsiveness, effective alternatives to instructor-led courses for laypeople and opening of the airway and assessment of breathing.31,32 healthcare providers learning basic life support and AED skills.41–55 • Recognition of gasping or abnormal breathing as a sign of cardiac It is essential that courses include hands-on practice as part of the arrest in unconscious unresponsive individuals.33,34 programme.
- 218. 1436 J. Soar et al. / Resuscitation 81 (2010) 1434–1444 The use of AEDs by individuals without prior formal training • Good quality chest compressions including adherence to rate, can be beneficial and may be life saving.45,56–60 Performance in the depth, full recoil and minimizing hands-off time, and ventilation use of an AED (e.g., speed of use, correct pad placement) can be using basic skills (e.g., pocket mask, bag mask). further improved with brief training of laypeople and healthcare • Defibrillation including charging during compressions for manual professionals.45,50,61,62 defibrillation. • Advanced life support algorithms. Duration and frequency of instructor-led basic life support • Non-technical skills (e.g., leadership and team training, commu- and AED training courses nication). The optimal duration of instructor-led basic life support and Extended training may cover advanced airway manage- AED training courses has not been determined and is likely to ment, management of peri-arrest arrhythmias; resuscitation in vary according to the characteristics of the participants (e.g., lay special circumstances, vascular access, cardiac arrest drugs, post- or healthcare; previous training; age), the curriculum, the ratio of resuscitation care and ethics. instructors to participants, the amount of hands-on training and the use of end of course assessments. Advanced level training methods Most studies show that CPR skills such as calling for help, chest compressions and ventilations decay within three to six months Pre-course training after initial training.43,46,63–68 AED skills are retained for longer than basic life support skills alone.59,64,69 A variety of methods (such as reading manuals, pretests and CPR performance can be retained or improved with re- e-learning can be used to prepare candidates before attending a evaluation and, if required, a brief refresher, or retraining after as life support course.99–107 A recent large randomized controlled little as three to six months.64,70–73 study of use of a commercially available e-learning simulation programme before attending an advanced life support course com- Use of CPR prompt/feedback devices pared with standard preparation with a course manual showed no improvement in cognitive or psychomotor skills during cardiac The use of CPR prompt/feedback devices may be considered arrest simulation testing.107,108 during CPR training for laypeople and healthcare professionals.35 There are numerous studies of alternative teaching methods Devices can be prompting (i.e., signal to perform an action e.g., that claim equivalence or benefit for computer or video- metronome for compression rate or voice feedback), give feed- based training and decrease the time instructors spend with back (i.e., after event information based on effect of an action learners.100,101,106,109–123 Any method of pre-course prepara- such as visual display of compression depth), or a combination of tion that is aimed at improving knowledge and skills or prompts and feedback. Training using a prompt/feedback device reducing instructor to learner face-to-face time should be for- can improve CPR skill performance, acquisition and retention. In mally assessed to ensure equivalent or improved learning these studies acquisition and retention was measured by testing outcomes compared with standard instructor-led courses. A on a manikin without using the device.63,74–78 Instructors and res- large multicentre randomised controlled trial to test if a 1-day cuers should be made aware that a compressible support surface face-to-face ALS course supplemented by e-learning material (e.g., mattress) can cause a prompt/feedback device to overestimate is equivalent to the 2-day face-to-face standard ALS course depth of compression.79,80 with respect to the course learning outcomes is ongoing [ISRCTN86380392]. Advanced level training Simulation and realistic training techniques Advanced level training curriculum Simulation training is an essential part of resuscitation train- ing. There is large variation in how simulation can be and is used Advanced level training is usually for healthcare providers. Cur- for resuscitation training.124 The lack of consistent definitions (e.g., ricula should be tailored to match individual learning needs, patient high vs. low fidelity simulation) makes comparisons of studies of case mix and the individual’s role within the healthcare systems different types of simulation training difficult. response to cardiac arrest. There is limited evidence about specific Simulation training has fairly consistently,33,125–136 although interventions that enhance learning and retention from advanced not universally137–143 been shown to improve knowledge and skill level life support courses. The ERC Advanced Life Support (ALS) performance on manikins. Evidence of change in real life perfor- course following Guidelines 2005 has been shown to reduce “no- mance is more limited. A small number of before and after studies flow” fraction but not other elements of quality of CPR performance examining the effects of resuscitation training (including simula- in cardiac arrest simulations.81 Increased clinical experience of tion) on real life performance have documented improvement in learners seems to improve long-term retention of knowledge and actual patient outcomes.144–148 These studies are limited by their skills.82,83 inability to separate the effect of simulation training from other Studies of advanced life support in actual or simulated educational and temporal factors. One randomised controlled trial in-hospital arrests,84–94 show improved resuscitation team per- and a prospective case control study which allocated participants formance when specific team and, or leadership training is added to simulator or standard resuscitation training showed improved to advanced level courses. Team training and rhythm recognition real life performance of those skills.127,149 skills will be essential to minimize hands-off time when using the There are conflicting data on the effect of increas- 2010 manual defibrillation strategy that includes charging during ing realism (e.g., use of actual resuscitation settings, high chest compressions.95,96 fidelity manikins) on learning, and few data on patient Core elements for advanced life support curricula should outcomes.125,128,133,135,137,138,140,141,150–154 One study reported a include: significant increase in knowledge when using manikins or live patient models for trauma teaching compared with no manikins • Cardiac arrest prevention.97,98 or live models.153 In this study there was no difference in knowl-
- 219. J. Soar et al. / Resuscitation 81 (2010) 1434–1444 1437 edge acquisition between using manikins or live patient models, discussion.87,89,127,129,149,187,195–205 The ideal format for debriefing although learners preferred using the manikins. remains to be determined. There is insufficient evidence for or against the use of more realistic techniques (e.g., high-fidelity manikins, in situ training) to improve outcomes (e.g., skills performance on manikins, skills European Resuscitation Council resuscitation courses performance in real arrests, willingness to perform) when com- pared with standard training (e.g., low fidelity manikins, education The ERC has a portfolio of training courses that aim to equip centre) in basic and advanced life support. The incremental cost learners with the ability to undertake resuscitation in a real clinical effectiveness of higher fidelity simulators should be determined.141 situation at the level that they would be expected to perform – be Future studies should focus on measuring the effect of training they laypeople, first responders in the community or the hospital, interventions (including simulation) on patient and real life pro- or a healthcare professional working for an EMS, on a general ward, cess focused outcomes. Chart note review,155 quality assurance in an acute area, or as a member of a resuscitation team. studies149 and quality of CPR monitoring technology89,156 have ERC courses focus on teaching in small groups using interactive confirmed the feasibility of this approach. discussion and hands-on practice for skills and clinical simula- tions using resuscitation manikins.6,206 Courses have a high ratio Advanced life support training intervals of instructors to candidates (e.g. 1:3–1:6 depending on the type of course). Full up to date information about ERC courses and termi- Knowledge and skill retention declines rapidly after initial nology is available on the ERC website www.erc.edu. resuscitation training. Refresher training is invariably required to maintain knowledge and skills; however, the optimal frequency for refresher training is unclear. Most studies show that ALS Ethos skills and knowledge decayed when tested at three to six months after training,65,157–164 two studies suggested seven to twelve ERC courses are taught by instructors who have been trained months,165,166 and one study eighteen months.167 in teaching and assessment. The ethos of ERC courses is to cre- ate a positive environment that promotes learning. First names are Assessment on advanced level courses encouraged among both faculty and candidates to reduce appre- hension. Interactions between faculty and candidates are designed The best method of assessment during courses is unknown. to be positive and teaching is conducted by encouragement with Written tests in ALS courses do not reliably predictor practical skill constructive feedback and debriefing on performance. A men- performance and should not be used as a substitute for demonstra- tor/mentee system is used to enhance feedback and support for the tion of clinical skill performance.168–171 Assessment at the end of candidate. Some stress is inevitable,207 particularly during assess- training does seem to have a beneficial effect on performance and ment, but the aim of the instructors is to enable the candidates to retention and should be considered.172,173 do their best. Alternative strategies that may improve advanced life support performance Course management Use of checklists and cognitive aids Courses are overseen by specialist committees within each Cognitive aids such as checklists may be used to improve adher- National Resuscitation Council and by the ERC international course ence to guidelines as long as they do not cause delays in starting committee. The ERC has developed a web-based course manage- CPR and the correct checklist is used.174–186 Checklists should be ment system (http://courses.erc.edu). The system can be used to tested in simulated resuscitations before implementation.84–94 register all ERC courses and enables course organizers to register a course from any country, assign instructors, record candidate atten- Mock codes dance and outcomes, and file the course director’s report directly Mock cardiac arrest codes and drills provide the opportu- with the ERC. Candidates may sign up online to a course, or may nity to test the individual and system responses to cardiac contact the organizer to register their interest in the course. At arrest. Mock codes can improve advanced life support provider the end of the course the system will generate course certificates knowledge,187 skill performance,188 confidence,189 familiarity for the candidates and faculty. These certificates are assigned a with the environment190 and identify common system and user unique number and can be accessed at any time by course organiz- errors.191,192 ers and directors. Participants that successfully complete courses are referred to as providers. For example someone that successfully Team briefings and debriefings completes an ALS course is known as an ALS provider. National Briefings and debriefings should be used during both learning Resuscitation Councils have access to information about courses and actual clinical activities. organised in their country. Successful teams such as sports teams meet before and after events. Surveys in the UK193,194 and Canada90 show that resuscita- tion teams rarely have formal briefings and debriefings. Debriefings Language and feedback are two separate but related entities in that various forms of feedback are components of debriefing. Debriefing tends Initially, the ERC courses were taught in English by an inter- to be face-to-face and involves both parties engaging in discussion. national faculty.206 As local instructors have been trained, and Feedback tends to provide information about prior events and can manuals and course materials have been translated into different use several methods (video recordings, defibrillator downloads or languages, courses are now mainly taught in the native language. trained observer feedback). Debriefing appears to be an effective Early translation of guidelines and course materials is essential as method for improving resuscitation performance and, potentially, delays in translation into the local language can cause significant patient outcomes as long as objective data forms the basis for the delays to implementation of guidelines.3
- 220. 1438 J. Soar et al. / Resuscitation 81 (2010) 1434–1444 Instructors gives the instructors an opportunity to debrief at the end of the course. A tried and tested method has evolved for identifying and train- ing instructors. The Basic Life Support (BLS) and Automated External Defibrillator (AED) Courses Identification of instructor potentials (IP) BLS/AED courses are appropriate for a wide range of providers. These will be individuals who, in the opinion of the faculty, These may include clinical and non-clinical healthcare profession- have passed and demonstrated a high level of performance dur- als (particularly those who are less likely to be faced with having ing a provider course and, importantly, have shown qualities of to manage a cardiac arrest), general practitioners, dentists, medical leadership, team working and clinical credibility, with skills that students, first-aid workers, lifeguards, those with a duty of care for include being articulate, supportive, and motivated. These individ- others (such as school teachers and care workers), and members of uals will be invited to take part in an instructor course and are first responder schemes, as well as members of the general public. called instructor potentials. Instructor potentials wishing to teach Separate BLS and AED provider courses are available, but the ERC on Advanced Life Support (ALS), European Paediatric Life Support encourages candidates to combine BLS skills with the use of an AED. (EPLS), Newborn Life Support (NLS), Immediate Life Support (ILS), and European Paediatric Immediate Life Support (EPILS) courses Provider course format should attend the Generic Instructor Course (GIC); for those wish- ing to teach only on the ERC Basic Life Support (BLS)/Automated The aim of this provider course is to enable each candidate External Defibrillation (AED) Course there is a specific BLS/AED to gain competency in BLS and the use of an AED. Each BLS/AED Instructor Course. provider course lasts approximately half a day and consists of skill demonstrations and hands-on practice, with a minimum number of lectures. The recommended ratio of instructor to candidates is Instructor courses 1:6, with at least one manikin and one AED for each group of 6 candidates. Formal assessment is not usually undertaken, but each These are conducted by experienced instructors and, in the case candidate receives individual feedback on their performance. Those of the Generic Instructor Course (see below), include an educator who need a certificate of competency for professional or personal who has undertaken specific training in medical educational prac- use may be assessed continuously during the course or definitively tice and the principles of adult learning. Assessment is formative at the end. by the faculty and feedback is given as appropriate. BLS/AED Instructor Course Instructor candidate (IC) stage Many of the candidates attending a BLS/AED provider course Following successful completion of an instructor course (see are laypeople, and some want subsequently to become instruc- below) the individual is designated instructor candidate (IC) status tors themselves. For this reason, the ERC has developed a one-day and normally will teach on two separate courses, under supervi- BLS/AED instructor course. Candidates for this course must be sion, receiving constructive feedback on his or her performance. healthcare professionals, or laypeople who hold the ERC BLS/AED Following successful completion of these two courses the IC nor- provider certificate and are designated as instructor potentials. The mally progresses to full instructor status. Occasionally the faculty aim is be as inclusive as possible regarding course attendance, will decide that a further course is required or, rarely, that the can- the overriding criterion being that all candidates should have the didate is not suitable to progress to be an instructor. An appeal can potential and knowledge to teach the subject. The BLS/AED instruc- be lodged with the relevant ERC International Course Committee tor course follows the principles of the Generic Instructor Course who will make the final decision. (GIC), with an emphasis on teaching people. Following successful completion of the course, each candidate becomes an instructor Course Director (CD) status candidate (IC) and teaches on two BLS/AED courses before becom- ing a full instructor. Each ERC course is led by an approved Course Director. Indi- viduals are selected for approval as Course Directors through The Immediate Life Support (ILS) Course nomination by their peers and approved by their National Resus- citation Council (NRC) or the ERC International Course Committee. The Immediate Life Support (ILS) course is for the majority Course Directors are relatively senior individuals who are clinically of healthcare professionals who attend cardiac arrests rarely but credible, have demonstrated their qualities as a teacher and asses- have the potential to be first responders or resuscitation team sor and posses the leadership skills to lead a faculty of instructors. members.208 The course teaches healthcare professionals the skills They will have embraced the educational principles inherent in the that are most likely to result in successful resuscitation whilst instructor course. A key component of ERC courses are the faculty awaiting the arrival of the resuscitation team.209 Importantly, ILS meetings. These usually take place at the start and end of each day also includes a section on the initial care of the sick adult and pre- of the course. They are led by the course director. The aim of these venting cardiac arrest and complements other short courses that meetings is to brief the teaching faculty and to facilitate evaluation focus on the initial treatment of sick patients.210 A recent cohort of each candidate’s performance. At the end of each course a final study found that the number of cardiac arrest calls decreased while faculty meeting is held. During this meeting the faculty will review pre-arrest calls increased after implementing a programme that the performance of each candidate and decide whether they have included ILS teaching in two hospitals; the intervention was asso- successfully completed the course. As described above, candidates ciated with a decrease in true arrests, and increase in initial survival that have shown exceptional ability are selected for invitation to after cardiac arrest and survival to discharge.211 train as instructors. Where there are instructor candidates on the Potential ILS candidates include nurses, nursing students, doc- courses, their performance is also evaluated and feedback provided tors, medical students, dentists, physiotherapists, radiographers, by their mentor or the course director. This faculty meeting also and cardiac technicians.
- 221. J. Soar et al. / Resuscitation 81 (2010) 1434–1444 1439 Course format Course content The ILS course is delivered over one day and comprises lectures, The course content is based on the current ERC Guidelines for hands-on skills teaching and cardiac arrest simulation teach- Resuscitation. Candidates are expected to have studied the ALS ing (CASTeach) using manikins. The programme includes several course materials carefully before the course. options that enable instructors to tailor the course to their candi- The course aims to train candidates to highlight the causes of date group. The ILS course is designed to be straightforward to run. cardiac arrest and identify sick patients in danger of deterioration Most courses are conducted in hospitals with small groups of can- and to manage cardiac arrest and the immediate peri-arrest prob- didates (average 12 candidates). Course centres should try as far as lems encountered in and around the first hour or so of the event. possible to train candidates to use the equipment (e.g., defibrillator It is not a course in advanced intensive care or cardiology. Compe- type) that is available locally. tence in basic life support is expected before the candidate enrols for the course. Course content Emphasis is placed on the techniques of safe defibrillation and ECG interpretation, the management of the airway and ventila- The course covers those skills that are most likely to result in tion, the management of peri-arrest rhythms, simple acid-base successful resuscitation: causes and prevention of cardiac arrest balance, and of special circumstances relating to cardiac arrest. including use of the ABCDE approach, starting CPR, basic airway Post-resuscitation care, ethical aspects related to resuscitation and skills and defibrillation (AED or manual). The course includes an care of the bereaved are included in the course. optional session on issues relevant to the candidate group (e.g., anaphylaxis, equipment checks). Once all the skills have been cov- Assessment and testing ered there is a cardiac arrest demonstration by the instructors that outlines the first responder role to the candidates. This is Each candidate is assessed continuously during the course and followed by the CASTeach station where candidates practice. ILS reviewed at the end of each day at a faculty meeting. Feedback candidates are not usually expected to undertake the role of team is given as required. Candidates are expected to be able to use leader. Candidates should be able to start a resuscitation attempt the ABCDE approach to assess and treat the sick patient, recog- and continue until more experienced help arrives. When appro- nise cardiac arrest, provide good quality CPR and safe defibrillation priate, the instructor takes over as resuscitation team leader. This throughout the course. There is a cardiac arrest simulation testing is not always necessary because in some simulations resuscitation (CASTest) towards the end of the course. This tests the participant’s may be successful before more experienced help arrives. Standard- applied knowledge and skills during a simulated cardiac arrest. ised simulations are used that can be adapted to the workplace and The reliability and measurement properties of the CASTest have clinical role of the candidate. been reported.169,214,215 A multiple choice question (MCQ) paper taken at the end of the course tests core knowledge. Candidates are Assessment required to achieve 75% to pass this test. The measurement prop- erties of the multiple choice papers have been assessed from over Candidates are assessed continuously and must show their com- 8000 candidates and found to have high internal consistency and petence throughout the ILS course. There are no formal testing discrimination properties (Data from Resuscitation Council (UK) stations at the end of the course. Candidates are sent assessment and Dr Carl Gwinnutt). forms with the pre-course materials. The forms indicate clearly how their performance will be measured against pre-determined cri- The European Paediatric Life Support (EPLS) Course teria. Assessment on the ILS course enables the candidate to see what is expected, and frame their learning around achievement The EPLS course is designed for healthcare workers who are of these outcomes. The following practical skills are assessed on involved in the resuscitation of a newborn, an infant or a child the ILS course: airway management, CPR and defibrillation. With a whether in or out-of-hospital. The course aims at providing care- supportive approach, most candidates achieve the course learning givers with knowledge and skills for the management of the outcomes. critically ill child during the first hour of illness and to prevent progression of diseases to cardiac arrest. The Advanced Life Support (ALS) Course EPLS is not a course in neonatal or paediatric intensive care aimed for advanced providers. The target candidates for this course are doctors and senior Competence in paediatric basic life support is a prerequisite nurses working in acute areas of the hospital and those who may be although refresher teaching in basic life support and relief of foreign resuscitation team leaders and members.212,213 The course is also body airway obstruction is included. The EPLS course is suitable suitable for senior paramedics and some hospital technicians. The for doctors, nurses, emergency medical technicians, paramedics etc ILS course is more suitable for first responder nurses, doctors who who have a duty to respond to sick newborns, infants and children rarely encounter cardiac arrest in their practice, and emergency in their practice.216,217 medical technicians. Experience in paediatrics is necessary to keep simulations real- Each instructor acts as a mentor for a small group of candidates. istic and answer to candidates’ questions so a minimum of 50% of The course normally lasts for 2 or 2.5 days. the faculty must have regular experience in neonatal or paediatric practice. The course lasts for 2–2.5 days. Course format Course format The course format has very few formal lectures and teaching concentrates on hands-on skills, clinically-based simulations in The course format has few formal lectures. Teaching of knowl- small groups with emphasis on the team leader approach, and edge and skills is delivered in small groups using clinically interactive group discussions. A formal mentor/mentee session is based simulations (e.g., cardiac arrest, cardiac and respiratory fail- included to enable candidates to give and receive feedback. ure, delivery room simulations). The emphasis is on assessment
- 222. 1440 J. Soar et al. / Resuscitation 81 (2010) 1434–1444 and treatment of the sick child, team working and leader- bag-mask ventilation and AED use. With a supportive approach, ship. most candidates achieve the course learning outcomes. Course content The Newborn Life Support (NLS) Course The course content follows the current ERC guidelines for neona- This one-day course is designed for healthcare workers likely to tal and paediatric resuscitation. The course candidates are expected be present at the birth of a baby in the course of their job. It aims to to have studied the manual before attending the course. A pre- give those who may be called upon to start resuscitation at birth the course MCQ is sent with the manual to candidates 4–6 weeks background knowledge and skills to approach the management of before the course to encourage candidates to read the course mate- the newborn infant during the first 10–20 min. The course is suit- rials. able for midwives, nurses, EMS personnel, and doctors and, like The EPLS course is aimed at training candidates to under- most such courses, works best with candidates from a mixture of stand the causes and mechanisms of cardiorespiratory arrest in specialties. neonates and children, to recognise and treat the critically ill neonate, infant or child and to manage cardiac arrest. Skills taught Course format include airway management, bag-mask ventilation, log roll and cervical collar placement, oxygen delivery, an introduction to intu- The NLS manual is sent to each of the candidates four weeks bation and vascular access, safe defibrillation, cardioversion and before the course. Each candidate receives a MCQ together with AED use. the manual and is asked to complete this and bring it with them to Each candidate is assessed individually and reviewed by the fac- the course. There is an introduction followed by two short lectures. ulty. Feedback is given as required. A BLS assessment follows the The candidates are then divided into four groups and undertake BLS refresher course and a simulation-based test at the end of the three workstations before lunch. The afternoon is then taken up by course emphasises the assessment of the sick child and other core a demonstration simulation followed by two hours of simulation skills. An end of course MCQ with a pass mark of 74% tests core teaching in small groups and, finally, a theoretical and practical knowledge. assessment by an MCQ and an individual practical airway test. The course places appropriate emphasis on airway management but The European Paediatric Immediate Life Support (EPILS) also covers chest compression, umbilical venous access and drugs. Course Both basic infant and four infant advanced manikins should be available as well as other airway adjuncts. Resuscitaires, ideally Course format complete with sufficient gas cylinders for the whole day, should also be available. EPILS is a one-day course comprising one lecture, hands-on skills and simulation teaching. The programme includes options The Generic Instructor Course (GIC) to enable teaching to be tailored for candidate groups. This course is for candidates who have been recommended as Course content instructor potential (IP) emanating from ERC provider courses (ALS, EPLS, NLS, ILS, EPILS). Candidates with IP status from certain other The course is aimed at training nurses, EMS personnel, and doc- provider courses can also attend (e.g., European Trauma Course, Pre tors to recognize and treat critically ill infants and children, prevent Hospital Trauma Care, Italy). There should be a maximum of 24 can- cardiorespiratory arrest and to treat children in cardiorespiratory didates with a ratio of at least one instructor to three candidates. arrest during the first few minutes whilst awaiting the arrival of a Instructors must be full and experienced ERC instructors who have resuscitation team. This interactive course is based on short practi- been through a formal process of training to become a GIC instruc- cal simulations adapted to the workplace and to the actual clinical tor. Groups should not exceed six candidates. The emphasis of the role of candidates. course is on developing teaching and assessment skills, as well as Basic life support, bag-mask ventilation, chest compressions, promoting team leadership and providing constructive feedback. choking, and intraosseous access are included; drugs during car- Core knowledge of the original provider course is assumed. The diac arrest and laryngeal mask insertion are optional. The EPILS course lasts for 2 days or 2.5 days. course is designed to be simple to run. Most courses are conducted in hospitals with small groups of candidates (average 5–6 candi- Course format dates with one instructor). There needs to be at least one baby and one child manikin for every 6 candidates. Course centres should The course format is largely interactive. An ERC medical educa- try as far as possible to train candidates to use the equipment (e.g., tor plays a key role leading the educational process, the discussions defibrillator type) that is available in their clinical setting. and feedback. This lecture is interspersed with group activities. The remainder of the course is conducted in small group discussions and Assessment skill and simulation based hands on sessions. Mentor/mentee ses- sions are included and there is a faculty meeting at the beginning Candidates are sent a pre-course MCQ paper with pre-course of the course and at the end of each day. materials to help them prepare for the course. The MCQ paper helps to ensure that candidates read the course materials before attend- Course content ing the course and does not count towards the final assessment. There are no formal testing stations during the course. Candi- Candidates are given precourse reading material and are date’s performances are assessed continuously. Assessment forms expected to have read this before attending. The theoretical back- are given to the candidates at the beginning of the course and ground of adult learning and effective teaching and assessment instructors provide feedback throughout the course. The following is covered by the educator at the beginning of the course. Each practical skills are assessed on the EPILS course: basic life support, teaching and assessment skill is demonstrated by the faculty. The
- 223. J. Soar et al. / Resuscitation 81 (2010) 1434–1444 1441 candidates then get the opportunity to practice: equipment famil- 3. Berdowski J, Schmohl A, Tijssen JG, Koster RW. Time needed for a regional iarisation, lecturing, teaching skills by means of the four stage emergency medical system to implement resuscitation Guidelines 2005 – The Netherlands experience. Resuscitation 2009;80:1336–41. approach, intermediate fidelity simulation sessions using simula- 4. Bigham BL, Koprowicz K, Aufderheide TP, et al. Delayed prehospital implemen- tions, small group teaching sessions (open and closed discussions), tation of the 2005 American heart association guidelines for cardiopulmonary and assessment. resuscitation and emergency cardiac care. Prehosp Emerg Care 2010. 5. Soar J, Mancini ME, Bhanji F, et al. 2010. International consensus on car- For each teaching tool, a “mini-topic” is extracted from the orig- diopulmonary resuscitation and emergency cardiovascular care science with inal provider course material. Throughout the course, emphasis is treatment recommendations. Part 12: education, implementation, and teams. placed on the role of the instructor and each candidate has the Resuscitation; doi:10.1016/j.resuscitation.2010.08.030, in press. opportunity to adopt the instructor role. The concept of construc- 6. Baskett PJ, Nolan JP, Handley A, Soar J, Biarent D, Richmond S. European resusci- tation council guidelines for resuscitation 2005. Section 9. Principles of training tive feedback is a key element and is also emphasised. Finally, the in resuscitation. Resuscitation 2005;67:S181–9. roles and qualities of an ERC Instructor are discussed. 7. Andersen PO, Jensen MK, Lippert A, Ostergaard D. Identifying non-technical skills and barriers for improvement of teamwork in cardiac arrest teams. Resus- citation 2010;81:695–702. Assessment 8. Flin R, Patey R, Glavin R, Maran N. Anaesthetists’ non-technical skills. Br J Anaesth 2010;105:38–44. 9. Axelsson A, Thoren A, Holmberg S, Herlitz J. Attitudes of trained Swedish lay Each candidate is assessed formatively by the faculty throughout rescuers toward CPR performance in an emergency: a survey of 1012 recently the course. Candidates’ performances and attitudes are discussed at trained CPR rescuers. Resuscitation 2000;44:27–36. the daily faculty meetings and feedback given as required. Success- 10. Hubble MW, Bachman M, Price R, Martin N, Huie D. Willingness of high school ful candidates may proceed to the status of instructor candidate students to perform cardiopulmonary resuscitation and automated external defibrillation. Prehosp Emerg Care 2003;7:219–24. (IC). Candidates who successfully complete the course but who are 11. Swor RA, Jackson RE, Compton S, et al. Cardiac arrest in private locations: considered by the faculty to need specific support in their devel- different strategies are needed to improve outcome. Resuscitation 2003;58: opment may be recommended to undertake their IC placements at 171–6. 12. Swor R, Khan I, Domeier R, Honeycutt L, Chu K, Compton S. CPR training and nominated centres. CPR performance: do CPR-trained bystanders perform CPR? Acad Emerg Med 2006;13:596–601. 13. Vaillancourt C, Stiell IG, Wells GA. Understanding and improving low bystander The Educator Master Class CPR rates: a systematic review of the literature. CJEM 2008;10:51–65. 14. Boucek CD, Phrampus P, Lutz J, Dongilli T, Bircher NG. Willingness to perform Medical Educators are an essential component of the GIC Fac- mouth-to-mouth ventilation by health care providers: a survey. Resuscitation 2009;80:849–53. ulty. This two-day course is designed for those aspiring to become 15. Caves ND, Irwin MG. Attitudes to basic life support among medical students fol- medical educators for the ERC and is run when there is a need for lowing the 2003 SARS outbreak in Hong Kong. Resuscitation 2006;68:93–100. expansion of Educator numbers. Suitable candidates are selected 16. Coons SJ, Guy MC. Performing bystander CPR for sudden cardiac arrest: behav- ioral intentions among the general adult population in Arizona. Resuscitation by the ERC Educational Advisory Group (EAG) following a written 2009;80:334–40. application and generally must have a background and qualification 17. Dwyer T. Psychological factors inhibit family members’ confidence to initiate in medical education or have demonstrated a special commitment CPR. Prehosp Emerg Care 2008;12:157–61. to educational practice over a number of years. They should have 18. Jelinek GA, Gennat H, Celenza T, O’Brien D, Jacobs I, Lynch D. Community attitudes towards performing cardiopulmonary resuscitation in Western Aus- experience of a provider course and a GIC and should have studied tralia. Resuscitation 2001;51:239–46. the background reading for the course. 19. Johnston TC, Clark MJ, Dingle GA, FitzGerald G. Factors influencing Queens- The instructors for the course are experienced educators. landers’ willingness to perform bystander cardiopulmonary resuscitation. Resuscitation 2003;56:67–75. 20. Kuramoto N, Morimoto T, Kubota Y, et al. Public perception of and willingness Course format to perform bystander CPR in Japan. Resuscitation 2008;79:475–81. 21. Omi W, Taniguchi T, Kaburaki T, et al. The attitudes of Japanese high school stu- dents toward cardiopulmonary resuscitation. Resuscitation 2008;78:340–5. The course consists mainly of closed discussion groups for the 22. Riegel B, Mosesso VN, Birnbaum A, et al. Stress reactions and perceived dif- whole course, led by one or two of the instructors, together with ficulties of lay responders to a medical emergency. Resuscitation 2006;70: 98–106. breakout small group discussions and problem solving. 23. Shibata K, Taniguchi T, Yoshida M, Yamamoto K. Obstacles to bystander car- diopulmonary resuscitation in Japan. Resuscitation 2000;44:187–93. 24. Taniguchi T, Omi W, Inaba H. Attitudes toward the performance of bystander Course content cardiopulmonary resuscitation in Japan. Resuscitation 2007;75:82–7. 25. Moser DK, Dracup K, Doering LV. Effect of cardiopulmonary resuscitation train- The course covers the theoretical framework for medical edu- ing for parents of high-risk neonates on perceived anxiety, control, and burden. Heart Lung 1999;28:326–33. cators, assessment and quality control, teaching methodologies, 26. Axelsson A, Herlitz J, Ekstrom L, Holmberg S. Bystander-initiated cardiopul- critical appraisal, the role of the mentor, multi-professional educa- monary resuscitation out-of-hospital. A first description of the bystanders and tion strategies and continued development of the medical educator. their experiences. Resuscitation 1996;33:3–11. 27. Donohoe RT, Haefeli K, Moore F. Public perceptions and experiences of myocar- dial infarction, cardiac arrest and CPR in London. Resuscitation 2006;71:70–9. Assessment 28. Hamasu S, Morimoto T, Kuramoto N, et al. Effects of BLS training on fac- tors associated with attitude toward CPR in college students. Resuscitation 2009;80:359–64. Each candidate is assessed formatively by the faculty through- 29. Parnell MM, Pearson J, Galletly DC, Larsen PD. Knowledge of and attitudes out the course. Successful candidates may proceed to the status towards resuscitation in New Zealand high-school students. Emerg Med J of educator candidate where they will be supervised and assessed 2006;23:899–902. 30. Swor R, Compton S, Farr L, et al. Perceived self-efficacy in performing and will- by an experienced educator and course director until it is decided ingness to learn cardiopulmonary resuscitation in an elderly population in a whether or not they will be suitable educators to work on their suburban community. Am J Crit Care 2003;12:65–70. own. 31. Koster RW, Baubin MA, Caballero A, et al. European resuscitation council guide- lines for resuscitation 2010. Section 2. Adult basic life support and use of automated external defibrillators. Resuscitation 2010;81:1277–92. 32. Koster RW, Sayre MR, Botha M, et al. International consensus on car- References diopulmonary resuscitation and emergency cardiovascular care science with treatment recommendations. Part 5: adult basic life support. Resuscitation; 1. Chamberlain DA, Hazinski MF. Education in resuscitation. Resuscitation doi:10.1016/j.resuscitation.2010.08.005. 2003;59:11–43. 33. Perkins GD, Walker G, Christensen K, Hulme J, Monsieurs KG. Teaching recog- 2. Yeung J, Perkins GD. Timing of drug administration during CPR and the role of nition of agonal breathing improves accuracy of diagnosing cardiac arrest. simulation. Resuscitation 2010;81:265–6. Resuscitation 2006;70:432–7.
- 224. 1442 J. Soar et al. / Resuscitation 81 (2010) 1434–1444 34. Bobrow BJ, Zuercher M, Ewy GA, et al. Gasping during cardiac arrest in 61. Jerin JM, Ansell BA, Larsen MP, Cummins RO. Automated external defibrilla- humans is frequent and associated with improved survival. Circulation tors: skill maintenance using computer-assisted learning. Acad Emerg Med 2008;118:2550–4. 1998;5:709–17. 35. Yeung J, Meeks R, Edelson D, Gao F, Soar J, Perkins GD. The use of CPR 62. de Vries W, Handley AJ. A web-based micro-simulation program for self- feedback/prompt devices during training and CPR performance: a systematic learning BLS skills and the use of an AED. Can laypeople train themselves review. Resuscitation 2009;80:743–51. without a manikin? Resuscitation 2007;75:491–8. 36. Lam KK, Lau FL, Chan WK, Wong WN. Effect of severe acute respiratory syn- 63. Spoone BB, Fallaha JF, Kocierz L, Smith CM, Smith SC, Perkins GD. An evalu- drome on bystander willingness to perform cardiopulmonary resuscitation ation of objective feedback in basic life support (BLS) training. Resuscitation (CPR) – is compression-only preferred to standard CPR? Prehosp Disaster Med 2007;73:417–24. 2007;22:325–9. 64. Andresen D, Arntz HR, Grafling W, et al. Public access resuscitation program 37. Locke CJ, Berg RA, Sanders AB, et al. Bystander cardiopulmonary resuscita- including defibrillator training for laypersons: a randomized trial to evaluate tion. Concerns about mouth-to-mouth contact. Arch Intern Med 1995;155: the impact of training course duration. Resuscitation 2008;76:419–24. 938–43. 65. Smith KK, Gilcreast D, Pierce K. Evaluation of staff’s retention of ACLS and BLS 38. Kitamura T, Iwami T, Kawamura T. Conventional and chest-compression-only skills. Resuscitation 2008;78:59–65. cardiopulmonary resuscitation by bystanders for children who have out-of- 66. Woollard M, Whitfeild R, Smith A, et al. Skill acquisition and retention in auto- hospital cardiac arrests: a prospective, nationwide, population-based cohort mated external defibrillator (AED) use and CPR by lay responders: a prospective study. Lancet 2010;375:1347–54. study. Resuscitation 2004;60:17–28. 39. Biarent D, Bingham R, Eich C, et al. European resuscitation council guide- 67. Berden HJ, Willems FF, Hendrick JM, Pijls NH, Knape JT. How frequently should lines for resuscitation 2010. Section 6. Paediatric life support. Resuscitation basic cardiopulmonary resuscitation training be repeated to maintain adequate 2010;81:1364–88. skills? BMJ 1993;306:1576–7. 40. Hoke RS, Chamberlain DA, Handley AJ. A reference automated external defib- 68. Woollard M, Whitfield R, Newcombe RG, Colquhoun M, Vetter N, Chamberlain rillator provider course for Europe. Resuscitation 2006;69:421–33. D. Optimal refresher training intervals for AED and CPR skills: a randomised 41. Lynch B, Einspruch EL, Nichol G, Becker LB, Aufderheide TP, Idris A. Effective- controlled trial. Resuscitation 2006;71:237–47. ness of a 30-min CPR self-instruction program for lay responders: a controlled 69. Riegel B, Nafziger SD, McBurnie MA, et al. How well are cardiopulmonary randomized study. Resuscitation 2005;67:31–43. resuscitation and automated external defibrillator skills retained over time? 42. Todd KH, Braslow A, Brennan RT, et al. Randomized, controlled trial of Results from the Public Access Defibrillation (PAD) Trial. Acad Emerg Med video self-instruction versus traditional CPR training. Ann Emerg Med 2006;13:254–63. 1998;31:364–9. 70. Castle N, Garton H, Kenward G. Confidence vs competence: basic life support 43. Einspruch EL, Lynch B, Aufderheide TP, Nichol G, Becker L. Retention of skills of health professionals. Br J Nurs 2007;16:664–6. CPR skills learned in a traditional AHA heartsaver course versus 30-min 71. Wik L, Myklebust H, Auestad BH, Steen PA. Twelve-month retention of CPR video self-training: a controlled randomized study. Resuscitation 2007;74: skills with automatic correcting verbal feedback. Resuscitation 2005;66:27–30. 476–86. 72. Christenson J, Nafziger S, Compton S, et al. The effect of time on CPR and 44. Todd KH, Heron SL, Thompson M, Dennis R, O’Connor J, Kellermann AL. Simple automated external defibrillator skills in the public access defibrillation trial. CPR: a randomized, controlled trial of video self-instructional cardiopulmonary Resuscitation 2007;74:52–62. resuscitation training in an African American church congregation. Ann Emerg 73. Niles D, Sutton RM, Donoghue A, et al. “Rolling Refreshers”: a novel approach to Med 1999;34:730–7. maintain CPR psychomotor skill competence. Resuscitation 2009;80:909–12. 45. Reder S, Cummings P, Quan L. Comparison of three instructional methods 74. Beckers SK, Skorning MH, Fries M, et al. CPREzy improves performance for teaching cardiopulmonary resuscitation and use of an automatic external of external chest compressions in simulated cardiac arrest. Resuscitation defibrillator to high school students. Resuscitation 2006;69:443–53. 2007;72:100–7. 46. Roppolo LP, Pepe PE, Campbell L, et al. Prospective, randomized trial of the 75. Isbye DL, Hoiby P, Rasmussen MB, et al. Voice advisory manikin versus effectiveness and retention of 30-min layperson training for cardiopulmonary instructor facilitated training in cardiopulmonary resuscitation. Resuscitation resuscitation and automated external defibrillators: The American Airlines 2008;79:73–81. Study. Resuscitation 2007;74:276–85. 76. Monsieurs KG, De Regge M, Vogels C, Calle PA. Improved basic life support 47. Batcheller AM, Brennan RT, Braslow A, Urrutia A, Kaye W. Cardiopulmonary performance by ward nurses using the CAREvent Public Access Resuscitator resuscitation performance of subjects over forty is better following half-hour (PAR) in a simulated setting. Resuscitation 2005;67:45–50. video self-instruction compared to traditional four-hour classroom training. 77. Sutton RM, Donoghue A, Myklebust H, et al. The voice advisory manikin (VAM): Resuscitation 2000;43:101–10. an innovative approach to pediatric lay provider basic life support skill educa- 48. Braslow A, Brennan RT, Newman MM, Bircher NG, Batcheller AM, Kaye W. tion. Resuscitation 2007;75:161–8. CPR training without an instructor: development and evaluation of a video 78. Wik L, Myklebust H, Auestad BH, Steen PA. Retention of basic life support skills self-instructional system for effective performance of cardiopulmonary resus- 6 months after training with an automated voice advisory manikin system citation. Resuscitation 1997;34:207–20. without instructor involvement. Resuscitation 2002;52:273–9. 49. Isbye DL, Rasmussen LS, Lippert FK, Rudolph SF, Ringsted CV. Laypersons may 79. Nishisaki A, Nysaether J, Sutton R, et al. Effect of mattress deflection on learn basic life support in 24 min using a personal resuscitation manikin. Resus- CPR quality assessment for older children and adolescents. Resuscitation citation 2006;69:435–42. 2009;80:540–5. 50. Moule P, Albarran JW, Bessant E, Brownfield C, Pollock J. A non-randomized 80. Perkins GD, Kocierz L, Smith SC, McCulloch RA, Davies RP. Compression feed- comparison of e-learning and classroom delivery of basic life support back devices over estimate chest compression depth when performed on a bed. with automated external defibrillator use: a pilot study. Int J Nurs Pract Resuscitation 2009;80:79–82. 2008;14:427–34. 81. Perkins GD, Boyle W, Bridgestock H, et al. Quality of CPR during advanced 51. Liberman M, Golberg N, Mulder D, Sampalis J. Teaching cardiopulmonary resuscitation training. Resuscitation 2008;77:69–74. resuscitation to CEGEP students in Quebec – a pilot project. Resuscitation 82. Jensen ML, Lippert F, Hesselfeldt R, et al. The significance of clinical experi- 2000;47:249–57. ence on learning outcome from resuscitation training-a randomised controlled 52. Jones I, Handley AJ, Whitfield R, Newcombe R, Chamberlain D. A preliminary study. Resuscitation 2009;80:238–43. feasibility study of a short DVD-based distance-learning package for basic life 83. Ali J, Howard M, Williams J. Is attrition of advanced trauma life support acquired support. Resuscitation 2007;75:350–6. skills affected by trauma patient volume? Am J Surg 2002;183:142–5. 53. Brannon TS, White LA, Kilcrease JN, Richard LD, Spillers JG, Phelps CL. Use 84. Thomas EJ, Taggart B, Crandell S, et al. Teaching teamwork during the Neonatal of instructional video to prepare parents for learning infant cardiopulmonary Resuscitation Program: a randomized trial. J Perinatol 2007;27:409–14. resuscitation. Proc (Bayl Univ Med Cent) 2009;22:133–7. 85. Cooper S. Developing leaders for advanced life support: evaluation of a training 54. de Vries W, Turner N, Monsieurs K, Bierens J, Koster R. comparison of instructor- programme. Resuscitation 2001;49:33–8. led automated external defibrillation training and three alternative DVD-based 86. Gilfoyle E, Gottesman R, Razack S. Development of a leadership skills workshop training methods. Resuscitation 2010;81:1004–9. in paediatric advanced resuscitation. Med Teach 2007;29:e276–83. 55. Perkins GD, Mancini ME. Resuscitation training for healthcare workers. Resus- 87. DeVita MA, Schaefer J, Lutz J, Wang H, Dongilli T. Improving medical emergency citation 2009;80:841–2. team (MET) performance using a novel curriculum and a computerized human 56. Mattei LC, McKay U, Lepper MW, Soar J. Do nurses and physiotherapists patient simulator. Qual Saf Health Care 2005;14:326–31. require training to use an automated external defibrillator? Resuscitation 88. Cooper S, Wakelam A. Leadership of resuscitation teams: “Lighthouse Leader- 2002;53:277–80. ship”. Resuscitation 1999;42:27–45. 57. Gundry JW, Comess KA, DeRook FA, Jorgenson D, Bardy GH. Comparison of 89. Edelson DP, Litzinger B, Arora V, et al. Improving in-hospital cardiac naive sixth-grade children with trained professionals in the use of an auto- arrest process and outcomes with performance debriefing. Arch Intern Med mated external defibrillator. Circulation 1999;100:1703–7. 2008;168:1063–9. 58. Beckers S, Fries M, Bickenbach J, Derwall M, Kuhlen R, Rossaint R. Minimal 90. Hayes CW, Rhee A, Detsky ME, Leblanc VR, Wax RS. Residents feel unprepared instructions improve the performance of laypersons in the use of semiauto- and unsupervised as leaders of cardiac arrest teams in teaching hospitals: a matic and automatic external defibrillators. Crit Care 2005;9:R110–6. survey of internal medicine residents. Crit Care Med 2007;35:1668–72. 59. Beckers SK, Fries M, Bickenbach J, et al. Retention of skills in medical stu- 91. Hunziker S, Tschan F, Semmer NK, et al. Hands-on time during cardiopul- dents following minimal theoretical instructions on semi and fully automated monary resuscitation is affected by the process of teambuilding: a prospective external defibrillators. Resuscitation 2007;72:444–50. randomised simulator-based trial. BMC Emerg Med 2009;9:3. 60. Mitchell KB, Gugerty L, Muth E. Effects of brief training on use of automated 92. Makinen M, Aune S, Niemi-Murola L, et al. Assessment of CPR-D skills of nurses external defibrillators by people without medical expertise. Hum Factors in Goteborg, Sweden and Espoo, Finland: teaching leadership makes a differ- 2008;50:301–10. ence. Resuscitation 2007;72:264–9.
- 225. J. Soar et al. / Resuscitation 81 (2010) 1434–1444 1443 93. Marsch SC, Muller C, Marquardt K, Conrad G, Tschan F, Hunziker PR. Human 122. Ryan G, Lyon P, Kumar K, Bell J, Barnet S, Shaw T. Online CME: an effective factors affect the quality of cardiopulmonary resuscitation in simulated cardiac alternative to face-to-face delivery. Med Teach 2007;29:e251–7. arrests. Resuscitation 2004;60:51–6. 123. Schlomer RS, Anderson MA, Shaw R. Teaching strategies and knowledge reten- 94. Morey JC, Simon R, Jay GD, et al. Error reduction and performance improvement tion. J Nurs Staff Dev 1997;13:249–53. in the emergency department through formal teamwork training: evaluation 124. Perkins GD. Simulation in resuscitation training. Resuscitation results of the MedTeams project. Health Serv Res 2002;37:1553–81. 2007;73:202–11. 95. Perkins GD, Davies RP, Soar J, Thickett DR. The impact of manual defibrillation 125. Campbell DM, Barozzino T, Farrugia M, Sgro M. High-fidelity simulation in technique on no-flow time during simulated cardiopulmonary resuscitation. neonatal resuscitation. Paediatr Child Health 2009;14:19–23. Resuscitation 2007;73:109–14. 126. Donoghue AJ, Durbin DR, Nadel FM, Stryjewski GR, Kost SI, Nadkarni VM. 96. Perkins GD, Lockey AS. Defibrillation-safety versus efficacy. Resuscitation Effect of high-fidelity simulation on Pediatric Advanced Life Support train- 2008;79:1–3. ing in pediatric house staff: a randomized trial. Pediatr Emerg Care 2009;25: 97. Perkins GD, Barrett H, Bullock I, et al. The Acute Care Undergraduate TEach- 139–44. ing (ACUTE) Initiative: consensus development of core competencies in 127. Mayo PH, Hackney JE, Mueck JT, Ribaudo V, Schneider RF. Achieving house staff acute care for undergraduates in the United Kingdom. Intensive Care Med competence in emergency airway management: results of a teaching program 2005;31:1627–33. using a computerized patient simulator. Crit Care Med 2004;32:2422–7. 98. DeVita MA, Smith GB, Adam SK, et al. “Identifying the hospitalised patient in 128. Owen H, Mugford B, Follows V, Plummer JL. Comparison of three crisis” – a consensus conference on the afferent limb of rapid response systems. simulation-based training methods for management of medical emergencies. Resuscitation 2010;81:375–82. Resuscitation 2006;71:204–11. 99. Schwid HA, Rooke GA, Ross BK, Sivarajan M. Use of a computerized advanced 129. Wayne DB, Butter J, Siddall VJ, et al. Simulation-based training of internal cardiac life support simulator improves retention of advanced cardiac life sup- medicine residents in advanced cardiac life support protocols: a randomized port guidelines better than a textbook review. Crit Care Med 1999;27:821–4. trial. Teach Learn Med 2005;17:210–6. 100. Polglase RF, Parish DC, Buckley RL, Smith RW, Joiner TA. Problem-based ACLS 130. Ali J, Cohen RJ, Gana TJ, Al-Bedah KF. Effect of the Advanced Trauma Life Sup- instruction: a model approach for undergraduate emergency medical educa- port program on medical students’ performance in simulated trauma patient tion. Ann Emerg Med 1989;18:997–1000. management. J Trauma 1998;44:588–91. 101. Clark LJ, Watson J, Cobbe SM, Reeve W, Swann IJ, Macfarlane PW. CPR’ 98: a 131. Hunt EA, Vera K, Diener-West M, et al. Delays and errors in cardiopulmonary practical multimedia computer-based guide to cardiopulmonary resuscitation resuscitation and defibrillation by pediatric residents during simulated car- for medical students. Resuscitation 2000;44:109–17. diopulmonary arrests. Resuscitation 2009;80:819–25. 102. Hudson JN. Computer-aided learning in the real world of medical education: 132. Rodgers D, Securro SJ, Pauley R. The Effect of high-fidelity simulation on edu- does the quality of interaction with the computer affect student learning? Med cational outcomes in an advanced cardiovascular life support course. Simul Educ 2004;38:887–95. Healthc 2009;4:200–6. 103. Jang KS, Hwang SY, Park SJ, Kim YM, Kim MJ. Effects of a Web-based teaching 133. Barsuk D, Ziv A, Lin G, et al. Using advanced simulation for recognition and method on undergraduate nursing students’ learning of electrocardiography. correction of gaps in airway and breathing management skills in prehospital J Nurs Educ 2005;44:35–9. trauma care. Anesth Analg 2005;100:803–9, table of contents. 104. Kim JH, Kim WO, Min KT, Yang JY, Nam YT. Learning by computer simulation 134. Kory PD, Eisen LA, Adachi M, Ribaudo VA, Rosenthal ME, Mayo PH. Initial air- does not lead to better test performance than textbook study in the diagnosis way management skills of senior residents: simulation training compared with and treatment of dysrhythmias. J Clin Anesth 2002;14:395–400. traditional training. Chest 2007;132:1927–31. 105. Leong SL, Baldwin CD, Adelman AM. Integrating web-based computer 135. Marshall RL, Smith JS, Gorman PJ, Krummel TM, Haluck RS, Cooney RN. Use of a cases into a required clerkship: development and evaluation. Acad Med human patient simulator in the development of resident trauma management 2003;78:295–301. skills. J Trauma 2001;51:17–21. 106. Rosser JC, Herman B, Risucci DA, Murayama M, Rosser LE, Merrell RC. Effec- 136. Wayne DB, Siddall VJ, Butter J, et al. A longitudinal study of internal tiveness of a CD-ROM multimedia tutorial in transferring cognitive knowledge medicine residents’ retention of advanced cardiac life support skills. Acad Med essential for laparoscopic skill training. Am J Surg 2000;179:320–4. 2006;81:S9–12. 107. Papadimitriou L, Xanthos T, Bassiakou E, Stroumpoulis K, Barouxis D, Iacovi- 137. Cherry RA, Williams J, George J, Ali J. The effectiveness of a human patient dou N. Distribution of pre-course BLS/AED manuals does not influence skill simulator in the ATLS shock skills station. J Surg Res 2007;139:229–35. acquisition and retention in lay rescuers: a randomised study. Resuscitation 138. Curran VR, Aziz K, O’Young S, Bessell C. Evaluation of the effect of a comput- 2010;81:348–52. erized training simulator (ANAKIN) on the retention of neonatal resuscitation 108. Perkins GD, Fullerton JN, Davis-Gomez N, et al. The effect of pre-course e- skills. Teach Learn Med 2004;16:157–64. learning prior to advanced life support training: A randomised controlled trial. 139. Friedman Z, You-Ten KE, Bould MD, Naik V. Teaching lifesaving procedures: the Resuscitation 2010;81:877–81. impact of model fidelity on acquisition and transfer of cricothyrotomy skills to 109. Gerard JM, Scalzo AJ, Laffey SP, Sinks G, Fendya D, Seratti P. Evaluation of a performance on cadavers. Anesth Analg 2008;107:1663–9. novel Web-based pediatric advanced life support course. Arch Pediatr Adolesc 140. Hoadley TA. Learning advanced cardiac life support: a comparison study of Med 2006;160:649–55. the effects of low- and high-fidelity simulation. Nurs Educ Perspect 2009;30: 110. Xie ZZ, Chen JJ, Scamell RW, Gonzalez MA. An interactive multimedia training 91–5. system for advanced cardiac life support. Comput Methods Programs Biomed 141. Iglesias-Vazquez JA, Rodriguez-Nunez A, Penas-Penas M, Sanchez-Santos L, 1999;60:117–31. Cegarra-Garcia M, Barreiro-Diaz MV. Cost-efficiency assessment of Advanced 111. Buzzell PR, Chamberlain VM, Pintauro SJ. The effectiveness of web-based, mul- Life Support (ALS) courses based on the comparison of advanced simulators timedia tutorials for teaching methods of human body composition analysis. with conventional manikins. BMC Emerg Med 2007;7:18. Adv Physiol Educ 2002;26:21–9. 142. Schwartz LR, Fernandez R, Kouyoumjian SR, Jones KA, Compton S. A random- 112. Christenson J, Parrish K, Barabe S, et al. A comparison of multimedia and stan- ized comparison trial of case-based learning versus human patient simulation dard advanced cardiac life support learning. Acad Emerg Med 1998;5:702–8. in medical student education. Acad Emerg Med 2007;14:130–7. 113. Engum SA, Jeffries P, Fisher L. Intravenous catheter training system: 143. Wang XP, Martin SM, Li YL, Chen J, Zhang YM. Effect of emergency care simu- computer-based education versus traditional learning methods. Am J Surg lator combined with problem-based learning in teaching of cardiopulmonary 2003;186:67–74. resuscitation. Zhonghua Yi Xue Za Zhi 2008;88:1651–3. 114. Flynn ER, Wolf ZR, McGoldrick TB, Jablonski RA, Dean LM, McKee EP. Effect of 144. Pottle A, Brant S. Does resuscitation training affect outcome from cardiac three teaching methods on a nursing staff’s knowledge of medication error risk arrest? Accid Emerg Nurs 2000;8:46–51. reduction strategies. J Nurs Staff Dev 1996;12:19–26. 145. Birnbaum ML, Robinson NE, Kuska BM, Stone HL, Fryback DG, Rose JH. Effect of 115. Fordis M, King JE, Ballantyne CM, et al. Comparison of the instructional efficacy advanced cardiac life-support training in rural, community hospitals. Crit Care of Internet-based CME with live interactive CME workshops: a randomized Med 1994;22:741–9. controlled trial. JAMA 2005;294:1043–51. 146. Makker R, Gray-Siracusa K, Evers M. Evaluation of advanced cardiac life support 116. Goldrick B, Appling-Stevens S, Larson E. Infection control programmed in a community teaching hospital by use of actual cardiac arrests. Heart Lung instruction: an alternative to classroom instruction in baccalaureate nursing 1995;24:116–20. education. J Nurs Educ 1990;29:20–5. 147. Schneider T, Mauer D, Diehl P, Eberle B, Dick W. Does standardized mega- 117. Harrington SS, Walker BL. A comparison of computer-based and instructor-led code training improve the quality of pre-hospital advanced cardiac life support training for long-term care staff. J Contin Educ Nurs 2002;33:39–45. (ACLS)? Resuscitation 1995;29:129–34. 118. Jeffries PR. Computer versus lecture: a comparison of two methods of teach- 148. Bruppacher HR, Alam SK, LeBlanc VR, et al. Simulation-based training improves ing oral medication administration in a nursing skills laboratory. J Nurs Educ physicians’ performance in patient care in high-stakes clinical setting of cardiac 2001;40:323–9. surgery. Anesthesiology 2010;112:985–92. 119. Jeffries PR, Woolf S, Linde B. Technology-based vs. traditional instruction. A 149. Wayne DB, Didwania A, Feinglass J, Fudala MJ, Barsuk JH, McGaghie WC. comparison of two methods for teaching the skill of performing a 12-lead ECG Simulation-based education improves quality of care during cardiac arrest Nurs Educ Perspect 2003;24:70–4. team responses at an academic teaching hospital: a case-control study. Chest 120. Miller SW, Jackson RA. A comparison of a multi-media instructional module 2008;133:56–61. with a traditional lecture format for geriatric pharmacy training. Am J Pharm 150. Cavaleiro AP, Guimaraes H, Calheiros F. Training neonatal skills with simula- Educ 1985;49:173–6. tors? Acta Paediatr 2009;98:636–9. 121. O’Leary S, Diepenhorst L, Churley-Strom R, Magrane D. Educational games 151. Knudson MM, Khaw L, Bullard MK, et al. Trauma training in simulation: trans- in an obstetrics and gynecology core curriculum. Am J Obstet Gynecol lating skills from SIM time to real time. J Trauma 2008;64:255–63, discussion 2005;193:1848–51. 63–4.
- 226. 1444 J. Soar et al. / Resuscitation 81 (2010) 1434–1444 152. Miotto HC, Couto BR, Goulart EM, Amaral CF, Moreira Mda C. Advanced cardiac 184. Neily J, DeRosier JM, Mills PD, Bishop MJ, Weeks WB, Bagian JP. Awareness life support courses: live actors do not improve training results compared with and use of a cognitive aid for anesthesiology. Jt Comm J Qual Patient Saf conventional manikins. Resuscitation 2008;76:244–8. 2007;33:502–11. 153. Ali J, Al Ahmadi K, Williams JI, Cherry RA. The standardized live patient 185. Zanner R, Wilhelm D, Feussner H, Schneider G. Evaluation of M-AID, a first aid and mechanical patient models – their roles in trauma teaching. J Trauma application for mobile phones. Resuscitation 2007;74:487–94. 2009;66:98–102. 186. Nelson KL, Shilkofski NA, Haggerty JA, Saliski M, Hunt EA. The use of cogni- 154. Mueller MP, Christ T, Dobrev D, et al. Teaching antiarrhythmic therapy and tive AIDS during simulated pediatric cardiopulmonary arrests. Simul Healthc ECG in simulator-based interdisciplinary undergraduate medical education. 2008;3:138–45. Br J Anaesth 2005;95:300–4. 187. Mikrogianakis A, Osmond MH, Nuth JE, Shephard A, Gaboury I, Jabbour M. 155. Kobayashi L, Lindquist DG, Jenouri IM, et al. Comparison of sudden car- Evaluation of a multidisciplinary pediatric mock trauma code educational ini- diac arrest resuscitation performance data obtained from in-hospital incident tiative: a pilot study. J Trauma 2008;64:761–7. chart review and in situ high-fidelity medical simulation. Resuscitation 188. Farah R, Stiner E, Zohar Z, Zveibil F, Eisenman A. Cardiopulmonary resuscita- 2010;81:463–71. tion surprise drills for assessing, improving and maintaining cardiopulmonary 156. Edelson DP, Eilevstjonn J, Weidman EK, Retzer E, Hoek TL, Abella BS. Capnog- resuscitation skills of hospital personnel. Eur J Emerg Med 2007;14:332–6. raphy and chest-wall impedance algorithms for ventilation detection during 189. Cappelle C, Paul RI. Educating residents: the effects of a mock code program. cardiopulmonary resuscitation. Resuscitation 2010;81:317–22. Resuscitation 1996;31:107–11. 157. Duran R, Aladag N, Vatansever U, Kucukugurluoglu Y, Sut N, Acunas B. Profi- 190. Villamaria FJ, Pliego JF, Wehbe-Janek H, et al. Using simulation to orient code ciency and knowledge gained and retained by pediatric residents after neonatal blue teams to a new hospital facility. Simul Healthc 2008;3:209–16. resuscitation course. Pediatr Int 2008;50:644–7. 191. Hunt EA, Hohenhaus SM, Luo X, Frush KS. Simulation of pediatric trauma stabi- 158. Anthonypillai F. Retention of advanced cardiopulmonary resuscitation knowl- lization in 35 North Carolina emergency departments: identification of targets edge by intensive care trained nurses. Intensive Crit Care Nurs 1992;8:180–4. for performance improvement. Pediatrics 2006;117:641–8. 159. Boonmak P, Boonmak S, Srichaipanha S, Poomsawat S, Knowledge. skill after 192. Hunt EA, Walker AR, Shaffner DH, Miller MR, Pronovost PJ. Simulation brief ACLS training. J Med Assoc Thai 2004;87:1311–4. of in-hospital pediatric medical emergencies and cardiopulmonary arrests: 160. Kaye W, Wynne G, Marteau T, et al. An advanced resuscitation training course highlighting the importance of the first 5 minutes. Pediatrics 2008;121: for preregistration house officers. Journal of the Royal College of Physicians of e34–43. London 1990;24:51–4. 193. Pittman J, Turner B, Gabbott DA. Communication between members of the 161. Semeraro F, Signore L, Cerchiari EL. Retention of CPR performance in anaes- cardiac arrest team – a postal survey. Resuscitation 2001;49:175–7. thetists. Resuscitation 2006;68:101–8. 194. Morgan R, Westmoreland C. Survey of junior hospital doctors’ attitudes to 162. Skidmore MB, Urquhart H. Retention of skills in neonatal resuscitation. Paediatr cardiopulmonary resuscitation. Postgrad Med J 2002;78:413–5. Child Health 2001;6:31–5. 195. Savoldelli GL, Naik VN, Park J, Joo HS, Chow R, Hamstra SJ. Value of debriefing 163. Trevisanuto D, Ferrarese P, Cavicchioli P, Fasson A, Zanardo V, Zacchello F. during simulated crisis management: oral versus video-assisted oral feedback. Knowledge gained by pediatric residents after neonatal resuscitation program Anesthesiology 2006;105:279–85. courses. Paediatr Anaesth 2005;15:944–7. 196. Clay AS, Que L, Petrusa ER, Sebastian M, Govert J. Debriefing in the inten- 164. Young R, King L. An evaluation of knowledge and skill retention following an sive care unit: a feedback tool to facilitate bedside teaching. Crit Care Med in-house advanced life support course. Nurs Crit Care 2000;5:7–14. 2007;35:738–54. 165. Grant EC, Marczinski CA, Menon K. Using pediatric advanced life support in 197. Dine CJ, Gersh RE, Leary M, Riegel BJ, Bellini LM, Abella BS. Improving car- pediatric residency training: does the curriculum need resuscitation? Pediatr diopulmonary resuscitation quality and resuscitation training by combining Crit Care Med 2007;8:433–9. audiovisual feedback and debriefing. Crit Care Med 2008;36:2817–22. 166. O’Steen DS, Kee CC, Minick MP. The retention of advanced cardiac life support 198. Falcone Jr RA, Daugherty M, Schweer L, Patterson M, Brown RL, Garcia VF. knowledge among registered nurses. J Nurs Staff Dev 1996;12:66–72. Multidisciplinary pediatric trauma team training using high-fidelity trauma 167. Hammond F, Saba M, Simes T, Cross R. Advanced life support: retention of simulation. J Pediatr Surg 2008;43:1065–71. registered nurses’ knowledge 18 months after initial training. Aust Crit Care 199. Goffman D, Heo H, Pardanani S, Merkatz IR, Bernstein PS. Improving shoulder 2000;13:99–104. dystocia management among resident and attending physicians using simula- 168. Nadel FM, Lavelle JM, Fein JA, Giardino AP, Decker JM, Durbin DR. Assessing tions. Am J Obstet Gynecol 2008;199, 294 e1–e5. pediatric senior residents’ training in resuscitation: fund of knowledge, tech- 200. Hoyt DB, Shackford SR, Fridland PH, et al. Video recording trauma resuscita- nical skills, and perception of confidence. Pediatr Emerg Care 2000;16:73–6. tions: an effective teaching technique. J Trauma 1988;28:435–40. 169. Napier F, Davies RP, Baldock C, et al. Validation for a scoring system of the ALS 201. Morgan PJ, Tarshis J, LeBlanc V, et al. Efficacy of high-fidelity simulation debrief- cardiac arrest simulation test (CASTest). Resuscitation 2009;80:1034–8. ing on the performance of practicing anaesthetists in simulated scenarios. Br J 170. White JR, Shugerman R, Brownlee C, Quan L. Performance of advanced Anaesth 2009;103:531–7. resuscitation skills by pediatric housestaff. Arch Pediatr Adolesc Med 202. Pope C, Smith A, Goodwin D, Mort M. Passing on tacit knowledge in anaesthe- 1998;152:1232–5. sia: a qualitative study. Med Educ 2003;37:650–5. 171. Rodgers DL, Bhanji F, McKee BR. Written evaluation is not a predictor for skills 203. Scherer LA, Chang MC, Meredith JW, Battistella FD. Videotape review leads to performance in an Advanced Cardiovascular Life Support course. Resuscitation rapid and sustained learning. Am J Surg 2003;185:516–20. 2010;81:453–6. 204. Townsend RN, Clark R, Ramenofsky ML, Diamond DL. ATLS-based video- 172. Kromann CB, Jensen ML, Ringsted C. The effect of testing on skills learning. Med tape trauma resuscitation review: education and outcome. J Trauma Educ 2009;43:21–7. 1993;34:133–8. 173. Kromann CB, Bohnstedt C, Jensen ML, Ringsted C. The testing effect on skills 205. Weng TI, Huang CH, Ma MH, et al. Improving the rate of return of sponta- learning might last 6 months. Adv Health Sci Educ Theory Pract 2009. neous circulation for out-of-hospital cardiac arrests with a formal, structured 174. Choa M, Park I, Chung HS, Yoo SK, Shim H, Kim S. The effectiveness of car- emergency resuscitation team. Resuscitation 2004;60:137–42. diopulmonary resuscitation instruction: animation versus dispatcher through 206. Baskett PJ, Lim A. The varying ethical attitudes towards resuscitation in Europe. a cellular phone. Resuscitation 2008;77:87–94. Resuscitation 2004;62:267–73. 175. Choa M, Cho J, Choi YH, Kim S, Sung JM, Chung HS. Animation-assisted CPRII 207. Sandroni C, Fenici P, Cavallaro F, Bocci MG, Scapigliati A, Antonelli M. Haemo- program as a reminder tool in achieving effective one-person-CPR perfor- dynamic effects of mental stress during cardiac arrest simulation testing on mance. Resuscitation 2009;80:680–4. advanced life support courses. Resuscitation 2005;66:39–44. 176. Ertl L, Christ F. Significant improvement of the quality of bystander first 208. Soar J, Perkins GD, Harris S, et al. The immediate life support course. Resusci- aid using an expert system with a mobile multimedia device. Resuscitation tation 2003;57:21–6. 2007;74:286–95. 209. Soar J, McKay U. A revised role for the hospital cardiac arrest team? Resuscita- 177. Ward P, Johnson LA, Mulligan NW, Ward MC, Jones DL. Improving cardiopul- tion 1998;38:145–9. monary resuscitation skills retention: effect of two checklists designed to 210. Smith GB, Osgood VM, Crane S. ALERT – a multiprofessional training course in prompt correct performance. Resuscitation 1997;34:221–5. the care of the acutely ill adult patient. Resuscitation 2002;52:281–6. 178. Berkenstadt H, Yusim Y, Ziv A, Ezri T, Perel A. An assessment of a point-of- 211. Spearpoint KG, Gruber PC, Brett SJ. Impact of the immediate life support course care information system for the anesthesia provider in simulated malignant on the incidence and outcome of in-hospital cardiac arrest calls: an observa- hyperthermia crisis. Anesth Analg 2006;102:530–2. tional study over 6 years. Resuscitation 2009;80:638–43. 179. Lerner C, Gaca AM, Frush DP, et al. Enhancing pediatric safety: assessing and 212. Nolan J. Advanced life support training. Resuscitation 2001;50:9–11. improving resident competency in life-threatening events with a computer- 213. Perkins G, Lockey A. The advanced life support provider course. BMJ based interactive resuscitation tool. Pediatr Radiol 2009;39:703–9. 2002;325:S81. 180. Schneider AJ, Murray WB, Mentzer SC, Miranda F, Vaduva S. “Helper:” A critical 214. Ringsted C, Lippert F, Hesselfeldt R, et al. Assessment of advanced life support events prompter for unexpected emergencies. J Clin Monit 1995;11:358–64. competence when combining different test methods – reliability and validity. 181. Dyson E, Voisey S, Hughes S, Higgins B, McQuillan PJ. Educational psychol- Resuscitation 2007;75:153–60. ogy in medical learning: a randomised controlled trial of two aide memoires 215. Perkins GD, Davies RP, Stallard N, Bullock I, Stevens H, Lockey A. Advanced for the recall of causes of electromechanical dissociation. Emerg Med J life support cardiac arrest scenario test evaluation. Resuscitation 2007;75: 2004;21:457–60. 484–90. 182. McCallum Z, South M. Development and use of a portable paediatric resusci- 216. Buss PW, McCabe M, Evans RJ, Davies A, Jenkins H. A survey of basic resuscita- tation card. J Paediatr Child Health 2004;40:477–80. tion knowledge among resident paediatricians. Arch Dis Child 1993;68:75–8. 183. Mills PD, DeRosier JM, Neily J, McKnight SD, Weeks WB, Bagian JP. A cognitive 217. Carapiet D, Fraser J, Wade A, Buss PW, Bingham R. Changes in paediatric resus- aid for cardiac arrest: you can’t use it if you don’t know about it. Jt Comm J Qual citation knowledge among doctors. Arch Dis Child 2001;84:412–4. Saf 2004;30:488–96.
- 227. Resuscitation 81 (2010) 1445–1451 Contents lists available at ScienceDirect Resuscitation journal homepage: www.elsevier.com/locate/resuscitation European Resuscitation Council Guidelines for Resuscitation 2010 Section 10. The ethics of resuscitation and end-of-life decisions Freddy K. Lippert a,∗ , Violetta Raffay b , Marios Georgiou c , Petter A. Steen d , Leo Bossaert e a The Capital Region of Denmark, Copenhagen, Denmark b Municipal Institute for Emergency Medicine Novi Sad, Novi Sad, AP Vojvodina, Serbia c Nicosia General Hospital, Nicosia Cyprus, Cyprus Resuscitation Council, Cyprus d University of Oslo, Norway e Department of Critical Care, University of Antwerp, Antwerp, Belgium Introduction tant, which is why information for healthcare providers is included in these resuscitation guidelines. Sudden unexpected cardiac arrest is an event with often dev- This section of the guidelines deals with some recurring ethical astating consequences to the individual victim, family and friends. aspects and end-of-life decisions. While some resuscitation attempts are successful with good long- term outcome, the majority are not, despite significant efforts and • Key principles of ethics some improvements during the last decade. • Sudden death in a global perspective Healthcare professionals are obliged to do what is necessary to • Outcome and prognostication protect and save lives. Society as a whole and especially emergency • When to start and when to stop resuscitation attempts medical services (EMS), hospitals and other healthcare institutions • Advance directives and do-not-attempt resuscitation orders need to plan for, organise and provide an appropriate response • Organ procurement in case of sudden cardiac arrest. This often implies the use of • Family presence during resuscitation many resources and high costs, especially in the more affluent • Research in resuscitation and informed consent countries. New technology and medical evidence and increasing • Research and training on the recently dead expectations of the public have rendered ethical considerations an important part of any end-of-life intervention or decision. This Principles of ethics includes achieving the best results for the individual patient, rela- tives and for society as whole by appropriate allocation of available resources. The key principles of ethics are referred to as autonomy, benef- Several considerations are required to ensure that decisions to icence, non-maleficence, justice and further more dignity and attempt or withhold resuscitation attempts are appropriate, and honesty.12 that patients are treated with dignity. These decisions are complex Autonomy is the right of the patient to accept or refuse any treat- and may be influenced by individual, international and local cul- ment. Autonomy relates to patients being able to make informed tural, legal, traditional, religious, social and economic factors.1–11 decisions on their own behalf, rather than being subjected to Sometimes the decisions can be made in advance, but often paternalistic decisions being made for them by healthcare pro- these difficult decisions have to be made in a matter of seconds fessionals. This principle has been introduced during the past or minutes at the time of the emergency and especially in the out- 40 years, arising from legislature, primarily the Helsinki Decla- of-hospital setting, based upon limited information. Therefore it ration of Human Rights and its subsequent modifications and is important that healthcare providers understand the principles amendments.13 Autonomy requires that the patient is adequately involved before they are faced with a situation where a decision informed, competent, free from undue pressure and that there is to resuscitate or not must be made. For healthcare professionals consistency in the patient’s preferences. The principle is considered end-of-life decisions and ethical considerations should be made in universal in medical practice; however, it may often be difficult to advance and in the context of the society. Although there is little apply in an emergency, such as sudden cardiac arrest. science to guide end-of-life decision-making, the subject is impor- Non-maleficence means doing no harm or, even more appro- priate, no further harm. Resuscitation should not be attempted in obviously futile cases. Beneficence implies that healthcare providers must provide ben- ∗ Corresponding author. efits in the best interest of the individual patient while balancing E-mail address: lippert@regionh.dk (F.K. Lippert). benefit and risks. Commonly, this will involve attempting resusci- 0300-9572/$ – see front matter © 2010 European Resuscitation Council. Published by Elsevier Ireland Ltd. All rights reserved. doi:10.1016/j.resuscitation.2010.08.013
- 228. 1446 F.K. Lippert et al. / Resuscitation 81 (2010) 1445–1451 tation, but on occasion it will mean withholding cardiopulmonary pool of survivors with an unacceptable quality of life. Cardiac arrest resuscitation (CPR). survivors may experience post-arrest problems including anxiety, Justice implies the concern and duty to distribute limited health depression, post-traumatic stress, and difficulties with cognitive resources equally within a society, and the decision of who gets function. Clinicians should be aware of these potential problems, what treatment (fairness and equality). If resuscitation is provided, screen for them and, if found, treat them.23–38 Future interven- it should be made available to all who will benefit from it within tional resuscitation studies should include long-term follow up the frame of available resources. evaluation. Dignity and honesty are frequently added as essential elements of ethics. Patients always have the right to be treated with dignity Prognostication in cardiac arrest and information should be honest without suppressing important facts. Transparency and disclosure of conflict of interests (COI) is In well-developed pre-hospital systems, about one third to one another important part of the ethics of medical professionalism. half of patients may achieve Return of Spontaneous Circulation The importance of this is emphasized by the COI policy operated by (ROSC) with CPR, with a smaller proportion surviving to the hos- the International Liaison Committee on Resuscitation (ILCOR).14 pital critical care unit, and an even smaller proportion surviving to hospital discharge with good neurological outcome. Prognostica- Sudden death in a global perspective tion is of the essence to guide clinicians, and it would be important to be able to predict poor outcome with high specificity to reduce In Europe, with 46 countries and with a population on the unnecessary burden on the patient, family members and health European continent of 730 million, the incidence of sudden car- care providers, and reduce inappropriate use of resources. Unfor- diac arrest is estimated at between 0.4 and 1 per 1000 inhabitants tunately, there are currently no valid tools for prognostication of per year, thus involving between 350,000 and 700,000 people.15 poor outcome in the emergency setting, including the first few Approximately, 275,000 persons have a cardiac arrest treated by hours after ROSC. In fact, prediction of final neurological outcome the EMS in Europe.16 Out-of-hospital cardiac arrest is the third lead- in patients remaining comatose after ROSC is difficult during the ing cause of death in the USA.17 In Europe and USA ischaemic heart first 3 days.39 The inclusion of therapeutic hypothermia has further disease is considered the main cause of sudden cardiac arrest. challenged the previously established prognostic criteria.40 Health challenges look different in a worldwide perspective. Certain circumstances, for example hypothermia at the time of In the World Health Organization (WHO) 2002 Annual Report, cardiac arrest, will enhance the chances of recovery without neuro- two extreme findings are found almost side by side: 170 million logical damage, and the normal prognostic criteria (such as asystole children in poor countries were underweight, causing over three persisting for more than 20 min) are not applicable.41 million deaths yearly, and on the other extreme at least 300 mil- lion adults worldwide were overweight or clinically obese with When to start and when to stop resuscitation high risk of sudden cardiac arrest.18 In parallel, the cause of sudden attempts? death differs widely across the world. Outside Europe and North America, cardiac arrest of non-cardiac aetiology, such as trauma, In all cases of sudden cardiac arrest the healthcare provider is drowning or newborn asphyxia, is more important than cardiac being challenged with two main questions: when to start and when aetiology. More than 1.3 million people die yearly in road traffic to stop resuscitation attempts? In the individual case, the decision accidents.19 In 2008, there were 8.8 million deaths among children to start, continue or to terminate resuscitation attempts, is based less than 5 years old, with considerable inequities between coun- on the difficult balance between the benefits, risks and cost these tries. Diarrhoea and pneumonia still kill almost 3 million children interventions will place on patient, family members and healthcare less than 5 years old annually, especially in low-income countries. providers. In a broader perspective, cost to the society and health And about one third of deaths among children less than five years of care system is part of this. The standard of care remains the prompt age occur in the first month of life. More than 500,000 women die of initiation of CPR. However, ethical principles such as beneficence, complications during pregnancy or childbirth, 99% of them in devel- non-maleficence, autonomy, and justice have to be applied in the oping countries.20,21 Worldwide, it is estimated that approximately unique setting of emergency medicine. Physicians have to consider 150,000 people die from drowning each year, and the majority are the therapeutic efficacy of CPR, the potential risks, and the patient’s children.22 preferences.42,43 In summary, sudden death is a worldwide challenge. Aetiology Resuscitation is inappropriate and should not be provided when differs and treatment and prevention have to be tailored to the there is clear evidence that it will be futile or is against the local problems and resources. The obligation and challenges to pro- expressed wishes of the patient. Systems should be established to tect and save lives are evident both from the local and the global communicate these prospective decisions and simple algorithms perspective. should be developed to assist rescuers in limiting the burden of futile and unnecessary costly treatments. One prospective study Outcome from sudden cardiac arrest demonstrated that a basic life support termination of resuscitation rule (no shockable rhythm, unwitnessed by EMS and no return of Resuscitation efforts often focus on sudden and unexpected spontaneous circulation) was predictive of death when applied by cardiac arrest that should have been prevented. Included in the defibrillation-only emergency medical technicians.44 Subsequent decision on whether to commence resuscitation is the likelihood studies showed external generalisability of this rule, but it has of success and, if initially successful, the quality of life that can also been challenged.45–47 Prospectively validated termination of be expected following hospital discharge. Reliable and valid data resuscitation rules are recommended to guide termination of pre- are therefore essential to guide healthcare providers. Resuscitation hospital CPR in adults. Other rules for various provider levels, attempts are unsuccessful in 70–98% of cases and death ultimately including in-hospital providers, may be helpful to reduce variability is inevitable. in decision-making; but all rules should be validated prospectively Several studies have demonstrated that successful resuscitation before implementation. The implementation of a termination rule after cardiac arrest produces a good quality of life in most survivors. will carry a self-fulfilling prophecy, and should be challenged peri- There is little evidence to suggest that resuscitation leads to a large odically as new treatments evolve.
- 229. F.K. Lippert et al. / Resuscitation 81 (2010) 1445–1451 1447 Who should decide not to attempt resuscitation? mation is gathered. If it becomes clear that the underlying cause renders the situation to be futile, then resuscitation should be aban- Resuscitation protocols or standard operating procedures doned if the patient remains in asystole with all ALS measures in should define who has the obligation and responsibility to make the place. Additional information such as an advance directive may difficult decision not to attempt resuscitation or to abandon further become available and may render discontinuation of the resuscita- attempts. This goes for the pre-hospital and in-hospital setting and tion attempt ethically correct. might vary according to legislation, culture or local tradition. In general, resuscitation should be continued as long as VF In hospital, the decision is usually made, after appropriate con- persists. It is generally accepted that ongoing asystole for more sultations, by the senior physician in charge of the patient or the than 20 min in the absence of a reversible cause, and with ongo- leader of the resuscitation team when called. Medical emergency ing ALS, constitutes grounds for abandoning further resuscitation teams (METs), acting in response to concern about a patient’s con- attempts.60 There are, of course, reports of exceptional cases dition from ward staff, can initiate DNAR decisions.48–50 In the that do not support the general rule, and each case must be pre-hospital setting, in the absence of doctors, the decision can be assessed individually. Ultimately, the decision is based on the clin- made according to standard protocols or after consultation with a ical judgement that the patient’s arrest is unresponsive to ALS. In physician. out-of-hospital cardiac arrest of cardiac origin, if recovery is going Legislation on who can make decisions about death varies to occur, ROSC usually takes place on site. Patients with primary within countries. Many out-of-hospital cardiac arrest cases are cardiac arrest, who require ongoing CPR without any return of a attended by emergency medical technicians (EMTs) or paramedics, pulse during transport to hospital, rarely survive neurologically who face similar dilemmas about when to determine if resus- intact.61,62 citation is futile and when it should be abandoned. In general, Many will persist with the resuscitation attempt for longer if resuscitation is started in out-of-hospital cardiac arrest unless there the patient is a child. This decision is not generally justified on sci- is a valid advanced directive to the contrary or it is clear that entific grounds, though new data are encouraging.63 Nevertheless, resuscitation would be futile in cases of a mortal injury, such as the decision to persist in the distressing circumstances of the death decapitation, rigor mortis, dependent lividity and fetal maceration. of a child is understandable, and the potential enhanced recruit- In such cases, the non-physician is making a diagnosis of death but ment of cerebral cells in children after an ischaemic insult is an is not certifying death, which, in most countries, can be done only as yet unknown factor. If faced with a newly born baby with no by a physician. detectable heart rate, which remains undetectable for 10 min, it is appropriate to then consider stopping resuscitation.64 What constitutes futility? Advance directives Futility exists if resuscitation will be of no benefit in terms of prolonging life of acceptable quality. It is problematic that, Advance directives have been introduced in many coun- although predictors for non-survival after attempted resuscitation tries, emphasizing the importance of patient autonomy. Advance have been published, none have been tested on an indepen- directives are a method of communicating the patient’s wishes dent patient sample with sufficient predictive value, apart from concerning future care, particularly towards the end-of-life, and end-stage multi-organ failure with no reversible cause.51–56 Fur- must be expressed while the patient is mentally competent and thermore, studies on resuscitation are particularly dependent on not under duress. Advance directives are likely to specify limita- system factors such as time to start of CPR, time to defibrillation, tions concerning terminal care, including the withholding of CPR. etc. These intervals may be prolonged in any study cohort but are This may help healthcare attendants in assessing the patient’s often not applicable to an individual case. Inevitably, judgements wishes should the patient later become mentally incompetent. will have to be made, and there will be grey areas where subjec- However, challenges can arise. The relative may misinterpret tive opinions are required in patients with heart failure and severe the wishes of the patient, or may have a vested interest in the respiratory compromise, asphyxia, major trauma, head injury and death (or continued existence) of the patient. On the other hand, neurological disease. The age of the patient may influence the deci- healthcare providers tend to underestimate sick patients’ desire to sion but age itself is only a relatively weak independent predictor of live. outcome.56–58 However, high age is frequently associated with co- Written directions by the patient, legally administered living morbidity, which does have an influence on prognosis. At the other wills or powers of attorney may eliminate some of these prob- end of the scale, most physicians will err on the side of intervention lems but are not without limitations. The patient should describe in children for emotional reasons, even though the overall progno- as precisely as possible the situation envisaged when life support sis in children is often worse than in adults. It is therefore important should be withheld or discontinued. This may be aided by a medi- that clinicians understand the factors that influence resuscitation cal adviser. For instance, most people would prefer not to undergo success. CPR in the presence of end-stage multi-organ failure with no obvi- ous reversible cause, but the same persons would welcome the When to abandon further resuscitation attempts attempt at resuscitation should ventricular fibrillation (VF) occur in association with a remediable primary cardiac cause. Patients often The vast majority of resuscitation attempts do not succeed and change their minds with changes in circumstances, and therefore therefore have to be abandoned. Several factors will influence the the advanced directive should be as recent as possible and take into decision to stop the resuscitative effort. These will include the account any change of circumstances. medical history and anticipated prognosis from factors such as the In sudden out-of-hospital cardiac arrest, the attendants usually period between cardiac arrest and start of CPR by bystanders and do not know the patient’s situation and wishes, and an advance by healthcare professionals, the initial ECG rhythm, the interval to directive is often not readily available. In these circumstances, defibrillation and the period of advanced life support (ALS) with resuscitation should begin immediately and questions addressed continuing asystole, no reversible causes and no ROSC.59 later. There is no ethical difference in stopping the resuscita- In many cases, particularly in out-of-hospital cardiac arrest, the tion attempt that has started if the healthcare providers are later underlying cause of arrest may be unknown or merely surmised, presented with an advance directive limiting care. There is con- and the decision is made to start resuscitation while further infor- siderable international variation in the medical attitude towards
- 230. 1448 F.K. Lippert et al. / Resuscitation 81 (2010) 1445–1451 written advance directives.1 In some countries, the written advance tative measures to enable organ donation to take place mechanical directive is considered to be legally binding; in others not. chest compressions may be valuable in these circumstances.79,80 DNAR orders Family presence during resuscitation A do-not-attempt resuscitation (DNAR) order (also described The concept of a family member being present during the resus- more recently as a DNACPR decision) is a binding legal docu- citation process was introduced in the 1980s and has become ment that states that resuscitation should not be attempted in the accepted practice in many countries.81–86 Many relatives would event of cardiac or respiratory arrest; meaning that CPR should like to be present during resuscitation attempts and, of those who not be performed. Other treatment should be continued, partic- have had this experience, over 90% would wish to do so again. Most ularly pain relief and sedation, as required and indicated, if they parents would wish to be with their child at this time.82 are considered to be contributing to the quality of life. If not, Relatives have considered several benefits from being permit- orders not to continue or initiate any such treatments should be ted to be present during a resuscitation attempt, including coming specified independently of DNAR orders. For many years, DNAR to terms with the reality of death. However, this is a choice entirely orders in many countries were written by single doctors, often to be made by the relatives. Several measures are required to without consulting the patient, relatives or other health person- ensure that the experience of the relative is the best under the cir- nel, but there are now clear procedural requirements in many cumstances. This includes allocating personnel to take care of the countries.65 relatives.87,88 Although the ultimate responsibility and decision for DNAR In the event of an out-of-hospital arrest, the relatives may rests with the senior doctor in charge of the patient, it is wise for this already be present, and possibly performing basic life support (BLS). individual to consult others before making the decision. Following They should be offered the same choices and appreciation of their the principle of patient autonomy it is wise, if possible, to ascer- effort as bystander offering BLS. With increasing experience of fam- tain the patient’s wishes about a resuscitation attempt. This must ily presence during resuscitation attempts, it is clear that problems be done in advance, when the patient is able to make an informed rarely arise. Fifteen years ago, most staff would not have counte- choice. Opinions vary as to whether such discussions should occur nanced the presence of relatives during resuscitation, but there is routinely for every hospital admission or only if the diagnosis of an increasingly open attitude and appreciation of the autonomy of a potentially life-threatening condition is made. In presenting the both patient and relatives.1 Cultural and social variations still exist, facts to the patient, the doctor must be as certain as possible of the and must be understood and appreciated with sensitivity. diagnosis and prognosis and may seek a second medical opinion in this matter. It is vital that the doctor should not allow personal life values to distort the discussion—in matters of acceptability of Research in resuscitation and informed consent a certain quality of life, the patient’s opinion should prevail. It is considered essential for the doctor to have discussions with close There is an essential need to improve the quality of resuscita- relatives if at all possible. Whereas they may influence the doctor’s tion and thereby the long-term outcome. To achieve this, research decision, it should be made clear to them that the ultimate respon- and randomised clinical trials are crucial, not only to introduce sibility and decision will be that of the doctor. It is neither fair nor new and better interventions, but also to abandon the use of inef- reasonable to place the burden of decision on the relative. ficient and costly procedures and medications, whether old or According to the principle of autonomy, patients have the right new. As the ILCOR 2010 consensus on CPR and ECC Science clearly to refuse treatment; however, they do not have an automatic right reveals many current practises are based upon tradition and not on to demand a specific treatment—they cannot insist that resuscita- science.89,90 tion must be attempted in any circumstance. A doctor is required There are important ethical issues relating to undertaking ran- only to provide treatment that is likely to benefit the patient, and domised clinical trials for patients in cardiac arrest who cannot is not required to provide treatment that would be futile. However, give informed consent to participate in research studies. Progress it would be wise to seek a second opinion in making this decision, in improving the dismal rates of successful resuscitation will only for fear that the doctor’s own personal values, or the question of come through the advancement of science through clinical stud- available resources, might influence his or her opinion.66 ies. The utilitarian concept in ethics looks to the greatest good In adult cardiac arrest various studies have addressed the impact for the greatest number of people. This must be balanced with of advance directives and DNAR orders in directing appropri- respect for patient autonomy, according to which patients should ate resuscitation efforts. Most of these studies are old and often not be enrolled in research studies without their informed con- contradictory.67–76 Standardised orders for limiting life-sustaining sent. Over the past decade, legal directives have been introduced treatments decrease the incidence of futile resuscitation attempts into the USA and the European Union91,92 that place signifi- and should ensure that adult patient wishes are honoured. Instruc- cant barriers to research on patients during resuscitation without tions should be specific, detailed, and transferable across health informed consent from the patient or immediate relative.93 There care settings, and easily understood. Processes, protocols, and sys- are data showing that such regulations deter research progress in tems should be developed that fit within local cultural norms resuscitation.94 It can be argued that these directives may in them- and legal limitations to allow providers to honour patient wishes selves conflict with the fundamental human right to good medical regarding resuscitation efforts. treatment as set down in the Helsinki Declaration.13 The US author- ities have, to a very limited extent, sought to introduce methods of exemption,95 but these are still associated with problems and Organ procurement almost insurmountable difficulties.94,96,97 The issue of initiating life-prolonging treatment or continu- ing otherwise futile resuscitation attempts with the sole purpose Research and training on the recently dead of harvesting organs is debatable.77,78 There is variation between countries and cultures about the ethics of this process; at present no Research on the recently dead encounters similar restrictions consensus exists. If considering prolonging CPR and other resusci- unless previous permission is granted as part of an advance direc-
- 231. F.K. Lippert et al. / Resuscitation 81 (2010) 1445–1451 1449 tive by the patient, or permission can be given immediately by the 8. Konishi E. Nurses’ attitudes towards developing a do not resuscitate policy in Japan. Nursing Ethics 1998;5:218–27. relative. The management of resuscitation can be taught using sce- 9. Muller JH, Desmond B. Ethical dilemmas in a cross-cultural context. A Chinese narios with manikins and simulators or animal models, but training example. West J Med 1992;157:323–7. in certain skills required during resuscitation is difficult. Therefore 10. Edgren E. The ethics of resuscitation, differences between Europe and the the question arises as to whether it is ethically and morally appro- USA—Europe should not adopt American guidelines without debate. Resus- citation 1992;23:85–90. priate to undertake training and practice on the living or the dead. 11. Bülow H-H, Sprung C, Reinhart K, et al. The world’s major religions’ points There is a wide diversity of opinion on this matter.98,99 Many, par- of viewon end-of-life decisions in the intensive care unit. Intens Care Med ticularly those in the Islamic nations, find the concept of any skills 2008;34:423–30. 12. Beauchamp TL, Childress J. Principles of biomedical ethics. 6th ed. Oxford: training and practice on the recently dead completely unaccept- Oxford University Press; 2008. able because of an innate respect for the deceased. Others will 13. Association WM.Declaration of Helsinki Ethical principles for medical research accept the practice of non-invasive procedures that do not leave involving human subjects adopted by the 18th WMA General Assembly Helsinki, Finland, June 1964 and amended at the 29th, 35th, 41st, 48th, 52nd, a mark; and some accept that any procedure may be learned on 55th and 59th WMA Assemblies. Helsinki: World Medical Association; 1964. the dead body with the justification that the learning of skills is 14. Shuster M, Billi JE, Bossaert L, et al. International consensus on car- paramount for the well being of future patients. One option is to diopulmonary resuscitation and emergency cardiovascular care science with treatment recommendations. Part 4: Conflict of interest man- request informed consent for the procedure from the relative of agement before, during, and after the 2010 International Consensus the deceased. It is advised that healthcare professionals learn local Conference on Cardiopulmonary Resuscitation and Emergency Cardiovas- and hospital policies regarding this issue and follow the established cular Care Science With Treatment Recommendations. Resuscitation 2010; doi:10.1016/j.resuscitation.2010.08.024, in press. policy. 15. Sans S, Kesteloot H, Kromhout D. The burden of cardiovascular diseases mortality in Europe. Task Force of the European Society of Cardiology on Cardiovascular Mortality and Morbidity Statistics in Europe. Eur Heart J Summary 1997;18:1231–48. 16. Atwood C, Eisenberg MS, Herlitz J, Rea TD. Incidence of EMS-treated out-of- hospital cardiac arrest in Europe. Resuscitation 2005;67:75–80. Sudden unexpected cardiac arrest is a global challenge. Some 17. Nichol G, Aufderheide TP, Eigel B, et al. Regional systems of care for out- deaths are preventable and some arrests can be treated success- of-hospital cardiac arrest: a policy statement from the American Heart fully and result in a very good long-term outcome. However, most Association. Circulation 2010;121:709–29. 18. Organisation WH. World Health Report 2002; 2002. resuscitation attempts are futile and death is inevitable. End-of-life 19. Organisation WH. Global status report on road safety 2009. decision is an important part of resuscitation. 20. Organisation WH. WHO World Health Statistics 2009 and 2010; 2009. Scientific evidence does not provide much guidance for end- 21. Black RE, Cousens S, Johnson HL, et al. Global, regional, and national causes of child mortality in 2008: a systematic analysis. Lancet 2010;375:1969–87. of-life-decisions. Nevertheless, because of the importance of the 22. Layon AJ, Modell JH. Drowning: update 2009. Anesthesiology 2009;110: subject, the ERC has produced this guidance on this important 1390–401. and difficult topic for healthcare providers. End-of-life decisions 23. Moulaert VRMP, Verbunt JA, van Heugten CM, Wade DT. Cognitive impairments in survivors of out-of-hospital cardiac arrest: a systematic review. Resuscita- are complex and may be influenced by individual, international tion 2009;80:297–305. and local cultural, legal, traditional, religious, social and economic 24. Holler NG, Mantoni T, Nielsen SL, Lippert F, Rasmussen LS. Long-term survival factors. Solutions should be tailored accordingly. Sometimes the after out-of-hospital cardiac arrest. Resuscitation 2007;75:23–8. decisions can be made in advance, but often these difficult decisions 25. van Alem AP, de Vos R, Schmand B, Koster RW. Cognitive impairment in sur- vivors of out-of-hospital cardiac arrest. Am Heart J 2004;148:416–21. have to be made in an emergency and based upon limited informa- 26. Bunch TJ, White RD, Gersh BJ, et al. Long-term outcomes of out-of-hospital tion. Therefore it is important that healthcare providers understand cardiac arrest after successful early defibrillation. N Engl J Med 2003;348: the principles involved, the challenges and the need for research 2626–33. 27. Nichol G, Stiell IG, Hebert P, Wells GA, Vandemheen K, Laupacis A. What is the in resuscitation. End-of-life decisions and ethical considerations quality of life for survivors of cardiac arrest? A prospective study. Acad Emerg should be reflected in advance through education, discussions and Med 1999;6:95–102. debriefings for health care professionals to further strengthen indi- 28. Stiell I, Nichol G, Wells G, et al. Health-related quality of life is better for cardiac arrest survivors who received citizen cardiopulmonary resuscitation. Circula- vidual ethical competence. tion 2003;108:1939–44. 29. Granja C, Cabral G, Pinto AT, Costa-Pereira A. Quality of life 6-months after cardiac arrest. Resuscitation 2002;55:37–44. Acknowledgement 30. Lettieri C, Savonitto S, De Servi S, et al. Emergency percutaneous coronary inter- vention in patients with ST-elevation myocardial infarction complicated by out-of-hospital cardiac arrest: early and medium-term outcome. Am Heart J This section is dedicated in honour of the late Peter J.F. Baskett, 2009;157:569–75, e1. who was the previous and original author of these guidelines on 31. Tiainen M, Poutiainen E, Kovala T, Takkunen O, Happola O, Roine RO. Cogni- tive and neurophysiological outcome of cardiac arrest survivors treated with ethics100 . therapeutic hypothermia. Stroke 2007;38:2303–8. 32. Graf J, Muhlhoff C, Doig GS, et al. Health care costs, long-term survival, and quality of life following intensive care unit admission after cardiac arrest. Crit References Care 2008;12:R92. 33. Horsted TI, Rasmussen LS, Meyhoff CS, Nielsen SL. Long-term prognosis after out-of-hospital cardiac arrest. Resuscitation 2007;72:214–8. 1. Baskett PJ, Lim A. The varying ethical attitudes towards resuscitation in Europe. 34. Saner H, Borner Rodriguez E, Kummer-Bangerter A, Schuppel R, von Planta M. Resuscitation 2004;62:267–73. Quality of life in long-term survivors of out-of-hospital cardiac arrest. Resus- 2. da Costa DE, Ghazal H, Al Khusaiby S. Do not resuscitate orders and ethical citation 2002;53:7–13. decisions in a neonatal intensive care unit in a Muslim community. Arch Dis 35. O’Reilly SM, Grubb NR, O’Carroll RE. In-hospital cardiac arrest leads to chronic Child Fetal Neonatal Ed 2002;86:F115–9. memory impairment. Resuscitation 2003;58:73–9. 3. Richter J, Eisemann M, Zgonnikova E. Doctors’ authoritarianism in end-of-life 36. Lundgren-Nilsson A, Rosen H, Hofgren C, Sunnerhagen KS. The first year after treatment decisions. A comparison between Russia, Sweden and Germany. J successful cardiac resuscitation: function, activity, participation and quality of Med Ethics 2001;27:186–91. life. Resuscitation 2005;66:285–9. 4. De Leeuw R, Cuttini M, Nadai M, et al. Treatment choices for extremely preterm 37. Iwami T, Kawamura T, Hiraide A, et al. Effectiveness of bystander-initiated infants: an international perspective. J Pediatr 2000;137:608–16. cardiac-only resuscitation for patients with out-of-hospital cardiac arrest. Cir- 5. Sprung CL, Cohen SL, Sjokvist P, et al. End-of-life practices in European intensive culation 2007;116:2900–7. care units: the ethicus study. JAMA 2003;290:790–7. 38. Peberdy MA, Kaye W, Ornato JP, et al. Cardiopulmonary resuscitation of adults 6. Ho NK. Decision-making: initiation and withdrawing life support in the in the hospital: a report of 14720 cardiac arrests from the National Registry of asphyxiated infants in developing countries. Singapore Med J 2001;42:402–5. Cardiopulmonary Resuscitation. Resuscitation 2003;58:297–308. 7. Cuttini M, Nadai M, Kaminski M, et al. End-of-life decisions in neonatal inten- 39. Deakin CD, Nolan JP, Soar J, et al. European Resuscitation Council Guidelines sive care: physicians’ self-reported practices in seven European countries. for Resuscitation 2010. Section 4. Adult Advanced Life Support. Resuscitation Lancet 2000;355:2112–8. 2010;81:1305–52.
- 232. 1450 F.K. Lippert et al. / Resuscitation 81 (2010) 1445–1451 40. Rossetti AO, Oddo M, Logroscino G, Kaplan PW. Prognostication after cardiac gram of All-Inclusive Care for the Elderly. J Am Geriatr Soc 2000;48: arrest and hypothermia: a prospective study. Ann Neurol 2010;67:301–7. 1343–4. 41. Gilbert M, Busund R, Skagseth A, Nilsen PÅ, Solbø JP. Resuscitation from acci- 71. Schmidt TA, Hickman SE, Tolle SW, Brooks HS. The physician orders for dental hypothermia of 13.7 ◦ C with circulatory arrest. Lancet 2000;355:375–6. life-sustaining treatment program: Oregon emergency medical technicians’ 42. Mohr M, Kettler D. Ethical aspects of emergency medicine. Anaesthesist practical experiences and attitudes. J Am Geriatr Soc 2004;52:1430–4. 1997;46:275–81. 72. Hickman SE, Nelson CA, Moss AH, et al. Use of the Physician Orders for Life- 43. Horsted TI, Rasmussen LS, Lippert FK, Nielsen SL. Outcome of out-of-hospital Sustaining Treatment (POLST) paradigm program in the hospice setting. J cardiac arrest—why do physicians withhold resuscitation attempts? Resusci- Palliat Med 2009;12:133–41. tation 2004;63:287–93. 73. Teno J, Lynn J, Connors Jr AF, et al. The illusion of end-of-life resource savings 44. Morrison LJ, Visentin LM, Kiss A, et al. Validation of a rule for termination of with advance directives. SUPPORT Investigators. Study to Understand Prog- resuscitation in out-of-hospital cardiac arrest. N Engl J Med 2006;355:478–87. noses and Preferences for Outcomes and Risks of Treatment. J Am Geriatr Soc 45. Richman PB, Vadeboncoeur TF, Chikani V, Clark L, Bobrow BJ. Independent eval- 1997;45:513–8. uation of an out-of-hospital termination of resuscitation (TOR) clinical decision 74. Schneiderman LJ, Kronick R, Kaplan RM, Anderson JP, Langer RD. Effects of rule. Acad Emerg Med 2008;15:517–21. offering advance directives on medical treatments and costs. Ann Intern Med 46. Morrison LJ, Verbeek PR, Zhan C, Kiss A, Allan KS. Validation of a universal 1992;117:599–606. prehospital termination of resuscitation clinical prediction rule for advanced 75. Teno JM, Stevens M, Spernak S, Lynn J. Role of written advance directives in and basic life support providers. Resuscitation 2009;80:324–8. decision making: insights from qualitative and quantitative data. J Gen Intern 47. Skrifvars MB, Vayrynen T, Kuisma M, et al. Comparison of Helsinki and Euro- Med 1998;13:439–46. pean Resuscitation Council “do not attempt to resuscitate” guidelines, and a 76. Teno J, Lynn J, Wenger N, et al. Advance directives for seriously ill hospi- termination of resuscitation clinical prediction rule for out-of-hospital cardiac talized patients: effectiveness with the patient self-determination act and arrest patients found in asystole or pulseless electrical activity. Resuscitation the SUPPORT intervention SUPPORT Investigators. Study to Understand Prog- 2010;81:679–84. noses and Preferences for Outcomes and Risks of Treatment. J Am Geriatr Soc 48. Hillman K, Chen J, Cretikos M, et al. Introduction of the medical emergency team 1997;45:500–7. (MET) system: a cluster-randomised controlled trial. Lancet 2005;365:2091–7. 77. Bell D. Emergency medicine and organ donation—a core responsibility at a time 49. Parr MJ, Hadfield JH, Flabouris A, Bishop G, Hillman K. The Medical Emergency of need or threat to professional integrity. Resuscitation 2010;81:1061–2. Team: 12 month analysis of reasons for activation, immediate outcome and 78. Rady MY, Verheijde JL, McGregor JL. Scientific, legal, and ethical challenges not-for-resuscitation orders. Resuscitation 2001;50:39–44. of end-of-life organ procurement in emergency medicine. Resuscitation 50. Hillman K, Parr M, Flabouris A, Bishop G, Stewart A. Redefining in-hospital 2010;81:1069–78. resuscitation: the concept of the medical emergency team. Resuscitation 79. Fondevila C, Hessheimer AJ, Ruiz A, et al. Liver transplant using donors after 2001;48:105–10. unexpected cardiac death: novel preservation protocol and acceptance criteria. 51. Danciu SC, Klein L, Hosseini MM, Ibrahim L, Coyle BW, Kehoe RF. A predic- Am J Transplant 2007;7:1849–55. tive model for survival after in-hospital cardiopulmonary arrest. Resuscitation 80. Mateos-Rodríguez A, Pardillos-Ferrer L, Navalpotro-Pascual JM, Barba-Alonso 2004;62:35–42. C, Martin-Maldonado ME, Andrés-Belmonte A. Kidney transplant function 52. Dautzenberg PL, Broekman TC, Hooyer C, Schonwetter RS, Duursma SA. Review: using organs from non-heart-beating donors maintained by mechanical chest patient-related predictors of cardiopulmonary resuscitation of hospitalized compressions. Resuscitation 2010;81:904–7. patients. Age Ageing 1993;22:464–75. 81. Doyle CJ, Post H, Burney RE, Maino J, Keefe M, Rhee KJ. Family participation 53. Haukoos JS, Lewis RJ, Niemann JT. Prediction rules for estimating neu- during resuscitation: an option. Ann Emerg Med 1987;16:673–5. rologic outcome following out-of-hospital cardiac arrest. Resuscitation 82. Boie ET, Moore GP, Brummett C, Nelson DR. Do parents want to be present 2004;63:145–55. during invasive procedures performed on their children in the emergency 54. Herlitz J, Engdahl J, Svensson L, Young M, Ängquist K-A, Holmberg S. Can we department? A survey of 400 parents. Ann Emerg Med 1999;34:70–4. define patients with no chance of survival after out-of-hospital cardiac arrest? 83. Azoulay E, Sprung CL. Family–physician interactions in the intensive care unit. Heart 2004;90:1114–8. Crit Care Med 2004;32:2323–8. 55. Herlitz J, Svensson L, Silfverstolpe J, et al. Characteristics and outcome amongst 84. Boudreaux ED, Francis JL, Loyacano T. Family presence during invasive proce- young adults suffering from out-of-hospital cardiac arrest in whom cardiopul- dures and resuscitations in the emergency department: a critical review and monary resuscitation is attempted. J Intern Med 2006;260:435–41. suggestions for future research. Ann Emerg Med 2002;40:193–205. 56. Herlitz J, Engdahl J, Svensson L, Ängquist K-A, Young M, Holmberg S. Factors 85. Fulbrook P, Latour JM, Albarran JW, Fulbrook P, Latour JM, Albarran JW. Pae- associated with an increased chance of survival among patients suffering from diatric critical care nurses’ attitudes and experiences of parental presence an out-of-hospital cardiac arrest in a national perspective in Sweden. Am Heart during cardiopulmonary resuscitation: a European survey. Int J Nurs Stud J 2005;149:61–6. 2007;44:1238–49. 57. Herlitz J, Engdahl J, Svensson L, Young M, Angquist KA, Holmberg S. Charac- 86. Fulbrook P, Latour J, Albarran J, et al. The presence of family members during teristics and outcome among children suffering from out of hospital cardiac cardiopulmonary resuscitation: European federation of Critical Care Nursing arrest in Sweden. Resuscitation 2005;64:37–40. associations, European Society of Paediatric and Neonatal Intensive Care and 58. Ebell MH. Prearrest predictors of survival following in-hospital cardiopul- European Society of Cardiology Council on Cardiovascular Nursing and Allied monary resuscitation: a meta-analysis. J Fam Pract 1992;34:551–8. Professions Joint Position Statement. Eur J Cardiovasc Nurs 2007;6:255–8. 59. Larkin GL, Copes WS, Nathanson BH, Kaye W. Pre-resuscitation factors asso- 87. Eichhorn DJ, Meyers T, Guzzetta CE, et al. Family presence during invasive ciated with mortality in 49,130 cases of in-hospital cardiac arrest: a report procedures and resuscitation: hearing the voice of the patient. Am J Nurs from the National Registry for Cardiopulmonary Resuscitation. Resuscitation 2001;101:48–55. 2010;81:302–11. 88. Wagner JM. Lived experience of critically ill patients’ family members during 60. Bonnin MJ, Pepe PE, Kimball KT, Clark Jr PS. Distinct criteria for termination of cardiopulmonary resuscitation. Am J Crit Care 2004;13:416–20. resuscitation in the out-of-hospital setting. JAMA 1993;270:1457–62. 89. Gazmuri RJ, Nolan JP, Nadkarni VM, et al. Scientific knowledge gaps and clinical 61. Kellermann AL, Hackman BB, Somes G. Predicting the outcome of unsuccessful research priorities for cardiopulmonary resuscitation and emergency cardio- prehospital advanced cardiac life support. JAMA 1993;270:1433–6. vascular care identified during the 2005 International Consensus Conference 62. Olasveengen TM, Wik L, Steen PA. Quality of cardiopulmonary resuscitation on ECC and CPR Science with Treatment Recommendations. A consen- before and during transport in out-of-hospital cardiac arrest. Resuscitation sus statement from the International Liaison Committee on Resuscitation, 2008;76:185–90. the American Heart Association Emergency Cardiovascular Care Committee, 63. Nadkarni VM, Larkin GL, Peberdy MA, et al. First documented rhythm and clin- the Stroke Council, and the Cardiovascular Nursing Council. Resuscitation ical outcome from in-hospital cardiac arrest among children and adults. JAMA 2007;75:400–11. 2006;295:50–7. 90. Nolan JP, Hazinski MF, Billi JE et al. International consensus on car- 64. Wyllie J, Richmond S. European Resuscitation Council Guidelines for Resus- diopulmonary resuscitation and emergency cardiovascular care science with citation 2010. Section 7. Resuscitation of babies at birth. Resuscitation treatment recommendations. Part 1: Executive summary. Resuscitation; 2010;81:1389–99. doi:10.1016/j.resuscitation.2010.08.002. 65. Loertscher L, Reed DA, Bannon MP, Mueller PS. Cardiopulmonary resuscitation 91. U.S. Department of Health and Human Services, Protection of Human Subjects: and do-not-resuscitate orders: a guide for clinicians. Am J Med 2010;123:4–9. Informed Consent and Waiver of Informed Consent Requirements in Certain 66. Førde R, Aasland OG, Steen PA. Medical end-of-life decisions in Norway. Resus- Emergency Research. Final Rules. Codified at 21 CFR, Part 50, and 45 CFR, Part citation 2002;55:235–40. 46. Fed Regist 1996;61:51500–33. 67. Hammes BJ, Rooney BL. Death and end-of-life planning in one midwestern 92. Fontaine N, Rosengren B. Directive/20/EC of the European Parliament and community. Arch Intern Med 1998;158:383–90. Council of 4th April 2001 on the approximation of the laws, regulations and 68. Tolle SW, Tilden VP, Nelson CA, Dunn PM. A prospective study of the effi- administrative provisions of the Member States relating to the implementa- cacy of the physician order form for life-sustaining treatment. J Am Geriatr tion of good clinical practice in the conduct of trials on medical products for Soc 1998;46:1097–102. human use. Off J Eur Commun 2001;212:34–44. 69. Dunn PM, Schmidt TA, Carley MM, Donius M, Weinstein MA, Dull VT. A 93. Lemaire F, Bion J, Blanco J, et al. The European Union Directive on Clinical method to communicate patient preferences about medically indicated life- Research: present status of implementation in EU member states’ legislations sustaining treatment in the out-of-hospital setting. J Am Geriatr Soc 1996;44: with regard to the incompetent patient. Intens Care Med 2005;31:476–9. 785–91. 94. Nichol G, Huszti E, Rokosh J, Dumbrell A, McGowan J, Becker L. Impact of 70. Lee MA, Brummel-Smith K, Meyer J, Drew N, London MR. Physician orders informed consent requirements on cardiac arrest research in the United States: for life-sustaining treatment (POLST): outcomes in a PACE program. Pro- exception from consent or from research? Resuscitation 2004;62:3–23.
- 233. F.K. Lippert et al. / Resuscitation 81 (2010) 1445–1451 1451 95. Protection of human subjects, informed consent—FDA. Final rule. Fed Regist 98. Morag RM, DeSouza S, Steen PA, et al. Performing procedures on the newly 1996;61:51498–533. deceased for teaching purposes: what if we were to ask? Arch Intern Med 96. Mosesso Jr VN, Brown LH, Greene HL, et al. Conducting research using the 2005;165:92–6. emergency exception from informed consent: the Public Access Defibrillation 99. Hergenroeder GW, Prator BC, Chow AF, Powner DJ. Postmortem intubation (PAD) Trial experience. Resuscitation 2004;61:29–36. training: patient and family opinion. Med Educ 2007;41:1210–6. 97. Hiller KM, Haukoos JS, Heard K, Tashkin JS, Paradis NA. Impact of the Final Rule 100. Baskett PJ, Steen PA, Bossaert L. European Resuscitation Council Guidelines on the rate of clinical cardiac arrest research in the United States. Acad Emerg for Resuscitation 2005. Section 8. The ethics of resuscitation and end-of-life Med 2005;12:1091–8. decisions. Resuscitation 2005;67:S171–80.